tag_pk 	tag_title 	variable_phv 	variable_full_accession 	dataset_full_accession 	study_full_accession 	study_name 	study_phs 	study_version 	created 	modified 	variable_name	variable_description
1	LDL in blood	82951	phv00082951.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2017-12-20 22:10:23+00:00	2017-12-20 22:10:23+00:00 	ldl1	LDL CHOLESTEROL (mg/dl)
1	LDL in blood	84971	phv00084971.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2017-12-20 22:10:23+00:00	2017-12-20 22:10:23+00:00 	ldl1	LDL CHOLESTEROL (mg/dl)
1	LDL in blood	87098	phv00087098.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2017-12-20 22:10:23+00:00	2017-12-20 22:10:23+00:00 	ldlf	LDL CHOLESTEROL (mg/dl)
1	LDL in blood	253017	phv00253017.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2017-12-22 18:09:21+00:00	2017-12-22 18:09:21+00:00 	ldl_baseline	LDL value as calculated by Friedewald equation at baseline visit
1	LDL in blood	125931	phv00125931.v1.p1	pht001945.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2017-12-22 18:14:28+00:00	2017-12-22 18:14:28+00:00 	LDLC	Ldlc: HDL cholesterol - mg/dL
1	LDL in blood	126042	phv00126042.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2017-12-22 18:14:28+00:00	2017-12-22 18:14:28+00:00 	LDL01SI	LDL cholesterol (mmol/L)
1	LDL in blood	126047	phv00126047.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2017-12-22 18:14:28+00:00	2017-12-22 18:14:28+00:00 	LDL01F	Fasting low density lipoprotein cholesterol (mg/dl) (LDL)
1	LDL in blood	204764	phv00204764.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2017-12-22 22:54:23+00:00	2017-12-22 22:54:23+00:00 	LDL02	Recalibrated LDL cholesterol [Cohort, Exam 1]
1	LDL in blood	100492	phv00100492.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2017-12-22 22:59:20+00:00	2017-12-22 22:59:20+00:00 	LDLADJ	Adjusted LDL (mg/dl)
1	LDL in blood	258740	phv00258740.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2017-12-22 23:07:14+00:00	2017-12-22 23:07:14+00:00 	LDL_C	LDL-C from venous blood sample (mg/dL)
1	LDL in blood	123971	phv00123971.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2017-12-22 23:08:47+00:00	2017-12-22 23:08:47+00:00 	ldl	Ldl (mg/dL)
1	LDL in blood	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-01-12 23:42:13+00:00	2018-01-12 23:42:13+00:00 	TESTVAL	Test Result Value
1	LDL in blood	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-01-12 23:44:11+00:00	2018-01-12 23:44:11+00:00 	TESTNAME	Test Name
1	LDL in blood	1206	phv00001206.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 19:17:27+00:00	2018-03-02 19:17:27+00:00 	FB29	BLOOD ANALYSIS:  CHOLESTEROL, BETA
1	LDL in blood	1381	phv00001381.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 19:17:50+00:00	2018-03-02 19:17:50+00:00 	FC23	BLOOD ANALYSIS: BETA CHOLESTEROL (MG/100 ML)
1	LDL in blood	1401	phv00001401.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 19:18:20+00:00	2018-03-02 19:18:20+00:00 	FC45	BLOOD ANALYSIS, FASTING: BETA CHOLESTEROL (MG/100 ML)
1	LDL in blood	1584	phv00001584.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 19:18:48+00:00	2018-03-02 19:18:48+00:00 	FD39	BLOOD ANALYSIS, FASTING: BETA CHOLESTEROL (SEE VARIABLE #40 FOR DECK 132 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.)
1	LDL in blood	1591	phv00001591.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 19:19:03+00:00	2018-03-02 19:19:03+00:00 	FD46	BLOOD ANALYSIS: FASTING LIPIDS, CHOLESTEROL - BETA (SEE VARIABLE #47 FOR DECK 141 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.)
1	LDL in blood	7539	phv00007539.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 19:56:03+00:00	2018-03-02 19:56:03+00:00 	A12	LDL CHOLESTEROL
1	LDL in blood	7975	phv00007975.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 19:56:38+00:00	2018-03-02 19:56:38+00:00 	B357	BLOOD ANALYSIS-FASTING LIPIDS LDL CHOLESTEROL
1	LDL in blood	8733	phv00008733.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 19:58:37+00:00	2018-03-02 19:58:37+00:00 	C442	LDL
1	LDL in blood	277026	phv00277026.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 20:01:23+00:00	2018-03-02 20:01:23+00:00 	CALC_LDL1	Calculated LDL cholesterol, Exam 1
1	LDL in blood	277027	phv00277027.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 20:01:32+00:00	2018-03-02 20:01:32+00:00 	CALC_LDL2	Calculated LDL cholesterol, Exam 2
1	LDL in blood	277104	phv00277104.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 20:01:42+00:00	2018-03-02 20:01:42+00:00 	CALC_LDL1	Calculated LDL cholesterol, Exam 1
1	LDL in blood	277105	phv00277105.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 20:01:52+00:00	2018-03-02 20:01:52+00:00 	CALC_LDL2	Calculated LDL cholesterol, Exam 2
1	LDL in blood	277106	phv00277106.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 20:02:02+00:00	2018-03-02 20:02:02+00:00 	CALC_LDL3	Calculated LDL cholesterol, Exam 3
1	LDL in blood	277107	phv00277107.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 20:02:12+00:00	2018-03-02 20:02:12+00:00 	CALC_LDL4	Calculated LDL cholesterol, Exam 4
1	LDL in blood	277108	phv00277108.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 20:02:22+00:00	2018-03-02 20:02:22+00:00 	CALC_LDL5	Calculated LDL cholesterol, Exam 5
1	LDL in blood	277109	phv00277109.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 20:02:33+00:00	2018-03-02 20:02:33+00:00 	CALC_LDL6	Calculated LDL cholesterol, Exam 6
1	LDL in blood	277110	phv00277110.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 20:02:43+00:00	2018-03-02 20:02:43+00:00 	CALC_LDL7	Calculated LDL cholesterol, Exam 7
1	LDL in blood	277111	phv00277111.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 20:02:53+00:00	2018-03-02 20:02:53+00:00 	CALC_LDL8	Calculated LDL cholesterol, Exam 8
1	LDL in blood	277112	phv00277112.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 20:03:04+00:00	2018-03-02 20:03:04+00:00 	CALC_LDL9	Calculated LDL cholesterol, Exam 9
1	LDL in blood	253241	phv00253241.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 22:02:22+00:00	2018-03-14 22:02:22+00:00 	LABA69	LDL-cholesterol (mg/dL) (LABA69)
1	LDL in blood	204641	phv00204641.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 13:00:48+00:00	2018-03-15 13:00:48+00:00 	LDL22	Visit 2, re-calculated LDL-C in mg/dL [Cohort, Exam 2]
1	LDL in blood	204650	phv00204650.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 13:01:21+00:00	2018-03-15 13:01:21+00:00 	LDLSIU22	Visit 2, LDL cholesterol in mmol/L [Cohort, Exam 2]
1	LDL in blood	204768	phv00204768.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 13:01:53+00:00	2018-03-15 13:01:53+00:00 	LDLSIU02	Recalibrated LDL cholesterol in SI units [Cohort, Exam 1]
1	LDL in blood	204868	phv00204868.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 13:02:33+00:00	2018-03-15 13:02:33+00:00 	LDL32	Re-calibrated LDL cholesterol in mg/dL [Cohort, Exam 3]
1	LDL in blood	204869	phv00204869.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 13:03:06+00:00	2018-03-15 13:03:06+00:00 	LDLSIU32	Re-calibrated LDL cholesterol in mmol/L [Cohort, Exam 3]
1	LDL in blood	204960	phv00204960.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 13:03:31+00:00	2018-03-15 13:03:31+00:00 	LDL41	Re-calibrated LDL cholesterol in mg/dL [Cohort, Exam 4]
1	LDL in blood	204967	phv00204967.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 13:03:48+00:00	2018-03-15 13:03:48+00:00 	LDLSIU41	Re-calibrated LDL cholesterol in mmol/L [Cohort, Exam 4]
1	LDL in blood	113703	phv00113703.v2.p2	pht001588.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:46:33+00:00	2018-04-17 14:46:33+00:00 	AL1LDL	LDL CHOLESTEROL (MG/DL)
1	LDL in blood	115101	phv00115101.v2.p2	pht001644.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:46:33+00:00	2018-04-17 14:46:33+00:00 	BL1LDL	BL1LDL
1	LDL in blood	116372	phv00116372.v2.p2	pht001695.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:46:33+00:00	2018-04-17 14:46:33+00:00 	CL1LDL	LDL CHOLESTEROL (MG/DL)
1	LDL in blood	117573	phv00117573.v2.p2	pht001742.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:46:33+00:00	2018-04-17 14:46:33+00:00 	DL1LDL	LDL CHOLESTEROL (MG/DL)
1	LDL in blood	119616	phv00119616.v2.p2	pht001802.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:46:33+00:00	2018-04-17 14:46:33+00:00 	EL1LDL	LDL CHOLESTEROL (mg/dL)
1	LDL in blood	120671	phv00120671.v2.p2	pht001848.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:46:33+00:00	2018-04-17 14:46:33+00:00 	FL1LDL	LDL CHOLESTEROL (mg/dL)
1	LDL in blood	207664	phv00207664.v1.p1	pht004123.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 19:49:11+00:00	2018-04-25 19:49:11+00:00 	LIPC5	LDL cholesterol (value in mg/dL) Q5 [Lipid Lab, exam 3]
1	LDL in blood	207680	phv00207680.v1.p1	pht004124.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 19:50:28+00:00	2018-04-25 19:50:28+00:00 	LIPD8	LDL cholesterol. Q8 [Lipid Lab, exam 4]
1	LDL in blood	160493	phv00160493.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:26:43+00:00	2018-04-26 01:26:43+00:00 	ldlp31c	LDL PARTICLES (TOTAL) (nmol/L) FROM NMR LIPOPROFILE-3 SPECTRAL ANALYSIS
1	LDL in blood	85919	phv00085919.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:26:52+00:00	2018-04-26 01:26:52+00:00 	ldl2	LDL CHOLESTEROL (mg/dl)
1	LDL in blood	86401	phv00086401.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:27:18+00:00	2018-04-26 01:27:18+00:00 	ldl3	LDL CHOLESTEROL (mg/dl)
1	LDL in blood	86832	phv00086832.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:27:25+00:00	2018-04-26 01:27:25+00:00 	ldl4	LDL CHOLESTEROL (mg/dl)
1	LDL in blood	175238	phv00175238.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:27:38+00:00	2018-04-26 01:27:38+00:00 	ldl5	LDL CHOLESTEROL (mg/dl)
1	LDL in blood	175866	phv00175866.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:27:44+00:00	2018-04-26 01:27:44+00:00 	ldl1	LDL CHOLESTEROL (mg/dl)
1	LDL in blood	175885	phv00175885.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:27:49+00:00	2018-04-26 01:27:49+00:00 	ldl	LDL
1	LDL in blood	175950	phv00175950.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:27:56+00:00	2018-04-26 01:27:56+00:00 	ldlf	FAMILY COHORT: LDL CHOLESTEROL (mg/dl)
1	LDL in blood	176661	phv00176661.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:28:02+00:00	2018-04-26 01:28:02+00:00 	ldl5	LDL CHOLESTEROL (mg/dl)
1	LDL in blood	100043	phv00100043.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 17:52:06+00:00	2018-05-03 17:52:06+00:00 	LDLUNADJ	UNADJUSTED CALCULATED LDL (mg/dl)
1	LDL in blood	100282	phv00100282.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 17:57:38+00:00	2018-05-03 17:57:38+00:00 	LDLADJ	Adjusted LDL (mg/dl)
1	LDL in blood	106415	phv00106415.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 17:58:20+00:00	2018-05-03 17:58:20+00:00 	LDLUNADJ	UNADJUSTED CALCULATED LDL (mg/dl)
1	LDL in blood	106416	phv00106416.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 17:58:35+00:00	2018-05-03 17:58:35+00:00 	LDLADJ	Adjusted LDL (mg/dl)
1	LDL in blood	106992	phv00106992.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 17:58:52+00:00	2018-05-03 17:58:52+00:00 	LDLUNADJ	CALCULATED LDL (mg/dl)
1	LDL in blood	107344	phv00107344.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 17:59:10+00:00	2018-05-03 17:59:10+00:00 	LDLADJ	Adjusted LDL (mg/dl)
1	LDL in blood	77391	phv00077391.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 16:04:09+00:00	2018-05-15 16:04:09+00:00 	CORELDLC	Core LDL Cholesterol (Mg/dl)
1	LDL in blood	123972	phv00123972.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:43:12+00:00	2018-08-14 20:43:12+00:00 	ldl_orig	Ldl - original value
1	LDL in blood	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:03:40+00:00	2018-08-23 18:03:40+00:00 	TESTABBR	Test abbreviation
1	LDL in blood	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:03:40+00:00	2018-08-23 18:03:40+00:00 	TESTDESC	Test Description
1	LDL in blood	258741	phv00258741.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:53:36+00:00	2018-09-06 12:53:36+00:00 	LDL_mmol	LDL-C from venous blood sample (mmol)
2	HDL in blood	82952	phv00082952.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2017-12-20 22:06:09+00:00	2017-12-20 22:06:09+00:00 	hdl1	HDL CHOLESTEROL (mg/dl)
2	HDL in blood	84972	phv00084972.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2017-12-20 22:06:09+00:00	2017-12-20 22:06:09+00:00 	hdl1	HDL CHOLESTEROL (mg/dl)
2	HDL in blood	87099	phv00087099.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2017-12-20 22:06:09+00:00	2017-12-20 22:06:09+00:00 	hdlf	HDL CHOLESTEROL (mg/dl)
2	HDL in blood	126041	phv00126041.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2017-12-22 18:18:36+00:00	2017-12-22 18:18:36+00:00 	HDL01SI	HDL cholesterol (mmol/L)
2	HDL in blood	126046	phv00126046.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2017-12-22 18:18:36+00:00	2017-12-22 18:18:36+00:00 	HDL01F	Fasting high density lipoprotein cholesterol (mg/dl) (HDL)
2	HDL in blood	125930	phv00125930.v1.p1	pht001945.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2017-12-22 18:18:36+00:00	2017-12-22 18:18:36+00:00 	HDLC	Hdlc: HDL cholesterol - mg/dL
2	HDL in blood	253018	phv00253018.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2017-12-22 18:18:36+00:00	2017-12-22 18:18:36+00:00 	hdl_baseline	HDL value at baseline visit
2	HDL in blood	277575	phv00277575.v1.p1	pht006041.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2017-12-22 18:18:36+00:00	2017-12-22 18:18:36+00:00 	HDL	HDL Cholesterol result value Collection Interval: 1996-2000
2	HDL in blood	307856	phv00307856.v1.p1	pht006655.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2017-12-22 18:18:36+00:00	2017-12-22 18:18:36+00:00 	HDL	HDL Cholesterol result value Collection Interval: 1996-2000
2	HDL in blood	204761	phv00204761.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2017-12-22 22:49:33+00:00	2017-12-22 22:49:33+00:00 	HDL01	HDL cholesterol (recalibrated lipid) [Cohort, Exam 1]
2	HDL in blood	100426	phv00100426.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2017-12-22 22:56:56+00:00	2017-12-22 22:56:56+00:00 	HDL44	HDL (mg/dl)
2	HDL in blood	123968	phv00123968.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2017-12-22 23:02:07+00:00	2017-12-22 23:02:07+00:00 	hdl	Hdl (mg/dL)
2	HDL in blood	258743	phv00258743.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2017-12-22 23:04:09+00:00	2017-12-22 23:04:09+00:00 	HDL_C	HDL-C from venous blood sample (mg/dL)
2	HDL in blood	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-01-12 23:42:38+00:00	2018-01-12 23:42:38+00:00 	TESTVAL	Test Result Value
2	HDL in blood	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-01-12 23:44:18+00:00	2018-01-12 23:44:18+00:00 	TESTNAME	Test Name
2	HDL in blood	1207	phv00001207.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:14:47+00:00	2018-02-28 12:14:47+00:00 	FB30	BLOOD ANALYSIS:  CHOLESTEROL, ALPHA
2	HDL in blood	1382	phv00001382.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:15:21+00:00	2018-02-28 12:15:21+00:00 	FC24	BLOOD ANALYSIS: ALPHA CHOLESTEROL (MG/100 ML)
2	HDL in blood	1399	phv00001399.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:15:49+00:00	2018-02-28 12:15:49+00:00 	FC43	BLOOD ANALYSIS, FASTING: ALPHA CHOLESTEROL (MG/100 ML)
2	HDL in blood	1582	phv00001582.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:16:53+00:00	2018-02-28 12:16:53+00:00 	FD37	BLOOD ANALYSIS, FASTING: ALPHA CHOLESTEROL (SEE VARIABLE #40 FOR DECK 132 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.)
2	HDL in blood	1589	phv00001589.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:17:14+00:00	2018-02-28 12:17:14+00:00 	FD44	BLOOD ANALYSIS: FASTING LIPIDS, CHOLESTEROL - ALPHA (SEE VARIABLE #47 FOR DECK 141 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.)
2	HDL in blood	2656	phv00002656.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:17:48+00:00	2018-02-28 12:17:48+00:00 	FH333	BLOOD ANALYSIS: HDL CHOLESTEROL
2	HDL in blood	4519	phv00004519.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:18:35+00:00	2018-02-28 12:18:35+00:00 	FM544	BLOOD ANALYSIS - HDL CHOLESTEROL
2	HDL in blood	5552	phv00005552.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:19:05+00:00	2018-02-28 12:19:05+00:00 	FO732	BLOOD ANALYSIS - HDL CHOLESTEROL
2	HDL in blood	6028	phv00006028.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:19:38+00:00	2018-02-28 12:19:38+00:00 	FP596	BLOOD ANALYSIS - HDL CHOLESTEROL
2	HDL in blood	6320	phv00006320.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:20:13+00:00	2018-02-28 12:20:13+00:00 	FQ397	HDL CHOLESTEROL
2	HDL in blood	6660	phv00006660.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:20:43+00:00	2018-02-28 12:20:43+00:00 	FR438	BLOOD ANALYSIS - HDL CHOLESTEROL
2	HDL in blood	6667	phv00006667.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:21:09+00:00	2018-02-28 12:21:09+00:00 	FS534	HDL CHOLESTEROL MG/100ML
2	HDL in blood	7528	phv00007528.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:21:43+00:00	2018-02-28 12:21:43+00:00 	FT544	HDL CHOLESTEROL MG/100ML
2	HDL in blood	7972	phv00007972.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:22:23+00:00	2018-02-28 12:22:23+00:00 	B354	BLOOD ANALYSIS-FASTING LIPIDS ALPHA CHOLESTEROL BOTTOM FRACTION
2	HDL in blood	7973	phv00007973.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:22:47+00:00	2018-02-28 12:22:47+00:00 	B355	BLOOD ANALYSIS-FASTING LIPIDS HDL CHOLESTEROL - ALSO KNOWN AS ALPHA CHOLESTEROL - MEASURED BY ELECTROPHORESIS
2	HDL in blood	8728	phv00008728.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:24:15+00:00	2018-02-28 12:24:15+00:00 	C431	HDL CHOLESTEROL
2	HDL in blood	9122	phv00009122.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:25:05+00:00	2018-02-28 12:25:05+00:00 	D449	HDL CHOLESTEROL
2	HDL in blood	9574	phv00009574.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:25:52+00:00	2018-02-28 12:25:52+00:00 	E668	BLOOD ANALYSIS - HDL CHOLESTEROL
2	HDL in blood	10134	phv00010134.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:26:32+00:00	2018-02-28 12:26:32+00:00 	F725	BLOOD ANAYLSIS - HDL CHOLESTEROL
2	HDL in blood	10141	phv00010141.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:27:32+00:00	2018-02-28 12:27:32+00:00 	G703	HDL CHOLESTEROL MG/100ML
2	HDL in blood	21392	phv00021392.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:27:56+00:00	2018-02-28 12:27:56+00:00 	G3A713	HDL CHOLESTEROL, MG/DL
2	HDL in blood	55263	phv00055263.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:31:01+00:00	2018-02-28 12:31:01+00:00 	HDL	HDL cholesterol (mg/dl)
2	HDL in blood	70732	phv00070732.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:31:47+00:00	2018-02-28 12:31:47+00:00 	FU577	LAB VALUES: HDL CHOLESTEROL, MG/DL
2	HDL in blood	71891	phv00071891.v4.p10	pht000742.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:32:11+00:00	2018-02-28 12:32:11+00:00 	HDL_CHOL	HDL cholesterol, plasma
2	HDL in blood	172176	phv00172176.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:33:14+00:00	2018-02-28 12:33:14+00:00 	HDL	HDL cholesterol (sample type: plasma)
2	HDL in blood	227059	phv00227059.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:33:48+00:00	2018-02-28 12:33:48+00:00 	HDL	HDL cholesterol (sample type: EDTA plasma)
2	HDL in blood	255345	phv00255345.v1.p10	pht005143.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:34:20+00:00	2018-02-28 12:34:20+00:00 	HDL	HDL Cholesterol (sample type: plasma)
2	HDL in blood	275405	phv00275405.v1.p10	pht006010.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:34:55+00:00	2018-02-28 12:34:55+00:00 	HDL	HDL cholesterol (sample type: EDTA plasma) Collection Interval: Exam 2
2	HDL in blood	275414	phv00275414.v1.p10	pht006011.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:35:12+00:00	2018-02-28 12:35:12+00:00 	HDL_CHOL	HDL cholesterol (sample type: plasma) Collection Interval: Omni 1 Exam 3
2	HDL in blood	277040	phv00277040.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:35:39+00:00	2018-02-28 12:35:39+00:00 	HDL1	HDL cholesterol, Exam 1
2	HDL in blood	277041	phv00277041.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:35:51+00:00	2018-02-28 12:35:51+00:00 	HDL2	HDL cholesterol, Exam 2
2	HDL in blood	277162	phv00277162.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:36:43+00:00	2018-02-28 12:36:43+00:00 	HDL1	HDL cholesterol, Exam 1
2	HDL in blood	277163	phv00277163.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:36:51+00:00	2018-02-28 12:36:51+00:00 	HDL2	HDL cholesterol, Exam 2
2	HDL in blood	277164	phv00277164.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:36:59+00:00	2018-02-28 12:36:59+00:00 	HDL3	HDL cholesterol, Exam 3
2	HDL in blood	277165	phv00277165.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:37:09+00:00	2018-02-28 12:37:09+00:00 	HDL4	HDL cholesterol, Exam 4
2	HDL in blood	277166	phv00277166.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:37:18+00:00	2018-02-28 12:37:18+00:00 	HDL5	HDL cholesterol, Exam 5
2	HDL in blood	277167	phv00277167.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:37:27+00:00	2018-02-28 12:37:27+00:00 	HDL6	HDL cholesterol, Exam 6
2	HDL in blood	277168	phv00277168.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:37:36+00:00	2018-02-28 12:37:36+00:00 	HDL7	HDL cholesterol, Exam 7
2	HDL in blood	277169	phv00277169.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:37:46+00:00	2018-02-28 12:37:46+00:00 	HDL8	HDL cholesterol, Exam 8
2	HDL in blood	277170	phv00277170.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:37:56+00:00	2018-02-28 12:37:56+00:00 	HDL9	HDL cholesterol, Exam 9
2	HDL in blood	7537	phv00007537.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:43:49+00:00	2018-02-28 12:43:49+00:00 	A10	HDL CHOLESTROL
2	HDL in blood	227018	phv00227018.v1.p10	pht004801.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-28 12:47:32+00:00	2018-02-28 12:47:32+00:00 	HDL	HDL cholesterol (Sample type - EDTA plasma) Collection Interval: Exam 1
2	HDL in blood	253239	phv00253239.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 22:02:01+00:00	2018-03-14 22:02:01+00:00 	LABA68	HDL-cholesterol (mg/dL) (LABA68)
2	HDL in blood	204765	phv00204765.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 13:53:44+00:00	2018-03-15 13:53:44+00:00 	HDLSIU02	Recalibrated HDL cholesterol in SI units [Cohort, Exam 1]
2	HDL in blood	204645	phv00204645.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 13:54:11+00:00	2018-03-15 13:54:11+00:00 	HDLSIU21	Visit 2, HDL cholesterol in mmol/L [Cohort, Exam 2]
2	HDL in blood	204867	phv00204867.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 13:55:59+00:00	2018-03-15 13:55:59+00:00 	HDLSIU31	Re-calibrated HDL cholesterol in mmol/L [Cohort, Exam 3]
2	HDL in blood	204966	phv00204966.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 13:57:54+00:00	2018-03-15 13:57:54+00:00 	HDLSIU41	Re-calibrated HDL cholesterol in mmol/L [Cohort, Exam 4]
2	HDL in blood	214065	phv00214065.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:41:34+00:00	2018-03-15 17:41:34+00:00 	HDL	HDL cholesterol (mg/dl)
2	HDL in blood	207651	phv00207651.v1.p1	pht004122.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:56:58+00:00	2018-03-15 17:56:58+00:00 	LIPB03A	HDL cholesterol (value). Q3a [Lipid Lab, exam 2]
2	HDL in blood	207662	phv00207662.v1.p1	pht004123.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 18:00:32+00:00	2018-03-15 18:00:32+00:00 	LIPC3A	HDL cholesterol (value in mg/dL) Q3a [Lipid Lab, exam 3]
2	HDL in blood	207677	phv00207677.v1.p1	pht004124.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 18:01:17+00:00	2018-03-15 18:01:17+00:00 	LIPD3A	HDL cholesterol (value). Q3a [Lipid Lab, exam 4]
2	HDL in blood	113702	phv00113702.v2.p2	pht001588.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:48:32+00:00	2018-04-17 14:48:32+00:00 	AL1HDL	TOTAL HDL CHOLESTEROL (MG/DL)
2	HDL in blood	115100	phv00115100.v2.p2	pht001644.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:48:32+00:00	2018-04-17 14:48:32+00:00 	BL1HDL	BL1HDL
2	HDL in blood	116371	phv00116371.v2.p2	pht001695.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:48:32+00:00	2018-04-17 14:48:32+00:00 	CL1HDL	TOTAL HDL CHOLESTEROL (MG/DL)
2	HDL in blood	117572	phv00117572.v2.p2	pht001742.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:48:32+00:00	2018-04-17 14:48:32+00:00 	DL1HDL	TOTAL HDL CHOLESTEROL (MG/DL)
2	HDL in blood	119613	phv00119613.v2.p2	pht001802.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:48:33+00:00	2018-04-17 14:48:33+00:00 	EL1HDL	TOTAL HDL CHOLESTEROL (mg/dL)
2	HDL in blood	120670	phv00120670.v2.p2	pht001848.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:48:33+00:00	2018-04-17 14:48:33+00:00 	FL1HDL	TOTAL HDL CHOLESTEROL (mg/dL)
2	HDL in blood	160497	phv00160497.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:38:28+00:00	2018-04-26 02:38:28+00:00 	hdlp31c	HDL PARTICLES (TOTAL) (umol/L) FROM NMR LIPOPROFILE-3 SPECTRAL ANALYSIS
2	HDL in blood	160506	phv00160506.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:38:35+00:00	2018-04-26 02:38:35+00:00 	nhdlc31c	CALCULATED HDL CHOLESTEROL (mg/dL) FROM NMR LIPOPROFILE-3 SPECTRAL ANALYSIS
2	HDL in blood	85920	phv00085920.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:38:42+00:00	2018-04-26 02:38:42+00:00 	hdl2	HDL CHOLESTEROL (mg/dl)
2	HDL in blood	86402	phv00086402.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:38:49+00:00	2018-04-26 02:38:49+00:00 	hdl3	HDL CHOLESTEROL (mg/dl)
2	HDL in blood	86833	phv00086833.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:38:55+00:00	2018-04-26 02:38:55+00:00 	hdl4	HDL CHOLESTEROL (mg/dl)
2	HDL in blood	175239	phv00175239.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:39:12+00:00	2018-04-26 02:39:12+00:00 	hdl5	HDL CHOLESTROL (mg/dl)
2	HDL in blood	176662	phv00176662.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:39:18+00:00	2018-04-26 02:39:18+00:00 	hdl5	HDL CHOLESTROL (mg/dl)
2	HDL in blood	100042	phv00100042.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:00:14+00:00	2018-05-03 18:00:14+00:00 	HDL44	HDL (mg/dl)
2	HDL in blood	105865	phv00105865.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:00:37+00:00	2018-05-03 18:00:37+00:00 	HDL44	HDL (mg/dl)
2	HDL in blood	106991	phv00106991.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:00:55+00:00	2018-05-03 18:00:55+00:00 	HDL44	HDL (mg/dl)
2	HDL in blood	77388	phv00077388.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 16:21:09+00:00	2018-05-15 16:21:09+00:00 	COREHDLC	Core HDL Cholesterol (Mg/dl)
2	HDL in blood	308048	phv00308048.v1.p1	pht006661.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:13:09+00:00	2018-08-02 19:13:09+00:00 	SHDL	Serum High-Density Lipoprotein result value Collection Interval: 2000-2004
2	HDL in blood	307766	phv00307766.v1.p1	pht006650.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:13:17+00:00	2018-08-02 19:13:17+00:00 	HDL	HDL Cholesterol Collection Interval: 2006-2011
2	HDL in blood	277855	phv00277855.v1.p1	pht006048.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:13:25+00:00	2018-08-02 19:13:25+00:00 	SHDL	Serum High-Density Lipoprotein result value Collection Interval: 2000-2004
2	HDL in blood	277407	phv00277407.v1.p1	pht006036.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:13:33+00:00	2018-08-02 19:13:33+00:00 	SHDLV	Serum High-Density Lipoprotein Average result value Collection Interval: 2009-2011
2	HDL in blood	277306	phv00277306.v1.p1	pht006031.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:13:43+00:00	2018-08-02 19:13:43+00:00 	HDL	HDL Cholesterol Collection Interval: 2007-2009
2	HDL in blood	122566	phv00122566.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:42:41+00:00	2018-08-14 20:42:41+00:00 	CHOLHDL	HDL levels
2	HDL in blood	123969	phv00123969.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:42:53+00:00	2018-08-14 20:42:53+00:00 	hdl_orig	Hdl - original value
2	HDL in blood	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 17:56:35+00:00	2018-08-23 17:56:35+00:00 	TESTABBR	Test abbreviation
2	HDL in blood	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 17:56:35+00:00	2018-08-23 17:56:35+00:00 	TESTDESC	Test Description
2	HDL in blood	259055	phv00259055.v1.p1	pht003918.v2.p1	phs000741.v2.p1	GOLDN	741	2	2018-09-06 12:19:34+00:00	2018-09-06 12:19:34+00:00 	HDL	High Density Lipoprotein
2	HDL in blood	258744	phv00258744.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:53:57+00:00	2018-09-06 12:53:57+00:00 	HDL_mmol	HDL-C from venous blood sample (mmol)
3	Triglycerides in blood	87101	phv00087101.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2017-12-20 22:11:59+00:00	2017-12-20 22:13:35+00:00 	trigf	TRIGLYCERIDES (mg/dl)
3	Triglycerides in blood	82950	phv00082950.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2017-12-20 22:12:46+00:00	2017-12-20 22:12:46+00:00 	trig1	TRIGLYCERIDES (mg/dl)
3	Triglycerides in blood	84968	phv00084968.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2017-12-20 22:13:06+00:00	2017-12-20 22:13:06+00:00 	trig1	TRIGLYCERIDES (mg/dl)
3	Triglycerides in blood	125933	phv00125933.v1.p1	pht001945.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2017-12-22 18:29:07+00:00	2017-12-22 18:29:07+00:00 	TRR	Trr: triglyceride - mg/dL
3	Triglycerides in blood	277574	phv00277574.v1.p1	pht006041.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2017-12-22 18:35:25+00:00	2017-12-22 18:35:25+00:00 	TRIG	Triglyceride result value Collection Interval: 1996-2000
3	Triglycerides in blood	126043	phv00126043.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2017-12-22 18:38:23+00:00	2017-12-22 18:38:23+00:00 	TRG01SI	Triglycerides (mmol/L)
3	Triglycerides in blood	126048	phv00126048.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2017-12-22 18:38:23+00:00	2017-12-22 18:38:23+00:00 	TRG01F	Fasting triglyceride level (mg/dl)
3	Triglycerides in blood	253019	phv00253019.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2017-12-22 18:38:23+00:00	2017-12-22 18:38:23+00:00 	trigs_baseline	Triglycerides value at baseline visit
3	Triglycerides in blood	307855	phv00307855.v1.p1	pht006655.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2017-12-22 18:38:23+00:00	2017-12-22 18:38:23+00:00 	TRIG	Triglyceride result value Collection Interval: 1996-2000
3	Triglycerides in blood	204738	phv00204738.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2017-12-22 22:48:33+00:00	2017-12-22 22:48:33+00:00 	TRGSIU01	Total triglycerides In SI units [Cohort, Exam 1]
3	Triglycerides in blood	100425	phv00100425.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2017-12-22 22:55:37+00:00	2017-12-22 22:55:37+00:00 	TRIG44	TRIGLYCERIDE (mg/dl)
3	Triglycerides in blood	123974	phv00123974.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2017-12-22 23:01:08+00:00	2017-12-22 23:01:08+00:00 	triglyceride	Triglyceride (mg/dL)
3	Triglycerides in blood	258736	phv00258736.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2017-12-22 23:03:39+00:00	2017-12-22 23:03:39+00:00 	NetTG	Net Triglycerides from venous blood sample (mg/dL)
3	Triglycerides in blood	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-01-12 23:42:46+00:00	2018-01-12 23:42:46+00:00 	TESTVAL	Test Result Value
3	Triglycerides in blood	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-01-12 23:44:24+00:00	2018-01-12 23:44:24+00:00 	TESTNAME	Test Name
3	Triglycerides in blood	253240	phv00253240.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 22:01:39+00:00	2018-03-14 22:01:39+00:00 	LABA67	Triglycerides (mg/dL) (LABA67)
3	Triglycerides in blood	207636	phv00207636.v1.p1	pht004121.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:11:01+00:00	2018-03-15 14:11:01+00:00 	LIPA02	Total Triglycerides (mg/dL)  [Lipid Lab, exam 1]
3	Triglycerides in blood	204651	phv00204651.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:27:45+00:00	2018-03-15 17:27:45+00:00 	TRGSIU21	Visit 2, total triglycerides in Mmol/L [Cohort, Exam 2]
3	Triglycerides in blood	204877	phv00204877.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:28:20+00:00	2018-03-15 17:28:20+00:00 	TRGSIU31	Triglycerides in SI units [Cohort, Exam 3]
3	Triglycerides in blood	204968	phv00204968.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:28:41+00:00	2018-03-15 17:28:41+00:00 	TRGSIU41	Visit 4, triglycerides in SI units [Cohort, Exam 4]
3	Triglycerides in blood	207649	phv00207649.v1.p1	pht004122.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:29:18+00:00	2018-03-15 17:29:18+00:00 	LIPB02A	Triglyceride (value). Q2a [Lipid Lab, exam 2]
3	Triglycerides in blood	207661	phv00207661.v1.p1	pht004123.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:32:24+00:00	2018-03-15 17:32:24+00:00 	LIPC2A	Triglyceride (value in mg/dL). Q2a [Lipid Lab, exam 3]
3	Triglycerides in blood	207676	phv00207676.v1.p1	pht004124.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:35:33+00:00	2018-03-15 17:35:33+00:00 	LIPD2A	Triglyceride (value). Q2a [Lipid Lab, exam 4]
3	Triglycerides in blood	214066	phv00214066.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:38:32+00:00	2018-03-15 17:38:32+00:00 	TRIG	Triglycerides mg/dl
3	Triglycerides in blood	113701	phv00113701.v2.p2	pht001588.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:49:33+00:00	2018-04-17 14:49:33+00:00 	AL1NTRIG	TRIGLYCERIDES (MG/DL)
3	Triglycerides in blood	115099	phv00115099.v2.p2	pht001644.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:49:33+00:00	2018-04-17 14:49:33+00:00 	BL1NTRIG	BL1NTRIG
3	Triglycerides in blood	116373	phv00116373.v2.p2	pht001695.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:49:33+00:00	2018-04-17 14:49:33+00:00 	CL1NTRIG	TRIGLYCERIDES (MG/DL)
3	Triglycerides in blood	117574	phv00117574.v2.p2	pht001742.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:49:33+00:00	2018-04-17 14:49:33+00:00 	DL1NTRIG	TRIGLYCERIDES (MG/DL)
3	Triglycerides in blood	119614	phv00119614.v2.p2	pht001802.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:49:33+00:00	2018-04-17 14:49:33+00:00 	EL1NTRIG	TRIGLYCERIDES (mg/dL)
3	Triglycerides in blood	120668	phv00120668.v2.p2	pht001848.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:49:33+00:00	2018-04-17 14:49:33+00:00 	FL1NTRIG	TRIGLYCERIDES (mg/dL)
3	Triglycerides in blood	85918	phv00085918.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:41:32+00:00	2018-04-26 02:41:32+00:00 	trig2	TRIGLYCERIDES (mg/dl)
3	Triglycerides in blood	86400	phv00086400.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:41:38+00:00	2018-04-26 02:41:38+00:00 	trig3	TRIGLYCERIDES (mg/dl)
3	Triglycerides in blood	86831	phv00086831.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:41:44+00:00	2018-04-26 02:41:44+00:00 	trig4	TRIGLYCERIDES (mg/dl)
3	Triglycerides in blood	175237	phv00175237.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:41:52+00:00	2018-04-26 02:41:52+00:00 	trig5	TRIGLYCERIDES (mg/dl)
3	Triglycerides in blood	176660	phv00176660.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:41:58+00:00	2018-04-26 02:41:58+00:00 	trig5	TRIGLYCERIDES (mg/dl)
3	Triglycerides in blood	160504	phv00160504.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:42:53+00:00	2018-04-26 02:42:53+00:00 	ntrg31c	CALCULATED TOTAL TRIGLYCERIDES (mg/dL) FROM NMR LIPOPROFILE-3 SPECTRAL ANALYSIS
3	Triglycerides in blood	55264	phv00055264.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:35:11+00:00	2018-04-26 17:35:11+00:00 	Trig	Triglycerides mg/dl
3	Triglycerides in blood	71892	phv00071892.v4.p10	pht000742.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:35:40+00:00	2018-04-26 17:35:40+00:00 	TRIG	Triglycerides, plasma
3	Triglycerides in blood	172172	phv00172172.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:36:10+00:00	2018-04-26 17:36:10+00:00 	TRIG	Triglycerides (sample type: plasma)
3	Triglycerides in blood	227015	phv00227015.v1.p10	pht004801.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:36:37+00:00	2018-04-26 17:36:37+00:00 	TRIG	Triglycerides (Sample type - EDTA plasma) Collection Interval: Exam 1
3	Triglycerides in blood	227056	phv00227056.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:36:57+00:00	2018-04-26 17:36:57+00:00 	TRIG	Triglycerides (sample type: EDTA plasma)
3	Triglycerides in blood	255342	phv00255342.v1.p10	pht005143.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:37:24+00:00	2018-04-26 17:37:24+00:00 	TRIG	Triglycerides (sample type: plasma)
3	Triglycerides in blood	275403	phv00275403.v1.p10	pht006010.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:37:45+00:00	2018-04-26 17:37:45+00:00 	TRIG	Triglyceride (sample type: EDTA plasma) Collection Interval: Exam 2
3	Triglycerides in blood	275415	phv00275415.v1.p10	pht006011.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:38:06+00:00	2018-04-26 17:38:06+00:00 	TRIG	Triglycerides (sample type: plasma) Collection Interval: Omni 1 Exam 3
3	Triglycerides in blood	931	phv00000931.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:39:37+00:00	2018-04-26 17:39:37+00:00 	MF489	BLOOD ANALYSIS: TRIGLYCERIDES, WHOLE SERUM, EXAM 7
3	Triglycerides in blood	1052	phv00001052.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:42:44+00:00	2018-04-26 17:42:44+00:00 	FA18	BLOOD ANALYSIS:  TRIGLYCERIDES, CENTRIFUGED (MG PER 100 ML)
3	Triglycerides in blood	1053	phv00001053.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:43:02+00:00	2018-04-26 17:43:02+00:00 	FA19	BLOOD ANALYSIS:  TRIGLYCERIDES, CENTRIFUGED (MG PER 100 ML)
3	Triglycerides in blood	1054	phv00001054.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:43:40+00:00	2018-04-26 17:43:40+00:00 	FA20	BLOOD ANALYSIS:  TRIGLYCERIDES, WHOLE SERUM
3	Triglycerides in blood	1209	phv00001209.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:44:06+00:00	2018-04-26 17:44:06+00:00 	FB32	BLOOD ANALYSIS:  TRIGLYCERIDE, WHOLE SERUM
3	Triglycerides in blood	1390	phv00001390.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:44:29+00:00	2018-04-26 17:44:29+00:00 	FC32	BLOOD ANALYSIS: TRIGLYCERIDE (EQ/HL)
3	Triglycerides in blood	1402	phv00001402.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:45:05+00:00	2018-04-26 17:45:05+00:00 	FC46	BLOOD ANALYSIS: FASTING: TRIGLYCERIDE
3	Triglycerides in blood	1593	phv00001593.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:45:23+00:00	2018-04-26 17:45:23+00:00 	FD48	BLOOD ANALYSIS, FASTING: TRIGLYCERIDE
3	Triglycerides in blood	1594	phv00001594.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:45:49+00:00	2018-04-26 17:45:49+00:00 	FD49	BLOOD ANALYSIS: FASTING LIPIDS, TRIGLYCERIDE
3	Triglycerides in blood	6321	phv00006321.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:46:12+00:00	2018-04-26 17:46:12+00:00 	FQ398	TRIGLYCERIDE
3	Triglycerides in blood	6661	phv00006661.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:46:42+00:00	2018-04-26 17:46:42+00:00 	FR439	BLOOD ANALYSIS - TRIGYCERLIDE
3	Triglycerides in blood	6669	phv00006669.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:47:22+00:00	2018-04-26 17:47:22+00:00 	FS536	TRIGLYCERIDES MG/100ML
3	Triglycerides in blood	7530	phv00007530.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:47:43+00:00	2018-04-26 17:47:43+00:00 	FT546	TRIGLYCERIDES MG/100ML
3	Triglycerides in blood	7540	phv00007540.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:48:05+00:00	2018-04-26 17:48:05+00:00 	A13	TRIGLYCERIDES
3	Triglycerides in blood	7976	phv00007976.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:48:48+00:00	2018-04-26 17:48:48+00:00 	B358	BLOOD ANALYSIS-FASTING LIPIDS TRIGLYCERIDE
3	Triglycerides in blood	8105	phv00008105.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:49:36+00:00	2018-04-26 17:49:36+00:00 	B758	TRIGLYCERIDES
3	Triglycerides in blood	8730	phv00008730.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:50:13+00:00	2018-04-26 17:50:13+00:00 	C433	TRIGLYCERIDE
3	Triglycerides in blood	9124	phv00009124.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:51:35+00:00	2018-04-26 17:51:35+00:00 	D451	TRIGLYCERIDE
3	Triglycerides in blood	9576	phv00009576.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:52:53+00:00	2018-04-26 17:52:53+00:00 	E670	BLOOD ANALYSIS - TRIGLYCERIDES
3	Triglycerides in blood	10136	phv00010136.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:53:24+00:00	2018-04-26 17:53:24+00:00 	F727	BLOOD ANALYSIS - TRIGLYCERIDES
3	Triglycerides in blood	10144	phv00010144.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:54:03+00:00	2018-04-26 17:54:03+00:00 	G706	TRIGLYCERIDES MG/100ML
3	Triglycerides in blood	21393	phv00021393.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 17:54:58+00:00	2018-04-26 17:54:58+00:00 	G3A714	TRIGLYCERIDES, MG/DL
3	Triglycerides in blood	70733	phv00070733.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:14:53+00:00	2018-04-26 18:14:53+00:00 	FU576	LAB VALUES: TRIGLYCERIDES, MG/DL
3	Triglycerides in blood	81038	phv00081038.v1.p10	pht001045.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:15:19+00:00	2018-04-26 18:15:19+00:00 	TG	Plasma Total Triglycerides Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38)
3	Triglycerides in blood	277049	phv00277049.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:16:05+00:00	2018-04-26 18:16:05+00:00 	TRIG1	Triglycerides, Exam 1
3	Triglycerides in blood	277050	phv00277050.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:16:20+00:00	2018-04-26 18:16:20+00:00 	TRIG2	Triglycerides, Exam 2
3	Triglycerides in blood	277203	phv00277203.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:16:44+00:00	2018-04-26 18:16:44+00:00 	TRIG1	Triglycerides, Exam 1
3	Triglycerides in blood	277204	phv00277204.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:17:35+00:00	2018-04-26 18:17:35+00:00 	TRIG2	Triglycerides, Exam 2
3	Triglycerides in blood	277205	phv00277205.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:18:02+00:00	2018-04-26 18:18:02+00:00 	TRIG3	Triglycerides, Exam 3
3	Triglycerides in blood	277206	phv00277206.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:18:51+00:00	2018-04-26 18:18:51+00:00 	TRIG4	Triglycerides, Exam 4
3	Triglycerides in blood	277207	phv00277207.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:19:35+00:00	2018-04-26 18:19:35+00:00 	TRIG5	Triglycerides, Exam 5
3	Triglycerides in blood	277208	phv00277208.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:20:14+00:00	2018-04-26 18:20:14+00:00 	TRIG6	Triglycerides, Exam 6
3	Triglycerides in blood	277209	phv00277209.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:20:31+00:00	2018-04-26 18:20:31+00:00 	TRIG7	Triglycerides, Exam 7
3	Triglycerides in blood	277210	phv00277210.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:21:04+00:00	2018-04-26 18:21:04+00:00 	TRIG8	Triglycerides, Exam 8
3	Triglycerides in blood	277211	phv00277211.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-04-26 18:21:20+00:00	2018-04-26 18:21:20+00:00 	TRIG9	Triglycerides, Exam 9
3	Triglycerides in blood	100041	phv00100041.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:01:36+00:00	2018-05-03 18:01:36+00:00 	TRIG44	TRIGLYCERIDE (mg/dl)
3	Triglycerides in blood	105864	phv00105864.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:02:02+00:00	2018-05-03 18:02:02+00:00 	TRIG44	TRIGLYCERIDE (mg/dl)
3	Triglycerides in blood	106990	phv00106990.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:02:15+00:00	2018-05-03 18:02:15+00:00 	TRIG44	TRIGLYCERIDE (mg/dl)
3	Triglycerides in blood	77397	phv00077397.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-07 23:10:22+00:00	2018-05-07 23:10:22+00:00 	CORETRI	Core Triglyceride (Mg/dl)
3	Triglycerides in blood	307767	phv00307767.v1.p1	pht006650.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:16:06+00:00	2018-08-02 19:16:06+00:00 	TRIG	Triglyceride Collection Interval: 2006-2011
3	Triglycerides in blood	277307	phv00277307.v1.p1	pht006031.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:16:14+00:00	2018-08-02 19:16:14+00:00 	TRIG	Triglyceride Collection Interval: 2007-2009
3	Triglycerides in blood	123975	phv00123975.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:42:08+00:00	2018-08-14 20:42:08+00:00 	triglyceride_orig	Triglyceride - original value
3	Triglycerides in blood	277405	phv00277405.v1.p1	pht006036.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:20:31+00:00	2018-08-14 22:20:31+00:00 	STRV	Serum Triglycerides Average result value Collection Interval: 2009-2011
3	Triglycerides in blood	277850	phv00277850.v1.p1	pht006048.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:10:10+00:00	2018-08-14 23:10:10+00:00 	STRV	Serum Triglycerides Average result value Collection Interval: 2000-2004
3	Triglycerides in blood	308043	phv00308043.v1.p1	pht006661.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:11:38+00:00	2018-08-16 00:11:38+00:00 	STRV	Serum Triglycerides Average result value Collection Interval: 2000-2004
3	Triglycerides in blood	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:08:58+00:00	2018-08-23 18:08:58+00:00 	TESTABBR	Test abbreviation
3	Triglycerides in blood	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:08:58+00:00	2018-08-23 18:08:58+00:00 	TESTDESC	Test Description
3	Triglycerides in blood	259054	phv00259054.v1.p1	pht003918.v2.p1	phs000741.v2.p1	GOLDN	741	2	2018-09-06 12:18:38+00:00	2018-09-06 12:18:38+00:00 	TG	Fasting Triglyceride level
3	Triglycerides in blood	258737	phv00258737.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:52:20+00:00	2018-09-06 12:52:20+00:00 	Triglycerides_mmol	Net Triglycerides from venous blood sample (mmol)
4	Total cholesterol in blood	84974	phv00084974.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2017-12-20 22:17:41+00:00	2017-12-20 22:17:41+00:00 	chol1	TOTAL CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	82956	phv00082956.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2017-12-20 22:18:13+00:00	2017-12-20 22:18:13+00:00 	chol1	TOTAL CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	87100	phv00087100.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2017-12-20 22:18:51+00:00	2017-12-20 22:18:51+00:00 	cholf	TOTAL CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	126040	phv00126040.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2017-12-22 18:40:52+00:00	2017-12-22 18:40:52+00:00 	TCL01SI	Total cholesterol (mmol/L)
4	Total cholesterol in blood	126045	phv00126045.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2017-12-22 18:40:52+00:00	2017-12-22 18:40:52+00:00 	TCL01F	Fasting total cholesterol (mg/dl) (TCL)
4	Total cholesterol in blood	125927	phv00125927.v1.p1	pht001945.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2017-12-22 18:40:52+00:00	2017-12-22 18:40:52+00:00 	CHR	Chr: total cholesterol - mg/dL
4	Total cholesterol in blood	253020	phv00253020.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2017-12-22 18:40:52+00:00	2017-12-22 18:40:52+00:00 	totchol_baseline	Total cholesterol value at baseline visit
4	Total cholesterol in blood	277573	phv00277573.v1.p1	pht006041.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2017-12-22 18:40:52+00:00	2017-12-22 18:40:52+00:00 	CHOL	Cholesterol result value Collection Interval: 1996-2000
4	Total cholesterol in blood	307854	phv00307854.v1.p1	pht006655.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2017-12-22 18:40:52+00:00	2017-12-22 18:40:52+00:00 	CHOL	Cholesterol result value Collection Interval: 1996-2000
4	Total cholesterol in blood	204735	phv00204735.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2017-12-22 22:50:20+00:00	2017-12-22 22:50:20+00:00 	TCHSIU01	Total cholesterol in SI units [Cohort, Exam 1]
4	Total cholesterol in blood	100491	phv00100491.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2017-12-22 22:56:24+00:00	2017-12-22 22:56:24+00:00 	CHOLADJ	Adjusted Cholesterol (mg/dl)
4	Total cholesterol in blood	123953	phv00123953.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2017-12-22 23:01:37+00:00	2017-12-22 23:01:37+00:00 	cholesterol	Cholesterol (mg/dL)
4	Total cholesterol in blood	258733	phv00258733.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2017-12-22 23:04:38+00:00	2017-12-22 23:04:38+00:00 	Cholesterol	Cholesterol from venous blood sample (mg/dL)
4	Total cholesterol in blood	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-01-12 23:42:55+00:00	2018-01-12 23:42:55+00:00 	TESTVAL	Test Result Value
4	Total cholesterol in blood	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-01-12 23:44:33+00:00	2018-01-12 23:44:33+00:00 	TESTNAME	Test Name
4	Total cholesterol in blood	253238	phv00253238.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 22:01:50+00:00	2018-03-14 22:01:50+00:00 	LABA66	Total cholesterol (mg/dL) (LABA66)
4	Total cholesterol in blood	207635	phv00207635.v1.p1	pht004121.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:10:35+00:00	2018-03-15 14:10:35+00:00 	LIPA01	Total cholesterol (mg/dL) [Lipid Lab, exam 1]
4	Total cholesterol in blood	204644	phv00204644.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:21:57+00:00	2018-03-15 17:21:57+00:00 	TCHSIU21	Visit 2, total cholesterol in Mmol/L [Cohort, Exam 2]
4	Total cholesterol in blood	204875	phv00204875.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:24:36+00:00	2018-03-15 17:24:36+00:00 	TCHSIU31	Total cholesterol in SI units [Cohort, Exam 3]
4	Total cholesterol in blood	204965	phv00204965.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:24:59+00:00	2018-03-15 17:24:59+00:00 	TCHSIU41	Visit 4, total cholesterol in SI units [Cohort, Exam 4]
4	Total cholesterol in blood	214064	phv00214064.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:41:13+00:00	2018-03-15 17:41:13+00:00 	CHOL	Cholesterol mg/dl
4	Total cholesterol in blood	207660	phv00207660.v1.p1	pht004123.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 17:58:44+00:00	2018-03-15 17:58:44+00:00 	LIPC1A	Cholesterol (value in mg/dL). Q1a [Lipid Lab, exam 3]
4	Total cholesterol in blood	207675	phv00207675.v1.p1	pht004124.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 18:07:16+00:00	2018-03-15 18:07:16+00:00 	LIPD1A	Cholesterol (value). Q1a [Lipid Lab, exam 4]
4	Total cholesterol in blood	207647	phv00207647.v1.p1	pht004122.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 18:08:35+00:00	2018-03-15 18:08:35+00:00 	LIPB01A	Cholesterol (value). Q1a [Lipid Lab, exam 2]
4	Total cholesterol in blood	113700	phv00113700.v2.p2	pht001588.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:50:30+00:00	2018-04-17 14:50:30+00:00 	AL1CHOL	TOTAL CHOLESTEROL (MG/DL)
4	Total cholesterol in blood	115098	phv00115098.v2.p2	pht001644.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:50:30+00:00	2018-04-17 14:50:30+00:00 	BL1CHOL	BL1CHOL
4	Total cholesterol in blood	116369	phv00116369.v2.p2	pht001695.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:50:30+00:00	2018-04-17 14:50:30+00:00 	CL1CHOL	TOTAL CHOLESTEROL (MG/DL)
4	Total cholesterol in blood	117570	phv00117570.v2.p2	pht001742.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:50:30+00:00	2018-04-17 14:50:30+00:00 	DL1CHOL	TOTAL PLASMA CHOLESTEROL (MG/DL)
4	Total cholesterol in blood	119612	phv00119612.v2.p2	pht001802.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:50:30+00:00	2018-04-17 14:50:30+00:00 	EL1CHOL	TOTAL PLASMA CHOLESTEROL (mg/dL)
4	Total cholesterol in blood	120669	phv00120669.v2.p2	pht001848.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:50:30+00:00	2018-04-17 14:50:30+00:00 	FL1CHOL	TOTAL PLASMA CHOLESTEROL (mg/dL)
4	Total cholesterol in blood	85921	phv00085921.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:44:46+00:00	2018-04-26 02:44:46+00:00 	chol2	TOTAL CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	86404	phv00086404.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:45:00+00:00	2018-04-26 02:45:00+00:00 	chol3	TOTAL CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	86836	phv00086836.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:45:07+00:00	2018-04-26 02:45:07+00:00 	chol4	TOTAL CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	175242	phv00175242.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:45:16+00:00	2018-04-26 02:45:16+00:00 	chol5	TOTAL CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	175867	phv00175867.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:45:22+00:00	2018-04-26 02:45:22+00:00 	chol1	TOTAL CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	175951	phv00175951.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:45:28+00:00	2018-04-26 02:45:28+00:00 	cholf	FAMILY COHORT: TOTAL CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	176665	phv00176665.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 02:45:36+00:00	2018-04-26 02:45:36+00:00 	chol5	TOTAL CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	100040	phv00100040.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:07:28+00:00	2018-05-03 18:07:28+00:00 	CHOLUNAD	UNADJUSTED CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	100083	phv00100083.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:07:43+00:00	2018-05-03 18:07:43+00:00 	CHOLADJ	Adjusted Cholesterol (mg/dl)
4	Total cholesterol in blood	101790	phv00101790.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:08:15+00:00	2018-05-03 18:08:15+00:00 	CHOL44	CHOLESTEROL
4	Total cholesterol in blood	102573	phv00102573.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:08:24+00:00	2018-05-03 18:08:24+00:00 	CHOL44	CHOLESTEROL
4	Total cholesterol in blood	106389	phv00106389.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:08:44+00:00	2018-05-03 18:08:44+00:00 	CHOLADJ	Adjusted Cholesterol
4	Total cholesterol in blood	106414	phv00106414.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:09:02+00:00	2018-05-03 18:09:02+00:00 	CHOLUNAD	UNADJUSTED CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	106989	phv00106989.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:09:22+00:00	2018-05-03 18:09:22+00:00 	CHOL44	CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	107325	phv00107325.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:09:59+00:00	2018-05-03 18:09:59+00:00 	CHOLADJ	Adjusted Cholesterol (mg/dl)
4	Total cholesterol in blood	108160	phv00108160.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:10:11+00:00	2018-05-03 18:10:11+00:00 	CHOL44	CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	108574	phv00108574.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:10:23+00:00	2018-05-03 18:10:23+00:00 	CHOL44	CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	109342	phv00109342.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:10:36+00:00	2018-05-03 18:10:36+00:00 	CHOL44	CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	110484	phv00110484.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:10:58+00:00	2018-05-03 18:10:58+00:00 	CHOL44	CHOLESTEROL (mg/dl)
4	Total cholesterol in blood	110489	phv00110489.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:11:07+00:00	2018-05-03 18:11:07+00:00 	CHOLADJ	CHOL44 ADJUSTED FOR DRIFT (mg/dl)
4	Total cholesterol in blood	7536	phv00007536.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:08:57+00:00	2018-05-09 12:08:57+00:00 	A9	TOTAL CHOLESTEROL
4	Total cholesterol in blood	7970	phv00007970.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:09:20+00:00	2018-05-09 12:09:20+00:00 	B352	BLOOD ANALYSIS-FASTING LIPIDS TOTAL CHOLESTEROL
4	Total cholesterol in blood	8087	phv00008087.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:09:49+00:00	2018-05-09 12:09:49+00:00 	B740	CHOLESTEROL
4	Total cholesterol in blood	8726	phv00008726.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:10:53+00:00	2018-05-09 12:10:53+00:00 	C429	TOTAL CHOLESTEROL
4	Total cholesterol in blood	55262	phv00055262.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:11:33+00:00	2018-05-09 12:11:33+00:00 	Chol	Cholesterol mg/dl
4	Total cholesterol in blood	172171	phv00172171.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:11:59+00:00	2018-05-09 12:11:59+00:00 	CHOL	Cholesterol (sample type: plasma)
4	Total cholesterol in blood	227014	phv00227014.v1.p10	pht004801.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:13:08+00:00	2018-05-09 12:13:08+00:00 	CHOL	Total cholesterol (Sample type - EDTA plasma) Collection Interval: Exam 1
4	Total cholesterol in blood	227055	phv00227055.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:14:16+00:00	2018-05-09 12:14:16+00:00 	CHOL	Cholesterol (sample type: EDTA plasma)
4	Total cholesterol in blood	255341	phv00255341.v1.p10	pht005143.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:14:46+00:00	2018-05-09 12:14:46+00:00 	CHOL	Total Cholesterol (sample type: plasma)
4	Total cholesterol in blood	275402	phv00275402.v1.p10	pht006010.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:15:15+00:00	2018-05-09 12:15:15+00:00 	CHOL	Total Cholesterol (sample type: EDTA plasma) Collection Interval: Exam 2
4	Total cholesterol in blood	9121	phv00009121.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:15:56+00:00	2018-05-09 12:15:56+00:00 	D448	TOTAL CHOLESTEROL
4	Total cholesterol in blood	9573	phv00009573.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:16:32+00:00	2018-05-09 12:16:32+00:00 	E667	BLOOD ANALYSIS - TOTAL CHOLESTEROL
4	Total cholesterol in blood	10135	phv00010135.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:17:06+00:00	2018-05-09 12:17:06+00:00 	F726	BLOOD ANALYSIS - TOTAL CHOLESTEROL
4	Total cholesterol in blood	1050	phv00001050.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:17:24+00:00	2018-05-09 12:17:24+00:00 	FA16	BLOOD ANALYSIS:  CHOLESTEROL (MG PER 100 ML)
4	Total cholesterol in blood	1205	phv00001205.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:17:44+00:00	2018-05-09 12:17:44+00:00 	FB28	BLOOD ANALYSIS:  CHOLESTEROL, TOTAL
4	Total cholesterol in blood	1377	phv00001377.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:22:06+00:00	2018-05-09 12:22:06+00:00 	FC19	BLOOD ANALYSIS: SERUM CHOLESTEROL (MG/100 ML)
4	Total cholesterol in blood	1380	phv00001380.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:22:25+00:00	2018-05-09 12:22:25+00:00 	FC22	BLOOD ANALYSIS: TOTAL CHOLESTEROL (MG/100 ML)
4	Total cholesterol in blood	1398	phv00001398.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:22:46+00:00	2018-05-09 12:22:46+00:00 	FC42	BLOOD ANALYSIS, FASTING: TOTAL CHOLESTEROL (MG/100 ML)
4	Total cholesterol in blood	1581	phv00001581.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:23:06+00:00	2018-05-09 12:23:06+00:00 	FD36	BLOOD ANALYSIS, FASTING: TOTAL CHOLESTEROL SERUM & PLASMA (SEE VARIABLE #40 FOR DECK 132 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.)
4	Total cholesterol in blood	1586	phv00001586.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:23:48+00:00	2018-05-09 12:23:48+00:00 	FD41	BLOOD ANALYSIS: FASTING LIPIDS, CHOLESTEROL - TOTAL SERUM & PLASMA (SEE VARIABLE #47 FOR DECK 141 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.)
4	Total cholesterol in blood	2033	phv00002033.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:20:47+00:00	2018-05-09 14:20:47+00:00 	FF80	BLOOD ANALYSIS, CHOLESTEROL
4	Total cholesterol in blood	2417	phv00002417.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:21:08+00:00	2018-05-09 14:21:08+00:00 	FG313	BLOOD ANALYSIS, CHOLESTEROL
4	Total cholesterol in blood	2655	phv00002655.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:21:51+00:00	2018-05-09 14:21:51+00:00 	FH332	BLOOD ANALYSIS: CHOLESTEROL
4	Total cholesterol in blood	4518	phv00004518.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:22:18+00:00	2018-05-09 14:22:18+00:00 	FM545	BLOOD ANALYSIS - TOTAL CHOLESTEROL
4	Total cholesterol in blood	5551	phv00005551.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:23:14+00:00	2018-05-09 14:23:14+00:00 	FO731	BLOOD ANALYSIS - TOTAL CHOLESTEROL
4	Total cholesterol in blood	6027	phv00006027.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:23:58+00:00	2018-05-09 14:23:58+00:00 	FP595	BLOOD ANALYSIS - TOTAL CHOLESTEROL
4	Total cholesterol in blood	6319	phv00006319.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:24:31+00:00	2018-05-09 14:24:31+00:00 	FQ396	TOTAL CHOLESTEROL
4	Total cholesterol in blood	6659	phv00006659.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:25:04+00:00	2018-05-09 14:25:04+00:00 	FR437	BLOOD ANALYSYS - TOTAL CHOLESTEROL
4	Total cholesterol in blood	6668	phv00006668.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:25:55+00:00	2018-05-09 14:25:55+00:00 	FS535	TOTAL CHOLESTEROL MG/100ML
4	Total cholesterol in blood	7529	phv00007529.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:26:25+00:00	2018-05-09 14:26:25+00:00 	FT545	TOTAL CHOLESTEROL MG/100ML
4	Total cholesterol in blood	70731	phv00070731.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:26:55+00:00	2018-05-09 14:26:55+00:00 	FU575	LAB VALUES: TOTAL CHOLESTEROL, MG/DL
4	Total cholesterol in blood	21391	phv00021391.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:27:31+00:00	2018-05-09 14:27:31+00:00 	G3A712	TOTAL CHOLESTEROL, MG/DL
4	Total cholesterol in blood	10142	phv00010142.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:27:52+00:00	2018-05-09 14:27:52+00:00 	G704	TOTAL CHOLESTEROL MG/100ML
4	Total cholesterol in blood	626	phv00000626.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:28:44+00:00	2018-05-09 14:28:44+00:00 	MF160	BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 2
4	Total cholesterol in blood	647	phv00000647.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:29:01+00:00	2018-05-09 14:29:01+00:00 	MF182	BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 3
4	Total cholesterol in blood	672	phv00000672.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:29:19+00:00	2018-05-09 14:29:19+00:00 	MF208	BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 4
4	Total cholesterol in blood	763	phv00000763.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:29:36+00:00	2018-05-09 14:29:36+00:00 	MF311	BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 5
4	Total cholesterol in blood	846	phv00000846.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:29:57+00:00	2018-05-09 14:29:57+00:00 	MF397	BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 6
4	Total cholesterol in blood	927	phv00000927.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:30:39+00:00	2018-05-09 14:30:39+00:00 	MF485	BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 7
4	Total cholesterol in blood	1018	phv00001018.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:30:57+00:00	2018-05-09 14:30:57+00:00 	MF581	BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 1 OR EXAM 2
4	Total cholesterol in blood	534	phv00000534.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:31:22+00:00	2018-05-09 14:31:22+00:00 	MF62	BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 1
4	Total cholesterol in blood	277047	phv00277047.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:32:01+00:00	2018-05-09 14:32:01+00:00 	TC1	Total cholesterol, Exam 1
4	Total cholesterol in blood	277194	phv00277194.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:32:12+00:00	2018-05-09 14:32:12+00:00 	TC1	Total cholesterol, Exam 1
4	Total cholesterol in blood	277048	phv00277048.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:32:23+00:00	2018-05-09 14:32:23+00:00 	TC2	Total cholesterol, Exam 2
4	Total cholesterol in blood	277195	phv00277195.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:32:34+00:00	2018-05-09 14:32:34+00:00 	TC2	Total cholesterol, Exam 2
4	Total cholesterol in blood	277196	phv00277196.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:32:46+00:00	2018-05-09 14:32:46+00:00 	TC3	Total cholesterol, Exam 3
4	Total cholesterol in blood	277197	phv00277197.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:32:57+00:00	2018-05-09 14:32:57+00:00 	TC4	Total cholesterol, Exam 4
4	Total cholesterol in blood	277198	phv00277198.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:33:09+00:00	2018-05-09 14:33:09+00:00 	TC5	Total cholesterol, Exam 5
4	Total cholesterol in blood	277199	phv00277199.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:33:20+00:00	2018-05-09 14:33:20+00:00 	TC6	Total cholesterol, Exam 6
4	Total cholesterol in blood	277200	phv00277200.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:33:31+00:00	2018-05-09 14:33:31+00:00 	TC7	Total cholesterol, Exam 7
4	Total cholesterol in blood	277201	phv00277201.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:33:42+00:00	2018-05-09 14:33:42+00:00 	TC8	Total cholesterol, Exam 8
4	Total cholesterol in blood	277202	phv00277202.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:33:53+00:00	2018-05-09 14:33:53+00:00 	TC9	Total cholesterol, Exam 9
4	Total cholesterol in blood	71890	phv00071890.v4.p10	pht000742.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:34:08+00:00	2018-05-09 14:34:08+00:00 	TOT_CHOL	Total cholesterol, plasma
4	Total cholesterol in blood	275413	phv00275413.v1.p10	pht006011.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 14:34:18+00:00	2018-05-09 14:34:18+00:00 	TOT_CHOL	Total cholesterol (sample type: plasma) Collection Interval: Omni 1 Exam 3
4	Total cholesterol in blood	77396	phv00077396.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 16:37:59+00:00	2018-05-15 16:37:59+00:00 	CORETCHO	Core Total Cholesterol (Mg/dl)
4	Total cholesterol in blood	307765	phv00307765.v1.p1	pht006650.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:15:31+00:00	2018-08-02 19:15:31+00:00 	CHOL	Total Cholesterol Collection Interval: 2006-2011
4	Total cholesterol in blood	277305	phv00277305.v1.p1	pht006031.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:15:39+00:00	2018-08-02 19:15:39+00:00 	CHOL	Total Cholesterol Collection Interval: 2007-2009
4	Total cholesterol in blood	123954	phv00123954.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:39:26+00:00	2018-08-14 20:39:26+00:00 	cholesterol_orig	Cholesterol - original value
4	Total cholesterol in blood	277402	phv00277402.v1.p1	pht006036.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:21:02+00:00	2018-08-14 22:21:02+00:00 	SCHV	Serum Cholesterol Average result value Collection Interval: 2009-2011
4	Total cholesterol in blood	277847	phv00277847.v1.p1	pht006048.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:10:37+00:00	2018-08-14 23:10:37+00:00 	SCHV	Serum Cholesterol Average result value Collection Interval: 2000-2004
4	Total cholesterol in blood	308040	phv00308040.v1.p1	pht006661.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:12:08+00:00	2018-08-16 00:12:08+00:00 	SCHV	Serum Cholesterol Average result value Collection Interval: 2000-2004
4	Total cholesterol in blood	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:07:55+00:00	2018-08-23 18:07:55+00:00 	TESTABBR	Test abbreviation
4	Total cholesterol in blood	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:07:55+00:00	2018-08-23 18:07:55+00:00 	TESTDESC	Test Description
4	Total cholesterol in blood	258734	phv00258734.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:51:51+00:00	2018-09-06 12:51:51+00:00 	Cholesterol_mmol	Cholesterol from venous blood sample (mmol)
7	Resting arm systolic BP	226390	phv00226390.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2017-12-26 20:47:32+00:00	2017-12-26 20:47:32+00:00 	SBPA5	Average systolic blood pressure  (SBPA5)
7	Resting arm systolic BP	259052	phv00259052.v1.p1	pht003918.v2.p1	phs000741.v2.p1	GOLDN	741	2	2017-12-27 17:38:18+00:00	2017-12-27 17:38:18+00:00 	SBP	Systolic Blood pressure
7	Resting arm systolic BP	258702	phv00258702.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2017-12-27 17:51:04+00:00	2017-12-27 17:51:04+00:00 	Systolic_BP_Av3	Systolic blood pressure (average of all three measurements)
7	Resting arm systolic BP	258701	phv00258701.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2017-12-27 17:51:34+00:00	2017-12-27 17:51:34+00:00 	Systolic_BP	Systolic blood pressure (average of last two measurements)
7	Resting arm systolic BP	252995	phv00252995.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2017-12-27 20:57:20+00:00	2017-12-27 20:57:20+00:00 	sbp_baseline	Systolic blood pressure at baseline visit
7	Resting arm systolic BP	122561	phv00122561.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2017-12-27 23:03:26+00:00	2017-12-27 23:03:26+00:00 	SYS1	1st systolic bp
7	Resting arm systolic BP	122563	phv00122563.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2017-12-27 23:03:34+00:00	2017-12-27 23:03:34+00:00 	SYS2	2nd systolic bp
7	Resting arm systolic BP	122647	phv00122647.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2017-12-27 23:03:41+00:00	2017-12-27 23:03:41+00:00 	mnsys	Mean systolic - two readings
7	Resting arm systolic BP	100435	phv00100435.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-01-08 21:26:58+00:00	2018-01-08 21:26:58+00:00 	AVZMSYS	AVE ZERO MUD SYSTOL (mm Hg)
7	Resting arm systolic BP	128370	phv00128370.v1.p1	pht001974.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:08:54+00:00	2018-02-22 21:08:54+00:00 	SBPA13	13: Systolic (first BP)
7	Resting arm systolic BP	128372	phv00128372.v1.p1	pht001974.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:08:54+00:00	2018-02-22 21:08:54+00:00 	SBPA15	15: Zero reading (first BP)
7	Resting arm systolic BP	128373	phv00128373.v1.p1	pht001974.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:08:54+00:00	2018-02-22 21:08:54+00:00 	SBPA16	16: Systolic (second BP)
7	Resting arm systolic BP	128375	phv00128375.v1.p1	pht001974.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:08:54+00:00	2018-02-22 21:08:54+00:00 	SBPA18	18: Zero Reading (second BP)
7	Resting arm systolic BP	128376	phv00128376.v1.p1	pht001974.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:08:54+00:00	2018-02-22 21:08:54+00:00 	SBPA19	19: Systolic (computed net average)
7	Resting arm systolic BP	125871	phv00125871.v1.p1	pht001941.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:39:11+00:00	2018-02-22 21:39:11+00:00 	BAPA9A	9a: Sphygmomanometer (SBP)
7	Resting arm systolic BP	125876	phv00125876.v1.p1	pht001941.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:42:46+00:00	2018-02-22 21:42:46+00:00 	BAPA10A	10a: Sphygmomanometer (SBP)
7	Resting arm systolic BP	125881	phv00125881.v1.p1	pht001941.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:42:46+00:00	2018-02-22 21:42:46+00:00 	BAPA11A	11a: Sphygmomanometer (SBP)
7	Resting arm systolic BP	125886	phv00125886.v1.p1	pht001941.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:42:46+00:00	2018-02-22 21:42:46+00:00 	BAPA12A	12a: Sphygmomanometer (SBP)
7	Resting arm systolic BP	125891	phv00125891.v1.p1	pht001941.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:42:46+00:00	2018-02-22 21:42:46+00:00 	BAPA13A	13a: Sphygmomanometer (SBP)
7	Resting arm systolic BP	125896	phv00125896.v1.p1	pht001941.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:42:46+00:00	2018-02-22 21:42:46+00:00 	BAPA14A	14a: Sphygmomanometer (mean accepted SBP)
7	Resting arm systolic BP	210281	phv00210281.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:57:43+00:00	2018-03-19 16:57:43+00:00 	SBPA12	[First blood pressure measurement]. 1st systolic. Q12 [Siting Blood Pressure, exam 1]
7	Resting arm systolic BP	210284	phv00210284.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:58:39+00:00	2018-03-19 16:58:39+00:00 	SBPA15	[Second blood pressure measurement]. 2nd systolic. Q15 [Siting Blood Pressure, exam 1]
7	Resting arm systolic BP	210287	phv00210287.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:59:06+00:00	2018-03-19 16:59:06+00:00 	SBPA18	[Third blood pressure measurement]. 3rd systolic. Q18 [Siting Blood Pressure, exam 1]
7	Resting arm systolic BP	210290	phv00210290.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:59:27+00:00	2018-03-19 16:59:27+00:00 	SBPA21	[Computed net average of second and third blood pressure measurement]. 2nd and 3rd systolic. Q21 [Siting Blood Pressure, exam 1]
7	Resting arm systolic BP	210307	phv00210307.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:59:49+00:00	2018-03-19 16:59:49+00:00 	SBPB12	First blood pressure measurement, systolic. Q12 [Sitting Blood Pressure, exam 2]
7	Resting arm systolic BP	210310	phv00210310.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:00:06+00:00	2018-03-19 17:00:06+00:00 	SBPB15	Second blood pressure measurement, systolic. Q15 [Sitting Blood Pressure, exam 2]
7	Resting arm systolic BP	210313	phv00210313.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:00:47+00:00	2018-03-19 17:00:47+00:00 	SBPB18	Third blood pressure measurement, systolic. Q18 [Sitting Blood Pressure, exam 2]
7	Resting arm systolic BP	210316	phv00210316.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:01:20+00:00	2018-03-19 17:01:20+00:00 	SBPB21	Computed net average of second and third blood pressure measurements, systolic. Q21 [Sitting Blood Pressure, exam 2]
7	Resting arm systolic BP	210331	phv00210331.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:01:43+00:00	2018-03-19 17:01:43+00:00 	SBPC13	1st systolic blood pressure measurement, systolic. Q13 [Sitting Blood Pressure, exam 3]
7	Resting arm systolic BP	210334	phv00210334.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:02:04+00:00	2018-03-19 17:02:04+00:00 	SBPC16	2nd systolic blood pressure measurement, systolic. Q16 [Sitting Blood Pressure, exam 3]
7	Resting arm systolic BP	210337	phv00210337.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:02:20+00:00	2018-03-19 17:02:20+00:00 	SBPC19	3rd systolic blood pressure measurement, systolic. Q19 [Sitting Blood Pressure, exam 3]
7	Resting arm systolic BP	210340	phv00210340.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:02:40+00:00	2018-03-19 17:02:40+00:00 	SBPC22	[Computed net average of second and third blood pressure measurements]. 2nd and 3rd systolic blood pressure average. Q22 [Sitting Blood Pressure, exam 3]
7	Resting arm systolic BP	210357	phv00210357.v1.p1	pht004195.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:03:06+00:00	2018-03-19 17:03:06+00:00 	SBPD13	1st systolic blood pressure measurement. Q13 [Sitting Blood Pressure, exam 4]
7	Resting arm systolic BP	210360	phv00210360.v1.p1	pht004195.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:03:23+00:00	2018-03-19 17:03:23+00:00 	SBPD16	2nd systolic blood pressure measurement. Q16 [Sitting Blood Pressure, exam 4]
7	Resting arm systolic BP	210363	phv00210363.v1.p1	pht004195.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:03:46+00:00	2018-03-19 17:03:46+00:00 	SBPD19	1st and 2nd systolic blood pressure average. Q19 [Sitting Blood Pressure, exam 4]
7	Resting arm systolic BP	214058	phv00214058.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:04:09+00:00	2018-03-19 17:04:09+00:00 	SYSTBP	Seated Systolic Blood Pressure
7	Resting arm systolic BP	214088	phv00214088.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:05:15+00:00	2018-03-19 17:05:15+00:00 	SYST120	Seated systolic BP- first reading
7	Resting arm systolic BP	214090	phv00214090.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:05:37+00:00	2018-03-19 17:05:37+00:00 	SYST220	Seated systolic BP- second reading
7	Resting arm systolic BP	214092	phv00214092.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:06:08+00:00	2018-03-19 17:06:08+00:00 	SYST320	Seated systolic BP- third reading
7	Resting arm systolic BP	210283	phv00210283.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:35:13+00:00	2018-03-19 17:35:13+00:00 	SBPA14	[First blood pressure measurement]. 1st zero reading. Q14 [Siting Blood Pressure, exam 1]
7	Resting arm systolic BP	210286	phv00210286.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:35:48+00:00	2018-03-19 17:35:48+00:00 	SBPA17	[Second blood pressure measurement]. 2nd zero reading. Q17 [Siting Blood Pressure, exam 1]
7	Resting arm systolic BP	210289	phv00210289.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:36:17+00:00	2018-03-19 17:36:17+00:00 	SBPA20	[Third blood pressure measurement]. 3rd zero reading. Q20 [Siting Blood Pressure, exam 1]
7	Resting arm systolic BP	210309	phv00210309.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:37:36+00:00	2018-03-19 17:37:36+00:00 	SBPB14	First blood pressure measurement, zero reading. Q14 [Sitting Blood Pressure, exam 2]
7	Resting arm systolic BP	210312	phv00210312.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:37:55+00:00	2018-03-19 17:37:55+00:00 	SBPB17	Second blood pressure measurement, zero reading. Q17 [Sitting Blood Pressure, exam 2]
7	Resting arm systolic BP	210315	phv00210315.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:38:17+00:00	2018-03-19 17:38:17+00:00 	SBPB20	Third blood pressure measurement, zero reading. Q20 [Sitting Blood Pressure, exam 2]
7	Resting arm systolic BP	210333	phv00210333.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:39:14+00:00	2018-03-19 17:39:14+00:00 	SBPC15	1st blood pressure measurement, zero reading. Q15 [Sitting Blood Pressure, exam 3]
7	Resting arm systolic BP	210336	phv00210336.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:39:37+00:00	2018-03-19 17:39:37+00:00 	SBPC18	2nd blood pressure measurement, zero reading. Q18 [Sitting Blood Pressure, exam 3]
7	Resting arm systolic BP	210339	phv00210339.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:40:06+00:00	2018-03-19 17:40:06+00:00 	SBPC21	3rd blood pressure measurement, zero reading. Q21 [Sitting Blood Pressure, exam 3]
7	Resting arm systolic BP	210359	phv00210359.v1.p1	pht004195.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:40:48+00:00	2018-03-19 17:40:48+00:00 	SBPD15	1st blood pressure measurement, zero reading. Q15 [Sitting Blood Pressure, exam 4]
7	Resting arm systolic BP	210362	phv00210362.v1.p1	pht004195.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:41:07+00:00	2018-03-19 17:41:07+00:00 	SBPD18	2nd blood pressure measurement, zero reading. Q18 [Sitting Blood Pressure, exam 4]
7	Resting arm systolic BP	202844	phv00202844.v1.p1	pht004027.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:58:20+00:00	2018-03-19 17:58:20+00:00 	ARMSBP13	Redefined supine brachial systolic blood pressure [Ankle Brachial BP Index, exam 1]
7	Resting arm systolic BP	202853	phv00202853.v1.p1	pht004028.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:59:42+00:00	2018-03-19 17:59:42+00:00 	ARMSBP33	Redefined supine brachial systolic blood pressure [Ankle Brachial BP Index, exam 3]
7	Resting arm systolic BP	202863	phv00202863.v1.p1	pht004029.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 18:00:26+00:00	2018-03-19 18:00:26+00:00 	ARMSBP43	Redefined supine brachial systolic blood pressure  [Ankle Brachial BP Index, exam 4]
7	Resting arm systolic BP	112475	phv00112475.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	A02R1S	FIRST READING SBP
7	Resting arm systolic BP	112477	phv00112477.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	A02RZ1S	RZ1 SBP
7	Resting arm systolic BP	112479	phv00112479.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	A02SBP1	FIRST CORRECTED SBP (A02R1S - A02RZ1S)
7	Resting arm systolic BP	112481	phv00112481.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	A02R2S	SECOND READING SBP
7	Resting arm systolic BP	112483	phv00112483.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	A02RZ2S	RZ2 SBP
7	Resting arm systolic BP	112485	phv00112485.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	A02SBP2	SECOND CORRECTED SBP (A02R2S - A02RZ2S)
7	Resting arm systolic BP	112487	phv00112487.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	A02R3S	THIRD READING SBP
7	Resting arm systolic BP	112489	phv00112489.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	A02RZ3S	RZ3 SBP
7	Resting arm systolic BP	112491	phv00112491.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	A02SBP3	THIRD CORRECTED SBP (A02R3S - A02RZ3S)
7	Resting arm systolic BP	112494	phv00112494.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	A02SBP	MEAN OF 2ND AND 3RD SBPS
7	Resting arm systolic BP	114113	phv00114113.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	B02R1S	FIRST READING SBP. Q 11
7	Resting arm systolic BP	114115	phv00114115.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	B02RZ1S	RZ1 SBP. Q 12
7	Resting arm systolic BP	114117	phv00114117.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	B02SBP1	FIRST CORRECTED SBP (R1_S - RZ1_S). Q 13
7	Resting arm systolic BP	114119	phv00114119.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	B02R2S	SECOND READING SBP. Q 14
7	Resting arm systolic BP	114121	phv00114121.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	B02RZ2S	RZ2 SBP. Q 15
7	Resting arm systolic BP	114123	phv00114123.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	B02SBP2	SECOND CORRECTED SBP  (R2_S - RZ2_S). Q 16
7	Resting arm systolic BP	114125	phv00114125.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	B02R3S	THIRD READING SBP. Q 17
7	Resting arm systolic BP	114127	phv00114127.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	B02RZ3S	RZ3 SBP. Q 18
7	Resting arm systolic BP	114129	phv00114129.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	B02SBP3	THIRD CORRECTED SBP (R3_S - RZ3_S). Q 19
7	Resting arm systolic BP	114131	phv00114131.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	B02SUMSY	SECOND & THIRD SYS  (R2_RZ2_S + R3_RZ3_D).  Q 20
7	Resting arm systolic BP	114133	phv00114133.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	B02AVGSY	AVERAGE SBP (SUM_S/2). Q 21
7	Resting arm systolic BP	115330	phv00115330.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	C02R1S	FIRST READING SBP. Q 11
7	Resting arm systolic BP	115332	phv00115332.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	C02RZ1S	RZ1 SBP. Q 12
7	Resting arm systolic BP	115334	phv00115334.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	C02SBP1	FIRST CORRECTED SBP (R1_S - RZ1_S). Q 13
7	Resting arm systolic BP	115336	phv00115336.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	C02R2S	SECOND READING SBP. Q 14
7	Resting arm systolic BP	115338	phv00115338.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	C02RZ2S	RZ2 SBP. Q 15
7	Resting arm systolic BP	115340	phv00115340.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	C02SBP2	SECOND CORRECTED SBP  (R2_S - RZ2_S). Q 16
7	Resting arm systolic BP	115342	phv00115342.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	C02R3S	THIRD READING SBP. Q 17
7	Resting arm systolic BP	115344	phv00115344.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	C02RZ3S	RZ3 SBP. Q 18
7	Resting arm systolic BP	115346	phv00115346.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	C02SBP3	THIRD CORRECTED SBP (R3_S - RZ3_S). Q 19
7	Resting arm systolic BP	115348	phv00115348.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	C02SUMSY	2ND AND 3RD SYS  (R2_RZ2_S + R3_RZ3_D). Q 20
7	Resting arm systolic BP	115350	phv00115350.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	C02AVGSY	AVERAGE SBP (SUM_S/2). Q 21
7	Resting arm systolic BP	116553	phv00116553.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	D02R1S	FIRST READING SBP. Q 11
7	Resting arm systolic BP	116555	phv00116555.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	D02RZ1S	RZ1 SBP. Q 12
7	Resting arm systolic BP	116557	phv00116557.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	D02SBP1	FIRST CORRECTED SBP (R1_S - RZ1_S). Q 13
7	Resting arm systolic BP	116559	phv00116559.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	D02R2S	SECOND READING SBP. Q 14
7	Resting arm systolic BP	116561	phv00116561.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	D02RZ2S	RZ2 SBP. Q 15
7	Resting arm systolic BP	116563	phv00116563.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	D02SBP2	SECOND CORRECTED SBP  (R2_S - RZ2_S). Q 16
7	Resting arm systolic BP	116565	phv00116565.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	D02R3S	THIRD READING SBP. Q 17
7	Resting arm systolic BP	116567	phv00116567.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	D02RZ3S	RZ3 SBP. Q 18
7	Resting arm systolic BP	116569	phv00116569.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	D02SBP3	THIRD CORRECTED SBP (R3_S - RZ3_S). Q 19
7	Resting arm systolic BP	116571	phv00116571.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	D02SUMSY	2ND AND 3RD SYS  (R2_RZ2_S + R3_RZ3_D). Q 20
7	Resting arm systolic BP	116573	phv00116573.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	D02AVGSY	AVERAGE SBP (SUM_S/2). Q 21
7	Resting arm systolic BP	118276	phv00118276.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	E02R1S	FIRST READING SBP. Q 11
7	Resting arm systolic BP	118278	phv00118278.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	E02RZ1S	RZ1 SBP. Q 12
7	Resting arm systolic BP	118280	phv00118280.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	E02SBP1	FIRST CORRECTED SBP (R1_S - RZ1_S). Q 13
7	Resting arm systolic BP	118282	phv00118282.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	E02R2S	SECOND READING SBP. Q 14
7	Resting arm systolic BP	118284	phv00118284.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	E02RZ2S	RZ2 SBP. Q 15
7	Resting arm systolic BP	118286	phv00118286.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	E02SBP2	SECOND CORRECTED SBP  (R2_S - RZ2_S). Q 16
7	Resting arm systolic BP	118288	phv00118288.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	E02R3S	THIRD READING SBP. Q 17
7	Resting arm systolic BP	118290	phv00118290.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	E02RZ3S	RZ3 SBP. Q 18
7	Resting arm systolic BP	118292	phv00118292.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	E02SBP3	THIRD CORRECTED SBP (R3_S - RZ3_S). Q 19
7	Resting arm systolic BP	118294	phv00118294.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	E02SUMSY	2ND AND 3RD SYS  (R2_RZ2_S + R3_RZ3_S). Q 20
7	Resting arm systolic BP	118296	phv00118296.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	E02AVGSY	AVERAGE SBP (SUM_S/2). Q 21
7	Resting arm systolic BP	119703	phv00119703.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	F02R1S	FIRST READING SBP. Q 11
7	Resting arm systolic BP	119705	phv00119705.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	F02RZ1S	RZ1 SBP. Q 12
7	Resting arm systolic BP	119707	phv00119707.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	F02SBP1	FIRST CORRECTED SBP (R1_S - RZ1_S). Q 13
7	Resting arm systolic BP	119709	phv00119709.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	F02R2S	SECOND READING SBP. Q 14
7	Resting arm systolic BP	119711	phv00119711.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	F02RZ2S	RZ2 SBP. Q 15
7	Resting arm systolic BP	119713	phv00119713.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	F02SBP2	SECOND CORRECTED SBP  (R2_S - RZ2_S). Q 16
7	Resting arm systolic BP	119715	phv00119715.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	F02R3S	THIRD READING SBP. Q 17
7	Resting arm systolic BP	119717	phv00119717.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	F02RZ3S	RZ3 SBP. Q 18
7	Resting arm systolic BP	119719	phv00119719.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	F02SBP3	THIRD CORRECTED SBP (R3_S - RZ3_S). Q 19
7	Resting arm systolic BP	119721	phv00119721.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	F02SUMSY	2ND AND 3RD SYS  (R2_RZ2_S + R3_RZ3_S). Q 20
7	Resting arm systolic BP	119723	phv00119723.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:13:47+00:00	2018-04-17 15:13:47+00:00 	F02AVGSY	AVERAGE SBP (SUM_S/2). Q 21
7	Resting arm systolic BP	115205	phv00115205.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:14:34+00:00	2018-04-19 20:14:34+00:00 	C1MSBP	AVERAGE SYSTOLIC BLOOD PRESSURE (mmHg)
7	Resting arm systolic BP	116135	phv00116135.v2.p2	pht001680.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:15:10+00:00	2018-04-19 20:15:10+00:00 	C40SBP	SYSTOLIC BLOOD PRESSURE
7	Resting arm systolic BP	116228	phv00116228.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:15:43+00:00	2018-04-19 20:15:43+00:00 	C42AYS1	SYSTOLIC Y-TUBED BP -1ST READING
7	Resting arm systolic BP	116236	phv00116236.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:16:40+00:00	2018-04-19 20:16:40+00:00 	C42AYS3	SYSTOLIC Y-TUBED BP -3RD READING
7	Resting arm systolic BP	116240	phv00116240.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:17:03+00:00	2018-04-19 20:17:03+00:00 	C42AYS4	SYSTOLIC Y-TUBED BP -4TH READING
7	Resting arm systolic BP	116244	phv00116244.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:17:25+00:00	2018-04-19 20:17:25+00:00 	C42AYS5	SYSTOLIC Y-TUBED BP -5TH READING
7	Resting arm systolic BP	116252	phv00116252.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:18:00+00:00	2018-04-19 20:18:00+00:00 	C42AYS7	SYSTOLIC Y-TUBED BP - 7TH READING
7	Resting arm systolic BP	116256	phv00116256.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:18:17+00:00	2018-04-19 20:18:17+00:00 	C42AYS8	SYSTOLIC Y-TUBED BP - 8TH READING
7	Resting arm systolic BP	116260	phv00116260.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:18:41+00:00	2018-04-19 20:18:41+00:00 	C42AYS9	SYSTOLIC Y-TUBED BP - 9TH READING
7	Resting arm systolic BP	116264	phv00116264.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:19:00+00:00	2018-04-19 20:19:00+00:00 	C42AYS10	SYSTOLIC Y-TUBED BP - 10TH READING
7	Resting arm systolic BP	116272	phv00116272.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:19:46+00:00	2018-04-19 20:19:46+00:00 	C42AEYS2	END OF TEST Y-TUBED SYSTOLIC -2ND READ
7	Resting arm systolic BP	116276	phv00116276.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:20:12+00:00	2018-04-19 20:20:12+00:00 	C42AEYS3	END OF TEST Y-TUBED SYSTOLIC -3RD READ
7	Resting arm systolic BP	119238	phv00119238.v2.p2	pht001789.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:21:36+00:00	2018-04-19 20:21:36+00:00 	E40SBP	SYSTOLIC BLOOD PRESSURE. Q 3
7	Resting arm systolic BP	83399	phv00083399.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:59:53+00:00	2018-04-23 03:59:53+00:00 	s1bp1	SEATED BP: SYSTOLIC 1ST READING (mmHg)
7	Resting arm systolic BP	83403	phv00083403.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:59:59+00:00	2018-04-23 03:59:59+00:00 	s2bp1	SEATED BP: SYSTOLIC 2ND READING (mmHg)
7	Resting arm systolic BP	83406	phv00083406.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:00:06+00:00	2018-04-23 04:00:06+00:00 	s3bp1	SEATED BP: SYSTOLIC 3RD READING (mmHg)
7	Resting arm systolic BP	83410	phv00083410.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:00:12+00:00	2018-04-23 04:00:12+00:00 	sbp1c	SEATED SYSTOLIC BLOOD PRESSURE (mmHg)
7	Resting arm systolic BP	84494	phv00084494.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:00:20+00:00	2018-04-23 04:00:20+00:00 	presys1	SYSTOLIC BLOOD PRESSURE BEFORE SERIES 7 MRI
7	Resting arm systolic BP	84496	phv00084496.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:00:28+00:00	2018-04-23 04:00:28+00:00 	postsys1	SYSTOLIC BLOOD PRESSURE AFTER SERIES 7 MRI
7	Resting arm systolic BP	85703	phv00085703.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:00:36+00:00	2018-04-23 04:00:36+00:00 	sbpcp1	SYSTOLIC BLOOD PRESSURE (FROM OSCILLOMETRIC CUFF), (mmHg)
7	Resting arm systolic BP	85732	phv00085732.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:00:56+00:00	2018-04-23 04:00:56+00:00 	s1bp1	SEATED BP: SYSTOLIC 1ST READING (mmHg)
7	Resting arm systolic BP	85735	phv00085735.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:01:03+00:00	2018-04-23 04:01:03+00:00 	s2bp1	SEATED BP: SYSTOLIC 2ND READING (mmHg)
7	Resting arm systolic BP	85737	phv00085737.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:01:08+00:00	2018-04-23 04:01:08+00:00 	s3bp1	SEATED BP: SYSTOLIC 3RD READING (mmHg)
7	Resting arm systolic BP	85740	phv00085740.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:01:15+00:00	2018-04-23 04:01:15+00:00 	sbp1c	SEATED SYSTOLIC BLOOD PRESSURE (mmHg)
7	Resting arm systolic BP	86224	phv00086224.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:01:21+00:00	2018-04-23 04:01:21+00:00 	sbp2c	SEATED SYSTOLIC BLOOD PRESSURE (mmHg)
7	Resting arm systolic BP	86232	phv00086232.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:01:27+00:00	2018-04-23 04:01:27+00:00 	s1bp2	SEATED BP: SYSTOLIC 1ST READING (mmHg)
7	Resting arm systolic BP	86234	phv00086234.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:01:32+00:00	2018-04-23 04:01:32+00:00 	s2bp2	SEATED BP: SYSTOLIC 2ND READING (mmHg)
7	Resting arm systolic BP	86236	phv00086236.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:01:37+00:00	2018-04-23 04:01:37+00:00 	s3bp2	SEATED BP: SYSTOLIC 3RD READING (mmHg)
7	Resting arm systolic BP	86707	phv00086707.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:01:42+00:00	2018-04-23 04:01:42+00:00 	sbp3c	SEATED SYSTOLIC BLOOD PRESSURE (mmHg)
7	Resting arm systolic BP	86715	phv00086715.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:01:47+00:00	2018-04-23 04:01:47+00:00 	s1bp3	SEATED BP: SYSTOLIC 1ST READING (mmHg)
7	Resting arm systolic BP	86718	phv00086718.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:01:52+00:00	2018-04-23 04:01:52+00:00 	s2bp3	SEATED BP: SYSTOLIC 2ND READING (mmHg)
7	Resting arm systolic BP	86720	phv00086720.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:01:57+00:00	2018-04-23 04:01:57+00:00 	s3bp3	SEATED BP: SYSTOLIC 3RD READING (mmHg)
7	Resting arm systolic BP	87029	phv00087029.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:02:02+00:00	2018-04-23 04:02:02+00:00 	sbp4c	SEATED SYSTOLIC BLOOD PRESSURE (mmhg)
7	Resting arm systolic BP	87037	phv00087037.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:02:07+00:00	2018-04-23 04:02:07+00:00 	s1bp4	SEATED BP: SYSTOLIC 1ST READING (mmhg)
7	Resting arm systolic BP	87040	phv00087040.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:02:12+00:00	2018-04-23 04:02:12+00:00 	s2bp4	SEATED BP: SYSTOLIC 2ND READING (mmhg)
7	Resting arm systolic BP	87042	phv00087042.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:03:19+00:00	2018-04-23 04:03:19+00:00 	s3bp4	SEATED BP: SYSTOLIC 3RD READING (mmhg)
7	Resting arm systolic BP	87084	phv00087084.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:03:26+00:00	2018-04-23 04:03:26+00:00 	sbpfc	MEAN: SEATED SYSTOLIC BLOOD PRESSURE (mmHg)
7	Resting arm systolic BP	87505	phv00087505.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:03:33+00:00	2018-04-23 04:03:33+00:00 	s1bpf	1ST READING: SEATED SYSTOLIC BP (mmHg)
7	Resting arm systolic BP	87509	phv00087509.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:03:41+00:00	2018-04-23 04:03:41+00:00 	s2bpf	2ND READING: SEATED SYSTOLIC BP (mmHg)
7	Resting arm systolic BP	87512	phv00087512.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:03:46+00:00	2018-04-23 04:03:46+00:00 	s3bpf	3RD READING: SEATED SYSTOLIC BP (mmHg)
7	Resting arm systolic BP	175587	phv00175587.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:03:51+00:00	2018-04-23 04:03:51+00:00 	s1bp5	SEATED BP: SYSTOLIC 1ST READING (mmHg)
7	Resting arm systolic BP	175591	phv00175591.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:03:59+00:00	2018-04-23 04:03:59+00:00 	s2bp5	SEATED BP: SYSTOLIC 2ND READING (mmHg)
7	Resting arm systolic BP	175594	phv00175594.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:04:04+00:00	2018-04-23 04:04:04+00:00 	s3bp5	SEATED BP: SYSTOLIC 3RD READING (mmHg)
7	Resting arm systolic BP	175601	phv00175601.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:04:10+00:00	2018-04-23 04:04:10+00:00 	sbp5c	SEATED SYSTOLIC BLOOD PRESSURE (mmHg)
7	Resting arm systolic BP	175862	phv00175862.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:04:20+00:00	2018-04-23 04:04:20+00:00 	sbp1c	SEATED SYSTOLIC BLOOD PRESSURE (mmHg)
7	Resting arm systolic BP	175947	phv00175947.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:04:27+00:00	2018-04-23 04:04:27+00:00 	sbpfc	FAMILY COHORT: MEAN: SEATED SYSTOLIC BLOOD PRESSURE (mmHg)
7	Resting arm systolic BP	177021	phv00177021.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:04:45+00:00	2018-04-23 04:04:45+00:00 	s1bp5	SEATED BP: SYSTOLIC 1ST READING (mmHg)
7	Resting arm systolic BP	177025	phv00177025.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:04:50+00:00	2018-04-23 04:04:50+00:00 	s2bp5	SEATED BP: SYSTOLIC 2ND READING (mmHg)
7	Resting arm systolic BP	177028	phv00177028.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:04:56+00:00	2018-04-23 04:04:56+00:00 	s3bp5	SEATED BP: SYSTOLIC 3RD READING (mmHg)
7	Resting arm systolic BP	177035	phv00177035.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:05:01+00:00	2018-04-23 04:05:01+00:00 	sbp5c	SEATED SYSTOLIC BLOOD PRESSURE (mmHg)
7	Resting arm systolic BP	79854	phv00079854.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-24 23:28:12+00:00	2018-04-24 23:28:12+00:00 	SYSTBP1	Systolic blood pressure (1st reading)
7	Resting arm systolic BP	79856	phv00079856.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-24 23:28:12+00:00	2018-04-24 23:28:12+00:00 	SYSTBP2	Systolic blood pressure (2nd reading)
7	Resting arm systolic BP	79863	phv00079863.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-24 23:28:12+00:00	2018-04-24 23:28:12+00:00 	SYST	Systolic BP
7	Resting arm systolic BP	205847	phv00205847.v1.p1	pht004079.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 21:29:14+00:00	2018-04-25 21:29:14+00:00 	ECHA7	Systolic blood pressure 7 [Cohort (Jackson only), Exam 3]
7	Resting arm systolic BP	283297	phv00283297.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-25 23:52:06+00:00	2018-04-25 23:52:06+00:00 	SYSTBP1	Systolic blood pressure (1st reading)
7	Resting arm systolic BP	283299	phv00283299.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-26 00:00:08+00:00	2018-04-26 00:00:08+00:00 	SYSTBP2	Systolic blood pressure (2nd reading)
7	Resting arm systolic BP	283536	phv00283536.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-26 00:01:52+00:00	2018-04-26 00:01:52+00:00 	SYST	F136 Systolic blood pressure at onset, mm/Hg
7	Resting arm systolic BP	101961	phv00101961.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:17:05+00:00	2018-05-03 18:17:05+00:00 	AVESYS	SYSTOLIC BP (mm Hg)
7	Resting arm systolic BP	102574	phv00102574.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:17:15+00:00	2018-05-03 18:17:15+00:00 	AVESYS	SYSTOLIC BP (mm Hg)
7	Resting arm systolic BP	104697	phv00104697.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:17:25+00:00	2018-05-03 18:17:25+00:00 	AVESYS	SYSTOLIC BP (mm Hg)
7	Resting arm systolic BP	105432	phv00105432.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:17:40+00:00	2018-05-03 18:17:40+00:00 	AVESYS	AVE SYSTOLIC BP (mm Hg)
7	Resting arm systolic BP	106794	phv00106794.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:17:53+00:00	2018-05-03 18:17:53+00:00 	AVESYS	SYSTOLIC BP (mm Hg)
7	Resting arm systolic BP	107774	phv00107774.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:18:04+00:00	2018-05-03 18:18:04+00:00 	AVESYS	SYSTOLIC BP (mm Hg)
7	Resting arm systolic BP	108830	phv00108830.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:18:16+00:00	2018-05-03 18:18:16+00:00 	AVESYS	SYSTOLIC BP (mm Hg)
7	Resting arm systolic BP	110337	phv00110337.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:18:33+00:00	2018-05-03 18:18:33+00:00 	AVESYS	SYSTOLIC BP (mm Hg)
7	Resting arm systolic BP	99441	phv00099441.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:19:52+00:00	2018-05-03 18:19:52+00:00 	AVZMSYS	AVE ZERO MUDDLER SYSTOLIC BP  (mm Hg)
7	Resting arm systolic BP	104020	phv00104020.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:20:30+00:00	2018-05-03 18:20:30+00:00 	AVZMSYS	AVE ZERO MUDDLER SYSTOLIC BP (mm Hg)
7	Resting arm systolic BP	1569	phv00001569.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:32:47+00:00	2018-05-03 18:32:47+00:00 	FD22	BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN
7	Resting arm systolic BP	1811	phv00001811.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:33:15+00:00	2018-05-03 18:33:15+00:00 	FE75	BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN
7	Resting arm systolic BP	2026	phv00002026.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:35:53+00:00	2018-05-03 18:35:53+00:00 	FF71	BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN
7	Resting arm systolic BP	1372	phv00001372.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:36:24+00:00	2018-05-03 18:36:24+00:00 	FC14	BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN (MM HG)
7	Resting arm systolic BP	1195	phv00001195.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:38:29+00:00	2018-05-03 18:38:29+00:00 	FB18	BLOOD PRESSURE: SYSTOLIC, TAKEN BY NURSE
7	Resting arm systolic BP	1197	phv00001197.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:38:46+00:00	2018-05-03 18:38:46+00:00 	FB20	BLOOD PRESSURE: SYSTOLIC, PHYSICIAN'S FIRST READING
7	Resting arm systolic BP	1199	phv00001199.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:39:00+00:00	2018-05-03 18:39:00+00:00 	FB22	BLOOD PRESSURE: SYSTOLIC, PHYSICIAN'S SECOND READING
7	Resting arm systolic BP	1370	phv00001370.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:39:24+00:00	2018-05-03 18:39:24+00:00 	FC12	BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE (MM HG)
7	Resting arm systolic BP	1374	phv00001374.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:39:42+00:00	2018-05-03 18:39:42+00:00 	FC16	BLOOD PRESSURE, SYSTOLIC, SECOND READING TAKEN BY PHYSICIAN (MM HG)
7	Resting arm systolic BP	1567	phv00001567.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:39:57+00:00	2018-05-03 18:39:57+00:00 	FD20	BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE
7	Resting arm systolic BP	1571	phv00001571.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:40:15+00:00	2018-05-03 18:40:15+00:00 	FD24	BLOOD PRESSURE, SYSTOLIC, SECOND READING TAKEN BY PHYSICIAN
7	Resting arm systolic BP	1809	phv00001809.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:40:39+00:00	2018-05-03 18:40:39+00:00 	FE73	BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE
7	Resting arm systolic BP	1813	phv00001813.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:41:01+00:00	2018-05-03 18:41:01+00:00 	FE77	BLOOD PRESSURE, SYSTOLIC, SECOND READING TAKEN BY PHYSICIAN
7	Resting arm systolic BP	2024	phv00002024.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:41:22+00:00	2018-05-03 18:41:22+00:00 	FF69	BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE
7	Resting arm systolic BP	2028	phv00002028.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:41:43+00:00	2018-05-03 18:41:43+00:00 	FF73	BLOOD PRESSURE, SYSTOLIC, SECOND READING TAKEN BY PHYSICIAN
7	Resting arm systolic BP	2208	phv00002208.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:42:04+00:00	2018-05-03 18:42:04+00:00 	FG68	BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE
7	Resting arm systolic BP	2212	phv00002212.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:42:52+00:00	2018-05-03 18:42:52+00:00 	FG72	BLOOD PRESSURE, SYSTOLIC, SECOND READING TAKEN BY PHYSICIAN
7	Resting arm systolic BP	2429	phv00002429.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:43:14+00:00	2018-05-03 18:43:14+00:00 	FH68	BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE
7	Resting arm systolic BP	2433	phv00002433.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:44:05+00:00	2018-05-03 18:44:05+00:00 	FH72	BLOOD PRESSURE, SYSTOLIC, SECOND READING TAKEN BY PHYSICIAN
7	Resting arm systolic BP	2673	phv00002673.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:45:25+00:00	2018-05-03 18:45:25+00:00 	FI21	BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE (MM HG)
7	Resting arm systolic BP	2675	phv00002675.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:45:50+00:00	2018-05-03 18:45:50+00:00 	FI23	BLOOD PRESSURE, SYSTOLIC, FIRST TAKEN BY PHYSICIAN (MM HG)
7	Resting arm systolic BP	2677	phv00002677.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:46:10+00:00	2018-05-03 18:46:10+00:00 	FI25	BLOOD PRESSURE, SYSTOLIC, SECOND TAKEN BY PHYSICIAN
7	Resting arm systolic BP	3172	phv00003172.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:46:50+00:00	2018-05-03 18:46:50+00:00 	FJ270	BLOOD PRESSURE: SYSTOLIC - SUPINE
7	Resting arm systolic BP	3176	phv00003176.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:47:37+00:00	2018-05-03 18:47:37+00:00 	FJ274	BLOOD PRESSURE: SYSTOLIC - 2ND READING BY PHYSICIAN
7	Resting arm systolic BP	3591	phv00003591.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:48:30+00:00	2018-05-03 18:48:30+00:00 	FK369	BLOOD PRESSURE: SYSTOLIC - 2ND PHYSICIAN
7	Resting arm systolic BP	3306	phv00003306.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:49:08+00:00	2018-05-03 18:49:08+00:00 	FK55	BLOOD PRESSURE, SYSTOLIC-NURSE
7	Resting arm systolic BP	4546	phv00004546.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:50:15+00:00	2018-05-03 18:50:15+00:00 	FN310	BLOOD PRESSURE: SYSTOLIC - 1ST MD READING
7	Resting arm systolic BP	4548	phv00004548.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:50:38+00:00	2018-05-03 18:50:38+00:00 	FN404	BLOOD PRESSURE: SYSTOLIC - 2ND MD READING
7	Resting arm systolic BP	5138	phv00005138.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:51:20+00:00	2018-05-03 18:51:20+00:00 	FO329	BLOOD PRESSURE: SYSTOLIC - 1ST M.D. READING
7	Resting arm systolic BP	5228	phv00005228.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:52:00+00:00	2018-05-03 18:52:00+00:00 	FO424	BLOOD PRESSURE: SYSTOLIC - 2ND MD READING
7	Resting arm systolic BP	5766	phv00005766.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:53:23+00:00	2018-05-03 18:53:23+00:00 	FP296	BLOOD PRESSURE: SYSTOLIC - 1ST MD READING
7	Resting arm systolic BP	5855	phv00005855.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:54:55+00:00	2018-05-03 18:54:55+00:00 	FP390	BLOOD PRESSURE: SYSTOLIC - 2ND MD READING
7	Resting arm systolic BP	254610	phv00254610.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:57:12+00:00	2018-05-03 18:57:12+00:00 	fv019	Blood Pressure: First reading - Systolic (nearest 2mm Hg) Collection Interval: Exam 29
7	Resting arm systolic BP	254707	phv00254707.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 18:57:54+00:00	2018-05-03 18:57:54+00:00 	fv153	Blood Pressure: Second reading - Systolic blood pressure to nearest 2 mm Hg Collection Interval: Exam 29
7	Resting arm systolic BP	620	phv00000620.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:00:23+00:00	2018-05-03 19:00:23+00:00 	MF154	BLOOD PRESSURE: ADMISSION, SYSTOLIC, EXAM 2
7	Resting arm systolic BP	622	phv00000622.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:00:38+00:00	2018-05-03 19:00:38+00:00 	MF156	BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 2
7	Resting arm systolic BP	624	phv00000624.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:00:53+00:00	2018-05-03 19:00:53+00:00 	MF158	BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 2
7	Resting arm systolic BP	640	phv00000640.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:01:13+00:00	2018-05-03 19:01:13+00:00 	MF174	BLOOD PRESSURE: ADMISSION, SYSTOLIC, EXAM 3
7	Resting arm systolic BP	642	phv00000642.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:01:27+00:00	2018-05-03 19:01:27+00:00 	MF176	BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 3
7	Resting arm systolic BP	644	phv00000644.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:01:43+00:00	2018-05-03 19:01:43+00:00 	MF178	BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 3
7	Resting arm systolic BP	719	phv00000719.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:02:07+00:00	2018-05-03 19:02:07+00:00 	MF264	BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 4
7	Resting arm systolic BP	721	phv00000721.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:02:21+00:00	2018-05-03 19:02:21+00:00 	MF266	BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 4
7	Resting arm systolic BP	757	phv00000757.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:02:33+00:00	2018-05-03 19:02:33+00:00 	MF305	BLOOD PRESSURE: ADMISSION, SYSTOLIC, EXAM 5
7	Resting arm systolic BP	759	phv00000759.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:02:46+00:00	2018-05-03 19:02:46+00:00 	MF307	BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 5
7	Resting arm systolic BP	761	phv00000761.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:03:03+00:00	2018-05-03 19:03:03+00:00 	MF309	BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 5
7	Resting arm systolic BP	833	phv00000833.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:03:19+00:00	2018-05-03 19:03:19+00:00 	MF384	BLOOD PRESSURE: ADMISSION, SYSTOLIC, EXAM 6
7	Resting arm systolic BP	835	phv00000835.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:03:34+00:00	2018-05-03 19:03:34+00:00 	MF386	BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 6
7	Resting arm systolic BP	837	phv00000837.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:03:53+00:00	2018-05-03 19:03:53+00:00 	MF388	BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 6
7	Resting arm systolic BP	918	phv00000918.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:04:09+00:00	2018-05-03 19:04:09+00:00 	MF476	BLOOD PRESSURE: ADMISSION, SYSTOLIC, EXAM 7
7	Resting arm systolic BP	920	phv00000920.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:04:29+00:00	2018-05-03 19:04:29+00:00 	MF478	BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 7
7	Resting arm systolic BP	922	phv00000922.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:04:45+00:00	2018-05-03 19:04:45+00:00 	MF480	BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 7
7	Resting arm systolic BP	528	phv00000528.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:08:12+00:00	2018-05-03 19:08:12+00:00 	MF56	BLOOD PRESSURE: ADMISSION, SYSTOLIC, EXAM 1
7	Resting arm systolic BP	530	phv00000530.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:08:27+00:00	2018-05-03 19:08:27+00:00 	MF58	BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 1
7	Resting arm systolic BP	532	phv00000532.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-03 19:08:53+00:00	2018-05-03 19:08:53+00:00 	MF60	BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 1
7	Resting arm systolic BP	8539	phv00008539.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 11:53:47+00:00	2018-05-04 11:53:47+00:00 	C184	FIRST SYSTOLIC BLOOD PRESSURE BY PHYSICIAN
7	Resting arm systolic BP	250293	phv00250293.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 11:54:32+00:00	2018-05-04 11:54:32+00:00 	e035	Numerical Data - Part I: Nurse's blood pressure - Systolic (nearest 2mm Hg) Collection Interval: Exam 1
7	Resting arm systolic BP	251070	phv00251070.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 11:56:31+00:00	2018-05-04 11:56:31+00:00 	g450	Numerical Data - Part I: Technician's blood pressure - Systolic (nearest 2 mm Hg) Collection Interval: Exam 2
7	Resting arm systolic BP	7572	phv00007572.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 11:58:04+00:00	2018-05-04 11:58:04+00:00 	A53	NURSE SYSTOLIC BLOOD PRESSURE
7	Resting arm systolic BP	254087	phv00254087.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:01:06+00:00	2018-05-04 12:01:06+00:00 	j116	Physical Exam - Blood Pressure: Physician Blood Pressure first reading - Systolic
7	Resting arm systolic BP	254154	phv00254154.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:01:25+00:00	2018-05-04 12:01:25+00:00 	j255	Physical Exam - Blood Pressure: Physician Blood Pressure second reading - Systolic
7	Resting arm systolic BP	10433	phv00010433.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:02:33+00:00	2018-05-04 12:02:33+00:00 	G354	PHYSICIAN SYSTOLIC BLOOD PRESSURE - SECOND READING (TO NEAREST 2 MM HG)
7	Resting arm systolic BP	250915	phv00250915.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:03:03+00:00	2018-05-04 12:03:03+00:00 	g271	Physical Exam - Head, Neck and Respiratory: Physician blood pressure (first reading), systolic (nearest 2mm Hg) Collection Interval: Exam 2
7	Resting arm systolic BP	255001	phv00255001.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:07:53+00:00	2018-05-04 12:07:53+00:00 	fw020	Physical Exam - Physician blood pressure 1st reading - systolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 30
7	Resting arm systolic BP	274721	phv00274721.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:08:15+00:00	2018-05-04 12:08:15+00:00 	FX020	Physical Exam - Physician blood pressure 1st reading - systolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 31
7	Resting arm systolic BP	275078	phv00275078.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:08:34+00:00	2018-05-04 12:08:34+00:00 	fy020	Physical Exam - Physician blood pressure 1st reading - systolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 32
7	Resting arm systolic BP	255097	phv00255097.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:08:57+00:00	2018-05-04 12:08:57+00:00 	fw174	Physical Exam - Physician blood pressure 2nd reading - systolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 30
7	Resting arm systolic BP	274822	phv00274822.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:09:15+00:00	2018-05-04 12:09:15+00:00 	FX174	Physical Exam - Physician blood pressure 2nd reading - systolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 31
7	Resting arm systolic BP	275179	phv00275179.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:09:30+00:00	2018-05-04 12:09:30+00:00 	fy174	Physical Exam - Physician blood pressure 2nd reading - systolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 32
7	Resting arm systolic BP	250561	phv00250561.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:10:50+00:00	2018-05-04 12:10:50+00:00 	e485	Physical Exam - Physician Blood Pressure First Reading - Systolic (nearest 2mm Hg) Collection Interval: Exam 1
7	Resting arm systolic BP	250652	phv00250652.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:11:24+00:00	2018-05-04 12:11:24+00:00 	e581	Physical Exam - Physician Blood Pressure Second Reading - Systolic (nearest 2mm Hg) Collection Interval: Exam 1
7	Resting arm systolic BP	177352	phv00177352.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:13:26+00:00	2018-05-04 12:13:26+00:00 	g3b0149	Physical Exam-Blood Pressure: Physician Blood Pressure first reading - Systolic
7	Resting arm systolic BP	177417	phv00177417.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:14:17+00:00	2018-05-04 12:14:17+00:00 	g3b0280	Physical Exam-Blood Pressure: Physician Blood Pressure second reading - Systolic
7	Resting arm systolic BP	8756	phv00008756.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:15:17+00:00	2018-05-04 12:15:17+00:00 	D192	PHYSICIAN - SYSTOLIC BLOOD PRESSURE - 1ST READING
7	Resting arm systolic BP	8758	phv00008758.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:15:33+00:00	2018-05-04 12:15:33+00:00 	D288	PHYSICIAN - SYSTOLIC BLOOD PRESSURE - 2ND READING
7	Resting arm systolic BP	6512	phv00006512.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:16:57+00:00	2018-05-04 12:16:57+00:00 	FR239	PHYSICIAN BLOOD PRESSURE (FIRST READING) SYSTOLIC (TO NEAREST 2 MM HG)
7	Resting arm systolic BP	6607	phv00006607.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:17:17+00:00	2018-05-04 12:17:17+00:00 	FR380	PHYSICIAN BLOOD PRESSURE (SECOND READING) SYSTOLIC (TO NEAREST 2 MM HG)
7	Resting arm systolic BP	251341	phv00251341.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:18:06+00:00	2018-05-04 12:18:06+00:00 	h111	Physician Blood Pressure first reading - Systolic (nearest 2 mm Hg) Collection Interval: Exam 3
7	Resting arm systolic BP	251408	phv00251408.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:18:36+00:00	2018-05-04 12:18:36+00:00 	h233	Physician Blood Pressure second reading - Systolic (nearest 2 mm Hg) Collection Interval: Exam 3
7	Resting arm systolic BP	72212	phv00072212.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:18:58+00:00	2018-05-04 12:18:58+00:00 	H233	PHYSICIAN BLOOD PRESSURE, 2ND READING: SYSTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG)
7	Resting arm systolic BP	72138	phv00072138.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:19:21+00:00	2018-05-04 12:19:21+00:00 	H111	PHYSICIAN BLOOD PRESSURE, FIRST READING: SYSTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG)
7	Resting arm systolic BP	6921	phv00006921.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:20:21+00:00	2018-05-04 12:20:21+00:00 	FS312	PHYSICIAN SYSTOLIC BLOOD PRESSURE - 1ST READING (TO NEAREST 2MM HG)
7	Resting arm systolic BP	7041	phv00007041.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:20:51+00:00	2018-05-04 12:20:51+00:00 	FS479	PHYSICIAN SYSTOLIC BLOOD PRESSURE - 2ND READING (TO NEAREST 2 MM HG)
7	Resting arm systolic BP	10360	phv00010360.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:21:31+00:00	2018-05-04 12:21:31+00:00 	G271	PHYSICIAN SYSTOLIC BLOOD PRESSURE - FIRST READING (TO NEAREST 2 MM HG)
7	Resting arm systolic BP	9905	phv00009905.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:23:10+00:00	2018-05-04 12:23:10+00:00 	F476	PHYSICIAN SYSTOLIC BLOOD PRESSURE - FIRST READING (TO NEAREST 2MM HG)
7	Resting arm systolic BP	250994	phv00250994.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:56:26+00:00	2018-05-04 12:56:26+00:00 	g354	Physical Exam - Final Blood Pressure: Physician blood pressure (second reading) - Systolic (nearest 2 mm Hg) Collection Interval: Exam 2
7	Resting arm systolic BP	10000	phv00010000.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:57:44+00:00	2018-05-04 12:57:44+00:00 	F576	PHYSICIAN SYSTOLIC BLOOD PRESSURE - SECOND READING (TO NEAREST 2MM HG)
7	Resting arm systolic BP	7574	phv00007574.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:58:28+00:00	2018-05-04 12:58:28+00:00 	A55	PHYSICIAN SYSTOLIC BLOOD PRESSURE, FIRST
7	Resting arm systolic BP	7576	phv00007576.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:58:43+00:00	2018-05-04 12:58:43+00:00 	A57	PHYSICIAN SYSTOLIC BLOOD PRESSURE, SECOND
7	Resting arm systolic BP	3690	phv00003690.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 12:59:30+00:00	2018-05-04 12:59:30+00:00 	FL388	PHYSICIAN SYSTOLIC BP 2ND READING
7	Resting arm systolic BP	4108	phv00004108.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:00:15+00:00	2018-05-04 13:00:15+00:00 	FM427	PHYSICIAN SYSTOLIC BP 2ND READING (UNEQUAL # OF UNKNOWN SBP'S AND DBP'S)
7	Resting arm systolic BP	3688	phv00003688.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:00:44+00:00	2018-05-04 13:00:44+00:00 	FL291	PHYSICIAN SYSTOLIC PRESSURE 1ST READ
7	Resting arm systolic BP	4106	phv00004106.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:01:12+00:00	2018-05-04 13:01:12+00:00 	FM331	PHYSICIAN SYSTOLIC PRESSURE 1ST READ (UNEQUAL # OF UNKNOWN SBP'S AND DBP'S)
7	Resting arm systolic BP	55256	phv00055256.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:02:47+00:00	2018-05-04 13:02:47+00:00 	SystBP	Seated Systolic Blood Pressure
7	Resting arm systolic BP	55285	phv00055285.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:03:15+00:00	2018-05-04 13:03:15+00:00 	SYST120	Seated systolic BP- first reading
7	Resting arm systolic BP	55287	phv00055287.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:03:25+00:00	2018-05-04 13:03:25+00:00 	SYST220	Seated systolic BP- second reading
7	Resting arm systolic BP	55289	phv00055289.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:03:37+00:00	2018-05-04 13:03:37+00:00 	SYST320	Seated systolic BP- third reading
7	Resting arm systolic BP	8630	phv00008630.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:04:31+00:00	2018-05-04 13:04:31+00:00 	C286	SECOND SYSTOLIC BLOOD PRESSURE BY PHYSICIAN
7	Resting arm systolic BP	55182	phv00055182.v4.p10	pht000394.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:05:45+00:00	2018-05-04 13:05:45+00:00 	WT018	SUPINE SBP
7	Resting arm systolic BP	8770	phv00008770.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:09:09+00:00	2018-05-04 13:09:09+00:00 	D413	SYSTOLIC BLOOD PRESSURE-NURSE
7	Resting arm systolic BP	9558	phv00009558.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:09:37+00:00	2018-05-04 13:09:37+00:00 	E035	SYSTOLIC BLOOD PRESSURE - NURSE
7	Resting arm systolic BP	10122	phv00010122.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:10:36+00:00	2018-05-04 13:10:36+00:00 	F026	SYSTOLIC BLOOD PRESSURE - NURSE (TO NEAREST 2MM HG)
7	Resting arm systolic BP	1045	phv00001045.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:11:00+00:00	2018-05-04 13:11:00+00:00 	FA11	SYSTOLIC BLOOD PRESSURE, SECOND EXAMINER (MM HG)
7	Resting arm systolic BP	1041	phv00001041.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:11:18+00:00	2018-05-04 13:11:18+00:00 	FA7	SYSTOLIC BLOOD PRESSURE, NURSE (MM HG)
7	Resting arm systolic BP	1043	phv00001043.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:11:36+00:00	2018-05-04 13:11:36+00:00 	FA9	SYSTOLIC BLOOD PRESSURE, FIRST EXAMINER (MM HG)
7	Resting arm systolic BP	3675	phv00003675.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:12:22+00:00	2018-05-04 13:12:22+00:00 	FL021	SYSTOLIC BLOOD PRESSURE-NURSE
7	Resting arm systolic BP	4091	phv00004091.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:12:56+00:00	2018-05-04 13:12:56+00:00 	FM31	SYSTOLIC BLOOD PRESSURE-NURSE
7	Resting arm systolic BP	4533	phv00004533.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:33:05+00:00	2018-05-04 13:33:05+00:00 	FN21	SYSTOLIC BLOOD PRESSURE - NURSE
7	Resting arm systolic BP	5548	phv00005548.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:34:38+00:00	2018-05-04 13:34:38+00:00 	FO020	SYSTOLIC NURSE'S BLOOD PRESSURE
7	Resting arm systolic BP	5934	phv00005934.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:45:07+00:00	2018-05-04 13:45:07+00:00 	FP025	SYSTOLIC BLOOD PRESSURE - NURSE
7	Resting arm systolic BP	6041	phv00006041.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:45:34+00:00	2018-05-04 13:45:34+00:00 	FQ013	SYSTOLIC BLOOD PRESSURE-NUMERICAL DATA I (FIRST READING) TO NEAREST 2 MM HG
7	Resting arm systolic BP	6043	phv00006043.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:45:49+00:00	2018-05-04 13:45:49+00:00 	FQ017	SYSTOLIC BLOOD PRESSURE-NUMERICAL DATA I (SECOND READING) TO NEAREST 2 MM HG
7	Resting arm systolic BP	6250	phv00006250.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:46:13+00:00	2018-05-04 13:46:13+00:00 	FQ304	SYSTOLIC BLOOD PRESSURE-2ND EXAMINER (FIRST READING) TO NEAREST 2 MM HG
7	Resting arm systolic BP	6252	phv00006252.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:46:33+00:00	2018-05-04 13:46:33+00:00 	FQ308	SYSTOLIC BLOOD PRESSURE-2ND EXAMINER (SECOND READING) TO NEAREST 2 MM HG
7	Resting arm systolic BP	6680	phv00006680.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:46:56+00:00	2018-05-04 13:46:56+00:00 	FS015	SYSTOLIC BLOOD PRESSURE - TECHNICIAN (TO NEAREST 2MM HG)
7	Resting arm systolic BP	7474	phv00007474.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:47:15+00:00	2018-05-04 13:47:15+00:00 	FT483	SYSTOLIC BLOOD PRESSURE - 2ND READING (TO NEAREST 2 MM HG)
7	Resting arm systolic BP	70375	phv00070375.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:47:35+00:00	2018-05-04 13:47:35+00:00 	FU019	SYSTOLIC BLOOD PRESSURE - 1ST READING (TO NEAREST 2 MM HG)
7	Resting arm systolic BP	70500	phv00070500.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:47:59+00:00	2018-05-04 13:47:59+00:00 	FU195	SYSTOLIC BLOOD PRESSURE - 2ND READING(TO NEAREST 2 MM HG)
7	Resting arm systolic BP	273914	phv00273914.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:52:48+00:00	2018-05-04 13:52:48+00:00 	g3a290	Systolic blood pressure: Physician's first reading Collection Interval: Exam 1
7	Resting arm systolic BP	274407	phv00274407.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:53:05+00:00	2018-05-04 13:53:05+00:00 	g3a290	Systolic blood pressure: Physician's first reading
7	Resting arm systolic BP	21092	phv00021092.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:53:26+00:00	2018-05-04 13:53:26+00:00 	G3A290	SYSTOLIC BLOOD PRESSURE: PHYSICIAN'S FIRST READING (TO NEAREST 2MM HG)
7	Resting arm systolic BP	21147	phv00021147.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:54:06+00:00	2018-05-04 13:54:06+00:00 	G3A347	SYSTOLIC BLOOD PRESSURE: PHYSICIAN'S SECOND READING (TO NEAREST 2MM HG)
7	Resting arm systolic BP	273969	phv00273969.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:54:17+00:00	2018-05-04 13:54:17+00:00 	g3a347	Systolic blood pressure: Physician's second reading Collection Interval: Exam 1
7	Resting arm systolic BP	274462	phv00274462.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:54:28+00:00	2018-05-04 13:54:28+00:00 	g3a347	Systolic blood pressure: Physician's second reading
7	Resting arm systolic BP	21239	phv00021239.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:55:01+00:00	2018-05-04 13:55:01+00:00 	G3A456	SYSTOLIC BLOOD PRESSURE: TECHNICIAN'S READING
7	Resting arm systolic BP	274061	phv00274061.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:55:12+00:00	2018-05-04 13:55:12+00:00 	g3a456	Systolic blood pressure: Technician's reading Collection Interval: Exam 1
7	Resting arm systolic BP	274552	phv00274552.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:55:21+00:00	2018-05-04 13:55:21+00:00 	g3a456	Systolic blood pressure: Technician's reading
7	Resting arm systolic BP	10507	phv00010507.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:56:23+00:00	2018-05-04 13:56:23+00:00 	G450	SYSTOLIC BLOOD PRESSURE - TECHNICIAN (TO NEAREST 2 MM HG)
7	Resting arm systolic BP	56853	phv00056853.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:57:21+00:00	2018-05-04 13:57:21+00:00 	pm220a1	Systolic pressure, first seated bp reading
7	Resting arm systolic BP	56855	phv00056855.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:57:37+00:00	2018-05-04 13:57:37+00:00 	pm220b1	Systolic pressure, second seated bp reading
7	Resting arm systolic BP	56857	phv00056857.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:57:54+00:00	2018-05-04 13:57:54+00:00 	pm220c1	Systolic pressure, third seated bp reading
7	Resting arm systolic BP	254768	phv00254768.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:58:56+00:00	2018-05-04 13:58:56+00:00 	fv263	Technician's Blood Pressure (Clinic only) - Systolic (nearest 2 mm Hg) Collection Interval: Exam 29
7	Resting arm systolic BP	7110	phv00007110.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:59:28+00:00	2018-05-04 13:59:28+00:00 	FT018	TECHNICIAN'S SYSTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG)
7	Resting arm systolic BP	70557	phv00070557.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 13:59:55+00:00	2018-05-04 13:59:55+00:00 	FU270	TECHNICIAN'S SYSTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG)
7	Resting arm systolic BP	7683	phv00007683.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 14:03:49+00:00	2018-05-04 14:03:49+00:00 	B22	BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE
7	Resting arm systolic BP	7687	phv00007687.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 14:04:06+00:00	2018-05-04 14:04:06+00:00 	B26	BLOOD PRESSURE, SYSTOLIC, SECOND PHYSICIAN
7	Resting arm systolic BP	8711	phv00008711.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 14:04:38+00:00	2018-05-04 14:04:38+00:00 	C414	BP-SYSTOLIC - NURSE
7	Resting arm systolic BP	9395	phv00009395.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 14:05:05+00:00	2018-05-04 14:05:05+00:00 	E485	BLOOD PRESSURE: SYSTOLIC - 1ST MD READING
7	Resting arm systolic BP	9486	phv00009486.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-04 14:05:44+00:00	2018-05-04 14:05:44+00:00 	E581	BLOOD PRESSURE: SYSTOLIC - 2ND MD READING
7	Resting arm systolic BP	251691	phv00251691.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:21:19+00:00	2018-05-14 12:21:19+00:00 	h630	Doppler Ankle Brachial Blood Pressure Measurements - Tech Obtained: Systolic Blood Pressures by Doppler, to be taken in the following order with participant supine after 5 minutes of rest - Left arm Collection Interval: Exam 3
7	Resting arm systolic BP	251692	phv00251692.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:21:54+00:00	2018-05-14 12:21:54+00:00 	h631	Doppler Ankle Brachial Blood Pressure Measurements - Tech Obtained: Systolic Blood Pressures by Doppler, to be taken in the following order with participant supine after 5 minutes of rest - Left arm Collection Interval: Exam 3
7	Resting arm systolic BP	251688	phv00251688.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:22:14+00:00	2018-05-14 12:22:14+00:00 	h627	Doppler Ankle Brachial Blood Pressure Measurements - Tech Obtained: Systolic Blood Pressures by Doppler, to be taken in the following order with participant supine after 5 minutes of rest - Right arm Collection Interval: Exam 3
7	Resting arm systolic BP	251696	phv00251696.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:22:51+00:00	2018-05-14 12:22:51+00:00 	h635	Doppler Ankle Brachial Blood Pressure Measurements - Tech Obtained: Third Systolic Blood Pressure Measurement (order as in repeat SBP) - Left arm Collection Interval: Exam 3
7	Resting arm systolic BP	251699	phv00251699.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:23:21+00:00	2018-05-14 12:23:21+00:00 	h638	Doppler Ankle Brachial Blood Pressure Measurements - Tech Obtained: Third Systolic Blood Pressure Measurement (order as in repeat SBP) - Right arm Collection Interval: Exam 3
7	Resting arm systolic BP	251695	phv00251695.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:23:40+00:00	2018-05-14 12:23:40+00:00 	h634	Doppler Ankle Brachial Blood Pressure Measurements - Tech Obtained: Repeat Systolic Blood Pressure Measurements (reverse order) - Right arm Collection Interval: Exam 3
7	Resting arm systolic BP	257543	phv00257543.v1.p10	pht005149.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:24:19+00:00	2018-05-14 12:24:19+00:00 	G3B0554	Ankle Brachial Blood Pressure Measurements: first systolic blood pressure, left arm
7	Resting arm systolic BP	257540	phv00257540.v1.p10	pht005149.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:24:56+00:00	2018-05-14 12:24:56+00:00 	G3B0551	Ankle Brachial Blood Pressure Measurements: first systolic blood pressure, right arm
7	Resting arm systolic BP	257544	phv00257544.v1.p10	pht005149.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:25:27+00:00	2018-05-14 12:25:27+00:00 	G3B0555	Ankle Brachial Blood Pressure Measurements:  repeat systolic blood pressure, left arm
7	Resting arm systolic BP	257547	phv00257547.v1.p10	pht005149.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:25:49+00:00	2018-05-14 12:25:49+00:00 	G3B0558	Ankle Brachial Blood Pressure Measurements:  repeat systolic blood pressure, right arm
7	Resting arm systolic BP	257548	phv00257548.v1.p10	pht005149.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:26:19+00:00	2018-05-14 12:26:19+00:00 	G3B0562	Ankle Brachial Blood Pressure Measurements:  third systolic blood pressure, left arm
7	Resting arm systolic BP	257551	phv00257551.v1.p10	pht005149.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:26:54+00:00	2018-05-14 12:26:54+00:00 	G3B0559	Ankle Brachial Blood Pressure Measurements:  third systolic blood pressure, right arm
7	Resting arm systolic BP	257564	phv00257564.v1.p10	pht005150.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:31:31+00:00	2018-05-14 12:31:31+00:00 	j810	Ankle Brachial Blood Pressure Measurements: First systolic blood pressure, left arm
7	Resting arm systolic BP	257561	phv00257561.v1.p10	pht005150.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:31:55+00:00	2018-05-14 12:31:55+00:00 	j807	Ankle Brachial Blood Pressure Measurements: First systolic blood pressure, right arm
7	Resting arm systolic BP	257565	phv00257565.v1.p10	pht005150.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:32:16+00:00	2018-05-14 12:32:16+00:00 	j811	Ankle Brachial Blood Pressure Measurements: Repeat systolic blood pressure, left arm
7	Resting arm systolic BP	257568	phv00257568.v1.p10	pht005150.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:32:45+00:00	2018-05-14 12:32:45+00:00 	j814	Ankle Brachial Blood Pressure Measurements: Repeat systolic blood pressure, right arm
7	Resting arm systolic BP	257572	phv00257572.v1.p10	pht005150.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:33:09+00:00	2018-05-14 12:33:09+00:00 	j818	Ankle Brachial Blood Pressure Measurements: Third systolic blood pressure, left arm
7	Resting arm systolic BP	257569	phv00257569.v1.p10	pht005150.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:33:28+00:00	2018-05-14 12:33:28+00:00 	j815	Ankle Brachial Blood Pressure Measurements: Third systolic blood pressure, right arm
7	Resting arm systolic BP	23140	phv00023140.v1.p10	pht000138.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:34:39+00:00	2018-05-14 12:34:39+00:00 	L_AR_REP	REPEAT SYSTOLIC BLOOD PRESSURE MEASUREMENT BY DOPPLER IN LEFT ARM
7	Resting arm systolic BP	23141	phv00023141.v1.p10	pht000138.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:35:18+00:00	2018-05-14 12:35:18+00:00 	R_AR_REP	REPEAT SYSTOLIC BLOOD PRESURE MEASUREMENT BY DOPPLER IN RIGHT ARM
7	Resting arm systolic BP	23132	phv00023132.v1.p10	pht000138.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:35:57+00:00	2018-05-14 12:35:57+00:00 	L_ARM	SYSTOLIC BLOOD PRESSURE BY DOPPLER IN LEFT ARM
7	Resting arm systolic BP	23131	phv00023131.v1.p10	pht000138.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:36:34+00:00	2018-05-14 12:36:34+00:00 	R_ARM	SYSTOLIC BLOOD PRESSURE BY DOPPLER IN RIGHT ARM
7	Resting arm systolic BP	21592	phv00021592.v5.p10	pht000077.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:37:36+00:00	2018-05-14 12:37:36+00:00 	L_ARM	SYSTOLIC BLOOD PRESSURE BY DOPPLER IN LEFT ARM
7	Resting arm systolic BP	21600	phv00021600.v5.p10	pht000077.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:38:18+00:00	2018-05-14 12:38:18+00:00 	L_ARM_RE	REPEAT SYSTOLIC BLOOD PRESURE MEASUREMENT (BY  DOPPLER) ON LEFT ARM
7	Resting arm systolic BP	21601	phv00021601.v5.p10	pht000077.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:39:10+00:00	2018-05-14 12:39:10+00:00 	R_ARM_RE	REPEAT SYSTOLIC BLOOD PRESURE MEASUREMENT (BY  DOPPLER) ON RIGHT ARM
7	Resting arm systolic BP	21591	phv00021591.v5.p10	pht000077.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:39:32+00:00	2018-05-14 12:39:32+00:00 	R_ARM	SYSTOLIC BLOOD PRESSURE BY DOPPLER IN RIGHT ARM
7	Resting arm systolic BP	21581	phv00021581.v5.p10	pht000076.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:40:28+00:00	2018-05-14 12:40:28+00:00 	L_AR_REP	REPEAT SYSTOLIC BLOOD PRESSURE MEASUREMENT BY  DOPPLER IN LEFT ARM
7	Resting arm systolic BP	21582	phv00021582.v5.p10	pht000076.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:41:08+00:00	2018-05-14 12:41:08+00:00 	R_AR_REP	REPEAT SYSTOLIC BLOOD PRESURE MEASUREMENT BY  DOPPLER IN RIGHT ARM
7	Resting arm systolic BP	21572	phv00021572.v5.p10	pht000076.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:41:29+00:00	2018-05-14 12:41:29+00:00 	R_ARM	SYSTOLIC BLOOD PRESSURE BY DOPPLER IN RIGHT ARM
7	Resting arm systolic BP	8160	phv00008160.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:43:05+00:00	2018-05-14 12:43:05+00:00 	B516	SYSTOLIC-RESTING, SIT
7	Resting arm systolic BP	2210	phv00002210.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 12:44:27+00:00	2018-05-14 12:44:27+00:00 	FG70	BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN
7	Resting arm systolic BP	21599	phv00021599.v5.p10	pht000077.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:43:34+00:00	2018-05-14 13:43:34+00:00 	R_AN_REP	REPEAT SYSTOLIC BLOOD PRESURE MEASUREMENT (BY  DOPPLER) ON RIGHT ANKLE
7	Resting arm systolic BP	24479	phv00024479.v5.p10	pht000195.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:44:01+00:00	2018-05-14 13:44:01+00:00 	sbp	BRACHIAL SYSTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA)
7	Resting arm systolic BP	56835	phv00056835.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:46:38+00:00	2018-05-14 13:46:38+00:00 	avg23bps_s2	Average of 2nd and 3rd Systolic BP measures
7	Resting arm systolic BP	7685	phv00007685.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:46:58+00:00	2018-05-14 13:46:58+00:00 	B24	BLOOD PRESSURE, SYSTOLIC, FIRST PHYSICIAN
7	Resting arm systolic BP	24374	phv00024374.v4.p10	pht000194.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:47:27+00:00	2018-05-14 13:47:27+00:00 	BR05	MEAN SYSTOLIC BASELINE BLOOD PRESSURE, MMHG
7	Resting arm systolic BP	24456	phv00024456.v5.p10	pht000195.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:47:59+00:00	2018-05-14 13:47:59+00:00 	brsbp	BASELINE SYSTOLIC BLOOD PRESSURE (RENAMED FROM EF23)
7	Resting arm systolic BP	276847	phv00276847.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:48:59+00:00	2018-05-14 13:48:59+00:00 	CHF035	Vital Signs - Systolic Blood Pressure
7	Resting arm systolic BP	2431	phv00002431.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:50:00+00:00	2018-05-14 13:50:00+00:00 	FH70	BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN
7	Resting arm systolic BP	3246	phv00003246.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:50:50+00:00	2018-05-14 13:50:50+00:00 	FJ366	BLOOD PRESSURE, SYSTOLIC, BY NURSE
7	Resting arm systolic BP	6336	phv00006336.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:51:55+00:00	2018-05-14 13:51:55+00:00 	FR013	TECHNICIAN SYSTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG) WERE NOT DONE
7	Resting arm systolic BP	21573	phv00021573.v5.p10	pht000076.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:53:54+00:00	2018-05-14 13:53:54+00:00 	L_ARM	SYSTOLIC BLOOD PRESSURE BY DOPPLER IN LEFT ARM
7	Resting arm systolic BP	55283	phv00055283.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:54:30+00:00	2018-05-14 13:54:30+00:00 	PLPSYS20	Palpated Systolic BP
7	Resting arm systolic BP	56851	phv00056851.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 13:54:58+00:00	2018-05-14 13:54:58+00:00 	pm219a	Palpated systolic (for pulse obliteration pressure)
7	Resting arm systolic BP	56863	phv00056863.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:00:01+00:00	2018-05-14 14:00:01+00:00 	pm226c	Right or left arm brachial systolic bp (first reading)
7	Resting arm systolic BP	56868	phv00056868.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:00:30+00:00	2018-05-14 14:00:30+00:00 	pm226h	Right or Left arm brachial systolic bp (second reading)
7	Resting arm systolic BP	72632	phv00072632.v4.p10	pht000748.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:00:52+00:00	2018-05-14 14:00:52+00:00 	PSBP	Mean systolic baseline blood pressure
7	Resting arm systolic BP	24412	phv00024412.v4.p10	pht000194.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:01:18+00:00	2018-05-14 14:01:18+00:00 	sbp	BRACHIAL SYSTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA)
7	Resting arm systolic BP	72661	phv00072661.v4.p10	pht000748.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:01:53+00:00	2018-05-14 14:01:53+00:00 	sbp	Systolic blood pressure entered by technician
7	Resting arm systolic BP	24865	phv00024865.v1.p10	pht000211.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:02:14+00:00	2018-05-14 14:02:14+00:00 	sbp	BRACHIAL SYSTOLIC PRESSURE (FROM TONOMETRY DATA) (MMHG)
7	Resting arm systolic BP	24778	phv00024778.v5.p10	pht000209.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:02:29+00:00	2018-05-14 14:02:29+00:00 	sbp	BRACHIAL SYSTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) (OLD NAME: TONSBP)
7	Resting arm systolic BP	24824	phv00024824.v4.p10	pht000210.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:02:47+00:00	2018-05-14 14:02:47+00:00 	sbp	BRACHIAL SYSTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA)
7	Resting arm systolic BP	277045	phv00277045.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:04:29+00:00	2018-05-14 14:04:29+00:00 	SBP1	Average systolic blood pressure, Exam 1
7	Resting arm systolic BP	277185	phv00277185.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:04:40+00:00	2018-05-14 14:04:40+00:00 	SBP1	Average systolic blood pressure, Exam 1
7	Resting arm systolic BP	277046	phv00277046.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:04:51+00:00	2018-05-14 14:04:51+00:00 	SBP2	Average systolic blood pressure, Exam 2
7	Resting arm systolic BP	277186	phv00277186.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:05:00+00:00	2018-05-14 14:05:00+00:00 	SBP2	Average systolic blood pressure, Exam 2
7	Resting arm systolic BP	277187	phv00277187.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:05:10+00:00	2018-05-14 14:05:10+00:00 	SBP3	Average systolic blood pressure, Exam 3
7	Resting arm systolic BP	277188	phv00277188.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:05:18+00:00	2018-05-14 14:05:18+00:00 	SBP4	Average systolic blood pressure, Exam 4
7	Resting arm systolic BP	277189	phv00277189.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:05:27+00:00	2018-05-14 14:05:27+00:00 	SBP5	Average systolic blood pressure, Exam 5
7	Resting arm systolic BP	277190	phv00277190.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:05:38+00:00	2018-05-14 14:05:38+00:00 	SBP6	Average systolic blood pressure, Exam 6
7	Resting arm systolic BP	277191	phv00277191.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:05:50+00:00	2018-05-14 14:05:50+00:00 	SBP7	Average systolic blood pressure, Exam 7
7	Resting arm systolic BP	277192	phv00277192.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:06:01+00:00	2018-05-14 14:06:01+00:00 	SBP8	Average systolic blood pressure, Exam 8
7	Resting arm systolic BP	277193	phv00277193.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:06:12+00:00	2018-05-14 14:06:12+00:00 	SBP9	Average systolic blood pressure, Exam 9
7	Resting arm systolic BP	24891	phv00024891.v1.p10	pht000211.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:06:45+00:00	2018-05-14 14:06:45+00:00 	TM12	MANUAL BLOOD PRESSURE: SYSTOLIC (FIRST IF ODD ID#)  (MMHG)
7	Resting arm systolic BP	24893	phv00024893.v1.p10	pht000211.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 14:07:02+00:00	2018-05-14 14:07:02+00:00 	TM14	AUTO BLOOD PRESSURE AND PULSE: SYSTOLIC (FIRST IF EVEN ID#) (MMHG)
7	Resting arm systolic BP	24461	phv00024461.v5.p10	pht000195.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 18:05:11+00:00	2018-05-14 18:05:11+00:00 	EF34	POST SYSTOLIC BLOOD PRESSURE
7	Resting arm systolic BP	2947	phv00002947.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 18:06:10+00:00	2018-05-14 18:06:10+00:00 	FJ4	BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN
7	Resting arm systolic BP	3316	phv00003316.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 18:07:37+00:00	2018-05-14 18:07:37+00:00 	FK68	BLOOD PRESSURE, SYSTOLIC
7	Resting arm systolic BP	7358	phv00007358.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 18:09:03+00:00	2018-05-14 18:09:03+00:00 	FT319	MEDICAL HISTORY - BLOOD PRESSURE - 1ST READING (TO NEAREST 2MM HG)
7	Resting arm systolic BP	174611	phv00174611.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-05-16 02:20:44+00:00	2018-05-16 02:20:44+00:00 	rbrach5	RIGHT BRACHIAL BP (mmHg)
7	Resting arm systolic BP	176034	phv00176034.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-05-16 02:20:55+00:00	2018-05-16 02:20:55+00:00 	rbrach5	RIGHT BRACHIAL BP (mmHg)
7	Resting arm systolic BP	82665	phv00082665.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-05-16 02:21:06+00:00	2018-05-16 02:21:06+00:00 	rbrach1	RIGHT BRACHIAL BP (mmHg)
7	Resting arm systolic BP	84466	phv00084466.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-05-16 02:21:13+00:00	2018-05-16 02:21:13+00:00 	rbrach1	RIGHT BRACHIAL BP (mmHg)
7	Resting arm systolic BP	86286	phv00086286.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-05-16 02:21:21+00:00	2018-05-16 02:21:21+00:00 	rbrach3	RIGHT BRACHIAL BP (mmHg)
7	Resting arm systolic BP	87482	phv00087482.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-05-16 02:21:29+00:00	2018-05-16 02:21:29+00:00 	rbrachf	SYSTOLIC READINGS: RIGHT BRACHIAL
7	Resting arm systolic BP	124560	phv00124560.v1.p1	pht001921.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-05-23 15:59:15+00:00	2018-05-23 15:59:15+00:00 	ABBA5	5: Doppler systolic BP (mm Hg)
7	Resting arm systolic BP	124562	phv00124562.v1.p1	pht001921.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-05-23 16:00:37+00:00	2018-05-23 16:00:37+00:00 	ABBA7	7: First brachial Doppler BP (mm Hg)
7	Resting arm systolic BP	124567	phv00124567.v1.p1	pht001921.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-05-23 16:00:51+00:00	2018-05-23 16:00:51+00:00 	ABBA12	12: Second brachial BP (mm Hg)
7	Resting arm systolic BP	123001	phv00123001.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-06-18 19:15:42+00:00	2018-06-18 19:15:42+00:00 	sbp	Mean Systolic BP
7	Resting arm systolic BP	277302	phv00277302.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:51:10+00:00	2018-08-02 18:51:10+00:00 	DINA_SYS3	Dinamap: Systolic pressure; 3rd of 3 readings Collection Interval: 2007-2009
7	Resting arm systolic BP	277298	phv00277298.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:51:20+00:00	2018-08-02 18:51:20+00:00 	DINA_SYS2	Dinamap: Systolic pressure; 2nd of 3 readings Collection Interval: 2007-2009
7	Resting arm systolic BP	277294	phv00277294.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:51:29+00:00	2018-08-02 18:51:29+00:00 	DINA_SYS1	Dinamap: Systolic pressure; 1st of 3 readings Collection Interval: 2007-2009
7	Resting arm systolic BP	277344	phv00277344.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:52:07+00:00	2018-08-02 18:52:07+00:00 	DINA_SYS3	Dinamap: Systolic pressure; 3rd of 3 readings Collection Interval: 2009-2011
7	Resting arm systolic BP	277340	phv00277340.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:52:16+00:00	2018-08-02 18:52:16+00:00 	DINA_SYS2	Dinamap: Systolic pressure; 2nd of 3 readings Collection Interval: 2009-2011
7	Resting arm systolic BP	277336	phv00277336.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:52:24+00:00	2018-08-02 18:52:24+00:00 	DINA_SYS1	Dinamap: Systolic pressure; 1st of 3 readings Collection Interval: 2009-2011
7	Resting arm systolic BP	307737	phv00307737.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:52:32+00:00	2018-08-02 18:52:32+00:00 	BpTRU_SYS3	BpTRU: Systolic; 3rd of 3 readings Collection Interval: 2007-2009
7	Resting arm systolic BP	307735	phv00307735.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:52:50+00:00	2018-08-02 18:52:50+00:00 	BpTRU_SYS2	BpTRU: Systolic; 2nd of 3 readings Collection Interval: 2007-2009
7	Resting arm systolic BP	307733	phv00307733.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:52:59+00:00	2018-08-02 18:52:59+00:00 	BpTRU_SYS1	BpTRU: Systolic; 1st of 3 readings Collection Interval: 2007-2009
7	Resting arm systolic BP	277772	phv00277772.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:53:40+00:00	2018-08-02 18:53:40+00:00 	RAND_SYS3	Random Zero Sphygmomanometer BP: Systolic #3 Collection Interval: 2000-2004
7	Resting arm systolic BP	277770	phv00277770.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:53:51+00:00	2018-08-02 18:53:51+00:00 	RAND_SYS2	Random Zero Sphygmomanometer BP: Systolic #2 Collection Interval: 2000-2004
7	Resting arm systolic BP	277768	phv00277768.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:54:00+00:00	2018-08-02 18:54:00+00:00 	RAND_SYS1	Random Zero Sphygmomanometer BP: Systolic #1 Collection Interval: 2000-2004
7	Resting arm systolic BP	277664	phv00277664.v1.p1	pht006045.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:54:09+00:00	2018-08-02 18:54:09+00:00 	ECHOSYS	Dinamap BP while lying on Echo bed: systolic Collection Interval: 2001-2004
7	Resting arm systolic BP	277533	phv00277533.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:54:17+00:00	2018-08-02 18:54:17+00:00 	DINA_SYS3	Dinamap: Systolic pressure; 3rd of 3 readings Collection Interval: 1996-2000
7	Resting arm systolic BP	277529	phv00277529.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:54:26+00:00	2018-08-02 18:54:26+00:00 	DINA_SYS2	Dinamap: Systolic pressure; 2nd of 3 readings Collection Interval: 1996-2000
7	Resting arm systolic BP	277525	phv00277525.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:54:34+00:00	2018-08-02 18:54:34+00:00 	DINA_SYS1	Dinamap: Systolic pressure; 1st of 3 readings Collection Interval: 1996-2000
7	Resting arm systolic BP	277522	phv00277522.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:54:44+00:00	2018-08-02 18:54:44+00:00 	RAND_SYS3	Random-zero sphygmomanometer: Systolic; 3rd of 3 readings Collection Interval: 1996-2000
7	Resting arm systolic BP	277520	phv00277520.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:54:53+00:00	2018-08-02 18:54:53+00:00 	RAND_SYS2	Random-zero sphygmomanometer: Systolic; 2nd of 3 readings Collection Interval: 1996-2000
7	Resting arm systolic BP	277518	phv00277518.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:55:01+00:00	2018-08-02 18:55:01+00:00 	RAND_SYS1	Random-zero sphygmomanometer: Systolic; 1st of 3 readings Collection Interval: 1996-2000
7	Resting arm systolic BP	307750	phv00307750.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:55:52+00:00	2018-08-02 18:55:52+00:00 	BpTRU_SYS3	BpTRU: Systolic; 3rd of 3 readings Collection Interval: 2006-2011
7	Resting arm systolic BP	307748	phv00307748.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:55:59+00:00	2018-08-02 18:55:59+00:00 	BpTRU_SYS2	BpTRU: Systolic; 2nd of 3 readings Collection Interval: 2006-2011
7	Resting arm systolic BP	307746	phv00307746.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:56:07+00:00	2018-08-02 18:56:07+00:00 	BpTRU_SYS1	BpTRU: Systolic; 1st of 3 readings Collection Interval: 2006-2011
7	Resting arm systolic BP	277787	phv00277787.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:56:15+00:00	2018-08-02 18:56:15+00:00 	RSYSBP	Ankle brachial index measurement: Right arm systolic blood pressure Collection Interval: 2000-2004
7	Resting arm systolic BP	277786	phv00277786.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:56:23+00:00	2018-08-02 18:56:23+00:00 	LSYSBP	Ankle brachial index measurement: Left arm systolic blood pressure Collection Interval: 2000-2004
7	Resting arm systolic BP	277783	phv00277783.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:56:31+00:00	2018-08-02 18:56:31+00:00 	DINA_SYS3	Dinamap BP: Systolic #3 Collection Interval: 2000-2004
7	Resting arm systolic BP	277779	phv00277779.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:56:38+00:00	2018-08-02 18:56:38+00:00 	DINA_SYS2	Dinamap BP: Systolic #2 Collection Interval: 2000-2004
7	Resting arm systolic BP	277775	phv00277775.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:56:45+00:00	2018-08-02 18:56:45+00:00 	DINA_SYS1	Dinamap BP: Systolic #1 Collection Interval: 2000-2004
7	Resting arm systolic BP	307963	phv00307963.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:57:23+00:00	2018-08-02 18:57:23+00:00 	RAND_SYS3	Random Zero Sphygmomanometer BP: Systolic #3 Collection Interval: 2000-2004
7	Resting arm systolic BP	307961	phv00307961.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:57:31+00:00	2018-08-02 18:57:31+00:00 	RAND_SYS2	Random Zero Sphygmomanometer BP: Systolic #2 Collection Interval: 2000-2004
7	Resting arm systolic BP	307959	phv00307959.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:57:46+00:00	2018-08-02 18:57:46+00:00 	RAND_SYS1	Random Zero Sphygmomanometer BP: Systolic #1 Collection Interval: 2000-2004
7	Resting arm systolic BP	307814	phv00307814.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:57:54+00:00	2018-08-02 18:57:54+00:00 	DINA_SYS3	Dinamap: Systolic pressure; 3rd of 3 readings Collection Interval: 1996-2000
7	Resting arm systolic BP	307810	phv00307810.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:58:03+00:00	2018-08-02 18:58:03+00:00 	DINA_SYS2	Dinamap: Systolic pressure; 2nd of 3 readings Collection Interval: 1996-2000
7	Resting arm systolic BP	307806	phv00307806.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:58:11+00:00	2018-08-02 18:58:11+00:00 	DINA_SYS1	Dinamap: Systolic pressure; 1st of 3 readings Collection Interval: 1996-2000
7	Resting arm systolic BP	307803	phv00307803.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:58:19+00:00	2018-08-02 18:58:19+00:00 	RAND_SYS3	Random-zero sphygmomanometer: Systolic; 3rd of 3 readings Collection Interval: 1996-2000
7	Resting arm systolic BP	307801	phv00307801.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:58:27+00:00	2018-08-02 18:58:27+00:00 	RAND_SYS2	Random-zero sphygmomanometer: Systolic; 2nd of 3 readings Collection Interval: 1996-2000
7	Resting arm systolic BP	307799	phv00307799.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:58:35+00:00	2018-08-02 18:58:35+00:00 	RAND_SYS1	Random-zero sphygmomanometer: Systolic; 1st of 3 readings Collection Interval: 1996-2000
7	Resting arm systolic BP	307762	phv00307762.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:58:45+00:00	2018-08-02 18:58:45+00:00 	DINA_SYS3	Dinamap: Systolic pressure; 3rd of 3 readings Collection Interval: 2006-2011
7	Resting arm systolic BP	307758	phv00307758.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:58:54+00:00	2018-08-02 18:58:54+00:00 	DINA_SYS2	Dinamap: Systolic pressure; 2nd of 3 readings Collection Interval: 2006-2011
7	Resting arm systolic BP	307754	phv00307754.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:59:06+00:00	2018-08-02 18:59:06+00:00 	DINA_SYS1	Dinamap: Systolic pressure; 1st of 3 readings Collection Interval: 2006-2011
7	Resting arm systolic BP	307978	phv00307978.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:59:31+00:00	2018-08-02 18:59:31+00:00 	RSYSBP	Ankle brachial index measurement: Right arm systolic blood pressure Collection Interval: 2000-2004
7	Resting arm systolic BP	307977	phv00307977.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:59:39+00:00	2018-08-02 18:59:39+00:00 	LSYSBP	Ankle brachial index measurement: Left arm systolic blood pressure Collection Interval: 2000-2004
7	Resting arm systolic BP	307974	phv00307974.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:59:48+00:00	2018-08-02 18:59:48+00:00 	DINA_SYS3	Dinamap BP: Systolic #3 Collection Interval: 2000-2004
7	Resting arm systolic BP	307970	phv00307970.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:59:56+00:00	2018-08-02 18:59:56+00:00 	DINA_SYS2	Dinamap BP: Systolic #2 Collection Interval: 2000-2004
7	Resting arm systolic BP	307966	phv00307966.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:00:05+00:00	2018-08-02 19:00:05+00:00 	DINA_SYS1	Dinamap BP: Systolic #1 Collection Interval: 2000-2004
7	Resting arm systolic BP	159590	phv00159590.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-02 19:10:33+00:00	2018-08-02 19:10:33+00:00 	sysBP	Systolic blood pressure [mmHg] Collection Interval: Collected in Exam 1
7	Resting arm systolic BP	277669	phv00277669.v1.p1	pht006045.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:00:58+00:00	2018-08-14 23:00:58+00:00 	ECHO_SBP	Systolic BP Collection Interval: 2001-2004
7	Resting arm systolic BP	123110	phv00123110.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:03:36+00:00	2018-08-17 20:03:36+00:00 	RARMBP1	Ankle-Arm: Right Arm Systolic Blood Pressure 1
7	Resting arm systolic BP	123113	phv00123113.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:03:45+00:00	2018-08-17 20:03:45+00:00 	LARMBP1	Ankle-Arm: Left Arm Systolic Blood Pressure 1
7	Resting arm systolic BP	123114	phv00123114.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:03:57+00:00	2018-08-17 20:03:57+00:00 	LARMBP2	Ankle-Arm: Left Arm Systolic Blood Pressure 2
7	Resting arm systolic BP	123117	phv00123117.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:04:07+00:00	2018-08-17 20:04:07+00:00 	RARMBP2	Ankle-Arm: Right Arm Systolic Blood Pressure 2
7	Resting arm systolic BP	123844	phv00123844.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:57:34+00:00	2018-08-21 17:57:34+00:00 	PM10SYS1	BP: 10 PM - Systolic 1
7	Resting arm systolic BP	123847	phv00123847.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:58:09+00:00	2018-08-21 17:58:09+00:00 	PM10SYS2	BP: 10 PM - Systolic 2
7	Resting arm systolic BP	123850	phv00123850.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:58:24+00:00	2018-08-21 17:58:24+00:00 	PM10SYS3	BP: 10 PM - Systolic 3
7	Resting arm systolic BP	123854	phv00123854.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:58:38+00:00	2018-08-21 17:58:38+00:00 	AM7SYS1	BP: 7 AM - Systolic 1
7	Resting arm systolic BP	123857	phv00123857.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:58:58+00:00	2018-08-21 17:58:58+00:00 	AM7SYS2	BP: 7 AM - Systolic 2
7	Resting arm systolic BP	123860	phv00123860.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:59:10+00:00	2018-08-21 17:59:10+00:00 	AM7SYS3	BP: 7 AM - Systolic 3
7	Resting arm systolic BP	123864	phv00123864.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:23:29+00:00	2018-08-21 18:23:29+00:00 	AM10SYS1	BP: 10 AM - Systolic 1
7	Resting arm systolic BP	123867	phv00123867.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:23:42+00:00	2018-08-21 18:23:42+00:00 	AM10SYS2	BP: 10 AM - Systolic 2
7	Resting arm systolic BP	123870	phv00123870.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:23:53+00:00	2018-08-21 18:23:53+00:00 	AM10SYS3	BP: 10 AM - Systolic 3
7	Resting arm systolic BP	124246	phv00124246.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:51:06+00:00	2018-08-21 18:51:06+00:00 	pm10sys	BP: 10 PM Systolic
7	Resting arm systolic BP	124248	phv00124248.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:51:17+00:00	2018-08-21 18:51:17+00:00 	am7sys	BP: 7 AM Systolic
7	Resting arm systolic BP	124250	phv00124250.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:51:28+00:00	2018-08-21 18:51:28+00:00 	am10sys	BP: 10 AM Systolic
7	Resting arm systolic BP	114878	phv00114878.v2.p2	pht001633.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:42:34+00:00	2018-08-22 23:42:34+00:00 	B28SBP4	PRE-INSTRUCTION BASELINE SBP #4
7	Resting arm systolic BP	114874	phv00114874.v2.p2	pht001633.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:42:49+00:00	2018-08-22 23:42:49+00:00 	B28SBP3	PRE-INSTRUCTION BASELINE SBP #3
7	Resting arm systolic BP	114870	phv00114870.v2.p2	pht001633.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:43:03+00:00	2018-08-22 23:43:03+00:00 	B28SBP2	PRE-INSTRUCTION BASELINE SBP #2
7	Resting arm systolic BP	114866	phv00114866.v2.p2	pht001633.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:43:17+00:00	2018-08-22 23:43:17+00:00 	B28SBP1	PRE-INSTRUCTION BASELINE SBP #1
7	Resting arm systolic BP	116232	phv00116232.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 18:49:37+00:00	2018-08-23 18:49:37+00:00 	C42AYS2	SYSTOLIC Y-TUBED BP -2ND READING
7	Resting arm systolic BP	116268	phv00116268.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 18:50:32+00:00	2018-08-23 18:50:32+00:00 	C42AEYS1	END OF TEST Y-TUBED SYSTOLIC -1ST READ
7	Resting arm systolic BP	116248	phv00116248.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 18:50:50+00:00	2018-08-23 18:50:50+00:00 	C42AYS6	SYSTOLIC Y-TUBED BP - 6TH READING
7	Resting arm systolic BP	258089	phv00258089.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:04:54+00:00	2018-08-24 17:04:54+00:00 	ABPA1A	Right brachial systolic blood  pressure (mm HG) (ABPA1A)
7	Resting arm systolic BP	258094	phv00258094.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:05:06+00:00	2018-08-24 17:05:06+00:00 	ABPA1F	Left brachial systolic blood pressure (mm HG) (ABPA1F)
8	Resting arm diastolic BP	226391	phv00226391.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2017-12-26 20:47:50+00:00	2017-12-26 20:47:50+00:00 	SBPA6	Average diastolic blood pressure  (SBPA6)
8	Resting arm diastolic BP	259053	phv00259053.v1.p1	pht003918.v2.p1	phs000741.v2.p1	GOLDN	741	2	2017-12-27 17:37:35+00:00	2017-12-27 17:37:35+00:00 	DBP	Diastolic blood pressure
8	Resting arm diastolic BP	258704	phv00258704.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2017-12-27 17:50:35+00:00	2017-12-27 17:50:35+00:00 	Diastolic_BP_Av3	Diastolic blood pressure (average of all three measurements)
8	Resting arm diastolic BP	258703	phv00258703.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2017-12-27 17:50:54+00:00	2017-12-27 17:50:54+00:00 	Diastolic_BP	Diastolic blood pressure (average of last two measurements)
8	Resting arm diastolic BP	252996	phv00252996.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2017-12-27 20:57:59+00:00	2017-12-27 20:57:59+00:00 	dbp_baseline	Diastolic blood pressure at baseline visit
8	Resting arm diastolic BP	122562	phv00122562.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2017-12-27 23:04:02+00:00	2017-12-27 23:04:02+00:00 	DIAS1	1st diastolic bp
8	Resting arm diastolic BP	122564	phv00122564.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2017-12-27 23:04:08+00:00	2017-12-27 23:04:08+00:00 	DIAS2	2nd diastolic bp
8	Resting arm diastolic BP	122648	phv00122648.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2017-12-27 23:04:16+00:00	2017-12-27 23:04:16+00:00 	mndias	Mean diastolic - two readings
8	Resting arm diastolic BP	100436	phv00100436.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-01-08 21:27:18+00:00	2018-01-08 21:27:18+00:00 	AVZMDIA	AVE ZERO MUD DIASTOL-adj (mm Hg)
8	Resting arm diastolic BP	128371	phv00128371.v1.p1	pht001974.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:10:22+00:00	2018-02-22 21:10:22+00:00 	SBPA14	14: Diastolic (first BP)
8	Resting arm diastolic BP	128372	phv00128372.v1.p1	pht001974.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:10:22+00:00	2018-02-22 21:10:22+00:00 	SBPA15	15: Zero reading (first BP)
8	Resting arm diastolic BP	128374	phv00128374.v1.p1	pht001974.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:10:22+00:00	2018-02-22 21:10:22+00:00 	SBPA17	17: Diastolic (second BP)
8	Resting arm diastolic BP	128375	phv00128375.v1.p1	pht001974.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:10:22+00:00	2018-02-22 21:10:22+00:00 	SBPA18	18: Zero Reading (second BP)
8	Resting arm diastolic BP	128377	phv00128377.v1.p1	pht001974.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:10:22+00:00	2018-02-22 21:10:22+00:00 	SBPA20	20: Diastolic (computed net average)
8	Resting arm diastolic BP	125872	phv00125872.v1.p1	pht001941.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:39:31+00:00	2018-02-22 21:39:31+00:00 	BAPA9B	9b: Sphygmomanometer (DBP)
8	Resting arm diastolic BP	125877	phv00125877.v1.p1	pht001941.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:45:49+00:00	2018-02-22 21:45:49+00:00 	BAPA10B	10b: Sphygmomanometer (DBP)
8	Resting arm diastolic BP	125882	phv00125882.v1.p1	pht001941.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:45:49+00:00	2018-02-22 21:45:49+00:00 	BAPA11B	11b: Sphygmomanometer (DBP)
8	Resting arm diastolic BP	125887	phv00125887.v1.p1	pht001941.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:45:49+00:00	2018-02-22 21:45:49+00:00 	BAPA12B	12b: Sphygmomanometer (DBP)
8	Resting arm diastolic BP	125892	phv00125892.v1.p1	pht001941.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:45:49+00:00	2018-02-22 21:45:49+00:00 	BAPA13B	13b: Sphygmomanometer (DBP)
8	Resting arm diastolic BP	125897	phv00125897.v1.p1	pht001941.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:45:49+00:00	2018-02-22 21:45:49+00:00 	BAPA14B	14b: Sphygmomanometer (mean accepted DBP)
8	Resting arm diastolic BP	529	phv00000529.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:35:49+00:00	2018-02-27 12:35:49+00:00 	MF57	BLOOD PRESSURE: ADMISSION, DIASTOLIC, EXAM 1
8	Resting arm diastolic BP	531	phv00000531.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:36:09+00:00	2018-02-27 12:36:09+00:00 	MF59	BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 1
8	Resting arm diastolic BP	533	phv00000533.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:36:20+00:00	2018-02-27 12:36:20+00:00 	MF61	BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 1
8	Resting arm diastolic BP	621	phv00000621.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:36:33+00:00	2018-02-27 12:36:33+00:00 	MF155	BLOOD PRESSURE: ADMISSION, DIASTOLIC, EXAM 2
8	Resting arm diastolic BP	623	phv00000623.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:36:43+00:00	2018-02-27 12:36:43+00:00 	MF157	BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 2
8	Resting arm diastolic BP	625	phv00000625.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:36:55+00:00	2018-02-27 12:36:55+00:00 	MF159	BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 2
8	Resting arm diastolic BP	641	phv00000641.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:37:09+00:00	2018-02-27 12:37:09+00:00 	MF175	BLOOD PRESSURE: ADMISSION, DIASTOLIC, EXAM 3
8	Resting arm diastolic BP	643	phv00000643.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:37:19+00:00	2018-02-27 12:37:19+00:00 	MF177	BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 3
8	Resting arm diastolic BP	645	phv00000645.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:37:33+00:00	2018-02-27 12:37:33+00:00 	MF179	BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 3
8	Resting arm diastolic BP	720	phv00000720.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:37:43+00:00	2018-02-27 12:37:43+00:00 	MF265	BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 4
8	Resting arm diastolic BP	722	phv00000722.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:37:53+00:00	2018-02-27 12:37:53+00:00 	MF267	BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 4
8	Resting arm diastolic BP	758	phv00000758.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:38:04+00:00	2018-02-27 12:38:04+00:00 	MF306	BLOOD PRESSURE: ADMISSION, DIASTOLIC, EXAM 5
8	Resting arm diastolic BP	760	phv00000760.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:39:14+00:00	2018-02-27 12:39:14+00:00 	MF308	BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 5
8	Resting arm diastolic BP	762	phv00000762.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:39:26+00:00	2018-02-27 12:39:26+00:00 	MF310	BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 5
8	Resting arm diastolic BP	834	phv00000834.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:39:40+00:00	2018-02-27 12:39:40+00:00 	MF385	BLOOD PRESSURE: ADMISSION, DIASTOLIC, EXAM 6
8	Resting arm diastolic BP	836	phv00000836.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:39:51+00:00	2018-02-27 12:39:51+00:00 	MF387	BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 6
8	Resting arm diastolic BP	838	phv00000838.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:40:04+00:00	2018-02-27 12:40:04+00:00 	MF389	BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 6
8	Resting arm diastolic BP	919	phv00000919.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:40:16+00:00	2018-02-27 12:40:16+00:00 	MF477	BLOOD PRESSURE: ADMISSION, DIASTOLIC, EXAM 7
8	Resting arm diastolic BP	921	phv00000921.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:40:30+00:00	2018-02-27 12:40:30+00:00 	MF479	BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 7
8	Resting arm diastolic BP	923	phv00000923.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:40:44+00:00	2018-02-27 12:40:44+00:00 	MF481	BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 7
8	Resting arm diastolic BP	1042	phv00001042.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:43:35+00:00	2018-02-27 12:43:35+00:00 	FA8	DIASTOLIC BLOOD PRESSURE, NURSE (MM HG)
8	Resting arm diastolic BP	1044	phv00001044.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:43:45+00:00	2018-02-27 12:43:45+00:00 	FA10	DIASTOLIC BLOOD PRESSURE, FIRST EXAMINER (MM HG)
8	Resting arm diastolic BP	1046	phv00001046.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:44:00+00:00	2018-02-27 12:44:00+00:00 	FA12	DIASTOLIC BLOOD PRESSURE, SECOND EXAMINER (MM HG)
8	Resting arm diastolic BP	1196	phv00001196.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:44:17+00:00	2018-02-27 12:44:17+00:00 	FB19	BLOOD PRESSURE: DIASTOLIC, TAKEN BY NURSE
8	Resting arm diastolic BP	1198	phv00001198.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:44:30+00:00	2018-02-27 12:44:30+00:00 	FB21	BLOOD PRESSURE: DIASTOLIC, PHYSICIAN'S FIRST READING
8	Resting arm diastolic BP	1200	phv00001200.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:44:44+00:00	2018-02-27 12:44:44+00:00 	FB23	BLOOD PRESSURE: DIASTOLIC, PHYSICIAN'S SECOND READING
8	Resting arm diastolic BP	1371	phv00001371.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:45:08+00:00	2018-02-27 12:45:08+00:00 	FC13	BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE (MM HG)
8	Resting arm diastolic BP	1373	phv00001373.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:45:19+00:00	2018-02-27 12:45:19+00:00 	FC15	BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN (MM HG)
8	Resting arm diastolic BP	1375	phv00001375.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:45:32+00:00	2018-02-27 12:45:32+00:00 	FC17	BLOOD PRESSURE, DIASTOLIC, SECOND READING TAKEN BY PHYSICIAN (MM HG)
8	Resting arm diastolic BP	1568	phv00001568.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:46:32+00:00	2018-02-27 12:46:32+00:00 	FD21	BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE
8	Resting arm diastolic BP	1570	phv00001570.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:46:50+00:00	2018-02-27 12:46:50+00:00 	FD23	BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN
8	Resting arm diastolic BP	1572	phv00001572.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:47:02+00:00	2018-02-27 12:47:02+00:00 	FD25	BLOOD PRESSURE, DIASTOLIC, SECOND READING TAKEN BY PHYSICIAN
8	Resting arm diastolic BP	1810	phv00001810.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:47:18+00:00	2018-02-27 12:47:18+00:00 	FE74	BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE
8	Resting arm diastolic BP	1812	phv00001812.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:47:33+00:00	2018-02-27 12:47:33+00:00 	FE76	BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN
8	Resting arm diastolic BP	1814	phv00001814.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:47:45+00:00	2018-02-27 12:47:45+00:00 	FE78	BLOOD PRESSURE, DIASTOLIC, SECOND READING TAKEN BY PHYSICIAN
8	Resting arm diastolic BP	2025	phv00002025.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:48:05+00:00	2018-02-27 12:48:05+00:00 	FF70	BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE
8	Resting arm diastolic BP	2027	phv00002027.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:48:17+00:00	2018-02-27 12:48:17+00:00 	FF72	BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN
8	Resting arm diastolic BP	2029	phv00002029.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:48:28+00:00	2018-02-27 12:48:28+00:00 	FF74	BLOOD PRESSURE, DIASTOLIC, SECOND READING TAKEN BY PHYSICIAN
8	Resting arm diastolic BP	2209	phv00002209.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:48:50+00:00	2018-02-27 12:48:50+00:00 	FG69	BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE
8	Resting arm diastolic BP	2211	phv00002211.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:49:05+00:00	2018-02-27 12:49:05+00:00 	FG71	BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN
8	Resting arm diastolic BP	2213	phv00002213.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:49:17+00:00	2018-02-27 12:49:17+00:00 	FG73	BLOOD PRESSURE, DIASTOLIC, SECOND READING TAKEN BY PHYSICIAN
8	Resting arm diastolic BP	2430	phv00002430.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:49:28+00:00	2018-02-27 12:49:28+00:00 	FH69	BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE
8	Resting arm diastolic BP	2432	phv00002432.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:49:39+00:00	2018-02-27 12:49:39+00:00 	FH71	BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN
8	Resting arm diastolic BP	2434	phv00002434.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:49:56+00:00	2018-02-27 12:49:56+00:00 	FH73	BLOOD PRESSURE, DIASTOLIC, SECOND READING TAKEN BY PHYSICIAN
8	Resting arm diastolic BP	2674	phv00002674.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:50:10+00:00	2018-02-27 12:50:10+00:00 	FI22	BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE (MM HG)
8	Resting arm diastolic BP	2676	phv00002676.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:50:21+00:00	2018-02-27 12:50:21+00:00 	FI24	BLOOD PRESSURE, DIASTOLIC, FIRST TAKEN BY PHYSICIAN (MM HG)
8	Resting arm diastolic BP	2678	phv00002678.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:50:33+00:00	2018-02-27 12:50:33+00:00 	FI26	BLOOD PRESSURE, DIASTOLIC, SECOND TAKEN BY PHYSICIAN (MM HG)
8	Resting arm diastolic BP	2948	phv00002948.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:52:58+00:00	2018-02-27 12:52:58+00:00 	FJ5	BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN
8	Resting arm diastolic BP	3173	phv00003173.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:53:15+00:00	2018-02-27 12:53:15+00:00 	FJ271	BLOOD PRESSURE: DIASTOLIC - SUPINE
8	Resting arm diastolic BP	3177	phv00003177.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:53:43+00:00	2018-02-27 12:53:43+00:00 	FJ275	BLOOD PRESSURE: DIASTOLIC - 2ND READING BY PHYSICIAN
8	Resting arm diastolic BP	3247	phv00003247.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:54:01+00:00	2018-02-27 12:54:01+00:00 	FJ367	BLOOD PRESSURE, DIASTOLIC, BY NURSE
8	Resting arm diastolic BP	3307	phv00003307.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:54:16+00:00	2018-02-27 12:54:16+00:00 	FK56	BLOOD PRESSURE, DIASTOLIC-NURSE
8	Resting arm diastolic BP	3317	phv00003317.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:55:36+00:00	2018-02-27 12:55:36+00:00 	FK69	BLOOD PRESSURE, DIASTOLIC
8	Resting arm diastolic BP	3592	phv00003592.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:56:20+00:00	2018-02-27 12:56:20+00:00 	FK370	BLOOD PRESSURE: DIASTOLIC - 2ND PHYSICIAN
8	Resting arm diastolic BP	3676	phv00003676.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:56:35+00:00	2018-02-27 12:56:35+00:00 	FL022	DIASTOLIC BLOOD PRESSURE-NURSE
8	Resting arm diastolic BP	3689	phv00003689.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:56:49+00:00	2018-02-27 12:56:49+00:00 	FL292	PHYSICIAN DIASTOLIC PRESSURE 1ST READ
8	Resting arm diastolic BP	3691	phv00003691.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:57:03+00:00	2018-02-27 12:57:03+00:00 	FL389	PHYSICIAN DIASTOLIC BP 2ND READING
8	Resting arm diastolic BP	4092	phv00004092.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:57:27+00:00	2018-02-27 12:57:27+00:00 	FM32	DIASTOLIC BLOOD PRESSURE-NURSE
8	Resting arm diastolic BP	4107	phv00004107.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:57:46+00:00	2018-02-27 12:57:46+00:00 	FM332	PHYSICIAN DIASTOLIC PRESSURE 1ST READ (UNEQUAL # OF UNKNOWN SBP'S AND DBP'S)
8	Resting arm diastolic BP	4109	phv00004109.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:58:02+00:00	2018-02-27 12:58:02+00:00 	FM428	PHYSICIAN DIASTOLIC BP 2ND READING (UNEQUAL # OF UNKNOWN SBP'S AND DBP'S)
8	Resting arm diastolic BP	4534	phv00004534.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:58:22+00:00	2018-02-27 12:58:22+00:00 	FN22	DIASTOLIC BLOOD PRESSURE - NURSE
8	Resting arm diastolic BP	4547	phv00004547.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:58:36+00:00	2018-02-27 12:58:36+00:00 	FN311	BLOOD PRESSURE: DIASTOLIC - 1ST MD READING
8	Resting arm diastolic BP	4549	phv00004549.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:58:48+00:00	2018-02-27 12:58:48+00:00 	FN405	BLOOD PRESSURE: DIASTOLIC - 2ND MD READING
8	Resting arm diastolic BP	5139	phv00005139.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:59:09+00:00	2018-02-27 12:59:09+00:00 	FO330	BLOOD PRESSURE: DIASTOLIC - 1ST M.D. READING
8	Resting arm diastolic BP	5229	phv00005229.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:59:26+00:00	2018-02-27 12:59:26+00:00 	FO425	BLOOD PRESSURE: DIASTOLIC - 2ND MD READING
8	Resting arm diastolic BP	5549	phv00005549.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 12:59:55+00:00	2018-02-27 12:59:55+00:00 	FO021	DIASTOLIC NURSE'S BLOOD PRESSURE
8	Resting arm diastolic BP	5767	phv00005767.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:00:10+00:00	2018-02-27 13:00:10+00:00 	FP297	BLOOD PRESSURE: DIASTOLIC - 1ST MD READING
8	Resting arm diastolic BP	5856	phv00005856.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:00:21+00:00	2018-02-27 13:00:21+00:00 	FP391	BLOOD PRESSURE: DIASTOLIC - 2ND MD READING
8	Resting arm diastolic BP	5935	phv00005935.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:00:35+00:00	2018-02-27 13:00:35+00:00 	FP026	DIASTOLIC BLOOD PRESSURE - NURSE
8	Resting arm diastolic BP	6042	phv00006042.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:00:51+00:00	2018-02-27 13:00:51+00:00 	FQ014	DIASTOLIC BLOOD PRESSURE-NUMERICAL DATA I (FIRST READING) TO NEAREST 2 MM HG
8	Resting arm diastolic BP	6044	phv00006044.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:01:05+00:00	2018-02-27 13:01:05+00:00 	FQ018	DIASTOLIC BLOOD PRESSURE-NUMERICAL DATA I (SECOND READING) TO NEAREST 2 MM HG
8	Resting arm diastolic BP	6251	phv00006251.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:01:18+00:00	2018-02-27 13:01:18+00:00 	FQ305	DIASTOLIC BLOOD PRESSURE-2ND EXAMINER (FIRST READING) TO NEAREST 2 MM HG
8	Resting arm diastolic BP	6253	phv00006253.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:01:29+00:00	2018-02-27 13:01:29+00:00 	FQ309	DIASTOLIC BLOOD PRESURE-2ND EXAMINER (SECOND READING) TO NEAREST 2 MM HG
8	Resting arm diastolic BP	6337	phv00006337.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:02:28+00:00	2018-02-27 13:02:28+00:00 	FR014	TECHNICIAN DIASTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG) WERE NOT DONE
8	Resting arm diastolic BP	6513	phv00006513.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:30:52+00:00	2018-02-27 13:30:52+00:00 	FR240	PHYSICIAN BLOOD PRESSURE (FIRST READING) DIASTOLIC (TO NEAREST 2 MM HG)
8	Resting arm diastolic BP	6608	phv00006608.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:31:09+00:00	2018-02-27 13:31:09+00:00 	FR381	PHYSICIAN BLOOD PRESSURE (SECOND READING) DIASTOLIC (TO NEAREST 2 MM HG)
8	Resting arm diastolic BP	6681	phv00006681.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:31:22+00:00	2018-02-27 13:31:22+00:00 	FS016	DIASTOLIC BLOOD PRESSURE - TECHNICIAN (TO NEAREST 2MM HG)
8	Resting arm diastolic BP	6922	phv00006922.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:31:36+00:00	2018-02-27 13:31:36+00:00 	FS313	PHYSICIAN DIASTOLIC BLOOD PRESSURE - 1ST READING (TO NEAREST 2MM HG)
8	Resting arm diastolic BP	7042	phv00007042.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:32:11+00:00	2018-02-27 13:32:11+00:00 	FS480	PHYSICIAN DIASTOLIC BLOOD PRESSURE - 2ND READING (TO NEAREST 2 MM HG)
8	Resting arm diastolic BP	7111	phv00007111.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:32:30+00:00	2018-02-27 13:32:30+00:00 	FT019	TECHNICIANS'S DIASTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG)
8	Resting arm diastolic BP	7475	phv00007475.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:32:44+00:00	2018-02-27 13:32:44+00:00 	FT484	DIASTOLIC BLOOD PRESSURE - 2ND READING (TO NEAREST 2 MM HG)
8	Resting arm diastolic BP	7573	phv00007573.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:33:20+00:00	2018-02-27 13:33:20+00:00 	A54	NURSE DIASTOLIC BLOOD PRESSURE
8	Resting arm diastolic BP	7575	phv00007575.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:33:30+00:00	2018-02-27 13:33:30+00:00 	A56	PHYSICIAN DIASTOLIC BLOOD PRESSURE, FIRST
8	Resting arm diastolic BP	7577	phv00007577.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:33:40+00:00	2018-02-27 13:33:40+00:00 	A58	PHYSICIAN DIASTOLIC BLOOD PRESSURE, SECOND
8	Resting arm diastolic BP	7684	phv00007684.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:34:05+00:00	2018-02-27 13:34:05+00:00 	B23	BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE
8	Resting arm diastolic BP	7686	phv00007686.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:34:16+00:00	2018-02-27 13:34:16+00:00 	B25	BLOOD PRESSURE, DIASTOLIC, FIRST PHYSICIAN
8	Resting arm diastolic BP	7688	phv00007688.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:34:29+00:00	2018-02-27 13:34:29+00:00 	B27	BLOOD PRESSURE, DIASTOLIC, SECOND TAKEN BY PHYSICIAN
8	Resting arm diastolic BP	8161	phv00008161.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:35:21+00:00	2018-02-27 13:35:21+00:00 	B517	DIASTOLIC-RESTING, SIT
8	Resting arm diastolic BP	8540	phv00008540.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:40:11+00:00	2018-02-27 13:40:11+00:00 	C185	FIRST DIASTOLIC BLOOD PRESSURE BY PHYSICIAN
8	Resting arm diastolic BP	8712	phv00008712.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:41:04+00:00	2018-02-27 13:41:04+00:00 	C415	BP-DIASTOLIC- NURSE
8	Resting arm diastolic BP	8757	phv00008757.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:41:25+00:00	2018-02-27 13:41:25+00:00 	D193	PHYSICIAN - DIASTOLIC BLOOD PRESSURE - 1ST READING
8	Resting arm diastolic BP	8759	phv00008759.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:41:43+00:00	2018-02-27 13:41:43+00:00 	D289	PHYSICIAN - DIASTOLIC BLOOD PRESSURE - 2ND READING
8	Resting arm diastolic BP	8771	phv00008771.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:41:55+00:00	2018-02-27 13:41:55+00:00 	D414	DIASTOLIC BLOOD PRESSURE-NURSE
8	Resting arm diastolic BP	9396	phv00009396.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:42:15+00:00	2018-02-27 13:42:15+00:00 	E486	BLOOD PRESSURE: DIASTOLIC - 1ST MD READING
8	Resting arm diastolic BP	9487	phv00009487.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:44:12+00:00	2018-02-27 13:44:12+00:00 	E582	BLOOD PRESSURE: DIASTOLIC - 2ND MD READING
8	Resting arm diastolic BP	9559	phv00009559.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:44:23+00:00	2018-02-27 13:44:23+00:00 	E036	DIASTOLIC BLOOD PRESSURE - NURSE
8	Resting arm diastolic BP	9906	phv00009906.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:44:34+00:00	2018-02-27 13:44:34+00:00 	F477	PHYSICIAN DIASTOLIC BLOOD PRESSURE - FIRST READING (TO NEAREST 2MM HG)
8	Resting arm diastolic BP	10001	phv00010001.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:44:57+00:00	2018-02-27 13:44:57+00:00 	F577	PHYSICIAN DIASTOLIC BLOOD PRESSURE - SECOND READING (TO NEAREST 2MM HG)
8	Resting arm diastolic BP	10123	phv00010123.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:45:19+00:00	2018-02-27 13:45:19+00:00 	F027	DIASTOLIC BLOOD PRESSURE - NURSE (TO NEAREST 2MM HG)
8	Resting arm diastolic BP	10361	phv00010361.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:45:33+00:00	2018-02-27 13:45:33+00:00 	G272	PHYSICIAN DIASTOLIC BLOOD PRESSURE - FIRST READING (TO NEAREST 2 MM HG)
8	Resting arm diastolic BP	10434	phv00010434.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:46:01+00:00	2018-02-27 13:46:01+00:00 	G355	PHYSICIAN DIASTOLIC BLOOD PRESSURE - SECOND READING (TO NEAREST 2 MM HG)
8	Resting arm diastolic BP	10508	phv00010508.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:46:15+00:00	2018-02-27 13:46:15+00:00 	G451	DIASTOLIC BLOOD PRESSURE - TECHNICIAN (TO NEAREST 2 MM HG)
8	Resting arm diastolic BP	21093	phv00021093.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:46:28+00:00	2018-02-27 13:46:28+00:00 	G3A291	DIASTOLIC BLOOD PRESSURE: PHYSICIAN'S FIRST READING (TO NEAREST 2MM HG)
8	Resting arm diastolic BP	21148	phv00021148.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:46:43+00:00	2018-02-27 13:46:43+00:00 	G3A348	DIASTOLIC BLOOD PRESSURE: PHYSICIAN'S SECOND READING (TO NEAREST 2MM HG)
8	Resting arm diastolic BP	21240	phv00021240.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:46:54+00:00	2018-02-27 13:46:54+00:00 	G3A457	DIASTOLIC BLOOD PRESSURE: TECHNICIAN'S READING
8	Resting arm diastolic BP	55257	phv00055257.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:48:47+00:00	2018-02-27 13:48:47+00:00 	DiasBP	Seated Diastolic Blood Pressure
8	Resting arm diastolic BP	55286	phv00055286.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:51:02+00:00	2018-02-27 13:51:02+00:00 	DIAS120	Seated diastolic BP- first reading
8	Resting arm diastolic BP	55288	phv00055288.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:51:11+00:00	2018-02-27 13:51:11+00:00 	DIAS220	Seated diastolic BP- second  reading
8	Resting arm diastolic BP	55290	phv00055290.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:51:19+00:00	2018-02-27 13:51:19+00:00 	DIAS320	Seated diastolic BP- third reading
8	Resting arm diastolic BP	56836	phv00056836.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:51:40+00:00	2018-02-27 13:51:40+00:00 	avg23bpd_s2	Average of 2nd and 3rd Diastolic BP measures
8	Resting arm diastolic BP	56854	phv00056854.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:51:53+00:00	2018-02-27 13:51:53+00:00 	pm220a2	Diastolic pressure, first seated bp reading
8	Resting arm diastolic BP	56856	phv00056856.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:52:10+00:00	2018-02-27 13:52:10+00:00 	pm220b2	Diastolic pressure, second seated bp reading
8	Resting arm diastolic BP	70376	phv00070376.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:53:30+00:00	2018-02-27 13:53:30+00:00 	FU020	DIASTOLIC BLOOD PRESSURE - 1ST READING (TO NEAREST 2 MM HG)
8	Resting arm diastolic BP	70501	phv00070501.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:53:42+00:00	2018-02-27 13:53:42+00:00 	FU196	DIASTOLIC BLOOD PRESSURE - 2ND READING(TO NEAREST 2 MM HG)
8	Resting arm diastolic BP	70558	phv00070558.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:54:01+00:00	2018-02-27 13:54:01+00:00 	FU271	TECHNICIANS'S DIASTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG)
8	Resting arm diastolic BP	72139	phv00072139.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:54:13+00:00	2018-02-27 13:54:13+00:00 	H112	PHYSICIAN BLOOD PRESSURE, FIRST READING: DIASTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG)
8	Resting arm diastolic BP	72213	phv00072213.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:54:27+00:00	2018-02-27 13:54:27+00:00 	H234	PHYSICIAN BLOOD PRESSURE, 2ND READING: DIASTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG)
8	Resting arm diastolic BP	177354	phv00177354.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:55:51+00:00	2018-02-27 13:55:51+00:00 	g3b0151	Physical Exam-Blood Pressure: Physician Blood Pressure first reading - Diastolic
8	Resting arm diastolic BP	177419	phv00177419.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:56:10+00:00	2018-02-27 13:56:10+00:00 	g3b0282	Physical Exam-Blood Pressure: Physician Blood Pressure second reading - Diastolic
8	Resting arm diastolic BP	250294	phv00250294.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:56:40+00:00	2018-02-27 13:56:40+00:00 	e036	Numerical Data - Part I: Nurse's blood pressure - Diastolic (nearest 2mm Hg) Collection Interval: Exam 1
8	Resting arm diastolic BP	250562	phv00250562.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:56:52+00:00	2018-02-27 13:56:52+00:00 	e486	Physical Exam - Physician Blood Pressure First Reading - Diastolic (nearest 2mm Hg) Collection Interval: Exam 1
8	Resting arm diastolic BP	250653	phv00250653.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:57:15+00:00	2018-02-27 13:57:15+00:00 	e582	Physical Exam - Physician Blood Pressure Second Reading - Diastolic (nearest 2mm Hg) Collection Interval: Exam 1
8	Resting arm diastolic BP	250916	phv00250916.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:59:28+00:00	2018-02-27 13:59:28+00:00 	g272	Physical Exam - Head, Neck and Respiratory: Physician blood pressure (first reading), diastolic (nearest 2 mm Hg) Collection Interval: Exam 2
8	Resting arm diastolic BP	250995	phv00250995.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:59:47+00:00	2018-02-27 13:59:47+00:00 	g355	Physical Exam - Final Blood Pressure: Physician blood pressure (second reading) - Diastolic (nearest 2 mm Hg) Collection Interval: Exam 2
8	Resting arm diastolic BP	251071	phv00251071.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 13:59:58+00:00	2018-02-27 13:59:58+00:00 	g451	Numerical Data - Part I: Technician's blood pressure - Diastolic (nearest 2 mm Hg) Collection Interval: Exam 2
8	Resting arm diastolic BP	251342	phv00251342.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:00:15+00:00	2018-02-27 14:00:15+00:00 	h112	Physician Blood Pressure first reading - Diastolic (nearest 2 mm Hg) Collection Interval: Exam 3
8	Resting arm diastolic BP	251409	phv00251409.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:00:26+00:00	2018-02-27 14:00:26+00:00 	h234	Physician Blood Pressure second reading - Diastolic (nearest 2 mm Hg) Collection Interval: Exam 3
8	Resting arm diastolic BP	254089	phv00254089.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:00:42+00:00	2018-02-27 14:00:42+00:00 	j118	Physical Exam - Blood Pressure: Physician Blood Pressure first reading - Diastolic
8	Resting arm diastolic BP	254156	phv00254156.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:00:53+00:00	2018-02-27 14:00:53+00:00 	j257	Physical Exam - Blood Pressure: Physician Blood Pressure second reading - Diastolic
8	Resting arm diastolic BP	254611	phv00254611.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:01:09+00:00	2018-02-27 14:01:09+00:00 	fv020	Blood Pressure: First reading - Diastolic (nearest 2mm Hg) Collection Interval: Exam 29
8	Resting arm diastolic BP	254708	phv00254708.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:03:19+00:00	2018-02-27 14:03:19+00:00 	fv154	Blood Pressure: Second reading - Diastolic blood pressure to nearest 2 mm Hg Collection Interval: Exam 29
8	Resting arm diastolic BP	254769	phv00254769.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:03:31+00:00	2018-02-27 14:03:31+00:00 	fv264	Technician's Blood Pressure (Clinic only) - Diastolic (nearest 2 mm Hg) Collection Interval: Exam 29
8	Resting arm diastolic BP	255003	phv00255003.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:03:50+00:00	2018-02-27 14:03:50+00:00 	fw022	Physical Exam - Physician blood pressure 1st reading - diastolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 30
8	Resting arm diastolic BP	255099	phv00255099.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:04:01+00:00	2018-02-27 14:04:01+00:00 	fw176	Physical Exam - Physician blood pressure 2nd reading - diastolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 30
8	Resting arm diastolic BP	273915	phv00273915.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:04:14+00:00	2018-02-27 14:04:14+00:00 	g3a291	Diastolic blood pressure: Physician's first reading Collection Interval: Exam 1
8	Resting arm diastolic BP	273970	phv00273970.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:04:29+00:00	2018-02-27 14:04:29+00:00 	g3a348	Diastolic blood pressure: Physician's second reading Collection Interval: Exam 1
8	Resting arm diastolic BP	274062	phv00274062.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:04:43+00:00	2018-02-27 14:04:43+00:00 	g3a457	Diastolic blood pressure: Technician's reading Collection Interval: Exam 1
8	Resting arm diastolic BP	274408	phv00274408.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:04:55+00:00	2018-02-27 14:04:55+00:00 	g3a291	Diastolic blood pressure: Physician's first reading
8	Resting arm diastolic BP	274463	phv00274463.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:05:15+00:00	2018-02-27 14:05:15+00:00 	g3a348	Diastolic blood pressure: Physician's second reading
8	Resting arm diastolic BP	274553	phv00274553.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:05:26+00:00	2018-02-27 14:05:26+00:00 	g3a457	Diastolic blood pressure: Technician's reading
8	Resting arm diastolic BP	274723	phv00274723.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:05:38+00:00	2018-02-27 14:05:38+00:00 	FX022	Physical Exam - Physician blood pressure 1st reading - diastolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 31
8	Resting arm diastolic BP	274824	phv00274824.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:05:49+00:00	2018-02-27 14:05:49+00:00 	FX176	Physical Exam - Physician blood pressure 2nd reading - diastolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 31
8	Resting arm diastolic BP	275080	phv00275080.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:06:07+00:00	2018-02-27 14:06:07+00:00 	fy022	Physical Exam - Physician blood pressure 1st reading - diastolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 32
8	Resting arm diastolic BP	275181	phv00275181.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:06:19+00:00	2018-02-27 14:06:19+00:00 	fy176	Physical Exam - Physician blood pressure 2nd reading - diastolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 32
8	Resting arm diastolic BP	276848	phv00276848.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:06:46+00:00	2018-02-27 14:06:46+00:00 	CHF036	Vital Signs - Diastolic Blood Pressure
8	Resting arm diastolic BP	277034	phv00277034.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:06:55+00:00	2018-02-27 14:06:55+00:00 	DBP1	Average diastolic blood pressure, Exam 1
8	Resting arm diastolic BP	277035	phv00277035.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:07:04+00:00	2018-02-27 14:07:04+00:00 	DBP2	Average diastolic blood pressure, Exam 2
8	Resting arm diastolic BP	277137	phv00277137.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:07:12+00:00	2018-02-27 14:07:12+00:00 	DBP1	Average diastolic blood pressure, Exam 1
8	Resting arm diastolic BP	277138	phv00277138.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:07:26+00:00	2018-02-27 14:07:26+00:00 	DBP2	Average diastolic blood pressure, Exam 2
8	Resting arm diastolic BP	277139	phv00277139.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:07:35+00:00	2018-02-27 14:07:35+00:00 	DBP3	Average diastolic blood pressure, Exam 3
8	Resting arm diastolic BP	277140	phv00277140.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:07:44+00:00	2018-02-27 14:07:44+00:00 	DBP4	Average diastolic blood pressure, Exam 4
8	Resting arm diastolic BP	277141	phv00277141.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:07:55+00:00	2018-02-27 14:07:55+00:00 	DBP5	Average diastolic blood pressure, Exam 5
8	Resting arm diastolic BP	277142	phv00277142.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:08:07+00:00	2018-02-27 14:08:07+00:00 	DBP6	Average diastolic blood pressure, Exam 6
8	Resting arm diastolic BP	277143	phv00277143.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:08:17+00:00	2018-02-27 14:08:17+00:00 	DBP7	Average diastolic blood pressure, Exam 7
8	Resting arm diastolic BP	277144	phv00277144.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:08:26+00:00	2018-02-27 14:08:26+00:00 	DBP8	Average diastolic blood pressure, Exam 8
8	Resting arm diastolic BP	277145	phv00277145.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:08:35+00:00	2018-02-27 14:08:35+00:00 	DBP9	Average diastolic blood pressure, Exam 9
8	Resting arm diastolic BP	55183	phv00055183.v4.p10	pht000394.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:18:06+00:00	2018-02-27 14:18:06+00:00 	WT019	SUPINE DBP
8	Resting arm diastolic BP	56858	phv00056858.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 14:53:57+00:00	2018-02-27 14:53:57+00:00 	pm220c2	Diastolic pressure, third seated bp reading
8	Resting arm diastolic BP	8631	phv00008631.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-27 18:25:51+00:00	2018-02-27 18:25:51+00:00 	C287	SECOND DIASTOLIC BLOOD PRESSURE BY PHYSICIAN
8	Resting arm diastolic BP	210282	phv00210282.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:47:06+00:00	2018-03-19 17:47:06+00:00 	SBPA13	[First blood pressure measurement]. 1st diastolic. Q13 [Siting Blood Pressure, exam 1]
8	Resting arm diastolic BP	210285	phv00210285.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:47:53+00:00	2018-03-19 17:47:53+00:00 	SBPA16	[Second blood pressure measurement]. 2nd diastolic. Q16 [Siting Blood Pressure, exam 1]
8	Resting arm diastolic BP	210288	phv00210288.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:48:16+00:00	2018-03-19 17:48:16+00:00 	SBPA19	[Third blood pressure measurement]. 3rd diastolic. Q19 [Siting Blood Pressure, exam 1]
8	Resting arm diastolic BP	210291	phv00210291.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:48:44+00:00	2018-03-19 17:48:44+00:00 	SBPA22	[Third blood pressure measurement]. 2nd and 3rd diastolic. Q22 [Siting Blood Pressure, exam 1]
8	Resting arm diastolic BP	210308	phv00210308.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:50:23+00:00	2018-03-19 17:50:23+00:00 	SBPB13	First blood pressure measurement, diastolic Q13 [Sitting Blood Pressure, exam 2]
8	Resting arm diastolic BP	210311	phv00210311.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:50:50+00:00	2018-03-19 17:50:50+00:00 	SBPB16	Second blood pressure measurement, diastolic. Q16 [Sitting Blood Pressure, exam 2]
8	Resting arm diastolic BP	210314	phv00210314.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:51:26+00:00	2018-03-19 17:51:26+00:00 	SBPB19	Third blood pressure measurement, diastolic. Q19 [Sitting Blood Pressure, exam 2]
8	Resting arm diastolic BP	210317	phv00210317.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:51:53+00:00	2018-03-19 17:51:53+00:00 	SBPB22	Computed net average of second and third blood pressure measurements, diastolic. Q22 [Sitting Blood Pressure, exam 2]
8	Resting arm diastolic BP	210332	phv00210332.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:52:50+00:00	2018-03-19 17:52:50+00:00 	SBPC14	1st diastolic blood pressure measurement, diastolic. Q14 [Sitting Blood Pressure, exam 3]
8	Resting arm diastolic BP	210335	phv00210335.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:53:14+00:00	2018-03-19 17:53:14+00:00 	SBPC17	2nd diastolic blood pressure measurement, diastolic. Q17 [Sitting Blood Pressure, exam 3]
8	Resting arm diastolic BP	210338	phv00210338.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:53:38+00:00	2018-03-19 17:53:38+00:00 	SBPC20	3rd diastolic blood pressure measurement, diastolic. Q20 [Sitting Blood Pressure, exam 3]
8	Resting arm diastolic BP	210341	phv00210341.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:54:08+00:00	2018-03-19 17:54:08+00:00 	SBPC23	[Computed net average of second and third blood pressure measurements]. 2nd and 3rd diastolic blood pressure average. Q23 [Sitting Blood Pressure, exam 3]
8	Resting arm diastolic BP	210358	phv00210358.v1.p1	pht004195.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:54:44+00:00	2018-03-19 17:54:44+00:00 	SBPD14	1st diastolic blood pressure measurement. Q14 [Sitting Blood Pressure, exam 4]
8	Resting arm diastolic BP	210361	phv00210361.v1.p1	pht004195.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:55:05+00:00	2018-03-19 17:55:05+00:00 	SBPD17	2nd diastolic blood pressure measurement. Q17 [Sitting Blood Pressure, exam 4]
8	Resting arm diastolic BP	210364	phv00210364.v1.p1	pht004195.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 17:55:25+00:00	2018-03-19 17:55:25+00:00 	SBPD20	1st and 2nd diastolic blood pressure average. Q20 [Sitting Blood Pressure, exam 4]
8	Resting arm diastolic BP	214059	phv00214059.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 19:24:12+00:00	2018-03-19 19:24:12+00:00 	DIASBP	Seated Diastolic Blood Pressure
8	Resting arm diastolic BP	214089	phv00214089.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 19:24:40+00:00	2018-03-19 19:24:40+00:00 	DIAS120	Seated diastolic BP- first reading
8	Resting arm diastolic BP	214091	phv00214091.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 19:24:57+00:00	2018-03-19 19:24:57+00:00 	DIAS220	Seated diastolic BP- second  reading
8	Resting arm diastolic BP	214093	phv00214093.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 19:25:11+00:00	2018-03-19 19:25:11+00:00 	DIAS320	Seated diastolic BP- third reading
8	Resting arm diastolic BP	210283	phv00210283.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 14:57:19+00:00	2018-03-20 14:57:19+00:00 	SBPA14	[First blood pressure measurement]. 1st zero reading. Q14 [Siting Blood Pressure, exam 1]
8	Resting arm diastolic BP	210286	phv00210286.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 14:57:48+00:00	2018-03-20 14:57:48+00:00 	SBPA17	[Second blood pressure measurement]. 2nd zero reading. Q17 [Siting Blood Pressure, exam 1]
8	Resting arm diastolic BP	210289	phv00210289.v1.p1	pht004192.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 14:58:12+00:00	2018-03-20 14:58:12+00:00 	SBPA20	[Third blood pressure measurement]. 3rd zero reading. Q20 [Siting Blood Pressure, exam 1]
8	Resting arm diastolic BP	210309	phv00210309.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 14:59:15+00:00	2018-03-20 14:59:15+00:00 	SBPB14	First blood pressure measurement, zero reading. Q14 [Sitting Blood Pressure, exam 2]
8	Resting arm diastolic BP	210312	phv00210312.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 14:59:42+00:00	2018-03-20 14:59:42+00:00 	SBPB17	Second blood pressure measurement, zero reading. Q17 [Sitting Blood Pressure, exam 2]
8	Resting arm diastolic BP	210315	phv00210315.v1.p1	pht004193.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:00:01+00:00	2018-03-20 15:00:01+00:00 	SBPB20	Third blood pressure measurement, zero reading. Q20 [Sitting Blood Pressure, exam 2]
8	Resting arm diastolic BP	210333	phv00210333.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:00:29+00:00	2018-03-20 15:00:29+00:00 	SBPC15	1st blood pressure measurement, zero reading. Q15 [Sitting Blood Pressure, exam 3]
8	Resting arm diastolic BP	210336	phv00210336.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:00:47+00:00	2018-03-20 15:00:47+00:00 	SBPC18	2nd blood pressure measurement, zero reading. Q18 [Sitting Blood Pressure, exam 3]
8	Resting arm diastolic BP	210339	phv00210339.v1.p1	pht004194.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:01:14+00:00	2018-03-20 15:01:14+00:00 	SBPC21	3rd blood pressure measurement, zero reading. Q21 [Sitting Blood Pressure, exam 3]
8	Resting arm diastolic BP	210359	phv00210359.v1.p1	pht004195.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:02:00+00:00	2018-03-20 15:02:00+00:00 	SBPD15	1st blood pressure measurement, zero reading. Q15 [Sitting Blood Pressure, exam 4]
8	Resting arm diastolic BP	210362	phv00210362.v1.p1	pht004195.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:02:23+00:00	2018-03-20 15:02:23+00:00 	SBPD18	2nd blood pressure measurement, zero reading. Q18 [Sitting Blood Pressure, exam 4]
8	Resting arm diastolic BP	112476	phv00112476.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	A02R1D	FIRST READING DIASTOLIC
8	Resting arm diastolic BP	112478	phv00112478.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	A02RZ1D	RZ1 DBP
8	Resting arm diastolic BP	112480	phv00112480.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	A02DBP1	FIRST CORRECTED DBP (A02R1D - A02RZ1D)
8	Resting arm diastolic BP	112482	phv00112482.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	A02R2D	SECOND READING DBP
8	Resting arm diastolic BP	112484	phv00112484.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	A02RZ2D	RZ2 DBP
8	Resting arm diastolic BP	112486	phv00112486.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	A02DBP2	SECOND CORRECTED DBP (A02R2D - A02RZ2D)
8	Resting arm diastolic BP	112488	phv00112488.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	A02R3D	THIRD READING DBP
8	Resting arm diastolic BP	112490	phv00112490.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	A02RZ3D	RZ3 DBP
8	Resting arm diastolic BP	112492	phv00112492.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	A02DBP3	THIRD CORRECTED DBP (A02R3D - A02RZ3D)
8	Resting arm diastolic BP	112495	phv00112495.v2.p2	pht001560.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	A02DBP	MEAN OF 2ND AND 3RD DBPS
8	Resting arm diastolic BP	114114	phv00114114.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	B02R1D	FIRST READING DBP 5TH PHASE. Q 11
8	Resting arm diastolic BP	114116	phv00114116.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	B02RZ1D	RZ1 DBP. Q 12
8	Resting arm diastolic BP	114118	phv00114118.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	B02DBP1	FIRST CORRECTED DBP  (R1_D - RZ1_D). Q 13
8	Resting arm diastolic BP	114120	phv00114120.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	B02R2D	SECOND READING DBP. Q 14
8	Resting arm diastolic BP	114122	phv00114122.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	B02RZ2D	RZ2 DBP. Q 15
8	Resting arm diastolic BP	114124	phv00114124.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	B02DBP2	SECOND CORRECTED DBP (R2_D - RZ2_D). Q 16
8	Resting arm diastolic BP	114126	phv00114126.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	B02R3D	THIRD READING DBP. Q 17
8	Resting arm diastolic BP	114128	phv00114128.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	B02RZ3D	RZ3 DBP. Q 18
8	Resting arm diastolic BP	114130	phv00114130.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	B02DBP3	THIRD CORRECTED DBP  (R3_D - RZ3_D). Q 19
8	Resting arm diastolic BP	114132	phv00114132.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	B02SUMDI	SECOND & THIRD DIAS (R2_RZ2_D + R3_RZ3_D). Q 20
8	Resting arm diastolic BP	114134	phv00114134.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	B02AVGDI	AVERAGE DBP  (SUM_D/2). Q 21
8	Resting arm diastolic BP	115331	phv00115331.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	C02R1D	FIRST READING DBP 5TH PHASE. Q 11
8	Resting arm diastolic BP	115333	phv00115333.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	C02RZ1D	RZ1 DBP. Q 12
8	Resting arm diastolic BP	115335	phv00115335.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	C02DBP1	FIRST CORRECTED DBP  (R1_D - RZ1_D). Q 13
8	Resting arm diastolic BP	115337	phv00115337.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	C02R2D	SECOND READING DBP. Q 14
8	Resting arm diastolic BP	115339	phv00115339.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	C02RZ2D	RZ2 DBP. Q 15
8	Resting arm diastolic BP	115341	phv00115341.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	C02DBP2	SECOND CORRECTED DBP (R2_D - RZ2_D). Q 16
8	Resting arm diastolic BP	115343	phv00115343.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	C02R3D	THIRD READING DBP. Q 17
8	Resting arm diastolic BP	115345	phv00115345.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	C02RZ3D	RZ3 DBP. Q 18
8	Resting arm diastolic BP	115347	phv00115347.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	C02DBP3	THIRD CORRECTED DBP  (R3_D - RZ3_D). Q 19
8	Resting arm diastolic BP	115349	phv00115349.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	C02SUMDI	2ND AND 3RD DIAS (R2_RZ2_D + R3_RZ3_D). Q 20
8	Resting arm diastolic BP	115351	phv00115351.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	C02AVGDI	AVERAGE DBP  (SUM_D/2).
8	Resting arm diastolic BP	116554	phv00116554.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	D02R1D	FIRST READING DBP 5TH PHASE. Q 11
8	Resting arm diastolic BP	116556	phv00116556.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	D02RZ1D	RZ1 DBP. Q 12
8	Resting arm diastolic BP	116560	phv00116560.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	D02R2D	SECOND READING DBP. Q 14
8	Resting arm diastolic BP	116562	phv00116562.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	D02RZ2D	RZ2 DBP. Q 15
8	Resting arm diastolic BP	116566	phv00116566.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	D02R3D	THIRD READING DBP. Q 17
8	Resting arm diastolic BP	116568	phv00116568.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	D02RZ3D	RZ3 DBP. Q 18
8	Resting arm diastolic BP	116572	phv00116572.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	D02SUMDI	2ND AND 3RD DIAS (R2_RZ2_D + R3_RZ3_D). Q 20
8	Resting arm diastolic BP	116574	phv00116574.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	D02AVGDI	AVERAGE DBP  (SUM_D/2). Q 21
8	Resting arm diastolic BP	118277	phv00118277.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	E02R1D	FIRST READING DBP 5TH PHASE. Q 11
8	Resting arm diastolic BP	118279	phv00118279.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	E02RZ1D	RZ1 DBP. Q 12
8	Resting arm diastolic BP	118281	phv00118281.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	E02DBP1	FIRST CORRECTED DBP  (R1_D - RZ1_D). Q 13
8	Resting arm diastolic BP	118283	phv00118283.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	E02R2D	SECOND READING DBP. Q 14
8	Resting arm diastolic BP	118285	phv00118285.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	E02RZ2D	RZ2 DBP. Q 15
8	Resting arm diastolic BP	118287	phv00118287.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	E02DBP2	SECOND CORRECTED DBP (R2_D - RZ2_D). Q 16
8	Resting arm diastolic BP	118289	phv00118289.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	E02R3D	THIRD READING DBP. Q 17
8	Resting arm diastolic BP	118291	phv00118291.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:08+00:00	2018-04-17 15:27:08+00:00 	E02RZ3D	RZ3 DBP. Q 18
8	Resting arm diastolic BP	118293	phv00118293.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	E02DBP3	THIRD CORRECTED DBP  (R3_D - RZ3_D). Q 19
8	Resting arm diastolic BP	118295	phv00118295.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	E02SUMDI	2ND AND 3RD DIAS (R2_RZ2_D + R3_RZ3_D). Q 20
8	Resting arm diastolic BP	118297	phv00118297.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	E02AVGDI	AVERAGE DBP  (SUM_D/2). Q 21
8	Resting arm diastolic BP	119704	phv00119704.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	F02R1D	FIRST READING DBP 5TH PHASE. Q 11
8	Resting arm diastolic BP	119706	phv00119706.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	F02RZ1D	RZ1 DBP. Q 12
8	Resting arm diastolic BP	119708	phv00119708.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	F02DBP1	FIRST CORRECTED DBP  (R1_D - RZ1_D). Q 13
8	Resting arm diastolic BP	119710	phv00119710.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	F02R2D	SECOND READING DBP. Q 14
8	Resting arm diastolic BP	119712	phv00119712.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	F02RZ2D	RZ2 DBP. Q15
8	Resting arm diastolic BP	119714	phv00119714.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	F02DBP2	SECOND CORRECTED DBP (R2_D - RZ2_D). Q 16
8	Resting arm diastolic BP	119716	phv00119716.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	F02R3D	THIRD READING DBP. Q 17
8	Resting arm diastolic BP	119718	phv00119718.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	F02RZ3D	RZ3 DBP. Q 18
8	Resting arm diastolic BP	119720	phv00119720.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	F02DBP3	THIRD CORRECTED DBP  (R3_D - RZ3_D). Q 19
8	Resting arm diastolic BP	119722	phv00119722.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	F02SUMDI	2ND AND 3RD DIAS (R2_RZ2_D + R3_RZ3_D). Q 20
8	Resting arm diastolic BP	119724	phv00119724.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 15:27:09+00:00	2018-04-17 15:27:09+00:00 	F02AVGDI	AVERAGE DBP  (SUM_D/2). Q 21
8	Resting arm diastolic BP	115204	phv00115204.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:23:31+00:00	2018-04-19 20:23:31+00:00 	C1MDBP	AVERAGE DIASTOLIC BLOOD PRESSURE (mmHg)
8	Resting arm diastolic BP	116229	phv00116229.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:24:04+00:00	2018-04-19 20:24:04+00:00 	C42AYD1	DIASTOLIC Y-TUBED BP 1ST READING
8	Resting arm diastolic BP	116233	phv00116233.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:24:23+00:00	2018-04-19 20:24:23+00:00 	C42AYD2	DIASTOLIC Y-TUBED BP 2ND READING
8	Resting arm diastolic BP	116237	phv00116237.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:24:57+00:00	2018-04-19 20:24:57+00:00 	C42AYD3	DIASTOLIC Y-TUBED BP 3RD READING
8	Resting arm diastolic BP	116241	phv00116241.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:25:23+00:00	2018-04-19 20:25:23+00:00 	C42AYD4	DIASTOLIC Y-TUBED BP 4TH READING
8	Resting arm diastolic BP	116245	phv00116245.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:25:41+00:00	2018-04-19 20:25:41+00:00 	C42AYD5	DIASTOLIC Y-TUBED BP 5TH READING
8	Resting arm diastolic BP	116249	phv00116249.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:25:56+00:00	2018-04-19 20:25:56+00:00 	C42AYD6	DIASTOLIC Y-TUBED BP 6TH READING
8	Resting arm diastolic BP	116253	phv00116253.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:26:12+00:00	2018-04-19 20:26:12+00:00 	C42AYD7	DIASTOLIC Y-TUBED BP 7TH READING
8	Resting arm diastolic BP	116257	phv00116257.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:26:26+00:00	2018-04-19 20:26:26+00:00 	C42AYD8	DIASTOLIC Y-TUBED BP 8TH READING
8	Resting arm diastolic BP	116261	phv00116261.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:26:47+00:00	2018-04-19 20:26:47+00:00 	C42AYD9	DIASTOLIC Y-TUBED BP 9TH READING
8	Resting arm diastolic BP	116265	phv00116265.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:27:03+00:00	2018-04-19 20:27:03+00:00 	C42AYD10	DIASTOLIC Y-TUBED BP 10TH READING
8	Resting arm diastolic BP	116269	phv00116269.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:27:27+00:00	2018-04-19 20:27:27+00:00 	C42AEYD1	END OF TEST Y-TUBED DIASTOLIC 1ST READ
8	Resting arm diastolic BP	116273	phv00116273.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:27:50+00:00	2018-04-19 20:27:50+00:00 	C42AEYD2	END OF TEST Y-TUBED DIASTOLIC 2ND READ
8	Resting arm diastolic BP	116277	phv00116277.v2.p2	pht001685.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:28:25+00:00	2018-04-19 20:28:25+00:00 	C42AEYD3	END OF TEST Y-TUBED DIASTOLIC 3RD READ
8	Resting arm diastolic BP	119239	phv00119239.v2.p2	pht001789.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:28:40+00:00	2018-04-19 20:28:40+00:00 	E40DBP	DIASTOLIC BLOOD PRESSURE. Q 3
8	Resting arm diastolic BP	83400	phv00083400.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:07:36+00:00	2018-04-23 04:07:36+00:00 	d1bp1	SEATED BP: DIASTOLIC 1ST READING (mmHg)
8	Resting arm diastolic BP	83404	phv00083404.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:07:43+00:00	2018-04-23 04:07:43+00:00 	d2bp1	SEATED BP: DIASTOLIC 2ND READING (mmHg)
8	Resting arm diastolic BP	83407	phv00083407.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:07:49+00:00	2018-04-23 04:07:49+00:00 	d3bp1	SEATED BP: DIASTOLIC 3RD READING (mmHg)
8	Resting arm diastolic BP	83411	phv00083411.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:07:54+00:00	2018-04-23 04:07:54+00:00 	dbp1c	SEATED DIASTOLIC BLOOD PRESSURE (mmHg)
8	Resting arm diastolic BP	84495	phv00084495.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:08:00+00:00	2018-04-23 04:08:00+00:00 	predia1	DIASTOLIC BLOOD PRESSURE BEFORE SERIES 7 MRI
8	Resting arm diastolic BP	84497	phv00084497.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:08:05+00:00	2018-04-23 04:08:05+00:00 	postdia1	DIASTOLIC BLOOD PRESSURE AFTER SERIES 7 MRI
8	Resting arm diastolic BP	85704	phv00085704.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:08:11+00:00	2018-04-23 04:08:11+00:00 	dbpcp1	DIASTOLIC BLOOD PRESSURE (FROM OSCILLOMETRIC CUFF), (mmHg)
8	Resting arm diastolic BP	85733	phv00085733.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:08:17+00:00	2018-04-23 04:08:17+00:00 	d1bp1	SEATED BP: DIASTOLIC 1ST READING (mmHg)
8	Resting arm diastolic BP	85736	phv00085736.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:08:24+00:00	2018-04-23 04:08:24+00:00 	d2bp1	SEATED BP: DIASTOLIC 2ND READING (mmHg)
8	Resting arm diastolic BP	85738	phv00085738.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:08:29+00:00	2018-04-23 04:08:29+00:00 	d3bp1	SEATED BP: DIASTOLIC 3RD READING (mmHg)
8	Resting arm diastolic BP	85741	phv00085741.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:08:35+00:00	2018-04-23 04:08:35+00:00 	dbp1c	SEATED DIASTOLIC BLOOD PRESSURE (mmHg)
8	Resting arm diastolic BP	86225	phv00086225.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:08:40+00:00	2018-04-23 04:08:40+00:00 	dbp2c	SEATED DIASTOLIC BLOOD PRESSURE (mmHg)
8	Resting arm diastolic BP	86233	phv00086233.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:08:46+00:00	2018-04-23 04:08:46+00:00 	d1bp2	SEATED BP: DIASTOLIC 1ST READING (mmHg)
8	Resting arm diastolic BP	86235	phv00086235.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:08:51+00:00	2018-04-23 04:08:51+00:00 	d2bp2	SEATED BP: DIASTOLIC 2ND READING (mmHg)
8	Resting arm diastolic BP	86237	phv00086237.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:08:56+00:00	2018-04-23 04:08:56+00:00 	d3bp2	SEATED BP: DIASTOLIC 3RD READING (mmHg)
8	Resting arm diastolic BP	86708	phv00086708.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:09:02+00:00	2018-04-23 04:09:02+00:00 	dbp3c	SEATED DIASTOLIC BLOOD PRESSURE (mmHg)
8	Resting arm diastolic BP	86716	phv00086716.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:09:06+00:00	2018-04-23 04:09:06+00:00 	d1bp3	SEATED BP: DIASTOLIC 1ST READING (mmHg)
8	Resting arm diastolic BP	86719	phv00086719.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:09:11+00:00	2018-04-23 04:09:11+00:00 	d2bp3	SEATED BP: DIASTOLIC 2ND READING (mmHg)
8	Resting arm diastolic BP	86721	phv00086721.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:09:18+00:00	2018-04-23 04:09:18+00:00 	d3bp3	SEATED BP: DIASTOLIC 3RD READING (mmHg)
8	Resting arm diastolic BP	87030	phv00087030.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:09:23+00:00	2018-04-23 04:09:23+00:00 	dbp4c	SEATED DIASTOLIC BLOOD PRESSURE (mmhg)
8	Resting arm diastolic BP	87038	phv00087038.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:09:29+00:00	2018-04-23 04:09:29+00:00 	d1bp4	SEATED BP: DIASTOLIC 1ST READING (mmhg)
8	Resting arm diastolic BP	87041	phv00087041.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:09:36+00:00	2018-04-23 04:09:36+00:00 	d2bp4	SEATED BP: DIASTOLIC 2ND READING (mmhg)
8	Resting arm diastolic BP	87043	phv00087043.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:09:41+00:00	2018-04-23 04:09:41+00:00 	d3bp4	SEATED BP: DIASTOLIC 3RD READING (mmhg)
8	Resting arm diastolic BP	87085	phv00087085.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:09:47+00:00	2018-04-23 04:09:47+00:00 	dbpfc	MEAN: SEATED DIASTOLIC BLOOD PRESSURE (mmHg)
8	Resting arm diastolic BP	87506	phv00087506.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:09:52+00:00	2018-04-23 04:09:52+00:00 	d1bpf	1ST READING: SEATED DIASTOLIC BP (mmHg)
8	Resting arm diastolic BP	87510	phv00087510.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:09:58+00:00	2018-04-23 04:09:58+00:00 	d2bpf	2ND READING: SEATED DIASTOLIC BP (mmHg)
8	Resting arm diastolic BP	87513	phv00087513.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:10:03+00:00	2018-04-23 04:10:03+00:00 	d3bpf	3RD READING: SEATED DIASTOLIC BP (mmHg)
8	Resting arm diastolic BP	175588	phv00175588.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:10:08+00:00	2018-04-23 04:10:08+00:00 	d1bp5	SEATED BP: DIASTOLIC 1ST READING (mmHg)
8	Resting arm diastolic BP	175592	phv00175592.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:10:13+00:00	2018-04-23 04:10:13+00:00 	d2bp5	SEATED BP: DIASTOLIC 2ND READING (mmHg)
8	Resting arm diastolic BP	175595	phv00175595.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:10:18+00:00	2018-04-23 04:10:18+00:00 	d3bp5	SEATED BP: DIASTOLIC 3RD READING (mmHg)
8	Resting arm diastolic BP	175602	phv00175602.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:10:23+00:00	2018-04-23 04:10:23+00:00 	dbp5c	SEATED DIASTOLIC BLOOD PRESSURE (mmHg)
8	Resting arm diastolic BP	177022	phv00177022.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:10:31+00:00	2018-04-23 04:10:31+00:00 	d1bp5	SEATED BP: DIASTOLIC 1ST READING (mmHg)
8	Resting arm diastolic BP	177026	phv00177026.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:10:44+00:00	2018-04-23 04:10:44+00:00 	d2bp5	SEATED BP: DIASTOLIC 2ND READING (mmHg)
8	Resting arm diastolic BP	177029	phv00177029.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:10:52+00:00	2018-04-23 04:10:52+00:00 	d3bp5	SEATED BP: DIASTOLIC 3RD READING (mmHg)
8	Resting arm diastolic BP	177036	phv00177036.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 04:10:57+00:00	2018-04-23 04:10:57+00:00 	dbp5c	SEATED DIASTOLIC BLOOD PRESSURE (mmHg)
8	Resting arm diastolic BP	205848	phv00205848.v1.p1	pht004079.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 21:29:36+00:00	2018-04-25 21:29:36+00:00 	ECHA8	Diastolic blood pressure 8 [Cohort (Jackson only), Exam 3]
8	Resting arm diastolic BP	101960	phv00101960.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:15:07+00:00	2018-05-03 18:15:07+00:00 	AVEDIA	DIASTOLIC BP (mm Hg)
8	Resting arm diastolic BP	102575	phv00102575.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:15:23+00:00	2018-05-03 18:15:23+00:00 	AVEDIA	DIASTOLIC BP (mm Hg)
8	Resting arm diastolic BP	104698	phv00104698.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:15:35+00:00	2018-05-03 18:15:35+00:00 	AVEDIA	DIASTOLIC BP (mm Hg)
8	Resting arm diastolic BP	105433	phv00105433.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:15:46+00:00	2018-05-03 18:15:46+00:00 	AVEDIA	AVE DIASTOLIC BP (mm Hg)
8	Resting arm diastolic BP	106795	phv00106795.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:15:59+00:00	2018-05-03 18:15:59+00:00 	AVEDIA	DIASTOLIC BP (mm Hg)
8	Resting arm diastolic BP	107775	phv00107775.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:16:18+00:00	2018-05-03 18:16:18+00:00 	AVEDIA	DIASTOLIC BP (mm Hg)
8	Resting arm diastolic BP	108831	phv00108831.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:16:30+00:00	2018-05-03 18:16:30+00:00 	AVEDIA	DIASTOLIC BP (mm Hg)
8	Resting arm diastolic BP	110338	phv00110338.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:16:42+00:00	2018-05-03 18:16:42+00:00 	AVEDIA	DIASTOLIC BP (mm Hg)
8	Resting arm diastolic BP	99442	phv00099442.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:19:17+00:00	2018-05-03 18:19:17+00:00 	AVZMDIA	AVE ZERO MEDDLER DIASTOLIC BP  (mm Hg)
8	Resting arm diastolic BP	104021	phv00104021.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:20:46+00:00	2018-05-03 18:20:46+00:00 	AVZMDIA	AVE ZERO MUDDLER DIASTOLIC BP (mm Hg)
8	Resting arm diastolic BP	79855	phv00079855.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-07 22:37:35+00:00	2018-05-07 22:37:35+00:00 	DIASBP1	Diastolic blood pressure (1st reading)
8	Resting arm diastolic BP	79857	phv00079857.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-07 22:37:36+00:00	2018-05-07 22:37:36+00:00 	DIASBP2	Diastolic blood pressure (2nd reading)
8	Resting arm diastolic BP	79865	phv00079865.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-07 22:37:36+00:00	2018-05-07 22:37:36+00:00 	DIAS	Diastolic BP
8	Resting arm diastolic BP	283298	phv00283298.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-07 22:37:36+00:00	2018-05-07 22:37:36+00:00 	DIASBP1	Diastolic blood pressure (1st reading)
8	Resting arm diastolic BP	283300	phv00283300.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-07 22:37:36+00:00	2018-05-07 22:37:36+00:00 	DIASBP2	Diastolic blood pressure (2nd reading)
8	Resting arm diastolic BP	283537	phv00283537.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-07 22:37:36+00:00	2018-05-07 22:37:36+00:00 	DIAS	F136 Diastolic blood pressure at onset, mm/Hg
8	Resting arm diastolic BP	7359	phv00007359.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 15:30:32+00:00	2018-05-09 15:30:32+00:00 	FT320	MEDICAL HISTORY - BLOOD PRESSURE - 1ST READING (TO NEAREST 2MM HG)
8	Resting arm diastolic BP	24462	phv00024462.v5.p10	pht000195.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 11:45:30+00:00	2018-05-14 11:45:30+00:00 	EF35	POST DIASTOLIC BLOOD PRESSURE
8	Resting arm diastolic BP	24457	phv00024457.v5.p10	pht000195.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 11:46:47+00:00	2018-05-14 11:46:47+00:00 	brdbp	BASELINE DIASTOLIC BLOOD PRESSURE (RENAMED FROM EF24)
8	Resting arm diastolic BP	24480	phv00024480.v5.p10	pht000195.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 11:47:24+00:00	2018-05-14 11:47:24+00:00 	dbp	BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA)
8	Resting arm diastolic BP	24413	phv00024413.v4.p10	pht000194.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 11:47:36+00:00	2018-05-14 11:47:36+00:00 	dbp	BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA)
8	Resting arm diastolic BP	66713	phv00066713.v4.p10	pht000673.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 11:48:25+00:00	2018-05-14 11:48:25+00:00 	DBP	DIASTOLIC BLOOD PRESSURE ENTERED BY TECHNICIAN, MMHG
8	Resting arm diastolic BP	72660	phv00072660.v4.p10	pht000748.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 11:48:44+00:00	2018-05-14 11:48:44+00:00 	dbp	Diastolic blood pressure entered by technician
8	Resting arm diastolic BP	24866	phv00024866.v1.p10	pht000211.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 11:49:12+00:00	2018-05-14 11:49:12+00:00 	dbp	BRACHIAL DIASTOLIC PRESSURE (FROM TONOMETRY DATA) (MMHG)
8	Resting arm diastolic BP	24779	phv00024779.v5.p10	pht000209.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 11:50:08+00:00	2018-05-14 11:50:08+00:00 	dbp	BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) (OLD NAME: TONDBP)
8	Resting arm diastolic BP	24825	phv00024825.v4.p10	pht000210.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 11:50:27+00:00	2018-05-14 11:50:27+00:00 	dbp	BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA)
8	Resting arm diastolic BP	24892	phv00024892.v1.p10	pht000211.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 11:51:38+00:00	2018-05-14 11:51:38+00:00 	TM13	MANUAL BLOOD PRESSURE: DIASTOLIC (FIRST IF ODD ID#) (MMHG)
8	Resting arm diastolic BP	24894	phv00024894.v1.p10	pht000211.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 11:51:54+00:00	2018-05-14 11:51:54+00:00 	TM15	AUTO BLOOD PRESSURE AND PULSE: DIASTOLIC (FIRST IF EVEN ID#) (MMHG)
8	Resting arm diastolic BP	8197	phv00008197.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-14 11:59:51+00:00	2018-05-14 11:59:51+00:00 	B553	DIASTOLIC-RESTING, SIT
8	Resting arm diastolic BP	123002	phv00123002.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-06-18 19:16:36+00:00	2018-06-18 19:16:36+00:00 	dbp	Mean Diastolic BP
8	Resting arm diastolic BP	277346	phv00277346.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:02:05+00:00	2018-08-02 19:02:05+00:00 	DINA_DIA3	Dinamap: Diastolic pressure; 3rd of 3 readings Collection Interval: 2009-2011
8	Resting arm diastolic BP	277342	phv00277342.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:02:14+00:00	2018-08-02 19:02:14+00:00 	DINA_DIA2	Dinamap: Diastolic pressure; 2nd of 3 readings Collection Interval: 2009-2011
8	Resting arm diastolic BP	277338	phv00277338.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:02:22+00:00	2018-08-02 19:02:22+00:00 	DINA_DIA1	Dinamap: Diastolic pressure; 1st of 3 readings Collection Interval: 2009-2011
8	Resting arm diastolic BP	307738	phv00307738.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:02:32+00:00	2018-08-02 19:02:32+00:00 	BpTRU_DIA3	BpTRU: Diastolic; 3rd of 3 readings Collection Interval: 2007-2009
8	Resting arm diastolic BP	307736	phv00307736.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:02:43+00:00	2018-08-02 19:02:43+00:00 	BpTRU_DIA2	BpTRU: Diastolic; 2nd of 3 readings Collection Interval: 2007-2009
8	Resting arm diastolic BP	307734	phv00307734.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:02:51+00:00	2018-08-02 19:02:51+00:00 	BpTRU_DIA1	BpTRU: Diastolic; 1st of 3 readings Collection Interval: 2007-2009
8	Resting arm diastolic BP	277303	phv00277303.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:03:01+00:00	2018-08-02 19:03:01+00:00 	DINA_DIA3	Dinamap: Diastolic pressure; 3rd of 3 readings Collection Interval: 2007-2009
8	Resting arm diastolic BP	277299	phv00277299.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:03:10+00:00	2018-08-02 19:03:10+00:00 	DINA_DIA2	Dinamap: Diastolic pressure; 2nd of 3 readings Collection Interval: 2007-2009
8	Resting arm diastolic BP	277295	phv00277295.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:03:18+00:00	2018-08-02 19:03:18+00:00 	DINA_DIA1	Dinamap: Diastolic pressure; 1st of 3 readings Collection Interval: 2007-2009
8	Resting arm diastolic BP	277771	phv00277771.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:04:00+00:00	2018-08-02 19:04:00+00:00 	RAND_DIA2	Random Zero Sphygmomanometer BP: Diastolic #2 Collection Interval: 2000-2004
8	Resting arm diastolic BP	277769	phv00277769.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:04:08+00:00	2018-08-02 19:04:08+00:00 	RAND_DIA1	Random Zero Sphygmomanometer BP: Diastolic #1 Collection Interval: 2000-2004
8	Resting arm diastolic BP	277665	phv00277665.v1.p1	pht006045.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:04:17+00:00	2018-08-02 19:04:17+00:00 	ECHODIA	Dinamap BP while lying on Echo bed: diastolic Collection Interval: 2001-2004
8	Resting arm diastolic BP	277535	phv00277535.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:04:25+00:00	2018-08-02 19:04:25+00:00 	DINA_DIA3	Dinamap: Diastolic pressure; 3rd of 3 readings Collection Interval: 1996-2000
8	Resting arm diastolic BP	277531	phv00277531.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:04:35+00:00	2018-08-02 19:04:35+00:00 	DINA_DIA2	Dinamap: Diastolic pressure; 2nd of 3 readings Collection Interval: 1996-2000
8	Resting arm diastolic BP	277527	phv00277527.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:04:43+00:00	2018-08-02 19:04:43+00:00 	DINA_DIA1	Dinamap: Diastolic pressure; 1st of 3 readings Collection Interval: 1996-2000
8	Resting arm diastolic BP	277523	phv00277523.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:04:53+00:00	2018-08-02 19:04:53+00:00 	RAND_DIA3	Random-zero sphygmomanometer: Diastolic; 3rd of 3 readings Collection Interval: 1996-2000
8	Resting arm diastolic BP	277521	phv00277521.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:05:00+00:00	2018-08-02 19:05:00+00:00 	RAND_DIA2	Random-zero sphygmomanometer: Diastolic; 2nd of 3 readings Collection Interval: 1996-2000
8	Resting arm diastolic BP	277519	phv00277519.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:05:14+00:00	2018-08-02 19:05:14+00:00 	RAND_DIA1	Random-zero sphygmomanometer: Diastolic; 1st of 3 readings Collection Interval: 1996-2000
8	Resting arm diastolic BP	307763	phv00307763.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:05:51+00:00	2018-08-02 19:05:51+00:00 	DINA_DIA3	Dinamap: Diastolic pressure; 3rd of 3 readings Collection Interval: 2006-2011
8	Resting arm diastolic BP	307759	phv00307759.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:06:05+00:00	2018-08-02 19:06:05+00:00 	DINA_DIA2	Dinamap: Diastolic pressure; 2nd of 3 readings Collection Interval: 2006-2011
8	Resting arm diastolic BP	307755	phv00307755.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:06:16+00:00	2018-08-02 19:06:16+00:00 	DINA_DIA1	Dinamap: Diastolic pressure; 1st of 3 readings Collection Interval: 2006-2011
8	Resting arm diastolic BP	307751	phv00307751.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:06:24+00:00	2018-08-02 19:06:24+00:00 	BpTRU_DIA3	BpTRU: Diastolic; 3rd of 3 readings Collection Interval: 2006-2011
8	Resting arm diastolic BP	307749	phv00307749.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:06:32+00:00	2018-08-02 19:06:32+00:00 	BpTRU_DIA2	BpTRU: Diastolic; 2nd of 3 readings Collection Interval: 2006-2011
8	Resting arm diastolic BP	307747	phv00307747.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:06:40+00:00	2018-08-02 19:06:40+00:00 	BpTRU_DIA1	BpTRU: Diastolic; 1st of 3 readings Collection Interval: 2006-2011
8	Resting arm diastolic BP	277785	phv00277785.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:06:49+00:00	2018-08-02 19:06:49+00:00 	DINA_DIA3	Dinamap BP: Diastolic #3 Collection Interval: 2000-2004
8	Resting arm diastolic BP	277781	phv00277781.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:06:57+00:00	2018-08-02 19:06:57+00:00 	DINA_DIA2	Dinamap BP: Diastolic #2 Collection Interval: 2000-2004
8	Resting arm diastolic BP	277777	phv00277777.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:07:06+00:00	2018-08-02 19:07:06+00:00 	DINA_DIA1	Dinamap BP: Diastolic #1 Collection Interval: 2000-2004
8	Resting arm diastolic BP	277773	phv00277773.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:07:14+00:00	2018-08-02 19:07:14+00:00 	RAND_DIA3	Random Zero Sphygmomanometer BP: Diastolic #3 Collection Interval: 2000-2004
8	Resting arm diastolic BP	307976	phv00307976.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:08:01+00:00	2018-08-02 19:08:01+00:00 	DINA_DIA3	Dinamap BP: Diastolic #3 Collection Interval: 2000-2004
8	Resting arm diastolic BP	307972	phv00307972.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:08:09+00:00	2018-08-02 19:08:09+00:00 	DINA_DIA2	Dinamap BP: Diastolic #2 Collection Interval: 2000-2004
8	Resting arm diastolic BP	307968	phv00307968.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:08:17+00:00	2018-08-02 19:08:17+00:00 	DINA_DIA1	Dinamap BP: Diastolic #1 Collection Interval: 2000-2004
8	Resting arm diastolic BP	307964	phv00307964.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:08:25+00:00	2018-08-02 19:08:25+00:00 	RAND_DIA3	Random Zero Sphygmomanometer BP: Diastolic #3 Collection Interval: 2000-2004
8	Resting arm diastolic BP	307962	phv00307962.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:08:34+00:00	2018-08-02 19:08:34+00:00 	RAND_DIA2	Random Zero Sphygmomanometer BP: Diastolic #2 Collection Interval: 2000-2004
8	Resting arm diastolic BP	307960	phv00307960.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:08:44+00:00	2018-08-02 19:08:44+00:00 	RAND_DIA1	Random Zero Sphygmomanometer BP: Diastolic #1 Collection Interval: 2000-2004
8	Resting arm diastolic BP	307816	phv00307816.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:08:52+00:00	2018-08-02 19:08:52+00:00 	DINA_DIA3	Dinamap: Diastolic pressure; 3rd of 3 readings Collection Interval: 1996-2000
8	Resting arm diastolic BP	307812	phv00307812.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:09:00+00:00	2018-08-02 19:09:00+00:00 	DINA_DIA2	Dinamap: Diastolic pressure; 2nd of 3 readings Collection Interval: 1996-2000
8	Resting arm diastolic BP	307808	phv00307808.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:09:08+00:00	2018-08-02 19:09:08+00:00 	DINA_DIA1	Dinamap: Diastolic pressure; 1st of 3 readings Collection Interval: 1996-2000
8	Resting arm diastolic BP	307804	phv00307804.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:09:17+00:00	2018-08-02 19:09:17+00:00 	RAND_DIA3	Random-zero sphygmomanometer: Diastolic; 3rd of 3 readings Collection Interval: 1996-2000
8	Resting arm diastolic BP	307802	phv00307802.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:09:26+00:00	2018-08-02 19:09:26+00:00 	RAND_DIA2	Random-zero sphygmomanometer: Diastolic; 2nd of 3 readings Collection Interval: 1996-2000
8	Resting arm diastolic BP	307800	phv00307800.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 19:09:34+00:00	2018-08-02 19:09:34+00:00 	RAND_DIA1	Random-zero sphygmomanometer: Diastolic; 1st of 3 readings Collection Interval: 1996-2000
8	Resting arm diastolic BP	159583	phv00159583.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-02 19:10:41+00:00	2018-08-02 19:10:41+00:00 	diasBP	Diastolic blood pressure [mmHg] Collection Interval: Collected in Exam 1
8	Resting arm diastolic BP	277670	phv00277670.v1.p1	pht006045.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:00:51+00:00	2018-08-14 23:00:51+00:00 	ECHO_DBP	Diastolic BP Collection Interval: 2001-2004
8	Resting arm diastolic BP	123845	phv00123845.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:58:02+00:00	2018-08-21 17:58:02+00:00 	PM10DIA1	BP: 10 PM - Diastolic 1
8	Resting arm diastolic BP	123848	phv00123848.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:58:16+00:00	2018-08-21 17:58:16+00:00 	PM10DIA2	BP: 10 PM - Diastolic 2
8	Resting arm diastolic BP	123851	phv00123851.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:58:31+00:00	2018-08-21 17:58:31+00:00 	PM10DIA3	BP: 10 PM - Diastolic 3
8	Resting arm diastolic BP	123855	phv00123855.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:58:45+00:00	2018-08-21 17:58:45+00:00 	AM7DIA1	BP: 7 AM - Diastolic 1
8	Resting arm diastolic BP	123858	phv00123858.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:59:04+00:00	2018-08-21 17:59:04+00:00 	AM7DIA2	BP: 7 AM - Diastolic 2
8	Resting arm diastolic BP	123861	phv00123861.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:59:16+00:00	2018-08-21 17:59:16+00:00 	AM7DIA3	BP: 7 AM - Diastolic 3
8	Resting arm diastolic BP	123865	phv00123865.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:23:36+00:00	2018-08-21 18:23:36+00:00 	AM10DIA1	BP: 10 AM - Diastolic 1
8	Resting arm diastolic BP	123868	phv00123868.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:23:47+00:00	2018-08-21 18:23:47+00:00 	AM10DIA2	BP: 10 AM - Diastolic 2
8	Resting arm diastolic BP	123871	phv00123871.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:23:58+00:00	2018-08-21 18:23:58+00:00 	AM10DIA3	BP: 10 AM - Diastolic 3
8	Resting arm diastolic BP	124247	phv00124247.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:51:11+00:00	2018-08-21 18:51:11+00:00 	pm10dia	BP: 10 PM Diastolic
8	Resting arm diastolic BP	124249	phv00124249.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:51:21+00:00	2018-08-21 18:51:21+00:00 	am7dia	BP: 7 AM Diastolic
8	Resting arm diastolic BP	124251	phv00124251.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:51:34+00:00	2018-08-21 18:51:34+00:00 	am10dia	BP: 10 AM Diastolic
8	Resting arm diastolic BP	114879	phv00114879.v2.p2	pht001633.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:42:27+00:00	2018-08-22 23:42:27+00:00 	B28DBP4	PRE-INSTRUCTION BASELINE DBP #4
8	Resting arm diastolic BP	114875	phv00114875.v2.p2	pht001633.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:42:41+00:00	2018-08-22 23:42:41+00:00 	B28DBP3	PRE-INSTRUCTION BASELINE DBP #3
8	Resting arm diastolic BP	114871	phv00114871.v2.p2	pht001633.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:42:57+00:00	2018-08-22 23:42:57+00:00 	B28DBP2	PRE-INSTRUCTION BASELINE DBP #2
8	Resting arm diastolic BP	114867	phv00114867.v2.p2	pht001633.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:43:10+00:00	2018-08-22 23:43:10+00:00 	B28DBP1	PRE-INSTRUCTION BASELINE DBP #1
8	Resting arm diastolic BP	116136	phv00116136.v2.p2	pht001680.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 18:44:53+00:00	2018-08-23 18:44:53+00:00 	C40DBP	DIASTOLIC BLOOD PRESSURE
8	Resting arm diastolic BP	116570	phv00116570.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 21:38:28+00:00	2018-08-23 21:38:28+00:00 	D02DBP3	THIRD CORRECTED DBP  (R3_D - RZ3_D). Q 19
12	Height	125860	phv00125860.v1.p1	pht001940.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:24:41+00:00	2018-02-22 21:24:41+00:00 	antv1	1: Standing height to nearest cm
12	Height	539	phv00000539.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:47:24+00:00	2018-03-01 16:47:24+00:00 	MF67	HEIGHT: FULL INCHES, EXAM 1
12	Height	540	phv00000540.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:47:38+00:00	2018-03-01 16:47:38+00:00 	MF68	HEIGHT: IN EXCESS OF FULL INCHES, EXAM 1
12	Height	680	phv00000680.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:47:50+00:00	2018-03-01 16:47:50+00:00 	MF217	STANDING HEIGHT: FULL INCHES, EXAM 4
12	Height	681	phv00000681.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:48:03+00:00	2018-03-01 16:48:03+00:00 	MF218	STANDING HEIGHT: IN EXCESS OF FULL INCHES, EXAM 4
12	Height	744	phv00000744.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:48:21+00:00	2018-03-01 16:48:21+00:00 	MF290	HEIGHT: FULL INCHES, EXAM 5
12	Height	745	phv00000745.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:48:38+00:00	2018-03-01 16:48:38+00:00 	MF291	HEIGHT: IN EXCESS OF FULL INCHES, EXAM 5
12	Height	1367	phv00001367.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:48:51+00:00	2018-03-01 16:48:51+00:00 	FC7	HEIGHT, TO NEXT LOWER QUARTER INCH
12	Height	1564	phv00001564.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:49:03+00:00	2018-03-01 16:49:03+00:00 	FD13	HEIGHT, TO NEXT LOWER QUARTER INCH
12	Height	1808	phv00001808.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:50:22+00:00	2018-03-01 16:50:22+00:00 	FE68	HEIGHT, TO NEXT LOWER QUARTER INCH
12	Height	2023	phv00002023.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:50:39+00:00	2018-03-01 16:50:39+00:00 	FF64	HEIGHT, TO NEXT LOWER QUARTER INCH
12	Height	2207	phv00002207.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:51:15+00:00	2018-03-01 16:51:15+00:00 	FG63	HEIGHT, TO NEXT LOWER QUARTER INCH (INCHES X 100; FOR USE DIVIDE BY 100)
12	Height	2428	phv00002428.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:51:34+00:00	2018-03-01 16:51:34+00:00 	FH63	HEIGHT, TO NEXT LOWER QUARTER INCH (INCHES X 100; FOR USE DIVIDE BY 100)
12	Height	2671	phv00002671.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:51:58+00:00	2018-03-01 16:51:58+00:00 	FI15	HEIGHT, INCHES
12	Height	2672	phv00002672.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:52:17+00:00	2018-03-01 16:52:17+00:00 	FI16	HEIGHT, FRAC
12	Height	3245	phv00003245.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:52:34+00:00	2018-03-01 16:52:34+00:00 	FJ361	HEIGHT (INCHES)
12	Height	3303	phv00003303.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:52:50+00:00	2018-03-01 16:52:50+00:00 	FK48	HEIGHT (INCHES)
12	Height	3669	phv00003669.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:53:06+00:00	2018-03-01 16:53:06+00:00 	FL010	HEIGHT
12	Height	4085	phv00004085.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:53:22+00:00	2018-03-01 16:53:22+00:00 	FM20	HEIGHT (IN INCHES TO NEXT LOWER 1/4 INCH)
12	Height	4527	phv00004527.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:53:37+00:00	2018-03-01 16:53:37+00:00 	FN9	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	5542	phv00005542.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:53:57+00:00	2018-03-01 16:53:57+00:00 	FO008	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	5922	phv00005922.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:54:21+00:00	2018-03-01 16:54:21+00:00 	FP008	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	6034	phv00006034.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:54:43+00:00	2018-03-01 16:54:43+00:00 	FQ006	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	6329	phv00006329.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:54:58+00:00	2018-03-01 16:54:58+00:00 	FR006	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	6673	phv00006673.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:55:16+00:00	2018-03-01 16:55:16+00:00 	FS008	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	7101	phv00007101.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:55:52+00:00	2018-03-01 16:55:52+00:00 	FT008	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	7570	phv00007570.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:56:11+00:00	2018-03-01 16:56:11+00:00 	A51	BODY HEIGHT
12	Height	7571	phv00007571.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:56:25+00:00	2018-03-01 16:56:25+00:00 	A52	FRACTIONAL BODY HEIGHT
12	Height	7677	phv00007677.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:56:41+00:00	2018-03-01 16:56:41+00:00 	B14	BODY HEIGHT (CM)
12	Height	7679	phv00007679.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:56:54+00:00	2018-03-01 16:56:54+00:00 	B16	BODY HEIGHT (INCHES)
12	Height	7680	phv00007680.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:57:10+00:00	2018-03-01 16:57:10+00:00 	B17	BODY HEIGHT (FRACTION)
12	Height	8714	phv00008714.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:57:25+00:00	2018-03-01 16:57:25+00:00 	C417	HEIGHT IN INCHES
12	Height	8763	phv00008763.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:57:40+00:00	2018-03-01 16:57:40+00:00 	D402	HEIGHT (IN INCHES TO NEXT LOWER 1/4 INCH)
12	Height	9553	phv00009553.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:57:52+00:00	2018-03-01 16:57:52+00:00 	E025	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	10109	phv00010109.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:58:08+00:00	2018-03-01 16:58:08+00:00 	F008	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	10499	phv00010499.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:58:26+00:00	2018-03-01 16:58:26+00:00 	G441	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	21231	phv00021231.v5.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 16:58:51+00:00	2018-03-01 16:58:51+00:00 	G3A446	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	55258	phv00055258.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:44:20+00:00	2018-03-01 17:44:20+00:00 	Height	Height in centimeters
12	Height	56840	phv00056840.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:44:46+00:00	2018-03-01 17:44:46+00:00 	pm207	Height in cm
12	Height	70555	phv00070555.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:45:02+00:00	2018-03-01 17:45:02+00:00 	FU258	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	72337	phv00072337.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:45:24+00:00	2018-03-01 17:45:24+00:00 	H399	HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH)
12	Height	177539	phv00177539.v3.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:45:56+00:00	2018-03-01 17:45:56+00:00 	g3b0483	Anthropometry: Height
12	Height	250288	phv00250288.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:48:14+00:00	2018-03-01 17:48:14+00:00 	e025	Numerical Data - Part I: Height Collection Interval: Exam 1
12	Height	251062	phv00251062.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:51:55+00:00	2018-03-01 17:51:55+00:00 	g441	Numerical Data - Part I - Basic Information: Height (to next lower 1/4 inch) Collection Interval: Exam 2
12	Height	251535	phv00251535.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:52:11+00:00	2018-03-01 17:52:11+00:00 	h399	Numerical Data - Part I: Basic Information: Height (nearest 1/4 inch) Collection Interval: Exam 3
12	Height	254284	phv00254284.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:52:31+00:00	2018-03-01 17:52:31+00:00 	j472	Numerical Data/Anthropometry: Height
12	Height	254766	phv00254766.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:52:54+00:00	2018-03-01 17:52:54+00:00 	fv260	Numerical Data (Anthropometry) - Basic Information: Height Collection Interval: Exam 29
12	Height	255158	phv00255158.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:53:17+00:00	2018-03-01 17:53:17+00:00 	fw305	Numerical Data: Basic Information: Height Collection Interval: Original Cohort Exam 30
12	Height	274053	phv00274053.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:53:45+00:00	2018-03-01 17:53:45+00:00 	g3a446	Height Collection Interval: Exam 1
12	Height	274544	phv00274544.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:54:00+00:00	2018-03-01 17:54:00+00:00 	g3a446	Height
12	Height	274883	phv00274883.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:54:22+00:00	2018-03-01 17:54:22+00:00 	FX305	Numerical Data: Basic Information: Height Collection Interval: Original Cohort Exam 31
12	Height	275241	phv00275241.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:54:39+00:00	2018-03-01 17:54:39+00:00 	fy305	Numerical Data: Basic Information: Height Collection Interval: Original Cohort Exam 32
12	Height	277042	phv00277042.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:55:03+00:00	2018-03-01 17:55:03+00:00 	HGT1	Height, Exam 1
12	Height	277043	phv00277043.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:55:13+00:00	2018-03-01 17:55:13+00:00 	HGT2	Height, Exam 2
12	Height	277171	phv00277171.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:55:24+00:00	2018-03-01 17:55:24+00:00 	HGT1	Height, Exam 1
12	Height	277172	phv00277172.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:55:35+00:00	2018-03-01 17:55:35+00:00 	HGT2	Height, Exam 2
12	Height	277173	phv00277173.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:55:50+00:00	2018-03-01 17:55:50+00:00 	HGT3	Height, Exam 3
12	Height	277174	phv00277174.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:56:01+00:00	2018-03-01 17:56:01+00:00 	HGT4	Height, Exam 4
12	Height	277175	phv00277175.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:56:13+00:00	2018-03-01 17:56:13+00:00 	HGT5	Height, Exam 5
12	Height	277176	phv00277176.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:56:28+00:00	2018-03-01 17:56:28+00:00 	HGT6	Height, Exam 6
12	Height	277177	phv00277177.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:56:40+00:00	2018-03-01 17:56:40+00:00 	HGT7	Height, Exam 7
12	Height	277178	phv00277178.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:56:53+00:00	2018-03-01 17:56:53+00:00 	HGT8	Height, Exam 8
12	Height	277179	phv00277179.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-01 17:57:07+00:00	2018-03-01 17:57:07+00:00 	HGT9	Height, Exam 9
12	Height	226281	phv00226281.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 21:57:03+00:00	2018-03-14 21:57:03+00:00 	HEIGHT	Height (corrected)
12	Height	203151	phv00203151.v1.p1	pht004032.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:44:55+00:00	2018-03-15 14:44:55+00:00 	ANTA01	[Height and weight]. Standing height (to the nearest cm). Q1 [Anthropometry Form, ANTA, exam 1]
12	Height	203175	phv00203175.v1.p1	pht004034.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:45:51+00:00	2018-03-15 14:45:51+00:00 	ANTC1	[Height and weight]. Standing height (to the nearest cm, rounding down). Q1 [Anthropometry Form, ANTC, exam 3]
12	Height	203193	phv00203193.v1.p1	pht004035.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:46:26+00:00	2018-03-15 14:46:26+00:00 	ANTD1	[Height and weight]. Standing height (to the nearest cm, rounding down). Q1 [Anthropometry Form, ANTD, exam 4]
12	Height	113634	phv00113634.v2.p2	pht001583.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:43:40+00:00	2018-04-17 16:43:40+00:00 	A20HGT	PT'S HGT, CM. Q 1
12	Height	114829	phv00114829.v2.p2	pht001632.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:43:40+00:00	2018-04-17 16:43:40+00:00 	B20HGT	SUBJECT'S HEIGHT STANDING IN CM. Q 1
12	Height	115856	phv00115856.v2.p2	pht001671.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:43:40+00:00	2018-04-17 16:43:40+00:00 	C20HGT	SUBJECT'S HEIGHT STANDING (CM). Q 1
12	Height	117230	phv00117230.v2.p2	pht001720.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:43:40+00:00	2018-04-17 16:43:40+00:00 	D20HGT	SUBJECT'S HEIGHT STANDING (CM). Q 1a
12	Height	119093	phv00119093.v2.p2	pht001785.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:43:40+00:00	2018-04-17 16:43:40+00:00 	E20HGT	SUBJECT'S HEIGHT STANDING (CM). Q 1a
12	Height	120994	phv00120994.v2.p2	pht001857.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:43:40+00:00	2018-04-17 16:43:40+00:00 	F20HGT	SUBJECT'S HEIGHT STANDING (CM). Q 1a
12	Height	79858	phv00079858.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-17 23:17:49+00:00	2018-04-17 23:17:49+00:00 	HEIGHTX	F80 Height cm
12	Height	283311	phv00283311.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-17 23:17:49+00:00	2018-04-17 23:17:49+00:00 	HEIGHT	Height, in
12	Height	283539	phv00283539.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-17 23:17:49+00:00	2018-04-17 23:17:49+00:00 	HEIGHT	F136 Height, cm
12	Height	115704	phv00115704.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:53:08+00:00	2018-04-19 19:53:08+00:00 	C12HGT	HEIGHT IN INCHES
12	Height	116480	phv00116480.v2.p2	pht001706.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:53:33+00:00	2018-04-19 19:53:33+00:00 	DDXPTHT	PATIENT DATA: HEIGHT (CM)
12	Height	118136	phv00118136.v2.p2	pht001755.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:54:10+00:00	2018-04-19 19:54:10+00:00 	EHT	HEIGHT
12	Height	118250	phv00118250.v2.p2	pht001756.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:54:24+00:00	2018-04-19 19:54:24+00:00 	EHT	HEIGHT
12	Height	118957	phv00118957.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:54:36+00:00	2018-04-19 19:54:36+00:00 	E12HGT	HEIGHT IN INCHES
12	Height	119506	phv00119506.v2.p2	pht001795.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:55:01+00:00	2018-04-19 19:55:01+00:00 	E53HEIGT	HEIGHT (IN) - FORM 53
12	Height	99550	phv00099550.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 21:45:27+00:00	2018-04-20 21:45:27+00:00 	STHT13	STANDING HEIGHT - CM
12	Height	100382	phv00100382.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 21:46:10+00:00	2018-04-20 21:46:10+00:00 	STHT13	STANDING HEIGHT - CM
12	Height	105412	phv00105412.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 21:46:39+00:00	2018-04-20 21:46:39+00:00 	STHT13	STANDING HEIGHT - CM
12	Height	110375	phv00110375.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 21:46:53+00:00	2018-04-20 21:46:53+00:00 	STHT13	STANDING HEIGHT - CM
12	Height	106775	phv00106775.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 21:50:21+00:00	2018-04-20 21:50:21+00:00 	STHT13	STANDING HEIGHT - CM
12	Height	82683	phv00082683.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:06:45+00:00	2018-04-23 03:06:45+00:00 	htcm1	HEIGHT (cm)
12	Height	83471	phv00083471.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:06:52+00:00	2018-04-23 03:06:52+00:00 	lunghta4	HEIGHT (cm)
12	Height	83706	phv00083706.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:07:00+00:00	2018-04-23 03:07:00+00:00 	lunghta4	HEIGHT (cm)
12	Height	84482	phv00084482.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:07:12+00:00	2018-04-23 03:07:12+00:00 	htcm1	HEIGHT (cm)
12	Height	85799	phv00085799.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:07:26+00:00	2018-04-23 03:07:26+00:00 	htcm2	HEIGHT (cm)
12	Height	86298	phv00086298.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:07:33+00:00	2018-04-23 03:07:33+00:00 	htcm3	HEIGHT (cm)
12	Height	86751	phv00086751.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:07:40+00:00	2018-04-23 03:07:40+00:00 	htcm4	HEIGHT (cm)
12	Height	87078	phv00087078.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:07:48+00:00	2018-04-23 03:07:48+00:00 	htcmf	HEIGHT (cm)
12	Height	87697	phv00087697.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:07:54+00:00	2018-04-23 03:07:54+00:00 	lunghta4	HEIGHT (cm)
12	Height	174630	phv00174630.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:08:00+00:00	2018-04-23 03:08:00+00:00 	htcm5	HEIGHT (cm)
12	Height	175858	phv00175858.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:08:07+00:00	2018-04-23 03:08:07+00:00 	htcm1	HEIGHT (cm)
12	Height	175943	phv00175943.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:08:13+00:00	2018-04-23 03:08:13+00:00 	htcmf	FAMILY COHORT: HEIGHT (cm)
12	Height	176053	phv00176053.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:08:19+00:00	2018-04-23 03:08:19+00:00 	htcm5	HEIGHT (cm)
12	Height	206817	phv00206817.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 20:07:27+00:00	2018-04-25 20:07:27+00:00 	HFAA19A1	[Physical exam - vital signs]. Q19a1- Height (cm/in) at hospital admission (or at onset of event) [Heart Failure Hospital Record Abstraction Form, HFA]
12	Height	206855	phv00206855.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 20:07:45+00:00	2018-04-25 20:07:45+00:00 	HFAA19A	[Physical exam - vital signs]. Q19a - Height at hospital admission (or at onset of event) [Heart Failure Hospital Record Abstraction Form, HFA]
12	Height	214060	phv00214060.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 20:08:02+00:00	2018-04-25 20:08:02+00:00 	HEIGHT	Height in centimeters
12	Height	159592	phv00159592.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:43:38+00:00	2018-08-10 21:43:38+00:00 	Height_CM	Height [cm] Collection Interval: Collected in Exam 1
12	Height	277282	phv00277282.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:06:43+00:00	2018-08-14 22:06:43+00:00 	HEIGHT	Standing height in cm Collection Interval: 2007-2009
12	Height	277331	phv00277331.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:12:53+00:00	2018-08-14 22:12:53+00:00 	HEIGHT	Height Collection Interval: 2009-2011
12	Height	277514	phv00277514.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:40:20+00:00	2018-08-14 22:40:20+00:00 	HEIGHT	Standing height in cm Collection Interval: 1996-2000
12	Height	277667	phv00277667.v1.p1	pht006045.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:00:32+00:00	2018-08-14 23:00:32+00:00 	ECHO_HT	Height (inches) Collection Interval: 2001-2004
12	Height	277764	phv00277764.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:07:15+00:00	2018-08-14 23:07:15+00:00 	HEIGHT	HEIGHT Collection Interval: 2000-2004
12	Height	307742	phv00307742.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:51:14+00:00	2018-08-15 23:51:14+00:00 	HEIGHT	Standing height Collection Interval: 2006-2011
12	Height	307795	phv00307795.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:55:51+00:00	2018-08-15 23:55:51+00:00 	HEIGHT	Standing height in cm Collection Interval: 1996-2000
12	Height	307955	phv00307955.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:08:42+00:00	2018-08-16 00:08:42+00:00 	HEIGHT	HEIGHT Collection Interval: 2000-2004
12	Height	122640	phv00122640.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:54:10+00:00	2018-08-16 23:54:10+00:00 	htcm	Height in centimeters
12	Height	114609	phv00114609.v2.p2	pht001626.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:23:02+00:00	2018-08-22 23:23:02+00:00 	B12HGT	HT, IN INCHES
12	Height	252982	phv00252982.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:12:13+00:00	2018-08-24 17:12:13+00:00 	height_baseline	Height at baseline visit
12	Height	258683	phv00258683.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:22:28+00:00	2018-09-06 12:22:28+00:00 	Height	Height of participant
12	Height	267371	phv00267371.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:12:41+00:00	2018-09-06 13:12:41+00:00 	height	Height  in cm
12	Height	259392	phv00259392.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-06 13:24:42+00:00	2018-09-06 13:24:42+00:00 	height	Height during adulthood
12	Height	121870	phv00121870.v2.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 15:53:53+00:00	2018-09-07 15:53:53+00:00 	clotht_cms	Height at time of blood clot
13	Weight	125861	phv00125861.v1.p1	pht001940.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:25:10+00:00	2018-02-22 21:25:10+00:00 	antv2	2: Weight to nearest kilogram
13	Weight	632	phv00000632.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:13:19+00:00	2018-03-02 14:13:19+00:00 	MF166	WEIGHT, EXAM 2
13	Weight	646	phv00000646.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:13:35+00:00	2018-03-02 14:13:35+00:00 	MF180	WEIGHT, EXAM 3
13	Weight	679	phv00000679.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:13:52+00:00	2018-03-02 14:13:52+00:00 	MF216	WEIGHT, EXAM 4
13	Weight	746	phv00000746.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:14:22+00:00	2018-03-02 14:14:22+00:00 	MF292	WEIGHT, EXAM 5
13	Weight	829	phv00000829.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:14:41+00:00	2018-03-02 14:14:41+00:00 	MF380	WEIGHT, EXAM 6
13	Weight	915	phv00000915.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:15:00+00:00	2018-03-02 14:15:00+00:00 	MF470	WEIGHT, EXAM 7
13	Weight	541	phv00000541.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:15:15+00:00	2018-03-02 14:15:15+00:00 	MF69	WEIGHT, EXAM 1
13	Weight	1037	phv00001037.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:15:37+00:00	2018-03-02 14:15:37+00:00 	FA2	WEIGHT (WHOLE POUNDS)
13	Weight	1189	phv00001189.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:15:54+00:00	2018-03-02 14:15:54+00:00 	FB9	BODY WEIGHT
13	Weight	1366	phv00001366.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:16:15+00:00	2018-03-02 14:16:15+00:00 	FC6	BODY WEIGHT
13	Weight	1563	phv00001563.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:16:38+00:00	2018-03-02 14:16:38+00:00 	FD12	BODY WEIGHT (TO NEAREST POUND)
13	Weight	1807	phv00001807.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:16:59+00:00	2018-03-02 14:16:59+00:00 	FE67	BODY WEIGHT (TO NEAREST POUND)
13	Weight	2022	phv00002022.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:17:15+00:00	2018-03-02 14:17:15+00:00 	FF63	BODY WEIGHT (TO NEAREST POUND)
13	Weight	2206	phv00002206.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:17:32+00:00	2018-03-02 14:17:32+00:00 	FG62	BODY WEIGHT (TO NEAREST POUND)
13	Weight	2427	phv00002427.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:17:51+00:00	2018-03-02 14:17:51+00:00 	FH62	BODY WEIGHT (TO NEAREST POUND)
13	Weight	2670	phv00002670.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:18:11+00:00	2018-03-02 14:18:11+00:00 	FI14	BODY WEIGHT (TO NEAREST POUND)
13	Weight	3244	phv00003244.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:18:31+00:00	2018-03-02 14:18:31+00:00 	FJ360	WEIGHT (TO NEAREST POUND)
13	Weight	3302	phv00003302.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:18:51+00:00	2018-03-02 14:18:51+00:00 	FK47	WEIGHT (TO NEAREST POUND)
13	Weight	3668	phv00003668.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:19:09+00:00	2018-03-02 14:19:09+00:00 	FL009	WEIGHT
13	Weight	4084	phv00004084.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:19:23+00:00	2018-03-02 14:19:23+00:00 	FM19	WEIGHT (TO NEAREST POUND)
13	Weight	4526	phv00004526.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:19:43+00:00	2018-03-02 14:19:43+00:00 	FN8	WEIGHT (POUNDS, TO NEAREST POUND)
13	Weight	5541	phv00005541.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:19:57+00:00	2018-03-02 14:19:57+00:00 	FO007	WEIGHT (TO NEAREST POUND)
13	Weight	5921	phv00005921.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:20:16+00:00	2018-03-02 14:20:16+00:00 	FP007	WEIGHT (TO NEAREST POUND, WITHOUT SHOES AND IN LIGHT CLOTHES)
13	Weight	6033	phv00006033.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:20:31+00:00	2018-03-02 14:20:31+00:00 	FQ005	WEIGHT (TO NEAREST POUND)
13	Weight	6328	phv00006328.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:20:45+00:00	2018-03-02 14:20:45+00:00 	FR005	WEIGHT (TO NEAREST POUND)
13	Weight	6671	phv00006671.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:26:53+00:00	2018-03-02 14:26:53+00:00 	FS005	WEIGHT (TO NEAREST POUND)
13	Weight	7098	phv00007098.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:27:19+00:00	2018-03-02 14:27:19+00:00 	FT004	WEIGHT (TO NEAREST POUND)
13	Weight	7569	phv00007569.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:27:47+00:00	2018-03-02 14:27:47+00:00 	A50	BODY WEIGHT
13	Weight	7676	phv00007676.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:29:59+00:00	2018-03-02 14:29:59+00:00 	B13	BODY WEIGHT (KG)
13	Weight	7678	phv00007678.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 14:30:19+00:00	2018-03-02 14:30:19+00:00 	B15	BODY WEIGHT (LB)
13	Weight	8713	phv00008713.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:16:08+00:00	2018-03-02 15:16:08+00:00 	C416	WEIGHT IN POUNDS
13	Weight	9100	phv00009100.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:16:47+00:00	2018-03-02 15:16:47+00:00 	D401	WEIGHT (TO NEAREST POUND)
13	Weight	9552	phv00009552.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:17:13+00:00	2018-03-02 15:17:13+00:00 	E024	WEIGHT (TO NEAREST POUND)
13	Weight	10108	phv00010108.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:17:40+00:00	2018-03-02 15:17:40+00:00 	F007	WEIGHT (TO NEAREST POUND)
13	Weight	10498	phv00010498.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:17:55+00:00	2018-03-02 15:17:55+00:00 	G440	WEIGHT (TO NEAREST POUND)
13	Weight	21229	phv00021229.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:18:16+00:00	2018-03-02 15:18:16+00:00 	G3A444	WEIGHT (TO NEAREST POUND)
13	Weight	55259	phv00055259.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:19:15+00:00	2018-03-02 15:19:15+00:00 	Weight	Weight in kilograms
13	Weight	55291	phv00055291.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:19:33+00:00	2018-03-02 15:19:33+00:00 	WEIGHT20	Weight in kilograms
13	Weight	56838	phv00056838.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:20:00+00:00	2018-03-02 15:20:00+00:00 	pm202	Weight in kilograms
13	Weight	70552	phv00070552.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:20:23+00:00	2018-03-02 15:20:23+00:00 	FU252	WEIGHT (TO NEAREST POUND)
13	Weight	72335	phv00072335.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:21:06+00:00	2018-03-02 15:21:06+00:00 	H393	WEIGHT (TO NEAREST POUND)
13	Weight	177537	phv00177537.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:21:50+00:00	2018-03-02 15:21:50+00:00 	g3b0481	Anthropometry: Weight
13	Weight	227264	phv00227264.v1.p10	pht004809.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:22:09+00:00	2018-03-02 15:22:09+00:00 	weight_kg	Weight in Kg from FHS Offspring Exam 9 or OMNI1 Exam 4 Collection Interval: Test performed at Offspring Exam9 and Omni 1 Exam 4
13	Weight	227263	phv00227263.v1.p10	pht004809.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:22:40+00:00	2018-03-02 15:22:40+00:00 	wgt_new	Weight from FHS Offspring Exam 9 or OMNI 1 Exam 4 Collection Interval: Test performed at Offspring Exam9 and Omni 1 Exam 4
13	Weight	250287	phv00250287.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:23:03+00:00	2018-03-02 15:23:03+00:00 	e024	Numerical Data - Part I: Weight Collection Interval: Exam 1
13	Weight	251061	phv00251061.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:23:24+00:00	2018-03-02 15:23:24+00:00 	g440	Numerical Data - Part I - Basic Information: Weight (to nearest pound) Collection Interval: Exam 2
13	Weight	251532	phv00251532.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:23:40+00:00	2018-03-02 15:23:40+00:00 	h393	Numerical Data - Part I: Basic Information: Weight (nearest pound) Collection Interval: Exam 3
13	Weight	254286	phv00254286.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:24:08+00:00	2018-03-02 15:24:08+00:00 	j474	Numerical Data/Anthropometry: Weight
13	Weight	254763	phv00254763.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:24:30+00:00	2018-03-02 15:24:30+00:00 	fv254	Numerical Data (Anthropometry) - Basic Information: Weight Collection Interval: Exam 29
13	Weight	255155	phv00255155.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:24:57+00:00	2018-03-02 15:24:57+00:00 	fw298	Numerical Data: Basic Information - Weight Collection Interval: Original Cohort Exam 30
13	Weight	274051	phv00274051.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:25:18+00:00	2018-03-02 15:25:18+00:00 	g3a444	Weight Collection Interval: Exam 1
13	Weight	274542	phv00274542.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:25:55+00:00	2018-03-02 15:25:55+00:00 	g3a444	Weight
13	Weight	274880	phv00274880.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:26:15+00:00	2018-03-02 15:26:15+00:00 	FX298	Numerical Data: Basic Information - Weight Collection Interval: Original Cohort Exam 31
13	Weight	275238	phv00275238.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:26:36+00:00	2018-03-02 15:26:36+00:00 	fy298	Numerical Data: Basic Information - Weight Collection Interval: Original Cohort Exam 32
13	Weight	277055	phv00277055.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:27:04+00:00	2018-03-02 15:27:04+00:00 	WGT1	Weight, Exam 1
13	Weight	277056	phv00277056.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:27:16+00:00	2018-03-02 15:27:16+00:00 	WGT2	Weight, Exam 2
13	Weight	277227	phv00277227.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:27:30+00:00	2018-03-02 15:27:30+00:00 	WGT1	Weight, Exam 1
13	Weight	277228	phv00277228.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:27:42+00:00	2018-03-02 15:27:42+00:00 	WGT2	Weight, Exam 2
13	Weight	277229	phv00277229.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:28:02+00:00	2018-03-02 15:28:02+00:00 	WGT3	Weight, Exam 3
13	Weight	277230	phv00277230.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:28:13+00:00	2018-03-02 15:28:13+00:00 	WGT4	Weight, Exam 4
13	Weight	277231	phv00277231.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:28:25+00:00	2018-03-02 15:28:25+00:00 	WGT5	Weight, Exam 5
13	Weight	277232	phv00277232.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:28:38+00:00	2018-03-02 15:28:38+00:00 	WGT6	Weight, Exam 6
13	Weight	277233	phv00277233.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:28:51+00:00	2018-03-02 15:28:51+00:00 	WGT7	Weight, Exam 7
13	Weight	277234	phv00277234.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:29:04+00:00	2018-03-02 15:29:04+00:00 	WGT8	Weight, Exam 8
13	Weight	277235	phv00277235.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:29:20+00:00	2018-03-02 15:29:20+00:00 	WGT9	Weight, Exam 9
13	Weight	203154	phv00203154.v1.p1	pht004032.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:42:23+00:00	2018-03-15 14:42:23+00:00 	ANTA04	[Height and weight]. Weight (to the nearest lb). Q4 [Anthropometry Form, ANTA, exam 1]
13	Weight	203166	phv00203166.v1.p1	pht004033.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:42:51+00:00	2018-03-15 14:42:51+00:00 	ANTB01	[Wait]. Weight (to the nearest lb). Q1 [Anthropometry Form, ANTAB, exam 2]
13	Weight	203176	phv00203176.v1.p1	pht004034.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:43:30+00:00	2018-03-15 14:43:30+00:00 	ANTC2	[Height and weight]. Weight (to the nearest lb, rounding down). Q2 [Anthropometry Form, ANTC, exam 3]
13	Weight	203187	phv00203187.v1.p1	pht004035.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:43:56+00:00	2018-03-15 14:43:56+00:00 	ANTD2	[Height and weight]. Weight (to the nearest lb, rounding down). Q2 [Anthropometry Form, ANTD, exam 4]
13	Weight	214061	phv00214061.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:55:55+00:00	2018-03-15 14:55:55+00:00 	WEIGHT	Weight in kilograms
13	Weight	214094	phv00214094.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:56:22+00:00	2018-03-15 14:56:22+00:00 	WEIGHT20	Weight in kilograms
13	Weight	113635	phv00113635.v2.p2	pht001583.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:44:29+00:00	2018-04-17 16:44:29+00:00 	A20WGT	PT'S WGT, LBS. Q 2
13	Weight	114831	phv00114831.v2.p2	pht001632.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:44:29+00:00	2018-04-17 16:44:29+00:00 	B20WGT	SUBJECT'S WEIGHT IN POUNDS. Q 3
13	Weight	115857	phv00115857.v2.p2	pht001671.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:44:29+00:00	2018-04-17 16:44:29+00:00 	C20WGT	SUBJECT'S WEIGHT (LBS). Q 2
13	Weight	117231	phv00117231.v2.p2	pht001720.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:44:29+00:00	2018-04-17 16:44:29+00:00 	D20WGT	SUBJECT'S WEIGHT (LBS). Q 2a
13	Weight	119094	phv00119094.v2.p2	pht001785.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:44:29+00:00	2018-04-17 16:44:29+00:00 	E20WGT	SUBJECT'S WEIGHT (LBS). Q 2a
13	Weight	120996	phv00120996.v2.p2	pht001857.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:44:29+00:00	2018-04-17 16:44:29+00:00 	F20WGT	SUBJECT'S WEIGHT (LBS). Q 2a
13	Weight	114073	phv00114073.v2.p2	pht001594.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:56:43+00:00	2018-04-19 19:56:43+00:00 	FY012WT	WEIGHT - MON 12
13	Weight	116479	phv00116479.v2.p2	pht001706.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:58:17+00:00	2018-04-19 19:58:17+00:00 	DDXPTWT	PATIENT DATA: WEIGHT (KG)
13	Weight	117442	phv00117442.v2.p2	pht001725.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:58:47+00:00	2018-04-19 19:58:47+00:00 	D46X3WGT	PPT WEIGHT DURING EXAM 3
13	Weight	117443	phv00117443.v2.p2	pht001725.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:58:55+00:00	2018-04-19 19:58:55+00:00 	D46X4WGT	PPT WEIGHT DURING EXAM 4
13	Weight	117926	phv00117926.v2.p2	pht001749.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:59:37+00:00	2018-04-19 19:59:37+00:00 	FY096WGT	WEIGHT - MON 96
13	Weight	118251	phv00118251.v2.p2	pht001756.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:59:51+00:00	2018-04-19 19:59:51+00:00 	EWT	WEIGHT
13	Weight	119261	phv00119261.v2.p2	pht001790.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:00:53+00:00	2018-04-19 20:00:53+00:00 	E46X4WGT	PPT WEIGHT DURING EXAM 4. Q 2
13	Weight	119262	phv00119262.v2.p2	pht001790.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:01:10+00:00	2018-04-19 20:01:10+00:00 	E46X5WGT	PPT WEIGHT DURING EXAM 5. Q 2
13	Weight	119573	phv00119573.v2.p2	pht001795.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 20:01:50+00:00	2018-04-19 20:01:50+00:00 	E53WGT	WEIGHT (LBS) - FORM 53
13	Weight	99349	phv00099349.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:00:20+00:00	2018-04-20 22:00:20+00:00 	WEIGHT13	WEIGHT - LBS
13	Weight	105414	phv00105414.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:08:39+00:00	2018-04-20 22:08:39+00:00 	WEIGHT13	WEIGHT - LBS
13	Weight	106776	phv00106776.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:09:05+00:00	2018-04-20 22:09:05+00:00 	WEIGHT13	WEIGHT - LBS
13	Weight	110376	phv00110376.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:09:19+00:00	2018-04-20 22:09:19+00:00 	WEIGHT13	WEIGHT - LBS
13	Weight	102454	phv00102454.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:09:46+00:00	2018-04-20 22:09:46+00:00 	WEIGHT13	WEIGHT - LBS
13	Weight	100383	phv00100383.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:09:58+00:00	2018-04-20 22:09:58+00:00 	WEIGHT13	WEIGHT - LBS
13	Weight	101789	phv00101789.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:12:25+00:00	2018-04-20 22:12:25+00:00 	WEIGHT33	WEIGHT IN POUNDS
13	Weight	104028	phv00104028.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:15:17+00:00	2018-04-20 22:15:17+00:00 	WEIGHT33	WEIGHT IN POUNDS AT YEAR 3 VISIT
13	Weight	104759	phv00104759.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:15:37+00:00	2018-04-20 22:15:37+00:00 	WEIGHT33	WEIGHT IN POUNDS
13	Weight	107778	phv00107778.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:16:00+00:00	2018-04-20 22:16:00+00:00 	WEIGHT33	WEIGHT IN POUNDS AT YEAR 6 VISIT
13	Weight	108569	phv00108569.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:16:15+00:00	2018-04-20 22:16:15+00:00 	WEIGHT33	WEIGHT IN POUNDS AT YEAR 7 VISIT
13	Weight	109512	phv00109512.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:16:30+00:00	2018-04-20 22:16:30+00:00 	WEIGHT33	WEIGHT IN POUNDS AT YEAR 8 VISIT
13	Weight	82685	phv00082685.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:10:38+00:00	2018-04-23 03:10:38+00:00 	wtlb1	WEIGHT (lbs)
13	Weight	83472	phv00083472.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:11:18+00:00	2018-04-23 03:11:18+00:00 	lungwta4	WEIGHT (lbs)
13	Weight	83707	phv00083707.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:11:26+00:00	2018-04-23 03:11:26+00:00 	lungwta4	WEIGHT (lbs)
13	Weight	84484	phv00084484.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:11:32+00:00	2018-04-23 03:11:32+00:00 	wtlb1	WEIGHT (lbs)
13	Weight	85800	phv00085800.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:11:51+00:00	2018-04-23 03:11:51+00:00 	wtlb2	WEIGHT (lbs.)
13	Weight	86299	phv00086299.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:11:58+00:00	2018-04-23 03:11:58+00:00 	wtlb3	WEIGHT (lbs)
13	Weight	86752	phv00086752.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:12:07+00:00	2018-04-23 03:12:07+00:00 	wtlb4	WEIGHT (lbs)
13	Weight	87079	phv00087079.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:12:13+00:00	2018-04-23 03:12:13+00:00 	wtlbf	WEIGHT (lbs)
13	Weight	87698	phv00087698.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:12:24+00:00	2018-04-23 03:12:24+00:00 	lungwta4	WEIGHT (lbs)
13	Weight	174632	phv00174632.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:12:41+00:00	2018-04-23 03:12:41+00:00 	wtlb5	WEIGHT (lbs)
13	Weight	174745	phv00174745.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:12:51+00:00	2018-04-23 03:12:51+00:00 	ctwtlb5	WEIGHT AT CT
13	Weight	175859	phv00175859.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:12:57+00:00	2018-04-23 03:12:57+00:00 	wtlb1	WEIGHT (lbs)
13	Weight	175944	phv00175944.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:13:03+00:00	2018-04-23 03:13:03+00:00 	wtlbf	FAMILY COHORT: WEIGHT (lbs)
13	Weight	176055	phv00176055.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:13:09+00:00	2018-04-23 03:13:09+00:00 	wtlb5	WEIGHT (lbs)
13	Weight	176060	phv00176060.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:13:16+00:00	2018-04-23 03:13:16+00:00 	bcswtkg5	BODY COMPOSITION SCALE: CURRENT BODY WEIGHT (kg)
13	Weight	176168	phv00176168.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:13:24+00:00	2018-04-23 03:13:24+00:00 	ctwtlb5	WEIGHT AT CT
13	Weight	79859	phv00079859.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-24 22:08:59+00:00	2018-04-24 22:08:59+00:00 	WEIGHTX	F80 Weight kg
13	Weight	283540	phv00283540.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-24 22:08:59+00:00	2018-04-24 22:08:59+00:00 	WEIGHTADM	F136 Weight at onset, kg
13	Weight	283541	phv00283541.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-24 22:08:59+00:00	2018-04-24 22:08:59+00:00 	WEIGHTDSCH	F136 Weight, last recorded, kg
13	Weight	206818	phv00206818.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 20:11:05+00:00	2018-04-25 20:11:05+00:00 	HFAA20A1	[Physical exam - vital signs]. Q20a1- Weight (lbs/kg) at hospital admission (or at onset of event) [Heart Failure Hospital Record Abstraction Form, HFA]
13	Weight	206819	phv00206819.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 20:11:24+00:00	2018-04-25 20:11:24+00:00 	HFAA20B1	[Physical exam - vital signs]. Q20b1- Weight (lbs/kg) at hospital discharge (or last recorded) [Heart Failure Hospital Record Abstraction Form, HFA]
13	Weight	206856	phv00206856.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 20:12:51+00:00	2018-04-25 20:12:51+00:00 	HFAA20A	[Physical exam - vital signs]. Q20a - Weight at hospital admission (or at onset of event) [Heart Failure Hospital Record Abstraction Form, HFA]
13	Weight	206857	phv00206857.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 20:13:04+00:00	2018-04-25 20:13:04+00:00 	HFAA20B	[Physical exam - vital signs]. Q20b - Weight at hospital discharge (or last recorded) [Heart Failure Hospital Record Abstraction Form, HFA]
13	Weight	283312	phv00283312.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:23:45+00:00	2018-05-15 17:23:45+00:00 	WEIGHT	Weight, lb
13	Weight	159591	phv00159591.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:57:11+00:00	2018-08-10 21:57:11+00:00 	Weight_KG	Weight [kg] Collection Interval: Collected in Exam 1
13	Weight	277283	phv00277283.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:06:55+00:00	2018-08-14 22:06:55+00:00 	WEIGHT	Standing weight in kg Collection Interval: 2007-2009
13	Weight	277332	phv00277332.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:12:46+00:00	2018-08-14 22:12:46+00:00 	WEIGHT	Weight Collection Interval: 2009-2011
13	Weight	277515	phv00277515.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:40:13+00:00	2018-08-14 22:40:13+00:00 	WEIGHT	Weight in kg Collection Interval: 1996-2000
13	Weight	277668	phv00277668.v1.p1	pht006045.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:00:25+00:00	2018-08-14 23:00:25+00:00 	ECHO_WT	Weight (pounds) Collection Interval: 2001-2004
13	Weight	277765	phv00277765.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:07:08+00:00	2018-08-14 23:07:08+00:00 	WEIGHT	WEIGHT Collection Interval: 2000-2004
13	Weight	307743	phv00307743.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:51:06+00:00	2018-08-15 23:51:06+00:00 	WEIGHT	Standing weight Collection Interval: 2006-2011
13	Weight	307796	phv00307796.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:55:44+00:00	2018-08-15 23:55:44+00:00 	WEIGHT	Weight in kg Collection Interval: 1996-2000
13	Weight	307956	phv00307956.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:08:34+00:00	2018-08-16 00:08:34+00:00 	WEIGHT	WEIGHT Collection Interval: 2000-2004
13	Weight	122639	phv00122639.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:54:01+00:00	2018-08-16 23:54:01+00:00 	wtkg	Weight in kilograms
13	Weight	123776	phv00123776.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:54:53+00:00	2018-08-21 17:54:53+00:00 	WHTKG	Weight (kg)
13	Weight	253218	phv00253218.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:31:28+00:00	2018-08-24 16:31:28+00:00 	ANTA4	Weight (kg) (ANTA4)
13	Weight	252979	phv00252979.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:11:43+00:00	2018-08-24 17:11:43+00:00 	weight_baseline	Weight at baseline visit
13	Weight	118137	phv00118137.v2.p2	pht001755.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 18:12:43+00:00	2018-08-28 18:12:43+00:00 	EWT	WEIGHT
13	Weight	258684	phv00258684.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:22:50+00:00	2018-09-06 12:22:50+00:00 	Weight	Weight of participant
13	Weight	267372	phv00267372.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:12:13+00:00	2018-09-06 13:12:13+00:00 	weight	Weight in kg
13	Weight	259393	phv00259393.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-06 13:25:06+00:00	2018-09-06 13:25:06+00:00 	weight	Weight at index date
13	Weight	121871	phv00121871.v2.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 15:56:44+00:00	2018-09-07 15:56:44+00:00 	clotwt_kgs	Weight at time of blood clot
14	BMI	126013	phv00126013.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 19:55:29+00:00	2018-02-22 19:55:29+00:00 	BMI01	Body mass index, visit 1
14	BMI	56588	phv00056588.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:07:39+00:00	2018-02-26 19:07:39+00:00 	BMI_s1	BMI = weight/((height/100)*(height/100))
14	BMI	56833	phv00056833.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:09:01+00:00	2018-02-26 19:09:01+00:00 	bmi_s2	Body Mass Index (BMI = pm202/((pm207/100)*(pm207/100)))
14	BMI	277024	phv00277024.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:42:18+00:00	2018-02-26 19:42:18+00:00 	BMI1	Body mass index, Exam 1
14	BMI	277025	phv00277025.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:42:51+00:00	2018-02-26 19:42:51+00:00 	BMI2	Body mass index, Exam 2
14	BMI	277095	phv00277095.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:43:12+00:00	2018-02-26 19:43:12+00:00 	BMI1	Body mass index, Exam 1
14	BMI	277096	phv00277096.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:43:32+00:00	2018-02-26 19:43:32+00:00 	BMI2	Body mass index, Exam 2
14	BMI	277097	phv00277097.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:43:47+00:00	2018-02-26 19:43:47+00:00 	BMI3	Body mass index, Exam 3
14	BMI	277098	phv00277098.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:44:00+00:00	2018-02-26 19:44:00+00:00 	BMI4	Body mass index, Exam 4
14	BMI	277099	phv00277099.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:44:16+00:00	2018-02-26 19:44:16+00:00 	BMI5	Body mass index, Exam 5
14	BMI	277100	phv00277100.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:44:33+00:00	2018-02-26 19:44:33+00:00 	BMI6	Body mass index, Exam 6
14	BMI	277101	phv00277101.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:44:47+00:00	2018-02-26 19:44:47+00:00 	BMI7	Body mass index, Exam 7
14	BMI	277102	phv00277102.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:45:03+00:00	2018-02-26 19:45:03+00:00 	BMI8	Body mass index, Exam 8
14	BMI	277103	phv00277103.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:45:17+00:00	2018-02-26 19:45:17+00:00 	BMI9	Body mass index, Exam 9
14	BMI	4077	phv00004077.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:49:15+00:00	2018-02-26 19:49:15+00:00 	FL517	BODY MASS INDEX, EXAM19
14	BMI	4521	phv00004521.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:49:33+00:00	2018-02-26 19:49:33+00:00 	FM537	BODY MASS INDEX
14	BMI	4933	phv00004933.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:49:48+00:00	2018-02-26 19:49:48+00:00 	FN505	BODY MASS INDEX
14	BMI	5554	phv00005554.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:49:59+00:00	2018-02-26 19:49:59+00:00 	FO726	BODY MASS INDEX
14	BMI	6023	phv00006023.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:50:13+00:00	2018-02-26 19:50:13+00:00 	FP590	BODY MASS INDEX
14	BMI	6323	phv00006323.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:50:31+00:00	2018-02-26 19:50:31+00:00 	FQ392	BODY MASS INDEX
14	BMI	6657	phv00006657.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:50:45+00:00	2018-02-26 19:50:45+00:00 	FR432	BODY MASS INDEX (ROUNDED TO HUNDREDTHS)
14	BMI	7092	phv00007092.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:50:59+00:00	2018-02-26 19:50:59+00:00 	FS537	BODY MASS INDEX
14	BMI	7531	phv00007531.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:51:15+00:00	2018-02-26 19:51:15+00:00 	FT537	BODY MASS INDEX
14	BMI	8735	phv00008735.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:51:31+00:00	2018-02-26 19:51:31+00:00 	C448	BODY MASS INDEX
14	BMI	9118	phv00009118.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:51:45+00:00	2018-02-26 19:51:45+00:00 	D443	BODY MASS INDEX
14	BMI	9570	phv00009570.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:52:02+00:00	2018-02-26 19:52:02+00:00 	E662	BODY MASS INDEX
14	BMI	10130	phv00010130.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:52:17+00:00	2018-02-26 19:52:17+00:00 	F719	BODY MASS INDEX
14	BMI	10691	phv00010691.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:52:39+00:00	2018-02-26 19:52:39+00:00 	G709	BODY MASS INDEX
14	BMI	70735	phv00070735.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-02-26 19:53:02+00:00	2018-02-26 19:53:02+00:00 	FU580	BODY MASS INDEX, CALCULATED: (FU252 0.454)/((FU258 2.54)/100) 2; FU252 WEIGHT, FU258 HEIGHT
14	BMI	226255	phv00226255.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 21:55:33+00:00	2018-03-14 21:55:33+00:00 	BMI	BMI (kg/m2)
14	BMI	204719	phv00204719.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:33:24+00:00	2018-03-15 14:33:24+00:00 	BMI01	Body Mass Index in Kg/(m2) [Cohort, Exam 1]
14	BMI	204637	phv00204637.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:37:48+00:00	2018-03-15 14:37:48+00:00 	BMI21	Visit 2, Body Mass Index in kg/m2 [Cohort, Exam 2]
14	BMI	204836	phv00204836.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:38:49+00:00	2018-03-15 14:38:49+00:00 	BMI32	Body Mass Index in kg/m**2 [Cohort, Exam 3]
14	BMI	205014	phv00205014.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:39:28+00:00	2018-03-15 14:39:28+00:00 	BMI41	Body Mass Index in Kg/M**2 [Cohort, Exam 4]
14	BMI	215389	phv00215389.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:41:17+00:00	2018-03-15 14:41:17+00:00 	BMI_S1	BMI = weight/((height/100)*(height/100))
14	BMI	113661	phv00113661.v2.p2	pht001583.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:42:13+00:00	2018-04-17 16:42:13+00:00 	A20BMI	BODY MASS INDEX, KG/M**2
14	BMI	114862	phv00114862.v2.p2	pht001632.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:42:13+00:00	2018-04-17 16:42:13+00:00 	B20BMI	B20BMI
14	BMI	115869	phv00115869.v2.p2	pht001671.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:42:13+00:00	2018-04-17 16:42:13+00:00 	C20BMI	BODY MASS INDEX (KG/M**2)
14	BMI	117249	phv00117249.v2.p2	pht001720.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:42:13+00:00	2018-04-17 16:42:13+00:00 	D20BMI	BODY MASS INDEX (KG/M**2)
14	BMI	119120	phv00119120.v2.p2	pht001785.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:42:13+00:00	2018-04-17 16:42:13+00:00 	E20BMI	BODY MASS INDEX (KG/M**2)
14	BMI	121003	phv00121003.v2.p2	pht001857.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:42:13+00:00	2018-04-17 16:42:13+00:00 	F20BMI	BODY MASS INDEX (KG/M**2)
14	BMI	79867	phv00079867.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-17 23:05:14+00:00	2018-04-17 23:05:14+00:00 	BMIX	BMI
14	BMI	283344	phv00283344.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-17 23:05:14+00:00	2018-04-17 23:05:14+00:00 	BMI	Body-mass Index (BMI), kg/m2
14	BMI	283345	phv00283345.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-17 23:05:14+00:00	2018-04-17 23:05:14+00:00 	BMIC	Body-mass Index (BMI), kg/m2
14	BMI	99468	phv00099468.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:18:43+00:00	2018-04-20 22:18:43+00:00 	BMI	BODY MASS INDEX
14	BMI	100386	phv00100386.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:18:55+00:00	2018-04-20 22:18:55+00:00 	BMI	BODY MASS INDEX (kg/m2)
14	BMI	105306	phv00105306.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:19:06+00:00	2018-04-20 22:19:06+00:00 	BMI	BODY MASS INDEX (kg/m2)
14	BMI	106840	phv00106840.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:19:21+00:00	2018-04-20 22:19:21+00:00 	BMI	BODY MASS INDEX (kg/m2)
14	BMI	110612	phv00110612.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:19:35+00:00	2018-04-20 22:19:35+00:00 	BMI	BODY MASS INDEX (kg/m2)
14	BMI	82691	phv00082691.v2.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:15:07+00:00	2018-04-23 03:15:07+00:00 	bmi1c	BODY MASS INDEX (kg)/(m^2)
14	BMI	83481	phv00083481.v2.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:15:15+00:00	2018-04-23 03:15:15+00:00 	lbmia4	BMI
14	BMI	83716	phv00083716.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:15:23+00:00	2018-04-23 03:15:23+00:00 	lbmia4	BMI
14	BMI	84490	phv00084490.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:15:28+00:00	2018-04-23 03:15:28+00:00 	bmi1c	BODY MASS INDEX (kg)/(m^2)
14	BMI	85803	phv00085803.v3.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:15:34+00:00	2018-04-23 03:15:34+00:00 	bmi2c	BODY MASS INDEX (kg/m^2)
14	BMI	86302	phv00086302.v3.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:15:39+00:00	2018-04-23 03:15:39+00:00 	bmi3c	BODY MASS INDEX (kg/m^2)
14	BMI	86755	phv00086755.v3.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:15:45+00:00	2018-04-23 03:15:45+00:00 	bmi4c	BODY MASS INDEX (kg/m^2)
14	BMI	87080	phv00087080.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:15:51+00:00	2018-04-23 03:15:51+00:00 	bmifc	BODY MASS INDEX
14	BMI	87707	phv00087707.v2.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:15:57+00:00	2018-04-23 03:15:57+00:00 	lbmia4	BMI
14	BMI	174644	phv00174644.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:16:03+00:00	2018-04-23 03:16:03+00:00 	bmi5c	BODY MASS INDEX (kg/m^2)
14	BMI	174746	phv00174746.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:16:08+00:00	2018-04-23 03:16:08+00:00 	ctbmi5	BMI AT CT
14	BMI	176067	phv00176067.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:16:16+00:00	2018-04-23 03:16:16+00:00 	bmi5c	BODY MASS INDEX (kg/m^2)
14	BMI	176169	phv00176169.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:16:22+00:00	2018-04-23 03:16:22+00:00 	ctbmi5	BMI AT CT
14	BMI	219025	phv00219025.v1.p3	pht004326.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:16:28+00:00	2018-04-23 03:16:28+00:00 	bmisc	BODY MASS INDEX (KG/M^2) AT MESA STRESS EXAM
14	BMI	159593	phv00159593.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:56:26+00:00	2018-08-10 20:56:26+00:00 	BMI	BMI Collection Interval: Collected in Exam 1
14	BMI	122641	phv00122641.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:54:17+00:00	2018-08-16 23:54:17+00:00 	bmi	Body mass index
14	BMI	122994	phv00122994.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:53:16+00:00	2018-08-17 19:53:16+00:00 	lnbmi	Log (BMI)
14	BMI	252983	phv00252983.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:12:24+00:00	2018-08-24 17:12:24+00:00 	bmi_baseline	Body mass index at baseline visit
14	BMI	258685	phv00258685.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:23:06+00:00	2018-09-06 12:23:06+00:00 	BMI	Body mass index of participant
14	BMI	267373	phv00267373.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:13:00+00:00	2018-09-06 13:13:00+00:00 	bmi	BMI
15	Waist circumference	125862	phv00125862.v1.p1	pht001940.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-22 21:25:33+00:00	2018-02-22 21:25:33+00:00 	antv3a	3a: Waist to nearest cm
15	Waist circumference	203159	phv00203159.v1.p1	pht004032.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:51:52+00:00	2018-03-19 16:51:52+00:00 	ANTA07A	[Body size]. Waist girth (to the nearest cm). Q7a [Anthropometry Form, ANTA, exam 1]
15	Waist circumference	203171	phv00203171.v1.p1	pht004033.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:52:11+00:00	2018-03-19 16:52:11+00:00 	ANTB04A	[Body size]. Waist girth (nearest cm). Q4a [Anthropometry Form, ANTAB, exam 2]
15	Waist circumference	203177	phv00203177.v1.p1	pht004034.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:52:32+00:00	2018-03-19 16:52:32+00:00 	ANTC3A	[Body size]. Waist girth (to the nearest cm, rounding down). Q3a [Anthropometry Form, ANTC, exam 3]
15	Waist circumference	203188	phv00203188.v1.p1	pht004035.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:52:53+00:00	2018-03-19 16:52:53+00:00 	ANTD3A	[Body size]. Waist girth (to the nearest cm, rounding down). Q3a [Anthropometry Form, ANTD, exam 4]
15	Waist circumference	214062	phv00214062.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:53:19+00:00	2018-03-19 16:53:19+00:00 	WAIST	Waist measurement in centimeters
15	Waist circumference	23150	phv00023150.v3.p10	pht000139.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:46:08+00:00	2018-03-21 14:46:08+00:00 	WAIST	WAIST CIRCUMFERENCE, MM
15	Waist circumference	23159	phv00023159.v3.p10	pht000140.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:46:32+00:00	2018-03-21 14:46:32+00:00 	WAIST	WAIST CIRCUMFERENCE, MM
15	Waist circumference	686	phv00000686.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:47:41+00:00	2018-03-21 14:47:41+00:00 	MF223	GIRTH: WAIST, EXAM 4
15	Waist circumference	748	phv00000748.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:48:08+00:00	2018-03-21 14:48:08+00:00 	MF294	GIRTH: WAIST, EXAM 5
15	Waist circumference	3672	phv00003672.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:49:00+00:00	2018-03-21 14:49:00+00:00 	FL018	WAIST GIRTH
15	Waist circumference	4088	phv00004088.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:49:36+00:00	2018-03-21 14:49:36+00:00 	FM28	WAIST GIRTH (INCHES WITH 2 DECIMALS)
15	Waist circumference	5544	phv00005544.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:50:10+00:00	2018-03-21 14:50:10+00:00 	FO016	WAIST GIRTH (INCHES, TO NEXT LOWER 1/4 INCH)
15	Waist circumference	5924	phv00005924.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:50:36+00:00	2018-03-21 14:50:36+00:00 	FP015	WAIST GIRTH (INCHES, TO NEXT LOWER 1/4 INCH)
15	Waist circumference	8767	phv00008767.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:51:21+00:00	2018-03-21 14:51:21+00:00 	D410	WAIST GIRTH (INCHES WITH 2 DECIMALS)
15	Waist circumference	9555	phv00009555.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:51:46+00:00	2018-03-21 14:51:46+00:00 	E032	WAIST GIRTH (INCHES, TO NEXT LOWER 1/4 INCH)
15	Waist circumference	10112	phv00010112.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:52:16+00:00	2018-03-21 14:52:16+00:00 	F016	WAIST GIRTH (INCHES, TO NEXT LOWER 1/4 INCH)
15	Waist circumference	10502	phv00010502.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:52:35+00:00	2018-03-21 14:52:35+00:00 	G445	REGIONAL ANTHROPOMETRY - WAIST GIRTH (INCHES) (TO NEXT LOWER 1/4 INCH)
15	Waist circumference	72341	phv00072341.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 14:54:09+00:00	2018-03-21 14:54:09+00:00 	H403	WAIST GIRTH AT UMBILICUS (INCHES, TO NEXT LOWER 1/4 INCH)
15	Waist circumference	274057	phv00274057.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 15:00:23+00:00	2018-03-21 15:00:23+00:00 	g3a451	Waist girth Collection Interval: Exam 1
15	Waist circumference	177543	phv00177543.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 15:01:08+00:00	2018-03-21 15:01:08+00:00 	g3b0487	Anthropometry: Waist girth at umbilicus
15	Waist circumference	250290	phv00250290.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 15:01:36+00:00	2018-03-21 15:01:36+00:00 	e032	Numerical Data - Part I: Waist girth Collection Interval: Exam 1
15	Waist circumference	251065	phv00251065.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 15:02:11+00:00	2018-03-21 15:02:11+00:00 	g445	Numerical Data - Part I - Regional Anthropometry: Waist girth (to next lower 1/4 inch) Collection Interval: Exam 2
15	Waist circumference	251538	phv00251538.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 18:53:44+00:00	2018-03-21 18:53:44+00:00 	h403	Numerical Data - Part I: Regional Anthropometry: Waist Girth at umbilicus (to next lower 1/4 inch) Collection Interval: Exam 3
15	Waist circumference	21235	phv00021235.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-21 18:54:34+00:00	2018-03-21 18:54:34+00:00 	G3A451	WAIST GIRTH (INCHES, TO NEXT LOWER 1/4 INCH)
15	Waist circumference	277053	phv00277053.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 11:34:24+00:00	2018-03-22 11:34:24+00:00 	WAIST1	Waist girth, Exam 1
15	Waist circumference	277054	phv00277054.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 11:34:45+00:00	2018-03-22 11:34:45+00:00 	WAIST2	Waist girth, Exam 2
15	Waist circumference	277221	phv00277221.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 11:35:15+00:00	2018-03-22 11:35:15+00:00 	WAIST4	Waist girth, Exam 4
15	Waist circumference	277222	phv00277222.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 11:35:39+00:00	2018-03-22 11:35:39+00:00 	WAIST5	Waist girth, Exam 5
15	Waist circumference	277223	phv00277223.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 11:36:06+00:00	2018-03-22 11:36:06+00:00 	WAIST6	Waist girth, Exam 6
15	Waist circumference	277224	phv00277224.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 11:36:23+00:00	2018-03-22 11:36:23+00:00 	WAIST7	Waist girth, Exam 7
15	Waist circumference	277225	phv00277225.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 11:36:40+00:00	2018-03-22 11:36:40+00:00 	WAIST8	Waist girth, Exam 8
15	Waist circumference	277226	phv00277226.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 11:36:58+00:00	2018-03-22 11:36:58+00:00 	WAIST9	Waist girth, Exam 9
15	Waist circumference	72342	phv00072342.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 11:38:11+00:00	2018-03-22 11:38:11+00:00 	H405	WAIST GIRT AT ILIAC CREST (INCHES, TO NEXT LOWER 1/4 INCH
15	Waist circumference	55260	phv00055260.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 11:38:50+00:00	2018-03-22 11:38:50+00:00 	Waist	Waist measurement in centimeters
15	Waist circumference	251540	phv00251540.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 11:41:08+00:00	2018-03-22 11:41:08+00:00 	h405	Numerical Data - Part I: Regional Anthropometry: Waist Girth at iliac crest (to next lower 1/4 inch) Collection Interval: Exam 3
15	Waist circumference	254291	phv00254291.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 11:41:45+00:00	2018-03-22 11:41:45+00:00 	j480	Numerical Data/Anthropometry: Waist girth at umbilicus
15	Waist circumference	274548	phv00274548.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-22 12:36:56+00:00	2018-03-22 12:36:56+00:00 	g3a451	Waist girth
15	Waist circumference	113650	phv00113650.v2.p2	pht001583.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	A20WST1	MEAS. 1: WAIST GIRTH, CM. Q 4
15	Waist circumference	113651	phv00113651.v2.p2	pht001583.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	A20WST2	MEAS. 2: WAIST GIRTH, CM. Q 4
15	Waist circumference	113659	phv00113659.v2.p2	pht001583.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	A20WST	MEAN WAIST GIRTH, CM
15	Waist circumference	114853	phv00114853.v2.p2	pht001632.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	B20WST1	WAIST 1. Q 5c
15	Waist circumference	114854	phv00114854.v2.p2	pht001632.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	B20WST2	WAIST 2. Q 5c
15	Waist circumference	114855	phv00114855.v2.p2	pht001632.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	B20WST	MEAN( B20WST1,  B20WST2 )
15	Waist circumference	115859	phv00115859.v2.p2	pht001671.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	C20WST1	WAIST GIRTH  (CM). Q 4b
15	Waist circumference	117233	phv00117233.v2.p2	pht001720.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	D20WST1	WAIST GIRTH 1 (CM). Q 4a
15	Waist circumference	117234	phv00117234.v2.p2	pht001720.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	D20WST2	WAIST GIRTH 2 (CM). Q 4a
15	Waist circumference	117247	phv00117247.v2.p2	pht001720.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	D20WST	MEAN (D20WST1, D20WST2) (CM)
15	Waist circumference	119095	phv00119095.v2.p2	pht001785.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	E20WST1	WAIST GIRTH 1 (CM). Q 4a
15	Waist circumference	119096	phv00119096.v2.p2	pht001785.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	E20WST2	WAIST GIRTH 2 (CM). Q 4a
15	Waist circumference	119117	phv00119117.v2.p2	pht001785.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	E20WST	MEAN (E20WST1, E20WST2) (CM)
15	Waist circumference	120998	phv00120998.v2.p2	pht001857.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:46:12+00:00	2018-04-17 16:46:12+00:00 	F20WST1	WAIST GIRTH 1 (CM). Q 3a
15	Waist circumference	99351	phv00099351.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:20:21+00:00	2018-04-20 22:20:21+00:00 	WAIST13	WAIST CIRCUMFERENCE - CM
15	Waist circumference	100385	phv00100385.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:20:32+00:00	2018-04-20 22:20:32+00:00 	WAIST13	WAIST CIRCUMFERENCE - CM
15	Waist circumference	102455	phv00102455.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:20:45+00:00	2018-04-20 22:20:45+00:00 	WAIST13	WAIST CIRCUMFERENCE - CM
15	Waist circumference	105416	phv00105416.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:21:00+00:00	2018-04-20 22:21:00+00:00 	WAIST13	WAIST CIRCUMFERENCE - CM
15	Waist circumference	106778	phv00106778.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:21:12+00:00	2018-04-20 22:21:12+00:00 	WAIST13	WAIST CIRCUMFERENCE - CM
15	Waist circumference	110377	phv00110377.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:21:25+00:00	2018-04-20 22:21:25+00:00 	WAIST13	WAIST CIRCUMFERENCE - CM
15	Waist circumference	82687	phv00082687.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:18:57+00:00	2018-04-23 03:18:57+00:00 	waistcm1	WAIST CIRCUMFERENCE (cm)
15	Waist circumference	84486	phv00084486.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:19:04+00:00	2018-04-23 03:19:04+00:00 	waistcm1	WAIST CIRCUMFERENCE (cm)
15	Waist circumference	85801	phv00085801.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:19:11+00:00	2018-04-23 03:19:11+00:00 	waistcm2	WAIST CIRCUMFERENCE (cm)
15	Waist circumference	86301	phv00086301.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:19:24+00:00	2018-04-23 03:19:24+00:00 	waistcm3	WAIST CIRCUMFERENCE (cm)
15	Waist circumference	86754	phv00086754.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:19:31+00:00	2018-04-23 03:19:31+00:00 	waistcm4	WAIST CIRCUMFERENCE (cm)
15	Waist circumference	87519	phv00087519.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:19:38+00:00	2018-04-23 03:19:38+00:00 	waistcmf	WAIST (cm)
15	Waist circumference	174634	phv00174634.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:19:45+00:00	2018-04-23 03:19:45+00:00 	waistcm5	WAIST CIRCUMFERENCE (cm)
15	Waist circumference	176057	phv00176057.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:19:50+00:00	2018-04-23 03:19:50+00:00 	waistcm5	WAIST CIRCUMFERENCE (cm)
15	Waist circumference	79860	phv00079860.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-24 22:44:33+00:00	2018-04-24 22:44:33+00:00 	WAISTX	F80 Waist circumference cm
15	Waist circumference	283313	phv00283313.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-24 22:44:33+00:00	2018-04-24 22:44:33+00:00 	WAIST	Waist circumference, in
15	Waist circumference	277284	phv00277284.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:07:21+00:00	2018-08-14 22:07:21+00:00 	WAIST	Waist circumference in cm Collection Interval: 2007-2009
15	Waist circumference	277333	phv00277333.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:12:39+00:00	2018-08-14 22:12:39+00:00 	WAIST	Waist circumference Collection Interval: 2009-2011
15	Waist circumference	277516	phv00277516.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:41:10+00:00	2018-08-14 22:41:10+00:00 	WAIST	Waist circumference (cm) Collection Interval: 1996-2000
15	Waist circumference	277766	phv00277766.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:07:01+00:00	2018-08-14 23:07:01+00:00 	WAIST	Waist circumference(cm) Collection Interval: 2000-2004
15	Waist circumference	307744	phv00307744.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:50:59+00:00	2018-08-15 23:50:59+00:00 	WAIST	Waist circumference Collection Interval: 2006-2011
15	Waist circumference	307797	phv00307797.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:55:36+00:00	2018-08-15 23:55:36+00:00 	WAIST	Waist circumference (cm) Collection Interval: 1996-2000
15	Waist circumference	307957	phv00307957.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:08:21+00:00	2018-08-16 00:08:21+00:00 	WAIST	Waist circumference (cm) Collection Interval: 2000-2004
15	Waist circumference	122555	phv00122555.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:46:41+00:00	2018-08-16 23:46:41+00:00 	WAIST	Waist size (cm)
15	Waist circumference	122996	phv00122996.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:53:00+00:00	2018-08-17 19:53:00+00:00 	waistcm	Mean waist circumference (cm)
15	Waist circumference	253219	phv00253219.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:32:08+00:00	2018-08-24 16:32:08+00:00 	ANTA10A	Waist girth (cm) (ANTA10A)
15	Waist circumference	252980	phv00252980.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:11:53+00:00	2018-08-24 17:11:53+00:00 	waist_baseline	Waist circumference at baseline visit
15	Waist circumference	258690	phv00258690.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:33:53+00:00	2018-09-06 12:33:53+00:00 	Abd_Circ	Abdominal Circumference Average
16	Hip circumference	3673	phv00003673.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:47:15+00:00	2018-03-02 15:47:15+00:00 	FL019	HIP GIRTH
16	Hip circumference	4089	phv00004089.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:47:34+00:00	2018-03-02 15:47:34+00:00 	FM29	HIP GIRTH (INCHES WITH 2 DECIMALS)
16	Hip circumference	4531	phv00004531.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:47:58+00:00	2018-03-02 15:47:58+00:00 	FN18	HIP GIRTH (INCHES WITH 2 DECIMALS)
16	Hip circumference	5545	phv00005545.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:48:16+00:00	2018-03-02 15:48:16+00:00 	FO017	HIP GIRTH (INCHES, TO NEXT LOWER 1/4 INCH)
16	Hip circumference	5925	phv00005925.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:48:33+00:00	2018-03-02 15:48:33+00:00 	FP016	HIP GIRTH (INCHES, TO NEXT LOWER 1/4 INCH)
16	Hip circumference	8768	phv00008768.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:48:50+00:00	2018-03-02 15:48:50+00:00 	D411	HIP GIRTH (INCHES WITH 2 DECIMALS)
16	Hip circumference	9556	phv00009556.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:49:09+00:00	2018-03-02 15:49:09+00:00 	E033	HIP GIRTH (INCHES, TO NEXT LOWER 1/4 INCH)
16	Hip circumference	10113	phv00010113.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:49:24+00:00	2018-03-02 15:49:24+00:00 	F017	HIP GIRTH (INCHES, TO NEXT LOWER 1/4 INCH)
16	Hip circumference	10503	phv00010503.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:49:54+00:00	2018-03-02 15:49:54+00:00 	G446	REGIONAL ANTHROPOMETRY - HIP GIRTH (INCHES) (TO NEXT LOWER 1/4 INCH)
16	Hip circumference	55261	phv00055261.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:50:18+00:00	2018-03-02 15:50:18+00:00 	Hip	Hip measurement in centimeters
16	Hip circumference	177545	phv00177545.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:50:58+00:00	2018-03-02 15:50:58+00:00 	g3b0489	Anthropometry: Hip girth
16	Hip circumference	250291	phv00250291.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:51:40+00:00	2018-03-02 15:51:40+00:00 	e033	Numerical Data - Part I: Hip girth Collection Interval: Exam 1
16	Hip circumference	251066	phv00251066.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 15:52:03+00:00	2018-03-02 15:52:03+00:00 	g446	Numerical Data - Part I - Regional Anthropometry: Hip girth (to next lower 1/4 inch) Collection Interval: Exam 2
16	Hip circumference	254293	phv00254293.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 16:01:48+00:00	2018-03-02 16:01:48+00:00 	j482	Numerical Data/Anthropometry: Hip girth
16	Hip circumference	277044	phv00277044.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 16:02:24+00:00	2018-03-02 16:02:24+00:00 	HIP2	Hip girth, Exam 2
16	Hip circumference	277180	phv00277180.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 16:02:35+00:00	2018-03-02 16:02:35+00:00 	HIP4	Hip girth, Exam 4
16	Hip circumference	277181	phv00277181.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 16:03:07+00:00	2018-03-02 16:03:07+00:00 	HIP5	Hip girth, Exam 5
16	Hip circumference	277182	phv00277182.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 16:03:19+00:00	2018-03-02 16:03:19+00:00 	HIP6	Hip girth, Exam 6
16	Hip circumference	277183	phv00277183.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 16:03:32+00:00	2018-03-02 16:03:32+00:00 	HIP7	Hip girth, Exam 7
16	Hip circumference	277184	phv00277184.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-03-02 16:03:43+00:00	2018-03-02 16:03:43+00:00 	HIP9	Hip girth, Exam 9
16	Hip circumference	203160	phv00203160.v1.p1	pht004032.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:15:51+00:00	2018-03-19 20:15:51+00:00 	ANTA07B	[Body size]. Hip girth (to the nearest cm). Q7b [Anthropometry Form, ANTA, exam 1]
16	Hip circumference	203172	phv00203172.v1.p1	pht004033.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:16:08+00:00	2018-03-19 20:16:08+00:00 	ANTB04B	[Body size]. Hip girth (nearest cm). Q4b [Anthropometry Form, ANTAB, exam 2]
16	Hip circumference	203178	phv00203178.v1.p1	pht004034.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:16:28+00:00	2018-03-19 20:16:28+00:00 	ANTC3B	[Body size].Hip girth (to the nearest cm, rounding down). Q3b [Anthropometry Form, ANTC, exam 3]
16	Hip circumference	203189	phv00203189.v1.p1	pht004035.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:16:59+00:00	2018-03-19 20:16:59+00:00 	ANTD3B	[Height and weight].  Hip girth (to the nearest cm, rounding down). Q3b [Anthropometry Form, ANTD, exam 4]
16	Hip circumference	113648	phv00113648.v2.p2	pht001583.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	A20HIPS1	MEAS. 1: HIP GIRTH, CM. Q 4
16	Hip circumference	113649	phv00113649.v2.p2	pht001583.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	A20HIPS2	MEAS. 2: HIP GIRTH, CM. Q 4
16	Hip circumference	113658	phv00113658.v2.p2	pht001583.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	A20HIP	MEAN HIP GIRTH, CM
16	Hip circumference	114850	phv00114850.v2.p2	pht001632.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	B20HIPS1	HIPS 1. Q 5b
16	Hip circumference	114851	phv00114851.v2.p2	pht001632.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	B20HIPS2	HIPS 2. Q 5b
16	Hip circumference	114852	phv00114852.v2.p2	pht001632.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	B20HIP	MEAN( B20HIPS1, B20HIPS2 )
16	Hip circumference	115860	phv00115860.v2.p2	pht001671.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	C20HIPS1	HIP GIRTH   (CM), Q 4c
16	Hip circumference	117235	phv00117235.v2.p2	pht001720.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	D20HIPS1	HIP GIRTH 1  (CM). Q 4b
16	Hip circumference	117236	phv00117236.v2.p2	pht001720.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	D20HIPS2	HIP GIRTH 2  (CM). Q 4b
16	Hip circumference	117248	phv00117248.v2.p2	pht001720.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	D20HIP	MEAN (D20HIPS1, D20HIPS2) (CM)
16	Hip circumference	119097	phv00119097.v2.p2	pht001785.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	E20HIPS1	HIP GIRTH 1  (CM). Q 4b
16	Hip circumference	119098	phv00119098.v2.p2	pht001785.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	E20HIPS2	HIP GIRTH 2  (CM). Q 4b
16	Hip circumference	119118	phv00119118.v2.p2	pht001785.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:52:36+00:00	2018-04-17 16:52:36+00:00 	E20HIP	MEAN (E20HIPS1, E20HIPS2) (CM)
16	Hip circumference	99350	phv00099350.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:21:57+00:00	2018-04-20 22:21:57+00:00 	HIP13	HIP CIRCUMFERENCE - CM
16	Hip circumference	100384	phv00100384.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:22:10+00:00	2018-04-20 22:22:10+00:00 	HIP13	HIP CIRCUMFERENCE - CM
16	Hip circumference	105415	phv00105415.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:22:20+00:00	2018-04-20 22:22:20+00:00 	HIP13	HIP CIRCUMFERENCE - CM
16	Hip circumference	106777	phv00106777.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-04-20 22:22:46+00:00	2018-04-20 22:22:46+00:00 	HIP13	HIP CIRCUMFERENCE - CM
16	Hip circumference	176058	phv00176058.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:20:38+00:00	2018-04-23 03:20:38+00:00 	hipcm5	HIP CIRCUMFERENCE (cm)
16	Hip circumference	82688	phv00082688.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:20:46+00:00	2018-04-23 03:20:46+00:00 	hipcm1	HIP CIRCUMFERENCE (cm)
16	Hip circumference	84489	phv00084489.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:20:54+00:00	2018-04-23 03:20:54+00:00 	hipcm1	HIP CIRCUMFERENCE (CM)
16	Hip circumference	85802	phv00085802.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:21:03+00:00	2018-04-23 03:21:03+00:00 	hipcm2	HIP CIRCUMFERENCE (cm)
16	Hip circumference	86300	phv00086300.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:21:09+00:00	2018-04-23 03:21:09+00:00 	hipcm3	HIP CIRCUMFERENCE (cm)
16	Hip circumference	86753	phv00086753.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:21:17+00:00	2018-04-23 03:21:17+00:00 	hipcm4	HIP CIRCUMFERENCE (cm)
16	Hip circumference	87518	phv00087518.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:21:23+00:00	2018-04-23 03:21:23+00:00 	hipcmf	HIP (cm)
16	Hip circumference	174635	phv00174635.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:21:29+00:00	2018-04-23 03:21:29+00:00 	hipcm5	HIP CIRCUMFERENCE (cm)
16	Hip circumference	79861	phv00079861.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-24 22:55:33+00:00	2018-04-24 22:55:33+00:00 	HIPX	F80 Hip circumference cm
16	Hip circumference	214063	phv00214063.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 20:19:07+00:00	2018-04-25 20:19:07+00:00 	HIP	Hip measurement in centimeters
16	Hip circumference	277285	phv00277285.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:07:11+00:00	2018-08-14 22:07:11+00:00 	HIP	Hip circumference in cm Collection Interval: 2007-2009
16	Hip circumference	277334	phv00277334.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:12:30+00:00	2018-08-14 22:12:30+00:00 	HIP	Hip circumference Collection Interval: 2009-2011
16	Hip circumference	277517	phv00277517.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:41:04+00:00	2018-08-14 22:41:04+00:00 	HIP	Hip circumference (cm) Collection Interval: 1996-2000
16	Hip circumference	277767	phv00277767.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:06:55+00:00	2018-08-14 23:06:55+00:00 	HIP	Hip circumference(cm) Collection Interval: 2000-2004
16	Hip circumference	307745	phv00307745.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:50:52+00:00	2018-08-15 23:50:52+00:00 	HIP	Hip circumference Collection Interval: 2006-2011
16	Hip circumference	307798	phv00307798.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:55:29+00:00	2018-08-15 23:55:29+00:00 	HIP	Hip circumference (cm) Collection Interval: 1996-2000
16	Hip circumference	307958	phv00307958.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:08:27+00:00	2018-08-16 00:08:27+00:00 	HIP	Hip circumference (cm) Collection Interval: 2000-2004
16	Hip circumference	122554	phv00122554.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:46:32+00:00	2018-08-16 23:46:32+00:00 	HIP	Hip size (cm)
16	Hip circumference	122997	phv00122997.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:52:53+00:00	2018-08-17 19:52:53+00:00 	hipcm	Mean hip circumference (cm)
16	Hip circumference	253220	phv00253220.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:32:19+00:00	2018-08-24 16:32:19+00:00 	ANTA10B	Hip girth (cm) (ANTA10B)
16	Hip circumference	258691	phv00258691.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:23:29+00:00	2018-09-06 12:23:29+00:00 	Hip_Circ	Hip Circumference Average
17	Waist-hip ratio	226399	phv00226399.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 21:57:55+00:00	2018-03-14 21:57:55+00:00 	WAIST_HIP	Waist to Hip Ratio
17	Waist-hip ratio	204640	phv00204640.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:53:58+00:00	2018-03-19 16:53:58+00:00 	WSTHPR21	Visit 2, waist-hip ratio [Cohort, Exam 2]
17	Waist-hip ratio	204723	phv00204723.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:54:17+00:00	2018-03-19 16:54:17+00:00 	WSTHPR01	Waist-to-hip ratio [Cohort, Exam 1]
17	Waist-hip ratio	204872	phv00204872.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:54:39+00:00	2018-03-19 16:54:39+00:00 	WSTHPR31	Waist-to-hip ratio [Cohort, Exam 3]
17	Waist-hip ratio	204954	phv00204954.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:55:19+00:00	2018-03-19 16:55:19+00:00 	WSTHPR41	Waist-to-hip ratio [Cohort, Exam 4]
17	Waist-hip ratio	79869	phv00079869.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-04-24 23:00:41+00:00	2018-04-24 23:00:41+00:00 	WHRX	Waist hip ratio
17	Waist-hip ratio	252981	phv00252981.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:12:03+00:00	2018-08-24 17:12:03+00:00 	whr_baseline	Waist hip ratio at baseline visit
18	Ischemic stroke	87878	phv00087878.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:32:42+00:00	2018-04-29 00:32:42+00:00 	strktt	TIME TO STROKE OR LAST FOLLOW-UP (DAYS)
18	Ischemic stroke	87877	phv00087877.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:32:52+00:00	2018-04-29 00:32:52+00:00 	strktype	STROKE TYPE
18	Ischemic stroke	218146	phv00218146.v1.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:47:48+00:00	2018-04-29 00:47:48+00:00 	strkbis1	BRAIN INFARCTION SUBTYPE 1
18	Ischemic stroke	218147	phv00218147.v1.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:47:56+00:00	2018-04-29 00:47:56+00:00 	strkbis2	BRAIN INFARCTION SUBTYPE 2
18	Ischemic stroke	218148	phv00218148.v1.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:48:03+00:00	2018-04-29 00:48:03+00:00 	strkbis3	BRAIN INFARCTION SUBTYPE 3
18	Ischemic stroke	87876	phv00087876.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-05-01 00:10:42+00:00	2018-05-01 00:10:42+00:00 	strk	STROKE
18	Ischemic stroke	207614	phv00207614.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:16:48+00:00	2018-05-03 14:16:48+00:00 	INISC07	Def/Prob Ischemic Inc. Stroke by 2007
18	Ischemic stroke	207619	phv00207619.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:18:47+00:00	2018-05-03 14:18:47+00:00 	FTISC07	Follow-up ISC strokes (days)
18	Ischemic stroke	100830	phv00100830.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:22:48+00:00	2018-06-29 16:22:48+00:00 	STKTYPE	STROKE TYPE
18	Ischemic stroke	192507	phv00192507.v3.p3	pht003402.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:16:30+00:00	2018-07-02 22:16:30+00:00 	STRKISCH	Ischemic Stroke
18	Ischemic stroke	193187	phv00193187.v3.p3	pht003407.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:16:30+00:00	2018-07-02 22:16:30+00:00 	STRKISCH	Ischemic Stroke
18	Ischemic stroke	193802	phv00193802.v3.p3	pht003415.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:16:30+00:00	2018-07-02 22:16:30+00:00 	STRKISCH	Ischemic Stroke
18	Ischemic stroke	193823	phv00193823.v3.p3	pht003416.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:16:30+00:00	2018-07-02 22:16:30+00:00 	STRKISCH	Ischemic Stroke
18	Ischemic stroke	71905	phv00071905.v4.p10	pht000743.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 18:34:11+00:00	2018-08-09 18:34:11+00:00 	CVA_TYPE	Type of CVA Collection Interval: Through 2005
18	Ischemic stroke	207624	phv00207624.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-09 19:37:04+00:00	2018-08-09 19:37:04+00:00 	YRISC07	Event Year for INISC07
18	Ischemic stroke	207629	phv00207629.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-09 19:37:12+00:00	2018-08-09 19:37:12+00:00 	AGISC07	Age for INISC07
18	Ischemic stroke	204442	phv00204442.v1.p1	pht004060.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:44:15+00:00	2018-08-16 18:44:15+00:00 	SDXA5	[Review of computer's MI diagnosis]. Stroke diagnosis. Q5 [Stroke Final Diagnosis Form, SDX]
18	Ischemic stroke	203810	phv00203810.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:46:00+00:00	2018-08-16 18:46:00+00:00 	COMPDIAG	Computer diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary]
18	Ischemic stroke	203812	phv00203812.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:46:28+00:00	2018-08-16 18:46:28+00:00 	YEAR	Event year from STRC12, STRC14 Or CELB04 [Cohort Surveillance Stroke Derived Variable Dictionary]
18	Ischemic stroke	203813	phv00203813.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:49:15+00:00	2018-08-16 18:49:15+00:00 	FINALDX	Final diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary]
18	Ischemic stroke	203814	phv00203814.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:49:34+00:00	2018-08-16 18:49:34+00:00 	COMP_DX	Formatted computer diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary]
18	Ischemic stroke	203815	phv00203815.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:49:58+00:00	2018-08-16 18:49:58+00:00 	FINAL_DX	Formatted final diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary]
18	Ischemic stroke	190981	phv00190981.v5.p10	pht003335.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-24 22:15:40+00:00	2018-08-24 22:15:40+00:00 	DATE	Date of Event
18	Ischemic stroke	36471	phv00036471.v11.p10	pht000309.v12.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-24 22:15:47+00:00	2018-08-24 22:15:47+00:00 	DATE	Date of Event Collection Interval: Events reviewed through 12/2015
18	Ischemic stroke	190979	phv00190979.v5.p10	pht003335.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-24 22:15:55+00:00	2018-08-24 22:15:55+00:00 	EVENT	Event Number
18	Ischemic stroke	36469	phv00036469.v11.p10	pht000309.v12.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-24 22:16:02+00:00	2018-08-24 22:16:02+00:00 	EVENT	Event Number Collection Interval: Events reviewed through 12/2015
18	Ischemic stroke	276974	phv00276974.v1.p10	pht006024.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-24 22:16:40+00:00	2018-08-24 22:16:40+00:00 	stroke_tiadate	Date of stroke/TIA (or censoring date)
18	Ischemic stroke	276972	phv00276972.v1.p10	pht006024.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-24 22:16:47+00:00	2018-08-24 22:16:47+00:00 	stroke_tiatype	Stroke/TIA type
18	Ischemic stroke	276971	phv00276971.v1.p10	pht006024.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-24 22:16:54+00:00	2018-08-24 22:16:54+00:00 	stroke_tia	Stroke/TIA status
18	Ischemic stroke	276965	phv00276965.v1.p10	pht006023.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-24 22:17:01+00:00	2018-08-24 22:17:01+00:00 	stroke	Stroke status
18	Ischemic stroke	276968	phv00276968.v1.p10	pht006023.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-24 22:17:08+00:00	2018-08-24 22:17:08+00:00 	strokedate	Date of stroke
18	Ischemic stroke	276966	phv00276966.v1.p10	pht006023.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-24 22:17:16+00:00	2018-08-24 22:17:16+00:00 	stroke_type	Stroke type
18	Ischemic stroke	121308	phv00121308.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:17:03+00:00	2018-08-30 20:17:03+00:00 	Y01STKDG	STROKE DIAGNOSIS TYPE
18	Ischemic stroke	121307	phv00121307.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:17:16+00:00	2018-08-30 20:17:16+00:00 	Y01STROK	STROKE
18	Ischemic stroke	121525	phv00121525.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:17:57+00:00	2018-08-30 20:17:57+00:00 	Y01STKDG	STROKE DIAGNOSIS TYPE
18	Ischemic stroke	121524	phv00121524.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:18:11+00:00	2018-08-30 20:18:11+00:00 	Y01STROK	STROKE
18	Ischemic stroke	259387	phv00259387.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-07 16:13:18+00:00	2018-09-07 16:13:18+00:00 	sttype	Stroke type
18	Ischemic stroke	121730	phv00121730.v1.p2	pht001874.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-13 19:49:33+00:00	2018-12-13 19:49:33+00:00 	Z33ESTYP	STROKE TYPE
18	Ischemic stroke	259383	phv00259383.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-12-20 19:10:57+00:00	2018-12-20 19:10:57+00:00 	priorstk	Prior Stroke
19	Hemorrhagic stroke	87877	phv00087877.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:35:03+00:00	2018-04-29 00:35:03+00:00 	strktype	STROKE TYPE
19	Hemorrhagic stroke	87876	phv00087876.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:35:37+00:00	2018-04-29 00:35:37+00:00 	strk	STROKE
19	Hemorrhagic stroke	87878	phv00087878.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:36:57+00:00	2018-04-29 00:36:57+00:00 	strktt	TIME TO STROKE OR LAST FOLLOW-UP (DAYS)
19	Hemorrhagic stroke	207615	phv00207615.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:17:08+00:00	2018-05-03 14:17:08+00:00 	INHEM07	Def/Prob Hemorrhagic Inc. Stroke by 2007
19	Hemorrhagic stroke	207616	phv00207616.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:17:45+00:00	2018-05-03 14:17:45+00:00 	INCHM07	Def/Prob Combined Hemm Inc. Stroke by 2007
19	Hemorrhagic stroke	207620	phv00207620.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:19:03+00:00	2018-05-03 14:19:03+00:00 	FTHEM07	Follow-up HEM strokes (days)
19	Hemorrhagic stroke	207621	phv00207621.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:19:29+00:00	2018-05-03 14:19:29+00:00 	FTCHM07	Follow-up CHM strokes (days)
19	Hemorrhagic stroke	100830	phv00100830.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:23:08+00:00	2018-06-29 16:23:08+00:00 	STKTYPE	STROKE TYPE
19	Hemorrhagic stroke	192504	phv00192504.v3.p3	pht003402.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:15:35+00:00	2018-07-02 22:15:35+00:00 	STRKHEMO	Hemorrhagic Stroke
19	Hemorrhagic stroke	193184	phv00193184.v3.p3	pht003407.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:15:35+00:00	2018-07-02 22:15:35+00:00 	STRKHEMO	Hemorrhagic Stroke
19	Hemorrhagic stroke	193801	phv00193801.v3.p3	pht003415.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:15:35+00:00	2018-07-02 22:15:35+00:00 	STRKHEMO	Hemorrhagic Stroke
19	Hemorrhagic stroke	193822	phv00193822.v3.p3	pht003416.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:15:35+00:00	2018-07-02 22:15:35+00:00 	STRKHEMO	Hemorrhagic Stroke
19	Hemorrhagic stroke	36469	phv00036469.v11.p10	pht000309.v12.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:17:19+00:00	2018-07-03 12:17:19+00:00 	EVENT	Event Number Collection Interval: Events reviewed through 12/2015
19	Hemorrhagic stroke	190979	phv00190979.v5.p10	pht003335.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:18:08+00:00	2018-07-03 12:18:08+00:00 	EVENT	Event Number
19	Hemorrhagic stroke	36471	phv00036471.v11.p10	pht000309.v12.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:20:46+00:00	2018-07-03 12:20:46+00:00 	DATE	Date of Event Collection Interval: Events reviewed through 12/2015
19	Hemorrhagic stroke	190981	phv00190981.v5.p10	pht003335.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:21:26+00:00	2018-07-03 12:21:26+00:00 	DATE	Date of Event
19	Hemorrhagic stroke	276966	phv00276966.v1.p10	pht006023.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:22:41+00:00	2018-07-03 12:22:41+00:00 	stroke_type	Stroke type
19	Hemorrhagic stroke	276968	phv00276968.v1.p10	pht006023.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:52:19+00:00	2018-07-03 12:52:19+00:00 	strokedate	Date of stroke
19	Hemorrhagic stroke	276965	phv00276965.v1.p10	pht006023.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:53:12+00:00	2018-07-03 12:53:12+00:00 	stroke	Stroke status
19	Hemorrhagic stroke	276971	phv00276971.v1.p10	pht006024.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:55:32+00:00	2018-07-03 12:55:32+00:00 	stroke_tia	Stroke/TIA status
19	Hemorrhagic stroke	276972	phv00276972.v1.p10	pht006024.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:56:18+00:00	2018-07-03 12:56:18+00:00 	stroke_tiatype	Stroke/TIA type
19	Hemorrhagic stroke	276974	phv00276974.v1.p10	pht006024.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:58:29+00:00	2018-07-03 12:58:29+00:00 	stroke_tiadate	Date of stroke/TIA (or censoring date)
19	Hemorrhagic stroke	71905	phv00071905.v4.p10	pht000743.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 18:34:18+00:00	2018-08-09 18:34:18+00:00 	CVA_TYPE	Type of CVA Collection Interval: Through 2005
19	Hemorrhagic stroke	207625	phv00207625.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-09 18:51:40+00:00	2018-08-09 18:51:40+00:00 	YRHEM07	Event year for INHEM07
19	Hemorrhagic stroke	207626	phv00207626.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-09 18:51:48+00:00	2018-08-09 18:51:48+00:00 	YRCHM07	Event year for INCHM07
19	Hemorrhagic stroke	207630	phv00207630.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-09 18:51:56+00:00	2018-08-09 18:51:56+00:00 	AGHEM07	Age for INHEM07
19	Hemorrhagic stroke	207631	phv00207631.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-09 18:52:03+00:00	2018-08-09 18:52:03+00:00 	AGCHM07	Age for INCHM07
19	Hemorrhagic stroke	204442	phv00204442.v1.p1	pht004060.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:44:21+00:00	2018-08-16 18:44:21+00:00 	SDXA5	[Review of computer's MI diagnosis]. Stroke diagnosis. Q5 [Stroke Final Diagnosis Form, SDX]
19	Hemorrhagic stroke	203810	phv00203810.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:46:06+00:00	2018-08-16 18:46:06+00:00 	COMPDIAG	Computer diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary]
19	Hemorrhagic stroke	203812	phv00203812.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:46:33+00:00	2018-08-16 18:46:33+00:00 	YEAR	Event year from STRC12, STRC14 Or CELB04 [Cohort Surveillance Stroke Derived Variable Dictionary]
19	Hemorrhagic stroke	203813	phv00203813.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:49:21+00:00	2018-08-16 18:49:21+00:00 	FINALDX	Final diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary]
19	Hemorrhagic stroke	203814	phv00203814.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:49:41+00:00	2018-08-16 18:49:41+00:00 	COMP_DX	Formatted computer diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary]
19	Hemorrhagic stroke	203815	phv00203815.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:50:05+00:00	2018-08-16 18:50:05+00:00 	FINAL_DX	Formatted final diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary]
19	Hemorrhagic stroke	121308	phv00121308.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:17:09+00:00	2018-08-30 20:17:09+00:00 	Y01STKDG	STROKE DIAGNOSIS TYPE
19	Hemorrhagic stroke	121307	phv00121307.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:17:21+00:00	2018-08-30 20:17:21+00:00 	Y01STROK	STROKE
19	Hemorrhagic stroke	121525	phv00121525.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:18:03+00:00	2018-08-30 20:18:03+00:00 	Y01STKDG	STROKE DIAGNOSIS TYPE
19	Hemorrhagic stroke	121524	phv00121524.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:18:18+00:00	2018-08-30 20:18:18+00:00 	Y01STROK	STROKE
19	Hemorrhagic stroke	259387	phv00259387.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-07 16:13:27+00:00	2018-09-07 16:13:27+00:00 	sttype	Stroke type
19	Hemorrhagic stroke	121730	phv00121730.v1.p2	pht001874.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-13 19:49:14+00:00	2018-12-13 19:49:14+00:00 	Z33ESTYP	STROKE TYPE
19	Hemorrhagic stroke	259383	phv00259383.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-12-20 19:10:37+00:00	2018-12-20 19:10:37+00:00 	priorstk	Prior Stroke
20	Other stroke	128093	phv00128093.v1.p1	pht001967.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-23 15:41:16+00:00	2018-02-23 15:41:16+00:00 	PFHA5A	5a: Has doctor said you had Stroke?
20	Other stroke	128094	phv00128094.v1.p1	pht001967.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-23 15:41:16+00:00	2018-02-23 15:41:16+00:00 	PFHA5B	5b: Age when told you had stroke?
20	Other stroke	128395	phv00128395.v1.p1	pht001976.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-23 15:41:16+00:00	2018-02-23 15:41:16+00:00 	SSFA1	1: Told by a physician you had a stroke
20	Other stroke	128396	phv00128396.v1.p1	pht001976.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-02-23 15:41:16+00:00	2018-02-23 15:41:16+00:00 	SSFA2	2: When did first stroke occur
20	Other stroke	204684	phv00204684.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 12:30:48+00:00	2018-05-03 12:30:48+00:00 	PRVSTR21	Prevalent stroke at visit 2 [Cohort, Exam 2]
20	Other stroke	204912	phv00204912.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 12:37:35+00:00	2018-05-03 12:37:35+00:00 	PRVSTR31	Prevalent stroke at visit 3 [Cohort, Exam 3]
20	Other stroke	205007	phv00205007.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 12:37:59+00:00	2018-05-03 12:37:59+00:00 	PRVSTR41	Prevalent stroke at visit 4 [Cohort, Exam 4]
20	Other stroke	202904	phv00202904.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:16:20+00:00	2018-05-03 13:16:20+00:00 	AFUcomp29_A	[Stroke/TIA]. Since our last contact have you been told by a physician that you had a stroke, slight stroke, transient ischemic attack or TIA? [Annual Follow-up Questionnaire Form, AFUA]
20	Other stroke	204458	phv00204458.v1.p1	pht004061.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:18:05+00:00	2018-05-03 13:18:05+00:00 	STRC23	[Hospital information]. History of prior stroke. Q23 [Cohort Stroke Abstraction Form]
20	Other stroke	203758	phv00203758.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:49:47+00:00	2018-05-03 13:49:47+00:00 	CORA06J	Did the coroner's report mention any of the following as contributing to or being present at death? Recent stroke, other or unspecified type. Q6j [Coroner / Medical Examiner Form]
20	Other stroke	203794	phv00203794.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:50:16+00:00	2018-05-03 13:50:16+00:00 	CORA21A	Is there a history of stroke prior to this event? Q21a [Coroner / Medical Examiner Form]
20	Other stroke	203795	phv00203795.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:51:03+00:00	2018-05-03 13:51:03+00:00 	CORA21B	Did a stroke occur within four weeks prior to this event? Q21b [Coroner / Medical Examiner Form]
20	Other stroke	203812	phv00203812.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:52:50+00:00	2018-05-03 13:52:50+00:00 	YEAR	Event year from STRC12, STRC14 Or CELB04 [Cohort Surveillance Stroke Derived Variable Dictionary]
20	Other stroke	203941	phv00203941.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:54:06+00:00	2018-05-03 13:54:06+00:00 	HRAA28G	[Second transfer]. Were any of the following mentioned as being present during this hospital stay? Stroke Present? Q28g [Hospital Abstraction Form]
20	Other stroke	203984	phv00203984.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:54:36+00:00	2018-05-03 13:54:36+00:00 	HRAA39	[Second transfer]. Is there a history of stroke prior to this event? Q39 [Hospital Abstraction Form]
20	Other stroke	203985	phv00203985.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:55:03+00:00	2018-05-03 13:55:03+00:00 	HRAA40	[Second transfer]. Did a stroke occur within 4 weeks prior to this event? Q40 [Hospital Abstraction Form]
20	Other stroke	204310	phv00204310.v1.p1	pht004054.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:55:47+00:00	2018-05-03 13:55:47+00:00 	IFIA18	[History]. Did ( ) ever have a stroke? Q18 [Informant Interview Form, IFI]
20	Other stroke	204311	phv00204311.v1.p1	pht004054.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:56:14+00:00	2018-05-03 13:56:14+00:00 	IFIA19A	[History]. Did he/she have a stroke within four weeks of his/her final illness? Q19a [Informant Interview Form, IFI]
20	Other stroke	204347	phv00204347.v1.p1	pht004054.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:56:40+00:00	2018-05-03 13:56:40+00:00 	IFIA19	[History]. Stroke in four weeks before death. Q19 [Informant Interview Form, IFI]
20	Other stroke	204410	phv00204410.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:57:03+00:00	2018-05-03 13:57:03+00:00 	PHQA03I	[Medical history]. Did the decedent have a history of any of the following? Stroke (CVA). Q3i [Physician Questionnaire Form, exam 1]
20	Other stroke	204442	phv00204442.v1.p1	pht004060.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:58:01+00:00	2018-05-03 13:58:01+00:00 	SDXA5	[Review of computer's MI diagnosis]. Stroke diagnosis. Q5 [Stroke Final Diagnosis Form, SDX]
20	Other stroke	204445	phv00204445.v1.p1	pht004060.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 13:59:18+00:00	2018-05-03 13:59:18+00:00 	SDXA1CY	Year of SDX completion [Stroke Final Diagnosis Form, SDX]
20	Other stroke	204563	phv00204563.v1.p1	pht004061.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:08:07+00:00	2018-05-03 14:08:07+00:00 	STRC24Y	[Hospital information]. History of prior stroke. Month/year of first stroke: year. Q24 [Cohort Stroke Abstraction Form]
20	Other stroke	204564	phv00204564.v1.p1	pht004061.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:08:41+00:00	2018-05-03 14:08:41+00:00 	STRC25Y	[Hospital information]. History of prior stroke. Month/year of most recent stroke: year. Q25 [Cohort Stroke Abstraction Form]
20	Other stroke	204602	phv00204602.v1.p1	pht004061.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:09:34+00:00	2018-05-03 14:09:34+00:00 	FUSTR24	Follow up days for STRC24 (DATE OF FIRST STROKE) from exam 1
20	Other stroke	204603	phv00204603.v1.p1	pht004061.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:09:58+00:00	2018-05-03 14:09:58+00:00 	FUSTR25	Follow up days for STRC25 (DATE OF MOST RECENT STROKE) from exam 1
20	Other stroke	206814	phv00206814.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:13:18+00:00	2018-05-03 14:13:18+00:00 	HFAA14A	[Medical history]. Q14a - Stroke/transient ischemic attack [Heart Failure Hospital Record Abstraction Form, HFA]
20	Other stroke	206998	phv00206998.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:13:49+00:00	2018-05-03 14:13:49+00:00 	HFAA75	Q75 - Stroke (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA]
20	Other stroke	207025	phv00207025.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:14:19+00:00	2018-05-03 14:14:19+00:00 	HFAA16Q	[Medical history]. Q16q - Precipitating factor: stroke/transient ischemic attack (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA]
20	Other stroke	207314	phv00207314.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:14:45+00:00	2018-05-03 14:14:45+00:00 	HOM10D	Has a doctor ever said that you had any of the following: stroke? Q10d [Home Interview, exam 1]
20	Other stroke	207612	phv00207612.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:15:27+00:00	2018-05-03 14:15:27+00:00 	INDP07	Def/Prob incident stroke by 2007
20	Other stroke	207613	phv00207613.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:16:00+00:00	2018-05-03 14:16:00+00:00 	INDPP07	Def/Prob/Poss Inc. Stroke by 2007
20	Other stroke	207617	phv00207617.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:18:10+00:00	2018-05-03 14:18:10+00:00 	FTDP07	Follow-up DP strokes (days)
20	Other stroke	207618	phv00207618.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:18:30+00:00	2018-05-03 14:18:30+00:00 	FTDPP07	Follow-up DPP strokes (days)
20	Other stroke	210409	phv00210409.v1.p1	pht004197.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:20:33+00:00	2018-05-03 14:20:33+00:00 	STROKE01	Stroke [Stroke, exam 1]
20	Other stroke	210402	phv00210402.v1.p1	pht004197.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:21:36+00:00	2018-05-03 14:21:36+00:00 	STKLC01	Stroke-left carotid [Stroke, exam 1]
20	Other stroke	210403	phv00210403.v1.p1	pht004197.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:21:54+00:00	2018-05-03 14:21:54+00:00 	STKRC01	Stroke-right carotid [Stroke, exam 1]
20	Other stroke	210421	phv00210421.v1.p1	pht004198.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:23:35+00:00	2018-05-03 14:23:35+00:00 	STKLC21	Stroke-left carotid [Stroke, exam 2]
20	Other stroke	210422	phv00210422.v1.p1	pht004198.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:23:52+00:00	2018-05-03 14:23:52+00:00 	STKRC21	Stroke-right carotid [Stroke, exam 2]
20	Other stroke	210428	phv00210428.v1.p1	pht004198.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:24:17+00:00	2018-05-03 14:24:17+00:00 	STROKE21	Stroke [Stroke, exam 2]
20	Other stroke	210440	phv00210440.v1.p1	pht004199.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:24:51+00:00	2018-05-03 14:24:51+00:00 	STKLC31	Stroke-left carotid [Stroke, exam 3]
20	Other stroke	210441	phv00210441.v1.p1	pht004199.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:25:09+00:00	2018-05-03 14:25:09+00:00 	STKRC31	Stroke-right carotid [Stroke, exam 3]
20	Other stroke	210442	phv00210442.v1.p1	pht004199.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:25:57+00:00	2018-05-03 14:25:57+00:00 	STKVB31	Stroke-vertebrobasilar system [VBI]  [Stroke, exam 3]
20	Other stroke	210423	phv00210423.v1.p1	pht004198.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:26:26+00:00	2018-05-03 14:26:26+00:00 	STKVB21	Stroke-vertebrobasilar system [VBI] [Stroke, exam 2]
20	Other stroke	210404	phv00210404.v1.p1	pht004197.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:26:51+00:00	2018-05-03 14:26:51+00:00 	STKVB01	Stroke-vertebrobasilar system [VBI] [Stroke, exam 1]
20	Other stroke	210447	phv00210447.v1.p1	pht004199.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:27:29+00:00	2018-05-03 14:27:29+00:00 	STROKE31	Stroke [Stroke, exam 3]
20	Other stroke	210459	phv00210459.v1.p1	pht004200.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:27:56+00:00	2018-05-03 14:27:56+00:00 	STKLC41	Stroke-left carotid [Stroke, exam 4]
20	Other stroke	210460	phv00210460.v1.p1	pht004200.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:28:12+00:00	2018-05-03 14:28:12+00:00 	STKRC41	Stroke-right carotid [Stroke, exam 4]
20	Other stroke	210461	phv00210461.v1.p1	pht004200.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:28:30+00:00	2018-05-03 14:28:30+00:00 	STKVB41	Stroke-vertebrobasilar system [VBI] [Stroke, exam 4]
20	Other stroke	210466	phv00210466.v1.p1	pht004200.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:28:51+00:00	2018-05-03 14:28:51+00:00 	STROKE41	Stroke [Stroke, exam 4]
20	Other stroke	210471	phv00210471.v1.p1	pht004201.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:29:23+00:00	2018-05-03 14:29:23+00:00 	TIAB01	[Medical history]. Have you ever been told by a physician that you had a stroke, slight stroke, transient ischemic attack or transient ischemic attack [TIA]? Q1 [TIA/Stroke, exam 1]
20	Other stroke	210594	phv00210594.v1.p1	pht004201.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:32:31+00:00	2018-05-03 14:32:31+00:00 	HX_STROKE	History of stroke [TIA/Stroke, exam 1]
20	Other stroke	210597	phv00210597.v1.p1	pht004202.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:33:29+00:00	2018-05-03 14:33:29+00:00 	TIAC01	[Medical history]. Since the last ARIC visit, have you been told by a physician that you had a stroke, slight stroke, transient ischemic attack or transient ischemic attack [TIA]? Q1 [TIA/Stroke, exam 2]
20	Other stroke	210596	phv00210596.v1.p1	pht004202.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:33:57+00:00	2018-05-03 14:33:57+00:00 	TIACCY	Contact year [4] [TIA/Stroke, exam 2]
20	Other stroke	210470	phv00210470.v1.p1	pht004201.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:35:43+00:00	2018-05-03 14:35:43+00:00 	TIABCY	Contact year [1] [TIA/Stroke, exam 1]
20	Other stroke	210598	phv00210598.v1.p1	pht004202.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:38:05+00:00	2018-05-03 14:38:05+00:00 	TIAC02	[Medical history]. During this time, when did the (first) stroke or transient ischemic attack [TIA] occur? Q2 [TIA/Stroke, exam 2]
20	Other stroke	210785	phv00210785.v1.p1	pht004203.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:39:25+00:00	2018-05-03 14:39:25+00:00 	TIADCY	Contact year [7] [TIA/Stroke, exam 3]
20	Other stroke	210786	phv00210786.v1.p1	pht004203.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:39:45+00:00	2018-05-03 14:39:45+00:00 	TIAD1	[Medical history]. Since the last ARIC visit, have you been told by a physician that you had a stroke, slight stroke, transient ischemic attack or transient ischemic attack [TIA]? Q1 [TIA/Stroke, exam 3]
20	Other stroke	210840	phv00210840.v1.p1	pht004204.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:40:32+00:00	2018-05-03 14:40:32+00:00 	TIAE1	[Medical history]. Since the last ARIC visit, have you been told by a physician that you had a stroke, slight stroke, transient ischemic attack or transient ischemic attack [TIA]? Q1 [TIA/Stroke Form, Cohort Visit 4]
20	Other stroke	210894	phv00210894.v1.p1	pht004204.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:41:22+00:00	2018-05-03 14:41:22+00:00 	TIAECY	Contact year [10] [TIA/Stroke Form, Cohort Visit 4]
20	Other stroke	210963	phv00210963.v1.p1	pht004205.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 14:42:16+00:00	2018-05-03 14:42:16+00:00 	TIBECY	Administrative information. Contact Year [10]. [TIA/Stroke Form, Cohort Visit 4]
20	Other stroke	87877	phv00087877.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-05-16 02:22:38+00:00	2018-05-16 02:22:38+00:00 	strktype	STROKE TYPE
20	Other stroke	126146	phv00126146.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 14:28:43+00:00	2018-06-08 14:28:43+00:00 	STR01	Stroke(self-reported)
20	Other stroke	125007	phv00125007.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 15:28:15+00:00	2018-06-08 15:28:15+00:00 	AFUA8	8. Told by a physician that you had a stroke, slight stroke, transient ischemic attack, or TIA?
20	Other stroke	125092	phv00125092.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:30:45+00:00	2018-06-08 16:30:45+00:00 	AFUA8	8. Told by a physician that you had a stroke, slight stroke, transient ischemic attack, or TIA?
20	Other stroke	125177	phv00125177.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:52:32+00:00	2018-06-08 16:52:32+00:00 	AFUB8	8. Told by a physician that you had a stroke, slight stroke, transient ischemic attack, or TIA?
20	Other stroke	125263	phv00125263.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:00:12+00:00	2018-06-08 17:00:12+00:00 	AFUB8	8. Told by a physician that you had a stroke, slight stroke, transient ischemic attack, or TIA?
20	Other stroke	125390	phv00125390.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:15:05+00:00	2018-06-08 17:15:05+00:00 	AFUC22A	22a. Since our last contact, have you been told by a physician that you had a stroke
20	Other stroke	125610	phv00125610.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:47:31+00:00	2018-06-08 19:47:31+00:00 	AFUI8	TOLD BY DOCTOR HAD STROKE, TIA    Q8
20	Other stroke	125698	phv00125698.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:55:52+00:00	2018-06-08 19:55:52+00:00 	AFUJ8	TOLD BY DOCTOR HAD STROKE, TIA    Q8
20	Other stroke	125521	phv00125521.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:09:54+00:00	2018-06-08 20:09:54+00:00 	AFUI8	TOLD BY DOCTOR HAD STROKE, TIA    Q8
20	Other stroke	125785	phv00125785.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:15:07+00:00	2018-06-08 20:15:07+00:00 	AFUK8A	TOLD BY DOCTOR HAD STROKE, TIA      Q8A
20	Other stroke	117058	phv00117058.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:00+00:00	2018-06-18 20:38:00+00:00 	D08TIA	STROKE OR TIA. Q 19
20	Other stroke	117059	phv00117059.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:00+00:00	2018-06-18 20:38:00+00:00 	D08TIAAG	AGE FIRST DIAGNOSED WITH STROKE/TIA. Q 19
20	Other stroke	117941	phv00117941.v2.p2	pht001749.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:00+00:00	2018-06-18 20:38:00+00:00 	FY096TIA	STROKE OR TIA - MON 108
20	Other stroke	117942	phv00117942.v2.p2	pht001749.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:00+00:00	2018-06-18 20:38:00+00:00 	FY096TAA	AGE FIRST TOLD STROKE OR TIA - MON 96
20	Other stroke	117970	phv00117970.v2.p2	pht001749.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:00+00:00	2018-06-18 20:38:00+00:00 	FY108TIA	STROKE OR TIA - MON 108
20	Other stroke	118538	phv00118538.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:00+00:00	2018-06-18 20:38:00+00:00 	E08TIA	STROKE OR TIA? Q 21
20	Other stroke	118539	phv00118539.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:00+00:00	2018-06-18 20:38:00+00:00 	E08TIAAG	AGE DIAGNOSED-STROKE/TIA. Q 21
20	Other stroke	119916	phv00119916.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:00+00:00	2018-06-18 20:38:00+00:00 	F08TIA	STROKE OR TIA? Q22
20	Other stroke	119926	phv00119926.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:00+00:00	2018-06-18 20:38:00+00:00 	F08TIAAG	AGE DIAGNOSED-STROKE/TIA. Q 22
20	Other stroke	119927	phv00119927.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:01+00:00	2018-06-18 20:38:01+00:00 	F08TIAYR	HAD STROKE IN THE PAST YEAR? Q 22
20	Other stroke	121266	phv00121266.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:01+00:00	2018-06-18 20:38:01+00:00 	Y01STKEP	ENDPT - STROKE
20	Other stroke	121307	phv00121307.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:01+00:00	2018-06-18 20:38:01+00:00 	Y01STROK	STROKE
20	Other stroke	121308	phv00121308.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:01+00:00	2018-06-18 20:38:01+00:00 	Y01STKDG	STROKE DIAGNOSIS TYPE
20	Other stroke	121463	phv00121463.v2.p2	pht001870.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:01+00:00	2018-06-18 20:38:01+00:00 	Y00STROK	DISCHG DIAG - STROKE, TIA
20	Other stroke	121482	phv00121482.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:01+00:00	2018-06-18 20:38:01+00:00 	Y01STKEP	ENDPT - STROKE
20	Other stroke	121524	phv00121524.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:38:01+00:00	2018-06-18 20:38:01+00:00 	Y01STROK	STROKE
20	Other stroke	100792	phv00100792.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:17:48+00:00	2018-06-29 16:17:48+00:00 	INCSTRK	INCIDENT STROKE
20	Other stroke	100793	phv00100793.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:18:03+00:00	2018-06-29 16:18:03+00:00 	TTOSTK	TIME TO STROKE
20	Other stroke	100794	phv00100794.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:18:26+00:00	2018-06-29 16:18:26+00:00 	STBLMOD	STK MODIFIED BL STAT
20	Other stroke	100815	phv00100815.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:19:56+00:00	2018-06-29 16:19:56+00:00 	STKBASE	STROKE AT BL (SELF-REPORT)
20	Other stroke	100830	phv00100830.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:23:23+00:00	2018-06-29 16:23:23+00:00 	STKTYPE	STROKE TYPE
20	Other stroke	100824	phv00100824.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:24:05+00:00	2018-06-29 16:24:05+00:00 	EVTYPE	EVENT TYPE
20	Other stroke	100825	phv00100825.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:24:21+00:00	2018-06-29 16:24:21+00:00 	TTOEVENT	TIME TO EVENT
20	Other stroke	197704	phv00197704.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:56:05+00:00	2018-06-29 18:56:05+00:00 	stroke	Prevalent stroke
20	Other stroke	274016	phv00274016.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 11:49:51+00:00	2018-07-03 11:49:51+00:00 	g3a394	CDI - Stroke/TIA Collection Interval: Exam 1
20	Other stroke	274509	phv00274509.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 11:50:04+00:00	2018-07-03 11:50:04+00:00 	g3a394	CDI - Stroke/TIA
20	Other stroke	255320	phv00255320.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:02:22+00:00	2018-07-03 12:02:22+00:00 	fw591	Circulatory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Stroke, TIA Variable appears on Form B only Collection Interval: Original Cohort Exam 30
20	Other stroke	274797	phv00274797.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:04:33+00:00	2018-07-03 12:04:33+00:00 	FX131	Medical History - Cerebrovascular Disease: Have you been told by a doctor you had a stroke or TIA? Collection Interval: Original Cohort Exam 31
20	Other stroke	275154	phv00275154.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:05:36+00:00	2018-07-03 12:05:36+00:00 	fy131	Medical History - Cerebrovascular Disease: Have you been told by a doctor you had a stroke or TIA? Collection Interval: Original Cohort Exam 32
20	Other stroke	275379	phv00275379.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:06:06+00:00	2018-07-03 12:06:06+00:00 	fy591	Circulatory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for stroke, TIA? Collection Interval: Original Cohort Exam 32
20	Other stroke	6304	phv00006304.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:07:05+00:00	2018-07-03 12:07:05+00:00 	FQ375	SECOND EXAMINER OPINION - OTHER STROKE/TIA/PARKINSON'S DISEASE IN INTERIM
20	Other stroke	10098	phv00010098.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:10:11+00:00	2018-07-03 12:10:11+00:00 	F708	DID YOU HAVE A STROKE BEFORE AGE 65
20	Other stroke	23793	phv00023793.v1.p10	pht000160.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:10:52+00:00	2018-07-03 12:10:52+00:00 	datestro	DATE OF STROKE, NUMBER OF DAYS SINCE EXAM 1
20	Other stroke	23900	phv00023900.v1.p10	pht000172.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:11:07+00:00	2018-07-03 12:11:07+00:00 	datestro	DATE OF STROKE, NUMBER OF DAYS SINCE EXAM 1
20	Other stroke	195499	phv00195499.v1.p10	pht003463.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:14:27+00:00	2018-07-03 12:14:27+00:00 	ex2_prevstrk	Exclude for prevalent Stroke
20	Other stroke	195500	phv00195500.v1.p10	pht003463.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:15:14+00:00	2018-07-03 12:15:14+00:00 	ex2_exclude	Exclude for prevalent Dementia or Stroke
20	Other stroke	36469	phv00036469.v11.p10	pht000309.v12.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:17:32+00:00	2018-07-03 12:17:32+00:00 	EVENT	Event Number Collection Interval: Events reviewed through 12/2015
20	Other stroke	190979	phv00190979.v5.p10	pht003335.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:18:17+00:00	2018-07-03 12:18:17+00:00 	EVENT	Event Number
20	Other stroke	36471	phv00036471.v11.p10	pht000309.v12.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:20:56+00:00	2018-07-03 12:20:56+00:00 	DATE	Date of Event Collection Interval: Events reviewed through 12/2015
20	Other stroke	190981	phv00190981.v5.p10	pht003335.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:21:36+00:00	2018-07-03 12:21:36+00:00 	DATE	Date of Event
20	Other stroke	276966	phv00276966.v1.p10	pht006023.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:22:51+00:00	2018-07-03 12:22:51+00:00 	stroke_type	Stroke type
20	Other stroke	276968	phv00276968.v1.p10	pht006023.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:52:29+00:00	2018-07-03 12:52:29+00:00 	strokedate	Date of stroke
20	Other stroke	276965	phv00276965.v1.p10	pht006023.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:53:19+00:00	2018-07-03 12:53:19+00:00 	stroke	Stroke status
20	Other stroke	276971	phv00276971.v1.p10	pht006024.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:55:47+00:00	2018-07-03 12:55:47+00:00 	stroke_tia	Stroke/TIA status
20	Other stroke	276972	phv00276972.v1.p10	pht006024.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:56:28+00:00	2018-07-03 12:56:28+00:00 	stroke_tiatype	Stroke/TIA type
20	Other stroke	276974	phv00276974.v1.p10	pht006024.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 12:58:37+00:00	2018-07-03 12:58:37+00:00 	stroke_tiadate	Date of stroke/TIA (or censoring date)
20	Other stroke	276989	phv00276989.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:00:10+00:00	2018-07-03 13:00:10+00:00 	HOSP5	Hospitalization for stroke Collection Interval: 1975 through 2014
20	Other stroke	71905	phv00071905.v4.p10	pht000743.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 18:35:08+00:00	2018-08-09 18:35:08+00:00 	CVA_TYPE	Type of CVA Collection Interval: Through 2005
20	Other stroke	87876	phv00087876.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-08-09 18:45:33+00:00	2018-08-09 18:45:33+00:00 	strk	STROKE
20	Other stroke	85761	phv00085761.v3.p3	pht001117.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-08-09 18:45:50+00:00	2018-08-09 18:45:50+00:00 	fhxstka2	AGE OF FIRST STROKE DX
20	Other stroke	87878	phv00087878.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-08-09 18:46:05+00:00	2018-08-09 18:46:05+00:00 	strktt	TIME TO STROKE OR LAST FOLLOW-UP (DAYS)
20	Other stroke	87144	phv00087144.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-08-09 18:46:23+00:00	2018-08-09 18:46:23+00:00 	strokef	STROKE
20	Other stroke	85760	phv00085760.v3.p3	pht001117.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-08-09 18:46:40+00:00	2018-08-09 18:46:40+00:00 	fhxstk2	HISTORY OF STROKE INDICATOR
20	Other stroke	87883	phv00087883.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-08-09 18:47:01+00:00	2018-08-09 18:47:01+00:00 	dthtype	DEATH TYPE
20	Other stroke	207622	phv00207622.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-09 19:36:16+00:00	2018-08-09 19:36:16+00:00 	YRDPP07	Event year for INDPP07
20	Other stroke	207623	phv00207623.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-09 19:36:23+00:00	2018-08-09 19:36:23+00:00 	YRDP07	Event year for INDP07
20	Other stroke	207627	phv00207627.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-09 19:36:31+00:00	2018-08-09 19:36:31+00:00 	AGDPP07	Age for INDPP07
20	Other stroke	207628	phv00207628.v1.p1	pht004120.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-09 19:36:39+00:00	2018-08-09 19:36:39+00:00 	AGDP07	Age for INDP07
20	Other stroke	159619	phv00159619.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:44:12+00:00	2018-08-10 21:44:12+00:00 	Stroke	Stroke Collection Interval: Collected in Exam 1
20	Other stroke	277440	phv00277440.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:32:09+00:00	2018-08-14 22:32:09+00:00 	STROKE	Have you ever been told by a physician that you had a stroke  cerebral hemorrhage  or brain attack? Collection Interval: 2009-2011
20	Other stroke	277441	phv00277441.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:32:18+00:00	2018-08-14 22:32:18+00:00 	STRK_YR	In what year or how old were you when you were first told this? - year Collection Interval: 2009-2011
20	Other stroke	277442	phv00277442.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:32:28+00:00	2018-08-14 22:32:28+00:00 	STRK_AGE	In what year or how old were you when you were first told this? - age Collection Interval: 2009-2011
20	Other stroke	277607	phv00277607.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:50:19+00:00	2018-08-14 22:50:19+00:00 	STRK_AGE	In what year or how old were you when it first occurred? - age Collection Interval: 1996-2000
20	Other stroke	277606	phv00277606.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:50:25+00:00	2018-08-14 22:50:25+00:00 	STRK_YR	In what year or how old were you when it first occurred? - year Collection Interval: 1996-2000
20	Other stroke	277605	phv00277605.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:50:38+00:00	2018-08-14 22:50:38+00:00 	STROKE	Have you ever been told by a physician that you had a stroke or cerebral hemorrhage? Collection Interval: 1996-2000
20	Other stroke	277656	phv00277656.v1.p1	pht006044.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:58:58+00:00	2018-08-14 22:58:58+00:00 	STROKE	Self-reported stroke Collection Interval: 2002-2006
20	Other stroke	277891	phv00277891.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:16:49+00:00	2018-08-14 23:16:49+00:00 	STRK_AGE	In what year or how old were you when it first occurred? - age Collection Interval: 2000-2004
20	Other stroke	277890	phv00277890.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:16:56+00:00	2018-08-14 23:16:56+00:00 	STRK_YR	In what year or how old were you when it first occurred? - year Collection Interval: 2000-2004
20	Other stroke	277889	phv00277889.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:17:02+00:00	2018-08-14 23:17:02+00:00 	STROKE	Have you ever been told by a physician that you had a stroke/cerebral hemorrhage/ or brain attack? Collection Interval: 2000-2004
20	Other stroke	307888	phv00307888.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:01:24+00:00	2018-08-16 00:01:24+00:00 	STRK_AGE	In what year or how old were you when it first occurred? - age Collection Interval: 1996-2000
20	Other stroke	307887	phv00307887.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:01:31+00:00	2018-08-16 00:01:31+00:00 	STRK_YR	In what year or how old were you when it first occurred? - year Collection Interval: 1996-2000
20	Other stroke	307886	phv00307886.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:01:38+00:00	2018-08-16 00:01:38+00:00 	STROKE	Have you ever been told by a physician that you had a stroke or cerebral hemorrhage? Collection Interval: 1996-2000
20	Other stroke	307937	phv00307937.v1.p1	pht006658.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:06:44+00:00	2018-08-16 00:06:44+00:00 	STROKE	Self-reported stroke Collection Interval: 2002-2006
20	Other stroke	307946	phv00307946.v1.p1	pht006658.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:07:50+00:00	2018-08-16 00:07:50+00:00 	MR_STROKE	Stroke Flag: Determined by MR Scan Collection Interval: 2002-2006
20	Other stroke	308084	phv00308084.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:16:24+00:00	2018-08-16 00:16:24+00:00 	STRK_AGE	In what year or how old were you when it first occurred? - age Collection Interval: 2000-2004
20	Other stroke	308083	phv00308083.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:16:30+00:00	2018-08-16 00:16:30+00:00 	STRK_YR	In what year or how old were you when it first occurred? - year Collection Interval: 2000-2004
20	Other stroke	308082	phv00308082.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:16:38+00:00	2018-08-16 00:16:38+00:00 	STROKE	Have you ever been told by a physician that you had a stroke/cerebral hemorrhage/ or brain attack? Collection Interval: 2000-2004
20	Other stroke	203810	phv00203810.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:46:11+00:00	2018-08-16 18:46:11+00:00 	COMPDIAG	Computer diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary]
20	Other stroke	203813	phv00203813.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:49:26+00:00	2018-08-16 18:49:26+00:00 	FINALDX	Final diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary]
20	Other stroke	203814	phv00203814.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:49:47+00:00	2018-08-16 18:49:47+00:00 	COMP_DX	Formatted computer diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary]
20	Other stroke	203815	phv00203815.v1.p1	pht004048.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-16 18:50:10+00:00	2018-08-16 18:50:10+00:00 	FINAL_DX	Formatted final diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary]
20	Other stroke	122293	phv00122293.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:29:54+00:00	2018-08-16 23:29:54+00:00 	STROKE	Stroke (A)
20	Other stroke	122294	phv00122294.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:30:00+00:00	2018-08-16 23:30:00+00:00 	STRDIAG	Stroke diagnosed by doctor (A)
20	Other stroke	122295	phv00122295.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:30:07+00:00	2018-08-16 23:30:07+00:00 	STRAGE	Age when stroke noted (A)
20	Other stroke	124310	phv00124310.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 19:01:33+00:00	2018-08-21 19:01:33+00:00 	STRODIDAY	Days from visit date - Diagnosed Stroke (CVA)
20	Other stroke	252985	phv00252985.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:12:49+00:00	2018-08-24 17:12:49+00:00 	stroke_baseline	Self report stroke at baseline visit
20	Other stroke	121525	phv00121525.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:50:31+00:00	2018-08-30 19:50:31+00:00 	Y01STKDG	STROKE DIAGNOSIS TYPE
20	Other stroke	121730	phv00121730.v1.p2	pht001874.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:12:10+00:00	2018-08-30 20:12:10+00:00 	Z33ESTYP	STROKE TYPE
20	Other stroke	121729	phv00121729.v1.p2	pht001874.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:12:29+00:00	2018-08-30 20:12:29+00:00 	Z33ESTRK	STROKE
20	Other stroke	258768	phv00258768.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 13:05:10+00:00	2018-09-06 13:05:10+00:00 	Stroke	Have you ever had a stroke? Self-report
20	Other stroke	259383	phv00259383.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-06 13:19:59+00:00	2018-09-06 13:19:59+00:00 	priorstk	Prior Stroke
20	Other stroke	259387	phv00259387.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-06 13:22:27+00:00	2018-09-06 13:22:27+00:00 	sttype	Stroke type
20	Other stroke	121848	phv00121848.v1.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 13:26:48+00:00	2018-09-07 13:26:48+00:00 	stroke	Ever had a stroke
20	Other stroke	190834	phv00190834.v6.p10	pht003317.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 13:59:34+00:00	2018-09-27 13:59:34+00:00 	LASTSOE	Date of the latest record in the 2015  SOE dataset (vr_soe_2015_a_0991)
21	Age at enrollment/collection	226251	phv00226251.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 21:55:18+00:00	2018-03-14 21:55:18+00:00 	AGE	Age
21	Age at enrollment/collection	126009	phv00126009.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:33:32+00:00	2018-03-16 01:33:32+00:00 	AGE01	Age(yrs) at baseline clinic visit
21	Age at enrollment/collection	204623	phv00204623.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 13:52:15+00:00	2018-03-27 13:52:15+00:00 	V2AGE22	Age at visit 2 [Cohort, Exam 2]
21	Age at enrollment/collection	204712	phv00204712.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 13:52:35+00:00	2018-03-27 13:52:35+00:00 	V1AGE01	Age at visit 1 [Cohort, Exam 1]
21	Age at enrollment/collection	204871	phv00204871.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 13:52:57+00:00	2018-03-27 13:52:57+00:00 	V3AGE31	Age at visit 3 [Cohort, Exam 3]
21	Age at enrollment/collection	204975	phv00204975.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 13:53:18+00:00	2018-03-27 13:53:18+00:00 	V4AGE41	Age at visit 4 [Cohort, Exam 4]
21	Age at enrollment/collection	204693	phv00204693.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 13:57:53+00:00	2018-03-27 13:57:53+00:00 	V2DAYS	Days since exam 1 [Cohort, Exam 2]
21	Age at enrollment/collection	204921	phv00204921.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 13:58:11+00:00	2018-03-27 13:58:11+00:00 	V3DAYS	Days since exam 1 [Cohort, Exam 3]
21	Age at enrollment/collection	205017	phv00205017.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 13:58:31+00:00	2018-03-27 13:58:31+00:00 	V4DAYS	Days since exam 1 [Cohort, Exam 4]
21	Age at enrollment/collection	112421	phv00112421.v2.p2	pht001559.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:42:53+00:00	2018-04-17 14:42:53+00:00 	A01AGE1	EXAM 1 AGE, TELEPHONE INTERVIEW
21	Age at enrollment/collection	112439	phv00112439.v2.p2	pht001559.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 14:43:42+00:00	2018-04-17 14:43:42+00:00 	A01AGE2	AGE VERIFY
21	Age at enrollment/collection	82639	phv00082639.v2.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:42:38+00:00	2018-04-23 02:42:38+00:00 	age1c	AGE
21	Age at enrollment/collection	84442	phv00084442.v3.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:46:04+00:00	2018-04-23 02:46:04+00:00 	age1c	AGE
21	Age at enrollment/collection	85773	phv00085773.v3.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:46:15+00:00	2018-04-23 02:46:15+00:00 	age2c	AGE AT EXAM 2
21	Age at enrollment/collection	86259	phv00086259.v4.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:46:24+00:00	2018-04-23 02:46:24+00:00 	age3c	AGE AT EXAM3
21	Age at enrollment/collection	86727	phv00086727.v3.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:46:35+00:00	2018-04-23 02:46:35+00:00 	age4c	AGE AT EXAM 4
21	Age at enrollment/collection	87071	phv00087071.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:46:44+00:00	2018-04-23 02:46:44+00:00 	agefc	AGE
21	Age at enrollment/collection	174588	phv00174588.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:46:51+00:00	2018-04-23 02:46:51+00:00 	age5c	AGE AT EXAM 5
21	Age at enrollment/collection	87678	phv00087678.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:46:59+00:00	2018-04-23 02:46:59+00:00 	lagea4	AGE AT SPIROMETRY
21	Age at enrollment/collection	175854	phv00175854.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:47:20+00:00	2018-04-23 02:47:20+00:00 	age1c	AGE
21	Age at enrollment/collection	175875	phv00175875.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:47:28+00:00	2018-04-23 02:47:28+00:00 	age	AGE
21	Age at enrollment/collection	176011	phv00176011.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:47:35+00:00	2018-04-23 02:47:35+00:00 	age5c	AGE AT EXAM 5
21	Age at enrollment/collection	176846	phv00176846.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:47:49+00:00	2018-04-23 02:47:49+00:00 	mriage5	AGE AT EXAM 5 MRI
21	Age at enrollment/collection	219024	phv00219024.v1.p3	pht004326.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:47:56+00:00	2018-04-23 02:47:56+00:00 	agesc	AGE AT STRESS EXAM
21	Age at enrollment/collection	83452	phv00083452.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:48:59+00:00	2018-04-23 02:48:59+00:00 	lagea4	AGE AT SPIROMETRY
21	Age at enrollment/collection	83687	phv00083687.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:49:09+00:00	2018-04-23 02:49:09+00:00 	lagea4	AGE AT SPIROMETRY
21	Age at enrollment/collection	175939	phv00175939.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:53:23+00:00	2018-04-29 00:53:23+00:00 	agefc	FAMILY COHORT: AGE
21	Age at enrollment/collection	176077	phv00176077.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:53:35+00:00	2018-04-29 00:53:35+00:00 	ageans5	Q3) HOW OLD ARE YOU? (PPT RESPONSE)
21	Age at enrollment/collection	176078	phv00176078.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:53:45+00:00	2018-04-29 00:53:45+00:00 	age5	Q3) HOW OLD ARE YOU?
21	Age at enrollment/collection	85818	phv00085818.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:06:33+00:00	2018-04-29 01:06:33+00:00 	E12CTDyC	TIME BETWEEN CT SCANS, IN DAYS
21	Age at enrollment/collection	86272	phv00086272.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:06:39+00:00	2018-04-29 01:06:39+00:00 	E13DyC	TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS
21	Age at enrollment/collection	86309	phv00086309.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:06:47+00:00	2018-04-29 01:06:47+00:00 	E13CTDyC	TIME BETWEEN EXAM 1 AND 3 CT SCANS, IN DAYS
21	Age at enrollment/collection	86740	phv00086740.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:06:53+00:00	2018-04-29 01:06:53+00:00 	e14dyc	TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS
21	Age at enrollment/collection	90111	phv00090111.v1.p3	pht001205.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:09:45+00:00	2018-04-29 01:09:45+00:00 	e14ctdyc	TIME BETWEEN EXAM 1 AND 4 CT SCANS, IN DAYS
21	Age at enrollment/collection	90112	phv00090112.v1.p3	pht001205.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:09:50+00:00	2018-04-29 01:09:50+00:00 	e24ctdyc	TIME BETWEEN EXAM 2/3 AND 4 CT SCANS, IN DAYS
21	Age at enrollment/collection	174590	phv00174590.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:09:56+00:00	2018-04-29 01:09:56+00:00 	e15dyc	TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS
21	Age at enrollment/collection	174740	phv00174740.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:10:02+00:00	2018-04-29 01:10:02+00:00 	e15ctdyc	TIME BETWEEN EXAM 1 AND 5 CT SCANS, (DAYS)
21	Age at enrollment/collection	176013	phv00176013.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:10:08+00:00	2018-04-29 01:10:08+00:00 	e15dyc	TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS
21	Age at enrollment/collection	176163	phv00176163.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:10:17+00:00	2018-04-29 01:10:17+00:00 	e15ctdyc	TIME BETWEEN EXAM 1 AND 5 CT SCANS, (DAYS)
21	Age at enrollment/collection	176836	phv00176836.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:10:22+00:00	2018-04-29 01:10:22+00:00 	e15mridyc	TIME BETWEEN EXAM 1 AND EXAM 5 MRI SCANS, IN DAYS
21	Age at enrollment/collection	191695	phv00191695.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:10:27+00:00	2018-04-29 01:10:27+00:00 	e15ecgdyc	TIME BETWEEN EXAM 1 AND EXAM 5 ECG READINGS, IN DAYS
21	Age at enrollment/collection	85786	phv00085786.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:10:40+00:00	2018-04-29 01:10:40+00:00 	E12DyC	TIME BETWEEN EXAM VISITS, IN DAYS
21	Age at enrollment/collection	215388	phv00215388.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-31 16:22:14+00:00	2018-05-31 16:22:14+00:00 	AGE_S1	Age = StdyDtqa - DOB
21	Age at enrollment/collection	126008	phv00126008.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:02:58+00:00	2018-06-12 01:02:58+00:00 	AGE01HI	Age(yrs) at home induction interview
21	Age at enrollment/collection	127576	phv00127576.v1.p1	pht001956.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-19 13:23:18+00:00	2018-06-19 13:23:18+00:00 	AGE01HI	Participant's age of eligibility at H
21	Age at enrollment/collection	125067	phv00125067.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:28:18+00:00	2018-07-09 19:28:18+00:00 	AFUA1M	(Month only) 1. Date of status determination
21	Age at enrollment/collection	125068	phv00125068.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:28:32+00:00	2018-07-09 19:28:32+00:00 	AFUA1Y	(Year only) 1. Date of status determination
21	Age at enrollment/collection	125153	phv00125153.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:32:16+00:00	2018-07-09 19:32:16+00:00 	AFUA1Y	(Year only) 1. Date of status determination
21	Age at enrollment/collection	125152	phv00125152.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:32:30+00:00	2018-07-09 19:32:30+00:00 	AFUA1M	(Month only) 1. Date of status determination
21	Age at enrollment/collection	125238	phv00125238.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:39:34+00:00	2018-07-09 19:39:34+00:00 	AFUB1M	(Month only) 1. Date of status determination
21	Age at enrollment/collection	125239	phv00125239.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:39:51+00:00	2018-07-09 19:39:51+00:00 	AFUB1Y	(Year only) 1. Date of status determination
21	Age at enrollment/collection	125324	phv00125324.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:50:08+00:00	2018-07-09 19:50:08+00:00 	AFUB1M	(Month only) 1. Date of status determination
21	Age at enrollment/collection	125325	phv00125325.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:50:20+00:00	2018-07-09 19:50:20+00:00 	AFUB1Y	(Year only) 1. Date of status determination
21	Age at enrollment/collection	125499	phv00125499.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:56:24+00:00	2018-07-09 19:56:24+00:00 	AFUC1M	(Month only) 1. Date of status determination
21	Age at enrollment/collection	125500	phv00125500.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:56:36+00:00	2018-07-09 19:56:36+00:00 	AFUC1Y	(Year only) 1. Date of status determination
21	Age at enrollment/collection	125579	phv00125579.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:02:25+00:00	2018-07-09 20:02:25+00:00 	AFUI1Y	YEAR OF STATUS                    Q1
21	Age at enrollment/collection	125578	phv00125578.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:02:38+00:00	2018-07-09 20:02:38+00:00 	AFUI1M	MONTH OF STATUS                   Q1
21	Age at enrollment/collection	125667	phv00125667.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:06:38+00:00	2018-07-09 20:06:38+00:00 	AFUI1M	MONTH OF STATUS                   Q1
21	Age at enrollment/collection	125668	phv00125668.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:06:58+00:00	2018-07-09 20:06:58+00:00 	AFUI1Y	YEAR OF STATUS                    Q1
21	Age at enrollment/collection	125758	phv00125758.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:15:54+00:00	2018-07-09 20:15:54+00:00 	AFUJ1D	DAY OF STATUS                     Q1
21	Age at enrollment/collection	125759	phv00125759.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:16:13+00:00	2018-07-09 20:16:13+00:00 	AFUJ1M	MONTH OF STATUS                   Q1
21	Age at enrollment/collection	125760	phv00125760.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:16:24+00:00	2018-07-09 20:16:24+00:00 	AFUJ1Y	YEAR OF STATUS                    Q1
21	Age at enrollment/collection	125756	phv00125756.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:16:51+00:00	2018-07-09 20:16:51+00:00 	AFUJ1	DATE STATUS DETERMINED            Q1
21	Age at enrollment/collection	125843	phv00125843.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:31:30+00:00	2018-07-09 20:31:30+00:00 	AFUK1M	MONTH OF STATUS                     Q1
21	Age at enrollment/collection	125844	phv00125844.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:31:43+00:00	2018-07-09 20:31:43+00:00 	AFUK1Y	YEAR OF STATUS                      Q1
21	Age at enrollment/collection	125920	phv00125920.v1.p1	pht001943.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 17:38:32+00:00	2018-07-12 17:38:32+00:00 	DOBYR	CARe PARTICIPANT DATE OF BIRTH YEAR
21	Age at enrollment/collection	125585	phv00125585.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:24:28+00:00	2018-07-12 18:24:28+00:00 	FTRA1M	(Month only) 1: Date of clinic visit
21	Age at enrollment/collection	125672	phv00125672.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:24:49+00:00	2018-07-12 18:24:49+00:00 	FTRA1M	(Month only) 1: Date of clinic visit
21	Age at enrollment/collection	125854	phv00125854.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:25:20+00:00	2018-07-12 18:25:20+00:00 	FTRA1M	(Month only) 1: Date of clinic visit
21	Age at enrollment/collection	125679	phv00125679.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:25:58+00:00	2018-07-12 18:25:58+00:00 	FTRA1	1: Date of clinic visit
21	Age at enrollment/collection	125855	phv00125855.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:26:24+00:00	2018-07-12 18:26:24+00:00 	FTRA1Y	(Year only) 1: Date of clinic visit
21	Age at enrollment/collection	125673	phv00125673.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:26:53+00:00	2018-07-12 18:26:53+00:00 	FTRA1Y	(Year only) 1: Date of clinic visit
21	Age at enrollment/collection	125586	phv00125586.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:27:16+00:00	2018-07-12 18:27:16+00:00 	FTRA1Y	(Year only) 1: Date of clinic visit
21	Age at enrollment/collection	159836	phv00159836.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:44:14+00:00	2018-08-10 20:44:14+00:00 	Age_Enroll	Age at enrollment Collection Interval: Collected in Exam 1
21	Age at enrollment/collection	71906	phv00071906.v3.p10	pht000743.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-13 17:53:20+00:00	2018-08-13 17:53:20+00:00 	mri_date	Date of brain MRI scan Collection Interval: Through 2005
21	Age at enrollment/collection	277280	phv00277280.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:06:11+00:00	2018-08-14 22:06:11+00:00 	AGE	Age at time of examination in years Collection Interval: 2007-2009
21	Age at enrollment/collection	277327	phv00277327.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:12:03+00:00	2018-08-14 22:12:03+00:00 	AGE	Age at time of examination in years Collection Interval: 2009-2011
21	Age at enrollment/collection	277507	phv00277507.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:40:43+00:00	2018-08-14 22:40:43+00:00 	AGE	Age at time of examination in years Collection Interval: 1996-2000
21	Age at enrollment/collection	277654	phv00277654.v1.p1	pht006044.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:57:21+00:00	2018-08-14 22:57:21+00:00 	AGE_MR	Age at time of MR examination in years Collection Interval: 2002-2006
21	Age at enrollment/collection	277758	phv00277758.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:07:31+00:00	2018-08-14 23:07:31+00:00 	AGE	Age at time of examination in years Collection Interval: 2000-2004
21	Age at enrollment/collection	307740	phv00307740.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:51:32+00:00	2018-08-15 23:51:32+00:00 	AGE	Age at time of examination in years Collection Interval: 2006-2011
21	Age at enrollment/collection	307788	phv00307788.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:54:56+00:00	2018-08-15 23:54:56+00:00 	AGE	Age at time of examination in years Collection Interval: 1996-2000
21	Age at enrollment/collection	307935	phv00307935.v1.p1	pht006658.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:06:58+00:00	2018-08-16 00:06:58+00:00 	AGE_MR	Age at time of MR examination in years Collection Interval: 2002-2006
21	Age at enrollment/collection	307949	phv00307949.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:08:59+00:00	2018-08-16 00:08:59+00:00 	AGE	Age at time of examination in years Collection Interval: 2000-2004
21	Age at enrollment/collection	122015	phv00122015.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:02:11+00:00	2018-08-16 23:02:11+00:00 	age	Subject age at time of study
21	Age at enrollment/collection	113714	phv00113714.v2.p2	pht001589.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:09:39+00:00	2018-08-17 21:09:39+00:00 	EXAMAGE	CALCULATED AGE AT EXAM 1
21	Age at enrollment/collection	124328	phv00124328.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 19:02:43+00:00	2018-08-21 19:02:43+00:00 	age_dna	Age at DNA draw
21	Age at enrollment/collection	114610	phv00114610.v2.p2	pht001626.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:22:52+00:00	2018-08-22 23:22:52+00:00 	B12AGE	AGE OF SUBJECT
21	Age at enrollment/collection	115119	phv00115119.v2.p2	pht001645.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:52:11+00:00	2018-08-22 23:52:11+00:00 	EXAMAGE	AGE AT EXAM 1 (VERIFIED AT EXAM 2)
21	Age at enrollment/collection	115705	phv00115705.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:29:24+00:00	2018-08-23 17:29:24+00:00 	C12AGE	C12AGE
21	Age at enrollment/collection	116378	phv00116378.v2.p2	pht001697.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 19:10:44+00:00	2018-08-23 19:10:44+00:00 	EXAMAGE	CALCULATED AGE AT EXAM 1
21	Age at enrollment/collection	116390	phv00116390.v2.p2	pht001697.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 19:11:19+00:00	2018-08-23 19:11:19+00:00 	EX3_AGE	CALCULATED AGE AT EXAM 3
21	Age at enrollment/collection	116478	phv00116478.v2.p2	pht001706.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 21:31:07+00:00	2018-08-23 21:31:07+00:00 	DDXSPAGE	SPINE: AGE AT EXAM
21	Age at enrollment/collection	116492	phv00116492.v2.p2	pht001706.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 21:34:30+00:00	2018-08-23 21:34:30+00:00 	DDXHPAGE	HIP: AGE AT EXAM
21	Age at enrollment/collection	116506	phv00116506.v2.p2	pht001706.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 21:35:55+00:00	2018-08-23 21:35:55+00:00 	DDXWBAGE	WHOLE BODY: AGE AT EXAM
21	Age at enrollment/collection	252976	phv00252976.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:11:25+00:00	2018-08-24 17:11:25+00:00 	age_baseline	Age at baseline study
21	Age at enrollment/collection	252977	phv00252977.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:11:34+00:00	2018-08-24 17:11:34+00:00 	age_at_dna	Age at blood draw
21	Age at enrollment/collection	117592	phv00117592.v2.p2	pht001744.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:54:28+00:00	2018-08-24 22:54:28+00:00 	EX4_AGE	CALCULATED AGE AT EXAM 4
21	Age at enrollment/collection	117579	phv00117579.v2.p2	pht001744.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:54:41+00:00	2018-08-24 22:54:41+00:00 	EXAMAGE	CALCULATED AGE AT EXAM 1
21	Age at enrollment/collection	118135	phv00118135.v2.p2	pht001755.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 18:12:52+00:00	2018-08-28 18:12:52+00:00 	EAGE	AGE
21	Age at enrollment/collection	118249	phv00118249.v2.p2	pht001756.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 18:14:50+00:00	2018-08-28 18:14:50+00:00 	EAGE	AGE
21	Age at enrollment/collection	118959	phv00118959.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:37:01+00:00	2018-08-28 23:37:01+00:00 	E12AGE	AGE - SPIROMETER
21	Age at enrollment/collection	119507	phv00119507.v2.p2	pht001795.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:59:09+00:00	2018-08-29 20:59:09+00:00 	E53AGE	AGE - FORM 53
21	Age at enrollment/collection	119637	phv00119637.v2.p2	pht001804.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:03:09+00:00	2018-08-29 21:03:09+00:00 	EX5_AGE	CALCULATED AGE AT EXAM 5
21	Age at enrollment/collection	119631	phv00119631.v2.p2	pht001804.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:03:22+00:00	2018-08-29 21:03:22+00:00 	EXAMAGE	CALCULATED AGE AT EXAM 1
21	Age at enrollment/collection	120748	phv00120748.v2.p2	pht001851.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:14:43+00:00	2018-08-29 23:14:43+00:00 	EX6_AGE	CALCULATED AGE AT EXAM 6
21	Age at enrollment/collection	120739	phv00120739.v2.p2	pht001851.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:15:39+00:00	2018-08-29 23:15:39+00:00 	EXAMAGE	CALCULATED AGE AT EXAM 1
21	Age at enrollment/collection	202104	phv00202104.v2.p1	pht003918.v2.p1	phs000741.v2.p1	GOLDN	741	2	2018-09-06 12:08:17+00:00	2018-09-06 12:08:17+00:00 	age	Age of participant
21	Age at enrollment/collection	258680	phv00258680.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:22:09+00:00	2018-09-06 12:22:09+00:00 	Dec_Age	Age at enrollment
21	Age at enrollment/collection	258650	phv00258650.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:11:11+00:00	2018-09-06 13:11:11+00:00 	age	Subject age
21	Age at enrollment/collection	259378	phv00259378.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-06 13:18:11+00:00	2018-09-06 13:18:11+00:00 	age	Age at index date
21	Age at enrollment/collection	121846	phv00121846.v1.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 13:26:10+00:00	2018-09-07 13:26:10+00:00 	enrollage	Age at Time of Enrollment
21	Age at enrollment/collection	78437	phv00078437.v6.p3	pht000998.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:36:57+00:00	2018-09-21 17:36:57+00:00 	AGE	Age at screening
21	Age at enrollment/collection	79440	phv00079440.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:37:36+00:00	2018-09-21 17:37:36+00:00 	F43AGE	Age when completed Form 43
21	Age at enrollment/collection	169576	phv00169576.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:39:39+00:00	2018-09-21 17:39:39+00:00 	F154FINDYS	Days since randomization or enrollment to form finish
21	Age at enrollment/collection	78411	phv00078411.v6.p3	pht000997.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:40:28+00:00	2018-09-21 17:40:28+00:00 	LSTVISDY	Days from rand to last visit
21	Age at enrollment/collection	78413	phv00078413.v6.p3	pht000997.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:40:35+00:00	2018-09-21 17:40:35+00:00 	LSTMAMDY	Days from rand to last mammogram
21	Age at enrollment/collection	78415	phv00078415.v6.p3	pht000997.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:40:41+00:00	2018-09-21 17:40:41+00:00 	LSTPAPDY	Days from rand to last pap smear
21	Age at enrollment/collection	78419	phv00078419.v6.p3	pht000997.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:41:43+00:00	2018-09-21 17:41:43+00:00 	LSTASPDY	Days from rand to last aspiration
21	Age at enrollment/collection	79874	phv00079874.v6.p3	pht001020.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:41:48+00:00	2018-09-21 17:41:48+00:00 	PELVICDY	Days from randomization to pelvic exam
21	Age at enrollment/collection	79911	phv00079911.v6.p3	pht001021.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:41:53+00:00	2018-09-21 17:41:53+00:00 	ENDODY	Days from randomization to endometrial aspiration
21	Age at enrollment/collection	79926	phv00079926.v6.p3	pht001022.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:42:00+00:00	2018-09-21 17:42:00+00:00 	TVUDY	Days from randomization to ultrasound
21	Age at enrollment/collection	79946	phv00079946.v6.p3	pht001023.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:42:06+00:00	2018-09-21 17:42:06+00:00 	CBECLCDY	Days from randomization to CBE
21	Age at enrollment/collection	80000	phv00080000.v6.p3	pht001026.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:42:11+00:00	2018-09-21 17:42:11+00:00 	PAPCOLDY	Days from randomization to pap smear collection
21	Age at enrollment/collection	77319	phv00077319.v6.p3	pht000983.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:42:47+00:00	2018-09-21 17:42:47+00:00 	HIPDAYS	Hip scan days from randomization/enrollment
21	Age at enrollment/collection	77332	phv00077332.v6.p3	pht000984.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:43:11+00:00	2018-09-21 17:43:11+00:00 	SPNDAYS	Spine scan days from randomization/enrollment
21	Age at enrollment/collection	77341	phv00077341.v6.p3	pht000985.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:43:24+00:00	2018-09-21 17:43:24+00:00 	WBDAYS	Whole body scan days from randomization/enrollment
21	Age at enrollment/collection	77363	phv00077363.v6.p3	pht000986.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:43:57+00:00	2018-09-21 17:43:57+00:00 	CBCDAYS	CBC Days since randomization/enrollment
21	Age at enrollment/collection	77372	phv00077372.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:44:09+00:00	2018-09-21 17:44:09+00:00 	COREDAYS	Core Days since randomization/enrollment
21	Age at enrollment/collection	77441	phv00077441.v6.p3	pht000989.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:44:41+00:00	2018-09-21 17:44:41+00:00 	ECGBASEDAYS	Baseline ECG days since randomization
21	Age at enrollment/collection	77444	phv00077444.v6.p3	pht000989.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:44:46+00:00	2018-09-21 17:44:46+00:00 	ECGFUDAYS	Follow-up ECG days since randomization
21	Age at enrollment/collection	77451	phv00077451.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:45:30+00:00	2018-09-21 17:45:30+00:00 	F143DAYS	F143 Days since enrollment
21	Age at enrollment/collection	77672	phv00077672.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:45:39+00:00	2018-09-21 17:45:39+00:00 	F144DAYS	F144 Days since enrollment
21	Age at enrollment/collection	77798	phv00077798.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:45:49+00:00	2018-09-21 17:45:49+00:00 	F145DAYS	F145 Days since enrollment
21	Age at enrollment/collection	77908	phv00077908.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:45:59+00:00	2018-09-21 17:45:59+00:00 	F146DAYS	F146 Days since enrollment
21	Age at enrollment/collection	78110	phv00078110.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:46:08+00:00	2018-09-21 17:46:08+00:00 	F147DAYS	F147 Days since enrollment
21	Age at enrollment/collection	78234	phv00078234.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:46:40+00:00	2018-09-21 17:46:40+00:00 	F148DAYS	F148 Days since enrollment
21	Age at enrollment/collection	78358	phv00078358.v6.p3	pht000996.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:46:50+00:00	2018-09-21 17:46:50+00:00 	F149DAYS	F149 Days since enrollment
21	Age at enrollment/collection	78386	phv00078386.v6.p3	pht000997.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:47:30+00:00	2018-09-21 17:47:30+00:00 	F20DAYS	F20 Days since randomization/enrollment
21	Age at enrollment/collection	78436	phv00078436.v6.p3	pht000998.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:47:51+00:00	2018-09-21 17:47:51+00:00 	F2DAYS	F2 Days since randomization
21	Age at enrollment/collection	78507	phv00078507.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:48:03+00:00	2018-09-21 17:48:03+00:00 	F30DAYS	F30 Days since randomization/enrollment
21	Age at enrollment/collection	78607	phv00078607.v6.p3	pht001000.v7.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:48:13+00:00	2018-09-21 17:48:13+00:00 	F31DAYS	F31 Days since randomization/enrollment
21	Age at enrollment/collection	78667	phv00078667.v6.p3	pht001001.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:48:23+00:00	2018-09-21 17:48:23+00:00 	F32DAYS	F32 Days since randomization/enrollment
21	Age at enrollment/collection	78773	phv00078773.v6.p3	pht001003.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:48:33+00:00	2018-09-21 17:48:33+00:00 	F34DAYS	F34 Days since randomization/enrollment
21	Age at enrollment/collection	78831	phv00078831.v6.p3	pht001004.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:48:43+00:00	2018-09-21 17:48:43+00:00 	F35DAYS	F35 Days since randomization
21	Age at enrollment/collection	78870	phv00078870.v6.p3	pht001005.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:48:55+00:00	2018-09-21 17:48:55+00:00 	F37DAYS	F37 Days since randomization/enrollment
21	Age at enrollment/collection	79088	phv00079088.v6.p3	pht001006.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:49:07+00:00	2018-09-21 17:49:07+00:00 	F38DAYS	F38 Days since randomization/enrollment
21	Age at enrollment/collection	79231	phv00079231.v6.p3	pht001007.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:49:24+00:00	2018-09-21 17:49:24+00:00 	F39DAYS	F39 Days since randomization/enrollment
21	Age at enrollment/collection	79307	phv00079307.v6.p3	pht001008.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:49:53+00:00	2018-09-21 17:49:53+00:00 	F40DAYS	F40 Days since randomization/enrollment
21	Age at enrollment/collection	79315	phv00079315.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:50:03+00:00	2018-09-21 17:50:03+00:00 	F41DAYS	F41 Days since randomization/enrollment
21	Age at enrollment/collection	79333	phv00079333.v6.p3	pht001010.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:50:13+00:00	2018-09-21 17:50:13+00:00 	F42DAYS	F42 Days since enrollment
21	Age at enrollment/collection	79439	phv00079439.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:50:25+00:00	2018-09-21 17:50:25+00:00 	F43DAYS	F43 Days since randomization/enrollment
21	Age at enrollment/collection	79557	phv00079557.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:50:44+00:00	2018-09-21 17:50:44+00:00 	F48DAYS	F48 Days since enrollment
21	Age at enrollment/collection	79852	phv00079852.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:55:28+00:00	2018-09-21 17:55:28+00:00 	F80DAYS	F80 Days since randomization/enrollment
21	Age at enrollment/collection	79873	phv00079873.v6.p3	pht001020.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:55:39+00:00	2018-09-21 17:55:39+00:00 	F81DAYS	F81 Days since randomization
21	Age at enrollment/collection	79910	phv00079910.v6.p3	pht001021.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:55:48+00:00	2018-09-21 17:55:48+00:00 	F82DAYS	F82 Days since randomization
21	Age at enrollment/collection	79925	phv00079925.v6.p3	pht001022.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:55:58+00:00	2018-09-21 17:55:58+00:00 	F83DAYS	F83 Days since randomization
21	Age at enrollment/collection	79945	phv00079945.v6.p3	pht001023.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:56:19+00:00	2018-09-21 17:56:19+00:00 	F84DAYS	F84 Days since randomization
21	Age at enrollment/collection	79984	phv00079984.v6.p3	pht001025.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:56:58+00:00	2018-09-21 17:56:58+00:00 	F90DAYS	F90 Days since randomization
21	Age at enrollment/collection	79999	phv00079999.v6.p3	pht001026.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:57:20+00:00	2018-09-21 17:57:20+00:00 	F92DAYS	F92 Days since randomization
21	Age at enrollment/collection	80432	phv00080432.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:58:03+00:00	2018-09-21 17:58:03+00:00 	CADDAYS	Days since CT randomization to CaD randomization
21	Age at enrollment/collection	111542	phv00111542.v6.p3	pht001514.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:58:16+00:00	2018-09-21 17:58:16+00:00 	F134DAYS	F134 Days since randomization or enrollment
21	Age at enrollment/collection	111657	phv00111657.v6.p3	pht001517.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:58:30+00:00	2018-09-21 17:58:30+00:00 	F60DAYS	F60 Days since randomization/enrollment
21	Age at enrollment/collection	154928	phv00154928.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:58:55+00:00	2018-09-21 17:58:55+00:00 	ECGDAYS	ECG Days since randomization
21	Age at enrollment/collection	155607	phv00155607.v5.p3	pht002120.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:59:23+00:00	2018-09-21 17:59:23+00:00 	F85DAYS	F85 Days from randomization
21	Age at enrollment/collection	155608	phv00155608.v5.p3	pht002120.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:59:30+00:00	2018-09-21 17:59:30+00:00 	MAMMDY	Days from randomization to mammogram
21	Age at enrollment/collection	156382	phv00156382.v5.p3	pht002125.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:59:54+00:00	2018-09-21 17:59:54+00:00 	F60DAYS	F60 Days since randomization/enrollment
21	Age at enrollment/collection	169401	phv00169401.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:00:07+00:00	2018-09-21 18:00:07+00:00 	F150DAYS	F150 Days since randomization
21	Age at enrollment/collection	169509	phv00169509.v4.p3	pht002750.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:00:25+00:00	2018-09-21 18:00:25+00:00 	F153DAYS	F153 Days since randomization or enrollment
21	Age at enrollment/collection	169529	phv00169529.v4.p3	pht002751.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:00:49+00:00	2018-09-21 18:00:49+00:00 	F153DAYS	F153 Days since randomization or enrollment
21	Age at enrollment/collection	169547	phv00169547.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:01:18+00:00	2018-09-21 18:01:18+00:00 	F154DAYS	Days since randomization or enrollment
21	Age at enrollment/collection	169605	phv00169605.v4.p3	pht002754.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:01:40+00:00	2018-09-21 18:01:40+00:00 	F44DAYS	F44 Days since randomization/enrollment
21	Age at enrollment/collection	202367	phv00202367.v2.p3	pht002769.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:02:56+00:00	2018-09-21 18:02:56+00:00 	LAST33WHIDY	Days enrollment to last WHI Form 33/33D
21	Age at enrollment/collection	202368	phv00202368.v2.p3	pht002769.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:03:02+00:00	2018-09-21 18:03:02+00:00 	LAST33EXT1DY	Days enrollment to last Ext1 Form 33/33D
21	Age at enrollment/collection	202379	phv00202379.v2.p3	pht002770.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:03:42+00:00	2018-09-21 18:03:42+00:00 	LAST33WHIDY	Days enrollment to last WHI form 33/33D
21	Age at enrollment/collection	202380	phv00202380.v2.p3	pht002770.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:03:48+00:00	2018-09-21 18:03:48+00:00 	LAST33EXT1DY	Days enrollment to last Ext1 form 33/33D
21	Age at enrollment/collection	192298	phv00192298.v3.p3	pht003395.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:04:16+00:00	2018-09-21 18:04:16+00:00 	EXTDAYS	Days since randomization/enrollment to WHI Extension 1 enrollment
21	Age at enrollment/collection	192301	phv00192301.v3.p3	pht003395.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:04:24+00:00	2018-09-21 18:04:24+00:00 	EXT2DAYS	Days since randomization/enrollment to WHI Extension 2 enrollment
21	Age at enrollment/collection	192307	phv00192307.v3.p3	pht003396.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:05:16+00:00	2018-09-21 18:05:16+00:00 	F151DAYS	F151 Days since randomization or enrollment
21	Age at enrollment/collection	192336	phv00192336.v3.p3	pht003397.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:05:35+00:00	2018-09-21 18:05:35+00:00 	F33DAYS	F33 Days since randomization/enrollment
21	Age at enrollment/collection	192362	phv00192362.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:05:47+00:00	2018-09-21 18:05:47+00:00 	F45DAYS	F45 Days since randomization/enrollment
21	Age at enrollment/collection	192421	phv00192421.v3.p3	pht003399.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:06:07+00:00	2018-09-21 18:06:07+00:00 	FUSTARTDY	Days since rand/enroll to start of participant's follow-up status
21	Age at enrollment/collection	192422	phv00192422.v3.p3	pht003399.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:06:12+00:00	2018-09-21 18:06:12+00:00 	FUENDDY	Days since rand/enroll to end of participant's follow-up status
21	Age at enrollment/collection	192446	phv00192446.v3.p3	pht003400.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:07:27+00:00	2018-09-21 18:07:27+00:00 	PRDY	F130 Days to Progesterone receptor assay
21	Age at enrollment/collection	192443	phv00192443.v3.p3	pht003400.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:07:34+00:00	2018-09-21 18:07:34+00:00 	ERDY	F130 Days to Estrogen Assay
21	Age at enrollment/collection	192469	phv00192469.v3.p3	pht003401.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:08:09+00:00	2018-09-21 18:08:09+00:00 	ERDY	F130 Days to Estrogen Assay
21	Age at enrollment/collection	192472	phv00192472.v3.p3	pht003401.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:08:16+00:00	2018-09-21 18:08:16+00:00 	PRDY	F130 Days to Progesterone receptor assay
21	Age at enrollment/collection	192821	phv00192821.v3.p3	pht003402.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:18:35+00:00	2018-09-21 18:18:35+00:00 	ENDEXT1DY	Days enrollment to end of Ext1 followup
21	Age at enrollment/collection	193503	phv00193503.v3.p3	pht003407.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:23:33+00:00	2018-09-21 18:23:33+00:00 	ENDWHIDY	Days enrollment to end of WHI core study followup
21	Age at enrollment/collection	193504	phv00193504.v3.p3	pht003407.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:23:39+00:00	2018-09-21 18:23:39+00:00 	ENDEXT1DY	Days enrollment to end of Ext1 followup
21	Age at enrollment/collection	193505	phv00193505.v3.p3	pht003407.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:23:45+00:00	2018-09-21 18:23:45+00:00 	ENDFOLLOWDY	Days enrollment to end of followup
21	Age at enrollment/collection	193683	phv00193683.v3.p3	pht003413.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:25:55+00:00	2018-09-21 18:25:55+00:00 	LAST33DY	Days enrollment to last form 33/33D
21	Age at enrollment/collection	193795	phv00193795.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:27:06+00:00	2018-09-21 18:27:06+00:00 	LAST33DY	Days enrollment to last form 33/33D
21	Age at enrollment/collection	202398	phv00202398.v2.p3	pht003418.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:28:13+00:00	2018-09-21 18:28:13+00:00 	DRAWDY	Draw Days since randomization/enrollment
21	Age at enrollment/collection	193863	phv00193863.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:28:40+00:00	2018-09-21 18:28:40+00:00 	TESTDY	Test Days Since Draw
21	Age at enrollment/collection	282954	phv00282954.v1.p3	pht006212.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:29:09+00:00	2018-09-21 18:29:09+00:00 	STARTDY	Days from CT randomization to start of CaD adherence period
21	Age at enrollment/collection	282955	phv00282955.v1.p3	pht006212.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:29:15+00:00	2018-09-21 18:29:15+00:00 	STCADDY	Days from CaD randomization to start of CaD adherence period
21	Age at enrollment/collection	282956	phv00282956.v1.p3	pht006212.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:29:22+00:00	2018-09-21 18:29:22+00:00 	ENDDY	Days from CT randomization to end of CaD adherence period
21	Age at enrollment/collection	282957	phv00282957.v1.p3	pht006212.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:29:29+00:00	2018-09-21 18:29:29+00:00 	ENDCADDY	Days from CaD randomization to end of CaD adherence period
21	Age at enrollment/collection	282967	phv00282967.v1.p3	pht006213.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:29:53+00:00	2018-09-21 18:29:53+00:00 	STARTDY	Days from rand to start of HRT adherence period
21	Age at enrollment/collection	282968	phv00282968.v1.p3	pht006213.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:29:59+00:00	2018-09-21 18:29:59+00:00 	ENDDY	Days from rand to end of HRT adherence period
21	Age at enrollment/collection	282978	phv00282978.v1.p3	pht006214.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:30:47+00:00	2018-09-21 18:30:47+00:00 	F155DAYS	F155 Days since randomization or enrollment
21	Age at enrollment/collection	283187	phv00283187.v1.p3	pht006215.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:31:26+00:00	2018-09-21 18:31:26+00:00 	F156DAYS	F156 Days since randomization or enrollment
21	Age at enrollment/collection	283255	phv00283255.v1.p3	pht006216.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:32:13+00:00	2018-09-21 18:32:13+00:00 	F157DAYS	F157 Days since randomization or enrollment
21	Age at enrollment/collection	283286	phv00283286.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:32:49+00:00	2018-09-21 18:32:49+00:00 	F301DY	F301 Days since randomization or enrollment
21	Age at enrollment/collection	283289	phv00283289.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:32:54+00:00	2018-09-21 18:32:54+00:00 	EXAMDY	Exam days since randomization
21	Age at enrollment/collection	283402	phv00283402.v1.p3	pht006218.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:33:31+00:00	2018-09-21 18:33:31+00:00 	F60DAYS	F60 Days since randomization/enrollment
21	Age at enrollment/collection	283455	phv00283455.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:40:37+00:00	2018-09-21 18:40:37+00:00 	ENDWHIDY	Days enrollment to end of WHI core study followup
21	Age at enrollment/collection	283456	phv00283456.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:40:44+00:00	2018-09-21 18:40:44+00:00 	ENDEXT1DY	Days enrollment to end of Ext1 followup
21	Age at enrollment/collection	283457	phv00283457.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:40:50+00:00	2018-09-21 18:40:50+00:00 	ENDFOLLOWDY	Days enrollment to end of followup
21	Age at enrollment/collection	283458	phv00283458.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:40:56+00:00	2018-09-21 18:40:56+00:00 	F135DY	F135 Days from enrollment to Form 135 completion
21	Age at enrollment/collection	56587	phv00056587.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age_s1	Age = StdyDtqa - DOB
21	Age at enrollment/collection	56723	phv00056723.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age_s2	Age (age = formdate - DOB)
21	Age at enrollment/collection	177891	phv00177891.v3.p10	pht003097.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	adate1	Acquisition date time
21	Age at enrollment/collection	177930	phv00177930.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age1	Age at Exam 1
21	Age at enrollment/collection	177948	phv00177948.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age10	Age at Exam 10
21	Age at enrollment/collection	177950	phv00177950.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age11	Age at Exam 11
21	Age at enrollment/collection	177952	phv00177952.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age12	Age at Exam 12
21	Age at enrollment/collection	177954	phv00177954.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age13	Age at Exam 13
21	Age at enrollment/collection	177956	phv00177956.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age14	Age at Exam 14
21	Age at enrollment/collection	177958	phv00177958.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age15	Age at Exam 15
21	Age at enrollment/collection	177960	phv00177960.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age16	Age at Exam 16
21	Age at enrollment/collection	177962	phv00177962.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age17	Age at Exam 17
21	Age at enrollment/collection	177964	phv00177964.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age18	Age at Exam 18
21	Age at enrollment/collection	177966	phv00177966.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age19	Age at Exam 19
21	Age at enrollment/collection	253991	phv00253991.v1.p10	pht004374.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	age	Age at NP battery (years)
21	Age at enrollment/collection	277020	phv00277020.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	AGE1	Age at Exam 1
21	Age at enrollment/collection	277077	phv00277077.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:09:55+00:00	2018-09-27 14:09:55+00:00 	AGE1	Age at Exam 1
21	Age at enrollment/collection	177932	phv00177932.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	age2	Age at Exam 2
21	Age at enrollment/collection	177970	phv00177970.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	age21	Age at Exam 21
21	Age at enrollment/collection	177972	phv00177972.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	age22	Age at Exam 22
21	Age at enrollment/collection	177974	phv00177974.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	age23	Age at Exam 23
21	Age at enrollment/collection	177976	phv00177976.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	age24	Age at Exam 24
21	Age at enrollment/collection	177978	phv00177978.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	age25	Age at Exam 25
21	Age at enrollment/collection	177980	phv00177980.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	age26	Age at Exam 26
21	Age at enrollment/collection	177982	phv00177982.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	age27	Age at Exam 27
21	Age at enrollment/collection	177984	phv00177984.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	age28	Age at Exam 28
21	Age at enrollment/collection	226999	phv00226999.v1.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	age29	Age at Exam 29
21	Age at enrollment/collection	177968	phv00177968.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	age20	Age at Exam 20
21	Age at enrollment/collection	277021	phv00277021.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	AGE2	Age at Exam 2
21	Age at enrollment/collection	277078	phv00277078.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:13:58+00:00	2018-09-27 14:13:58+00:00 	AGE2	Age at Exam 2
21	Age at enrollment/collection	177934	phv00177934.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	age3	Age at Exam 3
21	Age at enrollment/collection	177936	phv00177936.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	age4	Age at Exam 4
21	Age at enrollment/collection	177938	phv00177938.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	age5	Age at Exam 5
21	Age at enrollment/collection	177940	phv00177940.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	age6	Age at Exam 6
21	Age at enrollment/collection	177942	phv00177942.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	age7	Age at Exam 7
21	Age at enrollment/collection	177944	phv00177944.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	age8	Age at Exam 8
21	Age at enrollment/collection	177946	phv00177946.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	age9	Age at Exam 9
21	Age at enrollment/collection	227002	phv00227002.v1.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	age30	Age at Exam 30
21	Age at enrollment/collection	227005	phv00227005.v1.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	age31	Age at Exam 31
21	Age at enrollment/collection	227008	phv00227008.v1.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	age32	Age at Exam 32
21	Age at enrollment/collection	277079	phv00277079.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	AGE3	Age at Exam 3
21	Age at enrollment/collection	277080	phv00277080.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	AGE4	Age at Exam 4
21	Age at enrollment/collection	277081	phv00277081.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	AGE5	Age at Exam 5
21	Age at enrollment/collection	277082	phv00277082.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	AGE6	Age at Exam 6
21	Age at enrollment/collection	277083	phv00277083.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	AGE7	Age at Exam 7
21	Age at enrollment/collection	277084	phv00277084.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	AGE8	Age at Exam 8
21	Age at enrollment/collection	277085	phv00277085.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:16:15+00:00	2018-09-27 14:16:15+00:00 	AGE9	Age at Exam 9
21	Age at enrollment/collection	22793	phv00022793.v5.p10	pht000113.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:18:08+00:00	2018-09-27 14:18:08+00:00 	assayday	DATE OF TESTING: NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	24370	phv00024370.v5.p10	pht000193.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:18:08+00:00	2018-09-27 14:18:08+00:00 	aldodate	DATE SAMPLE OBTAINED - NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	24639	phv00024639.v1.p10	pht000201.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:18:08+00:00	2018-09-27 14:18:08+00:00 	AGEYRS	AGE AT KNEE X_RAY FILMS
21	Age at enrollment/collection	56608	phv00056608.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:18:08+00:00	2018-09-27 14:18:08+00:00 	alcohdt	Usual Alcohol Intake Date
21	Age at enrollment/collection	56610	phv00056610.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:18:08+00:00	2018-09-27 14:18:08+00:00 	choldt	Cholesterol/HDL/Triglycerides Date
21	Age at enrollment/collection	64594	phv00064594.v1.p10	pht000603.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:18:08+00:00	2018-09-27 14:18:08+00:00 	AGEYRS	AGE AT KNEE X_RAY FILMS
21	Age at enrollment/collection	64599	phv00064599.v2.p10	pht000604.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:18:08+00:00	2018-09-27 14:18:08+00:00 	AGEYRS	AGE AT KNEE X_RAY FILMS
21	Age at enrollment/collection	66684	phv00066684.v4.p10	pht000670.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:18:08+00:00	2018-09-27 14:18:08+00:00 	blddrwdt	Blood draw date Collection Interval: Offspring Exam 8  and Omni 1 Exam 3
21	Age at enrollment/collection	227267	phv00227267.v1.p10	pht004809.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:18:08+00:00	2018-09-27 14:18:08+00:00 	CollectionDate	Urine collection date Collection Interval: Test performed at Offspring Exam9 and Omni 1 Exam 4
21	Age at enrollment/collection	238804	phv00238804.v1.p10	pht004811.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:18:08+00:00	2018-09-27 14:18:08+00:00 	awcdate	Header Start Date (K8) v: awcdate
21	Age at enrollment/collection	250279	phv00250279.v1.p10	pht004812.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:18:08+00:00	2018-09-27 14:18:08+00:00 	awcdate	Header Start Date (K8) v: awcdate
21	Age at enrollment/collection	23156	phv00023156.v3.p10	pht000139.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	ctdate	CT SCAN DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	23165	phv00023165.v3.p10	pht000140.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	CTDATE	DATE OF CT TEST , NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	66818	phv00066818.v2.p10	pht000675.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	ctdate	DATE OF CT SCAN, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	76334	phv00076334.v2.p10	pht000903.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	ctdate	Date of CT Scan Collection Interval: 2002-2005
21	Age at enrollment/collection	76346	phv00076346.v3.p10	pht000904.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	ctdate	Date of CT Scan
21	Age at enrollment/collection	76357	phv00076357.v2.p10	pht000905.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	ctdate	CT Scan Date Collection Interval: 2002-2005
21	Age at enrollment/collection	76363	phv00076363.v3.p10	pht000906.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	ctdate	Date of CT Scan
21	Age at enrollment/collection	90345	phv00090345.v2.p10	pht001224.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	ctdate	Date of CT Scan Collection Interval: 2002-2005
21	Age at enrollment/collection	90351	phv00090351.v2.p10	pht001225.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	ctdate	Date of CT Scan
21	Age at enrollment/collection	90355	phv00090355.v2.p10	pht001226.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	ctdate	Date of CT Scan Collection Interval: 2002-2005
21	Age at enrollment/collection	90359	phv00090359.v2.p10	pht001227.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	ctdate	Date of CT Scan
21	Age at enrollment/collection	195453	phv00195453.v1.p10	pht003459.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	ctdate	Date of CT scan
21	Age at enrollment/collection	196517	phv00196517.v1.p10	pht003629.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	ctdate	Date of round 2 CT scan
21	Age at enrollment/collection	257598	phv00257598.v1.p10	pht005153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	CT_DATE	CT scan date
21	Age at enrollment/collection	257624	phv00257624.v1.p10	pht005156.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	CT_DATE	CT scan date Collection Interval: 2002 - 2005
21	Age at enrollment/collection	257650	phv00257650.v1.p10	pht005158.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	CT_DATE	CT scan date
21	Age at enrollment/collection	257661	phv00257661.v1.p10	pht005159.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:27:28+00:00	2018-09-27 14:27:28+00:00 	CTDATE	CT scan date
21	Age at enrollment/collection	21691	phv00021691.v5.p10	pht000080.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:34:10+00:00	2018-09-27 14:34:10+00:00 	date	DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	21936	phv00021936.v5.p10	pht000092.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:34:10+00:00	2018-09-27 14:34:10+00:00 	date	TEST DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	22789	phv00022789.v5.p10	pht000112.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:34:10+00:00	2018-09-27 14:34:10+00:00 	date	EXAM 6 DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	36346	phv00036346.v4.p10	pht000298.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:34:10+00:00	2018-09-27 14:34:10+00:00 	date	EXAM DATE: NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	56634	phv00056634.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:34:10+00:00	2018-09-27 14:34:10+00:00 	date	Date Test Administered
21	Age at enrollment/collection	64606	phv00064606.v2.p10	pht000605.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:34:10+00:00	2018-09-27 14:34:10+00:00 	date	CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	64617	phv00064617.v2.p10	pht000606.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:34:10+00:00	2018-09-27 14:34:10+00:00 	date	CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	65269	phv00065269.v2.p10	pht000607.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:34:10+00:00	2018-09-27 14:34:10+00:00 	date	CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	65288	phv00065288.v1.p10	pht000608.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:34:11+00:00	2018-09-27 14:34:11+00:00 	date	CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	219227	phv00219227.v2.p10	pht004361.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:34:11+00:00	2018-09-27 14:34:11+00:00 	DATE	Framingham Heart Study exam date (blood draw date)
21	Age at enrollment/collection	21750	phv00021750.v1.p10	pht000086.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date_d	DATE BLOOD DRAWN, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	21751	phv00021751.v1.p10	pht000086.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date_t	DATE OF TEST, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	23628	phv00023628.v1.p10	pht000155.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date1920	COLLECTION DATE FOR EXAM 19/20 HBA, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	24535	phv00024535.v3.p10	pht000196.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date1	CARDIAC MRI SCAN DATE ENTERED ONTO PAPER FORM - NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	56611	phv00056611.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date10	Date questionnaire was completed
21	Age at enrollment/collection	56617	phv00056617.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date02	Date form filled out
21	Age at enrollment/collection	177993	phv00177993.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date10	Exam date for Exam 10
21	Age at enrollment/collection	177994	phv00177994.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date11	Exam date for Exam 11
21	Age at enrollment/collection	177995	phv00177995.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date12	Exam date for Exam 12
21	Age at enrollment/collection	177996	phv00177996.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date13	Exam date for Exam 13
21	Age at enrollment/collection	177997	phv00177997.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date14	Exam date for Exam 14
21	Age at enrollment/collection	177998	phv00177998.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date15	Exam date for Exam 15
21	Age at enrollment/collection	177999	phv00177999.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date16	Exam date for Exam 16
21	Age at enrollment/collection	178000	phv00178000.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date17	Exam date for Exam 17
21	Age at enrollment/collection	178001	phv00178001.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date18	Exam date for Exam 18
21	Age at enrollment/collection	178002	phv00178002.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	date19	Exam date for Exam 19
21	Age at enrollment/collection	277063	phv00277063.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	DATE1	Date of Exam 1
21	Age at enrollment/collection	277263	phv00277263.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:43:29+00:00	2018-09-27 14:43:29+00:00 	DATE1	Date of Exam 1
21	Age at enrollment/collection	23627	phv00023627.v1.p10	pht000155.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date22	COLLECTION DATE FOR EXAM 22 HBA, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	56613	phv00056613.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date20	Date questionnaire was completed
21	Age at enrollment/collection	142460	phv00142460.v1.p10	pht002080.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date22	Date of Follow-up X-ray Collection Interval: Exams 10, 14, and 22
21	Age at enrollment/collection	177985	phv00177985.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date2	Exam date for Exam 2
21	Age at enrollment/collection	178003	phv00178003.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date20	Exam date for Exam 20
21	Age at enrollment/collection	178004	phv00178004.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date21	Exam date for Exam 21
21	Age at enrollment/collection	178005	phv00178005.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date22	Exam date for Exam 22
21	Age at enrollment/collection	178006	phv00178006.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date23	Exam date for Exam 23
21	Age at enrollment/collection	178007	phv00178007.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date24	Exam date for Exam 24
21	Age at enrollment/collection	178008	phv00178008.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date25	Exam date for Exam 25
21	Age at enrollment/collection	178009	phv00178009.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date26	Exam date for Exam 26
21	Age at enrollment/collection	178010	phv00178010.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date27	Exam date for Exam 27
21	Age at enrollment/collection	178011	phv00178011.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date28	Exam date for Exam 28
21	Age at enrollment/collection	226998	phv00226998.v1.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	date29	Exam date for Exam 29
21	Age at enrollment/collection	277064	phv00277064.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	DATE2	Date of Exam 2
21	Age at enrollment/collection	277264	phv00277264.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:46:17+00:00	2018-09-27 14:46:17+00:00 	DATE2	Date of Exam 2
21	Age at enrollment/collection	56614	phv00056614.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	date50	Date of Study
21	Age at enrollment/collection	177986	phv00177986.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	date3	Exam date for Exam 3
21	Age at enrollment/collection	177987	phv00177987.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	date4	Exam date for Exam 4
21	Age at enrollment/collection	177988	phv00177988.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	date5	Exam date for Exam 5
21	Age at enrollment/collection	177989	phv00177989.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	date6	Exam date for Exam 6
21	Age at enrollment/collection	177990	phv00177990.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	date7	Exam date for Exam 7
21	Age at enrollment/collection	177991	phv00177991.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	date8	Exam date for Exam 8
21	Age at enrollment/collection	177992	phv00177992.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	date9	Exam date for Exam 9
21	Age at enrollment/collection	227001	phv00227001.v1.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	date30	Exam date for Exam 30
21	Age at enrollment/collection	227004	phv00227004.v1.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	date31	Exam date for Exam 31
21	Age at enrollment/collection	227007	phv00227007.v1.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	date32	Exam date for Exam 32
21	Age at enrollment/collection	277265	phv00277265.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	DATE3	Date of Exam 3
21	Age at enrollment/collection	277266	phv00277266.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	DATE4	Date of Exam 4
21	Age at enrollment/collection	277267	phv00277267.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	DATE5	Date of Exam 5
21	Age at enrollment/collection	277268	phv00277268.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	DATE6	Date of Exam 6
21	Age at enrollment/collection	277269	phv00277269.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	DATE7	Date of Exam 7
21	Age at enrollment/collection	277270	phv00277270.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	DATE8	Date of Exam 8
21	Age at enrollment/collection	277271	phv00277271.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:49:27+00:00	2018-09-27 14:49:27+00:00 	DATE9	Date of Exam 9
21	Age at enrollment/collection	23246	phv00023246.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	EBCT02	DATE OF CT TESTING, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	23555	phv00023555.v5.p10	pht000151.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	DRAWDATE	DATE BLOOD DRAWN, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	54699	phv00054699.v1.p10	pht000390.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	E005	AGE AT LAST BIRTHDAY
21	Age at enrollment/collection	54982	phv00054982.v1.p10	pht000390.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	E365	AGE (SAME AS E005), AGE AT LAST BIRTHDAY
21	Age at enrollment/collection	55155	phv00055155.v4.p10	pht000392.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	e_dte	DATE OF EXAMINATION, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	56618	phv00056618.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	ecgdt	Date of ECG
21	Age at enrollment/collection	66688	phv00066688.v4.p10	pht000671.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	drawdate	DATE OF SAMPLE DRAWN, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	70894	phv00070894.v4.p10	pht000683.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	drawdate	DATE OF BLOOD DRAWN DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	70901	phv00070901.v1.p10	pht000685.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	drawdate	BLOOD DRAW DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	69674	phv00069674.v4.p10	pht000686.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	drawdate	BLOOD DRAW DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	70905	phv00070905.v4.p10	pht000694.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	drawdt	BLOOD DRAW DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	71898	phv00071898.v4.p10	pht000742.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	drawdate	Date blood drawn or urine sample obtained
21	Age at enrollment/collection	72014	phv00072014.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	ecgdate_s1	Date of ECG for first sleep study Collection Interval: 1998-2003
21	Age at enrollment/collection	72015	phv00072015.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	ecgdate_s2	Date of ECG for second sleep study Collection Interval: 1998-2003
21	Age at enrollment/collection	220753	phv00220753.v1.p10	pht004369.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	DRAW_DATE	Date of DNA draw
21	Age at enrollment/collection	220760	phv00220760.v1.p10	pht004370.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	DRAW_DATE	Date of DNA draw
21	Age at enrollment/collection	275421	phv00275421.v1.p10	pht006011.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:52:14+00:00	2018-09-27 14:52:14+00:00 	DRAWDATE	Date blood drawn or urine sample obtained Collection Interval: Omni 1 Exam 3
21	Age at enrollment/collection	21871	phv00021871.v4.p10	pht000089.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	examdate	DATE OF FILLING QUESTIONNAIRE, NUMBER OF DAYS FROM EXAM 1
21	Age at enrollment/collection	21923	phv00021923.v1.p10	pht000090.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	edate	DATE OF EXAM, NUMBER OF DAYS FROM EXAM 1
21	Age at enrollment/collection	23772	phv00023772.v1.p10	pht000158.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	edate_a	DATE OF EXAM - PART A, NUMBER OF DAYS FROM EXAM 1 DATE
21	Age at enrollment/collection	23773	phv00023773.v1.p10	pht000158.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	edate_b	DATE OF EXAM - PART B, NUMBER OF DAYS FROM EXAM 1 DATE
21	Age at enrollment/collection	24575	phv00024575.v5.p10	pht000198.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	edate	DATE BLOOD DRAWN, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	55022	phv00055022.v1.p10	pht000390.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	examdate1	EXAM DATE PART I, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	55023	phv00055023.v1.p10	pht000390.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	examdate2	EXAM DATE PART II, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	55024	phv00055024.v1.p10	pht000390.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	examdate3	EXAM DATE PART III, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	55088	phv00055088.v1.p10	pht000391.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	examdate	EYE EXAMINATION DATE
21	Age at enrollment/collection	66803	phv00066803.v4.p10	pht000674.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	edate	BLOOD DRAWN DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	253873	phv00253873.v1.p10	pht000690.v11.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	examdate	Date of neuropsychological test battery
21	Age at enrollment/collection	253875	phv00253875.v1.p10	pht000691.v11.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	examdate	Date of neuropsychological test battery
21	Age at enrollment/collection	227019	phv00227019.v1.p10	pht004801.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	EDATE	Blood draw date Collection Interval: Exam 1
21	Age at enrollment/collection	227101	phv00227101.v1.p10	pht004806.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	EDATE	Blood draw date Collection Interval: Exam 1
21	Age at enrollment/collection	255346	phv00255346.v1.p10	pht005143.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	EDATE	Exam date
21	Age at enrollment/collection	257949	phv00257949.v1.p10	pht005174.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	examdate	EXAM DATE
21	Age at enrollment/collection	257971	phv00257971.v1.p10	pht005175.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	examdate	EXAM DATE Collection Interval: Exam performed at Exam 17 through Exam 32
21	Age at enrollment/collection	275409	phv00275409.v1.p10	pht006010.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	EDATE	Blood draw date Collection Interval: Exam 2
21	Age at enrollment/collection	275426	phv00275426.v1.p10	pht006012.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:55:48+00:00	2018-09-27 14:55:48+00:00 	EDATE	Exam 1 date
21	Age at enrollment/collection	156623	phv00156623.v3.p10	pht000169.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	f6_7scdt	Femur scan date
21	Age at enrollment/collection	56620	phv00056620.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	fevfvcdt	FEV1 FVC Date
21	Age at enrollment/collection	56621	phv00056621.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	heightdt	Height Date
21	Age at enrollment/collection	57972	phv00057972.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	formdate_ql	Date questionnaire completed, Number of days since Exam 1
21	Age at enrollment/collection	69853	phv00069853.v4.p10	pht000687.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	gfibdate	BLOOD DRAW DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	121924	phv00121924.v1.p10	pht001182.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	f2scdt	Femur scan date
21	Age at enrollment/collection	121943	phv00121943.v3.p10	pht001892.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	f2scdt	Femur scan date
21	Age at enrollment/collection	159558	phv00159558.v3.p10	pht002236.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	exdate	Date of foot study call back exam Collection Interval: Exam dates from 12/2000 to 6/2008
21	Age at enrollment/collection	162081	phv00162081.v1.p10	pht002346.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	f2scdt	Femur scan date Collection Interval: Test done at Generation 3 Exam 2 between April 2010 and March 2011
21	Age at enrollment/collection	163499	phv00163499.v1.p10	pht002430.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	g3ex2date	Quadriceps strength measure date
21	Age at enrollment/collection	163508	phv00163508.v3.p10	pht002431.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	exdate	Foot study date Collection Interval: Original Cohort Exams 27 and 28, Offspring Exam 8
21	Age at enrollment/collection	163512	phv00163512.v1.p10	pht002432.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	g3ex2date	Osteoporosis study questionnaire date
21	Age at enrollment/collection	172208	phv00172208.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	exdate	Framingham Heart Study Exam date (blood draw date)
21	Age at enrollment/collection	177805	phv00177805.v2.p10	pht003096.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	f7_5scdt	Femur scan date for exam 7.5 Collection Interval: Scans done from January 2002 through July 2008
21	Age at enrollment/collection	177807	phv00177807.v2.p10	pht003096.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	f8cbscdt	Femur scan date for exam 8 callback Collection Interval: Scans done from January 2002 through July 2008
21	Age at enrollment/collection	227061	phv00227061.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 14:58:16+00:00	2018-09-27 14:58:16+00:00 	EXDATE	Framingham Heart Study exam date (blood draw date)
21	Age at enrollment/collection	21813	phv00021813.v4.p10	pht000088.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	hex6_03	EXAM DATE - PART A, NUMBER OF DAYS FROM EXAM 1
21	Age at enrollment/collection	21814	phv00021814.v4.p10	pht000088.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	hex6_36	IMPEDANCE & REFLECTANCE: IMPED PROGRAM - RIGHT EAR. DATE - NUMBER OF DAYS FROM EXAM 1
21	Age at enrollment/collection	21815	phv00021815.v4.p10	pht000088.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	hex6_37	IMPEDANCE & REFLECTANCE: IMPED PROGRAM - LEFT EAR. DATE - NUMBER OF DAYS FROM EXAM 1
21	Age at enrollment/collection	21816	phv00021816.v4.p10	pht000088.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	hex6_38	DPOAE: EMAV PROGRAM - RIGHT EAR. DATE - NUMBER OF DAYS FROM EXAM 1
21	Age at enrollment/collection	21817	phv00021817.v4.p10	pht000088.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	hex6_39	DPOAE: EMAV PROGRAM - LEFT EAR. DATE - NUMBER OF DAYS FROM EXAM 1
21	Age at enrollment/collection	21818	phv00021818.v4.p10	pht000088.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	hex6_46	DPOAE: VIRTUAL 330 - RIGHT EAR TEST EACH EAR HAVING PTA >= 50 DP HL.  DO DP - GRAM AND I/O FUNCTION AT 2KHZ. DATE - NUMBER OF DAYS FROM EXAM 1
21	Age at enrollment/collection	21819	phv00021819.v4.p10	pht000088.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	hex6_47	DPOAE: VIRTUAL 330 - RIGHT EAR TEST EACH EAR HAVING PTA <= 50 DP HL.  DO DP - GRAM AND I/O FUNCTION AT 2KHZ. DATE - NUMBER OF DAYS FROM EXAM 1
21	Age at enrollment/collection	21820	phv00021820.v4.p10	pht000088.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	hex6_54	EXAM DATE - PART B, NUMBER OF DAYS FROM EXAM 1
21	Age at enrollment/collection	36495	phv00036495.v4.p10	pht000313.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	labdate	DATE WHEN SPECIMEN WERE COLLECTED, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	56622	phv00056622.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	hipdt	Hip Date
21	Age at enrollment/collection	190832	phv00190832.v6.p10	pht003317.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	LASTATT	Date of last exam attended through 2012
21	Age at enrollment/collection	202020	phv00202020.v3.p10	pht003905.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	mr99date	MRI Date
21	Age at enrollment/collection	220874	phv00220874.v2.p10	pht004375.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:02:54+00:00	2018-09-27 15:02:54+00:00 	KADATE	Date of Kaplan Albert exam Collection Interval: Questionnaire administered at Original cohort Exams 14 and 15
21	Age at enrollment/collection	257714	phv00257714.v1.p10	pht003313.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:12:09+00:00	2018-09-27 15:12:09+00:00 	mri_date	Date of MRI Collection Interval: 12/2000 - 6/2009
21	Age at enrollment/collection	202028	phv00202028.v4.p10	pht003906.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:12:09+00:00	2018-09-27 15:12:09+00:00 	mri_date	Brain MRI scan date
21	Age at enrollment/collection	220687	phv00220687.v1.p10	pht004364.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:12:09+00:00	2018-09-27 15:12:09+00:00 	mri_date	Scan Date of MRI Collection Interval: 2005-2010
21	Age at enrollment/collection	220701	phv00220701.v3.p10	pht004365.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:12:09+00:00	2018-09-27 15:12:09+00:00 	mri_date	Date of MRI scan Collection Interval: Brain MRI Scans Dates 3/1999 to 8/2011
21	Age at enrollment/collection	220738	phv00220738.v3.p10	pht004366.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:12:09+00:00	2018-09-27 15:12:09+00:00 	mri_date	Date of MRI scan
21	Age at enrollment/collection	220742	phv00220742.v1.p10	pht004367.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:12:09+00:00	2018-09-27 15:12:09+00:00 	mri_date	MRI Scan Date Collection Interval: 1999-2005
21	Age at enrollment/collection	257780	phv00257780.v1.p10	pht005165.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:12:09+00:00	2018-09-27 15:12:09+00:00 	mri_date	MRI date
21	Age at enrollment/collection	276647	phv00276647.v1.p10	pht006016.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:12:09+00:00	2018-09-27 15:12:09+00:00 	mri_date	Date of MRI scan
21	Age at enrollment/collection	24754	phv00024754.v4.p10	pht000207.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:15:17+00:00	2018-09-27 15:15:17+00:00 	mridate	NUMBER OF DAYS BETWEEN EXAM 1 AND NEUROPSYCH BATTERY TEST
21	Age at enrollment/collection	65292	phv00065292.v2.p10	pht000609.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:15:17+00:00	2018-09-27 15:15:17+00:00 	OSSage	AGE AT X-RAY
21	Age at enrollment/collection	72714	phv00072714.v4.p10	pht000748.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:15:17+00:00	2018-09-27 15:15:17+00:00 	pdate	Date of PAT scan
21	Age at enrollment/collection	76396	phv00076396.v3.p10	pht000909.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:15:17+00:00	2018-09-27 15:15:17+00:00 	of67quad_date	Quadriceps Strength: Measurement Date
21	Age at enrollment/collection	202067	phv00202067.v3.p10	pht003910.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:15:17+00:00	2018-09-27 15:15:17+00:00 	NPDATE	Neuropsychological battery exam date
21	Age at enrollment/collection	220862	phv00220862.v3.p10	pht004374.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:15:17+00:00	2018-09-27 15:15:17+00:00 	np_date	Date of NP battery
21	Age at enrollment/collection	257586	phv00257586.v1.p10	pht005151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:15:17+00:00	2018-09-27 15:15:17+00:00 	Ns2fscdt	Femur scan date Collection Interval: Test performed at Exam 2
21	Age at enrollment/collection	257587	phv00257587.v1.p10	pht005151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:15:17+00:00	2018-09-27 15:15:17+00:00 	Ns2sscdt	Spine scan date Collection Interval: Test performed at Exam 2
21	Age at enrollment/collection	57974	phv00057974.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	pm203	Date of wt measurment, Number of days since Exam 1
21	Age at enrollment/collection	57975	phv00057975.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	pm208	Date of ht measurement, Number of days since Exam 1
21	Age at enrollment/collection	57976	phv00057976.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	pm213	Date of neck measurement, Number of days since Exam 1
21	Age at enrollment/collection	57977	phv00057977.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	pm221	Date of seated bp measurement, Number of days since Exam 1
21	Age at enrollment/collection	57978	phv00057978.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	pm228	Date of AAI measurement, Number of days since Exam 1
21	Age at enrollment/collection	57979	phv00057979.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	pm233	Date of ECG measurement, Number of days since Exam 1
21	Age at enrollment/collection	70902	phv00070902.v1.p10	pht000685.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	rundate	LABORATORY ANALYSIS DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	72016	phv00072016.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	psgdate_s1	Date of PSG for first sleep study Collection Interval: 1998-2003
21	Age at enrollment/collection	72017	phv00072017.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	psgdate_s2	Date of PSG for second sleep study Collection Interval: 1998-2003
21	Age at enrollment/collection	121925	phv00121925.v2.p10	pht001182.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	s2scdt	Spine scan date
21	Age at enrollment/collection	121942	phv00121942.v3.p10	pht001892.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	s2scdt	Spine scan date
21	Age at enrollment/collection	141875	phv00141875.v3.p10	pht002073.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	psgdate	Date of Polysomnogram Collection Interval: Test performed 1995-1998
21	Age at enrollment/collection	162082	phv00162082.v1.p10	pht002346.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:18:33+00:00	2018-09-27 15:18:33+00:00 	s2scdt	Spine scan date Collection Interval: Test done at Generation 3 Exam 2 between April 2010 and March 2011
21	Age at enrollment/collection	156624	phv00156624.v3.p10	pht000169.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:22:22+00:00	2018-09-27 15:22:22+00:00 	s6_7scdt	Spine scan date
21	Age at enrollment/collection	36378	phv00036378.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:22:22+00:00	2018-09-27 15:22:22+00:00 	sampdate	DATE ECG DONE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	177806	phv00177806.v2.p10	pht003096.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:22:22+00:00	2018-09-27 15:22:22+00:00 	s7_5scdt	Spine scan date for exam 7.5 Collection Interval: Scans done from January 2002 through July 2008
21	Age at enrollment/collection	177808	phv00177808.v2.p10	pht003096.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:22:22+00:00	2018-09-27 15:22:22+00:00 	s8cbscdt	Spine scan date for exam 8 callback Collection Interval: Scans done from January 2002 through July 2008
21	Age at enrollment/collection	24587	phv00024587.v2.p10	pht000200.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	sample_date	IGF BLOOD DRAW DATE, NUMBER OF DAYS SINE EXAM 1
21	Age at enrollment/collection	54674	phv00054674.v2.p10	pht000387.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scandate	DATE OF THE SCAN, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	54690	phv00054690.v3.p10	pht000388.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scandate	DATE OF THE CT SCAN, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	121955	phv00121955.v3.p10	pht001893.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scandate	QCT image scan date
21	Age at enrollment/collection	121971	phv00121971.v2.p10	pht001894.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scandate	QCT Image Scan Date
21	Age at enrollment/collection	171910	phv00171910.v1.p10	pht002854.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scandate	CT Scan date
21	Age at enrollment/collection	202016	phv00202016.v2.p10	pht003904.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	SCAN_DATE1	Round 1 CT Dates
21	Age at enrollment/collection	202017	phv00202017.v2.p10	pht003904.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	SCAN_DATE2	Round 2 CT Dates
21	Age at enrollment/collection	257591	phv00257591.v1.p10	pht005152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scan_date	CT SCAN DATE
21	Age at enrollment/collection	257604	phv00257604.v1.p10	pht005154.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scan_date	CT SCAN DATE
21	Age at enrollment/collection	257639	phv00257639.v1.p10	pht005157.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scan_date	CT SCAN  DATE
21	Age at enrollment/collection	257667	phv00257667.v1.p10	pht005160.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scan_date	CT SCAN DATE
21	Age at enrollment/collection	257672	phv00257672.v1.p10	pht005161.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scan_date	CT scan date
21	Age at enrollment/collection	257676	phv00257676.v1.p10	pht005162.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scan_date	CT SCAN DATE
21	Age at enrollment/collection	257682	phv00257682.v1.p10	pht005163.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scan_date	CT SCAN DATE
21	Age at enrollment/collection	276582	phv00276582.v1.p10	pht006014.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:37:20+00:00	2018-09-27 15:37:20+00:00 	scandate	Scan Date Collection Interval: Test Performed after Offspring Exam 9
21	Age at enrollment/collection	23551	phv00023551.v5.p10	pht000150.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	SDATE	STUDY DATE, NUMBER OF DAYS FROM EXAM 1
21	Age at enrollment/collection	24436	phv00024436.v4.p10	pht000194.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdate	STUDY DATE, DAYS SINCE EXAM 1
21	Age at enrollment/collection	24509	phv00024509.v5.p10	pht000195.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdate	DATE OF SCAN, DAYS SINCE EXAM 1
21	Age at enrollment/collection	24801	phv00024801.v5.p10	pht000209.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdate	STUDY DATE, DAYS SINCE EXAM 1 (OLD NAME:SDATE2)
21	Age at enrollment/collection	24845	phv00024845.v4.p10	pht000210.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdate	STUDY DATE, DAYS SINCE EXAM 1
21	Age at enrollment/collection	24906	phv00024906.v1.p10	pht000211.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdate	STUDY DATE, DAYS SINCE EXAM 1
21	Age at enrollment/collection	66764	phv00066764.v4.p10	pht000673.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdate	STUDY DATE, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	73842	phv00073842.v4.p10	pht000832.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdt_8_1	Study date
21	Age at enrollment/collection	76412	phv00076412.v4.p10	pht000910.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdt_8_1	Study Date
21	Age at enrollment/collection	167130	phv00167130.v5.p10	pht002572.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdate	STUDY DATE
21	Age at enrollment/collection	167261	phv00167261.v1.p10	pht002573.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdate	STUDY DATE
21	Age at enrollment/collection	196545	phv00196545.v2.p10	pht003631.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdt_2	Study Date
21	Age at enrollment/collection	196562	phv00196562.v2.p10	pht003632.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdt_2	Study Date
21	Age at enrollment/collection	257782	phv00257782.v1.p10	pht005166.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdt_1	Study Date
21	Age at enrollment/collection	257812	phv00257812.v1.p10	pht005167.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdt_3	Study Date Collection Interval: Omni 1 Exam 3
21	Age at enrollment/collection	257816	phv00257816.v1.p10	pht005168.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdt_9	Study Date Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4
21	Age at enrollment/collection	257831	phv00257831.v1.p10	pht005169.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdt_9_1	Study Date Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4
21	Age at enrollment/collection	257847	phv00257847.v1.p10	pht005170.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	sdt_1	Study Date
21	Age at enrollment/collection	276640	phv00276640.v1.p10	pht006015.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:42:22+00:00	2018-09-27 15:42:22+00:00 	SDATE	Study date
21	Age at enrollment/collection	23197	phv00023197.v3.p10	pht000144.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:40+00:00	2018-09-27 15:44:40+00:00 	studydat	DATE OF TEST, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	23203	phv00023203.v3.p10	pht000145.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:40+00:00	2018-09-27 15:44:40+00:00 	studydat	DATE OF TEST, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	24883	phv00024883.v1.p10	pht000211.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:40+00:00	2018-09-27 15:44:40+00:00 	TM02	DATE OF FHS CLINIC EXAM?
21	Age at enrollment/collection	55248	phv00055248.v4.p10	pht000394.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:40+00:00	2018-09-27 15:44:40+00:00 	study_da	DATE WALKTEST COMPLETED, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	56627	phv00056627.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:40+00:00	2018-09-27 15:44:40+00:00 	stdatep	PSG start date
21	Age at enrollment/collection	56628	phv00056628.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:40+00:00	2018-09-27 15:44:40+00:00 	stdydtqa	PSG Study Date
21	Age at enrollment/collection	56629	phv00056629.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:40+00:00	2018-09-27 15:44:40+00:00 	stdydtsn	PSG study date
21	Age at enrollment/collection	56630	phv00056630.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:41+00:00	2018-09-27 15:44:41+00:00 	sysdiadt	Systolic/Diastolic Blood Pressure Date
21	Age at enrollment/collection	57980	phv00057980.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:41+00:00	2018-09-27 15:44:41+00:00 	sh331	Today's date, Number of days since Exam 1
21	Age at enrollment/collection	57981	phv00057981.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:41+00:00	2018-09-27 15:44:41+00:00 	stdatep	PSG start date, Number of days since Exam 1
21	Age at enrollment/collection	156710	phv00156710.v1.p10	pht002147.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:41+00:00	2018-09-27 15:44:41+00:00 	studydat	DATE OF TEST Collection Interval: Scan done 2002 - 2005
21	Age at enrollment/collection	162093	phv00162093.v1.p10	pht002347.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:41+00:00	2018-09-27 15:44:41+00:00 	studydat	Date of CT test Collection Interval: CT scans done between 2002-2005
21	Age at enrollment/collection	162101	phv00162101.v2.p10	pht002348.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:41+00:00	2018-09-27 15:44:41+00:00 	stdydtqa1	PSG study date Collection Interval: Test done 1995 - 1998
21	Age at enrollment/collection	166998	phv00166998.v1.p10	pht002571.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:41+00:00	2018-09-27 15:44:41+00:00 	studydat	DATE OF TEST Collection Interval: Scans done between 2002-2005
21	Age at enrollment/collection	190765	phv00190765.v2.p10	pht003311.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:41+00:00	2018-09-27 15:44:41+00:00 	stdydtqa	PSG study date Collection Interval: Tests performed between 1995 and 1998
21	Age at enrollment/collection	196579	phv00196579.v2.p10	pht003633.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:41+00:00	2018-09-27 15:44:41+00:00 	sdt_alb_2	Study Date, Albuterol
21	Age at enrollment/collection	196596	phv00196596.v2.p10	pht003634.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:41+00:00	2018-09-27 15:44:41+00:00 	sdt_alb_8	Study date, Albuterol Collection Interval: Offspring Exam 8, Omni 1 Exam 3
21	Age at enrollment/collection	257865	phv00257865.v1.p10	pht005171.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:44:41+00:00	2018-09-27 15:44:41+00:00 	sdt_post_9_1	Study date, Albuterol Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4
21	Age at enrollment/collection	156625	phv00156625.v3.p10	pht000169.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:46:45+00:00	2018-09-27 15:46:45+00:00 	u6_7dte	Heel ultrasound date
21	Age at enrollment/collection	56631	phv00056631.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:46:45+00:00	2018-09-27 15:46:45+00:00 	wtcldt20	Date, if weight measured at clinic on other date
21	Age at enrollment/collection	56632	phv00056632.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:46:45+00:00	2018-09-27 15:46:45+00:00 	waistdt	Waist Date
21	Age at enrollment/collection	56633	phv00056633.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:46:45+00:00	2018-09-27 15:46:45+00:00 	weightdt	Weight Date
21	Age at enrollment/collection	56720	phv00056720.v2.p10	pht000396.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:46:45+00:00	2018-09-27 15:46:45+00:00 	visitdt	Date of follow-up visit, Number of days since exam 1
21	Age at enrollment/collection	65398	phv00065398.v2.p10	pht000610.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:46:45+00:00	2018-09-27 15:46:45+00:00 	wb22scdt	WHOLEBODY SCAN DATE EX22, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	65397	phv00065397.v2.p10	pht000610.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:46:45+00:00	2018-09-27 15:46:45+00:00 	wb23scdt	WHOLEBODY SCAN DATE EX23, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	65451	phv00065451.v4.p10	pht000611.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:46:45+00:00	2018-09-27 15:46:45+00:00 	wb6_7scdt	WHOLEBODY SCAN DATE EX6/7, NUMBER OF DAYS SINCE EXAM 1
21	Age at enrollment/collection	142459	phv00142459.v1.p10	pht002080.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:46:45+00:00	2018-09-27 15:46:45+00:00 	xdate10	Date of Baseline X-ray Collection Interval: Exams 10, 14, and 22
21	Age at enrollment/collection	156751	phv00156751.v3.p10	pht002149.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:46:45+00:00	2018-09-27 15:46:45+00:00 	wb2scdt	Whole body DXA scan date
21	Age at enrollment/collection	162111	phv00162111.v1.p10	pht002349.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 15:46:45+00:00	2018-09-27 15:46:45+00:00 	wb2scdt	Whole body DXA scan date Collection Interval: Test done at Generation 3 Exam 2 between September 2010 to March 2011
21	Age at enrollment/collection	98799	phv00098799.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:14:35+00:00	2018-09-27 18:14:35+00:00 	AGE01	SELF-REPORTED AGE AT BASELINE
21	Age at enrollment/collection	99568	phv00099568.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:17:17+00:00	2018-09-27 18:17:17+00:00 	AGEBL	CALCULATED AGE AT BASELINE
21	Age at enrollment/collection	100487	phv00100487.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:17:49+00:00	2018-09-27 18:17:49+00:00 	AGEBL	CALCULATED AGE AT BASELINE
21	Age at enrollment/collection	102006	phv00102006.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:18:32+00:00	2018-09-27 18:18:32+00:00 	AGEY10	Age at visit
21	Age at enrollment/collection	102583	phv00102583.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:18:42+00:00	2018-09-27 18:18:42+00:00 	AGEY11	AGE AT YEAR 11
21	Age at enrollment/collection	104377	phv00104377.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:18:54+00:00	2018-09-27 18:18:54+00:00 	AGEY3	CALCULATED AGE AT YR 3 VISIT
21	Age at enrollment/collection	104783	phv00104783.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:19:05+00:00	2018-09-27 18:19:05+00:00 	AGEY4	CALCULATED AGE AT YR 4 VISIT
21	Age at enrollment/collection	105116	phv00105116.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:19:23+00:00	2018-09-27 18:19:23+00:00 	AGE01	SELF-REPORTED AGE AT BASELINE
21	Age at enrollment/collection	105622	phv00105622.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:19:35+00:00	2018-09-27 18:19:35+00:00 	AGEBL	CALCULATED AGE AT BASELINE VISIT
21	Age at enrollment/collection	106844	phv00106844.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:19:55+00:00	2018-09-27 18:19:55+00:00 	AGEY5	CALCULATED AGE AT YR 5 VISIT
21	Age at enrollment/collection	107780	phv00107780.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:20:08+00:00	2018-09-27 18:20:08+00:00 	AGEY6	CALCULATED AGE AT YR 6 VISIT
21	Age at enrollment/collection	108813	phv00108813.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:20:21+00:00	2018-09-27 18:20:21+00:00 	AGEY7	CALCULATED AGE AT YR 7 VISIT
21	Age at enrollment/collection	109604	phv00109604.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:20:31+00:00	2018-09-27 18:20:31+00:00 	AGEY8	CALCULATED AGE AT YR 8 VISIT
21	Age at enrollment/collection	109855	phv00109855.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:20:44+00:00	2018-09-27 18:20:44+00:00 	AGEY9	CALCULATED AGE AT YR 9 VISIT
21	Age at enrollment/collection	276886	phv00276886.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:36:21+00:00	2018-10-10 17:36:21+00:00 	CHF011d	Date of hospital admit
21	Age at enrollment/collection	276887	phv00276887.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:37:05+00:00	2018-10-10 17:37:05+00:00 	CHF015d	Date of HF onset, if different
21	Age at enrollment/collection	276846	phv00276846.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:37:25+00:00	2018-10-10 17:37:25+00:00 	CHF031	Vital Signs - date same as onset
21	Age at enrollment/collection	276888	phv00276888.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:37:54+00:00	2018-10-10 17:37:54+00:00 	CHF034d	Date of Vital Signs - If no
21	Age at enrollment/collection	276852	phv00276852.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:38:12+00:00	2018-10-10 17:38:12+00:00 	CHF040	Hematologic labs date same as onset
21	Age at enrollment/collection	276894	phv00276894.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:38:41+00:00	2018-10-10 17:38:41+00:00 	CHF043	Lab tests - if no, enter date
21	Age at enrollment/collection	276857	phv00276857.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:38:59+00:00	2018-10-10 17:38:59+00:00 	CHF048	Chemistry labs date same as onset
21	Age at enrollment/collection	276889	phv00276889.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:39:22+00:00	2018-10-10 17:39:22+00:00 	CHF051d	Date of Chem labs - if no
21	Age at enrollment/collection	276863	phv00276863.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:39:42+00:00	2018-10-10 17:39:42+00:00 	CHF057	Albumin - Protein Labs date same as onset
21	Age at enrollment/collection	276895	phv00276895.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:40:00+00:00	2018-10-10 17:40:00+00:00 	CHF060	Albumin labs - if no, enter date
21	Age at enrollment/collection	276866	phv00276866.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:40:29+00:00	2018-10-10 17:40:29+00:00 	CHF063	Cardiac marker date same as onset
21	Age at enrollment/collection	276890	phv00276890.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:40:47+00:00	2018-10-10 17:40:47+00:00 	CHF066d	Date of Cardiac marker - if no
21	Age at enrollment/collection	276816	phv00276816.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:41:18+00:00	2018-10-10 17:41:18+00:00 	CHF087	ECG date same as onset
21	Age at enrollment/collection	276891	phv00276891.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:41:42+00:00	2018-10-10 17:41:42+00:00 	CHF090d	Date of ECG - if no
21	Age at enrollment/collection	252987	phv00252987.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-12-20 00:35:04+00:00	2018-12-20 00:35:04+00:00 	cac_score_age	Age when CAC score was obtained
22	Gender	226279	phv00226279.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 21:56:47+00:00	2018-03-14 21:56:47+00:00 	GENDER	Gender (F=Female, M=Male)
22	Gender	204634	phv00204634.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:59:11+00:00	2018-03-15 14:59:11+00:00 	GENDER	Sex (from FTRA22) [Cohort, Exam 2]
22	Gender	204711	phv00204711.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 14:59:38+00:00	2018-03-15 14:59:38+00:00 	GENDER	Sex (uncorrected from FTRA22) [Cohort, Exam 1]
22	Gender	204963	phv00204963.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 15:00:06+00:00	2018-03-15 15:00:06+00:00 	GENDER	Sex (From FTRA22) [Cohort, Exam 4]
22	Gender	112420	phv00112420.v2.p2	pht001559.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:54:41+00:00	2018-04-17 16:54:41+00:00 	A01SEX	EXAM 1 SEX, TELEPHONE INTERVIEW
22	Gender	113152	phv00113152.v2.p2	pht001570.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:54:41+00:00	2018-04-17 16:54:41+00:00 	SEX	SEX (VERIFIED AT EXAM 2)
22	Gender	113716	phv00113716.v2.p2	pht001589.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:54:41+00:00	2018-04-17 16:54:41+00:00 	SEX	SEX (VERIFIED AT EXAM 2)
22	Gender	115114	phv00115114.v2.p2	pht001645.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:54:41+00:00	2018-04-17 16:54:41+00:00 	SEX	SEX (VERIFIED AT EXAM 2)
22	Gender	116380	phv00116380.v2.p2	pht001697.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:54:41+00:00	2018-04-17 16:54:41+00:00 	SEX	SEX (VERIFIED AT EXAM 2)
22	Gender	114611	phv00114611.v2.p2	pht001626.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-18 15:10:00+00:00	2018-04-18 15:10:00+00:00 	B12SEX	SEX OF SUBJECT
22	Gender	116485	phv00116485.v2.p2	pht001706.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-18 15:14:15+00:00	2018-04-18 15:14:15+00:00 	DDXPTSEX	PATIENT DATA: SEX
22	Gender	117581	phv00117581.v2.p2	pht001744.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-18 15:20:52+00:00	2018-04-18 15:20:52+00:00 	SEX	SEX (VERIFIED AT EXAM 2)
22	Gender	119473	phv00119473.v2.p2	pht001795.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-18 15:21:48+00:00	2018-04-18 15:21:48+00:00 	E53SEX	SEX - FORM 53
22	Gender	119633	phv00119633.v2.p2	pht001804.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-18 15:22:00+00:00	2018-04-18 15:22:00+00:00 	SEX	SEX (VERIFIED AT PPTS LAST EXAM)
22	Gender	120741	phv00120741.v2.p2	pht001851.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-18 15:22:12+00:00	2018-04-18 15:22:12+00:00 	SEX	SEX (VERIFIED AT PPTS LAST EXAM)
22	Gender	82643	phv00082643.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:59:57+00:00	2018-04-23 02:59:57+00:00 	gender1	GENDER
22	Gender	84446	phv00084446.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:00:09+00:00	2018-04-23 03:00:09+00:00 	gender1	GENDER
22	Gender	85782	phv00085782.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:00:15+00:00	2018-04-23 03:00:15+00:00 	gender1	GENDER
22	Gender	86268	phv00086268.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:00:22+00:00	2018-04-23 03:00:22+00:00 	gender1	GENDER
22	Gender	86736	phv00086736.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:00:28+00:00	2018-04-23 03:00:28+00:00 	gender1	GENDER
22	Gender	87073	phv00087073.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:00:35+00:00	2018-04-23 03:00:35+00:00 	genderf	GENDER
22	Gender	174586	phv00174586.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:00:41+00:00	2018-04-23 03:00:41+00:00 	gender1	GENDER
22	Gender	175856	phv00175856.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:00:46+00:00	2018-04-23 03:00:46+00:00 	gender1	GENDER
22	Gender	175877	phv00175877.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:00:52+00:00	2018-04-23 03:00:52+00:00 	gender	GENDER
22	Gender	175940	phv00175940.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:01:00+00:00	2018-04-23 03:01:00+00:00 	genderf	FAMILY COHORT: GENDER
22	Gender	176009	phv00176009.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:01:06+00:00	2018-04-23 03:01:06+00:00 	gender1	GENDER
22	Gender	219022	phv00219022.v1.p3	pht004326.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:01:13+00:00	2018-04-23 03:01:13+00:00 	gender1	GENDER
22	Gender	207078	phv00207078.v1.p1	pht004103.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 20:33:35+00:00	2018-04-25 20:33:35+00:00 	HHXB10	[Reproductive history]. Sex of participant. Q10 [Health/Medical History, exam 2]
22	Gender	208795	phv00208795.v1.p1	pht004142.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 20:34:01+00:00	2018-04-25 20:34:01+00:00 	PFTA02	Sex (M, F) [Pulmonary Function Test, exam 1]
22	Gender	127524	phv00127524.v1.p1	pht001956.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-26 19:50:11+00:00	2018-04-26 19:50:11+00:00 	ELGA4	4: Participant's gender
22	Gender	126012	phv00126012.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-26 19:50:51+00:00	2018-04-26 19:50:51+00:00 	GENDER	Gender of participant
22	Gender	125811	phv00125811.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-26 19:55:53+00:00	2018-04-26 19:55:53+00:00 	AFUK18	GENDER OF PARTICIPANT (M,F)         Q18
22	Gender	125724	phv00125724.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-26 19:57:32+00:00	2018-04-26 19:57:32+00:00 	AFUJ18	GENDER OF PARTICIPANT (M,F)       Q18
22	Gender	125635	phv00125635.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-26 19:58:26+00:00	2018-04-26 19:58:26+00:00 	AFUI18	GENDER OF PARTICIPANT (M,F)       Q18
22	Gender	125546	phv00125546.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-26 19:58:46+00:00	2018-04-26 19:58:46+00:00 	AFUI18	GENDER OF PARTICIPANT (M,F)       Q18
22	Gender	125034	phv00125034.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-26 20:01:36+00:00	2018-04-26 20:01:36+00:00 	AFUA18	18. Is the participant male or female?
22	Gender	125119	phv00125119.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-26 20:01:54+00:00	2018-04-26 20:01:54+00:00 	AFUA18	18. Is the participant male or female?
22	Gender	125205	phv00125205.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-26 20:02:16+00:00	2018-04-26 20:02:16+00:00 	AFUB18	18. Is the participant male or female?
22	Gender	125291	phv00125291.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-26 20:02:31+00:00	2018-04-26 20:02:31+00:00 	AFUB18	18. Is the participant male or female?
22	Gender	98797	phv00098797.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:03:18+00:00	2018-05-03 18:03:18+00:00 	GEND01	GENDER
22	Gender	100302	phv00100302.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:04:06+00:00	2018-05-03 18:04:06+00:00 	GEND01	GENDER
22	Gender	100810	phv00100810.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:04:25+00:00	2018-05-03 18:04:25+00:00 	GEND01	GENDER
22	Gender	101950	phv00101950.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:04:39+00:00	2018-05-03 18:04:39+00:00 	GEND01	GENDER
22	Gender	105644	phv00105644.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:04:56+00:00	2018-05-03 18:04:56+00:00 	GEND01	GENDER
22	Gender	106545	phv00106545.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:05:10+00:00	2018-05-03 18:05:10+00:00 	GEND01	GENDER
22	Gender	108393	phv00108393.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:05:24+00:00	2018-05-03 18:05:24+00:00 	GEND01	GENDER
22	Gender	109144	phv00109144.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:06:02+00:00	2018-05-03 18:06:02+00:00 	GEND01	GENDER
22	Gender	109854	phv00109854.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:06:21+00:00	2018-05-03 18:06:21+00:00 	GEND01	GENDER
22	Gender	197400	phv00197400.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:06:36+00:00	2018-05-03 18:06:36+00:00 	gender	Gender
22	Gender	177929	phv00177929.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 11:57:21+00:00	2018-05-09 11:57:21+00:00 	sex	Participant gender
22	Gender	21228	phv00021228.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 11:58:46+00:00	2018-05-09 11:58:46+00:00 	G3A440	SEX OF PARTICIPANT
22	Gender	253990	phv00253990.v1.p10	pht004374.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 11:59:45+00:00	2018-05-09 11:59:45+00:00 	SEX	Participant sex
22	Gender	277017	phv00277017.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:00:17+00:00	2018-05-09 12:00:17+00:00 	SEX	Sex of participant
22	Gender	277067	phv00277067.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-09 12:00:46+00:00	2018-05-09 12:00:46+00:00 	SEX	Sex of participant
22	Gender	159571	phv00159571.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:36:53+00:00	2018-08-10 21:36:53+00:00 	gender	Gender Collection Interval: Collected in Exam 1
22	Gender	277506	phv00277506.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:40:51+00:00	2018-08-14 22:40:51+00:00 	GENDER	Participants gender Collection Interval: 1996-2000
22	Gender	307787	phv00307787.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:55:06+00:00	2018-08-15 23:55:06+00:00 	GENDER	Participants gender Collection Interval: 1996-2000
22	Gender	115706	phv00115706.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:29:06+00:00	2018-08-23 17:29:06+00:00 	C12SEX	C12SEX
22	Gender	253224	phv00253224.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:37:01+00:00	2018-08-24 16:37:01+00:00 	GENDERNUM	Gender (0=Female, 1=Male)
22	Gender	252975	phv00252975.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:11:10+00:00	2018-08-24 17:11:10+00:00 	SEX	Sex of participant
22	Gender	118961	phv00118961.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:36:39+00:00	2018-08-28 23:36:39+00:00 	E12SEX	SEX - SPIROMETER
22	Gender	202103	phv00202103.v2.p1	pht003918.v2.p1	phs000741.v2.p1	GOLDN	741	2	2018-09-06 12:07:24+00:00	2018-09-06 12:07:24+00:00 	sex	Gender of participant
22	Gender	258679	phv00258679.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:21:53+00:00	2018-09-06 12:21:53+00:00 	Gender	Gender of participant
22	Gender	258649	phv00258649.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:10:34+00:00	2018-09-06 13:10:34+00:00 	gender	Gender of participant
22	Gender	259379	phv00259379.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-06 13:18:50+00:00	2018-09-06 13:18:50+00:00 	sex	Sex
22	Gender	121845	phv00121845.v1.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 13:25:47+00:00	2018-09-07 13:25:47+00:00 	gender	Gender
23	Race/ancestry/ethnicity	204633	phv00204633.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 15:14:48+00:00	2018-03-15 15:14:48+00:00 	RACEGRP	Race (from FTRA23) [Cohort, Exam 2]
23	Race/ancestry/ethnicity	204710	phv00204710.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 15:15:25+00:00	2018-03-15 15:15:25+00:00 	RACEGRP	Race (from FTRA23) [Cohort, Exam 1]
23	Race/ancestry/ethnicity	204962	phv00204962.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 15:15:50+00:00	2018-03-15 15:15:50+00:00 	RACEGRP	Race (from FTRA23) [Cohort, Exam 4]
23	Race/ancestry/ethnicity	214052	phv00214052.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 15:16:14+00:00	2018-03-15 15:16:14+00:00 	RACE	Race
23	Race/ancestry/ethnicity	112422	phv00112422.v2.p2	pht001559.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:55:42+00:00	2018-04-17 16:55:42+00:00 	A01RACE1	EXAM 1 RACE, TELEPHONE INTERVIEW
23	Race/ancestry/ethnicity	112440	phv00112440.v2.p2	pht001559.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:55:42+00:00	2018-04-17 16:55:42+00:00 	A01RACE2	RACE VERIFY
23	Race/ancestry/ethnicity	113715	phv00113715.v2.p2	pht001589.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:56:08+00:00	2018-04-17 16:56:08+00:00 	RACE	RACE (VERIFIED AY EXAM 2)
23	Race/ancestry/ethnicity	115113	phv00115113.v2.p2	pht001645.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 16:56:08+00:00	2018-04-17 16:56:08+00:00 	RACE	RACE (VERIFIED AT EXAM 2)
23	Race/ancestry/ethnicity	114607	phv00114607.v2.p2	pht001626.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:29:04+00:00	2018-04-19 19:29:04+00:00 	B12RACE	RACE CODE
23	Race/ancestry/ethnicity	116379	phv00116379.v2.p2	pht001697.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:29:21+00:00	2018-04-19 19:29:21+00:00 	RACE	RACE (VERIFIED AY EXAM 2)
23	Race/ancestry/ethnicity	117580	phv00117580.v2.p2	pht001744.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:30:05+00:00	2018-04-19 19:30:05+00:00 	RACE	RACE (VERIFIED AY EXAM 2)
23	Race/ancestry/ethnicity	119632	phv00119632.v2.p2	pht001804.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:30:31+00:00	2018-04-19 19:30:31+00:00 	RACE	RACE (VERIFIED AT PPTS LAST EXAM)
23	Race/ancestry/ethnicity	120740	phv00120740.v2.p2	pht001851.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-19 19:30:49+00:00	2018-04-19 19:30:49+00:00 	RACE	RACE (VERIFIED AT PPTS LAST EXAM)
23	Race/ancestry/ethnicity	219021	phv00219021.v1.p3	pht004326.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:51:24+00:00	2018-04-23 02:51:24+00:00 	race1c	RACE
23	Race/ancestry/ethnicity	176008	phv00176008.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:51:32+00:00	2018-04-23 02:51:32+00:00 	race1c	RACE / ETHNICITY
23	Race/ancestry/ethnicity	175967	phv00175967.v1.p3	pht003088.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:51:40+00:00	2018-04-23 02:51:40+00:00 	racegrp	RACE GROUP
23	Race/ancestry/ethnicity	175941	phv00175941.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:51:54+00:00	2018-04-23 02:51:54+00:00 	racefc	FAMILY COHORT: RACE AND ETHNICITY
23	Race/ancestry/ethnicity	175876	phv00175876.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:52:05+00:00	2018-04-23 02:52:05+00:00 	race	RACE
23	Race/ancestry/ethnicity	175855	phv00175855.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:52:22+00:00	2018-04-23 02:52:22+00:00 	race1c	RACE
23	Race/ancestry/ethnicity	174585	phv00174585.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:52:35+00:00	2018-04-23 02:52:35+00:00 	race1c	RACE / ETHNICITY
23	Race/ancestry/ethnicity	87074	phv00087074.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:52:46+00:00	2018-04-23 02:52:46+00:00 	racefc	RACE AND ETHNICITY
23	Race/ancestry/ethnicity	86729	phv00086729.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:52:55+00:00	2018-04-23 02:52:55+00:00 	race1c	RACE / ETHNICITY
23	Race/ancestry/ethnicity	86261	phv00086261.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:53:06+00:00	2018-04-23 02:53:06+00:00 	race1c	RACE / ETHNICITY
23	Race/ancestry/ethnicity	85775	phv00085775.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:53:14+00:00	2018-04-23 02:53:14+00:00 	race1c	RACE / ETHNICITY
23	Race/ancestry/ethnicity	84444	phv00084444.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:53:22+00:00	2018-04-23 02:53:22+00:00 	race1c	RACE / ETHNICITY
23	Race/ancestry/ethnicity	82641	phv00082641.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:53:29+00:00	2018-04-23 02:53:29+00:00 	race1c	RACE
23	Race/ancestry/ethnicity	87659	phv00087659.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:54:29+00:00	2018-04-23 02:54:29+00:00 	scrhispf	SPANISH/HISPANIC/LATINO
23	Race/ancestry/ethnicity	86734	phv00086734.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:54:35+00:00	2018-04-23 02:54:35+00:00 	othhisp1	OTHER HISPANIC
23	Race/ancestry/ethnicity	86266	phv00086266.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:54:46+00:00	2018-04-23 02:54:46+00:00 	othhisp1	OTHER HISPANIC
23	Race/ancestry/ethnicity	85780	phv00085780.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:54:53+00:00	2018-04-23 02:54:53+00:00 	othhisp1	OTHER HISPANIC
23	Race/ancestry/ethnicity	85776	phv00085776.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:55:56+00:00	2018-04-23 02:55:56+00:00 	mexican1	MEXICAN, CHICANO, MEXICAN-AMERICAN
23	Race/ancestry/ethnicity	86262	phv00086262.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:56:08+00:00	2018-04-23 02:56:08+00:00 	mexican1	MEXICAN, CHICANO, MEXICAN-AMERICAN
23	Race/ancestry/ethnicity	86730	phv00086730.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:56:16+00:00	2018-04-23 02:56:16+00:00 	mexican1	MEXICAN, CHICANO, MEXICAN-AMERICAN
23	Race/ancestry/ethnicity	85777	phv00085777.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:57:04+00:00	2018-04-23 02:57:04+00:00 	dominic1	DOMINICAN
23	Race/ancestry/ethnicity	86263	phv00086263.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:57:10+00:00	2018-04-23 02:57:10+00:00 	dominic1	DOMINICAN
23	Race/ancestry/ethnicity	86731	phv00086731.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:57:18+00:00	2018-04-23 02:57:18+00:00 	dominic1	DOMINICAN
23	Race/ancestry/ethnicity	85778	phv00085778.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:57:48+00:00	2018-04-23 02:57:48+00:00 	puert1	PUERTO RICAN
23	Race/ancestry/ethnicity	86264	phv00086264.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:57:53+00:00	2018-04-23 02:57:53+00:00 	puert1	PUERTO RICAN
23	Race/ancestry/ethnicity	86732	phv00086732.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:58:00+00:00	2018-04-23 02:58:00+00:00 	puert1	PUERTO RICAN
23	Race/ancestry/ethnicity	85779	phv00085779.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:58:30+00:00	2018-04-23 02:58:30+00:00 	cuban1	CUBAN
23	Race/ancestry/ethnicity	86265	phv00086265.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:58:38+00:00	2018-04-23 02:58:38+00:00 	cuban1	CUBAN
23	Race/ancestry/ethnicity	86733	phv00086733.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 02:58:44+00:00	2018-04-23 02:58:44+00:00 	cuban1	CUBAN
23	Race/ancestry/ethnicity	99569	phv00099569.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:12:02+00:00	2018-05-03 18:12:02+00:00 	RACE01	RACE
23	Race/ancestry/ethnicity	100488	phv00100488.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:12:15+00:00	2018-05-03 18:12:15+00:00 	RACE01	RACE
23	Race/ancestry/ethnicity	100837	phv00100837.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:12:25+00:00	2018-05-03 18:12:25+00:00 	RACE01	RACE
23	Race/ancestry/ethnicity	105645	phv00105645.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:12:38+00:00	2018-05-03 18:12:38+00:00 	RACE01	RACE
23	Race/ancestry/ethnicity	99434	phv00099434.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:13:32+00:00	2018-05-03 18:13:32+00:00 	HISP01	HISPANIC ORIGIN
23	Race/ancestry/ethnicity	105652	phv00105652.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:13:45+00:00	2018-05-03 18:13:45+00:00 	HISP01	HISPANIC ORIGIN
23	Race/ancestry/ethnicity	98800	phv00098800.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:14:07+00:00	2018-05-03 18:14:07+00:00 	ROTHER01	SPECIFY OTHER RACE
23	Race/ancestry/ethnicity	105117	phv00105117.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-05-03 18:14:20+00:00	2018-05-03 18:14:20+00:00 	ROTHER01	SPECIFY OTHER RACE
23	Race/ancestry/ethnicity	72539	phv00072539.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:07:05+00:00	2018-05-11 18:07:05+00:00 	H701	WHICH OF THE FOLLOWING BEST DESCRIBES YOU - ETHNICITY NOT HISPANIC OR LATINO
23	Race/ancestry/ethnicity	55250	phv00055250.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:07:48+00:00	2018-05-11 18:07:48+00:00 	race	Race
23	Race/ancestry/ethnicity	177598	phv00177598.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:09:19+00:00	2018-05-11 18:09:19+00:00 	g3b0625	Sociodemographic questions-Self administered: Which of the following best describes your race (check ALL that apply): Caucasian or White
23	Race/ancestry/ethnicity	177599	phv00177599.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:09:35+00:00	2018-05-11 18:09:35+00:00 	g3b0626	Sociodemographic questions-Self administered: Which of the following best describes your race (check ALL that apply): African-American or Black
23	Race/ancestry/ethnicity	177600	phv00177600.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:09:52+00:00	2018-05-11 18:09:52+00:00 	g3b0627	Sociodemographic questions-Self administered: Which of the following best describes your race (check ALL that apply): Asian
23	Race/ancestry/ethnicity	177601	phv00177601.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:10:17+00:00	2018-05-11 18:10:17+00:00 	g3b0628	Sociodemographic questions-Self administered: Which of the following best describes your race (check ALL that apply): Native Hawaiian or other Pacific Islander
23	Race/ancestry/ethnicity	177602	phv00177602.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:10:36+00:00	2018-05-11 18:10:36+00:00 	g3b0629	Sociodemographic questions-Self administered: Which of the following best describes your race (check ALL that apply): American Indian or Alaska native
23	Race/ancestry/ethnicity	72530	phv00072530.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:10:56+00:00	2018-05-11 18:10:56+00:00 	H702	WHICH OF THE FOLLOWING BEST DESCRIBES YOU - RACE CAUCASIAN OR WHITE
23	Race/ancestry/ethnicity	251748	phv00251748.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:11:20+00:00	2018-05-11 18:11:20+00:00 	h702	Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your race (check ALL that apply): Caucasian or white Collection Interval: Exam 3
23	Race/ancestry/ethnicity	72531	phv00072531.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:11:46+00:00	2018-05-11 18:11:46+00:00 	H703	WHICH OF THE FOLLOWING BEST DESCRIBES YOU - RACE AFRICAN AMERICAN OR BLACK
23	Race/ancestry/ethnicity	251749	phv00251749.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:12:01+00:00	2018-05-11 18:12:01+00:00 	h703	Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your race (check ALL that apply): African-American or black Collection Interval: Exam 3
23	Race/ancestry/ethnicity	72532	phv00072532.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:12:52+00:00	2018-05-11 18:12:52+00:00 	H704	WHICH OF THE FOLLOWING BEST DESCRIBES YOU - RACE ASIAN
23	Race/ancestry/ethnicity	251750	phv00251750.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:13:06+00:00	2018-05-11 18:13:06+00:00 	h704	Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your race (check ALL that apply): Asian Collection Interval: Exam 3
23	Race/ancestry/ethnicity	72533	phv00072533.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:13:26+00:00	2018-05-11 18:13:26+00:00 	H705	WHICH OF THE FOLLOWING BEST DESCRIBES YOU - RACE NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER
23	Race/ancestry/ethnicity	251751	phv00251751.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:13:44+00:00	2018-05-11 18:13:44+00:00 	h705	Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your race (check ALL that apply): Native Hawaiian or other Pacific Islander Collection Interval: Exam 3
23	Race/ancestry/ethnicity	72534	phv00072534.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:14:08+00:00	2018-05-11 18:14:08+00:00 	H706	WHICH OF THE FOLLOWING BEST DESCRIBES YOU - RACE AMERICAN INDIAN OR ALASKA NATIVE
23	Race/ancestry/ethnicity	72538	phv00072538.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:15:45+00:00	2018-05-11 18:15:45+00:00 	H700	WHICH OF THE FOLLOWING BEST DESCRIBES YOU - ETHNICITY HISPANIC OR LATINO
23	Race/ancestry/ethnicity	177597	phv00177597.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:16:39+00:00	2018-05-11 18:16:39+00:00 	g3b0624	Sociodemographic questions-Self administered: Which of the following best describes your ethnicity (check ONE)?
23	Race/ancestry/ethnicity	251746	phv00251746.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:19:48+00:00	2018-05-11 18:19:48+00:00 	h700	Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your ethnicity (check which applies): Hispanic or Latino Collection Interval: Exam 3
23	Race/ancestry/ethnicity	251747	phv00251747.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:20:11+00:00	2018-05-11 18:20:11+00:00 	h701	Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your ethnicity (check which applies): Not Hispanic or Latino Collection Interval: Exam 3
23	Race/ancestry/ethnicity	21244	phv00021244.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:26:44+00:00	2018-05-11 18:26:44+00:00 	G3A483	WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): CAUCASIAN OR WHITE
23	Race/ancestry/ethnicity	21245	phv00021245.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:27:23+00:00	2018-05-11 18:27:23+00:00 	G3A484	WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): SPANISH/HISPANIC/LATINO
23	Race/ancestry/ethnicity	21246	phv00021246.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:27:42+00:00	2018-05-11 18:27:42+00:00 	G3A485	WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): AFRICAN-AMERICAN OR BLACK
23	Race/ancestry/ethnicity	21247	phv00021247.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:28:13+00:00	2018-05-11 18:28:13+00:00 	G3A486	WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): ASIAN
23	Race/ancestry/ethnicity	21248	phv00021248.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:28:34+00:00	2018-05-11 18:28:34+00:00 	G3A487	WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER
23	Race/ancestry/ethnicity	21249	phv00021249.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:29:06+00:00	2018-05-11 18:29:06+00:00 	G3A488	WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): AMERICAN INDIAN OR ALASKA NATIVE
23	Race/ancestry/ethnicity	21250	phv00021250.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:29:33+00:00	2018-05-11 18:29:33+00:00 	G3A489	WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): OTHER
23	Race/ancestry/ethnicity	274066	phv00274066.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:33:11+00:00	2018-05-11 18:33:11+00:00 	g3a483	Which of the following best describe you? (check all that apply): Caucasian or white Collection Interval: Exam 1
23	Race/ancestry/ethnicity	274067	phv00274067.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:33:30+00:00	2018-05-11 18:33:30+00:00 	g3a484	Which of the following best describe you? (check all that apply): Spanish/Hispanic/Latino Collection Interval: Exam 1
23	Race/ancestry/ethnicity	274068	phv00274068.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:33:44+00:00	2018-05-11 18:33:44+00:00 	g3a485	Which of the following best describe you? (check all that apply): African-american or black Collection Interval: Exam 1
23	Race/ancestry/ethnicity	274069	phv00274069.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:34:17+00:00	2018-05-11 18:34:17+00:00 	g3a486	Which of the following best describe you? (check all that apply): Asian Collection Interval: Exam 1
23	Race/ancestry/ethnicity	274070	phv00274070.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:34:35+00:00	2018-05-11 18:34:35+00:00 	g3a487	Which of the following best describe you? (check all that apply): Native Hawaiian or other Pacific Islander Collection Interval: Exam 1
23	Race/ancestry/ethnicity	274071	phv00274071.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:35:02+00:00	2018-05-11 18:35:02+00:00 	g3a488	Which of the following best describe you? (check all that apply): American Indian or Alaska native Collection Interval: Exam 1
23	Race/ancestry/ethnicity	274072	phv00274072.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:35:30+00:00	2018-05-11 18:35:30+00:00 	g3a489	Which of the following best describe you? (check all that apply): Other Collection Interval: Exam 1
23	Race/ancestry/ethnicity	274557	phv00274557.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:37:05+00:00	2018-05-11 18:37:05+00:00 	g3a483	Which of the following best describe you? (check all that apply): Caucasian or white
23	Race/ancestry/ethnicity	274558	phv00274558.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:37:20+00:00	2018-05-11 18:37:20+00:00 	g3a484	Which of the following best describe you? (check all that apply): Spanish/Hispanic/Latino
23	Race/ancestry/ethnicity	274559	phv00274559.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:37:34+00:00	2018-05-11 18:37:34+00:00 	g3a485	Which of the following best describe you? (check all that apply): African-american or black
23	Race/ancestry/ethnicity	274560	phv00274560.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:37:47+00:00	2018-05-11 18:37:47+00:00 	g3a486	Which of the following best describe you? (check all that apply): Asian
23	Race/ancestry/ethnicity	274561	phv00274561.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:38:04+00:00	2018-05-11 18:38:04+00:00 	g3a487	Which of the following best describe you? (check all that apply): Native Hawaiian or other Pacific Islander
23	Race/ancestry/ethnicity	274562	phv00274562.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:38:19+00:00	2018-05-11 18:38:19+00:00 	g3a488	Which of the following best describe you? (check all that apply): American Indian or Alaska native
23	Race/ancestry/ethnicity	274563	phv00274563.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:38:39+00:00	2018-05-11 18:38:39+00:00 	g3a489	Which of the following best describe you? (check all that apply): Other
23	Race/ancestry/ethnicity	251752	phv00251752.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-11 18:51:50+00:00	2018-05-11 18:51:50+00:00 	h706	Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your race (check ALL that apply): American Indian or Alaska native Collection Interval: Exam 3
23	Race/ancestry/ethnicity	79316	phv00079316.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	SPANISH	Are you Spanish/Hispanic/Latino
23	Race/ancestry/ethnicity	79317	phv00079317.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	WHITE	White
23	Race/ancestry/ethnicity	79318	phv00079318.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	BLACK	Black, African-American, or Negro
23	Race/ancestry/ethnicity	79319	phv00079319.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	AMERINDIAN	American Indian or Alaskan Native
23	Race/ancestry/ethnicity	79320	phv00079320.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	ASIAINDIAN	Asian Indian
23	Race/ancestry/ethnicity	79321	phv00079321.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	CHINESE	Chinese
23	Race/ancestry/ethnicity	79322	phv00079322.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	FILIPINO	Filipino
23	Race/ancestry/ethnicity	79323	phv00079323.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	JAPANESE	Japanese
23	Race/ancestry/ethnicity	79324	phv00079324.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	KOREAN	Korean
23	Race/ancestry/ethnicity	79325	phv00079325.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	VIETNAMESE	Vietnamese
23	Race/ancestry/ethnicity	79326	phv00079326.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	OTHERASIAN	Other Asian
23	Race/ancestry/ethnicity	79327	phv00079327.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	HAWAIIAN	Native Hawaiian
23	Race/ancestry/ethnicity	79328	phv00079328.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	GUAMANIAN	Guamanian or Chamorro
23	Race/ancestry/ethnicity	79329	phv00079329.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	SAMOAN	Samoan
23	Race/ancestry/ethnicity	79330	phv00079330.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	OTHRPACISL	Other Pacific Islander
23	Race/ancestry/ethnicity	79331	phv00079331.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:01:58+00:00	2018-05-15 17:01:58+00:00 	OTHERRACE	Some other race
23	Race/ancestry/ethnicity	78450	phv00078450.v6.p3	pht000998.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-05-15 17:03:49+00:00	2018-05-15 17:03:49+00:00 	RACE	Racial or ethnic group
23	Race/ancestry/ethnicity	159572	phv00159572.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:53:37+00:00	2018-08-10 21:53:37+00:00 	race	Race Collection Interval: Collected in Exam 1
23	Race/ancestry/ethnicity	159573	phv00159573.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:53:47+00:00	2018-08-10 21:53:47+00:00 	ethnic	Your ethnic background Collection Interval: Collected in Exam 1
23	Race/ancestry/ethnicity	277509	phv00277509.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:40:28+00:00	2018-08-14 22:40:28+00:00 	RACE	Self-reported race/ethnicity Collection Interval: 1996-2000
23	Race/ancestry/ethnicity	307790	phv00307790.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:54:41+00:00	2018-08-15 23:54:41+00:00 	RACE	Self-reported race/ethnicity Collection Interval: 1996-2000
23	Race/ancestry/ethnicity	122968	phv00122968.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:06:38+00:00	2018-08-17 00:06:38+00:00 	AMINDIAN	Race - Native American (0=no,1=yes)
23	Race/ancestry/ethnicity	122969	phv00122969.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:06:43+00:00	2018-08-17 00:06:43+00:00 	ASIAN	Race - Asian (0=no,1=yes)
23	Race/ancestry/ethnicity	122970	phv00122970.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:06:49+00:00	2018-08-17 00:06:49+00:00 	BLACK	Race - Black (0=no,1=yes)
23	Race/ancestry/ethnicity	122971	phv00122971.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:06:54+00:00	2018-08-17 00:06:54+00:00 	HAWAIIP	Race - Hawaiian or Pacific Islander (0=no,1=yes)
23	Race/ancestry/ethnicity	122972	phv00122972.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:07:00+00:00	2018-08-17 00:07:00+00:00 	WHITE	Race - Caucasian (0=no,1=yes)
23	Race/ancestry/ethnicity	122991	phv00122991.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:51:18+00:00	2018-08-17 19:51:18+00:00 	race	Subject's Race
23	Race/ancestry/ethnicity	122992	phv00122992.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:51:31+00:00	2018-08-17 19:51:31+00:00 	ethnicity	Subject's Ethnicity
23	Race/ancestry/ethnicity	122993	phv00122993.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:51:41+00:00	2018-08-17 19:51:41+00:00 	othrace	Subject's Race description
23	Race/ancestry/ethnicity	226254	phv00226254.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:10:11+00:00	2018-08-22 21:10:11+00:00 	BKGRD1_C7	7-level re-classification of Hispanic/Latino background
23	Race/ancestry/ethnicity	116486	phv00116486.v2.p2	pht001706.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 21:33:48+00:00	2018-08-23 21:33:48+00:00 	DDXPTETH	PATIENT DATA: ETHNIC
23	Race/ancestry/ethnicity	253242	phv00253242.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:54:34+00:00	2018-08-24 16:54:34+00:00 	REGION	"6-Groups for Hispanic/Latino background, plus 1 ""unknown"" group for missing or other"
23	Race/ancestry/ethnicity	258651	phv00258651.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:11:27+00:00	2018-09-06 13:11:27+00:00 	race	Race of participant
23	Race/ancestry/ethnicity	259380	phv00259380.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-06 13:19:08+00:00	2018-09-06 13:19:08+00:00 	race	Race
23	Race/ancestry/ethnicity	259381	phv00259381.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-06 13:19:17+00:00	2018-09-06 13:19:17+00:00 	ethnicity	Ethnicity
23	Race/ancestry/ethnicity	121875	phv00121875.v2.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 15:57:35+00:00	2018-09-07 15:57:35+00:00 	Hispanic	Hispanic or Latino
23	Race/ancestry/ethnicity	121876	phv00121876.v2.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 15:58:35+00:00	2018-09-07 15:58:35+00:00 	race_afram	Race - black or african american
23	Race/ancestry/ethnicity	121877	phv00121877.v2.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 15:59:14+00:00	2018-09-07 15:59:14+00:00 	race_amind	Race - american indian/alaska native
23	Race/ancestry/ethnicity	121878	phv00121878.v2.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 15:59:27+00:00	2018-09-07 15:59:27+00:00 	race_asian	Race - asian
23	Race/ancestry/ethnicity	121879	phv00121879.v2.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 15:59:37+00:00	2018-09-07 15:59:37+00:00 	race_other	Race - other
23	Race/ancestry/ethnicity	121880	phv00121880.v2.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 15:59:55+00:00	2018-09-07 15:59:55+00:00 	race_pacisl	Race - native hawaiian or other pacific islander
23	Race/ancestry/ethnicity	121881	phv00121881.v2.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 16:00:04+00:00	2018-09-07 16:00:04+00:00 	race_white	Race - white
24	CAC	82657	phv00082657.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:28:26+00:00	2018-04-23 03:28:26+00:00 	agatum1c	MEAN: AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	82660	phv00082660.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:28:47+00:00	2018-04-23 03:28:47+00:00 	agatpm1c	MEAN: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED
24	CAC	82661	phv00082661.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:28:55+00:00	2018-04-23 03:28:55+00:00 	agatpm1t	NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E1
24	CAC	82856	phv00082856.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:29:01+00:00	2018-04-23 03:29:01+00:00 	agatu11c	SCAN 1: AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	82857	phv00082857.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:29:06+00:00	2018-04-23 03:29:06+00:00 	agatu21c	SCAN 2: AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	82862	phv00082862.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:29:12+00:00	2018-04-23 03:29:12+00:00 	agatp11c	SCAN 1: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED
24	CAC	82863	phv00082863.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:29:19+00:00	2018-04-23 03:29:19+00:00 	agatp21c	SCAN 2: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED
24	CAC	84517	phv00084517.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:29:24+00:00	2018-04-23 03:29:24+00:00 	agatum1c	MEAN: AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	84521	phv00084521.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:29:30+00:00	2018-04-23 03:29:30+00:00 	agatpm1c	MEAN: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED
24	CAC	84522	phv00084522.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:29:35+00:00	2018-04-23 03:29:35+00:00 	agatpm1t	NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E1
24	CAC	84526	phv00084526.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:29:40+00:00	2018-04-23 03:29:40+00:00 	agatu11c	SCAN 1: AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	84530	phv00084530.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:29:45+00:00	2018-04-23 03:29:45+00:00 	agatp11c	SCAN 1: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED
24	CAC	84534	phv00084534.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:29:51+00:00	2018-04-23 03:29:51+00:00 	agatu21c	SCAN 2: AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	84538	phv00084538.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:29:57+00:00	2018-04-23 03:29:57+00:00 	agatp21c	SCAN 2: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED
24	CAC	85810	phv00085810.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:30:02+00:00	2018-04-23 03:30:02+00:00 	AGATUM2C	MEAN TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	85813	phv00085813.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:30:08+00:00	2018-04-23 03:30:08+00:00 	AGATPM2C	MEAN TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED
24	CAC	85814	phv00085814.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:30:15+00:00	2018-04-23 03:30:15+00:00 	agatpm2t	NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E2
24	CAC	85819	phv00085819.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:30:20+00:00	2018-04-23 03:30:20+00:00 	AGATU12C	SCAN 1:  TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	85820	phv00085820.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:30:25+00:00	2018-04-23 03:30:25+00:00 	AGATU22C	SCAN 2:  TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	85825	phv00085825.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:30:31+00:00	2018-04-23 03:30:31+00:00 	AGATP12C	SCAN 1:  TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED
24	CAC	85826	phv00085826.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:30:35+00:00	2018-04-23 03:30:35+00:00 	AGATP22C	SCAN 2:  TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED
24	CAC	86310	phv00086310.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:30:41+00:00	2018-04-23 03:30:41+00:00 	AGATUM3C	MEAN TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	86313	phv00086313.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:30:46+00:00	2018-04-23 03:30:46+00:00 	AGATPM3C	MEAN TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED
24	CAC	86314	phv00086314.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:30:51+00:00	2018-04-23 03:30:51+00:00 	agatpm3t	NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E3
24	CAC	86318	phv00086318.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:30:56+00:00	2018-04-23 03:30:56+00:00 	AGATU13C	SCAN 1:  TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	86319	phv00086319.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:31:58+00:00	2018-04-23 03:31:58+00:00 	AGATU23C	SCAN 2:  TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	86324	phv00086324.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:32:03+00:00	2018-04-23 03:32:03+00:00 	AGATP13C	SCAN 1:  TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED
24	CAC	86325	phv00086325.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:32:08+00:00	2018-04-23 03:32:08+00:00 	AGATP23C	SCAN 2:  TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED
24	CAC	86769	phv00086769.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:32:16+00:00	2018-04-23 03:32:16+00:00 	agatpm4t	NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E4
24	CAC	86773	phv00086773.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:32:22+00:00	2018-04-23 03:32:22+00:00 	AGATU14C	SCAN 1:  TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	86774	phv00086774.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:32:27+00:00	2018-04-23 03:32:27+00:00 	AGATU24C	SCAN 2:  TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	86779	phv00086779.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:32:32+00:00	2018-04-23 03:32:32+00:00 	AGATP14C	SCAN 1:  TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED
24	CAC	86780	phv00086780.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:32:38+00:00	2018-04-23 03:32:38+00:00 	AGATP24C	SCAN 2:  TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED
24	CAC	87105	phv00087105.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:32:43+00:00	2018-04-23 03:32:43+00:00 	agatpmfc	MEAN: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED
24	CAC	87106	phv00087106.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:32:49+00:00	2018-04-23 03:32:49+00:00 	lnagatfc	NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY)
24	CAC	87531	phv00087531.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:32:55+00:00	2018-04-23 03:32:55+00:00 	agatumfc	MEAN: AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	87536	phv00087536.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:33:01+00:00	2018-04-23 03:33:01+00:00 	agatu1fc	SCAN 1: AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	87537	phv00087537.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:33:06+00:00	2018-04-23 03:33:06+00:00 	agatu2fc	SCAN 2: AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	87544	phv00087544.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:33:14+00:00	2018-04-23 03:33:14+00:00 	agatp1fc	SCAN 1: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED
24	CAC	87545	phv00087545.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:33:20+00:00	2018-04-23 03:33:20+00:00 	agatp2fc	SCAN 2: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED
24	CAC	174608	phv00174608.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:36:47+00:00	2018-04-23 03:36:47+00:00 	agatpm5t	NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E5
24	CAC	174752	phv00174752.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:36:52+00:00	2018-04-23 03:36:52+00:00 	pagatm5	TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED
24	CAC	174753	phv00174753.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:36:57+00:00	2018-04-23 03:36:57+00:00 	uagatm5	TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	176031	phv00176031.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:37:02+00:00	2018-04-23 03:37:02+00:00 	agatpm5t	NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E5
24	CAC	176175	phv00176175.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:37:08+00:00	2018-04-23 03:37:08+00:00 	pagatm5	TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED
24	CAC	176176	phv00176176.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:37:13+00:00	2018-04-23 03:37:13+00:00 	uagatm5	TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED
24	CAC	126002	phv00126002.v1.p1	pht001948.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:00:01+00:00	2018-06-12 01:00:01+00:00 	CSTA24	24. Agatston score all coronary (does not include others)
24	CAC	23216	phv00023216.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:20:06+00:00	2018-06-14 17:20:06+00:00 	EBCT08	CORONARY ARTERY CALCIUM SCORE - WEIGHT EQ.:  LEFT MAIN
24	CAC	23217	phv00023217.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:20:36+00:00	2018-06-14 17:20:36+00:00 	EBCT09	CORONARY ARTERY CALCIUM SCORE - WEIGHT EQ.:  LEFT ANTERIOR DESCENDING
24	CAC	23218	phv00023218.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:20:52+00:00	2018-06-14 17:20:52+00:00 	EBCT10	CORONARY ARTERY CALCIUM SCORE - WEIGHT EQ.:  LEFT CIRCUMFLEX
24	CAC	23219	phv00023219.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:21:03+00:00	2018-06-14 17:21:03+00:00 	EBCT11	CORONARY ARTERY CALCIUM SCORE - WEIGHT EQ.:  RIGHT CORONARY
24	CAC	23220	phv00023220.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:21:13+00:00	2018-06-14 17:21:13+00:00 	EBCT12	CORONARY ARTERY CALCIUM SCORE - WEIGHT EQ.:  TOTAL
24	CAC	23221	phv00023221.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:21:24+00:00	2018-06-14 17:21:24+00:00 	EBCT13	CORONARY ARTERY CALCIUM SCORE - VOLUME(MM3):  LEFT MAIN
24	CAC	23222	phv00023222.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:21:35+00:00	2018-06-14 17:21:35+00:00 	EBCT14	CORONARY ARTERY CALCIUM SCORE - VOLUME(MM3):  LEFT ANTERIOR DESCENDING
24	CAC	23223	phv00023223.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:21:45+00:00	2018-06-14 17:21:45+00:00 	EBCT15	CORONARY ARTERY CALCIUM SCORE - VOLUME(MM3):  LEFT CIRCUMFLEX
24	CAC	23224	phv00023224.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:21:57+00:00	2018-06-14 17:21:57+00:00 	EBCT16	CORONARY ARTERY CALCIUM SCORE - VOLUME(MM3):  RIGHT CORONARY
24	CAC	23225	phv00023225.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:22:07+00:00	2018-06-14 17:22:07+00:00 	EBCT17	CORONARY ARTERY CALCIUM SCORE - VOLUME(MM3):  TOTAL
24	CAC	23226	phv00023226.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:22:16+00:00	2018-06-14 17:22:16+00:00 	EBCT18	CORONARY ARTERY CALCIUM SCORE - VOLUME/W.E.:  LEFT MAIN
24	CAC	23227	phv00023227.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:22:26+00:00	2018-06-14 17:22:26+00:00 	EBCT19	CORONARY ARTERY CALCIUM SCORE - VOLUME/W.E.:  LEFT ANTERIOR DESCENDING
24	CAC	23228	phv00023228.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:22:37+00:00	2018-06-14 17:22:37+00:00 	EBCT20	CORONARY ARTERY CALCIUM SCORE - VOLUME/W.E.:  LEFT CIRCUMFLEX
24	CAC	23229	phv00023229.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:22:46+00:00	2018-06-14 17:22:46+00:00 	EBCT21	CORONARY ARTERY CALCIUM SCORE - VOLUME/W.E.:  RIGHT CORONARY
24	CAC	23230	phv00023230.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:22:57+00:00	2018-06-14 17:22:57+00:00 	EBCT22	CORONARY ARTERY CALCIUM SCORE - VOLUME/W.E.:  TOTAL
24	CAC	23231	phv00023231.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:23:07+00:00	2018-06-14 17:23:07+00:00 	EBCT23	CORONARY ARTERY CALCIUM SCORE - SCORE:  LEFT MAIN
24	CAC	23232	phv00023232.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:23:17+00:00	2018-06-14 17:23:17+00:00 	EBCT24	CORONARY ARTERY CALCIUM SCORE - SCORE:  LEFT ANTERIOR DESCENDING
24	CAC	23233	phv00023233.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:23:28+00:00	2018-06-14 17:23:28+00:00 	EBCT25	CORONARY ARTERY CALCIUM SCORE - SCORE:  LEFT CIRCUMFLEX
24	CAC	23234	phv00023234.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:23:38+00:00	2018-06-14 17:23:38+00:00 	EBCT26	CORONARY ARTERY CALCIUM SCORE - SCORE:  RIGHT CORONARY
24	CAC	23235	phv00023235.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:23:49+00:00	2018-06-14 17:23:49+00:00 	EBCT27	CORONARY ARTERY CALCIUM SCORE - SCORE:  TOTAL
24	CAC	23194	phv00023194.v3.p10	pht000144.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:28:32+00:00	2018-06-14 17:28:32+00:00 	CA1	CORONARY ARTERY SCAN 1 CALCIUM SCORE (AGATSTON)
24	CAC	23195	phv00023195.v3.p10	pht000144.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:28:41+00:00	2018-06-14 17:28:41+00:00 	CA2	CORONARY ARTERY SCAN 2 CALCIUM SCORE (AGATSTON)
24	CAC	23200	phv00023200.v3.p10	pht000145.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:28:52+00:00	2018-06-14 17:28:52+00:00 	CA1	CORONARY ARTERY SCAN 1 CALCIUM SCORE (AGATSTON)
24	CAC	23201	phv00023201.v3.p10	pht000145.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:29:05+00:00	2018-06-14 17:29:05+00:00 	CA2	CORONARY ARTERY SCAN 2 CALCIUM SCORE (AGATSTON)
24	CAC	257670	phv00257670.v1.p10	pht005161.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:34:09+00:00	2018-06-14 17:34:09+00:00 	CAC_S	Coronary artery calcium score (Agatston)
24	CAC	257671	phv00257671.v1.p10	pht005161.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:34:54+00:00	2018-06-14 17:34:54+00:00 	CAC_V	Coronary artery calcium volume
24	CAC	100691	phv00100691.v1.p1	pht001459.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:50:23+00:00	2018-06-27 23:50:23+00:00 	CACSCORE	Coronary Artery Calcification by electron beam CYT scan
24	CAC	118019	phv00118019.v2.p2	pht001754.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-08 23:01:59+00:00	2018-08-08 23:01:59+00:00 	ER2TSCOR	Total: Agatston Score
24	CAC	277347	phv00277347.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:16:10+00:00	2018-08-14 22:16:10+00:00 	MD1CAC_S	CAC SCORE IN WHOLE HEART Collection Interval: 2009-2011
24	CAC	307984	phv00307984.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:09:48+00:00	2018-08-16 00:09:48+00:00 	R3WHS24	CAC Score in whole heart; Results of CT scan run 2 of 2 Collection Interval: 2000-2004
24	CAC	307983	phv00307983.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:09:55+00:00	2018-08-16 00:09:55+00:00 	R3WHS14	CAC Score in whole heart; Results of CT scan run 1 of 2 Collection Interval: 2000-2004
24	CAC	252986	phv00252986.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:13:06+00:00	2018-08-24 17:13:06+00:00 	cac_agatston_score	Coronary artery calcification score
24	CAC	118018	phv00118018.v2.p2	pht001754.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-27 23:23:12+00:00	2018-08-27 23:23:12+00:00 	ER2TSCR9	9 PIX TOTAL SCORE
24	CAC	118017	phv00118017.v2.p2	pht001754.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-27 23:23:19+00:00	2018-08-27 23:23:19+00:00 	ER2TSCR8	8 PIX TOTAL SCORE
24	CAC	118016	phv00118016.v2.p2	pht001754.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-27 23:23:26+00:00	2018-08-27 23:23:26+00:00 	ER2TSCR7	7 PIX TOTAL SCORE
24	CAC	118015	phv00118015.v2.p2	pht001754.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-27 23:23:32+00:00	2018-08-27 23:23:32+00:00 	ER2TSCR6	6 PIX TOTAL SCORE
24	CAC	118014	phv00118014.v2.p2	pht001754.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-27 23:23:39+00:00	2018-08-27 23:23:39+00:00 	ER2TSCR5	5 PIX TOTAL SCORE
24	CAC	118013	phv00118013.v2.p2	pht001754.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-27 23:23:46+00:00	2018-08-27 23:23:46+00:00 	ER2TSCR4	4 PIX TOTAL SCORE
24	CAC	118012	phv00118012.v2.p2	pht001754.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-27 23:23:53+00:00	2018-08-27 23:23:53+00:00 	ER2TSCR3	3 PIX TOTAL SCORE
24	CAC	118011	phv00118011.v2.p2	pht001754.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-27 23:24:00+00:00	2018-08-27 23:24:00+00:00 	ER2TSCR2	2 PIX TOTAL SCORE
24	CAC	120787	phv00120787.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:39:16+00:00	2018-08-29 23:39:16+00:00 	FR3SCR41	SCAN 1 ARTERY 4 UNADJUSTED AGATSTON SCORE
24	CAC	120786	phv00120786.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:39:22+00:00	2018-08-29 23:39:22+00:00 	FR3SCR31	SCAN 1 ARTERY 3 UNADJUSTED AGATSTON SCORE
24	CAC	120785	phv00120785.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:39:28+00:00	2018-08-29 23:39:28+00:00 	FR3SCR21	SCAN 1 ARTERY 2 UNADJUSTED AGATSTON SCORE
24	CAC	120784	phv00120784.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:39:35+00:00	2018-08-29 23:39:35+00:00 	FR3SCR11	SCAN 1 ARTERY 1 UNADJUSTED AGATSTON SCORE
24	CAC	120783	phv00120783.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:39:42+00:00	2018-08-29 23:39:42+00:00 	FR3VOL41	SCAN 1 ARTERY 4 UNADJUSTED VOLUME
24	CAC	120782	phv00120782.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:39:49+00:00	2018-08-29 23:39:49+00:00 	FR3VOL31	SCAN 1 ARTERY 3 UNADJUSTED VOLUME
24	CAC	120781	phv00120781.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:39:57+00:00	2018-08-29 23:39:57+00:00 	FR3VOL21	SCAN 1 ARTERY 2 UNADJUSTED VOLUME
24	CAC	120780	phv00120780.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:40:12+00:00	2018-08-29 23:40:12+00:00 	FR3VOL11	SCAN 1 ARTERY 1 UNADJUSTED VOLUME
24	CAC	120795	phv00120795.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:40:46+00:00	2018-08-29 23:40:46+00:00 	FR3ARM41	SCAN 1 ARTERY 4 CALCIUM MASS
24	CAC	120794	phv00120794.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:40:52+00:00	2018-08-29 23:40:52+00:00 	FR3ARM31	SCAN 1 ARTERY 3 CALCIUM MASS
24	CAC	120793	phv00120793.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:40:58+00:00	2018-08-29 23:40:58+00:00 	FR3ARM21	SCAN 1 ARTERY 2 CALCIUM MASS
24	CAC	120792	phv00120792.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:41:04+00:00	2018-08-29 23:41:04+00:00 	FR3ARM11	SCAN 1 ARTERY 1 CALCIUM MASS
24	CAC	120791	phv00120791.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:41:11+00:00	2018-08-29 23:41:11+00:00 	FR3ISV41	SCAN 1 ARTERY 4 UNADJUSTED ISOVOL
24	CAC	120790	phv00120790.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:41:18+00:00	2018-08-29 23:41:18+00:00 	FR3ISV31	SCAN 1 ARTERY 3 UNADJUSTED ISOVOL
24	CAC	120789	phv00120789.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:41:26+00:00	2018-08-29 23:41:26+00:00 	FR3ISV21	SCAN 1 ARTERY 2 UNADJUSTED ISOVOL
24	CAC	120788	phv00120788.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:41:34+00:00	2018-08-29 23:41:34+00:00 	FR3ISV11	SCAN 1 ARTERY 1 UNADJUSTED ISOVOL
24	CAC	120815	phv00120815.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:42:41+00:00	2018-08-29 23:42:41+00:00 	FR3PHS41	SCAN 1 ARTERY 4 ADJUSTED AGATSTON SCORE
24	CAC	120814	phv00120814.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:42:47+00:00	2018-08-29 23:42:47+00:00 	FR3PHS31	SCAN 1 ARTERY 3 ADJUSTED AGATSTON SCORE
24	CAC	120813	phv00120813.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:42:53+00:00	2018-08-29 23:42:53+00:00 	FR3PHS21	SCAN 1 ARTERY 2 ADJUSTED AGATSTON SCORE
24	CAC	120812	phv00120812.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:42:59+00:00	2018-08-29 23:42:59+00:00 	FR3PHS11	SCAN 1 ARTERY 1 ADJUSTED AGATSTON SCORE
24	CAC	120811	phv00120811.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:43:07+00:00	2018-08-29 23:43:07+00:00 	FR3PVL41	SCAN 1 ARTERY 4 ADJUSTED VOLUME
24	CAC	120810	phv00120810.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:43:13+00:00	2018-08-29 23:43:13+00:00 	FR3PVL31	SCAN 1 ARTERY 3 ADJUSTED VOLUME
24	CAC	120809	phv00120809.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:43:19+00:00	2018-08-29 23:43:19+00:00 	FR3PVL21	SCAN 1 ARTERY 2 ADJUSTED VOLUME
24	CAC	120808	phv00120808.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:43:25+00:00	2018-08-29 23:43:25+00:00 	FR3PVL11	SCAN 1 ARTERY 1 ADJUSTED VOLUME
24	CAC	120819	phv00120819.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:44:32+00:00	2018-08-29 23:44:32+00:00 	FR3PHI41	SCAN 1 ARTERY 4 ADJUSED ISOVOL
24	CAC	120818	phv00120818.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:44:38+00:00	2018-08-29 23:44:38+00:00 	FR3PHI31	SCAN 1 ARTERY 3 ADJUSED ISOVOL
24	CAC	120817	phv00120817.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:44:44+00:00	2018-08-29 23:44:44+00:00 	FR3PHI21	SCAN 1 ARTERY 2 ADJUSED ISOVOL
24	CAC	120816	phv00120816.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:44:50+00:00	2018-08-29 23:44:50+00:00 	FR3PHI11	SCAN 1 ARTERY 1 ADJUSED ISOVOL
24	CAC	120845	phv00120845.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:45:51+00:00	2018-08-29 23:45:51+00:00 	FR3SCR42	SCAN 2 ARTERY 4 UNADJUSTED AGATSTON SCORE
24	CAC	120844	phv00120844.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:45:56+00:00	2018-08-29 23:45:56+00:00 	FR3SCR32	SCAN 2 ARTERY 3 UNADJUSTED AGATSTON SCORE
24	CAC	120843	phv00120843.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:46:03+00:00	2018-08-29 23:46:03+00:00 	FR3SCR22	SCAN 2 ARTERY 2 UNADJUSTED AGATSTON SCORE
24	CAC	120842	phv00120842.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:46:09+00:00	2018-08-29 23:46:09+00:00 	FR3SCR12	SCAN 2 ARTERY 1 UNADJUSTED AGATSTON SCORE
24	CAC	120841	phv00120841.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:46:15+00:00	2018-08-29 23:46:15+00:00 	FR3VOL42	SCAN 2 ARTERY 4 UNADJUSTED VOLUME
24	CAC	120840	phv00120840.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:46:22+00:00	2018-08-29 23:46:22+00:00 	FR3VOL32	SCAN 2 ARTERY 3 UNADJUSTED VOLUME
24	CAC	120839	phv00120839.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:46:28+00:00	2018-08-29 23:46:28+00:00 	FR3VOL22	SCAN 2 ARTERY 2 UNADJUSTED VOLUME
24	CAC	120838	phv00120838.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:46:36+00:00	2018-08-29 23:46:36+00:00 	FR3VOL12	SCAN 2 ARTERY 1 UNADJUSTED VOLUME
24	CAC	120853	phv00120853.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:47:00+00:00	2018-08-29 23:47:00+00:00 	FR3ARM42	SCAN 2 ARTERY 4 CALCIUM MASS
24	CAC	120852	phv00120852.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:47:06+00:00	2018-08-29 23:47:06+00:00 	FR3ARM32	SCAN 2 ARTERY 3 CALCIUM MASS
24	CAC	120851	phv00120851.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:47:12+00:00	2018-08-29 23:47:12+00:00 	FR3ARM22	SCAN 2 ARTERY 2 CALCIUM MASS
24	CAC	120850	phv00120850.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:47:19+00:00	2018-08-29 23:47:19+00:00 	FR3ARM12	SCAN 2 ARTERY 1 CALCIUM MASS
24	CAC	120849	phv00120849.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:47:25+00:00	2018-08-29 23:47:25+00:00 	FR3ISV42	SCAN 2 ARTERY 4 UNADJUSTED ISOVOL
24	CAC	120848	phv00120848.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:47:32+00:00	2018-08-29 23:47:32+00:00 	FR3ISV32	SCAN 2 ARTERY 3 UNADJUSTED ISOVOL
24	CAC	120847	phv00120847.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:47:37+00:00	2018-08-29 23:47:37+00:00 	FR3ISV22	SCAN 2 ARTERY 2 UNADJUSTED ISOVOL
24	CAC	120846	phv00120846.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:47:44+00:00	2018-08-29 23:47:44+00:00 	FR3ISV12	SCAN 2 ARTERY 1 UNADJUSTED ISOVOL
24	CAC	120873	phv00120873.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:50:32+00:00	2018-08-29 23:50:32+00:00 	FR3PHS42	SCAN 2 ARTERY 4 ADJUSTED AGATSTON SCORE
24	CAC	120872	phv00120872.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:50:39+00:00	2018-08-29 23:50:39+00:00 	FR3PHS32	SCAN 2 ARTERY 3 ADJUSTED AGATSTON SCORE
24	CAC	120871	phv00120871.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:50:46+00:00	2018-08-29 23:50:46+00:00 	FR3PHS22	SCAN 2 ARTERY 2 ADJUSTED AGATSTON SCORE
24	CAC	120870	phv00120870.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:50:53+00:00	2018-08-29 23:50:53+00:00 	FR3PHS12	SCAN 2 ARTERY 1 ADJUSTED AGATSTON SCORE
24	CAC	120869	phv00120869.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:51:00+00:00	2018-08-29 23:51:00+00:00 	FR3PVL42	SCAN 2 ARTERY 4 ADJUSTED VOLUME
24	CAC	120868	phv00120868.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:51:06+00:00	2018-08-29 23:51:06+00:00 	FR3PVL32	SCAN 2 ARTERY 3 ADJUSTED VOLUME
24	CAC	120867	phv00120867.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:51:12+00:00	2018-08-29 23:51:12+00:00 	FR3PVL22	SCAN 2 ARTERY 2 ADJUSTED VOLUME
24	CAC	120866	phv00120866.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:51:19+00:00	2018-08-29 23:51:19+00:00 	FR3PVL12	SCAN 2 ARTERY 1 ADJUSTED VOLUME
24	CAC	120887	phv00120887.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:51:57+00:00	2018-08-29 23:51:57+00:00 	FR3UAIS2	SCAN 2 UNADJUSTED ISOVOL
24	CAC	120886	phv00120886.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:52:03+00:00	2018-08-29 23:52:03+00:00 	FR3UAIS1	SCAN 1 UNADJUSTED ISOVOL
24	CAC	120885	phv00120885.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:52:08+00:00	2018-08-29 23:52:08+00:00 	FR3ADSC2	SCAN 2 ADJUSTED AGATSTON SCORE
24	CAC	120884	phv00120884.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:52:15+00:00	2018-08-29 23:52:15+00:00 	FR3ADSC1	SCAN 1 ADJUSTED AGATSTON SCORE
24	CAC	120883	phv00120883.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:52:22+00:00	2018-08-29 23:52:22+00:00 	FR3UASC2	SCAN 2 UNADJUSTED AGATSTON SCORE
24	CAC	120882	phv00120882.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:52:28+00:00	2018-08-29 23:52:28+00:00 	FR3UASC1	SCAN 1 UNADJUSTED AGATSTON SCORE
24	CAC	120877	phv00120877.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:52:35+00:00	2018-08-29 23:52:35+00:00 	FR3PHI42	SCAN 2 ARTERY 4 ADJUSED ISOVOL
24	CAC	120876	phv00120876.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:52:41+00:00	2018-08-29 23:52:41+00:00 	FR3PHI32	SCAN 2 ARTERY 3 ADJUSED ISOVOL
24	CAC	120875	phv00120875.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:52:47+00:00	2018-08-29 23:52:47+00:00 	FR3PHI22	SCAN 2 ARTERY 2 ADJUSED ISOVOL
24	CAC	120874	phv00120874.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:52:54+00:00	2018-08-29 23:52:54+00:00 	FR3PHI12	SCAN 2 ARTERY 1 ADJUSED ISOVOL
24	CAC	120895	phv00120895.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:53:23+00:00	2018-08-29 23:53:23+00:00 	FR3MASS2	SCAN 2 MASS
24	CAC	120894	phv00120894.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:53:28+00:00	2018-08-29 23:53:28+00:00 	FR3MASS1	SCAN 1 MASS
24	CAC	120893	phv00120893.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:53:35+00:00	2018-08-29 23:53:35+00:00 	FR3PVOL2	SCAN 2 ADJUSTED VOLUME
24	CAC	120892	phv00120892.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:53:41+00:00	2018-08-29 23:53:41+00:00 	FR3PVOL1	SCAN 1 ADJUSTED VOLUME
24	CAC	120891	phv00120891.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:53:48+00:00	2018-08-29 23:53:48+00:00 	FR3VOL2	SCAN 2 UNADJSTED VOLUME
24	CAC	120890	phv00120890.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:53:56+00:00	2018-08-29 23:53:56+00:00 	FR3VOL1	SCAN 1 UNADJSTED VOLUME
24	CAC	120889	phv00120889.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:54:03+00:00	2018-08-29 23:54:03+00:00 	FR3ADIS2	SCAN 2 ADJUSTED ISOVOL
24	CAC	120888	phv00120888.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:54:10+00:00	2018-08-29 23:54:10+00:00 	FR3ADIS1	SCAN 1 ADJUSTED ISOVOL
24	CAC	120902	phv00120902.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:55:00+00:00	2018-08-29 23:55:00+00:00 	FR3MASS	AVERAGE MASS
24	CAC	120901	phv00120901.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:55:05+00:00	2018-08-29 23:55:05+00:00 	FR3PHVOL	AVERAGE ADJUSTED VOLUME
24	CAC	120900	phv00120900.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:55:11+00:00	2018-08-29 23:55:11+00:00 	FR3VOL	AVERAGE UNADJUSTED VOLUME
24	CAC	120899	phv00120899.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:55:17+00:00	2018-08-29 23:55:17+00:00 	FR3UADIS	AVERAGE UNADJUSTED ISOVOL
24	CAC	120898	phv00120898.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:55:24+00:00	2018-08-29 23:55:24+00:00 	FR3ADJIS	AVERAGE ADJUSTED ISOVOL
24	CAC	120897	phv00120897.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:55:30+00:00	2018-08-29 23:55:30+00:00 	FR3ADJSC	AVERAGE ADJUSTED AGASTON SCORE
24	CAC	120896	phv00120896.v2.p2	pht001854.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:55:37+00:00	2018-08-29 23:55:37+00:00 	FR3UASCR	AVERAGE UNADJUSTED AGATSTON SCORE
25	Carotid IMT	209827	phv00209827.v1.p1	pht004164.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:11:29+00:00	2018-04-24 20:11:29+00:00 	LOPART45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPA [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 1]
25	Carotid IMT	209828	phv00209828.v1.p1	pht004164.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:11:55+00:00	2018-04-24 20:11:55+00:00 	ROPART45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPA [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 1]
25	Carotid IMT	209831	phv00209831.v1.p1	pht004164.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:12:12+00:00	2018-04-24 20:12:12+00:00 	LINART45	Imputed RTA [the reader trend adjusted] far wall thickness, LINA [left internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 1]
25	Carotid IMT	209832	phv00209832.v1.p1	pht004164.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:12:33+00:00	2018-04-24 20:12:33+00:00 	RINART45	Imputed RTA [the reader trend adjusted] far wall thickness, RINA [right internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 1]
25	Carotid IMT	209849	phv00209849.v1.p1	pht004165.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:12:53+00:00	2018-04-24 20:12:53+00:00 	LOPBWT45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPA [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 2]
25	Carotid IMT	209850	phv00209850.v1.p1	pht004165.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:13:12+00:00	2018-04-24 20:13:12+00:00 	ROPBWT45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPA [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 2]
25	Carotid IMT	209853	phv00209853.v1.p1	pht004165.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:13:29+00:00	2018-04-24 20:13:29+00:00 	LINBWT45	Imputed RTA [the reader trend adjusted] far wall thickness, LINA [left internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 2]
25	Carotid IMT	209854	phv00209854.v1.p1	pht004165.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:13:46+00:00	2018-04-24 20:13:46+00:00 	RINBWT45	Imputed RTA [the reader trend adjusted] far wall thickness, RINA [right internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 2]
25	Carotid IMT	209861	phv00209861.v1.p1	pht004166.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:14:04+00:00	2018-04-24 20:14:04+00:00 	LINCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LINC [left internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 3]
25	Carotid IMT	209862	phv00209862.v1.p1	pht004166.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:14:21+00:00	2018-04-24 20:14:21+00:00 	RINCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, RINC [right internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 3]
25	Carotid IMT	209863	phv00209863.v1.p1	pht004166.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:14:36+00:00	2018-04-24 20:14:36+00:00 	LOPCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPC [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 3]
25	Carotid IMT	209864	phv00209864.v1.p1	pht004166.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:14:51+00:00	2018-04-24 20:14:51+00:00 	ROPCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPC [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 3]
25	Carotid IMT	209873	phv00209873.v1.p1	pht004167.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:15:13+00:00	2018-04-24 20:15:13+00:00 	LOPDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPD [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 4]
25	Carotid IMT	209874	phv00209874.v1.p1	pht004167.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:15:27+00:00	2018-04-24 20:15:27+00:00 	ROPDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPD [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 4]
25	Carotid IMT	209877	phv00209877.v1.p1	pht004167.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:15:44+00:00	2018-04-24 20:15:44+00:00 	LINDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LIND [left internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 4]
25	Carotid IMT	209878	phv00209878.v1.p1	pht004167.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:16:06+00:00	2018-04-24 20:16:06+00:00 	RINDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, RIND [right internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 4]
25	Carotid IMT	209889	phv00209889.v1.p1	pht004168.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:16:21+00:00	2018-04-24 20:16:21+00:00 	LOPART45	Imputed RTA  [the reader trend adjusted] far wall thickness, LOPA [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 1]
25	Carotid IMT	209890	phv00209890.v1.p1	pht004168.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:16:39+00:00	2018-04-24 20:16:39+00:00 	ROPART45	Imputed RTA  [the reader trend adjusted] far wall thickness, ROPA [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 1]
25	Carotid IMT	209893	phv00209893.v1.p1	pht004168.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:16:54+00:00	2018-04-24 20:16:54+00:00 	LINART45	Imputed RTA  [the reader trend adjusted] far wall thickness, LINA [left internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 1]
25	Carotid IMT	209894	phv00209894.v1.p1	pht004168.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:17:08+00:00	2018-04-24 20:17:08+00:00 	RINART45	Imputed RTA [the reader trend adjusted] far wall thickness, RINA [right internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 1]
25	Carotid IMT	209905	phv00209905.v1.p1	pht004169.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:17:26+00:00	2018-04-24 20:17:26+00:00 	LOPBRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPB [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 2]
25	Carotid IMT	209906	phv00209906.v1.p1	pht004169.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:17:42+00:00	2018-04-24 20:17:42+00:00 	ROPBRT45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPB [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 2]
25	Carotid IMT	209909	phv00209909.v1.p1	pht004169.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:17:58+00:00	2018-04-24 20:17:58+00:00 	LINBRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LINB [left internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 2]
25	Carotid IMT	209910	phv00209910.v1.p1	pht004169.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:18:12+00:00	2018-04-24 20:18:12+00:00 	RINBRT45	Imputed RTA [the reader trend adjusted] far wall thickness, RINB [right internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 2]
25	Carotid IMT	209923	phv00209923.v1.p1	pht004170.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:18:26+00:00	2018-04-24 20:18:26+00:00 	LINCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LINC [left internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 3]
25	Carotid IMT	209924	phv00209924.v1.p1	pht004170.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:18:52+00:00	2018-04-24 20:18:52+00:00 	RINCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, RINC [right internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 3]
25	Carotid IMT	209925	phv00209925.v1.p1	pht004170.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:19:07+00:00	2018-04-24 20:19:07+00:00 	LOPCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPC [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 3]
25	Carotid IMT	209926	phv00209926.v1.p1	pht004170.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:19:19+00:00	2018-04-24 20:19:19+00:00 	ROPCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPC [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 3]
25	Carotid IMT	209935	phv00209935.v1.p1	pht004171.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:19:36+00:00	2018-04-24 20:19:36+00:00 	LOPDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPD [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 4]
25	Carotid IMT	209936	phv00209936.v1.p1	pht004171.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:19:51+00:00	2018-04-24 20:19:51+00:00 	ROPDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPD [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 4]
25	Carotid IMT	209939	phv00209939.v1.p1	pht004171.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:20:08+00:00	2018-04-24 20:20:08+00:00 	LINDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LIND [left internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 4]
25	Carotid IMT	209940	phv00209940.v1.p1	pht004171.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:20:26+00:00	2018-04-24 20:20:26+00:00 	RINDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, RIND [right internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 4]
25	Carotid IMT	210147	phv00210147.v1.p1	pht004184.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:20:49+00:00	2018-04-24 20:20:49+00:00 	LOPART45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPA [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 1]
25	Carotid IMT	210148	phv00210148.v1.p1	pht004184.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:21:05+00:00	2018-04-24 20:21:05+00:00 	ROPART45	Imputed RTA [the reader trend adjusted]  far wall thickness, ROPA [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 1]
25	Carotid IMT	210151	phv00210151.v1.p1	pht004184.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:21:20+00:00	2018-04-24 20:21:20+00:00 	LINART45	Imputed RTA [the reader trend adjusted] far wall thickness, LINA [left internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 1]
25	Carotid IMT	210152	phv00210152.v1.p1	pht004184.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:21:35+00:00	2018-04-24 20:21:35+00:00 	RINART45	Imputed RTA [the reader trend adjusted] far wall thickness, RINA [right internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 1]
25	Carotid IMT	210163	phv00210163.v1.p1	pht004185.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:21:53+00:00	2018-04-24 20:21:53+00:00 	LOPBRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPB [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 2]
25	Carotid IMT	210164	phv00210164.v1.p1	pht004185.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:22:31+00:00	2018-04-24 20:22:31+00:00 	ROPBRT45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPB [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 2]
25	Carotid IMT	210167	phv00210167.v1.p1	pht004185.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:22:54+00:00	2018-04-24 20:22:54+00:00 	LINBRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LINB [left common carotid: anterior angle] [Reader-trend-adjusted ultrasound, white females, exam 2]
25	Carotid IMT	210168	phv00210168.v1.p1	pht004185.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:23:09+00:00	2018-04-24 20:23:09+00:00 	RINBRT45	Imputed RTA [the reader trend adjusted] far wall thickness, RINB [right internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 2]
25	Carotid IMT	210181	phv00210181.v1.p1	pht004186.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:23:25+00:00	2018-04-24 20:23:25+00:00 	LINCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LINC [left internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 3]
25	Carotid IMT	210182	phv00210182.v1.p1	pht004186.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:23:39+00:00	2018-04-24 20:23:39+00:00 	RINCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, RINC [right internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 3]
25	Carotid IMT	210183	phv00210183.v1.p1	pht004186.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:23:54+00:00	2018-04-24 20:23:54+00:00 	LOPCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPC [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 3]
25	Carotid IMT	210184	phv00210184.v1.p1	pht004186.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:24:10+00:00	2018-04-24 20:24:10+00:00 	ROPCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPC [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 3]
25	Carotid IMT	210193	phv00210193.v1.p1	pht004187.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:24:23+00:00	2018-04-24 20:24:23+00:00 	LOPDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPC [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 4]
25	Carotid IMT	210194	phv00210194.v1.p1	pht004187.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:24:36+00:00	2018-04-24 20:24:36+00:00 	ROPDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPD [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 4]
25	Carotid IMT	210197	phv00210197.v1.p1	pht004187.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:24:50+00:00	2018-04-24 20:24:50+00:00 	LINDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LINC [left internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 4]
25	Carotid IMT	210198	phv00210198.v1.p1	pht004187.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:25:04+00:00	2018-04-24 20:25:04+00:00 	RINDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, RIND [right internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 4]
25	Carotid IMT	210209	phv00210209.v1.p1	pht004188.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:25:18+00:00	2018-04-24 20:25:18+00:00 	LOPART45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPA [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 1]
25	Carotid IMT	210210	phv00210210.v1.p1	pht004188.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:25:32+00:00	2018-04-24 20:25:32+00:00 	ROPART45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPA [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 1]
25	Carotid IMT	210213	phv00210213.v1.p1	pht004188.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:26:03+00:00	2018-04-24 20:26:03+00:00 	LINART45	Imputed RTA [the reader trend adjusted] far wall thickness, LINA [left internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 1]
25	Carotid IMT	210214	phv00210214.v1.p1	pht004188.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:26:18+00:00	2018-04-24 20:26:18+00:00 	RINART45	Imputed RTA [the reader trend adjusted] far wall thickness, RINA [right internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 1]
25	Carotid IMT	210225	phv00210225.v1.p1	pht004189.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:26:34+00:00	2018-04-24 20:26:34+00:00 	LOPBRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPB [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 2]
25	Carotid IMT	210226	phv00210226.v1.p1	pht004189.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:26:49+00:00	2018-04-24 20:26:49+00:00 	ROPBRT45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPB [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 2]
25	Carotid IMT	210229	phv00210229.v1.p1	pht004189.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:27:02+00:00	2018-04-24 20:27:02+00:00 	LINBRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LINB [left internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 2]
25	Carotid IMT	210230	phv00210230.v1.p1	pht004189.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:27:17+00:00	2018-04-24 20:27:17+00:00 	RINBRT45	Imputed RTA [the reader trend adjusted] far wall thickness, RINB [right internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 2]
25	Carotid IMT	210243	phv00210243.v1.p1	pht004190.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:27:36+00:00	2018-04-24 20:27:36+00:00 	LINCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LINC [left internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 3]
25	Carotid IMT	210244	phv00210244.v1.p1	pht004190.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:27:51+00:00	2018-04-24 20:27:51+00:00 	RINCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, RINC [right internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 3]
25	Carotid IMT	210245	phv00210245.v1.p1	pht004190.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:28:04+00:00	2018-04-24 20:28:04+00:00 	LOPCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPC [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 3]
25	Carotid IMT	210246	phv00210246.v1.p1	pht004190.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:28:21+00:00	2018-04-24 20:28:21+00:00 	ROPCRT45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPC [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 3]
25	Carotid IMT	210255	phv00210255.v1.p1	pht004191.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:28:35+00:00	2018-04-24 20:28:35+00:00 	LOPDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LOPD [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 4]
25	Carotid IMT	210256	phv00210256.v1.p1	pht004191.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:28:50+00:00	2018-04-24 20:28:50+00:00 	ROPDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, ROPD [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 4]
25	Carotid IMT	210259	phv00210259.v1.p1	pht004191.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:29:04+00:00	2018-04-24 20:29:04+00:00 	LINDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, LIND [left internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 4]
25	Carotid IMT	210260	phv00210260.v1.p1	pht004191.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:29:21+00:00	2018-04-24 20:29:21+00:00 	RINDRT45	Imputed RTA [the reader trend adjusted] far wall thickness, RIND [right internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 4]
25	Carotid IMT	212480	phv00212480.v1.p1	pht004209.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:40:31+00:00	2018-04-24 20:40:31+00:00 	LOPADA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 1]
25	Carotid IMT	212481	phv00212481.v1.p1	pht004209.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:40:47+00:00	2018-04-24 20:40:47+00:00 	ROPADA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 1]
25	Carotid IMT	212484	phv00212484.v1.p1	pht004209.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:41:01+00:00	2018-04-24 20:41:01+00:00 	LINADA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, black females, exam 1]
25	Carotid IMT	212485	phv00212485.v1.p1	pht004209.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:41:14+00:00	2018-04-24 20:41:14+00:00 	RINADA45	Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, black females, exam 1]
25	Carotid IMT	212499	phv00212499.v1.p1	pht004210.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:41:30+00:00	2018-04-24 20:41:30+00:00 	LOPADA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black males, exam 1]
25	Carotid IMT	212500	phv00212500.v1.p1	pht004210.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:41:44+00:00	2018-04-24 20:41:44+00:00 	ROPADA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black males, exam 1]
25	Carotid IMT	212503	phv00212503.v1.p1	pht004210.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:42:02+00:00	2018-04-24 20:42:02+00:00 	LINADA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, black males, exam 1]
25	Carotid IMT	212518	phv00212518.v1.p1	pht004211.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:42:29+00:00	2018-04-24 20:42:29+00:00 	LOPADA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 1]
25	Carotid IMT	212519	phv00212519.v1.p1	pht004211.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:42:45+00:00	2018-04-24 20:42:45+00:00 	ROPADA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 1]
25	Carotid IMT	212522	phv00212522.v1.p1	pht004211.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:43:02+00:00	2018-04-24 20:43:02+00:00 	LINADA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white females, exam 1]
25	Carotid IMT	212523	phv00212523.v1.p1	pht004211.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:43:18+00:00	2018-04-24 20:43:18+00:00 	RINADA45	Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, white females, exam 1]
25	Carotid IMT	212537	phv00212537.v1.p1	pht004212.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:43:31+00:00	2018-04-24 20:43:31+00:00 	LOPADA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 1]
25	Carotid IMT	212538	phv00212538.v1.p1	pht004212.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:43:44+00:00	2018-04-24 20:43:44+00:00 	ROPADA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 1]
25	Carotid IMT	212541	phv00212541.v1.p1	pht004212.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:43:57+00:00	2018-04-24 20:43:57+00:00 	LINADA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white males, exam 1]
25	Carotid IMT	212542	phv00212542.v1.p1	pht004212.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:44:12+00:00	2018-04-24 20:44:12+00:00 	RINADA45	Derived average far wall thickness, right Internal carotid [Ultrasound Imputed Values, white males, exam 1]
25	Carotid IMT	212654	phv00212654.v1.p1	pht004214.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:51:06+00:00	2018-04-24 20:51:06+00:00 	LOPBDA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 2]
25	Carotid IMT	212655	phv00212655.v1.p1	pht004214.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:51:20+00:00	2018-04-24 20:51:20+00:00 	ROPBDA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 2]
25	Carotid IMT	212658	phv00212658.v1.p1	pht004214.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:51:37+00:00	2018-04-24 20:51:37+00:00 	LINBDA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, black females, exam 2]
25	Carotid IMT	212659	phv00212659.v1.p1	pht004214.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:51:53+00:00	2018-04-24 20:51:53+00:00 	RINBDA45	Derived average far wall thickness, right Internal carotid [Ultrasound Imputed Values, black females, exam 2]
25	Carotid IMT	212672	phv00212672.v1.p1	pht004215.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:52:07+00:00	2018-04-24 20:52:07+00:00 	LOPBDA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black males, exam 2]
25	Carotid IMT	212673	phv00212673.v1.p1	pht004215.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:52:21+00:00	2018-04-24 20:52:21+00:00 	ROPBDA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black males, exam 2]
25	Carotid IMT	212676	phv00212676.v1.p1	pht004215.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:52:35+00:00	2018-04-24 20:52:35+00:00 	LINBDA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, black males, exam 2]
25	Carotid IMT	212677	phv00212677.v1.p1	pht004215.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:52:48+00:00	2018-04-24 20:52:48+00:00 	RINBDA45	Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, black males, exam 2]
25	Carotid IMT	212690	phv00212690.v1.p1	pht004216.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:53:02+00:00	2018-04-24 20:53:02+00:00 	LOPBDA45	Derived average far wall thickness, left common carotid: optimal angle  [Ultrasound Imputed Values, white females, exam 2]
25	Carotid IMT	212691	phv00212691.v1.p1	pht004216.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:53:16+00:00	2018-04-24 20:53:16+00:00 	ROPBDA45	Derived average far wall thickness, right common carotid: optimal angle  [Ultrasound Imputed Values, white females, exam 2]
25	Carotid IMT	212694	phv00212694.v1.p1	pht004216.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:53:30+00:00	2018-04-24 20:53:30+00:00 	LINBDA45	Derived average far wall thickness, left internal carotid  [Ultrasound Imputed Values, white females, exam 2]
25	Carotid IMT	212695	phv00212695.v1.p1	pht004216.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:53:46+00:00	2018-04-24 20:53:46+00:00 	RINBDA45	Derived average far wall thickness, right Internal carotid  [Ultrasound Imputed Values, white females, exam 2]
25	Carotid IMT	212708	phv00212708.v1.p1	pht004217.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:53:59+00:00	2018-04-24 20:53:59+00:00 	LOPBDA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 2]
25	Carotid IMT	212709	phv00212709.v1.p1	pht004217.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:54:11+00:00	2018-04-24 20:54:11+00:00 	ROPBDA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 2]
25	Carotid IMT	212712	phv00212712.v1.p1	pht004217.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:56:00+00:00	2018-04-24 20:56:00+00:00 	LINBDA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white males, exam 2]
25	Carotid IMT	212713	phv00212713.v1.p1	pht004217.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:56:16+00:00	2018-04-24 20:56:16+00:00 	RINBDA45	Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, white males, exam 2]
25	Carotid IMT	213831	phv00213831.v1.p1	pht004219.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:56:32+00:00	2018-04-24 20:56:32+00:00 	LOPCDA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 3]
25	Carotid IMT	213832	phv00213832.v1.p1	pht004219.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:56:47+00:00	2018-04-24 20:56:47+00:00 	ROPCDA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 3]
25	Carotid IMT	213835	phv00213835.v1.p1	pht004219.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:57:18+00:00	2018-04-24 20:57:18+00:00 	LINCDA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, black females, exam 3]
25	Carotid IMT	213836	phv00213836.v1.p1	pht004219.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:57:33+00:00	2018-04-24 20:57:33+00:00 	RINCDA45	Derived Average Far Wall Thickness, Right Internal Carotid [Ultrasound Imputed Values, black females, exam 3]
25	Carotid IMT	213849	phv00213849.v1.p1	pht004220.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:57:50+00:00	2018-04-24 20:57:50+00:00 	LOPCDA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed values, black males, exam 3]
25	Carotid IMT	213850	phv00213850.v1.p1	pht004220.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:58:04+00:00	2018-04-24 20:58:04+00:00 	ROPCDA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed values, black males, exam 3]
25	Carotid IMT	213853	phv00213853.v1.p1	pht004220.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:58:19+00:00	2018-04-24 20:58:19+00:00 	LINCDA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed values, black males, exam 3]
25	Carotid IMT	213854	phv00213854.v1.p1	pht004220.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:58:34+00:00	2018-04-24 20:58:34+00:00 	RINCDA45	Derived average far wall thickness, right internal carotid [Ultrasound Imputed values, black males, exam 3]
25	Carotid IMT	213867	phv00213867.v1.p1	pht004221.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:58:50+00:00	2018-04-24 20:58:50+00:00 	LOPCDA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 3]
25	Carotid IMT	213868	phv00213868.v1.p1	pht004221.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:59:22+00:00	2018-04-24 20:59:22+00:00 	ROPCDA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 3]
25	Carotid IMT	213871	phv00213871.v1.p1	pht004221.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:59:35+00:00	2018-04-24 20:59:35+00:00 	LINCDA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white females, exam 3]
25	Carotid IMT	213872	phv00213872.v1.p1	pht004221.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 20:59:48+00:00	2018-04-24 20:59:48+00:00 	RINCDA45	Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, white females, exam 3]
25	Carotid IMT	213885	phv00213885.v1.p1	pht004222.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:00:03+00:00	2018-04-24 21:00:03+00:00 	LOPCDA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 3]
25	Carotid IMT	213886	phv00213886.v1.p1	pht004222.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:00:17+00:00	2018-04-24 21:00:17+00:00 	ROPCDA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 3]
25	Carotid IMT	213889	phv00213889.v1.p1	pht004222.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:00:31+00:00	2018-04-24 21:00:31+00:00 	LINCDA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white males, exam 3]
25	Carotid IMT	213890	phv00213890.v1.p1	pht004222.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:00:46+00:00	2018-04-24 21:00:46+00:00 	RINCDA45	Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, white males, exam 3]
25	Carotid IMT	213978	phv00213978.v1.p1	pht004224.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:01:03+00:00	2018-04-24 21:01:03+00:00 	LOPDDA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 4]
25	Carotid IMT	213979	phv00213979.v1.p1	pht004224.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:01:15+00:00	2018-04-24 21:01:15+00:00 	ROPDDA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 4]
25	Carotid IMT	213982	phv00213982.v1.p1	pht004224.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:01:26+00:00	2018-04-24 21:01:26+00:00 	LINDDA45	Derived Average far wall thickness, left internal carotid [Ultrasound Imputed Values, black females, exam 4]
25	Carotid IMT	213983	phv00213983.v1.p1	pht004224.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:01:41+00:00	2018-04-24 21:01:41+00:00 	RINDDA45	Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, black females, exam 4]
25	Carotid IMT	213996	phv00213996.v1.p1	pht004225.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:01:55+00:00	2018-04-24 21:01:55+00:00 	LOPDDA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black males, exam 4]
25	Carotid IMT	213997	phv00213997.v1.p1	pht004225.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:02:18+00:00	2018-04-24 21:02:18+00:00 	ROPDDA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black males, exam 4]
25	Carotid IMT	214000	phv00214000.v1.p1	pht004225.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:02:31+00:00	2018-04-24 21:02:31+00:00 	LINDDA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, black males, exam 4]
25	Carotid IMT	214001	phv00214001.v1.p1	pht004225.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:02:47+00:00	2018-04-24 21:02:47+00:00 	RINDDA45	Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, black males, exam 4]
25	Carotid IMT	214014	phv00214014.v1.p1	pht004226.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:03:07+00:00	2018-04-24 21:03:07+00:00 	LOPDDA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 4]
25	Carotid IMT	214015	phv00214015.v1.p1	pht004226.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:03:21+00:00	2018-04-24 21:03:21+00:00 	ROPDDA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 4]
25	Carotid IMT	214018	phv00214018.v1.p1	pht004226.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:03:34+00:00	2018-04-24 21:03:34+00:00 	LINDDA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white females, exam 4]
25	Carotid IMT	214019	phv00214019.v1.p1	pht004226.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:03:46+00:00	2018-04-24 21:03:46+00:00 	RINDDA45	Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, white females, exam 4]
25	Carotid IMT	214032	phv00214032.v1.p1	pht004227.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:03:59+00:00	2018-04-24 21:03:59+00:00 	LOPDDA45	Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 4]
25	Carotid IMT	214033	phv00214033.v1.p1	pht004227.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:04:13+00:00	2018-04-24 21:04:13+00:00 	ROPDDA45	Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 4]
25	Carotid IMT	214036	phv00214036.v1.p1	pht004227.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:04:28+00:00	2018-04-24 21:04:28+00:00 	LINDDA45	Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white males, exam 4]
25	Carotid IMT	214037	phv00214037.v1.p1	pht004227.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:04:42+00:00	2018-04-24 21:04:42+00:00 	RINDDA45	Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, white males, exam 4]
25	Carotid IMT	212504	phv00212504.v1.p1	pht004210.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 21:15:54+00:00	2018-04-24 21:15:54+00:00 	RINADA45	Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, black males, exam 1]
25	Carotid IMT	209840	phv00209840.v1.p1	pht004164.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:17:24+00:00	2018-04-26 16:17:24+00:00 	MNA45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, black females, exam 1]
25	Carotid IMT	209871	phv00209871.v1.p1	pht004166.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:36:59+00:00	2018-04-26 16:36:59+00:00 	MNC45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, black females, exam 3]
25	Carotid IMT	209885	phv00209885.v1.p1	pht004167.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:38:14+00:00	2018-04-26 16:38:14+00:00 	MND45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, black females, exam 4]
25	Carotid IMT	209902	phv00209902.v1.p1	pht004168.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:39:00+00:00	2018-04-26 16:39:00+00:00 	MNA45_1	Mean of the RT45 Variables [Reader-trend-adjusted ultrasound, black males, exam 1]
25	Carotid IMT	209917	phv00209917.v1.p1	pht004169.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:39:45+00:00	2018-04-26 16:39:45+00:00 	MNB45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, black males, exam 2]
25	Carotid IMT	209933	phv00209933.v1.p1	pht004170.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:40:21+00:00	2018-04-26 16:40:21+00:00 	MNC45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, black males, exam 3]
25	Carotid IMT	209947	phv00209947.v1.p1	pht004171.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:41:00+00:00	2018-04-26 16:41:00+00:00 	MND45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, black males, exam 4]
25	Carotid IMT	210160	phv00210160.v1.p1	pht004184.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:41:43+00:00	2018-04-26 16:41:43+00:00 	MNA45_1	Mean of the RT45 Variables [Reader-trend-adjusted ultrasound, white females, exam 1]
25	Carotid IMT	210175	phv00210175.v1.p1	pht004185.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:42:36+00:00	2018-04-26 16:42:36+00:00 	MNB45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white females, exam 2]
25	Carotid IMT	210191	phv00210191.v1.p1	pht004186.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:43:32+00:00	2018-04-26 16:43:32+00:00 	MNC45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white females, exam 3]
25	Carotid IMT	210205	phv00210205.v1.p1	pht004187.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:44:16+00:00	2018-04-26 16:44:16+00:00 	MND45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white females, exam 4]
25	Carotid IMT	210222	phv00210222.v1.p1	pht004188.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:44:51+00:00	2018-04-26 16:44:51+00:00 	MNA45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white males, exam 1]
25	Carotid IMT	210237	phv00210237.v1.p1	pht004189.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:45:22+00:00	2018-04-26 16:45:22+00:00 	MNB45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white males, exam 2]
25	Carotid IMT	210253	phv00210253.v1.p1	pht004190.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:45:53+00:00	2018-04-26 16:45:53+00:00 	MNC45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white males, exam 3]
25	Carotid IMT	210267	phv00210267.v1.p1	pht004191.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:46:25+00:00	2018-04-26 16:46:25+00:00 	MND45_1	Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white males, exam 4]
25	Carotid IMT	212494	phv00212494.v1.p1	pht004209.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:47:44+00:00	2018-04-26 16:47:44+00:00 	SUM45_1	Mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 1]
25	Carotid IMT	212495	phv00212495.v1.p1	pht004209.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:47:59+00:00	2018-04-26 16:47:59+00:00 	SUM45_2	Weighted mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 1]
25	Carotid IMT	212513	phv00212513.v1.p1	pht004210.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:49:39+00:00	2018-04-26 16:49:39+00:00 	SUM45_1	Mean of the DA45 variables [Ultrasound Imputed Values, black males, exam 1]
25	Carotid IMT	212514	phv00212514.v1.p1	pht004210.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:50:03+00:00	2018-04-26 16:50:03+00:00 	SUM45_2	Weighted mean of the DA45 variables [Ultrasound Imputed Values, black males, exam 1]
25	Carotid IMT	212501	phv00212501.v1.p1	pht004210.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:51:36+00:00	2018-04-26 16:51:36+00:00 	LBIADA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black males, exam 1]
25	Carotid IMT	212502	phv00212502.v1.p1	pht004210.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:51:56+00:00	2018-04-26 16:51:56+00:00 	RBIADA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black males, exam 1]
25	Carotid IMT	212482	phv00212482.v1.p1	pht004209.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:53:09+00:00	2018-04-26 16:53:09+00:00 	LBIADA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black females, exam 1]
25	Carotid IMT	212483	phv00212483.v1.p1	pht004209.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:53:27+00:00	2018-04-26 16:53:27+00:00 	RBIADA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black females, exam 1]
25	Carotid IMT	212520	phv00212520.v1.p1	pht004211.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:54:28+00:00	2018-04-26 16:54:28+00:00 	LBIADA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white females, exam 1]
25	Carotid IMT	212521	phv00212521.v1.p1	pht004211.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:54:42+00:00	2018-04-26 16:54:42+00:00 	RBIADA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white females, exam 1]
25	Carotid IMT	212532	phv00212532.v1.p1	pht004211.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:55:34+00:00	2018-04-26 16:55:34+00:00 	SUM45_1	Mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 1]
25	Carotid IMT	212533	phv00212533.v1.p1	pht004211.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:55:49+00:00	2018-04-26 16:55:49+00:00 	SUM45_2	Weighted mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 1]
25	Carotid IMT	212539	phv00212539.v1.p1	pht004212.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:56:35+00:00	2018-04-26 16:56:35+00:00 	LBIADA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white males, exam 1]
25	Carotid IMT	212540	phv00212540.v1.p1	pht004212.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:56:51+00:00	2018-04-26 16:56:51+00:00 	RBIADA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white males, exam 1]
25	Carotid IMT	212551	phv00212551.v1.p1	pht004212.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:57:37+00:00	2018-04-26 16:57:37+00:00 	SUM45_1	Mean of the DA45 variables [Ultrasound Imputed Values, white males, exam 1]
25	Carotid IMT	212552	phv00212552.v1.p1	pht004212.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:57:56+00:00	2018-04-26 16:57:56+00:00 	SUM45_2	Weighted mean of the DA45 variables [Ultrasound Imputed Values, white males, exam 1]
25	Carotid IMT	212656	phv00212656.v1.p1	pht004214.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:59:05+00:00	2018-04-26 16:59:05+00:00 	LBIBDA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black females, exam 2]
25	Carotid IMT	212657	phv00212657.v1.p1	pht004214.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 16:59:20+00:00	2018-04-26 16:59:20+00:00 	RBIBDA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black females, exam 2]
25	Carotid IMT	212668	phv00212668.v1.p1	pht004214.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:00:08+00:00	2018-04-26 17:00:08+00:00 	SUM45_21	Mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 2]
25	Carotid IMT	212669	phv00212669.v1.p1	pht004214.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:00:23+00:00	2018-04-26 17:00:23+00:00 	SUM45_22	Weighted mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 2]
25	Carotid IMT	212674	phv00212674.v1.p1	pht004215.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:01:27+00:00	2018-04-26 17:01:27+00:00 	LBIBDA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black males, exam 2]
25	Carotid IMT	212675	phv00212675.v1.p1	pht004215.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:01:43+00:00	2018-04-26 17:01:43+00:00 	RBIBDA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black males, exam 2]
25	Carotid IMT	212686	phv00212686.v1.p1	pht004215.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:02:27+00:00	2018-04-26 17:02:27+00:00 	SUM45_21	Mean of the DA45 variables [Ultrasound Imputed Values, black males, exam 2]
25	Carotid IMT	212687	phv00212687.v1.p1	pht004215.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:02:43+00:00	2018-04-26 17:02:43+00:00 	SUM45_22	Weighted mean of the DA45 variables [Ultrasound Imputed Values, black males, exam 2]
25	Carotid IMT	212692	phv00212692.v1.p1	pht004216.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:03:51+00:00	2018-04-26 17:03:51+00:00 	LBIBDA45	Derived average far wall thickness, left bifurcation  [Ultrasound Imputed Values, white females, exam 2]
25	Carotid IMT	212693	phv00212693.v1.p1	pht004216.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:04:06+00:00	2018-04-26 17:04:06+00:00 	RBIBDA45	Derived average far wall thickness, right bifurcation  [Ultrasound Imputed Values, white females, exam 2]
25	Carotid IMT	212704	phv00212704.v1.p1	pht004216.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:04:40+00:00	2018-04-26 17:04:40+00:00 	SUM45_21	Mean of the DA45 variables  [Ultrasound Imputed Values, white females, exam 2]
25	Carotid IMT	212705	phv00212705.v1.p1	pht004216.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:04:54+00:00	2018-04-26 17:04:54+00:00 	SUM45_22	Weighted mean of the DA45 variables  [Ultrasound Imputed Values, white females, exam 2]
25	Carotid IMT	212710	phv00212710.v1.p1	pht004217.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:05:45+00:00	2018-04-26 17:05:45+00:00 	LBIBDA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white males, exam 2]
25	Carotid IMT	212711	phv00212711.v1.p1	pht004217.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:05:59+00:00	2018-04-26 17:05:59+00:00 	RBIBDA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white males, exam 2]
25	Carotid IMT	212722	phv00212722.v1.p1	pht004217.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:06:43+00:00	2018-04-26 17:06:43+00:00 	SUM45_21	Mean of the DA45 variables [Ultrasound Imputed Values, white males, exam 2]
25	Carotid IMT	212723	phv00212723.v1.p1	pht004217.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:07:02+00:00	2018-04-26 17:07:02+00:00 	SUM45_22	Weighted mean of the DA45 variables [Ultrasound Imputed Values, white males, exam 2]
25	Carotid IMT	213833	phv00213833.v1.p1	pht004219.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:07:53+00:00	2018-04-26 17:07:53+00:00 	LBICDA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black females, exam 3]
25	Carotid IMT	213834	phv00213834.v1.p1	pht004219.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:08:09+00:00	2018-04-26 17:08:09+00:00 	RBICDA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black females, exam 3]
25	Carotid IMT	213845	phv00213845.v1.p1	pht004219.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:08:53+00:00	2018-04-26 17:08:53+00:00 	SUM45_31	Mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 3]
25	Carotid IMT	213846	phv00213846.v1.p1	pht004219.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:09:08+00:00	2018-04-26 17:09:08+00:00 	SUM45_32	Weighted mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 3]
25	Carotid IMT	213851	phv00213851.v1.p1	pht004220.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:10:44+00:00	2018-04-26 17:10:44+00:00 	LBICDA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed values, black males, exam 3]
25	Carotid IMT	213852	phv00213852.v1.p1	pht004220.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:11:08+00:00	2018-04-26 17:11:08+00:00 	RBICDA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed values, black males, exam 3]
25	Carotid IMT	213863	phv00213863.v1.p1	pht004220.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:11:55+00:00	2018-04-26 17:11:55+00:00 	SUM45_31	Mean of the DA45 variables [Ultrasound Imputed values, black males, exam 3]
25	Carotid IMT	213864	phv00213864.v1.p1	pht004220.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:12:13+00:00	2018-04-26 17:12:13+00:00 	SUM45_32	Weighted mean of the DA45 variables [Ultrasound Imputed values, black males, exam 3]
25	Carotid IMT	213869	phv00213869.v1.p1	pht004221.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:13:29+00:00	2018-04-26 17:13:29+00:00 	LBICDA45	Derived average far wall thickness, left bifurcation  [Ultrasound Imputed Values, white females, exam 3]
25	Carotid IMT	213870	phv00213870.v1.p1	pht004221.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:13:42+00:00	2018-04-26 17:13:42+00:00 	RBICDA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white females, exam 3]
25	Carotid IMT	213881	phv00213881.v1.p1	pht004221.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:14:31+00:00	2018-04-26 17:14:31+00:00 	SUM45_31	Mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 3]
25	Carotid IMT	213882	phv00213882.v1.p1	pht004221.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:14:46+00:00	2018-04-26 17:14:46+00:00 	SUM45_32	Weighted mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 3]
25	Carotid IMT	213887	phv00213887.v1.p1	pht004222.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:15:48+00:00	2018-04-26 17:15:48+00:00 	LBICDA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white males, exam 3]
25	Carotid IMT	213888	phv00213888.v1.p1	pht004222.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:16:07+00:00	2018-04-26 17:16:07+00:00 	RBICDA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white males, exam 3]
25	Carotid IMT	213899	phv00213899.v1.p1	pht004222.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:16:51+00:00	2018-04-26 17:16:51+00:00 	SUM45_31	Mean of the DA45 variables [Ultrasound Imputed Values, white males, exam 3]
25	Carotid IMT	213900	phv00213900.v1.p1	pht004222.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:17:04+00:00	2018-04-26 17:17:04+00:00 	SUM45_32	Weighted mean of the DA45 variables [Ultrasound Imputed Values, white males, exam 3]
25	Carotid IMT	213980	phv00213980.v1.p1	pht004224.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:17:55+00:00	2018-04-26 17:17:55+00:00 	LBIDDA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black females, exam 4]
25	Carotid IMT	213981	phv00213981.v1.p1	pht004224.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:18:10+00:00	2018-04-26 17:18:10+00:00 	RBIDDA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black females, exam 4]
25	Carotid IMT	213992	phv00213992.v1.p1	pht004224.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:19:26+00:00	2018-04-26 17:19:26+00:00 	SUM45_41	Mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 4]
25	Carotid IMT	213993	phv00213993.v1.p1	pht004224.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:19:40+00:00	2018-04-26 17:19:40+00:00 	SUM45_42	Weighted mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 4]
25	Carotid IMT	213998	phv00213998.v1.p1	pht004225.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:20:45+00:00	2018-04-26 17:20:45+00:00 	LBIDDA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black males, exam 4]
25	Carotid IMT	213999	phv00213999.v1.p1	pht004225.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:21:01+00:00	2018-04-26 17:21:01+00:00 	RBIDDA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black males, exam 4]
25	Carotid IMT	214010	phv00214010.v1.p1	pht004225.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:21:47+00:00	2018-04-26 17:21:47+00:00 	SUM45_41	Mean of the DA45 variables [Ultrasound Imputed Values, black males, exam 4]
25	Carotid IMT	214011	phv00214011.v1.p1	pht004225.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:22:00+00:00	2018-04-26 17:22:00+00:00 	SUM45_42	Weighted mean of the DA45 variables [Ultrasound Imputed Values, black males, exam 4]
25	Carotid IMT	214016	phv00214016.v1.p1	pht004226.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:22:52+00:00	2018-04-26 17:22:52+00:00 	LBIDDA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white females, exam 4]
25	Carotid IMT	214017	phv00214017.v1.p1	pht004226.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:23:06+00:00	2018-04-26 17:23:06+00:00 	RBIDDA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white females, exam 4]
25	Carotid IMT	214028	phv00214028.v1.p1	pht004226.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:23:54+00:00	2018-04-26 17:23:54+00:00 	SUM45_41	Mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 4]
25	Carotid IMT	214029	phv00214029.v1.p1	pht004226.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 17:24:07+00:00	2018-04-26 17:24:07+00:00 	SUM45_42	Weighted mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 4]
25	Carotid IMT	214034	phv00214034.v1.p1	pht004227.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 18:01:23+00:00	2018-04-26 18:01:23+00:00 	LBIDDA45	Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white males, exam 4]
25	Carotid IMT	214035	phv00214035.v1.p1	pht004227.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 18:01:37+00:00	2018-04-26 18:01:37+00:00 	RBIDDA45	Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white males, exam 4]
25	Carotid IMT	214046	phv00214046.v1.p1	pht004227.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 18:02:17+00:00	2018-04-26 18:02:17+00:00 	SUM45_41	Mean of the day 45 variables [Ultrasound Imputed Values, white males, exam 4]
25	Carotid IMT	214047	phv00214047.v1.p1	pht004227.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 18:02:32+00:00	2018-04-26 18:02:32+00:00 	SUM45_42	Weighted mean of the day 45 variables [Ultrasound Imputed Values, white males, exam 4]
25	Carotid IMT	209957	phv00209957.v1.p1	pht004172.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:32:25+00:00	2018-04-26 20:32:25+00:00 	LBIBJS45	Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, black females, exam 2]
25	Carotid IMT	209958	phv00209958.v1.p1	pht004172.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:33:36+00:00	2018-04-26 20:33:36+00:00 	RBIBJS45	Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, black females, exam 2]
25	Carotid IMT	209959	phv00209959.v1.p1	pht004172.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:33:51+00:00	2018-04-26 20:33:51+00:00 	LINBJS45	Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, black females, exam 2]
25	Carotid IMT	209960	phv00209960.v1.p1	pht004172.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:34:11+00:00	2018-04-26 20:34:11+00:00 	RINBJS45	Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, black females, exam 2]
25	Carotid IMT	209961	phv00209961.v1.p1	pht004172.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:34:29+00:00	2018-04-26 20:34:29+00:00 	LOPBJS45	Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black females, exam 2]
25	Carotid IMT	209962	phv00209962.v1.p1	pht004172.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:34:46+00:00	2018-04-26 20:34:46+00:00 	ROPBJS45	Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black females, exam 2]
25	Carotid IMT	209964	phv00209964.v1.p1	pht004172.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:35:01+00:00	2018-04-26 20:35:01+00:00 	MNB45_1S	Mean of the JS45 Variables [Reader-trend-shift-adjusted ultrasound, black females, exam 2]
25	Carotid IMT	209974	phv00209974.v1.p1	pht004173.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:35:56+00:00	2018-04-26 20:35:56+00:00 	LBICJS45	Imputed R/T Adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, black females, exam 3]
25	Carotid IMT	209975	phv00209975.v1.p1	pht004173.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:36:11+00:00	2018-04-26 20:36:11+00:00 	RBICJS45	Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, black females, exam 3]
25	Carotid IMT	209976	phv00209976.v1.p1	pht004173.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:36:29+00:00	2018-04-26 20:36:29+00:00 	LINCJS45	Imputed R/T Adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, black females, exam 3]
25	Carotid IMT	209977	phv00209977.v1.p1	pht004173.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:36:46+00:00	2018-04-26 20:36:46+00:00 	RINCJS45	Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, black females, exam 3]
25	Carotid IMT	209978	phv00209978.v1.p1	pht004173.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:37:02+00:00	2018-04-26 20:37:02+00:00 	LOPCJS45	Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black females, exam 3]
25	Carotid IMT	209981	phv00209981.v1.p1	pht004173.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:37:30+00:00	2018-04-26 20:37:30+00:00 	MNC45_1S	Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, black females, exam 3]
25	Carotid IMT	209989	phv00209989.v1.p1	pht004174.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:38:05+00:00	2018-04-26 20:38:05+00:00 	LINDJS45	Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, black females, exam 4]
25	Carotid IMT	209990	phv00209990.v1.p1	pht004174.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:38:19+00:00	2018-04-26 20:38:19+00:00 	RINDJS45	Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, black females, exam 4]
25	Carotid IMT	209991	phv00209991.v1.p1	pht004174.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:38:35+00:00	2018-04-26 20:38:35+00:00 	LBIDJS45	Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, black females, exam 4]
25	Carotid IMT	209992	phv00209992.v1.p1	pht004174.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:38:51+00:00	2018-04-26 20:38:51+00:00 	RBIDJS45	Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, black females, exam 4]
25	Carotid IMT	209993	phv00209993.v1.p1	pht004174.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:39:07+00:00	2018-04-26 20:39:07+00:00 	LOPDJS45	Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black females, exam 4]
25	Carotid IMT	209994	phv00209994.v1.p1	pht004174.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:39:22+00:00	2018-04-26 20:39:22+00:00 	ROPDJS45	Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black females, exam 4]
25	Carotid IMT	209996	phv00209996.v1.p1	pht004174.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:39:40+00:00	2018-04-26 20:39:40+00:00 	MND45_1S	Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, black females, exam 4]
25	Carotid IMT	210006	phv00210006.v1.p1	pht004175.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:40:48+00:00	2018-04-26 20:40:48+00:00 	LBIBJS45	Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, black male, exam 2]
25	Carotid IMT	210007	phv00210007.v1.p1	pht004175.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:41:04+00:00	2018-04-26 20:41:04+00:00 	RBIBJS45	Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, black male, exam 2]
25	Carotid IMT	210008	phv00210008.v1.p1	pht004175.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:41:19+00:00	2018-04-26 20:41:19+00:00 	LINBJS45	Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, black male, exam 2]
25	Carotid IMT	210009	phv00210009.v1.p1	pht004175.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:41:35+00:00	2018-04-26 20:41:35+00:00 	RINBJS45	Imputed R/T adjusted av45, shifted, RIN [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 2]
25	Carotid IMT	210010	phv00210010.v1.p1	pht004175.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:41:50+00:00	2018-04-26 20:41:50+00:00 	LOPBJS45	Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 2]
25	Carotid IMT	210011	phv00210011.v1.p1	pht004175.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:42:04+00:00	2018-04-26 20:42:04+00:00 	ROPBJS45	Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 2]
25	Carotid IMT	210013	phv00210013.v1.p1	pht004175.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:42:19+00:00	2018-04-26 20:42:19+00:00 	MNB45_1S	Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, black male, exam 2]
25	Carotid IMT	210023	phv00210023.v1.p1	pht004176.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:42:58+00:00	2018-04-26 20:42:58+00:00 	LBICJS45	Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, black male, exam 3]
25	Carotid IMT	210024	phv00210024.v1.p1	pht004176.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:43:12+00:00	2018-04-26 20:43:12+00:00 	RBICJS45	Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, black male, exam 3]
25	Carotid IMT	210025	phv00210025.v1.p1	pht004176.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:43:26+00:00	2018-04-26 20:43:26+00:00 	LINCJS45	Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, black male, exam 3]
25	Carotid IMT	210026	phv00210026.v1.p1	pht004176.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:43:41+00:00	2018-04-26 20:43:41+00:00 	RINCJS45	Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, black male, exam 3]
25	Carotid IMT	210027	phv00210027.v1.p1	pht004176.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:43:55+00:00	2018-04-26 20:43:55+00:00 	LOPCJS45	Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 3]
25	Carotid IMT	210028	phv00210028.v1.p1	pht004176.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:44:10+00:00	2018-04-26 20:44:10+00:00 	ROPCJS45	Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 3]
25	Carotid IMT	210030	phv00210030.v1.p1	pht004176.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:44:25+00:00	2018-04-26 20:44:25+00:00 	MNC45_1S	Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, black male, exam 3]
25	Carotid IMT	210038	phv00210038.v1.p1	pht004177.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:44:55+00:00	2018-04-26 20:44:55+00:00 	LINDJS45	Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, black male, exam 4]
25	Carotid IMT	210039	phv00210039.v1.p1	pht004177.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:45:09+00:00	2018-04-26 20:45:09+00:00 	RINDJS45	Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, black male, exam 4]
25	Carotid IMT	210040	phv00210040.v1.p1	pht004177.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:45:25+00:00	2018-04-26 20:45:25+00:00 	LBIDJS45	Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, black male, exam 4]
25	Carotid IMT	210041	phv00210041.v1.p1	pht004177.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:45:39+00:00	2018-04-26 20:45:39+00:00 	RBIDJS45	Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, black male, exam 4]
25	Carotid IMT	210042	phv00210042.v1.p1	pht004177.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:45:54+00:00	2018-04-26 20:45:54+00:00 	LOPDJS45	Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 4]
25	Carotid IMT	210043	phv00210043.v1.p1	pht004177.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:46:12+00:00	2018-04-26 20:46:12+00:00 	ROPDJS45	Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 4]
25	Carotid IMT	210045	phv00210045.v1.p1	pht004177.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:46:27+00:00	2018-04-26 20:46:27+00:00 	MND45_1S	Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, black male, exam 4]
25	Carotid IMT	210055	phv00210055.v1.p1	pht004178.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:47:32+00:00	2018-04-26 20:47:32+00:00 	LBIBJS45	Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, white females, exam 2]
25	Carotid IMT	210056	phv00210056.v1.p1	pht004178.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:47:50+00:00	2018-04-26 20:47:50+00:00 	RBIBJS45	Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white females, exam 2]
25	Carotid IMT	210057	phv00210057.v1.p1	pht004178.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:48:05+00:00	2018-04-26 20:48:05+00:00 	LINBJS45	Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, white females, exam 2]
25	Carotid IMT	210058	phv00210058.v1.p1	pht004178.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:48:20+00:00	2018-04-26 20:48:20+00:00 	RINBJS45	Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, white females, exam 2]
25	Carotid IMT	210059	phv00210059.v1.p1	pht004178.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:48:33+00:00	2018-04-26 20:48:33+00:00 	LOPBJS45	Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white females, exam 2]
25	Carotid IMT	210060	phv00210060.v1.p1	pht004178.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:48:49+00:00	2018-04-26 20:48:49+00:00 	ROPBJS45	Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white females, exam 2]
25	Carotid IMT	210062	phv00210062.v1.p1	pht004178.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:49:13+00:00	2018-04-26 20:49:13+00:00 	MNB45_1S	Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, white females, exam 2]
25	Carotid IMT	210072	phv00210072.v1.p1	pht004179.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:49:45+00:00	2018-04-26 20:49:45+00:00 	LBICJS45	Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, white females, exam 3]
25	Carotid IMT	210073	phv00210073.v1.p1	pht004179.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:50:00+00:00	2018-04-26 20:50:00+00:00 	RBICJS45	Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white females, exam 3]
25	Carotid IMT	210074	phv00210074.v1.p1	pht004179.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:50:14+00:00	2018-04-26 20:50:14+00:00 	LINCJS45	Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, white females, exam 3]
25	Carotid IMT	210075	phv00210075.v1.p1	pht004179.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:50:33+00:00	2018-04-26 20:50:33+00:00 	RINCJS45	Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, white females, exam 3]
25	Carotid IMT	210076	phv00210076.v1.p1	pht004179.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:50:51+00:00	2018-04-26 20:50:51+00:00 	LOPCJS45	Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white females, exam 3]
25	Carotid IMT	210077	phv00210077.v1.p1	pht004179.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:51:05+00:00	2018-04-26 20:51:05+00:00 	ROPCJS45	Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white females, exam 3]
25	Carotid IMT	210079	phv00210079.v1.p1	pht004179.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:51:20+00:00	2018-04-26 20:51:20+00:00 	MNC45_1S	Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, white females, exam 3]
25	Carotid IMT	210087	phv00210087.v1.p1	pht004180.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:51:57+00:00	2018-04-26 20:51:57+00:00 	LINDJS45	Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, white females, exam 4]
25	Carotid IMT	210088	phv00210088.v1.p1	pht004180.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:52:11+00:00	2018-04-26 20:52:11+00:00 	RINDJS45	Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, white females, exam 4]
25	Carotid IMT	210089	phv00210089.v1.p1	pht004180.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:52:25+00:00	2018-04-26 20:52:25+00:00 	LBIDJS45	Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, white females, exam 4]
25	Carotid IMT	210090	phv00210090.v1.p1	pht004180.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:52:40+00:00	2018-04-26 20:52:40+00:00 	RBIDJS45	Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white females, exam 4]
25	Carotid IMT	210091	phv00210091.v1.p1	pht004180.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:52:54+00:00	2018-04-26 20:52:54+00:00 	LOPDJS45	Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white females, exam 4]
25	Carotid IMT	210092	phv00210092.v1.p1	pht004180.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:53:10+00:00	2018-04-26 20:53:10+00:00 	ROPDJS45	Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white females, exam 4]
25	Carotid IMT	210094	phv00210094.v1.p1	pht004180.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:53:25+00:00	2018-04-26 20:53:25+00:00 	MND45_1S	Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, white females, exam 4]
25	Carotid IMT	210104	phv00210104.v1.p1	pht004181.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:54:02+00:00	2018-04-26 20:54:02+00:00 	LBIBJS45	Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, white males, exam 2]
25	Carotid IMT	210105	phv00210105.v1.p1	pht004181.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:54:26+00:00	2018-04-26 20:54:26+00:00 	RBIBJS45	Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white males, exam 2]
25	Carotid IMT	210106	phv00210106.v1.p1	pht004181.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:54:40+00:00	2018-04-26 20:54:40+00:00 	LINBJS45	Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, white males, exam 2]
25	Carotid IMT	210107	phv00210107.v1.p1	pht004181.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:54:53+00:00	2018-04-26 20:54:53+00:00 	RINBJS45	Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, white males, exam 2]
25	Carotid IMT	210108	phv00210108.v1.p1	pht004181.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:55:06+00:00	2018-04-26 20:55:06+00:00 	LOPBJS45	Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white males, exam 2]
25	Carotid IMT	210109	phv00210109.v1.p1	pht004181.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:55:23+00:00	2018-04-26 20:55:23+00:00 	ROPBJS45	Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white males, exam 2]
25	Carotid IMT	210111	phv00210111.v1.p1	pht004181.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:55:39+00:00	2018-04-26 20:55:39+00:00 	MNB45_1S	Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, white males, exam 2]
25	Carotid IMT	210121	phv00210121.v1.p1	pht004182.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:56:30+00:00	2018-04-26 20:56:30+00:00 	LBICJS45	Imputed R/T Adjusted av45, Shifted, LBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white males, exam 3]
25	Carotid IMT	210122	phv00210122.v1.p1	pht004182.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:56:44+00:00	2018-04-26 20:56:44+00:00 	RBICJS45	Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white males, exam 3]
25	Carotid IMT	210123	phv00210123.v1.p1	pht004182.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:56:59+00:00	2018-04-26 20:56:59+00:00 	LINCJS45	Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, white males, exam 3]
25	Carotid IMT	210124	phv00210124.v1.p1	pht004182.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:57:14+00:00	2018-04-26 20:57:14+00:00 	RINCJS45	Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, white males, exam 3]
25	Carotid IMT	210125	phv00210125.v1.p1	pht004182.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:57:30+00:00	2018-04-26 20:57:30+00:00 	LOPCJS45	Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white males, exam 3]
25	Carotid IMT	210126	phv00210126.v1.p1	pht004182.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:57:44+00:00	2018-04-26 20:57:44+00:00 	ROPCJS45	Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white males, exam 3]
25	Carotid IMT	210128	phv00210128.v1.p1	pht004182.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:58:02+00:00	2018-04-26 20:58:02+00:00 	MNC45_1S	Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, white males, exam 3]
25	Carotid IMT	210136	phv00210136.v1.p1	pht004183.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:58:30+00:00	2018-04-26 20:58:30+00:00 	LINDJS45	Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, white males, exam 4]
25	Carotid IMT	210137	phv00210137.v1.p1	pht004183.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:58:45+00:00	2018-04-26 20:58:45+00:00 	RINDJS45	Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, white males, exam 4]
25	Carotid IMT	210138	phv00210138.v1.p1	pht004183.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:59:01+00:00	2018-04-26 20:59:01+00:00 	LBIDJS45	Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, white males, exam 4]
25	Carotid IMT	210139	phv00210139.v1.p1	pht004183.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:59:18+00:00	2018-04-26 20:59:18+00:00 	RBIDJS45	Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white males, exam 4]
25	Carotid IMT	210140	phv00210140.v1.p1	pht004183.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:59:32+00:00	2018-04-26 20:59:32+00:00 	LOPDJS45	Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white males, exam 4]
25	Carotid IMT	210141	phv00210141.v1.p1	pht004183.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 20:59:48+00:00	2018-04-26 20:59:48+00:00 	ROPDJS45	Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white males, exam 4]
25	Carotid IMT	210143	phv00210143.v1.p1	pht004183.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-26 21:00:03+00:00	2018-04-26 21:00:03+00:00 	MND45_1S	Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, white males, exam 4]
25	Carotid IMT	211101	phv00211101.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:32:07+00:00	2018-05-04 22:32:07+00:00 	ROPAAV45	Average far wall width, right common carotid: optimal angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211102	phv00211102.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:33:55+00:00	2018-05-04 22:33:55+00:00 	RANAAV45	Average far wall width, right common carotid: anterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211103	phv00211103.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:34:29+00:00	2018-05-04 22:34:29+00:00 	RPOAAV45	Average far wall width, right common carotid: posterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211095	phv00211095.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:34:55+00:00	2018-05-04 22:34:55+00:00 	LOPAAV45	Average far wall width, left common carotid: optimal angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211096	phv00211096.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:35:15+00:00	2018-05-04 22:35:15+00:00 	LANAAV45	Average far wall width, left common carotid: anterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211097	phv00211097.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:35:37+00:00	2018-05-04 22:35:37+00:00 	LPOAAV45	Average far wall width, left common carotid: posterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211053	phv00211053.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:36:03+00:00	2018-05-04 22:36:03+00:00 	LOPAMX23	Maximum near wall width, left common carotid: optimal angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211054	phv00211054.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:36:25+00:00	2018-05-04 22:36:25+00:00 	LANAMX23	Maximum near wall width, left common carotid: anterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211055	phv00211055.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:36:46+00:00	2018-05-04 22:36:46+00:00 	LPOAMX23	Maximum near wall width, left common carotid: posterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211059	phv00211059.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:37:28+00:00	2018-05-04 22:37:28+00:00 	ROPAMX23	Maximum near wall width, right common carotid: optimal angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211060	phv00211060.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:37:50+00:00	2018-05-04 22:37:50+00:00 	RANAMX23	Maximum near wall width, right common carotid: anterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211061	phv00211061.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:38:09+00:00	2018-05-04 22:38:09+00:00 	RPOAMX23	Maximum near wall width, right common carotid: posterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211081	phv00211081.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:38:33+00:00	2018-05-04 22:38:33+00:00 	LOPAMX45	Maximum far wall width, left common carotid: optimal angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211082	phv00211082.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:38:58+00:00	2018-05-04 22:38:58+00:00 	LANAMX45	Maximum far wall width, left common carotid: anterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211083	phv00211083.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:39:17+00:00	2018-05-04 22:39:17+00:00 	LPOAMX45	Maximum far wall width, left common carotid: posterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211087	phv00211087.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:39:40+00:00	2018-05-04 22:39:40+00:00 	ROPAMX45	Maximum far wall width, right common carotid: optimal angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211088	phv00211088.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:39:59+00:00	2018-05-04 22:39:59+00:00 	RANAMX45	Maximum far wall width, right common carotid: anterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211089	phv00211089.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-04 22:40:24+00:00	2018-05-04 22:40:24+00:00 	RPOAMX45	Maximum far wall width, right common carotid: posterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	126104	phv00126104.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:27:42+00:00	2018-06-12 01:27:42+00:00 	cca45_1	Maximum likelihood estimate of average right and left common carotid far wall CIMT
25	Carotid IMT	126103	phv00126103.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:28:38+00:00	2018-06-12 01:28:38+00:00 	sum45_1	Maximum likelihood estimate of the average far wall CIMT at the optimal
25	Carotid IMT	211057	phv00211057.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:25:32+00:00	2018-06-12 14:25:32+00:00 	LINAMX23	Maximum near wall width, left internal carotid [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211058	phv00211058.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:25:52+00:00	2018-06-12 14:25:52+00:00 	RPPAMX23	Maximum near wall width, right popliteal [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211062	phv00211062.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:26:47+00:00	2018-06-12 14:26:47+00:00 	RBIAMX23	Maximum near wall width, right bifurcation [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211063	phv00211063.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:27:14+00:00	2018-06-12 14:27:14+00:00 	RINAMX23	Maximum near wall width, right internal carotid [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211064	phv00211064.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:27:35+00:00	2018-06-12 14:27:35+00:00 	QC1AMX23	Maximum near wall width (QC scan 0 1) [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211065	phv00211065.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:27:57+00:00	2018-06-12 14:27:57+00:00 	QC2AMX23	Maximum near wall width (QC scan 02) [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211066	phv00211066.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:28:21+00:00	2018-06-12 14:28:21+00:00 	LPPAAV23	Average near wall width, left popliteal [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211067	phv00211067.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:28:41+00:00	2018-06-12 14:28:41+00:00 	LOPAAV23	Average near wall width, left common carotid: optimal angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211068	phv00211068.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:29:01+00:00	2018-06-12 14:29:01+00:00 	LANAAV23	Average near wall width, left common carotid: anterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211069	phv00211069.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:29:19+00:00	2018-06-12 14:29:19+00:00 	LPOAAV23	Average near wall width, left common carotid: posterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211070	phv00211070.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:29:42+00:00	2018-06-12 14:29:42+00:00 	LBIAAV23	Average near wall width, left bifurcation [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211071	phv00211071.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:30:08+00:00	2018-06-12 14:30:08+00:00 	LINAAV23	Average near wall width, left internal carotid [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211072	phv00211072.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:30:30+00:00	2018-06-12 14:30:30+00:00 	RPPAAV23	Average near wall width, right popliteal [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211073	phv00211073.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:30:48+00:00	2018-06-12 14:30:48+00:00 	ROPAAV23	Average near wall width, right common carotid: optimal angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211074	phv00211074.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:31:10+00:00	2018-06-12 14:31:10+00:00 	RANAAV23	Average near wall width, right common carotid: anterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211075	phv00211075.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:31:29+00:00	2018-06-12 14:31:29+00:00 	RPOAAV23	Average near wall width, right common carotid: posterior angle [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211076	phv00211076.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:31:47+00:00	2018-06-12 14:31:47+00:00 	RBIAAV23	Average near wall width, right bifurcation [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211077	phv00211077.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:32:05+00:00	2018-06-12 14:32:05+00:00 	RINAAV23	Average near wall width, right internal carotid [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211078	phv00211078.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:32:24+00:00	2018-06-12 14:32:24+00:00 	QC1AAV23	Average near wall width (QC scan 0 1) [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211079	phv00211079.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:45:06+00:00	2018-06-12 14:45:06+00:00 	QC2AAV23	Average near wall width (QC scan 02) [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211080	phv00211080.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:45:27+00:00	2018-06-12 14:45:27+00:00 	LPPAMX45	Maximum far wall width, left popliteal [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211084	phv00211084.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:46:26+00:00	2018-06-12 14:46:26+00:00 	LBIAMX45	Maximum far wall width, left bifurcation [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211085	phv00211085.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:46:43+00:00	2018-06-12 14:46:43+00:00 	LINAMX45	Maximum far wall width, left internal carotid [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211086	phv00211086.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:47:08+00:00	2018-06-12 14:47:08+00:00 	RPPAMX45	Maximum far wall width, right popliteal [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211090	phv00211090.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:47:48+00:00	2018-06-12 14:47:48+00:00 	RBIAMX45	Maximum far wall width, right bifurcation [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211091	phv00211091.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:48:13+00:00	2018-06-12 14:48:13+00:00 	RINAMX45	Maximum far wall width, right internal carotid [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211092	phv00211092.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:48:31+00:00	2018-06-12 14:48:31+00:00 	QC1AMX45	Maximum far wall width (QC scan 0 1) [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211093	phv00211093.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:48:51+00:00	2018-06-12 14:48:51+00:00 	QC2AMX45	Maximum far wall width (QC scan 02) [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211094	phv00211094.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:49:06+00:00	2018-06-12 14:49:06+00:00 	LPPAAV45	Average far wall width, left popliteal [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211098	phv00211098.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:50:20+00:00	2018-06-12 14:50:20+00:00 	LBIAAV45	Average far wall width, left bifurcation [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211099	phv00211099.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:50:43+00:00	2018-06-12 14:50:43+00:00 	LINAAV45	Average far wall width, left internal carotid [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211100	phv00211100.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:51:02+00:00	2018-06-12 14:51:02+00:00 	RPPAAV45	Average far wall width, right popliteal [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211104	phv00211104.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:51:56+00:00	2018-06-12 14:51:56+00:00 	RBIAAV45	Average far wall width, right bifurcation [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211105	phv00211105.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:53:48+00:00	2018-06-12 14:53:48+00:00 	RINAAV45	Average far wall width, right internal carotid [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211106	phv00211106.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 14:55:43+00:00	2018-06-12 14:55:43+00:00 	QC1AAV45	Average far wall width (QC scan 0 1) [Ultrasound Derived Data, exam 1]
25	Carotid IMT	211107	phv00211107.v1.p1	pht004207.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:19:20+00:00	2018-06-12 16:19:20+00:00 	QC2AAV45	Average far wall width (QC scan 02) [Ultrasound Derived Data, exam 1]
25	Carotid IMT	212559	phv00212559.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:19:39+00:00	2018-06-12 16:19:39+00:00 	LOPBMX23	Maximum near wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212560	phv00212560.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:20:06+00:00	2018-06-12 16:20:06+00:00 	LANBMX23	Maximum near wall width (left common carotid: anterior angle)
25	Carotid IMT	212561	phv00212561.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:20:27+00:00	2018-06-12 16:20:27+00:00 	LPOBMX23	Maximum near wall width (left common carotid: posterior angle) [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212562	phv00212562.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:20:50+00:00	2018-06-12 16:20:50+00:00 	LBIBMX23	Maximum near wall width (left bifurcation)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212563	phv00212563.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:21:05+00:00	2018-06-12 16:21:05+00:00 	LBNBMX23	Maximum near wall width (left bifurcation focus-near wall)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212564	phv00212564.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:21:26+00:00	2018-06-12 16:21:26+00:00 	LINBMX23	Maximum near wall width (left internal carotid)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212565	phv00212565.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:21:54+00:00	2018-06-12 16:21:54+00:00 	ROPBMX23	Maximum near wall width (right common carotid: anterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212566	phv00212566.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:22:12+00:00	2018-06-12 16:22:12+00:00 	RANBMX23	Maximum near wall width (right common carotid: anterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212567	phv00212567.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:22:30+00:00	2018-06-12 16:22:30+00:00 	RPOBMX23	Maximum near wall width (right common carotid: posterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212568	phv00212568.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:22:52+00:00	2018-06-12 16:22:52+00:00 	RBIBMX23	Maximum near wall width (right bifurcation)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212569	phv00212569.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:23:10+00:00	2018-06-12 16:23:10+00:00 	RBNBMX23	Maximum near wall width (right bifurcation focus-near wall)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212570	phv00212570.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:23:28+00:00	2018-06-12 16:23:28+00:00 	RINBMX23	Maximum near wall width (right internal carotid)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212571	phv00212571.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:23:45+00:00	2018-06-12 16:23:45+00:00 	QC1BMX23	Maximum near wall width (first QC repeat scan)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212572	phv00212572.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:24:03+00:00	2018-06-12 16:24:03+00:00 	QC2BMX23	Maximum near wall width (QC scan 02)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212573	phv00212573.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:24:19+00:00	2018-06-12 16:24:19+00:00 	LOPBAV23	Average near wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 2]  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212574	phv00212574.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:24:35+00:00	2018-06-12 16:24:35+00:00 	LANBAV23	Average near wall width (left common carotid: anterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212575	phv00212575.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:24:51+00:00	2018-06-12 16:24:51+00:00 	LPOBAV23	Average near wall width (left common carotid: posterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212576	phv00212576.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:25:04+00:00	2018-06-12 16:25:04+00:00 	LBIBAV23	Average near wall width (left bifurcation)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212577	phv00212577.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:25:21+00:00	2018-06-12 16:25:21+00:00 	LBNBAV23	Average near wall width (left bifurcation focus-near wall)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212578	phv00212578.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:25:35+00:00	2018-06-12 16:25:35+00:00 	LINBAV23	Average near wall width (left internal carotid)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212579	phv00212579.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:25:53+00:00	2018-06-12 16:25:53+00:00 	ROPBAV23	Average near wall width (right common carotid: anterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212580	phv00212580.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:26:29+00:00	2018-06-12 16:26:29+00:00 	RANBAV23	Average near wall width (right common carotid: anterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212581	phv00212581.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:28:35+00:00	2018-06-12 16:28:35+00:00 	RPOBAV23	Average near wall width (right common carotid: posterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212582	phv00212582.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:28:54+00:00	2018-06-12 16:28:54+00:00 	RBIBAV23	Average near wall width (right bifurcation)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212583	phv00212583.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:29:43+00:00	2018-06-12 16:29:43+00:00 	RBNBAV23	Average near wall width (right bifurcation focus-near wall)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212584	phv00212584.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:29:57+00:00	2018-06-12 16:29:57+00:00 	RINBAV23	Average near wall width (right internal carotid)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212585	phv00212585.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:30:27+00:00	2018-06-12 16:30:27+00:00 	QC1BAV23	Average near wall width (first QC repeat scan)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212586	phv00212586.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:30:44+00:00	2018-06-12 16:30:44+00:00 	QC2BAV23	Average near wall width (QC scan 02)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212587	phv00212587.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:31:02+00:00	2018-06-12 16:31:02+00:00 	LOPBMX45	Maximum far wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212588	phv00212588.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:31:16+00:00	2018-06-12 16:31:16+00:00 	LANBMX45	Maximum far wall width (left common carotid: anterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212589	phv00212589.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:31:35+00:00	2018-06-12 16:31:35+00:00 	LPOBMX45	Maximum far wall width (left common carotid: posterior angle) [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212590	phv00212590.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:31:53+00:00	2018-06-12 16:31:53+00:00 	LBIBMX45	Maximum far wall width (left bifurcation)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212591	phv00212591.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:32:07+00:00	2018-06-12 16:32:07+00:00 	LBFBMX45	Maximum far wall width (left bifurcation focus-far wall)
25	Carotid IMT	212592	phv00212592.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:32:22+00:00	2018-06-12 16:32:22+00:00 	LINBMX45	Maximum far wall width (left internal carotid)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212593	phv00212593.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:33:04+00:00	2018-06-12 16:33:04+00:00 	ROPBMX45	Maximum far wall width (right common carotid: anterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212594	phv00212594.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:33:22+00:00	2018-06-12 16:33:22+00:00 	RANBMX45	Maximum far wall width (right common carotid: anterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212595	phv00212595.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:33:40+00:00	2018-06-12 16:33:40+00:00 	RPOBMX45	Maximum far wall width (right common carotid: posterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212596	phv00212596.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:33:58+00:00	2018-06-12 16:33:58+00:00 	RBIBMX45	Maximum far wall width (right bifurcation)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212597	phv00212597.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:34:13+00:00	2018-06-12 16:34:13+00:00 	RBFBMX45	Maximum far wall width (right bifurcation focus-far wall)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212598	phv00212598.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:34:27+00:00	2018-06-12 16:34:27+00:00 	RINBMX45	Maximum far wall width (right internal carotid)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212599	phv00212599.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:34:45+00:00	2018-06-12 16:34:45+00:00 	QC1BMX45	Maximum far wall width (first QC repeat scan)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212600	phv00212600.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:35:01+00:00	2018-06-12 16:35:01+00:00 	QC2BMX45	Maximum far wall width (QC scan 02)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212601	phv00212601.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:35:18+00:00	2018-06-12 16:35:18+00:00 	LOPBAV45	Average far wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 2]  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212602	phv00212602.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:35:38+00:00	2018-06-12 16:35:38+00:00 	LANBAV45	Average far wall width (left common carotid: anterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212603	phv00212603.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:35:54+00:00	2018-06-12 16:35:54+00:00 	LPOBAV45	Average far wall width (left common carotid: posterior angle) [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212604	phv00212604.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:36:10+00:00	2018-06-12 16:36:10+00:00 	LBIBAV45	Average far wall width (left bifurcation)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212605	phv00212605.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 16:36:37+00:00	2018-06-12 16:36:37+00:00 	LBFBAV45	Average far wall width (left bifurcation focus-far wall)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212606	phv00212606.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:22:46+00:00	2018-06-12 19:22:46+00:00 	LINBAV45	Average far wall width (left internal carotid)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212607	phv00212607.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:23:08+00:00	2018-06-12 19:23:08+00:00 	ROPBAV45	Average far wall width (right common carotid: anterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212608	phv00212608.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:23:26+00:00	2018-06-12 19:23:26+00:00 	RANBAV45	Average far wall width (right common carotid: anterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212609	phv00212609.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:23:44+00:00	2018-06-12 19:23:44+00:00 	RPOBAV45	Average far wall width (right common carotid: posterior angle)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212610	phv00212610.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:24:04+00:00	2018-06-12 19:24:04+00:00 	RBIBAV45	Average far wall width (right bifurcation)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212611	phv00212611.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:24:22+00:00	2018-06-12 19:24:22+00:00 	RBFBAV45	Average far wall width (right bifurcation focus-far wall)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212612	phv00212612.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:24:42+00:00	2018-06-12 19:24:42+00:00 	RINBAV45	Average far wall width (right internal carotid)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	212613	phv00212613.v1.p1	pht004213.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:24:59+00:00	2018-06-12 19:24:59+00:00 	QC1BAV45	Average far wall width (first QC repeat scan)  [Ultrasound Derived Data, exam 2]
25	Carotid IMT	213911	phv00213911.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:27:14+00:00	2018-06-12 19:27:14+00:00 	LOPDMX23	Maximum near wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213912	phv00213912.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:27:33+00:00	2018-06-12 19:27:33+00:00 	ROPDMX23	Maximum near wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213913	phv00213913.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:27:48+00:00	2018-06-12 19:27:48+00:00 	LBIDMX23	Maximum near wall width (left bifurcation) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213914	phv00213914.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:28:10+00:00	2018-06-12 19:28:10+00:00 	RBIDMX23	Maximum near wall width (right bifurcation) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213915	phv00213915.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:28:25+00:00	2018-06-12 19:28:25+00:00 	LBNDMX23	Maximum near wall width (left bifurcation focus-near wall) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213916	phv00213916.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:28:41+00:00	2018-06-12 19:28:41+00:00 	RBNDMX23	Maximum near wall width (right bifurcation focus-near wall) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213917	phv00213917.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:28:58+00:00	2018-06-12 19:28:58+00:00 	LINDMX23	Maximum near wall width (left internal carotid) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213918	phv00213918.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:29:15+00:00	2018-06-12 19:29:15+00:00 	RINDMX23	Maximum near wall width (right internal carotid) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213919	phv00213919.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:29:34+00:00	2018-06-12 19:29:34+00:00 	QC1DMX23	Maximum near wall width (first QC repeat scan) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213920	phv00213920.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:29:50+00:00	2018-06-12 19:29:50+00:00 	QC2DMX23	Maximum near wall width (QC scan 02) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213921	phv00213921.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:30:09+00:00	2018-06-12 19:30:09+00:00 	LOPDAV23	Average near wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213922	phv00213922.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:30:24+00:00	2018-06-12 19:30:24+00:00 	ROPDAV23	Average near wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213923	phv00213923.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:30:38+00:00	2018-06-12 19:30:38+00:00 	LBIDAV23	Average near wall width (left bifurcation) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213924	phv00213924.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:30:52+00:00	2018-06-12 19:30:52+00:00 	RBIDAV23	Average near wall width (right bifurcation) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213925	phv00213925.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:31:14+00:00	2018-06-12 19:31:14+00:00 	LBNDAV23	Average near wall width (left bifurcation focus-near wall) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213926	phv00213926.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:32:15+00:00	2018-06-12 19:32:15+00:00 	RBNDAV23	Average near wall width (right bifurcation focus-near wall) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213927	phv00213927.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:32:31+00:00	2018-06-12 19:32:31+00:00 	LINDAV23	Average near wall width (left internal carotid) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213928	phv00213928.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:32:50+00:00	2018-06-12 19:32:50+00:00 	RINDAV23	Average near wall width (right internal carotid) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213929	phv00213929.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:33:06+00:00	2018-06-12 19:33:06+00:00 	QC1DAV23	Average near wall width (first QC repeat scan) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213930	phv00213930.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:33:23+00:00	2018-06-12 19:33:23+00:00 	QC2DAV23	Average near wall width (QC scan 02) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213931	phv00213931.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:33:41+00:00	2018-06-12 19:33:41+00:00 	LOPDMX45	Maximum far wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213932	phv00213932.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:33:55+00:00	2018-06-12 19:33:55+00:00 	ROPDMX45	Maximum far wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213933	phv00213933.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:34:10+00:00	2018-06-12 19:34:10+00:00 	LBIDMX45	Maximum far wall width (left bifurcation) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213934	phv00213934.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:34:28+00:00	2018-06-12 19:34:28+00:00 	RBIDMX45	Maximum far wall width (right bifurcation) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213935	phv00213935.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:34:42+00:00	2018-06-12 19:34:42+00:00 	LBFDMX45	Maximum far wall width (left bifurcation focus-far wall) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213936	phv00213936.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:34:57+00:00	2018-06-12 19:34:57+00:00 	RBFDMX45	Maximum far wall width (right bifurcation focus-far wall) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213937	phv00213937.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:35:14+00:00	2018-06-12 19:35:14+00:00 	LINDMX45	Maximum far wall width (left internal carotid) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213938	phv00213938.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:35:32+00:00	2018-06-12 19:35:32+00:00 	RINDMX45	Maximum far wall width (right internal carotid) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213939	phv00213939.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:35:46+00:00	2018-06-12 19:35:46+00:00 	QC1DMX45	Maximum far wall width (first QC repeat scan) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213940	phv00213940.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:36:02+00:00	2018-06-12 19:36:02+00:00 	QC2DMX45	Maximum far wall width (QC scan 02) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213941	phv00213941.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:36:20+00:00	2018-06-12 19:36:20+00:00 	LOPDAV45	Average far wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213942	phv00213942.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:36:35+00:00	2018-06-12 19:36:35+00:00 	ROPDAV45	Average far wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213943	phv00213943.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:36:50+00:00	2018-06-12 19:36:50+00:00 	LBIDAV45	Average far wall width (left bifurcation) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213944	phv00213944.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:37:04+00:00	2018-06-12 19:37:04+00:00 	RBIDAV45	Average far wall width (right bifurcation) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213945	phv00213945.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:37:20+00:00	2018-06-12 19:37:20+00:00 	LBFDAV45	Average far wall width (left bifurcation focus-far wall)  [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213946	phv00213946.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:37:36+00:00	2018-06-12 19:37:36+00:00 	RBFDAV45	Average far wall width (right bifurcation focus-far wall) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213947	phv00213947.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:37:50+00:00	2018-06-12 19:37:50+00:00 	LINDAV45	Average far wall width (left internal carotid) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213948	phv00213948.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:38:16+00:00	2018-06-12 19:38:16+00:00 	RINDAV45	Average far wall width (right internal carotid) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213949	phv00213949.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:38:33+00:00	2018-06-12 19:38:33+00:00 	QC1DAV45	Average far wall width (first QC repeat scan) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	213950	phv00213950.v1.p1	pht004223.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-12 19:59:54+00:00	2018-06-12 19:59:54+00:00 	QC2DAV45	Average far wall width (QC scan 02) [Ultrasound Derived Data, exam 4]
25	Carotid IMT	100864	phv00100864.v1.p1	pht001468.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:52:45+00:00	2018-06-27 23:52:45+00:00 	CCA_FWME	Mean of the mean far wall intima media t (var=CCA_FWME)
25	Carotid IMT	100865	phv00100865.v1.p1	pht001468.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:52:58+00:00	2018-06-27 23:52:58+00:00 	ICA_FWME	Mean of the mean far wall intima-media t
25	Carotid IMT	100444	phv00100444.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:58:40+00:00	2018-06-27 23:58:40+00:00 	MAXINT	MAXINT FROM BASELINE REREADS (mm)
25	Carotid IMT	100446	phv00100446.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:59:16+00:00	2018-06-27 23:59:16+00:00 	MAXCOM	AVE N&F WALL MAX COM (mm)
25	Carotid IMT	100094	phv00100094.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:04:36+00:00	2018-06-28 00:04:36+00:00 	MAXCOM	AVE N&F WALL MAX, COM (mm)
25	Carotid IMT	100095	phv00100095.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:04:48+00:00	2018-06-28 00:04:48+00:00 	MAXINT	AVE N&F WALL MAX, INT (mm)
25	Carotid IMT	101179	phv00101179.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:06:14+00:00	2018-06-28 00:06:14+00:00 	MAXCOMBL	ORIGINAL BASELINE MAXCOM
25	Carotid IMT	101180	phv00101180.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:06:27+00:00	2018-06-28 00:06:27+00:00 	MAXINTBL	ORIGINAL BASELINE MAXINT
25	Carotid IMT	101287	phv00101287.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:07:31+00:00	2018-06-28 00:07:31+00:00 	MAXCOM55	BL REREAD MAXCOM
25	Carotid IMT	101288	phv00101288.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:07:49+00:00	2018-06-28 00:07:49+00:00 	MAXINT55	BL REREAD MAXINT
25	Carotid IMT	101289	phv00101289.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:08:02+00:00	2018-06-28 00:08:02+00:00 	MAXCOM41	YEAR 5 MAXCOM
25	Carotid IMT	101290	phv00101290.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:08:13+00:00	2018-06-28 00:08:13+00:00 	MAXINT41	YEAR 5 MAXINT
25	Carotid IMT	102978	phv00102978.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:08:30+00:00	2018-06-28 00:08:30+00:00 	MAXCOM92	AVE N&F WALL MAX,  COMMON,  YR 11
25	Carotid IMT	102979	phv00102979.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:08:49+00:00	2018-06-28 00:08:49+00:00 	MAXINT92	AVE N&F WALL MAX,  INTERNAL,  YR 11
25	Carotid IMT	101130	phv00101130.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:41:57+00:00	2018-06-29 16:41:57+00:00 	PW1BL	ORIG BASELINE P WAVE, RT SIDE
25	Carotid IMT	101131	phv00101131.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:42:08+00:00	2018-06-29 16:42:08+00:00 	CW1BL	ORIG BASELINE C WAVE, RT SIDE
25	Carotid IMT	101137	phv00101137.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:44:01+00:00	2018-06-29 16:44:01+00:00 	PW2BL	ORIG BASELINE P WAVE, LEFT SIDE
25	Carotid IMT	101138	phv00101138.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:44:16+00:00	2018-06-29 16:44:16+00:00 	CW2BL	ORIG BASELINE C WAVE, LEFT SIDE
25	Carotid IMT	101139	phv00101139.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:44:28+00:00	2018-06-29 16:44:28+00:00 	VMAX1BL	ORIG BASELINE VESSEL MAX, R. COMMON
25	Carotid IMT	101140	phv00101140.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:44:40+00:00	2018-06-29 16:44:40+00:00 	NMAX1BL	ORIG BASELINE NEAR WALL MAX, R. COMMON
25	Carotid IMT	101147	phv00101147.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:45:00+00:00	2018-06-29 16:45:00+00:00 	FMAX2BL	ORIG BASELINE FAR WALL MAX, R. ANTERIOR
25	Carotid IMT	101160	phv00101160.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:45:47+00:00	2018-06-29 16:45:47+00:00 	NMAX5BL	ORIG BASELINE NEAR WALL MAX, L. COMMON
25	Carotid IMT	101155	phv00101155.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:46:12+00:00	2018-06-29 16:46:12+00:00 	NMAX4BL	ORIG BASELINE NEAR WALL MAX, R. POSTERIOR
25	Carotid IMT	101154	phv00101154.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:46:24+00:00	2018-06-29 16:46:24+00:00 	VMAX4BL	ORIG BASELINE VESSEL MAX, R. POSTERIOR
25	Carotid IMT	101150	phv00101150.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:47:08+00:00	2018-06-29 16:47:08+00:00 	NMAX3BL	ORIG BASELINE NEAR WALL MAX, R. LATERAL
25	Carotid IMT	101149	phv00101149.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:47:19+00:00	2018-06-29 16:47:19+00:00 	VMAX3BL	ORIG BASELINE VESSEL MAX, R. LATERAL
25	Carotid IMT	101152	phv00101152.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:47:55+00:00	2018-06-29 16:47:55+00:00 	FMAX3BL	ORIG BASELINE FAR WALL MAX, R. LATERAL
25	Carotid IMT	101157	phv00101157.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:48:36+00:00	2018-06-29 16:48:36+00:00 	FMAX4BL	ORIG BASELINE FAR WALL MAX, R. POSTERIOR
25	Carotid IMT	101159	phv00101159.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:49:02+00:00	2018-06-29 16:49:02+00:00 	VMAX5BL	ORIG BASELINE VESSEL MAX, L. COMMON
25	Carotid IMT	101164	phv00101164.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:49:29+00:00	2018-06-29 16:49:29+00:00 	VMAX6BL	ORIG BASELINE VESSEL MAX, L. ANTERIOR
25	Carotid IMT	101165	phv00101165.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:49:41+00:00	2018-06-29 16:49:41+00:00 	NMAX6BL	ORIG BASELINE NEAR WALL MAX, L. ANTERIOR
25	Carotid IMT	101167	phv00101167.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:50:00+00:00	2018-06-29 16:50:00+00:00 	FMAX6BL	ORIG BASELINE FAR WALL MAX, L. ANTERIOR
25	Carotid IMT	101169	phv00101169.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:50:43+00:00	2018-06-29 16:50:43+00:00 	VMAX7BL	ORIG BASELINE VESSEL MAX, L. LATERAL
25	Carotid IMT	101170	phv00101170.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:50:54+00:00	2018-06-29 16:50:54+00:00 	NMAX7BL	ORIG BASELINE NEAR WALL MAX, L. LATERAL
25	Carotid IMT	101174	phv00101174.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:51:20+00:00	2018-06-29 16:51:20+00:00 	VMAX8BL	ORIG BASELINE VESSEL MAX, L. POSTERIOR
25	Carotid IMT	101172	phv00101172.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:51:30+00:00	2018-06-29 16:51:30+00:00 	FMAX7BL	ORIG BASELINE FAR WALL MAX, L. LATERAL
25	Carotid IMT	101175	phv00101175.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:52:15+00:00	2018-06-29 16:52:15+00:00 	NMAX8BL	ORIG BASELINE NEAR WALL MAX, L. POSTERIOR
25	Carotid IMT	101177	phv00101177.v1.p1	pht001471.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:52:41+00:00	2018-06-29 16:52:41+00:00 	FMAX8BL	ORIG BASELINE FAR WALL MAX, L. POSTERIOR
25	Carotid IMT	101192	phv00101192.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:55:45+00:00	2018-06-29 16:55:45+00:00 	VMAX192	VESSEL MAX, R COM CAROT
25	Carotid IMT	101193	phv00101193.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:55:56+00:00	2018-06-29 16:55:56+00:00 	NMAX192	NEAR WALL MAX, R COM CAROT
25	Carotid IMT	101195	phv00101195.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:56:22+00:00	2018-06-29 16:56:22+00:00 	FMAX192	FAR WALL MAX, R COM CAROT
25	Carotid IMT	101198	phv00101198.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:56:34+00:00	2018-06-29 16:56:34+00:00 	NMAX292	NEAR WALL MAX, R ANT OBLIQ
25	Carotid IMT	101200	phv00101200.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:56:55+00:00	2018-06-29 16:56:55+00:00 	FMAX292	FAR WALL MAX, R ANT OBLIQ
25	Carotid IMT	101203	phv00101203.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:57:56+00:00	2018-06-29 16:57:56+00:00 	NMAX392	NEAR WALL MAX, R LAT OBLIQ
25	Carotid IMT	101210	phv00101210.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:58:45+00:00	2018-06-29 16:58:45+00:00 	FMAX492	FAR WALL MAX, R POST OBLIQ
25	Carotid IMT	101212	phv00101212.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:59:15+00:00	2018-06-29 16:59:15+00:00 	VMAX592	VESSEL MAX, L COM CAROT
25	Carotid IMT	101213	phv00101213.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:59:26+00:00	2018-06-29 16:59:26+00:00 	NMAX592	NEAR WALL MAX, L COM CAROT
25	Carotid IMT	101215	phv00101215.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:59:46+00:00	2018-06-29 16:59:46+00:00 	FMAX592	FAR WALL MAX, L COM CAROT
25	Carotid IMT	101217	phv00101217.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:00:07+00:00	2018-06-29 17:00:07+00:00 	VMAX692	VESSEL MAX, L ANT OBLIQ
25	Carotid IMT	101218	phv00101218.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:00:19+00:00	2018-06-29 17:00:19+00:00 	NMAX692	NEAR WALL MAX, L ANT OBLIQ
25	Carotid IMT	101220	phv00101220.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:00:42+00:00	2018-06-29 17:00:42+00:00 	FMAX692	FAR WALL MAX, L ANT OBLIQ
25	Carotid IMT	101222	phv00101222.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:00:52+00:00	2018-06-29 17:00:52+00:00 	VMAX792	VESSEL MAX, L LAT OBLIQ
25	Carotid IMT	101223	phv00101223.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:01:02+00:00	2018-06-29 17:01:02+00:00 	NMAX792	NEAR WALL MAX, L LAT OBLIQ
25	Carotid IMT	101227	phv00101227.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:01:51+00:00	2018-06-29 17:01:51+00:00 	VMAX892	VESSEL MAX, L POST OBLIQ
25	Carotid IMT	101228	phv00101228.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:02:02+00:00	2018-06-29 17:02:02+00:00 	NMAX892	NEAR WALL MAX, L POST OBLIQ
25	Carotid IMT	101230	phv00101230.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:02:29+00:00	2018-06-29 17:02:29+00:00 	FMAX892	FAR WALL MAX, L POST OBLIQ
25	Carotid IMT	101208	phv00101208.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:03:23+00:00	2018-06-29 17:03:23+00:00 	NMAX492	NEAR WALL MAX, R POST OBLIQ
25	Carotid IMT	101205	phv00101205.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:03:45+00:00	2018-06-29 17:03:45+00:00 	FMAX392	FAR WALL MAX, R LAT OBLIQ
25	Carotid IMT	101207	phv00101207.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:04:23+00:00	2018-06-29 17:04:23+00:00 	VMAX492	VESSEL MAX, R POST OBLIQ
25	Carotid IMT	101202	phv00101202.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:04:53+00:00	2018-06-29 17:04:53+00:00 	VMAX392	VESSEL MAX, R LAT OBLIQ
25	Carotid IMT	101197	phv00101197.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:05:33+00:00	2018-06-29 17:05:33+00:00 	VMAX292	VESSEL MAX, R ANT OBLIQ
25	Carotid IMT	101235	phv00101235.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:06:54+00:00	2018-06-29 17:06:54+00:00 	PW155	BL REREAD P WAVE, RT SIDE
25	Carotid IMT	101236	phv00101236.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:07:09+00:00	2018-06-29 17:07:09+00:00 	PW255	BL REREAD P WAVE, LFT SIDE
25	Carotid IMT	101237	phv00101237.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:07:19+00:00	2018-06-29 17:07:19+00:00 	VMAX155	BL REREAD VESSEL MAX, R. COMMON
25	Carotid IMT	101238	phv00101238.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:07:32+00:00	2018-06-29 17:07:32+00:00 	NMAX155	BL REREAD NEAR WALL MAX, R. COMMON
25	Carotid IMT	101239	phv00101239.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:07:46+00:00	2018-06-29 17:07:46+00:00 	FMAX155	BL REREAD FAR WALL MAX, R. COMMON
25	Carotid IMT	101240	phv00101240.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:08:09+00:00	2018-06-29 17:08:09+00:00 	VMAX255	BL REREAD VESSEL MAX, R. ANTERIOR
25	Carotid IMT	101241	phv00101241.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:08:21+00:00	2018-06-29 17:08:21+00:00 	NMAX255	BL REREAD NEAR WALL MAX, R. ANTERIOR
25	Carotid IMT	101242	phv00101242.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:08:32+00:00	2018-06-29 17:08:32+00:00 	FMAX255	BL REREAD FAR WALL MAX, R. ANTERIOR
25	Carotid IMT	101243	phv00101243.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:08:59+00:00	2018-06-29 17:08:59+00:00 	VMAX355	BL REREAD VESSEL MAX, R. LATERAL
25	Carotid IMT	101244	phv00101244.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:09:17+00:00	2018-06-29 17:09:17+00:00 	NMAX355	BL REREAD NEAR WALL MAX, R. LATERAL
25	Carotid IMT	101245	phv00101245.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:09:28+00:00	2018-06-29 17:09:28+00:00 	FMAX355	BL REREAD FAR WALL MAX, R. LATERAL
25	Carotid IMT	101246	phv00101246.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:09:44+00:00	2018-06-29 17:09:44+00:00 	VMAX455	BL REREAD VESSEL MAX, R. POSTERIOR
25	Carotid IMT	101250	phv00101250.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:09:54+00:00	2018-06-29 17:09:54+00:00 	NMAX555	BL REREAD NEAR WALL MAX, L. COMMON
25	Carotid IMT	101248	phv00101248.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:10:04+00:00	2018-06-29 17:10:04+00:00 	FMAX455	BL REREAD FAR WALL MAX, R. POSTERIOR
25	Carotid IMT	101249	phv00101249.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:10:14+00:00	2018-06-29 17:10:14+00:00 	VMAX555	BL REREAD VESSEL MAX, L. COMMON
25	Carotid IMT	101251	phv00101251.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:10:28+00:00	2018-06-29 17:10:28+00:00 	FMAX555	BL REREAD FAR WALL MAX, L. COMMON
25	Carotid IMT	101252	phv00101252.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:10:56+00:00	2018-06-29 17:10:56+00:00 	VMAX655	BL REREAD VESSEL MAX, L. ANTERIOR
25	Carotid IMT	101253	phv00101253.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:11:07+00:00	2018-06-29 17:11:07+00:00 	NMAX655	BL REREAD NEAR WALL MAX, L. ANTERIOR
25	Carotid IMT	101254	phv00101254.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:11:24+00:00	2018-06-29 17:11:24+00:00 	FMAX655	BL REREAD FAR WALL MAX, L. ANTERIOR
25	Carotid IMT	101255	phv00101255.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:11:42+00:00	2018-06-29 17:11:42+00:00 	VMAX755	BL REREAD VESSEL MAX, L. LATERAL
25	Carotid IMT	101256	phv00101256.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:11:53+00:00	2018-06-29 17:11:53+00:00 	NMAX755	BL REREAD NEAR WALL MAX, L. LATERAL
25	Carotid IMT	101257	phv00101257.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:12:04+00:00	2018-06-29 17:12:04+00:00 	FMAX755	BL REREAD FAR WALL MAX, L. LATERAL
25	Carotid IMT	101258	phv00101258.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:24:52+00:00	2018-06-29 17:24:52+00:00 	VMAX855	BL REREAD VESSEL MAX, L. POSTERIOR
25	Carotid IMT	101261	phv00101261.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:25:38+00:00	2018-06-29 17:25:38+00:00 	PW141	YEAR 5 P WAVE, RT SIDE
25	Carotid IMT	101262	phv00101262.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:25:50+00:00	2018-06-29 17:25:50+00:00 	PW241	YEAR 5 P WAVE, LFT SIDE
25	Carotid IMT	101263	phv00101263.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:26:01+00:00	2018-06-29 17:26:01+00:00 	VMAX141	YEAR 5 VESSEL MAX, R. COMMON
25	Carotid IMT	101264	phv00101264.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:26:15+00:00	2018-06-29 17:26:15+00:00 	NMAX141	YEAR 5 NEAR WALL MAX, R. COMMON
25	Carotid IMT	101265	phv00101265.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:26:32+00:00	2018-06-29 17:26:32+00:00 	FMAX141	YEAR 5 FAR WALL MAX, R. COMMON
25	Carotid IMT	101266	phv00101266.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:26:48+00:00	2018-06-29 17:26:48+00:00 	VMAX241	YEAR 5 VESSEL MAX, R. ANTERIOR
25	Carotid IMT	101268	phv00101268.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:27:01+00:00	2018-06-29 17:27:01+00:00 	FMAX241	YEAR 5 FAR WALL MAX, R. ANTERIOR
25	Carotid IMT	101267	phv00101267.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:27:15+00:00	2018-06-29 17:27:15+00:00 	NMAX241	YEAR 5 NEAR WALL MAX, R. ANTERIOR
25	Carotid IMT	101269	phv00101269.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:27:35+00:00	2018-06-29 17:27:35+00:00 	VMAX341	YEAR 5 VESSEL MAX, R. LATERAL
25	Carotid IMT	101270	phv00101270.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:27:49+00:00	2018-06-29 17:27:49+00:00 	NMAX341	YEAR 5 NEAR WALL MAX, R. LATERAL
25	Carotid IMT	101271	phv00101271.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:27:59+00:00	2018-06-29 17:27:59+00:00 	FMAX341	YEAR 5 FAR WALL MAX, R. LATERAL
25	Carotid IMT	101272	phv00101272.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:28:07+00:00	2018-06-29 17:28:07+00:00 	VMAX441	YEAR 5 VESSEL MAX, R. POSTERIOR
25	Carotid IMT	101273	phv00101273.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:28:25+00:00	2018-06-29 17:28:25+00:00 	NMAX441	YEAR 5 NEAR WALL MAX, R. POSTERIOR
25	Carotid IMT	101274	phv00101274.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:28:37+00:00	2018-06-29 17:28:37+00:00 	FMAX441	YEAR 5 FAR WALL MAX, R. POSTERIOR
25	Carotid IMT	101275	phv00101275.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:28:49+00:00	2018-06-29 17:28:49+00:00 	VMAX541	YEAR 5 VESSEL MAX, L. COMMON
25	Carotid IMT	101276	phv00101276.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:29:04+00:00	2018-06-29 17:29:04+00:00 	NMAX541	YEAR 5 NEAR WALL MAX, L. COMMON
25	Carotid IMT	101277	phv00101277.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:29:14+00:00	2018-06-29 17:29:14+00:00 	FMAX541	YEAR 5 FAR WALL MAX, L. COMMON
25	Carotid IMT	101278	phv00101278.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:29:26+00:00	2018-06-29 17:29:26+00:00 	VMAX641	YEAR 5 VESSEL MAX, L. ANTERIOR
25	Carotid IMT	101279	phv00101279.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:29:37+00:00	2018-06-29 17:29:37+00:00 	NMAX641	YEAR 5 NEAR WALL MAX, L. ANTERIOR
25	Carotid IMT	101280	phv00101280.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:33:02+00:00	2018-06-29 17:33:02+00:00 	FMAX641	YEAR 5 FAR WALL MAX, L. ANTERIOR
25	Carotid IMT	101281	phv00101281.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:33:54+00:00	2018-06-29 17:33:54+00:00 	VMAX741	YEAR 5 VESSEL MAX, L. LATERAL
25	Carotid IMT	101282	phv00101282.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:34:04+00:00	2018-06-29 17:34:04+00:00 	NMAX741	YEAR 5 NEAR WALL MAX, L. LATERAL
25	Carotid IMT	101283	phv00101283.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:34:13+00:00	2018-06-29 17:34:13+00:00 	FMAX741	YEAR 5 FAR WALL MAX, L. LATERAL
25	Carotid IMT	101284	phv00101284.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:34:31+00:00	2018-06-29 17:34:31+00:00 	VMAX841	YEAR 5 VESSEL MAX, L. POSTERIOR
25	Carotid IMT	101285	phv00101285.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:34:43+00:00	2018-06-29 17:34:43+00:00 	NMAX841	YEAR 5 NEAR WALL MAX, L. POSTERIOR
25	Carotid IMT	101286	phv00101286.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:34:56+00:00	2018-06-29 17:34:56+00:00 	FMAX841	YEAR 5 FAR WALL MAX, L. POSTERIOR
25	Carotid IMT	101300	phv00101300.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:36:29+00:00	2018-06-29 17:36:29+00:00 	FMAX348	FAR WALL MAX, LONGITUDINAL
25	Carotid IMT	101301	phv00101301.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:36:38+00:00	2018-06-29 17:36:38+00:00 	VMAX448	VESSEL MAX, WIDEST PORTION
25	Carotid IMT	21730	phv00021730.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:38:52+00:00	2018-07-03 17:38:52+00:00 	CCD_MEME	MEAN OF MEAN IMT FOR BOTH LEFT AND RIGHT COMMON CAROTID ARTERIES IN DIASTOLE (MM)
25	Carotid IMT	21728	phv00021728.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:39:12+00:00	2018-07-03 17:39:12+00:00 	CCD_MEMX	MEAN OF MAX IMT FOR BOTH LEFT AND RIGHT COMMON CAROTID ARTERIES IN DIASTOLE (MM)
25	Carotid IMT	21731	phv00021731.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:39:27+00:00	2018-07-03 17:39:27+00:00 	CCS_MEME	MEAN OF MEAN IMT FOR BOTH LEFT AND RIGHT COMMON CAROTID ARTERIES IN SYSTOLE (MM)
25	Carotid IMT	21729	phv00021729.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:39:37+00:00	2018-07-03 17:39:37+00:00 	CCS_MEMX	MEAN OF MAX IMT FOR BOTH LEFT AND RIGHT COMMON CAROTID ARTERIES IN SYSTOLE (MM)
25	Carotid IMT	21733	phv00021733.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:39:51+00:00	2018-07-03 17:39:51+00:00 	ICB_MEME	MEAN OF MEAN IMT FOR BOTH LEFT AND RIGHT COMMON  CAROTID BULB/INTERNAL CAROTID ARTERY (MM)
25	Carotid IMT	21732	phv00021732.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:40:31+00:00	2018-07-03 17:40:31+00:00 	ICB_MEMX	MEAN OF MAX IMT FOR BOTH LEFT AND RIGHT COMMON  CAROTID BULB/INTERNAL CAROTID ARTERY (MM)
25	Carotid IMT	21735	phv00021735.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:40:48+00:00	2018-07-03 17:40:48+00:00 	ICD_MEME	MEAN OF MEAN IMT FOR BOTH LEFT AND RIGHT DISTAL INTERNAL CAROTID ARTERIES (MM)
25	Carotid IMT	21734	phv00021734.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:40:58+00:00	2018-07-03 17:40:58+00:00 	ICD_MEMX	MEAN OF MAX IMT FOR BOTH LEFT AND RIGHT DISTAL  INTERNAL CAROTID ARTERIES (MM)
25	Carotid IMT	21721	phv00021721.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:41:23+00:00	2018-07-03 17:41:23+00:00 	LB_MEME	MEAN OF MEAN IMT LEFT COMMON CAROTID BULB/INTERNAL CAROTID ARTERY (MM)
25	Carotid IMT	21720	phv00021720.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:41:36+00:00	2018-07-03 17:41:36+00:00 	LB_MEMX	MEAN OF MAX IMT LEFT COMMON CAROTID  BULB/INTERNAL CAROTID ARTERY (MM)
25	Carotid IMT	21719	phv00021719.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:41:49+00:00	2018-07-03 17:41:49+00:00 	LCD_MEME	MEAN OF MEAN IMT LEFT COMMON CAROTID ARTERY IN DIASTOLE (MM)
25	Carotid IMT	21717	phv00021717.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:42:00+00:00	2018-07-03 17:42:00+00:00 	LCD_MEMX	MEAN OF MAX IMT LEFT COMMON CAROTID ARTERY IN DIASTOLE (MM)
25	Carotid IMT	21718	phv00021718.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:42:51+00:00	2018-07-03 17:42:51+00:00 	LCS_MEME	MEAN OF MEAN IMT LEFT COMMON CAROTID ARTERY IN SYSTOLE (MM)
25	Carotid IMT	21716	phv00021716.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:43:56+00:00	2018-07-03 17:43:56+00:00 	LCS_MEMX	MEAN OF MAX IMT LEFT COMMON CAROTID ARTERY IN SYSTOLE (MM)
25	Carotid IMT	21723	phv00021723.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:44:11+00:00	2018-07-03 17:44:11+00:00 	LI_MEME	MEAN OF MEAN IMT LEFT INTERNAL CAROTID ARTERY  PROPER (MM)
25	Carotid IMT	21722	phv00021722.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:44:20+00:00	2018-07-03 17:44:20+00:00 	LI_MEMX	MEAN OF MAX IMT LEFT INTERNAL CAROTID ARTERY  PROPER (MM)
25	Carotid IMT	21736	phv00021736.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:44:59+00:00	2018-07-03 17:44:59+00:00 	R_MAXIMT	MAX IMT ON RIGHT SIDE (MM)
25	Carotid IMT	21713	phv00021713.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:45:26+00:00	2018-07-03 17:45:26+00:00 	RB_MEME	MEAN OF MEAN IMT RIGHT COMMON CAROTID  BULB/INTERNAL CAROTID ARTERY (MM)
25	Carotid IMT	21712	phv00021712.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:45:36+00:00	2018-07-03 17:45:36+00:00 	RB_MEMX	MEAN OF MAX IMT RIGHT COMMON CAROTID BULB/INTERNAL  CAROTID ARTERY (MM)
25	Carotid IMT	21707	phv00021707.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:45:59+00:00	2018-07-03 17:45:59+00:00 	RCD_MEME	MEAN OF MEAN IMT RIGHT COMMON CAROTID ARTERY  IN DIASTOLE (MM)
25	Carotid IMT	21705	phv00021705.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:46:11+00:00	2018-07-03 17:46:11+00:00 	RCD_MEMX	MEAN OF MAX IMT RIGHT COMMON CAROTID ARTERY  IN DIASTOLE (MM)
25	Carotid IMT	21706	phv00021706.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:46:32+00:00	2018-07-03 17:46:32+00:00 	RCS_MEME	MEAN OF MEAN IMT RIGHT COMMON CAROTID ARTERY IN SYSTOLE (MM)
25	Carotid IMT	21704	phv00021704.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:46:45+00:00	2018-07-03 17:46:45+00:00 	RCS_MEMX	MEAN OF MAX IMT RIGHT COMMON CAROTID ARTERY IN SYSTOLE (MM)
25	Carotid IMT	21715	phv00021715.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:47:02+00:00	2018-07-03 17:47:02+00:00 	RI_MEME	MEAN OF MEAN IMT RIGHT INTERNAL CAROTID ARTERY PROPER (MM)
25	Carotid IMT	21714	phv00021714.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:47:12+00:00	2018-07-03 17:47:12+00:00 	RI_MEMX	MEAN OF MAX IMT RIGHT INTERNAL CAROTID ARTERY PROPER (MM)
25	Carotid IMT	76366	phv00076366.v4.p10	pht000907.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:48:19+00:00	2018-07-03 17:48:19+00:00 	cca_fw_mean_imt	Mean of the mean common carotid IMT far wall of both sides
25	Carotid IMT	76367	phv00076367.v4.p10	pht000907.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:48:30+00:00	2018-07-03 17:48:30+00:00 	ica_fw_mean_imt	Mean of the mean internal carotid IMT far wall both sides
25	Carotid IMT	21737	phv00021737.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:53:17+00:00	2018-07-03 17:53:17+00:00 	L_MAXIMT	MAX IMT ON LEFT SIDE (MM)
25	Carotid IMT	128575	phv00128575.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:58:38+00:00	2018-07-09 20:58:38+00:00 	sum45_1	Maximum likelihood estimate of the average far wall CIMT at the optimal
25	Carotid IMT	128576	phv00128576.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:58:51+00:00	2018-07-09 20:58:51+00:00 	cca45_1	Maximum likelihood estimate of average right and left common carotid far wall CIMT across circumferential views
25	Carotid IMT	128525	phv00128525.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 21:01:06+00:00	2018-07-09 21:01:06+00:00 	lco_av45	Average far wall CIMT for the left common carotid artery in millimeters
25	Carotid IMT	128526	phv00128526.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 21:01:06+00:00	2018-07-09 21:01:06+00:00 	rco_av45	Average far wall CIMT for the right common carotid artery in millimeters
25	Carotid IMT	128527	phv00128527.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 21:01:06+00:00	2018-07-09 21:01:06+00:00 	lbo_av45	Left bifurcation optimal average far wall in millimeters
25	Carotid IMT	128528	phv00128528.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 21:01:06+00:00	2018-07-09 21:01:06+00:00 	rbo_av45	Right bifurcation optimal average far wall in millimeters
25	Carotid IMT	128529	phv00128529.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 21:01:06+00:00	2018-07-09 21:01:06+00:00 	lio_av45	Left Internal optimal average far wall in millimeters
25	Carotid IMT	128530	phv00128530.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 21:01:06+00:00	2018-07-09 21:01:06+00:00 	rio_av45	Right internal optimal average far wall in millimeters
25	Carotid IMT	128531	phv00128531.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:38:11+00:00	2018-07-10 13:38:11+00:00 	lcl_av45	Left common lateral average far wall in millimeters
25	Carotid IMT	128532	phv00128532.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:38:11+00:00	2018-07-10 13:38:11+00:00 	lca_av45	Left common anterior average far wall in millimeters
25	Carotid IMT	128533	phv00128533.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:38:11+00:00	2018-07-10 13:38:11+00:00 	lcp_av45	Left common posterior average far wall in millimeters
25	Carotid IMT	128534	phv00128534.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:38:11+00:00	2018-07-10 13:38:11+00:00 	rcl_av45	Right common lateral average far wall in millimeters
25	Carotid IMT	128535	phv00128535.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:38:11+00:00	2018-07-10 13:38:11+00:00 	rca_av45	Right common anterior average far wall in millimeters
25	Carotid IMT	128536	phv00128536.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:38:11+00:00	2018-07-10 13:38:11+00:00 	rcp_av45	Right common posterior average far wall in millimeters
25	Carotid IMT	128537	phv00128537.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:38:11+00:00	2018-07-10 13:38:11+00:00 	lbo_mx45	Left bifurcation optimal maximum far wall in millimeters
25	Carotid IMT	128538	phv00128538.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:38:11+00:00	2018-07-10 13:38:11+00:00 	rbo_mx45	Right bifurcation optimal maximum far wall in millimeters
25	Carotid IMT	128539	phv00128539.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:38:11+00:00	2018-07-10 13:38:11+00:00 	lio_mx45	Left internal optimal maximum far wall in millimeters
25	Carotid IMT	128540	phv00128540.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	rio_mx45	Right internal optimal maximum far wall in millimeters
25	Carotid IMT	128541	phv00128541.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	lcl_mx45	Left common lateral maximum far wall in millimeters
25	Carotid IMT	128542	phv00128542.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	lca_mx45	Left common anterior maximum far wall in millimeters
25	Carotid IMT	128543	phv00128543.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	lcp_mx45	Left common posterior maximum far wall in millimeters
25	Carotid IMT	128544	phv00128544.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	rcl_mx45	Right common lateral maximum far wall in millimeters
25	Carotid IMT	128545	phv00128545.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	rca_mx45	Right common anterior maximum far wall in millimeters
25	Carotid IMT	128546	phv00128546.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	rcp_mx45	Right common posterior maximum far wall in millimeters
25	Carotid IMT	128547	phv00128547.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	lbo_av23	Left bifurcation optimal average near wall in millimeters
25	Carotid IMT	128548	phv00128548.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	rbo_av23	Right bifurcation optimal average near wall in millimeters
25	Carotid IMT	128549	phv00128549.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	lio_av23	Left internal optimal average near wall in millimeters
25	Carotid IMT	128550	phv00128550.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	rio_av23	Right internal optimal average near wall in millimeters
25	Carotid IMT	128551	phv00128551.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	lcl_av23	Left common lateral average near wall in millimeters
25	Carotid IMT	128552	phv00128552.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	lca_av23	Left common anterior average near wall in millimeters
25	Carotid IMT	128553	phv00128553.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	lcp_av23	Left common posterior average near wall in millimeters
25	Carotid IMT	128554	phv00128554.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	rcl_av23	Right common lateral average near wall in millimeters
25	Carotid IMT	128555	phv00128555.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	rca_av23	Right common anterior average near wall in millimeters
25	Carotid IMT	128556	phv00128556.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	rcp_av23	Right common posterior average near wall in millimeters
25	Carotid IMT	128557	phv00128557.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:42:21+00:00	2018-07-10 13:42:21+00:00 	lbo_mx23	Left bifurcation optimal maximum near wall in millimeters
25	Carotid IMT	128558	phv00128558.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:44:15+00:00	2018-07-10 13:44:15+00:00 	rbo_mx23	Right bifurcation optimal maximum near wall in millimeters
25	Carotid IMT	128559	phv00128559.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:44:15+00:00	2018-07-10 13:44:15+00:00 	lio_mx23	Left internal optimal maximum near wall in millimeters
25	Carotid IMT	128560	phv00128560.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:44:15+00:00	2018-07-10 13:44:15+00:00 	rio_mx23	Right internal optimal maximum near wall in millimeters
25	Carotid IMT	128561	phv00128561.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:44:15+00:00	2018-07-10 13:44:15+00:00 	lcl_mx23	Left common lateral maximum near wall in millimeters
25	Carotid IMT	128562	phv00128562.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:44:15+00:00	2018-07-10 13:44:15+00:00 	lca_mx23	Left common anterior maximum near wall in millimeters
25	Carotid IMT	128563	phv00128563.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:44:15+00:00	2018-07-10 13:44:15+00:00 	lcp_mx23	Left common posterior maximum near wall in millimeters
25	Carotid IMT	128564	phv00128564.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:44:15+00:00	2018-07-10 13:44:15+00:00 	rcl_mx23	Right common lateral maximum near wall in millimeters
25	Carotid IMT	128565	phv00128565.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:44:15+00:00	2018-07-10 13:44:15+00:00 	rca_mx23	Right common anterior maximum near wall in millimeters
25	Carotid IMT	128566	phv00128566.v1.p1	pht001978.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 13:44:15+00:00	2018-07-10 13:44:15+00:00 	rcp_mx23	Right common posterior maximum near wall in millimeters
25	Carotid IMT	252988	phv00252988.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-02 18:38:28+00:00	2018-08-02 18:38:28+00:00 	imt_mean_farwall_cca_baseline	Carotid intima-media far wall thickness at baseline visit
25	Carotid IMT	115224	phv00115224.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:15:07+00:00	2018-08-03 19:15:07+00:00 	C1LCPMAX	MAXIMUM THICKNESS OF LCP (mm)
25	Carotid IMT	115223	phv00115223.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:15:16+00:00	2018-08-03 19:15:16+00:00 	C1LCPMEN	MEAN INTIMA-MEDIA THICKNESS OF LCP (mm)
25	Carotid IMT	115221	phv00115221.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:15:25+00:00	2018-08-03 19:15:25+00:00 	C1RCAMAX	MAXIMUM THICKNESS OF RCA (mm)
25	Carotid IMT	115220	phv00115220.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:15:35+00:00	2018-08-03 19:15:35+00:00 	C1RCAMEN	MEAN INTIMA-MEDIA THICKNESS OF RCA (mm)
25	Carotid IMT	115218	phv00115218.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:15:44+00:00	2018-08-03 19:15:44+00:00 	C1LCAMAX	MAXIMUM THICKNESS OF LCA (mm)
25	Carotid IMT	115217	phv00115217.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:15:53+00:00	2018-08-03 19:15:53+00:00 	C1LCAMEN	MEAN INTIMA-MEDIA THICKNESS OF LCA (mm)
25	Carotid IMT	115215	phv00115215.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:16:01+00:00	2018-08-03 19:16:01+00:00 	C1RCOMAX	MAXIMUM THICKNESS OF RCO (mm)
25	Carotid IMT	115214	phv00115214.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:16:09+00:00	2018-08-03 19:16:09+00:00 	C1RCOMEN	MEAN INTIMA-MEDIA THICKNESS OF RCO (mm)
25	Carotid IMT	115212	phv00115212.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:16:18+00:00	2018-08-03 19:16:18+00:00 	C1LCOMAX	MAXIMUM THICKNESS OF LCO (mm)
25	Carotid IMT	115211	phv00115211.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:16:25+00:00	2018-08-03 19:16:25+00:00 	C1LCOMEN	MEAN INTIMA-MEDIA THICKNESS OF LCO (mm)
25	Carotid IMT	115239	phv00115239.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:16:52+00:00	2018-08-03 19:16:52+00:00 	C1RIMAX	MAXIMUM THICKNESS OF RI (mm)
25	Carotid IMT	115238	phv00115238.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:17:00+00:00	2018-08-03 19:17:00+00:00 	C1RIMEN	MEAN INTIMA-MEDIA THICKNESS OF RI (mm)
25	Carotid IMT	115236	phv00115236.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:17:08+00:00	2018-08-03 19:17:08+00:00 	C1LIMAX	MAXIMUM THICKNESS OF LI (mm)
25	Carotid IMT	115233	phv00115233.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:17:16+00:00	2018-08-03 19:17:16+00:00 	C1RBMAX	MAXIMUM THICKNESS OF RB (mm)
25	Carotid IMT	115232	phv00115232.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:17:24+00:00	2018-08-03 19:17:24+00:00 	C1RBMEN	MEAN INTIMA-MEDIA THICKNESS OF RB (mm)
25	Carotid IMT	115230	phv00115230.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:17:32+00:00	2018-08-03 19:17:32+00:00 	C1LBMAX	MAXIMUM THICKNESS OF LB (mm)
25	Carotid IMT	115229	phv00115229.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:17:41+00:00	2018-08-03 19:17:41+00:00 	C1LBMEN	MEAN INTIMA-MEDIA THICKNESS OF LB (mm)
25	Carotid IMT	115227	phv00115227.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:17:48+00:00	2018-08-03 19:17:48+00:00 	C1RCPMAX	MAXIMUM THICKNESS OF RCP (mm)
25	Carotid IMT	115226	phv00115226.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:17:57+00:00	2018-08-03 19:17:57+00:00 	C1RCPMEN	MEAN INTIMA-MEDIA THICKNESS OF RCP (mm)
25	Carotid IMT	115235	phv00115235.v2.p2	pht001650.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 19:20:09+00:00	2018-08-03 19:20:09+00:00 	C1LIMEN	MEAN INTIMA-MEDIA THICKNESS OF LI(mm)
25	Carotid IMT	111971	phv00111971.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:29:31+00:00	2018-09-04 23:29:31+00:00 	rcfwmax4	RIGHT COMMON CAROTID FAR WALL MAX
25	Carotid IMT	111972	phv00111972.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:29:41+00:00	2018-09-04 23:29:41+00:00 	rcfwmin4	RIGHT COMMON CAROTID FAR WALL MIN
25	Carotid IMT	111973	phv00111973.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:29:52+00:00	2018-09-04 23:29:52+00:00 	rcfwmn4	RIGHT COMMON CAROTID FAR WALL MEAN
25	Carotid IMT	111975	phv00111975.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:30:01+00:00	2018-09-04 23:30:01+00:00 	rcnwmax4	RIGHT COMMON CAROTID NEAR WALL MAX
25	Carotid IMT	111976	phv00111976.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:30:10+00:00	2018-09-04 23:30:10+00:00 	rcnwmin4	RIGHT COMMON CAROTID NEAR WALL MIN
25	Carotid IMT	111977	phv00111977.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:30:20+00:00	2018-09-04 23:30:20+00:00 	rcnwmn4	RIGHT COMMON CAROTID NEAR WALL MEAN
25	Carotid IMT	112048	phv00112048.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:31:28+00:00	2018-09-04 23:31:28+00:00 	lcfwmin4	LEFT COMMON CAROTID FAR WALL MIN
25	Carotid IMT	112049	phv00112049.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:31:37+00:00	2018-09-04 23:31:37+00:00 	lcfwmn4	LEFT COMMON CAROTID FAR WALL MEAN
25	Carotid IMT	112051	phv00112051.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:31:46+00:00	2018-09-04 23:31:46+00:00 	lcnwmax4	LEFT COMMON CAROTID NEAR WALL MAX
25	Carotid IMT	112052	phv00112052.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:32:00+00:00	2018-09-04 23:32:00+00:00 	lcnwmin4	LEFT COMMON CAROTID NEAR WALL MIN
25	Carotid IMT	112053	phv00112053.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:32:11+00:00	2018-09-04 23:32:11+00:00 	lcnwmn4	LEFT COMMON CAROTID NEAR WALL MEAN
25	Carotid IMT	112125	phv00112125.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:32:52+00:00	2018-09-04 23:32:52+00:00 	maxcom4c	COMMON CAROTID INTIMAL-MEDIAL THICKNESS
25	Carotid IMT	84966	phv00084966.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:34:25+00:00	2018-09-04 23:34:25+00:00 	ccafwm1	MEAN OF MEAN FAR WALL IMT FOR COMMON CAROTID ARTERY
25	Carotid IMT	84967	phv00084967.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-04 23:34:32+00:00	2018-09-04 23:34:32+00:00 	icafwm1	MEAN OF MEAN FAR WALL IMT FOR INTERNAL CAROTID ARTERY
25	Carotid IMT	84793	phv00084793.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:58:34+00:00	2018-10-22 04:58:34+00:00 	maxcom1c	COMMON CAROTID INTIMAL-MEDIAL THICKNESS (mm)
25	Carotid IMT	84794	phv00084794.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:58:43+00:00	2018-10-22 04:58:43+00:00 	maxint1c	INTERNAL CAROTID INTIMAL-MEDIAL THICKNESS (mm)
25	Carotid IMT	87109	phv00087109.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:58:49+00:00	2018-10-22 04:58:49+00:00 	maxcomfc	COMMON CAROTID INTIMAL-MEDIAL THICKNESS (mm)
25	Carotid IMT	87110	phv00087110.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:58:56+00:00	2018-10-22 04:58:56+00:00 	maxintfc	INTERNAL CAROTID INTIMAL-MEDIAL THICKNESS (mm)
25	Carotid IMT	112126	phv00112126.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:59:12+00:00	2018-10-22 04:59:12+00:00 	maxint4c	INTERNAL CAROTID INTIMAL-MEDIAL THICKNESS
25	Carotid IMT	175615	phv00175615.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:07:45+00:00	2018-10-22 05:07:45+00:00 	ldccamnavg5	LT DISTAL CCA MEAN CIMT (mm) AVG
25	Carotid IMT	175617	phv00175617.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:07:54+00:00	2018-10-22 05:07:54+00:00 	ldccamnv15	LT DISTAL CCA MEAN CIMT (mm) V1
25	Carotid IMT	175619	phv00175619.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:08:00+00:00	2018-10-22 05:08:00+00:00 	ldccamnv25	LT DISTAL CCA MEAN CIMT (mm) V2
25	Carotid IMT	175621	phv00175621.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:08:05+00:00	2018-10-22 05:08:05+00:00 	ldccamnv35	LT DISTAL CCA MEAN CIMT (mm) V3
25	Carotid IMT	175623	phv00175623.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:08:12+00:00	2018-10-22 05:08:12+00:00 	ldccamxavg5	LT DISTAL CCA MAX CIMT (mm) AVG
25	Carotid IMT	175625	phv00175625.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:08:18+00:00	2018-10-22 05:08:18+00:00 	ldccamxv15	LT DISTAL CCA MAX CIMT (mm) V1
25	Carotid IMT	175627	phv00175627.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:08:28+00:00	2018-10-22 05:08:28+00:00 	ldccamxv25	LT DISTAL CCA MAX CIMT (mm) V2
25	Carotid IMT	175629	phv00175629.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:08:35+00:00	2018-10-22 05:08:35+00:00 	ldccamxv35	LT DISTAL CCA MAX CIMT (mm) V3
25	Carotid IMT	175631	phv00175631.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:08:43+00:00	2018-10-22 05:08:43+00:00 	licamnavg5	LT ICA MEAN CIMT (mm) AVG
25	Carotid IMT	175633	phv00175633.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:08:57+00:00	2018-10-22 05:08:57+00:00 	licamnv15	LT ICA MEAN CIMT (mm) V1
25	Carotid IMT	175635	phv00175635.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:09:03+00:00	2018-10-22 05:09:03+00:00 	licamnv25	LT ICA MEAN CIMT (mm) V2
25	Carotid IMT	175637	phv00175637.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:09:10+00:00	2018-10-22 05:09:10+00:00 	licamnv35	LT ICA MEAN CIMT (mm) V3
25	Carotid IMT	175639	phv00175639.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:09:16+00:00	2018-10-22 05:09:16+00:00 	licamxavg5	LT ICA MAX CIMT (mm) AVG
25	Carotid IMT	175641	phv00175641.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:09:22+00:00	2018-10-22 05:09:22+00:00 	licamxv15	LT ICA MAX CIMT (mm) V1
25	Carotid IMT	175643	phv00175643.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:09:28+00:00	2018-10-22 05:09:28+00:00 	licamxv25	LT ICA MAX CIMT (mm) V2
25	Carotid IMT	175645	phv00175645.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:09:35+00:00	2018-10-22 05:09:35+00:00 	licamxv35	LT ICA MAX CIMT (mm) V3
25	Carotid IMT	175647	phv00175647.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:09:41+00:00	2018-10-22 05:09:41+00:00 	lbmnavg5	LT BULB MEAN CIMT (mm) AVG
25	Carotid IMT	175649	phv00175649.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:09:47+00:00	2018-10-22 05:09:47+00:00 	lbmnv15	LT BULB MEAN CIMT (mm) V1
25	Carotid IMT	175651	phv00175651.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:09:53+00:00	2018-10-22 05:09:53+00:00 	lbmnv25	LT BULB MEAN CIMT (mm) V2
25	Carotid IMT	175653	phv00175653.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:09:59+00:00	2018-10-22 05:09:59+00:00 	lbmnv35	LT BULB MEAN CIMT (mm) V3
25	Carotid IMT	175655	phv00175655.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:10:06+00:00	2018-10-22 05:10:06+00:00 	lbmxavg5	LT BULB MAX CIMT (mm) AVG
25	Carotid IMT	175657	phv00175657.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:10:11+00:00	2018-10-22 05:10:11+00:00 	lbmxv15	LT BULB MAX CIMT (mm) V1
25	Carotid IMT	175659	phv00175659.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:10:17+00:00	2018-10-22 05:10:17+00:00 	lbmxv25	LT BULB MAX CIMT (mm) V2
25	Carotid IMT	175661	phv00175661.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:10:24+00:00	2018-10-22 05:10:24+00:00 	lbmxv35	LT BULB MAX CIMT (mm) V3
25	Carotid IMT	175675	phv00175675.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:10:29+00:00	2018-10-22 05:10:29+00:00 	rdccamnavg5	RT DISTAL CCA MEAN CIMT (mm) AVG
25	Carotid IMT	175677	phv00175677.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:10:35+00:00	2018-10-22 05:10:35+00:00 	rdccamnv15	RT DISTAL CCA MEAN CIMT (mm) V1
25	Carotid IMT	175679	phv00175679.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:10:42+00:00	2018-10-22 05:10:42+00:00 	rdccamnv25	RT DISTAL CCA MEAN CIMT (mm) V2
25	Carotid IMT	175681	phv00175681.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:10:48+00:00	2018-10-22 05:10:48+00:00 	rdccamnv35	RT DISTAL CCA MEAN CIMT (mm) V3
25	Carotid IMT	175683	phv00175683.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:10:54+00:00	2018-10-22 05:10:54+00:00 	rdccamxavg5	RT DISTAL CCA MAX CIMT (mm) AVG
25	Carotid IMT	175685	phv00175685.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:11:00+00:00	2018-10-22 05:11:00+00:00 	rdccamxv15	RT DISTAL CCA MAX CIMT (mm) V1
25	Carotid IMT	175687	phv00175687.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:11:06+00:00	2018-10-22 05:11:06+00:00 	rdccamxv25	RT DISTAL CCA MAX CIMT (mm) V2
25	Carotid IMT	175689	phv00175689.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:11:12+00:00	2018-10-22 05:11:12+00:00 	rdccamxv35	RT DISTAL CCA MAX CIMT (mm) V3
25	Carotid IMT	175691	phv00175691.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:11:18+00:00	2018-10-22 05:11:18+00:00 	ricamnavg5	RT ICA MEAN CIMT (mm) AVG
25	Carotid IMT	175693	phv00175693.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:11:24+00:00	2018-10-22 05:11:24+00:00 	ricamnv15	RT ICA MEAN CIMT (mm) V1
25	Carotid IMT	175695	phv00175695.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:11:29+00:00	2018-10-22 05:11:29+00:00 	ricamnv25	RT ICA MEAN CIMT (mm) V2
25	Carotid IMT	175697	phv00175697.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:11:35+00:00	2018-10-22 05:11:35+00:00 	ricamnv35	RT ICA MEAN CIMT (mm) V3
25	Carotid IMT	175699	phv00175699.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:11:42+00:00	2018-10-22 05:11:42+00:00 	ricamxavg5	RT ICA MAX CIMT (mm) AVG
25	Carotid IMT	175701	phv00175701.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:11:48+00:00	2018-10-22 05:11:48+00:00 	ricamxv15	RT ICA MAX CIMT (mm) V1
25	Carotid IMT	175703	phv00175703.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:14:01+00:00	2018-10-22 05:14:01+00:00 	ricamxv25	RT ICA MAX CIMT (mm) V2
25	Carotid IMT	175705	phv00175705.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:14:16+00:00	2018-10-22 05:14:16+00:00 	ricamxv35	RT ICA MAX CIMT (mm) V3
25	Carotid IMT	175707	phv00175707.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:14:21+00:00	2018-10-22 05:14:21+00:00 	rbmnavg5	RT BULB MEAN CIMT (mm) AVG
25	Carotid IMT	175709	phv00175709.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:14:27+00:00	2018-10-22 05:14:27+00:00 	rbmnv15	RT BULB MEAN CIMT (mm) V1
25	Carotid IMT	175711	phv00175711.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:14:33+00:00	2018-10-22 05:14:33+00:00 	rbmnv25	RT BULB MEAN CIMT (mm) V2
25	Carotid IMT	175713	phv00175713.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:14:39+00:00	2018-10-22 05:14:39+00:00 	rbmnv35	RT BULB MEAN CIMT (mm) V3
25	Carotid IMT	175715	phv00175715.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:14:44+00:00	2018-10-22 05:14:44+00:00 	rbmxavg5	RT BULB MAX CIMT (mm) AVG
25	Carotid IMT	175717	phv00175717.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:14:50+00:00	2018-10-22 05:14:50+00:00 	rbmxv15	RT BULB MAX CIMT (mm) V1
25	Carotid IMT	175719	phv00175719.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:14:56+00:00	2018-10-22 05:14:56+00:00 	rbmxv25	RT BULB MAX CIMT (mm) V2
25	Carotid IMT	175721	phv00175721.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:15:02+00:00	2018-10-22 05:15:02+00:00 	rbmxv35	RT BULB MAX CIMT (mm) V3
25	Carotid IMT	177049	phv00177049.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:15:07+00:00	2018-10-22 05:15:07+00:00 	ldccamnavg5	LT DISTAL CCA MEAN CIMT (mm) AVG
25	Carotid IMT	177051	phv00177051.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:15:13+00:00	2018-10-22 05:15:13+00:00 	ldccamnv15	LT DISTAL CCA MEAN CIMT (mm) V1
25	Carotid IMT	177053	phv00177053.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:15:20+00:00	2018-10-22 05:15:20+00:00 	ldccamnv25	LT DISTAL CCA MEAN CIMT (mm) V2
25	Carotid IMT	177055	phv00177055.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:15:25+00:00	2018-10-22 05:15:25+00:00 	ldccamnv35	LT DISTAL CCA MEAN CIMT (mm) V3
25	Carotid IMT	177057	phv00177057.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:15:33+00:00	2018-10-22 05:15:33+00:00 	ldccamxavg5	LT DISTAL CCA MAX CIMT (mm) AVG
25	Carotid IMT	177059	phv00177059.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:15:39+00:00	2018-10-22 05:15:39+00:00 	ldccamxv15	LT DISTAL CCA MAX CIMT (mm) V1
25	Carotid IMT	177061	phv00177061.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:15:44+00:00	2018-10-22 05:15:44+00:00 	ldccamxv25	LT DISTAL CCA MAX CIMT (mm) V2
25	Carotid IMT	177063	phv00177063.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:15:51+00:00	2018-10-22 05:15:51+00:00 	ldccamxv35	LT DISTAL CCA MAX CIMT (mm) V3
25	Carotid IMT	177065	phv00177065.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:15:58+00:00	2018-10-22 05:15:58+00:00 	licamnavg5	LT ICA MEAN CIMT (mm) AVG
25	Carotid IMT	177067	phv00177067.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:16:04+00:00	2018-10-22 05:16:04+00:00 	licamnv15	LT ICA MEAN CIMT (mm) V1
25	Carotid IMT	177069	phv00177069.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:16:09+00:00	2018-10-22 05:16:09+00:00 	licamnv25	LT ICA MEAN CIMT (mm) V2
25	Carotid IMT	177071	phv00177071.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:16:15+00:00	2018-10-22 05:16:15+00:00 	licamnv35	LT ICA MEAN CIMT (mm) V3
25	Carotid IMT	177073	phv00177073.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:16:21+00:00	2018-10-22 05:16:21+00:00 	licamxavg5	LT ICA MAX CIMT (mm) AVG
25	Carotid IMT	177075	phv00177075.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:16:27+00:00	2018-10-22 05:16:27+00:00 	licamxv15	LT ICA MAX CIMT (mm) V1
25	Carotid IMT	177077	phv00177077.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:16:32+00:00	2018-10-22 05:16:32+00:00 	licamxv25	LT ICA MAX CIMT (mm) V2
25	Carotid IMT	177079	phv00177079.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:16:38+00:00	2018-10-22 05:16:38+00:00 	licamxv35	LT ICA MAX CIMT (mm) V3
25	Carotid IMT	177081	phv00177081.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:16:44+00:00	2018-10-22 05:16:44+00:00 	lbmnavg5	LT BULB MEAN CIMT (mm) AVG
25	Carotid IMT	177083	phv00177083.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:16:49+00:00	2018-10-22 05:16:49+00:00 	lbmnv15	LT BULB MEAN CIMT (mm) V1
25	Carotid IMT	177085	phv00177085.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:16:55+00:00	2018-10-22 05:16:55+00:00 	lbmnv25	LT BULB MEAN CIMT (mm) V2
25	Carotid IMT	177087	phv00177087.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:17:00+00:00	2018-10-22 05:17:00+00:00 	lbmnv35	LT BULB MEAN CIMT (mm) V3
25	Carotid IMT	177089	phv00177089.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:17:06+00:00	2018-10-22 05:17:06+00:00 	lbmxavg5	LT BULB MAX CIMT (mm) AVG
25	Carotid IMT	177091	phv00177091.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:17:12+00:00	2018-10-22 05:17:12+00:00 	lbmxv15	LT BULB MAX CIMT (mm) V1
25	Carotid IMT	177093	phv00177093.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:17:17+00:00	2018-10-22 05:17:17+00:00 	lbmxv25	LT BULB MAX CIMT (mm) V2
25	Carotid IMT	177095	phv00177095.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:17:23+00:00	2018-10-22 05:17:23+00:00 	lbmxv35	LT BULB MAX CIMT (mm) V3
25	Carotid IMT	177109	phv00177109.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:17:29+00:00	2018-10-22 05:17:29+00:00 	rdccamnavg5	RT DISTAL CCA MEAN CIMT (mm) AVG
25	Carotid IMT	177111	phv00177111.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:17:36+00:00	2018-10-22 05:17:36+00:00 	rdccamnv15	RT DISTAL CCA MEAN CIMT (mm) V1
25	Carotid IMT	177113	phv00177113.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:17:41+00:00	2018-10-22 05:17:41+00:00 	rdccamnv25	RT DISTAL CCA MEAN CIMT (mm) V2
25	Carotid IMT	177115	phv00177115.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:21:16+00:00	2018-10-22 05:21:16+00:00 	rdccamnv35	RT DISTAL CCA MEAN CIMT (mm) V3
25	Carotid IMT	177117	phv00177117.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:21:22+00:00	2018-10-22 05:21:22+00:00 	rdccamxavg5	RT DISTAL CCA MAX CIMT (mm) AVG
25	Carotid IMT	177119	phv00177119.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:21:27+00:00	2018-10-22 05:21:27+00:00 	rdccamxv15	RT DISTAL CCA MAX CIMT (mm) V1
25	Carotid IMT	177121	phv00177121.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:21:33+00:00	2018-10-22 05:21:33+00:00 	rdccamxv25	RT DISTAL CCA MAX CIMT (mm) V2
25	Carotid IMT	177123	phv00177123.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:21:38+00:00	2018-10-22 05:21:38+00:00 	rdccamxv35	RT DISTAL CCA MAX CIMT (mm) V3
25	Carotid IMT	177125	phv00177125.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:21:44+00:00	2018-10-22 05:21:44+00:00 	ricamnavg5	RT ICA MEAN CIMT (mm) AVG
25	Carotid IMT	177127	phv00177127.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:21:50+00:00	2018-10-22 05:21:50+00:00 	ricamnv15	RT ICA MEAN CIMT (mm) V1
25	Carotid IMT	177129	phv00177129.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:21:56+00:00	2018-10-22 05:21:56+00:00 	ricamnv25	RT ICA MEAN CIMT (mm) V2
25	Carotid IMT	177131	phv00177131.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:22:02+00:00	2018-10-22 05:22:02+00:00 	ricamnv35	RT ICA MEAN CIMT (mm) V3
25	Carotid IMT	177133	phv00177133.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:22:07+00:00	2018-10-22 05:22:07+00:00 	ricamxavg5	RT ICA MAX CIMT (mm) AVG
25	Carotid IMT	177135	phv00177135.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:22:14+00:00	2018-10-22 05:22:14+00:00 	ricamxv15	RT ICA MAX CIMT (mm) V1
25	Carotid IMT	177137	phv00177137.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:22:20+00:00	2018-10-22 05:22:20+00:00 	ricamxv25	RT ICA MAX CIMT (mm) V2
25	Carotid IMT	177139	phv00177139.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:22:25+00:00	2018-10-22 05:22:25+00:00 	ricamxv35	RT ICA MAX CIMT (mm) V3
25	Carotid IMT	177141	phv00177141.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:22:32+00:00	2018-10-22 05:22:32+00:00 	rbmnavg5	RT BULB MEAN CIMT (mm) AVG
25	Carotid IMT	177143	phv00177143.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:22:39+00:00	2018-10-22 05:22:39+00:00 	rbmnv15	RT BULB MEAN CIMT (mm) V1
25	Carotid IMT	177145	phv00177145.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:22:45+00:00	2018-10-22 05:22:45+00:00 	rbmnv25	RT BULB MEAN CIMT (mm) V2
25	Carotid IMT	177147	phv00177147.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:22:51+00:00	2018-10-22 05:22:51+00:00 	rbmnv35	RT BULB MEAN CIMT (mm) V3
25	Carotid IMT	177149	phv00177149.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:22:57+00:00	2018-10-22 05:22:57+00:00 	rbmxavg5	RT BULB MAX CIMT (mm) AVG
25	Carotid IMT	177151	phv00177151.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:23:03+00:00	2018-10-22 05:23:03+00:00 	rbmxv15	RT BULB MAX CIMT (mm) V1
25	Carotid IMT	177153	phv00177153.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:23:08+00:00	2018-10-22 05:23:08+00:00 	rbmxv25	RT BULB MAX CIMT (mm) V2
25	Carotid IMT	177155	phv00177155.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:23:15+00:00	2018-10-22 05:23:15+00:00 	rbmxv35	RT BULB MAX CIMT (mm) V3
25	Carotid IMT	84956	phv00084956.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:34:44+00:00	2018-10-22 05:34:44+00:00 	rcfwmax1	RIGHT COMMON CAROTID FAR WALL MAX (mm)
25	Carotid IMT	84957	phv00084957.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:34:50+00:00	2018-10-22 05:34:50+00:00 	rcfwmin1	RIGHT COMMON CAROTID FAR WALL MIN (mm)
25	Carotid IMT	84958	phv00084958.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:35:17+00:00	2018-10-22 05:35:17+00:00 	rcfwmn1	RIGHT COMMON CAROTID FAR WALL MEAN (mm)
25	Carotid IMT	84959	phv00084959.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:35:24+00:00	2018-10-22 05:35:24+00:00 	rcnwmax1	RIGHT COMMON CAROTID NEAR WALL MAX (mm)
25	Carotid IMT	84960	phv00084960.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:35:30+00:00	2018-10-22 05:35:30+00:00 	rcnwmin1	RIGHT COMMON CAROTID NEAR WALL MIN (mm)
25	Carotid IMT	84961	phv00084961.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:35:37+00:00	2018-10-22 05:35:37+00:00 	rcnwmn1	RIGHT COMMON CAROTID NEAR WALL MEAN (mm)
25	Carotid IMT	87557	phv00087557.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:35:55+00:00	2018-10-22 05:35:55+00:00 	rcfwmaxf	RIGHT COMMON CAROTID FAR WALL MAX (mm)
25	Carotid IMT	87558	phv00087558.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:36:01+00:00	2018-10-22 05:36:01+00:00 	rcnwmaxf	RIGHT COMMON CAROTID NEAR WALL MAX (mm)
25	Carotid IMT	128698	phv00128698.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:36:07+00:00	2018-10-22 05:36:07+00:00 	rcfwmnf	RIGHT COMMON CAROTID FAR WALL MEAN
25	Carotid IMT	84878	phv00084878.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:39:36+00:00	2018-10-22 05:39:36+00:00 	lcfwmin1	LEFT COMMON CAROTID FAR WALL MIN (mm)
25	Carotid IMT	84879	phv00084879.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:39:42+00:00	2018-10-22 05:39:42+00:00 	lcfwmn1	LEFT COMMON CAROTID FAR WALL MEAN (mm)
25	Carotid IMT	84881	phv00084881.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:39:47+00:00	2018-10-22 05:39:47+00:00 	lcnwmax1	LEFT COMMON CAROTID NEAR WALL MAX (mm)
25	Carotid IMT	84882	phv00084882.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:39:52+00:00	2018-10-22 05:39:52+00:00 	lcnwmin1	LEFT COMMON CAROTID NEAR WALL MIN (mm)
25	Carotid IMT	84883	phv00084883.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:39:59+00:00	2018-10-22 05:39:59+00:00 	lcnwmn1	LEFT COMMON CAROTID NEAR WALL MEAN (mm)
25	Carotid IMT	87559	phv00087559.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:40:40+00:00	2018-10-22 05:40:40+00:00 	lcfwmaxf	LEFT COMMON CAROTID FAR WALL MAX (mm)
25	Carotid IMT	87560	phv00087560.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:40:45+00:00	2018-10-22 05:40:45+00:00 	lcnwmaxf	LEFT COMMON CAROTID NEAR WALL MAX (mm)
25	Carotid IMT	112047	phv00112047.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:40:51+00:00	2018-10-22 05:40:51+00:00 	lcfwmax4	LEFT COMMON CAROTID FAR WALL MAX
25	Carotid IMT	84877	phv00084877.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:41:39+00:00	2018-10-22 05:41:39+00:00 	lcfwmax1	LEFT COMMON CAROTID FAR WALL MAX (mm)
25	Carotid IMT	84820	phv00084820.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:44:11+00:00	2018-10-22 05:44:11+00:00 	rafwmax1	RIGHT ANTERIOR OBLIQUE FAR WALL MAX (mm)
25	Carotid IMT	84821	phv00084821.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:44:17+00:00	2018-10-22 05:44:17+00:00 	rafwmin1	RIGHT ANTERIOR OBLIQUE FAR WALL MIN (mm)
25	Carotid IMT	84822	phv00084822.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:44:23+00:00	2018-10-22 05:44:23+00:00 	rafwmn1	RIGHT ANTERIOR OBLIQUE FAR WALL MEAN (mm)
25	Carotid IMT	84824	phv00084824.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:44:28+00:00	2018-10-22 05:44:28+00:00 	ranwmax1	RIGHT ANTERIOR OBLIQUE NEAR WALL MAX (mm)
25	Carotid IMT	84825	phv00084825.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:44:34+00:00	2018-10-22 05:44:34+00:00 	ranwmin1	RIGHT ANTERIOR OBLIQUE NEAR WALL MIN (mm)
25	Carotid IMT	84826	phv00084826.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:44:42+00:00	2018-10-22 05:44:42+00:00 	ranwmn1	RIGHT ANTERIOR OBLIQUE NEAR WALL MEAN (mm)
25	Carotid IMT	84896	phv00084896.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:45:23+00:00	2018-10-22 05:45:23+00:00 	lafwmax1	LEFT ANTERIOR OBLIQUE FAR WALL MAX (mm)
25	Carotid IMT	84897	phv00084897.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:45:28+00:00	2018-10-22 05:45:28+00:00 	lafwmin1	LEFT ANTERIOR OBLIQUE FAR WALL MIN (mm)
25	Carotid IMT	84898	phv00084898.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:45:34+00:00	2018-10-22 05:45:34+00:00 	lafwmn1	LEFT ANTERIOR OBLIQUE FAR WALL MEAN (mm)
25	Carotid IMT	84900	phv00084900.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:45:40+00:00	2018-10-22 05:45:40+00:00 	lanwmax1	LEFT ANTERIOR OBLIQUE NEAR WALL MAX (mm)
25	Carotid IMT	84901	phv00084901.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:45:45+00:00	2018-10-22 05:45:45+00:00 	lanwmin1	LEFT ANTERIOR OBLIQUE NEAR WALL MIN (mm)
25	Carotid IMT	84902	phv00084902.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:45:50+00:00	2018-10-22 05:45:50+00:00 	lanwmn1	LEFT ANTERIOR OBLIQUE NEAR WALL MEAN (mm)
25	Carotid IMT	87561	phv00087561.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:46:28+00:00	2018-10-22 05:46:28+00:00 	rafwmaxf	RIGHT ANTERIOR OBLIQUE FAR WALL MAX (mm)
25	Carotid IMT	87562	phv00087562.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:46:35+00:00	2018-10-22 05:46:35+00:00 	ranwmaxf	RIGHT ANTERIOR OBLIQUE NEAR WALL MAX (mm)
25	Carotid IMT	87567	phv00087567.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:46:40+00:00	2018-10-22 05:46:40+00:00 	lafwmaxf	LEFT ANTERIOR OBLIQUE FAR WALL MAX (mm)
25	Carotid IMT	87568	phv00087568.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:46:46+00:00	2018-10-22 05:46:46+00:00 	lanwmaxf	LEFT ANTERIOR OBLIQUE NEAR WALL MAX (mm)
25	Carotid IMT	111993	phv00111993.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:46:51+00:00	2018-10-22 05:46:51+00:00 	rafwmax4	RIGHT ANTERIOR OBLIQUE FAR WALL MAX
25	Carotid IMT	111994	phv00111994.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:46:58+00:00	2018-10-22 05:46:58+00:00 	rafwmin4	RIGHT ANTERIOR OBLIQUE FAR WALL MIN
25	Carotid IMT	111995	phv00111995.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:47:03+00:00	2018-10-22 05:47:03+00:00 	rafwmn4	RIGHT ANTERIOR OBLIQUE FAR WALL MEAN
25	Carotid IMT	111997	phv00111997.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:47:08+00:00	2018-10-22 05:47:08+00:00 	ranwmax4	RIGHT ANTERIOR OBLIQUE NEAR WALL MAX
25	Carotid IMT	111998	phv00111998.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:47:13+00:00	2018-10-22 05:47:13+00:00 	ranwmin4	RIGHT ANTERIOR OBLIQUE NEAR WALL MIN
25	Carotid IMT	111999	phv00111999.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:48:18+00:00	2018-10-22 05:48:18+00:00 	ranwmn4	RIGHT ANTERIOR OBLIQUE NEAR WALL MEAN
25	Carotid IMT	112069	phv00112069.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:48:56+00:00	2018-10-22 05:48:56+00:00 	lafwmax4	LEFT ANTERIOR OBLIQUE FAR WALL MAX
25	Carotid IMT	112070	phv00112070.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:49:02+00:00	2018-10-22 05:49:02+00:00 	lafwmin4	LEFT ANTERIOR OBLIQUE FAR WALL MIN
25	Carotid IMT	112071	phv00112071.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:49:07+00:00	2018-10-22 05:49:07+00:00 	lafwmn4	LEFT ANTERIOR OBLIQUE FAR WALL MEAN
25	Carotid IMT	112073	phv00112073.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:49:14+00:00	2018-10-22 05:49:14+00:00 	lanwmax4	LEFT ANTERIOR OBLIQUE NEAR WALL MAX
25	Carotid IMT	112074	phv00112074.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:49:19+00:00	2018-10-22 05:49:19+00:00 	lanwmin4	LEFT ANTERIOR OBLIQUE NEAR WALL MIN
25	Carotid IMT	112075	phv00112075.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:49:24+00:00	2018-10-22 05:49:24+00:00 	lanwmn4	LEFT ANTERIOR OBLIQUE NEAR WALL MEAN
25	Carotid IMT	84840	phv00084840.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:52:16+00:00	2018-10-22 05:52:16+00:00 	rlfwmin1	RIGHT LATERAL OBLIQUE FAR WALL MIN (mm)
25	Carotid IMT	84841	phv00084841.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:52:21+00:00	2018-10-22 05:52:21+00:00 	rlfwmn1	RIGHT LATERAL OBLIQUE FAR WALL MEAN (mm)
25	Carotid IMT	84843	phv00084843.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:52:27+00:00	2018-10-22 05:52:27+00:00 	rlnwmax1	RIGHT LATERAL OBLIQUE NEAR WALL MAX (mm)
25	Carotid IMT	84844	phv00084844.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:52:33+00:00	2018-10-22 05:52:33+00:00 	rlnwmin1	RIGHT LATERAL OBLIQUE NEAR WALL MIN (mm)
25	Carotid IMT	84845	phv00084845.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:52:38+00:00	2018-10-22 05:52:38+00:00 	rlnwmn1	RIGHT LATERAL OBLIQUE NEAR WALL MEAN (mm)
25	Carotid IMT	84915	phv00084915.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:53:20+00:00	2018-10-22 05:53:20+00:00 	llfwmax1	LEFT LATERAL OBLIQUE FAR WALL MAX (mm)
25	Carotid IMT	84916	phv00084916.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:53:26+00:00	2018-10-22 05:53:26+00:00 	llfwmin1	LEFT LATERAL OBLIQUE FAR WALL MIN (mm)
25	Carotid IMT	84917	phv00084917.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:53:32+00:00	2018-10-22 05:53:32+00:00 	llfwmn1	LEFT LATERAL OBLIQUE FAR WALL MEAN (mm)
25	Carotid IMT	84919	phv00084919.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:53:38+00:00	2018-10-22 05:53:38+00:00 	llnwmax1	LEFT LATERAL OBLIQUE NEAR WALL MAX (mm)
25	Carotid IMT	84920	phv00084920.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:53:43+00:00	2018-10-22 05:53:43+00:00 	llnwmin1	LEFT LATERAL OBLIQUE NEAR WALL MIN (mm)
25	Carotid IMT	84921	phv00084921.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:53:49+00:00	2018-10-22 05:53:49+00:00 	llnwmn1	LEFT LATERAL OBLIQUE NEAR WALL MEAN (mm)
25	Carotid IMT	87569	phv00087569.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:54:29+00:00	2018-10-22 05:54:29+00:00 	llfwmaxf	LEFT LATERAL OBLIQUE FAR WALL MAX (mm)
25	Carotid IMT	87570	phv00087570.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:54:49+00:00	2018-10-22 05:54:49+00:00 	llnwmaxf	LEFT LATERAL OBLIQUE NEAR WALL MAX (mm)
25	Carotid IMT	112011	phv00112011.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:54:54+00:00	2018-10-22 05:54:54+00:00 	rlfwmax4	RIGHT LATERAL OBLIQUE FAR WALL MAX
25	Carotid IMT	112012	phv00112012.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:55:00+00:00	2018-10-22 05:55:00+00:00 	rlfwmin4	RIGHT LATERAL OBLIQUE FAR WALL MIN
25	Carotid IMT	112013	phv00112013.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:55:05+00:00	2018-10-22 05:55:05+00:00 	rlfwmn4	RIGHT LATERAL OBLIQUE FAR WALL MEAN
25	Carotid IMT	112015	phv00112015.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:55:10+00:00	2018-10-22 05:55:10+00:00 	rlnwmax4	RIGHT LATERAL OBLIQUE NEAR WALL MAX
25	Carotid IMT	112016	phv00112016.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:55:15+00:00	2018-10-22 05:55:15+00:00 	rlnwmin4	RIGHT LATERAL OBLIQUE NEAR WALL MIN
25	Carotid IMT	84839	phv00084839.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:55:21+00:00	2018-10-22 05:55:21+00:00 	rlfwmax1	RIGHT LATERAL OBLIQUE FAR WALL MAX (mm)
25	Carotid IMT	112017	phv00112017.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:56:33+00:00	2018-10-22 05:56:33+00:00 	rlnwmn4	RIGHT LATERAL OBLIQUE NEAR WALL MEAN
25	Carotid IMT	112087	phv00112087.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:57:16+00:00	2018-10-22 05:57:16+00:00 	llfwmax4	LEFT LATERAL OBLIQUE FAR WALL MAX
25	Carotid IMT	112088	phv00112088.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:57:22+00:00	2018-10-22 05:57:22+00:00 	llfwmin4	LEFT LATERAL OBLIQUE FAR WALL MIN
25	Carotid IMT	112089	phv00112089.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:57:29+00:00	2018-10-22 05:57:29+00:00 	llfwmn4	LEFT LATERAL OBLIQUE FAR WALL MEAN
25	Carotid IMT	112091	phv00112091.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:57:34+00:00	2018-10-22 05:57:34+00:00 	llnwmax4	LEFT LATERAL OBLIQUE NEAR WALL MAX
25	Carotid IMT	112092	phv00112092.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:57:41+00:00	2018-10-22 05:57:41+00:00 	llnwmin4	LEFT LATERAL OBLIQUE NEAR WALL MIN
25	Carotid IMT	112093	phv00112093.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 05:57:49+00:00	2018-10-22 05:57:49+00:00 	llnwmn4	LEFT LATERAL OBLIQUE NEAR WALL MEAN
25	Carotid IMT	84859	phv00084859.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:00:43+00:00	2018-10-22 06:00:43+00:00 	rpfwmin1	RIGHT POSTERIOR OBLIQUE FAR WALL MIN (mm)
25	Carotid IMT	84860	phv00084860.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:00:48+00:00	2018-10-22 06:00:48+00:00 	rpfwmn1	RIGHT POSTERIOR OBLIQUE FAR WALL MEAN (mm)
25	Carotid IMT	84862	phv00084862.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:00:54+00:00	2018-10-22 06:00:54+00:00 	rpnwmax1	RIGHT POSTERIOR OBLIQUE NEAR WALL MAX (mm)
25	Carotid IMT	84863	phv00084863.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:01:00+00:00	2018-10-22 06:01:00+00:00 	rpnwmin1	RIGHT POSTERIOR OBLIQUE NEAR WALL MIN (mm)
25	Carotid IMT	84864	phv00084864.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:01:09+00:00	2018-10-22 06:01:09+00:00 	rpnwmn1	RIGHT POSTERIOR OBLIQUE NEAR WALL MEAN (mm)
25	Carotid IMT	84934	phv00084934.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:01:49+00:00	2018-10-22 06:01:49+00:00 	lpfwmax1	LEFT POSTERIOR OBLIQUE FAR WALL MAX (mm)
25	Carotid IMT	84935	phv00084935.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:01:56+00:00	2018-10-22 06:01:56+00:00 	lpfwmin1	LEFT POSTERIOR OBLIQUE FAR WALL MIN (mm)
25	Carotid IMT	84936	phv00084936.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:02:02+00:00	2018-10-22 06:02:02+00:00 	lpfwmn1	LEFT POSTERIOR OBLIQUE FAR WALL MEAN (mm)
25	Carotid IMT	84938	phv00084938.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:02:08+00:00	2018-10-22 06:02:08+00:00 	lpnwmax1	LEFT POSTERIOR OBLIQUE NEAR WALL MAX (mm)
25	Carotid IMT	84939	phv00084939.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:02:15+00:00	2018-10-22 06:02:15+00:00 	lpnwmin1	LEFT POSTERIOR OBLIQUE NEAR WALL MIN (mm)
25	Carotid IMT	84940	phv00084940.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:02:21+00:00	2018-10-22 06:02:21+00:00 	lpnwmn1	LEFT POSTERIOR OBLIQUE NEAR WALL MEAN (mm)
25	Carotid IMT	87565	phv00087565.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:03:01+00:00	2018-10-22 06:03:01+00:00 	rpfwmnf	RIGHT POSTERIOR OBLIQUE FAR WALL MEAN (mm)
25	Carotid IMT	87566	phv00087566.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:03:09+00:00	2018-10-22 06:03:09+00:00 	rpnwmaxf	RIGHT POSTERIOR OBLIQUE NEAR WALL MAX (mm)
25	Carotid IMT	87571	phv00087571.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:03:14+00:00	2018-10-22 06:03:14+00:00 	lpfwmaxf	LEFT POSTERIOR OBLIQUE FAR WALL MAX (mm)
25	Carotid IMT	87572	phv00087572.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:03:20+00:00	2018-10-22 06:03:20+00:00 	lpnwmaxf	LEFT POSTERIOR OBLIQUE NEAR WALL MAX (mm)
25	Carotid IMT	112029	phv00112029.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:03:26+00:00	2018-10-22 06:03:26+00:00 	rpfwmax4	RIGHT POSTERIOR OBLIQUE FAR WALL MAX
25	Carotid IMT	112030	phv00112030.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:03:31+00:00	2018-10-22 06:03:31+00:00 	rpfwmin4	RIGHT POSTERIOR OBLIQUE FAR WALL MIN
25	Carotid IMT	112031	phv00112031.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:03:37+00:00	2018-10-22 06:03:37+00:00 	rpfwmn4	RIGHT POSTERIOR OBLIQUE FAR WALL MEAN
25	Carotid IMT	112033	phv00112033.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:03:43+00:00	2018-10-22 06:03:43+00:00 	rpnwmax4	RIGHT POSTERIOR OBLIQUE NEAR WALL MAX
25	Carotid IMT	112034	phv00112034.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:03:50+00:00	2018-10-22 06:03:50+00:00 	rpnwmin4	RIGHT POSTERIOR OBLIQUE NEAR WALL MIN
25	Carotid IMT	84858	phv00084858.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:03:56+00:00	2018-10-22 06:03:56+00:00 	rpfwmax1	RIGHT POSTERIOR OBLIQUE FAR WALL MAX (mm)
25	Carotid IMT	112035	phv00112035.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:05:00+00:00	2018-10-22 06:05:00+00:00 	rpnwmn4	RIGHT POSTERIOR OBLIQUE NEAR WALL MEAN
25	Carotid IMT	112105	phv00112105.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:05:43+00:00	2018-10-22 06:05:43+00:00 	lpfwmax4	LEFT POSTERIOR OBLIQUE FAR WALL MAX
25	Carotid IMT	112106	phv00112106.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:05:48+00:00	2018-10-22 06:05:48+00:00 	lpfwmin4	LEFT POSTERIOR OBLIQUE FAR WALL MIN
25	Carotid IMT	112107	phv00112107.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:05:55+00:00	2018-10-22 06:05:55+00:00 	lpfwmn4	LEFT POSTERIOR OBLIQUE FAR WALL MEAN
25	Carotid IMT	112109	phv00112109.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:06:01+00:00	2018-10-22 06:06:01+00:00 	lpnwmax4	LEFT POSTERIOR OBLIQUE NEAR WALL MAX
25	Carotid IMT	112110	phv00112110.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:06:09+00:00	2018-10-22 06:06:09+00:00 	lpnwmin4	LEFT POSTERIOR OBLIQUE NEAR WALL MIN
25	Carotid IMT	112111	phv00112111.v1.p3	pht001528.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 06:06:14+00:00	2018-10-22 06:06:14+00:00 	lpnwmn4	LEFT POSTERIOR OBLIQUE NEAR WALL MEAN
26	Myocardial infarction	85757	phv00085757.v3.p3	pht001117.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:43:31+00:00	2018-04-23 03:43:31+00:00 	fhxmia2	AGE OF FIRST MI DX
26	Myocardial infarction	87853	phv00087853.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:43:43+00:00	2018-04-23 03:43:43+00:00 	mi	MYOCARDIAL INFARCTION (MI)
26	Myocardial infarction	87854	phv00087854.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:43:50+00:00	2018-04-23 03:43:50+00:00 	mitype	MI TYPE
26	Myocardial infarction	87855	phv00087855.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:44:07+00:00	2018-04-23 03:44:07+00:00 	mitt	TIME TO MI OR LAST FOLLOW-UP (DAYS)
26	Myocardial infarction	174566	phv00174566.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:44:44+00:00	2018-04-23 03:44:44+00:00 	major21	MAJOR ABNORMALITY 2 PER MINNESOTA CODE: MAJOR Q WAVE ABNORMALITIES [OLD MYOCARDIAL INFARCTION (MI)]
26	Myocardial infarction	175077	phv00175077.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:44:50+00:00	2018-04-23 03:44:50+00:00 	major25	MAJOR Q WAVE ABNORMALITIES [OLD MYOCARDIAL INFARCTION (MI)]
26	Myocardial infarction	176500	phv00176500.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:44:58+00:00	2018-04-23 03:44:58+00:00 	major25	MAJOR Q WAVE ABNORMALITIES [OLD MYOCARDIAL INFARCTION (MI)]
26	Myocardial infarction	176844	phv00176844.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:45:04+00:00	2018-04-23 03:45:04+00:00 	myoscar5	MYOCARDIAL SCAR (VISUAL ASSESSMENT OF ANY SIZE) USING LATE GAD ENHANCEMENT IMAGES
26	Myocardial infarction	83492	phv00083492.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:45:47+00:00	2018-04-23 03:45:47+00:00 	sphaa4	HEART ATTACK IN PAST MONTH
26	Myocardial infarction	83727	phv00083727.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:46:11+00:00	2018-04-23 03:46:11+00:00 	sphaa4	HEART ATTACK IN PAST MONTH
26	Myocardial infarction	87142	phv00087142.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:46:25+00:00	2018-04-23 03:46:25+00:00 	heartaf	HEART ATTACK
26	Myocardial infarction	87718	phv00087718.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:46:32+00:00	2018-04-23 03:46:32+00:00 	sphaa4	HEART ATTACK IN PAST MONTH
26	Myocardial infarction	121263	phv00121263.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-02 19:31:23+00:00	2018-05-02 19:31:23+00:00 	Y01MIEP	ENDPT - MYOCARDIAL INFARCTION
26	Myocardial infarction	121479	phv00121479.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-02 19:31:23+00:00	2018-05-02 19:31:23+00:00 	Y01MIEP	ENDPT - MYOCARDIAL INFARCTION
26	Myocardial infarction	121288	phv00121288.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-02 20:24:08+00:00	2018-05-02 20:24:08+00:00 	Y01MI	MYOCARDIAL INFARCTION?
26	Myocardial infarction	121505	phv00121505.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-02 20:24:08+00:00	2018-05-02 20:24:08+00:00 	Y01MI	MYOCARDIAL INFARCTION?
26	Myocardial infarction	207493	phv00207493.v1.p1	pht004116.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:20:32+00:00	2018-05-03 20:20:32+00:00 	MI07	Hospitalized myocardial infarction by 2007
26	Myocardial infarction	207512	phv00207512.v1.p1	pht004116.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:21:10+00:00	2018-05-03 20:21:10+00:00 	SMI07	ECG MI by 2007
26	Myocardial infarction	207525	phv00207525.v1.p1	pht004116.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:21:33+00:00	2018-05-03 20:21:33+00:00 	FUMI07	Follow up time for MI07 (days)
26	Myocardial infarction	207524	phv00207524.v1.p1	pht004116.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:21:52+00:00	2018-05-03 20:21:52+00:00 	FUSMI07	Follow up time for SMI07 (days)
26	Myocardial infarction	207532	phv00207532.v1.p1	pht004116.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:22:25+00:00	2018-05-03 20:22:25+00:00 	YRSMI07	Event year for SMI07
26	Myocardial infarction	207539	phv00207539.v1.p1	pht004116.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:22:49+00:00	2018-05-03 20:22:49+00:00 	AGSMI07	Age for SMI07
26	Myocardial infarction	204704	phv00204704.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:27:31+00:00	2018-05-03 20:27:31+00:00 	ECGMI04	Prevalent myocardial infarction from adjudicated electrocardiograms [Cohort, Exam 1]
26	Myocardial infarction	204705	phv00204705.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:27:50+00:00	2018-05-03 20:27:50+00:00 	PREVMI05	Prevalent MI from ECG or medical history [Cohort, Exam 1]
26	Myocardial infarction	204709	phv00204709.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:28:19+00:00	2018-05-03 20:28:19+00:00 	MACHMI02	Prevalent myocardial infarction from original machine coded ECGs [Cohort, Exam 1]
26	Myocardial infarction	204748	phv00204748.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:29:08+00:00	2018-05-03 20:29:08+00:00 	MDDXMI02	MD diagnosed myocardial infarction [Cohort, Exam 1]
26	Myocardial infarction	204749	phv00204749.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:29:26+00:00	2018-05-03 20:29:26+00:00 	HXOFMI02	History of myocardial infarction [Cohort, Exam 1]
26	Myocardial infarction	204613	phv00204613.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:31:16+00:00	2018-05-03 20:31:16+00:00 	MDDXMI21	Visit 2, MD diagnosed myocardial infarction [Cohort, Exam 2]
26	Myocardial infarction	204614	phv00204614.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:31:34+00:00	2018-05-03 20:31:34+00:00 	HXOFMI21	Visit 2, history of myocardial infarction [Cohort, Exam 2]
26	Myocardial infarction	204620	phv00204620.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:32:12+00:00	2018-05-03 20:32:12+00:00 	ECGMI24	Prevalent myocardial infarction from adjudicated ECG [Cohort, Exam 2]
26	Myocardial infarction	204622	phv00204622.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:32:47+00:00	2018-05-03 20:32:47+00:00 	MACHMI22	Previous myocardial infarction from machine coded [Cohort, Exam 2]
26	Myocardial infarction	204831	phv00204831.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:34:20+00:00	2018-05-03 20:34:20+00:00 	MDDXMI31	Visit 3, MD diagnosed myocardial infarction [Cohort, Exam 3]
26	Myocardial infarction	204832	phv00204832.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:34:36+00:00	2018-05-03 20:34:36+00:00 	HXOFMI31	Visit 3, history of myocardial infarction [Cohort, Exam 3]
26	Myocardial infarction	204841	phv00204841.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:35:18+00:00	2018-05-03 20:35:18+00:00 	ECGMI32	Prevalent myocardial infarction from adjudicated ECG [Cohort, Exam 3]
26	Myocardial infarction	204842	phv00204842.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:35:44+00:00	2018-05-03 20:35:44+00:00 	MACHMI31	Pre myocardial infarction from machine coded ECG [Cohort, Exam 3]
26	Myocardial infarction	204935	phv00204935.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:38:35+00:00	2018-05-03 20:38:35+00:00 	MDDXMI41	Visit 4, MD diagnosed myocardial infarction [Cohort, Exam 4]
26	Myocardial infarction	204936	phv00204936.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:38:53+00:00	2018-05-03 20:38:53+00:00 	HXOFMI41	Visit 4, history of myocardial infarction [Cohort, Exam 4]
26	Myocardial infarction	204944	phv00204944.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:39:21+00:00	2018-05-03 20:39:21+00:00 	ECGMI41	Prevalent myocardial infarction from adjudicated ECG [Cohort, Exam 4]
26	Myocardial infarction	204945	phv00204945.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:39:39+00:00	2018-05-03 20:39:39+00:00 	MACHMI41	Pre myocardial infarction from machine coded ECG [Cohort, Exam 4]
26	Myocardial infarction	206805	phv00206805.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-17 15:56:04+00:00	2018-05-17 15:56:04+00:00 	HFAA11K	[Medical history]. Q11k - Myocardial infarction [Heart Failure Hospital Record Abstraction Form, HFA]
26	Myocardial infarction	206841	phv00206841.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-17 15:58:17+00:00	2018-05-17 15:58:17+00:00 	HFAA26A	[Physical exam and symptoms - findings]. Did the patient have any of the following CARDIOVASCULAR signs or symptoms? (Anytime during hospitalization) Q26a - MI (Age Undetermined) - removed from current form version [Heart Failure Hospital Record Abstraction Form, HFA]
26	Myocardial infarction	206999	phv00206999.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-17 16:05:35+00:00	2018-05-17 16:05:35+00:00 	HFAA76	Q76 - Myocardial infarction (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA]
26	Myocardial infarction	6230	phv00006230.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:32:58+00:00	2018-05-18 18:32:58+00:00 	FQ282	MI LOCATION - ANTERIOR
26	Myocardial infarction	6231	phv00006231.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:33:39+00:00	2018-05-18 18:33:39+00:00 	FQ283	MI LOCATION - INFERIOR
26	Myocardial infarction	6232	phv00006232.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:34:05+00:00	2018-05-18 18:34:05+00:00 	FQ284	MI LOCATION - TRUE POSTERIOR
26	Myocardial infarction	6625	phv00006625.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:34:41+00:00	2018-05-18 18:34:41+00:00 	FR399	ECG - MI - ANTERIOR
26	Myocardial infarction	6626	phv00006626.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:35:06+00:00	2018-05-18 18:35:06+00:00 	FR400	ECG - MI - INFERIOR
26	Myocardial infarction	6627	phv00006627.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:35:30+00:00	2018-05-18 18:35:30+00:00 	FR401	ECG - MI - TRUE POSTERIOR
26	Myocardial infarction	7665	phv00007665.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:36:14+00:00	2018-05-18 18:36:14+00:00 	A163	MYOCARDIAL INFARCTION
26	Myocardial infarction	71969	phv00071969.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:36:29+00:00	2018-05-18 18:36:29+00:00 	antlatmi_s1	Anterolateral myocardial infarction (MI) for first sleep study Collection Interval: 1998-2003
26	Myocardial infarction	72008	phv00072008.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:36:43+00:00	2018-05-18 18:36:43+00:00 	antlatmi_s2	Anterolateral myocardial infarction (MI) for second sleep study Collection Interval: 1998-2003
26	Myocardial infarction	71967	phv00071967.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:36:58+00:00	2018-05-18 18:36:58+00:00 	antsepmi_s1	Anteroseptal myocardial infarction (MI) for first sleep study Collection Interval: 1998-2003
26	Myocardial infarction	72006	phv00072006.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:37:16+00:00	2018-05-18 18:37:16+00:00 	antsepmi_s2	Anteroseptal myocardial infarction (MI) for second sleep study Collection Interval: 1998-2003
26	Myocardial infarction	7906	phv00007906.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:37:50+00:00	2018-05-18 18:37:50+00:00 	B274	ECG: MYOCARDIAL INFARCTION
26	Myocardial infarction	8653	phv00008653.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:38:04+00:00	2018-05-18 18:38:04+00:00 	C309	ECG: MYOCARDIAL INFARCTION--ANTERIOR
26	Myocardial infarction	8654	phv00008654.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:38:16+00:00	2018-05-18 18:38:16+00:00 	C310	ECG: MYOCARDIAL INFARCTION--INFERIOR
26	Myocardial infarction	8655	phv00008655.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:38:30+00:00	2018-05-18 18:38:30+00:00 	C311	ECG: MYOCARDIAL INFARCTION--TRUE POSTERIOR
26	Myocardial infarction	9049	phv00009049.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:38:43+00:00	2018-05-18 18:38:43+00:00 	D313	ECG: ANTERIOR MYOCARDIAL INFARCTION
26	Myocardial infarction	9050	phv00009050.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:39:17+00:00	2018-05-18 18:39:17+00:00 	D314	ECG: INFERIOR MYOCARDIAL INFARCTION
26	Myocardial infarction	9051	phv00009051.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:39:30+00:00	2018-05-18 18:39:30+00:00 	D315	ECG: TRUE POSTERIOR MYOCARDIAL INFARCTION
26	Myocardial infarction	9504	phv00009504.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:40:16+00:00	2018-05-18 18:40:16+00:00 	E599	ECG: MYOCARDIAL INFARCT-ANTERIOR
26	Myocardial infarction	250670	phv00250670.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:40:29+00:00	2018-05-18 18:40:29+00:00 	e599	Electrocardiograph - Part II: Myocardial Infarction Location - Anterior Collection Interval: Exam 1
26	Myocardial infarction	9505	phv00009505.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:40:43+00:00	2018-05-18 18:40:43+00:00 	E600	ECG: MYOCARDIAL INFARCT-INFERIOR
26	Myocardial infarction	250671	phv00250671.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:41:00+00:00	2018-05-18 18:41:00+00:00 	e600	Electrocardiograph - Part II: Myocardial Infarction Location- Inferior Collection Interval: Exam 1
26	Myocardial infarction	9506	phv00009506.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:41:14+00:00	2018-05-18 18:41:14+00:00 	E601	ECG: MYOCARDIAL INFARCT-TRUE POSTERIOR
26	Myocardial infarction	250672	phv00250672.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:41:29+00:00	2018-05-18 18:41:29+00:00 	e601	Electrocardiograph - Part II: Myocardial Infarction Location- True Posterior Collection Interval: Exam 1
26	Myocardial infarction	10018	phv00010018.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:42:34+00:00	2018-05-18 18:42:34+00:00 	F594	MYOCARDIAL INFARCTION LOCATION: ANTERIOR
26	Myocardial infarction	10019	phv00010019.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:42:50+00:00	2018-05-18 18:42:50+00:00 	F595	MYOCARDIAL INFARCTION LOCATION: INFERIOR
26	Myocardial infarction	10020	phv00010020.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:43:06+00:00	2018-05-18 18:43:06+00:00 	F596	MYOCARDIAL INFARCTION LOCATION: TRUE POSTERIOR
26	Myocardial infarction	1170	phv00001170.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:43:54+00:00	2018-05-18 18:43:54+00:00 	FA170	ECG:  MYOCARDIAL INFARCTION
26	Myocardial infarction	1332	phv00001332.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:44:08+00:00	2018-05-18 18:44:08+00:00 	FB184	ECG:  MYOCARDIAL INFARCTION
26	Myocardial infarction	1527	phv00001527.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:44:22+00:00	2018-05-18 18:44:22+00:00 	FC193	ECG: MYOCARDIAL INFARCTION
26	Myocardial infarction	1718	phv00001718.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:44:40+00:00	2018-05-18 18:44:40+00:00 	FD189	ECG: MYOCARDIAL INFARCTION
26	Myocardial infarction	1995	phv00001995.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:45:37+00:00	2018-05-18 18:45:37+00:00 	FE282	ECG: MYOCARDIAL INFARCTION
26	Myocardial infarction	2175	phv00002175.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:45:56+00:00	2018-05-18 18:45:56+00:00 	FF245	ECG: MYOCARDIAL INFARCTION
26	Myocardial infarction	2370	phv00002370.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:46:13+00:00	2018-05-18 18:46:13+00:00 	FG253	ECG: MYOCARDIAL INFARCTION
26	Myocardial infarction	2610	phv00002610.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:46:52+00:00	2018-05-18 18:46:52+00:00 	FH270	ECG: MYOCARDIAL INFARCTION
26	Myocardial infarction	2816	phv00002816.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-18 18:47:07+00:00	2018-05-18 18:47:07+00:00 	FI181	ECG: MYOCARDIAL INFARCTION
26	Myocardial infarction	3199	phv00003199.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:38:45+00:00	2018-05-21 12:38:45+00:00 	FJ297	ECG: MYOCARDIAL INFARCTION
26	Myocardial infarction	3614	phv00003614.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:39:27+00:00	2018-05-21 12:39:27+00:00 	FK392	ECG: MYOCARDIAL INFARCTION
26	Myocardial infarction	4021	phv00004021.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:39:44+00:00	2018-05-21 12:39:44+00:00 	FL413	ECG: ANTERIOR MYOCARDIAL INFARCTION
26	Myocardial infarction	4022	phv00004022.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:39:57+00:00	2018-05-21 12:39:57+00:00 	FL414	ECG: INFERIOR MYOCARDIAL INFARCTION
26	Myocardial infarction	4023	phv00004023.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:40:22+00:00	2018-05-21 12:40:22+00:00 	FL415	ECG: TRUE POSTERIOR MYOCARDIAL INFARCTION
26	Myocardial infarction	4445	phv00004445.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:40:38+00:00	2018-05-21 12:40:38+00:00 	FM452	ECG: ANTERIOR MYOCARDIAL INFARCTION
26	Myocardial infarction	4446	phv00004446.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:40:52+00:00	2018-05-21 12:40:52+00:00 	FM453	ECG: INFERIOR MYOCARDIAL INFARCTION
26	Myocardial infarction	4447	phv00004447.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:41:12+00:00	2018-05-21 12:41:12+00:00 	FM454	ECG: TRUE POSTERIOR MYOCARDIAL INFARCTION
26	Myocardial infarction	4886	phv00004886.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:42:06+00:00	2018-05-21 12:42:06+00:00 	FN428	ECG: MYOCARDIAL INFARCT-ANTERIOR
26	Myocardial infarction	4887	phv00004887.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:42:20+00:00	2018-05-21 12:42:20+00:00 	FN429	ECG: MYOCARDIAL INFARCT-INFERIOR
26	Myocardial infarction	4888	phv00004888.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:42:35+00:00	2018-05-21 12:42:35+00:00 	FN430	ECG: MYOCARDIAL INFARCT-TRUE POSTERIOR
26	Myocardial infarction	5246	phv00005246.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:42:53+00:00	2018-05-21 12:42:53+00:00 	FO442	ECG: MYOCARDIAL INFARCT-ANTERIOR
26	Myocardial infarction	5247	phv00005247.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:43:07+00:00	2018-05-21 12:43:07+00:00 	FO443	ECG: MYOCARDIAL INFARCT-INFERIOR
26	Myocardial infarction	5248	phv00005248.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:43:21+00:00	2018-05-21 12:43:21+00:00 	FO444	ECG: MYOCARDIAL INFARCT-TRUE POSTERIOR
26	Myocardial infarction	5873	phv00005873.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:43:37+00:00	2018-05-21 12:43:37+00:00 	FP408	ECG: MYOCARDIAL INFARCT-ANTERIOR
26	Myocardial infarction	5874	phv00005874.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:43:52+00:00	2018-05-21 12:43:52+00:00 	FP409	ECG: MYOCARDIAL INFARCT-INFERIOR
26	Myocardial infarction	5875	phv00005875.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:44:09+00:00	2018-05-21 12:44:09+00:00 	FP410	ECG: MYOCARDIAL INFARCT-TRUE POSTERIOR
26	Myocardial infarction	7059	phv00007059.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:45:16+00:00	2018-05-21 12:45:16+00:00 	FS498	ECG: MYOCARDIAL INFARCTION LOCATION: ANTERIOR
26	Myocardial infarction	7060	phv00007060.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:45:31+00:00	2018-05-21 12:45:31+00:00 	FS499	ECG: MYOCARDIAL INFARCTION LOCATION: INFERIOR
26	Myocardial infarction	7061	phv00007061.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:45:50+00:00	2018-05-21 12:45:50+00:00 	FS500	ECG: MYOCARDIAL INFARCTION LOCATION: TRUE POSTERIOR
26	Myocardial infarction	7494	phv00007494.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:46:35+00:00	2018-05-21 12:46:35+00:00 	FT504	ECG: MYOCARDIAL INFARCTION LOCATION: ANTERIOR
26	Myocardial infarction	7495	phv00007495.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:46:50+00:00	2018-05-21 12:46:50+00:00 	FT505	ECG: MYOCARDIAL INFARCTION LOCATION: INFERIOR
26	Myocardial infarction	70520	phv00070520.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:47:25+00:00	2018-05-21 12:47:25+00:00 	FU216	ECG: MYOCARDIAL INFARCTION LOCATION: ANTERIOR
26	Myocardial infarction	70521	phv00070521.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:47:39+00:00	2018-05-21 12:47:39+00:00 	FU217	ECG: MYOCARDIAL INFARCTION LOCATION: INFERIOR
26	Myocardial infarction	70522	phv00070522.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:47:56+00:00	2018-05-21 12:47:56+00:00 	FU218	ECG: MYOCARDIAL INFARCTION LOCATION: TRUE POSTERIOR
26	Myocardial infarction	254729	phv00254729.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:48:18+00:00	2018-05-21 12:48:18+00:00 	fv218	Electrocardiograph: Myocardial Infarction Location: Anterior Collection Interval: Exam 29
26	Myocardial infarction	254730	phv00254730.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:48:45+00:00	2018-05-21 12:48:45+00:00 	fv219	Electrocardiograph: Myocardial Infarction Location: Inferior Collection Interval: Exam 29
26	Myocardial infarction	254731	phv00254731.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:49:02+00:00	2018-05-21 12:49:02+00:00 	fv220	Electrocardiograph: Myocardial Infarction Location: True Posterior Collection Interval: Exam 29
26	Myocardial infarction	255120	phv00255120.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:49:42+00:00	2018-05-21 12:49:42+00:00 	fw259	Electrocardiograph: Myocardial Infarction Location - Anterior Collection Interval: Original Cohort Exam 30
26	Myocardial infarction	255121	phv00255121.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:49:57+00:00	2018-05-21 12:49:57+00:00 	fw260	Electrocardiograph: Myocardial Infarction Location - Inferior Collection Interval: Original Cohort Exam 30
26	Myocardial infarction	255122	phv00255122.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:50:11+00:00	2018-05-21 12:50:11+00:00 	fw261	Electrocardiograph: Myocardial Infarction Location - True Posterior Collection Interval: Original Cohort Exam 30
26	Myocardial infarction	255312	phv00255312.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:50:28+00:00	2018-05-21 12:50:28+00:00 	fw582	Heart Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Heart attack or myocardial infarction or MI Variable appears on Form B only Collection Interval: Original Cohort Exam 30
26	Myocardial infarction	274773	phv00274773.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:51:00+00:00	2018-05-21 12:51:00+00:00 	FX085	Medical History - Chest Discomfort: Have you since your last exam been told by your doctor you have/had a heart attack or myocardial infarction? Collection Interval: Original Cohort Exam 31
26	Myocardial infarction	274845	phv00274845.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:52:31+00:00	2018-05-21 12:52:31+00:00 	FX259	Electrocardiograph: Myocardial Infarction Location - Anterior Collection Interval: Original Cohort Exam 31
26	Myocardial infarction	274846	phv00274846.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:52:44+00:00	2018-05-21 12:52:44+00:00 	FX260	Electrocardiograph: Myocardial Infarction Location - Inferior Collection Interval: Original Cohort Exam 31
26	Myocardial infarction	274847	phv00274847.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:52:58+00:00	2018-05-21 12:52:58+00:00 	FX261	Electrocardiograph: Myocardial Infarction Location - True Posterior Collection Interval: Original Cohort Exam 31
26	Myocardial infarction	275037	phv00275037.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:53:23+00:00	2018-05-21 12:53:23+00:00 	FX582	Heart Problems (Form B) - Since last exam or medical history update, have you seen a doctor or other healthcare provider or been hospitalized for heart attack or myocardial infarction or MI ? Collection Interval: Original Cohort Exam 31
26	Myocardial infarction	275130	phv00275130.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:54:07+00:00	2018-05-21 12:54:07+00:00 	fy085	Medical History - Chest Discomfort: Have you since your last exam been told by your doctor you have/had a heart attack or myocardial infarction? Collection Interval: Original Cohort Exam 32
26	Myocardial infarction	275203	phv00275203.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:54:21+00:00	2018-05-21 12:54:21+00:00 	fy259	Electrocardiograph: Myocardial Infarction Location - Anterior Collection Interval: Original Cohort Exam 32
26	Myocardial infarction	275204	phv00275204.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:54:34+00:00	2018-05-21 12:54:34+00:00 	fy260	Electrocardiograph: Myocardial Infarction Location - Inferior Collection Interval: Original Cohort Exam 32
26	Myocardial infarction	275205	phv00275205.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:54:48+00:00	2018-05-21 12:54:48+00:00 	fy261	Electrocardiograph: Myocardial Infarction Location - True Posterior Collection Interval: Original Cohort Exam 32
26	Myocardial infarction	275371	phv00275371.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:55:03+00:00	2018-05-21 12:55:03+00:00 	fy582	Heart Problems (Form B) - Since your last Framingham Heart Study exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for heart attack or myocardial infarction or MI? Collection Interval: Original Cohort Exam 32
26	Myocardial infarction	10451	phv00010451.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:55:29+00:00	2018-05-21 12:55:29+00:00 	G372	ECG: MYOCARDIAL INFARCTION LOCATION: ANTERIOR
26	Myocardial infarction	251012	phv00251012.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:55:43+00:00	2018-05-21 12:55:43+00:00 	g372	Electrocardiograph - Part II - Myocardial Infarction Location: Anterior Collection Interval: Exam 2
26	Myocardial infarction	10452	phv00010452.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:56:02+00:00	2018-05-21 12:56:02+00:00 	G373	ECG: MYOCARDIAL INFARCTION LOCATION: INFERIOR
26	Myocardial infarction	251013	phv00251013.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:56:19+00:00	2018-05-21 12:56:19+00:00 	g373	Electrocardiograph - Part II - Myocardial Infarction Location: Inferior Collection Interval: Exam 2
26	Myocardial infarction	10453	phv00010453.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:56:33+00:00	2018-05-21 12:56:33+00:00 	G374	ECG: MYOCARDIAL INFARCTION LOCATION: TRUE POSTERIOR
26	Myocardial infarction	251014	phv00251014.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:56:46+00:00	2018-05-21 12:56:46+00:00 	g374	Electrocardiograph - Part II - Myocardial Infarction Location: True posterior Collection Interval: Exam 2
26	Myocardial infarction	21036	phv00021036.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:57:16+00:00	2018-05-21 12:57:16+00:00 	G3A184	HAVE YOU EVER BEEN TOLD BY A DOCTOR YOU HAD A HEART ATTACK OR MYOCARDIAL INFARCTION?
26	Myocardial infarction	273870	phv00273870.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:57:29+00:00	2018-05-21 12:57:29+00:00 	g3a184	Have you ever been told by a doctor you had a heart attack or myocardial infarction? Collection Interval: Exam 1
26	Myocardial infarction	274363	phv00274363.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:57:46+00:00	2018-05-21 12:57:46+00:00 	g3a184	Have you ever been told by a doctor you had a heart attack or myocardial infarction?
26	Myocardial infarction	21167	phv00021167.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:58:07+00:00	2018-05-21 12:58:07+00:00 	G3A367	ECG: MYOCARDIAL INFARCTION LOCATION: ANTERIOR
26	Myocardial infarction	273989	phv00273989.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:58:20+00:00	2018-05-21 12:58:20+00:00 	g3a367	ECG: Myocardial infarction location: Anterior Collection Interval: Exam 1
26	Myocardial infarction	274482	phv00274482.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:58:35+00:00	2018-05-21 12:58:35+00:00 	g3a367	ECG: Myocardial infarction location: Anterior
26	Myocardial infarction	21168	phv00021168.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:58:56+00:00	2018-05-21 12:58:56+00:00 	G3A368	ECG: MYOCARDIAL INFARCTION LOCATION: INFERIOR
26	Myocardial infarction	273990	phv00273990.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:59:11+00:00	2018-05-21 12:59:11+00:00 	g3a368	ECG: Myocardial infarction location: Inferior Collection Interval: Exam 1
26	Myocardial infarction	274483	phv00274483.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:59:25+00:00	2018-05-21 12:59:25+00:00 	g3a368	ECG: Myocardial infarction location: Inferior
26	Myocardial infarction	21169	phv00021169.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:59:40+00:00	2018-05-21 12:59:40+00:00 	G3A369	ECG: MYOCARDIAL INFARCTION LOCATION: TRUE POSTERIOR
26	Myocardial infarction	273991	phv00273991.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 12:59:53+00:00	2018-05-21 12:59:53+00:00 	g3a369	ECG: Myocardial infarction location: True posterior Collection Interval: Exam 1
26	Myocardial infarction	274484	phv00274484.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:00:09+00:00	2018-05-21 13:00:09+00:00 	g3a369	ECG: Myocardial infarction location: True posterior
26	Myocardial infarction	177477	phv00177477.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:04:20+00:00	2018-05-21 13:04:20+00:00 	g3b0384	Electrocardiograph: Myocardial Infarction Location: Anterior
26	Myocardial infarction	177478	phv00177478.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:04:32+00:00	2018-05-21 13:04:32+00:00 	g3b0385	Electrocardiograph: Myocardial Infarction Location: Inferior
26	Myocardial infarction	177479	phv00177479.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:04:46+00:00	2018-05-21 13:04:46+00:00 	g3b0386	Electrocardiograph: Myocardial Infarction Location: True Posterior
26	Myocardial infarction	72156	phv00072156.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:05:43+00:00	2018-05-21 13:05:43+00:00 	H131	SINCE YOUR LAST EXAM, HAVE YOU BEEN TOLD BY A DOCTOR YOU HAD A HEART ATTACK OR MYOCARDIAL INFARCTION?
26	Myocardial infarction	251472	phv00251472.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:06:00+00:00	2018-05-21 13:06:00+00:00 	h319	Electrocardiograph - Part II: Myocardial Infarction Location: Anterior Collection Interval: Exam 3
26	Myocardial infarction	251473	phv00251473.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:06:13+00:00	2018-05-21 13:06:13+00:00 	h320	Electrocardiograph - Part II: Myocardial Infarction Location: Inferior Collection Interval: Exam 3
26	Myocardial infarction	251474	phv00251474.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:06:32+00:00	2018-05-21 13:06:32+00:00 	h321	Electrocardiograph - Part II: Myocardial Infarction Location: True Posterior Collection Interval: Exam 3
26	Myocardial infarction	276988	phv00276988.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:08:19+00:00	2018-05-21 13:08:19+00:00 	HOSP4	Hospitalization for myocardial infarction Collection Interval: 1975 through 2014
26	Myocardial infarction	71968	phv00071968.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:09:06+00:00	2018-05-21 13:09:06+00:00 	infmi_s1	Inferior myocardial infarction (MI) for first sleep study Collection Interval: 1998-2003
26	Myocardial infarction	72007	phv00072007.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:09:21+00:00	2018-05-21 13:09:21+00:00 	infmi_s2	Inferior myocardial infarction (MI) for second sleep study Collection Interval: 1998-2003
26	Myocardial infarction	254221	phv00254221.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:09:40+00:00	2018-05-21 13:09:40+00:00 	j374	Electrocardiograph-Part II: Myocardial Infarction Location: Anterior
26	Myocardial infarction	254222	phv00254222.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:09:55+00:00	2018-05-21 13:09:55+00:00 	j375	Electrocardiograph-Part II: Myocardial Infarction Location: Inferior
26	Myocardial infarction	254223	phv00254223.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:10:10+00:00	2018-05-21 13:10:10+00:00 	j376	Electrocardiograph-Part II: Myocardial Infarction Location: True Posterior
26	Myocardial infarction	571	phv00000571.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:10:28+00:00	2018-05-21 13:10:28+00:00 	MF101	ECG: MYOCARDIAL INFARCTION, EXAM 2
26	Myocardial infarction	649	phv00000649.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:10:42+00:00	2018-05-21 13:10:42+00:00 	MF184	ECG: MYOCARDIAL INFARCTION, EXAM 3
26	Myocardial infarction	734	phv00000734.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:11:22+00:00	2018-05-21 13:11:22+00:00 	MF279	ECG: MYOCARDIAL INFARCTION, EXAM 4
26	Myocardial infarction	817	phv00000817.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:11:40+00:00	2018-05-21 13:11:40+00:00 	MF367	ECG: MYOCARDIAL INFARCTION, EXAM 5
26	Myocardial infarction	517	phv00000517.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:11:57+00:00	2018-05-21 13:11:57+00:00 	MF43	ECG: MYOCARDIAL INFARCTION, EXAM 1
26	Myocardial infarction	883	phv00000883.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:12:13+00:00	2018-05-21 13:12:13+00:00 	MF437	ECG: MYOCARDIAL INFARCTION, EXAM 6
26	Myocardial infarction	1007	phv00001007.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:12:30+00:00	2018-05-21 13:12:30+00:00 	MF567	ECG: MYOCARDIAL INFARCTION, EXAM 7
26	Myocardial infarction	71981	phv00071981.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:12:51+00:00	2018-05-21 13:12:51+00:00 	truposmi_s1	True posterior myocardial infarction (MI) for first sleep study Collection Interval: 1998-2003
26	Myocardial infarction	36471	phv00036471.v11.p10	pht000309.v12.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:14:42+00:00	2018-05-21 13:14:42+00:00 	DATE	Date of Event Collection Interval: Events reviewed through 12/2015
26	Myocardial infarction	36469	phv00036469.v11.p10	pht000309.v12.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:15:00+00:00	2018-05-21 13:15:00+00:00 	EVENT	Event Number Collection Interval: Events reviewed through 12/2015
26	Myocardial infarction	277010	phv00277010.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 13:16:36+00:00	2018-05-21 13:16:36+00:00 	HDATE	Hospitalization date Collection Interval: 1975 through 2014
26	Myocardial infarction	7496	phv00007496.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-21 17:25:00+00:00	2018-05-21 17:25:00+00:00 	FT506	ECG: MYOCARDIAL INFARCTION LOCATION: TRUE POSTERIOR
26	Myocardial infarction	121461	phv00121461.v2.p2	pht001870.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 17:35:51+00:00	2018-05-24 17:35:51+00:00 	Y00MI	DISCHG DIAG - MYOCARDIAL INFARCTION
26	Myocardial infarction	203786	phv00203786.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:43:24+00:00	2018-05-29 13:43:24+00:00 	CORA15A	Is there a history of a myocardial infarction prior to the onset of this event? Q15a [Coroner / Medical Examiner Form]
26	Myocardial infarction	203749	phv00203749.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:43:57+00:00	2018-05-29 13:43:57+00:00 	CORA06A	Did the coroner's report mention any of the following as contributing to or being present at death? Recent myocardial infarction. Q6a [Coroner / Medical Examiner Form]
26	Myocardial infarction	203840	phv00203840.v1.p1	pht004050.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:45:10+00:00	2018-05-29 13:45:10+00:00 	WCARICDX	Worst computer myocardial infarction diagnosis for hospitalized event [CHD Derived Variable Dictionary - Events Cohort]
26	Myocardial infarction	203841	phv00203841.v1.p1	pht004050.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:45:37+00:00	2018-05-29 13:45:37+00:00 	CMIDX	Myocardial infarction classification of an event [CHD Derived Variable Dictionary - Events Cohort]
26	Myocardial infarction	203902	phv00203902.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:45:59+00:00	2018-05-29 13:45:59+00:00 	HRAA19F	[Second transfer]. Is there a history of myocardial infarction prior to onset of this event? Q19f [Hospital Abstraction Form]
26	Myocardial infarction	203903	phv00203903.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:46:21+00:00	2018-05-29 13:46:21+00:00 	HRAA19G	[Second transfer]. Did a myocardial infarction occur within four weeks of this event? Q19g [Hospital Abstraction Form]
26	Myocardial infarction	203907	phv00203907.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:47:00+00:00	2018-05-29 13:47:00+00:00 	HRAA20D	[Second transfer]. Is there mention of acute myocardial infarction [MI] in the discharge summary? Q20d [Hospital Abstraction Form]
26	Myocardial infarction	203975	phv00203975.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:47:22+00:00	2018-05-29 13:47:22+00:00 	HRAA32	[Second transfer]. Is there a history of myocardial infarction prior to the onset of this event? Q32 [Hospital Abstraction Form]
26	Myocardial infarction	204408	phv00204408.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:47:42+00:00	2018-05-29 13:47:42+00:00 	PHQA03F	[Medical history]. Did the decedent have a history of any of the following? Myocardial infarction. Q3f [Physician Questionnaire Form, exam 1]
26	Myocardial infarction	204460	phv00204460.v1.p1	pht004061.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:48:01+00:00	2018-05-29 13:48:01+00:00 	STRC28	[Hospital information]. History of myocardial infarction prior to the onset of this event. Q28 [Cohort Stroke Abstraction Form]
26	Myocardial infarction	204461	phv00204461.v1.p1	pht004061.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:48:26+00:00	2018-05-29 13:48:26+00:00 	STRC29A	[Hospital information]. Are any of the following conditions documented as having been present within four weeks prior to or during this hospitalization? Myocardial infarction. Q29a [Cohort Stroke Abstraction Form]
26	Myocardial infarction	204740	phv00204740.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:49:52+00:00	2018-05-29 13:49:52+00:00 	RPOSMI01	Rose possible myocardial infarction [Cohort, Exam 1]
26	Myocardial infarction	207023	phv00207023.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:53:42+00:00	2018-05-29 13:53:42+00:00 	HFAA16O	[Medical history]. Q16o - Precipitating factor: myocardial infarction (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA]
26	Myocardial infarction	207500	phv00207500.v1.p1	pht004116.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 13:54:43+00:00	2018-05-29 13:54:43+00:00 	SOURCINC	Incident Source: myocardial infarction or fatal coronary heart disease
26	Myocardial infarction	207502	phv00207502.v1.p1	pht004116.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 19:58:07+00:00	2018-05-29 19:58:07+00:00 	SOURCIS	Incident Source: myocardial infarction , fatal coronary heart disease  or SMI
26	Myocardial infarction	207513	phv00207513.v1.p1	pht004116.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 19:58:53+00:00	2018-05-29 19:58:53+00:00 	ECGMI_V2	ECG serial change myocardial infarction by V2
26	Myocardial infarction	207514	phv00207514.v1.p1	pht004116.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 19:59:17+00:00	2018-05-29 19:59:17+00:00 	ECGMI_V3	ECG serial change myocardial infarction by V3
26	Myocardial infarction	207515	phv00207515.v1.p1	pht004116.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 19:59:38+00:00	2018-05-29 19:59:38+00:00 	ECGMI_V4	ECG serial change myocardial infarction by V4
26	Myocardial infarction	216060	phv00216060.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 20:00:25+00:00	2018-05-29 20:00:25+00:00 	V2ECG21	Myocardial infarction, by Minnesota code [ECG data, exam 2]
26	Myocardial infarction	215643	phv00215643.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 20:00:53+00:00	2018-05-29 20:00:53+00:00 	V1ECG21	Myocardial infarction, by Minnesota code [ECG data, exam 1]
26	Myocardial infarction	216894	phv00216894.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-29 20:01:17+00:00	2018-05-29 20:01:17+00:00 	V4ECG21	Myocardial infarction, by Minnesota code [ECG data, exam 4]
26	Myocardial infarction	124993	phv00124993.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 15:22:43+00:00	2018-06-08 15:22:43+00:00 	AFUA7A	7a. Heart attack
26	Myocardial infarction	125008	phv00125008.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 15:28:34+00:00	2018-06-08 15:28:34+00:00 	AFUA9	9. Were you (was [name]) hospitalized for a heart attack since our last contact?
26	Myocardial infarction	125078	phv00125078.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:28:59+00:00	2018-06-08 16:28:59+00:00 	AFUA7A	7a. Heart attack
26	Myocardial infarction	125093	phv00125093.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:31:11+00:00	2018-06-08 16:31:11+00:00 	AFUA9	9. Were you (was [name]) hospitalized for a heart attack since our last contact?
26	Myocardial infarction	125163	phv00125163.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:45:02+00:00	2018-06-08 16:45:02+00:00 	AFUB7A	7a. Heart attack
26	Myocardial infarction	125178	phv00125178.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:52:51+00:00	2018-06-08 16:52:51+00:00 	AFUB9	9. Were you (was [name]) hospitalized for a heart attack since our last contact?
26	Myocardial infarction	125249	phv00125249.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:58:43+00:00	2018-06-08 16:58:43+00:00 	AFUB7A	7a. Heart attack
26	Myocardial infarction	125264	phv00125264.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:00:27+00:00	2018-06-08 17:00:27+00:00 	AFUB9	9. Were you (was [name]) hospitalized for a heart attack since our last contact?
26	Myocardial infarction	125392	phv00125392.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:15:21+00:00	2018-06-08 17:15:21+00:00 	AFUC23	23. Were you hospitalized for a heart attack since our last contact?
26	Myocardial infarction	125597	phv00125597.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:45:08+00:00	2018-06-08 19:45:08+00:00 	AFUI7A	DOCTOR - HEART ATTACK             Q7A
26	Myocardial infarction	125611	phv00125611.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:48:03+00:00	2018-06-08 19:48:03+00:00 	AFUI9	BEEN HOSPITLIZED FOR HEART ATTACK Q9
26	Myocardial infarction	125685	phv00125685.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:53:01+00:00	2018-06-08 19:53:01+00:00 	AFUJ7A	DOCTOR - HEART ATTACK             Q7A
26	Myocardial infarction	125699	phv00125699.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:56:11+00:00	2018-06-08 19:56:11+00:00 	AFUJ9	BEEN HOSPITLIZED FOR HEART ATTACK Q9
26	Myocardial infarction	125509	phv00125509.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:05:22+00:00	2018-06-08 20:05:22+00:00 	AFUI7A	DOCTOR - HEART ATTACK             Q7A
26	Myocardial infarction	125522	phv00125522.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:10:24+00:00	2018-06-08 20:10:24+00:00 	AFUI9	BEEN HOSPITLIZED FOR HEART ATTACK Q9
26	Myocardial infarction	125773	phv00125773.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:13:27+00:00	2018-06-08 20:13:27+00:00 	AFUK7A	DOCTOR - HEART ATTACK               Q7A
26	Myocardial infarction	125787	phv00125787.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:15:29+00:00	2018-06-08 20:15:29+00:00 	AFUK9	BEEN HOSPITLIZED FOR HEART ATTACK   Q9
26	Myocardial infarction	126085	phv00126085.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:22:24+00:00	2018-06-12 01:22:24+00:00 	XMI01MD	History of MD diagnosed MI
26	Myocardial infarction	126088	phv00126088.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:23:46+00:00	2018-06-12 01:23:46+00:00 	XMI01	History of MI(derived)
26	Myocardial infarction	207503	phv00207503.v1.p1	pht004116.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-06-15 13:36:09+00:00	2018-06-15 13:36:09+00:00 	SOURCISP	Incident Source: myocardial infarction , fatal coronary heart disease, procedure or SMI
26	Myocardial infarction	127710	phv00127710.v1.p1	pht001963.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:19:36+00:00	2018-06-20 15:19:36+00:00 	MHXA34	34: Age when first heart attack.
26	Myocardial infarction	127708	phv00127708.v1.p1	pht001963.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:20:27+00:00	2018-06-20 15:20:27+00:00 	MHXA32	32: Hospitalized for heart attack a week +?
26	Myocardial infarction	127707	phv00127707.v1.p1	pht001963.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:20:53+00:00	2018-06-20 15:20:53+00:00 	MHXA31	31: What did the doctor say it was?
26	Myocardial infarction	127693	phv00127693.v1.p1	pht001963.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:23:36+00:00	2018-06-20 15:23:36+00:00 	MHXA17	17: What did the doctor say it was?
26	Myocardial infarction	128091	phv00128091.v1.p1	pht001967.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:19:29+00:00	2018-06-20 18:19:29+00:00 	PFHA4A	4a: Has doctor said you had Heart attack?
26	Myocardial infarction	128092	phv00128092.v1.p1	pht001967.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:19:41+00:00	2018-06-20 18:19:41+00:00 	PFHA4B	4b: Age when told you had heart attack?
26	Myocardial infarction	100798	phv00100798.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:40:24+00:00	2018-06-27 23:40:24+00:00 	INCMI	INCIDENT MI
26	Myocardial infarction	100799	phv00100799.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:40:44+00:00	2018-06-27 23:40:44+00:00 	FATALMI	FATAL OR NONFATAL MI
26	Myocardial infarction	100800	phv00100800.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:40:59+00:00	2018-06-27 23:40:59+00:00 	MIBLMOD	MI  MODIFIED BL STAT
26	Myocardial infarction	100801	phv00100801.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:41:20+00:00	2018-06-27 23:41:20+00:00 	TTOMI	TIME TO MI
26	Myocardial infarction	100817	phv00100817.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:46:39+00:00	2018-06-27 23:46:39+00:00 	MIBLMOD	MI  MODIFIED BL STAT
26	Myocardial infarction	100811	phv00100811.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:19:40+00:00	2018-06-29 16:19:40+00:00 	MIBASE	MI AT BL (SELF-REPORT)
26	Myocardial infarction	100824	phv00100824.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:45:47+00:00	2018-06-29 17:45:47+00:00 	EVTYPE	EVENT TYPE
26	Myocardial infarction	100825	phv00100825.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:46:54+00:00	2018-06-29 17:46:54+00:00 	TTOEVENT	TIME TO EVENT
26	Myocardial infarction	197703	phv00197703.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:56:15+00:00	2018-06-29 18:56:15+00:00 	mi	Prevalent heart attacks
26	Myocardial infarction	215676	phv00215676.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-05 15:32:44+00:00	2018-07-05 15:32:44+00:00 	V1ECG56	Novacode prevalent myocardial infarction/ischemia; by software [ECG data, exam 1]
26	Myocardial infarction	216093	phv00216093.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-05 15:33:21+00:00	2018-07-05 15:33:21+00:00 	V2ECG56	Novacode prevalent myocardial infarction/ischemia; by software [ECG data, exam 2]
26	Myocardial infarction	216510	phv00216510.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-05 15:34:03+00:00	2018-07-05 15:34:03+00:00 	V3ECG56	Novacode prevalent myocardial infarction/ischemia; by software [ECG data, exam 3]
26	Myocardial infarction	216927	phv00216927.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-05 15:34:30+00:00	2018-07-05 15:34:30+00:00 	V4ECG56	Novacode prevalent myocardial infarction/ischemia; by software [ECG data, exam 4]
26	Myocardial infarction	190979	phv00190979.v5.p10	pht003335.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 18:16:58+00:00	2018-08-09 18:16:58+00:00 	EVENT	Event Number
26	Myocardial infarction	190981	phv00190981.v5.p10	pht003335.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 18:17:27+00:00	2018-08-09 18:17:27+00:00 	DATE	Date of Event
26	Myocardial infarction	159615	phv00159615.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:43:13+00:00	2018-08-10 21:43:13+00:00 	HeartAttack	Heart attack [MI] Collection Interval: Collected in Exam 1
26	Myocardial infarction	277435	phv00277435.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:29:07+00:00	2018-08-14 22:29:07+00:00 	MI_AGE	In what year or how old were you when it first occurred? - age Collection Interval: 2009-2011
26	Myocardial infarction	277434	phv00277434.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:29:15+00:00	2018-08-14 22:29:15+00:00 	MI_YR	In what year or how old were you when it first occurred? - year Collection Interval: 2009-2011
26	Myocardial infarction	277433	phv00277433.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:29:22+00:00	2018-08-14 22:29:22+00:00 	MI	Have you ever been told by a physician that you had a heart attack or myocardial infarction? Collection Interval: 2009-2011
26	Myocardial infarction	277600	phv00277600.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:48:33+00:00	2018-08-14 22:48:33+00:00 	MI_AGE	In what year or how old were you when it first occurred? - age Collection Interval: 1996-2000
26	Myocardial infarction	277599	phv00277599.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:48:40+00:00	2018-08-14 22:48:40+00:00 	MI_YR	In what year or how old were you when it first occurred? - year Collection Interval: 1996-2000
26	Myocardial infarction	277598	phv00277598.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:48:46+00:00	2018-08-14 22:48:46+00:00 	MI	Have you ever been told by a physician that you had a heart attack or myocardial infarction? Collection Interval: 1996-2000
26	Myocardial infarction	277884	phv00277884.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:15:47+00:00	2018-08-14 23:15:47+00:00 	MI_AGE	In what year or how old were you when it first occurred? - age Collection Interval: 2000-2004
26	Myocardial infarction	277883	phv00277883.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:15:53+00:00	2018-08-14 23:15:53+00:00 	MI_YR	In what year or how old were you when it first occurred? - year Collection Interval: 2000-2004
26	Myocardial infarction	277882	phv00277882.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:16:00+00:00	2018-08-14 23:16:00+00:00 	MI	Have you ever been told by a physician that you had a heart attack or myocardial infarction? Collection Interval: 2000-2004
26	Myocardial infarction	307881	phv00307881.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:00:37+00:00	2018-08-16 00:00:37+00:00 	MI_AGE	In what year or how old were you when it first occurred? - age Collection Interval: 1996-2000
26	Myocardial infarction	307880	phv00307880.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:00:44+00:00	2018-08-16 00:00:44+00:00 	MI_YR	In what year or how old were you when it first occurred? - year Collection Interval: 1996-2000
26	Myocardial infarction	307879	phv00307879.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:00:51+00:00	2018-08-16 00:00:51+00:00 	MI	Have you ever been told by a physician that you had a heart attack or myocardial infarction? Collection Interval: 1996-2000
26	Myocardial infarction	308077	phv00308077.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:17:31+00:00	2018-08-16 00:17:31+00:00 	MI_AGE	In what year or how old were you when it first occurred? - age Collection Interval: 2000-2004
26	Myocardial infarction	308076	phv00308076.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:17:37+00:00	2018-08-16 00:17:37+00:00 	MI_YR	In what year or how old were you when it first occurred? - year Collection Interval: 2000-2004
26	Myocardial infarction	308075	phv00308075.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:17:47+00:00	2018-08-16 00:17:47+00:00 	MI	Have you ever been told by a physician that you had a heart attack or myocardial infarction? Collection Interval: 2000-2004
26	Myocardial infarction	122273	phv00122273.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:23:43+00:00	2018-08-16 23:23:43+00:00 	HRTATTK	Heart attack (A)
26	Myocardial infarction	122274	phv00122274.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:23:50+00:00	2018-08-16 23:23:50+00:00 	HRTDIAG	Heart attack diagnosed by doctor (A)
26	Myocardial infarction	122275	phv00122275.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:23:57+00:00	2018-08-16 23:23:57+00:00 	HRTAGE	Age when heart attack noted (A)
26	Myocardial infarction	113026	phv00113026.v2.p2	pht001570.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:19:37+00:00	2018-08-17 18:19:37+00:00 	A09HRTAG	AGE AT HEART ATTACK
26	Myocardial infarction	113025	phv00113025.v2.p2	pht001570.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:19:45+00:00	2018-08-17 18:19:45+00:00 	A09HRTAK	HAS/HAD HEART ATTACK?
26	Myocardial infarction	123755	phv00123755.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:52:24+00:00	2018-08-21 17:52:24+00:00 	INFARCT	ECG: Infarct
26	Myocardial infarction	124278	phv00124278.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 19:01:01+00:00	2018-08-21 19:01:01+00:00 	DIAHRTDAY	Days from visit date - Diagnosed Myocardial Infarction
26	Myocardial infarction	114391	phv00114391.v2.p2	pht001607.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:21:43+00:00	2018-08-22 21:21:43+00:00 	B09HRTST	STATUS, HEART ATTACK. Q 1
26	Myocardial infarction	114390	phv00114390.v2.p2	pht001607.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:21:57+00:00	2018-08-22 21:21:57+00:00 	B09HRTAG	AGE AT HEART ATTACK. Q 1
26	Myocardial infarction	114389	phv00114389.v2.p2	pht001607.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:22:14+00:00	2018-08-22 21:22:14+00:00 	B09HRTAK	HAD HEART ATTACK? Q 1
26	Myocardial infarction	115430	phv00115430.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 16:57:12+00:00	2018-08-23 16:57:12+00:00 	C08HRTAG	AGE HEART ATTACK DIAGNOSED. Q 3
26	Myocardial infarction	115429	phv00115429.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 16:57:19+00:00	2018-08-23 16:57:19+00:00 	C08HRTAK	HEART ATTACK. Q 3
26	Myocardial infarction	116961	phv00116961.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:17:48+00:00	2018-08-24 00:17:48+00:00 	D08HRTAG	AGE AT HEART ATTACK. Q 3
26	Myocardial infarction	116960	phv00116960.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:17:55+00:00	2018-08-24 00:17:55+00:00 	D08HRTAK	HEART ATTACK? Q 3
26	Myocardial infarction	226366	phv00226366.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:27:27+00:00	2018-08-24 16:27:27+00:00 	MI_ECG	Myocardial infarction defined by ECG results
26	Myocardial infarction	258068	phv00258068.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:02:20+00:00	2018-08-24 17:02:20+00:00 	MHEA4	Heart attack - self (MHEA4)
26	Myocardial infarction	252984	phv00252984.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:12:35+00:00	2018-08-24 17:12:35+00:00 	mi_baseline	Self report heart attack at baseline visit
26	Myocardial infarction	117946	phv00117946.v2.p2	pht001749.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-27 23:09:19+00:00	2018-08-27 23:09:19+00:00 	FY096HAK	HEART ATTACK? - MON 96
26	Myocardial infarction	118435	phv00118435.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 22:43:23+00:00	2018-08-28 22:43:23+00:00 	E08HRTAG	AGE DIAGNOSED-HEART ATTACK. Q 8
26	Myocardial infarction	118434	phv00118434.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 22:43:30+00:00	2018-08-28 22:43:30+00:00 	E08HRTAK	HEART ATTACK? Q 8
26	Myocardial infarction	119814	phv00119814.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:10:10+00:00	2018-08-29 21:10:10+00:00 	F08HRTAG	AGE DIAGNOSED-HEART ATTACK. Q 3
26	Myocardial infarction	119809	phv00119809.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:10:17+00:00	2018-08-29 21:10:17+00:00 	F08HRTAK	HEART ATTACK? Q 3
26	Myocardial infarction	258767	phv00258767.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 13:04:51+00:00	2018-09-06 13:04:51+00:00 	Heart_attack	Have you ever had a heart attack? Self-report
26	Myocardial infarction	259382	phv00259382.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-06 13:19:43+00:00	2018-09-06 13:19:43+00:00 	priormi	Prior MI
26	Myocardial infarction	121850	phv00121850.v1.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 15:49:40+00:00	2018-09-07 15:49:40+00:00 	MI	Ever had a heart attack (mi)
26	Myocardial infarction	190834	phv00190834.v6.p10	pht003317.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 13:59:52+00:00	2018-09-27 13:59:52+00:00 	LASTSOE	Date of the latest record in the 2015  SOE dataset (vr_soe_2015_a_0991)
27	Coronary angioplasty	82875	phv00082875.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:49:07+00:00	2018-04-23 03:49:07+00:00 	angct1	ANGIOPLASTY AT ANY TIME IN THE PAST?
27	Coronary angioplasty	87147	phv00087147.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:49:16+00:00	2018-04-23 03:49:16+00:00 	ballnf	BALLOON ANGIOPLASTY
27	Coronary angioplasty	90119	phv00090119.v1.p3	pht001205.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:49:22+00:00	2018-04-23 03:49:22+00:00 	angct4	ANGIOPLASTY AT ANY TIME IN THE PAST?
27	Coronary angioplasty	174749	phv00174749.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:49:49+00:00	2018-04-23 03:49:49+00:00 	angct5	ANGIOPLASTY AT ANY TIME IN THE PAST?
27	Coronary angioplasty	176172	phv00176172.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:49:56+00:00	2018-04-23 03:49:56+00:00 	angct5	ANGIOPLASTY AT ANY TIME IN THE PAST?
27	Coronary angioplasty	87862	phv00087862.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:51:05+00:00	2018-04-23 03:51:05+00:00 	ptca	PTCA, COR. STENT, OR COR. ATHERECTOMY
27	Coronary angioplasty	87863	phv00087863.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:51:11+00:00	2018-04-23 03:51:11+00:00 	ptcatype	PTCA TYPE
27	Coronary angioplasty	87864	phv00087864.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:51:17+00:00	2018-04-23 03:51:17+00:00 	ptcatt	TIME TO PTCA OR LAST FOLLOW-UP (DAYS)
27	Coronary angioplasty	202950	phv00202950.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 16:08:37+00:00	2018-05-03 16:08:37+00:00 	AFUcomp15a_G	[Invasive procedures]. Did you have angioplasty of the coronary arteries [Annual Follow-up Questionnaire Form, AFUG]
27	Coronary angioplasty	203793	phv00203793.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 16:09:19+00:00	2018-05-03 16:09:19+00:00 	CORA20	Is there a history of coronary angioplasty prior to this event? Q20 [Coroner / Medical Examiner Form]
27	Coronary angioplasty	203945	phv00203945.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 16:10:06+00:00	2018-05-03 16:10:06+00:00 	HRAA29C	[Second transfer]. Were the following special procedures or operations performed during this hospital stay? Coronary angioplasty. Q29c [Hospital Abstraction Form]
27	Coronary angioplasty	203981	phv00203981.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 16:11:47+00:00	2018-05-03 16:11:47+00:00 	HRAA37	[Second transfer]. Is there a history of coronary angioplasty prior to this event? Q37 [Hospital Abstraction Form]
27	Coronary angioplasty	204406	phv00204406.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 16:12:24+00:00	2018-05-03 16:12:24+00:00 	PHQA03D	[Medical history]. Did the decedent have a history of any of the following? Coronary angioplasty. Q3d [Physician Questionnaire Form, exam 1]
27	Coronary angioplasty	207175	phv00207175.v1.p1	pht004104.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 16:15:02+00:00	2018-05-03 16:15:02+00:00 	HHXC7A	[Invasive procedures]. PROBE FOR TYPE OF PROCEDURE. Angioplasty of the coronary arteries: Q7a [Health/Medical History, exam 3]
27	Coronary angioplasty	207215	phv00207215.v1.p1	pht004106.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 16:16:52+00:00	2018-05-03 16:16:52+00:00 	HHXD7A	[Invasive procedures]. Did you have: angioplasty of the coronary arteries: Q7a [Health/Medical History, exam 4]
27	Coronary angioplasty	208854	phv00208854.v1.p1	pht004143.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 16:17:24+00:00	2018-05-03 16:17:24+00:00 	PHEA09A	[Invasive procedures]. [Probe for type of procedure]. Angioplasty of coronary artery(ies)? Q9a [Physical Examination Form, exam 1]
27	Coronary angioplasty	214102	phv00214102.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 16:18:05+00:00	2018-05-03 16:18:05+00:00 	CA15	MD said pt had coronary angioplasty?
27	Coronary angioplasty	125027	phv00125027.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:15:30+00:00	2018-06-08 16:15:30+00:00 	AFUA15A	15a. Angioplasty of the coronary arteries
27	Coronary angioplasty	125112	phv00125112.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:39:10+00:00	2018-06-08 16:39:10+00:00 	AFUA15A	15a. Angioplasty of the coronary arteries
27	Coronary angioplasty	125198	phv00125198.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:54:47+00:00	2018-06-08 16:54:47+00:00 	AFUB15A	15a. Angioplasty of the coronary arteries
27	Coronary angioplasty	125284	phv00125284.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:01:19+00:00	2018-06-08 17:01:19+00:00 	AFUB15A	15a. Angioplasty of the coronary arteries
27	Coronary angioplasty	125463	phv00125463.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:16:44+00:00	2018-06-08 17:16:44+00:00 	AFUC45A	45a. Angioplasty or stent of the coronary arteries
27	Coronary angioplasty	125628	phv00125628.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:48:56+00:00	2018-06-08 19:48:56+00:00 	AFUI15A	ANGIOPLASTY OF CORONARY ARTERIES  Q15A
27	Coronary angioplasty	125717	phv00125717.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:57:03+00:00	2018-06-08 19:57:03+00:00 	AFUJ15A	ANGIOPLASTY OF CORONARY ARTERIES  Q15A
27	Coronary angioplasty	125539	phv00125539.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:11:20+00:00	2018-06-08 20:11:20+00:00 	AFUI15A	ANGIOPLASTY OF CORONARY ARTERIES  Q15A
27	Coronary angioplasty	125804	phv00125804.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:17:42+00:00	2018-06-08 20:17:42+00:00 	AFUK15A	ANGIOPLA./STENT - CORONARY ARTERIES Q15A
27	Coronary angioplasty	5072	phv00005072.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:47:38+00:00	2018-06-14 17:47:38+00:00 	FO230	HISTORY OF CORONARY ARTERY ANGIOPLASTY
27	Coronary angioplasty	6202	phv00006202.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:52:43+00:00	2018-06-14 17:52:43+00:00 	FQ219	CORONARY ARTERY ANGIOPLASTY - INTERIM
27	Coronary angioplasty	6598	phv00006598.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:53:03+00:00	2018-06-14 17:53:03+00:00 	FR342	CARDIOVASCULAR PROCEDURES (IN THE INTERIM ONLY, NOT LIFETIME) CORONARY ARTERY ANGIOPLASTY (IF YES OR MAYBE, FILL IN FR343 AND FR344)
27	Coronary angioplasty	7032	phv00007032.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:53:22+00:00	2018-06-14 17:53:22+00:00 	FS441	CORONARY ARTERY ANGIOPLASTY
27	Coronary angioplasty	7465	phv00007465.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:53:39+00:00	2018-06-14 17:53:39+00:00 	FT445	CORONARY ARTERY ANGIOPLASTY
27	Coronary angioplasty	9388	phv00009388.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:54:06+00:00	2018-06-14 17:54:06+00:00 	E453	HISTORY OF CORONARY ARTERY ANGIOPLASTY
27	Coronary angioplasty	9896	phv00009896.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:54:27+00:00	2018-06-14 17:54:27+00:00 	F428	CORONARY ARTERY ANGIOPLASTY
27	Coronary angioplasty	10351	phv00010351.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:54:46+00:00	2018-06-14 17:54:46+00:00 	G233	CORONARY ARTERY ANGIOPLASTY
27	Coronary angioplasty	21082	phv00021082.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:55:19+00:00	2018-06-14 17:55:19+00:00 	G3A252	CORONARY ARTERY ANGIOPLASTY SEE NOTE BELOW
27	Coronary angioplasty	55299	phv00055299.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:55:42+00:00	2018-06-14 17:55:42+00:00 	CA15	MD said pt had coronary angioplasty?
27	Coronary angioplasty	70491	phv00070491.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:56:00+00:00	2018-06-14 17:56:00+00:00 	FU157	CORONARY ARTERY ANGIOPLASTY
27	Coronary angioplasty	72203	phv00072203.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:56:18+00:00	2018-06-14 17:56:18+00:00 	H212	CORONARY ARTERY ANGIOPLASTY/STENT/PCI
27	Coronary angioplasty	54692	phv00054692.v7.p10	pht000389.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:57:25+00:00	2018-06-14 17:57:25+00:00 	PROCNUM	Cardiovascular procedure codes
27	Coronary angioplasty	54697	phv00054697.v7.p10	pht000389.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 17:58:08+00:00	2018-06-14 17:58:08+00:00 	PROCDATE	Date of cardiovascular procedure
27	Coronary angioplasty	127730	phv00127730.v1.p1	pht001963.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:29:09+00:00	2018-06-20 15:29:09+00:00 	MHXA52B2	52b2: Specify other heart procedures
27	Coronary angioplasty	127737	phv00127737.v1.p1	pht001963.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:33:24+00:00	2018-06-20 15:33:24+00:00 	MHXA54A	54a: Ever had angioplasty of coronary arteries?
27	Coronary angioplasty	100780	phv00100780.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:42:00+00:00	2018-06-27 23:42:00+00:00 	INCANGIO	INCIDENT ANGIOPLASTY
27	Coronary angioplasty	100781	phv00100781.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:42:19+00:00	2018-06-27 23:42:19+00:00 	TTOANGI	TIME TO ANGIOPLASTY
27	Coronary angioplasty	100782	phv00100782.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:42:36+00:00	2018-06-27 23:42:36+00:00 	CORARTBL	CORONARY ARTERY ANGIOPLASTY AT BL
27	Coronary angioplasty	100824	phv00100824.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:46:07+00:00	2018-06-29 17:46:07+00:00 	EVTYPE	EVENT TYPE
27	Coronary angioplasty	100825	phv00100825.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:47:10+00:00	2018-06-29 17:47:10+00:00 	TTOEVENT	TIME TO EVENT
27	Coronary angioplasty	193548	phv00193548.v2.p3	pht003409.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:08:22+00:00	2018-06-29 23:08:22+00:00 	DTHCABGPTCA	F124 Coronary Death CABG/PTCA
27	Coronary angioplasty	193199	phv00193199.v3.p3	pht003407.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:09:20+00:00	2018-06-29 23:09:20+00:00 	PTCA	PTCA
27	Coronary angioplasty	192519	phv00192519.v3.p3	pht003402.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:10:04+00:00	2018-06-29 23:10:04+00:00 	PTCA	PTCA
27	Coronary angioplasty	193058	phv00193058.v3.p3	pht003406.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:11:42+00:00	2018-06-29 23:11:42+00:00 	PTCA	PTCA
27	Coronary angioplasty	193000	phv00193000.v3.p3	pht003405.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:12:17+00:00	2018-06-29 23:12:17+00:00 	PTCA	PTCA
27	Coronary angioplasty	283435	phv00283435.v1.p3	pht006220.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:13:39+00:00	2018-06-29 23:13:39+00:00 	DTHCABGPTCA	F124 Coronary Death CABG/PTCA
27	Coronary angioplasty	283700	phv00283700.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:14:34+00:00	2018-06-29 23:14:34+00:00 	PTCA	F136 PTCA
27	Coronary angioplasty	78536	phv00078536.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:15:23+00:00	2018-06-29 23:15:23+00:00 	PTCA	Angioplasty of coronary arteries ever
27	Coronary angioplasty	121382	phv00121382.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-06 18:36:14+00:00	2018-08-06 18:36:14+00:00 	Y01STENT	PTCA, CORONARY STENT OR ATHERECTOMY?
27	Coronary angioplasty	121602	phv00121602.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-06 18:36:30+00:00	2018-08-06 18:36:30+00:00 	Y01STENT	PTCA, CORONARY STENT OR ATHERECTOMY?
27	Coronary angioplasty	159632	phv00159632.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:19:45+00:00	2018-08-10 21:19:45+00:00 	Angioplasty	Angioplasty or cardiac stents placed Collection Interval: Collected in Exam 1
27	Coronary angioplasty	277439	phv00277439.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:30:06+00:00	2018-08-14 22:30:06+00:00 	ART_AGE	In what year or how old were you when you first had this procedure? - age Collection Interval: 2009-2011
27	Coronary angioplasty	277438	phv00277438.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:30:26+00:00	2018-08-14 22:30:26+00:00 	ART_YR	In what year or how old were you when you first had this procedure? - year Collection Interval: 2009-2011
27	Coronary angioplasty	277437	phv00277437.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:30:51+00:00	2018-08-14 22:30:51+00:00 	ARTERIES	Have you ever had coronary bypass surgery/angioplasty/balloon dilation/or stent because of blocked arteries? Collection Interval: 2009-2011
27	Coronary angioplasty	277602	phv00277602.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:49:27+00:00	2018-08-14 22:49:27+00:00 	ARTERIES	Ever had coronary bypass surgery/angioplasty/or balloon dilation because arteries of the heart were blocked? Collection Interval: 1996-2000
27	Coronary angioplasty	277603	phv00277603.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:49:42+00:00	2018-08-14 22:49:42+00:00 	ART_YR	In what year or how old were you when you first had this procedure? - year Collection Interval: 1996-2000
27	Coronary angioplasty	277604	phv00277604.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:49:56+00:00	2018-08-14 22:49:56+00:00 	ART_AGE	In what year or how old were you when you first had this procedure? - age Collection Interval: 1996-2000
27	Coronary angioplasty	277888	phv00277888.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:15:05+00:00	2018-08-14 23:15:05+00:00 	ART_AGE	In what year or how old were you when you first had this procedure? - age Collection Interval: 2000-2004
27	Coronary angioplasty	277887	phv00277887.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:15:18+00:00	2018-08-14 23:15:18+00:00 	ART_YR	In what year or how old were you when you first had this procedure? - year Collection Interval: 2000-2004
27	Coronary angioplasty	277886	phv00277886.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:15:32+00:00	2018-08-14 23:15:32+00:00 	ARTERIES	Have you ever had coronary bypass surgery/angioplasty/balloon dilation/or stent because of blocked arteries? Collection Interval: 2000-2004
27	Coronary angioplasty	307885	phv00307885.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:01:51+00:00	2018-08-16 00:01:51+00:00 	ART_AGE	In what year or how old were you when you first had this procedure? - age Collection Interval: 1996-2000
27	Coronary angioplasty	307884	phv00307884.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:02:04+00:00	2018-08-16 00:02:04+00:00 	ART_YR	In what year or how old were you when you first had this procedure? - year Collection Interval: 1996-2000
27	Coronary angioplasty	307883	phv00307883.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:02:17+00:00	2018-08-16 00:02:17+00:00 	ARTERIES	Ever had coronary bypass surgery/angioplasty/or balloon dilation because arteries of the heart were blocked? Collection Interval: 1996-2000
27	Coronary angioplasty	308081	phv00308081.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:16:45+00:00	2018-08-16 00:16:45+00:00 	ART_AGE	In what year or how old were you when you first had this procedure? - age Collection Interval: 2000-2004
27	Coronary angioplasty	308080	phv00308080.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:16:59+00:00	2018-08-16 00:16:59+00:00 	ART_YR	In what year or how old were you when you first had this procedure? - year Collection Interval: 2000-2004
27	Coronary angioplasty	308079	phv00308079.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:17:13+00:00	2018-08-16 00:17:13+00:00 	ARTERIES	Have you ever had coronary bypass surgery/angioplasty/balloon dilation/or stent because of blocked arteries? Collection Interval: 2000-2004
27	Coronary angioplasty	122383	phv00122383.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:34:28+00:00	2018-08-16 23:34:28+00:00 	ANGIOP	Has had coronary angioplasty
27	Coronary angioplasty	124262	phv00124262.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 19:00:02+00:00	2018-08-21 19:00:02+00:00 	ANGIODAY	Days from visit date - Diagnosed  Coronary Angioplasty
27	Coronary angioplasty	204151	phv00204151.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-27 22:40:44+00:00	2018-09-27 22:40:44+00:00 	HRAA29P1	[Second transfer]. Holter monitoring. Pacemaker (temporary, wires). Coronary stent. Q29p1 [Hospital Abstraction Form]
27	Coronary angioplasty	255316	phv00255316.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 17:42:43+00:00	2018-10-10 17:42:43+00:00 	fw586	Heart Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Procedure to unblock narrowed blood vessels to your heart muscles   Variable appears on Form B only Collection Interval: Original Cohort Exam 30
28	Coronary artery bypass graft	87865	phv00087865.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:53:46+00:00	2018-04-23 03:53:46+00:00 	cbg	CORONARY BYPASS GRAFT (CBG)
28	Coronary artery bypass graft	87866	phv00087866.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:53:53+00:00	2018-04-23 03:53:53+00:00 	cbgtype	CBG TYPE
28	Coronary artery bypass graft	87867	phv00087867.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:53:59+00:00	2018-04-23 03:53:59+00:00 	cbgtt	TIME TO CBG OR LAST FOLLOW-UP (DAYS)
28	Coronary artery bypass graft	206900	phv00206900.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 18:59:49+00:00	2018-04-24 18:59:49+00:00 	HFAA32B3	[Diagnostic tests]. Q32b3 - Were coronary bypass grafts present? [Heart Failure Hospital Record Abstraction Form, HFA]
28	Coronary artery bypass graft	206912	phv00206912.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 19:00:12+00:00	2018-04-24 19:00:12+00:00 	HFAA51	Q51 - Interventions: coronary artery bypass graft (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA]
28	Coronary artery bypass graft	206795	phv00206795.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 19:06:36+00:00	2018-04-24 19:06:36+00:00 	HFAA11E1	[Medical history]. Q11e1- Cardiac procedures: CABG [Heart Failure Hospital Record Abstraction Form, HFA]
28	Coronary artery bypass graft	121381	phv00121381.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 17:39:49+00:00	2018-05-24 17:39:49+00:00 	Y01BAPAS	CORONARY ARTERY BYPASS GRAFT?
28	Coronary artery bypass graft	121601	phv00121601.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 17:40:01+00:00	2018-05-24 17:40:01+00:00 	Y01BAPAS	CORONARY ARTERY BYPASS GRAFT?
28	Coronary artery bypass graft	125018	phv00125018.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:12:44+00:00	2018-06-08 16:12:44+00:00 	AFUA13A	13a. Coronary bypass
28	Coronary artery bypass graft	125103	phv00125103.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:38:45+00:00	2018-06-08 16:38:45+00:00 	AFUA13A	13a. Coronary bypass
28	Coronary artery bypass graft	125189	phv00125189.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:54:25+00:00	2018-06-08 16:54:25+00:00 	AFUB13A	13a. Coronary bypass
28	Coronary artery bypass graft	125275	phv00125275.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:00:57+00:00	2018-06-08 17:00:57+00:00 	AFUB13A	13a. Coronary bypass
28	Coronary artery bypass graft	125452	phv00125452.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:16:25+00:00	2018-06-08 17:16:25+00:00 	AFUC42A	42. Did you have coronary bypass
28	Coronary artery bypass graft	125620	phv00125620.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:48:32+00:00	2018-06-08 19:48:32+00:00 	AFUI13A	CORONARY BYPASS                   Q13A
28	Coronary artery bypass graft	125709	phv00125709.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:56:36+00:00	2018-06-08 19:56:36+00:00 	AFUJ13A	CORONARY BYPASS                   Q13A
28	Coronary artery bypass graft	125531	phv00125531.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:10:55+00:00	2018-06-08 20:10:55+00:00 	AFUI13A	CORONARY BYPASS                   Q13A
28	Coronary artery bypass graft	125796	phv00125796.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:16:03+00:00	2018-06-08 20:16:03+00:00 	AFUK13A	CORONARY BYPASS                     Q13A
28	Coronary artery bypass graft	54653	phv00054653.v1.p10	pht000386.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:09:25+00:00	2018-06-14 18:09:25+00:00 	procedure	TYPE OF PROCEDURE
28	Coronary artery bypass graft	54659	phv00054659.v1.p10	pht000386.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:09:44+00:00	2018-06-14 18:09:44+00:00 	procdate	PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1
28	Coronary artery bypass graft	255315	phv00255315.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:11:05+00:00	2018-06-14 18:11:05+00:00 	fw585	Heart Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Heart bypass operation or coronary bypass surgery or CABG Variable appears on Form B only Collection Interval: Original Cohort Exam 30
28	Coronary artery bypass graft	275040	phv00275040.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:11:19+00:00	2018-06-14 18:11:19+00:00 	FX585	Heart Problems (Form B) - Since last exam or medical history update, have you seen a doctor or other healthcare provider or been hospitalized for heart bypass operation or coronary bypass surgery or CABG? Collection Interval: Original Cohort Exam 31
28	Coronary artery bypass graft	275374	phv00275374.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:11:31+00:00	2018-06-14 18:11:31+00:00 	fy585	Heart Problems (Form B) - Since your last Framingham Heart Study exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for heart bypass operation or coronary bypass surgery or CABG? Collection Interval: Original Cohort Exam 32
28	Coronary artery bypass graft	4774	phv00004774.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:12:34+00:00	2018-06-14 18:12:34+00:00 	FN300	HISTORY OF CORONARY BYPASS SURGERY
28	Coronary artery bypass graft	5074	phv00005074.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:12:44+00:00	2018-06-14 18:12:44+00:00 	FO233	HISTORY OF CORONARY BYPASS SURGERY
28	Coronary artery bypass graft	5692	phv00005692.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:12:53+00:00	2018-06-14 18:12:53+00:00 	FP183	CORONARY BYPASS SURGERY
28	Coronary artery bypass graft	6203	phv00006203.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:13:02+00:00	2018-06-14 18:13:02+00:00 	FQ220	CORONARY BYPASS SURGERY - INTERIM
28	Coronary artery bypass graft	6600	phv00006600.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:20:22+00:00	2018-06-14 18:20:22+00:00 	FR345	CARDIOVASCULAR PROCEDURES (IN THE INTERIM ONLY, NOT LIFETIME) CORONARY BYPASS SURGERY (IF YES, FILL IN FR346)
28	Coronary artery bypass graft	7034	phv00007034.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:22:00+00:00	2018-06-14 18:22:00+00:00 	FS444	CORONARY BYPASS SURGERY
28	Coronary artery bypass graft	7467	phv00007467.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:22:13+00:00	2018-06-14 18:22:13+00:00 	FT448	CORONARY BYPASS SURGERY
28	Coronary artery bypass graft	9390	phv00009390.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:22:25+00:00	2018-06-14 18:22:25+00:00 	E456	HISTORY OF CORONARY BYPASS SURGERY
28	Coronary artery bypass graft	9898	phv00009898.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:22:38+00:00	2018-06-14 18:22:38+00:00 	F431	CORONARY BYPASS SURGERY
28	Coronary artery bypass graft	10097	phv00010097.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:23:04+00:00	2018-06-14 18:23:04+00:00 	F707	DID YOU HAVE HEART BYPASS SURGERY BEFORE AGE 55
28	Coronary artery bypass graft	10353	phv00010353.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:23:20+00:00	2018-06-14 18:23:20+00:00 	G236	CORONARY BYPASS SURGERY
28	Coronary artery bypass graft	21084	phv00021084.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:23:42+00:00	2018-06-14 18:23:42+00:00 	G3A255	CORONARY BYPASS SURGERY SEE NOTE BELOW
28	Coronary artery bypass graft	54692	phv00054692.v7.p10	pht000389.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:24:29+00:00	2018-06-14 18:24:29+00:00 	PROCNUM	Cardiovascular procedure codes
28	Coronary artery bypass graft	54697	phv00054697.v7.p10	pht000389.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:24:58+00:00	2018-06-14 18:24:58+00:00 	PROCDATE	Date of cardiovascular procedure
28	Coronary artery bypass graft	70493	phv00070493.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:29:15+00:00	2018-06-14 18:29:15+00:00 	FU160	CORONARY BYPASS SURGERY
28	Coronary artery bypass graft	127728	phv00127728.v1.p1	pht001963.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:26:41+00:00	2018-06-20 15:26:41+00:00 	MHXA52A	52a: Have a coronary bypass?
28	Coronary artery bypass graft	100783	phv00100783.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:42:56+00:00	2018-06-27 23:42:56+00:00 	INCBYPS	INCIDENT BYPASS SURGERY
28	Coronary artery bypass graft	100784	phv00100784.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:43:18+00:00	2018-06-27 23:43:18+00:00 	TTOBYPS	TIME TO BYPASS SURGERY
28	Coronary artery bypass graft	100785	phv00100785.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:43:35+00:00	2018-06-27 23:43:35+00:00 	BPSSURBL	CORONARY BYPASS SURGERY AT BL
28	Coronary artery bypass graft	100824	phv00100824.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:46:21+00:00	2018-06-29 17:46:21+00:00 	EVTYPE	EVENT TYPE
28	Coronary artery bypass graft	100825	phv00100825.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:47:21+00:00	2018-06-29 17:47:21+00:00 	TTOEVENT	TIME TO EVENT
28	Coronary artery bypass graft	78535	phv00078535.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:18:56+00:00	2018-06-29 23:18:56+00:00 	CABG	Coronary bypass surgery ever
28	Coronary artery bypass graft	192480	phv00192480.v3.p3	pht003402.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:19:34+00:00	2018-06-29 23:19:34+00:00 	CABG	CABG
28	Coronary artery bypass graft	193157	phv00193157.v3.p3	pht003407.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:20:17+00:00	2018-06-29 23:20:17+00:00 	CABG	CABG
28	Coronary artery bypass graft	193052	phv00193052.v3.p3	pht003406.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:20:35+00:00	2018-06-29 23:20:35+00:00 	CABG	CABG
28	Coronary artery bypass graft	192995	phv00192995.v3.p3	pht003405.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:20:55+00:00	2018-06-29 23:20:55+00:00 	CABG	CABG
28	Coronary artery bypass graft	283699	phv00283699.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:21:13+00:00	2018-06-29 23:21:13+00:00 	CABG	F136 CABG
28	Coronary artery bypass graft	283519	phv00283519.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:12:38+00:00	2018-07-02 22:12:38+00:00 	CABGHX	F136 History of CABG
28	Coronary artery bypass graft	127730	phv00127730.v1.p1	pht001963.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 18:23:26+00:00	2018-08-06 18:23:26+00:00 	MHXA52B2	52b2: Specify other heart procedures
28	Coronary artery bypass graft	159631	phv00159631.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:57:27+00:00	2018-08-10 20:57:27+00:00 	CABG	Coronary artery bypass surgery [CABG] Collection Interval: Collected in Exam 1
28	Coronary artery bypass graft	277439	phv00277439.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:30:13+00:00	2018-08-14 22:30:13+00:00 	ART_AGE	In what year or how old were you when you first had this procedure? - age Collection Interval: 2009-2011
28	Coronary artery bypass graft	277438	phv00277438.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:30:33+00:00	2018-08-14 22:30:33+00:00 	ART_YR	In what year or how old were you when you first had this procedure? - year Collection Interval: 2009-2011
28	Coronary artery bypass graft	277437	phv00277437.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:30:59+00:00	2018-08-14 22:30:59+00:00 	ARTERIES	Have you ever had coronary bypass surgery/angioplasty/balloon dilation/or stent because of blocked arteries? Collection Interval: 2009-2011
28	Coronary artery bypass graft	277602	phv00277602.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:49:33+00:00	2018-08-14 22:49:33+00:00 	ARTERIES	Ever had coronary bypass surgery/angioplasty/or balloon dilation because arteries of the heart were blocked? Collection Interval: 1996-2000
28	Coronary artery bypass graft	277603	phv00277603.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:49:48+00:00	2018-08-14 22:49:48+00:00 	ART_YR	In what year or how old were you when you first had this procedure? - year Collection Interval: 1996-2000
28	Coronary artery bypass graft	277604	phv00277604.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:50:02+00:00	2018-08-14 22:50:02+00:00 	ART_AGE	In what year or how old were you when you first had this procedure? - age Collection Interval: 1996-2000
28	Coronary artery bypass graft	277888	phv00277888.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:15:11+00:00	2018-08-14 23:15:11+00:00 	ART_AGE	In what year or how old were you when you first had this procedure? - age Collection Interval: 2000-2004
28	Coronary artery bypass graft	277887	phv00277887.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:15:24+00:00	2018-08-14 23:15:24+00:00 	ART_YR	In what year or how old were you when you first had this procedure? - year Collection Interval: 2000-2004
28	Coronary artery bypass graft	277886	phv00277886.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:15:38+00:00	2018-08-14 23:15:38+00:00 	ARTERIES	Have you ever had coronary bypass surgery/angioplasty/balloon dilation/or stent because of blocked arteries? Collection Interval: 2000-2004
28	Coronary artery bypass graft	307885	phv00307885.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:01:56+00:00	2018-08-16 00:01:56+00:00 	ART_AGE	In what year or how old were you when you first had this procedure? - age Collection Interval: 1996-2000
28	Coronary artery bypass graft	307884	phv00307884.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:02:10+00:00	2018-08-16 00:02:10+00:00 	ART_YR	In what year or how old were you when you first had this procedure? - year Collection Interval: 1996-2000
28	Coronary artery bypass graft	307883	phv00307883.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:02:23+00:00	2018-08-16 00:02:23+00:00 	ARTERIES	Ever had coronary bypass surgery/angioplasty/or balloon dilation because arteries of the heart were blocked? Collection Interval: 1996-2000
28	Coronary artery bypass graft	308081	phv00308081.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:16:51+00:00	2018-08-16 00:16:51+00:00 	ART_AGE	In what year or how old were you when you first had this procedure? - age Collection Interval: 2000-2004
28	Coronary artery bypass graft	308080	phv00308080.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:17:04+00:00	2018-08-16 00:17:04+00:00 	ART_YR	In what year or how old were you when you first had this procedure? - year Collection Interval: 2000-2004
28	Coronary artery bypass graft	308079	phv00308079.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:17:20+00:00	2018-08-16 00:17:20+00:00 	ARTERIES	Have you ever had coronary bypass surgery/angioplasty/balloon dilation/or stent because of blocked arteries? Collection Interval: 2000-2004
28	Coronary artery bypass graft	90120	phv00090120.v1.p3	pht001205.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-08-16 20:47:07+00:00	2018-08-16 20:47:07+00:00 	coronct4	CORONARY BYPASS AT ANY TIME IN THE PAST?
28	Coronary artery bypass graft	122382	phv00122382.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:34:43+00:00	2018-08-16 23:34:43+00:00 	BYPASS	Have you had a coronary bypass
28	Coronary artery bypass graft	283435	phv00283435.v1.p3	pht006220.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 16:25:06+00:00	2018-08-21 16:25:06+00:00 	DTHCABGPTCA	F124 Coronary Death CABG/PTCA
28	Coronary artery bypass graft	193548	phv00193548.v2.p3	pht003409.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 16:25:15+00:00	2018-08-21 16:25:15+00:00 	DTHCABGPTCA	F124 Coronary Death CABG/PTCA
29	Heart failure	87870	phv00087870.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:55:23+00:00	2018-04-23 03:55:23+00:00 	chf	CONGESTIVE HEART FAILURE (CHF)
29	Heart failure	87871	phv00087871.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:55:30+00:00	2018-04-23 03:55:30+00:00 	chftype	CHF TYPE
29	Heart failure	87872	phv00087872.v6.p3	pht001123.v7.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:55:43+00:00	2018-04-23 03:55:43+00:00 	chftt	TIME TO CHF OR LAST FOLLOW-UP (DAYS)
29	Heart failure	87140	phv00087140.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 03:55:49+00:00	2018-04-23 03:55:49+00:00 	hfailf	HEART FAILURE
29	Heart failure	121265	phv00121265.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-02 20:20:08+00:00	2018-05-02 20:20:08+00:00 	Y01CHFEP	ENDPT - CONGESTIVE HEART FAILURE
29	Heart failure	121301	phv00121301.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-02 20:20:08+00:00	2018-05-02 20:20:08+00:00 	Y01CHF	CONGESTIVE HEAT FAILURE
29	Heart failure	121481	phv00121481.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-02 20:20:08+00:00	2018-05-02 20:20:08+00:00 	Y01CHFEP	ENDPT - CONGESTIVE HEART FAILURE
29	Heart failure	121518	phv00121518.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-02 20:20:08+00:00	2018-05-02 20:20:08+00:00 	Y01CHF	CONGESTIVE HEAT FAILURE
29	Heart failure	204697	phv00204697.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:26:38+00:00	2018-05-03 20:26:38+00:00 	PREVHF01	Prevalent heart failure at baseline [Cohort, Exam 1]
29	Heart failure	202927	phv00202927.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:49:00+00:00	2018-05-03 20:49:00+00:00 	AFUcomp7b_G	[General health].  Has a doctor ever said you had any of the following? Heart failure or congestive heart failure [Annual Follow-up Questionnaire Form, AFUG]
29	Heart failure	202981	phv00202981.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:50:08+00:00	2018-05-03 20:50:08+00:00 	AFUcomp9_L	[General health]. Since we last contacted you on mm/dd/yyyy, has a doctor said that you had hear failure or congestive heart failure? [Annual Follow-up Questionnaire Form, AFUL]
29	Heart failure	206748	phv00206748.v1.p1	pht004101.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-17 15:48:04+00:00	2018-05-17 15:48:04+00:00 	HDXA1C_DAYS	Date of HDX completion HDXA1C [Heart Failure Diagnosis Form, HDXA]
29	Heart failure	113052	phv00113052.v2.p2	pht001570.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 17:40:58+00:00	2018-05-24 17:40:58+00:00 	A09CHF	HAS/HAD CONGESTIVE HEART FAILURE
29	Heart failure	121462	phv00121462.v2.p2	pht001870.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 17:41:35+00:00	2018-05-24 17:41:35+00:00 	Y00CHF	DISCHG DIAG - CONGESTIVE HEART FAILURE
29	Heart failure	124994	phv00124994.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 15:23:09+00:00	2018-06-08 15:23:09+00:00 	AFUA7B	7b. Heart failure or congestive heart failure
29	Heart failure	125079	phv00125079.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:29:14+00:00	2018-06-08 16:29:14+00:00 	AFUA7B	7b. Heart failure or congestive heart failure
29	Heart failure	125164	phv00125164.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:45:17+00:00	2018-06-08 16:45:17+00:00 	AFUB7B	7b. Heart failure or congestive heart failure
29	Heart failure	125250	phv00125250.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:58:58+00:00	2018-06-08 16:58:58+00:00 	AFUB7B	7b. Heart failure or congestive heart failure
29	Heart failure	125336	phv00125336.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:09:14+00:00	2018-06-08 17:09:14+00:00 	AFUC7B	7b. Ever reported a heart failure diagnosis in AFU without documented
29	Heart failure	125337	phv00125337.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:09:47+00:00	2018-06-08 17:09:47+00:00 	AFUC8	8. In the previous JHS phone call in (mm/dd/yyyy) you indicated that you had been diagnosed
29	Heart failure	125345	phv00125345.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:11:07+00:00	2018-06-08 17:11:07+00:00 	AFUC9	9. Since we last contacted you, has doctor said that you had heart failure
29	Heart failure	125598	phv00125598.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:45:51+00:00	2018-06-08 19:45:51+00:00 	AFUI7B	DOCTOR - HEART FAILURE            Q7B
29	Heart failure	125686	phv00125686.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:53:25+00:00	2018-06-08 19:53:25+00:00 	AFUJ7B	DOCTOR - HEART FAILURE            Q7B
29	Heart failure	125510	phv00125510.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:05:41+00:00	2018-06-08 20:05:41+00:00 	AFUI7B	DOCTOR - HEART FAILURE            Q7B
29	Heart failure	125774	phv00125774.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:13:44+00:00	2018-06-08 20:13:44+00:00 	AFUK7B	DOCTOR - HEART FAILURE              Q7B
29	Heart failure	190816	phv00190816.v6.p10	pht003316.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:42:58+00:00	2018-06-15 11:42:58+00:00 	chf	Congestive Heart Failure (CHF) status
29	Heart failure	190822	phv00190822.v6.p10	pht003316.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:43:43+00:00	2018-06-15 11:43:43+00:00 	chfdate	Date of Congestive Heart Failure (CHF) status
29	Heart failure	276886	phv00276886.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:45:54+00:00	2018-06-15 11:45:54+00:00 	CHF011d	Date of hospital admit
29	Heart failure	276887	phv00276887.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:46:13+00:00	2018-06-15 11:46:13+00:00 	CHF015d	Date of HF onset, if different
29	Heart failure	36469	phv00036469.v11.p10	pht000309.v12.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:46:56+00:00	2018-06-15 11:46:56+00:00 	EVENT	Event Number Collection Interval: Events reviewed through 12/2015
29	Heart failure	36471	phv00036471.v11.p10	pht000309.v12.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:47:17+00:00	2018-06-15 11:47:17+00:00 	DATE	Date of Event Collection Interval: Events reviewed through 12/2015
29	Heart failure	7918	phv00007918.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:49:38+00:00	2018-06-15 11:49:38+00:00 	B286	X RAY: CHF
29	Heart failure	9299	phv00009299.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:49:57+00:00	2018-06-15 11:49:57+00:00 	E346	1ST EXAMINER BELIEVES CHF
29	Heart failure	255313	phv00255313.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:50:39+00:00	2018-06-15 11:50:39+00:00 	fw583	Heart Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Heart failure or congestive heart failure or CHF Variable appears on Form B only Collection Interval: Original Cohort Exam 30
29	Heart failure	275038	phv00275038.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:50:50+00:00	2018-06-15 11:50:50+00:00 	FX583	Heart Problems (Form B) - Since last exam or medical history update, have you seen a doctor or other healthcare provider or been hospitalized for heart failure or congestive heart failure or CHF? Collection Interval: Original Cohort Exam 31
29	Heart failure	275372	phv00275372.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:51:00+00:00	2018-06-15 11:51:00+00:00 	fy583	Heart Problems (Form B) - Since your last Framingham Heart Study exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for heart failure or congestive heart failure or CHF ? Collection Interval: Original Cohort Exam 32
29	Heart failure	6537	phv00006537.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:51:59+00:00	2018-06-15 11:51:59+00:00 	FR264	RESPIRATORY SYMPTOMS - BEEN TOLD THAT YOU HAVE HAD HEART FAILURE OR CONGESTIVE HEART FAILURE IN THE INTERIM
29	Heart failure	6968	phv00006968.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:52:15+00:00	2018-06-15 11:52:15+00:00 	FS359	BEEN TOLD YOU HAVE HAD HEART FAILURE OR CONGESTIVE HEART FAILURE IN THE INTERIM
29	Heart failure	7400	phv00007400.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:52:35+00:00	2018-06-15 11:52:35+00:00 	FT361	BEEN TOLD YOU HAVE HAD HEART FAILURE OR CONGESTIVE HEART FAILURE IN THE INTERIM
29	Heart failure	10278	phv00010278.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:52:50+00:00	2018-06-15 11:52:50+00:00 	G135	BEEN TOLD THAT YOU HAVE HAD HEART FAILURE OR CONGESTIVE HEART FAILURE IN THE INTERIM
29	Heart failure	21020	phv00021020.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:53:05+00:00	2018-06-15 11:53:05+00:00 	G3A165	HAVE YOU BEEN TOLD YOU HAD HEART FAILURE OR CONGESTIVE HEART FAILURE?
29	Heart failure	70433	phv00070433.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:53:20+00:00	2018-06-15 11:53:20+00:00 	FU077	SHORTNESS OF BREATH: HAVE YOU SINCE YOUR LAST EXAM BEEN TOLD YOU HAD HEART FAILURE OR CONGESTIVE HEART FAILURE?
29	Heart failure	72131	phv00072131.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:53:36+00:00	2018-06-15 11:53:36+00:00 	H108	SINCE YOUR LAST EXAM HAVE YOU BEEN TOLD YOU HAD HEART FAILURE OR CONGESTIVE HEART FAILURE?
29	Heart failure	273854	phv00273854.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:54:02+00:00	2018-06-15 11:54:02+00:00 	g3a165	Have you been told you had heart failure or congestive heart failure? Collection Interval: Exam 1
29	Heart failure	274347	phv00274347.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:54:12+00:00	2018-06-15 11:54:12+00:00 	g3a165	Have you been told you had heart failure or congestive heart failure?
29	Heart failure	274757	phv00274757.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:54:31+00:00	2018-06-15 11:54:31+00:00 	FX060	Medical History - Respiratory Symptoms: Have you been told by your doctor you had heart failure or congestive heart failure? Collection Interval: Original Cohort Exam 31
29	Heart failure	275114	phv00275114.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:54:45+00:00	2018-06-15 11:54:45+00:00 	fy060	Medical History - Respiratory Symptoms: Have you been told by your doctor you had heart failure or congestive heart failure? Collection Interval: Original Cohort Exam 32
29	Heart failure	6538	phv00006538.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:55:36+00:00	2018-06-15 11:55:36+00:00 	FR265	RESPIRATORY SYMPTOMS - BEEN HOSPITALIZED FOR HEART FAILURE IN INTERIM
29	Heart failure	6969	phv00006969.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:55:49+00:00	2018-06-15 11:55:49+00:00 	FS360	BEEN HOSPITALIZED FOR HEART FAILURE IN INTERIM
29	Heart failure	7401	phv00007401.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:56:02+00:00	2018-06-15 11:56:02+00:00 	FT362	BEEN HOSPITALIZED FOR HEART FAILURE IN INTERIM
29	Heart failure	10279	phv00010279.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:56:22+00:00	2018-06-15 11:56:22+00:00 	G136	BEEN HOSPITALIZED FOR HEART FAILURE IN THE INTERIM
29	Heart failure	21021	phv00021021.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:56:39+00:00	2018-06-15 11:56:39+00:00 	G3A166	HAVE YOU BEEN HOSPITALIZED FOR HEART FAILURE?
29	Heart failure	70434	phv00070434.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:56:55+00:00	2018-06-15 11:56:55+00:00 	FU078	SHORTNESS OF BREATH: HAVE YOU SINCE YOUR LAST EXAM BEEN HOSPITALIZED FOR HEART FAILURE?
29	Heart failure	72132	phv00072132.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:57:08+00:00	2018-06-15 11:57:08+00:00 	H109	SINCE YOUR LAST EXAM HAVE YOU BEEN HOSPITALIZED FOR HEART FAILURE?
29	Heart failure	177351	phv00177351.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:57:30+00:00	2018-06-15 11:57:30+00:00 	g3b0147	Medical History-Respiratory Symptoms: Have you been hospitalized for heart failure?
29	Heart failure	250846	phv00250846.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:57:46+00:00	2018-06-15 11:57:46+00:00 	g136	Medical History - Respiratory and Heart: Been hospitalized for heart failure in interim Collection Interval: Exam 2
29	Heart failure	251340	phv00251340.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:58:00+00:00	2018-06-15 11:58:00+00:00 	h109	Medical History - Respiratory Symptoms - Part II - Shortness of breath: Since your last exam have you been hospitalized for heart failure? Collection Interval: Exam 3
29	Heart failure	254086	phv00254086.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:58:20+00:00	2018-06-15 11:58:20+00:00 	j114	Medical History - Respiratory Symptoms, Part II-Shortness of breath: Since your last exam: Have you been hospitalized for heart failure?
29	Heart failure	254649	phv00254649.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:58:34+00:00	2018-06-15 11:58:34+00:00 	fv063	Medical History - Respiratory Symptoms: Have you since your last exam been hospitalized for heart failure? Collection Interval: Exam 29
29	Heart failure	255037	phv00255037.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:58:48+00:00	2018-06-15 11:58:48+00:00 	fw064	Medical History - Respiratory Symptoms: Have you been hospitalized for heart failure? Variable appears on Form A only Collection Interval: Original Cohort Exam 30
29	Heart failure	273855	phv00273855.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:59:01+00:00	2018-06-15 11:59:01+00:00 	g3a166	Have you been hospitalized for heart failure? Collection Interval: Exam 1
29	Heart failure	274348	phv00274348.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:59:30+00:00	2018-06-15 11:59:30+00:00 	g3a166	Have you been hospitalized for heart failure?
29	Heart failure	274758	phv00274758.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 11:59:47+00:00	2018-06-15 11:59:47+00:00 	FX064	Medical History - Respiratory Symptoms: Have you been hospitalized for heart failure? Collection Interval: Original Cohort Exam 31
29	Heart failure	275115	phv00275115.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 12:00:03+00:00	2018-06-15 12:00:03+00:00 	fy064	Medical History - Respiratory Symptoms: Have you been hospitalized for heart failure? Collection Interval: Original Cohort Exam 32
29	Heart failure	276986	phv00276986.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 12:00:25+00:00	2018-06-15 12:00:25+00:00 	HOSP2	Hospitalization for heart failure Collection Interval: 1975 through 2014
29	Heart failure	113053	phv00113053.v2.p2	pht001570.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:22:47+00:00	2018-06-18 20:22:47+00:00 	A09CHFAG	AGE, CONGESTIVE HEART FAILURE
29	Heart failure	113054	phv00113054.v2.p2	pht001570.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-06-18 20:22:47+00:00	2018-06-18 20:22:47+00:00 	A09CHFST	STATUS OF CONGESTIVE HRT FAILURE
29	Heart failure	100786	phv00100786.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:43:54+00:00	2018-06-27 23:43:54+00:00 	INCCHF	INCIDENT CHF
29	Heart failure	100787	phv00100787.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:44:15+00:00	2018-06-27 23:44:15+00:00 	TTOCHF	TIME TO CHF
29	Heart failure	100788	phv00100788.v1.p1	pht001464.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:44:46+00:00	2018-06-27 23:44:46+00:00 	CHBLMOD	CHF MODIFIED BL STAT
29	Heart failure	100819	phv00100819.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:48:18+00:00	2018-06-27 23:48:18+00:00 	CHBLMOD	CHF MODIFIED BL STAT
29	Heart failure	100813	phv00100813.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:22:04+00:00	2018-06-29 16:22:04+00:00 	CHFBASE	CHF AT BL (SELF-REPORT)
29	Heart failure	100824	phv00100824.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:46:33+00:00	2018-06-29 17:46:33+00:00 	EVTYPE	EVENT TYPE
29	Heart failure	100825	phv00100825.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:47:41+00:00	2018-06-29 17:47:41+00:00 	TTOEVENT	TIME TO EVENT
29	Heart failure	77636	phv00077636.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:59:53+00:00	2018-07-02 21:59:53+00:00 	CHF_3	Heart failure
29	Heart failure	77761	phv00077761.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:59:53+00:00	2018-07-02 21:59:53+00:00 	CHF_4	Heart failure
29	Heart failure	77871	phv00077871.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:59:53+00:00	2018-07-02 21:59:53+00:00 	CHF_5	Heart failure
29	Heart failure	78035	phv00078035.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:59:53+00:00	2018-07-02 21:59:53+00:00 	CHF_6	Heart Failure
29	Heart failure	78175	phv00078175.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:59:53+00:00	2018-07-02 21:59:53+00:00 	CHF_7	Heart Failure
29	Heart failure	78316	phv00078316.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:59:53+00:00	2018-07-02 21:59:53+00:00 	CHF_8	Heart failure
29	Heart failure	78486	phv00078486.v6.p3	pht000998.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:59:53+00:00	2018-07-02 21:59:53+00:00 	CHF_F2	Heart failure ever
29	Heart failure	78533	phv00078533.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:59:53+00:00	2018-07-02 21:59:53+00:00 	CHF_F30	Congestive heart failure ever
29	Heart failure	192489	phv00192489.v3.p3	pht003402.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:59:53+00:00	2018-07-02 21:59:53+00:00 	CHF	CHF
29	Heart failure	192996	phv00192996.v3.p3	pht003405.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:59:53+00:00	2018-07-02 21:59:53+00:00 	CHF	CHF
29	Heart failure	193053	phv00193053.v3.p3	pht003406.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:59:53+00:00	2018-07-02 21:59:53+00:00 	CHF	CHF
29	Heart failure	193166	phv00193166.v3.p3	pht003407.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:02:16+00:00	2018-07-02 22:02:16+00:00 	CHF	CHF
29	Heart failure	202363	phv00202363.v2.p3	pht002769.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:04:10+00:00	2018-07-02 22:04:10+00:00 	F33CHF	F33 Congestive Heart Failure
29	Heart failure	202375	phv00202375.v2.p3	pht002770.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:04:10+00:00	2018-07-02 22:04:10+00:00 	F33CHF	F33 Congestive Heart Failure
29	Heart failure	193035	phv00193035.v3.p3	pht003405.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:04:10+00:00	2018-07-02 22:04:10+00:00 	CHFFATAL	CHF fatal
29	Heart failure	193097	phv00193097.v3.p3	pht003406.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:04:10+00:00	2018-07-02 22:04:10+00:00 	CHFFATAL	CHF fatal
29	Heart failure	193703	phv00193703.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:04:10+00:00	2018-07-02 22:04:10+00:00 	F33CHFHOSP	F33 Hospitalized Heart Failure
29	Heart failure	283453	phv00283453.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:11:43+00:00	2018-07-02 22:11:43+00:00 	UNCHF	Definite or possible decompensated heart failure for this case
29	Heart failure	283463	phv00283463.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:11:43+00:00	2018-07-02 22:11:43+00:00 	HFDIAG	F135 Heart failure diagnosis
29	Heart failure	283464	phv00283464.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:11:43+00:00	2018-07-02 22:11:43+00:00 	ADHFTYPE	HF type for definite or probable decompensated heart failure
29	Heart failure	283487	phv00283487.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:11:43+00:00	2018-07-02 22:11:43+00:00 	DIASHF	F136 Diastolic HF
29	Heart failure	283488	phv00283488.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:11:43+00:00	2018-07-02 22:11:43+00:00 	SYSTHF	F136 Systolic HF
29	Heart failure	283489	phv00283489.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:11:44+00:00	2018-07-02 22:11:44+00:00 	RIGHTSIDEHF	F136 Right-sided HF
29	Heart failure	283490	phv00283490.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:11:44+00:00	2018-07-02 22:11:44+00:00 	INFILTRATHF	F136 Infiltrative HF
29	Heart failure	283572	phv00283572.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:11:44+00:00	2018-07-02 22:11:44+00:00 	CHFPVD	F136 CHFPVD
29	Heart failure	190979	phv00190979.v5.p10	pht003335.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 18:30:55+00:00	2018-08-09 18:30:55+00:00 	EVENT	Event Number
29	Heart failure	190981	phv00190981.v5.p10	pht003335.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 18:31:12+00:00	2018-08-09 18:31:12+00:00 	DATE	Date of Event
29	Heart failure	159609	phv00159609.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:39:53+00:00	2018-08-10 21:39:53+00:00 	CongestHeartFail	Congestive heart failure Collection Interval: Collected in Exam 1
29	Heart failure	122280	phv00122280.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:24:34+00:00	2018-08-16 23:24:34+00:00 	HRTFAIL	Heart failure (A)
29	Heart failure	122281	phv00122281.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:24:41+00:00	2018-08-16 23:24:41+00:00 	HTFDIAG	Heart failure diagnosed by doctor (A)
29	Heart failure	122282	phv00122282.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:24:49+00:00	2018-08-16 23:24:49+00:00 	HTFAGE	Age when heart failure noted (A)
29	Heart failure	122283	phv00122283.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:25:02+00:00	2018-08-16 23:25:02+00:00 	HTFPRES	Heart failure problem still present (A)
29	Heart failure	114420	phv00114420.v2.p2	pht001607.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:25:40+00:00	2018-08-22 21:25:40+00:00 	B09CHFST	STATUS OF CONGESTIVE HRT FAIL. Q 10
29	Heart failure	114419	phv00114419.v2.p2	pht001607.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:25:57+00:00	2018-08-22 21:25:57+00:00 	B09CHFAG	AGE DX, CONGESTIVE HEART FAIL. Q 10
29	Heart failure	114418	phv00114418.v2.p2	pht001607.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:26:12+00:00	2018-08-22 21:26:12+00:00 	B09CHF	HAS(/D) CONGESTIVE HEART FAIL. Q 10
29	Heart failure	226365	phv00226365.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:27:37+00:00	2018-08-24 16:27:37+00:00 	MHEA5	Heart failure - self (MHEA5)
29	Heart failure	190834	phv00190834.v6.p10	pht003317.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 13:59:20+00:00	2018-09-27 13:59:20+00:00 	LASTSOE	Date of the latest record in the 2015  SOE dataset (vr_soe_2015_a_0991)
30	Hypertension	203796	phv00203796.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:50:36+00:00	2018-03-21 17:50:36+00:00 	CORA22	Is there a history of hypertension (high blood pressure) prior to this event? Q22 [Coroner / Medical Examiner Form]
30	Hypertension	203982	phv00203982.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:52:09+00:00	2018-03-21 17:52:09+00:00 	HRAA38	[Second transfer]. Is there a history of hypertension (high blood pressure) prior to this event? Q38 [Hospital Abstraction Form]
30	Hypertension	204407	phv00204407.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:52:24+00:00	2018-03-21 17:52:24+00:00 	PHQA03E	[Medical history]. Did the decedent have a history of any of the following? Hypertension. Q3e [Physician Questionnaire Form, exam 1]
30	Hypertension	204652	phv00204652.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:52:57+00:00	2018-03-21 17:52:57+00:00 	HYPERT24	Visit 2, hypertension, definition 4 [Cohort, Exam 2]
30	Hypertension	204653	phv00204653.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:53:15+00:00	2018-03-21 17:53:15+00:00 	HYPERT25	Visit 2, hypertension, definition 5 [Cohort, Exam 2]
30	Hypertension	204654	phv00204654.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:53:37+00:00	2018-03-21 17:53:37+00:00 	HYPERT26	Visit 2, hypertension, definition 6 [Cohort, Exam 2]
30	Hypertension	204727	phv00204727.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:53:56+00:00	2018-03-21 17:53:56+00:00 	HYPERT04	Hypertension, definition 4; replaces HYPERT01 [Cohort, Exam 1]
30	Hypertension	204728	phv00204728.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:54:11+00:00	2018-03-21 17:54:11+00:00 	HYPERT05	Hypertension, definition 5; replaces HYPER02 [Cohort, Exam 1]
30	Hypertension	204729	phv00204729.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:54:30+00:00	2018-03-21 17:54:30+00:00 	HYPERT06	Hypertension, definition 6; replaces HYPERT03 [Cohort, Exam 1]
30	Hypertension	204855	phv00204855.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:54:49+00:00	2018-03-21 17:54:49+00:00 	HYPERT34	Visit 3, hypertension, definition 4 [Cohort, Exam 3]
30	Hypertension	204856	phv00204856.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:55:02+00:00	2018-03-21 17:55:02+00:00 	HYPERT35	Visit 3, hypertension, definition 5 [Cohort, Exam 3]
30	Hypertension	204857	phv00204857.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:55:15+00:00	2018-03-21 17:55:15+00:00 	HYPERT36	Visit 3, hypertension, definition 6 [Cohort, Exam 3]
30	Hypertension	204946	phv00204946.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:55:30+00:00	2018-03-21 17:55:30+00:00 	HYPERT44	Hypertension, definition 4 [Cohort, Exam 4]
30	Hypertension	204947	phv00204947.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:55:52+00:00	2018-03-21 17:55:52+00:00 	HYPERT45	Hypertension, definition 5 [Cohort, Exam 4]
30	Hypertension	204948	phv00204948.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:56:05+00:00	2018-03-21 17:56:05+00:00 	HYPERT46	Hypertension, definition 6 [Cohort, Exam 4]
30	Hypertension	206804	phv00206804.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:56:31+00:00	2018-03-21 17:56:31+00:00 	HFAA11J	[Medical history]. Q11j - Cardio His: hypertension [Heart Failure Hospital Record Abstraction Form, HFA]
30	Hypertension	206806	phv00206806.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:58:14+00:00	2018-03-21 17:58:14+00:00 	HFAA11L	[Medical history]. Q11l - Pulmonary hypertension [Heart Failure Hospital Record Abstraction Form, HFA]
30	Hypertension	206881	phv00206881.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:58:32+00:00	2018-03-21 17:58:32+00:00 	HFAA29D10	[Diagnostic tests]. Record the following if present on transthoracic echocardiogram: Q29d10- Pulmonary hypertension [Heart Failure Hospital Record Abstraction Form, HFA]
30	Hypertension	207064	phv00207064.v1.p1	pht004103.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:58:59+00:00	2018-03-21 17:58:59+00:00 	HHXB05A	[Medical care]. Has a doctor ever said you had any of the following: (read each disease name and code N if No or never tested.) Q5 High blood pressure or hypertension (high blood). Q5A [Health/Medical History, exam 2]
30	Hypertension	207311	phv00207311.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 17:59:43+00:00	2018-03-21 17:59:43+00:00 	HOM10A	Has a doctor ever said that you had any of the following: high blood pressure or hypertension? Q10a [Home Interview, exam 1]
30	Hypertension	208966	phv00208966.v1.p1	pht004145.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 18:00:34+00:00	2018-03-21 18:00:34+00:00 	PHXA8A	[Medical care]. Has a doctor ever said you had high blood pressure or hypertension (high blood). Q8a [Personal History Form, exam 3]
30	Hypertension	214055	phv00214055.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 18:00:49+00:00	2018-03-21 18:00:49+00:00 	SRHYPE	Self-reported hypertension
30	Hypertension	202928	phv00202928.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 18:29:58+00:00	2018-03-21 18:29:58+00:00 	AFUcomp7c_G	[General health].  Has a doctor ever said you had any of the following? High blood pressure [Annual Follow-up Questionnaire Form, AFUG]
30	Hypertension	203033	phv00203033.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 18:30:50+00:00	2018-03-21 18:30:50+00:00 	AFUcomp14_M	[General health]. Since we last contacted you has a doctor said you had high blood pressure? [Annual Follow-up Questionnaire Form, AFUM]
30	Hypertension	82655	phv00082655.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:49:39+00:00	2018-04-23 22:49:39+00:00 	htn1c	HYPERTENSION BY JNC VI (1997) CRITERIA
30	Hypertension	82656	phv00082656.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:49:44+00:00	2018-04-23 22:49:44+00:00 	htnstg1c	HYPERTENSION STAGE
30	Hypertension	84459	phv00084459.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:49:49+00:00	2018-04-23 22:49:49+00:00 	htn1c	HYPERTENSION BY JNC VI (1997) CRITERIA
30	Hypertension	84460	phv00084460.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:49:54+00:00	2018-04-23 22:49:54+00:00 	htnstg1c	HYPERTENSION STAGE
30	Hypertension	85797	phv00085797.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:50:00+00:00	2018-04-23 22:50:00+00:00 	htn2c	HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 2
30	Hypertension	85798	phv00085798.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:50:06+00:00	2018-04-23 22:50:06+00:00 	htnstg2c	HYPERTENSION STAGE
30	Hypertension	86282	phv00086282.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:50:12+00:00	2018-04-23 22:50:12+00:00 	htn3c	HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 3
30	Hypertension	86283	phv00086283.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:50:18+00:00	2018-04-23 22:50:18+00:00 	htnstg3c	HYPERTENSION STAGE
30	Hypertension	86749	phv00086749.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:50:24+00:00	2018-04-23 22:50:24+00:00 	htn4c	HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 4
30	Hypertension	86750	phv00086750.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:50:30+00:00	2018-04-23 22:50:30+00:00 	htnstg4c	HYPERTENSION STAGE
30	Hypertension	87094	phv00087094.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:50:36+00:00	2018-04-23 22:50:36+00:00 	htnfc	HYPERTENSION BY JNC VI (1997) CRITERIA
30	Hypertension	87095	phv00087095.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:50:42+00:00	2018-04-23 22:50:42+00:00 	htnstgfc	HYPERTENSION STAGE BY JNC VI (1997) CRITERIA; REFERENCE 2
30	Hypertension	174595	phv00174595.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:50:48+00:00	2018-04-23 22:50:48+00:00 	htnstg5c	HYPERTENSION STAGE
30	Hypertension	174605	phv00174605.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:50:53+00:00	2018-04-23 22:50:53+00:00 	htn5c	HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5
30	Hypertension	175865	phv00175865.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:50:59+00:00	2018-04-23 22:50:59+00:00 	htn1c	HYPERTENSION BY JNC VI (1997) CRITERIA
30	Hypertension	175882	phv00175882.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:51:06+00:00	2018-04-23 22:51:06+00:00 	htn	HTN
30	Hypertension	176018	phv00176018.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:51:11+00:00	2018-04-23 22:51:11+00:00 	htnstg5c	HYPERTENSION STAGE
30	Hypertension	176028	phv00176028.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:51:16+00:00	2018-04-23 22:51:16+00:00 	htn5c	HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5
30	Hypertension	82997	phv00082997.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:52:28+00:00	2018-04-23 22:52:28+00:00 	highbp1	HYPERTENSION: SELF-REPORT
30	Hypertension	85233	phv00085233.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:52:36+00:00	2018-04-23 22:52:36+00:00 	highbp1	HYPERTENSION: SELF-REPORT
30	Hypertension	85762	phv00085762.v3.p3	pht001117.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:52:41+00:00	2018-04-23 22:52:41+00:00 	fhxhbp2	HISTORY OF HYPERTENSION INDICATOR
30	Hypertension	85763	phv00085763.v3.p3	pht001117.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:52:56+00:00	2018-04-23 22:52:56+00:00 	fhxhbpa2	AGE OF FIRST HYPERTENSION DX
30	Hypertension	87153	phv00087153.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:53:05+00:00	2018-04-23 22:53:05+00:00 	highbpf	HIGH BLOOD PRESSURE OR HYPERTENSION
30	Hypertension	175955	phv00175955.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 22:53:12+00:00	2018-04-23 22:53:12+00:00 	highbpf	FAMILY COHORT: HIGH BLOOD PRESSURE OR HYPERTENSION
30	Hypertension	116955	phv00116955.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 17:44:14+00:00	2018-05-24 17:44:14+00:00 	D08HBPPR	WAS HYPERTENSION DURING PREGNANCY? Q 1
30	Hypertension	118429	phv00118429.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 17:45:16+00:00	2018-05-24 17:45:16+00:00 	E08HBPPR	WAS HYPERTENSION DURING PREGNANCY? Q 1
30	Hypertension	119808	phv00119808.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 17:45:33+00:00	2018-05-24 17:45:33+00:00 	F08HBPPR	WAS HYPERTENSION DURING PREGNANCY?
30	Hypertension	121273	phv00121273.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 17:46:10+00:00	2018-05-24 17:46:10+00:00 	Y01HTNEP	ENDPT - HYPERTENSION
30	Hypertension	121368	phv00121368.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 17:46:47+00:00	2018-05-24 17:46:47+00:00 	Y01HTN	HYPERTENSION
30	Hypertension	121469	phv00121469.v2.p2	pht001870.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 17:49:36+00:00	2018-05-24 17:49:36+00:00 	Y00HTN	DISCHG DIAG - HYPERTENSION
30	Hypertension	121489	phv00121489.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 17:49:51+00:00	2018-05-24 17:49:51+00:00 	Y01HTNEP	ENDPT - HYPERTENSION
30	Hypertension	121587	phv00121587.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 18:06:12+00:00	2018-05-24 18:06:12+00:00 	Y01HTN	HYPERTENSION
30	Hypertension	124995	phv00124995.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 15:23:59+00:00	2018-06-08 15:23:59+00:00 	AFUA7C	7c. High blood pressure
30	Hypertension	125080	phv00125080.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:29:38+00:00	2018-06-08 16:29:38+00:00 	AFUA7C	7c. High blood pressure
30	Hypertension	125165	phv00125165.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:45:34+00:00	2018-06-08 16:45:34+00:00 	AFUB7C	7c. High blood pressure
30	Hypertension	125251	phv00125251.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:59:20+00:00	2018-06-08 16:59:20+00:00 	AFUB7C	7c. High blood pressure
30	Hypertension	125365	phv00125365.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:12:06+00:00	2018-06-08 17:12:06+00:00 	AFUC14	14. Has a doctor ever said that you had high blood pressure?
30	Hypertension	125599	phv00125599.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:46:07+00:00	2018-06-08 19:46:07+00:00 	AFUI7C	DOCTOR - HIGH BP                  Q7C
30	Hypertension	125687	phv00125687.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:53:44+00:00	2018-06-08 19:53:44+00:00 	AFUJ7C	DOCTOR - HIGH BP                  Q7C
30	Hypertension	125511	phv00125511.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:08:55+00:00	2018-06-08 20:08:55+00:00 	AFUI7C	DOCTOR - HIGH BP                  Q7C
30	Hypertension	125775	phv00125775.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:14:00+00:00	2018-06-08 20:14:00+00:00 	AFUK7C	DOCTOR - HIGH BP                    Q7C
30	Hypertension	10093	phv00010093.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:35:00+00:00	2018-06-18 15:35:00+00:00 	F703	DID YOU EVER HAVE HIGH BLOOD PRESSURE
30	Hypertension	7583	phv00007583.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:35:48+00:00	2018-06-18 15:35:48+00:00 	A70	HISTORY OF HYPERTENSION
30	Hypertension	7991	phv00007991.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:36:06+00:00	2018-06-18 15:36:06+00:00 	B373	HYPERTENSION-ON TREAT OR ELEVATED BP
30	Hypertension	21631	phv00021631.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:36:36+00:00	2018-06-18 15:36:36+00:00 	BW30	LIVE-BIRTH PREGNANCY #1: DID YOU HAVE HYPERTENSION DURING THIS PREGNANCY?
30	Hypertension	21643	phv00021643.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:36:51+00:00	2018-06-18 15:36:51+00:00 	BW43	LIVE-BIRTH PREGNANCY #2: DID YOU HAVE HYPERTENSION DURING THIS PREGNANCY?
30	Hypertension	21655	phv00021655.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:37:11+00:00	2018-06-18 15:37:11+00:00 	BW56	LIVE-BIRTH PREGNANCY #3: DID YOU HAVE HYPERTENSION DURING THIS PREGNANCY?
30	Hypertension	21667	phv00021667.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:37:20+00:00	2018-06-18 15:37:20+00:00 	BW69	LIVE-BIRTH PREGNANCY #4: DID YOU HAVE HYPERTENSION DURING THIS PREGNANCY?
30	Hypertension	21679	phv00021679.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:37:29+00:00	2018-06-18 15:37:29+00:00 	BW82	LIVE-BIRTH PREGNANCY #5: DID YOU HAVE HYPERTENSION DURING THIS PREGNANCY?
30	Hypertension	8676	phv00008676.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:38:01+00:00	2018-06-18 15:38:01+00:00 	C332	CDI: HYPERTENSION
30	Hypertension	4044	phv00004044.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:38:30+00:00	2018-06-18 15:38:30+00:00 	FL436	CDI: HYPERTENSION
30	Hypertension	20898	phv00020898.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:38:59+00:00	2018-06-18 15:38:59+00:00 	G3A038	IF EVER BEEN PREGNANT: DURING ANY OF THESE PREGNANCIES, WERE YOU TOLD YOU HAD HYPERTENSION (HIGH BLOOD PRESSURE)?
30	Hypertension	273732	phv00273732.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:39:09+00:00	2018-06-18 15:39:09+00:00 	g3a038	If ever been pregnant: During any of these pregnancies, were you told you had hypertension (high blood pressure)? Collection Interval: Exam 1
30	Hypertension	274225	phv00274225.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:39:18+00:00	2018-06-18 15:39:18+00:00 	g3a038	If ever been pregnant: During any of these pregnancies, were you told you had hypertension (high blood pressure)?
30	Hypertension	177249	phv00177249.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:40:24+00:00	2018-06-18 15:40:24+00:00 	g3b0013	Medical History - Medications: Since your last exam have you been told by doctor you have high blood pressure or hypertension?
30	Hypertension	177263	phv00177263.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:40:44+00:00	2018-06-18 15:40:44+00:00 	g3b0034	Medical History-Female Reproductive History: During any of these pregnancies, were you told you had high blood pressure or hypertension?
30	Hypertension	251798	phv00251798.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:41:53+00:00	2018-06-18 15:41:53+00:00 	h778	Medical History - Female Reproductive History: During any of these pregnancies, were you told you had high blood pressure (hypertension)? Collection Interval: Exam 3
30	Hypertension	254023	phv00254023.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:42:33+00:00	2018-06-18 15:42:33+00:00 	j014	Medical History - Medications: Since your last exam have you been told by doctor you have high blood pressure or hypertension?
30	Hypertension	254036	phv00254036.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:42:54+00:00	2018-06-18 15:42:54+00:00 	j036	Medical History - Female Reproductive History, Part 1: Since your last exam, during any of these pregnancies, were you told you had high blood pressure or hypertension?
30	Hypertension	487	phv00000487.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:43:13+00:00	2018-06-18 15:43:13+00:00 	MF13	HISTORY OF HYPERTENSION, EXAM 1
30	Hypertension	55253	phv00055253.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:43:33+00:00	2018-06-18 15:43:33+00:00 	SRHype	Self-Reported Hypertension
30	Hypertension	56625	phv00056625.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:44:04+00:00	2018-06-18 15:44:04+00:00 	srhypedt	Self-Reported Hypertension Date
30	Hypertension	7926	phv00007926.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:44:37+00:00	2018-06-18 15:44:37+00:00 	B294	HYPERTENSIVE STATUS
30	Hypertension	2180	phv00002180.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:46:08+00:00	2018-06-18 15:46:08+00:00 	FF250	CLINICAL DIAGNOSTIC IMPRESSION: HYPERTENSIVE STATUS (BASED ON TWO BLOOD PRESSURE READINGS TAKEN BY PHYSICIAN)
30	Hypertension	2375	phv00002375.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:47:02+00:00	2018-06-18 15:47:02+00:00 	FG258	CLINICAL DIAGNOSTIC IMPRESSION: HYPERTENSIVE STATUS (BASED ON TWO BLOOD PRESSURE READINGS TAKEN BY PHYSICIAN)
30	Hypertension	3634	phv00003634.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:48:00+00:00	2018-06-18 15:48:00+00:00 	FK412	HEART: HYPERTENSIVE STATUS
30	Hypertension	126039	phv00126039.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:44:53+00:00	2018-06-20 17:44:53+00:00 	HTN017	Hypertension status per JNC7
30	Hypertension	126037	phv00126037.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:46:10+00:00	2018-06-20 17:46:10+00:00 	BP601	JNC 6 BP classification
30	Hypertension	126036	phv00126036.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:46:27+00:00	2018-06-20 17:46:27+00:00 	BP701	JNC 7 BP classification
30	Hypertension	128087	phv00128087.v1.p1	pht001967.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:17:00+00:00	2018-06-20 18:17:00+00:00 	PFHA2A	2a: Has doctor said you have high blood pressure?
30	Hypertension	128088	phv00128088.v1.p1	pht001967.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:17:29+00:00	2018-06-20 18:17:29+00:00 	PFHA2B	2b: Age when told you had high blood pressure?
30	Hypertension	99658	phv00099658.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:49:23+00:00	2018-06-29 17:49:23+00:00 	HYPER	CALC. HTN STATUS
30	Hypertension	100496	phv00100496.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:49:51+00:00	2018-06-29 17:49:51+00:00 	HYPER	CALCULATED HTN STATUS
30	Hypertension	102009	phv00102009.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:50:01+00:00	2018-06-29 17:50:01+00:00 	HYPER	CALCULATED HTN STATUS
30	Hypertension	104380	phv00104380.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:50:23+00:00	2018-06-29 17:50:23+00:00 	HYPER	CALCULATED HTN STATUS
30	Hypertension	105096	phv00105096.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:50:33+00:00	2018-06-29 17:50:33+00:00 	HYPER	CALCULATED HTN STATUS
30	Hypertension	106417	phv00106417.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:50:43+00:00	2018-06-29 17:50:43+00:00 	HYPER	CALCULATED HTN STATUS
30	Hypertension	107346	phv00107346.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:50:54+00:00	2018-06-29 17:50:54+00:00 	HYPER	CALCULATED HTN STATUS
30	Hypertension	108217	phv00108217.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:51:07+00:00	2018-06-29 17:51:07+00:00 	HYPER	CALCULATED HTN STATUS
30	Hypertension	108908	phv00108908.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:51:17+00:00	2018-06-29 17:51:17+00:00 	HYPER	CALCULATED HTN STATUS
30	Hypertension	110523	phv00110523.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:51:26+00:00	2018-06-29 17:51:26+00:00 	HYPER	CALCULATED HTN STATUS
30	Hypertension	99459	phv00099459.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:54:52+00:00	2018-06-29 17:54:52+00:00 	IHYPER	CALC. ISO SYS HTN
30	Hypertension	100433	phv00100433.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:55:06+00:00	2018-06-29 17:55:06+00:00 	IHYPER	CALC ISO SYS HTN
30	Hypertension	101958	phv00101958.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:55:18+00:00	2018-06-29 17:55:18+00:00 	IHYPER	CALC. ISO SYS HTN
30	Hypertension	105628	phv00105628.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 17:55:28+00:00	2018-06-29 17:55:28+00:00 	IHYPER	CALC ISO SYS HTN
30	Hypertension	78556	phv00078556.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:47:22+00:00	2018-07-02 21:47:22+00:00 	HYPT	Hypertension ever
30	Hypertension	78602	phv00078602.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:47:22+00:00	2018-07-02 21:47:22+00:00 	HTNTRT	Hypertension
30	Hypertension	283526	phv00283526.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:47:22+00:00	2018-07-02 21:47:22+00:00 	HYPERTNHX	F136 History of hypertension
30	Hypertension	283528	phv00283528.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:47:22+00:00	2018-07-02 21:47:22+00:00 	PULMHTNHX	F136 History of pulmonary hypertension
30	Hypertension	283592	phv00283592.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:47:22+00:00	2018-07-02 21:47:22+00:00 	TTEPULMHTN	F136 TTE pulmonary hypertension
30	Hypertension	159612	phv00159612.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:46:05+00:00	2018-08-10 21:46:05+00:00 	HighBloodPres	High blood pressure Collection Interval: Collected in Exam 1
30	Hypertension	277418	phv00277418.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:26:24+00:00	2018-08-14 22:26:24+00:00 	HYT	Have you ever been told by a physician that you have high blood pressure or hypertension? Collection Interval: 2009-2011
30	Hypertension	277419	phv00277419.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:26:48+00:00	2018-08-14 22:26:48+00:00 	HYT_YR	In what year or how old were you when it was first diagnosed? - year Collection Interval: 2009-2011
30	Hypertension	277420	phv00277420.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:26:55+00:00	2018-08-14 22:26:55+00:00 	HYT_AGE	In what year or how old were you when it was first diagnosed? - age Collection Interval: 2009-2011
30	Hypertension	277501	phv00277501.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:38:06+00:00	2018-08-14 22:38:06+00:00 	PGHYTAGE	In what year or how old were you when the pregnancy-related hypertension first occurred? - age Collection Interval: 2009-2011
30	Hypertension	277500	phv00277500.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:38:13+00:00	2018-08-14 22:38:13+00:00 	PGHYTYR	In what year or how old were you when the pregnancy-related hypertension first occurred? - year Collection Interval: 2009-2011
30	Hypertension	277498	phv00277498.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:38:20+00:00	2018-08-14 22:38:20+00:00 	PG_HYT	During any of these pregancies were you ever told by a physician that you had high blood pressure or hyt? Collection Interval: 2009-2011
30	Hypertension	277594	phv00277594.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:48:03+00:00	2018-08-14 22:48:03+00:00 	HYT_AGE	In what year or how old were you when it was first diagnosed? - age Collection Interval: 1996-2000
30	Hypertension	277593	phv00277593.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:48:10+00:00	2018-08-14 22:48:10+00:00 	HYT_YR	In what year or how old were you when it was first diagnosed? - year Collection Interval: 1996-2000
30	Hypertension	277592	phv00277592.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:48:17+00:00	2018-08-14 22:48:17+00:00 	HYT	Have you ever been told by a physician that you have high blood pressure or hypertension? Collection Interval: 1996-2000
30	Hypertension	277869	phv00277869.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:14:23+00:00	2018-08-14 23:14:23+00:00 	HYT_AGE	In what year or how old were you when it was first diagnosed? - age Collection Interval: 2000-2004
30	Hypertension	277868	phv00277868.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:14:29+00:00	2018-08-14 23:14:29+00:00 	HYT_YR	In what year or how old were you when it was first diagnosed? - year Collection Interval: 2000-2004
30	Hypertension	277867	phv00277867.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:14:35+00:00	2018-08-14 23:14:35+00:00 	HYT	Have you ever been told by a physician that you have high blood pressure or hypertension? Collection Interval: 2000-2004
30	Hypertension	277962	phv00277962.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:50:03+00:00	2018-08-15 23:50:03+00:00 	PGHYTAGE	In what year or how old were you when the pregnancy-related hypertension first occurred? - age Collection Interval: 2000-2004
30	Hypertension	277961	phv00277961.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:50:10+00:00	2018-08-15 23:50:10+00:00 	PGHYTYR	In what year or how old were you when the pregnancy-related hypertension first occurred? - year Collection Interval: 2000-2004
30	Hypertension	277959	phv00277959.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:50:17+00:00	2018-08-15 23:50:17+00:00 	PG_HYT	During any of these pregancies were you ever told by a physician that you had high blood pressure or hyt? Collection Interval: 2000-2004
30	Hypertension	307875	phv00307875.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:00:01+00:00	2018-08-16 00:00:01+00:00 	HYT_AGE	In what year or how old were you when it was first diagnosed? - age Collection Interval: 1996-2000
30	Hypertension	307874	phv00307874.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:00:08+00:00	2018-08-16 00:00:08+00:00 	HYT_YR	In what year or how old were you when it was first diagnosed? - year Collection Interval: 1996-2000
30	Hypertension	307873	phv00307873.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:00:14+00:00	2018-08-16 00:00:14+00:00 	HYT	Have you ever been told by a physician that you have high blood pressure or hypertension? Collection Interval: 1996-2000
30	Hypertension	308062	phv00308062.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:15:23+00:00	2018-08-16 00:15:23+00:00 	HYT_AGE	In what year or how old were you when it was first diagnosed? - age Collection Interval: 2000-2004
30	Hypertension	308061	phv00308061.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:15:30+00:00	2018-08-16 00:15:30+00:00 	HYT_YR	In what year or how old were you when it was first diagnosed? - year Collection Interval: 2000-2004
30	Hypertension	308060	phv00308060.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:15:38+00:00	2018-08-16 00:15:38+00:00 	HYT	Have you ever been told by a physician that you have high blood pressure or hypertension? Collection Interval: 2000-2004
30	Hypertension	308155	phv00308155.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:25:40+00:00	2018-08-16 00:25:40+00:00 	PGHYTAGE	In what year or how old were you when the pregnancy-related hypertension first occurred? - age Collection Interval: 2000-2004
30	Hypertension	308154	phv00308154.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:25:47+00:00	2018-08-16 00:25:47+00:00 	PGHYTYR	In what year or how old were you when the pregnancy-related hypertension first occurred? - year Collection Interval: 2000-2004
30	Hypertension	308152	phv00308152.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:25:54+00:00	2018-08-16 00:25:54+00:00 	PG_HYT	During any of these pregancies were you ever told by a physician that you had high blood pressure or hyt? Collection Interval: 2000-2004
30	Hypertension	122289	phv00122289.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:26:42+00:00	2018-08-16 23:26:42+00:00 	HIBP	Person reports high blood pressure (AC)
30	Hypertension	122292	phv00122292.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:27:02+00:00	2018-08-16 23:27:02+00:00 	BPPRES	High blood pressure still present (AC)
30	Hypertension	112992	phv00112992.v2.p2	pht001569.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:16:00+00:00	2018-08-17 18:16:00+00:00 	A08HBP	HIGH BLOOD PRESSURE
30	Hypertension	113022	phv00113022.v2.p2	pht001570.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:18:28+00:00	2018-08-17 18:18:28+00:00 	A09HBPST	STILL HAVE HBP? Q 1.01C
30	Hypertension	113021	phv00113021.v2.p2	pht001570.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:18:36+00:00	2018-08-17 18:18:36+00:00 	A09HBPAG	AGE WHEN TOLD HAD HBP. Q 1.01B
30	Hypertension	113020	phv00113020.v2.p2	pht001570.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:18:43+00:00	2018-08-17 18:18:43+00:00 	A09HBPG1	HBP DX BASED ON > 1 VISIT? Q 1.01A
30	Hypertension	123016	phv00123016.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:53:44+00:00	2018-08-17 19:53:44+00:00 	hibloodp	High Blood Pressure
30	Hypertension	123017	phv00123017.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:54:25+00:00	2018-08-17 19:54:25+00:00 	htndx	HTN: self report of MD dx of HTN
30	Hypertension	123018	phv00123018.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:54:34+00:00	2018-08-17 19:54:34+00:00 	htnx	HTN: self report of MD dx of HTN or sys GE 140 or dia GE 90 or meds
30	Hypertension	123019	phv00123019.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:54:46+00:00	2018-08-17 19:54:46+00:00 	htn	HTN: abnormal bp (sys GE 140 or dia GE 90) or meds
30	Hypertension	114340	phv00114340.v2.p2	pht001601.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:51:48+00:00	2018-08-17 21:51:48+00:00 	B08HBP	HIGH BLOOD PRESSURE. Q 6
30	Hypertension	124274	phv00124274.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 19:00:41+00:00	2018-08-21 19:00:41+00:00 	DIABPDAY	Days from visit date - Diagnosed High Blood Pressure:
30	Hypertension	114387	phv00114387.v2.p2	pht001606.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:11:01+00:00	2018-08-22 21:11:01+00:00 	B09HBPST	STILL HAVE HBP? Q 1.01C
30	Hypertension	114386	phv00114386.v2.p2	pht001606.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:11:17+00:00	2018-08-22 21:11:17+00:00 	B09HBPAG	AGE WHEN TOLD HAD HBP. Q 1.01B
30	Hypertension	114385	phv00114385.v2.p2	pht001606.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:11:33+00:00	2018-08-22 21:11:33+00:00 	B09HBPG1	HBP DX BASED ON > 1 VISIT? Q 1.01A
30	Hypertension	115075	phv00115075.v2.p2	pht001640.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:48:11+00:00	2018-08-22 23:48:11+00:00 	B09P_HBP	GESTATIONAL HBP, ANY PREGNANCY? Q 11b
30	Hypertension	115425	phv00115425.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 16:57:27+00:00	2018-08-23 16:57:27+00:00 	C08HBPAG	AGE HIGH BP DIAGNOSED. Q 1
30	Hypertension	115424	phv00115424.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 16:57:34+00:00	2018-08-23 16:57:34+00:00 	C08HBP	HIGH BLOOD PRESSURE. Q 1
30	Hypertension	116340	phv00116340.v2.p2	pht001690.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 19:02:19+00:00	2018-08-23 19:02:19+00:00 	C09P_HBP	GESTATIONAL HBP?
30	Hypertension	116956	phv00116956.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:17:16+00:00	2018-08-24 00:17:16+00:00 	D08HBPAG	AGE WHEN TOLD HAD HBP. Q 1
30	Hypertension	116954	phv00116954.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:17:26+00:00	2018-08-24 00:17:26+00:00 	D08HBP	HIGH BLOOD PRESSURE? Q 1
30	Hypertension	117517	phv00117517.v2.p2	pht001733.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:45:45+00:00	2018-08-24 22:45:45+00:00 	D09P_HBP	GESTATIONAL HBP? Q 11b
30	Hypertension	117936	phv00117936.v2.p2	pht001749.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-27 23:09:36+00:00	2018-08-27 23:09:36+00:00 	FY096BPA	AGE FIRST TOLD HIGH BP - MON 96
30	Hypertension	117935	phv00117935.v2.p2	pht001749.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-27 23:09:43+00:00	2018-08-27 23:09:43+00:00 	FY096HBP	HIGH BLOOD PRESSURE? - MON 96
30	Hypertension	118430	phv00118430.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 22:43:37+00:00	2018-08-28 22:43:37+00:00 	E08HBPAG	AGE DIAGNOSED-HBP. Q 1
30	Hypertension	118428	phv00118428.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 22:43:47+00:00	2018-08-28 22:43:47+00:00 	E08HBP	HIGH BLOOD PRESSURE? Q 1
30	Hypertension	119587	phv00119587.v2.p2	pht001797.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:00:26+00:00	2018-08-29 21:00:26+00:00 	E09P_HBP	GESTATIONAL HBP?
30	Hypertension	119807	phv00119807.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:07:56+00:00	2018-08-29 21:07:56+00:00 	F08HBPAG	AGE DIAGNOSED-HBP. Q 1
30	Hypertension	119802	phv00119802.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:08:07+00:00	2018-08-29 21:08:07+00:00 	F08HBP	HIGH BLOOD PRESSURE? Q 1
30	Hypertension	120648	phv00120648.v2.p2	pht001843.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:08:40+00:00	2018-08-29 23:08:40+00:00 	F09P_HBP	GESTATIONAL HBP? Q 11b
30	Hypertension	121374	phv00121374.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:34:18+00:00	2018-08-30 00:34:18+00:00 	Y01HTNTP	TYPE OF HYPERTENSION
30	Hypertension	121593	phv00121593.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:55:57+00:00	2018-08-30 19:55:57+00:00 	Y01HTNTP	TYPE OF HYPERTENSION
30	Hypertension	258746	phv00258746.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:56:22+00:00	2018-09-06 12:56:22+00:00 	Hypertension	Based on Sys>140 OR Dias>90 (Based on physical examination & questionnaire data)
30	Hypertension	258747	phv00258747.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:57:13+00:00	2018-09-06 12:57:13+00:00 	Hypertension_diagnosis	Self-reported Hypertension diagnosis
30	Hypertension	258748	phv00258748.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:58:50+00:00	2018-09-06 12:58:50+00:00 	Hyp_diagnosis_years	How many years ago were you diagnosed with hypertension?
30	Hypertension	258756	phv00258756.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 13:01:02+00:00	2018-09-06 13:01:02+00:00 	Hypertension_13	Hypertension based on average of two BP measurements or hypertension meds
30	Hypertension	258757	phv00258757.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 13:01:13+00:00	2018-09-06 13:01:13+00:00 	Hypertension_All3	Hypertension diagnosis based on average of all three BP measurements or hypertension meds
30	Hypertension	102986	phv00102986.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-10 22:40:26+00:00	2018-12-10 22:40:26+00:00 	HYPER	CALCULATED HTN STATUS
30	Hypertension	259389	phv00259389.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-12-20 19:43:19+00:00	2018-12-20 19:43:19+00:00 	htnind	Treated hypertension at index date
31	Blood glucose	127613	phv00127613.v1.p1	pht001959.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:23:49+00:00	2018-03-16 01:23:49+00:00 	GLUCOSE	Glucose mg/dL
31	Blood glucose	203882	phv00203882.v1.p1	pht004052.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:09:40+00:00	2018-03-19 16:09:40+00:00 	CHMB07	Glucose (mg Per dL) Dec Pt Req. Q7 [Clinical Chemistry Lab, exam 2]
31	Blood glucose	204643	phv00204643.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:10:07+00:00	2018-03-19 16:10:07+00:00 	GLUSIU21	Visit 2, blood glucose in mmol/L [Cohort, Exam 2]
31	Blood glucose	204730	phv00204730.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:10:39+00:00	2018-03-19 16:10:39+00:00 	GLUCOS01	Derived glucose value in mg/dL [Cohort, Exam 1]
31	Blood glucose	204734	phv00204734.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:11:08+00:00	2018-03-19 16:11:08+00:00 	GLUSIU01	Recalibrated glucose in SI units [Cohort, Exam 1]
31	Blood glucose	204969	phv00204969.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:11:34+00:00	2018-03-19 16:11:34+00:00 	GLUSIU41	Visit 4, fasting glucose in SI units [Cohort, Exam 4]
31	Blood glucose	204970	phv00204970.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:11:55+00:00	2018-03-19 16:11:55+00:00 	GL2SIU41	Visit 4 , two hour glucose in SI units [Cohort, Exam 4]
31	Blood glucose	207663	phv00207663.v1.p1	pht004123.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:14:31+00:00	2018-03-19 16:14:31+00:00 	LIPC4A	Glucose (value in mg/dL) Q4a [Lipid Lab, exam 3]
31	Blood glucose	207678	phv00207678.v1.p1	pht004124.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:15:01+00:00	2018-03-19 16:15:01+00:00 	LIPD4A	Fasting glucose (value). Q4a [Lipid Lab, exam 4]
31	Blood glucose	207679	phv00207679.v1.p1	pht004124.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:15:35+00:00	2018-03-19 16:15:35+00:00 	LIPD5A	Two-hour glucose (value). Q5a [Lipid Lab, exam 4]
31	Blood glucose	112414	phv00112414.v2.p2	pht001557.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:46:19+00:00	2018-04-17 19:46:19+00:00 	AL3_GLU	GLUCOSE (MG/100 ML)
31	Blood glucose	117552	phv00117552.v2.p2	pht001737.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:46:19+00:00	2018-04-17 19:46:19+00:00 	DL7GLU	YEAR 7 GLUCOSE (ug/dL)
31	Blood glucose	119598	phv00119598.v2.p2	pht001799.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:46:19+00:00	2018-04-17 19:46:19+00:00 	EL7GLU	YEAR 10 FASTING GLUCOSE (mg/dL)
31	Blood glucose	119599	phv00119599.v2.p2	pht001799.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:46:19+00:00	2018-04-17 19:46:19+00:00 	EL7GLU2H	YEAR 10 2 HR GLUCOSE (mg/dL)
31	Blood glucose	119600	phv00119600.v2.p2	pht001799.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:46:19+00:00	2018-04-17 19:46:19+00:00 	EL7GLUR	YR 10 FASTING GLU (mg/dL) - RETURN VISIT
31	Blood glucose	120661	phv00120661.v2.p2	pht001845.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:46:19+00:00	2018-04-17 19:46:19+00:00 	FL7GLU	FASTING GLUCOSE (mg/dL)
31	Blood glucose	82953	phv00082953.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:18:42+00:00	2018-04-23 23:18:42+00:00 	glucos1c	FASTING GLUCOSE CALIBRATED (mg/dl)
31	Blood glucose	82954	phv00082954.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:18:48+00:00	2018-04-23 23:18:48+00:00 	glucos1u	FASTING GLUCOSE ORIGINAL (mg/dl)
31	Blood glucose	84969	phv00084969.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:18:53+00:00	2018-04-23 23:18:53+00:00 	glucos1c	EXAM 1 FASTING GLUCOSE- CALIBRATED
31	Blood glucose	84970	phv00084970.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:19:01+00:00	2018-04-23 23:19:01+00:00 	glucos1u	EXAM 1 FASTING GLUCOSE- ORIGINAL
31	Blood glucose	85932	phv00085932.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:19:08+00:00	2018-04-23 23:19:08+00:00 	glucos2c	EXAM 2 FASTING GLUCOSE- CALIBRATED
31	Blood glucose	86415	phv00086415.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:19:16+00:00	2018-04-23 23:19:16+00:00 	glucos3c	EXAM 3 FASTING GLUCOSE- CALIBRATED
31	Blood glucose	86834	phv00086834.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:19:22+00:00	2018-04-23 23:19:22+00:00 	glucos4c	EXAM 4 FASTING GLUCOSE- CALIBRATED
31	Blood glucose	87088	phv00087088.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:19:28+00:00	2018-04-23 23:19:28+00:00 	glucosfc	EXAM 1 FASTING GLUCOSE- CALIBRATED
31	Blood glucose	175240	phv00175240.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:19:34+00:00	2018-04-23 23:19:34+00:00 	glucose5	FASTING GLUCOSE (mg/dl)
31	Blood glucose	175863	phv00175863.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:19:41+00:00	2018-04-23 23:19:41+00:00 	glucos1c	EXAM 1 FASTING GLUCOSE- CALIBRATED
31	Blood glucose	175887	phv00175887.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:19:52+00:00	2018-04-23 23:19:52+00:00 	glucose	GLUCOSE
31	Blood glucose	175948	phv00175948.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:19:59+00:00	2018-04-23 23:19:59+00:00 	glucosfc	FAMILY COHORT: EXAM 1 FASTING GLUCOSE- CALIBRATED
31	Blood glucose	176663	phv00176663.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:20:05+00:00	2018-04-23 23:20:05+00:00 	glucose5	FASTING GLUCOSE (mg/dl)
31	Blood glucose	219026	phv00219026.v1.p3	pht004326.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:20:15+00:00	2018-04-23 23:20:15+00:00 	glucossc	FASTING GLUCOSE- CALIBRATED AT MESA STRESS EXAM
31	Blood glucose	172173	phv00172173.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:26:24+00:00	2018-06-05 15:26:24+00:00 	GLUC	Fasting glucose (sample type: plasma)
31	Blood glucose	227016	phv00227016.v1.p10	pht004801.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:26:42+00:00	2018-06-05 15:26:42+00:00 	GLUC	Glucose (Sample type - EDTA plasma) Collection Interval: Exam 1
31	Blood glucose	227057	phv00227057.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:27:03+00:00	2018-06-05 15:27:03+00:00 	GLUC	Glucose (sample type: EDTA plasma)
31	Blood glucose	255343	phv00255343.v1.p10	pht005143.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:27:29+00:00	2018-06-05 15:27:29+00:00 	GLUC	Glucose (sample type: plasma)
31	Blood glucose	275404	phv00275404.v1.p10	pht006010.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:27:49+00:00	2018-06-05 15:27:49+00:00 	GLUC	Glucose (sample type: EDTA plasma) Collection Interval: Exam 2
31	Blood glucose	172174	phv00172174.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:28:44+00:00	2018-06-05 15:28:44+00:00 	GLUC2	Post glucose (two hours post glucose tolerance test beverage taken) (sample type: plasma)
31	Blood glucose	227017	phv00227017.v1.p10	pht004801.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:29:09+00:00	2018-06-05 15:29:09+00:00 	GLUC2	Post glucose (oral glucose tolerance test, at 2 hours) (Sample type - serum) Collection Interval: Exam 1
31	Blood glucose	71893	phv00071893.v4.p10	pht000742.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:30:21+00:00	2018-06-05 15:30:21+00:00 	GLUCOSE	Glucose, plasma
31	Blood glucose	275416	phv00275416.v1.p10	pht006011.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:30:52+00:00	2018-06-05 15:30:52+00:00 	GLUCOSE	Glucose (sample type: plasma) Collection Interval: Omni 1 Exam 3
31	Blood glucose	126017	phv00126017.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:08:10+00:00	2018-06-12 01:08:10+00:00 	FPG01	Fasting glucose
31	Blood glucose	126020	phv00126020.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:09:14+00:00	2018-06-12 01:09:14+00:00 	FPG01SI	Fasting glucose (mM)
31	Blood glucose	100045	phv00100045.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:14:09+00:00	2018-06-28 00:14:09+00:00 	GLU44	BASELINE GLUCOSE (mg/dl)
31	Blood glucose	100051	phv00100051.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:14:20+00:00	2018-06-28 00:14:20+00:00 	GLU244	2 HR GLUCOSE (mg/dl)
31	Blood glucose	100427	phv00100427.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:14:30+00:00	2018-06-28 00:14:30+00:00 	GLU44	BASELINE GLUCOSE (mg/dl)
31	Blood glucose	105867	phv00105867.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:14:40+00:00	2018-06-28 00:14:40+00:00 	GLU44	BASELINE GLUCOSE (mg/dl)
31	Blood glucose	106408	phv00106408.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:14:50+00:00	2018-06-28 00:14:50+00:00 	GLUADJ	Glu44 adjusted for drift
31	Blood glucose	106994	phv00106994.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:15:05+00:00	2018-06-28 00:15:05+00:00 	GLU44	BASELINE GLUCOSE (mg/dl)
31	Blood glucose	107338	phv00107338.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:15:20+00:00	2018-06-28 00:15:20+00:00 	GLUADJ	Glu44 adjusted for drift
31	Blood glucose	110485	phv00110485.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:16:04+00:00	2018-06-28 00:16:04+00:00 	GLU44	Fasting glucose (mg/dl)
31	Blood glucose	110490	phv00110490.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:16:18+00:00	2018-06-28 00:16:18+00:00 	GLUADJ	GLU44 ADJUSTED FOR DRIFT (mg/dl)
31	Blood glucose	110486	phv00110486.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:16:30+00:00	2018-06-28 00:16:30+00:00 	GLU244	2 HR GLUCOSE (mg/dl)
31	Blood glucose	7558	phv00007558.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:29:49+00:00	2018-07-03 13:29:49+00:00 	A31	GLUCOSE
31	Blood glucose	8084	phv00008084.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:30:25+00:00	2018-07-03 13:30:25+00:00 	B737	GLUCOSE
31	Blood glucose	277022	phv00277022.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:31:05+00:00	2018-07-03 13:31:05+00:00 	BG1	Blood glucose, Exam 1 (includes fasting and non-fasting)
31	Blood glucose	277086	phv00277086.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:31:16+00:00	2018-07-03 13:31:16+00:00 	BG1	Blood glucose, Exam 1 (includes fasting and non-fasting)
31	Blood glucose	277023	phv00277023.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:31:29+00:00	2018-07-03 13:31:29+00:00 	BG2	Blood glucose, Exam 2 (includes fasting and non-fasting)
31	Blood glucose	277087	phv00277087.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:31:38+00:00	2018-07-03 13:31:38+00:00 	BG2	Blood glucose, Exam 2 (includes fasting and non-fasting)
31	Blood glucose	277088	phv00277088.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:31:49+00:00	2018-07-03 13:31:49+00:00 	BG3	Blood glucose, Exam 3 (includes fasting and non-fasting)
31	Blood glucose	277089	phv00277089.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:32:16+00:00	2018-07-03 13:32:16+00:00 	BG4	Blood glucose, Exam 4 (includes fasting and non-fasting)
31	Blood glucose	277090	phv00277090.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:32:28+00:00	2018-07-03 13:32:28+00:00 	BG5	Blood glucose, Exam 5 (includes fasting and non-fasting)
31	Blood glucose	277091	phv00277091.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:32:37+00:00	2018-07-03 13:32:37+00:00 	BG6	Blood glucose, Exam 6 (includes fasting and non-fasting)
31	Blood glucose	277092	phv00277092.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:32:46+00:00	2018-07-03 13:32:46+00:00 	BG7	Blood glucose, Exam 7 (includes fasting and non-fasting)
31	Blood glucose	277093	phv00277093.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:32:56+00:00	2018-07-03 13:32:56+00:00 	BG8	Blood glucose, Exam 8 (includes fasting and non-fasting)
31	Blood glucose	277094	phv00277094.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:33:10+00:00	2018-07-03 13:33:10+00:00 	BG9	Blood glucose, Exam 9 (includes fasting and non-fasting)
31	Blood glucose	80784	phv00080784.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:33:22+00:00	2018-07-03 13:33:22+00:00 	BLS1	BLOOD GLUCOSE AT EXAM 1
31	Blood glucose	80791	phv00080791.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:33:35+00:00	2018-07-03 13:33:35+00:00 	BLS10	BLOOD GLUCOSE AT EXAM 10
31	Blood glucose	80792	phv00080792.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:33:46+00:00	2018-07-03 13:33:46+00:00 	BLS13	BLOOD GLUCOSE AT EXAM 13
31	Blood glucose	80793	phv00080793.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:34:11+00:00	2018-07-03 13:34:11+00:00 	BLS14	BLOOD GLUCOSE AT EXAM 14
31	Blood glucose	80794	phv00080794.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:34:21+00:00	2018-07-03 13:34:21+00:00 	BLS15	BLOOD GLUCOSE AT EXAM 15
31	Blood glucose	80795	phv00080795.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:34:47+00:00	2018-07-03 13:34:47+00:00 	BLS16	BLOOD GLUCOSE AT EXAM 16
31	Blood glucose	80796	phv00080796.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:34:58+00:00	2018-07-03 13:34:58+00:00 	BLS17	BLOOD GLUCOSE AT EXAM 17
31	Blood glucose	80797	phv00080797.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:35:07+00:00	2018-07-03 13:35:07+00:00 	BLS18	BLOOD GLUCOSE AT EXAM 18
31	Blood glucose	80798	phv00080798.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:35:17+00:00	2018-07-03 13:35:17+00:00 	BLS19	BLOOD GLUCOSE AT EXAM 19
31	Blood glucose	80785	phv00080785.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:35:32+00:00	2018-07-03 13:35:32+00:00 	BLS2	BLOOD GLUCOSE AT EXAM 2
31	Blood glucose	80799	phv00080799.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:35:45+00:00	2018-07-03 13:35:45+00:00 	BLS20	BLOOD GLUCOSE AT EXAM 20
31	Blood glucose	80781	phv00080781.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:36:16+00:00	2018-07-03 13:36:16+00:00 	BLS21	BLOOD GLUCOSE AT EXAM 21
31	Blood glucose	80782	phv00080782.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:36:26+00:00	2018-07-03 13:36:26+00:00 	BLS22	BLOOD GLUCOSE AT EXAM 22
31	Blood glucose	80783	phv00080783.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:36:35+00:00	2018-07-03 13:36:35+00:00 	BLS23	BLOOD GLUCOSE AT EXAM 23
31	Blood glucose	80800	phv00080800.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:36:44+00:00	2018-07-03 13:36:44+00:00 	BLS26	BLOOD GLUCOSE AT EXAM 26
31	Blood glucose	80801	phv00080801.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:36:54+00:00	2018-07-03 13:36:54+00:00 	BLS27	BLOOD GLUCOSE AT EXAM 27
31	Blood glucose	80786	phv00080786.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:37:08+00:00	2018-07-03 13:37:08+00:00 	BLS3	BLOOD GLUCOSE AT EXAM 3
31	Blood glucose	80787	phv00080787.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:37:19+00:00	2018-07-03 13:37:19+00:00 	BLS4	BLOOD GLUCOSE AT EXAM 4
31	Blood glucose	80788	phv00080788.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:37:39+00:00	2018-07-03 13:37:39+00:00 	BLS6	BLOOD GLUCOSE AT EXAM 6
31	Blood glucose	80789	phv00080789.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:37:53+00:00	2018-07-03 13:37:53+00:00 	BLS8	BLOOD GLUCOSE AT EXAM 8
31	Blood glucose	80790	phv00080790.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:38:04+00:00	2018-07-03 13:38:04+00:00 	BLS9	BLOOD GLUCOSE AT EXAM 9
31	Blood glucose	8731	phv00008731.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:41:35+00:00	2018-07-03 13:41:35+00:00 	C434	GLUCOSE IN BLOOD
31	Blood glucose	276862	phv00276862.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:41:53+00:00	2018-07-03 13:41:53+00:00 	CHF056	Chemistry - Glucose
31	Blood glucose	9125	phv00009125.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:42:15+00:00	2018-07-03 13:42:15+00:00 	D452	GLUCOSE
31	Blood glucose	9577	phv00009577.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:42:31+00:00	2018-07-03 13:42:31+00:00 	E671	BLOOD ANALYSIS - GLUCOSE - BASELINE
31	Blood glucose	9578	phv00009578.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:42:53+00:00	2018-07-03 13:42:53+00:00 	E672	BLOOD ANALYSIS - GLUCOSE - 2 HOUR POST
31	Blood glucose	10798	phv00010798.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:43:49+00:00	2018-07-03 13:43:49+00:00 	F_GLUC3	FASTING BLOOD GLUCOSE AT EXAM 3 (SOURCE: C434 (EXAM 3))
31	Blood glucose	10799	phv00010799.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:43:59+00:00	2018-07-03 13:43:59+00:00 	F_GLUC4	FASTING BLOOD GLUCOSE AT EXAM 4 (SOURCE: D452 (EXAM 4))
31	Blood glucose	10800	phv00010800.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:44:07+00:00	2018-07-03 13:44:07+00:00 	F_GLUC5	FASTING BLOOD GLUCOSE AT EXAM 5 (SOURCE: E671 (EXAM 5))
31	Blood glucose	10801	phv00010801.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:44:16+00:00	2018-07-03 13:44:16+00:00 	F_GLUC6	FASTING BLOOD GLUCOSE AT EXAM 6 (SOURCE: F724 (EXAM 6))
31	Blood glucose	10802	phv00010802.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:44:25+00:00	2018-07-03 13:44:25+00:00 	F_GLUC7	FASTING BLOOD GLUCOSE AT EXAM 7 (SOURCE: G705 (EXAM 7))
31	Blood glucose	10133	phv00010133.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:45:32+00:00	2018-07-03 13:45:32+00:00 	F724	BLOOD ANALYSIS - GLUCOSE - BASELINE
31	Blood glucose	277038	phv00277038.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:45:47+00:00	2018-07-03 13:45:47+00:00 	FASTING_BG1	Fasting blood glucose, Exam 1 (fasting >= 8 hours)
31	Blood glucose	277039	phv00277039.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:45:55+00:00	2018-07-03 13:45:55+00:00 	FASTING_BG2	Fasting blood glucose, Exam 2 (fasting >= 8 hours)
31	Blood glucose	277155	phv00277155.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:46:03+00:00	2018-07-03 13:46:03+00:00 	FASTING_BG3	Fasting blood glucose, Exam 3 (>= 8 hours)
31	Blood glucose	277156	phv00277156.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:46:12+00:00	2018-07-03 13:46:12+00:00 	FASTING_BG4	Fasting blood glucose, Exam 4 (>= 8 hours)
31	Blood glucose	277157	phv00277157.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:46:20+00:00	2018-07-03 13:46:20+00:00 	FASTING_BG5	Fasting blood glucose, Exam 5 (>= 8 hours)
31	Blood glucose	277158	phv00277158.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:46:28+00:00	2018-07-03 13:46:28+00:00 	FASTING_BG6	Fasting blood glucose, Exam 6 (>= 8 hours)
31	Blood glucose	277159	phv00277159.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:46:38+00:00	2018-07-03 13:46:38+00:00 	FASTING_BG7	Fasting blood glucose, Exam 7 (>= 8 hours)
31	Blood glucose	277160	phv00277160.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:46:47+00:00	2018-07-03 13:46:47+00:00 	FASTING_BG8	Fasting blood glucose, Exam 8 (>= 8 hours)
31	Blood glucose	277161	phv00277161.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:46:57+00:00	2018-07-03 13:46:57+00:00 	FASTING_BG9	Fasting blood glucose, Exam 9 (>= 8 hours)
31	Blood glucose	1397	phv00001397.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:47:25+00:00	2018-07-03 13:47:25+00:00 	FC41	BLOOD ANALYSIS: SUGAR (AFTER GLUCOSE CHALLENGE) (MG/100 ML)
31	Blood glucose	4081	phv00004081.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:48:08+00:00	2018-07-03 13:48:08+00:00 	FL523	BLOOD ANALYSIS-GLUCOSE
31	Blood glucose	4517	phv00004517.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:48:22+00:00	2018-07-03 13:48:22+00:00 	FM543	BLOOD ANALYSIS - GLUCOSE
31	Blood glucose	4937	phv00004937.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:48:37+00:00	2018-07-03 13:48:37+00:00 	FN510	BLOOD ANALYSIS - GLUCOSE
31	Blood glucose	5550	phv00005550.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:48:49+00:00	2018-07-03 13:48:49+00:00 	FO733	BLOOD ANALYSIS - GLUCOSE (NON-FASTING)
31	Blood glucose	6026	phv00006026.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:48:59+00:00	2018-07-03 13:48:59+00:00 	FP597	BLOOD ANALYSIS - GLUCOSE - (NON-FASTING)
31	Blood glucose	6666	phv00006666.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:49:32+00:00	2018-07-03 13:49:32+00:00 	FS533	GLUCOSE MG/100ML
31	Blood glucose	7527	phv00007527.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:49:47+00:00	2018-07-03 13:49:47+00:00 	FT543	GLUCOSE MG/100ML
31	Blood glucose	70730	phv00070730.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:50:00+00:00	2018-07-03 13:50:00+00:00 	FU578	LAB VALUES: GLUCOSE, MG/DL
31	Blood glucose	21394	phv00021394.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:50:36+00:00	2018-07-03 13:50:36+00:00 	G3A715	GLUCOSE, MG/DL
31	Blood glucose	24364	phv00024364.v5.p10	pht000192.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:51:24+00:00	2018-07-03 13:51:24+00:00 	H2PG7	2-HOUR POST-ORAL GLUCOSE CHALLENGE TEST, EXAM 7 MEASURED IN MG/DL (NOTE: ALL SUBJECTS WITH IGT AND A SUBSET OF SUBJECTS WITH NGT AT EXAM 5 [BLOCK-RANDOMLY SELECTED FROM 5 QUINTILE STRATA OF FBS] WERE OFFERED A MORNING EXAM AT CYCLE 7 INCLUDING AN ORAL GLUCOSE TOLERANCE TEST.)
31	Blood glucose	7953	phv00007953.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:52:02+00:00	2018-07-03 13:52:02+00:00 	B335	BLOOD ANALYSIS: SUGAR
31	Blood glucose	1048	phv00001048.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:52:15+00:00	2018-07-03 13:52:15+00:00 	FA14	BLOOD ANALYSIS:  SUGAR (MG PER 100 ML)
31	Blood glucose	1203	phv00001203.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:52:27+00:00	2018-07-03 13:52:27+00:00 	FB26	BLOOD ANALYSIS:  SUGAR
31	Blood glucose	1379	phv00001379.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:52:37+00:00	2018-07-03 13:52:37+00:00 	FC21	BLOOD ANALYSIS: SUGAR (MG/100 ML)
31	Blood glucose	1580	phv00001580.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:52:51+00:00	2018-07-03 13:52:51+00:00 	FD35	BLOOD ANALYSIS, SUGAR
31	Blood glucose	1816	phv00001816.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:53:03+00:00	2018-07-03 13:53:03+00:00 	FE82	BLOOD ANALYSIS, SUGAR
31	Blood glucose	2031	phv00002031.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:53:14+00:00	2018-07-03 13:53:14+00:00 	FF78	BLOOD ANALYSIS, SUGAR
31	Blood glucose	2415	phv00002415.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:53:39+00:00	2018-07-03 13:53:39+00:00 	FG311	BLOOD ANALYSIS, SUGAR
31	Blood glucose	2653	phv00002653.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:53:51+00:00	2018-07-03 13:53:51+00:00 	FH330	BLOOD ANALYSIS: SUGAR
31	Blood glucose	2680	phv00002680.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:54:01+00:00	2018-07-03 13:54:01+00:00 	FI28	BLOOD ANALYSIS, SUGAR (MG/100ML)
31	Blood glucose	3259	phv00003259.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:54:11+00:00	2018-07-03 13:54:11+00:00 	FJ381	BLOOD ANALYSIS: SUGAR (MG/100ML)
31	Blood glucose	3665	phv00003665.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:54:21+00:00	2018-07-03 13:54:21+00:00 	FK456	BLOOD ANALYSIS: SUGAR (MG/100ML)
31	Blood glucose	630	phv00000630.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:54:44+00:00	2018-07-03 13:54:44+00:00 	MF164	BLOOD ANALYSIS: SUGAR, EXAM 2
31	Blood glucose	636	phv00000636.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:54:56+00:00	2018-07-03 13:54:56+00:00 	MF170	BLOOD ANALYSIS: SUGAR, EXAM 3
31	Blood glucose	675	phv00000675.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:55:04+00:00	2018-07-03 13:55:04+00:00 	MF211	BLOOD ANALYSIS: SUGAR, EXAM 4
31	Blood glucose	843	phv00000843.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:55:15+00:00	2018-07-03 13:55:15+00:00 	MF394	BLOOD ANALYSIS: SUGAR, EXAM 6
31	Blood glucose	537	phv00000537.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 13:55:27+00:00	2018-07-03 13:55:27+00:00 	MF65	BLOOD ANALYSIS: SUGAR, EXAM 1
31	Blood glucose	10143	phv00010143.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 17:00:52+00:00	2018-07-03 17:00:52+00:00 	G705	GLUCOSE MG/100ML
31	Blood glucose	119601	phv00119601.v2.p2	pht001799.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-03 21:45:30+00:00	2018-08-03 21:45:30+00:00 	EL7GLU2R	YR 10 2 HR GLU (mg/dL) - RETURN VISIT
31	Blood glucose	77384	phv00077384.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-03 21:47:21+00:00	2018-08-03 21:47:21+00:00 	COREGLUC	Core Glucose (Mg/dl)
31	Blood glucose	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-03 21:58:04+00:00	2018-08-03 21:58:04+00:00 	TESTNAME	Test Name
31	Blood glucose	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-03 21:58:22+00:00	2018-08-03 21:58:22+00:00 	TESTVAL	Test Result Value
31	Blood glucose	277404	phv00277404.v1.p1	pht006036.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:20:45+00:00	2018-08-14 22:20:45+00:00 	SGLV	Serum Glucose Average result value Collection Interval: 2009-2011
31	Blood glucose	277576	phv00277576.v1.p1	pht006041.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:45:05+00:00	2018-08-14 22:45:05+00:00 	GLUCOSE	Glucose result value Collection Interval: 1996-2000
31	Blood glucose	277849	phv00277849.v1.p1	pht006048.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:10:19+00:00	2018-08-14 23:10:19+00:00 	SGLV	Serum Glucose Average result value Collection Interval: 2000-2004
31	Blood glucose	307857	phv00307857.v1.p1	pht006655.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:57:33+00:00	2018-08-15 23:57:33+00:00 	GLUCOSE	Glucose result value Collection Interval: 1996-2000
31	Blood glucose	308042	phv00308042.v1.p1	pht006661.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:11:50+00:00	2018-08-16 00:11:50+00:00 	SGLV	Serum Glucose Average result value Collection Interval: 2000-2004
31	Blood glucose	123956	phv00123956.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:27:33+00:00	2018-08-21 18:27:33+00:00 	glucose_fast	Fasting glucose (mg/dL)
31	Blood glucose	123957	phv00123957.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:28:52+00:00	2018-08-21 18:28:52+00:00 	glucose_fast_orig	Glucose_fast - original value
31	Blood glucose	123959	phv00123959.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:28:58+00:00	2018-08-21 18:28:58+00:00 	glucose_ogtt	OGTT glucose (mg/dL; Oral Glucose Tolerance Test)
31	Blood glucose	123960	phv00123960.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:29:05+00:00	2018-08-21 18:29:05+00:00 	glucose_ogtt_orig	Glucose_ogtt - original value
31	Blood glucose	253229	phv00253229.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:45:44+00:00	2018-08-24 16:45:44+00:00 	LABA70	Glucose, fasting (mg/dL) (LABA70)
31	Blood glucose	253230	phv00253230.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:45:53+00:00	2018-08-24 16:45:53+00:00 	LABA71	Glucose, post OGTT (mg/dL) (LABA71)
31	Blood glucose	253001	phv00253001.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:16:15+00:00	2018-08-24 17:16:15+00:00 	fastglucose_baseline	Fasting glucose value at baseline visit
31	Blood glucose	121609	phv00121609.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:03:14+00:00	2018-08-30 20:03:14+00:00 	Y01OBS	HIGHEST BLOOD SUGAR LEVEL (NON-FAST) FROM MED REC
31	Blood glucose	121608	phv00121608.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:03:28+00:00	2018-08-30 20:03:28+00:00 	Y01FBS	HIGHEST FASTING BLOOD SUGAR LEVEL FROM MEDICAL RECORD
31	Blood glucose	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-04 22:04:57+00:00	2018-09-04 22:04:57+00:00 	TESTABBR	Test abbreviation
31	Blood glucose	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-04 22:12:20+00:00	2018-09-04 22:12:20+00:00 	TESTDESC	Test Description
31	Blood glucose	259056	phv00259056.v1.p1	pht003918.v2.p1	phs000741.v2.p1	GOLDN	741	2	2018-09-06 12:19:59+00:00	2018-09-06 12:19:59+00:00 	FBG	Fasting Blood Glucose
31	Blood glucose	258727	phv00258727.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:50:06+00:00	2018-09-06 12:50:06+00:00 	Finger_Glucose	Blood Glucose from finger stick assessment
31	Blood glucose	258730	phv00258730.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:50:24+00:00	2018-09-06 12:50:24+00:00 	Glucose	Glucose from venous blood sample
32	Insulin in blood	125954	phv00125954.v1.p1	pht001945.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:52:48+00:00	2018-03-16 01:52:48+00:00 	INSULIN	Insulin: the concentration of insulin in IU/mL
32	Insulin in blood	203874	phv00203874.v1.p1	pht004051.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:12:59+00:00	2018-03-19 20:12:59+00:00 	CHMA16	Insulin AmIU/mL. Q16 [Clinical Chemistry Lab, exam 1]
32	Insulin in blood	204739	phv00204739.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:13:19+00:00	2018-03-19 20:13:19+00:00 	INSSIU01	Insulin in SI Units [Cohort, Exam 1]
32	Insulin in blood	207683	phv00207683.v1.p1	pht004124.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:13:39+00:00	2018-03-19 20:13:39+00:00 	LIPD7A	Insulin (value). Q7a [Lipid Lab, exam 4]
32	Insulin in blood	214148	phv00214148.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:14:13+00:00	2018-03-19 20:14:13+00:00 	INSULN1	Insulin
32	Insulin in blood	113698	phv00113698.v2.p2	pht001587.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:49:11+00:00	2018-04-17 19:49:11+00:00 	AL4INS	INSULIN (uU/ML)
32	Insulin in blood	117565	phv00117565.v2.p2	pht001740.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:49:11+00:00	2018-04-17 19:49:11+00:00 	DL7INS0	YEAR 0 INSULIN (uU/ML)
32	Insulin in blood	117566	phv00117566.v2.p2	pht001740.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:49:11+00:00	2018-04-17 19:49:11+00:00 	DL7INS7	YEAR 7 INSULIN (uU/ML)
32	Insulin in blood	119604	phv00119604.v2.p2	pht001800.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:49:11+00:00	2018-04-17 19:49:11+00:00 	EL7INS	YEAR 10 FASTING INSULIN (uU/mL)
32	Insulin in blood	119605	phv00119605.v2.p2	pht001800.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:49:11+00:00	2018-04-17 19:49:11+00:00 	EL7INS2H	YEAR 10 2 HR INSULIN (uU/mL)
32	Insulin in blood	119606	phv00119606.v2.p2	pht001800.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:49:11+00:00	2018-04-17 19:49:11+00:00 	EL7INSR	YR 10 FASTING INS (uU/mL) - RETURN VISIT
32	Insulin in blood	119607	phv00119607.v2.p2	pht001800.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:49:11+00:00	2018-04-17 19:49:11+00:00 	EL7INS2R	YR 10 2 HR INS (uU/mL) - RETURN VISIT
32	Insulin in blood	120663	phv00120663.v2.p2	pht001846.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:49:11+00:00	2018-04-17 19:49:11+00:00 	FL7INS	FASTING INSULIN (uU/mL)
32	Insulin in blood	160488	phv00160488.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:57:11+00:00	2018-04-23 23:57:11+00:00 	inslnr1t	SERUM INSULIN RECODED TO E5 ELECSYS SCALE (MU/L)
32	Insulin in blood	160512	phv00160512.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:57:17+00:00	2018-04-23 23:57:17+00:00 	inslnrfc	MERCODIA INSULIN RECODED TO E5 ELECSYS SCALE (MU/L)
32	Insulin in blood	160542	phv00160542.v1.p3	pht002198.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:57:25+00:00	2018-04-23 23:57:25+00:00 	insln3	INSULIN (pg/mL)
32	Insulin in blood	175251	phv00175251.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:57:35+00:00	2018-04-23 23:57:35+00:00 	insulin5	SERUM INSULIN (mU/L)
32	Insulin in blood	176674	phv00176674.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-23 23:57:42+00:00	2018-04-23 23:57:42+00:00 	insulin5	SERUM INSULIN (mU/L)
32	Insulin in blood	126128	phv00126128.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:29:36+00:00	2018-06-12 01:29:36+00:00 	INL01F	Fasting insulin (uU/mL)
32	Insulin in blood	21925	phv00021925.v5.p10	pht000091.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:18:51+00:00	2018-06-15 13:18:51+00:00 	PFINSLN5	PLASMA FASTING INSULIN
32	Insulin in blood	21926	phv00021926.v5.p10	pht000091.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:19:24+00:00	2018-06-15 13:19:24+00:00 	P2INSLN5	PLASMA 2-H OGTT INSULIN
32	Insulin in blood	23558	phv00023558.v6.p10	pht000152.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:19:55+00:00	2018-06-15 13:19:55+00:00 	P_IN7	FASTING PLASMA LINCO INSULIN (PMOL/L)
32	Insulin in blood	70362	phv00070362.v4.p10	pht000688.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:20:40+00:00	2018-06-15 13:20:40+00:00 	insulin	INSULIN, PMOL/L (ELISA RESULTS WERE MULTIPLIED BY A FACTOR OF 6 TO GET PMOL/L UNITS FOR INSULIN)
32	Insulin in blood	201991	phv00201991.v2.p10	pht003901.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:21:02+00:00	2018-06-15 13:21:02+00:00 	INSULIN	Insulin (sample: EDTA plasma)
32	Insulin in blood	201995	phv00201995.v2.p10	pht003902.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:21:14+00:00	2018-06-15 13:21:14+00:00 	INSULIN	Insulin (sample: EDTA plasma)
32	Insulin in blood	227080	phv00227080.v1.p10	pht004804.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:21:26+00:00	2018-06-15 13:21:26+00:00 	INSULIN	Insulin (sample type: EDTA plasma)
32	Insulin in blood	227085	phv00227085.v1.p10	pht004805.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:21:48+00:00	2018-06-15 13:21:48+00:00 	INSULIN	Insulin (sample: EDTA plasma)
32	Insulin in blood	24360	phv00024360.v4.p10	pht000191.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:28:25+00:00	2018-06-15 13:28:25+00:00 	pos_in7	2 HOUR INSULIN, EXAM 7 (μU/ML)
32	Insulin in blood	100044	phv00100044.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:17:18+00:00	2018-06-28 00:17:18+00:00 	INS44	BASELINE INSULIN (IU/ml)
32	Insulin in blood	100050	phv00100050.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:17:36+00:00	2018-06-28 00:17:36+00:00 	INS244	2 HR INSULIN (IU/ml)
32	Insulin in blood	100428	phv00100428.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:17:48+00:00	2018-06-28 00:17:48+00:00 	INS44	BASELINE INSULIN (IU/ml)
32	Insulin in blood	105866	phv00105866.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:18:12+00:00	2018-06-28 00:18:12+00:00 	INS44	BASELINE INSULIN (IU/ml)
32	Insulin in blood	77389	phv00077389.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:39:20+00:00	2018-07-02 21:39:20+00:00 	COREINSU	Core Insulin (uIU/ml) (RIA method)
32	Insulin in blood	77390	phv00077390.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:39:20+00:00	2018-07-02 21:39:20+00:00 	COREINSU2	Core Insulin (uIU/ml) (automated ES300 method)
32	Insulin in blood	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:39:20+00:00	2018-07-02 21:39:20+00:00 	TESTVAL	Test Result Value
32	Insulin in blood	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 21:39:20+00:00	2018-07-02 21:39:20+00:00 	TESTNAME	Test Name
32	Insulin in blood	277401	phv00277401.v1.p1	pht006036.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:21:13+00:00	2018-08-14 22:21:13+00:00 	INSULIN	Plasma Insulin result value Collection Interval: 2009-2011
32	Insulin in blood	277577	phv00277577.v1.p1	pht006041.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:44:58+00:00	2018-08-14 22:44:58+00:00 	INSULIN	Insulin result value Collection Interval: 1996-2000
32	Insulin in blood	277856	phv00277856.v1.p1	pht006048.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:11:28+00:00	2018-08-14 23:11:28+00:00 	INSULIN	Plasma Insulin result value Collection Interval: 2000-2004
32	Insulin in blood	307858	phv00307858.v1.p1	pht006655.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:57:24+00:00	2018-08-15 23:57:24+00:00 	INSULIN	Insulin result value Collection Interval: 1996-2000
32	Insulin in blood	308049	phv00308049.v1.p1	pht006661.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:11:26+00:00	2018-08-16 00:11:26+00:00 	INSULIN	Plasma Insulin result value Collection Interval: 2000-2004
32	Insulin in blood	123962	phv00123962.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:29:41+00:00	2018-08-21 18:29:41+00:00 	insulin_fast	Fasting insulin (mg/dL)
32	Insulin in blood	123963	phv00123963.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:29:49+00:00	2018-08-21 18:29:49+00:00 	insulin_fast_orig	Insulin_fast - original value
32	Insulin in blood	123965	phv00123965.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:29:56+00:00	2018-08-21 18:29:56+00:00 	insulin_ogtt	OGTT insulin (mg/dL)
32	Insulin in blood	123966	phv00123966.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:30:02+00:00	2018-08-21 18:30:02+00:00 	insulin_ogtt_orig	Insulin_ogtt - original value
32	Insulin in blood	253227	phv00253227.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:45:00+00:00	2018-08-24 16:45:00+00:00 	INSULIN_FAST	Insulin, fasting (calibrated, converted to mU/L)
32	Insulin in blood	253228	phv00253228.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:45:13+00:00	2018-08-24 16:45:13+00:00 	INSULIN_OGTT	Insulin, post OGTT (calibrated, converted to mU/L)
32	Insulin in blood	253000	phv00253000.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:15:59+00:00	2018-08-24 17:15:59+00:00 	fastinsulin_baseline	Fasting insulin value at baseline visit
32	Insulin in blood	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-04 22:08:17+00:00	2018-09-04 22:08:17+00:00 	TESTABBR	Test abbreviation
32	Insulin in blood	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-04 22:13:31+00:00	2018-09-04 22:13:31+00:00 	TESTDESC	Test Description
32	Insulin in blood	258729	phv00258729.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:50:44+00:00	2018-09-06 12:50:44+00:00 	Insulin	Insulin from venous blood sample
33	HbA1c	125929	phv00125929.v1.p1	pht001945.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:45:39+00:00	2018-03-16 01:45:39+00:00 	GLYHB	Glyhb: hemoglobin A1c - %
33	HbA1c	174583	phv00174583.v1.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 00:30:07+00:00	2018-04-24 00:30:07+00:00 	hba1c2	SERUM HEMOGLOBIN A1C
33	HbA1c	175243	phv00175243.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 00:30:16+00:00	2018-04-24 00:30:16+00:00 	hba1c5	SERUM HEMOGLOBIN A1C
33	HbA1c	176666	phv00176666.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 00:30:23+00:00	2018-04-24 00:30:23+00:00 	hba1c5	SERUM HEMOGLOBIN A1C
33	HbA1c	71897	phv00071897.v4.p10	pht000742.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 14:55:36+00:00	2018-06-05 14:55:36+00:00 	A1C	Hemoglobin A1c, whole blood
33	HbA1c	275420	phv00275420.v1.p10	pht006011.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 14:55:57+00:00	2018-06-05 14:55:57+00:00 	A1C	Hemoglobin A1C (sample type: whole blood) Collection Interval: Omni 1 Exam 3
33	HbA1c	172163	phv00172163.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:32:18+00:00	2018-06-05 15:32:18+00:00 	HBA1C	Hemoglobin A1c (sample type: whole blood)
33	HbA1c	227047	phv00227047.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:32:36+00:00	2018-06-05 15:32:36+00:00 	HBA1C	Hemoglobin A1c (sample type: whole blood)
33	HbA1c	126015	phv00126015.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:06:18+00:00	2018-06-12 01:06:18+00:00 	A1C	Hemoglobin A1C
33	HbA1c	23624	phv00023624.v1.p10	pht000155.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:34:33+00:00	2018-06-14 18:34:33+00:00 	HBA1920	HBA1C% CORRESPONDING TO EXAM 19/20 DATE
33	HbA1c	23625	phv00023625.v1.p10	pht000155.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:34:59+00:00	2018-06-14 18:34:59+00:00 	HBA22	HBA1C% CORRESPONDING TO EXAM 22 DATE
33	HbA1c	23630	phv00023630.v5.p10	pht000156.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:35:46+00:00	2018-06-14 18:35:46+00:00 	HBA7	HBA1C %
33	HbA1c	21929	phv00021929.v5.p10	pht000091.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:36:39+00:00	2018-06-14 18:36:39+00:00 	HBA1C	HEMOGLOBIN A1C
33	HbA1c	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:32:04+00:00	2018-07-02 22:32:04+00:00 	TESTVAL	Test Result Value
33	HbA1c	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 22:32:04+00:00	2018-07-02 22:32:04+00:00 	TESTNAME	Test Name
33	HbA1c	258047	phv00258047.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:56:32+00:00	2018-08-24 16:56:32+00:00 	HBA1C_SI	Glycosylated hemoglobin (HbA1c) in SI units (mmol/mol), nearest integer
33	HbA1c	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-04 22:07:58+00:00	2018-09-04 22:07:58+00:00 	TESTABBR	Test abbreviation
33	HbA1c	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-04 22:13:12+00:00	2018-09-04 22:13:12+00:00 	TESTDESC	Test Description
34	Diabetes	204631	phv00204631.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 19:42:50+00:00	2018-03-19 19:42:50+00:00 	DIABTS22	Visit 2, diabetes [Cohort, Exam 2]
34	Diabetes	204632	phv00204632.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 19:43:11+00:00	2018-03-19 19:43:11+00:00 	DIABTS23	Diabetes - lower cut point 126 [mg/dL] [Cohort, Exam 2]
34	Diabetes	204752	phv00204752.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 19:43:30+00:00	2018-03-19 19:43:30+00:00 	DIABTS02	Diabetes - lower cut point 140 [mg/dL] [Cohort, Exam 1]
34	Diabetes	204753	phv00204753.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 19:43:49+00:00	2018-03-19 19:43:49+00:00 	DIABTS03	Diabetes - lower cut point 126 [mg/dL] [Cohort, Exam 1]
34	Diabetes	204898	phv00204898.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 19:44:11+00:00	2018-03-19 19:44:11+00:00 	DIABTS33	Diabetes using lower cut point 140 [mg/dL] [Cohort, Exam 3]
34	Diabetes	204899	phv00204899.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 19:44:24+00:00	2018-03-19 19:44:24+00:00 	DIABTS34	Diabetes using lower cut point 126 [mg/dL] [Cohort, Exam 3]
34	Diabetes	204958	phv00204958.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 19:44:42+00:00	2018-03-19 19:44:42+00:00 	DIABTS41	Diabetes using lower cut point 140 Mg/dL [Cohort, Exam 4]
34	Diabetes	204959	phv00204959.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 19:45:05+00:00	2018-03-19 19:45:05+00:00 	DIABTS42	Diabetes using lower cut point 126 Mg/dL [Cohort, Exam 4]
34	Diabetes	209125	phv00209125.v1.p1	pht004149.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:00:34+00:00	2018-04-10 14:00:34+00:00 	REXA2A	Has a doctor ever told you that you had sugar diabetes? Q2a [Retinal Examination Form, exam 3]
34	Diabetes	209161	phv00209161.v1.p1	pht004150.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:01:23+00:00	2018-04-10 14:01:23+00:00 	REXB2A	Has your doctor ever told you that you had diabetes? Q2A [Retinal Examination Form, exam 4]
34	Diabetes	209065	phv00209065.v1.p1	pht004146.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:02:09+00:00	2018-04-10 14:02:09+00:00 	PHXB6C	[Medical care]. Has a doctor ever said you had any of the following? Diabetes (sugar in the blood). Q6c [Personal History form, exam 4]
34	Diabetes	208974	phv00208974.v1.p1	pht004145.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:02:41+00:00	2018-04-10 14:02:41+00:00 	PHXA8K	[Medical care]. Diabetes (sugar in the blood)? Q8k [Personal History Form, exam 3]
34	Diabetes	207067	phv00207067.v1.p1	pht004103.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:07:43+00:00	2018-04-10 14:07:43+00:00 	HHXB05D	[Medical care]. Has a doctor ever said you had any of the following: (read each disease name and code N if No or Never Tested). Q5. Diabetes (sugar in the blood). Q5D [Health/Medical History, exam 2]
34	Diabetes	207315	phv00207315.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:08:42+00:00	2018-04-10 14:08:42+00:00 	HOM10E	Has a doctor ever said that you had any of the following: diabetes (sugar in the blood)? Q10e [Home Interview, exam 1]
34	Diabetes	206810	phv00206810.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:09:39+00:00	2018-04-10 14:09:39+00:00 	HFAA12A	[Medical history]. Q12a - Diabetes [Heart Failure Hospital Record Abstraction Form, HFA]
34	Diabetes	204412	phv00204412.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:12:15+00:00	2018-04-10 14:12:15+00:00 	PHQA03L	[Medical history]. Did the decedent have a history of any of the following? Diabetes. Q3l [Physician Questionnaire Form, exam 1]
34	Diabetes	204313	phv00204313.v1.p1	pht004054.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:12:54+00:00	2018-04-10 14:12:54+00:00 	IFIA19C	[History]. Did he/she have a history of diabetes? Q19c [Informant Interview Form, IFI]
34	Diabetes	203983	phv00203983.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:13:32+00:00	2018-04-10 14:13:32+00:00 	HRAA38B	[Second transfer]. Does this patient have diabetes (high blood sugar), either history or diagnosed this hospitalization? Q38b [Hospital Abstraction Form]
34	Diabetes	203797	phv00203797.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:13:55+00:00	2018-04-10 14:13:55+00:00 	CORA22A	Is there a history of diabetes? Q22a [Coroner / Medical Examiner Form]
34	Diabetes	203105	phv00203105.v1.p1	pht004031.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:14:21+00:00	2018-04-10 14:14:21+00:00 	AMHA1A	At what age were you first told you had diabetes? Q1a [AFU Medical History Form, AMH]
34	Diabetes	203040	phv00203040.v1.p1	pht004031.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:14:51+00:00	2018-04-10 14:14:51+00:00 	AMHA1	Has a doctor ever said you had diabetes, or sugar in the blood? Q1 [AFU Medical History Form, AMH]
34	Diabetes	203034	phv00203034.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:15:13+00:00	2018-04-10 14:15:13+00:00 	AFUcomp15_M	[General health]. Since we last contacted you has a doctor said you have diabetes or sugar in the blood? [Annual Follow-up Questionnaire Form, AFUM]
34	Diabetes	202929	phv00202929.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-10 14:15:39+00:00	2018-04-10 14:15:39+00:00 	AFUcomp7d_G	[General health].  Has a doctor ever said you had any of the following? Diabetes [sugar in the blood] [Annual Follow-up Questionnaire Form, AFUG]
34	Diabetes	112995	phv00112995.v2.p2	pht001569.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	A08DIAB	DIABETES
34	Diabetes	113060	phv00113060.v2.p2	pht001570.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	A09DIBST	STATUS OF DIABETES
34	Diabetes	114343	phv00114343.v2.p2	pht001601.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	B08DIAB	DIABETES. Q 6
34	Diabetes	114378	phv00114378.v2.p2	pht001604.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	B09DIBST	STATUS OF DIABETES. Q 1.04B
34	Diabetes	115076	phv00115076.v2.p2	pht001640.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	B09P_DIB	GESTATIONAL DIABETES, ANY PREGNANCY? Q 11c
34	Diabetes	115439	phv00115439.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	C08DIAB	DIABETES. Q 4
34	Diabetes	116341	phv00116341.v2.p2	pht001690.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	C09P_DIB	GESTATIONAL DIABETES?
34	Diabetes	116970	phv00116970.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	D08DIAB	DIABETES? Q 4
34	Diabetes	117518	phv00117518.v2.p2	pht001733.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	D09P_DIB	GESTATIONAL DIABETES? Q 11c
34	Diabetes	117939	phv00117939.v2.p2	pht001749.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	FY096DBT	DIABETES? - MON 96
34	Diabetes	117969	phv00117969.v2.p2	pht001749.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	FY108DBT	DIABETES? - MON 108
34	Diabetes	118444	phv00118444.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	E08DIAB	DIABETES? Q 4
34	Diabetes	118445	phv00118445.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	E08GDM	DIABETES DURING PREGNANCY. Q 4
34	Diabetes	119588	phv00119588.v2.p2	pht001797.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	E09P_DIB	GESTATIONAL DIABETES?
34	Diabetes	119805	phv00119805.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	F08DIAB	DIABETES? Q 4
34	Diabetes	119820	phv00119820.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	F08GDM	DIABETES DURING PREGNANCY. Q 4
34	Diabetes	120649	phv00120649.v2.p2	pht001843.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:56:24+00:00	2018-04-17 19:56:24+00:00 	F09P_DIB	GESTATIONAL DIABETES? Q 11c
34	Diabetes	82652	phv00082652.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 01:57:19+00:00	2018-04-24 01:57:19+00:00 	dm031c	EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM
34	Diabetes	82653	phv00082653.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 01:57:25+00:00	2018-04-24 01:57:25+00:00 	dm031t	RECODE OF DM031C COMBINING UNTREATED AND TREATED DIABETES - E1
34	Diabetes	82654	phv00082654.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 01:57:34+00:00	2018-04-24 01:57:34+00:00 	dm031t2	SECONDARY RECODE OF DM031C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E1
34	Diabetes	83011	phv00083011.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 01:57:41+00:00	2018-04-24 01:57:41+00:00 	dbpreg1	WOMEN: DIABETES OCCUR ONLY DURING PREGNANCY
34	Diabetes	195568	phv00195568.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 01:57:48+00:00	2018-04-24 01:57:48+00:00 	dmtype1c	EXAM 1 DIABETES TYPE
34	Diabetes	84456	phv00084456.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 01:57:55+00:00	2018-04-24 01:57:55+00:00 	dm031c	EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM
34	Diabetes	84457	phv00084457.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 01:58:13+00:00	2018-04-24 01:58:13+00:00 	dm031t	RECODE OF DM031C COMBINING UNTREATED AND TREATED DIABETES - E1
34	Diabetes	84458	phv00084458.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 01:58:39+00:00	2018-04-24 01:58:39+00:00 	dm031t2	SECONDARY RECODE OF DM031C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E1
34	Diabetes	85242	phv00085242.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 01:58:46+00:00	2018-04-24 01:58:46+00:00 	diabet1	DIABETES: SELF-REPORT
34	Diabetes	85247	phv00085247.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 01:58:54+00:00	2018-04-24 01:58:54+00:00 	dbpreg1	WOMEN: DIABETES OCCUR ONLY DURING PREGNANCY
34	Diabetes	128697	phv00128697.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 01:58:59+00:00	2018-04-24 01:58:59+00:00 	dmtype1c	DIABETES TYPE
34	Diabetes	85764	phv00085764.v3.p3	pht001117.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 01:59:07+00:00	2018-04-24 01:59:07+00:00 	fhxdb2	HISTORY OF DIABETES INDICATOR
34	Diabetes	85765	phv00085765.v3.p3	pht001117.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:00:58+00:00	2018-04-24 02:00:58+00:00 	fhxdba2	AGE OF FIRST DIABETES DX
34	Diabetes	85794	phv00085794.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:01:05+00:00	2018-04-24 02:01:05+00:00 	dm032c	EXAM 2 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM
34	Diabetes	85795	phv00085795.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:01:12+00:00	2018-04-24 02:01:12+00:00 	dm032t	RECODE OF DM032C COMBINING UNTREATED AND TREATED DIABETES - E2
34	Diabetes	85796	phv00085796.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:01:20+00:00	2018-04-24 02:01:20+00:00 	dm032t2	SECONDARY RECODE OF DM032C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E2
34	Diabetes	85837	phv00085837.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:01:26+00:00	2018-04-24 02:01:26+00:00 	eydiab2	DIABETES, OR HIGH BLOOD SUGAR OR SUGAR IN YOUR URINE
34	Diabetes	86279	phv00086279.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:01:33+00:00	2018-04-24 02:01:33+00:00 	dm033c	EXAM 3 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM
34	Diabetes	86280	phv00086280.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:01:38+00:00	2018-04-24 02:01:38+00:00 	dm033t	RECODE OF DM033C COMBINING UNTREATED AND TREATED DIABETES - E3
34	Diabetes	86281	phv00086281.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:01:45+00:00	2018-04-24 02:01:45+00:00 	dm033t2	SECONDARY RECODE OF DM033C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E3
34	Diabetes	86746	phv00086746.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:01:52+00:00	2018-04-24 02:01:52+00:00 	dm034c	EXAM 4 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM
34	Diabetes	86747	phv00086747.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:01:57+00:00	2018-04-24 02:01:57+00:00 	dm034t	RECODE OF DM034C COMBINING UNTREATED AND TREATED DIABETES - E4
34	Diabetes	86748	phv00086748.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:02:02+00:00	2018-04-24 02:02:02+00:00 	dm034t2	SECONDARY RECODE OF DM034C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E4
34	Diabetes	87089	phv00087089.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:02:08+00:00	2018-04-24 02:02:08+00:00 	dm03fc	DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM
34	Diabetes	87090	phv00087090.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:02:14+00:00	2018-04-24 02:02:14+00:00 	dm03ft	RECODE OF DM03FC COMBINING UNTREATED AND TREATED DIABETES - E1
34	Diabetes	87091	phv00087091.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:02:20+00:00	2018-04-24 02:02:20+00:00 	dm03ft2	SECONDARY RECODE OF DM03FC OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E1
34	Diabetes	87159	phv00087159.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:02:28+00:00	2018-04-24 02:02:28+00:00 	diabetf	DIABETES
34	Diabetes	87161	phv00087161.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:02:40+00:00	2018-04-24 02:02:40+00:00 	dbagef	DIABETES: AGE FIRST TREATED
34	Diabetes	87164	phv00087164.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:06:47+00:00	2018-04-24 02:06:47+00:00 	dbpregf	DIABETES: OCCUR ONLY DURING PREGNANCY
34	Diabetes	165067	phv00165067.v1.p3	pht002515.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:07:07+00:00	2018-04-24 02:07:07+00:00 	indm1a	INCIDENT DIABETES MELLITUS EXAM 2, 3, 4
34	Diabetes	174594	phv00174594.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:07:14+00:00	2018-04-24 02:07:14+00:00 	dm035c	DIABETES 2003 ADA FASTING CRITERIA
34	Diabetes	174609	phv00174609.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:07:19+00:00	2018-04-24 02:07:19+00:00 	dm035t	RECODE OF DM035C COMBINING UNTREATED AND TREATED DIABETES - E5
34	Diabetes	174610	phv00174610.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:07:25+00:00	2018-04-24 02:07:25+00:00 	dm035t2	SECONDARY RECODE OF DM035C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E5
34	Diabetes	175291	phv00175291.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:07:30+00:00	2018-04-24 02:07:30+00:00 	diab5	DIABETES: DEVELOPED SINCE LAST MESA VISIT
34	Diabetes	175888	phv00175888.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:07:37+00:00	2018-04-24 02:07:37+00:00 	diabetes	DIABETES
34	Diabetes	175956	phv00175956.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:07:57+00:00	2018-04-24 02:07:57+00:00 	diabetf	FAMILY COHORT: DIABETES
34	Diabetes	176017	phv00176017.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:08:03+00:00	2018-04-24 02:08:03+00:00 	dm035c	DIABETES 2003 ADA FASTING CRITERIA
34	Diabetes	176032	phv00176032.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:08:08+00:00	2018-04-24 02:08:08+00:00 	dm035t	RECODE OF DM035C COMBINING UNTREATED AND TREATED DIABETES - E5
34	Diabetes	176033	phv00176033.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:08:13+00:00	2018-04-24 02:08:13+00:00 	dm035t2	SECONDARY RECODE OF DM035C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E5
34	Diabetes	176714	phv00176714.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:08:19+00:00	2018-04-24 02:08:19+00:00 	diab5	DIABETES: DEVELOPED SINCE LAST MESA VISIT
34	Diabetes	197115	phv00197115.v1.p3	pht003659.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:08:24+00:00	2018-04-24 02:08:24+00:00 	dmage	AGE AT DIABETES DIAGNOSIS
34	Diabetes	197117	phv00197117.v1.p3	pht003659.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:08:29+00:00	2018-04-24 02:08:29+00:00 	dmsrtt	TIME TO SELF-REPORTED INCIDENT DIABETES
34	Diabetes	197118	phv00197118.v1.p3	pht003659.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:08:35+00:00	2018-04-24 02:08:35+00:00 	dmittt	TIME TO INCIDENT TREATED DIABETES
34	Diabetes	197119	phv00197119.v1.p3	pht003659.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:08:41+00:00	2018-04-24 02:08:41+00:00 	dmoe	OBSERVED DIABETES (UNTREATED AND TREATED) AT ANY MESA EXAM
34	Diabetes	197120	phv00197120.v1.p3	pht003659.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:09:10+00:00	2018-04-24 02:09:10+00:00 	dmoett	TIME TO OBSERVED DIABETES (UNTREATED AND TREATED) AT ANY MESA EXAM
34	Diabetes	197148	phv00197148.v1.p3	pht003659.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:09:17+00:00	2018-04-24 02:09:17+00:00 	dmittp	INCIDENT TREATED DIABETES: TIME POINT DIAGNOSIS DETERMINED
34	Diabetes	197149	phv00197149.v1.p3	pht003659.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:09:23+00:00	2018-04-24 02:09:23+00:00 	dmite2dyc	TIME FROM INCIDENT TREATED DIABETES DIAGNOSIS TO EXAM 2 (DAYS)
34	Diabetes	197150	phv00197150.v1.p3	pht003659.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:09:29+00:00	2018-04-24 02:09:29+00:00 	dmite5dyc	TIME FROM INCIDENT TREATED DIABETES DIAGNOSIS TO EXAM 5 (DAYS)
34	Diabetes	115440	phv00115440.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 18:26:42+00:00	2018-05-24 18:26:42+00:00 	C08DIBAG	AGE DIABETES DIAGNOSED. Q 4
34	Diabetes	117940	phv00117940.v2.p2	pht001749.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 18:28:28+00:00	2018-05-24 18:28:28+00:00 	FY096DBA	AGE FIRST TOLD DIABETES - MON 96
34	Diabetes	113059	phv00113059.v2.p2	pht001570.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 18:35:21+00:00	2018-05-24 18:35:21+00:00 	A09DIBAG	AGE, DIABETES DX'D
34	Diabetes	116972	phv00116972.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-05-24 18:36:55+00:00	2018-05-24 18:36:55+00:00 	D08DIBAG	AGE AT DIABETES. Q 4
34	Diabetes	124996	phv00124996.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 15:25:06+00:00	2018-06-08 15:25:06+00:00 	AFUA7D	7d. Diabetes or sugar in the blood
34	Diabetes	125081	phv00125081.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:29:53+00:00	2018-06-08 16:29:53+00:00 	AFUA7D	7d. Diabetes or sugar in the blood
34	Diabetes	125166	phv00125166.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:45:51+00:00	2018-06-08 16:45:51+00:00 	AFUB7D	7d. Diabetes or sugar in the blood
34	Diabetes	125252	phv00125252.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:59:33+00:00	2018-06-08 16:59:33+00:00 	AFUB7D	7d. Diabetes or sugar in the blood
34	Diabetes	125366	phv00125366.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:12:23+00:00	2018-06-08 17:12:23+00:00 	AFUC15	15. Has a doctor ever said that you have diabetes or sugar in the blood?
34	Diabetes	125600	phv00125600.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:46:40+00:00	2018-06-08 19:46:40+00:00 	AFUI7D	DOCTOR - DIABETES                 Q7D
34	Diabetes	125688	phv00125688.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:54:01+00:00	2018-06-08 19:54:01+00:00 	AFUJ7D	DOCTOR - DIABETES                 Q7D
34	Diabetes	125512	phv00125512.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:09:12+00:00	2018-06-08 20:09:12+00:00 	AFUI7D	DOCTOR - DIABETES                 Q7D
34	Diabetes	125776	phv00125776.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:14:17+00:00	2018-06-08 20:14:17+00:00 	AFUK7D	DOCTOR - DIABETES                   Q7D
34	Diabetes	126025	phv00126025.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:10:27+00:00	2018-06-12 01:10:27+00:00 	History	History of diabetes
34	Diabetes	126028	phv00126028.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:11:59+00:00	2018-06-12 01:11:59+00:00 	DMA0104	Diabetes status (Type I or II)
34	Diabetes	126027	phv00126027.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:13:08+00:00	2018-06-12 01:13:08+00:00 	AgeOnset	Age of diagnosis
34	Diabetes	126029	phv00126029.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:17:04+00:00	2018-06-12 01:17:04+00:00 	DM20104	Type 2 diabetes status (ADA 2004)
34	Diabetes	126030	phv00126030.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:18:18+00:00	2018-06-12 01:18:18+00:00 	DM10104	Type 1 diabetes status (ADA 2004)
34	Diabetes	126031	phv00126031.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:18:41+00:00	2018-06-12 01:18:41+00:00 	DM2014F	Type 2 diabetes status (ADA 2004) Fasting
34	Diabetes	21630	phv00021630.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:00:17+00:00	2018-06-18 13:00:17+00:00 	BW29	LIVE-BIRTH PREGNANCY #1: DID YOU HAVE DIABETES DURING THIS PREGNANCY?
34	Diabetes	21642	phv00021642.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:00:36+00:00	2018-06-18 13:00:36+00:00 	BW42	LIVE-BIRTH PREGNANCY #2: DID YOU HAVE DIABETES DURING THIS PREGNANCY?
34	Diabetes	21654	phv00021654.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:01:10+00:00	2018-06-18 13:01:10+00:00 	BW55	LIVE-BIRTH PREGNANCY #3: DID YOU HAVE DIABETES DURING THIS PREGNANCY?
34	Diabetes	21666	phv00021666.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:01:39+00:00	2018-06-18 13:01:39+00:00 	BW68	LIVE-BIRTH PREGNANCY #4: DID YOU HAVE DIABETES DURING THIS PREGNANCY?
34	Diabetes	21678	phv00021678.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:01:59+00:00	2018-06-18 13:01:59+00:00 	BW81	LIVE-BIRTH PREGNANCY #5: DID YOU HAVE DIABETES DURING THIS PREGNANCY?
34	Diabetes	80883	phv00080883.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:05:11+00:00	2018-06-18 13:05:11+00:00 	dm140_curr1	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 1
34	Diabetes	80892	phv00080892.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:05:22+00:00	2018-06-18 13:05:22+00:00 	dm140_curr10	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 10
34	Diabetes	80893	phv00080893.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:05:31+00:00	2018-06-18 13:05:31+00:00 	dm140_curr11	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 11
34	Diabetes	80894	phv00080894.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:05:40+00:00	2018-06-18 13:05:40+00:00 	dm140_curr12	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 12
34	Diabetes	80895	phv00080895.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:05:49+00:00	2018-06-18 13:05:49+00:00 	dm140_curr13	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 13
34	Diabetes	80896	phv00080896.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:05:57+00:00	2018-06-18 13:05:57+00:00 	dm140_curr14	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 14
34	Diabetes	80897	phv00080897.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:06:06+00:00	2018-06-18 13:06:06+00:00 	dm140_curr15	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 15
34	Diabetes	80898	phv00080898.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:06:14+00:00	2018-06-18 13:06:14+00:00 	dm140_curr16	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 16
34	Diabetes	80899	phv00080899.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:06:24+00:00	2018-06-18 13:06:24+00:00 	dm140_curr17	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 17
34	Diabetes	80900	phv00080900.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:06:32+00:00	2018-06-18 13:06:32+00:00 	dm140_curr18	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 18
34	Diabetes	80901	phv00080901.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:06:41+00:00	2018-06-18 13:06:41+00:00 	dm140_curr19	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 19
34	Diabetes	80884	phv00080884.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:07:22+00:00	2018-06-18 13:07:22+00:00 	dm140_curr2	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 2
34	Diabetes	80902	phv00080902.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:07:32+00:00	2018-06-18 13:07:32+00:00 	dm140_curr20	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 20
34	Diabetes	80903	phv00080903.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:07:40+00:00	2018-06-18 13:07:40+00:00 	dm140_curr21	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 21
34	Diabetes	80904	phv00080904.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:07:50+00:00	2018-06-18 13:07:50+00:00 	dm140_curr22	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 22
34	Diabetes	80905	phv00080905.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:07:59+00:00	2018-06-18 13:07:59+00:00 	dm140_curr23	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 23
34	Diabetes	80906	phv00080906.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:08:08+00:00	2018-06-18 13:08:08+00:00 	dm140_curr24	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 24
34	Diabetes	80907	phv00080907.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:08:16+00:00	2018-06-18 13:08:16+00:00 	dm140_curr25	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 25
34	Diabetes	80908	phv00080908.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:08:27+00:00	2018-06-18 13:08:27+00:00 	dm140_curr26	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 26
34	Diabetes	80909	phv00080909.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:08:36+00:00	2018-06-18 13:08:36+00:00 	dm140_curr27	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 27
34	Diabetes	80885	phv00080885.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:10:49+00:00	2018-06-18 13:10:49+00:00 	dm140_curr3	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 3
34	Diabetes	80886	phv00080886.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:11:18+00:00	2018-06-18 13:11:18+00:00 	dm140_curr4	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 4
34	Diabetes	80887	phv00080887.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:11:28+00:00	2018-06-18 13:11:28+00:00 	dm140_curr5	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 5
34	Diabetes	80888	phv00080888.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:11:38+00:00	2018-06-18 13:11:38+00:00 	dm140_curr6	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 6
34	Diabetes	80889	phv00080889.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:11:47+00:00	2018-06-18 13:11:47+00:00 	dm140_curr7	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 7
34	Diabetes	80890	phv00080890.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:11:58+00:00	2018-06-18 13:11:58+00:00 	dm140_curr8	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 8
34	Diabetes	80891	phv00080891.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:12:07+00:00	2018-06-18 13:12:07+00:00 	dm140_curr9	DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 9
34	Diabetes	80910	phv00080910.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:14:50+00:00	2018-06-18 13:14:50+00:00 	dm140_hx1	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 1
34	Diabetes	80919	phv00080919.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:15:08+00:00	2018-06-18 13:15:08+00:00 	dm140_hx10	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 10
34	Diabetes	80920	phv00080920.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:16:24+00:00	2018-06-18 13:16:24+00:00 	dm140_hx11	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 11
34	Diabetes	80921	phv00080921.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:16:33+00:00	2018-06-18 13:16:33+00:00 	dm140_hx12	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 12
34	Diabetes	80922	phv00080922.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:16:43+00:00	2018-06-18 13:16:43+00:00 	dm140_hx13	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 13
34	Diabetes	80923	phv00080923.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:16:52+00:00	2018-06-18 13:16:52+00:00 	dm140_hx14	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 14
34	Diabetes	80924	phv00080924.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:17:02+00:00	2018-06-18 13:17:02+00:00 	dm140_hx15	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 15
34	Diabetes	80925	phv00080925.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:17:12+00:00	2018-06-18 13:17:12+00:00 	dm140_hx16	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 16
34	Diabetes	80926	phv00080926.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:17:21+00:00	2018-06-18 13:17:21+00:00 	dm140_hx17	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 17
34	Diabetes	80927	phv00080927.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:17:35+00:00	2018-06-18 13:17:35+00:00 	dm140_hx18	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 18
34	Diabetes	80928	phv00080928.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:17:47+00:00	2018-06-18 13:17:47+00:00 	dm140_hx19	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 19
34	Diabetes	80911	phv00080911.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:18:28+00:00	2018-06-18 13:18:28+00:00 	dm140_hx2	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 2
34	Diabetes	80929	phv00080929.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:18:39+00:00	2018-06-18 13:18:39+00:00 	dm140_hx20	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 20
34	Diabetes	80930	phv00080930.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:18:49+00:00	2018-06-18 13:18:49+00:00 	dm140_hx21	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 21
34	Diabetes	80931	phv00080931.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:19:01+00:00	2018-06-18 13:19:01+00:00 	dm140_hx22	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 22
34	Diabetes	80932	phv00080932.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:19:10+00:00	2018-06-18 13:19:10+00:00 	dm140_hx23	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 23
34	Diabetes	80933	phv00080933.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:19:19+00:00	2018-06-18 13:19:19+00:00 	dm140_hx24	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 24
34	Diabetes	80934	phv00080934.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:19:32+00:00	2018-06-18 13:19:32+00:00 	dm140_hx25	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 25
34	Diabetes	80935	phv00080935.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:19:43+00:00	2018-06-18 13:19:43+00:00 	dm140_hx26	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 26
34	Diabetes	80936	phv00080936.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:19:52+00:00	2018-06-18 13:19:52+00:00 	dm140_hx27	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 27
34	Diabetes	80912	phv00080912.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:20:20+00:00	2018-06-18 13:20:20+00:00 	dm140_hx3	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 3
34	Diabetes	80913	phv00080913.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:20:32+00:00	2018-06-18 13:20:32+00:00 	dm140_hx4	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 4
34	Diabetes	80914	phv00080914.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:20:46+00:00	2018-06-18 13:20:46+00:00 	dm140_hx5	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 5
34	Diabetes	80915	phv00080915.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:21:58+00:00	2018-06-18 13:21:58+00:00 	dm140_hx6	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 6
34	Diabetes	80916	phv00080916.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:22:09+00:00	2018-06-18 13:22:09+00:00 	dm140_hx7	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 7
34	Diabetes	80917	phv00080917.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:22:19+00:00	2018-06-18 13:22:19+00:00 	dm140_hx8	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 8
34	Diabetes	80918	phv00080918.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:22:31+00:00	2018-06-18 13:22:31+00:00 	dm140_hx9	HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 9
34	Diabetes	80937	phv00080937.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:23:11+00:00	2018-06-18 13:23:11+00:00 	dm150_curr1	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 1
34	Diabetes	80946	phv00080946.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:23:21+00:00	2018-06-18 13:23:21+00:00 	dm150_curr10	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 10
34	Diabetes	80947	phv00080947.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:23:30+00:00	2018-06-18 13:23:30+00:00 	dm150_curr11	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 11
34	Diabetes	80948	phv00080948.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:23:38+00:00	2018-06-18 13:23:38+00:00 	dm150_curr12	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 12
34	Diabetes	80949	phv00080949.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:23:49+00:00	2018-06-18 13:23:49+00:00 	dm150_curr13	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 13
34	Diabetes	80951	phv00080951.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:23:59+00:00	2018-06-18 13:23:59+00:00 	dm150_curr15	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 15
34	Diabetes	80952	phv00080952.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:24:07+00:00	2018-06-18 13:24:07+00:00 	dm150_curr16	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 16
34	Diabetes	80953	phv00080953.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:24:17+00:00	2018-06-18 13:24:17+00:00 	dm150_curr17	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 17
34	Diabetes	80954	phv00080954.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:24:30+00:00	2018-06-18 13:24:30+00:00 	dm150_curr18	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 18
34	Diabetes	80955	phv00080955.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:24:39+00:00	2018-06-18 13:24:39+00:00 	dm150_curr19	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 19
34	Diabetes	80938	phv00080938.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:32:23+00:00	2018-06-18 13:32:23+00:00 	dm150_curr2	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 2
34	Diabetes	80956	phv00080956.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:32:43+00:00	2018-06-18 13:32:43+00:00 	dm150_curr20	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 20
34	Diabetes	80957	phv00080957.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:32:55+00:00	2018-06-18 13:32:55+00:00 	dm150_curr21	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 21
34	Diabetes	80958	phv00080958.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:33:05+00:00	2018-06-18 13:33:05+00:00 	dm150_curr22	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 22
34	Diabetes	80959	phv00080959.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:33:15+00:00	2018-06-18 13:33:15+00:00 	dm150_curr23	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 23
34	Diabetes	80960	phv00080960.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:33:24+00:00	2018-06-18 13:33:24+00:00 	dm150_curr24	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 24
34	Diabetes	80961	phv00080961.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:33:34+00:00	2018-06-18 13:33:34+00:00 	dm150_curr25	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 25
34	Diabetes	80962	phv00080962.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:33:46+00:00	2018-06-18 13:33:46+00:00 	dm150_curr26	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 26
34	Diabetes	80963	phv00080963.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:35:20+00:00	2018-06-18 13:35:20+00:00 	dm150_curr27	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 27
34	Diabetes	80939	phv00080939.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:35:53+00:00	2018-06-18 13:35:53+00:00 	dm150_curr3	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 3
34	Diabetes	80940	phv00080940.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:36:08+00:00	2018-06-18 13:36:08+00:00 	dm150_curr4	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 4
34	Diabetes	80941	phv00080941.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:36:20+00:00	2018-06-18 13:36:20+00:00 	dm150_curr5	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 5
34	Diabetes	80942	phv00080942.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:36:30+00:00	2018-06-18 13:36:30+00:00 	dm150_curr6	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 6
34	Diabetes	80943	phv00080943.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:36:41+00:00	2018-06-18 13:36:41+00:00 	dm150_curr7	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 7
34	Diabetes	80944	phv00080944.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:36:58+00:00	2018-06-18 13:36:58+00:00 	dm150_curr8	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 8
34	Diabetes	80945	phv00080945.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:37:07+00:00	2018-06-18 13:37:07+00:00 	dm150_curr9	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 9
34	Diabetes	80964	phv00080964.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:37:45+00:00	2018-06-18 13:37:45+00:00 	dm150_hx1	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 1
34	Diabetes	80973	phv00080973.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:38:00+00:00	2018-06-18 13:38:00+00:00 	dm150_hx10	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 10
34	Diabetes	80974	phv00080974.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:38:10+00:00	2018-06-18 13:38:10+00:00 	dm150_hx11	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 11
34	Diabetes	80975	phv00080975.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:38:19+00:00	2018-06-18 13:38:19+00:00 	dm150_hx12	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 12
34	Diabetes	80976	phv00080976.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:38:30+00:00	2018-06-18 13:38:30+00:00 	dm150_hx13	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 13
34	Diabetes	80977	phv00080977.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:38:41+00:00	2018-06-18 13:38:41+00:00 	dm150_hx14	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 14
34	Diabetes	80978	phv00080978.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:38:52+00:00	2018-06-18 13:38:52+00:00 	dm150_hx15	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 15
34	Diabetes	80979	phv00080979.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:39:01+00:00	2018-06-18 13:39:01+00:00 	dm150_hx16	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 16
34	Diabetes	80980	phv00080980.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:39:11+00:00	2018-06-18 13:39:11+00:00 	dm150_hx17	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 17
34	Diabetes	80981	phv00080981.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:39:22+00:00	2018-06-18 13:39:22+00:00 	dm150_hx18	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 18
34	Diabetes	80982	phv00080982.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:39:32+00:00	2018-06-18 13:39:32+00:00 	dm150_hx19	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 19
34	Diabetes	80965	phv00080965.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:46:45+00:00	2018-06-18 13:46:45+00:00 	dm150_hx2	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 2
34	Diabetes	80983	phv00080983.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:47:02+00:00	2018-06-18 13:47:02+00:00 	dm150_hx20	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 20
34	Diabetes	80984	phv00080984.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:47:15+00:00	2018-06-18 13:47:15+00:00 	dm150_hx21	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 21
34	Diabetes	80985	phv00080985.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:47:27+00:00	2018-06-18 13:47:27+00:00 	dm150_hx22	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 22
34	Diabetes	80986	phv00080986.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:47:37+00:00	2018-06-18 13:47:37+00:00 	dm150_hx23	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 23
34	Diabetes	80987	phv00080987.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:47:47+00:00	2018-06-18 13:47:47+00:00 	dm150_hx24	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 24
34	Diabetes	80988	phv00080988.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:47:56+00:00	2018-06-18 13:47:56+00:00 	dm150_hx25	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 25
34	Diabetes	80989	phv00080989.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:48:07+00:00	2018-06-18 13:48:07+00:00 	dm150_hx26	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 26
34	Diabetes	80990	phv00080990.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:48:17+00:00	2018-06-18 13:48:17+00:00 	dm150_hx27	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 27
34	Diabetes	80966	phv00080966.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:49:40+00:00	2018-06-18 13:49:40+00:00 	dm150_hx3	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 3
34	Diabetes	80967	phv00080967.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:49:53+00:00	2018-06-18 13:49:53+00:00 	dm150_hx4	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 4
34	Diabetes	80968	phv00080968.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:50:02+00:00	2018-06-18 13:50:02+00:00 	dm150_hx5	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 5
34	Diabetes	80969	phv00080969.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:50:12+00:00	2018-06-18 13:50:12+00:00 	dm150_hx6	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 6
34	Diabetes	80970	phv00080970.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:50:22+00:00	2018-06-18 13:50:22+00:00 	dm150_hx7	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 7
34	Diabetes	80971	phv00080971.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:50:31+00:00	2018-06-18 13:50:31+00:00 	dm150_hx8	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 8
34	Diabetes	80972	phv00080972.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:50:40+00:00	2018-06-18 13:50:40+00:00 	dm150_hx9	HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 9
34	Diabetes	80829	phv00080829.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:51:09+00:00	2018-06-18 13:51:09+00:00 	dm200_curr1	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 1
34	Diabetes	80838	phv00080838.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:51:20+00:00	2018-06-18 13:51:20+00:00 	dm200_curr10	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 10
34	Diabetes	80839	phv00080839.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:51:30+00:00	2018-06-18 13:51:30+00:00 	dm200_curr11	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 11
34	Diabetes	80840	phv00080840.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:51:39+00:00	2018-06-18 13:51:39+00:00 	dm200_curr12	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 12
34	Diabetes	80841	phv00080841.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:51:48+00:00	2018-06-18 13:51:48+00:00 	dm200_curr13	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 13
34	Diabetes	80842	phv00080842.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:51:57+00:00	2018-06-18 13:51:57+00:00 	dm200_curr14	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 14
34	Diabetes	80843	phv00080843.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:52:06+00:00	2018-06-18 13:52:06+00:00 	dm200_curr15	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 15
34	Diabetes	80844	phv00080844.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:52:15+00:00	2018-06-18 13:52:15+00:00 	dm200_curr16	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 16
34	Diabetes	80845	phv00080845.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:52:24+00:00	2018-06-18 13:52:24+00:00 	dm200_curr17	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 17
34	Diabetes	80846	phv00080846.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:52:34+00:00	2018-06-18 13:52:34+00:00 	dm200_curr18	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 18
34	Diabetes	80847	phv00080847.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:52:44+00:00	2018-06-18 13:52:44+00:00 	dm200_curr19	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 19
34	Diabetes	80830	phv00080830.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:53:19+00:00	2018-06-18 13:53:19+00:00 	dm200_curr2	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 2
34	Diabetes	80848	phv00080848.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:53:30+00:00	2018-06-18 13:53:30+00:00 	dm200_curr20	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 20
34	Diabetes	80849	phv00080849.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:53:39+00:00	2018-06-18 13:53:39+00:00 	dm200_curr21	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 21
34	Diabetes	80850	phv00080850.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:53:48+00:00	2018-06-18 13:53:48+00:00 	dm200_curr22	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 22
34	Diabetes	80851	phv00080851.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:53:58+00:00	2018-06-18 13:53:58+00:00 	dm200_curr23	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 23
34	Diabetes	80852	phv00080852.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:54:07+00:00	2018-06-18 13:54:07+00:00 	dm200_curr24	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 24
34	Diabetes	80853	phv00080853.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:54:16+00:00	2018-06-18 13:54:16+00:00 	dm200_curr25	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 25
34	Diabetes	80854	phv00080854.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:54:25+00:00	2018-06-18 13:54:25+00:00 	dm200_curr26	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 26
34	Diabetes	80855	phv00080855.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:54:37+00:00	2018-06-18 13:54:37+00:00 	dm200_curr27	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 27
34	Diabetes	80831	phv00080831.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:57:32+00:00	2018-06-18 13:57:32+00:00 	dm200_curr3	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 3
34	Diabetes	80832	phv00080832.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:57:45+00:00	2018-06-18 13:57:45+00:00 	dm200_curr4	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 4
34	Diabetes	80833	phv00080833.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:57:55+00:00	2018-06-18 13:57:55+00:00 	dm200_curr5	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 5
34	Diabetes	80834	phv00080834.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:58:03+00:00	2018-06-18 13:58:03+00:00 	dm200_curr6	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 6
34	Diabetes	80835	phv00080835.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:58:11+00:00	2018-06-18 13:58:11+00:00 	dm200_curr7	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 7
34	Diabetes	80836	phv00080836.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:58:19+00:00	2018-06-18 13:58:19+00:00 	dm200_curr8	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 8
34	Diabetes	80837	phv00080837.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:58:28+00:00	2018-06-18 13:58:28+00:00 	dm200_curr9	DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 9
34	Diabetes	80856	phv00080856.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:58:54+00:00	2018-06-18 13:58:54+00:00 	dm200_hx1	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 1
34	Diabetes	80865	phv00080865.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:59:02+00:00	2018-06-18 13:59:02+00:00 	dm200_hx10	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 10
34	Diabetes	80866	phv00080866.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:59:11+00:00	2018-06-18 13:59:11+00:00 	dm200_hx11	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 11
34	Diabetes	80867	phv00080867.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:59:19+00:00	2018-06-18 13:59:19+00:00 	dm200_hx12	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 12
34	Diabetes	80868	phv00080868.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:59:27+00:00	2018-06-18 13:59:27+00:00 	dm200_hx13	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 13
34	Diabetes	80869	phv00080869.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:59:35+00:00	2018-06-18 13:59:35+00:00 	dm200_hx14	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 14
34	Diabetes	80870	phv00080870.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:59:43+00:00	2018-06-18 13:59:43+00:00 	dm200_hx15	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 15
34	Diabetes	80871	phv00080871.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 13:59:52+00:00	2018-06-18 13:59:52+00:00 	dm200_hx16	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 16
34	Diabetes	80872	phv00080872.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:00:00+00:00	2018-06-18 14:00:00+00:00 	dm200_hx17	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 17
34	Diabetes	80873	phv00080873.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:00:09+00:00	2018-06-18 14:00:09+00:00 	dm200_hx18	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 18
34	Diabetes	80874	phv00080874.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:00:18+00:00	2018-06-18 14:00:18+00:00 	dm200_hx19	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 19
34	Diabetes	80857	phv00080857.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:00:54+00:00	2018-06-18 14:00:54+00:00 	dm200_hx2	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 2
34	Diabetes	80875	phv00080875.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:01:04+00:00	2018-06-18 14:01:04+00:00 	dm200_hx20	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 20
34	Diabetes	80876	phv00080876.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:01:13+00:00	2018-06-18 14:01:13+00:00 	dm200_hx21	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 21
34	Diabetes	80877	phv00080877.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:01:22+00:00	2018-06-18 14:01:22+00:00 	dm200_hx22	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 22
34	Diabetes	80878	phv00080878.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:01:31+00:00	2018-06-18 14:01:31+00:00 	dm200_hx23	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 23
34	Diabetes	80879	phv00080879.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:01:40+00:00	2018-06-18 14:01:40+00:00 	dm200_hx24	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 24
34	Diabetes	80880	phv00080880.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:01:49+00:00	2018-06-18 14:01:49+00:00 	dm200_hx25	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 25
34	Diabetes	80881	phv00080881.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:01:58+00:00	2018-06-18 14:01:58+00:00 	dm200_hx26	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 26
34	Diabetes	80882	phv00080882.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:02:11+00:00	2018-06-18 14:02:11+00:00 	dm200_hx27	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 27
34	Diabetes	80858	phv00080858.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:02:45+00:00	2018-06-18 14:02:45+00:00 	dm200_hx3	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 3
34	Diabetes	80859	phv00080859.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:02:56+00:00	2018-06-18 14:02:56+00:00 	dm200_hx4	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 4
34	Diabetes	80860	phv00080860.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:03:05+00:00	2018-06-18 14:03:05+00:00 	dm200_hx5	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 5
34	Diabetes	80861	phv00080861.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:03:14+00:00	2018-06-18 14:03:14+00:00 	dm200_hx6	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 6
34	Diabetes	80862	phv00080862.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:03:23+00:00	2018-06-18 14:03:23+00:00 	dm200_hx7	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 7
34	Diabetes	80863	phv00080863.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:03:32+00:00	2018-06-18 14:03:32+00:00 	dm200_hx8	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 8
34	Diabetes	80864	phv00080864.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:03:43+00:00	2018-06-18 14:03:43+00:00 	dm200_hx9	HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 9
34	Diabetes	10791	phv00010791.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:09:25+00:00	2018-06-18 14:09:25+00:00 	DIAB1	DIABETES MELLITUS STATUS AT EXAM 1 (SOURCE: CALCULATED)
34	Diabetes	10792	phv00010792.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:09:36+00:00	2018-06-18 14:09:36+00:00 	DIAB2	DIABETES MELLITUS STATUS AT EXAM 2 (SOURCE: CALCULATED)
34	Diabetes	10793	phv00010793.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:09:44+00:00	2018-06-18 14:09:44+00:00 	DIAB3	DIABETES MELLITUS STATUS AT EXAM 3 (SOURCE: CALCULATED)
34	Diabetes	10794	phv00010794.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:09:53+00:00	2018-06-18 14:09:53+00:00 	DIAB4	DIABETES MELLITUS STATUS AT EXAM 4 (SOURCE: CALCULATED)
34	Diabetes	10795	phv00010795.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:10:01+00:00	2018-06-18 14:10:01+00:00 	DIAB5	DIABETES MELLITUS STATUS AT EXAM 5 (SOURCE: CALCULATED)
34	Diabetes	10796	phv00010796.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:10:10+00:00	2018-06-18 14:10:10+00:00 	DIAB6	DIABETES MELLITUS STATUS AT EXAM 6 (SOURCE: CALCULATED)
34	Diabetes	10797	phv00010797.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:10:19+00:00	2018-06-18 14:10:19+00:00 	DIAB7	DIABETES MELLITUS STATUS AT EXAM 7 (SOURCE: CALCULATED)
34	Diabetes	255335	phv00255335.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:17:37+00:00	2018-06-18 14:17:37+00:00 	fw611	Other Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Diabetes Variable appears on Form B only Collection Interval: Original Cohort Exam 30
34	Diabetes	275060	phv00275060.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:18:14+00:00	2018-06-18 14:18:14+00:00 	FX611	Other Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for diabetes? Collection Interval: Original Cohort Exam 31
34	Diabetes	275394	phv00275394.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:19:12+00:00	2018-06-18 14:19:12+00:00 	fy611	Other Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for diabetes? Collection Interval: Original Cohort Exam 32
34	Diabetes	177253	phv00177253.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:28:04+00:00	2018-06-18 14:28:04+00:00 	g3b0017	Medical History - Medications: Since your last exam have you been told by a doctor you have high blood sugar or diabetes?
34	Diabetes	177265	phv00177265.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:28:40+00:00	2018-06-18 14:28:40+00:00 	g3b0036	Medical History-Female Reproductive History: During any of these pregnancies, were you told you had high blood sugar or diabetes?
34	Diabetes	72059	phv00072059.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:29:15+00:00	2018-06-18 14:29:15+00:00 	H016	SINCE YOUR LAST EXAM HAVE YOU BEEN TOLD BY A DOCTOR YOU HAVE HIGH BLOOD SUGAR OR DIABETES?
34	Diabetes	251277	phv00251277.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:29:27+00:00	2018-06-18 14:29:27+00:00 	h016	Medical History - Medications: Since your last exam have you been told by a doctor you have high blood sugar or diabetes? Collection Interval: Exam 3
34	Diabetes	251799	phv00251799.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:37:06+00:00	2018-06-18 14:37:06+00:00 	h779	Medical History - Female Reproductive History: During any of these pregnancies, were you told you have high blood sugar (gestational diabetes)? Collection Interval: Exam 3
34	Diabetes	254027	phv00254027.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:41:16+00:00	2018-06-18 14:41:16+00:00 	j018	Medical History - Medications: Since your last exam have you been told by a doctor you have high blood sugar or diabetes?
34	Diabetes	254038	phv00254038.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:44:56+00:00	2018-06-18 14:44:56+00:00 	j038	Medical History - Female Reproductive History, Part 1: Since your last exam, during any of these pregnancies, were you told you had high blood sugar or diabetes?
34	Diabetes	964	phv00000964.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 14:45:26+00:00	2018-06-18 14:45:26+00:00 	MF522	LIFETIME HISTORY OF DIABETES: AGE AT WHICH DIABETES WAS DIAGNOSED, EXAM 7
34	Diabetes	273718	phv00273718.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:09:17+00:00	2018-06-18 15:09:17+00:00 	g3a019	If yes to G33A016, did diabetes occur in pregnancy only? Collection Interval: Exam 1
34	Diabetes	20884	phv00020884.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:09:58+00:00	2018-06-18 15:09:58+00:00 	G3A019	IF YES TO G33A016, DID DIABETES OCCUR IN PREGNANCY ONLY?
34	Diabetes	274211	phv00274211.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:10:11+00:00	2018-06-18 15:10:11+00:00 	g3a019	If yes to G33A016, did diabetes occur in pregnancy only?
34	Diabetes	80950	phv00080950.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 15:20:03+00:00	2018-06-18 15:20:03+00:00 	dm150_curr14	DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 14
34	Diabetes	128095	phv00128095.v1.p1	pht001967.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:20:13+00:00	2018-06-20 18:20:13+00:00 	PFHA6A	6a: Had doctor said you had Sugar/diabetes?
34	Diabetes	128096	phv00128096.v1.p1	pht001967.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:20:30+00:00	2018-06-20 18:20:30+00:00 	PFHA6B	6b: Age told you had diabetes?
34	Diabetes	98820	phv00098820.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:57:24+00:00	2018-06-28 00:57:24+00:00 	DIAB01	DIABETES from eligibility questionnaire
34	Diabetes	99025	phv00099025.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:57:48+00:00	2018-06-28 00:57:48+00:00 	DIABET07	DIABETES from med hx
34	Diabetes	99345	phv00099345.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:57:59+00:00	2018-06-28 00:57:59+00:00 	DIABET12	DIABETES from self rpt at blood draw
34	Diabetes	99462	phv00099462.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:58:13+00:00	2018-06-28 00:58:13+00:00 	DIABWHO	WHO CALC. DIAB STATUS
34	Diabetes	99552	phv00099552.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:58:24+00:00	2018-06-28 00:58:24+00:00 	DIABADA	ADA Diabetic Status
34	Diabetes	100338	phv00100338.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:58:44+00:00	2018-06-28 00:58:44+00:00 	DIABET	RPDT HISTORY OF DIABETES
34	Diabetes	99924	phv00099924.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:59:12+00:00	2018-06-28 00:59:12+00:00 	DIAB30	DIABETIC
34	Diabetes	101530	phv00101530.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:59:24+00:00	2018-06-28 00:59:24+00:00 	DIABET59	HAVE DIABETES
34	Diabetes	101785	phv00101785.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:59:42+00:00	2018-06-28 00:59:42+00:00 	DIABET12	DIABETES
34	Diabetes	101793	phv00101793.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 00:59:55+00:00	2018-06-28 00:59:55+00:00 	DIAB74	Dr said you had diabetes
34	Diabetes	101794	phv00101794.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:00:10+00:00	2018-06-28 01:00:10+00:00 	DIABYR74	Number of years you've been diabetic
34	Diabetes	102446	phv00102446.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:00:25+00:00	2018-06-28 01:00:25+00:00 	DIABET12	DIABETES
34	Diabetes	103169	phv00103169.v1.p1	pht001476.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:00:57+00:00	2018-06-28 01:00:57+00:00 	DIABET32	TOLD BY MD YOU HAD DIABETES
34	Diabetes	103222	phv00103222.v1.p1	pht001477.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:01:09+00:00	2018-06-28 01:01:09+00:00 	DIABET32	TOLD BY MD YOU HAD DIABETES
34	Diabetes	103327	phv00103327.v1.p1	pht001479.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:01:35+00:00	2018-06-28 01:01:35+00:00 	DIABET32	TOLD BY MD YOU HAD DIABETES
34	Diabetes	103379	phv00103379.v1.p1	pht001480.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:03:48+00:00	2018-06-28 01:03:48+00:00 	DIABET32	TOLD BY MD YOU HAD DIABETES
34	Diabetes	103432	phv00103432.v1.p1	pht001481.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:04:21+00:00	2018-06-28 01:04:21+00:00 	DIABET32	TOLD BY MD YOU HAD DIABETES
34	Diabetes	103484	phv00103484.v1.p1	pht001482.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:04:49+00:00	2018-06-28 01:04:49+00:00 	DIABET32	TOLD BY MD YOU HAD DIABETES
34	Diabetes	103537	phv00103537.v1.p1	pht001483.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:05:15+00:00	2018-06-28 01:05:15+00:00 	DIABET32	TOLD BY MD YOU HAD DIABETES
34	Diabetes	103642	phv00103642.v1.p1	pht001485.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:05:43+00:00	2018-06-28 01:05:43+00:00 	DIABET32	TOLD BY MD YOU HAD DIABETES
34	Diabetes	103745	phv00103745.v1.p1	pht001487.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:06:04+00:00	2018-06-28 01:06:04+00:00 	DIABET32	TOLD BY MD YOU HAD DIABETES
34	Diabetes	104107	phv00104107.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:06:44+00:00	2018-06-28 01:06:44+00:00 	DIABET37	DIABETES
34	Diabetes	104826	phv00104826.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:07:42+00:00	2018-06-28 01:07:42+00:00 	DIABET39	DIABETES
34	Diabetes	105137	phv00105137.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:07:53+00:00	2018-06-28 01:07:53+00:00 	DIAB01	DIABETES
34	Diabetes	105964	phv00105964.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:08:03+00:00	2018-06-28 01:08:03+00:00 	DIABET57	DIABETES
34	Diabetes	105965	phv00105965.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:08:19+00:00	2018-06-28 01:08:19+00:00 	DIABYR57	HOW LONG HAD DIABETES
34	Diabetes	106406	phv00106406.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:08:45+00:00	2018-06-28 01:08:45+00:00 	DIABADA	1 'Normal' 2 'IFG' 3 'New Diabetes' 4 'K
34	Diabetes	107092	phv00107092.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:09:08+00:00	2018-06-28 01:09:08+00:00 	DIABET29	HAVE DIABETES
34	Diabetes	107337	phv00107337.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:09:42+00:00	2018-06-28 01:09:42+00:00 	DIABADA	ADA Diabetic Status
34	Diabetes	107948	phv00107948.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:09:50+00:00	2018-06-28 01:09:50+00:00 	DIABET59	HAVE DIABETES
34	Diabetes	108622	phv00108622.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:10:00+00:00	2018-06-28 01:10:00+00:00 	DIABET59	HAVE DIABETES
34	Diabetes	109389	phv00109389.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:10:10+00:00	2018-06-28 01:10:10+00:00 	DIABET59	HAVE DIABETES
34	Diabetes	110345	phv00110345.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:10:20+00:00	2018-06-28 01:10:20+00:00 	DIABET12	DIABETES
34	Diabetes	110521	phv00110521.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:10:48+00:00	2018-06-28 01:10:48+00:00 	DIABADA	ADA Diabetic Status
34	Diabetes	110522	phv00110522.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:11:00+00:00	2018-06-28 01:11:00+00:00 	DIABWHO	WHO Diabetic Status
34	Diabetes	197453	phv00197453.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-28 01:11:17+00:00	2018-06-28 01:11:17+00:00 	diabet15	MD said pt had diabetes? (no observations)
34	Diabetes	78464	phv00078464.v6.p3	pht000998.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 20:30:35+00:00	2018-07-02 20:30:35+00:00 	DIAB	Diabetes ever
34	Diabetes	78471	phv00078471.v6.p3	pht000998.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 20:30:35+00:00	2018-07-02 20:30:35+00:00 	DIABNW	Diabetes now
34	Diabetes	111545	phv00111545.v6.p3	pht001514.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 20:30:35+00:00	2018-07-02 20:30:35+00:00 	F134DIAB	Diabetes/high blood sugar ever
34	Diabetes	283531	phv00283531.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 20:32:50+00:00	2018-07-02 20:32:50+00:00 	DIABHX	F136 History of diabetes
34	Diabetes	126032	phv00126032.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 14:56:01+00:00	2018-07-10 14:56:01+00:00 	DMT01	Diabetes type
34	Diabetes	159611	phv00159611.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:21:49+00:00	2018-08-10 21:21:49+00:00 	Diabetes	Diabetes Collection Interval: Collected in Exam 1
34	Diabetes	277449	phv00277449.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:33:14+00:00	2018-08-14 22:33:14+00:00 	HBS_AGE	In what year or how old were you when it was first diagnosed? - age Collection Interval: 2009-2011
34	Diabetes	277448	phv00277448.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:33:21+00:00	2018-08-14 22:33:21+00:00 	HBS_YR	In what year or how old were you when it was first diagnosed? - year Collection Interval: 2009-2011
34	Diabetes	277447	phv00277447.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:33:29+00:00	2018-08-14 22:33:29+00:00 	HBS	Have you ever been told by a physician that you had diabetes or high blood sugar? Collection Interval: 2009-2011
34	Diabetes	277611	phv00277611.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:54:18+00:00	2018-08-14 22:54:18+00:00 	HBS_AGE	In what year or how old were you when it was first diagnosed? - age Collection Interval: 1996-2000
34	Diabetes	277610	phv00277610.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:54:24+00:00	2018-08-14 22:54:24+00:00 	HBS_YR	In what year or how old were you when it was first diagnosed? - year Collection Interval: 1996-2000
34	Diabetes	277609	phv00277609.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:54:30+00:00	2018-08-14 22:54:30+00:00 	HBS	Have you ever been told by a physician that you had diabetes or high blood sugar? Collection Interval: 1996-2000
34	Diabetes	277898	phv00277898.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:16:29+00:00	2018-08-14 23:16:29+00:00 	HBS_AGE	In what year or how old were you when it was first diagnosed? - age Collection Interval: 2000-2004
34	Diabetes	277897	phv00277897.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:16:36+00:00	2018-08-14 23:16:36+00:00 	HBS_YR	In what year or how old were you when it was first diagnosed? - year Collection Interval: 2000-2004
34	Diabetes	277896	phv00277896.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:16:42+00:00	2018-08-14 23:16:42+00:00 	HBS	Have you ever been told by a physician that you had diabetes or high blood sugar? Collection Interval: 2000-2004
34	Diabetes	307892	phv00307892.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:03:55+00:00	2018-08-16 00:03:55+00:00 	HBS_AGE	In what year or how old were you when it was first diagnosed? - age Collection Interval: 1996-2000
34	Diabetes	307891	phv00307891.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:04:02+00:00	2018-08-16 00:04:02+00:00 	HBS_YR	In what year or how old were you when it was first diagnosed? - year Collection Interval: 1996-2000
34	Diabetes	307890	phv00307890.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:04:10+00:00	2018-08-16 00:04:10+00:00 	HBS	Have you ever been told by a physician that you had diabetes or high blood sugar? Collection Interval: 1996-2000
34	Diabetes	308091	phv00308091.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:21:15+00:00	2018-08-16 00:21:15+00:00 	HBS_AGE	In what year or how old were you when it was first diagnosed? - age Collection Interval: 2000-2004
34	Diabetes	308090	phv00308090.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:21:21+00:00	2018-08-16 00:21:21+00:00 	HBS_YR	In what year or how old were you when it was first diagnosed? - year Collection Interval: 2000-2004
34	Diabetes	308089	phv00308089.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:21:28+00:00	2018-08-16 00:21:28+00:00 	HBS	Have you ever been told by a physician that you had diabetes or high blood sugar? Collection Interval: 2000-2004
34	Diabetes	122241	phv00122241.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:12:22+00:00	2018-08-16 23:12:22+00:00 	DIABETES	Diabetes (AC)
34	Diabetes	122242	phv00122242.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:13:09+00:00	2018-08-16 23:13:09+00:00 	DIADIAG	Diabetes diagnosed by doctor (AC)
34	Diabetes	122243	phv00122243.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:13:17+00:00	2018-08-16 23:13:17+00:00 	DIAAGE	Age when diabetes noted (AC)
34	Diabetes	122244	phv00122244.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:13:24+00:00	2018-08-16 23:13:24+00:00 	DIAPRES	Diabetes still present (AC)
34	Diabetes	123023	phv00123023.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:55:20+00:00	2018-08-17 19:55:20+00:00 	diabetesdx	Diabetes: self report of MD dx of diabetes
34	Diabetes	114377	phv00114377.v2.p2	pht001604.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:55:53+00:00	2018-08-17 21:55:53+00:00 	B09DIBAG	AGE AT 1ST DIABETES. Q 1.04A
34	Diabetes	124253	phv00124253.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:52:04+00:00	2018-08-21 18:52:04+00:00 	diabetesx	Diabetes: self report of MD dx of diabetes or meds
34	Diabetes	124255	phv00124255.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:52:43+00:00	2018-08-21 18:52:43+00:00 	diabetes2	Diabetes: MD dx of diabetes or meds or abn fasting (ogtt not considered)
34	Diabetes	124256	phv00124256.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:52:51+00:00	2018-08-21 18:52:51+00:00 	diabetes3	Diabetes: broad definition: MD dx or meds or abn fasting or abn ogtt glucose
34	Diabetes	124254	phv00124254.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:54:39+00:00	2018-08-21 18:54:39+00:00 	diabetes1	Diabetes: meds or abn fasting or abn ogtt glucose
34	Diabetes	124276	phv00124276.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 19:00:54+00:00	2018-08-21 19:00:54+00:00 	DIADIADAY	Days from visit date - Diagnosed  Diabetes
34	Diabetes	226261	phv00226261.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:21:26+00:00	2018-08-22 21:21:26+00:00 	DIABETES2	3-Level grouped diabetes - ADA
34	Diabetes	226262	phv00226262.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:21:43+00:00	2018-08-22 21:21:43+00:00 	DIABETES2_INDICATOR	Diabetes indicator - ADA
34	Diabetes	116971	phv00116971.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:19:40+00:00	2018-08-24 00:19:40+00:00 	D08GDM	DIABETES DURING PREGNANCY. Q 4
34	Diabetes	226357	phv00226357.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:25:04+00:00	2018-08-24 16:25:04+00:00 	MHEA16	Diabetes - self (MHEA16)
34	Diabetes	226359	phv00226359.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:26:39+00:00	2018-08-24 16:26:39+00:00 	MHEA16B	Diabetes - pregnancy self (MHEA16B)
34	Diabetes	258040	phv00258040.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:55:20+00:00	2018-08-24 16:55:20+00:00 	DIABETES_LAB	3-Level grouped diabetes - Lab
34	Diabetes	258041	phv00258041.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:55:30+00:00	2018-08-24 16:55:30+00:00 	DIABETES_SELF	Diabetes - self report only
34	Diabetes	252998	phv00252998.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:15:27+00:00	2018-08-24 17:15:27+00:00 	t2diabetes_baseline	Has Type 2 diabetes based on medication, self-report, fasting glucose at baseline visit
34	Diabetes	118385	phv00118385.v2.p2	pht001759.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 22:42:21+00:00	2018-08-28 22:42:21+00:00 	E05DIAB	EVER BEEN TOLD YOU ARE DIABETIC? Q 14
34	Diabetes	118446	phv00118446.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 22:45:46+00:00	2018-08-28 22:45:46+00:00 	E08DIBAG	AGE DIAGNOSED-DIABETES. Q 4
34	Diabetes	119819	phv00119819.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:10:01+00:00	2018-08-29 21:10:01+00:00 	F08DIBAG	AGE DIAGNOSED-DIABETES. Q 4
34	Diabetes	121271	phv00121271.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:26:11+00:00	2018-08-30 00:26:11+00:00 	Y01DIBEP	ENDPT - DIABETES MELLITUS
34	Diabetes	121363	phv00121363.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:32:29+00:00	2018-08-30 00:32:29+00:00 	Y01DMTYP	TYPE OF DIABETES MELLITUS
34	Diabetes	121354	phv00121354.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:33:11+00:00	2018-08-30 00:33:11+00:00 	Y01DIAB	DIABETES MELLITUS
34	Diabetes	121467	phv00121467.v2.p2	pht001870.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:47:34+00:00	2018-08-30 19:47:34+00:00 	Y00DIAB	DISCHG DIAG - DIABETES MELLITUS
34	Diabetes	121487	phv00121487.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:49:01+00:00	2018-08-30 19:49:01+00:00 	Y01DIBEP	ENDPT - DIABETES MELLITUS
34	Diabetes	121582	phv00121582.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:53:51+00:00	2018-08-30 19:53:51+00:00 	Y01DMTYP	TYPE OF DIABETES MELLITUS
34	Diabetes	121573	phv00121573.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:54:35+00:00	2018-08-30 19:54:35+00:00 	Y01DIAB	DIABETES MELLITUS
34	Diabetes	258758	phv00258758.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 13:01:46+00:00	2018-09-06 13:01:46+00:00 	Diabetes_Status	Diabetes Status (based on venous blood sample ONLY)
34	Diabetes	258759	phv00258759.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 13:02:19+00:00	2018-09-06 13:02:19+00:00 	Diabetes_Binary	Diabetes Status (based on venous blood sample and questionnaire data)
34	Diabetes	258760	phv00258760.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 13:02:51+00:00	2018-09-06 13:02:51+00:00 	Diabetes_diagnosis	Have you ever been diagnosed with diabetes? (Based on questionnaire)
34	Diabetes	258761	phv00258761.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 13:03:08+00:00	2018-09-06 13:03:08+00:00 	Diabetes_diagnosis_years	How many years ago were you diagnosed with diabetes?
34	Diabetes	259390	phv00259390.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-12-20 19:43:07+00:00	2018-12-20 19:43:07+00:00 	dmind	Treated diabetes milletus at index date
35	Atrial fibrillation/flutter	82701	phv00082701.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:20:04+00:00	2018-04-24 02:20:04+00:00 	ecgafib1	ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	82843	phv00082843.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:20:22+00:00	2018-04-24 02:20:22+00:00 	afib1c	ECG ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	84553	phv00084553.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:20:28+00:00	2018-04-24 02:20:28+00:00 	afib1c	ATRIAL FIBRILLATION / FLUTTER BY NOVACODE
35	Atrial fibrillation/flutter	174570	phv00174570.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:20:36+00:00	2018-04-24 02:20:36+00:00 	major61	MAJOR ABNORMALITY 6 PER MINNESOTA CODE: ATRIAL FIBRILLATION OR FLUTTER
35	Atrial fibrillation/flutter	174578	phv00174578.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:20:49+00:00	2018-04-24 02:20:49+00:00 	major10b1	MAJOR ABNORMALITY 10B: ATRIAL FLUTTER OR INTERMITTENT ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	87141	phv00087141.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:20:57+00:00	2018-04-24 02:20:57+00:00 	scrafibf	CURRENT ATRIAL FIBRILLATION OR A FIBRILLATING HEART
35	Atrial fibrillation/flutter	90303	phv00090303.v5.p3	pht001217.v5.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:21:05+00:00	2018-04-24 02:21:05+00:00 	afib	ATRIAL FIBRILLATION DIAGNOSIS
35	Atrial fibrillation/flutter	90304	phv00090304.v5.p3	pht001217.v5.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:21:15+00:00	2018-04-24 02:21:15+00:00 	afibtt	ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS)
35	Atrial fibrillation/flutter	90305	phv00090305.v5.p3	pht001217.v5.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:21:24+00:00	2018-04-24 02:21:24+00:00 	afibcd	ATRIAL FIBRILLATION CODE
35	Atrial fibrillation/flutter	90306	phv00090306.v5.p3	pht001217.v5.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:21:30+00:00	2018-04-24 02:21:30+00:00 	afiblbl	ATRIAL FIBRILLATION CODE DESCRIPTION
35	Atrial fibrillation/flutter	174900	phv00174900.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:21:37+00:00	2018-04-24 02:21:37+00:00 	ncs055	ATRIAL FIBRILLATION OR FLUTTER, BY SOFTWARE
35	Atrial fibrillation/flutter	174911	phv00174911.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:21:42+00:00	2018-04-24 02:21:42+00:00 	ncvf055	ATRIAL FIBRILLATION OR FLUTTER, BY VISUAL FLAG
35	Atrial fibrillation/flutter	174922	phv00174922.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:21:50+00:00	2018-04-24 02:21:50+00:00 	ncvf155	ATRIAL FLUTTER OR FIBRILLATION, BY VISUAL FLAG
35	Atrial fibrillation/flutter	175081	phv00175081.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:21:56+00:00	2018-04-24 02:21:56+00:00 	major65	ATRIAL FIBRILLATION OR FLUTTER
35	Atrial fibrillation/flutter	175089	phv00175089.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:22:08+00:00	2018-04-24 02:22:08+00:00 	major10b5	ATRIAL FLUTTER/INTERMITTENT ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	175125	phv00175125.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:22:13+00:00	2018-04-24 02:22:13+00:00 	afib5c	ECG ATRIAL FIBRILLATION / FLUTTER
35	Atrial fibrillation/flutter	176281	phv00176281.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:22:23+00:00	2018-04-24 02:22:23+00:00 	prafib5	PRESENCE OF: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	176292	phv00176292.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:22:29+00:00	2018-04-24 02:22:29+00:00 	ecgafib5	CONFIRMED: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	176323	phv00176323.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:22:36+00:00	2018-04-24 02:22:36+00:00 	ncs055	ATRIAL FIBRILLATION OR FLUTTER, BY SOFTWARE
35	Atrial fibrillation/flutter	176334	phv00176334.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:22:42+00:00	2018-04-24 02:22:42+00:00 	ncvf055	ATRIAL FIBRILLATION OR FLUTTER, BY VISUAL FLAG
35	Atrial fibrillation/flutter	176345	phv00176345.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:22:50+00:00	2018-04-24 02:22:50+00:00 	ncvf155	ATRIAL FLUTTER OR FIBRILLATION, BY VISUAL FLAG
35	Atrial fibrillation/flutter	176504	phv00176504.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:22:54+00:00	2018-04-24 02:22:54+00:00 	major65	ATRIAL FIBRILLATION OR FLUTTER
35	Atrial fibrillation/flutter	176512	phv00176512.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:23:18+00:00	2018-04-24 02:23:18+00:00 	major10b5	ATRIAL FLUTTER/INTERMITTENT ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	176548	phv00176548.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:23:23+00:00	2018-04-24 02:23:23+00:00 	afib5c	ECG ATRIAL FIBRILLATION / FLUTTER
35	Atrial fibrillation/flutter	82703	phv00082703.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:35:36+00:00	2018-04-24 02:35:36+00:00 	ecgaflt1	ATRIAL FLUTTER
35	Atrial fibrillation/flutter	176283	phv00176283.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:35:44+00:00	2018-04-24 02:35:44+00:00 	praflt5	PRESENCE OF: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	176294	phv00176294.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:35:52+00:00	2018-04-24 02:35:52+00:00 	ecgaflt5	CONFIRMED: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	202989	phv00202989.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:35:52+00:00	2018-04-24 15:35:52+00:00 	AFUcomp12_L	[General health]. Has a doctor ever said that you had an irregular heart beat called atrial fibrillation, or atrial fibrillation on a heart scan or electrocardiogram tracing? [Annual Follow-up Questionnaire Form, AFUL]
35	Atrial fibrillation/flutter	203032	phv00203032.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:36:20+00:00	2018-04-24 15:36:20+00:00 	AFUcomp12_M	[General health]. Since we last contacted you has a doctor said that you had an irregular heart beat called atrial fibrillation, or atrial fibrillation on a heart scan or electrocardiogram tracing? [Annual Follow-up Questionnaire Form, AFUM]
35	Atrial fibrillation/flutter	203303	phv00203303.v1.p1	pht004037.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:36:41+00:00	2018-04-24 15:36:41+00:00 	AF	Atrial fibrillation [Atrial Fibrillation, exam 1]
35	Atrial fibrillation/flutter	203304	phv00203304.v1.p1	pht004037.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:37:00+00:00	2018-04-24 15:37:00+00:00 	AFL	Atrial flutter [Atrial Fibrillation, exam 1]
35	Atrial fibrillation/flutter	203306	phv00203306.v1.p1	pht004038.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:37:21+00:00	2018-04-24 15:37:21+00:00 	AF	Atrial fibrillation  [Atrial Fibrillation, exam 2]
35	Atrial fibrillation/flutter	203307	phv00203307.v1.p1	pht004038.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:37:41+00:00	2018-04-24 15:37:41+00:00 	AFL	Atrial flutter  [Atrial Fibrillation, exam 2]
35	Atrial fibrillation/flutter	203309	phv00203309.v1.p1	pht004039.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:37:58+00:00	2018-04-24 15:37:58+00:00 	AF	Atrial fibrillation  [Atrial Fibrillation, exam 3]
35	Atrial fibrillation/flutter	203310	phv00203310.v1.p1	pht004039.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:38:16+00:00	2018-04-24 15:38:16+00:00 	AFL	Atrial flutter  [Atrial Fibrillation, exam 3]
35	Atrial fibrillation/flutter	203312	phv00203312.v1.p1	pht004040.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:38:38+00:00	2018-04-24 15:38:38+00:00 	AF	Atrial fibrillation [Atrial Fibrillation, exam 4]
35	Atrial fibrillation/flutter	203313	phv00203313.v1.p1	pht004040.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:38:59+00:00	2018-04-24 15:38:59+00:00 	AFL	Atrial flutter [Atrial Fibrillation, exam 4]
35	Atrial fibrillation/flutter	204377	phv00204377.v1.p1	pht004058.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:41:19+00:00	2018-04-24 15:41:19+00:00 	I_COTHER	Censoring date for follow up time of cohort participants for all types of events (including atrial fibrillation/ atrial flutter events) [Cohort Surveillance CHD Occurrence Data Dictionary]
35	Atrial fibrillation/flutter	204463	phv00204463.v1.p1	pht004061.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:41:45+00:00	2018-04-24 15:41:45+00:00 	STRC29C	[Hospital information]. Are any of the following conditions documented as having been present within four weeks prior to or during this hospitalization? Atrial fibrillation. Q29c [Cohort Stroke Abstraction Form]
35	Atrial fibrillation/flutter	206790	phv00206790.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:42:52+00:00	2018-04-24 15:42:52+00:00 	HFAA11B1	[Medical history]. Q11b1- Arrhythmia: atrial fibrillation/atrial flutter [Heart Failure Hospital Record Abstraction Form, HFA]
35	Atrial fibrillation/flutter	206843	phv00206843.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:43:18+00:00	2018-04-24 15:43:18+00:00 	HFAA26C	[Physical exam and symptoms - findings]. Did the patient have any of the following CARDIOVASCULAR signs or symptoms? (Anytime during hospitalization) Q26c - Atrial Fibrillation / Atrial Flutter (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA]
35	Atrial fibrillation/flutter	207019	phv00207019.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:43:49+00:00	2018-04-24 15:43:49+00:00 	HFAA16K	[Medical history]. Q16k - Precipitating factor: atrial fibrillation/flutter (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA]
35	Atrial fibrillation/flutter	207561	phv00207561.v1.p1	pht004118.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:44:07+00:00	2018-04-24 15:44:07+00:00 	AFECGV1	Prevalent atrial fibrillation at visit 1
35	Atrial fibrillation/flutter	207563	phv00207563.v1.p1	pht004118.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:44:41+00:00	2018-04-24 15:44:41+00:00 	AFDTHBY05	Fatal atrial fibrillation event by 31DECYY as indicated by death certificate
35	Atrial fibrillation/flutter	207564	phv00207564.v1.p1	pht004118.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:45:06+00:00	2018-04-24 15:45:06+00:00 	AFECGBY05	Incident atrial fibrillation event at visit 2, 3, or 4
35	Atrial fibrillation/flutter	207565	phv00207565.v1.p1	pht004118.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:45:25+00:00	2018-04-24 15:45:25+00:00 	FT05AFECG	Follow-up time (in days) for an incident atrial fibrillation event at visit 2, 3, or 4
35	Atrial fibrillation/flutter	207566	phv00207566.v1.p1	pht004118.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:45:51+00:00	2018-04-24 15:45:51+00:00 	AFHOSP1BY05	Incident atrial fibrillation event as determined by hospital discharge codes on the cohort eligibility form (CEL)
35	Atrial fibrillation/flutter	207568	phv00207568.v1.p1	pht004118.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:46:11+00:00	2018-04-24 15:46:11+00:00 	AFINCBY05	Incident atrial fibrillation event as determined by any source by 31DECYY.
35	Atrial fibrillation/flutter	207569	phv00207569.v1.p1	pht004118.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:46:39+00:00	2018-04-24 15:46:39+00:00 	FT05AFINC	Follow-up time (in days) for an incident atrial fibrillation event as determined by hospital discharge codes on the cohort eligibility form (CEL)
35	Atrial fibrillation/flutter	215644	phv00215644.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:47:00+00:00	2018-04-24 15:47:00+00:00 	V1ECG22	Atrial fibrillation flag [ECG data, exam 1]
35	Atrial fibrillation/flutter	215654	phv00215654.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:47:20+00:00	2018-04-24 15:47:20+00:00 	V1ECG34	Atrial fibrillation or flutter, by visual flag [ECG data, exam 1]
35	Atrial fibrillation/flutter	215662	phv00215662.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:47:39+00:00	2018-04-24 15:47:39+00:00 	V1ECG42	Atrial flutter rr fibrillation, by visual flag [ECG data, exam 1]
35	Atrial fibrillation/flutter	215702	phv00215702.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:48:17+00:00	2018-04-24 15:48:17+00:00 	V1ECG82	Atrial fibrillation/flutter; by visual flag [ECG data, exam 1]
35	Atrial fibrillation/flutter	215721	phv00215721.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:48:37+00:00	2018-04-24 15:48:37+00:00 	V1ECG101	Atrial fibrillation [ECG data, exam 1]
35	Atrial fibrillation/flutter	216061	phv00216061.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:48:56+00:00	2018-04-24 15:48:56+00:00 	V2ECG22	Atrial fibrillation flag [ECG data, exam 2]
35	Atrial fibrillation/flutter	216071	phv00216071.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:49:12+00:00	2018-04-24 15:49:12+00:00 	V2ECG34	Atrial fibrillation or flutter, by visual flag [ECG data, exam 2]
35	Atrial fibrillation/flutter	216079	phv00216079.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:49:27+00:00	2018-04-24 15:49:27+00:00 	V2ECG42	Atrial flutter rr fibrillation, by visual flag [ECG data, exam 2]
35	Atrial fibrillation/flutter	216119	phv00216119.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:49:52+00:00	2018-04-24 15:49:52+00:00 	V2ECG82	Atrial fibrillation/flutter; by visual flag [ECG data, exam 2]
35	Atrial fibrillation/flutter	216138	phv00216138.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:50:11+00:00	2018-04-24 15:50:11+00:00 	V2ECG101	Atrial fibrillation [ECG data, exam 2]
35	Atrial fibrillation/flutter	216478	phv00216478.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:50:28+00:00	2018-04-24 15:50:28+00:00 	V3ECG22	Atrial fibrillation flag [ECG data, exam 3]
35	Atrial fibrillation/flutter	216488	phv00216488.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:50:47+00:00	2018-04-24 15:50:47+00:00 	V3ECG34	Atrial fibrillation or flutter, by visual flag [ECG data, exam 3]
35	Atrial fibrillation/flutter	216496	phv00216496.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:51:04+00:00	2018-04-24 15:51:04+00:00 	V3ECG42	Atrial flutter rr fibrillation, by visual flag [ECG data, exam 3]
35	Atrial fibrillation/flutter	216536	phv00216536.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:51:22+00:00	2018-04-24 15:51:22+00:00 	V3ECG82	Atrial fibrillation/flutter; by visual flag [ECG data, exam 3]
35	Atrial fibrillation/flutter	216555	phv00216555.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:51:40+00:00	2018-04-24 15:51:40+00:00 	V3ECG101	Atrial fibrillation [ECG data, exam 3]
35	Atrial fibrillation/flutter	216895	phv00216895.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:51:55+00:00	2018-04-24 15:51:55+00:00 	V4ECG22	Atrial fibrillation flag [ECG data, exam 4]
35	Atrial fibrillation/flutter	216913	phv00216913.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:52:26+00:00	2018-04-24 15:52:26+00:00 	V4ECG42	Atrial flutter rr fibrillation, by visual flag [ECG data, exam 4]
35	Atrial fibrillation/flutter	216953	phv00216953.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:52:46+00:00	2018-04-24 15:52:46+00:00 	V4ECG82	Atrial fibrillation/flutter; by visual flag [ECG data, exam 4]
35	Atrial fibrillation/flutter	216972	phv00216972.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:53:07+00:00	2018-04-24 15:53:07+00:00 	V4ECG101	Atrial fibrillation [ECG data, exam 4]
35	Atrial fibrillation/flutter	207570	phv00207570.v1.p1	pht004118.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 16:02:08+00:00	2018-04-24 16:02:08+00:00 	AFLINCBY05	Incident atrial flutter event as determined by hospital discharge codes on the cohort eligibility form (CEL) or at cohort visits 2, 3, or 4
35	Atrial fibrillation/flutter	207571	phv00207571.v1.p1	pht004118.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 16:02:39+00:00	2018-04-24 16:02:39+00:00 	FT05AFLINC	Follow-up time for an incident atrial flutter event as determined by hospital discharge codes on the cohort eligibility form (CEL) or at cohort visits 2, 3, or 4
35	Atrial fibrillation/flutter	215645	phv00215645.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 16:03:01+00:00	2018-04-24 16:03:01+00:00 	V1ECG23	Atrial flutter flag [ECG data, exam 1]
35	Atrial fibrillation/flutter	215729	phv00215729.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 16:04:32+00:00	2018-04-24 16:04:32+00:00 	V1ECG109	Major10b: atrial flutter [ECG data, exam 1]
35	Atrial fibrillation/flutter	216062	phv00216062.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 16:04:58+00:00	2018-04-24 16:04:58+00:00 	V2ECG23	Atrial flutter flag [ECG data, exam 2]
35	Atrial fibrillation/flutter	216146	phv00216146.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 16:11:57+00:00	2018-04-24 16:11:57+00:00 	V2ECG109	Major10b: atrial flutter [ECG data, exam 2]
35	Atrial fibrillation/flutter	216479	phv00216479.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 16:14:59+00:00	2018-04-24 16:14:59+00:00 	V3ECG23	Atrial flutter flag [ECG data, exam 3]
35	Atrial fibrillation/flutter	216563	phv00216563.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 16:15:48+00:00	2018-04-24 16:15:48+00:00 	V3ECG109	Major10b: atrial flutter [ECG data, exam 3]
35	Atrial fibrillation/flutter	216896	phv00216896.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 16:16:18+00:00	2018-04-24 16:16:18+00:00 	V4ECG23	Atrial flutter flag [ECG data, exam 4]
35	Atrial fibrillation/flutter	216905	phv00216905.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 16:16:50+00:00	2018-04-24 16:16:50+00:00 	V4ECG34	Atrial fibrillation or flutter, by visual flag [ECG data, exam 4]
35	Atrial fibrillation/flutter	216980	phv00216980.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 16:17:43+00:00	2018-04-24 16:17:43+00:00 	V4ECG109	Major10b: atrial flutter [ECG data, exam 4]
35	Atrial fibrillation/flutter	207567	phv00207567.v1.p1	pht004118.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-02 15:01:50+00:00	2018-05-02 15:01:50+00:00 	FT05AFHOSP1	Follow-up time for AFHOSP1by05
35	Atrial fibrillation/flutter	100069	phv00100069.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:02:37+00:00	2018-06-29 18:02:37+00:00 	ECGAFIB	ATRIAL FIB BY ECG
35	Atrial fibrillation/flutter	100324	phv00100324.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:02:47+00:00	2018-06-29 18:02:47+00:00 	AFIB	HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	100457	phv00100457.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:02:58+00:00	2018-06-29 18:02:58+00:00 	ECGAFIB	ATRIAL FIB BY ECG
35	Atrial fibrillation/flutter	100678	phv00100678.v1.p1	pht001456.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:03:09+00:00	2018-06-29 18:03:09+00:00 	INCAFIB	Incident AFIB from all sources
35	Atrial fibrillation/flutter	100679	phv00100679.v1.p1	pht001456.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:03:19+00:00	2018-06-29 18:03:19+00:00 	TTOAFIB	Time from baseline to AFIB incident
35	Atrial fibrillation/flutter	101531	phv00101531.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:03:33+00:00	2018-06-29 18:03:33+00:00 	AFIB59	HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	101983	phv00101983.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:03:51+00:00	2018-06-29 18:03:51+00:00 	ECGAFIB	ATRIAL FIB BY ECG
35	Atrial fibrillation/flutter	102608	phv00102608.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:04:01+00:00	2018-06-29 18:04:01+00:00 	ECGAFIB	ATRIAL FIB BY ECG
35	Atrial fibrillation/flutter	102679	phv00102679.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:04:15+00:00	2018-06-29 18:04:15+00:00 	AFIB59	HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	103165	phv00103165.v1.p1	pht001476.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:04:31+00:00	2018-06-29 18:04:31+00:00 	AFIB32	TOLD BY MD YOU HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	103218	phv00103218.v1.p1	pht001477.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:04:42+00:00	2018-06-29 18:04:42+00:00 	AFIB32	TOLD BY MD YOU HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	103270	phv00103270.v1.p1	pht001478.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:04:57+00:00	2018-06-29 18:04:57+00:00 	AFIB32	TOLD BY MD YOU HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	103323	phv00103323.v1.p1	pht001479.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:05:17+00:00	2018-06-29 18:05:17+00:00 	AFIB32	TOLD BY MD YOU HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	103375	phv00103375.v1.p1	pht001480.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:05:36+00:00	2018-06-29 18:05:36+00:00 	AFIB32	TOLD BY MD YOU HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	103428	phv00103428.v1.p1	pht001481.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:05:47+00:00	2018-06-29 18:05:47+00:00 	AFIB32	TOLD BY MD YOU HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	103480	phv00103480.v1.p1	pht001482.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:05:56+00:00	2018-06-29 18:05:56+00:00 	AFIB32	TOLD BY MD YOU HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	103533	phv00103533.v1.p1	pht001483.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:06:07+00:00	2018-06-29 18:06:07+00:00 	AFIB32	TOLD BY MD YOU HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	103585	phv00103585.v1.p1	pht001484.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:06:22+00:00	2018-06-29 18:06:22+00:00 	AFIB32	TOLD BY MD YOU HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	103638	phv00103638.v1.p1	pht001485.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:06:36+00:00	2018-06-29 18:06:36+00:00 	AFIB32	TOLD BY MD YOU HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	103690	phv00103690.v1.p1	pht001486.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:06:47+00:00	2018-06-29 18:06:47+00:00 	AFIB32	TOLD BY MD YOU HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	104340	phv00104340.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:06:58+00:00	2018-06-29 18:06:58+00:00 	ECGAFIB	ATRIAL FIB BY ECG
35	Atrial fibrillation/flutter	104994	phv00104994.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:07:07+00:00	2018-06-29 18:07:07+00:00 	ECGAFIB	ATRIAL FIB BY ECG
35	Atrial fibrillation/flutter	105967	phv00105967.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:07:15+00:00	2018-06-29 18:07:15+00:00 	AFIB57	HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	106361	phv00106361.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:07:24+00:00	2018-06-29 18:07:24+00:00 	ECGAFIB	ATRIAL FIB BY ECG
35	Atrial fibrillation/flutter	107042	phv00107042.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:07:45+00:00	2018-06-29 18:07:45+00:00 	AFIB29	HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	107300	phv00107300.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:08:00+00:00	2018-06-29 18:08:00+00:00 	ECGAFIB	ATRIAL FIB BY ECG
35	Atrial fibrillation/flutter	107949	phv00107949.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:08:08+00:00	2018-06-29 18:08:08+00:00 	AFIB59	HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	108176	phv00108176.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:08:16+00:00	2018-06-29 18:08:16+00:00 	ECGAFIB	ATRIAL FIB BY ECG
35	Atrial fibrillation/flutter	108623	phv00108623.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:08:31+00:00	2018-06-29 18:08:31+00:00 	AFIB59	HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	108798	phv00108798.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:08:42+00:00	2018-06-29 18:08:42+00:00 	ECGAFIB	ATRIAL FIB BY ECG
35	Atrial fibrillation/flutter	109328	phv00109328.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:08:56+00:00	2018-06-29 18:08:56+00:00 	ECGAFIB	ATRIAL FIB BY ECG
35	Atrial fibrillation/flutter	109390	phv00109390.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:09:09+00:00	2018-06-29 18:09:09+00:00 	AFIB59	HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	109876	phv00109876.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:09:20+00:00	2018-06-29 18:09:20+00:00 	ECGAFIB	ATRIAL FIB BY ECG
35	Atrial fibrillation/flutter	110052	phv00110052.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:09:31+00:00	2018-06-29 18:09:31+00:00 	AFIB59	HAD ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	197352	phv00197352.v1.p1	pht003697.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:09:42+00:00	2018-06-29 18:09:42+00:00 	AFIB	A-fib/flutter
35	Atrial fibrillation/flutter	197387	phv00197387.v1.p1	pht003698.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:09:57+00:00	2018-06-29 18:09:57+00:00 	afib	A-fib/flutter
35	Atrial fibrillation/flutter	78538	phv00078538.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 18:39:47+00:00	2018-06-29 18:39:47+00:00 	ATRIALFB	Atrial fibrillation ever
35	Atrial fibrillation/flutter	193727	phv00193727.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 18:42:14+00:00	2018-06-29 18:42:14+00:00 	F33AFIBHSP	F33 Hospitalized Atrial Fibrillation
35	Atrial fibrillation/flutter	193154	phv00193154.v3.p3	pht003407.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 18:44:25+00:00	2018-06-29 18:44:25+00:00 	AFIBR	Atrial Fibrillation
35	Atrial fibrillation/flutter	77763	phv00077763.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 21:59:05+00:00	2018-06-29 21:59:05+00:00 	ATRIALFB_4	Atrial fibrillation
35	Atrial fibrillation/flutter	77873	phv00077873.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:00:18+00:00	2018-06-29 22:00:18+00:00 	ATRIALFB_5	Atrial fibrillation
35	Atrial fibrillation/flutter	77638	phv00077638.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:01:44+00:00	2018-06-29 22:01:44+00:00 	ATRIALFB_3	Atrial fibrillation
35	Atrial fibrillation/flutter	78037	phv00078037.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:01:44+00:00	2018-06-29 22:01:44+00:00 	ATRIALFB_6	Atrial fibrillation
35	Atrial fibrillation/flutter	78177	phv00078177.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:01:44+00:00	2018-06-29 22:01:44+00:00 	ATRIALFB_7	Atrial fibrillation
35	Atrial fibrillation/flutter	78318	phv00078318.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:01:44+00:00	2018-06-29 22:01:44+00:00 	ATRIALFB_8	Atrial fibrillation
35	Atrial fibrillation/flutter	193051	phv00193051.v3.p3	pht003406.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:04:08+00:00	2018-06-29 22:04:08+00:00 	AFIBR	Atrial Fibrillation
35	Atrial fibrillation/flutter	283695	phv00283695.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:06:44+00:00	2018-06-29 22:06:44+00:00 	AFIB	F136 Atrial fibrillation
35	Atrial fibrillation/flutter	193729	phv00193729.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:09:32+00:00	2018-06-29 22:09:32+00:00 	F33AFIBOP	F33 Outpatient Atrial Fibrillation
35	Atrial fibrillation/flutter	154931	phv00154931.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:37:50+00:00	2018-06-29 22:37:50+00:00 	ATR_FLUT	Atrial flutter
35	Atrial fibrillation/flutter	154930	phv00154930.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:38:06+00:00	2018-06-29 22:38:06+00:00 	ATR_FIBR	Atrial fibrillation
35	Atrial fibrillation/flutter	7660	phv00007660.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:37:57+00:00	2018-07-03 18:37:57+00:00 	A158	ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	71976	phv00071976.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:38:13+00:00	2018-07-03 18:38:13+00:00 	afib_s1	Atrial fibrillation/flutter for first sleep study Collection Interval: 1998-2003
35	Atrial fibrillation/flutter	71993	phv00071993.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:38:22+00:00	2018-07-03 18:38:22+00:00 	afib_s2	Atrial fibrillation/flutter for second sleep study Collection Interval: 1998-2003
35	Atrial fibrillation/flutter	273699	phv00273699.v1.p10	pht003315.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:38:32+00:00	2018-07-03 18:38:32+00:00 	afx	Atrial fibrillation/atrial flutter (AF) status
35	Atrial fibrillation/flutter	190813	phv00190813.v6.p10	pht003315.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:38:43+00:00	2018-07-03 18:38:43+00:00 	afxdate	Date of atrial fibrillation/atrial flutter status
35	Atrial fibrillation/flutter	7901	phv00007901.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:38:55+00:00	2018-07-03 18:38:55+00:00 	B269	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	8130	phv00008130.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:39:05+00:00	2018-07-03 18:39:05+00:00 	B486	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	8646	phv00008646.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:39:15+00:00	2018-07-03 18:39:15+00:00 	C302	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	276820	phv00276820.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:39:27+00:00	2018-07-03 18:39:27+00:00 	CHF094	ECG rhythm - Atrial Fibrillation
35	Atrial fibrillation/flutter	9042	phv00009042.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:39:38+00:00	2018-07-03 18:39:38+00:00 	D306	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	1339	phv00001339.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:39:49+00:00	2018-07-03 18:39:49+00:00 	FB191	ECG:  ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	1534	phv00001534.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:39:58+00:00	2018-07-03 18:39:58+00:00 	FC200	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	1725	phv00001725.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:40:09+00:00	2018-07-03 18:40:09+00:00 	FD196	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	1990	phv00001990.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:40:30+00:00	2018-07-03 18:40:30+00:00 	FE277	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	2170	phv00002170.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:40:42+00:00	2018-07-03 18:40:42+00:00 	FF240	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	2365	phv00002365.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:40:54+00:00	2018-07-03 18:40:54+00:00 	FG248	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	2605	phv00002605.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:41:03+00:00	2018-07-03 18:41:03+00:00 	FH265	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	2811	phv00002811.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:41:16+00:00	2018-07-03 18:41:16+00:00 	FI176	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	2916	phv00002916.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:41:27+00:00	2018-07-03 18:41:27+00:00 	FI236	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	3193	phv00003193.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:41:36+00:00	2018-07-03 18:41:36+00:00 	FJ291	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	3608	phv00003608.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:41:46+00:00	2018-07-03 18:41:46+00:00 	FK386	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	4014	phv00004014.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:41:56+00:00	2018-07-03 18:41:56+00:00 	FL406	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	4438	phv00004438.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:42:05+00:00	2018-07-03 18:42:05+00:00 	FM445	ECG: ATRIAL FIBRILLATION
35	Atrial fibrillation/flutter	4879	phv00004879.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:42:15+00:00	2018-07-03 18:42:15+00:00 	FN421	ECG: ATRIAL FIBRILLATION OR ATRIAL FLUTTER
35	Atrial fibrillation/flutter	255317	phv00255317.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:42:44+00:00	2018-07-03 18:42:44+00:00 	fw587	Heart Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Atrial fibrillation or atrial flutter (A-fib or AF) Variable appears on Form B only Collection Interval: Original Cohort Exam 30
35	Atrial fibrillation/flutter	274775	phv00274775.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:43:02+00:00	2018-07-03 18:43:02+00:00 	FX097	Medical History - Atrial Fibrillation/Syncope: Have you been told you have/had a heart rhythm problem called atrial fibrillation? Collection Interval: Original Cohort Exam 31
35	Atrial fibrillation/flutter	275042	phv00275042.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:43:20+00:00	2018-07-03 18:43:20+00:00 	FX587	Heart Problems (Form B) - Since last exam or medical history update, have you seen a doctor or other healthcare provider or been hospitalized for atrial fibrillation or atrial flutter? Collection Interval: Original Cohort Exam 31
35	Atrial fibrillation/flutter	275132	phv00275132.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:43:36+00:00	2018-07-03 18:43:36+00:00 	fy097	Medical History - Atrial Fibrillation/Syncope: Have you been told you have/had a heart rhythm problem called atrial fibrillation? Collection Interval: Original Cohort Exam 32
35	Atrial fibrillation/flutter	275376	phv00275376.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:43:51+00:00	2018-07-03 18:43:51+00:00 	fy587	Heart Problems (Form B) - Since your last Framingham Heart Study exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for atrial fibrillation or atrial flutter? Collection Interval: Original Cohort Exam 32
35	Atrial fibrillation/flutter	21037	phv00021037.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:44:18+00:00	2018-07-03 18:44:18+00:00 	G3A189	HAVE YOU BEEN TOLD YOU HAVE/HAD ATRIAL FIBRILLATION?
35	Atrial fibrillation/flutter	273871	phv00273871.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:44:33+00:00	2018-07-03 18:44:33+00:00 	g3a189	Have you been told you have/had atrial fibrillation? Collection Interval: Exam 1
35	Atrial fibrillation/flutter	274364	phv00274364.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:44:47+00:00	2018-07-03 18:44:47+00:00 	g3a189	Have you been told you have/had atrial fibrillation?
35	Atrial fibrillation/flutter	72165	phv00072165.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:45:12+00:00	2018-07-03 18:45:12+00:00 	H136	HAVE YOU BEEN TOLD YOU HAVE/HAD A HEART RHYTHM PROBLEM CALLED ATRIAL FIBRILLATION?
35	Atrial fibrillation/flutter	7661	phv00007661.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:46:07+00:00	2018-07-03 18:46:07+00:00 	A159	ATRIAL FLUTTER
35	Atrial fibrillation/flutter	7902	phv00007902.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:46:27+00:00	2018-07-03 18:46:27+00:00 	B270	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	8131	phv00008131.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:46:38+00:00	2018-07-03 18:46:38+00:00 	B487	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	8647	phv00008647.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:46:47+00:00	2018-07-03 18:46:47+00:00 	C303	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	9043	phv00009043.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:46:57+00:00	2018-07-03 18:46:57+00:00 	D307	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	1340	phv00001340.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:47:06+00:00	2018-07-03 18:47:06+00:00 	FB192	ECG:  ATRIAL FLUTTER
35	Atrial fibrillation/flutter	1535	phv00001535.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:47:16+00:00	2018-07-03 18:47:16+00:00 	FC201	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	1726	phv00001726.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:47:27+00:00	2018-07-03 18:47:27+00:00 	FD197	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	1991	phv00001991.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:47:39+00:00	2018-07-03 18:47:39+00:00 	FE278	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	2171	phv00002171.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:47:52+00:00	2018-07-03 18:47:52+00:00 	FF241	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	2366	phv00002366.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:48:02+00:00	2018-07-03 18:48:02+00:00 	FG249	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	2606	phv00002606.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:48:11+00:00	2018-07-03 18:48:11+00:00 	FH266	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	2812	phv00002812.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:48:26+00:00	2018-07-03 18:48:26+00:00 	FI177	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	2917	phv00002917.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:48:36+00:00	2018-07-03 18:48:36+00:00 	FI237	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	3194	phv00003194.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:48:45+00:00	2018-07-03 18:48:45+00:00 	FJ292	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	3609	phv00003609.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:48:55+00:00	2018-07-03 18:48:55+00:00 	FK387	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	4015	phv00004015.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:49:12+00:00	2018-07-03 18:49:12+00:00 	FL407	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	4439	phv00004439.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:49:25+00:00	2018-07-03 18:49:25+00:00 	FM446	ECG: ATRIAL FLUTTER
35	Atrial fibrillation/flutter	9494	phv00009494.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:50:03+00:00	2018-07-03 18:50:03+00:00 	E589	ECG: RHYTHM
35	Atrial fibrillation/flutter	250660	phv00250660.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:50:22+00:00	2018-07-03 18:50:22+00:00 	e589	Electrocardiograph - Part I: Rhythm Collection Interval: Exam 1
35	Atrial fibrillation/flutter	10008	phv00010008.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:50:36+00:00	2018-07-03 18:50:36+00:00 	F584	RHYTHM
35	Atrial fibrillation/flutter	5236	phv00005236.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:50:54+00:00	2018-07-03 18:50:54+00:00 	FO432	ECG: RHYTHM
35	Atrial fibrillation/flutter	5863	phv00005863.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:51:09+00:00	2018-07-03 18:51:09+00:00 	FP398	ECG: RHYTHM
35	Atrial fibrillation/flutter	6220	phv00006220.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:51:19+00:00	2018-07-03 18:51:19+00:00 	FQ272	ECG - RHYTHM
35	Atrial fibrillation/flutter	6615	phv00006615.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:51:29+00:00	2018-07-03 18:51:29+00:00 	FR389	ECG - RHYTHM
35	Atrial fibrillation/flutter	7049	phv00007049.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:51:53+00:00	2018-07-03 18:51:53+00:00 	FS488	ECG: RHYTHM
35	Atrial fibrillation/flutter	7484	phv00007484.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:52:05+00:00	2018-07-03 18:52:05+00:00 	FT494	ECG: RHYTHM
35	Atrial fibrillation/flutter	70510	phv00070510.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:52:41+00:00	2018-07-03 18:52:41+00:00 	FU206	ECG: RHYTHM
35	Atrial fibrillation/flutter	254719	phv00254719.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:53:02+00:00	2018-07-03 18:53:02+00:00 	fv208	Electrocardiograph: Rhythm - predominant Collection Interval: Exam 29
35	Atrial fibrillation/flutter	255109	phv00255109.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:53:13+00:00	2018-07-03 18:53:13+00:00 	fw248	Electrocardiograph: Rhythm - predominant Collection Interval: Original Cohort Exam 30
35	Atrial fibrillation/flutter	255110	phv00255110.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:53:37+00:00	2018-07-03 18:53:37+00:00 	fw249	Electrocardiograph: Rhythm - predominant other or combination Collection Interval: Original Cohort Exam 30
35	Atrial fibrillation/flutter	274834	phv00274834.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:53:51+00:00	2018-07-03 18:53:51+00:00 	FX248	Electrocardiograph: Rhythm - predominant Collection Interval: Original Cohort Exam 31
35	Atrial fibrillation/flutter	274835	phv00274835.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:54:02+00:00	2018-07-03 18:54:02+00:00 	FX249	Electrocardiograph: Rhythm - predominant other or combination Collection Interval: Original Cohort Exam 31
35	Atrial fibrillation/flutter	275192	phv00275192.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:54:15+00:00	2018-07-03 18:54:15+00:00 	fy248	Electrocardiograph: Rhythm - predominant Collection Interval: Original Cohort Exam 32
35	Atrial fibrillation/flutter	275193	phv00275193.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:54:23+00:00	2018-07-03 18:54:23+00:00 	fy249	Electrocardiograph: Rhythm - predominant other or combination Collection Interval: Original Cohort Exam 32
35	Atrial fibrillation/flutter	10441	phv00010441.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:54:49+00:00	2018-07-03 18:54:49+00:00 	G362	ECG: RHYTHM PREDOMINANT
35	Atrial fibrillation/flutter	251002	phv00251002.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:55:01+00:00	2018-07-03 18:55:01+00:00 	g362	Electrocardiograph - Part I: Rhythm - predominant Collection Interval: Exam 2
35	Atrial fibrillation/flutter	21157	phv00021157.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:55:18+00:00	2018-07-03 18:55:18+00:00 	G3A357	ECG: RHYTHM--PREDOMINANT
35	Atrial fibrillation/flutter	273979	phv00273979.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:55:26+00:00	2018-07-03 18:55:26+00:00 	g3a357	ECG: Rhythm--predominant Collection Interval: Exam 1
35	Atrial fibrillation/flutter	274472	phv00274472.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:55:34+00:00	2018-07-03 18:55:34+00:00 	g3a357	ECG: Rhythm--predominant
35	Atrial fibrillation/flutter	72266	phv00072266.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:55:51+00:00	2018-07-03 18:55:51+00:00 	H309	ECG: RHYTHM PREDOMINANT
35	Atrial fibrillation/flutter	251462	phv00251462.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:56:01+00:00	2018-07-03 18:56:01+00:00 	h309	Electrocardiograph - Part I: Rhythm - predominant Collection Interval: Exam 3
35	Atrial fibrillation/flutter	254211	phv00254211.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:56:18+00:00	2018-07-03 18:56:18+00:00 	j364	Electrocardiograph-Part I: Rhythm--predominant
35	Atrial fibrillation/flutter	76370	phv00076370.v6.p10	pht000908.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:56:39+00:00	2018-07-03 18:56:39+00:00 	RHYTHM	Type of rhythm
35	Atrial fibrillation/flutter	253900	phv00253900.v1.p10	pht003334.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:58:13+00:00	2018-07-03 18:58:13+00:00 	ECG_HR	Hour of ECG  (time of day) Collection Interval: Cases reviewed  1/1949 - 12/2012
35	Atrial fibrillation/flutter	253901	phv00253901.v1.p10	pht003334.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:58:35+00:00	2018-07-03 18:58:35+00:00 	ECG_MIN	Minute of ECG (time of day) Collection Interval: Cases reviewed  1/1949 - 12/2012
35	Atrial fibrillation/flutter	253904	phv00253904.v1.p10	pht003334.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:58:58+00:00	2018-07-03 18:58:58+00:00 	ECGDATE	Date of ECG Collection Interval: Cases reviewed  1/1949 - 12/2012
35	Atrial fibrillation/flutter	253887	phv00253887.v1.p10	pht003334.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:59:23+00:00	2018-07-03 18:59:23+00:00 	RHYTHM	Type of rhythm Collection Interval: Cases reviewed  1/1949 - 12/2012
35	Atrial fibrillation/flutter	76369	phv00076369.v6.p10	pht000908.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 19:05:39+00:00	2018-07-03 19:05:39+00:00 	ECG_HR	Hour of ECG  (time of day)
35	Atrial fibrillation/flutter	76382	phv00076382.v6.p10	pht000908.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 19:05:51+00:00	2018-07-03 19:05:51+00:00 	ECG_MIN	Minute of ECG (time of day)
35	Atrial fibrillation/flutter	76387	phv00076387.v6.p10	pht000908.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 19:06:24+00:00	2018-07-03 19:06:24+00:00 	ECGDATE	Date of ECG
35	Atrial fibrillation/flutter	177467	phv00177467.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 19:12:16+00:00	2018-07-03 19:12:16+00:00 	g3b0374	Electrocardiograph: Rhythm--predominant
35	Atrial fibrillation/flutter	226264	phv00226264.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:26:11+00:00	2018-08-22 21:26:11+00:00 	ECGA109	Novacode 1.5; Atrial flutter or fibrillation, by visual flag (ECGA109)
35	Atrial fibrillation/flutter	259385	phv00259385.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-06 13:21:37+00:00	2018-09-06 13:21:37+00:00 	prioraf	Prior AF
36	QRS duration from EKG	205437	phv00205437.v1.p1	pht004071.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 18:39:27+00:00	2018-03-21 18:39:27+00:00 	ECGC54	QRS interval [ECG Machine Coding (ECGC), exam 2]
36	QRS duration from EKG	205506	phv00205506.v1.p1	pht004072.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 18:39:42+00:00	2018-03-21 18:39:42+00:00 	ECGD54	QRS interval [ECG Machine Coding (ECGD04), exam 3]
36	QRS duration from EKG	205565	phv00205565.v1.p1	pht004073.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 18:39:57+00:00	2018-03-21 18:39:57+00:00 	ECGE54	QRS interval [ECG Machine Coding (ECGE04), exam 4]
36	QRS duration from EKG	205595	phv00205595.v1.p1	pht004074.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 18:40:12+00:00	2018-03-21 18:40:12+00:00 	ECGMA54	QRS interval  [ECG Composite 12 Lead (with adjudications as needed) (ECGMA03), exam 1]
36	QRS duration from EKG	205649	phv00205649.v1.p1	pht004075.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 18:40:26+00:00	2018-03-21 18:40:26+00:00 	ECGMB54	QRS interval [Cohort, Exam 2]
36	QRS duration from EKG	205723	phv00205723.v1.p1	pht004076.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 18:40:40+00:00	2018-03-21 18:40:40+00:00 	ECGMC54	QRS interval [ECG Composite 12 Lead (with adjudications as needed) (ECGMC35), exam 3]
36	QRS duration from EKG	205780	phv00205780.v1.p1	pht004077.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 18:40:58+00:00	2018-03-21 18:40:58+00:00 	ECGMD54	QRS interval [ECG Composite 12 Lead (with adjudications as needed) (ECGMD41), exam 4]
36	QRS duration from EKG	205843	phv00205843.v1.p1	pht004078.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 18:41:35+00:00	2018-03-21 18:41:35+00:00 	ECGB54	QRS interval [ECG Machine Coding, exam 1]
36	QRS duration from EKG	215632	phv00215632.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 19:56:25+00:00	2018-03-21 19:56:25+00:00 	V1ECG8	QRS duration [ECG data, exam 1]
36	QRS duration from EKG	216049	phv00216049.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 19:56:55+00:00	2018-03-21 19:56:55+00:00 	V2ECG8	QRS duration [ECG data, exam 2]
36	QRS duration from EKG	216466	phv00216466.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 19:57:09+00:00	2018-03-21 19:57:09+00:00 	V3ECG8	QRS duration [ECG data, exam 3]
36	QRS duration from EKG	216883	phv00216883.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 19:57:22+00:00	2018-03-21 19:57:22+00:00 	V4ECG8	QRS duration [ECG data, exam 4]
36	QRS duration from EKG	127162	phv00127162.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-23 18:57:21+00:00	2018-04-23 18:57:21+00:00 	ecga43	QRSDUR - QRS Duration
36	QRS duration from EKG	159098	phv00159098.v2.p3	pht002195.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:38:49+00:00	2018-04-24 02:38:49+00:00 	qrsdur1	QRS Duration
36	QRS duration from EKG	82715	phv00082715.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:40:59+00:00	2018-04-24 02:40:59+00:00 	qrsdur1	QRS INTERVAL (msec)
36	QRS duration from EKG	84567	phv00084567.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:41:10+00:00	2018-04-24 02:41:10+00:00 	qrsdur1	QRS INTERVAL (MSEC)
36	QRS duration from EKG	174885	phv00174885.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:46:54+00:00	2018-04-24 02:46:54+00:00 	qrsdur5	QRS INTERVAL (MSEC)
36	QRS duration from EKG	176308	phv00176308.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 02:47:03+00:00	2018-04-24 02:47:03+00:00 	qrsdur5	QRS INTERVAL (MSEC)
36	QRS duration from EKG	250999	phv00250999.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:34:02+00:00	2018-06-15 17:34:02+00:00 	g359	Electrocardiograph - Part I - Rates and Intervals: QRS interval Collection Interval: Exam 2
36	QRS duration from EKG	250657	phv00250657.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:37:22+00:00	2018-06-15 17:37:22+00:00 	e586	Electrocardiograph - Part I: Rates and Intervals: QRS interval Collection Interval: Exam 1
36	QRS duration from EKG	251459	phv00251459.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:38:02+00:00	2018-06-15 17:38:02+00:00 	h306	Electrocardiograph - Part I: Rates and Intervals: QRS interval Collection Interval: Exam 3
36	QRS duration from EKG	177464	phv00177464.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:43:48+00:00	2018-06-15 17:43:48+00:00 	g3b0371	Electrocardiograph: Rates and Intervals: QRS interval
36	QRS duration from EKG	254208	phv00254208.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:46:02+00:00	2018-06-15 17:46:02+00:00 	j361	Electrocardiograph-Part I: Rates and Intervals: QRS interval
36	QRS duration from EKG	254716	phv00254716.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:55:19+00:00	2018-06-15 17:55:19+00:00 	fv205	Electrocardiograph: Rates and Intervals: QRS interval Collection Interval: Exam 29
36	QRS duration from EKG	255106	phv00255106.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:08:10+00:00	2018-06-15 18:08:10+00:00 	fw245	Electrocardiograph: Rates and Intervals: QRS Interval (milliseconds) Collection Interval: Original Cohort Exam 30
36	QRS duration from EKG	274831	phv00274831.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:11:09+00:00	2018-06-15 18:11:09+00:00 	FX245	Electrocardiograph: Rates and Intervals: QRS Interval (milliseconds) Collection Interval: Original Cohort Exam 31
36	QRS duration from EKG	275189	phv00275189.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:15:44+00:00	2018-06-15 18:15:44+00:00 	fy245	Electrocardiograph: Rates and Intervals: QRS Interval (milliseconds) Collection Interval: Original Cohort Exam 32
36	QRS duration from EKG	36361	phv00036361.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:20:51+00:00	2018-06-15 18:20:51+00:00 	DIGECG_QRS1	QRS INTERVAL CYCLE 1 LEAD II (MS)(INTERVAL FROM QRS ONSET TO QRS OFFSET)
36	QRS duration from EKG	36362	phv00036362.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:21:27+00:00	2018-06-15 18:21:27+00:00 	DIGECG_QRS2	QRS INTERVAL CYCLE 2 LEAD II (MS) (INTERVAL FROM QRS ONSET TO QRS OFFSET)
36	QRS duration from EKG	36363	phv00036363.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:21:44+00:00	2018-06-15 18:21:44+00:00 	DIGECG_QRS3	QRS INTERVAL CYCLE 1 LEAD V2 (MS) (INTERVAL FROM QRS ONSET TO QRS OFFSET), DONE ON GEN 3 ONLY
36	QRS duration from EKG	36364	phv00036364.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:22:03+00:00	2018-06-15 18:22:03+00:00 	DIGECG_QRS4	QRS INTERVAL CYCLE 1 LEAD V5 (MS) (INTERVAL FROM QRS ONSET TO QRS OFFSET), DONE ON GEN 3 ONLY
36	QRS duration from EKG	23257	phv00023257.v5.p10	pht000149.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:37:44+00:00	2018-06-15 18:37:44+00:00 	DG7	QRS INTERVAL
36	QRS duration from EKG	7649	phv00007649.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:39:23+00:00	2018-06-15 18:39:23+00:00 	A147	QRS INTERVAL
36	QRS duration from EKG	10005	phv00010005.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:40:49+00:00	2018-06-15 18:40:49+00:00 	F581	QRS INTERVAL (HUNDREDTHS OF A SECOND)
36	QRS duration from EKG	7889	phv00007889.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:18:26+00:00	2018-06-19 13:18:26+00:00 	B257	ECG: QRS INTERVAL
36	QRS duration from EKG	8635	phv00008635.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:18:34+00:00	2018-06-19 13:18:34+00:00 	C291	ECG: QRS INTERVAL
36	QRS duration from EKG	9031	phv00009031.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:18:44+00:00	2018-06-19 13:18:44+00:00 	D294	ECG: QRS INTERVAL (HUNDREDTHS OF SECOND)
36	QRS duration from EKG	9491	phv00009491.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:18:52+00:00	2018-06-19 13:18:52+00:00 	E586	ECG: QRS INTERVAL (HUNDREDTHS OF SECOND)
36	QRS duration from EKG	1174	phv00001174.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:19:00+00:00	2018-06-19 13:19:00+00:00 	FA174	ECG:  QRS INTERVAL
36	QRS duration from EKG	1526	phv00001526.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:19:08+00:00	2018-06-19 13:19:08+00:00 	FC192	ECG: QRS INTERVAL
36	QRS duration from EKG	1717	phv00001717.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:19:17+00:00	2018-06-19 13:19:17+00:00 	FD188	ECG: QRS INTERVAL
36	QRS duration from EKG	1978	phv00001978.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:19:26+00:00	2018-06-19 13:19:26+00:00 	FE265	ECG: QRS INTERVAL
36	QRS duration from EKG	2158	phv00002158.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:19:35+00:00	2018-06-19 13:19:35+00:00 	FF228	ECG: QRS INTERVAL
36	QRS duration from EKG	2353	phv00002353.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:19:44+00:00	2018-06-19 13:19:44+00:00 	FG236	ECG: QRS INTERVAL
36	QRS duration from EKG	2593	phv00002593.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:19:53+00:00	2018-06-19 13:19:53+00:00 	FH253	ECG: QRS INTERVAL
36	QRS duration from EKG	2801	phv00002801.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:20:02+00:00	2018-06-19 13:20:02+00:00 	FI166	ECG: QRS INTERVAL
36	QRS duration from EKG	3180	phv00003180.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:20:12+00:00	2018-06-19 13:20:12+00:00 	FJ278	ECG: QRS INTERVAL
36	QRS duration from EKG	3595	phv00003595.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:20:20+00:00	2018-06-19 13:20:20+00:00 	FK373	ECG: QRS INTERVAL
36	QRS duration from EKG	4003	phv00004003.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:20:28+00:00	2018-06-19 13:20:28+00:00 	FL394	ECG: QRS INTERVAL (HUNDREDTHS OF SECOND)
36	QRS duration from EKG	4427	phv00004427.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:20:37+00:00	2018-06-19 13:20:37+00:00 	FM433	ECG: QRS INTERVAL (HUNDREDTHS OF SECOND)
36	QRS duration from EKG	4869	phv00004869.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:20:45+00:00	2018-06-19 13:20:45+00:00 	FN410	ECG: QRS INTERVAL (HUNDREDTHS OF SECOND)
36	QRS duration from EKG	5233	phv00005233.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:20:55+00:00	2018-06-19 13:20:55+00:00 	FO429	ECG: QRS INTERVAL (HUNDREDTHS OF SECOND)
36	QRS duration from EKG	5860	phv00005860.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:21:04+00:00	2018-06-19 13:21:04+00:00 	FP395	ECG: QRS INTERVAL (HUNDREDTHS OF SECOND)
36	QRS duration from EKG	6217	phv00006217.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:21:15+00:00	2018-06-19 13:21:15+00:00 	FQ269	ECG - QRS INTERVAL (HUNDREDTHS OF SECOND)
36	QRS duration from EKG	6219	phv00006219.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:21:25+00:00	2018-06-19 13:21:25+00:00 	FQ271	ECG - QRS INTERVAL (HUNDREDTHS OF SECOND)
36	QRS duration from EKG	6612	phv00006612.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:21:42+00:00	2018-06-19 13:21:42+00:00 	FR386	ECG - QRS INTERVAL (HUNDREDTHS OF A SECOND)
36	QRS duration from EKG	7046	phv00007046.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:22:05+00:00	2018-06-19 13:22:05+00:00 	FS485	ECG: QRS INTERVAL (HUNDREDTHS OF A SECOND)
36	QRS duration from EKG	7481	phv00007481.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:23:04+00:00	2018-06-19 13:23:04+00:00 	FT491	ECG RATES AND INTERVALS: QRS INTERVAL (HUNDREDTHS OF A SECOND)
36	QRS duration from EKG	70507	phv00070507.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:23:31+00:00	2018-06-19 13:23:31+00:00 	FU203	ECG RATES AND INTERVALS: QRS INTERVAL (HUNDREDTHS OF A SECOND)
36	QRS duration from EKG	10438	phv00010438.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:23:48+00:00	2018-06-19 13:23:48+00:00 	G359	ECG: QRS INTERVAL (HUNDREDTHS OF A SECOND)
36	QRS duration from EKG	21154	phv00021154.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:24:02+00:00	2018-06-19 13:24:02+00:00 	G3A354	ECG: QRS INTERVAL (HUNDREDTHS OF A SECOND)
36	QRS duration from EKG	273976	phv00273976.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:24:10+00:00	2018-06-19 13:24:10+00:00 	g3a354	ECG: QRS interval Collection Interval: Exam 1
36	QRS duration from EKG	274469	phv00274469.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:24:18+00:00	2018-06-19 13:24:18+00:00 	g3a354	ECG: QRS interval
36	QRS duration from EKG	72263	phv00072263.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:24:41+00:00	2018-06-19 13:24:41+00:00 	H306	ECG: QRS INTERVAL (HUNDREDTHS OF SECOND)
36	QRS duration from EKG	1331	phv00001331.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:33:32+00:00	2018-06-19 13:33:32+00:00 	FB183	ECG:  ORS INTERVAL
36	QRS duration from EKG	127128	phv00127128.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 01:42:39+00:00	2018-06-20 01:42:39+00:00 	QRSduration	QRSduration
36	QRS duration from EKG	127421	phv00127421.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:25:46+00:00	2018-06-20 13:25:46+00:00 	ecga302	QRSDI - QRS Duration in lead I
36	QRS duration from EKG	127422	phv00127422.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:26:03+00:00	2018-06-20 13:26:03+00:00 	ecga303	QRSDII - QRS Duration in lead II
36	QRS duration from EKG	127423	phv00127423.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:26:15+00:00	2018-06-20 13:26:15+00:00 	ecga304	QRSDIII - QRS Duration in lead III
36	QRS duration from EKG	127424	phv00127424.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:26:28+00:00	2018-06-20 13:26:28+00:00 	ecga305	QRSDAVR - QRS Duration in lead AVR
36	QRS duration from EKG	127425	phv00127425.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:26:56+00:00	2018-06-20 13:26:56+00:00 	ecga306	QRSDAVL - QRS Duration in lead AVL
36	QRS duration from EKG	127426	phv00127426.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:27:16+00:00	2018-06-20 13:27:16+00:00 	ecga307	QRSDAVF - QRS Duration in lead AVF
36	QRS duration from EKG	127427	phv00127427.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:27:31+00:00	2018-06-20 13:27:31+00:00 	ecga308	QRSDV1 - QRS Duration in lead V1
36	QRS duration from EKG	127428	phv00127428.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:27:51+00:00	2018-06-20 13:27:51+00:00 	ecga309	QRSDV2 - QRS Duration in lead V2
36	QRS duration from EKG	127429	phv00127429.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:28:08+00:00	2018-06-20 13:28:08+00:00 	ecga310	QRSDV3 - QRS Duration in lead V3
36	QRS duration from EKG	127430	phv00127430.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:28:19+00:00	2018-06-20 13:28:19+00:00 	ecga311	QRSDV4 - QRS Duration in lead V4
36	QRS duration from EKG	127431	phv00127431.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:28:31+00:00	2018-06-20 13:28:31+00:00 	ecga312	QRSDV5 - QRS Duration in lead V5
36	QRS duration from EKG	127432	phv00127432.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:28:44+00:00	2018-06-20 13:28:44+00:00 	ecga313	QRSDV6 - QRS Duration in lead V6
36	QRS duration from EKG	100061	phv00100061.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:26:52+00:00	2018-06-29 18:26:52+00:00 	QRSINT42	QRS INTERVAL, MSEC
36	QRS duration from EKG	100451	phv00100451.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:27:04+00:00	2018-06-29 18:27:04+00:00 	QRSINT42	QRS INTERVAL,  MSEC
36	QRS duration from EKG	101976	phv00101976.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:28:28+00:00	2018-06-29 18:28:28+00:00 	QRSINT42	QRS INTERVAL,  MSEC
36	QRS duration from EKG	102977	phv00102977.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:29:15+00:00	2018-06-29 18:29:15+00:00 	QRSINT42	QRS INTERVAL,  MSEC
36	QRS duration from EKG	104332	phv00104332.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:29:28+00:00	2018-06-29 18:29:28+00:00 	QRSINT42	QRS INTERVAL, MSEC
36	QRS duration from EKG	104986	phv00104986.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:30:00+00:00	2018-06-29 18:30:00+00:00 	QRSINT42	QRS INTERVAL, MSEC
36	QRS duration from EKG	106353	phv00106353.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:30:24+00:00	2018-06-29 18:30:24+00:00 	QRSINT42	QRS INTERVAL, MSEC
36	QRS duration from EKG	107292	phv00107292.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:30:47+00:00	2018-06-29 18:30:47+00:00 	QRSINT42	QRS INTERVAL,  MSEC
36	QRS duration from EKG	108168	phv00108168.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:31:10+00:00	2018-06-29 18:31:10+00:00 	QRSINT42	QRS INTERVAL, MSEC
36	QRS duration from EKG	108791	phv00108791.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:31:31+00:00	2018-06-29 18:31:31+00:00 	QRSINT42	QRS INTERVAL,  MSEC
36	QRS duration from EKG	109322	phv00109322.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:31:45+00:00	2018-06-29 18:31:45+00:00 	QRSINT42	QRS INTERVAL,  MSEC
36	QRS duration from EKG	109868	phv00109868.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:32:18+00:00	2018-06-29 18:32:18+00:00 	QRSINT42	QRS INTERVAL,  MSEC
36	QRS duration from EKG	155364	phv00155364.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:38:15+00:00	2018-06-29 23:38:15+00:00 	QRS_DUR	QRS Interval Duration (ms)
36	QRS duration from EKG	123558	phv00123558.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:41:00+00:00	2018-08-21 17:41:00+00:00 	QRSDURAN	ECG: QRS Duration (ms)
36	QRS duration from EKG	226263	phv00226263.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:22:02+00:00	2018-08-22 21:22:02+00:00 	ECGA10	QRS duration (ECGA10)
36	QRS duration from EKG	253002	phv00253002.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:16:33+00:00	2018-08-24 17:16:33+00:00 	ekg_qrs_baseline	QRS duration measured by electrocardiogram at baseline visit
37	QT interval from EKG	215633	phv00215633.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 20:55:29+00:00	2018-03-21 20:55:29+00:00 	V1ECG9	QT duration [ECG data, exam 1]
37	QT interval from EKG	216050	phv00216050.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 20:56:36+00:00	2018-03-21 20:56:36+00:00 	V2ECG9	QT duration [ECG data, exam 2]
37	QT interval from EKG	216467	phv00216467.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 20:57:29+00:00	2018-03-21 20:57:29+00:00 	V3ECG9	QT duration [ECG data, exam 3]
37	QT interval from EKG	216884	phv00216884.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 20:58:19+00:00	2018-03-21 20:58:19+00:00 	V4ECG9	QT duration [ECG data, exam 4]
37	QT interval from EKG	205943	phv00205943.v1.p1	pht004080.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:25:55+00:00	2018-03-21 21:25:55+00:00 	ERHA18	QT duration (Millisec). Q18 [ECG Rhythm Strip, exam 1]
37	QT interval from EKG	127166	phv00127166.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-23 18:54:55+00:00	2018-04-23 18:54:55+00:00 	ecga47	QTDUR - QT Duration
37	QT interval from EKG	84568	phv00084568.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:04:21+00:00	2018-04-24 03:04:21+00:00 	qtdur1	QT INTERVAL (MSEC)
37	QT interval from EKG	82716	phv00082716.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:06:05+00:00	2018-04-24 03:06:05+00:00 	qtdur1	QT INTERVAL (msec)
37	QT interval from EKG	174886	phv00174886.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:06:11+00:00	2018-04-24 03:06:11+00:00 	qtdur5	QT INTERVAL (MSEC)
37	QT interval from EKG	176309	phv00176309.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:06:17+00:00	2018-04-24 03:06:17+00:00 	qtdur5	QT INTERVAL (MSEC)
37	QT interval from EKG	251000	phv00251000.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:34:31+00:00	2018-06-15 17:34:31+00:00 	g360	Electrocardiograph - Part I - Rates and Intervals: Q-T interval Collection Interval: Exam 2
37	QT interval from EKG	250658	phv00250658.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:38:38+00:00	2018-06-15 17:38:38+00:00 	e587	Electrocardiograph - Part I: Rates and Intervals: Q-T interval Collection Interval: Exam 1
37	QT interval from EKG	251460	phv00251460.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:39:25+00:00	2018-06-15 17:39:25+00:00 	h307	Electrocardiograph - Part I: Rates and Intervals: Q-T interval Collection Interval: Exam 3
37	QT interval from EKG	177465	phv00177465.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:44:06+00:00	2018-06-15 17:44:06+00:00 	g3b0372	Electrocardiograph: Rates and Intervals: Q-T interval
37	QT interval from EKG	254209	phv00254209.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:46:46+00:00	2018-06-15 17:46:46+00:00 	j362	Electrocardiograph-Part I: Rates and Intervals: Q-T interval
37	QT interval from EKG	254717	phv00254717.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:57:37+00:00	2018-06-15 17:57:37+00:00 	fv206	Electrocardiograph: Rates and Intervals: Q-T interval Collection Interval: Exam 29
37	QT interval from EKG	255107	phv00255107.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:08:41+00:00	2018-06-15 18:08:41+00:00 	fw246	Electrocardiograph: Rates and Intervals: Q-T Interval (milliseconds) Collection Interval: Original Cohort Exam 30
37	QT interval from EKG	274832	phv00274832.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:11:34+00:00	2018-06-15 18:11:34+00:00 	FX246	Electrocardiograph: Rates and Intervals: Q-T Interval (milliseconds) Collection Interval: Original Cohort Exam 31
37	QT interval from EKG	275190	phv00275190.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:16:06+00:00	2018-06-15 18:16:06+00:00 	fy246	Electrocardiograph: Rates and Intervals: Q-T Interval (milliseconds) Collection Interval: Original Cohort Exam 32
37	QT interval from EKG	36353	phv00036353.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:23:11+00:00	2018-06-15 18:23:11+00:00 	DIGECG_QT1	QT INTERVAL CYCLE 1 LEAD II (MS) (INTERVAL FROM QRS ONSET TO T-WAVE OFFSET)
37	QT interval from EKG	36354	phv00036354.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:23:31+00:00	2018-06-15 18:23:31+00:00 	DIGECG_QT2	QT INTERVAL CYCLE 2 LEAD II (MS) (INTERVAL FROM QRS ONSET TO T-WAVE OFFSET)
37	QT interval from EKG	36355	phv00036355.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:23:49+00:00	2018-06-15 18:23:49+00:00 	DIGECG_QT3	QT INTERVAL CYCLE 1 LEAD V2 (MS) (INTERVAL FROM QRS ONSET TO T-WAVE OFFSET)
37	QT interval from EKG	36356	phv00036356.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:24:06+00:00	2018-06-15 18:24:06+00:00 	DIGECG_QT4	QT INTERVAL CYCLE 1 LEAD V5 (MS) (INTERVAL FROM QRS ONSET TO T-WAVE OFFSET)
37	QT interval from EKG	23258	phv00023258.v5.p10	pht000149.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:38:16+00:00	2018-06-15 18:38:16+00:00 	DG8	QT INTERVAL
37	QT interval from EKG	7650	phv00007650.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:39:38+00:00	2018-06-15 18:39:38+00:00 	A148	QT INTERVAL
37	QT interval from EKG	10006	phv00010006.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:41:35+00:00	2018-06-15 18:41:35+00:00 	F582	Q-T INTERVAL (HUNDREDTHS OF A SECOND)
37	QT interval from EKG	7890	phv00007890.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:25:39+00:00	2018-06-19 13:25:39+00:00 	B258	ECG: QT INTERVAL
37	QT interval from EKG	8636	phv00008636.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:25:56+00:00	2018-06-19 13:25:56+00:00 	C292	ECG: QT INTERVAL
37	QT interval from EKG	9032	phv00009032.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:26:14+00:00	2018-06-19 13:26:14+00:00 	D295	ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND)
37	QT interval from EKG	9492	phv00009492.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:26:32+00:00	2018-06-19 13:26:32+00:00 	E587	ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND)
37	QT interval from EKG	1979	phv00001979.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:27:00+00:00	2018-06-19 13:27:00+00:00 	FE266	ECG: QT INTERVAL
37	QT interval from EKG	2159	phv00002159.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:27:22+00:00	2018-06-19 13:27:22+00:00 	FF229	ECG: QT INTERVAL
37	QT interval from EKG	2354	phv00002354.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:27:35+00:00	2018-06-19 13:27:35+00:00 	FG237	ECG: QT INTERVAL
37	QT interval from EKG	2594	phv00002594.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:27:49+00:00	2018-06-19 13:27:49+00:00 	FH254	ECG: QT INTERVAL
37	QT interval from EKG	2802	phv00002802.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:28:02+00:00	2018-06-19 13:28:02+00:00 	FI167	ECG: Q-T INTERVAL
37	QT interval from EKG	3181	phv00003181.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:28:17+00:00	2018-06-19 13:28:17+00:00 	FJ279	ECG: QT INTERVAL
37	QT interval from EKG	3596	phv00003596.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:28:31+00:00	2018-06-19 13:28:31+00:00 	FK374	ECG: QT INTERVAL
37	QT interval from EKG	4004	phv00004004.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:28:45+00:00	2018-06-19 13:28:45+00:00 	FL395	ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND)
37	QT interval from EKG	4428	phv00004428.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:28:59+00:00	2018-06-19 13:28:59+00:00 	FM434	ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND)
37	QT interval from EKG	4870	phv00004870.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:29:35+00:00	2018-06-19 13:29:35+00:00 	FN411	ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND)
37	QT interval from EKG	5234	phv00005234.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:29:48+00:00	2018-06-19 13:29:48+00:00 	FO430	ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND)
37	QT interval from EKG	5861	phv00005861.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:30:05+00:00	2018-06-19 13:30:05+00:00 	FP396	ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND)
37	QT interval from EKG	6218	phv00006218.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:30:22+00:00	2018-06-19 13:30:22+00:00 	FQ270	ECG - Q-T INTERVAL (HUNDREDTHS OF SECOND)
37	QT interval from EKG	6613	phv00006613.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:30:38+00:00	2018-06-19 13:30:38+00:00 	FR387	ECG - Q-T INTERVAL (HUNDREDTHS OF A SECOND)
37	QT interval from EKG	7047	phv00007047.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:30:51+00:00	2018-06-19 13:30:51+00:00 	FS486	ECG: Q-T INTERVAL (HUNDREDTHS OF A SECOND)
37	QT interval from EKG	7482	phv00007482.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:31:06+00:00	2018-06-19 13:31:06+00:00 	FT492	ECG RATES AND INTERVALS: Q-T INTERVAL (HUNDREDTHS OF A SECOND)
37	QT interval from EKG	70508	phv00070508.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:31:26+00:00	2018-06-19 13:31:26+00:00 	FU204	ECG RATES AND INTERVALS: Q-T INTERVAL (HUNDREDTHS OF A SECOND)
37	QT interval from EKG	10439	phv00010439.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:31:40+00:00	2018-06-19 13:31:40+00:00 	G360	ECG: Q-T INTERVAL (HUNDREDTHS OF A SECOND)
37	QT interval from EKG	21155	phv00021155.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:32:01+00:00	2018-06-19 13:32:01+00:00 	G3A355	ECG: Q-T INTERVAL (HUNDREDTHS OF A SECOND)
37	QT interval from EKG	273977	phv00273977.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:32:10+00:00	2018-06-19 13:32:10+00:00 	g3a355	ECG: Q-T interval Collection Interval: Exam 1
37	QT interval from EKG	274470	phv00274470.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:32:19+00:00	2018-06-19 13:32:19+00:00 	g3a355	ECG: Q-T interval
37	QT interval from EKG	72264	phv00072264.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:32:34+00:00	2018-06-19 13:32:34+00:00 	H307	ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND)
37	QT interval from EKG	100059	phv00100059.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:11:42+00:00	2018-06-29 18:11:42+00:00 	QT42	Q-T INTERVAL, MSEC
37	QT interval from EKG	100450	phv00100450.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:12:12+00:00	2018-06-29 18:12:12+00:00 	QT42	Q-T INTERVAL,  MSEC
37	QT interval from EKG	101974	phv00101974.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:12:21+00:00	2018-06-29 18:12:21+00:00 	QT42	Q-T INTERVAL,  MSEC
37	QT interval from EKG	102596	phv00102596.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:12:43+00:00	2018-06-29 18:12:43+00:00 	QT42	Q-T INTERVAL,  MSEC
37	QT interval from EKG	104330	phv00104330.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:13:02+00:00	2018-06-29 18:13:02+00:00 	QT42	Q-T INTERVAL, MSEC
37	QT interval from EKG	104984	phv00104984.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:13:23+00:00	2018-06-29 18:13:23+00:00 	QT42	Q-T INTERVAL, MSEC
37	QT interval from EKG	106351	phv00106351.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:14:20+00:00	2018-06-29 18:14:20+00:00 	QT42	Q-T INTERVAL, MSEC
37	QT interval from EKG	107290	phv00107290.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:14:43+00:00	2018-06-29 18:14:43+00:00 	QT42	Q-T INTERVAL,  MSEC
37	QT interval from EKG	108166	phv00108166.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:15:17+00:00	2018-06-29 18:15:17+00:00 	QT42	Q-T INTERVAL, MSEC
37	QT interval from EKG	108789	phv00108789.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:15:38+00:00	2018-06-29 18:15:38+00:00 	QT42	Q-T INTERVAL,  MSEC
37	QT interval from EKG	109320	phv00109320.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:16:19+00:00	2018-06-29 18:16:19+00:00 	QT42	Q-T INTERVAL,  MSEC
37	QT interval from EKG	109866	phv00109866.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:16:29+00:00	2018-06-29 18:16:29+00:00 	QT42	Q-T INTERVAL,  MSEC
37	QT interval from EKG	155365	phv00155365.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 18:57:41+00:00	2018-07-02 18:57:41+00:00 	QTC_DUR	Bazett's Heart Rate-Corrected QT Interval (ms)
37	QT interval from EKG	155366	phv00155366.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 18:57:41+00:00	2018-07-02 18:57:41+00:00 	QT_DUR	QT Interval Duration (ms)
37	QT interval from EKG	123559	phv00123559.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:41:12+00:00	2018-08-21 17:41:12+00:00 	QT	ECG: QT (ms)
37	QT interval from EKG	123560	phv00123560.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:41:23+00:00	2018-08-21 17:41:23+00:00 	QTC	ECG: QTc (ms)
37	QT interval from EKG	226265	phv00226265.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:26:48+00:00	2018-08-22 21:26:48+00:00 	ECGA11	QT duration (ECGA11)
37	QT interval from EKG	226266	phv00226266.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:28:06+00:00	2018-08-22 21:28:06+00:00 	ECGA12	QTc calculated (ECGA12)
37	QT interval from EKG	253003	phv00253003.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:16:44+00:00	2018-08-24 17:16:44+00:00 	ekg_qt_baseline	QT interval measured by electrocardiogram at baseline visit
38	PR interval from EKG	215631	phv00215631.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 20:55:13+00:00	2018-03-21 20:55:13+00:00 	V1ECG7	PR duration [ECG data, exam 1]
38	PR interval from EKG	216048	phv00216048.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 20:56:08+00:00	2018-03-21 20:56:08+00:00 	V2ECG7	PR duration [ECG data, exam 2]
38	PR interval from EKG	216465	phv00216465.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 20:57:15+00:00	2018-03-21 20:57:15+00:00 	V3ECG7	PR duration [ECG data, exam 3]
38	PR interval from EKG	216882	phv00216882.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 20:58:05+00:00	2018-03-21 20:58:05+00:00 	V4ECG7	PR duration [ECG data, exam 4]
38	PR interval from EKG	127290	phv00127290.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-23 18:58:21+00:00	2018-04-23 18:58:21+00:00 	ecga171	PRDURII - PR Duration in lead II
38	PR interval from EKG	82714	phv00082714.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:30:40+00:00	2018-04-24 03:30:40+00:00 	prdur1	PR INTERVAL (msec)
38	PR interval from EKG	82837	phv00082837.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:30:48+00:00	2018-04-24 03:30:48+00:00 	prdur1c	PR INTERVAL (msec) - WITH 0=SUPRESSED RECODED TO MISSING
38	PR interval from EKG	84566	phv00084566.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:30:55+00:00	2018-04-24 03:30:55+00:00 	prdur1	PR INTERVAL (MSEC)
38	PR interval from EKG	84689	phv00084689.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:31:01+00:00	2018-04-24 03:31:01+00:00 	prdur1c	PR INTERVAL (MSEC) - WITH 0=SUPRESSED RECODED TO MISSING
38	PR interval from EKG	159097	phv00159097.v2.p3	pht002195.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:31:07+00:00	2018-04-24 03:31:07+00:00 	prdur1	PR Interval
38	PR interval from EKG	174884	phv00174884.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:31:16+00:00	2018-04-24 03:31:16+00:00 	prdur5	PR INTERVAL (MSEC)
38	PR interval from EKG	175123	phv00175123.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:31:22+00:00	2018-04-24 03:31:22+00:00 	prdur5c	PR INTERVAL (msec) - WITH 0=SUPRESSED RECODED TO MISSING
38	PR interval from EKG	176307	phv00176307.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:31:32+00:00	2018-04-24 03:31:32+00:00 	prdur5	PR INTERVAL (MSEC)
38	PR interval from EKG	176546	phv00176546.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:35:24+00:00	2018-04-24 03:35:24+00:00 	prdur5c	PR INTERVAL (msec) - WITH 0=SUPRESSED RECODED TO MISSING
38	PR interval from EKG	250998	phv00250998.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:33:12+00:00	2018-06-15 17:33:12+00:00 	g358	Electrocardiograph - Part I - Rates and Intervals: P-R interval Collection Interval: Exam 2
38	PR interval from EKG	251458	phv00251458.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:36:28+00:00	2018-06-15 17:36:28+00:00 	h305	Electrocardiograph - Part I: Rates and Intervals: P-R Interval Collection Interval: Exam 3
38	PR interval from EKG	177463	phv00177463.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:43:04+00:00	2018-06-15 17:43:04+00:00 	g3b0370	Electrocardiograph: Rates and Intervals: P-R Interval
38	PR interval from EKG	254207	phv00254207.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:45:42+00:00	2018-06-15 17:45:42+00:00 	j360	Electrocardiograph-Part I: Rates and Intervals: P-R Interval
38	PR interval from EKG	254715	phv00254715.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 17:55:05+00:00	2018-06-15 17:55:05+00:00 	fv204	Electrocardiograph: Rates and Intervals: P-R Interval Collection Interval: Exam 29
38	PR interval from EKG	255105	phv00255105.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:00:00+00:00	2018-06-15 18:00:00+00:00 	fw244	Electrocardiograph: Rates and Intervals: P-R Interval (milliseconds) Collection Interval: Original Cohort Exam 30
38	PR interval from EKG	274830	phv00274830.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:10:40+00:00	2018-06-15 18:10:40+00:00 	FX244	Electrocardiograph: Rates and Intervals: P-R Interval (milliseconds) Collection Interval: Original Cohort Exam 31
38	PR interval from EKG	275188	phv00275188.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:15:15+00:00	2018-06-15 18:15:15+00:00 	fy244	Electrocardiograph: Rates and Intervals: P-R Interval (milliseconds) Collection Interval: Original Cohort Exam 32
38	PR interval from EKG	36357	phv00036357.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:19:02+00:00	2018-06-15 18:19:02+00:00 	DIGECG_PR1	PR INTERVAL CYCLE 1 LEAD II (MS) (INTERVAL FROM P-WAVE ONSET TO QRS ONSET)
38	PR interval from EKG	36358	phv00036358.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:19:26+00:00	2018-06-15 18:19:26+00:00 	DIGECG_PR2	PR INTERVAL CYCLE 2 LEAD II (MS) (INTERVAL FROM P-WAVE ONSET TO QRS ONSET)
38	PR interval from EKG	36359	phv00036359.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:19:54+00:00	2018-06-15 18:19:54+00:00 	DIGECG_PR3	PR INTERVAL CYCLE 1 LEAD V2 (MS) (INTERVAL FROM P-WAVE ONSET TO QRS ONSET), DONE ON GEN 3 ONLY
38	PR interval from EKG	36360	phv00036360.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:20:12+00:00	2018-06-15 18:20:12+00:00 	DIGECG_PR4	PR INTERVAL CYCLE 1 LEAD V5 (MS) (INTERVAL FROM P-WAVE ONSET TO QRS ONSET), DONE ON GEN 3 ONLY
38	PR interval from EKG	23256	phv00023256.v5.p10	pht000149.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:37:11+00:00	2018-06-15 18:37:11+00:00 	DG6	P-R INTERVAL
38	PR interval from EKG	7648	phv00007648.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:39:08+00:00	2018-06-15 18:39:08+00:00 	A146	P-R INTERVAL
38	PR interval from EKG	10004	phv00010004.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:40:21+00:00	2018-06-15 18:40:21+00:00 	F580	P-R INTERVAL (HUNDREDTHS OF A SECOND)
38	PR interval from EKG	250656	phv00250656.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 18:56:41+00:00	2018-06-15 18:56:41+00:00 	e585	Electrocardiograph - Part I: Rates and Intervals: P-R interval Collection Interval: Exam 1
38	PR interval from EKG	7888	phv00007888.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:01:40+00:00	2018-06-19 13:01:40+00:00 	B256	ECG: P-R INTERVAL
38	PR interval from EKG	8634	phv00008634.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:02:09+00:00	2018-06-19 13:02:09+00:00 	C290	ECG: P-R INTERVAL
38	PR interval from EKG	9030	phv00009030.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:02:40+00:00	2018-06-19 13:02:40+00:00 	D293	ECG: P-R INTERVAL (HUNDREDTHS OF SECOND)
38	PR interval from EKG	9490	phv00009490.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:02:59+00:00	2018-06-19 13:02:59+00:00 	E585	ECG: P-R INTERVAL (HUNDREDTHS OF SECOND)
38	PR interval from EKG	1330	phv00001330.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:03:22+00:00	2018-06-19 13:03:22+00:00 	FB182	ECG: P-R INTERVAL
38	PR interval from EKG	1525	phv00001525.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:03:39+00:00	2018-06-19 13:03:39+00:00 	FC191	ECG: P-R INTERVAL
38	PR interval from EKG	1716	phv00001716.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:03:53+00:00	2018-06-19 13:03:53+00:00 	FD187	ECG: P-R INTERVAL
38	PR interval from EKG	1977	phv00001977.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:04:24+00:00	2018-06-19 13:04:24+00:00 	FE264	ECG: P-R INTERVAL
38	PR interval from EKG	2157	phv00002157.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:04:44+00:00	2018-06-19 13:04:44+00:00 	FF227	ECG: P-R INTERVAL
38	PR interval from EKG	2352	phv00002352.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:05:07+00:00	2018-06-19 13:05:07+00:00 	FG235	ECG: P-R INTERVAL
38	PR interval from EKG	2592	phv00002592.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:05:23+00:00	2018-06-19 13:05:23+00:00 	FH252	ECG: P-R INTERVAL
38	PR interval from EKG	2800	phv00002800.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:05:37+00:00	2018-06-19 13:05:37+00:00 	FI165	ECG: P-R INTERVAL
38	PR interval from EKG	3179	phv00003179.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:05:59+00:00	2018-06-19 13:05:59+00:00 	FJ277	ECG: P-R INTERVAL
38	PR interval from EKG	3594	phv00003594.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:06:20+00:00	2018-06-19 13:06:20+00:00 	FK372	ECG: P-R INTERVAL
38	PR interval from EKG	4002	phv00004002.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:06:34+00:00	2018-06-19 13:06:34+00:00 	FL393	ECG: P-R INTERVAL (HUNDREDTHS OF SECOND)
38	PR interval from EKG	4426	phv00004426.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:06:52+00:00	2018-06-19 13:06:52+00:00 	FM432	ECG: P-R INTERVAL (HUNDREDTHS OF SECOND)
38	PR interval from EKG	4868	phv00004868.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:07:21+00:00	2018-06-19 13:07:21+00:00 	FN409	ECG: P-R INTERVAL (HUNDREDTHS OF SECOND)
38	PR interval from EKG	5232	phv00005232.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:07:38+00:00	2018-06-19 13:07:38+00:00 	FO428	ECG: P-R INTERVAL (HUNDREDTHS OF SECOND)
38	PR interval from EKG	5859	phv00005859.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:07:55+00:00	2018-06-19 13:07:55+00:00 	FP394	ECG: P-R INTERVAL (HUNDREDTHS OF SECOND)
38	PR interval from EKG	6216	phv00006216.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:10:08+00:00	2018-06-19 13:10:08+00:00 	FQ268	ECG - P-R INTERVAL (HUNDREDTHS OF SECOND)
38	PR interval from EKG	6611	phv00006611.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:10:22+00:00	2018-06-19 13:10:22+00:00 	FR385	ECG - P-R INTERVAL (HUNDREDTHS OF A SECOND)
38	PR interval from EKG	7045	phv00007045.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:10:41+00:00	2018-06-19 13:10:41+00:00 	FS484	ECG: P-R INTERVAL (HUNDREDTHS OF A SECOND)
38	PR interval from EKG	7480	phv00007480.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:10:55+00:00	2018-06-19 13:10:55+00:00 	FT490	ECG RATES AND INTERVALS: P-R INTERVAL (HUNDREDTHS OF A SECOND)
38	PR interval from EKG	70506	phv00070506.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:11:23+00:00	2018-06-19 13:11:23+00:00 	FU202	ECG RATES AND INTERVALS: P-R INTERVAL (HUNDREDTHS OF A SECOND)
38	PR interval from EKG	10437	phv00010437.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:11:39+00:00	2018-06-19 13:11:39+00:00 	G358	ECG: P-R INTERVAL (HUNDREDTHS OF A SECOND)
38	PR interval from EKG	21153	phv00021153.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:12:00+00:00	2018-06-19 13:12:00+00:00 	G3A353	ECG: P-R INTERVAL (HUNDREDTHS OF A SECOND)
38	PR interval from EKG	273975	phv00273975.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:12:08+00:00	2018-06-19 13:12:08+00:00 	g3a353	ECG: P-R interval Collection Interval: Exam 1
38	PR interval from EKG	274468	phv00274468.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:12:18+00:00	2018-06-19 13:12:18+00:00 	g3a353	ECG: P-R interval
38	PR interval from EKG	72262	phv00072262.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 13:12:44+00:00	2018-06-19 13:12:44+00:00 	H305	ECG: P-R INTERVAL (HUNDREDTHS OF A SECOND)
38	PR interval from EKG	127289	phv00127289.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:38:29+00:00	2018-06-20 13:38:29+00:00 	ecga170	PRDURI - PR Duration in lead I
38	PR interval from EKG	127291	phv00127291.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:38:49+00:00	2018-06-20 13:38:49+00:00 	ecga172	PRDURIII - PR Duration in lead III
38	PR interval from EKG	127292	phv00127292.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:40:03+00:00	2018-06-20 13:40:03+00:00 	ecga173	PRDURAVR - PR Duration in lead AVR
38	PR interval from EKG	127293	phv00127293.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:40:14+00:00	2018-06-20 13:40:14+00:00 	ecga174	PRDURAVL - PR Duration in lead AVL
38	PR interval from EKG	127294	phv00127294.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:40:27+00:00	2018-06-20 13:40:27+00:00 	ecga175	PRDURAVF - PR Duration in lead AVF
38	PR interval from EKG	127295	phv00127295.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:40:39+00:00	2018-06-20 13:40:39+00:00 	ecga176	PRDURV1 - PR Duration in lead V1
38	PR interval from EKG	127296	phv00127296.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:41:02+00:00	2018-06-20 13:41:02+00:00 	ecga177	PRDURV2 - PR Duration in lead V2
38	PR interval from EKG	127297	phv00127297.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:41:13+00:00	2018-06-20 13:41:13+00:00 	ecga178	PRDURV3 - PR Duration in lead V3
38	PR interval from EKG	127298	phv00127298.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:41:33+00:00	2018-06-20 13:41:33+00:00 	ecga179	PRDURV4 - PR Duration in lead V4
38	PR interval from EKG	127299	phv00127299.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:41:45+00:00	2018-06-20 13:41:45+00:00 	ecga180	PRDURV5 - PR Duration in lead V5
38	PR interval from EKG	127300	phv00127300.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:41:57+00:00	2018-06-20 13:41:57+00:00 	ecga181	PRDURV6 - PR Duration in lead V6
38	PR interval from EKG	100058	phv00100058.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:33:59+00:00	2018-06-29 18:33:59+00:00 	PR42	P-R INTERVAL, MSEC
38	PR interval from EKG	101973	phv00101973.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:34:11+00:00	2018-06-29 18:34:11+00:00 	PR42	P-R INTERVAL,  MSEC
38	PR interval from EKG	102595	phv00102595.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:34:21+00:00	2018-06-29 18:34:21+00:00 	PR42	P-R INTERVAL,  MSEC
38	PR interval from EKG	104329	phv00104329.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:34:32+00:00	2018-06-29 18:34:32+00:00 	PR42	P-R INTERVAL, MSEC
38	PR interval from EKG	104983	phv00104983.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:34:43+00:00	2018-06-29 18:34:43+00:00 	PR42	P-R INTERVAL, MSEC
38	PR interval from EKG	106350	phv00106350.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:35:00+00:00	2018-06-29 18:35:00+00:00 	PR42	P-R INTERVAL, MSEC
38	PR interval from EKG	107289	phv00107289.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:35:12+00:00	2018-06-29 18:35:12+00:00 	PR42	P-R INTERVAL,  MSEC
38	PR interval from EKG	108165	phv00108165.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:35:21+00:00	2018-06-29 18:35:21+00:00 	PR42	P-R INTERVAL, MSEC
38	PR interval from EKG	108788	phv00108788.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:35:39+00:00	2018-06-29 18:35:39+00:00 	PR42	P-R INTERVAL,  MSEC
38	PR interval from EKG	109319	phv00109319.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:35:49+00:00	2018-06-29 18:35:49+00:00 	PR42	P-R INTERVAL,  MSEC
38	PR interval from EKG	109865	phv00109865.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:36:05+00:00	2018-06-29 18:36:05+00:00 	PR42	P-R INTERVAL,  MSEC
38	PR interval from EKG	155286	phv00155286.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:35:43+00:00	2018-06-29 23:35:43+00:00 	PR_DUR	PR Interval (msec)
38	PR interval from EKG	123557	phv00123557.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:40:46+00:00	2018-08-21 17:40:46+00:00 	PRINTERV	ECG: PR Interval (ms)
38	PR interval from EKG	226275	phv00226275.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:34:33+00:00	2018-08-22 21:34:33+00:00 	ECGA9	PR duration (ECGA9)
38	PR interval from EKG	253004	phv00253004.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:16:55+00:00	2018-08-24 17:16:55+00:00 	ekg_pr_baseline	PR interval measured by electrocardiogram at baseline visit
39	Resting heart rate from EKG	216881	phv00216881.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 20:59:05+00:00	2018-03-21 20:59:05+00:00 	V4ECG6	Heart rate [ECG data, exam 4]
39	Resting heart rate from EKG	216464	phv00216464.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:01:16+00:00	2018-03-21 21:01:16+00:00 	V3ECG6	Heart rate [ECG data, exam 3]
39	Resting heart rate from EKG	216047	phv00216047.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:02:06+00:00	2018-03-21 21:02:06+00:00 	V2ECG6	Heart rate [ECG data, exam 2]
39	Resting heart rate from EKG	215630	phv00215630.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:02:34+00:00	2018-03-21 21:02:34+00:00 	V1ECG6	Heart rate [ECG data, exam 1]
39	Resting heart rate from EKG	205820	phv00205820.v1.p1	pht004078.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:04:00+00:00	2018-03-21 21:04:00+00:00 	ECGB31	Heart rate [ECG Machine Coding, exam 1]
39	Resting heart rate from EKG	205779	phv00205779.v1.p1	pht004077.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:04:38+00:00	2018-03-21 21:04:38+00:00 	ECGMD31	Heart rate [ECG Composite 12 Lead (with adjudications as needed) (ECGMD41), exam 4]
39	Resting heart rate from EKG	205722	phv00205722.v1.p1	pht004076.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:05:55+00:00	2018-03-21 21:05:55+00:00 	ECGMC31	Heart rate [ECG Composite 12 Lead (with adjudications as needed) (ECGMC35), exam 3]
39	Resting heart rate from EKG	205674	phv00205674.v1.p1	pht004075.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:06:39+00:00	2018-03-21 21:06:39+00:00 	ECGMB31	Heart rate [Cohort, Exam 2]
39	Resting heart rate from EKG	205617	phv00205617.v1.p1	pht004074.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:07:22+00:00	2018-03-21 21:07:22+00:00 	ECGMA31	Heart rate  [ECG Composite 12 Lead (with adjudications as needed) (ECGMA03), exam 1]
39	Resting heart rate from EKG	205564	phv00205564.v1.p1	pht004073.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:08:03+00:00	2018-03-21 21:08:03+00:00 	ECGE31	Heart rate [ECG Machine Coding (ECGE04), exam 4]
39	Resting heart rate from EKG	205505	phv00205505.v1.p1	pht004072.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:11:57+00:00	2018-03-21 21:11:57+00:00 	ECGD31	Heart rate [ECG Machine Coding (ECGD04), exam 3]
39	Resting heart rate from EKG	205414	phv00205414.v1.p1	pht004071.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:12:52+00:00	2018-03-21 21:12:52+00:00 	ECGC31	Heart rate [ECG Machine Coding (ECGC), exam 2]
39	Resting heart rate from EKG	205946	phv00205946.v1.p1	pht004080.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:26:18+00:00	2018-03-21 21:26:18+00:00 	ERHA21	Heart rate per minute. Q21 [ECG Rhythm Strip, exam 1]
39	Resting heart rate from EKG	206106	phv00206106.v1.p1	pht004083.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:27:38+00:00	2018-03-21 21:27:38+00:00 	ESMA141	Heart rate-1st ECG-beats per minute [ECG Serial Change, exam 2]
39	Resting heart rate from EKG	206107	phv00206107.v1.p1	pht004083.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:28:12+00:00	2018-03-21 21:28:12+00:00 	ESMA142	Heart rate-follow up ECG-beats per minute [ECG Serial Change, exam 2]
39	Resting heart rate from EKG	206255	phv00206255.v1.p1	pht004084.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:29:58+00:00	2018-03-21 21:29:58+00:00 	ESMB141	Heart rate-1st ECG-beats per minute [ECG Serial Change, exam 3]
39	Resting heart rate from EKG	206256	phv00206256.v1.p1	pht004084.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:30:15+00:00	2018-03-21 21:30:15+00:00 	ESMB142	Heart rate-fup ECG-beats per minute [ECG Serial Change, exam 3]
39	Resting heart rate from EKG	206405	phv00206405.v1.p1	pht004085.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:33:59+00:00	2018-03-21 21:33:59+00:00 	ESMC141	Heart rate-1st ECG-beats per minute [ECG Serial Change, exam 4]
39	Resting heart rate from EKG	206406	phv00206406.v1.p1	pht004085.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-21 21:34:18+00:00	2018-03-21 21:34:18+00:00 	ESMC142	Heart rate-fup ECG-beats per minute [ECG Serial Change, exam 4]
39	Resting heart rate from EKG	127168	phv00127168.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-23 18:51:09+00:00	2018-04-23 18:51:09+00:00 	ecga49	VRATE - V Rate
39	Resting heart rate from EKG	82700	phv00082700.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:34:55+00:00	2018-04-24 03:34:55+00:00 	hrtrate1	HEART RATE (beats/min)
39	Resting heart rate from EKG	84546	phv00084546.v3.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:35:03+00:00	2018-04-24 03:35:03+00:00 	hrtrate1	HEART RATE (BEATS/MIN)
39	Resting heart rate from EKG	176280	phv00176280.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:35:11+00:00	2018-04-24 03:35:11+00:00 	hrtrate5	HEART RATE (60 SECOND):
39	Resting heart rate from EKG	159096	phv00159096.v2.p3	pht002195.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:36:23+00:00	2018-04-24 03:36:23+00:00 	heartrt1	Heart Rate
39	Resting heart rate from EKG	7887	phv00007887.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:19:39+00:00	2018-06-18 18:19:39+00:00 	B255	ECG: VENTRICULAR RATE
39	Resting heart rate from EKG	8633	phv00008633.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:28:59+00:00	2018-06-18 18:28:59+00:00 	C289	ECG: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	8760	phv00008760.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:29:12+00:00	2018-06-18 18:29:12+00:00 	D292	ECG: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	9489	phv00009489.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:29:20+00:00	2018-06-18 18:29:20+00:00 	E584	ECG: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	1181	phv00001181.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:29:28+00:00	2018-06-18 18:29:28+00:00 	FA181	ECG:  VENTRICULAR RATE
39	Resting heart rate from EKG	1329	phv00001329.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:29:41+00:00	2018-06-18 18:29:41+00:00 	FB181	ECG: VENTRICULAR RATE
39	Resting heart rate from EKG	1524	phv00001524.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:29:52+00:00	2018-06-18 18:29:52+00:00 	FC190	ECG: VENTRICULAR RATE
39	Resting heart rate from EKG	1715	phv00001715.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:30:02+00:00	2018-06-18 18:30:02+00:00 	FD186	ECG: VENTRICULAR RATE
39	Resting heart rate from EKG	1976	phv00001976.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:30:10+00:00	2018-06-18 18:30:10+00:00 	FE263	ECG: VENTRICULAR RATE
39	Resting heart rate from EKG	2156	phv00002156.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:30:20+00:00	2018-06-18 18:30:20+00:00 	FF226	ECG: VENTRICULAR RATE
39	Resting heart rate from EKG	2351	phv00002351.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:30:32+00:00	2018-06-18 18:30:32+00:00 	FG234	ECG: VENTRICULAR RATE
39	Resting heart rate from EKG	2591	phv00002591.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:30:41+00:00	2018-06-18 18:30:41+00:00 	FH251	ECG: VENTRICULAR RATE
39	Resting heart rate from EKG	2799	phv00002799.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:30:49+00:00	2018-06-18 18:30:49+00:00 	FI164	ECG: VENTRICULAR RATE
39	Resting heart rate from EKG	3178	phv00003178.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:30:58+00:00	2018-06-18 18:30:58+00:00 	FJ276	ECG: VENTRICULAR RATE
39	Resting heart rate from EKG	3593	phv00003593.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:31:07+00:00	2018-06-18 18:31:07+00:00 	FK371	ECG: VENTRICULAR RATE
39	Resting heart rate from EKG	3692	phv00003692.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:31:15+00:00	2018-06-18 18:31:15+00:00 	FL392	ECG: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	4110	phv00004110.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:31:24+00:00	2018-06-18 18:31:24+00:00 	FM431	ECG: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	4550	phv00004550.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:31:32+00:00	2018-06-18 18:31:32+00:00 	FN408	ECG: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	5231	phv00005231.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:31:42+00:00	2018-06-18 18:31:42+00:00 	FO427	ECG: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	5858	phv00005858.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:31:50+00:00	2018-06-18 18:31:50+00:00 	FP393	ECG: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	6215	phv00006215.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:32:00+00:00	2018-06-18 18:32:00+00:00 	FQ267	ECG - VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	6610	phv00006610.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:32:09+00:00	2018-06-18 18:32:09+00:00 	FR384	ECG - VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	7044	phv00007044.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:32:18+00:00	2018-06-18 18:32:18+00:00 	FS483	ECG: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	7479	phv00007479.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:32:26+00:00	2018-06-18 18:32:26+00:00 	FT489	ECG RATES AND INTERVALS: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	70505	phv00070505.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:32:34+00:00	2018-06-18 18:32:34+00:00 	FU201	ECG RATES AND INTERVALS: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	10436	phv00010436.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:32:48+00:00	2018-06-18 18:32:48+00:00 	G357	ECG: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	21152	phv00021152.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:32:57+00:00	2018-06-18 18:32:57+00:00 	G3A352	ECG: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	273974	phv00273974.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:33:05+00:00	2018-06-18 18:33:05+00:00 	g3a352	ECG: Ventricular rate per minute Collection Interval: Exam 1
39	Resting heart rate from EKG	274467	phv00274467.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:33:14+00:00	2018-06-18 18:33:14+00:00 	g3a352	ECG: Ventricular rate per minute
39	Resting heart rate from EKG	72261	phv00072261.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:33:22+00:00	2018-06-18 18:33:22+00:00 	H304	ECG: VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	742	phv00000742.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:33:30+00:00	2018-06-18 18:33:30+00:00 	MF287	ECG: VENTRICULAR RATE, EXAM 4
39	Resting heart rate from EKG	824	phv00000824.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:33:39+00:00	2018-06-18 18:33:39+00:00 	MF374	ECG: VENTRICULAR RATE, EXAM 5
39	Resting heart rate from EKG	890	phv00000890.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:33:49+00:00	2018-06-18 18:33:49+00:00 	MF444	ECG: VENTRICULAR RATE, EXAM 6
39	Resting heart rate from EKG	1015	phv00001015.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:33:58+00:00	2018-06-18 18:33:58+00:00 	MF575	ECG: VENTRICULAR RATE, EXAM 7
39	Resting heart rate from EKG	277212	phv00277212.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:34:07+00:00	2018-06-18 18:34:07+00:00 	VENT_RT1	Ventricular rate per minute by ECG, Exam 1
39	Resting heart rate from EKG	277213	phv00277213.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:34:16+00:00	2018-06-18 18:34:16+00:00 	VENT_RT2	Ventricular rate per minute by ECG, Exam 2
39	Resting heart rate from EKG	277214	phv00277214.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:34:24+00:00	2018-06-18 18:34:24+00:00 	VENT_RT3	Ventricular rate per minute by ECG, Exam 3
39	Resting heart rate from EKG	277215	phv00277215.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:34:33+00:00	2018-06-18 18:34:33+00:00 	VENT_RT4	Ventricular rate per minute by ECG, Exam 4
39	Resting heart rate from EKG	277216	phv00277216.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:34:42+00:00	2018-06-18 18:34:42+00:00 	VENT_RT5	Ventricular rate per minute by ECG, Exam 5
39	Resting heart rate from EKG	277217	phv00277217.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:34:51+00:00	2018-06-18 18:34:51+00:00 	VENT_RT6	Ventricular rate per minute by ECG, Exam 6
39	Resting heart rate from EKG	277218	phv00277218.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:35:00+00:00	2018-06-18 18:35:00+00:00 	VENT_RT7	Ventricular rate per minute by ECG, Exam 7
39	Resting heart rate from EKG	277219	phv00277219.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:35:12+00:00	2018-06-18 18:35:12+00:00 	VENT_RT8	Ventricular rate per minute by ECG, Exam 8
39	Resting heart rate from EKG	277220	phv00277220.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:35:21+00:00	2018-06-18 18:35:21+00:00 	VENT_RT9	Ventricular rate per minute by ECG, Exam 9
39	Resting heart rate from EKG	277051	phv00277051.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 14:56:46+00:00	2018-06-19 14:56:46+00:00 	VENT_RT1	Ventricular beats per minute by ECG, Exam 1
39	Resting heart rate from EKG	277052	phv00277052.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 14:57:04+00:00	2018-06-19 14:57:04+00:00 	VENT_RT2	Ventricular beats per minute by ECG, Exam 2
39	Resting heart rate from EKG	100054	phv00100054.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:49:59+00:00	2018-06-29 18:49:59+00:00 	HRATE42	HEART RATE
39	Resting heart rate from EKG	101969	phv00101969.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:50:10+00:00	2018-06-29 18:50:10+00:00 	HRATE42	HEART RATE
39	Resting heart rate from EKG	102591	phv00102591.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:50:22+00:00	2018-06-29 18:50:22+00:00 	HRATE42	HEART RATE
39	Resting heart rate from EKG	104326	phv00104326.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:50:33+00:00	2018-06-29 18:50:33+00:00 	HRATE42	HEART RATE
39	Resting heart rate from EKG	104980	phv00104980.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:50:46+00:00	2018-06-29 18:50:46+00:00 	HRATE42	HEART RATE
39	Resting heart rate from EKG	106347	phv00106347.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:51:04+00:00	2018-06-29 18:51:04+00:00 	HRATE42	HEART RATE
39	Resting heart rate from EKG	107286	phv00107286.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:51:15+00:00	2018-06-29 18:51:15+00:00 	HRATE42	HEART RATE
39	Resting heart rate from EKG	108162	phv00108162.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:51:27+00:00	2018-06-29 18:51:27+00:00 	HRATE42	HEART RATE
39	Resting heart rate from EKG	108784	phv00108784.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:51:37+00:00	2018-06-29 18:51:37+00:00 	HRATE42	HEART RATE
39	Resting heart rate from EKG	109315	phv00109315.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:51:48+00:00	2018-06-29 18:51:48+00:00 	HRATE42	HEART RATE
39	Resting heart rate from EKG	109861	phv00109861.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:51:58+00:00	2018-06-29 18:51:58+00:00 	HRATE42	Heart Rate
39	Resting heart rate from EKG	155154	phv00155154.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:28:21+00:00	2018-06-29 23:28:21+00:00 	HEART_RT	Heart rate (beats/minute)
39	Resting heart rate from EKG	36349	phv00036349.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:13:21+00:00	2018-07-03 18:13:21+00:00 	DIGECG_RR1	RR INTERVAL CYCLE 1 LEAD II (MS)(INTERVAL FROM R-WAVE TO CONSECUTIVE R-WAVE)
39	Resting heart rate from EKG	36350	phv00036350.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:13:42+00:00	2018-07-03 18:13:42+00:00 	DIGECG_RR2	RR INTERVAL CYCLE 2 LEAD II (MS)(INTERVAL FROM R-WAVE TO CONSECUTIVE R-WAVE)
39	Resting heart rate from EKG	36351	phv00036351.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:13:52+00:00	2018-07-03 18:13:52+00:00 	DIGECG_RR3	RR INTERVAL CYCLE 1 LEAD V2 (MS) (INTERVAL FROM R-WAVE TO CONSECUTIVE R-WAVE)
39	Resting heart rate from EKG	36352	phv00036352.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:14:03+00:00	2018-07-03 18:14:03+00:00 	DIGECG_RR4	RR INTERVAL CYCLE 1 LEAD V5 (MS) (INTERVAL FROM R-WAVE TO CONSECUTIVE R-WAVE)
39	Resting heart rate from EKG	23255	phv00023255.v5.p10	pht000149.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:14:41+00:00	2018-07-03 18:14:41+00:00 	DG5	VENTRICULAR RATE
39	Resting heart rate from EKG	8001	phv00008001.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:15:06+00:00	2018-07-03 18:15:06+00:00 	B384	TARGET HEART RATE
39	Resting heart rate from EKG	8162	phv00008162.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:15:30+00:00	2018-07-03 18:15:30+00:00 	B518	HEART RATE-RESTING, SIT
39	Resting heart rate from EKG	254206	phv00254206.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:16:04+00:00	2018-07-03 18:16:04+00:00 	j359	Electrocardiograph-Part I: Rates and Intervals: Ventricular rate per minute
39	Resting heart rate from EKG	177818	phv00177818.v3.p10	pht003097.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:17:05+00:00	2018-07-03 18:17:05+00:00 	vrate	Ventricular rate
39	Resting heart rate from EKG	177462	phv00177462.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:17:59+00:00	2018-07-03 18:17:59+00:00 	g3b0369	Electrocardiograph: Rates and Intervals: Ventricular rate per minute
39	Resting heart rate from EKG	7647	phv00007647.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:19:02+00:00	2018-07-03 18:19:02+00:00 	A145	VENTRICULAR RATE
39	Resting heart rate from EKG	10003	phv00010003.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:19:39+00:00	2018-07-03 18:19:39+00:00 	F579	VENTRICULAR RATE PER MINUTE
39	Resting heart rate from EKG	254714	phv00254714.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:20:03+00:00	2018-07-03 18:20:03+00:00 	fv203	Electrocardiograph: Rates and Intervals: Ventricular rate per minute Collection Interval: Exam 29
39	Resting heart rate from EKG	255104	phv00255104.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:20:24+00:00	2018-07-03 18:20:24+00:00 	fw243	Electrocardiograph: Rates and Intervals: Ventricular rate per minute Collection Interval: Original Cohort Exam 30
39	Resting heart rate from EKG	274829	phv00274829.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:20:36+00:00	2018-07-03 18:20:36+00:00 	FX243	Electrocardiograph: Rates and Intervals: Ventricular rate per minute Collection Interval: Original Cohort Exam 31
39	Resting heart rate from EKG	275187	phv00275187.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:20:47+00:00	2018-07-03 18:20:47+00:00 	fy243	Electrocardiograph: Rates and Intervals: Ventricular rate per minute Collection Interval: Original Cohort Exam 32
39	Resting heart rate from EKG	251457	phv00251457.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:21:53+00:00	2018-07-03 18:21:53+00:00 	h304	Electrocardiograph - Part I: Rates and Intervals: Ventricular rate per minute Collection Interval: Exam 3
39	Resting heart rate from EKG	71974	phv00071974.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:22:11+00:00	2018-07-03 18:22:11+00:00 	ventrate_s1	Ventricular rate for first sleep study Collection Interval: 1998-2003
39	Resting heart rate from EKG	71987	phv00071987.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:22:21+00:00	2018-07-03 18:22:21+00:00 	ventrate_s2	Ventricular rate for second sleep study Collection Interval: 1998-2003
39	Resting heart rate from EKG	55184	phv00055184.v4.p10	pht000394.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:22:50+00:00	2018-07-03 18:22:50+00:00 	WT020	SUPINE HEART RATE
39	Resting heart rate from EKG	250655	phv00250655.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:30:52+00:00	2018-07-03 18:30:52+00:00 	e584	Electrocardiograph - Part I: Rates and Intervals: Ventricular rate per minute Collection Interval: Exam 1
39	Resting heart rate from EKG	250997	phv00250997.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-07-03 18:32:53+00:00	2018-07-03 18:32:53+00:00 	g357	Electrocardiograph - Part I - Rates and Intervals: Ventricular rate per minute Collection Interval: Exam 2
39	Resting heart rate from EKG	253005	phv00253005.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:17:26+00:00	2018-08-24 17:17:26+00:00 	ekg_hr_baseline	Heart rate measured by electrocardiogram at baseline visit
40	LVH from EKG	204610	phv00204610.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:42:07+00:00	2018-03-20 15:42:07+00:00 	LVHSCR21	Cornell voltage in UV (S In V3+r In AVL) [Cohort, Exam 2]
40	LVH from EKG	204611	phv00204611.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:43:44+00:00	2018-03-20 15:43:44+00:00 	NLVHSC21	Cornell voltage in mm [Cohort, Exam 2]
40	LVH from EKG	204612	phv00204612.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:44:04+00:00	2018-03-20 15:44:04+00:00 	CLVH21	LVH present by Cornell definition [Cohort, Exam 2]
40	LVH from EKG	204698	phv00204698.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:44:25+00:00	2018-03-20 15:44:25+00:00 	LVHSCR01	Absolute value of ECGRA198 plus ECGRA170 Cornell voltage in Uv (S In V3+r In Avl) [Cohort, Exam 1]
40	LVH from EKG	204699	phv00204699.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:44:48+00:00	2018-03-20 15:44:48+00:00 	NLVHSC01	Cornell voltage in nm [Cohort, Exam 1]
40	LVH from EKG	204700	phv00204700.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:45:06+00:00	2018-03-20 15:45:06+00:00 	CLVH01	LVH present by Cornell definition [Cohort, Exam 1]
40	LVH from EKG	204828	phv00204828.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:45:34+00:00	2018-03-20 15:45:34+00:00 	LVHSCR31	Cornell voltage in UV (S in V3+r in AVL) [Cohort, Exam 3]
40	LVH from EKG	204829	phv00204829.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:45:54+00:00	2018-03-20 15:45:54+00:00 	NLVHSC31	Cornell voltage in mm [Cohort, Exam 3]
40	LVH from EKG	204830	phv00204830.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:46:12+00:00	2018-03-20 15:46:12+00:00 	CLVH31	LVH present by Cornell definition [Cohort, Exam 3]
40	LVH from EKG	204932	phv00204932.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:46:32+00:00	2018-03-20 15:46:32+00:00 	LVHSCR41	Cornell voltage in UV (S in visit 3+r in AVL) [Cohort, Exam 4]
40	LVH from EKG	204933	phv00204933.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:46:53+00:00	2018-03-20 15:46:53+00:00 	NLVHSC41	Cornell voltage in mm [Cohort, Exam 4]
40	LVH from EKG	204934	phv00204934.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:47:16+00:00	2018-03-20 15:47:16+00:00 	CLVH41	LVH present by Cornell definition [Cohort, Exam 4]
40	LVH from EKG	215647	phv00215647.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:49:05+00:00	2018-03-20 15:49:05+00:00 	V1ECG25	Left ventricular hypertrophy, by Cornell voltage [ECG data, exam 1]
40	LVH from EKG	215648	phv00215648.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:49:22+00:00	2018-03-20 15:49:22+00:00 	V1ECG26	Left ventricular hpertrophy, by Cornell voltage product [ECG data, exam 1]
40	LVH from EKG	215649	phv00215649.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:50:01+00:00	2018-03-20 15:50:01+00:00 	V1ECG27	Left ventricular hypertrophy, by Minnesota code [ECG data, exam 1]
40	LVH from EKG	215650	phv00215650.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:50:22+00:00	2018-03-20 15:50:22+00:00 	V1ECG28	Left ventricular hypertrophy, by Sokolow-Lyon [ECG data, exam 1]
40	LVH from EKG	215677	phv00215677.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:50:55+00:00	2018-03-20 15:50:55+00:00 	V1ECG57	Novacode left ventricular hypertrophy; by software [ECG data, exam 1]
40	LVH from EKG	215720	phv00215720.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:51:29+00:00	2018-03-20 15:51:29+00:00 	V1ECG100	Left ventricular hypertrophy plus major STT change [ECG data, exam 1]
40	LVH from EKG	216064	phv00216064.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:51:47+00:00	2018-03-20 15:51:47+00:00 	V2ECG25	Left ventricular hypertrophy, by Cornell voltage [ECG data, exam 2]
40	LVH from EKG	216065	phv00216065.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:52:05+00:00	2018-03-20 15:52:05+00:00 	V2ECG26	Left ventricular hpertrophy, by Cornell voltage product [ECG data, exam 2]
40	LVH from EKG	216066	phv00216066.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:52:30+00:00	2018-03-20 15:52:30+00:00 	V2ECG27	Left ventricular hypertrophy, by Minnesota code [ECG data, exam 2]
40	LVH from EKG	216067	phv00216067.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:52:51+00:00	2018-03-20 15:52:51+00:00 	V2ECG28	Left ventricular hypertrophy, by Sokolow-Lyon [ECG data, exam 2]
40	LVH from EKG	216094	phv00216094.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:53:27+00:00	2018-03-20 15:53:27+00:00 	V2ECG57	Novacode left ventricular hypertrophy; by software [ECG data, exam 2]
40	LVH from EKG	216137	phv00216137.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:53:47+00:00	2018-03-20 15:53:47+00:00 	V2ECG100	Left ventricular hypertrophy plus major STT change [ECG data, exam 2]
40	LVH from EKG	216481	phv00216481.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:55:59+00:00	2018-03-20 15:55:59+00:00 	V3ECG25	Left ventricular hypertrophy, by Cornell voltage [ECG data, exam 3]
40	LVH from EKG	216482	phv00216482.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:57:01+00:00	2018-03-20 15:57:01+00:00 	V3ECG26	Left ventricular hpertrophy, by Cornell voltage product [ECG data, exam 3]
40	LVH from EKG	216483	phv00216483.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:57:21+00:00	2018-03-20 15:57:21+00:00 	V3ECG27	Left ventricular hypertrophy, by Minnesota code [ECG data, exam 3]
40	LVH from EKG	216484	phv00216484.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:57:43+00:00	2018-03-20 15:57:43+00:00 	V3ECG28	Left ventricular hypertrophy, by Sokolow-Lyon [ECG data, exam 3]
40	LVH from EKG	216511	phv00216511.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:57:59+00:00	2018-03-20 15:57:59+00:00 	V3ECG57	Novacode left ventricular hypertrophy; by software [ECG data, exam 3]
40	LVH from EKG	216554	phv00216554.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:58:16+00:00	2018-03-20 15:58:16+00:00 	V3ECG100	Left ventricular hypertrophy plus major STT change [ECG data, exam 3]
40	LVH from EKG	216898	phv00216898.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:58:34+00:00	2018-03-20 15:58:34+00:00 	V4ECG25	Left ventricular hypertrophy, by Cornell voltage [ECG data, exam 4]
40	LVH from EKG	216899	phv00216899.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:58:50+00:00	2018-03-20 15:58:50+00:00 	V4ECG26	Left ventricular hpertrophy, by Cornell voltage product [ECG data, exam 4]
40	LVH from EKG	216900	phv00216900.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:59:07+00:00	2018-03-20 15:59:07+00:00 	V4ECG27	Left ventricular hypertrophy, by Minnesota code [ECG data, exam 4]
40	LVH from EKG	216901	phv00216901.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:59:27+00:00	2018-03-20 15:59:27+00:00 	V4ECG28	Left ventricular hypertrophy, by Sokolow-Lyon [ECG data, exam 4]
40	LVH from EKG	216928	phv00216928.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 15:59:44+00:00	2018-03-20 15:59:44+00:00 	V4ECG57	Novacode left ventricular hypertrophy; by software [ECG data, exam 4]
40	LVH from EKG	216971	phv00216971.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-20 16:00:00+00:00	2018-03-20 16:00:00+00:00 	V4ECG100	Left ventricular hypertrophy plus major STT change [ECG data, exam 4]
40	LVH from EKG	82842	phv00082842.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:42:07+00:00	2018-04-24 03:42:07+00:00 	ecglvh1c	ECG LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	84552	phv00084552.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:42:14+00:00	2018-04-24 03:42:14+00:00 	ecglvh1c	LEFT VENTRICULAR HYPERTROPHY BY NOVACODE
40	LVH from EKG	175124	phv00175124.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:42:24+00:00	2018-04-24 03:42:24+00:00 	ecglvh5c	ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE
40	LVH from EKG	218150	phv00218150.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:42:41+00:00	2018-04-24 03:42:41+00:00 	lvhcv5	LEFT VENTRICULAR HYPERTROPHY, BY CORNELL VOLTAGE
40	LVH from EKG	176547	phv00176547.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:42:46+00:00	2018-04-24 03:42:46+00:00 	ecglvh5c	ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE
40	LVH from EKG	176503	phv00176503.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:43:36+00:00	2018-04-24 03:43:36+00:00 	major55	LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	175080	phv00175080.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:43:42+00:00	2018-04-24 03:43:42+00:00 	major55	LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	174569	phv00174569.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 03:43:48+00:00	2018-04-24 03:43:48+00:00 	major51	MAJOR ABNORMALITY 5 PER MINNESOTA CODE: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	205852	phv00205852.v1.p1	pht004079.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 21:30:28+00:00	2018-04-25 21:30:28+00:00 	ECHA12	Left ventricular hypertrophy 12 [Cohort (Jackson only), Exam 3]
40	LVH from EKG	6249	phv00006249.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:38:45+00:00	2018-06-15 13:38:45+00:00 	FQ301	LVH
40	LVH from EKG	7666	phv00007666.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:40:54+00:00	2018-06-15 13:40:54+00:00 	A164	LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	10037	phv00010037.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:41:25+00:00	2018-06-15 13:41:25+00:00 	F613	LVH (IF COMPLETE LBBB PRESENT, LVH=UNKNOWN)
40	LVH from EKG	71950	phv00071950.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:42:08+00:00	2018-06-15 13:42:08+00:00 	lvh3_1_s1	Left ventricular hypertrophy (LVH) voltage for first sleep study Collection Interval: 1998-2003
40	LVH from EKG	71951	phv00071951.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:52:46+00:00	2018-06-15 13:52:46+00:00 	lvh3_3_s1	Left ventricular hypertrophy (LVH) voltage for first sleep study Collection Interval: 1998-2003
40	LVH from EKG	71982	phv00071982.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:53:11+00:00	2018-06-15 13:53:11+00:00 	lvh3_1_s2	Left ventricular hypertrophy (LVH) voltage for second sleep study Collection Interval: 1998-2003
40	LVH from EKG	71983	phv00071983.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:53:49+00:00	2018-06-15 13:53:49+00:00 	lvh3_3_s2	Left ventricular hypertrophy (LVH) voltage for second sleep study Collection Interval: 1998-2003
40	LVH from EKG	71954	phv00071954.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:56:53+00:00	2018-06-15 13:56:53+00:00 	lvhst_s1	Left ventricular hypertrophy (LVH) with S-T,T-wave abnormality for first sleep study Collection Interval: 1998-2003
40	LVH from EKG	71986	phv00071986.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 13:57:09+00:00	2018-06-15 13:57:09+00:00 	lvhst_s2	Left ventricular hypertrophy (LVH) with S-T,T-wave abnormality for second sleep study Collection Interval: 1998-2003
40	LVH from EKG	277036	phv00277036.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 14:01:07+00:00	2018-06-15 14:01:07+00:00 	DLVH1	Definite left ventricular hypertrophy, Exam 1
40	LVH from EKG	277037	phv00277037.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 14:01:18+00:00	2018-06-15 14:01:18+00:00 	DLVH2	Definite left ventricular hypertrophy, Exam 2
40	LVH from EKG	277146	phv00277146.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 14:01:27+00:00	2018-06-15 14:01:27+00:00 	DLVH1	Definite left ventricular hypertrophy, Exam 1
40	LVH from EKG	277147	phv00277147.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 14:01:37+00:00	2018-06-15 14:01:37+00:00 	DLVH2	Definite left ventricular hypertrophy, Exam 2
40	LVH from EKG	277148	phv00277148.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 14:01:46+00:00	2018-06-15 14:01:46+00:00 	DLVH3	Definite left ventricular hypertrophy, Exam 3
40	LVH from EKG	277149	phv00277149.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 14:01:54+00:00	2018-06-15 14:01:54+00:00 	DLVH4	Definite left ventricular hypertrophy, Exam 4
40	LVH from EKG	277150	phv00277150.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 14:02:03+00:00	2018-06-15 14:02:03+00:00 	DLVH5	Definite left ventricular hypertrophy, Exam 5
40	LVH from EKG	277151	phv00277151.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 14:02:12+00:00	2018-06-15 14:02:12+00:00 	DLVH6	Definite left ventricular hypertrophy, Exam 6
40	LVH from EKG	277152	phv00277152.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 14:02:21+00:00	2018-06-15 14:02:21+00:00 	DLVH7	Definite left ventricular hypertrophy, Exam 7
40	LVH from EKG	277153	phv00277153.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 14:02:30+00:00	2018-06-15 14:02:30+00:00 	DLVH8	Definite left ventricular hypertrophy, Exam 8
40	LVH from EKG	277154	phv00277154.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-15 14:02:39+00:00	2018-06-15 14:02:39+00:00 	DLVH9	Definite left ventricular hypertrophy, Exam 9
40	LVH from EKG	7907	phv00007907.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:39:06+00:00	2018-06-18 18:39:06+00:00 	B275	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	8674	phv00008674.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:39:32+00:00	2018-06-18 18:39:32+00:00 	C330	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	9070	phv00009070.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:39:51+00:00	2018-06-18 18:39:51+00:00 	D334	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	9523	phv00009523.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:40:25+00:00	2018-06-18 18:40:25+00:00 	E618	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	250689	phv00250689.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:40:34+00:00	2018-06-18 18:40:34+00:00 	e618	Electrocardiograph - Part II: Hypertrophy, enlargement, and other ECG Diagnoses: Left ventricular hypertrophy Collection Interval: Exam 1
40	LVH from EKG	1172	phv00001172.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:40:46+00:00	2018-06-18 18:40:46+00:00 	FA172	ECG:  LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	1333	phv00001333.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:40:57+00:00	2018-06-18 18:40:57+00:00 	FB185	ECG:  LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	1528	phv00001528.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:41:05+00:00	2018-06-18 18:41:05+00:00 	FC194	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	1996	phv00001996.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:42:40+00:00	2018-06-18 18:42:40+00:00 	FE283	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	2176	phv00002176.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:43:34+00:00	2018-06-18 18:43:34+00:00 	FF246	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	2371	phv00002371.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:44:11+00:00	2018-06-18 18:44:11+00:00 	FG254	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	2611	phv00002611.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:44:24+00:00	2018-06-18 18:44:24+00:00 	FH271	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	2817	phv00002817.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:44:37+00:00	2018-06-18 18:44:37+00:00 	FI182	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	3616	phv00003616.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:45:22+00:00	2018-06-18 18:45:22+00:00 	FK394	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	4042	phv00004042.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:46:54+00:00	2018-06-18 18:46:54+00:00 	FL434	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	4466	phv00004466.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:47:05+00:00	2018-06-18 18:47:05+00:00 	FM473	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	4903	phv00004903.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:47:41+00:00	2018-06-18 18:47:41+00:00 	FN445	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	5265	phv00005265.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:48:11+00:00	2018-06-18 18:48:11+00:00 	FO461	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	5892	phv00005892.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:48:56+00:00	2018-06-18 18:48:56+00:00 	FP427	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	650	phv00000650.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:49:43+00:00	2018-06-18 18:49:43+00:00 	MF185	ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 3
40	LVH from EKG	735	phv00000735.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:49:53+00:00	2018-06-18 18:49:53+00:00 	MF280	ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 4
40	LVH from EKG	818	phv00000818.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:50:02+00:00	2018-06-18 18:50:02+00:00 	MF368	ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 5
40	LVH from EKG	884	phv00000884.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:50:13+00:00	2018-06-18 18:50:13+00:00 	MF438	ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 6
40	LVH from EKG	1009	phv00001009.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:50:24+00:00	2018-06-18 18:50:24+00:00 	MF569	ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 7
40	LVH from EKG	6643	phv00006643.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:52:33+00:00	2018-06-18 18:52:33+00:00 	FR417	ECG - LVH
40	LVH from EKG	7078	phv00007078.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:53:03+00:00	2018-06-18 18:53:03+00:00 	FS517	ECG: LVH (IF COMPLETE LBBB PRESENT, LVH = UNKNOWN)
40	LVH from EKG	7513	phv00007513.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:53:29+00:00	2018-06-18 18:53:29+00:00 	FT523	ECG: LVH (IF COMPLETE LBBB PRESENT, LVH = UNKNOWN)
40	LVH from EKG	70539	phv00070539.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:54:37+00:00	2018-06-18 18:54:37+00:00 	FU235	ECG: LVH (IF COMPLETE LBBB PRESENT, LVH = UNKNOWN)
40	LVH from EKG	10470	phv00010470.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:55:49+00:00	2018-06-18 18:55:49+00:00 	G391	ECG: LVH (IF COMPLETE LBBB PRESENT, LVH = UNKNOWN)
40	LVH from EKG	21186	phv00021186.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:57:03+00:00	2018-06-18 18:57:03+00:00 	G3A386	ECG: LVH (IF COMPLETE LBBB PRESENT, LVH = UNKNOWN)
40	LVH from EKG	274008	phv00274008.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:57:13+00:00	2018-06-18 18:57:13+00:00 	g3a386	ECG: LVH Collection Interval: Exam 1
40	LVH from EKG	274501	phv00274501.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 18:57:22+00:00	2018-06-18 18:57:22+00:00 	g3a386	ECG: LVH
40	LVH from EKG	254748	phv00254748.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 12:44:01+00:00	2018-06-19 12:44:01+00:00 	fv237	Electrocardiograph: Hypertrophy, enlargement, and other ECG Diagnoses: LVH Collection Interval: Exam 29
40	LVH from EKG	255139	phv00255139.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 12:44:12+00:00	2018-06-19 12:44:12+00:00 	fw278	Electrocardiograph: Hypertrophy, enlargement, and other ECG Diagnoses - LVH Collection Interval: Original Cohort Exam 30
40	LVH from EKG	274864	phv00274864.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 12:44:21+00:00	2018-06-19 12:44:21+00:00 	FX278	Electrocardiograph: Hypertrophy, enlargement, and other ECG Diagnoses - LVH Collection Interval: Original Cohort Exam 31
40	LVH from EKG	275222	phv00275222.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 12:44:34+00:00	2018-06-19 12:44:34+00:00 	fy278	Electrocardiograph: Hypertrophy, enlargement, and other ECG Diagnoses - LVH Collection Interval: Original Cohort Exam 32
40	LVH from EKG	251031	phv00251031.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 12:44:46+00:00	2018-06-19 12:44:46+00:00 	g391	Electrocardiograph - Part II - Hypertrophy, enlargement, and other ECG Diagnoses: LVH Collection Interval: Exam 2
40	LVH from EKG	177496	phv00177496.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 12:45:39+00:00	2018-06-19 12:45:39+00:00 	g3b0403	Electrocardiograph: Hypertrophy, enlargement, and other ECG Diagnoses: LVH
40	LVH from EKG	251491	phv00251491.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 12:45:52+00:00	2018-06-19 12:45:52+00:00 	h338	Electrocardiograph - Part II: Hypertrophy, enlargement, and other ECG Diagnoses: LVH Collection Interval: Exam 3
40	LVH from EKG	254240	phv00254240.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 12:46:04+00:00	2018-06-19 12:46:04+00:00 	j393	Electrocardiograph-Part II: Hypertrophy, enlargement, and other ECG Diagnoses: LVH
40	LVH from EKG	72295	phv00072295.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 12:46:39+00:00	2018-06-19 12:46:39+00:00 	H338	ECG: LVH (IF COMPLETE LBBB PRESENT, RVH = UNKNOWN)
40	LVH from EKG	1719	phv00001719.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 14:20:51+00:00	2018-06-19 14:20:51+00:00 	FD190	ECG: LEFT VENTRICULAR HYPERTROPHY
40	LVH from EKG	567	phv00000567.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 14:21:37+00:00	2018-06-19 14:21:37+00:00 	MF97	ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 2
40	LVH from EKG	518	phv00000518.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-19 15:26:00+00:00	2018-06-19 15:26:00+00:00 	MF44	ECG: VENTRICULAR HYPERTROPHY OR STRAIN, EXAM 1
40	LVH from EKG	127130	phv00127130.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:57:41+00:00	2018-06-20 13:57:41+00:00 	ecga11	HRVCVOLT - cornell voltage criteria
40	LVH from EKG	100067	phv00100067.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:36:42+00:00	2018-06-29 18:36:42+00:00 	ECGLVH	LV HYPERTROPHY BY ECG
40	LVH from EKG	100455	phv00100455.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:36:57+00:00	2018-06-29 18:36:57+00:00 	ECGLVH	LV HYPERTROPHY BY ECG
40	LVH from EKG	101981	phv00101981.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:37:10+00:00	2018-06-29 18:37:10+00:00 	ECGLVH	LV HYPERTROPHY BY ECG
40	LVH from EKG	102606	phv00102606.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:37:26+00:00	2018-06-29 18:37:26+00:00 	ECGLVH	LV HYPERTROPHY BY ECG
40	LVH from EKG	104992	phv00104992.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:37:36+00:00	2018-06-29 18:37:36+00:00 	ECGLVH	LV HYPERTROPHY BY ECG
40	LVH from EKG	106359	phv00106359.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:37:50+00:00	2018-06-29 18:37:50+00:00 	ECGLVH	LV HYPERTROPHY BY ECG
40	LVH from EKG	107298	phv00107298.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:38:01+00:00	2018-06-29 18:38:01+00:00 	ECGLVH	LV HYPERTROPHY BY ECG
40	LVH from EKG	108174	phv00108174.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:38:17+00:00	2018-06-29 18:38:17+00:00 	ECGLVH	LV HYPERTROPHY BY ECG
40	LVH from EKG	108796	phv00108796.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:38:30+00:00	2018-06-29 18:38:30+00:00 	ECGLVH	LV HYPERTROPHY BY ECG
40	LVH from EKG	109326	phv00109326.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:38:45+00:00	2018-06-29 18:38:45+00:00 	ECGLVH	LV HYPERTROPHY BY ECG
40	LVH from EKG	109874	phv00109874.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:38:54+00:00	2018-06-29 18:38:54+00:00 	ECGLVH	LV HYPERTROPHY BY ECG
40	LVH from EKG	197326	phv00197326.v1.p1	pht003697.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:44:08+00:00	2018-06-29 18:44:08+00:00 	lvh3_1	Left ventricular hypertrophy (LVH) Voltage (MN code 3-1)
40	LVH from EKG	197327	phv00197327.v1.p1	pht003697.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:44:18+00:00	2018-06-29 18:44:18+00:00 	lvh3_3	Left ventricular hypertrophy (LVH) Voltage (MN code 3-3)
40	LVH from EKG	197330	phv00197330.v1.p1	pht003697.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:44:32+00:00	2018-06-29 18:44:32+00:00 	lvhst	Left ventricular hypertrophy (LVH) with ST, T-wave abnormality
40	LVH from EKG	197361	phv00197361.v1.p1	pht003698.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:45:37+00:00	2018-06-29 18:45:37+00:00 	lvh3_1	Left ventricular hypertrophy (LVH) Voltage (MN code 3-1)
40	LVH from EKG	197362	phv00197362.v1.p1	pht003698.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:45:48+00:00	2018-06-29 18:45:48+00:00 	lvh3_3	Left ventricular hypertrophy (LVH) Voltage (MN code 3-3)
40	LVH from EKG	197365	phv00197365.v1.p1	pht003698.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 18:45:58+00:00	2018-06-29 18:45:58+00:00 	lvhst	Left ventricular hypertrophy (LVH) with ST, T-wave abnormality
40	LVH from EKG	155170	phv00155170.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:31:35+00:00	2018-06-29 23:31:35+00:00 	LVHI	Left Ventricular Hypertrophy Index
40	LVH from EKG	155171	phv00155171.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:31:35+00:00	2018-06-29 23:31:35+00:00 	LVHI_CAT	Left Ventricular Hypertrophy Index > 120 (1,0)
40	LVH from EKG	155172	phv00155172.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 23:31:35+00:00	2018-06-29 23:31:35+00:00 	LVH_MINN	LVH by Minnesota Code
41	Pacemaker	216978	phv00216978.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 16:48:35+00:00	2018-04-12 16:48:35+00:00 	V4ECG107	Pacemaker [ECG data, exam 4]
41	Pacemaker	216949	phv00216949.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 16:49:05+00:00	2018-04-12 16:49:05+00:00 	V4ECG78	Artificial pacemaker; by Visual flag [ECG data, exam 4]
41	Pacemaker	216914	phv00216914.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 16:49:42+00:00	2018-04-12 16:49:42+00:00 	V4ECG43	Electronic pacemaker, by visual flag [ECG data, exam 4]
41	Pacemaker	216906	phv00216906.v1.p1	pht004234.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 16:50:44+00:00	2018-04-12 16:50:44+00:00 	V4ECG35	Ventricular or dual-chamber pacemaker, by visual flag [ECG data, exam 4]
41	Pacemaker	216561	phv00216561.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 16:52:30+00:00	2018-04-12 16:52:30+00:00 	V3ECG107	Pacemaker [ECG data, exam 3]
41	Pacemaker	216532	phv00216532.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 16:53:04+00:00	2018-04-12 16:53:04+00:00 	V3ECG78	Artificial pacemaker; by Visual flag [ECG data, exam 3]
41	Pacemaker	216497	phv00216497.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 16:53:34+00:00	2018-04-12 16:53:34+00:00 	V3ECG43	Electronic pacemaker, by visual flag [ECG data, exam 3]
41	Pacemaker	216489	phv00216489.v1.p1	pht004233.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 16:54:44+00:00	2018-04-12 16:54:44+00:00 	V3ECG35	Ventricular or dual-chamber pacemaker, by visual flag [ECG data, exam 3]
41	Pacemaker	216144	phv00216144.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 16:55:53+00:00	2018-04-12 16:55:53+00:00 	V2ECG107	Pacemaker [ECG data, exam 2]
41	Pacemaker	216115	phv00216115.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 16:56:44+00:00	2018-04-12 16:56:44+00:00 	V2ECG78	Artificial pacemaker; by Visual flag [ECG data, exam 2]
41	Pacemaker	216080	phv00216080.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 16:57:13+00:00	2018-04-12 16:57:13+00:00 	V2ECG43	Electronic pacemaker, by visual flag [ECG data, exam 2]
41	Pacemaker	216072	phv00216072.v1.p1	pht004232.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 16:59:00+00:00	2018-04-12 16:59:00+00:00 	V2ECG35	Ventricular or dual-chamber pacemaker, by visual flag [ECG data, exam 2]
41	Pacemaker	215727	phv00215727.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 17:00:18+00:00	2018-04-12 17:00:18+00:00 	V1ECG107	Pacemaker [ECG data, exam 1]
41	Pacemaker	215698	phv00215698.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 17:00:58+00:00	2018-04-12 17:00:58+00:00 	V1ECG78	Artificial pacemaker; by Visual flag [ECG data, exam 1]
41	Pacemaker	215663	phv00215663.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 17:01:23+00:00	2018-04-12 17:01:23+00:00 	V1ECG43	Electronic pacemaker, by visual flag [ECG data, exam 1]
41	Pacemaker	215655	phv00215655.v1.p1	pht004231.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 17:02:22+00:00	2018-04-12 17:02:22+00:00 	V1ECG35	Ventricular or dual-chamber pacemaker, by visual flag [ECG data, exam 1]
41	Pacemaker	207815	phv00207815.v1.p1	pht004128.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 17:05:03+00:00	2018-04-12 17:05:03+00:00 	MSCA4	[Exclusion]. Do you have a cardiac pacemaker or a heart valve prosthesis? Q4 [MRI Screening Form, exam 3]
41	Pacemaker	206911	phv00206911.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 17:05:32+00:00	2018-04-12 17:05:32+00:00 	HFAA50	Q50 - Interventions: biventricular Pacemaker (CRT) (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA]
41	Pacemaker	206910	phv00206910.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 18:43:10+00:00	2018-04-12 18:43:10+00:00 	HFAA49	Q49 - Interventions: pacemaker Placement (Non-Biventricular) (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA]
41	Pacemaker	206798	phv00206798.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 18:43:32+00:00	2018-04-12 18:43:32+00:00 	HFAA11E4	[Medical history]. Q11e4- Cardiac procedures: pacemaker [Heart Failure Hospital Record Abstraction Form, HFA]
41	Pacemaker	205047	phv00205047.v1.p1	pht004067.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 18:44:54+00:00	2018-04-12 18:44:54+00:00 	DSRA9	Do you have a cardiac pacemaker? Q9 [Dental Screening Form, exam 4]
41	Pacemaker	204151	phv00204151.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 18:45:34+00:00	2018-04-12 18:45:34+00:00 	HRAA29P1	[Second transfer]. Holter monitoring. Pacemaker (temporary, wires). Coronary stent. Q29p1 [Hospital Abstraction Form]
41	Pacemaker	203962	phv00203962.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-12 18:45:59+00:00	2018-04-12 18:45:59+00:00 	HRAA29P	[Second transfer]. Were the following special procedures or operations performed during this hospital stay? Pacemaker (temporary, wires). Q29p [Hospital Abstraction Form]
41	Pacemaker	127142	phv00127142.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-04-23 18:59:42+00:00	2018-04-23 18:59:42+00:00 	ecga23	AVD6XX - Atrioventricular (A-V) conduction defects (6 codes, the preceding 6 is not shown when a code is present)
41	Pacemaker	82702	phv00082702.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 21:18:10+00:00	2018-04-24 21:18:10+00:00 	ecgpmk1	PACEMAKER
41	Pacemaker	174576	phv00174576.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:07:59+00:00	2018-04-24 23:07:59+00:00 	major91	MAJOR ABNORMALITY 9 PER MINNESOTA CODE: PACEMAKER
41	Pacemaker	87149	phv00087149.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:08:06+00:00	2018-04-24 23:08:06+00:00 	pmkrf	PACEMAKER IMPLANT
41	Pacemaker	174642	phv00174642.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:08:13+00:00	2018-04-24 23:08:13+00:00 	pacem5	BODY COMPOSITION SCALE: DOES PPT HAVE A PACEMAKER?
41	Pacemaker	174901	phv00174901.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:08:19+00:00	2018-04-24 23:08:19+00:00 	ncs065	VENTRICULAR OR DUAL-CHAMBER PACEMAKER, BY SOFTWARE
41	Pacemaker	174912	phv00174912.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:08:26+00:00	2018-04-24 23:08:26+00:00 	ncvf065	VENTRICULAR OR DUAL-CHAMBER PACEMAKER, BY VISUAL FLAG
41	Pacemaker	174923	phv00174923.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:08:47+00:00	2018-04-24 23:08:47+00:00 	ncvf165	ELECTRONIC PACEMAKER, BY VISUAL FLAG
41	Pacemaker	175087	phv00175087.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:09:01+00:00	2018-04-24 23:09:01+00:00 	major95	PACEMAKER
41	Pacemaker	176065	phv00176065.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:09:56+00:00	2018-04-24 23:09:56+00:00 	pacem5	BODY COMPOSITION SCALE: DOES PPT HAVE A PACEMAKER?
41	Pacemaker	176282	phv00176282.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:10:01+00:00	2018-04-24 23:10:01+00:00 	prpmk5	PRESENCE OF: PACEMAKER
41	Pacemaker	176293	phv00176293.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:10:08+00:00	2018-04-24 23:10:08+00:00 	ecgpmk5	CONFIRMED: PACEMAKER
41	Pacemaker	176346	phv00176346.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:10:15+00:00	2018-04-24 23:10:15+00:00 	ncvf165	ELECTRONIC PACEMAKER, BY VISUAL FLAG
41	Pacemaker	176335	phv00176335.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:10:27+00:00	2018-04-24 23:10:27+00:00 	ncvf065	VENTRICULAR OR DUAL-CHAMBER PACEMAKER, BY VISUAL FLAG
41	Pacemaker	176324	phv00176324.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:10:33+00:00	2018-04-24 23:10:33+00:00 	ncs065	VENTRICULAR OR DUAL-CHAMBER PACEMAKER, BY SOFTWARE
41	Pacemaker	176510	phv00176510.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:10:47+00:00	2018-04-24 23:10:47+00:00 	major95	PACEMAKER
41	Pacemaker	127730	phv00127730.v1.p1	pht001963.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:29:16+00:00	2018-06-20 15:29:16+00:00 	MHXA52B2	52b2: Specify other heart procedures
41	Pacemaker	99037	phv00099037.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 17:26:47+00:00	2018-07-30 17:26:47+00:00 	IMPLAN07	A PACEMAKER IMPLANT
41	Pacemaker	100332	phv00100332.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 17:27:01+00:00	2018-07-30 17:27:01+00:00 	IMPLAN	A PACEMAKER IMPLANT
41	Pacemaker	105980	phv00105980.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 17:27:14+00:00	2018-07-30 17:27:14+00:00 	IMPLAN57	A PACEMAKER IMPLANT
41	Pacemaker	54692	phv00054692.v7.p10	pht000389.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-07 23:18:41+00:00	2018-08-07 23:18:41+00:00 	PROCNUM	Cardiovascular procedure codes
41	Pacemaker	54697	phv00054697.v7.p10	pht000389.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-07 23:19:20+00:00	2018-08-07 23:19:20+00:00 	PROCDATE	Date of cardiovascular procedure
41	Pacemaker	5236	phv00005236.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 11:52:15+00:00	2018-08-10 11:52:15+00:00 	FO432	ECG: RHYTHM
41	Pacemaker	5863	phv00005863.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 11:52:46+00:00	2018-08-10 11:52:46+00:00 	FP398	ECG: RHYTHM
41	Pacemaker	6220	phv00006220.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 11:53:19+00:00	2018-08-10 11:53:19+00:00 	FQ272	ECG - RHYTHM
41	Pacemaker	6615	phv00006615.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 11:54:14+00:00	2018-08-10 11:54:14+00:00 	FR389	ECG - RHYTHM
41	Pacemaker	7049	phv00007049.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 11:54:56+00:00	2018-08-10 11:54:56+00:00 	FS488	ECG: RHYTHM
41	Pacemaker	7484	phv00007484.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 11:55:28+00:00	2018-08-10 11:55:28+00:00 	FT494	ECG: RHYTHM
41	Pacemaker	70510	phv00070510.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 11:56:02+00:00	2018-08-10 11:56:02+00:00 	FU206	ECG: RHYTHM
41	Pacemaker	9494	phv00009494.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 11:57:05+00:00	2018-08-10 11:57:05+00:00 	E589	ECG: RHYTHM
41	Pacemaker	250660	phv00250660.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 11:58:21+00:00	2018-08-10 11:58:21+00:00 	e589	Electrocardiograph - Part I: Rhythm Collection Interval: Exam 1
41	Pacemaker	10008	phv00010008.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 11:59:24+00:00	2018-08-10 11:59:24+00:00 	F584	RHYTHM
41	Pacemaker	10441	phv00010441.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:00:26+00:00	2018-08-10 12:00:26+00:00 	G362	ECG: RHYTHM PREDOMINANT
41	Pacemaker	251002	phv00251002.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:01:08+00:00	2018-08-10 12:01:08+00:00 	g362	Electrocardiograph - Part I: Rhythm - predominant Collection Interval: Exam 2
41	Pacemaker	72266	phv00072266.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:08:07+00:00	2018-08-10 12:08:07+00:00 	H309	ECG: RHYTHM PREDOMINANT
41	Pacemaker	251462	phv00251462.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:08:56+00:00	2018-08-10 12:08:56+00:00 	h309	Electrocardiograph - Part I: Rhythm - predominant Collection Interval: Exam 3
41	Pacemaker	21157	phv00021157.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:09:46+00:00	2018-08-10 12:09:46+00:00 	G3A357	ECG: RHYTHM--PREDOMINANT
41	Pacemaker	273979	phv00273979.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:10:34+00:00	2018-08-10 12:10:34+00:00 	g3a357	ECG: Rhythm--predominant Collection Interval: Exam 1
41	Pacemaker	274472	phv00274472.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:11:06+00:00	2018-08-10 12:11:06+00:00 	g3a357	ECG: Rhythm--predominant
41	Pacemaker	71977	phv00071977.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:11:51+00:00	2018-08-10 12:11:51+00:00 	paced_s1	Paced for first sleep study Collection Interval: 1998-2003
41	Pacemaker	71995	phv00071995.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:12:10+00:00	2018-08-10 12:12:10+00:00 	paced_s2	Paced for second sleep study Collection Interval: 1998-2003
41	Pacemaker	276818	phv00276818.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:12:54+00:00	2018-08-10 12:12:54+00:00 	CHF092	ECG rhythm - A. Paced
41	Pacemaker	276819	phv00276819.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:13:12+00:00	2018-08-10 12:13:12+00:00 	CHF093	ECG rhythm - V. Paced
41	Pacemaker	8140	phv00008140.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:16:54+00:00	2018-08-10 12:16:54+00:00 	B496	ECG: PACEMAKER
41	Pacemaker	9029	phv00009029.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:17:09+00:00	2018-08-10 12:17:09+00:00 	D291	PACEMAKER
41	Pacemaker	9394	phv00009394.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:17:20+00:00	2018-08-10 12:17:20+00:00 	E464	HISTORY OF PERMANENT PACEMAKER INSERTION
41	Pacemaker	9899	phv00009899.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:17:31+00:00	2018-08-10 12:17:31+00:00 	F433	PERMANENT PACEMAKER INSERTION
41	Pacemaker	2926	phv00002926.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:17:45+00:00	2018-08-10 12:17:45+00:00 	FI246	ECG: PACEMAKER
41	Pacemaker	4001	phv00004001.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:17:58+00:00	2018-08-10 12:17:58+00:00 	FL391	PACEMAKER
41	Pacemaker	4425	phv00004425.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:18:15+00:00	2018-08-10 12:18:15+00:00 	FM430	ECG: PACEMAKER
41	Pacemaker	4778	phv00004778.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:18:34+00:00	2018-08-10 12:18:34+00:00 	FN308	HISTORY OF PERMANENT PACEMAKER INSERTION
41	Pacemaker	4867	phv00004867.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:18:47+00:00	2018-08-10 12:18:47+00:00 	FN407	PACEMAKER
41	Pacemaker	5078	phv00005078.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:19:03+00:00	2018-08-10 12:19:03+00:00 	FO241	HISTORY OF PERMANENT PACEMAKER INSERTION
41	Pacemaker	5693	phv00005693.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:19:22+00:00	2018-08-10 12:19:22+00:00 	FP185	PERMANENT PACEMAKER INSERTION
41	Pacemaker	6204	phv00006204.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:19:44+00:00	2018-08-10 12:19:44+00:00 	FQ221	PERMANENT PACEMAKER INSERTION - INTERIM
41	Pacemaker	6601	phv00006601.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:20:01+00:00	2018-08-10 12:20:01+00:00 	FR347	CARDIOVASCULAR PROCEDURES (IN THE INTERIM ONLY, NOT LIFETIME) PERMANENT PACEMAKER INSERTION (IF YES, FILL IN FR348)
41	Pacemaker	7035	phv00007035.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:20:22+00:00	2018-08-10 12:20:22+00:00 	FS446	PERMANENT PACEMAKER INSERTION
41	Pacemaker	7468	phv00007468.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:20:35+00:00	2018-08-10 12:20:35+00:00 	FT450	PERMANENT PACEMAKER INSERTION
41	Pacemaker	70494	phv00070494.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:20:49+00:00	2018-08-10 12:20:49+00:00 	FU162	PERMANENT PACEMAKER INSERTION
41	Pacemaker	10354	phv00010354.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:21:08+00:00	2018-08-10 12:21:08+00:00 	G238	PERMANENT PACEMAKER INSERTION
41	Pacemaker	21085	phv00021085.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:21:43+00:00	2018-08-10 12:21:43+00:00 	G3A257	PERMANENT PACEMAKER INSERTION SEE NOTE BELOW
41	Pacemaker	72205	phv00072205.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:21:59+00:00	2018-08-10 12:21:59+00:00 	H217	PERMANENT PACEMAKER INSERTION
41	Pacemaker	177467	phv00177467.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:24:16+00:00	2018-08-10 12:24:16+00:00 	g3b0374	Electrocardiograph: Rhythm--predominant
41	Pacemaker	254211	phv00254211.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:24:51+00:00	2018-08-10 12:24:51+00:00 	j364	Electrocardiograph-Part I: Rhythm--predominant
41	Pacemaker	254719	phv00254719.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:25:18+00:00	2018-08-10 12:25:18+00:00 	fv208	Electrocardiograph: Rhythm - predominant Collection Interval: Exam 29
41	Pacemaker	255109	phv00255109.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:25:46+00:00	2018-08-10 12:25:46+00:00 	fw248	Electrocardiograph: Rhythm - predominant Collection Interval: Original Cohort Exam 30
41	Pacemaker	274834	phv00274834.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:26:07+00:00	2018-08-10 12:26:07+00:00 	FX248	Electrocardiograph: Rhythm - predominant Collection Interval: Original Cohort Exam 31
41	Pacemaker	275192	phv00275192.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:26:32+00:00	2018-08-10 12:26:32+00:00 	fy248	Electrocardiograph: Rhythm - predominant Collection Interval: Original Cohort Exam 32
41	Pacemaker	76371	phv00076371.v6.p10	pht000908.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:41:39+00:00	2018-08-10 12:41:39+00:00 	ECGLOC	ECG location
41	Pacemaker	253889	phv00253889.v1.p10	pht003334.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-10 12:41:51+00:00	2018-08-10 12:41:51+00:00 	ECGLOC	ECG location Collection Interval: Cases reviewed  1/1949 - 12/2012
41	Pacemaker	193137	phv00193137.v3.p3	pht003406.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 15:47:34+00:00	2018-08-20 15:47:34+00:00 	AFPACEMKR	AV node ablation and pacemaker
41	Pacemaker	283522	phv00283522.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 15:47:34+00:00	2018-08-20 15:47:34+00:00 	PACEMKRHX	F136 History of pacemaker
42	Hematocrit	127614	phv00127614.v1.p1	pht001959.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:22:25+00:00	2018-03-16 01:22:25+00:00 	HEMATOCRIT	Hematocrit %
42	Hematocrit	207255	phv00207255.v1.p1	pht004107.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:41:41+00:00	2018-03-19 20:41:41+00:00 	HMTA01	Hematocrit % (MAV). Q1 [Hematology Form, exam 1]
42	Hematocrit	207270	phv00207270.v1.p1	pht004108.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:42:01+00:00	2018-03-19 20:42:01+00:00 	HMTB01	Hematocrit % (MAV). Q1 [Hematology Form, exam 2]
42	Hematocrit	207289	phv00207289.v1.p1	pht004109.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:42:25+00:00	2018-03-19 20:42:25+00:00 	HMTC5	Hematocrit. Q5 [Hematology Lab, exam 3]
42	Hematocrit	207301	phv00207301.v1.p1	pht004110.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:42:55+00:00	2018-03-19 20:42:55+00:00 	HMTC5	Hematocrit. Q5 [Hematology Lab, exam 4]
42	Hematocrit	128724	phv00128724.v1.p3	pht001984.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:40:15+00:00	2018-04-24 23:40:15+00:00 	hctdifa	HEMATOCRIT FROM CBC DIFFERENTIAL, %
42	Hematocrit	218992	phv00218992.v1.p3	pht004319.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-24 23:40:23+00:00	2018-04-24 23:40:23+00:00 	hct5	HEMATOCRIT (%)
42	Hematocrit	81031	phv00081031.v1.p10	pht001045.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:33:38+00:00	2018-06-05 15:33:38+00:00 	HCT	Hematocrit Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38)
42	Hematocrit	172181	phv00172181.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:34:05+00:00	2018-06-05 15:34:05+00:00 	HCT	Hematocrit (sample type: whole blood)
42	Hematocrit	227028	phv00227028.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:34:41+00:00	2018-06-05 15:34:41+00:00 	HCT	Hematocrit (sample type: whole blood)
42	Hematocrit	7643	phv00007643.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:02:22+00:00	2018-06-18 17:02:22+00:00 	A141	H.C.T.
42	Hematocrit	7555	phv00007555.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:02:44+00:00	2018-06-18 17:02:44+00:00 	A28	HEMATOCRIT
42	Hematocrit	7952	phv00007952.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:03:03+00:00	2018-06-18 17:03:03+00:00 	B334	BLOOD ANALYSIS: HEMATOCRIT
42	Hematocrit	8111	phv00008111.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:03:31+00:00	2018-06-18 17:03:31+00:00 	B764	HCT
42	Hematocrit	1202	phv00001202.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:04:08+00:00	2018-06-18 17:04:08+00:00 	FB25	BLOOD ANALYSIS:  HEMATOCRIT
42	Hematocrit	1376	phv00001376.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:04:35+00:00	2018-06-18 17:04:35+00:00 	FC18	HEMATOCRIT
42	Hematocrit	1579	phv00001579.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:04:53+00:00	2018-06-18 17:04:53+00:00 	FD34	BLOOD ANALYSIS, HEMATOCRIT
42	Hematocrit	1815	phv00001815.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:05:15+00:00	2018-06-18 17:05:15+00:00 	FE81	BLOOD ANALYSIS, HEMATOCRIT
42	Hematocrit	2030	phv00002030.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:06:25+00:00	2018-06-18 17:06:25+00:00 	FF77	BLOOD ANALYSIS, HEMATOCRIT
42	Hematocrit	2414	phv00002414.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:06:48+00:00	2018-06-18 17:06:48+00:00 	FG310	BLOOD ANALYSIS, HEMATOCRIT
42	Hematocrit	2652	phv00002652.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:07:07+00:00	2018-06-18 17:07:07+00:00 	FH329	BLOOD ANALYSIS: HEMATOCRIT
42	Hematocrit	2679	phv00002679.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:07:46+00:00	2018-06-18 17:07:46+00:00 	FI27	BLOOD ANALYSIS, HEMATOCRIT (%)
42	Hematocrit	3258	phv00003258.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:08:15+00:00	2018-06-18 17:08:15+00:00 	FJ380	BLOOD ANALYSIS: HEMATOCRIT (%)
42	Hematocrit	3664	phv00003664.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:08:40+00:00	2018-06-18 17:08:40+00:00 	FK455	BLOOD ANALYSIS: HEMATOCRIT (%)
42	Hematocrit	4080	phv00004080.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:09:33+00:00	2018-06-18 17:09:33+00:00 	FL522	BLOOD ANALYSIS-HEMATOCRIT
42	Hematocrit	4516	phv00004516.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:10:04+00:00	2018-06-18 17:10:04+00:00 	FM542	BLOOD ANALYSIS - HEMATOCRIT
42	Hematocrit	4936	phv00004936.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:10:31+00:00	2018-06-18 17:10:31+00:00 	FN511	BLOOD ANALYSIS - HEMATOCRIT
42	Hematocrit	677	phv00000677.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:11:01+00:00	2018-06-18 17:11:01+00:00 	MF213	BLOOD ANALYSIS: HEMATOCRIT, EXAM 4
42	Hematocrit	765	phv00000765.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:11:38+00:00	2018-06-18 17:11:38+00:00 	MF313	BLOOD ANALYSIS: HEMATOCRIT, EXAM 5
42	Hematocrit	842	phv00000842.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:12:01+00:00	2018-06-18 17:12:01+00:00 	MF393	BLOOD ANALYSIS: HEMATOCRIT, EXAM 6
42	Hematocrit	929	phv00000929.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:12:45+00:00	2018-06-18 17:12:45+00:00 	MF487	BLOOD ANALYSIS: HEMATOCRIT, EXAM 7
42	Hematocrit	276854	phv00276854.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:13:19+00:00	2018-06-18 17:13:19+00:00 	CHF045	Hematologic - Hct
42	Hematocrit	1047	phv00001047.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 17:14:15+00:00	2018-06-18 17:14:15+00:00 	FA13	HEMATOCRIT (PERCENT)
42	Hematocrit	112689	phv00112689.v2.p2	pht001563.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:38:23+00:00	2018-07-06 19:38:23+00:00 	A05HCT	HEMATOCRIT (%)
42	Hematocrit	99860	phv00099860.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:30:38+00:00	2018-07-30 16:30:38+00:00 	HEMATO23	HEMATOCRIT (%)
42	Hematocrit	100413	phv00100413.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:30:50+00:00	2018-07-30 16:30:50+00:00 	HEMATO23	HEMATOCRIT (%)
42	Hematocrit	105618	phv00105618.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:31:14+00:00	2018-07-30 16:31:14+00:00 	HEMATO23	HEMATOCRIT (%)
42	Hematocrit	106920	phv00106920.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:31:41+00:00	2018-07-30 16:31:41+00:00 	HEMATO23	HEMATOCRIT (%)
42	Hematocrit	77365	phv00077365.v6.p3	pht000986.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 15:48:59+00:00	2018-08-20 15:48:59+00:00 	HEMATOCR	Hematocrit (%)
42	Hematocrit	283662	phv00283662.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 15:48:59+00:00	2018-08-20 15:48:59+00:00 	HEMATOCRIT	F136 Hematocrit, %
42	Hematocrit	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 22:23:05+00:00	2018-08-20 22:23:05+00:00 	TESTVAL	Test Result Value
42	Hematocrit	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 22:23:05+00:00	2018-08-20 22:23:05+00:00 	TESTNAME	Test Name
42	Hematocrit	226303	phv00226303.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:40:50+00:00	2018-08-22 21:40:50+00:00 	LABA4	% Hematocrit (LABA4)
42	Hematocrit	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:00:14+00:00	2018-08-23 18:00:14+00:00 	TESTABBR	Test abbreviation
42	Hematocrit	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:00:14+00:00	2018-08-23 18:00:14+00:00 	TESTDESC	Test Description
42	Hematocrit	253008	phv00253008.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:21:32+00:00	2018-08-24 17:21:32+00:00 	hematocrit_baseline	Hematocrit value at baseline visit
43	Hemoglobin	127615	phv00127615.v1.p1	pht001959.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:15:26+00:00	2018-03-16 01:15:26+00:00 	HEMOGLOBIN	Hemoglobin G/DL
43	Hemoglobin	207256	phv00207256.v1.p1	pht004107.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:52:55+00:00	2018-03-19 20:52:55+00:00 	HMTA02	Hemoglobin g/dL (MAV). Q2 [Hematology Form, exam 1]
43	Hemoglobin	207271	phv00207271.v1.p1	pht004108.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:53:17+00:00	2018-03-19 20:53:17+00:00 	HMTB02	Hemoglobin g/dL (MAV). Q2 [Hematology Form, exam 2]
43	Hemoglobin	207288	phv00207288.v1.p1	pht004109.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:53:38+00:00	2018-03-19 20:53:38+00:00 	HMTC4	Hemoglobin. Q4 [Hematology Lab, exam 3]
43	Hemoglobin	207300	phv00207300.v1.p1	pht004110.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:54:03+00:00	2018-03-19 20:54:03+00:00 	HMTC4	Hemoglobin. Q4 [Hematology Lab, exam 4]
43	Hemoglobin	85933	phv00085933.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 03:01:03+00:00	2018-04-25 03:01:03+00:00 	hemogl2	SERUM HEMOGLOBIN
43	Hemoglobin	128727	phv00128727.v1.p3	pht001984.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 03:01:13+00:00	2018-04-25 03:01:13+00:00 	hgbdifa	HEMOGLOBIN FROM CBC DIFFERENTIAL, gm/dl
43	Hemoglobin	218993	phv00218993.v1.p3	pht004319.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 03:01:20+00:00	2018-04-25 03:01:20+00:00 	hgb5	HEMOGLOBIN (g/dL)
43	Hemoglobin	81032	phv00081032.v1.p10	pht001045.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:40:08+00:00	2018-06-05 15:40:08+00:00 	HGB	Hemoglobin Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38)
43	Hemoglobin	172180	phv00172180.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:40:29+00:00	2018-06-05 15:40:29+00:00 	HGB	Hemoglobin (sample type: whole blood)
43	Hemoglobin	227027	phv00227027.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:40:51+00:00	2018-06-05 15:40:51+00:00 	HGB	Hemoglobin (sample type: whole blood)
43	Hemoglobin	112688	phv00112688.v2.p2	pht001563.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:40:03+00:00	2018-07-06 19:40:03+00:00 	A05HGB	HEMOGLOBIN (G/DL)
43	Hemoglobin	99859	phv00099859.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:29:15+00:00	2018-07-30 16:29:15+00:00 	HEMOGL23	HEMOGLOBIN (g/dl)
43	Hemoglobin	100412	phv00100412.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:29:29+00:00	2018-07-30 16:29:29+00:00 	HEMOGL23	HEMOGLOBIN (g/dl)
43	Hemoglobin	105617	phv00105617.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:29:45+00:00	2018-07-30 16:29:45+00:00 	HEMOGL23	HEMOGLOBIN (g/dl)
43	Hemoglobin	106919	phv00106919.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:29:59+00:00	2018-07-30 16:29:59+00:00 	HEMOGL23	HEMOGLOBIN (g/dl)
43	Hemoglobin	535	phv00000535.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 13:50:08+00:00	2018-08-09 13:50:08+00:00 	MF63	BLOOD ANALYSIS: HEMOGLOBIN, EXAM 1
43	Hemoglobin	627	phv00000627.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 13:50:41+00:00	2018-08-09 13:50:41+00:00 	MF161	BLOOD ANALYSIS: HEMOGLOBIN, EXAM 2
43	Hemoglobin	634	phv00000634.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 13:51:14+00:00	2018-08-09 13:51:14+00:00 	MF168	BLOOD ANALYSIS: HEMOGLOBIN, EXAM 3
43	Hemoglobin	673	phv00000673.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 13:52:01+00:00	2018-08-09 13:52:01+00:00 	MF209	BLOOD ANALYSIS: HEMOGLOBIN, EXAM 4
43	Hemoglobin	764	phv00000764.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 13:52:34+00:00	2018-08-09 13:52:34+00:00 	MF312	BLOOD ANALYSIS: HEMOGLOBIN, EXAM 5
43	Hemoglobin	841	phv00000841.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 13:53:07+00:00	2018-08-09 13:53:07+00:00 	MF392	BLOOD ANALYSIS: HEMOGLOBIN, EXAM 6
43	Hemoglobin	7642	phv00007642.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 13:57:51+00:00	2018-08-09 13:57:51+00:00 	A140	H.G.B.
43	Hemoglobin	8110	phv00008110.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 13:58:28+00:00	2018-08-09 13:58:28+00:00 	B763	HGB
43	Hemoglobin	276333	phv00276333.v1.p10	pht006013.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 13:59:41+00:00	2018-12-12 00:33:03+00:00 	zHemoglobin	Hemoglobin (Sample type: Citrated plasma)
43	Hemoglobin	276853	phv00276853.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:00:22+00:00	2018-08-09 14:00:22+00:00 	CHF044	Hematologic - Hgb
43	Hemoglobin	77366	phv00077366.v6.p3	pht000986.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 15:51:35+00:00	2018-08-20 15:51:35+00:00 	HEMOGLBN	Hemoglobin (gm/dl)
43	Hemoglobin	283661	phv00283661.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 15:51:35+00:00	2018-08-20 15:51:35+00:00 	HEMOGLOBIN	F136 Hemoglobin, g/dl
43	Hemoglobin	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 20:22:20+00:00	2018-08-20 20:22:20+00:00 	TESTVAL	Test Result Value
43	Hemoglobin	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 20:22:20+00:00	2018-08-20 20:22:20+00:00 	TESTNAME	Test Name
43	Hemoglobin	226302	phv00226302.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:42:57+00:00	2018-08-22 21:42:57+00:00 	LABA3	Hemoglobin (g/dL) (LABA3)
43	Hemoglobin	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:01:20+00:00	2018-08-23 18:01:20+00:00 	TESTABBR	Test abbreviation
43	Hemoglobin	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:01:20+00:00	2018-08-23 18:01:20+00:00 	TESTDESC	Test Description
43	Hemoglobin	253007	phv00253007.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:19:59+00:00	2018-08-24 17:19:59+00:00 	hemoglobin_baseline	Hemoglobin value at baseline visit
44	Platelet count	127616	phv00127616.v1.p1	pht001959.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:19:06+00:00	2018-03-16 01:19:06+00:00 	PLATELET	Platelet TH/CMM
44	Platelet count	207258	phv00207258.v1.p1	pht004107.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:42:53+00:00	2018-03-19 16:42:53+00:00 	HMTA04	Platelet count x1000/mm3 (MAV). Q4 [Hematology Form, exam 1]
44	Platelet count	207273	phv00207273.v1.p1	pht004108.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:43:16+00:00	2018-03-19 16:43:16+00:00 	HMTB04	Platelet count x1000/mm3 (MAV). Q4 [Hematology Form, exam 2]
44	Platelet count	207294	phv00207294.v1.p1	pht004109.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:43:38+00:00	2018-03-19 16:43:38+00:00 	HMTC10	Platelet count Q10 [Hematology Lab, exam 3]
44	Platelet count	207306	phv00207306.v1.p1	pht004110.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:43:57+00:00	2018-03-19 16:43:57+00:00 	HMTC10	Platelet count. Q10 [Hematology Lab, exam 4]
44	Platelet count	128760	phv00128760.v1.p3	pht001984.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 21:06:57+00:00	2018-04-25 21:06:57+00:00 	pltca	PLATELET COUNT x10^3/ul
44	Platelet count	218991	phv00218991.v1.p3	pht004319.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 21:07:03+00:00	2018-04-25 21:07:03+00:00 	plt5	PLATELETS (x10E3/uL)
44	Platelet count	81034	phv00081034.v1.p10	pht001045.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:43:33+00:00	2018-06-05 15:43:33+00:00 	PLATELET	Platelet Count Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38)
44	Platelet count	172186	phv00172186.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:44:14+00:00	2018-06-05 15:44:14+00:00 	PLT	Platelet count (sample type: whole blood)
44	Platelet count	227033	phv00227033.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:44:42+00:00	2018-06-05 15:44:42+00:00 	PLT	Platelet count (sample type: whole blood)
44	Platelet count	112690	phv00112690.v2.p2	pht001563.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:43:12+00:00	2018-07-06 19:43:12+00:00 	A05PLATL	PLATELET COUNT
44	Platelet count	99861	phv00099861.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:33:01+00:00	2018-07-30 16:33:01+00:00 	PLATE23	PLATELET COUNT (/cc.mm)
44	Platelet count	100414	phv00100414.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:33:19+00:00	2018-07-30 16:33:19+00:00 	PLATE23	PLATELET COUNT (/cc.mm)
44	Platelet count	105619	phv00105619.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:33:32+00:00	2018-07-30 16:33:32+00:00 	PLATE23	PLATELET COUNT (/cc.mm)
44	Platelet count	106921	phv00106921.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:33:46+00:00	2018-07-30 16:33:46+00:00 	PLATE23	PLATELET COUNT (/cc.mm)
44	Platelet count	24567	phv00024567.v5.p10	pht000198.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-08 18:45:03+00:00	2018-08-08 18:45:03+00:00 	PRPPC	PLATELET COUNT ON PLATELET-RICH PLASMA (NOT WHOLE BLOOD)
44	Platelet count	227102	phv00227102.v1.p10	pht004806.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-08 18:45:22+00:00	2018-08-08 18:45:22+00:00 	PRPPC	Platelet count on platelet-rich plasma Collection Interval: Exam 1
44	Platelet count	276856	phv00276856.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-08 18:45:50+00:00	2018-08-08 18:45:50+00:00 	CHF047	Hematologic - Platelet
44	Platelet count	77367	phv00077367.v6.p3	pht000986.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 15:54:10+00:00	2018-08-20 15:54:10+00:00 	PLATELET	Platelet count (Kcell/microliter)
44	Platelet count	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 22:26:47+00:00	2018-08-20 22:26:47+00:00 	TESTVAL	Test Result Value
44	Platelet count	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 22:26:47+00:00	2018-08-20 22:26:47+00:00 	TESTNAME	Test Name
44	Platelet count	226310	phv00226310.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:52:27+00:00	2018-08-22 21:52:27+00:00 	LABA9	Platelet count (x10e9) (LABA9)
44	Platelet count	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:05:23+00:00	2018-08-23 18:05:23+00:00 	TESTABBR	Test abbreviation
44	Platelet count	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:05:23+00:00	2018-08-23 18:05:23+00:00 	TESTDESC	Test Description
44	Platelet count	253009	phv00253009.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:21:43+00:00	2018-08-24 17:21:43+00:00 	platelet_count_baseline	Platelet count at baseline visit
45	Red blood cell count	127629	phv00127629.v1.p1	pht001959.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:21:29+00:00	2018-03-16 01:21:29+00:00 	RED_CELL_COUNT	Red cell count M/CMM
45	Red blood cell count	207287	phv00207287.v1.p1	pht004109.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:39:27+00:00	2018-03-19 16:39:27+00:00 	HMTC3	Red blood count. Q3 [Hematology Lab, exam 3]
45	Red blood cell count	207299	phv00207299.v1.p1	pht004110.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:39:46+00:00	2018-03-19 16:39:46+00:00 	HMTC3	Red blood count. Q3 [Hematology Lab, exam 4]
45	Red blood cell count	128762	phv00128762.v1.p3	pht001984.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 21:08:17+00:00	2018-04-25 21:08:17+00:00 	rbcdifa	RED BLOOD CELL COUNT FROM CBC DIFFERENTIAL, m/cmm
45	Red blood cell count	218990	phv00218990.v1.p3	pht004319.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 21:08:24+00:00	2018-04-25 21:08:24+00:00 	rbc5	RED BLOOD CELL (RBC) (x10E6/uL)
45	Red blood cell count	81029	phv00081029.v1.p10	pht001045.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:45:36+00:00	2018-06-05 15:45:36+00:00 	RBC	Red Blood Cell Count Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38)
45	Red blood cell count	172179	phv00172179.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:46:00+00:00	2018-06-05 15:46:00+00:00 	RBC	Red blood count (sample type: whole blood)
45	Red blood cell count	227026	phv00227026.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:46:37+00:00	2018-06-05 15:46:37+00:00 	RBC	Red blood cell count (sample type: whole blood)
45	Red blood cell count	112687	phv00112687.v2.p2	pht001563.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:45:10+00:00	2018-07-06 19:45:10+00:00 	A05RBC	RED CELL COUNT (X 1,000,000)
45	Red blood cell count	226294	phv00226294.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-07-20 15:53:32+00:00	2018-07-20 15:53:32+00:00 	LABA2	Red Blood Count (x10e12) (LABA2)
45	Red blood cell count	8109	phv00008109.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 16:56:25+00:00	2018-08-09 16:56:25+00:00 	B762	RBC
45	Red blood cell count	7641	phv00007641.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 16:57:31+00:00	2018-08-09 16:57:31+00:00 	A139	RED BLOOD COUNT
45	Red blood cell count	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 22:31:21+00:00	2018-08-20 22:31:21+00:00 	TESTVAL	Test Result Value
45	Red blood cell count	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 22:31:21+00:00	2018-08-20 22:31:21+00:00 	TESTNAME	Test Name
45	Red blood cell count	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:06:01+00:00	2018-08-23 18:06:01+00:00 	TESTABBR	Test abbreviation
45	Red blood cell count	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:06:01+00:00	2018-08-23 18:06:01+00:00 	TESTDESC	Test Description
45	Red blood cell count	253010	phv00253010.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:21:53+00:00	2018-08-24 17:21:53+00:00 	red_blood_cell_count_baseline	Red blood cell count value at baseline visit
46	White blood cell count	127631	phv00127631.v1.p1	pht001959.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:19:58+00:00	2018-03-16 01:19:58+00:00 	WBC	White blood cells TH/CMM
46	White blood cell count	207257	phv00207257.v1.p1	pht004107.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:33:31+00:00	2018-03-19 16:33:31+00:00 	HMTA03	White blood count x1000/mm3 (MAV). Q3 [Hematology Form, exam 1]
46	White blood cell count	207272	phv00207272.v1.p1	pht004108.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:33:54+00:00	2018-03-19 16:33:54+00:00 	HMTB03	White blood count x1000/mm3 (MAV). Q3 [Hematology Form, exam 2]
46	White blood cell count	207286	phv00207286.v1.p1	pht004109.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:34:15+00:00	2018-03-19 16:34:15+00:00 	HMTC2	White blood count. Q2 [Hematology Lab, exam 3]
46	White blood cell count	207298	phv00207298.v1.p1	pht004110.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:34:34+00:00	2018-03-19 16:34:34+00:00 	HMTC2	White blood count. Q2 [Hematology Lab, exam 4]
46	White blood cell count	128764	phv00128764.v1.p3	pht001984.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 22:18:12+00:00	2018-04-25 22:18:12+00:00 	wbca	WHITE BLOOD CELL COUNT x10^3/ul
46	White blood cell count	218997	phv00218997.v1.p3	pht004319.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 22:18:19+00:00	2018-04-25 22:18:19+00:00 	wbc5	WHITE BLOOD CELL COUNT (x10E3/uL)
46	White blood cell count	81030	phv00081030.v1.p10	pht001045.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:48:50+00:00	2018-06-05 15:48:50+00:00 	WBC	White Blood Cell Count Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38)
46	White blood cell count	172178	phv00172178.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:49:53+00:00	2018-06-05 15:49:53+00:00 	WBC	White blood count (sample type: whole blood)
46	White blood cell count	227025	phv00227025.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:50:22+00:00	2018-06-05 15:50:22+00:00 	WBC	White blood cell count (sample type: whole blood)
46	White blood cell count	7640	phv00007640.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 16:52:53+00:00	2018-06-18 16:52:53+00:00 	A138	WHITE BLOOD COUNT
46	White blood cell count	8108	phv00008108.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 16:54:03+00:00	2018-06-18 16:54:03+00:00 	B761	WBC
46	White blood cell count	276855	phv00276855.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-18 16:54:41+00:00	2018-06-18 16:54:41+00:00 	CHF046	Hematologic - WBC
46	White blood cell count	112686	phv00112686.v2.p2	pht001563.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:46:04+00:00	2018-07-06 19:46:04+00:00 	A05WBC	WHITE CELL COUNT (X 1000)
46	White blood cell count	99858	phv00099858.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:34:27+00:00	2018-07-30 16:34:27+00:00 	WBLD23	WHITE BLOOD COUNT (x1,000/cubic mm)
46	White blood cell count	100411	phv00100411.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:34:39+00:00	2018-07-30 16:34:39+00:00 	WBLD23	WHITE BLOOD COUNT (x1, 000/cubic mm)
46	White blood cell count	105616	phv00105616.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:34:50+00:00	2018-07-30 16:34:50+00:00 	WBLD23	WHITE BLOOD COUNT (x1,000/cubic mm)
46	White blood cell count	106918	phv00106918.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:35:07+00:00	2018-07-30 16:35:07+00:00 	WBLD23	WHITE BLOOD COUNT (x1, 000/cubic mm)
46	White blood cell count	77368	phv00077368.v6.p3	pht000986.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 22:32:37+00:00	2018-08-20 22:32:37+00:00 	WBC	White blood cell (Kcell/microliter)
46	White blood cell count	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 22:32:37+00:00	2018-08-20 22:32:37+00:00 	TESTVAL	Test Result Value
46	White blood cell count	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 22:32:37+00:00	2018-08-20 22:32:37+00:00 	TESTNAME	Test Name
46	White blood cell count	226283	phv00226283.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:36:52+00:00	2018-08-22 21:36:52+00:00 	LABA1	White blood count (x10e9) (LABA1)
46	White blood cell count	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:09:48+00:00	2018-08-23 18:09:48+00:00 	TESTABBR	Test abbreviation
46	White blood cell count	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:09:48+00:00	2018-08-23 18:09:48+00:00 	TESTDESC	Test Description
46	White blood cell count	253006	phv00253006.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:19:43+00:00	2018-08-24 17:19:43+00:00 	white_blood_cell_count_baseline	White blood cell count value at baseline visit
47	Fibrinogen in blood	206650	phv00206650.v1.p1	pht004098.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:49:19+00:00	2018-03-19 16:49:19+00:00 	HEMA09	Fibrinogen value [Hemostasis Lab, exam 1]
47	Fibrinogen in blood	206658	phv00206658.v1.p1	pht004099.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:49:37+00:00	2018-03-19 16:49:37+00:00 	HEMC03	Fibrinogen value [Hemostasis Lab, exam 3]
47	Fibrinogen in blood	85014	phv00085014.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 22:20:25+00:00	2018-04-25 22:20:25+00:00 	fib1	FIBRINOGEN ANTIGEN (mg/dl)
47	Fibrinogen in blood	82965	phv00082965.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 22:20:33+00:00	2018-04-25 22:20:33+00:00 	fib1	FIBRINOGEN ANTIGEN (mg/dl)
47	Fibrinogen in blood	86823	phv00086823.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 22:20:45+00:00	2018-04-25 22:20:45+00:00 	fib4	FIBRINOGEN ANTIGEN (mg/dl)
47	Fibrinogen in blood	160532	phv00160532.v1.p3	pht002198.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 22:20:50+00:00	2018-04-25 22:20:50+00:00 	fibrgn3	FIBRINOGEN (mg/dL)
47	Fibrinogen in blood	115091	phv00115091.v2.p2	pht001642.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:49:02+00:00	2018-07-06 19:49:02+00:00 	BLEFIBR	FIBRINOGEN (MG/DL)
47	Fibrinogen in blood	116363	phv00116363.v2.p2	pht001694.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:49:02+00:00	2018-07-06 19:49:02+00:00 	CLEFIBR	FIBRINOGEN (MG/DL)
47	Fibrinogen in blood	117550	phv00117550.v2.p2	pht001736.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:49:02+00:00	2018-07-06 19:49:02+00:00 	DLEFIBR2	Y7 FIBRINOGEN (MG/DL) - 2003 RUN
47	Fibrinogen in blood	117558	phv00117558.v2.p2	pht001739.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:49:02+00:00	2018-07-06 19:49:02+00:00 	DLEFIBR	FIBRINOGEN (MG/DL)
47	Fibrinogen in blood	116349	phv00116349.v2.p2	pht001692.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-14 19:46:26+00:00	2018-07-14 19:46:26+00:00 	CL6FIBR	PLASMA FIBRINOGEN (MG/DL)
47	Fibrinogen in blood	100037	phv00100037.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:37:10+00:00	2018-07-30 16:37:10+00:00 	FIB44	FIBRINOGEN (mg/dl)
47	Fibrinogen in blood	100423	phv00100423.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:38:47+00:00	2018-07-30 16:38:47+00:00 	FIB44	FIBRINOGEN (mg/dl)
47	Fibrinogen in blood	105862	phv00105862.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:39:22+00:00	2018-07-30 16:39:22+00:00 	FIB44	FIBRINOGEN (mg/dl)
47	Fibrinogen in blood	106987	phv00106987.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:39:36+00:00	2018-07-30 16:39:36+00:00 	FIB44	FIBRINOGEN (mg/dl)
47	Fibrinogen in blood	1384	phv00001384.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-06 17:54:14+00:00	2018-08-06 17:54:14+00:00 	FC26	BLOOD ANALYSIS: FIBRINOGEN (MG/100 ML)
47	Fibrinogen in blood	5553	phv00005553.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-06 17:55:45+00:00	2018-08-06 17:55:45+00:00 	FO734	BLOOD ANALYSIS - FIBRINOGEN
47	Fibrinogen in blood	6029	phv00006029.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-06 17:56:12+00:00	2018-08-06 17:56:12+00:00 	FP598	BLOOD ANALYSIS - FIBRINOGEN
47	Fibrinogen in blood	21397	phv00021397.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-06 17:56:36+00:00	2018-08-06 17:56:36+00:00 	G3A718	FIBRINOGEN MG/DL
47	Fibrinogen in blood	21747	phv00021747.v1.p10	pht000086.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-06 17:57:16+00:00	2018-08-06 17:57:16+00:00 	FIB	FIBRINOGEN IN MG/DL - FIBRINOGEN LEVELS WERE PERFORMED FROM CITRATED PLASMA ON AN ELECTRA 800 AUTOMATIC COAGULATION TIMER (MEDICAL LABORATORY AUTOMATION, INC., PLEASANTVILLE, N.Y.) USING COMMERCIAL REAGENTS.
47	Fibrinogen in blood	21740	phv00021740.v5.p10	pht000084.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-06 18:51:37+00:00	2018-08-06 18:51:37+00:00 	FIBRINOG	FIBRINOGEN VALUE
47	Fibrinogen in blood	21745	phv00021745.v5.p10	pht000085.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-06 18:52:10+00:00	2018-08-06 18:52:10+00:00 	FIBRIN	FIBRINOGEN (MG/100ML)
47	Fibrinogen in blood	21754	phv00021754.v5.p10	pht000087.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-06 18:53:07+00:00	2018-08-06 18:53:07+00:00 	FIBRNGEN	FIBRINOGEN FROM PLASMA (MG/100ML)
47	Fibrinogen in blood	275425	phv00275425.v1.p10	pht006012.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-06 18:53:59+00:00	2018-08-06 18:53:59+00:00 	FIBRNGEN	Concentration of fibrinogen
47	Fibrinogen in blood	227093	phv00227093.v1.p10	pht004806.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-06 18:54:21+00:00	2018-08-06 18:54:21+00:00 	FIBRIN	Fibrinogen Collection Interval: Exam 1
47	Fibrinogen in blood	21748	phv00021748.v1.p10	pht000086.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-06 18:56:25+00:00	2018-08-06 18:56:25+00:00 	QBC	FIBRINOGEN IN MG/DL- QBC METHOD
47	Fibrinogen in blood	277398	phv00277398.v1.p1	pht006036.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:18:58+00:00	2018-08-14 22:18:58+00:00 	FIBRINOGEN	Fibrinogen level result value Collection Interval: 2009-2011
47	Fibrinogen in blood	277842	phv00277842.v1.p1	pht006048.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:09:09+00:00	2018-08-14 23:09:09+00:00 	FIBR	Fibrinogen level result value Collection Interval: 2000-2004
47	Fibrinogen in blood	308035	phv00308035.v1.p1	pht006661.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:12:27+00:00	2018-08-16 00:12:27+00:00 	FIBR	Fibrinogen level result value Collection Interval: 2000-2004
47	Fibrinogen in blood	77383	phv00077383.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 22:36:15+00:00	2018-08-20 22:36:15+00:00 	COREFIBR	Core Fibrinogen (mg/dl)
47	Fibrinogen in blood	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 22:36:15+00:00	2018-08-20 22:36:15+00:00 	TESTVAL	Test Result Value
47	Fibrinogen in blood	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-20 22:36:15+00:00	2018-08-20 22:36:15+00:00 	TESTNAME	Test Name
47	Fibrinogen in blood	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 17:55:28+00:00	2018-08-23 17:55:28+00:00 	TESTABBR	Test abbreviation
47	Fibrinogen in blood	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 17:55:28+00:00	2018-08-23 17:55:28+00:00 	TESTDESC	Test Description
47	Fibrinogen in blood	252991	phv00252991.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:14:05+00:00	2018-08-24 17:14:05+00:00 	fibrinogen_baseline	Fibrinogen value at baseline visit
48	Factor VII	206651	phv00206651.v1.p1	pht004098.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:47:41+00:00	2018-03-19 16:47:41+00:00 	HEMA11	Factor VII value [Hemostasis Lab, exam 1]
48	Factor VII	206657	phv00206657.v1.p1	pht004099.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:48:04+00:00	2018-03-19 16:48:04+00:00 	HEMC01	Factor VII value [Hemostasis Lab, exam 3]
48	Factor VII	116361	phv00116361.v2.p2	pht001694.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:51:17+00:00	2018-07-06 19:51:17+00:00 	CLEFACT7	FACTOR VII (%)
48	Factor VII	115090	phv00115090.v2.p2	pht001642.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:52:17+00:00	2018-07-06 19:52:17+00:00 	BLEFACT7	FACTOR VII (%)
48	Factor VII	117556	phv00117556.v2.p2	pht001739.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:52:18+00:00	2018-07-06 19:52:18+00:00 	DLEFACT7	FACTOR VII (%)
48	Factor VII	117563	phv00117563.v2.p2	pht001739.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-14 19:49:05+00:00	2018-07-14 19:49:05+00:00 	DLEF7ANT	FACTOR VII ANTIGEN (%)
48	Factor VII	100038	phv00100038.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:40:29+00:00	2018-07-30 16:40:29+00:00 	F744	FACTOR VII (%)
48	Factor VII	100424	phv00100424.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:40:43+00:00	2018-07-30 16:40:43+00:00 	F744	FACTOR VII (%)
48	Factor VII	105863	phv00105863.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:40:58+00:00	2018-07-30 16:40:58+00:00 	F744	FACTOR VII (%)
48	Factor VII	106988	phv00106988.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:41:13+00:00	2018-07-30 16:41:13+00:00 	F744	FACTOR VII (%)
48	Factor VII	24570	phv00024570.v5.p10	pht000198.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-07 16:51:10+00:00	2018-08-07 16:51:10+00:00 	FACTOR7	FACTOR VII (%)
48	Factor VII	227096	phv00227096.v1.p10	pht004806.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-07 16:51:45+00:00	2018-08-07 16:51:45+00:00 	FACTOR7	Factor VII Collection Interval: Exam 1
48	Factor VII	275764	phv00275764.v1.p10	pht006013.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-07 16:53:04+00:00	2018-08-07 16:53:04+00:00 	zCoagulation_Factor_VII	Coagulation_Factor_VII (Sample type: Citrated plasma)
48	Factor VII	77381	phv00077381.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:02:51+00:00	2018-08-21 00:02:51+00:00 	COREF7AG	Core Factor VII Antigen, activity (%)
48	Factor VII	77382	phv00077382.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:02:51+00:00	2018-08-21 00:02:51+00:00 	COREF7C	Core Factor VII concentration (%)
48	Factor VII	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:02:51+00:00	2018-08-21 00:02:51+00:00 	TESTVAL	Test Result Value
48	Factor VII	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:02:51+00:00	2018-08-21 00:02:51+00:00 	TESTNAME	Test Name
48	Factor VII	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 17:54:44+00:00	2018-08-23 17:54:44+00:00 	TESTABBR	Test abbreviation
48	Factor VII	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 17:54:44+00:00	2018-08-23 17:54:44+00:00 	TESTDESC	Test Description
49	Factor VIII	206649	phv00206649.v1.p1	pht004098.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:47:06+00:00	2018-03-19 16:47:06+00:00 	HEMA07	Factor VIII C value [Hemostasis Lab, exam 1]
49	Factor VIII	84463	phv00084463.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 22:51:12+00:00	2018-04-25 22:51:12+00:00 	f81c	CALIBRATED FACTOR VIII (%)
49	Factor VIII	85019	phv00085019.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 22:51:20+00:00	2018-04-25 22:51:20+00:00 	f81	FACTOR VIII (%)
49	Factor VIII	160522	phv00160522.v1.p3	pht002105.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 22:52:19+00:00	2018-04-25 22:52:19+00:00 	fviii_ss	FACTOR VIII %
49	Factor VIII	116362	phv00116362.v2.p2	pht001694.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:54:02+00:00	2018-07-06 19:54:02+00:00 	CLEFACT8	FACTOR VIII (%)
49	Factor VIII	117557	phv00117557.v2.p2	pht001739.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:54:02+00:00	2018-07-06 19:54:02+00:00 	DLEFACT8	FACTOR VIII (%)
49	Factor VIII	100039	phv00100039.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:42:01+00:00	2018-07-30 16:42:01+00:00 	F844	FACTOR VIII (%)
49	Factor VIII	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:04:25+00:00	2018-08-21 00:04:25+00:00 	TESTVAL	Test Result Value
49	Factor VIII	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:04:25+00:00	2018-08-21 00:04:25+00:00 	TESTNAME	Test Name
49	Factor VIII	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 17:55:12+00:00	2018-08-23 17:55:12+00:00 	TESTABBR	Test abbreviation
49	Factor VIII	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 17:55:12+00:00	2018-08-23 17:55:12+00:00 	TESTDESC	Test Description
50	von Willebrand factor	206654	phv00206654.v1.p1	pht004098.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:45:40+00:00	2018-03-19 16:45:40+00:00 	HEMA17	Von Willebrand Factor - Antigen value [Hemostasis Lab, exam 1]
50	von Willebrand factor	85076	phv00085076.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 22:52:56+00:00	2018-04-25 22:52:56+00:00 	vwf1	PERCENT VON WILLEBRAND FACTOR (vWF)
50	von Willebrand factor	115092	phv00115092.v2.p2	pht001642.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:56:44+00:00	2018-07-06 19:56:44+00:00 	BLEVWANT	VON WILLEBRAND ANTIGEN (%)
50	von Willebrand factor	116364	phv00116364.v2.p2	pht001694.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:56:44+00:00	2018-07-06 19:56:44+00:00 	CLEVWANT	VON WILLEBRAND ANTIGEN (%)
50	von Willebrand factor	116365	phv00116365.v2.p2	pht001694.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:56:44+00:00	2018-07-06 19:56:44+00:00 	CLEVWACT	VON WILLEBRAND ACTIVITY (%)
50	von Willebrand factor	117559	phv00117559.v2.p2	pht001739.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:56:44+00:00	2018-07-06 19:56:44+00:00 	DLEVWANT	VON WILLEBRAND ANTIGEN (%)
50	von Willebrand factor	117560	phv00117560.v2.p2	pht001739.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-06 19:56:44+00:00	2018-07-06 19:56:44+00:00 	DLEVWACT	VON WILLEBRAND ACTIVITY (%)
50	von Willebrand factor	227097	phv00227097.v1.p10	pht004806.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-07 16:59:40+00:00	2018-08-07 16:59:40+00:00 	vwf	Von Willebrand factor Collection Interval: Exam 1
50	von Willebrand factor	275717	phv00275717.v1.p10	pht006013.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-07 17:00:25+00:00	2018-12-12 00:33:03+00:00 	zvWF	VWF (Sample type: Citrated plasma)
50	von Willebrand factor	24571	phv00024571.v5.p10	pht000198.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-07 17:01:07+00:00	2018-08-07 17:01:07+00:00 	VW_FACTO	VON WILLEBRAND FACTOR (%)
50	von Willebrand factor	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:05:52+00:00	2018-08-21 00:05:52+00:00 	TESTVAL	Test Result Value
50	von Willebrand factor	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:05:52+00:00	2018-08-21 00:05:52+00:00 	TESTNAME	Test Name
50	von Willebrand factor	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:09:26+00:00	2018-08-23 18:09:26+00:00 	TESTABBR	Test abbreviation
50	von Willebrand factor	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:09:26+00:00	2018-08-23 18:09:26+00:00 	TESTDESC	Test Description
51	VTE	202930	phv00202930.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 13:58:00+00:00	2018-04-25 13:58:00+00:00 	AFUcomp7e_G	[General health].  Has a doctor ever said you had any of the following? Blood clot in a leg [deep vein thrombosis] [Annual Follow-up Questionnaire Form, AFUG]
51	VTE	202992	phv00202992.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 13:58:15+00:00	2018-04-25 13:58:15+00:00 	AFUcomp16d_L	[General health]. Were you hospitalized for a blood clot in a leg or deep vein thrombosis at that time? [Annual Follow-up Questionnaire Form, AFUL]
51	VTE	203035	phv00203035.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 13:58:28+00:00	2018-04-25 13:58:28+00:00 	AFUcomp16_M	[General health]. Since we last contacted you has a doctor said that you had a blood clot in a leg or deep vein thrombosis? [Annual Follow-up Questionnaire Form, AFUM]
51	VTE	207698	phv00207698.v1.p1	pht004125.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-25 13:58:42+00:00	2018-04-25 13:58:42+00:00 	MHQA9A	Has a doctor ever told you that you had a blood clot in a leg (deep vein thrombosis)? This does not include varicose veins or phlebitis. Q9A [Medical History Questionnaire, exam 4]
51	VTE	121341	phv00121341.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-14 20:01:56+00:00	2018-07-14 20:01:56+00:00 	Y01VTD	VENOUS THROMBOEMBOLIC DISEASE
51	VTE	121466	phv00121466.v2.p2	pht001870.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-14 20:02:20+00:00	2018-07-14 20:02:20+00:00 	Y00VT_PE	DISCHG DIAG - VENOUS THROMB/PULMONARY EMBOL
51	VTE	121560	phv00121560.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-07-14 20:03:18+00:00	2018-07-14 20:03:18+00:00 	Y01VTD	VENOUS THROMBOEMBOLIC DISEASE
51	VTE	273565	phv00273565.v1.p1	pht005981.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:43:46+00:00	2018-07-30 16:43:46+00:00 	vt	Lite: VT case (through dec01)
51	VTE	273566	phv00273566.v1.p1	pht005981.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:44:00+00:00	2018-07-30 16:44:00+00:00 	ttoevent	Days from baseline to VT or censoring (through dec01)
51	VTE	273567	phv00273567.v1.p1	pht005981.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:44:12+00:00	2018-07-30 16:44:12+00:00 	vtpehx01	LITE : Self-report of DVT or PE at baseline
51	VTE	273568	phv00273568.v1.p1	pht005981.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:44:23+00:00	2018-07-30 16:44:23+00:00 	second	LITE: primary or secondary VTE by MD review (through dec01)
51	VTE	276977	phv00276977.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:02:27+00:00	2018-08-09 15:02:27+00:00 	EVENT1	First event Collection Interval: 1975 through 2014
51	VTE	276978	phv00276978.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:02:46+00:00	2018-08-09 15:02:46+00:00 	EVENT2	Second event Collection Interval: 1975 through 2014
51	VTE	276979	phv00276979.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:03:15+00:00	2018-08-09 15:03:15+00:00 	EVENT3	Third event Collection Interval: 1975 through 2014
51	VTE	276980	phv00276980.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:03:36+00:00	2018-08-09 15:03:36+00:00 	EVENT4	Fourth event Collection Interval: 1975 through 2014
51	VTE	7028	phv00007028.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:04:27+00:00	2018-08-09 15:04:27+00:00 	FS434	VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) - LEFT
51	VTE	7029	phv00007029.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:04:54+00:00	2018-08-09 15:04:54+00:00 	FS435	VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) - RIGHT
51	VTE	7461	phv00007461.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:05:33+00:00	2018-08-09 15:05:33+00:00 	FT437	VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS)
51	VTE	10342	phv00010342.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:06:29+00:00	2018-08-09 15:06:29+00:00 	G220	VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) - LEFT
51	VTE	10343	phv00010343.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:07:13+00:00	2018-08-09 15:07:13+00:00 	G221	VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) - RIGHT
51	VTE	70486	phv00070486.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:08:05+00:00	2018-08-09 15:08:05+00:00 	FU149	VENOUS DISEASE: SINCE LAST EXAM HAVE YOU HAD A DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS)
51	VTE	70487	phv00070487.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:08:45+00:00	2018-08-09 15:08:45+00:00 	FU150	VENOUS DISEASE: SINCE LAST EXAM HAVE YOU HAD A PULMONARY EMBOLUS (BLOOD CLOTS IN LUNGS)
51	VTE	255326	phv00255326.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:09:42+00:00	2018-08-09 15:09:42+00:00 	fw597	Circulatory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Blood clot or embolism in leg or lung  Variable appears on Form B only Collection Interval: Original Cohort Exam 30
51	VTE	275051	phv00275051.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:11:38+00:00	2018-08-09 15:11:38+00:00 	FX597	Circulatory Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for blood clot or embolism in leg or lung? Collection Interval: Original Cohort Exam 31
51	VTE	275385	phv00275385.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:12:11+00:00	2018-08-09 15:12:11+00:00 	fy597	Circulatory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for blood clot or embolism in leg or lung? Collection Interval: Original Cohort Exam 32
51	VTE	21065	phv00021065.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:20:09+00:00	2018-08-09 15:20:09+00:00 	G3A230	HAVE YOU EVER HAD A DEEP VEIN THROMBOSIS (BLOOD IN LEG OR ARMS)
51	VTE	273898	phv00273898.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:20:31+00:00	2018-08-09 15:20:31+00:00 	g3a230	Have you ever had a deep vein thrombosis (blood in leg or arms) Collection Interval: Exam 1
51	VTE	274391	phv00274391.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:20:55+00:00	2018-08-09 15:20:55+00:00 	g3a230	Have you ever had a deep vein thrombosis (blood in leg or arms)
51	VTE	1100	phv00001100.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:21:38+00:00	2018-08-09 15:21:38+00:00 	FA81	HOSPITALIZED SINCE LAST EXAM FOR PULMONARY EMBOLUS
51	VTE	21066	phv00021066.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:22:24+00:00	2018-08-09 15:22:24+00:00 	G3A231	HAVE YOU EVER HAD A PULMONARY EMBOLUS (BLOOD CLOT IN LUNGS)
51	VTE	273899	phv00273899.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:22:52+00:00	2018-08-09 15:22:52+00:00 	g3a231	Have you ever had a pulmonary embolus (blood clot in lungs) Collection Interval: Exam 1
51	VTE	274392	phv00274392.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:23:17+00:00	2018-08-09 15:23:17+00:00 	g3a231	Have you ever had a pulmonary embolus (blood clot in lungs)
51	VTE	257557	phv00257557.v1.p10	pht005150.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:24:10+00:00	2018-08-09 15:24:10+00:00 	j803	Ankle Brachial Blood Pressure Measurements: Had any problems with blood clots in legs?
51	VTE	71923	phv00071923.v2.p10	pht000744.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:26:48+00:00	2018-08-09 15:26:48+00:00 	PE024	PE FINAL DIAGNOSTIC SUMMARY: SOE 110 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994)
51	VTE	71924	phv00071924.v2.p10	pht000744.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:27:16+00:00	2018-08-09 15:27:16+00:00 	PE025	PE FINAL DIAGNOSTIC SUMMARY: SOE 111 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994)
51	VTE	71925	phv00071925.v2.p10	pht000744.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:27:36+00:00	2018-08-09 15:27:36+00:00 	PE026	PE FINAL DIAGNOSTIC SUMMARY: SOE 112 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994)
51	VTE	71926	phv00071926.v2.p10	pht000744.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:28:00+00:00	2018-08-09 15:28:00+00:00 	PE027	PE FINAL DIAGNOSTIC SUMMARY: SOE 113 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994)
51	VTE	71927	phv00071927.v2.p10	pht000744.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:28:22+00:00	2018-08-09 15:28:22+00:00 	PE028	PE FINAL DIAGNOSTIC SUMMARY: Other PE 1 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994)
51	VTE	71930	phv00071930.v2.p10	pht000744.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:29:17+00:00	2018-08-09 15:29:17+00:00 	PE031	DVT FINAL DIAGNOSTIC SUMMARY: SOE 114 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994)
51	VTE	71931	phv00071931.v2.p10	pht000744.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:30:12+00:00	2018-08-09 15:30:12+00:00 	PE032	DVT FINAL DIAGNOSTIC SUMMARY: Other DVT 1 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994)
51	VTE	10478	phv00010478.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 15:34:22+00:00	2018-08-09 15:34:22+00:00 	G404	CDI: DEEP VEIN THROMBOSIS
51	VTE	193695	phv00193695.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:15:48+00:00	2018-08-21 00:15:48+00:00 	F33VTEHOSP	F33 Hospitalized Blood Clot (DVT or PE)
51	VTE	193696	phv00193696.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:15:48+00:00	2018-08-21 00:15:48+00:00 	F33VTEHOSPDY	Days enrollment to F33 Hospitalized Blood Clot
51	VTE	193697	phv00193697.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:15:48+00:00	2018-08-21 00:15:48+00:00 	F33VTEOP	F33 Outpatient DVT or PE
51	VTE	193698	phv00193698.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:15:48+00:00	2018-08-21 00:15:48+00:00 	F33VTEOPDY	Days enrollment to F33 Outpatient DVT or PE
51	VTE	121342	phv00121342.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:30:43+00:00	2018-08-30 00:30:43+00:00 	Y01DVTDG	DIAGNOSIS FOR DEEP VEIN THROMBOSIS
51	VTE	121349	phv00121349.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:31:38+00:00	2018-08-30 00:31:38+00:00 	Y01PEDG	DIAGNOSIS FOR PULMONARY EMBOLISM
51	VTE	121486	phv00121486.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:43:49+00:00	2018-08-30 19:43:49+00:00 	Y01VTDEP	ENDPT - DEEP VEIN THROMB/PULMONARY EMBOL
51	VTE	121270	phv00121270.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:43:57+00:00	2018-08-30 19:43:57+00:00 	Y01VTDEP	ENDPT - DEEP VEIN THROMB/PULMONARY EMBOL
51	VTE	121561	phv00121561.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:52:40+00:00	2018-08-30 19:52:40+00:00 	Y01DVTDG	DIAGNOSIS FOR DEEP VEIN THROMBOSIS
51	VTE	121568	phv00121568.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:53:25+00:00	2018-08-30 19:53:25+00:00 	Y01PEDG	DIAGNOSIS FOR PULMONARY EMBOLISM
51	VTE	121735	phv00121735.v1.p2	pht001874.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:12:00+00:00	2018-08-30 20:12:00+00:00 	Z33EPE	PULMONARY EMOBOLUS
51	VTE	121860	phv00121860.v2.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 15:50:48+00:00	2018-09-07 15:50:48+00:00 	VTE	Ever had a blood clot in your vein
51	VTE	71936	phv00071936.v3.p10	pht000744.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 14:56:53+00:00	2018-09-28 14:56:53+00:00 	pe004	PULMONARY EMBOLUS: Date of clinical occurrence Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994)
51	VTE	71942	phv00071942.v3.p10	pht000744.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 14:57:08+00:00	2018-09-28 14:57:08+00:00 	pe011	DEEP VENOUS THROMBOSIS: Date of clinical occurrence Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994)
51	VTE	277005	phv00277005.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 14:57:52+00:00	2018-09-28 14:57:52+00:00 	EDATE1	First event date Collection Interval: 1975 through 2014
51	VTE	277006	phv00277006.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 14:58:07+00:00	2018-09-28 14:58:07+00:00 	EDATE2	Second event date Collection Interval: 1975 through 2014
51	VTE	277007	phv00277007.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 14:58:24+00:00	2018-09-28 14:58:24+00:00 	EDATE3	Third event date Collection Interval: 1975 through 2014
51	VTE	277008	phv00277008.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 14:58:38+00:00	2018-09-28 14:58:38+00:00 	EDATE4	Fourth event date Collection Interval: 1975 through 2014
51	VTE	259384	phv00259384.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-12-20 19:14:09+00:00	2018-12-20 19:14:09+00:00 	priorvt	Prior VT
51	VTE	259388	phv00259388.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-12-20 19:14:20+00:00	2018-12-20 19:14:20+00:00 	vttype	VT type
52	CRP in blood	125941	phv00125941.v1.p1	pht001945.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:48:04+00:00	2018-03-16 01:48:04+00:00 	HSCRP	Hscrp: high sensitivity C-reactive protein in mg/dL
52	CRP in blood	116475	phv00116475.v2.p2	pht001705.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:00:15+00:00	2018-04-17 20:00:15+00:00 	DL6CRPBN	Y7 CRP (BNII Method) in uG per ML
52	CRP in blood	120758	phv00120758.v2.p2	pht001853.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:00:15+00:00	2018-04-17 20:00:15+00:00 	FL6CRP	C-REACTIVE PROTEIN IN uG PER ML
52	CRP in blood	120759	phv00120759.v2.p2	pht001853.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:00:15+00:00	2018-04-17 20:00:15+00:00 	FL6CRPBN	RERUN CRP (uG/ml - BNII METHOD)
52	CRP in blood	82967	phv00082967.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:34:38+00:00	2018-04-25 23:34:38+00:00 	crp1	C-REACTIVE PROTEIN (CRP) (mg/L)
52	CRP in blood	85015	phv00085015.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:34:46+00:00	2018-04-25 23:34:46+00:00 	crp1	C-REACTIVE PROTEIN (CRP) (mg/L)
52	CRP in blood	85016	phv00085016.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:34:52+00:00	2018-04-25 23:34:52+00:00 	crp1t	NATURAL LOG TRANSFORMED C-REACTIVE PROTEIN (CRP)
52	CRP in blood	87661	phv00087661.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:34:59+00:00	2018-04-25 23:34:59+00:00 	crpf	C-REACTIVE PROTEIN (CRP), (mg/L)
52	CRP in blood	87662	phv00087662.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:35:07+00:00	2018-04-25 23:35:07+00:00 	crpft	NATURAL LOG TRANSFORMED C-REACTIVE PROTEIN (CRP)
52	CRP in blood	160534	phv00160534.v1.p3	pht002198.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:35:15+00:00	2018-04-25 23:35:15+00:00 	crp3	CRP (mg/L)
52	CRP in blood	86825	phv00086825.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:36:09+00:00	2018-04-25 23:36:09+00:00 	crp4	C-REACTIVE PROTEIN (mg/l)
52	CRP in blood	21690	phv00021690.v5.p10	pht000080.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 14:32:29+00:00	2018-06-05 14:32:29+00:00 	CRP	CONCENTRATION OF C-REACTIVE PROTEIN, MG/L
52	CRP in blood	21693	phv00021693.v5.p10	pht000081.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 14:33:54+00:00	2018-06-05 14:33:54+00:00 	CRP	CONCENTRATION OF C-REACTIVE PROTEIN, MG/L
52	CRP in blood	21697	phv00021697.v5.p10	pht000082.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 14:34:48+00:00	2018-06-05 14:34:48+00:00 	CRP	C-REACTIVE PROTEIN FROM SERUM (MG/L)
52	CRP in blood	36343	phv00036343.v4.p10	pht000298.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 14:35:19+00:00	2018-06-05 14:35:19+00:00 	crp	CONCENTRATION OF C-REACTIVE PROTEIN, MG/L
52	CRP in blood	172158	phv00172158.v4.p10	pht002888.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 14:35:56+00:00	2018-06-05 14:35:56+00:00 	crp	C-Reactive protein
52	CRP in blood	172177	phv00172177.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:09:20+00:00	2018-06-05 15:09:20+00:00 	CRP	C-reactive protein (CRP) (sample type: serum)
52	CRP in blood	227060	phv00227060.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:09:56+00:00	2018-06-05 15:09:56+00:00 	CRP	C-reactive protein (sample type: serum)
52	CRP in blood	100498	phv00100498.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:45:46+00:00	2018-07-30 16:45:46+00:00 	CRPBLORG	C-reactive protein,  original values (mg/dL)
52	CRP in blood	100499	phv00100499.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:45:58+00:00	2018-07-30 16:45:58+00:00 	CRPBLADJ	C-reactive protein,  adjusted original va
52	CRP in blood	106421	phv00106421.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:46:11+00:00	2018-07-30 16:46:11+00:00 	CRPYR5	C-reactive protein, year5 (mg/L)
52	CRP in blood	107353	phv00107353.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:46:24+00:00	2018-07-30 16:46:24+00:00 	CRPYR5	C-reactive protein,  year5 (mg/L)
52	CRP in blood	277397	phv00277397.v1.p1	pht006036.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:18:45+00:00	2018-08-14 22:18:45+00:00 	CCRPV	C reactive protein result value Collection Interval: 2009-2011
52	CRP in blood	277841	phv00277841.v1.p1	pht006048.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:09:19+00:00	2018-08-14 23:09:19+00:00 	CCRP	C reactive protein result value Collection Interval: 2000-2004
52	CRP in blood	308034	phv00308034.v1.p1	pht006661.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:10:28+00:00	2018-08-16 00:10:28+00:00 	CCRP	C reactive protein result value Collection Interval: 2000-2004
52	CRP in blood	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:21:34+00:00	2018-08-21 00:21:34+00:00 	TESTVAL	Test Result Value
52	CRP in blood	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:21:34+00:00	2018-08-21 00:21:34+00:00 	TESTNAME	Test Name
52	CRP in blood	123990	phv00123990.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:40:47+00:00	2018-08-21 18:40:47+00:00 	crpam	Crp am (ug/mL)
52	CRP in blood	123991	phv00123991.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:40:53+00:00	2018-08-21 18:40:53+00:00 	crpam_orig	Crp am - original value
52	CRP in blood	123993	phv00123993.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:40:57+00:00	2018-08-21 18:40:57+00:00 	lncrpam	Log (Crp am)
52	CRP in blood	123994	phv00123994.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:41:02+00:00	2018-08-21 18:41:02+00:00 	crppm	Crp pm (ug/mL)
52	CRP in blood	123995	phv00123995.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:41:08+00:00	2018-08-21 18:41:08+00:00 	crppm_orig	Crp pm - original value
52	CRP in blood	123997	phv00123997.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:41:13+00:00	2018-08-21 18:41:13+00:00 	lncrppm	Log (crp pm)
52	CRP in blood	124170	phv00124170.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:47:44+00:00	2018-08-21 18:47:44+00:00 	ln_crpam	Log CRP am
52	CRP in blood	124171	phv00124171.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:47:55+00:00	2018-08-21 18:47:55+00:00 	ln_crppm	Log CRP pm
52	CRP in blood	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 17:53:00+00:00	2018-08-23 17:53:00+00:00 	TESTABBR	Test abbreviation
52	CRP in blood	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 17:53:00+00:00	2018-08-23 17:53:00+00:00 	TESTDESC	Test Description
52	CRP in blood	252992	phv00252992.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:14:18+00:00	2018-08-24 17:14:18+00:00 	crp_baseline	CRP value at baseline visit
53	Interleukin 6 in blood	121064	phv00121064.v2.p2	pht001862.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:02:33+00:00	2018-04-17 20:02:33+00:00 	FL6IL6	IL6 PG/ML
53	Interleukin 6 in blood	85009	phv00085009.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:37:31+00:00	2018-04-25 23:37:31+00:00 	il61	INTERLEUKIN-6 (IL-6) (pg/mL)
53	Interleukin 6 in blood	85011	phv00085011.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:37:38+00:00	2018-04-25 23:37:38+00:00 	il61t	NATURAL LOG TRANSFORMED INTERLEUKIN-6 (IL-6)
53	Interleukin 6 in blood	160518	phv00160518.v1.p3	pht002105.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:37:52+00:00	2018-04-25 23:37:52+00:00 	il6_ss	IL6 (PG/ML)
53	Interleukin 6 in blood	160530	phv00160530.v1.p3	pht002198.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:38:02+00:00	2018-04-25 23:38:02+00:00 	il63	IL6 (pg/mL)
53	Interleukin 6 in blood	219027	phv00219027.v1.p3	pht004326.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:38:10+00:00	2018-04-25 23:38:10+00:00 	il6_ss	IL6 RESULTS (PG/ML)
53	Interleukin 6 in blood	100500	phv00100500.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:47:48+00:00	2018-07-30 16:47:48+00:00 	IL6BL	IL-6 at baseline (pg/ml)
53	Interleukin 6 in blood	23796	phv00023796.v5.p10	pht000161.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:06:27+00:00	2018-08-09 14:06:27+00:00 	il6	INTERLEUKIN-6 FROM SERUM (PG/ML)
53	Interleukin 6 in blood	80999	phv00080999.v3.p10	pht001043.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:06:48+00:00	2018-08-09 14:06:48+00:00 	il6	Interleukin-6 concentration
53	Interleukin 6 in blood	172223	phv00172223.v4.p10	pht002891.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:07:16+00:00	2018-08-09 14:07:16+00:00 	il6	Interleukin-6
53	Interleukin 6 in blood	80991	phv00080991.v3.p10	pht001043.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:08:36+00:00	2018-08-09 14:08:36+00:00 	raw1	Interleukin-6 raw OD reading for first well
53	Interleukin 6 in blood	80992	phv00080992.v3.p10	pht001043.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:09:38+00:00	2018-08-09 14:09:38+00:00 	blcor1	Interleukin-6 baseline corrected OD reading for first well
53	Interleukin 6 in blood	80993	phv00080993.v3.p10	pht001043.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:10:32+00:00	2018-08-09 14:10:32+00:00 	conc1	Interleukin-6 concentration for first well
53	Interleukin 6 in blood	80994	phv00080994.v3.p10	pht001043.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:11:13+00:00	2018-08-09 14:11:13+00:00 	raw2	Interleukin-6 raw OD reading for second well
53	Interleukin 6 in blood	80995	phv00080995.v3.p10	pht001043.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:11:56+00:00	2018-08-09 14:11:56+00:00 	blcor2	Interleukin-6 baseline corrected OD reading for second well
53	Interleukin 6 in blood	80997	phv00080997.v3.p10	pht001043.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:12:39+00:00	2018-08-09 14:12:39+00:00 	mresult	Interleukin-6 mean concentration
53	Interleukin 6 in blood	172220	phv00172220.v4.p10	pht002891.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:13:31+00:00	2018-08-09 14:13:31+00:00 	res1	Interleukin-6 result for first well
53	Interleukin 6 in blood	172221	phv00172221.v4.p10	pht002891.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:14:17+00:00	2018-08-09 14:14:17+00:00 	res2	Interleukin-6 result for second well
53	Interleukin 6 in blood	80996	phv00080996.v3.p10	pht001043.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-09 14:14:58+00:00	2018-08-09 14:14:58+00:00 	conc2	Interleukin-6 concentration for second well
53	Interleukin 6 in blood	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:23:50+00:00	2018-08-21 00:23:50+00:00 	TESTVAL	Test Result Value
53	Interleukin 6 in blood	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:23:50+00:00	2018-08-21 00:23:50+00:00 	TESTNAME	Test Name
53	Interleukin 6 in blood	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:02:17+00:00	2018-08-23 18:02:17+00:00 	TESTABBR	Test abbreviation
53	Interleukin 6 in blood	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 18:02:17+00:00	2018-08-23 18:02:17+00:00 	TESTDESC	Test Description
53	Interleukin 6 in blood	252993	phv00252993.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:14:44+00:00	2018-08-24 17:14:44+00:00 	il6_baseline	IL6 value at baseline visit
54	Creatinine in blood	127612	phv00127612.v1.p1	pht001959.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:35:08+00:00	2018-03-16 01:35:08+00:00 	CREATININE	Creatinine mg/dL
54	Creatinine in blood	203867	phv00203867.v1.p1	pht004051.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:17:36+00:00	2018-03-19 16:17:36+00:00 	CHMA09	Creatinine (mg/dL). Q9 [Clinical Chemistry Lab, exam 1]
54	Creatinine in blood	203883	phv00203883.v1.p1	pht004052.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:17:55+00:00	2018-03-19 16:17:55+00:00 	CHMB08	Creatinine (mg Per dL) Dec Pt Req. Q8 [Clinical Chemistry Lab, exam 2]
54	Creatinine in blood	207682	phv00207682.v1.p1	pht004124.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:19:24+00:00	2018-03-19 16:19:24+00:00 	LIPD6A	Creatinine (value). Q6a [Lipid Lab, exam 4]
54	Creatinine in blood	112413	phv00112413.v2.p2	pht001557.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:06:08+00:00	2018-04-17 20:06:08+00:00 	AL3CREAT	CREATININE (MG/DL)
54	Creatinine in blood	118008	phv00118008.v2.p2	pht001753.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:06:08+00:00	2018-04-17 20:06:08+00:00 	EL7CREAT	SERUM CREATININE (mg/dL)
54	Creatinine in blood	119692	phv00119692.v2.p2	pht001807.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:06:08+00:00	2018-04-17 20:06:08+00:00 	FL7CREAT	SERUM CREATININE (mg/dL)
54	Creatinine in blood	82955	phv00082955.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:40:38+00:00	2018-04-25 23:40:38+00:00 	creatin1	CREATININE (mg/dl)
54	Creatinine in blood	84973	phv00084973.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:40:44+00:00	2018-04-25 23:40:44+00:00 	creatin1	CREATININE (mg/dl)
54	Creatinine in blood	86403	phv00086403.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:40:51+00:00	2018-04-25 23:40:51+00:00 	creatin3	CREATININE (mg/dl)
54	Creatinine in blood	86835	phv00086835.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:40:58+00:00	2018-04-25 23:40:58+00:00 	creatin4	CREATININE (mg/dl)
54	Creatinine in blood	87102	phv00087102.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:41:07+00:00	2018-04-25 23:41:07+00:00 	creatinf	CREATININE (mg/dl)
54	Creatinine in blood	175241	phv00175241.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:41:13+00:00	2018-04-25 23:41:13+00:00 	creatin5	SERUM CREATININE (mg/dl)
54	Creatinine in blood	176664	phv00176664.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-25 23:41:20+00:00	2018-04-25 23:41:20+00:00 	creatin5	SERUM CREATININE (mg/dl)
54	Creatinine in blood	206961	phv00206961.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-10 14:43:08+00:00	2018-05-10 14:43:08+00:00 	HFAA44B	[Biochemical analysis]. Q44b - Serum creatinine (mg/dL) last [Heart Failure Hospital Record Abstraction Form, HFA]
54	Creatinine in blood	206960	phv00206960.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-10 14:43:37+00:00	2018-05-10 14:43:37+00:00 	HFAA44A	[Biochemical analysis]. Q44a - Serum creatinine (mg/dL) worst [Heart Failure Hospital Record Abstraction Form, HFA]
54	Creatinine in blood	204180	phv00204180.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-10 14:44:19+00:00	2018-05-10 14:44:19+00:00 	HRAA43DD	[Biomarkers]. Serum creatinine.  Q43dd [Hospital Abstraction Form]
54	Creatinine in blood	204187	phv00204187.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-10 14:44:47+00:00	2018-05-10 14:44:47+00:00 	HRAA56AD1	[Biomarkers: day four]. First serum creatinine. Q56ad1 [Hospital Abstraction Form]
54	Creatinine in blood	204188	phv00204188.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-10 14:45:10+00:00	2018-05-10 14:45:10+00:00 	HRAA56AD3	[Biomarkers: day four]. Second serum creatinine. Q56ad3 [Hospital Abstraction Form]
54	Creatinine in blood	204189	phv00204189.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-10 14:45:39+00:00	2018-05-10 14:45:39+00:00 	HRAA56AD5	[Biomarkers: day four]. Last serum creatinine. Q56ad5 [Hospital Abstraction Form]
54	Creatinine in blood	276860	phv00276860.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:45:37+00:00	2018-06-04 18:45:37+00:00 	CHF054	Chemistry - Creatinine
54	Creatinine in blood	277030	phv00277030.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:46:44+00:00	2018-06-04 18:46:44+00:00 	CREAT1	Creatinine, Exam 1
54	Creatinine in blood	277031	phv00277031.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:46:54+00:00	2018-06-04 18:46:54+00:00 	CREAT2	Creatinine, Exam 2
54	Creatinine in blood	277122	phv00277122.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:47:07+00:00	2018-06-04 18:47:07+00:00 	CREAT2	Creatinine, Exam 2
54	Creatinine in blood	277123	phv00277123.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:47:17+00:00	2018-06-04 18:47:17+00:00 	CREAT5	Creatinine, Exam 5
54	Creatinine in blood	277124	phv00277124.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:47:26+00:00	2018-06-04 18:47:26+00:00 	CREAT6	Creatinine, Exam 6
54	Creatinine in blood	277125	phv00277125.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:47:49+00:00	2018-06-04 18:47:49+00:00 	CREAT7	Creatinine, Exam 7
54	Creatinine in blood	277126	phv00277126.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:48:00+00:00	2018-06-04 18:48:00+00:00 	CREAT8	Creatinine, Exam 8
54	Creatinine in blood	277127	phv00277127.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:48:09+00:00	2018-06-04 18:48:09+00:00 	CREAT9	Creatinine, Exam 9
54	Creatinine in blood	2416	phv00002416.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:49:06+00:00	2018-06-04 18:49:06+00:00 	FG312	BLOOD ANALYSIS, CREATININE
54	Creatinine in blood	2654	phv00002654.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:49:26+00:00	2018-06-04 18:49:26+00:00 	FH331	BLOOD ANALYSIS: CREATININE
54	Creatinine in blood	6662	phv00006662.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:49:44+00:00	2018-06-04 18:49:44+00:00 	FR440	BLOOD ANALYSIS - CREATININE
54	Creatinine in blood	6322	phv00006322.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:50:59+00:00	2018-06-04 18:50:59+00:00 	FQ399	CREATININE
54	Creatinine in blood	6665	phv00006665.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:51:54+00:00	2018-06-04 18:51:54+00:00 	FS532	CREATININE MG/100ML
54	Creatinine in blood	7526	phv00007526.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:52:11+00:00	2018-06-04 18:52:11+00:00 	FT542	CREATININE MG/100ML
54	Creatinine in blood	23207	phv00023207.v5.p10	pht000146.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:52:30+00:00	2018-06-04 18:52:30+00:00 	HIT_CREA	SERUM CREATININE (MG/100ML)
54	Creatinine in blood	70734	phv00070734.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:53:28+00:00	2018-06-04 18:53:28+00:00 	FU579	LAB VALUES: CREATININE, MG/DL
54	Creatinine in blood	21396	phv00021396.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:54:02+00:00	2018-06-04 18:54:02+00:00 	G3A717	CREATININE, MG/DL
54	Creatinine in blood	80753	phv00080753.v2.p10	pht001039.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:54:45+00:00	2018-06-04 18:54:45+00:00 	screconc	Serum creatinine concentration
54	Creatinine in blood	24648	phv00024648.v5.p10	pht000202.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 14:57:17+00:00	2018-06-05 14:57:17+00:00 	CREAT	CREATININE (MG/DL)
54	Creatinine in blood	24666	phv00024666.v5.p10	pht000203.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 14:57:41+00:00	2018-06-05 14:57:41+00:00 	CREAT	CREATININE (MG/DL)
54	Creatinine in blood	81024	phv00081024.v1.p10	pht001045.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 14:58:04+00:00	2018-06-05 14:58:04+00:00 	CREAT	Creatinine Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38)
54	Creatinine in blood	172175	phv00172175.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:05:04+00:00	2018-06-05 15:05:04+00:00 	CREAT	Creatinine (sample type: serum)
54	Creatinine in blood	227058	phv00227058.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:05:31+00:00	2018-06-05 15:05:31+00:00 	CREAT	Creatinine (sample type: serum)
54	Creatinine in blood	255344	phv00255344.v1.p10	pht005143.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:06:45+00:00	2018-06-05 15:06:45+00:00 	CREAT	Creatinine (sample type: serum)
54	Creatinine in blood	71894	phv00071894.v4.p10	pht000742.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:07:55+00:00	2018-06-05 15:07:55+00:00 	CREATINI	Creatinine, serum
54	Creatinine in blood	275417	phv00275417.v1.p10	pht006011.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:08:17+00:00	2018-06-05 15:08:17+00:00 	CREATINI	Creatinine (sample type: serum) Collection Interval: Omni 1 Exam 3
54	Creatinine in blood	275408	phv00275408.v1.p10	pht006010.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:41:41+00:00	2018-06-05 15:41:41+00:00 	HIT_CREA	Creatinine (sample type: serum) Collection Interval: Exam 2
54	Creatinine in blood	126131	phv00126131.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:34:49+00:00	2018-06-12 01:34:49+00:00 	CRT01CC	Creatinine calibrated to cleveland clinic-equivalent MN LAB (mg/dl)
54	Creatinine in blood	100049	phv00100049.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:48:15+00:00	2018-07-30 16:48:15+00:00 	CRE44	CREATININE (mg/dl)
54	Creatinine in blood	100432	phv00100432.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:48:27+00:00	2018-07-30 16:48:27+00:00 	CRE44	CREATININE (mg/dl)
54	Creatinine in blood	100484	phv00100484.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:48:38+00:00	2018-07-30 16:48:38+00:00 	CREADJ	New cohort cre44 adjusted for drift (mg/--incomplete)
54	Creatinine in blood	105871	phv00105871.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:48:56+00:00	2018-07-30 16:48:56+00:00 	CRE44	CREATININE (mg/dl)
54	Creatinine in blood	106410	phv00106410.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:49:08+00:00	2018-07-30 16:49:08+00:00 	CREADJ	Cre44 adjusted for drift
54	Creatinine in blood	106998	phv00106998.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:49:20+00:00	2018-07-30 16:49:20+00:00 	CRE44	CREATININE (mg/dl)
54	Creatinine in blood	110488	phv00110488.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:49:34+00:00	2018-07-30 16:49:34+00:00 	CRE44	CREATININE (mg/dl)
54	Creatinine in blood	110492	phv00110492.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 16:49:48+00:00	2018-07-30 16:49:48+00:00 	CREADJ	CRE44 ADJUSTED FOR DRIFT (mg/dl)
54	Creatinine in blood	124035	phv00124035.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:50:40+00:00	2018-08-14 20:50:40+00:00 	creatinine	Creatinine (mg/dL)
54	Creatinine in blood	124036	phv00124036.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:50:51+00:00	2018-08-14 20:50:51+00:00 	creatinine_orig	Creatinine - original value
54	Creatinine in blood	124179	phv00124179.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:51:08+00:00	2018-08-14 20:51:08+00:00 	creatinine_gL	Creatinine (g/L)
54	Creatinine in blood	277309	phv00277309.v1.p1	pht006031.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:09:46+00:00	2018-08-14 22:09:46+00:00 	SCREATP	Serum Creatinine Collection Interval: 2007-2009
54	Creatinine in blood	277403	phv00277403.v1.p1	pht006036.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:20:54+00:00	2018-08-14 22:20:54+00:00 	SCRV	Serum Creatinine Average result value Collection Interval: 2009-2011
54	Creatinine in blood	277578	phv00277578.v1.p1	pht006041.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:44:48+00:00	2018-08-14 22:44:48+00:00 	SCR_PLUS	Serum Creatinine Collection Interval: 1996-2000
54	Creatinine in blood	277848	phv00277848.v1.p1	pht006048.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:10:26+00:00	2018-08-14 23:10:26+00:00 	SCR_PLUS	Serum Creatinine Collection Interval: 2000-2004
54	Creatinine in blood	307769	phv00307769.v1.p1	pht006650.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:52:50+00:00	2018-08-15 23:52:50+00:00 	SCREATP	Serum Creatinine Collection Interval: 2006-2011
54	Creatinine in blood	307859	phv00307859.v1.p1	pht006655.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:57:17+00:00	2018-08-15 23:57:17+00:00 	SCR_PLUS	Serum Creatinine Collection Interval: 1996-2000
54	Creatinine in blood	308041	phv00308041.v1.p1	pht006661.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:11:58+00:00	2018-08-16 00:11:58+00:00 	SCR_PLUS	Serum Creatinine Collection Interval: 2000-2004
54	Creatinine in blood	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:25:02+00:00	2018-08-21 00:25:02+00:00 	TESTVAL	Test Result Value
54	Creatinine in blood	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:25:02+00:00	2018-08-21 00:25:02+00:00 	TESTNAME	Test Name
54	Creatinine in blood	283659	phv00283659.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:25:02+00:00	2018-08-21 00:25:02+00:00 	SERUMCREAT	F136 Serum creatinine, mg/dl
54	Creatinine in blood	226307	phv00226307.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:45:02+00:00	2018-08-22 21:45:02+00:00 	LABA76	Creatinine (mg/dL) (LABA76)
54	Creatinine in blood	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-04 22:06:13+00:00	2018-09-04 22:06:13+00:00 	TESTABBR	Test abbreviation
54	Creatinine in blood	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-04 22:12:32+00:00	2018-09-04 22:12:32+00:00 	TESTDESC	Test Description
54	Creatinine in blood	161767	phv00161767.v3.p10	pht002234.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-12-11 23:56:48+00:00	2018-12-11 23:56:48+00:00 	creatinine	Creatinine
54	Creatinine in blood	166800	phv00166800.v3.p10	pht002566.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-12-11 23:58:29+00:00	2018-12-11 23:58:29+00:00 	creatinine	Creatinine
54	Creatinine in blood	172326	phv00172326.v1.p10	pht002895.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-12-11 23:58:41+00:00	2018-12-11 23:58:41+00:00 	creatinine	Creatinine
55	Cystatin C in blood	84545	phv00084545.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:11:51+00:00	2018-04-26 00:11:51+00:00 	cystatc1	CYSTATIN C (mg/L)
55	Cystatin C in blood	196280	phv00196280.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:11:57+00:00	2018-04-26 00:11:57+00:00 	cystatc5	CYSTATIN-C (mg/L) AT EXAM 5
55	Cystatin C in blood	275482	phv00275482.v1.p10	pht006013.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-07 16:45:41+00:00	2018-08-07 16:45:41+00:00 	zCystatin_C	Cystatin_C (Sample type: Citrated plasma)
55	Cystatin C in blood	23208	phv00023208.v5.p10	pht000146.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-08-07 16:47:03+00:00	2018-08-07 16:47:03+00:00 	cys	CYSTATIN C (MG/L)
55	Cystatin C in blood	277308	phv00277308.v1.p1	pht006031.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:09:56+00:00	2018-08-14 22:09:56+00:00 	CYSTATIN	Cystatin C Collection Interval: 2007-2009
55	Cystatin C in blood	307768	phv00307768.v1.p1	pht006650.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:53:08+00:00	2018-08-15 23:53:08+00:00 	CYSTATIN	Cystatin C Collection Interval: 2006-2011
55	Cystatin C in blood	193862	phv00193862.v3.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:26:56+00:00	2018-08-21 00:26:56+00:00 	TESTVAL	Test Result Value
55	Cystatin C in blood	282937	phv00282937.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-21 00:26:56+00:00	2018-08-21 00:26:56+00:00 	TESTNAME	Test Name
55	Cystatin C in blood	124064	phv00124064.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:45:58+00:00	2018-08-21 18:45:58+00:00 	cystatinc	Plasma cystatin c am (mg/L)
55	Cystatin C in blood	124065	phv00124065.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:46:04+00:00	2018-08-21 18:46:04+00:00 	cystatinc_orig	Cystatin c - original value
55	Cystatin C in blood	282935	phv00282935.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 17:53:28+00:00	2018-08-23 17:53:28+00:00 	TESTABBR	Test abbreviation
55	Cystatin C in blood	282938	phv00282938.v1.p3	pht003419.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-08-23 17:53:28+00:00	2018-08-23 17:53:28+00:00 	TESTDESC	Test Description
56	Albumin-creatinine ratio in urine	119620	phv00119620.v2.p2	pht001803.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:09:51+00:00	2018-04-17 20:09:51+00:00 	EL8RATIO	ALB/CREAT RATIO (mg/g): 1000(UALB/UCRET)
56	Albumin-creatinine ratio in urine	120679	phv00120679.v2.p2	pht001849.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:09:51+00:00	2018-04-17 20:09:51+00:00 	FL1RATIO	ALB/CREAT RATIO (mg/g) 1000*(UALB/UCRET)
56	Albumin-creatinine ratio in urine	83437	phv00083437.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:14:20+00:00	2018-04-26 00:14:20+00:00 	ualbcre1	URINARY ALBUMIN/CREATININE (mg/g)
56	Albumin-creatinine ratio in urine	85746	phv00085746.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:14:26+00:00	2018-04-26 00:14:26+00:00 	ualbcre1	URINARY ALBUMIN/CREATININE (mg/g)
56	Albumin-creatinine ratio in urine	85929	phv00085929.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:14:45+00:00	2018-04-26 00:14:45+00:00 	ualbcre2	URINARY ALBUMIN/CREATININE (mg/g)
56	Albumin-creatinine ratio in urine	86412	phv00086412.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:14:53+00:00	2018-04-26 00:14:53+00:00 	ualbcre3	URINARY ALBUMIN/CREATININE (mg/g)
56	Albumin-creatinine ratio in urine	175607	phv00175607.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:15:01+00:00	2018-04-26 00:15:01+00:00 	ualbcre5	URINARY ALBUMIN/CREATININE (mg/g)
56	Albumin-creatinine ratio in urine	177041	phv00177041.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:15:22+00:00	2018-04-26 00:15:22+00:00 	ualbcre5	URINARY ALBUMIN/CREATININE (mg/g)
56	Albumin-creatinine ratio in urine	127643	phv00127643.v1.p1	pht001960.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 13:59:00+00:00	2018-06-20 13:59:00+00:00 	RS_UA_CR_RATIO	Spot UA creatinine ratio mg/g
56	Albumin-creatinine ratio in urine	127651	phv00127651.v1.p1	pht001961.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 14:03:12+00:00	2018-06-20 14:03:12+00:00 	uacr24h	24 hour urine albumin creatinine ratio: mg/g
56	Albumin-creatinine ratio in urine	110615	phv00110615.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-07-30 17:13:18+00:00	2018-07-30 17:13:18+00:00 	UAB72	MICROALBUMEN (mg/g creatinine)
56	Albumin-creatinine ratio in urine	124041	phv00124041.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:44:31+00:00	2018-08-21 18:44:31+00:00 	mcratio	M:c ratio (ug/mg)
56	Albumin-creatinine ratio in urine	124042	phv00124042.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 18:44:42+00:00	2018-08-21 18:44:42+00:00 	mcratio_orig	M:c ratio - original value
56	Albumin-creatinine ratio in urine	226309	phv00226309.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:52:10+00:00	2018-08-22 21:52:10+00:00 	LABA81	Albumin/creatinine ratio (mg/g) (LABA81)
57	GFR	82961	phv00082961.v2.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:36:42+00:00	2018-04-26 00:36:42+00:00 	egfr1c	ESTIMATED GLOMERULAR FILTRATION RATE BY SIMPLIFIED MDRD EQUATION
57	GFR	195567	phv00195567.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:36:48+00:00	2018-04-26 00:36:48+00:00 	cepgfr1c	EXAM 1 EGFR USING CKD-EPI EQUATION (ML/MIN/1.73 M2) (GFR)
57	GFR	84464	phv00084464.v3.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:36:56+00:00	2018-04-26 00:36:56+00:00 	egfr1c	ESTIMATED GLOMERULAR FILTRATION RATE BY SIMPLIFIED MDRD EQUATION
57	GFR	111943	phv00111943.v3.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:37:02+00:00	2018-04-26 00:37:02+00:00 	cepgfr1c	EXAM 1 (CALIBRATED CR) EGFR USING CKD-EPI EQUATION
57	GFR	86284	phv00086284.v5.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:37:11+00:00	2018-04-26 00:37:11+00:00 	egfr3c	EXAM 3 GLOMERULAR FILTRATION RATE (GFR)
57	GFR	111948	phv00111948.v5.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 00:37:21+00:00	2018-04-26 00:37:21+00:00 	cepgfr3c	EXAM 3 (CALIBRATED CR) eGFR USING CKD-EPI EQUATION
57	GFR	111951	phv00111951.v4.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:06:25+00:00	2018-04-26 01:06:25+00:00 	egfr4c	GLOMERULAR FILTRATION RATE (GFR)
57	GFR	111952	phv00111952.v4.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:06:33+00:00	2018-04-26 01:06:33+00:00 	cepgfr4c	EXAM 4 (CALIBRATED CR) EGFR USING CKD-EPI EQUATION
57	GFR	87096	phv00087096.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:06:42+00:00	2018-04-26 01:06:42+00:00 	egfrfc	ESTIMATED GLOMERULAR FILTRATION RATE BY SIMPLIFIED MDRD EQUATION
57	GFR	174602	phv00174602.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:06:48+00:00	2018-04-26 01:06:48+00:00 	egfr5c	EXAM 5 eGFR USING MDRD EQUATION (mL/min/1.73 m2) (GFR)
57	GFR	174604	phv00174604.v2.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:06:59+00:00	2018-04-26 01:06:59+00:00 	cepgfr5c	EXAM 5 eGFR USING CKD-EPI EQUATION (mL/min/1.73 m2) (GFR)
57	GFR	176025	phv00176025.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:07:05+00:00	2018-04-26 01:07:05+00:00 	egfr5c	EXAM 5 eGFR USING MDRD EQUATION (mL/min/1.73 m2) (GFR)
57	GFR	176027	phv00176027.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-26 01:07:11+00:00	2018-04-26 01:07:11+00:00 	cepgfr5c	EXAM 5 eGFR USING CKD-EPI EQUATION (mL/min/1.73 m2) (GFR)
57	GFR	126132	phv00126132.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:34:35+00:00	2018-06-12 01:34:35+00:00 	GFR01CC	EGFR based on the MDRD formula
62	FVC	208817	phv00208817.v1.p1	pht004142.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:28:33+00:00	2018-03-19 20:28:33+00:00 	PFTA24	FVC (liters) [Pulmonary Function Test, exam 1]
62	FVC	113262	phv00113262.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:44+00:00	2018-04-17 17:09:44+00:00 	A12FVC1	FVC, TRIAL 1
62	FVC	114615	phv00114615.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:44+00:00	2018-04-17 17:09:44+00:00 	B12FVC1	FORCED VITAL CAPACITY, TRIAL #1
62	FVC	115620	phv00115620.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:44+00:00	2018-04-17 17:09:44+00:00 	C12FVC1	FORCED VITAL CAPACITY, TRIAL #1
62	FVC	115632	phv00115632.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	C12FVC2	FORCED VITAL CAPACITY, TRIAL #2
62	FVC	115644	phv00115644.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	C12FVC3	FORCED VITAL CAPACITY, TRIAL #3
62	FVC	115656	phv00115656.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	C12FVC4	FORCED VITAL CAPACITY, TRIAL #4
62	FVC	115668	phv00115668.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	C12FVC5	FORCED VITAL CAPACITY, TRIAL #5
62	FVC	115687	phv00115687.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	C12FVC	MAXIMUM FVC
62	FVC	118839	phv00118839.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	E12FVC1	FORCED VITAL CAPACITY, TRIAL #1
62	FVC	118863	phv00118863.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	E12FVC3	FORCED VITAL CAPACITY, TRIAL #3
62	FVC	118875	phv00118875.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	E12FVC4	FORCED VITAL CAPACITY, TRIAL #4
62	FVC	118887	phv00118887.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	E12FVC5	FORCED VITAL CAPACITY, TRIAL #5
62	FVC	118899	phv00118899.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	E12FVC6	FORCED VITAL CAPACITY, TRIAL #6
62	FVC	118911	phv00118911.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	E12FVC7	FORCED VITAL CAPACITY, TRIAL #7
62	FVC	118923	phv00118923.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	E12FVC8	FORCED VITAL CAPACITY, TRIAL #8
62	FVC	118941	phv00118941.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	E12FVC	MAXIMUM FVC (5 TRIALS)
62	FVC	118970	phv00118970.v2.p2	pht001782.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:09:45+00:00	2018-04-17 17:09:45+00:00 	E128VC	MAXIMUM FVC (8 TRIALS)
62	FVC	83474	phv00083474.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 02:22:50+00:00	2018-04-28 02:22:50+00:00 	fvca4	FORCED VITAL CAPACITY (ml)
62	FVC	83709	phv00083709.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 02:23:00+00:00	2018-04-28 02:23:00+00:00 	fvca4	FORCED VITAL CAPACITY (ml)
62	FVC	87700	phv00087700.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 02:30:02+00:00	2018-04-28 02:30:02+00:00 	fvca4	FORCED VITAL CAPACITY (ml)
62	FVC	214068	phv00214068.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-10 16:59:24+00:00	2018-05-10 16:59:24+00:00 	FVC	Forced vital capacity (Liters)
62	FVC	128209	phv00128209.v1.p1	pht001969.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:58:13+00:00	2018-06-20 17:58:13+00:00 	pula17	BEST_FVC - Best forced vital capacity from best curve (best curve is an acceptable curve that has Max [FVC + FEV1 ] ): measured in liters
62	FVC	128219	phv00128219.v1.p1	pht001969.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:58:13+00:00	2018-06-20 17:58:13+00:00 	pula27	SCND_FVC - Best forced vital capacity from 2nd best curve (Second best curve is second highest  [FVC + FEV1 ] ): measured in liters
62	FVC	128229	phv00128229.v1.p1	pht001969.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:58:13+00:00	2018-06-20 17:58:13+00:00 	pula37	THRD_FVC - Best forced vital capacity from 3rd best curve (Third best curve is third highest [ FVC + FEV1 ] ): measured in liters
62	FVC	128242	phv00128242.v1.p1	pht001969.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:47:39+00:00	2018-07-09 20:47:39+00:00 	FVC01PP	Derived FVC % predicted
62	FVC	159849	phv00159849.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:34:00+00:00	2018-08-10 21:34:00+00:00 	FVCpp_post	FVC % pred post-bronch Collection Interval: Collected in Exam 1
62	FVC	159852	phv00159852.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:34:35+00:00	2018-08-10 21:34:35+00:00 	FVC_post	FVC post-bronch Collection Interval: Collected in Exam 1
62	FVC	159854	phv00159854.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:34:57+00:00	2018-08-10 21:34:57+00:00 	FVC_pre	FVC pre-bronch Collection Interval: Collected in Exam 1
62	FVC	113295	phv00113295.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 20:46:56+00:00	2018-08-17 20:46:56+00:00 	A12FVC4	FVC, TRIAL 4
62	FVC	113284	phv00113284.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 20:47:05+00:00	2018-08-17 20:47:05+00:00 	A12FVC3	FVC, TRIAL 3
62	FVC	113273	phv00113273.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 20:47:14+00:00	2018-08-17 20:47:14+00:00 	A12FVC2	FVC, TRIAL 2
62	FVC	113306	phv00113306.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 20:47:37+00:00	2018-08-17 20:47:37+00:00 	A12FVC5	FVC, TRIAL 5
62	FVC	113317	phv00113317.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 20:48:53+00:00	2018-08-17 20:48:53+00:00 	A12FVC6	FVC, TRIAL 6
62	FVC	113402	phv00113402.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 20:55:30+00:00	2018-08-17 20:55:30+00:00 	A12FVC	MAXIMUM FVC
62	FVC	114663	phv00114663.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:26:03+00:00	2018-08-22 23:26:03+00:00 	B12FVC5	FORCED VITAL CAPACITY, TRIAL #5
62	FVC	114651	phv00114651.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:26:32+00:00	2018-08-22 23:26:32+00:00 	B12FVC4	FORCED VITAL CAPACITY, TRIAL #4
62	FVC	114639	phv00114639.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:26:43+00:00	2018-08-22 23:26:43+00:00 	B12FVC3	FORCED VITAL CAPACITY, TRIAL #3
62	FVC	114627	phv00114627.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:26:54+00:00	2018-08-22 23:26:54+00:00 	B12FVC2	FORCED VITAL CAPACITY, TRIAL #2
62	FVC	114694	phv00114694.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:28:01+00:00	2018-08-22 23:28:01+00:00 	B12FVC	MAXIMUM FVC
62	FVC	114675	phv00114675.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:28:11+00:00	2018-08-22 23:28:11+00:00 	B12FVC6	FORCED VITAL CAPACITY, TRIAL #6
62	FVC	226383	phv00226383.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:28:05+00:00	2018-08-24 16:28:05+00:00 	PRBA25	FVC (mL) (PRBA25)
62	FVC	258076	phv00258076.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:03:10+00:00	2018-08-24 17:03:10+00:00 	PRBA36	Predicted FVC (mL) (recalculated) (PRBA36)
62	FVC	253022	phv00253022.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:22:46+00:00	2018-08-24 17:22:46+00:00 	fvc_pre_bd_baseline	Forced vital capacity measured by spirometry at baseline visit
62	FVC	99664	phv00099664.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:29:54+00:00	2018-09-27 16:29:54+00:00 	FVC18	FVC (L)
62	FVC	99667	phv00099667.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:30:07+00:00	2018-09-27 16:30:07+00:00 	FVCPCT18	FVC PERCENT PREDICTED
62	FVC	99670	phv00099670.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:30:23+00:00	2018-09-27 16:30:23+00:00 	FVCPRD18	FVC PREDICTED VALUE
62	FVC	107762	phv00107762.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:30:46+00:00	2018-09-27 16:30:46+00:00 	FVC18	FVC (L)
62	FVC	107764	phv00107764.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:31:04+00:00	2018-09-27 16:31:04+00:00 	FVCPRD18	FVC PREDICTED (L)
62	FVC	110359	phv00110359.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:31:20+00:00	2018-09-27 16:31:20+00:00 	FVCPRD18	FVC PREDICTED (L)
62	FVC	110364	phv00110364.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:31:33+00:00	2018-09-27 16:31:33+00:00 	FVC18	FVC
62	FVC	22555	phv00022555.v5.p10	pht000101.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:42+00:00	2018-10-05 15:33:42+00:00 	FVC_5_1	FORCED VITAL CAPACITY - BEST EFFORT (LITERS)
62	FVC	22571	phv00022571.v4.p10	pht000102.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:42+00:00	2018-10-05 15:33:42+00:00 	fvc_1_3	FORCED VITAL CAPACITY - BEST EFFORT (LITERS)
62	FVC	22584	phv00022584.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:42+00:00	2018-10-05 15:33:42+00:00 	FVC_A	FORCED VITAL CAPACITY - TRIAL 1
62	FVC	22597	phv00022597.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:42+00:00	2018-10-05 15:33:42+00:00 	FVC_B	FORCED VITAL CAPACITY - TRIAL 1
62	FVC	22610	phv00022610.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:42+00:00	2018-10-05 15:33:42+00:00 	FVC_C	FORCED VITAL CAPACITY - TRIAL 3
62	FVC	22623	phv00022623.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:42+00:00	2018-10-05 15:33:42+00:00 	FVC_D	FORCED VITAL CAPACITY - TRIAL 4
62	FVC	22636	phv00022636.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:42+00:00	2018-10-05 15:33:42+00:00 	FVC_E	FORCED VITAL CAPACITY - TRIAL 5
62	FVC	22651	phv00022651.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:43+00:00	2018-10-05 15:33:43+00:00 	B_FVC	FORCED VITAL CAPACITY - SUMMARY
62	FVC	22664	phv00022664.v5.p10	pht000104.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:43+00:00	2018-10-05 15:33:43+00:00 	FVC_6_1	FORCED VITAL CAPACITY - BEST EFFORT (LITERS)
62	FVC	22678	phv00022678.v5.p10	pht000105.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:43+00:00	2018-10-05 15:33:43+00:00 	FVC_3_1	FORCED VITAL CAPACITY - BEST EFFORT (LITERS)
62	FVC	22689	phv00022689.v5.p10	pht000106.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:43+00:00	2018-10-05 15:33:43+00:00 	FVC_7_1	FORCED VITAL CAPACITY - BEST EFFORT (LITERS)
62	FVC	55266	phv00055266.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:43+00:00	2018-10-05 15:33:43+00:00 	FVC	Forced Vital Capacity (Litres)
62	FVC	73832	phv00073832.v4.p10	pht000832.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:43+00:00	2018-10-05 15:33:43+00:00 	fvc_8_1	Forced vital capacity - highest value among acceptable maneuvers
62	FVC	196552	phv00196552.v2.p10	pht003632.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:43+00:00	2018-10-05 15:33:43+00:00 	fvc_2	Forced Vital Capacity (FVC) - Highest value among acceptable maneuvers
62	FVC	196569	phv00196569.v2.p10	pht003633.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:43+00:00	2018-10-05 15:33:43+00:00 	fvc_alb_2	Forced Vital Capacity (FVC) - Highest value among acceptable maneuvers, Albuterol
62	FVC	196586	phv00196586.v2.p10	pht003634.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:43+00:00	2018-10-05 15:33:43+00:00 	fvc_alb_8	Forced Vital Capacity (FVC) - Highest value among acceptable maneuvers, Albuterol Collection Interval: Offspring Exam 8, Omni 1 Exam 3
62	FVC	257838	phv00257838.v1.p10	pht005169.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:43+00:00	2018-10-05 15:33:43+00:00 	FVC_9_1	Forced Vital Capacity (liters) - Highest value among acceptable maneuvers Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4
62	FVC	257853	phv00257853.v1.p10	pht005170.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:43+00:00	2018-10-05 15:33:43+00:00 	fvc_1	Forced Vital Capacity (FVC) - Highest value among acceptable maneuvers
62	FVC	257872	phv00257872.v1.p10	pht005171.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:33:43+00:00	2018-10-05 15:33:43+00:00 	FVC_post_9_1	Forced Vital Capacity (liters) - Highest value among acceptable maneuvers, Albuterol Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4
63	FEV1	208819	phv00208819.v1.p1	pht004142.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 20:28:58+00:00	2018-03-19 20:28:58+00:00 	PFTA26	FEV(1) (liters) [Pulmonary Function Test, exam 1]
63	FEV1	113263	phv00113263.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	A12FEV11	FEV1, TRIAL 1
63	FEV1	113274	phv00113274.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	A12FEV12	FEV1, TRIAL 2
63	FEV1	113285	phv00113285.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	A12FEV13	FEV1, TRIAL 3
63	FEV1	113296	phv00113296.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	A12FEV14	FEV1, TRIAL 4
63	FEV1	113307	phv00113307.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	A12FEV15	FEV1, TRIAL 5
63	FEV1	113318	phv00113318.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	A12FEV16	FEV1, TRIAL 6
63	FEV1	113403	phv00113403.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	A12FE1	MAXIMUM FEV1
63	FEV1	114616	phv00114616.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	B12FEV11	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #1
63	FEV1	114628	phv00114628.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	B12FEV12	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #2
63	FEV1	114640	phv00114640.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	B12FEV13	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #3
63	FEV1	114652	phv00114652.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	B12FEV14	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #4
63	FEV1	114664	phv00114664.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	B12FEV15	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #5
63	FEV1	114676	phv00114676.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	B12FEV16	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #6
63	FEV1	114695	phv00114695.v2.p2	pht001627.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:17:00+00:00	2018-04-17 17:17:00+00:00 	B12FE1	MAXIMUM FEV1
63	FEV1	115621	phv00115621.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:19:59+00:00	2018-04-17 17:19:59+00:00 	C12FEV11	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #1
63	FEV1	115633	phv00115633.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:19:59+00:00	2018-04-17 17:19:59+00:00 	C12FEV12	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #2
63	FEV1	115645	phv00115645.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:19:59+00:00	2018-04-17 17:19:59+00:00 	C12FEV13	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #3
63	FEV1	115657	phv00115657.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:19:59+00:00	2018-04-17 17:19:59+00:00 	C12FEV14	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #4
63	FEV1	115669	phv00115669.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:19:59+00:00	2018-04-17 17:19:59+00:00 	C12FEV15	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #5
63	FEV1	115688	phv00115688.v2.p2	pht001667.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 17:19:59+00:00	2018-04-17 17:19:59+00:00 	C12FE1	MAXIMUM FEV1
63	FEV1	118840	phv00118840.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:34:18+00:00	2018-04-17 19:34:18+00:00 	E12FEV11	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #1
63	FEV1	118852	phv00118852.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:34:18+00:00	2018-04-17 19:34:18+00:00 	E12FEV12	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #2
63	FEV1	118864	phv00118864.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:34:18+00:00	2018-04-17 19:34:18+00:00 	E12FEV13	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #3
63	FEV1	118876	phv00118876.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:34:18+00:00	2018-04-17 19:34:18+00:00 	E12FEV14	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #4
63	FEV1	118888	phv00118888.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:34:18+00:00	2018-04-17 19:34:18+00:00 	E12FEV15	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #5
63	FEV1	118900	phv00118900.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:34:18+00:00	2018-04-17 19:34:18+00:00 	E12FEV16	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #6
63	FEV1	118912	phv00118912.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:34:18+00:00	2018-04-17 19:34:18+00:00 	E12FEV17	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #7
63	FEV1	118924	phv00118924.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:34:18+00:00	2018-04-17 19:34:18+00:00 	E12FEV18	FORCED EXPIRATORY VOL/1 SECOND, TRIAL #8
63	FEV1	118942	phv00118942.v2.p2	pht001781.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 19:34:18+00:00	2018-04-17 19:34:18+00:00 	E12FE1	MAXIMUM FEV1 (5 TRIALS)
63	FEV1	83475	phv00083475.v2.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:23:37+00:00	2018-04-28 21:23:37+00:00 	fev1a4	FORCED EXPIRATORY VOLUME AT 1 SECOND (ml/sec)
63	FEV1	87701	phv00087701.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:25:28+00:00	2018-04-28 21:25:28+00:00 	fev1a4	FORCED EXPIRATORY VOLUME AT 1 SECOND (ml/sec)
63	FEV1	83710	phv00083710.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:40:35+00:00	2018-04-28 21:40:35+00:00 	fev1a4	FORCED EXPIRATORY VOLUME AT 1 SECOND (ml/sec)
63	FEV1	214067	phv00214067.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-10 16:58:48+00:00	2018-05-10 16:58:48+00:00 	FEV1	Forced expiratory volume in one second (Liters)
63	FEV1	128210	phv00128210.v1.p1	pht001969.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:56:44+00:00	2018-06-20 17:56:44+00:00 	pula18	BEST_FEV1 - Forced expiratory volume in 1 second, FEV1.0 from the best curve: measured in liters
63	FEV1	128220	phv00128220.v1.p1	pht001969.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:56:44+00:00	2018-06-20 17:56:44+00:00 	pula28	SCND_FEV1 - Forced expiratory volume in 1 second, FEV1.0  from the 2nd best curve: measured in liters
63	FEV1	128230	phv00128230.v1.p1	pht001969.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:56:44+00:00	2018-06-20 17:56:44+00:00 	pula38	THRD_FEV1 - Forced expiratory volume in 1 second, FEV1.0 from the 3rd best curve: measured in liters
63	FEV1	128243	phv00128243.v1.p1	pht001969.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:48:08+00:00	2018-07-09 20:48:08+00:00 	FEV01PP	Derived FEV1 % predicted
63	FEV1	159853	phv00159853.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:31:48+00:00	2018-08-10 21:31:48+00:00 	FEV1_pre	FEV1 pre-bronch Collection Interval: Collected in Exam 1
63	FEV1	159851	phv00159851.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:31:56+00:00	2018-08-10 21:31:56+00:00 	FEV1_post	FEV1 post-bronch Collection Interval: Collected in Exam 1
63	FEV1	159848	phv00159848.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:32:04+00:00	2018-08-10 21:32:04+00:00 	FEV1pp_post	FEV1 % pred post-bronch Collection Interval: Collected in Exam 1
63	FEV1	226384	phv00226384.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:28:13+00:00	2018-08-24 16:28:13+00:00 	PRBA29	FEV1 (mL) (PRBA29)
63	FEV1	253023	phv00253023.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:22:55+00:00	2018-08-24 17:22:55+00:00 	fev1_pre_bd_baseline	Forced expiratory volume in 1 second measured by spirometry at baseline visit
63	FEV1	118971	phv00118971.v2.p2	pht001782.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:37:55+00:00	2018-08-28 23:37:55+00:00 	E128E1	MAXIMUM FEV1 (8 TRIALS)
63	FEV1	99665	phv00099665.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:32:13+00:00	2018-09-27 16:32:13+00:00 	FEV118	FEV1 (L)
63	FEV1	99668	phv00099668.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:32:24+00:00	2018-09-27 16:32:24+00:00 	FEVPCT18	FEV PERCENT PREDICTED
63	FEV1	99671	phv00099671.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:32:37+00:00	2018-09-27 16:32:37+00:00 	FEVPRD18	FEV PREDICTED VALUE
63	FEV1	107763	phv00107763.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:33:37+00:00	2018-09-27 16:33:37+00:00 	FEV118	FEV1 (L)
63	FEV1	107765	phv00107765.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:33:48+00:00	2018-09-27 16:33:48+00:00 	FEVPRD18	FEV1 PREDICTED (%)
63	FEV1	110360	phv00110360.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:34:19+00:00	2018-09-27 16:34:19+00:00 	FEVPRD18	FEV1 PREDICTED (%)
63	FEV1	110365	phv00110365.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:34:30+00:00	2018-09-27 16:34:30+00:00 	FEV118	FEV1 (L)
63	FEV1	2684	phv00002684.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:21+00:00	2018-10-05 15:24:21+00:00 	FI32	LUNG FUNCTION: FEV1
63	FEV1	3251	phv00003251.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:21+00:00	2018-10-05 15:24:21+00:00 	FJ371	LUNG FUNCTION: FEV1
63	FEV1	22556	phv00022556.v5.p10	pht000101.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:21+00:00	2018-10-05 15:24:21+00:00 	FV1_5_1	FORCED EXPIRATORY VOLUME AT 1 SECOND (LITERS) - BEST EFFORT
63	FEV1	22569	phv00022569.v4.p10	pht000102.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:21+00:00	2018-10-05 15:24:21+00:00 	fv1_1_3	FORCED EXPIRATORY VOLUME AT 1 SECOND (LITERS) - BEST EFFORT
63	FEV1	22586	phv00022586.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	FEV1_A	FORCED EXPIRATORY VOLUME  - TRIAL 1  IN 1.0 SECONDS
63	FEV1	22598	phv00022598.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	FEV1_B	FORCED EXPIRATORY VOLUME  - TRIAL 1  IN 1.0 SECONDS
63	FEV1	22611	phv00022611.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	FEV1_C	FORCED EXPIRATORY VOLUME  - TRIAL 3 IN 1.0 SECONDS
63	FEV1	22624	phv00022624.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	FEV1_D	FORCED EXPIRATORY VOLUME  - TRIAL 4 IN 1.0 SECONDS
63	FEV1	22637	phv00022637.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	FEV1_E	FORCED EXPIRATORY VOLUME  - TRIAL 5 IN 1.0 SECONDS
63	FEV1	22652	phv00022652.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	B_FEV1	FORCED EXPIRATORY VOLUME  - SUMMARY IN 1.0 SECONDS
63	FEV1	22665	phv00022665.v5.p10	pht000104.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	FV1_6_1	FORCED EXPIRATORY VOLUME AT 1 SECOND (LITERS) - BEST EFFORT
63	FEV1	22679	phv00022679.v5.p10	pht000105.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	FV1_3_1	FORCED EXPIRATORY VOLUME AT 1 SECOND (LITERS) - BEST EFFORT
63	FEV1	22690	phv00022690.v5.p10	pht000106.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	FV1_7_1	FORCED EXPIRATORY VOLUME AT 1 SECOND (LITERS) - BEST EFFORT
63	FEV1	55265	phv00055265.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	FEV1	Forced Expiratory Volume in One Second (Litres)
63	FEV1	73829	phv00073829.v4.p10	pht000832.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	fv1_8_1	Forced expiratory volume at 1 second - highest value among acceptable maneuvers
63	FEV1	196549	phv00196549.v2.p10	pht003632.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	fv1_2	Forced Expiratory Volume at 1 second (FEV1) - Highest value among acceptable maneuvers
63	FEV1	196566	phv00196566.v2.p10	pht003633.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	fv1_alb_2	Forced Expiratory Volume at 1 second (FEV1) - Highest value among acceptable maneuvers, Albuterol
63	FEV1	196583	phv00196583.v2.p10	pht003634.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	fv1_alb_8	Forced Expiratory Volume at 1 second (FEV1) - Highest value among acceptable maneuvers, Albuterol Collection Interval: Offspring Exam 8, Omni 1 Exam 3
63	FEV1	257835	phv00257835.v1.p10	pht005169.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	FV1_9_1	Forced Expiratory Volume at 1 second (liters) - Highest value among acceptable maneuvers Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4
63	FEV1	257850	phv00257850.v1.p10	pht005170.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	fv1_1	Forced Expiratory Volume at 1 second (FEV1) - Highest value among acceptable maneuvers
63	FEV1	257869	phv00257869.v1.p10	pht005171.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:24:22+00:00	2018-10-05 15:24:22+00:00 	FV1_post_9_1	Forced Expiratory Volume at 1 second (liters) - Highest value among acceptable maneuvers, Albuterol Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4
64	Asthma	113384	phv00113384.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-23 18:17:36+00:00	2018-04-23 18:17:36+00:00 	A12ASTHM	EVER HAD ASTHMA
64	Asthma	113385	phv00113385.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-23 18:17:53+00:00	2018-04-23 18:17:53+00:00 	A12ASSTL	DOES SUBJECT STILL HAVE ASTHMA
64	Asthma	113666	phv00113666.v2.p2	pht001584.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-23 18:18:39+00:00	2018-04-23 18:18:39+00:00 	A21ASMA	PT HAS EXERCISE-INDUCED ASTHMA. Q 3
64	Asthma	114600	phv00114600.v2.p2	pht001626.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-23 18:19:00+00:00	2018-04-23 18:19:00+00:00 	B12ASTHM	EVER HAD ASTHMA. Q 7A
64	Asthma	114601	phv00114601.v2.p2	pht001626.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-23 18:19:16+00:00	2018-04-23 18:19:16+00:00 	B12ASSTL	STILL HAS ASTHMA. Q 7B
64	Asthma	117045	phv00117045.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-23 18:19:46+00:00	2018-04-23 18:19:46+00:00 	D08ASTH	ASTHMA. Q 14
64	Asthma	117047	phv00117047.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-23 18:20:08+00:00	2018-04-23 18:20:08+00:00 	D08ASTYR	HAD ASTHMA IN THE PAST YEAR. Q 14
64	Asthma	117253	phv00117253.v2.p2	pht001721.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-23 18:20:33+00:00	2018-04-23 18:20:33+00:00 	D21ASMA	EVER HAD EXERCISE-INDUCED ASTHMA. Q 3
64	Asthma	118519	phv00118519.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-23 18:21:03+00:00	2018-04-23 18:21:03+00:00 	E08ASTH	ASTHMA? Q 14
64	Asthma	202933	phv00202933.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:13:52+00:00	2018-04-24 15:13:52+00:00 	AFUcomp7h_G	[General health].  Has a doctor ever said you had any of the following? Asthma [Annual Follow-up Questionnaire Form, AFUG]
64	Asthma	203002	phv00203002.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:14:27+00:00	2018-04-24 15:14:27+00:00 	AFUcomp20a_L	[General health]. Has a doctor ever said you had asthma? Did the doctor say that you have asthma since we last contracted you on mm/dd/yyyy? [Annual Follow-up Questionnaire Form, AFUL]
64	Asthma	206783	phv00206783.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:15:30+00:00	2018-04-24 15:15:30+00:00 	HFAA10A	[Medical history]. Q10a - Asthma [Heart Failure Hospital Record Abstraction Form, HFA]
64	Asthma	207069	phv00207069.v1.p1	pht004103.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:15:54+00:00	2018-04-24 15:15:54+00:00 	HHXB05F	[Medical care]. Has a doctor ever said you had any of the following: (read each disease name and code N if No or Never Tested). Q5. Asthma. Q5F [Health/Medical History, exam 2]
64	Asthma	207318	phv00207318.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:17:24+00:00	2018-04-24 15:17:24+00:00 	HOM10H	Has a doctor ever said that you had any of the following: asthma? Q10h [Home Interview, exam 1]
64	Asthma	208976	phv00208976.v1.p1	pht004145.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:17:46+00:00	2018-04-24 15:17:46+00:00 	PHXA8M	[Medical care]. Asthma? Q8m [Personal History Form, exam 3]
64	Asthma	209067	phv00209067.v1.p1	pht004146.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:18:09+00:00	2018-04-24 15:18:09+00:00 	PHXB6E	[Medical care]. Has a doctor ever said you had any of the following? Asthma. Q6e [Personal History form, exam 4]
64	Asthma	209714	phv00209714.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:18:28+00:00	2018-04-24 15:18:28+00:00 	RPAA35	[Asthma]. Ever had asthma? Q35 [Respiratory Symptoms and Physical Activity Form, exam 1]
64	Asthma	209715	phv00209715.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:18:50+00:00	2018-04-24 15:18:50+00:00 	RPAA36	[Asthma]. Was asthma confirmed by a doctor? Q36 [Respiratory Symptoms and Physical Activity Form, exam 1]
64	Asthma	209716	phv00209716.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:19:08+00:00	2018-04-24 15:19:08+00:00 	RPAA37	[Asthma]. Age asthma started Q37 [Respiratory Symptoms and Physical Activity Form, exam 1]
64	Asthma	209717	phv00209717.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:19:25+00:00	2018-04-24 15:19:25+00:00 	RPAA38	[Asthma]. Still have asthma? Q38 [Respiratory Symptoms and Physical Activity Form, exam 1]
64	Asthma	209718	phv00209718.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:19:44+00:00	2018-04-24 15:19:44+00:00 	RPAA39	[Asthma]. Age asthma stopped. Q39 [Respiratory Symptoms and Physical Activity Form, exam 1]
64	Asthma	214107	phv00214107.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:20:03+00:00	2018-04-24 15:20:03+00:00 	ASTHMA15	MD said pt had asthma?
64	Asthma	214108	phv00214108.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-04-24 15:20:20+00:00	2018-04-24 15:20:20+00:00 	ASTH1215	Pt had attack of asthma in last 12 months?
64	Asthma	82975	phv00082975.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:45:31+00:00	2018-04-28 21:45:31+00:00 	asthma1	ASTHMA: SELF-REPORT
64	Asthma	83530	phv00083530.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:45:38+00:00	2018-04-28 21:45:38+00:00 	qastha4	ASTHMA
64	Asthma	83531	phv00083531.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:45:46+00:00	2018-04-28 21:45:46+00:00 	qasdvya4	AGE DEVELOPED FIRST ASTHMA SYMP
64	Asthma	83532	phv00083532.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:45:53+00:00	2018-04-28 21:45:53+00:00 	qasdvaa4	ASTHMA AS A CHILD
64	Asthma	83533	phv00083533.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:46:13+00:00	2018-04-28 21:46:13+00:00 	qasdgya4	AGE DIAGNOSED WITH ASTHMA
64	Asthma	83537	phv00083537.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:46:19+00:00	2018-04-28 21:46:19+00:00 	qasrcya4	AGE AT FIRST RECURRENCE OF ASTHMA
64	Asthma	83765	phv00083765.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:46:25+00:00	2018-04-28 21:46:25+00:00 	qastha4	ASTHMA
64	Asthma	83767	phv00083767.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:46:31+00:00	2018-04-28 21:46:31+00:00 	qasdvaa4	ASTHMA AS A CHILD
64	Asthma	83766	phv00083766.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:46:38+00:00	2018-04-28 21:46:38+00:00 	qasdvya4	AGE DEVELOPED FIRST ASTHMA SYMP
64	Asthma	83768	phv00083768.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:46:44+00:00	2018-04-28 21:46:44+00:00 	qasdgya4	AGE DIAGNOSED WITH ASTHMA
64	Asthma	83772	phv00083772.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:46:50+00:00	2018-04-28 21:46:50+00:00 	qasrcya4	AGE AT FIRST RECURRENCE OF ASTHMA
64	Asthma	85211	phv00085211.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:46:56+00:00	2018-04-28 21:46:56+00:00 	asthma1	ASTHMA: SELF-REPORT
64	Asthma	85936	phv00085936.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:47:23+00:00	2018-04-28 21:47:23+00:00 	asthma2	ASTHMA: SELF-REPORT
64	Asthma	86418	phv00086418.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:47:29+00:00	2018-04-28 21:47:29+00:00 	asthma3	ASTHMA: SELF-REPORT
64	Asthma	86870	phv00086870.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:47:34+00:00	2018-04-28 21:47:34+00:00 	asthma4	ASTHMA: SELF-REPORT
64	Asthma	87119	phv00087119.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:47:41+00:00	2018-04-28 21:47:41+00:00 	asthmaf	ASTHMA
64	Asthma	87756	phv00087756.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:47:46+00:00	2018-04-28 21:47:46+00:00 	qastha4	ASTHMA
64	Asthma	87757	phv00087757.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:47:53+00:00	2018-04-28 21:47:53+00:00 	qasdvya4	AGE DEVELOPED FIRST ASTHMA SYMP
64	Asthma	87758	phv00087758.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:47:58+00:00	2018-04-28 21:47:58+00:00 	qasdvaa4	ASTHMA AS A CHILD
64	Asthma	87759	phv00087759.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:48:04+00:00	2018-04-28 21:48:04+00:00 	qasdgya4	AGE DIAGNOSED WITH ASTHMA
64	Asthma	87763	phv00087763.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:48:09+00:00	2018-04-28 21:48:09+00:00 	qasrcya4	AGE AT FIRST RECURRENCE OF ASTHMA
64	Asthma	175295	phv00175295.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:48:15+00:00	2018-04-28 21:48:15+00:00 	asthma5	ASTHMA: SELF-REPORT
64	Asthma	175296	phv00175296.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:48:21+00:00	2018-04-28 21:48:21+00:00 	devlpyr5	FIRST ASTHMA SYMPTOMS: AGE
64	Asthma	175298	phv00175298.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:48:28+00:00	2018-04-28 21:48:28+00:00 	diagyr5	DOCTOR DIAGNOSIS OF ASTHMA: AGE
64	Asthma	175302	phv00175302.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:48:35+00:00	2018-04-28 21:48:35+00:00 	recuryr5	FIRST RECURRENCE OF ASTHMA SYMPTOMS: AGE
64	Asthma	175872	phv00175872.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:48:41+00:00	2018-04-28 21:48:41+00:00 	asthma1	ASTHMA: SELF-REPORT
64	Asthma	175890	phv00175890.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:48:48+00:00	2018-04-28 21:48:48+00:00 	asthma	ASTHMA
64	Asthma	175954	phv00175954.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:48:54+00:00	2018-04-28 21:48:54+00:00 	asthmaf	FAMILY COHORT: ASTHMA
64	Asthma	176718	phv00176718.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:48:59+00:00	2018-04-28 21:48:59+00:00 	asthma5	ASTHMA: SELF-REPORT
64	Asthma	176719	phv00176719.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:49:06+00:00	2018-04-28 21:49:06+00:00 	devlpyr5	FIRST ASTHMA SYMPTOMS: AGE
64	Asthma	176721	phv00176721.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:49:12+00:00	2018-04-28 21:49:12+00:00 	diagyr5	DOCTOR DIAGNOSIS OF ASTHMA: AGE
64	Asthma	176725	phv00176725.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 21:49:18+00:00	2018-04-28 21:49:18+00:00 	recuryr5	FIRST RECURRENCE OF ASTHMA SYMPTOMS: AGE
64	Asthma	125000	phv00125000.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 15:26:57+00:00	2018-06-08 15:26:57+00:00 	AFUA7H	7h. Asthma
64	Asthma	125085	phv00125085.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:30:14+00:00	2018-06-08 16:30:14+00:00 	AFUA7H	7h. Asthma
64	Asthma	125170	phv00125170.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:51:55+00:00	2018-06-08 16:51:55+00:00 	AFUB7H	7h. Asthma
64	Asthma	125256	phv00125256.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:59:53+00:00	2018-06-08 16:59:53+00:00 	AFUB7H	7h. Asthma
64	Asthma	125382	phv00125382.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:13:44+00:00	2018-06-08 17:13:44+00:00 	AFUC20	20. Has a doctor ever said that you had asthma?
64	Asthma	125383	phv00125383.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:14:08+00:00	2018-06-08 17:14:08+00:00 	AFUC20A	20a. Did the doctor sat that you have asthma since we last contacted you?
64	Asthma	125604	phv00125604.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:46:58+00:00	2018-06-08 19:46:58+00:00 	AFUI7H	DOCTOR - ASTHMA                   Q7H
64	Asthma	125692	phv00125692.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:55:27+00:00	2018-06-08 19:55:27+00:00 	AFUJ7H	DOCTOR - ASTHMA                   Q7H
64	Asthma	125516	phv00125516.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:09:33+00:00	2018-06-08 20:09:33+00:00 	AFUI7H	DOCTOR - ASTHMA                   Q7H
64	Asthma	125780	phv00125780.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:14:44+00:00	2018-06-08 20:14:44+00:00 	AFUK7H	DOCTOR - ASTHMA                     Q7H
64	Asthma	128344	phv00128344.v1.p1	pht001973.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:56:59+00:00	2018-06-20 16:56:59+00:00 	RPAA13	13: Have you ever had asthma?
64	Asthma	128345	phv00128345.v1.p1	pht001973.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:58:38+00:00	2018-06-20 16:58:38+00:00 	RPAA14	14: Was it confirmed by a doctor?
64	Asthma	128346	phv00128346.v1.p1	pht001973.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:58:55+00:00	2018-06-20 16:58:55+00:00 	RPAA16	16: Do you still have asthma?
64	Asthma	128353	phv00128353.v1.p1	pht001973.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:59:15+00:00	2018-06-20 16:59:15+00:00 	RPAA15	15: What age did your asthma start?
64	Asthma	128354	phv00128354.v1.p1	pht001973.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:59:27+00:00	2018-06-20 16:59:27+00:00 	RPAA17	17: What age did asthma stop?
64	Asthma	128103	phv00128103.v1.p1	pht001967.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:21:13+00:00	2018-06-20 18:21:13+00:00 	PFHA10A	10a: Has doctor said you have Asthma?
64	Asthma	128104	phv00128104.v1.p1	pht001967.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:22:54+00:00	2018-06-20 18:22:54+00:00 	PFHA10B	10b: Age when told this
64	Asthma	159701	phv00159701.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:51:20+00:00	2018-08-10 20:51:20+00:00 	Asthma	Asthma: have you ever had asthma Collection Interval: Collected in Exam 1
64	Asthma	159702	phv00159702.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:51:31+00:00	2018-08-10 20:51:31+00:00 	AsthmaAge	Asthma: at about what age did asthma start Collection Interval: Collected in Exam 1
64	Asthma	159703	phv00159703.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:51:43+00:00	2018-08-10 20:51:43+00:00 	AsthmaAgeDK	Asthma: asthma as a child; age not known Collection Interval: Collected in Exam 1
64	Asthma	159704	phv00159704.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:52:15+00:00	2018-08-10 20:52:15+00:00 	AsthmaDxByDr	Asthma: diagnosed by doctor or other health professional Collection Interval: Collected in Exam 1
64	Asthma	159705	phv00159705.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:52:22+00:00	2018-08-10 20:52:22+00:00 	AsthmaStillHave	Asthma: do you still have asthma Collection Interval: Collected in Exam 1
64	Asthma	159706	phv00159706.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:52:29+00:00	2018-08-10 20:52:29+00:00 	AsthmaAgeStop	Asthma: if you no longer have asthma at what age did it stop Collection Interval: Collected in Exam 1
64	Asthma	159707	phv00159707.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:52:43+00:00	2018-08-10 20:52:43+00:00 	AsthmaStopChild	Asthma: asthma stopped as a child; age not known Collection Interval: Collected in Exam 1
64	Asthma	122253	phv00122253.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:56:23+00:00	2018-08-14 20:56:23+00:00 	ASTHMA	Asthma (AC)
64	Asthma	122254	phv00122254.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:56:37+00:00	2018-08-14 20:56:37+00:00 	ASTDIAG	Asthma diagnosed by doctor (AC)
64	Asthma	122255	phv00122255.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:57:07+00:00	2018-08-14 20:57:07+00:00 	ASTAGE	Age when asthma noted (AC)
64	Asthma	122256	phv00122256.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:57:18+00:00	2018-08-14 20:57:18+00:00 	ASTPRES	Asthma still present (AC)
64	Asthma	124265	phv00124265.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:58:17+00:00	2018-08-14 20:58:17+00:00 	ASTDIADAY	Days from visit date - Diagnosed Asthma
64	Asthma	123024	phv00123024.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:58:28+00:00	2018-08-14 20:58:28+00:00 	activeasthma	Asthma: MD dx of Asthma and on Asthma meds in past 3 days
64	Asthma	113388	phv00113388.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 20:54:15+00:00	2018-08-17 20:54:15+00:00 	A12ASSTP	AGE WHEN ASTHMA STOPPED
64	Asthma	113387	phv00113387.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 20:54:23+00:00	2018-08-17 20:54:23+00:00 	A12ASAGE	AGE WHEN ASTHMA STARTED
64	Asthma	113386	phv00113386.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 20:54:30+00:00	2018-08-17 20:54:30+00:00 	A12ASDOC	WAS ASTHMA CONFIRMED BY A DOCTOR
64	Asthma	226252	phv00226252.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:09:04+00:00	2018-08-22 21:09:04+00:00 	ASTHMA_EVER	Ever asthma
64	Asthma	114604	phv00114604.v2.p2	pht001626.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:23:48+00:00	2018-08-22 23:23:48+00:00 	B12ASSTP	AGE ASTHMA SYMPTOMS STOPPED. Q 7E
64	Asthma	114603	phv00114603.v2.p2	pht001626.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:23:56+00:00	2018-08-22 23:23:56+00:00 	B12ASAGE	AGE OF ONSET OF ASTHMA. Q 7D
64	Asthma	114602	phv00114602.v2.p2	pht001626.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:24:03+00:00	2018-08-22 23:24:03+00:00 	B12ASDOC	ASTHMA CONFIRMED BY MD. Q 7C
64	Asthma	117046	phv00117046.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:20:11+00:00	2018-08-24 00:20:11+00:00 	D08ASTAG	AGE FIRST DIAGNOSED WITH ASTHMA. Q 14
64	Asthma	226387	phv00226387.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:28:45+00:00	2018-08-24 16:28:45+00:00 	RSEA32	Asthma: ever (RSEA32)
64	Asthma	226388	phv00226388.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:28:52+00:00	2018-08-24 16:28:52+00:00 	RSEA34	Asthma diagnosed by doctor (RSEA34)
64	Asthma	226389	phv00226389.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:28:57+00:00	2018-08-24 16:28:57+00:00 	RSEA35	Asthma: now (RSEA35)
64	Asthma	258081	phv00258081.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:03:25+00:00	2018-08-24 17:03:25+00:00 	RSEA33	Age started: asthma (RSEA33)
64	Asthma	118521	phv00118521.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 22:45:28+00:00	2018-08-28 22:45:28+00:00 	E08ASTYR	HAD ASTHMA IN THE PAST YEAR? Q 14
64	Asthma	118520	phv00118520.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 22:45:34+00:00	2018-08-28 22:45:34+00:00 	E08ASTAG	AGE DIAGNOSED-ASTHMA. Q 14
64	Asthma	119905	phv00119905.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:12:26+00:00	2018-08-29 21:12:26+00:00 	F08ASTYR	HAD ASTHMA IN THE PAST YEAR? Q 14
64	Asthma	119904	phv00119904.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:12:34+00:00	2018-08-29 21:12:34+00:00 	F08ASTAG	AGE DIAGNOSED-ASTHMA. Q 14
64	Asthma	119892	phv00119892.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:12:40+00:00	2018-08-29 21:12:40+00:00 	F08ASTH	ASTHMA? Q 14
64	Asthma	121272	phv00121272.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:26:03+00:00	2018-08-30 00:26:03+00:00 	Y01ASTEP	ENDPT - ASTHMA
64	Asthma	121364	phv00121364.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:33:52+00:00	2018-08-30 00:33:52+00:00 	Y01ASTHM	ASTHMA
64	Asthma	121468	phv00121468.v2.p2	pht001870.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:47:27+00:00	2018-08-30 19:47:27+00:00 	Y00ASTHM	DISCHG DIAG - ASTHMA
64	Asthma	121488	phv00121488.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:48:54+00:00	2018-08-30 19:48:54+00:00 	Y01ASTEP	ENDPT - ASTHMA
64	Asthma	121583	phv00121583.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 19:55:22+00:00	2018-08-30 19:55:22+00:00 	Y01ASTHM	ASTHMA
64	Asthma	258652	phv00258652.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:11:42+00:00	2018-09-06 13:11:42+00:00 	asthma	Subject have asthma
64	Asthma	77634	phv00077634.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:26:22+00:00	2018-09-21 17:26:22+00:00 	ASTHMA_3	Asthma
64	Asthma	77759	phv00077759.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:26:29+00:00	2018-09-21 17:26:29+00:00 	ASTHMA_4	Asthma
64	Asthma	77869	phv00077869.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:26:35+00:00	2018-09-21 17:26:35+00:00 	ASTHMA_5	Asthma
64	Asthma	78033	phv00078033.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:26:40+00:00	2018-09-21 17:26:40+00:00 	ASTHMA_6	Asthma
64	Asthma	78173	phv00078173.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:26:45+00:00	2018-09-21 17:26:45+00:00 	ASTHMA_7	Asthma
64	Asthma	78314	phv00078314.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:26:52+00:00	2018-09-21 17:26:52+00:00 	ASTHMA_8	Asthma
64	Asthma	78512	phv00078512.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:26:57+00:00	2018-09-21 17:26:57+00:00 	ASTHMA	Asthma ever
64	Asthma	283509	phv00283509.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:27:03+00:00	2018-09-21 17:27:03+00:00 	ASTHMAHX	F136 History of asthma
64	Asthma	101661	phv00101661.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:35:03+00:00	2018-09-27 16:35:03+00:00 	ASTHMA59	HAD ASTHMA
64	Asthma	102854	phv00102854.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:35:19+00:00	2018-09-27 16:35:19+00:00 	ASTHMA59	HAD ASTHMA
64	Asthma	103164	phv00103164.v1.p1	pht001476.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:35:31+00:00	2018-09-27 16:35:31+00:00 	ASTHMA32	TOLD BY MD YOU HAD ASTHMA
64	Asthma	103217	phv00103217.v1.p1	pht001477.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:35:45+00:00	2018-09-27 16:35:45+00:00 	ASTHMA32	TOLD BY MD YOU HAD ASTHMA
64	Asthma	103269	phv00103269.v1.p1	pht001478.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:35:57+00:00	2018-09-27 16:35:57+00:00 	ASTHMA32	TOLD BY MD YOU HAD ASTHMA
64	Asthma	103322	phv00103322.v1.p1	pht001479.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:36:16+00:00	2018-09-27 16:36:16+00:00 	ASTHMA32	TOLD BY MD YOU HAD ASTHMA
64	Asthma	103374	phv00103374.v1.p1	pht001480.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:36:29+00:00	2018-09-27 16:36:29+00:00 	ASTHMA32	TOLD BY MD YOU HAD ASTHMA
64	Asthma	103427	phv00103427.v1.p1	pht001481.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:36:44+00:00	2018-09-27 16:36:44+00:00 	ASTHMA32	TOLD BY MD YOU HAD ASTHMA
64	Asthma	103479	phv00103479.v1.p1	pht001482.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:36:55+00:00	2018-09-27 16:36:55+00:00 	ASTHMA32	TOLD BY MD YOU HAD ASTHMA
64	Asthma	103532	phv00103532.v1.p1	pht001483.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:37:06+00:00	2018-09-27 16:37:06+00:00 	ASTHMA32	TOLD BY MD YOU HAD ASTHMA
64	Asthma	103584	phv00103584.v1.p1	pht001484.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:37:16+00:00	2018-09-27 16:37:16+00:00 	ASTHMA32	TOLD BY MD YOU HAD ASTHMA
64	Asthma	103637	phv00103637.v1.p1	pht001485.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:37:28+00:00	2018-09-27 16:37:28+00:00 	ASTHMA32	TOLD BY MD YOU HAD ASTHMA
64	Asthma	103689	phv00103689.v1.p1	pht001486.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:37:40+00:00	2018-09-27 16:37:40+00:00 	ASTHMA32	TOLD BY MD YOU HAD ASTHMA
64	Asthma	103740	phv00103740.v1.p1	pht001487.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:37:56+00:00	2018-09-27 16:37:56+00:00 	ASTHMA32	TOLD BY MD YOU HAD ASTHMA
64	Asthma	105885	phv00105885.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:38:10+00:00	2018-09-27 16:38:10+00:00 	ASTHMA	ASTHMA CONF BY DOCTOR
64	Asthma	107849	phv00107849.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:38:23+00:00	2018-09-27 16:38:23+00:00 	ASTHMA56	EVER HAD ASTHMA
64	Asthma	108215	phv00108215.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:38:39+00:00	2018-09-27 16:38:39+00:00 	ASTHMA	Ever asthma confirmed by a doctor
64	Asthma	110173	phv00110173.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:38:55+00:00	2018-09-27 16:38:55+00:00 	ASTHMA59	HAD ASTHMA
64	Asthma	197463	phv00197463.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:39:10+00:00	2018-09-27 16:39:10+00:00 	asthma15	MD said pt had asthma?
64	Asthma	99466	phv00099466.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:40:34+00:00	2018-09-27 16:40:34+00:00 	ASTHCUR	CURRENT ASTHMA DX BY DOC
64	Asthma	100442	phv00100442.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:40:49+00:00	2018-09-27 16:40:49+00:00 	ASTHCUR	CURRENT ASTHMA DX BY DOC
64	Asthma	106023	phv00106023.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:41:32+00:00	2018-09-27 16:41:32+00:00 	ASTHH57	DO YOU STILL HAVE IT
64	Asthma	106024	phv00106024.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:41:47+00:00	2018-09-27 16:41:47+00:00 	ASTHDR57	WAS IT CONFIRMED BY A DOCTOR
64	Asthma	106025	phv00106025.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:42:10+00:00	2018-09-27 16:42:10+00:00 	ASTHAG57	AT WHAT AGE DID IT START
64	Asthma	106026	phv00106026.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:42:21+00:00	2018-09-27 16:42:21+00:00 	ASTHST57	AT WHAT AGE DID IT STOP
64	Asthma	106407	phv00106407.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:42:38+00:00	2018-09-27 16:42:38+00:00 	ASTHCUR	CURRENT ASTHMA DX BY DOC
64	Asthma	197464	phv00197464.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:43:11+00:00	2018-09-27 16:43:11+00:00 	asth1215	Pt had attack of asthma in last 12 months?
64	Asthma	99087	phv00099087.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:43:40+00:00	2018-09-27 16:43:40+00:00 	ATH07	ASTHMA
64	Asthma	99088	phv00099088.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:44:24+00:00	2018-09-27 16:44:24+00:00 	ATHH07	DO YOU STILL HAVE IT
64	Asthma	99089	phv00099089.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:44:42+00:00	2018-09-27 16:44:42+00:00 	ATHDR07	WAS IT CONFIRMED BY A DOCTOR
64	Asthma	99090	phv00099090.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:44:54+00:00	2018-09-27 16:44:54+00:00 	ATHT07	AT WHAT AGE DID IT START
64	Asthma	104144	phv00104144.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:45:17+00:00	2018-09-27 16:45:17+00:00 	ATH37	ASTHMA
64	Asthma	107851	phv00107851.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:46:17+00:00	2018-09-27 16:46:17+00:00 	ASDR56	ASTHMA CONFIRMED BY DOCTOR
64	Asthma	107850	phv00107850.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:46:54+00:00	2018-09-27 16:46:54+00:00 	ASSTIL56	STILL HAVE ASTHMA
64	Asthma	107853	phv00107853.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:47:07+00:00	2018-09-27 16:47:07+00:00 	ASSTOP56	AT WHAT AGE DID ASTHMA STOP
64	Asthma	107852	phv00107852.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:47:56+00:00	2018-09-27 16:47:56+00:00 	ASLAST56	WHAT AGE WAS LAST EPISODE OF ASTHMA
64	Asthma	55304	phv00055304.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:42:24+00:00	2018-10-04 15:42:24+00:00 	ASTHMA15	MD said pt had asthma?
64	Asthma	4065	phv00004065.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:44:47+00:00	2018-10-04 15:44:47+00:00 	FL475	CDI: ASTHMA
64	Asthma	4487	phv00004487.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:44:47+00:00	2018-10-04 15:44:47+00:00 	FM502	CLINICAL DIAGNOSTIC IMPRESSION: ASTHMA
64	Asthma	4923	phv00004923.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:44:47+00:00	2018-10-04 15:44:47+00:00 	FN473	CDI-ASTHMA
64	Asthma	5285	phv00005285.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:44:47+00:00	2018-10-04 15:44:47+00:00 	FO489	CLINICAL DIAGNOSTIC IMPRESSION: ASTHMA
64	Asthma	5665	phv00005665.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:44:47+00:00	2018-10-04 15:44:47+00:00 	FP146	ASTHMA IN INTERIM
64	Asthma	7778	phv00007778.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:44:47+00:00	2018-10-04 15:44:47+00:00 	B128	ASTHMA
64	Asthma	8701	phv00008701.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:44:47+00:00	2018-10-04 15:44:47+00:00 	C374	CDI: ASTHMA
64	Asthma	9088	phv00009088.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:44:47+00:00	2018-10-04 15:44:47+00:00 	D360	CDI: ASTHMA
64	Asthma	9543	phv00009543.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:44:47+00:00	2018-10-04 15:44:47+00:00 	E646	CDI-ASTHMA
64	Asthma	10057	phv00010057.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:44:47+00:00	2018-10-04 15:44:47+00:00 	F641	CDI: ASTHMA
64	Asthma	250709	phv00250709.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:44:47+00:00	2018-10-04 15:44:47+00:00 	e646	Clinical Diagnostic Impressions - Part III: Non Cardiovascular Diagnoses - Asthma Collection Interval: Exam 1
64	Asthma	276870	phv00276870.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:44:47+00:00	2018-10-04 15:44:47+00:00 	CHF071	Asthma
64	Asthma	5912	phv00005912.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:46:46+00:00	2018-10-04 15:46:46+00:00 	FP455	CLINICAL DIAGNOSTIC IMPRESSION- ASTHMA
64	Asthma	6529	phv00006529.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:46:46+00:00	2018-10-04 15:46:46+00:00 	FR256	RESPIRATORY SYMPTOMS - HAVE YOU HAD ASTHMA IN THE INTERIM?
64	Asthma	6650	phv00006650.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:46:46+00:00	2018-10-04 15:46:46+00:00 	FR425	NON-CARDIOVASCULAR - ASTHMA
64	Asthma	6960	phv00006960.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:46:46+00:00	2018-10-04 15:46:46+00:00 	FS351	HAVE YOU HAD ASTHMA IN THE INTERIM?
64	Asthma	7085	phv00007085.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:46:46+00:00	2018-10-04 15:46:46+00:00 	FS525	1ST EXAMINER OPINIONS: ASTHMA
64	Asthma	7392	phv00007392.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:46:46+00:00	2018-10-04 15:46:46+00:00 	FT353	HAVE YOU HAD ASTHMA IN THE INTERIM?
64	Asthma	7519	phv00007519.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:46:46+00:00	2018-10-04 15:46:46+00:00 	FT530	NON CARDIOVASCULAR DIAGNOSTIC 1ST EXAMINER OPINIONS - ASTHMA
64	Asthma	70545	phv00070545.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:46:46+00:00	2018-10-04 15:46:46+00:00 	FU242	NON CARDIOVASCULAR DIAGNOSTIC 1ST EXAMINER OPINIONS: ASTHMA
64	Asthma	254754	phv00254754.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:46:46+00:00	2018-10-04 15:46:46+00:00 	fv244	Clinical Diagnostic Impression: Non Cardiovascular Diagnoses First Examiner Opinions: Asthma Collection Interval: Exam 29
64	Asthma	255145	phv00255145.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:46:46+00:00	2018-10-04 15:46:46+00:00 	fw286	Clinical Diagnostic Impression - Asthma Collection Interval: Original Cohort Exam 30
64	Asthma	274870	phv00274870.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:46:46+00:00	2018-10-04 15:46:46+00:00 	FX286	Clinical Diagnostic Impression - Asthma Collection Interval: Original Cohort Exam 31
64	Asthma	275228	phv00275228.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:46:46+00:00	2018-10-04 15:46:46+00:00 	fy286	Clinical Diagnostic Impression - Asthma Collection Interval: Original Cohort Exam 32
64	Asthma	10270	phv00010270.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	G127	HAVE YOU HAD ASTHMA IN THE INTERIM?
64	Asthma	21205	phv00021205.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	G3A407	CDI - ASTHMA
64	Asthma	21292	phv00021292.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	G3A539	HAVE YOU EVER HAD ASTHMA?
64	Asthma	21293	phv00021293.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	G3A540	ASTHMA: DO YOU STILL HAVE IT?
64	Asthma	21294	phv00021294.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	G3A541	ASTHMA: WAS IT DIAGNOSED BY A DOCTOR OR OTHER HEALTH PROFESSIONAL?
64	Asthma	21295	phv00021295.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	G3A542	ASTHMA: AT WHAT AGE DID IT START? (AGE IN YEARS)
64	Asthma	21296	phv00021296.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	G3A543	ASTHMA: IF YOU NO LONGER HAVE IT, AT WHAT AGE DID IT STOP? (AGE IN YEARS)
64	Asthma	250838	phv00250838.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g127	Medical History - Respiratory and Heart: Have you had asthma in the interim Collection Interval: Exam 2
64	Asthma	274028	phv00274028.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g3a407	CDI - Asthma Collection Interval: Exam 1
64	Asthma	274119	phv00274119.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g3a539	Have you ever had asthma? Collection Interval: Exam 1
64	Asthma	274120	phv00274120.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g3a540	Asthma: Do you still have it? Collection Interval: Exam 1
64	Asthma	274121	phv00274121.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g3a541	Asthma: Was it diagnosed by a doctor or other health professional? Collection Interval: Exam 1
64	Asthma	274122	phv00274122.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g3a542	Asthma: At what age did it start? Collection Interval: Exam 1
64	Asthma	274123	phv00274123.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g3a543	Asthma: If you no longer have it, at what age did it stop? Collection Interval: Exam 1
64	Asthma	274521	phv00274521.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g3a407	CDI - Asthma
64	Asthma	274610	phv00274610.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g3a539	Have you ever had asthma?
64	Asthma	274611	phv00274611.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g3a540	Asthma: Do you still have it?
64	Asthma	274612	phv00274612.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g3a541	Asthma: Was it diagnosed by a doctor or other health professional?
64	Asthma	274613	phv00274613.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g3a542	Asthma: At what age did it start?
64	Asthma	274614	phv00274614.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:58:52+00:00	2018-10-04 15:58:52+00:00 	g3a543	Asthma: If you no longer have it, at what age did it stop?
64	Asthma	10489	phv00010489.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:00:36+00:00	2018-10-04 16:00:36+00:00 	G418	CDI: ASTHMA
64	Asthma	10661	phv00010661.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:00:36+00:00	2018-10-04 16:00:36+00:00 	G670	RESPIRATORY: HAVE YOU EVER HAD ASTHMA?
64	Asthma	177516	phv00177516.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:00:37+00:00	2018-10-04 16:00:37+00:00 	g3b0431	Clinical Diagnostic Impression: Asthma
64	Asthma	177565	phv00177565.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:00:37+00:00	2018-10-04 16:00:37+00:00 	g3b0591	Respiratory Disease Questionnaire-Technician administered: Since your last exam have you had asthma?
64	Asthma	177566	phv00177566.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:00:37+00:00	2018-10-04 16:00:37+00:00 	g3b0592	Respiratory Disease Questionnaire-Technician administered: Do you still have it?
64	Asthma	177567	phv00177567.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:00:37+00:00	2018-10-04 16:00:37+00:00 	g3b0593	Respiratory Disease Questionnaire-Technician administered: Was it diagnosed by a doctor or other health care professional?
64	Asthma	177568	phv00177568.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:00:37+00:00	2018-10-04 16:00:37+00:00 	g3b0594	Respiratory Disease Questionnaire-Technician administered: If it started since your last exam, at what age did it start?
64	Asthma	177569	phv00177569.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:00:37+00:00	2018-10-04 16:00:37+00:00 	g3b0595	Respiratory Disease Questionnaire-Technician administered: If you no longer have it, at what age did it stop?
64	Asthma	251049	phv00251049.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:00:37+00:00	2018-10-04 16:00:37+00:00 	g418	Clinical Diagnostic Impression - Part III - Non Cardiovascular Diagnoses First Examiner Opinions: Asthma Collection Interval: Exam 2
64	Asthma	251235	phv00251235.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:00:37+00:00	2018-10-04 16:00:37+00:00 	g670	Respiratory Questionnaire - Asthma: Have you even had asthma? Collection Interval: Exam 2
64	Asthma	72313	phv00072313.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:01:33+00:00	2018-10-04 16:01:33+00:00 	H359	CLINICAL DIAGNOSTIC IMPRESSION: ASTHMA
64	Asthma	72488	phv00072488.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:01:33+00:00	2018-10-04 16:01:33+00:00 	H647	SINCE YOUR LAST EXAM HAVE YOU HAD ASTHMA?
64	Asthma	251510	phv00251510.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:01:33+00:00	2018-10-04 16:01:33+00:00 	h359	Clinical Diagnostic Impression - Part II: Non Cardiovascular Diagnoses First Examiner Opinions: Pulmonary: Asthma Collection Interval: Exam 3
64	Asthma	251703	phv00251703.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 16:01:33+00:00	2018-10-04 16:01:33+00:00 	h647	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Since your last exam have you had asthma? Collection Interval: Exam 3
64	Asthma	56803	phv00056803.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:33:46+00:00	2018-10-04 17:33:46+00:00 	hi201d	Asthma: has a doctor ever told you that you have asthma?
64	Asthma	56804	phv00056804.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:33:46+00:00	2018-10-04 17:33:46+00:00 	hi201e	Current asthma:  if hi201d= 1 (yes), do you still have asthma?
64	Asthma	72489	phv00072489.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:33:46+00:00	2018-10-04 17:33:46+00:00 	H648	ASTHMA: DO YOU STILL HAVE IT?
64	Asthma	72490	phv00072490.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:33:46+00:00	2018-10-04 17:33:46+00:00 	H649	ASTHMA: WAS IT DIAGNOSED BY A DOCTOR OR OTHER HEALTH PROFESSIONAL?
64	Asthma	72509	phv00072509.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:33:46+00:00	2018-10-04 17:33:46+00:00 	H650	ASTHMA: AT WHAT AGE DID IT START?
64	Asthma	72510	phv00072510.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:33:46+00:00	2018-10-04 17:33:46+00:00 	H651	ASTHMA: IF YOU NO LONGER HAVE IT, AT WHAT AGE DID IT STOP?
64	Asthma	251704	phv00251704.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:33:46+00:00	2018-10-04 17:33:46+00:00 	h648	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Do you still have it? Collection Interval: Exam 3
64	Asthma	251705	phv00251705.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:33:46+00:00	2018-10-04 17:33:46+00:00 	h649	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Was it diagnosed by a doctor or other health professional? Collection Interval: Exam 3
64	Asthma	251706	phv00251706.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:33:46+00:00	2018-10-04 17:33:46+00:00 	h650	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: At what age did it start? Collection Interval: Exam 3
64	Asthma	251707	phv00251707.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:33:46+00:00	2018-10-04 17:33:46+00:00 	h651	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: If you no longer have it, at what age did it stop? Collection Interval: Exam 3
64	Asthma	484	phv00000484.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:36:12+00:00	2018-10-04 17:36:12+00:00 	MF10	HISTORY OF ALLERGY OR ASTHMA, EXAM 1
64	Asthma	701	phv00000701.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:36:12+00:00	2018-10-04 17:36:12+00:00 	MF246	INTERIM HISTORY OF ALLERGIES: ASTHMA, EXAM 4
64	Asthma	789	phv00000789.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:36:12+00:00	2018-10-04 17:36:12+00:00 	MF339	LIFETIME HISTORY OF HAY FEVER AND ASTHMA, EXAM 5 (IF BOTH PRESENT, ONLY ASTHMA IS CODED)
64	Asthma	22715	phv00022715.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:36:12+00:00	2018-10-04 17:36:12+00:00 	RQ014	EVER HAD ASTHMA
64	Asthma	254260	phv00254260.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:36:12+00:00	2018-10-04 17:36:12+00:00 	j421	Clinical Diagnostic Impression-Part II-Pulmonary: Asthma
64	Asthma	254489	phv00254489.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:36:12+00:00	2018-10-04 17:36:12+00:00 	j832	Respiratory Disease Questionnaire Part 1-Tech administered: Respiratory Diagnosis: Have you ever had asthma?
64	Asthma	254492	phv00254492.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:36:12+00:00	2018-10-04 17:36:12+00:00 	j835	Respiratory Disease Questionnaire Part 1-Tech administered: Respiratory Diagnosis: At what age did it start?
64	Asthma	254493	phv00254493.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:36:12+00:00	2018-10-04 17:36:12+00:00 	j836	Respiratory Disease Questionnaire Part 1-Tech administered: Respiratory Diagnosis: If you no longer have it, at what age did it stop?
64	Asthma	8468	phv00008468.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:16:21+00:00	2018-10-05 18:16:21+00:00 	C93	WHEEZING OR ASTHMA
64	Asthma	8881	phv00008881.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:16:21+00:00	2018-10-05 18:16:21+00:00 	D117	WHEEZING OR ASTHMA
64	Asthma	603	phv00000603.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	MF135	LIFETIME HISTORY OF ALLERGIES: HIVES, HAY FEVER, ASTHMA, EXAM 2
64	Asthma	3399	phv00003399.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	FK151	RESPIRATORY: WHEEZING OR ASTHMA
64	Asthma	3856	phv00003856.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	FL212	WHEEZING OR ASTHMA
64	Asthma	4292	phv00004292.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	FM256	WHEEZING OR ASTHMA
64	Asthma	4694	phv00004694.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	FN197	WHEEZING OR ASTHMA
64	Asthma	4695	phv00004695.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	FN198	TYPE OF WHEEZING OR ASTHMA
64	Asthma	5045	phv00005045.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	FO192	WHEEZING OR ASTHMA
64	Asthma	5046	phv00005046.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	FO193	WHEEZING OR ASTHMA - TYPE
64	Asthma	6183	phv00006183.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	FQ198	WHEEZING OR ASTHMA
64	Asthma	9292	phv00009292.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	E339	WHEEZING OR ASTHMA
64	Asthma	9293	phv00009293.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	E340	TYPE OF WHEEZING OR ASTHMA
64	Asthma	9799	phv00009799.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	F309	WHEEZING OR ASTHMA
64	Asthma	250472	phv00250472.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	e339	Medical History - Respiratory: Wheezing or asthma Collection Interval: Exam 1
64	Asthma	250473	phv00250473.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 18:19:35+00:00	2018-10-05 18:19:35+00:00 	e340	Medical History - Respiratory: Type of wheezing or asthma Collection Interval: Exam 1
65	Asthma severity	83121	phv00083121.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:24:34+00:00	2018-04-28 22:24:34+00:00 	istrd1c	INHALED STEROIDS FOR ASTHMA
65	Asthma severity	83134	phv00083134.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:24:54+00:00	2018-04-28 22:24:54+00:00 	oaia1c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
65	Asthma severity	85366	phv00085366.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:25:00+00:00	2018-04-28 22:25:00+00:00 	istrd1c	INHALED STEROIDS FOR ASTHMA
65	Asthma severity	85379	phv00085379.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:25:09+00:00	2018-04-28 22:25:09+00:00 	oaia1c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
65	Asthma severity	86047	phv00086047.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:44:02+00:00	2018-04-28 22:44:02+00:00 	istrd2c	INHALED STEROIDS FOR ASTHMA
65	Asthma severity	86058	phv00086058.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:44:10+00:00	2018-04-28 22:44:10+00:00 	oaia2c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
65	Asthma severity	86529	phv00086529.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:44:15+00:00	2018-04-28 22:44:15+00:00 	istrd3c	INHALED STEROIDS FOR ASTHMA
65	Asthma severity	86540	phv00086540.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:44:21+00:00	2018-04-28 22:44:21+00:00 	oaia3c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
65	Asthma severity	86966	phv00086966.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:44:27+00:00	2018-04-28 22:44:27+00:00 	istrd4c	INHALED STEROIDS FOR ASTHMA
65	Asthma severity	86977	phv00086977.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:44:48+00:00	2018-04-28 22:44:48+00:00 	oaia4c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
65	Asthma severity	87342	phv00087342.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:44:54+00:00	2018-04-28 22:44:54+00:00 	istrdfc	INHALED STEROIDS FOR ASTHMA
65	Asthma severity	87355	phv00087355.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:45:29+00:00	2018-04-28 22:45:29+00:00 	oaiafc	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
65	Asthma severity	175368	phv00175368.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:45:36+00:00	2018-04-28 22:45:36+00:00 	istrd5c	INHALED STEROIDS FOR ASTHMA
65	Asthma severity	175381	phv00175381.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:45:46+00:00	2018-04-28 22:45:46+00:00 	oaia5c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
65	Asthma severity	175874	phv00175874.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:45:52+00:00	2018-04-28 22:45:52+00:00 	istrd1c	INHALED STEROIDS FOR ASTHMA
65	Asthma severity	175958	phv00175958.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:45:59+00:00	2018-04-28 22:45:59+00:00 	istrdfc	FAMILY COHORT: INHALED STEROIDS FOR ASTHMA
65	Asthma severity	175959	phv00175959.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:47:53+00:00	2018-04-28 22:47:53+00:00 	oaiafc	FAMILY COHORT: ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
65	Asthma severity	176791	phv00176791.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:48:00+00:00	2018-04-28 22:48:00+00:00 	istrd5c	INHALED STEROIDS FOR ASTHMA
65	Asthma severity	176804	phv00176804.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 22:48:10+00:00	2018-04-28 22:48:10+00:00 	oaia5c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
65	Asthma severity	159708	phv00159708.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:54:40+00:00	2018-08-10 20:54:40+00:00 	AsthmaTreat	Asthma: received medical treatment or used medications/inhaler Collection Interval: Collected in Exam 1
65	Asthma severity	1099	phv00001099.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:52:23+00:00	2018-10-04 14:52:23+00:00 	FA80	HOSPITALIZED SINCE LAST EXAM FOR ASTHMA
65	Asthma severity	1118	phv00001118.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:52:23+00:00	2018-10-04 14:52:23+00:00 	FA107	UNDER MEDICAL CARE BUT NOT HOSPITALIZED SINCE LAST EXAM FOR ASTHMA
65	Asthma severity	3014	phv00003014.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:52:23+00:00	2018-10-04 14:52:23+00:00 	FJ71	RESPIRATORY SYMPTOMS & CHF COMPLAINTS: ASTHMA-LONG DURATION
65	Asthma severity	3015	phv00003015.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:52:23+00:00	2018-10-04 14:52:23+00:00 	FJ72	RESPIRATORY SYMPTOMS & CHF COMPLAINTS: ASTHMA-SEASONAL
65	Asthma severity	3016	phv00003016.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:52:23+00:00	2018-10-04 14:52:23+00:00 	FJ73	RESPIRATORY SYMPTOMS & CHF COMPLAINTS: ASTHMA-WITH RESPIRATORY INFECTION
65	Asthma severity	21297	phv00021297.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:52:23+00:00	2018-10-04 14:52:23+00:00 	G3A544	ASTHMA: HAVE YOU RECEIVED MEDICAL TREATMENT FOR THIS IN THE PAST 12 MONTHS?
65	Asthma severity	55305	phv00055305.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:52:23+00:00	2018-10-04 14:52:23+00:00 	ASTH1215	Pt had attack of asthma in last 12 months?
65	Asthma severity	274124	phv00274124.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:52:23+00:00	2018-10-04 14:52:23+00:00 	g3a544	Asthma: Have you received medical treatment for this in the past 12 months? Collection Interval: Exam 1
65	Asthma severity	274615	phv00274615.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:52:23+00:00	2018-10-04 14:52:23+00:00 	g3a544	Asthma: Have you received medical treatment for this in the past 12 months?
65	Asthma severity	10662	phv00010662.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:53:51+00:00	2018-10-04 14:53:51+00:00 	G671	RESPIRATORY: HAVE YOU HAD AN ATTACK OF ASTHMA AT ANY TIME IN THE LAST 12 MONTHS?
65	Asthma severity	10663	phv00010663.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:53:51+00:00	2018-10-04 14:53:51+00:00 	G672	RESPIRATORY: ARE YOU CURRENTLY TAKING ANY MEDICATIONS (INCLUDING INHALERS, AEROSOLS, OR TABLETS) FOR ASTHMA?
65	Asthma severity	251236	phv00251236.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:53:51+00:00	2018-10-04 14:53:51+00:00 	g671	Respiratory Questionnaire - Asthma: Have you had an attack of asthma at any time in the last 12 months? Collection Interval: Exam 2
65	Asthma severity	251237	phv00251237.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 14:53:51+00:00	2018-10-04 14:53:51+00:00 	g672	Respiratory Questionnaire - Asthma: Are you currently taking any medicines (including inhalers, aerosols, or tablets) for asthma? Collection Interval: Exam 2
65	Asthma severity	22716	phv00022716.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:12:10+00:00	2018-10-04 15:12:10+00:00 	RQ015	HAD AN ATTACK OF ASTHMA AT ANY TIME IN THE LAST 12 MONTHS
65	Asthma severity	22717	phv00022717.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:12:10+00:00	2018-10-04 15:12:10+00:00 	RQ016	CURRENTLY TAKING ANY MEDICINES (INC. INHALERS, AEROSOLS, OR TABLETS) FOR ASTHMA
65	Asthma severity	55372	phv00055372.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:12:10+00:00	2018-10-04 15:12:10+00:00 	ISTRD1	Inhaled steroids for asthma
65	Asthma severity	56964	phv00056964.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:12:10+00:00	2018-10-04 15:12:10+00:00 	ISTRD2	Inhaled steroids for asthma
65	Asthma severity	72491	phv00072491.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:12:10+00:00	2018-10-04 15:12:10+00:00 	H652	ASTHMA: HAVE YOU RECEIVED MEDICAL TREATMENT FOR THIS IN THE PAST 12 MONTHS?
65	Asthma severity	251708	phv00251708.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 15:12:11+00:00	2018-10-04 15:12:11+00:00 	h652	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Have you received medical treatment for this in the past 12 months? Collection Interval: Exam 3
65	Asthma severity	2713	phv00002713.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 17:54:10+00:00	2018-10-05 17:54:10+00:00 	FI61	INTERIM HISTORY OF RESPIRATORY SYMPTOMS AND CHF COMPLAINTS: TROUBLED WITH WHEEZING-ASTHMA
65	Asthma severity	3013	phv00003013.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 17:54:10+00:00	2018-10-05 17:54:10+00:00 	FJ70	RESPIRATORY SYMPTOMS & CHF COMPLAINTS: TROUBLE WITH WHEEZING-ASTHMA
65	Asthma severity	4293	phv00004293.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 17:54:10+00:00	2018-10-05 17:54:10+00:00 	FM257	WHEEZING OR ASTHMA IS OF LONG DURATION?
65	Asthma severity	4294	phv00004294.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 17:54:10+00:00	2018-10-05 17:54:10+00:00 	FM258	WHEEZING OR ASTHMA IS SEASONAL?
65	Asthma severity	4295	phv00004295.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 17:54:10+00:00	2018-10-05 17:54:10+00:00 	FM259	WHEEZING OR ASTHMA WITH RESPIRATORY INFECTION?
65	Asthma severity	8469	phv00008469.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 17:54:10+00:00	2018-10-05 17:54:10+00:00 	C94	WHEEZING OR ASTHMA - OF LONG DURATION
65	Asthma severity	8470	phv00008470.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 17:54:10+00:00	2018-10-05 17:54:10+00:00 	C95	WHEEZING OR ASTHMA - SEASONAL
65	Asthma severity	8471	phv00008471.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 17:54:10+00:00	2018-10-05 17:54:10+00:00 	C96	WHEEZING OR ASTHMA - WITH RESPIRATORY INFECTIONS
65	Asthma severity	8882	phv00008882.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 17:54:10+00:00	2018-10-05 17:54:10+00:00 	D118	WHEEZING OR ASTHMA IS OF LONG DURATION?
65	Asthma severity	8883	phv00008883.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 17:54:10+00:00	2018-10-05 17:54:10+00:00 	D119	WHEEZING OR ASTHMA IS SEASONAL?
65	Asthma severity	8884	phv00008884.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 17:54:10+00:00	2018-10-05 17:54:10+00:00 	D120	WHEEZING OR ASTHMA COMES WITH RESPIRATORY INFECTION?
65	Asthma severity	115478	phv00115478.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-12 23:48:45+00:00	2018-12-12 23:48:45+00:00 	C08ASMA	CURRENTLY TAKING ASTHMA MEDICATION. Q 12
65	Asthma severity	114364	phv00114364.v2.p2	pht001601.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-12 23:49:07+00:00	2018-12-12 23:49:07+00:00 	B08ASMA	TAKE MEDICINE FOR ASTHMA. Q 6
65	Asthma severity	113016	phv00113016.v2.p2	pht001569.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-12 23:49:15+00:00	2018-12-12 23:49:15+00:00 	A08ASMA	TAKE MEDICINE FOR ASTHMA
65	Asthma severity	119935	phv00119935.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-12 23:51:14+00:00	2018-12-12 23:51:14+00:00 	F08ASMA	CURRENTLY TAKING MEDS FOR ASTHMA. Q 29
65	Asthma severity	121748	phv00121748.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-12 23:51:28+00:00	2018-12-12 23:51:28+00:00 	B09ASLUS	TIME SINCE LAST USED ASTHMA MED. Q 4.04B
65	Asthma severity	121750	phv00121750.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-12 23:52:07+00:00	2018-12-12 23:52:07+00:00 	B09ASTMO	DURATION OF ASTHMA MED USE: MONTHS. Q 4.04C
65	Asthma severity	121749	phv00121749.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-12 23:52:23+00:00	2018-12-12 23:52:23+00:00 	B09ASTYR	DURATION OF ASTHMA MED USE: YEARS. Q 4.04C
65	Asthma severity	121740	phv00121740.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-12 23:52:27+00:00	2018-12-12 23:52:27+00:00 	B09ASTUS	TOTAL DURATION OF ASTHMA MED USE: MONTHS
65	Asthma severity	122123	phv00122123.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ASTPLNOW	Still take asthma spray
65	Asthma severity	122124	phv00122124.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ASTHSPY	Ever take asthma spray (AC)
65	Asthma severity	226253	phv00226253.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ASTHMA_MEDS	Asthma Med Use - self/scanned (current asthma by MD diagnosis)
65	Asthma severity	226316	phv00226316.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	MED_ANTIASTHMATICS	Antiasthmatic or bronchodilator agents
65	Asthma severity	117066	phv00117066.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	D08ASMA	CURRENTLY TAKING MEDS FOR ASTHMA. Q 24
65	Asthma severity	258083	phv00258083.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	RSEA37	Medical treatment: asthma in 12 months (RSEA37)
65	Asthma severity	118546	phv00118546.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	E08ASMA	CURRENTLY TAKING MEDS FOR ASTHMA. Q 26
65	Asthma severity	56977	phv00056977.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA2	Oral anti-inflammatory asthma drugs (leukotriene receptor antagonists and inhibitors of lipo-oxygenase)
65	Asthma severity	99614	phv00099614.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ISTRD06	Inhaled steroids for asthma
65	Asthma severity	99627	phv00099627.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
65	Asthma severity	100553	phv00100553.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ISTRD06	Inhaled steroids for asthma
65	Asthma severity	100566	phv00100566.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
65	Asthma severity	104422	phv00104422.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ISTRD06	Inhaled steroids for asthma
65	Asthma severity	104435	phv00104435.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
65	Asthma severity	105052	phv00105052.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ISTRD06	Inhaled steroids for asthma
65	Asthma severity	105065	phv00105065.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
65	Asthma severity	106473	phv00106473.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ISTRD06	Inhaled steroids for asthma
65	Asthma severity	106486	phv00106486.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
65	Asthma severity	107398	phv00107398.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ISTRD06	Inhaled steroids for asthma
65	Asthma severity	107411	phv00107411.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
65	Asthma severity	108259	phv00108259.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ISTRD06	Inhaled steroids for asthma
65	Asthma severity	108272	phv00108272.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
65	Asthma severity	109013	phv00109013.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ISTRD06	Inhaled steroids for asthma
65	Asthma severity	109026	phv00109026.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
65	Asthma severity	109724	phv00109724.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ISTRD06	Inhaled steroids for asthma
65	Asthma severity	109737	phv00109737.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
65	Asthma severity	110679	phv00110679.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
65	Asthma severity	102131	phv00102131.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	ISTRD06	Inhaled steroids for asthma
65	Asthma severity	102144	phv00102144.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
65	Asthma severity	103117	phv00103117.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
65	Asthma severity	197547	phv00197547.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	istrd	Inhaled steroids for asthma
65	Asthma severity	199069	phv00199069.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	istrd2	Inhaled steroids for asthma
65	Asthma severity	199082	phv00199082.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-12-27 02:07:35+00:00	2018-12-27 02:07:35+00:00 	oaia2	Oral Anti-inflammatory asthma drugs (leukotriene receptor antagonists and inhibitor)
66	COPD	83483	phv00083483.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:12:42+00:00	2018-04-28 23:12:42+00:00 	cpmesaa4	COPD - MESA
66	COPD	83484	phv00083484.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:12:51+00:00	2018-04-28 23:12:51+00:00 	cpgolda4	COPD - GOLD
66	COPD	83485	phv00083485.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:13:02+00:00	2018-04-28 23:13:02+00:00 	cp2005a4	COPD - 2005 PFT
66	COPD	83545	phv00083545.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:13:09+00:00	2018-04-28 23:13:09+00:00 	qcopda4	COPD
66	COPD	83546	phv00083546.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:13:36+00:00	2018-04-28 23:13:36+00:00 	qcopdaa4	AGE WITH COPD
66	COPD	83620	phv00083620.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:13:43+00:00	2018-04-28 23:13:43+00:00 	copdlla4	COPD- 2005 DEFINITION
66	COPD	83718	phv00083718.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:14:00+00:00	2018-04-28 23:14:00+00:00 	cpmesaa4	COPD - MESA
66	COPD	83719	phv00083719.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:14:07+00:00	2018-04-28 23:14:07+00:00 	cpgolda4	COPD - GOLD
66	COPD	83720	phv00083720.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:14:13+00:00	2018-04-28 23:14:13+00:00 	cp2005a4	COPD - 2005 PFT
66	COPD	83780	phv00083780.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:14:28+00:00	2018-04-28 23:14:28+00:00 	qcopda4	COPD
66	COPD	83781	phv00083781.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:14:34+00:00	2018-04-28 23:14:34+00:00 	qcopdaa4	AGE WITH COPD
66	COPD	83850	phv00083850.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:14:41+00:00	2018-04-28 23:14:41+00:00 	copdlla4	COPD- 2005 DEFINITION
66	COPD	87709	phv00087709.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:14:56+00:00	2018-04-28 23:14:56+00:00 	cpmesaa4	COPD - MESA
66	COPD	87710	phv00087710.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:15:03+00:00	2018-04-28 23:15:03+00:00 	cpgolda4	COPD - GOLD
66	COPD	87711	phv00087711.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:15:09+00:00	2018-04-28 23:15:09+00:00 	cp2005a4	COPD - 2005 PFT
66	COPD	87771	phv00087771.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:15:22+00:00	2018-04-28 23:15:22+00:00 	qcopda4	COPD
66	COPD	87772	phv00087772.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:15:28+00:00	2018-04-28 23:15:28+00:00 	qcopdaa4	AGE WITH COPD
66	COPD	87846	phv00087846.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:15:35+00:00	2018-04-28 23:15:35+00:00 	copdlla4	COPD - 2005 DEFINITION
66	COPD	175294	phv00175294.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:15:48+00:00	2018-04-28 23:15:48+00:00 	emphys5	EMPHYSEMA OR COPD: SELF-REPORT
66	COPD	176717	phv00176717.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:16:01+00:00	2018-04-28 23:16:01+00:00 	emphys5	EMPHYSEMA OR COPD: SELF-REPORT
66	COPD	206784	phv00206784.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 16:34:36+00:00	2018-05-03 16:34:36+00:00 	HFAA10B	[Medical history]. Q10b - Chronic bronchitis/COPD [Heart Failure Hospital Record Abstraction Form, HFA]
66	COPD	214106	phv00214106.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 16:34:57+00:00	2018-05-03 16:34:57+00:00 	COPD15	MD said pt had COPD?
66	COPD	159734	phv00159734.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:14:43+00:00	2018-08-10 21:14:43+00:00 	CopdStillHave	COPD: do you still have COPD Collection Interval: Collected in Exam 1
66	COPD	159733	phv00159733.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:14:51+00:00	2018-08-10 21:14:51+00:00 	CopdAge	COPD: at about what age did COPD start Collection Interval: Collected in Exam 1
66	COPD	159732	phv00159732.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:14:59+00:00	2018-08-10 21:14:59+00:00 	CopdDxByDr	COPD: diagnosed by doctor or other health professional Collection Interval: Collected in Exam 1
66	COPD	159731	phv00159731.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:15:07+00:00	2018-08-10 21:15:07+00:00 	COPD	COPD: have you ever had COPD Collection Interval: Collected in Exam 1
66	COPD	308100	phv00308100.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:22:01+00:00	2018-08-16 00:22:01+00:00 	LUNGAGE	In what year or how old were you when this condition was first diagnosed? - age Collection Interval: 2000-2004
66	COPD	308099	phv00308099.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:22:09+00:00	2018-08-16 00:22:09+00:00 	LUNGYR	In what year or how old were you when this condition was first diagnosed? - year Collection Interval: 2000-2004
66	COPD	308098	phv00308098.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:22:16+00:00	2018-08-16 00:22:16+00:00 	LUNG	Have you ever been told by a physician that you had emphysema/chronic bronchitis/or obstructive lung disease? Collection Interval: 2000-2004
66	COPD	277907	phv00277907.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:29:09+00:00	2018-08-16 00:29:09+00:00 	LUNGAGE	In what year or how old were you when this condition was first diagnosed? - age Collection Interval: 2000-2004
66	COPD	277906	phv00277906.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:29:17+00:00	2018-08-16 00:29:17+00:00 	LUNGYR	In what year or how old were you when this condition was first diagnosed? - year Collection Interval: 2000-2004
66	COPD	277905	phv00277905.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:29:25+00:00	2018-08-16 00:29:25+00:00 	LUNG	Have you ever been told by a physician that you had emphysema/chronic bronchitis/or obstructive lung disease? Collection Interval: 2000-2004
66	COPD	258042	phv00258042.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:56:05+00:00	2018-08-24 16:56:05+00:00 	COPD_BY_BD	COPD by BD test (for all valid PRE_BD)
66	COPD	169348	phv00169348.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-09-10 17:45:14+00:00	2018-09-10 17:45:14+00:00 	EmphStillHave	Emphysema: do you still have it Collection Interval: Collected in Exam 1
66	COPD	169347	phv00169347.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-09-10 17:45:21+00:00	2018-09-10 17:45:21+00:00 	EmphAge	Emphysema: at about what age did it start Collection Interval: Collected in Exam 1
66	COPD	159730	phv00159730.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-09-10 17:45:28+00:00	2018-09-10 17:45:28+00:00 	EmphDxByDr	Emphysema: diagnosed by doctor or other health professional Collection Interval: Collected in Exam 1
66	COPD	159729	phv00159729.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-09-10 17:45:36+00:00	2018-09-10 17:45:36+00:00 	Emphysema	Emphysema: have you ever had emphysema Collection Interval: Collected in Exam 1
66	COPD	119923	phv00119923.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:47:00+00:00	2018-09-10 17:47:00+00:00 	F08EMPYR	HAD EMPHYSEMA IN THE PAST YEAR? Q 20
66	COPD	119922	phv00119922.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:47:07+00:00	2018-09-10 17:47:07+00:00 	F08EMPAG	AGE DIAGNOSED-EMPHYSEMA. Q 20
66	COPD	119914	phv00119914.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:47:14+00:00	2018-09-10 17:47:14+00:00 	F08EMPH	EMPHYSEMA? Q 20
66	COPD	118535	phv00118535.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:47:21+00:00	2018-09-10 17:47:21+00:00 	E08EMPAG	AGE DIAGNOSED-EMPHYSEMA. Q 19
66	COPD	118534	phv00118534.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:47:28+00:00	2018-09-10 17:47:28+00:00 	E08EMPH	EMPHYSEMA? Q 19
66	COPD	117055	phv00117055.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:47:36+00:00	2018-09-10 17:47:36+00:00 	D08EMPAG	AGE FIRST DIAGNOSED WITH EMPHYSEMA. Q 17
66	COPD	117054	phv00117054.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:47:43+00:00	2018-09-10 17:47:43+00:00 	D08EMPH	EMPHYSEMA. Q 17
66	COPD	113383	phv00113383.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:47:51+00:00	2018-09-10 17:47:51+00:00 	A12EMAGE	AGE WHEN EMPHYSEMA STARTED
66	COPD	113382	phv00113382.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:47:57+00:00	2018-09-10 17:47:57+00:00 	A12EMDOC	WAS EMPHYSEMA CONFIRMED BY A DOCTOR
66	COPD	113381	phv00113381.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:48:05+00:00	2018-09-10 17:48:05+00:00 	A12EMSTL	DOES SUBJECT STILL HAVE EMPHYSEMA
66	COPD	113380	phv00113380.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:48:21+00:00	2018-09-10 17:48:21+00:00 	A12EMPH	EVER HAD EMPHYSEMA
66	COPD	159845	phv00159845.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-09-10 17:50:16+00:00	2018-09-10 17:50:16+00:00 	Chronic_Bronchitis	Chronic bronchitis calc. from cough/phlegm ques Collection Interval: Collected in Exam 1
66	COPD	159728	phv00159728.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-09-10 17:50:24+00:00	2018-09-10 17:50:24+00:00 	ChronBroncDxByDr	Chronic bronchitis: diagnosed by doctor or other health professional Collection Interval: Collected in Exam 1
66	COPD	159727	phv00159727.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-09-10 17:50:32+00:00	2018-09-10 17:50:32+00:00 	ChronBronch	Chronic bronchitis: have you ever had chronic bronchitis Collection Interval: Collected in Exam 1
66	COPD	169345	phv00169345.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-09-10 17:50:42+00:00	2018-09-10 17:50:42+00:00 	ChronBrncStillHv	Chronic bronchitis: do you still have it Collection Interval: Collected in Exam 1
66	COPD	169344	phv00169344.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-09-10 17:50:49+00:00	2018-09-10 17:50:49+00:00 	ChronBroncAge	Chronic bronchitis: at about what age did it start Collection Interval: Collected in Exam 1
66	COPD	119915	phv00119915.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:51:56+00:00	2018-09-10 17:51:56+00:00 	F08BRON	CHRONIC BRONCHITIS? Q 21
66	COPD	118536	phv00118536.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:52:02+00:00	2018-09-10 17:52:02+00:00 	E08BRON	CHRONIC BRONCHITIS? Q 20
66	COPD	117056	phv00117056.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:52:09+00:00	2018-09-10 17:52:09+00:00 	D08BRON	CHRONIC BRONCHITIS. Q 18
66	COPD	113379	phv00113379.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:52:16+00:00	2018-09-10 17:52:16+00:00 	A12CBAGE	AGE WHEN CHRONIC BRONCHITIS STARTED
66	COPD	113378	phv00113378.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:52:23+00:00	2018-09-10 17:52:23+00:00 	A12CBDOC	CHRONIC BRONCHITIS CONFIRMED BY A DOCTOR
66	COPD	113377	phv00113377.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:52:35+00:00	2018-09-10 17:52:35+00:00 	A12CBSTL	DOES PT STILL HAVE CHRONIC BRONCHITIS
66	COPD	113376	phv00113376.v2.p2	pht001575.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-09-10 17:52:43+00:00	2018-09-10 17:52:43+00:00 	A12CBRON	EVER HAD ATTACKS OF CHRONIC BRONCHITIS
66	COPD	5909	phv00005909.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:16:22+00:00	2018-09-19 22:16:22+00:00 	FP452	CLINICAL DIAGNOSTIC IMPRESSION- EMPHYSEMA
66	COPD	5282	phv00005282.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:16:29+00:00	2018-09-19 22:16:29+00:00 	FO486	CLINICAL DIAGNOSTIC IMPRESSION: EMPHYSEMA
66	COPD	4920	phv00004920.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:16:36+00:00	2018-09-19 22:16:36+00:00 	FN470	CDI-EMPHYSEMA
66	COPD	4484	phv00004484.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:16:44+00:00	2018-09-19 22:16:44+00:00 	FM499	CLINICAL DIAGNOSTIC IMPRESSION: EMPHYSEMA
66	COPD	4062	phv00004062.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:16:51+00:00	2018-09-19 22:16:51+00:00 	FL472	CDI: EMPHYSEMA
66	COPD	2196	phv00002196.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:16:58+00:00	2018-09-19 22:16:58+00:00 	FF277	CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, EMPHYSEMA
66	COPD	2012	phv00002012.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:17:05+00:00	2018-09-19 22:17:05+00:00 	FE343	CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, EMPHYSEMA
66	COPD	1783	phv00001783.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:17:12+00:00	2018-09-19 22:17:12+00:00 	FD287	CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, EMPHYSEMA
66	COPD	21203	phv00021203.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:17:41+00:00	2018-09-19 22:17:41+00:00 	G3A405	CDI - EMPHYSEMA
66	COPD	10486	phv00010486.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:17:48+00:00	2018-09-19 22:17:48+00:00 	G415	CDI: EMPHYSEMA
66	COPD	10054	phv00010054.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:17:55+00:00	2018-09-19 22:17:55+00:00 	F638	CDI: EMPHYSEMA
66	COPD	9540	phv00009540.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:18:01+00:00	2018-09-19 22:18:01+00:00 	E643	CDI-EMPHYSEMA
66	COPD	9085	phv00009085.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:18:09+00:00	2018-09-19 22:18:09+00:00 	D357	CDI: EMPHYSEMA
66	COPD	8697	phv00008697.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:18:17+00:00	2018-09-19 22:18:17+00:00 	C370	CDI: EMPHYSEMA
66	COPD	7516	phv00007516.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:18:24+00:00	2018-09-19 22:18:24+00:00 	FT527	NON CARDIOVASCULAR DIAGNOSTIC 1ST EXAMINER OPINIONS - EMPHYSEMA
66	COPD	7082	phv00007082.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:18:31+00:00	2018-09-19 22:18:31+00:00 	FS522	1ST EXAMINER OPINIONS: EMPHYSEMA
66	COPD	6647	phv00006647.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:18:38+00:00	2018-09-19 22:18:38+00:00 	FR422	NON-CARDIOVASCULAR - EMPHYSEMA
66	COPD	6316	phv00006316.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:18:46+00:00	2018-09-19 22:18:46+00:00 	FQ389	EMPHYSEMA IN INTERIM
66	COPD	70542	phv00070542.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:19:15+00:00	2018-09-19 22:19:15+00:00 	FU239	NON CARDIOVASCULAR DIAGNOSTIC 1ST EXAMINER OPINIONS: EMPHYSEMA
66	COPD	56800	phv00056800.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:19:22+00:00	2018-09-19 22:19:22+00:00 	hi201a	Emphysema: has a doctor ever told you that you have emphysema?
66	COPD	55301	phv00055301.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:19:30+00:00	2018-09-19 22:19:30+00:00 	EMPHYS15	MD said pt had emphysema?
66	COPD	21306	phv00021306.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:19:37+00:00	2018-09-19 22:19:37+00:00 	G3A553	EMPHYSEMA: AGE CONDITION BEGAN
66	COPD	21305	phv00021305.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:19:44+00:00	2018-09-19 22:19:44+00:00 	G3A552	EMPHYSEMA: HEALTH PROFESSIONAL DX?
66	COPD	21304	phv00021304.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:19:50+00:00	2018-09-19 22:19:50+00:00 	G3A551	HAVE YOU EVER HAD EMPHYSEMA?
66	COPD	251714	phv00251714.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:21:21+00:00	2018-09-19 22:21:21+00:00 	h658	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Since your last exam have you had emphysema? Collection Interval: Exam 3
66	COPD	251508	phv00251508.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:21:30+00:00	2018-09-19 22:21:30+00:00 	h357	Clinical Diagnostic Impression - Part II: Non Cardiovascular Diagnoses First Examiner Opinions: Pulmonary: Emphysema Collection Interval: Exam 3
66	COPD	251046	phv00251046.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:21:37+00:00	2018-09-19 22:21:37+00:00 	g415	Clinical Diagnostic Impression - Part III - Non Cardiovascular Diagnoses First Examiner Opinions: Emphysema Collection Interval: Exam 2
66	COPD	250706	phv00250706.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:21:45+00:00	2018-09-19 22:21:45+00:00 	e643	Clinical Diagnostic Impressions - Part III: Non Cardiovascular Diagnoses - Emphysema Collection Interval: Exam 1
66	COPD	177573	phv00177573.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:21:52+00:00	2018-09-19 22:21:52+00:00 	g3b0599	Respiratory Disease Questionnaire-Technician administered: Have you had the following condition diagnosed by a doctor or other health care professional? Emphysema
66	COPD	177514	phv00177514.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:21:59+00:00	2018-09-19 22:21:59+00:00 	g3b0429	Clinical Diagnostic Impression: Emphysema
66	COPD	72499	phv00072499.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:22:07+00:00	2018-09-19 22:22:07+00:00 	H660	SINCE YOUR LAST EXAM HAVE YOU HAD ...EMPHYSEMA: AGE CONDITION BEGAN
66	COPD	72498	phv00072498.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:22:14+00:00	2018-09-19 22:22:14+00:00 	H659	SINCE YOUR LAST EXAM HAVE YOU HAD ...EMPHYSEMA: HEALTH PROFESSIONAL DIAGNOSIS?
66	COPD	72497	phv00072497.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:22:21+00:00	2018-09-19 22:22:21+00:00 	H658	SINCE YOUR LAST EXAM HAVE YOU HAD ... EMPHYSEMA: CONDITION?
66	COPD	72311	phv00072311.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:22:29+00:00	2018-09-19 22:22:29+00:00 	H357	CLINICAL DIAGNOSTIC IMPRESSION: EMPHYSEMA
66	COPD	257608	phv00257608.v1.p10	pht005155.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:24:09+00:00	2018-09-19 22:24:09+00:00 	classification	Emphysema subtypes based upon pattern of involvement in the secondary pulmonary lobule
66	COPD	257607	phv00257607.v1.p10	pht005155.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:24:19+00:00	2018-09-19 22:24:19+00:00 	emphysema_cor	Absence (=0) or presence (=1) of emphysema by visual determination
66	COPD	255329	phv00255329.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:26:14+00:00	2018-09-19 22:26:14+00:00 	fw601	Respiratory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Emphysema  Variable appears on Form B only Collection Interval: Original Cohort Exam 30
66	COPD	255142	phv00255142.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:26:21+00:00	2018-09-19 22:26:21+00:00 	fw283	Clinical Diagnostic Impression - Emphysema Collection Interval: Original Cohort Exam 30
66	COPD	254751	phv00254751.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:26:29+00:00	2018-09-19 22:26:29+00:00 	fv241	Clinical Diagnostic Impression: Non Cardiovascular Diagnoses First Examiner Opinions: Emphysema Collection Interval: Exam 29
66	COPD	254498	phv00254498.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:26:36+00:00	2018-09-19 22:26:36+00:00 	j841	Respiratory Disease Questionnaire Part 1-Tech administered: Have you ever had the following condition diagnosed by a doctor or health care professional: Emphysema
66	COPD	254258	phv00254258.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:26:43+00:00	2018-09-19 22:26:43+00:00 	j419	Clinical Diagnostic Impression-Part II-Pulmonary: Emphysema
66	COPD	251716	phv00251716.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:26:50+00:00	2018-09-19 22:26:50+00:00 	h660	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Age condition began - Emphysema Collection Interval: Exam 3
66	COPD	251715	phv00251715.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:26:57+00:00	2018-09-19 22:26:57+00:00 	h659	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Health professional diagnosis - Emphysema Collection Interval: Exam 3
66	COPD	275388	phv00275388.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:28:50+00:00	2018-09-19 22:28:50+00:00 	fy601	Respiratory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for emphysema? Collection Interval: Original Cohort Exam 32
66	COPD	275225	phv00275225.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:28:57+00:00	2018-09-19 22:28:57+00:00 	fy283	Clinical Diagnostic Impression - Emphysema Collection Interval: Original Cohort Exam 32
66	COPD	275054	phv00275054.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:29:05+00:00	2018-09-19 22:29:05+00:00 	FX601	Respiratory Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for emphysema? Collection Interval: Original Cohort Exam 31
66	COPD	274867	phv00274867.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:29:12+00:00	2018-09-19 22:29:12+00:00 	FX283	Clinical Diagnostic Impression - Emphysema Collection Interval: Original Cohort Exam 31
66	COPD	274624	phv00274624.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:29:19+00:00	2018-09-19 22:29:19+00:00 	g3a553	Emphysema: Age condition began
66	COPD	274623	phv00274623.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:29:26+00:00	2018-09-19 22:29:26+00:00 	g3a552	Emphysema: Health professional dx?
66	COPD	274622	phv00274622.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:29:34+00:00	2018-09-19 22:29:34+00:00 	g3a551	Have you ever had emphysema?
66	COPD	274519	phv00274519.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:29:41+00:00	2018-09-19 22:29:41+00:00 	g3a405	CDI - Emphysema
66	COPD	274133	phv00274133.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:29:48+00:00	2018-09-19 22:29:48+00:00 	g3a553	Emphysema: Age condition began Collection Interval: Exam 1
66	COPD	274132	phv00274132.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:29:55+00:00	2018-09-19 22:29:55+00:00 	g3a552	Emphysema: Health professional dx? Collection Interval: Exam 1
66	COPD	274131	phv00274131.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:30:03+00:00	2018-09-19 22:30:03+00:00 	g3a551	Have you ever had emphysema? Collection Interval: Exam 1
66	COPD	274026	phv00274026.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-19 22:30:11+00:00	2018-09-19 22:30:11+00:00 	g3a405	CDI - Emphysema Collection Interval: Exam 1
66	COPD	82974	phv00082974.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-19 22:34:03+00:00	2018-09-19 22:34:03+00:00 	emphys1	EMPHYSEMA: SELF-REPORT
66	COPD	78513	phv00078513.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-19 22:34:11+00:00	2018-09-19 22:34:11+00:00 	EMPHYSEM	Emphysema ever
66	COPD	78315	phv00078315.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-19 22:34:19+00:00	2018-09-19 22:34:19+00:00 	EMPHYSEM_8	Emphysema / chronic bronchitis
66	COPD	78174	phv00078174.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-19 22:34:27+00:00	2018-09-19 22:34:27+00:00 	EMPHYSEM_7	Emphysema / chronic bronchitis
66	COPD	78034	phv00078034.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-19 22:34:35+00:00	2018-09-19 22:34:35+00:00 	EMPHYSEM_6	Emphysema / chronic bronchitis
66	COPD	77870	phv00077870.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-19 22:34:42+00:00	2018-09-19 22:34:42+00:00 	EMPHYSEM_5	Emphysema / chronic bronchitis
66	COPD	77760	phv00077760.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-19 22:34:49+00:00	2018-09-19 22:34:49+00:00 	EMPHYSEM_4	Emphysema / chronic bronchitis
66	COPD	77635	phv00077635.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-19 22:34:58+00:00	2018-09-19 22:34:58+00:00 	EMPHYSEM_3	Emphysema / chronic bronchitis
66	COPD	87118	phv00087118.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-19 22:36:33+00:00	2018-09-19 22:36:33+00:00 	emphysf	EMPHYSEMA
66	COPD	86869	phv00086869.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-19 22:36:41+00:00	2018-09-19 22:36:41+00:00 	emphys4	EMPHYSEMA: SELF-REPORT
66	COPD	86417	phv00086417.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-19 22:36:48+00:00	2018-09-19 22:36:48+00:00 	emphys3	EMPHYSEMA: SELF-REPORT
66	COPD	85935	phv00085935.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-19 22:36:56+00:00	2018-09-19 22:36:56+00:00 	emphys2	EMPHYSEMA: SELF-REPORT
66	COPD	85210	phv00085210.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-19 22:37:03+00:00	2018-09-19 22:37:03+00:00 	emphys1	EMPHYSEMA: SELF-REPORT
66	COPD	104143	phv00104143.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:39:57+00:00	2018-09-19 22:39:57+00:00 	EPH37	EMPHYSEMA
66	COPD	103744	phv00103744.v1.p1	pht001487.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:40:03+00:00	2018-09-19 22:40:03+00:00 	EMPHYS32	TOLD BY MD YOU HAD EMPHYSEMA
66	COPD	103693	phv00103693.v1.p1	pht001486.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:40:11+00:00	2018-09-19 22:40:11+00:00 	EMPHYS32	TOLD BY MD YOU HAD EMPHYSEMA
66	COPD	103641	phv00103641.v1.p1	pht001485.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:40:19+00:00	2018-09-19 22:40:19+00:00 	EMPHYS32	TOLD BY MD YOU HAD EMPHYSEMA
66	COPD	103588	phv00103588.v1.p1	pht001484.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:40:27+00:00	2018-09-19 22:40:27+00:00 	EMPHYS32	TOLD BY MD YOU HAD EMPHYSEMA
66	COPD	103536	phv00103536.v1.p1	pht001483.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:40:34+00:00	2018-09-19 22:40:34+00:00 	EMPHYS32	TOLD BY MD YOU HAD EMPHYSEMA
66	COPD	103483	phv00103483.v1.p1	pht001482.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:40:40+00:00	2018-09-19 22:40:40+00:00 	EMPHYS32	TOLD BY MD YOU HAD EMPHYSEMA
66	COPD	103431	phv00103431.v1.p1	pht001481.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:40:47+00:00	2018-09-19 22:40:47+00:00 	EMPHYS32	TOLD BY MD YOU HAD EMPHYSEMA
66	COPD	103378	phv00103378.v1.p1	pht001480.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:40:54+00:00	2018-09-19 22:40:54+00:00 	EMPHYS32	TOLD BY MD YOU HAD EMPHYSEMA
66	COPD	103326	phv00103326.v1.p1	pht001479.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:41:01+00:00	2018-09-19 22:41:01+00:00 	EMPHYS32	TOLD BY MD YOU HAD EMPHYSEMA
66	COPD	103273	phv00103273.v1.p1	pht001478.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:41:07+00:00	2018-09-19 22:41:07+00:00 	EMPHYS32	TOLD BY MD YOU HAD EMPHYSEMA
66	COPD	198889	phv00198889.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:41:50+00:00	2018-09-19 22:41:50+00:00 	hi201a	1a  emphysema
66	COPD	197460	phv00197460.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:41:57+00:00	2018-09-19 22:41:57+00:00 	emphys15	MD said pt had emphysema?
66	COPD	110172	phv00110172.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:42:04+00:00	2018-09-19 22:42:04+00:00 	EMPHYS59	HAD EMPHYSEMA
66	COPD	106018	phv00106018.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:42:10+00:00	2018-09-19 22:42:10+00:00 	EMPH57	EMPHYSEMA
66	COPD	105884	phv00105884.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:42:17+00:00	2018-09-19 22:42:17+00:00 	EMPHYSEM	EMPHYSEMA DX BY DOCTOR
66	COPD	105130	phv00105130.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:42:27+00:00	2018-09-19 22:42:27+00:00 	LUNG01	LUNG DISEASE, EMPHYSEMA, OR BRONCHITIS
66	COPD	124286	phv00124286.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-09-19 22:45:18+00:00	2018-09-19 22:45:18+00:00 	EMPDIADAY	Days from visit date - Diagnosed Emphysema
66	COPD	103221	phv00103221.v1.p1	pht001477.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:46:02+00:00	2018-09-19 22:46:02+00:00 	EMPHYS32	TOLD BY MD YOU HAD EMPHYSEMA
66	COPD	103168	phv00103168.v1.p1	pht001476.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:46:09+00:00	2018-09-19 22:46:09+00:00 	EMPHYS32	TOLD BY MD YOU HAD EMPHYSEMA
66	COPD	102853	phv00102853.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:46:17+00:00	2018-09-19 22:46:17+00:00 	EMPHYS59	HAD EMPHYSEMA
66	COPD	101660	phv00101660.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:46:24+00:00	2018-09-19 22:46:24+00:00 	EMPHYS59	HAD EMPHYSEMA
66	COPD	100319	phv00100319.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:46:31+00:00	2018-09-19 22:46:31+00:00 	EMPHYSEM	EMPHYSEMA DX BY DOCTOR
66	COPD	99464	phv00099464.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:46:38+00:00	2018-09-19 22:46:38+00:00 	EMPHYSEM	EMPHYSEMA DX BY DOCTOR
66	COPD	99083	phv00099083.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:46:44+00:00	2018-09-19 22:46:44+00:00 	EPH07	EMPHYSEMA
66	COPD	98813	phv00098813.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-19 22:46:51+00:00	2018-09-19 22:46:51+00:00 	LUNG01	LUNG DISEASE, EMPHYSEMA, OR BRONCHITIS
66	COPD	125373	phv00125373.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-09-19 22:46:59+00:00	2018-09-19 22:46:59+00:00 	AFUC18A	18a. Has a doctor ever said that you had chronic lung disease, such as bronchitis or emphysema?
66	COPD	125255	phv00125255.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-09-19 22:47:06+00:00	2018-09-19 22:47:06+00:00 	AFUB7G	7g. Chronic lung disease such as bronchitis or emphysema
66	COPD	125169	phv00125169.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-09-19 22:47:13+00:00	2018-09-19 22:47:13+00:00 	AFUB7G	7g. Chronic lung disease such as bronchitis or emphysema
66	COPD	125084	phv00125084.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-09-19 22:47:21+00:00	2018-09-19 22:47:21+00:00 	AFUA7G	7g. Chronic lung disease such as bronchitis or emphysema
66	COPD	124999	phv00124999.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-09-19 22:47:29+00:00	2018-09-19 22:47:29+00:00 	AFUA7G	7g. Chronic lung disease such as bronchitis or emphysema
66	COPD	209066	phv00209066.v1.p1	pht004146.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-19 22:48:27+00:00	2018-09-19 22:48:27+00:00 	PHXB6D	[Medical care]. Has a doctor ever said you had any of the following? Chronic lung disease, such as bronchitis, or emphysema. Q6d [Personal History form, exam 4]
66	COPD	208975	phv00208975.v1.p1	pht004145.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-19 22:48:38+00:00	2018-09-19 22:48:38+00:00 	PHXA8L	[Medical care]. Chronic lung disease, such as bronchitis, or emphysema? Q8l [Personal History Form, exam 3]
66	COPD	207317	phv00207317.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-19 22:48:46+00:00	2018-09-19 22:48:46+00:00 	HOM10G	Has a doctor ever said that you had any of the following: chronic lung disease, such as chronic bronchitis, or emphysema? Q10g [Home Interview, exam 1]
66	COPD	207068	phv00207068.v1.p1	pht004103.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-19 22:48:52+00:00	2018-09-19 22:48:52+00:00 	HHXB05E	[Medical care]. Has a doctor ever said you had any of the following: (read each disease name and code N if No or Never Tested). Q5. Chronic lung disease, such as chronic bronchitis, or emphysema. Q5E [Health/Medical History, exam 2]
66	COPD	202932	phv00202932.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-19 22:48:59+00:00	2018-09-19 22:48:59+00:00 	AFUcomp7g_G	[General health]. Has a doctor ever said you had any of the following? Chronic lung disease, such as bronchitis or emphysema [Annual Follow-up Questionnaire Form, AFUG]
66	COPD	175953	phv00175953.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-19 22:49:10+00:00	2018-09-19 22:49:10+00:00 	emphysf	FAMILY COHORT: EMPHYSEMA
66	COPD	175894	phv00175894.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-19 22:49:17+00:00	2018-09-19 22:49:17+00:00 	emphysema	EMPHYSEMA
66	COPD	175871	phv00175871.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-19 22:49:24+00:00	2018-09-19 22:49:24+00:00 	emphys1	EMPHYSEMA: SELF-REPORT
66	COPD	122252	phv00122252.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-09-19 22:50:07+00:00	2018-09-19 22:50:07+00:00 	EMPPRES	Emphysema still present (A)
66	COPD	122251	phv00122251.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-09-19 22:50:14+00:00	2018-09-19 22:50:14+00:00 	EMPAGE	Age when emphysema noted (A)
66	COPD	122250	phv00122250.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-09-19 22:50:21+00:00	2018-09-19 22:50:21+00:00 	EMPDIAG	Emphysema diagnosed by doctor (A)
66	COPD	122249	phv00122249.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-09-19 22:50:29+00:00	2018-09-19 22:50:29+00:00 	EMPHYSEM	Emphysema (A)
66	COPD	214104	phv00214104.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-19 22:50:35+00:00	2018-09-19 22:50:35+00:00 	EMPHYS15	MD said pt had emphysema?
66	COPD	209713	phv00209713.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-19 22:50:42+00:00	2018-09-19 22:50:42+00:00 	RPAA34	[Bronchitis]. Age emphysema started. Q34 [Respiratory Symptoms and Physical Activity Form, exam 1]
66	COPD	209712	phv00209712.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-19 22:50:49+00:00	2018-09-19 22:50:49+00:00 	RPAA33	[Bronchitis]. Was emphysema confirmed by a doctor? Q33 [Respiratory Symptoms and Physical Activity Form, exam 1]
66	COPD	209711	phv00209711.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-19 22:50:56+00:00	2018-09-19 22:50:56+00:00 	RPAA32	[Bronchitis]. Still have emphysema? Q32 [Respiratory Symptoms and Physical Activity Form, exam 1]
66	COPD	209710	phv00209710.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-19 22:51:02+00:00	2018-09-19 22:51:02+00:00 	RPAA31	[Emphysema]. Ever had emphysema? Q31 [Respiratory Symptoms and Physical Activity Form, exam 1]
66	COPD	83726	phv00083726.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-19 23:42:56+00:00	2018-09-19 23:42:56+00:00 	mrcbrna4	MRC DEFINED BRONCHITIS
66	COPD	83491	phv00083491.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-19 23:43:28+00:00	2018-09-19 23:43:28+00:00 	mrcbrna4	MRC DEFINED BRONCHITIS
66	COPD	87717	phv00087717.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-09-19 23:47:46+00:00	2018-09-19 23:47:46+00:00 	mrcbrna4	MRC DEFINED BRONCHITIS
66	COPD	4063	phv00004063.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:04:13+00:00	2018-09-20 21:04:13+00:00 	FL473	CDI: CHRONIC BRONCHITIS
66	COPD	3656	phv00003656.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:04:20+00:00	2018-09-20 21:04:20+00:00 	FK445	NON-CARDIOVASCULAR DISEASE: CHRONIC BRONCHITIS
66	COPD	3237	phv00003237.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:04:27+00:00	2018-09-20 21:04:27+00:00 	FJ349	NON-CARDIOVASCULAR DIAGNOSIS: CHRONIC BRONCHITIS
66	COPD	2838	phv00002838.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:04:33+00:00	2018-09-20 21:04:33+00:00 	FI218	CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC BRONCHITIS
66	COPD	2632	phv00002632.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:04:40+00:00	2018-09-20 21:04:40+00:00 	FH307	CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC BRONCHITIS
66	COPD	2394	phv00002394.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:04:47+00:00	2018-09-20 21:04:47+00:00 	FG288	CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC BRONCHITIS
66	COPD	2197	phv00002197.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:04:54+00:00	2018-09-20 21:04:54+00:00 	FF278	CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC BRONCHITIS
66	COPD	2013	phv00002013.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:05:00+00:00	2018-09-20 21:05:00+00:00 	FE344	CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC BRONCHITIS
66	COPD	1784	phv00001784.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:05:08+00:00	2018-09-20 21:05:08+00:00 	FD288	CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC BRONCHITIS
66	COPD	6648	phv00006648.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:05:51+00:00	2018-09-20 21:05:51+00:00 	FR423	NON-CARDIOVASCULAR - CHRONIC BRONCHITIS
66	COPD	6539	phv00006539.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:05:58+00:00	2018-09-20 21:05:58+00:00 	FR267	RESPIRATORY EXAMINER'S OPINIONS - CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTNUM AT LEAST 3 MONTHS IN PAST 12 MONTHS)
66	COPD	6317	phv00006317.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:06:06+00:00	2018-09-20 21:06:06+00:00 	FQ390	CHRONIC BRONCHITIS IN INTERIM (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN PAST 12 MONTHS)
66	COPD	5910	phv00005910.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:06:13+00:00	2018-09-20 21:06:13+00:00 	FP453	CLINICAL DIAGNOSTIC IMPRESSION- CHRONIC BRONCHITIS
66	COPD	5672	phv00005672.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:06:20+00:00	2018-09-20 21:06:20+00:00 	FP154	1ST EXAMINER BELIEVES CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN THE PAST 12 MONTHS)
66	COPD	5283	phv00005283.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:06:27+00:00	2018-09-20 21:06:27+00:00 	FO487	CLINICAL DIAGNOSTIC IMPRESSION: CHRONIC BRONCHITIS
66	COPD	5052	phv00005052.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:06:35+00:00	2018-09-20 21:06:35+00:00 	FO200	1ST EXAMINER BELIEVES CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN THE PAST 12 MONTHS)
66	COPD	4921	phv00004921.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:06:41+00:00	2018-09-20 21:06:41+00:00 	FN471	CDI-CHRONIC BRONCHITIS
66	COPD	4701	phv00004701.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:06:48+00:00	2018-09-20 21:06:48+00:00 	FN205	1ST EXAMINER BELIEVES CHRONIC BRONCHITIS
66	COPD	4485	phv00004485.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:06:55+00:00	2018-09-20 21:06:55+00:00 	FM500	CLINICAL DIAGNOSTIC IMPRESSION: CHRONIC BRONCHITIS
66	COPD	21303	phv00021303.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:07:54+00:00	2018-09-20 21:07:54+00:00 	G3A550	CHRONIC BRONCHITIS: AGE CONDITION BEGAN
66	COPD	21302	phv00021302.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:08:01+00:00	2018-09-20 21:08:01+00:00 	G3A549	CHRONIC BRONCHITIS: HEALTH PROFESSIONAL DX?
66	COPD	21301	phv00021301.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:08:07+00:00	2018-09-20 21:08:07+00:00 	G3A548	HAVE YOU EVER HAD CHRONIC BRONCHITIS?
66	COPD	10487	phv00010487.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:08:14+00:00	2018-09-20 21:08:14+00:00 	G416	CDI: CHRONIC BRONCHITIS
66	COPD	10280	phv00010280.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:08:21+00:00	2018-09-20 21:08:21+00:00 	G138	1ST EXAMINER OPINIONS - BELIEVES CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN PAST 12 MONTHS)
66	COPD	10055	phv00010055.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:08:28+00:00	2018-09-20 21:08:28+00:00 	F639	CDI: CHRONIC BRONCHITIS
66	COPD	9805	phv00009805.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:08:36+00:00	2018-09-20 21:08:36+00:00 	F316	1ST EXAMINER OPINIONS - BELIEVES CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN PAST 12 MONTHS)
66	COPD	9541	phv00009541.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:08:43+00:00	2018-09-20 21:08:43+00:00 	E644	CDI-CHRONIC BRONCHITIS
66	COPD	9300	phv00009300.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:08:55+00:00	2018-09-20 21:08:55+00:00 	E347	1ST EXAMINER BELIEVES CHRONIC BRONCHITIS
66	COPD	9086	phv00009086.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:09:01+00:00	2018-09-20 21:09:01+00:00 	D358	CDI: CHRONIC BRONCHITIS
66	COPD	8698	phv00008698.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:09:08+00:00	2018-09-20 21:09:08+00:00 	C371	CDI: CHRONIC BRONCHITIS
66	COPD	7945	phv00007945.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:09:14+00:00	2018-09-20 21:09:14+00:00 	B326	CHRONIC BRONCHITIS
66	COPD	7517	phv00007517.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:09:21+00:00	2018-09-20 21:09:21+00:00 	FT528	NON CARDIOVASCULAR DIAGNOSTIC 1ST EXAMINER OPINIONS - CHRONIC BRONCHITIS
66	COPD	7402	phv00007402.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:09:28+00:00	2018-09-20 21:09:28+00:00 	FT364	RESPIRATORY 1ST OPINIONS: 1ST EXAMINER BELIEVES CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN PAST 12 MONTHS)
66	COPD	7083	phv00007083.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:09:35+00:00	2018-09-20 21:09:35+00:00 	FS523	1ST EXAMINER OPINIONS: CHRONIC BRONCHITIS
66	COPD	6970	phv00006970.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:09:42+00:00	2018-09-20 21:09:42+00:00 	FS362	1ST EXAMINER OPINIONS: CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN PAST 12 MOS)
66	COPD	251711	phv00251711.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:12:25+00:00	2018-09-20 21:12:25+00:00 	h655	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Since your last exam have you had chronic bronchitis? Collection Interval: Exam 3
66	COPD	251047	phv00251047.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:12:32+00:00	2018-09-20 21:12:32+00:00 	g416	Clinical Diagnostic Impression - Part III - Non Cardiovascular Diagnoses First Examiner Opinions: Chronic bronchitis Collection Interval: Exam 2
66	COPD	250847	phv00250847.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:12:39+00:00	2018-09-20 21:12:39+00:00 	g138	Medical History - Respiratory and Heart: 1st examiner believes Chronic Bronchitis (Cough that produces sputum at least 3 months in past 12 months) Collection Interval: Exam 2
66	COPD	250707	phv00250707.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:12:47+00:00	2018-09-20 21:12:47+00:00 	e644	Clinical Diagnostic Impressions - Part III: Non Cardiovascular Diagnoses - Chronic bronchitis Collection Interval: Exam 1
66	COPD	250479	phv00250479.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:12:54+00:00	2018-09-20 21:12:54+00:00 	e347	Medical History - Respiratory: 1st Examiner believes chronic bronchitis Collection Interval: Exam 1
66	COPD	177572	phv00177572.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:13:01+00:00	2018-09-20 21:13:01+00:00 	g3b0598	Respiratory Disease Questionnaire-Technician administered: Have you had the following condition diagnosed by a doctor or other health care professional? Chronic bronchitis
66	COPD	72496	phv00072496.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:13:08+00:00	2018-09-20 21:13:08+00:00 	H657	SINCE YOUR LAST EXAM HAVE YOU HAD ...CHRONIC BRONCHITIS: AGE CONDITION BEGAN
66	COPD	72495	phv00072495.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:13:15+00:00	2018-09-20 21:13:15+00:00 	H656	SINCE YOUR LAST EXAM HAVE YOU HAD ... CHRONIC BRONCHITIS: HEALTH PROFESSIONAL DIAGNOSIS?
66	COPD	72494	phv00072494.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:13:22+00:00	2018-09-20 21:13:22+00:00 	H655	SINCE YOUR LAST EXAM HAVE YOU HAD ... CHRONIC BRONCHITIS: CONDITION?
66	COPD	70543	phv00070543.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:13:30+00:00	2018-09-20 21:13:30+00:00 	FU240	NON CARDIOVASCULAR DIAGNOSTIC 1ST EXAMINER OPINIONS: CHRONIC BRONCHITIS
66	COPD	56801	phv00056801.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:13:37+00:00	2018-09-20 21:13:37+00:00 	hi201b	Chronic bronchitis: has a doctor ever told you that you have chronic bronchitis?
66	COPD	55302	phv00055302.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:13:43+00:00	2018-09-20 21:13:43+00:00 	CRBRON15	MD said pt had chronic bronchitis?
66	COPD	274868	phv00274868.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:14:37+00:00	2018-09-20 21:14:37+00:00 	FX284	Clinical Diagnostic Impression - Chronic bronchitis Collection Interval: Original Cohort Exam 31
66	COPD	274621	phv00274621.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:14:43+00:00	2018-09-20 21:14:43+00:00 	g3a550	Chronic bronchitis: Age condition began
66	COPD	274620	phv00274620.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:14:50+00:00	2018-09-20 21:14:50+00:00 	g3a549	Chronic bronchitis: Health professional dx?
66	COPD	274619	phv00274619.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:14:57+00:00	2018-09-20 21:14:57+00:00 	g3a548	Have you ever had chronic bronchitis?
66	COPD	274130	phv00274130.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:15:03+00:00	2018-09-20 21:15:03+00:00 	g3a550	Chronic bronchitis: Age condition began Collection Interval: Exam 1
66	COPD	274129	phv00274129.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:15:10+00:00	2018-09-20 21:15:10+00:00 	g3a549	Chronic bronchitis: Health professional dx? Collection Interval: Exam 1
66	COPD	274128	phv00274128.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:15:17+00:00	2018-09-20 21:15:17+00:00 	g3a548	Have you ever had chronic bronchitis? Collection Interval: Exam 1
66	COPD	255328	phv00255328.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:15:25+00:00	2018-09-20 21:15:25+00:00 	fw600	Respiratory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Chronic Bronchitis Variable appears on Form B only Collection Interval: Original Cohort Exam 30
66	COPD	255143	phv00255143.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:15:33+00:00	2018-09-20 21:15:33+00:00 	fw284	Clinical Diagnostic Impression - Chronic bronchitis Collection Interval: Original Cohort Exam 30
66	COPD	254752	phv00254752.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:15:40+00:00	2018-09-20 21:15:40+00:00 	fv242	Clinical Diagnostic Impression: Non Cardiovascular Diagnoses First Examiner Opinions: Chronic bronchitis Collection Interval: Exam 29
66	COPD	254497	phv00254497.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:15:47+00:00	2018-09-20 21:15:47+00:00 	j840	Respiratory Disease Questionnaire Part 1-Tech administered: Have you ever had the following condition diagnosed by a doctor or health care professional: Chronic Bronchitis
66	COPD	251713	phv00251713.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:15:53+00:00	2018-09-20 21:15:53+00:00 	h657	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Age condition began - Chronic Bronchitis Collection Interval: Exam 3
66	COPD	251712	phv00251712.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:16:00+00:00	2018-09-20 21:16:00+00:00 	h656	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Health professional diagnosis - Chronic Bronchitis Collection Interval: Exam 3
66	COPD	275387	phv00275387.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:18:08+00:00	2018-09-20 21:18:08+00:00 	fy600	Respiratory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for chronic bronchitis? Collection Interval: Original Cohort Exam 32
66	COPD	275226	phv00275226.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:18:14+00:00	2018-09-20 21:18:14+00:00 	fy284	Clinical Diagnostic Impression - Chronic bronchitis Collection Interval: Original Cohort Exam 32
66	COPD	275053	phv00275053.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-20 21:18:21+00:00	2018-09-20 21:18:21+00:00 	FX600	Respiratory Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for chronic bronchitis? Collection Interval: Original Cohort Exam 31
66	COPD	283510	phv00283510.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-20 21:18:51+00:00	2018-09-20 21:18:51+00:00 	BRONCHITISHX	F136 History of chronic bronchitis/COPD
66	COPD	214105	phv00214105.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-20 21:22:19+00:00	2018-09-20 21:22:19+00:00 	CRBRON15	MD said pt had chronic bronchitis?
66	COPD	209709	phv00209709.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-20 21:22:32+00:00	2018-09-20 21:22:32+00:00 	RPAA30	[Bronchitis]. Age chronic bronchitis started. Q30 [Respiratory Symptoms and Physical Activity Form, exam 1]
66	COPD	209708	phv00209708.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-20 21:22:40+00:00	2018-09-20 21:22:40+00:00 	RPAA29	[Bronchitis]. Was chronic bronchitis confirmed by a doctor? Q29 [Respiratory Symptoms and Physical Activity Form, exam 1]
66	COPD	209707	phv00209707.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-20 21:22:48+00:00	2018-09-20 21:22:48+00:00 	RPAA28	[Bronchitis]. Still have chronic bronchitis? Q28 [Respiratory Symptoms and Physical Activity Form, exam 1]
66	COPD	209706	phv00209706.v1.p1	pht004161.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-09-20 21:22:55+00:00	2018-09-20 21:22:55+00:00 	RPAA27	[Bronchitis]. Ever had chronic bronchitis? Q27 [Respiratory Symptoms and Physical Activity Form, exam 1]
66	COPD	124267	phv00124267.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-09-20 21:25:43+00:00	2018-09-20 21:25:43+00:00 	BRODIADAY	Days from visit date - Diagnosed Chronic Bronchitis
66	COPD	198890	phv00198890.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-20 21:36:27+00:00	2018-09-20 21:36:27+00:00 	hi201b	1b  chronic bronchitis
66	COPD	197461	phv00197461.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-20 21:36:35+00:00	2018-09-20 21:36:35+00:00 	crbron15	MD said pt had chronic bronchitis?
66	COPD	106008	phv00106008.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-20 21:36:42+00:00	2018-09-20 21:36:42+00:00 	CBRN57	CHRONIC BRONCHITIS
66	COPD	104142	phv00104142.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-20 21:36:52+00:00	2018-09-20 21:36:52+00:00 	CRNC37	CHRONIC BRONCHITIS
66	COPD	99073	phv00099073.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-20 21:36:59+00:00	2018-09-20 21:36:59+00:00 	CRNC07	CHRONIC BRONCHITIS
66	COPD	193631	phv00193631.v3.p3	pht003413.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:22:19+00:00	2018-09-21 17:22:19+00:00 	F33COPD	F33 COPD
66	COPD	193632	phv00193632.v3.p3	pht003413.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:22:27+00:00	2018-09-21 17:22:27+00:00 	F33COPDDY	Days enrollment to F33 COPD
66	COPD	193741	phv00193741.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:22:41+00:00	2018-09-21 17:22:41+00:00 	F33COPD	F33 COPD
66	COPD	193742	phv00193742.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:22:50+00:00	2018-09-21 17:22:50+00:00 	F33COPDDY	Days enrollment to F33 COPD
66	COPD	100497	phv00100497.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:48:49+00:00	2018-09-27 16:48:49+00:00 	COPDBL	COPD at baseline
66	COPD	197462	phv00197462.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:49:11+00:00	2018-09-27 16:49:11+00:00 	copd15	MD said pt had COPD?
66	COPD	2393	phv00002393.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	FG287	CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC OBSTRUCTIVE LUNG DISEASE
66	COPD	2631	phv00002631.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	FH306	CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC OBSTRUCTIVE LUNG DISEASE
66	COPD	2837	phv00002837.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	FI217	CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC OBSTRUCTIVE LUNG DISEASE
66	COPD	3236	phv00003236.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	FJ348	NON-CARDIOVASCULAR DIAGNOSIS: CHRONIC OBSTRUCTIVE LUNG DISEASE
66	COPD	3655	phv00003655.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	FK444	NON-CARDIOVASCULAR DISEASE: CHRONIC OBSTRUCTIVE LUNG DISEASE
66	COPD	7944	phv00007944.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	B325	CHRONIC OBSTRUCTIVE LUNG DISEASE
66	COPD	21307	phv00021307.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	G3A554	HAVE YOU EVER HAD COPD?
66	COPD	21308	phv00021308.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	G3A555	COPD: HEALTH PROFESSIONAL DX?
66	COPD	55303	phv00055303.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	COPD15	MD said pt had COPD?
66	COPD	255330	phv00255330.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	fw602	Respiratory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: COPD (Chronic Obstructive Pulmonary Disease)   Variable appears on Form B only Collection Interval: Original Cohort Exam 30
66	COPD	274134	phv00274134.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	g3a554	Have you ever had COPD? Collection Interval: Exam 1
66	COPD	274135	phv00274135.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	g3a555	COPD: Health professional dx? Collection Interval: Exam 1
66	COPD	274625	phv00274625.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	g3a554	Have you ever had COPD?
66	COPD	274626	phv00274626.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	g3a555	COPD: Health professional dx?
66	COPD	275055	phv00275055.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	FX602	Respiratory Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for COPD (Chronic Obstructive Pulmonary Disease)? Collection Interval: Original Cohort Exam 31
66	COPD	275389	phv00275389.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	fy602	Respiratory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for COPD (Chronic Obstructive Pulmonary Disease)? Collection Interval: Original Cohort Exam 32
66	COPD	276871	phv00276871.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	CHF072	COPD, regular bronchodilator or steroid user - not PRN
66	COPD	276872	phv00276872.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:07:19+00:00	2018-09-28 17:07:19+00:00 	CHF073	COPD, PRN user of bronchodilator or steroids
66	COPD	21309	phv00021309.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:08:39+00:00	2018-09-28 17:08:39+00:00 	G3A556	COPD: AGE CONDITION BEGAN
66	COPD	56802	phv00056802.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:08:39+00:00	2018-09-28 17:08:39+00:00 	hi201c	COPD: has a doctor ever told you that you have COPD (chronic obstructive pulmonary disease)?
66	COPD	72500	phv00072500.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:08:39+00:00	2018-09-28 17:08:39+00:00 	H661	SINCE YOUR LAST EXAM HAVE YOU HAD ...COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE): CONDITION?
66	COPD	72501	phv00072501.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:08:39+00:00	2018-09-28 17:08:39+00:00 	H662	SINCE YOUR LAST EXAM HAVE YOU HAD ...COPD: HEALTH PROFESSIONAL DIAGNOSIS?
66	COPD	72502	phv00072502.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:08:39+00:00	2018-09-28 17:08:39+00:00 	H663	SINCE YOUR LAST EXAM HAVE YOU HAD ...COPD: AGE CONDITION BEGAN
66	COPD	177574	phv00177574.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:08:39+00:00	2018-09-28 17:08:39+00:00 	g3b0600	Respiratory Disease Questionnaire-Technician administered: Have you had the following condition diagnosed by a doctor or other health care professional? COPD (Chronic obstructive pulmonary disease)
66	COPD	251717	phv00251717.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:08:39+00:00	2018-09-28 17:08:39+00:00 	h661	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Since your last exam have you had COPD (Chronic obstructive pulmonary disease)? Collection Interval: Exam 3
66	COPD	251718	phv00251718.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:08:39+00:00	2018-09-28 17:08:39+00:00 	h662	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Health professional diagnosis - COPD (Chronic obstructive pulmonary disease) Collection Interval: Exam 3
66	COPD	251719	phv00251719.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:08:39+00:00	2018-09-28 17:08:39+00:00 	h663	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Age condition began - COPD (Chronic obstructive pulmonary disease) Collection Interval: Exam 3
66	COPD	254499	phv00254499.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:08:39+00:00	2018-09-28 17:08:39+00:00 	j842	Respiratory Disease Questionnaire Part 1-Tech administered: Have you ever had the following condition diagnosed by a doctor or health care professional: COPD
66	COPD	274136	phv00274136.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:08:39+00:00	2018-09-28 17:08:39+00:00 	g3a556	COPD: Age condition began Collection Interval: Exam 1
66	COPD	274627	phv00274627.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 17:08:39+00:00	2018-09-28 17:08:39+00:00 	g3a556	COPD: Age condition began
66	COPD	1120	phv00001120.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 17:14:17+00:00	2018-10-04 17:14:17+00:00 	FA109	UNDER MEDICAL CARE BUT NOT HOSPITALIZED SINCE LAST EXAM FOR EMPHYSEMA OR FIBROSIS
67	Sleep apnea	83431	phv00083431.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:30:44+00:00	2018-04-28 23:30:44+00:00 	apnea1	SLEEP APNEA DIAGNOSIS BY DOCTOR
67	Sleep apnea	86249	phv00086249.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:30:51+00:00	2018-04-28 23:30:51+00:00 	apnea2	HAVE YOU EVER BEEN TOLD BY DOCTOR YOU HAVE SLEEP APNEA
67	Sleep apnea	87066	phv00087066.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-28 23:30:59+00:00	2018-04-28 23:30:59+00:00 	apnea4	SLEEP APNEA DIAGNOSIS
67	Sleep apnea	206788	phv00206788.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-10 14:54:42+00:00	2018-05-10 14:54:42+00:00 	HFAA10F	[Medical history]. Q10f - f. Sleep apnea [Heart Failure Hospital Record Abstraction Form, HFA]
67	Sleep apnea	214103	phv00214103.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-10 14:55:05+00:00	2018-05-10 14:55:05+00:00 	SA15	MD said pt had sleep apnea?
67	Sleep apnea	214292	phv00214292.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-10 14:55:41+00:00	2018-05-10 14:55:41+00:00 	MDSA02	Have you ever been told by a doctor that you have sleep apnea?
67	Sleep apnea	159736	phv00159736.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:46:39+00:00	2018-08-10 20:46:39+00:00 	SleepApnea	Sleep apnea: have you ever had sleep apnea Collection Interval: Collected in Exam 1
67	Sleep apnea	159737	phv00159737.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:46:51+00:00	2018-08-10 20:46:51+00:00 	SleepApDxByDr	Sleep apnea: diagnosed by doctor or other health professional Collection Interval: Collected in Exam 1
67	Sleep apnea	159738	phv00159738.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:47:01+00:00	2018-08-10 20:47:01+00:00 	SleepApAge	Sleep apnea: at about what age did sleep apnea start Collection Interval: Collected in Exam 1
67	Sleep apnea	159739	phv00159739.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 20:47:10+00:00	2018-08-10 20:47:10+00:00 	SleepApStillHav	Sleep apnea: do you still have sleep apnea Collection Interval: Collected in Exam 1
67	Sleep apnea	122392	phv00122392.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:35:52+00:00	2018-08-16 23:35:52+00:00 	DIAAPN	Ever been diagnosed w/ sleep apnea
67	Sleep apnea	122393	phv00122393.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:36:09+00:00	2018-08-16 23:36:09+00:00 	YRDIAGN	Year diagnosed with sleep apnea
67	Sleep apnea	122504	phv00122504.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:44:48+00:00	2018-08-16 23:44:48+00:00 	CHAPN	Since last visit diagnosed OSA (sleep apnea)
67	Sleep apnea	123476	phv00123476.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:36:57+00:00	2018-08-21 17:36:57+00:00 	SLAPNDIA	95 Sleep Apnea
67	Sleep apnea	123477	phv00123477.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:39:07+00:00	2018-08-21 17:39:07+00:00 	AGEDIAAP	95 Age Diagnosed - Sleep Apnea
67	Sleep apnea	124264	phv00124264.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 19:00:30+00:00	2018-08-21 19:00:30+00:00 	APNDIADAY	Days from visit date - Diagnosed Sleep Apnea
67	Sleep apnea	283514	phv00283514.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 17:20:45+00:00	2018-09-21 17:20:45+00:00 	SLEEPAPNEAHX	F136 History of sleep apnea
67	Sleep apnea	197459	phv00197459.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:56:59+00:00	2018-09-27 16:56:59+00:00 	sa15	MD said pt had sleep apnea?
67	Sleep apnea	197677	phv00197677.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 16:58:43+00:00	2018-09-27 16:58:43+00:00 	mdsa02	Have you ever been told by a doctor that you have sleep apnea?
67	Sleep apnea	21310	phv00021310.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	G3A557	HAVE YOU EVER HAD SLEEP APNEA
67	Sleep apnea	21311	phv00021311.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	G3A558	SLEEP APNEA: HEALTH PROFESSIONAL DX?
67	Sleep apnea	21312	phv00021312.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	G3A559	SLEEP APNEA: AGE CONDITION BEGAN
67	Sleep apnea	72503	phv00072503.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	H664	SINCE YOUR LAST EXAM HAVE YOU HAD ... SLEEP APNEA: CONDITION?
67	Sleep apnea	72504	phv00072504.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	H665	SINCE YOUR LAST EXAM HAVE YOU HAD ...SLEEP APNEA: HEALTH PROFESSIONAL DIAGNOSIS?
67	Sleep apnea	177575	phv00177575.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	g3b0601	Respiratory Disease Questionnaire-Technician administered: Have you had the following condition diagnosed by a doctor or other health care professional? Sleep apnea
67	Sleep apnea	251720	phv00251720.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	h664	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Since your last exam have you had sleep apnea? Collection Interval: Exam 3
67	Sleep apnea	251721	phv00251721.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	h665	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Health professional diagnosis - Sleep Apnea Collection Interval: Exam 3
67	Sleep apnea	255331	phv00255331.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	fw603	Respiratory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Sleep Apnea   Variable appears on Form B only Collection Interval: Original Cohort Exam 30
67	Sleep apnea	274137	phv00274137.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	g3a557	Have you ever had sleep apnea Collection Interval: Exam 1
67	Sleep apnea	274138	phv00274138.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	g3a558	Sleep apnea: Health professional dx? Collection Interval: Exam 1
67	Sleep apnea	274139	phv00274139.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	g3a559	Sleep apnea: Age condition began Collection Interval: Exam 1
67	Sleep apnea	274628	phv00274628.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	g3a557	Have you ever had sleep apnea
67	Sleep apnea	274629	phv00274629.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	g3a558	Sleep apnea: Health professional dx?
67	Sleep apnea	274630	phv00274630.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	g3a559	Sleep apnea: Age condition began
67	Sleep apnea	275056	phv00275056.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	FX603	Respiratory Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for sleep apnea? Collection Interval: Original Cohort Exam 31
67	Sleep apnea	275390	phv00275390.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:33:08+00:00	2018-09-28 13:33:08+00:00 	fy603	Respiratory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for sleep apnea? Collection Interval: Original Cohort Exam 32
67	Sleep apnea	55489	phv00055489.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:34:54+00:00	2018-09-28 13:34:54+00:00 	MDSA02	Have you ever been told by a doctor that you have sleep apnea?
67	Sleep apnea	56675	phv00056675.v2.p10	pht000396.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:34:54+00:00	2018-09-28 13:34:54+00:00 	sleepApnea	Told by doctor that you had sleep apnea
67	Sleep apnea	72505	phv00072505.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:34:54+00:00	2018-09-28 13:34:54+00:00 	H666	SINCE YOUR LAST EXAM HAVE YOU HAD ...SLEEP APNEA: AGE CONDITION BEGAN
67	Sleep apnea	72574	phv00072574.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:34:54+00:00	2018-09-28 13:34:54+00:00 	H744	HAVE YOU EVER BEEN TOLD BY A DOCTOR OR OTHER HEALTH PROFESSIONAL THAT YOU HAVE SLEEP APNEA?
67	Sleep apnea	251722	phv00251722.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:34:54+00:00	2018-09-28 13:34:54+00:00 	h666	Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Age condition began - Sleep Apnea Collection Interval: Exam 3
67	Sleep apnea	251789	phv00251789.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:34:54+00:00	2018-09-28 13:34:54+00:00 	h744	Sleep Questionnaire - Part 2 - Self-administered: Have you ever been told by a doctor or other health professional that you have sleep apnea or obstructive sleep apnea? Collection Interval: Exam 3
67	Sleep apnea	254500	phv00254500.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:34:54+00:00	2018-09-28 13:34:54+00:00 	j843	Respiratory Disease Questionnaire Part 1-Tech administered: Have you ever had the following condition diagnosed by a doctor or health care professional: Sleep Apnea
67	Sleep apnea	254589	phv00254589.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:34:54+00:00	2018-09-28 13:34:54+00:00 	j942	Sleep Questionnaire Part 3-Self administered: Have you ever been told by a doctor or other health care professional that you have: Sleep apnea or obstructive sleep apnea?
68	AHI	214356	phv00214356.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-28 14:18:57+00:00	2018-03-28 14:18:57+00:00 	OAHI	Obstructive (all desats) apnea hypopnea (4% desat) Index)
68	AHI	122638	phv00122638.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:45:36+00:00	2018-08-14 20:45:36+00:00 	ahi	Apnea hypapnea index
68	AHI	124212	phv00124212.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:45:58+00:00	2018-08-14 20:45:58+00:00 	oahi	Calculated - Obstructive apnea (all desats) Hypopnea (4% desat) Index
68	AHI	124213	phv00124213.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:46:19+00:00	2018-08-14 20:46:19+00:00 	oahi3	Calculated - Obstructive apnea (all desats) Hypopnea (3% desat) Index
68	AHI	226392	phv00226392.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:30:05+00:00	2018-08-24 16:30:05+00:00 	SLPA54	Apnea/hypopnea index (3% desat) (SLPA54)
68	AHI	197745	phv00197745.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:57:10+00:00	2018-09-27 17:57:10+00:00 	oahi	Obstructive (all desats) apnea Hypopnea (4% desat) Index)
68	AHI	200047	phv00200047.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:57:40+00:00	2018-09-27 17:57:40+00:00 	oahi	Calculated - obstructive apnea (all desats) hypopnea (4% desat) index
68	AHI	55553	phv00055553.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 20:57:58+00:00	2018-10-04 20:57:58+00:00 	oahi	Obstructive (all desats) apnea Hypopnea (4% desat) Index)
68	AHI	57941	phv00057941.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 21:01:08+00:00	2018-10-04 21:01:08+00:00 	oahi	Obstructive (all desats) apnea Hypopnea (4% desat) Index)
68	AHI	55564	phv00055564.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 23:03:45+00:00	2018-10-04 23:03:45+00:00 	oai0p	Obstructive Apnea Index all desats
68	AHI	55565	phv00055565.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 23:08:29+00:00	2018-10-04 23:08:29+00:00 	oai4p	Obstructive Apnea Index 4% desats
68	AHI	55566	phv00055566.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 23:08:50+00:00	2018-10-04 23:08:50+00:00 	oai4pa	Obstructive Apnea Index 4% or arousal
68	AHI	55567	phv00055567.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 23:08:57+00:00	2018-10-04 23:08:57+00:00 	cai0p	Central Apnea Index all desats
68	AHI	55568	phv00055568.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 23:09:03+00:00	2018-10-04 23:09:03+00:00 	cai4p	Central Apnea Index 4% desats
68	AHI	55569	phv00055569.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 23:09:12+00:00	2018-10-04 23:09:12+00:00 	cai4pa	Central Apnea Index 4% or arousal
68	AHI	57952	phv00057952.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 23:09:20+00:00	2018-10-04 23:09:20+00:00 	oai0p	Obstructive Apnea Index all desats
68	AHI	57953	phv00057953.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 23:09:26+00:00	2018-10-04 23:09:26+00:00 	oai4p	Obstructive Apnea Index 4% desats
68	AHI	57954	phv00057954.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 23:09:32+00:00	2018-10-04 23:09:32+00:00 	oai4pa	Obstructive Apnea Index 4% or arousal
68	AHI	57955	phv00057955.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 23:09:39+00:00	2018-10-04 23:09:39+00:00 	cai0p	Central Apnea Index all desats
68	AHI	57956	phv00057956.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 23:09:46+00:00	2018-10-04 23:09:46+00:00 	cai4p	Central Apnea Index 4% desats
68	AHI	57957	phv00057957.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-04 23:09:52+00:00	2018-10-04 23:09:52+00:00 	cai4pa	Central Apnea Index 4% or arousal
68	AHI	214367	phv00214367.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-10-04 23:10:22+00:00	2018-10-04 23:10:22+00:00 	OAI0P	Obstructive apnea index all desats
68	AHI	214368	phv00214368.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-10-04 23:10:29+00:00	2018-10-04 23:10:29+00:00 	OAI4P	Obstructive apnea index 4% desats
68	AHI	214369	phv00214369.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-10-04 23:10:36+00:00	2018-10-04 23:10:36+00:00 	OAI4PA	Obstructive apnea index 4% or arousal
68	AHI	214370	phv00214370.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-10-04 23:10:42+00:00	2018-10-04 23:10:42+00:00 	CAI0P	Central apnea index all desats
68	AHI	214371	phv00214371.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-10-04 23:10:51+00:00	2018-10-04 23:10:51+00:00 	CAI4P	Central apnea index 4% desats
68	AHI	214372	phv00214372.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-10-04 23:10:57+00:00	2018-10-04 23:10:57+00:00 	CAI4PA	Central apnea index 4% or arousal
68	AHI	124218	phv00124218.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-10-04 23:11:04+00:00	2018-10-04 23:11:04+00:00 	oai0p	Calculated - Obstructive Apnea Index all desats
68	AHI	124219	phv00124219.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-10-04 23:11:34+00:00	2018-10-04 23:11:34+00:00 	oai4p	Calculated - Obstructive Apnea Index 4% desats
68	AHI	124220	phv00124220.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-10-04 23:11:40+00:00	2018-10-04 23:11:40+00:00 	cai0p	Calculated - Central Apnea Index all desats
68	AHI	124221	phv00124221.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-10-04 23:11:45+00:00	2018-10-04 23:11:45+00:00 	cai4p	Calculated - Central Apnea Index 4% desats
68	AHI	197756	phv00197756.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-04 23:11:52+00:00	2018-10-04 23:11:52+00:00 	oai0p	Obstructive Apnea Index all desats
68	AHI	197757	phv00197757.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-04 23:11:57+00:00	2018-10-04 23:11:57+00:00 	oai4p	Obstructive Apnea Index 4% desats
68	AHI	197758	phv00197758.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-04 23:12:02+00:00	2018-10-04 23:12:02+00:00 	oai4pa	Obstructive Apnea Index 4% or arousal
68	AHI	197759	phv00197759.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-04 23:12:08+00:00	2018-10-04 23:12:08+00:00 	cai0p	Central Apnea Index all desats
68	AHI	197760	phv00197760.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-04 23:12:13+00:00	2018-10-04 23:12:13+00:00 	cai4p	Central Apnea Index 4% desats
68	AHI	197761	phv00197761.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-04 23:12:17+00:00	2018-10-04 23:12:17+00:00 	cai4pa	Central Apnea Index 4% or arousal
68	AHI	55759	phv00055759.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	CARDNBP	Central Apnea RDI in NREM (Back position) overall
68	AHI	55831	phv00055831.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	CARDNBA	Central Apnea RDI in NREM (Back position) associated with arousal
68	AHI	55927	phv00055927.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	CARDNBP2	Central Apnea RDI in NREM (Back position) 2% desaturation
68	AHI	55999	phv00055999.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	CARDNBA2	Central Apnea RDI in NREM (Back position) 2% desaturation or arousal
68	AHI	56071	phv00056071.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	CARDNBP3	Central Apnea RDI in NREM (Back position) 3% desaturation
68	AHI	56143	phv00056143.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	CARDNBA3	Central Apnea RDI in NREM (Back position) 3% desaturation or arousal
68	AHI	56215	phv00056215.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	CARDNBP4	Central Apnea RDI in NREM (Back position) 4% desaturation
68	AHI	56287	phv00056287.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	CARDNBA4	Central Apnea RDI in NREM (Back position) 4% desaturation or arousal
68	AHI	56359	phv00056359.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	CARDNBP5	Central Apnea RDI in NREM (Back position) 5% desaturation
68	AHI	56431	phv00056431.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	CARDNBA5	Central Apnea RDI in NREM (Back position) 5% desaturation or arousal
68	AHI	57719	phv00057719.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	cardnbp	Central Apnea RDI in NREM (Back position) overall
68	AHI	57731	phv00057731.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	cardnba	Central Apnea RDI in NREM (Back position) associated with arousal
68	AHI	57743	phv00057743.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	cardnbp2	Central Apnea RDI in NREM (Back position) 2% desaturation
68	AHI	57755	phv00057755.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	cardnba2	Central Apnea RDI in NREM (Back position) 2% desaturation or arousal
68	AHI	57767	phv00057767.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	cardnbp3	Central Apnea RDI in NREM (Back position) 3% desaturation
68	AHI	57779	phv00057779.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	cardnba3	Central Apnea RDI in NREM (Back position) 3% desaturation or arousal
68	AHI	57791	phv00057791.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	cardnbp4	Central Apnea RDI in NREM (Back position) 4% desaturation
68	AHI	57803	phv00057803.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	cardnba4	Central Apnea RDI in NREM (Back position) 4% desaturation or arousal
68	AHI	57815	phv00057815.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	cardnbp5	Central Apnea RDI in NREM (Back position) 5% desaturation
68	AHI	57827	phv00057827.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:44:37+00:00	2018-12-06 18:05:54+00:00 	cardnba5	Central Apnea RDI in NREM (Back position) 5% desaturation or arousal
68	AHI	55764	phv00055764.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	CARDNOP	Central Apnea RDI in NREM (Other position) overall
68	AHI	55836	phv00055836.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	CARDNOA	Central Apnea RDI in NREM (Other position) associated with arousal
68	AHI	55932	phv00055932.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	CARDNOP2	Central Apnea RDI in NREM (Other position) 2% desaturation
68	AHI	56004	phv00056004.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	CARDNOA2	Central Apnea RDI in NREM (Other position) 2% desaturation or arousal
68	AHI	56076	phv00056076.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	CARDNOP3	Central Apnea RDI in NREM (Other position) 3% desaturation
68	AHI	56148	phv00056148.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	CARDNOA3	Central Apnea RDI in NREM (Other position) 3% desaturation or arousal
68	AHI	56220	phv00056220.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	CARDNOP4	Central Apnea RDI in NREM (Other position) 4% desaturation
68	AHI	56292	phv00056292.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	CARDNOA4	Central Apnea RDI in NREM (Other position) 4% desaturation or arousal
68	AHI	56364	phv00056364.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	CARDNOP5	Central Apnea RDI in NREM (Other position) 5% desaturation
68	AHI	56436	phv00056436.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	CARDNOA5	Central Apnea RDI in NREM (Other position) 5% desaturation or arousal
68	AHI	57720	phv00057720.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	cardnop	Central Apnea RDI in NREM (Other position) overall
68	AHI	57732	phv00057732.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	cardnoa	Central Apnea RDI in NREM (Other position) associated with arousal
68	AHI	57744	phv00057744.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	cardnop2	Central Apnea RDI in NREM (Other position) 2% desaturation
68	AHI	57756	phv00057756.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	cardnoa2	Central Apnea RDI in NREM (Other position) 2% desaturation or arousal
68	AHI	57768	phv00057768.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	cardnop3	Central Apnea RDI in NREM (Other position) 3% desaturation
68	AHI	57780	phv00057780.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	cardnoa3	Central Apnea RDI in NREM (Other position) 3% desaturation or arousal
68	AHI	57792	phv00057792.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	cardnop4	Central Apnea RDI in NREM (Other position) 4% desaturation
68	AHI	57804	phv00057804.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	cardnoa4	Central Apnea RDI in NREM (Other position) 4% desaturation or arousal
68	AHI	57816	phv00057816.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	cardnop5	Central Apnea RDI in NREM (Other position) 5% desaturation
68	AHI	57828	phv00057828.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:46:45+00:00	2018-12-06 18:05:54+00:00 	cardnoa5	Central Apnea RDI in NREM (Other position) 5% desaturation or arousal
68	AHI	55749	phv00055749.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	CARDRBP	Central Apnea RDI in REM (Back position) overall
68	AHI	55821	phv00055821.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	CARDRBA	Central Apnea RDI in REM (Back position) associated with arousal
68	AHI	55917	phv00055917.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	CARDRBP2	Central Apnea RDI in REM (Back position) 2% desaturation
68	AHI	55989	phv00055989.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	CARDRBA2	Central Apnea RDI in REM (Back position) 2% desaturation or arousal
68	AHI	56061	phv00056061.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	CARDRBP3	Central Apnea RDI in REM (Back position) 3% desaturation
68	AHI	56133	phv00056133.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	CARDRBA3	Central Apnea RDI in REM (Back position) 3% desaturation or arousal
68	AHI	56205	phv00056205.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	CARDRBP4	Central Apnea RDI in REM (Back position) 4% desaturation
68	AHI	56277	phv00056277.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	CARDRBA4	Central Apnea RDI in REM (Back position) 4% desaturation or arousal
68	AHI	56349	phv00056349.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	CARDRBP5	Central Apnea RDI in REM (Back position) 5% desaturation
68	AHI	56421	phv00056421.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	CARDRBA5	Central Apnea RDI in REM (Back position) 5% desaturation or arousal
68	AHI	57717	phv00057717.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	cardrbp	Central Apnea RDI in REM (Back position) overall
68	AHI	57729	phv00057729.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	cardrba	Central Apnea RDI in REM (Back position) associated with arousal
68	AHI	57741	phv00057741.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	cardrbp2	Central Apnea RDI in REM (Back position) 2% desaturation
68	AHI	57753	phv00057753.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	cardrba2	Central Apnea RDI in REM (Back position) 2% desaturation or arousal
68	AHI	57765	phv00057765.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	cardrbp3	Central Apnea RDI in REM (Back position) 3% desaturation
68	AHI	57777	phv00057777.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	cardrba3	Central Apnea RDI in REM (Back position) 3% desaturation or arousal
68	AHI	57789	phv00057789.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	cardrbp4	Central Apnea RDI in REM (Back position) 4% desaturation
68	AHI	57801	phv00057801.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	cardrba4	Central Apnea RDI in REM (Back position) 4% desaturation or arousal
68	AHI	57813	phv00057813.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	cardrbp5	Central Apnea RDI in REM (Back position) 5% desaturation
68	AHI	57825	phv00057825.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:48:10+00:00	2018-12-06 18:05:54+00:00 	cardrba5	Central Apnea RDI in REM (Back position) 5% desaturation or arousal
68	AHI	55754	phv00055754.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	CARDROP	Central Apnea RDI in REM (Other position) overall
68	AHI	55826	phv00055826.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	CARDROA	Central Apnea RDI in REM (Other position) associated with arousal
68	AHI	55922	phv00055922.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	CARDROP2	Central Apnea RDI in REM (Other position) 2% desaturation
68	AHI	55994	phv00055994.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	CARDROA2	Central Apnea RDI in REM (Other position) 2% desaturation or arousal
68	AHI	56066	phv00056066.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	CARDROP3	Central Apnea RDI in REM (Other position) 3% desaturation
68	AHI	56138	phv00056138.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	CARDROA3	Central Apnea RDI in REM (Other position) 3% desaturation or arousal
68	AHI	56210	phv00056210.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	CARDROP4	Central Apnea RDI in REM (Other position) 4% desaturation
68	AHI	56282	phv00056282.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	CARDROA4	Central Apnea RDI in REM (Other position) 4% desaturation or arousal
68	AHI	56354	phv00056354.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	CARDROP5	Central Apnea RDI in REM (Other position) 5% desaturation
68	AHI	56426	phv00056426.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	CARDROA5	Central Apnea RDI in REM (Other position) 5% desaturation or arousal
68	AHI	57718	phv00057718.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	cardrop	Central Apnea RDI in REM (Other position) overall
68	AHI	57730	phv00057730.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	cardroa	Central Apnea RDI in REM (Other position) associated with arousal
68	AHI	57742	phv00057742.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	cardrop2	Central Apnea RDI in REM (Other position) 2% desaturation
68	AHI	57754	phv00057754.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	cardroa2	Central Apnea RDI in REM (Other position) 2% desaturation or arousal
68	AHI	57766	phv00057766.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	cardrop3	Central Apnea RDI in REM (Other position) 3% desaturation
68	AHI	57778	phv00057778.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	cardroa3	Central Apnea RDI in REM (Other position) 3% desaturation or arousal
68	AHI	57790	phv00057790.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	cardrop4	Central Apnea RDI in REM (Other position) 4% desaturation
68	AHI	57802	phv00057802.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	cardroa4	Central Apnea RDI in REM (Other position) 4% desaturation or arousal
68	AHI	57814	phv00057814.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	cardrop5	Central Apnea RDI in REM (Other position) 5% desaturation
68	AHI	57826	phv00057826.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 12:50:12+00:00	2018-12-06 18:05:54+00:00 	cardroa5	Central Apnea RDI in REM (Other position) 5% desaturation or arousal
68	AHI	55779	phv00055779.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	OARDNBP	Obstructive Apnea RDI in NREM (Back position) overall
68	AHI	55851	phv00055851.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	OARDNBA	Obstructive Apnea RDI in NREM (Back position) associated with arousal
68	AHI	55947	phv00055947.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	OARDNBP2	Obstructive Apnea RDI in NREM (Back position) 2% desaturation
68	AHI	56019	phv00056019.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	OARDNBA2	Obstructive Apnea RDI in NREM (Back position) 2% desaturation or arousal
68	AHI	56091	phv00056091.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	OARDNBP3	Obstructive Apnea RDI in NREM (Back position) 3% desaturation
68	AHI	56163	phv00056163.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	OARDNBA3	Obstructive Apnea RDI in NREM (Back position) 3% desaturation or arousal
68	AHI	56235	phv00056235.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	OARDNBP4	Obstructive Apnea RDI in NREM (Back position) 4% desaturation
68	AHI	56307	phv00056307.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	OARDNBA4	Obstructive Apnea RDI in NREM (Back position) 4% desaturation or arousal
68	AHI	56379	phv00056379.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	OARDNBP5	Obstructive Apnea RDI in NREM (Back position) 5% desaturation
68	AHI	56451	phv00056451.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	OARDNBA5	Obstructive Apnea RDI in NREM (Back position) 5% desaturation or arousal
68	AHI	57723	phv00057723.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	oardnbp	Obstructive Apnea RDI in NREM (Back position) overall
68	AHI	57735	phv00057735.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	oardnba	Obstructive Apnea RDI in NREM (Back position) associated with arousal
68	AHI	57747	phv00057747.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	oardnbp2	Obstructive Apnea RDI in NREM (Back position) 2% desaturation
68	AHI	57759	phv00057759.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	oardnba2	Obstructive Apnea RDI in NREM (Back position) 2% desaturation or arousal
68	AHI	57771	phv00057771.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	oardnbp3	Obstructive Apnea RDI in NREM (Back position) 3% desaturation
68	AHI	57783	phv00057783.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	oardnba3	Obstructive Apnea RDI in NREM (Back position) 3% desaturation or arousal
68	AHI	57795	phv00057795.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	oardnbp4	Obstructive Apnea RDI in NREM (Back position) 4% desaturation
68	AHI	57807	phv00057807.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	oardnba4	Obstructive Apnea RDI in NREM (Back position) 4% desaturation or arousal
68	AHI	57819	phv00057819.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	oardnbp5	Obstructive Apnea RDI in NREM (Back position) 5% desaturation
68	AHI	57831	phv00057831.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:16:14+00:00	2018-12-06 18:05:54+00:00 	oardnba5	Obstructive Apnea RDI in NREM (Back position) 5% desaturation or arousal
68	AHI	55784	phv00055784.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	OARDNOP	Obstructive Apnea RDI in NREM (Other position) overall
68	AHI	55856	phv00055856.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	OARDNOA	Obstructive Apnea RDI in NREM (Other position) associated with arousal
68	AHI	55952	phv00055952.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	OARDNOP2	Obstructive Apnea RDI in NREM (Other position) 2% desaturation
68	AHI	56024	phv00056024.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	OARDNOA2	Obstructive Apnea RDI in NREM (Other position) 2% desaturation or arousal
68	AHI	56096	phv00056096.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	OARDNOP3	Obstructive Apnea RDI in NREM (Other position) 3% desaturation
68	AHI	56168	phv00056168.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	OARDNOA3	Obstructive Apnea RDI in NREM (Other position) 3% desaturation or arousal
68	AHI	56240	phv00056240.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	OARDNOP4	Obstructive Apnea RDI in NREM (Other position) 4% desaturation
68	AHI	56312	phv00056312.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	OARDNOA4	Obstructive Apnea RDI in NREM (Other position) 4% desaturation or arousal
68	AHI	56384	phv00056384.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	OARDNOP5	Obstructive Apnea RDI in NREM (Other position) 5% desaturation
68	AHI	56456	phv00056456.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	OARDNOA5	Obstructive Apnea RDI in NREM (Other position) 5% desaturation or arousal
68	AHI	57724	phv00057724.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	oardnop	Obstructive Apnea RDI in NREM (Other position) overall
68	AHI	57736	phv00057736.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	oardnoa	Obstructive Apnea RDI in NREM (Other position) associated with arousal
68	AHI	57748	phv00057748.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	oardnop2	Obstructive Apnea RDI in NREM (Other position) 2% desaturation
68	AHI	57760	phv00057760.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	oardnoa2	Obstructive Apnea RDI in NREM (Other position) 2% desaturation or arousal
68	AHI	57772	phv00057772.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	oardnop3	Obstructive Apnea RDI in NREM (Other position) 3% desaturation
68	AHI	57784	phv00057784.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	oardnoa3	Obstructive Apnea RDI in NREM (Other position) 3% desaturation or arousal
68	AHI	57796	phv00057796.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	oardnop4	Obstructive Apnea RDI in NREM (Other position) 4% desaturation
68	AHI	57808	phv00057808.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	oardnoa4	Obstructive Apnea RDI in NREM (Other position) 4% desaturation or arousal
68	AHI	57820	phv00057820.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	oardnop5	Obstructive Apnea RDI in NREM (Other position) 5% desaturation
68	AHI	57832	phv00057832.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:19:46+00:00	2018-12-06 18:05:54+00:00 	oardnoa5	Obstructive Apnea RDI in NREM (Other position) 5% desaturation or arousal
68	AHI	55769	phv00055769.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	OARDRBP	Obstructive Apnea RDI in REM (Back position) overall
68	AHI	55841	phv00055841.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	OARDRBA	Obstructive Apnea RDI in REM (Back position) associated with arousal
68	AHI	55937	phv00055937.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	OARDRBP2	Obstructive Apnea RDI in REM (Back position) 2% desaturation
68	AHI	56009	phv00056009.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	OARDRBA2	Obstructive Apnea RDI in REM (Back position) 2% desaturation or arousal
68	AHI	56081	phv00056081.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	OARDRBP3	Obstructive Apnea RDI in REM (Back position) 3% desaturation
68	AHI	56153	phv00056153.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	OARDRBA3	Obstructive Apnea RDI in REM (Back position) 3% desaturation or arousal
68	AHI	56225	phv00056225.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	OARDRBP4	Obstructive Apnea RDI in REM (Back position) 4% desaturation
68	AHI	56297	phv00056297.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	OARDRBA4	Obstructive Apnea RDI in REM (Back position) 4% desaturation or arousal
68	AHI	56369	phv00056369.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	OARDRBP5	Obstructive Apnea RDI in REM (Back position) 5% desaturation
68	AHI	56441	phv00056441.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	OARDRBA5	Obstructive Apnea RDI in REM (Back position) 5% desaturation or arousal
68	AHI	57721	phv00057721.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	oardrbp	Obstructive Apnea RDI in REM (Back position) overall
68	AHI	57733	phv00057733.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	oardrba	Obstructive Apnea RDI in REM (Back position) associated with arousal
68	AHI	57745	phv00057745.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	oardrbp2	Obstructive Apnea RDI in REM (Back position) 2% desaturation
68	AHI	57757	phv00057757.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	oardrba2	Obstructive Apnea RDI in REM (Back position) 2% desaturation or arousal
68	AHI	57769	phv00057769.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	oardrbp3	Obstructive Apnea RDI in REM (Back position) 3% desaturation
68	AHI	57781	phv00057781.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	oardrba3	Obstructive Apnea RDI in REM (Back position) 3% desaturation or arousal
68	AHI	57793	phv00057793.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	oardrbp4	Obstructive Apnea RDI in REM (Back position) 4% desaturation
68	AHI	57805	phv00057805.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	oardrba4	Obstructive Apnea RDI in REM (Back position) 4% desaturation or arousal
68	AHI	57817	phv00057817.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	oardrbp5	Obstructive Apnea RDI in REM (Back position) 5% desaturation
68	AHI	57829	phv00057829.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:25:15+00:00	2018-12-06 18:05:54+00:00 	oardrba5	Obstructive Apnea RDI in REM (Back position) 5% desaturation or arousal
68	AHI	55774	phv00055774.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	OARDROP	Obstructive Apnea RDI in REM (Other position) overall
68	AHI	55846	phv00055846.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	OARDROA	Obstructive Apnea RDI in REM (Other position) associated with arousal
68	AHI	55942	phv00055942.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	OARDROP2	Obstructive Apnea RDI in REM (Other position) 2% desaturation
68	AHI	56014	phv00056014.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	OARDROA2	Obstructive Apnea RDI in REM (Other position) 2% desaturation or arousal
68	AHI	56086	phv00056086.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	OARDROP3	Obstructive Apnea RDI in REM (Other position) 3% desaturation
68	AHI	56158	phv00056158.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	OARDROA3	Obstructive Apnea RDI in REM (Other position) 3% desaturation or arousal
68	AHI	56230	phv00056230.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	OARDROP4	Obstructive Apnea RDI in REM (Other position) 4% desaturation
68	AHI	56302	phv00056302.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	OARDROA4	Obstructive Apnea RDI in REM (Other position) 4% desaturation or arousal
68	AHI	56374	phv00056374.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	OARDROP5	Obstructive Apnea RDI in REM (Other position) 5% desaturation
68	AHI	56446	phv00056446.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	OARDROA5	Obstructive Apnea RDI in REM (Other position) 5% desaturation or arousal
68	AHI	57722	phv00057722.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	oardrop	Obstructive Apnea RDI in REM (Other position) overall
68	AHI	57734	phv00057734.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	oardroa	Obstructive Apnea RDI in REM (Other position) associated with arousal
68	AHI	57746	phv00057746.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	oardrop2	Obstructive Apnea RDI in REM (Other position) 2% desaturation
68	AHI	57758	phv00057758.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	oardroa2	Obstructive Apnea RDI in REM (Other position) 2% desaturation or arousal
68	AHI	57770	phv00057770.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	oardrop3	Obstructive Apnea RDI in REM (Other position) 3% desaturation
68	AHI	57782	phv00057782.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	oardroa3	Obstructive Apnea RDI in REM (Other position) 3% desaturation or arousal
68	AHI	57794	phv00057794.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	oardrop4	Obstructive Apnea RDI in REM (Other position) 4% desaturation
68	AHI	57806	phv00057806.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	oardroa4	Obstructive Apnea RDI in REM (Other position) 4% desaturation or arousal
68	AHI	57818	phv00057818.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	oardrop5	Obstructive Apnea RDI in REM (Other position) 5% desaturation
68	AHI	57830	phv00057830.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:27:21+00:00	2018-12-06 18:05:54+00:00 	oardroa5	Obstructive Apnea RDI in REM (Other position) 5% desaturation or arousal
68	AHI	55811	phv00055811.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:38:09+00:00	2018-12-06 18:05:54+00:00 	RDINBA	Hypopnea RDI in NREM (Back position) associated with arousal
68	AHI	55979	phv00055979.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:38:09+00:00	2018-12-06 18:05:54+00:00 	RDINBA2	Hypopnea RDI in NREM (Back position) 2% desaturation or arousal
68	AHI	56123	phv00056123.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:38:10+00:00	2018-12-06 18:05:54+00:00 	RDINBA3	Hypopnea RDI in NREM (Back position) 3% desaturation or arousal
68	AHI	56267	phv00056267.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:38:10+00:00	2018-12-06 18:05:54+00:00 	RDINBA4	Hypopnea RDI in NREM (Back position) 4% desaturation or arousal
68	AHI	56411	phv00056411.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:38:10+00:00	2018-12-06 18:05:54+00:00 	RDINBA5	Hypopnea RDI in NREM (Back position) 5% desaturation or arousal
68	AHI	57727	phv00057727.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:38:10+00:00	2018-12-06 18:05:54+00:00 	rdinba	Hypopnea RDI in NREM (Back position) associated with arousal
68	AHI	57751	phv00057751.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:38:10+00:00	2018-12-06 18:05:54+00:00 	rdinba2	Hypopnea RDI in NREM (Back position) 2% desaturation or arousal
68	AHI	57775	phv00057775.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:38:10+00:00	2018-12-06 18:05:54+00:00 	rdinba3	Hypopnea RDI in NREM (Back position) 3% desaturation or arousal
68	AHI	57799	phv00057799.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:38:10+00:00	2018-12-06 18:05:54+00:00 	rdinba4	Hypopnea RDI in NREM (Back position) 4% desaturation or arousal
68	AHI	57823	phv00057823.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:38:10+00:00	2018-12-06 18:05:54+00:00 	rdinba5	Hypopnea RDI in NREM (Back position) 5% desaturation or arousal
68	AHI	55739	phv00055739.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	RDINBP	Hypopnea RDI in NREM (Back position) overall
68	AHI	55816	phv00055816.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	RDINOA	Hypopnea RDI in NREM (Other position) associated with arousal
68	AHI	55907	phv00055907.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	RDINBP2	Hypopnea RDI in NREM (Back position) 2% desaturation
68	AHI	55984	phv00055984.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	RDINOA2	Hypopnea RDI in NREM (Other position) 2% desaturation or arousal
68	AHI	56051	phv00056051.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	RDINBP3	Hypopnea RDI in NREM (Back position) 3% desaturation
68	AHI	56128	phv00056128.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	RDINOA3	Hypopnea RDI in NREM (Other position) 3% desaturation or arousal
68	AHI	56195	phv00056195.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	RDINBP4	Hypopnea RDI in NREM (Back position) 4% desaturation
68	AHI	56272	phv00056272.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	RDINOA4	Hypopnea RDI in NREM (Other position) 4% desaturation or arousal
68	AHI	56339	phv00056339.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	RDINBP5	Hypopnea RDI in NREM (Back position) 5% desaturation
68	AHI	56416	phv00056416.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	RDINOA5	Hypopnea RDI in NREM (Other position) 5% desaturation or arousal
68	AHI	57715	phv00057715.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	rdinbp	Hypopnea RDI in NREM (Back position) overall
68	AHI	57728	phv00057728.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	rdinoa	Hypopnea RDI in NREM (Other position) associated with arousal
68	AHI	57739	phv00057739.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	rdinbp2	Hypopnea RDI in NREM (Back position) 2% desaturation
68	AHI	57752	phv00057752.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	rdinoa2	Hypopnea RDI in NREM (Other position) 2% desaturation or arousal
68	AHI	57763	phv00057763.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	rdinbp3	Hypopnea RDI in NREM (Back position) 3% desaturation
68	AHI	57776	phv00057776.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	rdinoa3	Hypopnea RDI in NREM (Other position) 3% desaturation or arousal
68	AHI	57787	phv00057787.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	rdinbp4	Hypopnea RDI in NREM (Back position) 4% desaturation
68	AHI	57800	phv00057800.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	rdinoa4	Hypopnea RDI in NREM (Other position) 4% desaturation or arousal
68	AHI	57811	phv00057811.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	rdinbp5	Hypopnea RDI in NREM (Back position) 5% desaturation
68	AHI	57824	phv00057824.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:44:36+00:00	2018-12-06 18:05:54+00:00 	rdinoa5	Hypopnea RDI in NREM (Other position) 5% desaturation or arousal
68	AHI	55744	phv00055744.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	RDINOP	Hypopnea RDI in NREM (Other position) overall
68	AHI	55801	phv00055801.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	RDIRBA	Hypopnea RDI in REM (Back position) associated with arousal
68	AHI	55912	phv00055912.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	RDINOP2	Hypopnea RDI in NREM (Other position) 2% desaturation
68	AHI	55969	phv00055969.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	RDIRBA2	Hypopnea RDI in REM (Back position) 2% desaturation or arousal
68	AHI	56056	phv00056056.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	RDINOP3	Hypopnea RDI in NREM (Other position) 3% desaturation
68	AHI	56113	phv00056113.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	RDIRBA3	Hypopnea RDI in REM (Back position) 3% desaturation or arousal
68	AHI	56200	phv00056200.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	RDINOP4	Hypopnea RDI in NREM (Other position) 4% desaturation
68	AHI	56257	phv00056257.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	RDIRBA4	Hypopnea RDI in REM (Back position) 4% desaturation or arousal
68	AHI	56344	phv00056344.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	RDINOP5	Hypopnea RDI in NREM (Other position) 5% desaturation
68	AHI	56401	phv00056401.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	RDIRBA5	Hypopnea RDI in REM (Back position) 5% desaturation or arousal
68	AHI	57716	phv00057716.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	rdinop	Hypopnea RDI in NREM (Other position) overall
68	AHI	57725	phv00057725.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	rdirba	Hypopnea RDI in REM (Back position) associated with arousal
68	AHI	57740	phv00057740.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	rdinop2	Hypopnea RDI in NREM (Other position) 2% desaturation
68	AHI	57749	phv00057749.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	rdirba2	Hypopnea RDI in REM (Back position) 2% desaturation or arousal
68	AHI	57764	phv00057764.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:36+00:00	2018-12-06 18:05:54+00:00 	rdinop3	Hypopnea RDI in NREM (Other position) 3% desaturation
68	AHI	57773	phv00057773.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:37+00:00	2018-12-06 18:05:54+00:00 	rdirba3	Hypopnea RDI in REM (Back position) 3% desaturation or arousal
68	AHI	57788	phv00057788.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:37+00:00	2018-12-06 18:05:54+00:00 	rdinop4	Hypopnea RDI in NREM (Other position) 4% desaturation
68	AHI	57797	phv00057797.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:37+00:00	2018-12-06 18:05:54+00:00 	rdirba4	Hypopnea RDI in REM (Back position) 4% desaturation or arousal
68	AHI	57812	phv00057812.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:37+00:00	2018-12-06 18:05:54+00:00 	rdinop5	Hypopnea RDI in NREM (Other position) 5% desaturation
68	AHI	57821	phv00057821.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:51:37+00:00	2018-12-06 18:05:54+00:00 	rdirba5	Hypopnea RDI in REM (Back position) 5% desaturation or arousal
68	AHI	55729	phv00055729.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:36+00:00	2018-12-06 18:05:54+00:00 	RDIRBP	Hypopnea RDI in REM (Back position) overall
68	AHI	55806	phv00055806.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:36+00:00	2018-12-06 18:05:54+00:00 	RDIROA	Hypopnea RDI in REM (Other position) associated with arousal
68	AHI	55897	phv00055897.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:36+00:00	2018-12-06 18:05:54+00:00 	RDIRBP2	Hypopnea RDI in REM (Back position) 2% desaturation
68	AHI	55974	phv00055974.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:36+00:00	2018-12-06 18:05:54+00:00 	RDIROA2	Hypopnea RDI in REM (Other position) 2% desaturation or arousal
68	AHI	56041	phv00056041.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:36+00:00	2018-12-06 18:05:54+00:00 	RDIRBP3	Hypopnea RDI in REM (Back position) 3% desaturation
68	AHI	56118	phv00056118.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:36+00:00	2018-12-06 18:05:54+00:00 	RDIROA3	Hypopnea RDI in REM (Other position) 3% desaturation or arousal
68	AHI	56185	phv00056185.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:36+00:00	2018-12-06 18:05:54+00:00 	RDIRBP4	Hypopnea RDI in REM (Back position) 4% desaturation
68	AHI	56262	phv00056262.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:36+00:00	2018-12-06 18:05:54+00:00 	RDIROA4	Hypopnea RDI in REM (Other position) 4% desaturation or arousal
68	AHI	56329	phv00056329.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:36+00:00	2018-12-06 18:05:54+00:00 	RDIRBP5	Hypopnea RDI in REM (Back position) 5% desaturation
68	AHI	56406	phv00056406.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:36+00:00	2018-12-06 18:05:54+00:00 	RDIROA5	Hypopnea RDI in REM (Other position) 5% desaturation or arousal
68	AHI	57713	phv00057713.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:37+00:00	2018-12-06 18:05:54+00:00 	rdirbp	Hypopnea RDI in REM (Back position) overall
68	AHI	57726	phv00057726.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:37+00:00	2018-12-06 18:05:54+00:00 	rdiroa	Hypopnea RDI in REM (Other position) associated with arousal
68	AHI	57737	phv00057737.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:37+00:00	2018-12-06 18:05:54+00:00 	rdirbp2	Hypopnea RDI in REM (Back position) 2% desaturation
68	AHI	57750	phv00057750.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:37+00:00	2018-12-06 18:05:54+00:00 	rdiroa2	Hypopnea RDI in REM (Other position) 2% desaturation or arousal
68	AHI	57761	phv00057761.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:37+00:00	2018-12-06 18:05:54+00:00 	rdirbp3	Hypopnea RDI in REM (Back position) 3% desaturation
68	AHI	57774	phv00057774.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:37+00:00	2018-12-06 18:05:54+00:00 	rdiroa3	Hypopnea RDI in REM (Other position) 3% desaturation or arousal
68	AHI	57785	phv00057785.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:37+00:00	2018-12-06 18:05:54+00:00 	rdirbp4	Hypopnea RDI in REM (Back position) 4% desaturation
68	AHI	57798	phv00057798.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:37+00:00	2018-12-06 18:05:54+00:00 	rdiroa4	Hypopnea RDI in REM (Other position) 4% desaturation or arousal
68	AHI	57809	phv00057809.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:37+00:00	2018-12-06 18:05:54+00:00 	rdirbp5	Hypopnea RDI in REM (Back position) 5% desaturation
68	AHI	57822	phv00057822.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 13:53:37+00:00	2018-12-06 18:05:54+00:00 	rdiroa5	Hypopnea RDI in REM (Other position) 5% desaturation or arousal
68	AHI	55734	phv00055734.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 14:04:40+00:00	2018-12-06 18:05:54+00:00 	RDIROP	Hypopnea RDI in REM (Other position) overall
68	AHI	55902	phv00055902.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 14:04:40+00:00	2018-12-06 18:05:54+00:00 	RDIROP2	Hypopnea RDI in REM (Other position) 2% desaturation
68	AHI	56046	phv00056046.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 14:04:40+00:00	2018-12-06 18:05:54+00:00 	RDIROP3	Hypopnea RDI in REM (Other position) 3% desaturation
68	AHI	56190	phv00056190.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 14:04:40+00:00	2018-12-06 18:05:54+00:00 	RDIROP4	Hypopnea RDI in REM (Other position) 4% desaturation
68	AHI	56334	phv00056334.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 14:04:40+00:00	2018-12-06 18:05:54+00:00 	RDIROP5	Hypopnea RDI in REM (Other position) 5% desaturation
68	AHI	57714	phv00057714.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 14:04:40+00:00	2018-12-06 18:05:54+00:00 	rdirop	Hypopnea RDI in REM (Other position) overall
68	AHI	57738	phv00057738.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 14:04:40+00:00	2018-12-06 18:05:54+00:00 	rdirop2	Hypopnea RDI in REM (Other position) 2% desaturation
68	AHI	57762	phv00057762.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 14:04:40+00:00	2018-12-06 18:05:54+00:00 	rdirop3	Hypopnea RDI in REM (Other position) 3% desaturation
68	AHI	57786	phv00057786.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 14:04:40+00:00	2018-12-06 18:05:54+00:00 	rdirop4	Hypopnea RDI in REM (Other position) 4% desaturation
68	AHI	57810	phv00057810.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-10 14:04:40+00:00	2018-12-06 18:05:54+00:00 	rdirop5	Hypopnea RDI in REM (Other position) 5% desaturation
69	Cigarette smoking	226257	phv00226257.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 21:56:03+00:00	2018-03-14 21:56:03+00:00 	CIGARETTE_PACK_YEARS	Cigarette Pack Years
69	Cigarette smoking	226258	phv00226258.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 21:56:17+00:00	2018-03-14 21:56:17+00:00 	CIGARETTE_USE	Cigarette use (1-Never,2=Former,3=Current)
69	Cigarette smoking	258106	phv00258106.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 22:00:13+00:00	2018-03-14 22:00:13+00:00 	TBEA1	Smoke at least 100 cigs in lifetime (TBEA1)
69	Cigarette smoking	258107	phv00258107.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 22:00:29+00:00	2018-03-14 22:00:29+00:00 	TBEA3	Present smoking status  (TBEA3)
69	Cigarette smoking	258108	phv00258108.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 22:00:37+00:00	2018-03-14 22:00:37+00:00 	TBEA4	Daily: cigs per day - present (TBEA4)
69	Cigarette smoking	258109	phv00258109.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 22:00:47+00:00	2018-03-14 22:00:47+00:00 	TBEA5	Some: number of days you smoked during past 30 days - original desc: some: past 30 days - smoke cigs  (TBEA5)
69	Cigarette smoking	258110	phv00258110.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 22:00:57+00:00	2018-03-14 22:00:57+00:00 	TBEA5A	Some: cigarettes per day on days you smoked during past 30 days - original desc: some: past 30 days - quit smoking 6 months or longer  (TBEA5A)
69	Cigarette smoking	258111	phv00258111.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 22:01:08+00:00	2018-03-14 22:01:08+00:00 	TBEA9	Average Cigs per day - entire time (TBEA9)
69	Cigarette smoking	204655	phv00204655.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:05:22+00:00	2018-03-27 14:05:22+00:00 	CIGT21	Visit 2, cigarette smoking status [Cohort, Exam 2]
69	Cigarette smoking	204713	phv00204713.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:05:40+00:00	2018-03-27 14:05:40+00:00 	CIGT01	Cigarette smoking status [Cohort, Exam 1]
69	Cigarette smoking	204714	phv00204714.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:06:01+00:00	2018-03-27 14:06:01+00:00 	CIGTYR01	Cigarette years of smoking [Cohort, Exam 1]
69	Cigarette smoking	204756	phv00204756.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:06:26+00:00	2018-03-27 14:06:26+00:00 	CURSMK01	Current cigarette smoker [Cohort, Exam 1]
69	Cigarette smoking	204757	phv00204757.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:06:47+00:00	2018-03-27 14:06:47+00:00 	FORSMK01	Former cigarette smoker [Cohort, Exam 1]
69	Cigarette smoking	204758	phv00204758.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:07:10+00:00	2018-03-27 14:07:10+00:00 	EVRSMK01	Ever smoked cigarettes [Cohort, Exam 1]
69	Cigarette smoking	204859	phv00204859.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:07:33+00:00	2018-03-27 14:07:33+00:00 	CIGT31	Version 3, cigarette smoking status [Cohort, Exam 3]
69	Cigarette smoking	204971	phv00204971.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:07:59+00:00	2018-03-27 14:07:59+00:00 	CIGT41	Cigarette smoking status [Cohort, Exam 4]
69	Cigarette smoking	204972	phv00204972.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:08:22+00:00	2018-03-27 14:08:22+00:00 	CURSMK41	Current cigarette smoker [Cohort, Exam 4]
69	Cigarette smoking	204973	phv00204973.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:08:41+00:00	2018-03-27 14:08:41+00:00 	FORSMK41	Former cigarette smoker [Cohort, Exam 4]
69	Cigarette smoking	204974	phv00204974.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:09:18+00:00	2018-03-27 14:09:18+00:00 	EVRSMK41	Ever smoked cigarettes [Cohort, Exam 4]
69	Cigarette smoking	207119	phv00207119.v1.p1	pht004103.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:10:21+00:00	2018-03-27 14:10:21+00:00 	HHXB44	[Smoking]. Have you ever smoked cigarettes? [Code No if less than 400 cigarettes in a lifetime]. Q44 [Health/Medical History, exam 2]
69	Cigarette smoking	207120	phv00207120.v1.p1	pht004103.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:10:45+00:00	2018-03-27 14:10:45+00:00 	HHXB45	[Smoking]. Do you now smoke cigarettes? Q45 [Health/Medical History, exam 2]
69	Cigarette smoking	207121	phv00207121.v1.p1	pht004103.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:11:08+00:00	2018-03-27 14:11:08+00:00 	HHXB46	[Smoking]. When did you smoke your last cigarette? Q46 [Health/Medical History, exam 2]
69	Cigarette smoking	207122	phv00207122.v1.p1	pht004103.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:11:25+00:00	2018-03-27 14:11:25+00:00 	HHXB47	[Smoking]. Prior to quitting, how many cigarettes did you usually smoke per day? [Code 00 if less than one per day]. Q47 [Health/Medical History, exam 2]
69	Cigarette smoking	207123	phv00207123.v1.p1	pht004103.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:11:45+00:00	2018-03-27 14:11:45+00:00 	HHXB48	[Smoking]. How many cigarettes do you smoke per day now? [Code 00 if less than one per day]. Q48 [Health/Medical History, exam 2]
69	Cigarette smoking	207124	phv00207124.v1.p1	pht004103.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:12:40+00:00	2018-03-27 14:12:40+00:00 	HHXB49	[Smoking]. Do/did you inhale the cigarette smoke? Q49 [Health/Medical History, exam 2]
69	Cigarette smoking	207368	phv00207368.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:13:09+00:00	2018-03-27 14:13:09+00:00 	HOM28	Have you ever smoked cigarettes? Q28 [Home Interview, exam 1]
69	Cigarette smoking	207369	phv00207369.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:13:30+00:00	2018-03-27 14:13:30+00:00 	HOM29	How old were you when you first started regular cigarette smoking? Q29 [Home Interview, exam 1]
69	Cigarette smoking	207370	phv00207370.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:13:55+00:00	2018-03-27 14:13:55+00:00 	HOM30	Do you now smoke cigarettes? Q30 [Home Interview, exam 1]
69	Cigarette smoking	207371	phv00207371.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:14:12+00:00	2018-03-27 14:14:12+00:00 	HOM31	Age stopped smoking cigarettes Q31 [Home Interview, exam 1]
69	Cigarette smoking	207372	phv00207372.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:14:28+00:00	2018-03-27 14:14:28+00:00 	HOM32	Number of cigarettes smoked per day. Q32 [Home Interview, exam 1]
69	Cigarette smoking	207373	phv00207373.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:15:12+00:00	2018-03-27 14:15:12+00:00 	HOM33	During the years that you have not smoked, was there ever a period of one year or more that you did not smoke cigarettes? Q33 [Home Interview, exam 1]
69	Cigarette smoking	207374	phv00207374.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:15:36+00:00	2018-03-27 14:15:36+00:00 	HOM34	How many years did you not smoke cigarettes? Q34 [Home Interview, exam 1]
69	Cigarette smoking	207375	phv00207375.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:15:52+00:00	2018-03-27 14:15:52+00:00 	HOM35	On the average of the entire time you smoked, how many cigarettes did you usually smoke per day? Q35 [Home Interview, exam 1]
69	Cigarette smoking	207376	phv00207376.v1.p1	pht004111.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 14:16:17+00:00	2018-03-27 14:16:17+00:00 	HOM36	(Do/did) you inhale the cigarette smoke? Q36 [Home Interview, exam 1]
69	Cigarette smoking	208996	phv00208996.v1.p1	pht004145.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:00:35+00:00	2018-03-27 15:00:35+00:00 	PHXA25	[Smoking]. Have you ever smoked cigarettes? Q25 [Personal History Form, exam 3]
69	Cigarette smoking	208998	phv00208998.v1.p1	pht004145.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:00:52+00:00	2018-03-27 15:00:52+00:00 	PHXA27	[Smoking]. Do you now smoke cigarettes? Q27 [Personal History Form, exam 3]
69	Cigarette smoking	208999	phv00208999.v1.p1	pht004145.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:01:09+00:00	2018-03-27 15:01:09+00:00 	PHXA28	[Smoking]. When did you smoke your last cigarette? Q28 [Personal History Form, exam 3]
69	Cigarette smoking	209000	phv00209000.v1.p1	pht004145.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:01:30+00:00	2018-03-27 15:01:30+00:00 	PHXA31	[Smoking]. Do (did) you inhale the cigarette smoke? Q31 [Personal History Form, exam 3]
69	Cigarette smoking	209026	phv00209026.v1.p1	pht004145.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:02:26+00:00	2018-03-27 15:02:26+00:00 	PHXA30	[Smoking]. How many cigarettes do you smoke per day now? Q30 [Personal History Form, exam 3]
69	Cigarette smoking	209034	phv00209034.v1.p1	pht004145.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:02:45+00:00	2018-03-27 15:02:45+00:00 	PHXA29	[Smoking]. Prior to quitting, how many cigarettes did you usually smoke per day? Q29 [Personal History Form, exam 3]
69	Cigarette smoking	209072	phv00209072.v1.p1	pht004146.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:03:13+00:00	2018-03-27 15:03:13+00:00 	PHXB7	[Smoking]. Have you ever smoked cigarettes? Q7 [Personal History form, exam 4]
69	Cigarette smoking	209073	phv00209073.v1.p1	pht004146.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:03:33+00:00	2018-03-27 15:03:33+00:00 	PHXB8	[Smoking]. Do you now smoke cigarettes? Q8 [Personal History form, exam 4]
69	Cigarette smoking	209086	phv00209086.v1.p1	pht004146.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:05:34+00:00	2018-03-27 15:05:34+00:00 	PHXB11	[Smoking]. How many cigarettes do you usually smoke per day now? Q11 [Personal History form, exam 4]
69	Cigarette smoking	209085	phv00209085.v1.p1	pht004146.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:05:55+00:00	2018-03-27 15:05:55+00:00 	PHXB10	[Smoking]. Prior to quitting, how many cigarettes did you usually smoke per day? Q10 [Personal History form, exam 4]
69	Cigarette smoking	209074	phv00209074.v1.p1	pht004146.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:06:19+00:00	2018-03-27 15:06:19+00:00 	PHXB9	[Smoking]. When did you smoke your last cigarette? Q9 [Personal History form, exam 4]
69	Cigarette smoking	214056	phv00214056.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:06:57+00:00	2018-03-27 15:06:57+00:00 	CGPKYR	Lifetime cigarette smoking: pack years
69	Cigarette smoking	214118	phv00214118.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:07:16+00:00	2018-03-27 15:07:16+00:00 	EVSMOK15	Have you ever smoked cigarettes (ever = at least 20 packs in lifetime)?
69	Cigarette smoking	214119	phv00214119.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:07:41+00:00	2018-03-27 15:07:41+00:00 	SMKNOW15	Do you now smoke cigarettes?
69	Cigarette smoking	214122	phv00214122.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:07:57+00:00	2018-03-27 15:07:57+00:00 	CIGDAY15	If yes to [SMKNOW15]: How many cigarettes do you smoke per day now?
69	Cigarette smoking	202966	phv00202966.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:09:07+00:00	2018-03-27 15:09:07+00:00 	AFUcomp30_G	[Other items]. Do you now smoke cigarettes? [Annual Follow-up Questionnaire Form, AFUG]
69	Cigarette smoking	204312	phv00204312.v1.p1	pht004054.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:10:02+00:00	2018-03-27 15:10:02+00:00 	IFIA19B	[History]. Did he/she have a history of cigarette smoking? Q19b [Informant Interview Form, IFI]
69	Cigarette smoking	204413	phv00204413.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:10:24+00:00	2018-03-27 15:10:24+00:00 	PHQA03M	[Medical history]. Did the decedent have a history of any of the following? Cigarette smoking. Q3m [Physician Questionnaire Form, exam 1]
69	Cigarette smoking	214120	phv00214120.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:14:55+00:00	2018-03-27 15:14:55+00:00 	MOSTOP15	If no to [SMKNOW15]: month stopped smoking?
69	Cigarette smoking	214121	phv00214121.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:15:13+00:00	2018-03-27 15:15:13+00:00 	YRSTOP15	If no to [SMKNOW15]: year stopped smoking?
69	Cigarette smoking	215390	phv00215390.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:15:45+00:00	2018-03-27 15:15:45+00:00 	SMOKSTAT_S1	Smoking status (never=0, current=1, former=2)
69	Cigarette smoking	214117	phv00214117.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:16:18+00:00	2018-03-27 15:16:18+00:00 	WHENSM15	Data on smoking collected when?
69	Cigarette smoking	203798	phv00203798.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:17:28+00:00	2018-03-27 15:17:28+00:00 	CORA22B	Is there a history of smoking? Q22b [Coroner / Medical Examiner Form]
69	Cigarette smoking	203911	phv00203911.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-27 15:17:49+00:00	2018-03-27 15:17:49+00:00 	HRAA21D	[Second transfer]. Smoking status. Q21d [Hospital Abstraction Form]
69	Cigarette smoking	83241	phv00083241.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:01:06+00:00	2018-04-29 00:01:06+00:00 	cig1c	CIGARETTE SMOKING STATUS
69	Cigarette smoking	83247	phv00083247.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:01:54+00:00	2018-04-29 00:01:54+00:00 	cigsday1	CIGARETTES: AVERAGE # SMOKED PER DAY
69	Cigarette smoking	83613	phv00083613.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:02:07+00:00	2018-04-29 00:02:07+00:00 	cig1ca4	CIGARETTE SMOKING STATUS
69	Cigarette smoking	83843	phv00083843.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:02:15+00:00	2018-04-29 00:02:15+00:00 	cig1ca4	CIGARETTE SMOKING STATUS
69	Cigarette smoking	85545	phv00085545.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:02:20+00:00	2018-04-29 00:02:20+00:00 	cig1c	CIGARETTE SMOKING STATUS
69	Cigarette smoking	85574	phv00085574.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:02:25+00:00	2018-04-29 00:02:25+00:00 	cigsday1	CIGARETTES: AVERAGE # SMOKED PER DAY
69	Cigarette smoking	86098	phv00086098.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:02:37+00:00	2018-04-29 00:02:37+00:00 	cigsday2	CIGARETTES:  AVERAGE # SMOKED PER DAY
69	Cigarette smoking	86102	phv00086102.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:02:42+00:00	2018-04-29 00:02:42+00:00 	cig2c	CIGARRETTE SMOKING STATUS, EXAM 2
69	Cigarette smoking	86582	phv00086582.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:02:48+00:00	2018-04-29 00:02:48+00:00 	cigsday3	CIGARETTES:  AVERAGE # SMOKED PER DAY
69	Cigarette smoking	86586	phv00086586.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:02:53+00:00	2018-04-29 00:02:53+00:00 	cig3c	CIGARRETTE SMOKING STATUS, EXAM 3
69	Cigarette smoking	87014	phv00087014.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:03:00+00:00	2018-04-29 00:03:00+00:00 	cigsday4	AVERAGE CIGARETTES SMOKED PER DAY
69	Cigarette smoking	87017	phv00087017.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:03:08+00:00	2018-04-29 00:03:08+00:00 	cig4c	CIGARETTE SMOKING STATUS, EXAM 4
69	Cigarette smoking	87082	phv00087082.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:03:13+00:00	2018-04-29 00:03:13+00:00 	cigfc	CIGARETTE SMOKING STATUS
69	Cigarette smoking	87256	phv00087256.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:03:22+00:00	2018-04-29 00:03:22+00:00 	cigsdayf	AVERAGE NUMBER OF CIGARETTES SMOKED PER DAY
69	Cigarette smoking	87839	phv00087839.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:03:35+00:00	2018-04-29 00:03:35+00:00 	cig1ca4	CIGARETTE SMOKING STATUS
69	Cigarette smoking	175433	phv00175433.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:03:42+00:00	2018-04-29 00:03:42+00:00 	cigsday5	AVERAGE CIGARETTES SMOKED PER DAY
69	Cigarette smoking	175450	phv00175450.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:03:47+00:00	2018-04-29 00:03:47+00:00 	cig5c	CIGARETTE SMOKING STATUS, EXAM 5
69	Cigarette smoking	175860	phv00175860.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:03:52+00:00	2018-04-29 00:03:52+00:00 	cig1c	CIGARETTE SMOKING STATUS
69	Cigarette smoking	175945	phv00175945.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:03:58+00:00	2018-04-29 00:03:58+00:00 	cigfc	FAMILY COHORT: CIGARETTE SMOKING STATUS
69	Cigarette smoking	176867	phv00176867.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:04:04+00:00	2018-04-29 00:04:04+00:00 	cigsday5	AVERAGE CIGARETTES SMOKED PER DAY
69	Cigarette smoking	176884	phv00176884.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:04:09+00:00	2018-04-29 00:04:09+00:00 	cig5c	CIGARETTE SMOKING STATUS, EXAM 5
69	Cigarette smoking	83242	phv00083242.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:10:34+00:00	2018-04-29 00:10:34+00:00 	pkyrs1c	PACK-YEARS OF CIGARETTE SMOKING
69	Cigarette smoking	83243	phv00083243.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:10:43+00:00	2018-04-29 00:10:43+00:00 	evsmk1	SMOKED AT LEAST 100 CIGARETTES IN LIFETIME
69	Cigarette smoking	83244	phv00083244.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:10:49+00:00	2018-04-29 00:10:49+00:00 	agesmk1	CIGARETTES:  AGE STARTED SMOKING
69	Cigarette smoking	83245	phv00083245.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:10:56+00:00	2018-04-29 00:10:56+00:00 	cursmk1	CIGARETTES: SMOKED IN LAST 30 DAYS
69	Cigarette smoking	83246	phv00083246.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:11:02+00:00	2018-04-29 00:11:02+00:00 	agequit1	CIGARETTES: AGE QUIT SMOKING
69	Cigarette smoking	83473	phv00083473.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:11:10+00:00	2018-04-29 00:11:10+00:00 	lsmoksa4	SMOKING STATUS
69	Cigarette smoking	83496	phv00083496.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:11:18+00:00	2018-04-29 00:11:18+00:00 	spsmka4	SMOKE IN PAST 2 HRS
69	Cigarette smoking	83582	phv00083582.v1.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:11:28+00:00	2018-04-29 00:11:28+00:00 	qsmokea4	SMOKE CIGARETTES
69	Cigarette smoking	83614	phv00083614.v2.p3	pht001112.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:11:34+00:00	2018-04-29 00:11:34+00:00 	lpya4	PACK-YEARS OF CIGARETTE SMOKING IN SPIROMETRY EXAM
69	Cigarette smoking	83708	phv00083708.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:11:44+00:00	2018-04-29 00:11:44+00:00 	lsmoksa4	SMOKING STATUS
69	Cigarette smoking	83731	phv00083731.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:11:50+00:00	2018-04-29 00:11:50+00:00 	spsmka4	SMOKE IN PAST 2 HRS
69	Cigarette smoking	83844	phv00083844.v2.p3	pht001114.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:11:59+00:00	2018-04-29 00:11:59+00:00 	lpya4	PACK-YEARS OF CIGARETTE SMOKING IN SPIROMETRY EXAM
69	Cigarette smoking	85544	phv00085544.v3.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:12:05+00:00	2018-04-29 00:12:05+00:00 	pkyrs1c	PACK-YEARS OF CIGARETTE SMOKING
69	Cigarette smoking	85570	phv00085570.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:12:11+00:00	2018-04-29 00:12:11+00:00 	evsmk1	SMOKED AT LEAST 100 CIGARETTES IN LIFETIME
69	Cigarette smoking	85571	phv00085571.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:12:21+00:00	2018-04-29 00:12:21+00:00 	agesmk1	CIGARETTES: AGE STARTED SMOKING
69	Cigarette smoking	85572	phv00085572.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:12:27+00:00	2018-04-29 00:12:27+00:00 	cursmk1	CIGARETTES: SMOKED IN LAST 30 DAYS
69	Cigarette smoking	85573	phv00085573.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:12:38+00:00	2018-04-29 00:12:38+00:00 	agequit1	CIGARETTES: AGE QUIT SMOKING
69	Cigarette smoking	86096	phv00086096.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:12:44+00:00	2018-04-29 00:12:44+00:00 	smkstat2	SMOKING STATUS
69	Cigarette smoking	86097	phv00086097.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:12:49+00:00	2018-04-29 00:12:49+00:00 	cursmk2	CIGARETTES:  SMOKED IN LAST 30 DAYS
69	Cigarette smoking	142658	phv00142658.v3.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:12:55+00:00	2018-04-29 00:12:55+00:00 	pkyrs2c	PACK-YEARS OF CIGARETTE SMOKING
69	Cigarette smoking	86580	phv00086580.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:13:00+00:00	2018-04-29 00:13:00+00:00 	smkstat3	SMOKING STATUS
69	Cigarette smoking	86581	phv00086581.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:13:06+00:00	2018-04-29 00:13:06+00:00 	cursmk3	CIGARETTES:  SMOKED IN LAST 30 DAYS
69	Cigarette smoking	142659	phv00142659.v4.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:13:11+00:00	2018-04-29 00:13:11+00:00 	pkyrs3c	PACK-YEARS OF CIGARETTE SMOKING
69	Cigarette smoking	87012	phv00087012.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:13:17+00:00	2018-04-29 00:13:17+00:00 	smkstat4	CURRENT SMOKING STATUS
69	Cigarette smoking	87013	phv00087013.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:13:22+00:00	2018-04-29 00:13:22+00:00 	cursmk4	SMOKED CIGARETTES: LAST 30 DAYS
69	Cigarette smoking	163138	phv00163138.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:13:28+00:00	2018-04-29 00:13:28+00:00 	pkyrs4c	PACK-YEARS OF CIGARETTE SMOKING
69	Cigarette smoking	87083	phv00087083.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:13:33+00:00	2018-04-29 00:13:33+00:00 	pkyrsfc	PACK-YEARS OF CIGARETTE SMOKING
69	Cigarette smoking	87252	phv00087252.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:13:39+00:00	2018-04-29 00:13:39+00:00 	evsmkf	SMOKED 100+ CIGARETTES IN LIFETIME
69	Cigarette smoking	87253	phv00087253.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:13:45+00:00	2018-04-29 00:13:45+00:00 	agesmkf	AGE FIRST STARTED SMOKING CIGARETTES
69	Cigarette smoking	87254	phv00087254.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:13:51+00:00	2018-04-29 00:13:51+00:00 	cursmkf	SMOKED CIGARETTES IN THE LAST 30 DAYS
69	Cigarette smoking	87255	phv00087255.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:13:56+00:00	2018-04-29 00:13:56+00:00 	agequitf	AGE QUIT SMOKING CIGARETTES
69	Cigarette smoking	87699	phv00087699.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:14:03+00:00	2018-04-29 00:14:03+00:00 	lsmoksa4	SMOKING STATUS
69	Cigarette smoking	87722	phv00087722.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:14:08+00:00	2018-04-29 00:14:08+00:00 	spsmka4	SMOKE IN PAST 2 HRS
69	Cigarette smoking	87808	phv00087808.v1.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:14:14+00:00	2018-04-29 00:14:14+00:00 	qsmokea4	SMOKE CIGARETTES
69	Cigarette smoking	87840	phv00087840.v2.p3	pht001122.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:14:20+00:00	2018-04-29 00:14:20+00:00 	lpya4	PACK-YEARS OF CIGARETTE SMOKING IN SPIROMETRY EXAM
69	Cigarette smoking	175428	phv00175428.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:14:25+00:00	2018-04-29 00:14:25+00:00 	smkstat5	CURRENT SMOKING STATUS
69	Cigarette smoking	175429	phv00175429.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:14:34+00:00	2018-04-29 00:14:34+00:00 	avcday5	CIGARETTES SMOKED PER DAY
69	Cigarette smoking	175432	phv00175432.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:14:40+00:00	2018-04-29 00:14:40+00:00 	cursmk5	SMOKED CIGARETTES: LAST 30 DAYS
69	Cigarette smoking	175451	phv00175451.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:14:46+00:00	2018-04-29 00:14:46+00:00 	pkyrs5c	EXAM 5 PACK-YEARS OF CIGARETTE SMOKING
69	Cigarette smoking	175861	phv00175861.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:14:53+00:00	2018-04-29 00:14:53+00:00 	pkyrs1c	PACK-YEARS OF CIGARETTE SMOKING
69	Cigarette smoking	175891	phv00175891.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:15:03+00:00	2018-04-29 00:15:03+00:00 	smoke_stat	SMOKE_STAT
69	Cigarette smoking	175946	phv00175946.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:15:10+00:00	2018-04-29 00:15:10+00:00 	pkyrsfc	FAMILY COHORT: PACK-YEARS OF CIGARETTE SMOKING
69	Cigarette smoking	176862	phv00176862.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:15:16+00:00	2018-04-29 00:15:16+00:00 	smkstat5	CURRENT SMOKING STATUS
69	Cigarette smoking	176863	phv00176863.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:15:33+00:00	2018-04-29 00:15:33+00:00 	avcday5	CIGARETTES SMOKED PER DAY
69	Cigarette smoking	176866	phv00176866.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:15:40+00:00	2018-04-29 00:15:40+00:00 	cursmk5	SMOKED CIGARETTES: LAST 30 DAYS
69	Cigarette smoking	176885	phv00176885.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:15:45+00:00	2018-04-29 00:15:45+00:00 	pkyrs5c	EXAM 5 PACK-YEARS OF CIGARETTE SMOKING
69	Cigarette smoking	204864	phv00204864.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:42:07+00:00	2018-05-03 20:42:07+00:00 	CURSMK31	Current smoker [Cohort, Exam 3]
69	Cigarette smoking	204865	phv00204865.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:42:32+00:00	2018-05-03 20:42:32+00:00 	FORSMK31	Former smoker [Cohort, Exam 3]
69	Cigarette smoking	204866	phv00204866.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-05-03 20:42:51+00:00	2018-05-03 20:42:51+00:00 	EVRSMK31	Ever smoker [Cohort, Exam 3]
69	Cigarette smoking	125054	phv00125054.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:19:34+00:00	2018-06-08 16:19:34+00:00 	AFUA30	30. Do you now smoke cigarettes?
69	Cigarette smoking	125139	phv00125139.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:40:53+00:00	2018-06-08 16:40:53+00:00 	AFUA30	30. Do you now smoke cigarettes?
69	Cigarette smoking	125225	phv00125225.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:55:36+00:00	2018-06-08 16:55:36+00:00 	AFUB30	30. Do you now smoke cigarettes?
69	Cigarette smoking	125311	phv00125311.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:01:55+00:00	2018-06-08 17:01:55+00:00 	AFUB30	30. Do you now smoke cigarettes?
69	Cigarette smoking	125492	phv00125492.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:17:36+00:00	2018-06-08 17:17:36+00:00 	AFUC50	50. Do you now smoke cigarettes?
69	Cigarette smoking	125654	phv00125654.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 19:49:46+00:00	2018-06-08 19:49:46+00:00 	AFUI30	SMOKE CIGARRETES                  Q30
69	Cigarette smoking	125743	phv00125743.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:02:33+00:00	2018-06-08 20:02:33+00:00 	AFUJ30	SMOKE CIGARRETES                  Q30
69	Cigarette smoking	125565	phv00125565.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:11:52+00:00	2018-06-08 20:11:52+00:00 	AFUI30	SMOKE CIGARRETES                  Q30
69	Cigarette smoking	125830	phv00125830.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 20:18:41+00:00	2018-06-08 20:18:41+00:00 	AFUK30	SMOKE CIGARRETES                    Q30
69	Cigarette smoking	126091	phv00126091.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:27:11+00:00	2018-06-12 01:27:11+00:00 	SMK01	Cigarette smoking only
69	Cigarette smoking	128496	phv00128496.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:31:31+00:00	2018-06-17 18:31:31+00:00 	TOBA1	1: Smoked at least 400 cigarettes
69	Cigarette smoking	128497	phv00128497.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:31:48+00:00	2018-06-17 18:31:48+00:00 	TOBA2	2: Age when first smoke cigarettes
69	Cigarette smoking	128498	phv00128498.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:32:30+00:00	2018-06-17 18:32:30+00:00 	TOBA3	3: Do you now smoke cigarettes
69	Cigarette smoking	128499	phv00128499.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:33:32+00:00	2018-06-17 18:33:32+00:00 	TOBA4A	4a: Since you last smoked (months)
69	Cigarette smoking	128500	phv00128500.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:33:51+00:00	2018-06-17 18:33:51+00:00 	TOBA4B	4b: Since you last smoked (years)
69	Cigarette smoking	128501	phv00128501.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:34:11+00:00	2018-06-17 18:34:11+00:00 	TOBA5	5: Cigarettes you smoke per day
69	Cigarette smoking	128502	phv00128502.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:34:37+00:00	2018-06-17 18:34:37+00:00 	TOBA6	6: Smoke more first few hrs after wake
69	Cigarette smoking	128503	phv00128503.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:36:06+00:00	2018-06-17 18:36:06+00:00 	TOBA7	7: How soon do you smoke?
69	Cigarette smoking	128504	phv00128504.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:36:58+00:00	2018-06-17 18:36:58+00:00 	TOBA8	8: Which cigarette hate to give up?
69	Cigarette smoking	128505	phv00128505.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:40:25+00:00	2018-06-17 18:40:25+00:00 	TOBA9	9: Difficult to refrain from smoking
69	Cigarette smoking	128506	phv00128506.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:40:44+00:00	2018-06-17 18:40:44+00:00 	TOBA10	10: Smoke when ill?
69	Cigarette smoking	128507	phv00128507.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:41:01+00:00	2018-06-17 18:41:01+00:00 	TOBA11	11: Cigarettes smoke usually per day
69	Cigarette smoking	128508	phv00128508.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:41:27+00:00	2018-06-17 18:41:27+00:00 	TOBA12	12: Years off cigarettes?
69	Cigarette smoking	128509	phv00128509.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:45:00+00:00	2018-06-17 18:45:00+00:00 	TOBA13	13: How deeply do you inhale?
69	Cigarette smoking	159641	phv00159641.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:01:50+00:00	2018-08-10 21:01:50+00:00 	SmokeMenthol	Do you now or did you smoke menthol cigarettes Collection Interval: Collected in Exam 1
69	Cigarette smoking	159747	phv00159747.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:01:59+00:00	2018-08-10 21:01:59+00:00 	EverSmokedCig	Have you ever smoked cigarettes? Collection Interval: Collected in Exam 1
69	Cigarette smoking	159748	phv00159748.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:02:07+00:00	2018-08-10 21:02:07+00:00 	SmokStartAge	How old were you when you first started cigarette smoking? [Years old] Collection Interval: Collected in Exam 1
69	Cigarette smoking	159749	phv00159749.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:02:15+00:00	2018-08-10 21:02:15+00:00 	SmokCigNow	Do you now smoke cigarettes [as of one month ago]? Collection Interval: Collected in Exam 1
69	Cigarette smoking	159636	phv00159636.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:02:26+00:00	2018-08-10 21:02:26+00:00 	HowSoonSmoke	How soon after waking do you smoke first cigarette Collection Interval: Collected in Exam 1
69	Cigarette smoking	159637	phv00159637.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:02:35+00:00	2018-08-10 21:02:35+00:00 	SmokeMore2hrs	Smoke more during first 2 hours of day than rest of day Collection Interval: Collected in Exam 1
69	Cigarette smoking	159640	phv00159640.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:02:43+00:00	2018-08-10 21:02:43+00:00 	SmokeSickBed	Smoke when so ill you are in bed most of day Collection Interval: Collected in Exam 1
69	Cigarette smoking	169389	phv00169389.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:05:58+00:00	2018-08-10 21:05:58+00:00 	YearsSinceQuit	Years since quit smoking Collection Interval: Collected in Exam 1
69	Cigarette smoking	169388	phv00169388.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:06:08+00:00	2018-08-10 21:06:08+00:00 	Duration_Smoking	Duration of smoking [yrs] Collection Interval: Collected in Exam 1
69	Cigarette smoking	159756	phv00159756.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:06:42+00:00	2018-08-10 21:06:42+00:00 	CigSmokHalfHr	How many cigarettes have you smoked in the past half hour [cigarettes] Collection Interval: Collected in Exam 1
69	Cigarette smoking	159755	phv00159755.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:06:51+00:00	2018-08-10 21:06:51+00:00 	CigSmok2hrs	How many cigarettes have you smoked in the past 2 hours [cigarettes] Collection Interval: Collected in Exam 1
69	Cigarette smoking	159754	phv00159754.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:07:00+00:00	2018-08-10 21:07:00+00:00 	CigSmok24hrs	How many cigarettes have you smoked in the past 24 hours [cigarettes] Collection Interval: Collected in Exam 1
69	Cigarette smoking	159753	phv00159753.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:07:10+00:00	2018-08-10 21:07:10+00:00 	CigSmok24hrs_NA	Cigarettes smoked past 24 hours - does not apply Collection Interval: Collected in Exam 1
69	Cigarette smoking	159752	phv00159752.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:07:21+00:00	2018-08-10 21:07:21+00:00 	CigPerDaySmokAvg	Average for entire time how many cigarettes smoked per day [cigarettes/day] Collection Interval: Collected in Exam 1
69	Cigarette smoking	159751	phv00159751.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:07:30+00:00	2018-08-10 21:07:30+00:00 	SmokStopAge	How old were you when you completely stopped smoking? [Years old] Collection Interval: Collected in Exam 1
69	Cigarette smoking	159750	phv00159750.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:07:39+00:00	2018-08-10 21:07:39+00:00 	CigPerDaySmokNow	How many cigarettes do you smoke per day now? [Cigarettes/day] Collection Interval: Collected in Exam 1
69	Cigarette smoking	159842	phv00159842.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:12:14+00:00	2018-08-10 21:12:14+00:00 	ATS_PackYears	Pack years (ATS) Collection Interval: Collected in Exam 1
69	Cigarette smoking	277459	phv00277459.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:34:28+00:00	2018-08-14 22:34:28+00:00 	SMOKE100	Smoked more than 100 cigarettes in life? Collection Interval: 2009-2011
69	Cigarette smoking	277465	phv00277465.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:34:49+00:00	2018-08-14 22:34:49+00:00 	AVGCIGDY	Average number of cigarettes per day Collection Interval: 2009-2011
69	Cigarette smoking	277464	phv00277464.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:34:56+00:00	2018-08-14 22:34:56+00:00 	LSMK_AGE	Age at which last quit smoking Collection Interval: 2009-2011
69	Cigarette smoking	277463	phv00277463.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:35:03+00:00	2018-08-14 22:35:03+00:00 	LSMK_YR	Year last quit smoking Collection Interval: 2009-2011
69	Cigarette smoking	277462	phv00277462.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:35:11+00:00	2018-08-14 22:35:11+00:00 	CIGARETT	Smoke cigarettes now? Collection Interval: 2009-2011
69	Cigarette smoking	277461	phv00277461.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:35:18+00:00	2018-08-14 22:35:18+00:00 	FSMK_AGE	Age at which first started smoking Collection Interval: 2009-2011
69	Cigarette smoking	277460	phv00277460.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:35:25+00:00	2018-08-14 22:35:25+00:00 	FSMK_YR	Year first started smoking Collection Interval: 2009-2011
69	Cigarette smoking	277624	phv00277624.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:55:08+00:00	2018-08-14 22:55:08+00:00 	AVGCIGDY	On average how many cigarettes per day do/did you usually smoke? Collection Interval: 1996-2000
69	Cigarette smoking	277623	phv00277623.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:55:17+00:00	2018-08-14 22:55:17+00:00 	LSMK_AGE	In what year or how old were you when you last quit smoking? - age Collection Interval: 1996-2000
69	Cigarette smoking	277622	phv00277622.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:55:25+00:00	2018-08-14 22:55:25+00:00 	LSMK_YR	In what year or how old were you when you last quit smoking? - year Collection Interval: 1996-2000
69	Cigarette smoking	277621	phv00277621.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:55:32+00:00	2018-08-14 22:55:32+00:00 	CIGARETT	Do you now smoke cigarettes? Collection Interval: 1996-2000
69	Cigarette smoking	277620	phv00277620.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:55:39+00:00	2018-08-14 22:55:39+00:00 	FSMK_AGE	In what year or how old were you when you first started smoking? - age Collection Interval: 1996-2000
69	Cigarette smoking	277619	phv00277619.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:55:46+00:00	2018-08-14 22:55:46+00:00 	FSMK_YR	In what year or how old were you when you first started smoking? - year Collection Interval: 1996-2000
69	Cigarette smoking	277618	phv00277618.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:55:53+00:00	2018-08-14 22:55:53+00:00 	SMOKE100	Have you smoked more than 100 cigarettes in your entire life? Collection Interval: 1996-2000
69	Cigarette smoking	277925	phv00277925.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:19:48+00:00	2018-08-14 23:19:48+00:00 	AVGCIGDY	On average; how many cigarettes per day do/did you usually smoke? Collection Interval: 2000-2004
69	Cigarette smoking	277924	phv00277924.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:19:54+00:00	2018-08-14 23:19:54+00:00 	LSMK_AGE	In what year or how old were you when you last quit smoking? - age Collection Interval: 2000-2004
69	Cigarette smoking	277923	phv00277923.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:20:02+00:00	2018-08-14 23:20:02+00:00 	LSMK_YR	In what year or how old were you when you last quit smoking? - year Collection Interval: 2000-2004
69	Cigarette smoking	277922	phv00277922.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:20:09+00:00	2018-08-14 23:20:09+00:00 	CIGARETT	Do you now smoke cigarettes? Collection Interval: 2000-2004
69	Cigarette smoking	277921	phv00277921.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:20:16+00:00	2018-08-14 23:20:16+00:00 	FSMK_AGE	In what year or how old were you when you first started smoking? - age Collection Interval: 2000-2004
69	Cigarette smoking	277920	phv00277920.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:20:26+00:00	2018-08-14 23:20:26+00:00 	FSMK_YR	In what year or how old were you when you first started smoking? - year Collection Interval: 2000-2004
69	Cigarette smoking	277919	phv00277919.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:20:34+00:00	2018-08-14 23:20:34+00:00 	SMOKE100	Have you smoked more than 100 cigarettes in your entire life? Collection Interval: 2000-2004
69	Cigarette smoking	307905	phv00307905.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:04:59+00:00	2018-08-16 00:04:59+00:00 	AVGCIGDY	On average how many cigarettes per day do/did you usually smoke? Collection Interval: 1996-2000
69	Cigarette smoking	307904	phv00307904.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:05:06+00:00	2018-08-16 00:05:06+00:00 	LSMK_AGE	In what year or how old were you when you last quit smoking? - age Collection Interval: 1996-2000
69	Cigarette smoking	307903	phv00307903.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:05:14+00:00	2018-08-16 00:05:14+00:00 	LSMK_YR	In what year or how old were you when you last quit smoking? - year Collection Interval: 1996-2000
69	Cigarette smoking	307902	phv00307902.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:05:24+00:00	2018-08-16 00:05:24+00:00 	CIGARETT	Do you now smoke cigarettes? Collection Interval: 1996-2000
69	Cigarette smoking	307901	phv00307901.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:05:32+00:00	2018-08-16 00:05:32+00:00 	FSMK_AGE	In what year or how old were you when you first started smoking? - age Collection Interval: 1996-2000
69	Cigarette smoking	307900	phv00307900.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:05:40+00:00	2018-08-16 00:05:40+00:00 	FSMK_YR	In what year or how old were you when you first started smoking? - year Collection Interval: 1996-2000
69	Cigarette smoking	307899	phv00307899.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:05:47+00:00	2018-08-16 00:05:47+00:00 	SMOKE100	Have you smoked more than 100 cigarettes in your entire life? Collection Interval: 1996-2000
69	Cigarette smoking	308118	phv00308118.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:23:13+00:00	2018-08-16 00:23:13+00:00 	AVGCIGDY	On average; how many cigarettes per day do/did you usually smoke? Collection Interval: 2000-2004
69	Cigarette smoking	308117	phv00308117.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:23:20+00:00	2018-08-16 00:23:20+00:00 	LSMK_AGE	In what year or how old were you when you last quit smoking? - age Collection Interval: 2000-2004
69	Cigarette smoking	308116	phv00308116.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:23:27+00:00	2018-08-16 00:23:27+00:00 	LSMK_YR	In what year or how old were you when you last quit smoking? - year Collection Interval: 2000-2004
69	Cigarette smoking	308115	phv00308115.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:23:33+00:00	2018-08-16 00:23:33+00:00 	CIGARETT	Do you now smoke cigarettes? Collection Interval: 2000-2004
69	Cigarette smoking	308114	phv00308114.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:23:40+00:00	2018-08-16 00:23:40+00:00 	FSMK_AGE	In what year or how old were you when you first started smoking? - age Collection Interval: 2000-2004
69	Cigarette smoking	308113	phv00308113.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:23:48+00:00	2018-08-16 00:23:48+00:00 	FSMK_YR	In what year or how old were you when you first started smoking? - year Collection Interval: 2000-2004
69	Cigarette smoking	308112	phv00308112.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:23:55+00:00	2018-08-16 00:23:55+00:00 	SMOKE100	Have you smoked more than 100 cigarettes in your entire life? Collection Interval: 2000-2004
69	Cigarette smoking	112438	phv00112438.v2.p2	pht001559.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-16 22:34:39+00:00	2018-08-16 22:34:39+00:00 	A01WQUIT	IF EX-SMOKER, WHEN QUIT
69	Cigarette smoking	112437	phv00112437.v2.p2	pht001559.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-16 22:34:46+00:00	2018-08-16 22:34:46+00:00 	A01TQUIT	PT TRIED TO STOP SMOKING W/I PAST 2 YRS
69	Cigarette smoking	112436	phv00112436.v2.p2	pht001559.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-16 22:34:54+00:00	2018-08-16 22:34:54+00:00 	A01SMNUM	# CIGARETTES SMOKED PER DAY
69	Cigarette smoking	112435	phv00112435.v2.p2	pht001559.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-16 22:35:01+00:00	2018-08-16 22:35:01+00:00 	A01SMNOW	CURRENT SMOKER?
69	Cigarette smoking	112434	phv00112434.v2.p2	pht001559.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-16 22:35:09+00:00	2018-08-16 22:35:09+00:00 	A01SM100	LIFETIME CIGARETTE COMSUMPTION > 99
69	Cigarette smoking	122542	phv00122542.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:45:53+00:00	2018-08-16 23:45:53+00:00 	CIGADY	Smoke >= 1 cigarette/day (C)
69	Cigarette smoking	122543	phv00122543.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:45:58+00:00	2018-08-16 23:45:58+00:00 	CIGAWK	Smoke >= 1 cigarette/week (C)
69	Cigarette smoking	122544	phv00122544.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:46:03+00:00	2018-08-16 23:46:03+00:00 	EVERCIG	Smoke >= 1 cigarette/week for a month (C)
69	Cigarette smoking	122545	phv00122545.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:46:09+00:00	2018-08-16 23:46:09+00:00 	MOSSMOK	Number of  months have been smoking (C)
69	Cigarette smoking	122546	phv00122546.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:46:14+00:00	2018-08-16 23:46:14+00:00 	NOCIGS	Average number of cigarettes smoked/day (C)
69	Cigarette smoking	113174	phv00113174.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:39:01+00:00	2018-08-17 18:39:01+00:00 	A09CGTDY	CIGARETTES, # SMOKED/DAY. Q 2.05
69	Cigarette smoking	113173	phv00113173.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:39:08+00:00	2018-08-17 18:39:08+00:00 	A09SLS3M	NEW SMOKER: STILL SMOKES? Q 2.04A
69	Cigarette smoking	113172	phv00113172.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:39:17+00:00	2018-08-17 18:39:17+00:00 	A09STS3M	STARTED SMOKING, PAST 3 MOS.? Q 2.04
69	Cigarette smoking	113171	phv00113171.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:39:25+00:00	2018-08-17 18:39:25+00:00 	A09SMKYR	HOW MANY YRS SMOKED CIGS REG.? Q 2.03
69	Cigarette smoking	113170	phv00113170.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:39:34+00:00	2018-08-17 18:39:34+00:00 	A09SMKAG	HOW OLD WHEN STARTED SMOKING? Q 2.02
69	Cigarette smoking	113169	phv00113169.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:39:42+00:00	2018-08-17 18:39:42+00:00 	A09YRSQT	EX-SMOKER: HOW LONG AGO QUIT SMOKING? Q 2.01
69	Cigarette smoking	113168	phv00113168.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:39:49+00:00	2018-08-17 18:39:49+00:00 	A09SMKNW	STILL SMOKES CIGARETTES REGULARLY? Q 2.01
69	Cigarette smoking	113179	phv00113179.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:40:21+00:00	2018-08-17 18:40:21+00:00 	A09CMENT	CURR BRAND: MENTHOLATED/NONMENTHOLATED. Q 2.06
69	Cigarette smoking	113178	phv00113178.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:40:29+00:00	2018-08-17 18:40:29+00:00 	A09CSIZE	CURR BRAND: REGULAR/KING SIZE/LONG. Q 2.06
69	Cigarette smoking	113177	phv00113177.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:40:37+00:00	2018-08-17 18:40:37+00:00 	A09CPACK	CURR BRAND: SOFT/HARD PACK. Q 2.06
69	Cigarette smoking	113176	phv00113176.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:40:46+00:00	2018-08-17 18:40:46+00:00 	A09CFILT	CURR BRAND: FILTERED/UNFILTERED. Q 2.06
69	Cigarette smoking	113175	phv00113175.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:40:55+00:00	2018-08-17 18:40:55+00:00 	A09CBRND	CURR BRAND: NAME. Q 2.06
69	Cigarette smoking	113189	phv00113189.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:41:30+00:00	2018-08-17 18:41:30+00:00 	A09XMEN2	OLD BRAND 2: MENTHOLATED/NONMENTHOLATED. Q 2.07
69	Cigarette smoking	113188	phv00113188.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:41:37+00:00	2018-08-17 18:41:37+00:00 	A09XSIZ2	OLD BRAND 2: REGULAR/KING SIZE/LONG. Q 2.07
69	Cigarette smoking	113187	phv00113187.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:41:45+00:00	2018-08-17 18:41:45+00:00 	A09XPAC2	OLD BRAND 2: SOFT/HARD PACK. Q 2.07
69	Cigarette smoking	113186	phv00113186.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:41:52+00:00	2018-08-17 18:41:52+00:00 	A09XFIL2	OLD BRAND 2: FILTERED/UNFILTERED. Q 2.07
69	Cigarette smoking	113185	phv00113185.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:41:59+00:00	2018-08-17 18:41:59+00:00 	A09XBRN2	OLD BRAND 2: NAME. Q 2.07
69	Cigarette smoking	113184	phv00113184.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:42:06+00:00	2018-08-17 18:42:06+00:00 	A09XMEN1	OLD BRAND 1: MENTHOLATED/NONMENTHOLATED. Q 2.07
69	Cigarette smoking	113183	phv00113183.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:42:13+00:00	2018-08-17 18:42:13+00:00 	A09XSIZ1	OLD BRAND 1: REGULAR/KING SIZE/LONG. Q 2.07
69	Cigarette smoking	113182	phv00113182.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:42:21+00:00	2018-08-17 18:42:21+00:00 	A09XPAC1	OLD BRAND 1: SOFT/HARD PACK. Q 2.07
69	Cigarette smoking	113181	phv00113181.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:42:29+00:00	2018-08-17 18:42:29+00:00 	A09XFIL1	OLD BRAND 1: FILTERED/UNFILTERED. Q 2.07
69	Cigarette smoking	113180	phv00113180.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:42:36+00:00	2018-08-17 18:42:36+00:00 	A09XBRN1	OLD BRAND 1: NAME. Q 2.07
69	Cigarette smoking	113199	phv00113199.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:43:04+00:00	2018-08-17 18:43:04+00:00 	A09XMEN4	OLD BRAND 4: MENTHOLATED/NONMENTHOLATED. Q 2.07
69	Cigarette smoking	113198	phv00113198.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:43:11+00:00	2018-08-17 18:43:11+00:00 	A09XSIZ4	OLD BRAND 4: REGULAR/KING SIZE/LONG. Q 2.07
69	Cigarette smoking	113197	phv00113197.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:43:21+00:00	2018-08-17 18:43:21+00:00 	A09XPAC4	OLD BRAND 4: SOFT/HARD PACK. Q 2.07
69	Cigarette smoking	113196	phv00113196.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:43:28+00:00	2018-08-17 18:43:28+00:00 	A09XFIL4	OLD BRAND 4: FILTERED/UNFILTERED. Q 2.07
69	Cigarette smoking	113195	phv00113195.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:43:35+00:00	2018-08-17 18:43:35+00:00 	A09XBRN4	OLD BRAND 4: NAME. Q 2.07
69	Cigarette smoking	113194	phv00113194.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:43:43+00:00	2018-08-17 18:43:43+00:00 	A09XMEN3	OLD BRAND 3: MENTHOLATED/NONMENTHOLATED. Q 2.07
69	Cigarette smoking	113193	phv00113193.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:43:50+00:00	2018-08-17 18:43:50+00:00 	A09XSIZ3	OLD BRAND 3: REGULAR/KING SIZE/LONG. Q 2.07
69	Cigarette smoking	113192	phv00113192.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:43:57+00:00	2018-08-17 18:43:57+00:00 	A09XPAC3	OLD BRAND 3: SOFT/HARD PACK. Q 2.07
69	Cigarette smoking	113191	phv00113191.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:44:06+00:00	2018-08-17 18:44:06+00:00 	A09XFIL3	OLD BRAND 3: FILTERED/UNFILTERED. Q 2.07
69	Cigarette smoking	113190	phv00113190.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:44:14+00:00	2018-08-17 18:44:14+00:00 	A09XBRN3	OLD BRAND 3: NAME. Q 2.07
69	Cigarette smoking	113202	phv00113202.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:46:05+00:00	2018-08-17 18:46:05+00:00 	A09SMK5Y	EXPECTS TO SMOKE IN 5 YRS? Q 2.10
69	Cigarette smoking	113201	phv00113201.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:46:12+00:00	2018-08-17 18:46:12+00:00 	A09TRYQT	TRIED TO STOP SMOKING, PAST 2 YRS? Q 2.09
69	Cigarette smoking	113210	phv00113210.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:46:39+00:00	2018-08-17 18:46:39+00:00 	A09CO	1985 FTC CARBON MONOXIDE OF CURRENT BRD
69	Cigarette smoking	113209	phv00113209.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:46:46+00:00	2018-08-17 18:46:46+00:00 	A09TAR	1985 FTC TAR OF CURRENT BRAND
69	Cigarette smoking	113208	phv00113208.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:46:53+00:00	2018-08-17 18:46:53+00:00 	A09NIC	1985 FTC NICOTINE OF CURRENT BRAND
69	Cigarette smoking	113200	phv00113200.v2.p2	pht001572.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:49:04+00:00	2018-08-17 18:49:04+00:00 	A09INHAL	HOW OFTEN SMOKE INHALED? Q 2.08
69	Cigarette smoking	123025	phv00123025.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:55:41+00:00	2018-08-17 19:55:41+00:00 	smokerx	Smoking: Smoker Status
69	Cigarette smoking	123026	phv00123026.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:55:49+00:00	2018-08-17 19:55:49+00:00 	yrssmoke	Smoking: Years smoked
69	Cigarette smoking	123027	phv00123027.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:55:59+00:00	2018-08-17 19:55:59+00:00 	packyr	Smoking: Average packs smoked/year
69	Cigarette smoking	113224	phv00113224.v2.p2	pht001573.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 20:44:53+00:00	2018-08-17 20:44:53+00:00 	A10SMOKE	CIGARETTE SMOKING STATUS
69	Cigarette smoking	113213	phv00113213.v2.p2	pht001573.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 20:45:02+00:00	2018-08-17 20:45:02+00:00 	A10CIGS	SUBJECT HAS SMOKED CIGARETTES. Q 2
69	Cigarette smoking	114071	phv00114071.v2.p2	pht001594.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:29:33+00:00	2018-08-17 21:29:33+00:00 	FY012SMK	# CIGS/DAY - MON 12
69	Cigarette smoking	114100	phv00114100.v2.p2	pht001596.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:36:06+00:00	2018-08-17 21:36:06+00:00 	B02SMOKE	SMOKES, DOESN'T REMEMBER, DOESN'T SMOKE. Q 1
69	Cigarette smoking	114372	phv00114372.v2.p2	pht001602.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:54:45+00:00	2018-08-17 21:54:45+00:00 	B09MENTH	MENTHOLATED/NONMENTHOLATED
69	Cigarette smoking	114371	phv00114371.v2.p2	pht001602.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:54:53+00:00	2018-08-17 21:54:53+00:00 	B09LNGTH	REGULAR/KING-SIZE/LONG
69	Cigarette smoking	114370	phv00114370.v2.p2	pht001602.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:55:00+00:00	2018-08-17 21:55:00+00:00 	B09PAKSZ	SOFT/HARD PACK
69	Cigarette smoking	114369	phv00114369.v2.p2	pht001602.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:55:08+00:00	2018-08-17 21:55:08+00:00 	B09FILTR	FILTERED/UNFILTERED
69	Cigarette smoking	114368	phv00114368.v2.p2	pht001602.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:55:15+00:00	2018-08-17 21:55:15+00:00 	B09BRAND	CIGARETTE BRAND NAME
69	Cigarette smoking	226277	phv00226277.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:35:46+00:00	2018-08-22 21:35:46+00:00 	EXPOSURE_YEAR	Adjusted years smoked
69	Cigarette smoking	114546	phv00114546.v2.p2	pht001621.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:14:20+00:00	2018-08-22 23:14:20+00:00 	B09SLS3M	BEGINNER, STILL SMOKES? Q 2.04a
69	Cigarette smoking	114545	phv00114545.v2.p2	pht001621.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:14:27+00:00	2018-08-22 23:14:27+00:00 	B09STS3M	STARTED SMOKING, PAST 3 MOS.? Q 2.04
69	Cigarette smoking	114544	phv00114544.v2.p2	pht001621.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:14:34+00:00	2018-08-22 23:14:34+00:00 	B09SMKYR	HOW MANY YRS SMOKED REGULARLY? Q 2.03
69	Cigarette smoking	114543	phv00114543.v2.p2	pht001621.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:14:41+00:00	2018-08-22 23:14:41+00:00 	B09SMKAG	HOW OLD WHEN STARTED? Q 2.02
69	Cigarette smoking	114542	phv00114542.v2.p2	pht001621.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:14:49+00:00	2018-08-22 23:14:49+00:00 	B09YRSQT	IF NOT, HOW LONG QUIT? Q 2.01
69	Cigarette smoking	114541	phv00114541.v2.p2	pht001621.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:14:56+00:00	2018-08-22 23:14:56+00:00 	B09SMKNW	STILL SMOKE? Q 2.01
69	Cigarette smoking	114550	phv00114550.v2.p2	pht001621.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:15:26+00:00	2018-08-22 23:15:26+00:00 	B09SMK5Y	DO YOU EXPECT TO SMOKE IN 5 YRS? Q 2.10
69	Cigarette smoking	114549	phv00114549.v2.p2	pht001621.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:15:33+00:00	2018-08-22 23:15:33+00:00 	B09TRYQT	HAVE YOU TRIED TO STOP, PAST 2 YRS? Q 2.10
69	Cigarette smoking	114548	phv00114548.v2.p2	pht001621.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:15:40+00:00	2018-08-22 23:15:40+00:00 	B09INHAL	HOW OFTEN SMOKE INHALED? Q 2.08
69	Cigarette smoking	114547	phv00114547.v2.p2	pht001621.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:15:47+00:00	2018-08-22 23:15:47+00:00 	B09CGTDY	CIGARETTES, # SMOKED/DAY. Q 2.05
69	Cigarette smoking	114582	phv00114582.v2.p2	pht001625.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:20:42+00:00	2018-08-22 23:20:42+00:00 	B10SMOKE	SMOKING STATUS
69	Cigarette smoking	114581	phv00114581.v2.p2	pht001625.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:20:50+00:00	2018-08-22 23:20:50+00:00 	B10EXLRG	HRS/WK EXP TO SMK IN LG AREA. Q 11
69	Cigarette smoking	114580	phv00114580.v2.p2	pht001625.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:20:57+00:00	2018-08-22 23:20:57+00:00 	B10EXSML	HRS/WK EXP TO SMK IN SMALL AREA. Q 10
69	Cigarette smoking	114579	phv00114579.v2.p2	pht001625.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:21:07+00:00	2018-08-22 23:21:07+00:00 	B10EXHME	HRS/WK EXP TO SMK IN HOME. Q 9
69	Cigarette smoking	114572	phv00114572.v2.p2	pht001625.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:21:15+00:00	2018-08-22 23:21:15+00:00 	B10CIGS	HAS SMOKED CIGARETTES. Q 2
69	Cigarette smoking	115079	phv00115079.v2.p2	pht001640.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:47:58+00:00	2018-08-22 23:47:58+00:00 	B09P_SMK	SMOKE >= 10 CIG. A DAY FOR >= 1 MONTH. Q 12
69	Cigarette smoking	115156	phv00115156.v2.p2	pht001646.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:53:54+00:00	2018-08-22 23:53:54+00:00 	FY048SMK	# OF CIGS/DAY - MON 48
69	Cigarette smoking	115149	phv00115149.v2.p2	pht001646.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:54:00+00:00	2018-08-22 23:54:00+00:00 	FY036SMK	# OF CIGS/DAY - MON 36
69	Cigarette smoking	115317	phv00115317.v2.p2	pht001652.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:59:41+00:00	2018-08-22 23:59:41+00:00 	C02SMOKE	SMOKES, DOESN'T REMEMBER, DOESN'T SMOKE. Q 1
69	Cigarette smoking	115544	phv00115544.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:17:58+00:00	2018-08-23 17:17:58+00:00 	C09UPC	CIGARETTES USED - UPC CODE
69	Cigarette smoking	115551	phv00115551.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:18:05+00:00	2018-08-23 17:18:05+00:00 	C09SLS3M	BEGINNER, STILL SMOKES? Q Q 2.04a
69	Cigarette smoking	115550	phv00115550.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:18:12+00:00	2018-08-23 17:18:12+00:00 	C09STS3M	STARTED SMOKING, PAST 3 MOS.? Q 2.04
69	Cigarette smoking	115549	phv00115549.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:18:20+00:00	2018-08-23 17:18:20+00:00 	C09SMKYR	HOW MANY YRS SMOKED REGULARLY? Q 2.03
69	Cigarette smoking	115548	phv00115548.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:18:27+00:00	2018-08-23 17:18:27+00:00 	C09SMKAG	HOW OLD WHEN STARTED? Q 2.02
69	Cigarette smoking	115547	phv00115547.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:18:35+00:00	2018-08-23 17:18:35+00:00 	C09YRSQT	IF NOT, HOW LONG QUIT? Q 2.01a
69	Cigarette smoking	115546	phv00115546.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:18:43+00:00	2018-08-23 17:18:43+00:00 	C09SMKNW	STILL SMOKE? Q 2.01
69	Cigarette smoking	115545	phv00115545.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:18:51+00:00	2018-08-23 17:18:51+00:00 	C09BRAND	CIGARETTE BRAND NAME
69	Cigarette smoking	115558	phv00115558.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:19:28+00:00	2018-08-23 17:19:28+00:00 	C09BURNW	PORTION OF CIGARETTE THAT IS UNSMOKED. Q 2.08
69	Cigarette smoking	115557	phv00115557.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:19:35+00:00	2018-08-23 17:19:35+00:00 	C09BURN	HOW FAR DO YOU LET CIGARETTE BURN. Q 2.07
69	Cigarette smoking	115556	phv00115556.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:19:42+00:00	2018-08-23 17:19:42+00:00 	C09MENTH	MENTHOLATED/NONMENTHOLATED. Q 2.06e
69	Cigarette smoking	115555	phv00115555.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:19:49+00:00	2018-08-23 17:19:49+00:00 	C09LNGTH	REGULAR/KING-SIZE/LONG. Q 2.06d
69	Cigarette smoking	115554	phv00115554.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:19:56+00:00	2018-08-23 17:19:56+00:00 	C09PAKSZ	SOFT/HARD PACK. Q 2.06c
69	Cigarette smoking	115553	phv00115553.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:20:04+00:00	2018-08-23 17:20:04+00:00 	C09FILTR	FILTERED/UNFILTERED. Q 2.06b
69	Cigarette smoking	115552	phv00115552.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:20:11+00:00	2018-08-23 17:20:11+00:00 	C09CGTDY	CIGARETTES, # SMOKED/DAY. Q 2.05
69	Cigarette smoking	115566	phv00115566.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:20:51+00:00	2018-08-23 17:20:51+00:00 	C09OTHER	QUIT ATTEMPT: OTHER. Q 2.12
69	Cigarette smoking	115565	phv00115565.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:20:58+00:00	2018-08-23 17:20:58+00:00 	C09COLDT	QUIT ATTEMPT: COLD TURKEY. Q 2.12
69	Cigarette smoking	115564	phv00115564.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:21:04+00:00	2018-08-23 17:21:04+00:00 	C09HELP	QUIT ATTEMPT: SOUGHT PROFESSIONAL HELP. Q 2.12
69	Cigarette smoking	115563	phv00115563.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:21:11+00:00	2018-08-23 17:21:11+00:00 	C09CUTDN	QUIT ATTEMPT: REDUCED # OF CIGS SMOKED. Q 2.12
69	Cigarette smoking	115562	phv00115562.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:21:18+00:00	2018-08-23 17:21:18+00:00 	C09LONG	LONGEST ATTEMPT TO QUIT. Q 2.11
69	Cigarette smoking	115561	phv00115561.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:21:26+00:00	2018-08-23 17:21:26+00:00 	C09ATTMP	HOW MANY ATTEMPTS TO QUIT >= 48 HRS. Q 2.10
69	Cigarette smoking	115560	phv00115560.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:21:32+00:00	2018-08-23 17:21:32+00:00 	C09TRYQT	TRIED TO QUIT IN LAST 3 YEARS. Q 2.10
69	Cigarette smoking	115559	phv00115559.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:21:39+00:00	2018-08-23 17:21:39+00:00 	C09FSTCG	HOW SOON SMOKE AFTER WAKING. Q 2.09
69	Cigarette smoking	115573	phv00115573.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:22:14+00:00	2018-08-23 17:22:14+00:00 	C09WORK	REASON QUIT -WORK POLICY. Q 2.13g
69	Cigarette smoking	115572	phv00115572.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:22:21+00:00	2018-08-23 17:22:21+00:00 	C09EXPEN	REASON QUIT -EXPENSE OF HABIT. Q 2.13f
69	Cigarette smoking	115571	phv00115571.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:22:28+00:00	2018-08-23 17:22:28+00:00 	C09TIRED	REASON QUIT -TIRED OF HABIT. Q 2.13e
69	Cigarette smoking	115570	phv00115570.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:22:34+00:00	2018-08-23 17:22:34+00:00 	C09FAMIL	REASON QUIT -FAMILY/FRIENDS SUGGESTED. Q 2.13d
69	Cigarette smoking	115569	phv00115569.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:22:41+00:00	2018-08-23 17:22:41+00:00 	C09PREGN	REASON QUIT -PREG OR RECENT BIRTH. Q 2.13c
69	Cigarette smoking	115568	phv00115568.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:22:48+00:00	2018-08-23 17:22:48+00:00 	C09CONCE	REASON QUIT -HEALTH CONCERN. Q 2.13b
69	Cigarette smoking	115567	phv00115567.v2.p2	pht001664.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:22:55+00:00	2018-08-23 17:22:55+00:00 	C09DOCTR	REASON QUIT -MD RECOMMENDED. Q 2.13a
69	Cigarette smoking	115592	phv00115592.v2.p2	pht001665.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:25:51+00:00	2018-08-23 17:25:51+00:00 	C10SMOKE	SMOKING STATUS
69	Cigarette smoking	115582	phv00115582.v2.p2	pht001665.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:25:58+00:00	2018-08-23 17:25:58+00:00 	C10CIGS	HAS SMOKED CIGARETTES. Q 2
69	Cigarette smoking	116285	phv00116285.v2.p2	pht001686.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 18:56:48+00:00	2018-08-23 18:56:48+00:00 	C42BSMOK	SMOKED SINCE LAST CUFF INFLATION?
69	Cigarette smoking	116413	phv00116413.v2.p2	pht001701.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 19:20:40+00:00	2018-08-23 19:20:40+00:00 	FY072SMK	# OF CIGS/DAY - MON 72
69	Cigarette smoking	116540	phv00116540.v2.p2	pht001707.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 21:37:16+00:00	2018-08-23 21:37:16+00:00 	D02SMOKE	SMOKES, DOESN'T REMEMBER, DOESN'T SMOKE. Q 1
69	Cigarette smoking	117147	phv00117147.v2.p2	pht001717.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:25:04+00:00	2018-08-24 00:25:04+00:00 	D10SMOKE	SMOKING STATUS
69	Cigarette smoking	117136	phv00117136.v2.p2	pht001717.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:25:11+00:00	2018-08-24 00:25:11+00:00 	D10CIGS	HAS SMOKED CIGARETTES. Q 2
69	Cigarette smoking	252990	phv00252990.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:13:52+00:00	2018-08-24 17:13:52+00:00 	current_smoker_baseline	Current smoking status of participant at baseline visit
69	Cigarette smoking	117533	phv00117533.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:46:47+00:00	2018-08-24 22:46:47+00:00 	D09PAKSZ	SOFT/HARD PACK. Q 2.04c
69	Cigarette smoking	117532	phv00117532.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:46:53+00:00	2018-08-24 22:46:53+00:00 	D09FILTR	FILTERED/UNFILTERED. Q 2.04b
69	Cigarette smoking	117531	phv00117531.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:47:00+00:00	2018-08-24 22:47:00+00:00 	D09CGTDY	CIGARETTES, # SMOKED/DAY. Q 2.03
69	Cigarette smoking	117530	phv00117530.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:47:08+00:00	2018-08-24 22:47:08+00:00 	D09SLS3M	BEGINNER, STILL SMOKES? Q 2.02a
69	Cigarette smoking	117529	phv00117529.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:47:15+00:00	2018-08-24 22:47:15+00:00 	D09STS3M	STARTED SMOKING, PAST 3 MOS.? Q 2.02
69	Cigarette smoking	117528	phv00117528.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:47:23+00:00	2018-08-24 22:47:23+00:00 	D09SMKNW	STILL SMOKE? Q 1.01
69	Cigarette smoking	117527	phv00117527.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:47:30+00:00	2018-08-24 22:47:30+00:00 	D09BRAND	CIGARETTE BRAND NAME
69	Cigarette smoking	117526	phv00117526.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:47:37+00:00	2018-08-24 22:47:37+00:00 	D09UPC	CIGARETTES USED - UPC CODE
69	Cigarette smoking	117537	phv00117537.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:50:46+00:00	2018-08-24 22:50:46+00:00 	D09ATTMP	HOW MANY ATTEMPTS TO QUIT >= 48 HRS. Q 2.05
69	Cigarette smoking	117536	phv00117536.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:50:55+00:00	2018-08-24 22:50:55+00:00 	D09TRYQT	TRIED TO QUIT IN LAST 2 YEARS. Q 2.05
69	Cigarette smoking	117535	phv00117535.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:51:02+00:00	2018-08-24 22:51:02+00:00 	D09MENTH	MENTHOLATED/NONMENTHOLATED. Q 2.04e
69	Cigarette smoking	117534	phv00117534.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:51:10+00:00	2018-08-24 22:51:10+00:00 	D09LNGTH	REGULAR/KING-SIZE/LONG. Q 2.04d
69	Cigarette smoking	117545	phv00117545.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:51:20+00:00	2018-08-24 22:51:20+00:00 	D09SPEND	EVER SPENT MONEY TO QUIT SMOKING. Q 2.09
69	Cigarette smoking	117544	phv00117544.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:51:27+00:00	2018-08-24 22:51:27+00:00 	D09ATTND	EVER PARTICIPATED IN CESSATION PROGRAM. Q 2.08
69	Cigarette smoking	117925	phv00117925.v2.p2	pht001749.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-27 23:09:55+00:00	2018-08-27 23:09:55+00:00 	FY096SMK	# OF CIGS/DAY - MON 96
69	Cigarette smoking	118268	phv00118268.v2.p2	pht001757.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 22:38:07+00:00	2018-08-28 22:38:07+00:00 	E02SMOKE	SMOKED IN PAST 24 HOURS? Q 1
69	Cigarette smoking	118744	phv00118744.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:26:02+00:00	2018-08-28 23:26:02+00:00 	E09STS3M	STARTED SMOKING, PAST 3 MOS? Q 2.02
69	Cigarette smoking	118743	phv00118743.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:26:09+00:00	2018-08-28 23:26:09+00:00 	E09QTFRQ	HOW LONG SINCE SMOKED REG - UNIT. Q 2.01a
69	Cigarette smoking	118742	phv00118742.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:26:16+00:00	2018-08-28 23:26:16+00:00 	E09QTNUM	HOW LONG SINCE SMOKED REG - NUMBER. Q 2.01a
69	Cigarette smoking	118741	phv00118741.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:26:22+00:00	2018-08-28 23:26:22+00:00 	E09SMKNW	STILL SMOKE? Q 2.01
69	Cigarette smoking	118740	phv00118740.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:26:28+00:00	2018-08-28 23:26:28+00:00 	E09BRAND	CIGARETTE BRAND NAME
69	Cigarette smoking	118739	phv00118739.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:26:34+00:00	2018-08-28 23:26:34+00:00 	E09UPC	CIGARETTES USED - UPC CODE
69	Cigarette smoking	118758	phv00118758.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:27:55+00:00	2018-08-28 23:27:55+00:00 	E09QUIT	HOW INTERESTED IN QUITTING SMOKING. Q 2.08
69	Cigarette smoking	118753	phv00118753.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:28:02+00:00	2018-08-28 23:28:02+00:00 	E09ATTMP	HOW MANY ATTEMPTS TO QUIT >= 48 HRS. Q 206
69	Cigarette smoking	118752	phv00118752.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:28:09+00:00	2018-08-28 23:28:09+00:00 	E09TRYQT	TRIED TO QUIT IN PAST 3 YRS. Q 2.06
69	Cigarette smoking	118751	phv00118751.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:28:16+00:00	2018-08-28 23:28:16+00:00 	E09MENTH	MENTHOLATED/NONMENTHOLATED. Q 2.05e
69	Cigarette smoking	118750	phv00118750.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:28:23+00:00	2018-08-28 23:28:23+00:00 	E09LNGTH	REGULAR/KING-SIZE/LONG. Q 2.05d
69	Cigarette smoking	118749	phv00118749.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:28:30+00:00	2018-08-28 23:28:30+00:00 	E09PAKSZ	SOFT/HARD PACK. Q 2.05c
69	Cigarette smoking	118748	phv00118748.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:28:36+00:00	2018-08-28 23:28:36+00:00 	E09FILTR	FILTERED/UNFILTERED. Q 2.05b
69	Cigarette smoking	118747	phv00118747.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:28:44+00:00	2018-08-28 23:28:44+00:00 	E09SMKDY	SMOKE EVERY DAY. Q 2.04
69	Cigarette smoking	118746	phv00118746.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:28:51+00:00	2018-08-28 23:28:51+00:00 	E09CGTDY	CIGARETTES, # SMOKED/DAY. Q 2.03
69	Cigarette smoking	118745	phv00118745.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:28:58+00:00	2018-08-28 23:28:58+00:00 	E09SLS3M	BEGINNER, STILL SMOKES? Q 2.02a
69	Cigarette smoking	118765	phv00118765.v2.p2	pht001778.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:32:45+00:00	2018-08-28 23:32:45+00:00 	E10CIGS	HAS SMOKED CIGARETTES. Q 2
69	Cigarette smoking	118780	phv00118780.v2.p2	pht001778.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:33:07+00:00	2018-08-28 23:33:07+00:00 	E10SMOKE	SMOKING STATUS
69	Cigarette smoking	118757	phv00118757.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:15:49+00:00	2018-08-29 20:15:49+00:00 	E09CHGOT	PLAN TO MAKE OTHER CHANGES IN NEXT 6 MOS. Q 2.07
69	Cigarette smoking	118756	phv00118756.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:15:56+00:00	2018-08-29 20:15:56+00:00 	E09CHGLO	PLAN TO CHANGE TO LOW TAR IN NEXT 6 MOS. Q 2.07
69	Cigarette smoking	118755	phv00118755.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:16:04+00:00	2018-08-29 20:16:04+00:00 	E09CHGNO	PLAN TO CUT DOWN IN NEXT 6 MOS. Q 2.07
69	Cigarette smoking	118754	phv00118754.v2.p2	pht001777.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:16:11+00:00	2018-08-29 20:16:11+00:00 	E09CHGQT	PLAN TO QUIT SMOKING IN NEXT 6 MOS. Q 2.07
69	Cigarette smoking	117543	phv00117543.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:16:53+00:00	2018-08-29 20:16:53+00:00 	D09AWARE	AWARE OF CESSATION PGMS IN COMMUNITY. Q 2.08
69	Cigarette smoking	117542	phv00117542.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:17:00+00:00	2018-08-29 20:17:00+00:00 	D09QUIT	HOW INTERESTED IN QUITTING SMOKING. 2,07
69	Cigarette smoking	117541	phv00117541.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:17:07+00:00	2018-08-29 20:17:07+00:00 	D09CHGOT	PLAN TO MAKE OTHER CHANGES IN NEXT 6 MOS. Q 2.06
69	Cigarette smoking	117540	phv00117540.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:17:15+00:00	2018-08-29 20:17:15+00:00 	D09CHGLO	PLAN TO CHANGE TO LOW TAR IN NEXT 6 MOS. Q 2.06
69	Cigarette smoking	117539	phv00117539.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:17:22+00:00	2018-08-29 20:17:22+00:00 	D09CHGNO	PLAN TO CUT DOWN IN NEXT 6 MOS. Q 2.06
69	Cigarette smoking	117538	phv00117538.v2.p2	pht001735.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:17:30+00:00	2018-08-29 20:17:30+00:00 	D09CHGQT	PLAN TO QUIT SMOKING IN NEXT 6 MOS. Q 2.06
69	Cigarette smoking	119523	phv00119523.v2.p2	pht001795.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:58:22+00:00	2018-08-29 20:58:22+00:00 	E53CIGN	# OF CIGS IN PAST 24 HRS
69	Cigarette smoking	119522	phv00119522.v2.p2	pht001795.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:58:30+00:00	2018-08-29 20:58:30+00:00 	E53CIG24	SMOKED IN PAST 24 HRS?
69	Cigarette smoking	119694	phv00119694.v2.p2	pht001808.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:05:14+00:00	2018-08-29 21:05:14+00:00 	F02SMOKE	SMOKED IN PAST 24 HOURS? Q 1
69	Cigarette smoking	120046	phv00120046.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:25:58+00:00	2018-08-29 21:25:58+00:00 	F09FILTR	FILTERED/UNFILTERED. Q 2.05
69	Cigarette smoking	120045	phv00120045.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:26:05+00:00	2018-08-29 21:26:05+00:00 	F09SMKDY	SMOKE EVERY DAY. Q 2.04
69	Cigarette smoking	120044	phv00120044.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:26:11+00:00	2018-08-29 21:26:11+00:00 	F09SLS3M	BEGINNER, STILL SMOKES? Q 2.02a
69	Cigarette smoking	120043	phv00120043.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:26:17+00:00	2018-08-29 21:26:17+00:00 	F09QTFRQ	HOW LONG SINCE SMOKED REG - UNIT. q 2.01a
69	Cigarette smoking	120042	phv00120042.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:26:23+00:00	2018-08-29 21:26:23+00:00 	F09QTNUM	HOW LONG SINCE SMOKED REG - NUMBER. Q 2.01a
69	Cigarette smoking	120041	phv00120041.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:26:31+00:00	2018-08-29 21:26:31+00:00 	F09CGTDY	CIGARETTES, # SMOKED/DAY. Q 2.03
69	Cigarette smoking	120040	phv00120040.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:26:37+00:00	2018-08-29 21:26:37+00:00 	F09STS3M	STARTED SMOKING, PAST 3 MOS? Q 2.02
69	Cigarette smoking	120039	phv00120039.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:26:44+00:00	2018-08-29 21:26:44+00:00 	F09SMKNW	STILL SMOKE? Q 2.01
69	Cigarette smoking	120062	phv00120062.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:27:31+00:00	2018-08-29 21:27:31+00:00 	F09CHNGS	SPECIFIED OTHER PLANNED CHANGES. Q 2.07
69	Cigarette smoking	120057	phv00120057.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:27:38+00:00	2018-08-29 21:27:38+00:00 	F09QUIT	HOW INTERESTED IN QUITTING SMOKING. Q 2.08
69	Cigarette smoking	120056	phv00120056.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:27:44+00:00	2018-08-29 21:27:44+00:00 	F09CHGOT	PLAN TO MAKE OTHER CHANGES. Q 2.07
69	Cigarette smoking	120055	phv00120055.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:27:51+00:00	2018-08-29 21:27:51+00:00 	F09CHGLO	PLAN TO CHANGE TO LOW TAR CIGARETTE. Q 2.07
69	Cigarette smoking	120054	phv00120054.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:27:58+00:00	2018-08-29 21:27:58+00:00 	F09CHGNO	PLAN TO CUT DOWN NUMBER OF CIGARET. Q 2.07
69	Cigarette smoking	120053	phv00120053.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:28:05+00:00	2018-08-29 21:28:05+00:00 	F09CHGQT	PLAN TO QUIT SMOKING COMPLETELY. Q 2.07
69	Cigarette smoking	120052	phv00120052.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:28:12+00:00	2018-08-29 21:28:12+00:00 	F09CIGDY	ON SMOKE DAYS, HOW MANY CIGARETTES. Q 2.04b
69	Cigarette smoking	120051	phv00120051.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:28:19+00:00	2018-08-29 21:28:19+00:00 	F09SMK30	SMOKED ON HOW MANY DAYS IN PAST 30. Q 2.04a
69	Cigarette smoking	120050	phv00120050.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:28:25+00:00	2018-08-29 21:28:25+00:00 	F09ATTMP	HOW MANY ATTEMPTS TO QUIT >= 48 HRS
69	Cigarette smoking	120049	phv00120049.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:28:32+00:00	2018-08-29 21:28:32+00:00 	F09TRYQT	TRIED TO QUIT IN PAST 5 YRS. Q 2.06
69	Cigarette smoking	120048	phv00120048.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:28:40+00:00	2018-08-29 21:28:40+00:00 	F09MENTH	MENTHOLATED/NONMENTHOLATED. Q 2.05c
69	Cigarette smoking	120047	phv00120047.v2.p2	pht001817.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:28:47+00:00	2018-08-29 21:28:47+00:00 	F09LNGTH	REGULAR/KING-SIZE/LONG. Q 2.05b
69	Cigarette smoking	120080	phv00120080.v2.p2	pht001818.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:29:58+00:00	2018-08-29 22:29:58+00:00 	F10SMOKE	SMOKING STATUS
69	Cigarette smoking	120065	phv00120065.v2.p2	pht001818.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:30:14+00:00	2018-08-29 22:30:14+00:00 	F10CIGS	HAS SMOKED CIGARETTES. Q 2
69	Cigarette smoking	120700	phv00120700.v2.p2	pht001850.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:11:25+00:00	2018-08-29 23:11:25+00:00 	FHL111A	NUMBER OF CIGARETTES
69	Cigarette smoking	120699	phv00120699.v2.p2	pht001850.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:11:31+00:00	2018-08-29 23:11:31+00:00 	FHL111	DID YOU SMOKE CIGARETTES
69	Cigarette smoking	121173	phv00121173.v2.p2	pht001866.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:20:04+00:00	2018-08-30 00:20:04+00:00 	py15	Pack-years @year 15
69	Cigarette smoking	121172	phv00121172.v2.p2	pht001866.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:20:11+00:00	2018-08-30 00:20:11+00:00 	py10	Pack-years @year 10
69	Cigarette smoking	121171	phv00121171.v2.p2	pht001866.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:20:17+00:00	2018-08-30 00:20:17+00:00 	py7	Pack-years @year 7
69	Cigarette smoking	121170	phv00121170.v2.p2	pht001866.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:20:24+00:00	2018-08-30 00:20:24+00:00 	py5	Pack-years @year 5
69	Cigarette smoking	121169	phv00121169.v2.p2	pht001866.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:20:31+00:00	2018-08-30 00:20:31+00:00 	py2	Pack-years @year 2
69	Cigarette smoking	121168	phv00121168.v2.p2	pht001866.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:20:37+00:00	2018-08-30 00:20:37+00:00 	py0	Pack-years @year 0
69	Cigarette smoking	121179	phv00121179.v2.p2	pht001866.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:20:53+00:00	2018-08-30 00:20:53+00:00 	ltsmk15	Lifetime pack-years of cigarettes smoked @year 15
69	Cigarette smoking	121178	phv00121178.v2.p2	pht001866.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:21:00+00:00	2018-08-30 00:21:00+00:00 	ltsmk10	Lifetime pack-years of cigarettes smoked @year 10
69	Cigarette smoking	121177	phv00121177.v2.p2	pht001866.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:21:06+00:00	2018-08-30 00:21:06+00:00 	ltsmk7	Lifetime pack-years of cigarettes smoked @year 7
69	Cigarette smoking	121176	phv00121176.v2.p2	pht001866.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:21:13+00:00	2018-08-30 00:21:13+00:00 	ltsmk5	Lifetime pack-years of cigarettes smoked @year 5
69	Cigarette smoking	121175	phv00121175.v2.p2	pht001866.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:21:20+00:00	2018-08-30 00:21:20+00:00 	ltsmk2	Lifetime pack-years of cigarettes smoked @year 2
69	Cigarette smoking	121174	phv00121174.v2.p2	pht001866.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:21:27+00:00	2018-08-30 00:21:27+00:00 	ltsmk0	Lifetime pack-years of cigarettes smoked @year 0
69	Cigarette smoking	121256	phv00121256.v2.p2	pht001868.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:23:28+00:00	2018-08-30 00:23:28+00:00 	ltsmk0	Lifetime pack-years of cigarettes smoked @year 0
69	Cigarette smoking	258705	phv00258705.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:35:29+00:00	2018-09-06 12:35:29+00:00 	Current_smoke	Current Smoker
69	Cigarette smoking	258706	phv00258706.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:36:13+00:00	2018-09-06 12:36:13+00:00 	Age_smoking	Age Started Smoking (years)
69	Cigarette smoking	258707	phv00258707.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:37:11+00:00	2018-09-06 12:37:11+00:00 	Length_sm_years	Length of time smoking (years)
69	Cigarette smoking	258708	phv00258708.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:37:27+00:00	2018-09-06 12:37:27+00:00 	Length_sm_months	Length of time smoking (months)
69	Cigarette smoking	258709	phv00258709.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:38:22+00:00	2018-09-06 12:38:22+00:00 	Man_cigarettes	Number of manufactured cigarettes per day
69	Cigarette smoking	258710	phv00258710.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:38:35+00:00	2018-09-06 12:38:35+00:00 	Hand_cigarettes	Number of hand-rolled cigarettes per day
69	Cigarette smoking	258713	phv00258713.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:38:49+00:00	2018-09-06 12:38:49+00:00 	Past_smoker	Past Smoker
69	Cigarette smoking	258714	phv00258714.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:39:03+00:00	2018-09-06 12:39:03+00:00 	Age_Quit	Age Quit Smoking
69	Cigarette smoking	258715	phv00258715.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:42:12+00:00	2018-09-06 12:42:12+00:00 	Length_Quit_Years	Length of time since Quitting (years)
69	Cigarette smoking	258716	phv00258716.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:42:25+00:00	2018-09-06 12:42:25+00:00 	Length_Quit_Months	Length of time since Quitting (months)
69	Cigarette smoking	267374	phv00267374.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:13:13+00:00	2018-09-06 13:13:13+00:00 	ever_Smoker	Ever smoked
69	Cigarette smoking	267375	phv00267375.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:13:37+00:00	2018-09-06 13:13:37+00:00 	Current_Smoker	Current smoking status
69	Cigarette smoking	267376	phv00267376.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:13:47+00:00	2018-09-06 13:13:47+00:00 	former_Smoker	Former smoking status
69	Cigarette smoking	267377	phv00267377.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:13:56+00:00	2018-09-06 13:13:56+00:00 	packyrs	Packs of cigarettes smoked per day multiplied by years of cigarette smoking, calculated at specified visit
69	Cigarette smoking	267378	phv00267378.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:14:05+00:00	2018-09-06 13:14:05+00:00 	cigsperday	Number of cigarettes smoked per day
69	Cigarette smoking	267379	phv00267379.v2.p1	pht005248.v2.p1	phs000988.v2.p1	NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica	988	2	2018-09-06 13:14:16+00:00	2018-09-06 13:14:16+00:00 	cigsperday_average	Number of cigarettes smoked per day, averaged over all years of smoking
69	Cigarette smoking	259394	phv00259394.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-09-06 13:25:24+00:00	2018-09-06 13:25:24+00:00 	smoke	Smoking status at index date
69	Cigarette smoking	121874	phv00121874.v2.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 15:57:07+00:00	2018-09-07 15:57:07+00:00 	smoking	Ever smoked (never, former, current)
69	Cigarette smoking	77460	phv00077460.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:08:05+00:00	2018-09-21 16:08:05+00:00 	LWPSMKNG_3	Smoking to lose weight
69	Cigarette smoking	77918	phv00077918.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:08:22+00:00	2018-09-21 16:08:22+00:00 	LWPSMKNG_6	5lbs on purpose/Started, increased smoking
69	Cigarette smoking	79571	phv00079571.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:08:59+00:00	2018-09-21 16:08:59+00:00 	LWGTSMK	Lost weight by increasing smoking
69	Cigarette smoking	78775	phv00078775.v6.p3	pht001003.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:09:25+00:00	2018-09-21 16:09:25+00:00 	SMOKAGE	Age started smoking cigarettes regularly
69	Cigarette smoking	78777	phv00078777.v6.p3	pht001003.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:09:49+00:00	2018-09-21 16:09:49+00:00 	QSMOKAGE	Age quit smoking regularly
69	Cigarette smoking	78778	phv00078778.v6.p3	pht001003.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:10:28+00:00	2018-09-21 16:10:28+00:00 	QSMOKHP	Quit smoking because of health problems
69	Cigarette smoking	78825	phv00078825.v6.p3	pht001003.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:11:07+00:00	2018-09-21 16:11:07+00:00 	SMOKING	Smoking status
69	Cigarette smoking	282910	phv00282910.v1.p3	pht001003.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:11:34+00:00	2018-09-21 16:11:34+00:00 	PACKYRS	Pack years of smoking
69	Cigarette smoking	282911	phv00282911.v1.p3	pht001003.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:11:41+00:00	2018-09-21 16:11:41+00:00 	PACKYRSC	Pack years of smoking (categorical)
69	Cigarette smoking	77559	phv00077559.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:13:02+00:00	2018-09-21 16:13:02+00:00 	SMOKENW_3	Smoke cigarettes now
69	Cigarette smoking	77704	phv00077704.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:13:12+00:00	2018-09-21 16:13:12+00:00 	SMOKENW_4	Smoke cigarettes now
69	Cigarette smoking	77811	phv00077811.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:13:20+00:00	2018-09-21 16:13:20+00:00 	SMOKENW_5	Smoke cigarettes now
69	Cigarette smoking	77961	phv00077961.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:13:30+00:00	2018-09-21 16:13:30+00:00 	SMOKENW_6	Smoke cigarettes now
69	Cigarette smoking	78123	phv00078123.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:13:39+00:00	2018-09-21 16:13:39+00:00 	SMOKENW_7	Smoke cigarettes now
69	Cigarette smoking	78247	phv00078247.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:13:48+00:00	2018-09-21 16:13:48+00:00 	SMOKENW_8	Smoke cigarettes now
69	Cigarette smoking	78774	phv00078774.v6.p3	pht001003.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:13:56+00:00	2018-09-21 16:13:56+00:00 	SMOKEVR	Smoked at least 100 cigarettes ever
69	Cigarette smoking	79634	phv00079634.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:14:05+00:00	2018-09-21 16:14:05+00:00 	SMOKENW	Smoke cigarettes now
69	Cigarette smoking	283507	phv00283507.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:14:13+00:00	2018-09-21 16:14:13+00:00 	SMOKERHX	F136 History of current smoker
69	Cigarette smoking	77560	phv00077560.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:15:03+00:00	2018-09-21 16:15:03+00:00 	CIGSDAY_3	How many cigarettes/day
69	Cigarette smoking	77705	phv00077705.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:15:10+00:00	2018-09-21 16:15:10+00:00 	CIGSDAY_4	Cigarettes per day
69	Cigarette smoking	77812	phv00077812.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:15:19+00:00	2018-09-21 16:15:19+00:00 	CIGSDAY_5	Cigarettes per day
69	Cigarette smoking	77962	phv00077962.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:15:30+00:00	2018-09-21 16:15:30+00:00 	CIGSDAY_6	How many cigarette per day
69	Cigarette smoking	78124	phv00078124.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:15:39+00:00	2018-09-21 16:15:39+00:00 	CIGSDAY_7	How many cigarette per day
69	Cigarette smoking	78248	phv00078248.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:15:48+00:00	2018-09-21 16:15:48+00:00 	CIGSDAY_8	Cigarettes per day
69	Cigarette smoking	78779	phv00078779.v6.p3	pht001003.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:15:57+00:00	2018-09-21 16:15:57+00:00 	CIGSDAY	Smoke or smoked, cigarettes/day
69	Cigarette smoking	78848	phv00078848.v6.p3	pht001004.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:16:07+00:00	2018-09-21 16:16:07+00:00 	CIGSDAY	How many cigarettes per day
69	Cigarette smoking	79635	phv00079635.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:16:15+00:00	2018-09-21 16:16:15+00:00 	CIGSDAY	Smoke, cigs/day
69	Cigarette smoking	282993	phv00282993.v1.p3	pht006214.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:16:25+00:00	2018-09-21 16:16:25+00:00 	CIGSDAY	Cigarettes per day
69	Cigarette smoking	79636	phv00079636.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:51:23+00:00	2018-09-21 16:51:23+00:00 	CIGFILTR	Type of filter on cigarette
69	Cigarette smoking	79637	phv00079637.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:51:47+00:00	2018-09-21 16:51:47+00:00 	CIGTAR	Type of tar and nicotine cigarette
69	Cigarette smoking	79638	phv00079638.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:52:41+00:00	2018-09-21 16:52:41+00:00 	CIGSIZE	Size cigarette usually smoked
69	Cigarette smoking	78781	phv00078781.v6.p3	pht001003.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:53:52+00:00	2018-09-21 16:53:52+00:00 	SMOKWGT	Smoked to lose weight
69	Cigarette smoking	78780	phv00078780.v6.p3	pht001003.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 16:58:24+00:00	2018-09-21 16:58:24+00:00 	SMOKYRS	Years a regular smoker
69	Cigarette smoking	78776	phv00078776.v6.p3	pht001003.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:04:48+00:00	2018-09-21 23:04:48+00:00 	SMOKNOW	Smoke cigarettes now
69	Cigarette smoking	98844	phv00098844.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:28:19+00:00	2018-09-27 17:28:19+00:00 	SMOKE101	SMOKED IN LIFETIME
69	Cigarette smoking	98845	phv00098845.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:28:30+00:00	2018-09-27 17:28:30+00:00 	SMOKE201	SMOKED CIGARETTES LAST 30 DAYS
69	Cigarette smoking	99155	phv00099155.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:28:40+00:00	2018-09-27 17:28:40+00:00 	SMOKE08	EVER SMOKED MORE THAN 100 CIGARETTES
69	Cigarette smoking	99445	phv00099445.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:28:51+00:00	2018-09-27 17:28:51+00:00 	SMOKE	SMOKING STATUS
69	Cigarette smoking	100466	phv00100466.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:29:04+00:00	2018-09-27 17:29:04+00:00 	SMOKE	SMOKING STATUS
69	Cigarette smoking	101622	phv00101622.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:29:32+00:00	2018-09-27 17:29:32+00:00 	SMOKE59	CURRENT SMOKING STATUS
69	Cigarette smoking	102802	phv00102802.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:29:45+00:00	2018-09-27 17:29:45+00:00 	SMOKE59	CURRENT SMOKING STATUS
69	Cigarette smoking	104378	phv00104378.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:29:57+00:00	2018-09-27 17:29:57+00:00 	SMOKE	Smoking status
69	Cigarette smoking	105010	phv00105010.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:30:20+00:00	2018-09-27 17:30:20+00:00 	SMOKE	Calculated smoking status at year 4
69	Cigarette smoking	105143	phv00105143.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:30:32+00:00	2018-09-27 17:30:32+00:00 	SMOKE101	SMOKED IN LIFETIME
69	Cigarette smoking	105144	phv00105144.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:30:42+00:00	2018-09-27 17:30:42+00:00 	SMOKE201	SMOKED CIGARETTES LAST 30 DAYS
69	Cigarette smoking	105886	phv00105886.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:30:56+00:00	2018-09-27 17:30:56+00:00 	SMOKE	SMOKING STATUS
69	Cigarette smoking	106196	phv00106196.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:31:06+00:00	2018-09-27 17:31:06+00:00 	SMOKE58	EVER SMOKED MORE THAN 100 CIGARETTES
69	Cigarette smoking	107229	phv00107229.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:31:31+00:00	2018-09-27 17:31:31+00:00 	SMOKE29	CURRENT SMOKING STATUS
69	Cigarette smoking	108097	phv00108097.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:31:50+00:00	2018-09-27 17:31:50+00:00 	SMOKE59	CURRENT SMOKING STATUS
69	Cigarette smoking	108732	phv00108732.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:32:00+00:00	2018-09-27 17:32:00+00:00 	SMOKE59	CURRENT SMOKING STATUS
69	Cigarette smoking	109464	phv00109464.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:32:14+00:00	2018-09-27 17:32:14+00:00 	SMOKE59	CURRENT SMOKING STATUS
69	Cigarette smoking	110131	phv00110131.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:32:25+00:00	2018-09-27 17:32:25+00:00 	SMOKE59	CURRENT SMOKING STATUS
69	Cigarette smoking	99446	phv00099446.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:32:59+00:00	2018-09-27 17:32:59+00:00 	PKYRS	PACK YEARS SMOKED
69	Cigarette smoking	100467	phv00100467.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:33:08+00:00	2018-09-27 17:33:08+00:00 	PKYRS	PACK YEARS SMOKED
69	Cigarette smoking	105892	phv00105892.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:33:17+00:00	2018-09-27 17:33:17+00:00 	PKYRS	PACK YEARS SMOKED
69	Cigarette smoking	99159	phv00099159.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:33:41+00:00	2018-09-27 17:33:41+00:00 	AMOUNT08	HOW MANY DID YOU SMOKE PER DAY ON AVER  (99=UNKNOWN)
69	Cigarette smoking	100341	phv00100341.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:33:50+00:00	2018-09-27 17:33:50+00:00 	AMOUNT	CIGS SMOKED/DAY
69	Cigarette smoking	106200	phv00106200.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:34:01+00:00	2018-09-27 17:34:01+00:00 	AMOUNT58	HOW MANY DID YOU SMOKE PER DAY ON AVER.
69	Cigarette smoking	101621	phv00101621.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:37:16+00:00	2018-09-27 17:37:16+00:00 	NUMCIG59	NUMBER CIGARETTES SMOKED PER DAY
69	Cigarette smoking	102801	phv00102801.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:37:25+00:00	2018-09-27 17:37:25+00:00 	NUMCIG59	NUMBER CIGARETTES SMOKED PER DAY
69	Cigarette smoking	104871	phv00104871.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:37:33+00:00	2018-09-27 17:37:33+00:00 	NUMCIG39	NUMBER OF CIGARETTES/DAY
69	Cigarette smoking	107228	phv00107228.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:37:45+00:00	2018-09-27 17:37:45+00:00 	NUMCIG29	NUMBER CIGARETTES SMOKED PER DAY
69	Cigarette smoking	108096	phv00108096.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:37:53+00:00	2018-09-27 17:37:53+00:00 	NUMCIG59	NUMBER CIGARETTES SMOKED PER DAY
69	Cigarette smoking	108731	phv00108731.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:38:07+00:00	2018-09-27 17:38:07+00:00 	NUMCIG59	NUMBER CIGARETTES SMOKED PER DAY
69	Cigarette smoking	109463	phv00109463.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:38:17+00:00	2018-09-27 17:38:17+00:00 	NUMCIG59	NUMBER CIGARETTES SMOKED PER DAY
69	Cigarette smoking	110130	phv00110130.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:38:26+00:00	2018-09-27 17:38:26+00:00 	NUMCIG59	NUMBER CIGARETTES SMOKED PER DAY
69	Cigarette smoking	99156	phv00099156.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:43:41+00:00	2018-09-27 17:43:41+00:00 	SMK3008	HAVE YOU SMOKED IN LAST 30 DAYS
69	Cigarette smoking	99157	phv00099157.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:43:51+00:00	2018-09-27 17:43:51+00:00 	SMKAGE08	HOW OLD WHEN YOU STARTED TO SMOKE
69	Cigarette smoking	99334	phv00099334.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:44:01+00:00	2018-09-27 17:44:01+00:00 	SMKHR11	SMOKE DURING THE PAST HOUR
69	Cigarette smoking	99477	phv00099477.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:44:11+00:00	2018-09-27 17:44:11+00:00 	SMKAMT	SMOKE AMOUNT
69	Cigarette smoking	100373	phv00100373.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:44:21+00:00	2018-09-27 17:44:21+00:00 	SMKAMT	SMOKE AMOUNT
69	Cigarette smoking	101620	phv00101620.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:44:33+00:00	2018-09-27 17:44:33+00:00 	SMK3059	SMOKED CIGARETTES DURING LAST 30 DAYS
69	Cigarette smoking	102800	phv00102800.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:44:44+00:00	2018-09-27 17:44:44+00:00 	SMK3059	SMOKED CIGARETTES DURING LAST 30 DAYS
69	Cigarette smoking	104287	phv00104287.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:44:56+00:00	2018-09-27 17:44:56+00:00 	SMK38	SMOKED MORE THAN 100 CIGARETTES
69	Cigarette smoking	104288	phv00104288.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:45:11+00:00	2018-09-27 17:45:11+00:00 	SMK3038	SMOKED CIGARETTES DURING LAST 30 DAYS
69	Cigarette smoking	104872	phv00104872.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:46:10+00:00	2018-09-27 17:46:10+00:00 	SMKQIT39	QUIT SMOKING IN LAST YEAR
69	Cigarette smoking	105890	phv00105890.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:46:47+00:00	2018-09-27 17:46:47+00:00 	SMKAMT	SMOKE AMOUNT
69	Cigarette smoking	106197	phv00106197.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:46:57+00:00	2018-09-27 17:46:57+00:00 	SMK3058	HAVE YOU SMOKED IN LAST 30 DAYS
69	Cigarette smoking	106198	phv00106198.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:47:08+00:00	2018-09-27 17:47:08+00:00 	SMKAGE58	HOW OLD WHEN YOU STARTED TO SMOKE
69	Cigarette smoking	107227	phv00107227.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:47:44+00:00	2018-09-27 17:47:44+00:00 	SMK3029	SMOKED CIGARETTES DURING LAST 30 DAYS
69	Cigarette smoking	108095	phv00108095.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:48:11+00:00	2018-09-27 17:48:11+00:00 	SMK3059	SMOKED CIGARETTES DURING LAST 30 DAYS
69	Cigarette smoking	108730	phv00108730.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:48:32+00:00	2018-09-27 17:48:32+00:00 	SMK3059	SMOKED CIGARETTES DURING LAST 30 DAYS
69	Cigarette smoking	109462	phv00109462.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:48:44+00:00	2018-09-27 17:48:44+00:00 	SMK3059	SMOKED CIGARETTES DURING LAST 30 DAYS
69	Cigarette smoking	110129	phv00110129.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:48:54+00:00	2018-09-27 17:48:54+00:00 	SMK3059	SMOKED CIGARETTES DURING LAST 30 DAYS
69	Cigarette smoking	197475	phv00197475.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:49:04+00:00	2018-09-27 17:49:04+00:00 	agesmk15	Age started smoking? (years)
69	Cigarette smoking	197478	phv00197478.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:49:15+00:00	2018-09-27 17:49:15+00:00 	smknow15	Do you now smoke cigarettes?
69	Cigarette smoking	197482	phv00197482.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:49:26+00:00	2018-09-27 17:49:26+00:00 	avesmk15	How many cigarettes per day did you average over all the time you smoked?
69	Cigarette smoking	99158	phv00099158.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:49:49+00:00	2018-09-27 17:49:49+00:00 	STOP08	HOW OLD WERE WHEN YOU STOPPED SMOKING  (99=UNKNOWN)
69	Cigarette smoking	106199	phv00106199.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:50:30+00:00	2018-09-27 17:50:30+00:00 	STOP58	HOW OLD WERE WHEN YOU STOPPED SMOKING
69	Cigarette smoking	7612	phv00007612.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	A99	SMOKES CIGARETTES
69	Cigarette smoking	7613	phv00007613.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	A100	AGE STARTED SMOKING CIGARETTES REGULARLY
69	Cigarette smoking	7614	phv00007614.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	A101	IF STOPPED, AGE STOPPED
69	Cigarette smoking	7615	phv00007615.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	A102	USUAL # OF CIGARETTES SMOKED, NOW OR EVER
69	Cigarette smoking	7736	phv00007736.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B86	SMOKING NOW
69	Cigarette smoking	7737	phv00007737.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B87	SMOKING LAST YEAR(NOT SMOKING NOW)
69	Cigarette smoking	7738	phv00007738.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B88	NO. OF CIGARETTES PER DAY
69	Cigarette smoking	7742	phv00007742.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B92	INHALES CIGARETTES
69	Cigarette smoking	7746	phv00007746.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B96	SMOKING TIME PATTERN
69	Cigarette smoking	7747	phv00007747.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B97	AGE START CIGARETTE SMOKING
69	Cigarette smoking	7748	phv00007748.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B98	MAX NO. CIGARETTES PER DAY
69	Cigarette smoking	7749	phv00007749.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B99	STOP SMOKING CIGARETTE LAST YEAR OR LONGER
69	Cigarette smoking	7750	phv00007750.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B100	NO. YEARS STOPPED SMOKING CIGARETTE
69	Cigarette smoking	7752	phv00007752.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B102	CIGARETTE RANK
69	Cigarette smoking	7994	phv00007994.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B376	EVER SMOKED CIGARETTES REGULARLY
69	Cigarette smoking	7995	phv00007995.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B377	NUMBER OF CIGARETTES SMOKED
69	Cigarette smoking	7996	phv00007996.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:04:00+00:00	2018-10-03 13:04:00+00:00 	B379	CURRENT CIGARETTE SMOKING
69	Cigarette smoking	21635	phv00021635.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:05:53+00:00	2018-10-03 13:05:53+00:00 	BW34	LIVE-BIRTH PREGNANCY #1: SMOKED CIGARETTES DURING  THE PREGNANCY?
69	Cigarette smoking	21647	phv00021647.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:05:53+00:00	2018-10-03 13:05:53+00:00 	BW47	LIVE-BIRTH PREGNANCY #2: SMOKED CIGARETTES DURING THE PREGNANCY
69	Cigarette smoking	21659	phv00021659.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:05:53+00:00	2018-10-03 13:05:53+00:00 	BW60	LIVE-BIRTH PREGNANCY #3: SMOKED CIGARETTES DURING  THE PREGNANCY?
69	Cigarette smoking	21671	phv00021671.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:05:53+00:00	2018-10-03 13:05:53+00:00 	BW73	LIVE-BIRTH PREGNANCY #4: SMOKED CIGARETTES DURING  THE PREGNANCY
69	Cigarette smoking	21683	phv00021683.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:05:53+00:00	2018-10-03 13:05:53+00:00 	BW86	LIVE-BIRTH PREGNANCY #5: SMOKED CIGARETTES DURING  THE PREGNANCY?
69	Cigarette smoking	24398	phv00024398.v4.p10	pht000194.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:05:53+00:00	2018-10-03 13:05:53+00:00 	BR25	HAVE YOU SMOKED CIGARETTES IN THE LAST 6 HOURS?
69	Cigarette smoking	24399	phv00024399.v4.p10	pht000194.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:05:53+00:00	2018-10-03 13:05:53+00:00 	BR26	IF SMOKED IN LAST 6 HOURS, HOW MANY HOURS SINCE YOUR LAST CIGARETTE? (NOTE: FOR TIME SINCE LAST CIGARETTE, BOTH BR26 AND BR27 NEED TO BE USED.)
69	Cigarette smoking	24400	phv00024400.v4.p10	pht000194.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:05:53+00:00	2018-10-03 13:05:53+00:00 	BR27	IF SMOKED IN LAST 6 HOURS, HOW MANY MINUTES SINCE YOUR LAST CIGARETTE? (NOTE: FOR TIME SINCE LAST CIGARETTE, BOTH BR26 AND BR27 NEED TO BE USED.)
69	Cigarette smoking	8442	phv00008442.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:07:44+00:00	2018-10-03 13:07:44+00:00 	C67	SMOKED CIGARETTES REGULARLY IN LAST YEAR
69	Cigarette smoking	8443	phv00008443.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:07:44+00:00	2018-10-03 13:07:44+00:00 	C68	CIGARETTES SMOKED PER DAY
69	Cigarette smoking	8444	phv00008444.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:07:44+00:00	2018-10-03 13:07:44+00:00 	C69	INHALED CIGARETTES
69	Cigarette smoking	8445	phv00008445.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:07:44+00:00	2018-10-03 13:07:44+00:00 	C70	STRENGTH OF CIGARETTE
69	Cigarette smoking	8446	phv00008446.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:07:44+00:00	2018-10-03 13:07:44+00:00 	C71	TYPE CIGARETTE
69	Cigarette smoking	8447	phv00008447.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:07:44+00:00	2018-10-03 13:07:44+00:00 	C72	FILTER CIGARETTE
69	Cigarette smoking	8448	phv00008448.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:07:44+00:00	2018-10-03 13:07:44+00:00 	C73	LENGTH OF CIGARETTE
69	Cigarette smoking	8449	phv00008449.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:07:45+00:00	2018-10-03 13:07:45+00:00 	C74	HOURS SINCE LAST CIGARETTE
69	Cigarette smoking	55254	phv00055254.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:07:45+00:00	2018-10-03 13:07:45+00:00 	CgPkYr	Lifetime cigarette smoking: pack years
69	Cigarette smoking	55319	phv00055319.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:07:45+00:00	2018-10-03 13:07:45+00:00 	CIGDAY15	If yes to [SMKNOW15]: How many cigarettes do you smoke per day now?
69	Cigarette smoking	55405	phv00055405.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:07:45+00:00	2018-10-03 13:07:45+00:00 	CGRTTS10	How many cigarettes 4 hours before going to sleep last night?
69	Cigarette smoking	56609	phv00056609.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:07:45+00:00	2018-10-03 13:07:45+00:00 	cgpkyrdt	Lifetime cigarette smoking Date
69	Cigarette smoking	277028	phv00277028.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:09:17+00:00	2018-10-03 13:09:17+00:00 	CPD1	Number of cigarettes smoked per day, Exam 1
69	Cigarette smoking	277029	phv00277029.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:09:17+00:00	2018-10-03 13:09:17+00:00 	CPD2	Number of cigarettes smoked per day, Exam 2
69	Cigarette smoking	277113	phv00277113.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:09:17+00:00	2018-10-03 13:09:17+00:00 	CPD1	Number of cigarettes smoked per day, Exam 1
69	Cigarette smoking	277114	phv00277114.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:09:17+00:00	2018-10-03 13:09:17+00:00 	CPD2	Number of cigarettes smoked per day, Exam 2
69	Cigarette smoking	277115	phv00277115.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:09:17+00:00	2018-10-03 13:09:17+00:00 	CPD3	Number of cigarettes smoked per day, Exam 3
69	Cigarette smoking	277116	phv00277116.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:09:17+00:00	2018-10-03 13:09:17+00:00 	CPD4	Number of cigarettes smoked per day, Exam 4
69	Cigarette smoking	277117	phv00277117.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:09:17+00:00	2018-10-03 13:09:17+00:00 	CPD5	Number of cigarettes smoked per day, Exam 5
69	Cigarette smoking	277118	phv00277118.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:09:17+00:00	2018-10-03 13:09:17+00:00 	CPD6	Number of cigarettes smoked per day, Exam 6
69	Cigarette smoking	277119	phv00277119.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:09:17+00:00	2018-10-03 13:09:17+00:00 	CPD7	Number of cigarettes smoked per day, Exam 7
69	Cigarette smoking	277120	phv00277120.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:09:17+00:00	2018-10-03 13:09:17+00:00 	CPD8	Number of cigarettes smoked per day, Exam 8
69	Cigarette smoking	277121	phv00277121.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:09:17+00:00	2018-10-03 13:09:17+00:00 	CPD9	Number of cigarettes smoked per day, Exam 9
69	Cigarette smoking	277032	phv00277032.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:10:22+00:00	2018-10-03 13:10:22+00:00 	CURRSMK1	Current smoking status, Exam 1
69	Cigarette smoking	277033	phv00277033.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:10:22+00:00	2018-10-03 13:10:22+00:00 	CURRSMK2	Current smoking status, Exam 2
69	Cigarette smoking	277128	phv00277128.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:10:22+00:00	2018-10-03 13:10:22+00:00 	CURRSMK1	Current smoking status, Exam 1
69	Cigarette smoking	277129	phv00277129.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:10:23+00:00	2018-10-03 13:10:23+00:00 	CURRSMK2	Current smoking status, Exam 2
69	Cigarette smoking	277130	phv00277130.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:10:23+00:00	2018-10-03 13:10:23+00:00 	CURRSMK3	Current smoking status, Exam 3
69	Cigarette smoking	277131	phv00277131.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:10:23+00:00	2018-10-03 13:10:23+00:00 	CURRSMK4	Current smoking status, Exam 4
69	Cigarette smoking	277132	phv00277132.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:10:23+00:00	2018-10-03 13:10:23+00:00 	CURRSMK5	Current smoking status, Exam 5
69	Cigarette smoking	277133	phv00277133.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:10:23+00:00	2018-10-03 13:10:23+00:00 	CURRSMK6	Current smoking status, Exam 6
69	Cigarette smoking	277134	phv00277134.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:10:23+00:00	2018-10-03 13:10:23+00:00 	CURRSMK7	Current smoking status, Exam 7
69	Cigarette smoking	277135	phv00277135.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:10:23+00:00	2018-10-03 13:10:23+00:00 	CURRSMK8	Current smoking status, Exam 8
69	Cigarette smoking	277136	phv00277136.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:10:23+00:00	2018-10-03 13:10:23+00:00 	CURRSMK9	Current smoking status, Exam 9
69	Cigarette smoking	8762	phv00008762.v6.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:11:32+00:00	2018-10-03 13:11:32+00:00 	D096	BRAND OF CIGARETTE XXXXXXXX (FIRST EIGHT LETTERS OF CIGARETTE BRAND)
69	Cigarette smoking	8862	phv00008862.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:11:32+00:00	2018-10-03 13:11:32+00:00 	D093	SMOKED CIGARETTES REGULARLY IN PAST YEAR
69	Cigarette smoking	8863	phv00008863.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:11:32+00:00	2018-10-03 13:11:32+00:00 	D094	HOW MANY CIGARETTES DO/DID YOU SMOKE PER DAY
69	Cigarette smoking	8865	phv00008865.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:11:32+00:00	2018-10-03 13:11:32+00:00 	D097	STRENGTH OF CIGARETTES SMOKED
69	Cigarette smoking	8866	phv00008866.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:11:32+00:00	2018-10-03 13:11:32+00:00 	D098	TYPE OF CIGARETTES SMOKED
69	Cigarette smoking	8867	phv00008867.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:11:32+00:00	2018-10-03 13:11:32+00:00 	D099	FILTER OF CIGARETTES SMOKED
69	Cigarette smoking	8868	phv00008868.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:11:32+00:00	2018-10-03 13:11:32+00:00 	D100	LENGTH OF CIGARETTES SMOKED
69	Cigarette smoking	8869	phv00008869.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:11:32+00:00	2018-10-03 13:11:32+00:00 	D101	NUMBER OF HOURS SINCE LAST CIGARETTE
69	Cigarette smoking	9272	phv00009272.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	E319	SMOKED CIGARETTES REGULARLY IN LAST YEAR
69	Cigarette smoking	9273	phv00009273.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	E320	HOW MANY CIGARETTES SMOKED PER DAY
69	Cigarette smoking	9274	phv00009274.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	E321	CIGARETTES - DO YOU INHALE?
69	Cigarette smoking	9275	phv00009275.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	E322	CIGARETTE BRAND XXXXXXXX (FIRST EIGHT LETTERS OF CIGARETTE BRAND)
69	Cigarette smoking	9276	phv00009276.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	E323	CIGARETTE-STRENGTH
69	Cigarette smoking	9277	phv00009277.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	E324	CIGARETTE-TYPE
69	Cigarette smoking	9278	phv00009278.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	E325	CIGARETTE-FILTER
69	Cigarette smoking	9279	phv00009279.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	E326	CIGARETTE-LENGTH
69	Cigarette smoking	9280	phv00009280.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	E327	HOURS SINCE LAST CIGARETTE
69	Cigarette smoking	250452	phv00250452.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	e319	Medical History - Smoking: Smoked cigarettes regularly in last year? Collection Interval: Exam 1
69	Cigarette smoking	250453	phv00250453.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	e320	Medical History - Smoking: How many cigarettes do/did you smoke per day? Collection Interval: Exam 1
69	Cigarette smoking	250454	phv00250454.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	e321	Medical History - Smoking: Do you inhale? Collection Interval: Exam 1
69	Cigarette smoking	250455	phv00250455.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	e322	Medical History - Smoking: Cigarette brand Collection Interval: Exam 1
69	Cigarette smoking	250456	phv00250456.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	e323	Medical History - Smoking: Cigarette-strength Collection Interval: Exam 1
69	Cigarette smoking	250457	phv00250457.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	e324	Medical History - Smoking: Cigarette-type Collection Interval: Exam 1
69	Cigarette smoking	250458	phv00250458.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	e325	Medical History - Smoking: Cigarette-filter Collection Interval: Exam 1
69	Cigarette smoking	250459	phv00250459.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	e326	Medical History - Smoking: Cigarette-length Collection Interval: Exam 1
69	Cigarette smoking	250460	phv00250460.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:16:04+00:00	2018-10-03 13:16:04+00:00 	e327	Medical History - Smoking: How many hours since last cigarette? Collection Interval: Exam 1
69	Cigarette smoking	1143	phv00001143.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	FA137	SMOKING HISTORY:  SMOKES CIGARETTES NOW (1 YEAR OR MORE DURING INTERIM)
69	Cigarette smoking	1144	phv00001144.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	FA138	SMOKING HISTORY:  USES FILTER
69	Cigarette smoking	1145	phv00001145.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	FA139	SMOKING HISTORY:  INHALES
69	Cigarette smoking	1146	phv00001146.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	FA140	SMOKING HISTORY:  PROPORTION OF CIGARETTE SMOKED
69	Cigarette smoking	9778	phv00009778.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	F288	SMOKED CIGARETTES REGULARLY IN LAST YEAR
69	Cigarette smoking	9779	phv00009779.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	F289	HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY
69	Cigarette smoking	9781	phv00009781.v6.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	F291	CIGARETTE BRAND XXXXXXXX (FIRST 8 LETTERS OF BRAND)
69	Cigarette smoking	9782	phv00009782.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	F292	STRENGTH OF CIGARETTES SMOKED
69	Cigarette smoking	9783	phv00009783.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	F293	TYPE OF CIGARETTES SMOKED
69	Cigarette smoking	9784	phv00009784.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	F294	FILTER OF CIGARETTES SMOKED
69	Cigarette smoking	9785	phv00009785.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	F295	LENGTH OF CIGARETTES SMOKED
69	Cigarette smoking	9786	phv00009786.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	F296	HOW MANY HOURS SINCE LAST CIGARETTE
69	Cigarette smoking	24446	phv00024446.v5.p10	pht000195.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	EF09	IF YES (TO EF08), HOW MANY HOURS SINCE YOUR LAST CIGARETTE?
69	Cigarette smoking	24447	phv00024447.v5.p10	pht000195.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	EF10	IF YES (TO EF08), HOW MANY MINUTES SINCE YOUR LAST CIGARETTE?
69	Cigarette smoking	55315	phv00055315.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:18:07+00:00	2018-10-03 13:18:07+00:00 	EVSMOK15	Have you ever smoked cigarettes ('ever' = at least 20 packs in lifetime)?
69	Cigarette smoking	1258	phv00001258.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FB86	INTERIM HISTORY OF SMOKING:  SMOKES CIGARETTES
69	Cigarette smoking	1259	phv00001259.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FB87	INTERIM HISTORY OF SMOKING: NUMBER CIGARETTES/DAY
69	Cigarette smoking	1260	phv00001260.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FB88	INTERIM HISTORY OF SMOKING: PORTION OF CIGARETTE SMOKED
69	Cigarette smoking	1261	phv00001261.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FB89	INTERIM HISTORY OF SMOKING:  USES FILTER
69	Cigarette smoking	1262	phv00001262.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FB90	INTERIM HISTORY OF SMOKING:  INHALES
69	Cigarette smoking	1452	phv00001452.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FC102	INTERIM HISTORY OF SMOKING: SMOKES CIGARETTES
69	Cigarette smoking	1453	phv00001453.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FC103	INTERIM HISTORY OF SMOKING: NO. OF CIGARETTES PER DAY
69	Cigarette smoking	1454	phv00001454.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FC104	INTERIM HISTORY OF SMOKING: PORTION OF CIGARETTE SMOKED
69	Cigarette smoking	1455	phv00001455.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FC105	INTERIM HISTORY OF SMOKING: USES FILTER ON CIGARETTE
69	Cigarette smoking	1456	phv00001456.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FC106	INTERIM HISTORY OF SMOKING: INHALES CIGARETTE
69	Cigarette smoking	1636	phv00001636.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FD95	INTERIM HISTORY OF SMOKING: SMOKES CIGARETTES
69	Cigarette smoking	1637	phv00001637.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FD96	INTERIM HISTORY OF SMOKING: NUMBER OF CIGARETTES PER DAY
69	Cigarette smoking	1638	phv00001638.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FD97	INTERIM HISTORY OF SMOKING: PORTION OF CIGARETTE SMOKED
69	Cigarette smoking	1639	phv00001639.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FD98	INTERIM HISTORY OF SMOKING: USES FILTER ON CIGARETTE
69	Cigarette smoking	1640	phv00001640.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:20:29+00:00	2018-10-03 13:20:29+00:00 	FD99	INTERIM HISTORY OF SMOKING: INHALES CIGARETTE
69	Cigarette smoking	1838	phv00001838.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FE108	INTERIM HISTORY OF SMOKING: AMOUNT SMOKED: CIGARETTES/DAY
69	Cigarette smoking	1843	phv00001843.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FE113	CIGARETTE SMOKING ONLY: MAXIMUM NO. OF CIGARETTES/DAY EVER SMOKED REGULARLY FOR AS LONG AS ONE YEAR
69	Cigarette smoking	1844	phv00001844.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FE114	CIGARETTE SMOKING ONLY: STOPPED SMOKING CIGARETTES FOR LAST YEAR OR LONGER
69	Cigarette smoking	1845	phv00001845.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FE115	CIGARETTE SMOKING ONLY: YEARS SINCE STOPPED SMOKING CIGARETTES
69	Cigarette smoking	1846	phv00001846.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FE116	CIGARETTE SMOKING ONLY: REASON FOR STOPPING
69	Cigarette smoking	1847	phv00001847.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FE117	CIGARETTE SMOKING ONLY: IF NOW SMOKING: PORTION OF CIGARETTE SMOKED
69	Cigarette smoking	1848	phv00001848.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FE118	CIGARETTE SMOKING ONLY: IF NOW SMOKING: USES FILTER CIGARETTES
69	Cigarette smoking	1849	phv00001849.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FE119	CIGARETTE SMOKING ONLY: IF NOW SMOKING: INHALES CIGARETTES
69	Cigarette smoking	2055	phv00002055.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FF108	INTERIM HISTORY OF SMOKING: EVER SMOKED
69	Cigarette smoking	2056	phv00002056.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FF109	INTERIM HISTORY OF SMOKING: SMOKED AT LEAST ONE YR. IN LAST TWO YRS.
69	Cigarette smoking	2057	phv00002057.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FF110	INTERIM HISTORY OF SMOKING: AMOUNT SMOKED: CIGARETTES/DAY
69	Cigarette smoking	2061	phv00002061.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FF114	CIGARETTE SMOKING ONLY: STOPPED SMOKING CIGARETTES FOR LAST YEAR OR LONGER
69	Cigarette smoking	2062	phv00002062.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FF115	CIGARETTE SMOKING ONLY: IF NOW SMOKING: PORTION OF CIGARETTE SMOKED
69	Cigarette smoking	2063	phv00002063.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FF116	CIGARETTE SMOKING ONLY: IF NOW SMOKING: USES FILTER CIGARETTES
69	Cigarette smoking	2064	phv00002064.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FF117	CIGARETTE SMOKING ONLY: IF NOW SMOKING: INHALES CIGARETTES
69	Cigarette smoking	2238	phv00002238.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FG104	INTERIM HISTORY OF SMOKING: AMOUNT SMOKED: CIGARETTES/DAY
69	Cigarette smoking	2242	phv00002242.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FG108	CIGARETTE SMOKING ONLY: IF NOW SMOKING: USES FILTER CIGARETTES
69	Cigarette smoking	2243	phv00002243.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:25:22+00:00	2018-10-03 13:25:22+00:00 	FG109	CIGARETTE SMOKING ONLY: IF NOW SMOKING: INHALES CIGARETTES
69	Cigarette smoking	2459	phv00002459.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FH102	INTERIM HISTORY OF SMOKING: AMOUNT SMOKED: CIGARETTES/DAY
69	Cigarette smoking	2463	phv00002463.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FH106	CIGARETTE SMOKING ONLY: IF NOW SMOKING: USES FILTER CIGARETTES
69	Cigarette smoking	2464	phv00002464.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FH107	CIGARETTE SMOKING ONLY: IF NOW SMOKING: INHALES CIGARETTES
69	Cigarette smoking	2981	phv00002981.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FJ38	SMOKING HISTORY: EVER SMOKED CIGARETTES REGULARLY
69	Cigarette smoking	2982	phv00002982.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FJ39	SMOKING HISTORY: FOR CURRENT & FORMER SMOKERS: CIGARETTES/DAY SMOKED DURING MOST OF SMOKING LIFETIME
69	Cigarette smoking	2983	phv00002983.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FJ40	SMOKING HISTORY: NO. CIGARETTES/DAY
69	Cigarette smoking	2984	phv00002984.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FJ41	SMOKING HISTORY: AGE STOPPED SMOKING
69	Cigarette smoking	2985	phv00002985.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FJ42	SMOKING HISTORY: AGE STARTED
69	Cigarette smoking	2986	phv00002986.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FJ43	SMOKING HISTORY: YEARS STOPPED DURING SMOKING PERIOD
69	Cigarette smoking	2987	phv00002987.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FJ44	SMOKING HISTORY: INHALE
69	Cigarette smoking	2988	phv00002988.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FJ45	SMOKING HISTORY: USE FILTER
69	Cigarette smoking	2989	phv00002989.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FJ46	SMOKING HISTORY: WHAT BRAND LAST SMOKED
69	Cigarette smoking	2990	phv00002990.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FJ47	CODE FOR CIGARETTE CARD EDITION
69	Cigarette smoking	2991	phv00002991.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FJ48	SMOKING HISTORY: HOW MANY HOURS SINCE YOUR LAST CIGARETTE
69	Cigarette smoking	3379	phv00003379.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FK131	SMOKING HISTORY: NUMBER OF CIGARETTES SMOKED PER DAY
69	Cigarette smoking	3380	phv00003380.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FK132	SMOKING HISTORY: DOES PATIENT INHALE
69	Cigarette smoking	3381	phv00003381.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FK133	SMOKING HISTORY: WHAT BRAND DID PATIENT SMOKE
69	Cigarette smoking	3382	phv00003382.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FK134	SMOKING HISTORY: CODE BRAND
69	Cigarette smoking	3383	phv00003383.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:28:22+00:00	2018-10-03 13:28:22+00:00 	FK135	SMOKING HISTORY: NUMBER OF HOURS SINCE LAST CIGARETTE
69	Cigarette smoking	3830	phv00003830.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FL186	SMOKE CIGARETTES REGULARLY IN PAST YEAR
69	Cigarette smoking	3831	phv00003831.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FL187	HOW MANY CIGARETTES DO/DID YOU SMOKE PER DAY
69	Cigarette smoking	3833	phv00003833.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FL189	STRENGTH OF CIGARETTES SMOKED
69	Cigarette smoking	3834	phv00003834.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FL190	TYPE OF CIGARETTES SMOKED
69	Cigarette smoking	3835	phv00003835.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FL191	FILTER OF CIGARETTES SMOKED
69	Cigarette smoking	3836	phv00003836.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FL192	LENGTH OF CIGARETTES SMOKED
69	Cigarette smoking	3837	phv00003837.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FL193	NUMBER OF HOURS SINCE LAST CIGARETTE
69	Cigarette smoking	4095	phv00004095.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FM235	BRAND OF CIGARETTE
69	Cigarette smoking	4273	phv00004273.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FM232	SMOKED CIGARETTES REGULARLY IN LAST YEAR
69	Cigarette smoking	4274	phv00004274.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FM233	HOW MANY CIGARETTES DO/DID YOU SMOKE PER DAY?
69	Cigarette smoking	4276	phv00004276.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FM236	STRENGTH OF CIGARETTES SMOKED
69	Cigarette smoking	4277	phv00004277.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FM237	TYPE OF CIGARETTES SMOKED
69	Cigarette smoking	4278	phv00004278.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FM238	FILTER OF CIGARETTES SMOKED
69	Cigarette smoking	4279	phv00004279.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FM239	LENGTH OF CIGARETTES SMOKED
69	Cigarette smoking	4280	phv00004280.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FM240	NUMBER OF HOURS SINCE LAST CIGARETTE
69	Cigarette smoking	4537	phv00004537.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FN188	CIGARETTE BRAND XXXXXXXX FIRST EIGHT LETTERS OF CIGARETTE BRAND
69	Cigarette smoking	4683	phv00004683.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FN185	SMOKED CIGARETTES REGULARLY IN LAST YEAR
69	Cigarette smoking	4684	phv00004684.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FN186	HOW MANY CIGARETTES SMOKED PER DAY
69	Cigarette smoking	4685	phv00004685.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:30:58+00:00	2018-10-03 13:30:58+00:00 	FN187	CIGARETTES - DO YOU INHALE?
69	Cigarette smoking	4686	phv00004686.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FN189	CIGARETTE-STRENGTH
69	Cigarette smoking	4687	phv00004687.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FN190	CIGARETTE-TYPE
69	Cigarette smoking	4688	phv00004688.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FN191	CIGARETTE-FILTER
69	Cigarette smoking	4689	phv00004689.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FN192	CIGARETTE-LENGTH
69	Cigarette smoking	4690	phv00004690.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FN193	HOURS SINCE LAST CIGARETTE
69	Cigarette smoking	5033	phv00005033.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FO180	SMOKED CIGARETTES REGULARLY IN LAST YEAR?
69	Cigarette smoking	5034	phv00005034.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FO181	CIGARETTES - HOW MANY CIGARETTES DO/DID YOU SMOKE PER DAY?
69	Cigarette smoking	5035	phv00005035.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FO182	CIGARETTES - DO YOU INHALE?
69	Cigarette smoking	5037	phv00005037.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FO184	CIGARETTE-STRENGTH
69	Cigarette smoking	5038	phv00005038.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FO185	CIGARETTE-TYPE
69	Cigarette smoking	5039	phv00005039.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FO186	CIGARETTE-FILTER
69	Cigarette smoking	5040	phv00005040.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FO187	CIGARETTE-LENGTH
69	Cigarette smoking	5041	phv00005041.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FO188	HOURS SINCE LAST CIGARETTE
69	Cigarette smoking	5036	phv00005036.v2.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:51:22+00:00	2018-10-03 13:51:22+00:00 	FO183	CIGARETTE BRAND XXXXXXXX FIRST EIGHT LETTERS OF CIGARETTE BRAND
69	Cigarette smoking	5652	phv00005652.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FP133	SMOKED CIGARETTES REGULARLY IN LAST YEAR
69	Cigarette smoking	5653	phv00005653.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FP134	HOW MANY CIGARETTES SMOKED PER DAY
69	Cigarette smoking	5654	phv00005654.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FP135	CIGARETTES - DO YOU INHALE?
69	Cigarette smoking	5655	phv00005655.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FP136	CIGARETTE BRAND XXXXXXXX FIRST EIGHT LETTERS OF CIGARETTE BRAND
69	Cigarette smoking	5656	phv00005656.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FP137	CIGARETTE-STRENGTH
69	Cigarette smoking	5657	phv00005657.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FP138	CIGARETTE-TYPE
69	Cigarette smoking	5658	phv00005658.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FP139	CIGARETTE-FILTER
69	Cigarette smoking	5659	phv00005659.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FP140	CIGARETTE-LENGTH
69	Cigarette smoking	5660	phv00005660.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FP141	HOURS SINCE LAST CIGARETTE
69	Cigarette smoking	6179	phv00006179.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FQ194	SMOKED CIGARETTES REGULARLY IN LAST YEAR?
69	Cigarette smoking	6180	phv00006180.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FQ195	IF YES (TO FQ194), HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY?
69	Cigarette smoking	6525	phv00006525.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FR252	SMOKING HISTORY SMOKED CIGARETTES REGULARLY IN THE LAST YEAR?
69	Cigarette smoking	6526	phv00006526.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FR253	SMOKING HISTORY HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY?
69	Cigarette smoking	6956	phv00006956.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FS347	SMOKING: SMOKED CIGARETTES REGULARLY IN THE LAST YEAR?
69	Cigarette smoking	6957	phv00006957.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FS348	SMOKING: HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY?
69	Cigarette smoking	7388	phv00007388.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FT349	SMOKING: SMOKED CIGARETTES REGULARLY IN THE LAST YEAR?
69	Cigarette smoking	7389	phv00007389.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FT350	SMOKING: HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY?
69	Cigarette smoking	70406	phv00070406.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FU050	SMOKING: SMOKED CIGARETTES REGULARLY SINCE YOUR LAST EXAM?
69	Cigarette smoking	70407	phv00070407.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:54:21+00:00	2018-10-03 13:54:21+00:00 	FU051	SMOKING: HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY?
69	Cigarette smoking	10259	phv00010259.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:56:29+00:00	2018-10-03 13:56:29+00:00 	G116	SMOKED CIGARETTES REGULARLY IN LAST YEAR
69	Cigarette smoking	10260	phv00010260.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:56:29+00:00	2018-10-03 13:56:29+00:00 	G117	HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY
69	Cigarette smoking	250827	phv00250827.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:56:29+00:00	2018-10-03 13:56:29+00:00 	g116	Medical History - Smoking: Smoked cigarettes regularly in the last year Collection Interval: Exam 2
69	Cigarette smoking	250828	phv00250828.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:56:29+00:00	2018-10-03 13:56:29+00:00 	g117	Medical History - Smoking: How many cigarettes do/did you smoke a day Collection Interval: Exam 2
69	Cigarette smoking	254617	phv00254617.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:56:29+00:00	2018-10-03 13:56:29+00:00 	fv026	Medical History - Smoking: Have you smoked cigarettes regularly since your last exam? Collection Interval: Exam 29
69	Cigarette smoking	254618	phv00254618.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:56:29+00:00	2018-10-03 13:56:29+00:00 	fv027	Medical History - Smoking: How many cigarettes do/did you smoke a day? Collection Interval: Exam 29
69	Cigarette smoking	255005	phv00255005.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:56:29+00:00	2018-10-03 13:56:29+00:00 	fw025	Medical History - Smoking: Do you smoke cigarettes regularly since last exam? Collection Interval: Original Cohort Exam 30
69	Cigarette smoking	255006	phv00255006.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:56:29+00:00	2018-10-03 13:56:29+00:00 	fw026	Medical History - Smoking: How many cigarettes do you smoke a day? Collection Interval: Original Cohort Exam 30
69	Cigarette smoking	274725	phv00274725.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:56:29+00:00	2018-10-03 13:56:29+00:00 	FX025	Medical History - Smoking: Have you smoked cigarettes regularly since last exam? Collection Interval: Original Cohort Exam 31
69	Cigarette smoking	274726	phv00274726.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:56:29+00:00	2018-10-03 13:56:29+00:00 	FX026	Medical History - Smoking: How many cigarettes do/did you smoke a day? Collection Interval: Original Cohort Exam 31
69	Cigarette smoking	275082	phv00275082.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:56:29+00:00	2018-10-03 13:56:29+00:00 	fy025	Medical History - Smoking: Have you smoked cigarettes regularly since last exam? Collection Interval: Original Cohort Exam 32
69	Cigarette smoking	275083	phv00275083.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 13:56:29+00:00	2018-10-03 13:56:29+00:00 	fy026	Medical History - Smoking: How many cigarettes do/did you smoke a day? Collection Interval: Original Cohort Exam 32
69	Cigarette smoking	10262	phv00010262.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	G119	CIGARETTE BRAND XXXXXXXX (FIRST 8 LETTERS OF BRAND)
69	Cigarette smoking	10263	phv00010263.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	G120	STRENGTH OF CIGARETTES SMOKED
69	Cigarette smoking	10264	phv00010264.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	G121	TYPE OF CIGARETTES SMOKED
69	Cigarette smoking	10265	phv00010265.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	G122	FILTER OF CIGARETTES SMOKED
69	Cigarette smoking	10266	phv00010266.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	G123	LENGTH OF CIGARETTES SMOKED
69	Cigarette smoking	10267	phv00010267.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	G124	HOW MANY HOURS SINCE LAST CIGARETTE?
69	Cigarette smoking	20925	phv00020925.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	G3A070	HAVE YOU EVER SMOKED CIGARETTES REGULARLY? (NO MEANS LESS THAN
69	Cigarette smoking	20926	phv00020926.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	G3A071	IF EVER SMOKED CIGS REGULARLY: HAVE YOU SMOKED CIGARETTES REGULARLY IN THE LAST YEAR?
69	Cigarette smoking	250829	phv00250829.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	g118	Medical History - Smoking: Do you inhale Collection Interval: Exam 2
69	Cigarette smoking	250830	phv00250830.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	g119	Medical History - Smoking: Cigarette brand Collection Interval: Exam 2
69	Cigarette smoking	250831	phv00250831.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	g120	Medical History - Smoking: Strength Collection Interval: Exam 2
69	Cigarette smoking	250832	phv00250832.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	g121	Medical History - Smoking: Type Collection Interval: Exam 2
69	Cigarette smoking	250833	phv00250833.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	g122	Medical History - Smoking: Filter Collection Interval: Exam 2
69	Cigarette smoking	250834	phv00250834.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	g123	Medical History - Smoking: Length Collection Interval: Exam 2
69	Cigarette smoking	250835	phv00250835.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:03+00:00	2018-10-03 14:23:03+00:00 	g124	Medical History - Smoking: How many hours since last cigarette Collection Interval: Exam 2
69	Cigarette smoking	273759	phv00273759.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:04+00:00	2018-10-03 14:23:04+00:00 	g3a070	Have you ever smoked cigarettes regularly? (no means less than 20 packs of cigarettes or 12 oz. of tobacco in a lifetime or less than 1 cigarette a day for a year.) Collection Interval: Exam 1
69	Cigarette smoking	273760	phv00273760.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:04+00:00	2018-10-03 14:23:04+00:00 	g3a071	If ever smoked cigarettes regularly: Have you smoked cigarettes regularly in the last year? Collection Interval: Exam 1
69	Cigarette smoking	274252	phv00274252.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:04+00:00	2018-10-03 14:23:04+00:00 	g3a070	Have you ever smoked cigarettes regularly? (no means less than 20 packs of cigarettes or 12 oz. of tobacco in a lifetime or less than 1 cigarette a day for a year.)
69	Cigarette smoking	274253	phv00274253.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:23:04+00:00	2018-10-03 14:23:04+00:00 	g3a071	If ever smoked cigarettes regularly: Have you smoked cigarettes regularly in the last year?
69	Cigarette smoking	20927	phv00020927.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:24:33+00:00	2018-10-03 14:24:33+00:00 	G3A072	IF EVER SMOKED CIGS REGULARLY: DO YOU NOW SMOKE CIGARETTS (AS OF 1 MONTH AGO)?
69	Cigarette smoking	20928	phv00020928.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:24:33+00:00	2018-10-03 14:24:33+00:00 	G3A073	IF EVER SMOKED CIGS REGULARLY: HOW MANY CIGARETTES DO YOU SMOKE PER DAY NOW?
69	Cigarette smoking	20929	phv00020929.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:24:33+00:00	2018-10-03 14:24:33+00:00 	G3A074	IF EVER SMOKED CIGS REGULARLY: ON THE AVERAGE OF THE ENTIRE TIME YOU SMOKED, HOW MANY CIGARETTES DID YOU SMOKE PER DAY?
69	Cigarette smoking	20930	phv00020930.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:24:33+00:00	2018-10-03 14:24:33+00:00 	G3A075	IF EVER SMOKED CIGS REGULARLY: HOW OLD WERE YOU WHEN YOU FIRST STARTED REGULAR CIGARETTE SMOKING?
69	Cigarette smoking	273761	phv00273761.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:24:33+00:00	2018-10-03 14:24:33+00:00 	g3a072	If ever smoked cigarettes regularly: Do you now smoke cigarettes (as of 1 month ago)? Collection Interval: Exam 1
69	Cigarette smoking	273762	phv00273762.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:24:33+00:00	2018-10-03 14:24:33+00:00 	g3a073	If ever smoked cigarettes regularly: How many cigarettes do you smoke per day now? Collection Interval: Exam 1
69	Cigarette smoking	273763	phv00273763.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:24:33+00:00	2018-10-03 14:24:33+00:00 	g3a074	If ever smoked cigarettes regularly: On the average of the entire time you smoked, how many cigarettes did you smoke per day? Collection Interval: Exam 1
69	Cigarette smoking	273764	phv00273764.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:24:33+00:00	2018-10-03 14:24:33+00:00 	g3a075	If ever smoked cigarettes regularly: How old were you when you first started regular cigarette smoking? Collection Interval: Exam 1
69	Cigarette smoking	274254	phv00274254.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:24:33+00:00	2018-10-03 14:24:33+00:00 	g3a072	If ever smoked cigarettes regularly: Do you now smoke cigarettes (as of 1 month ago)?
69	Cigarette smoking	274255	phv00274255.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:24:33+00:00	2018-10-03 14:24:33+00:00 	g3a073	If ever smoked cigarettes regularly: How many cigarettes do you smoke per day now?
69	Cigarette smoking	274256	phv00274256.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:24:33+00:00	2018-10-03 14:24:33+00:00 	g3a074	If ever smoked cigarettes regularly: On the average of the entire time you smoked, how many cigarettes did you smoke per day?
69	Cigarette smoking	274257	phv00274257.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:24:33+00:00	2018-10-03 14:24:33+00:00 	g3a075	If ever smoked cigarettes regularly: How old were you when you first started regular cigarette smoking?
69	Cigarette smoking	20931	phv00020931.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	G3A076	IF EVER SMOKED CIGS REGULARLY AND THEN STOPPED SMOKING CIGARETTES COMPLETELY, HOW OLD WERE YOU WHEN YOU STOPPED?
69	Cigarette smoking	20932	phv00020932.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	G3A077	IF EVER SMOKED CIGS REGULARLY: WHEN YOU WERE SMOKING, DID YOU EVER STOP SMOKING FOR > 6 MONTHS?
69	Cigarette smoking	20933	phv00020933.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	G3A078	IF EVER STOPPED FOR > 6 MONTHS: FOR HOW MANY YEARS IN TOTAL DID YOU STOP SMOKING CIGARETTS?
69	Cigarette smoking	177301	phv00177301.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3b0091	Medical History-Smoking: Since your last exam have you smoked cigarettes regularly?
69	Cigarette smoking	177302	phv00177302.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3b0092	Medical History-Smoking: Have you smoked cigarettes regularly in the last year?
69	Cigarette smoking	177303	phv00177303.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3b0093	Medical History-Smoking: Do you now smoke cigarettes (as of 1 month ago)?
69	Cigarette smoking	177304	phv00177304.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3b0094	Medical History-Smoking: How many cigarettes do you smoke per day now?
69	Cigarette smoking	177305	phv00177305.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3b0095	"Medical History-Smoking: Question refers to ""whole lifetime"". On the average of the entire time you smoked, how many cigarettes did you smoke per day?"
69	Cigarette smoking	177306	phv00177306.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3b0096	"Medical History-Smoking: Question refers to ""whole lifetime"". How old were you when you first started regular cigarette smoking?"
69	Cigarette smoking	177307	phv00177307.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3b0097	"Medical History-Smoking: Question refers to ""whole lifetime"". If you have stopped smoking cigarettes completely, how old were you when you stopped?"
69	Cigarette smoking	177308	phv00177308.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3b0098	"Medical History-Smoking: Question refers to ""whole lifetime"". When you were smoking, did you ever stop smoking for >6 months?"
69	Cigarette smoking	177309	phv00177309.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3b0099	"Medical History-Smoking: Question refers to ""whole lifetime"". For how many years in total did you stop smoking cigarettes?"
69	Cigarette smoking	273765	phv00273765.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3a076	If ever smoked cigarettes regularly and then stopped smoking cigarettes completely, how old were you when you stopped? Collection Interval: Exam 1
69	Cigarette smoking	273766	phv00273766.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3a077	If ever smoked cigarettes regularly: When you were smoking, did you ever stop smoking for > 6 months? Collection Interval: Exam 1
69	Cigarette smoking	273767	phv00273767.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3a078	If ever stopped for > 6 months: For how many years in total did you stop smoking cigarettes? Collection Interval: Exam 1
69	Cigarette smoking	274258	phv00274258.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3a076	If ever smoked cigarettes regularly and then stopped smoking cigarettes completely, how old were you when you stopped?
69	Cigarette smoking	274259	phv00274259.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3a077	If ever smoked cigarettes regularly: When you were smoking, did you ever stop smoking for > 6 months?
69	Cigarette smoking	274260	phv00274260.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:26:40+00:00	2018-10-03 14:26:40+00:00 	g3a078	If ever stopped for > 6 months: For how many years in total did you stop smoking cigarettes?
69	Cigarette smoking	10665	phv00010665.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:27:58+00:00	2018-10-03 14:27:58+00:00 	G674	RESPIRATORY: DO YOU NOW SMOKE CIGARETTES (I.E. WITHIN THE LAST WEEK)?
69	Cigarette smoking	10666	phv00010666.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:27:58+00:00	2018-10-03 14:27:58+00:00 	G675	RESPIRATORY: HAVE YOU EVER SMOKED CIGARETTES FOR AS LONG AS A YEAR?
69	Cigarette smoking	251239	phv00251239.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:27:58+00:00	2018-10-03 14:27:58+00:00 	g674	Respiratory Questionnaire - Smoking: Do you now smoke cigarettes? (i.e. within the last week) Collection Interval: Exam 2
69	Cigarette smoking	251240	phv00251240.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:27:58+00:00	2018-10-03 14:27:58+00:00 	g675	Respiratory Questionnaire - Smoking: Have you ever smoked cigarettes for as long as a year? Collection Interval: Exam 2
69	Cigarette smoking	10668	phv00010668.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	G677	RESPIRATORY: HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY?
69	Cigarette smoking	72088	phv00072088.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	H060	SINCE YOUR LAST EXAM HAVE YOU SMOKED CIGARETTES REGULARLY? (NO MEANS LESS THAN 1 CIGARETTE A DAY FOR 1 YEAR)
69	Cigarette smoking	72089	phv00072089.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	H061	HAVE YOU SMOKED CIGARETTES REGULARLY IN THE LAST YEAR?
69	Cigarette smoking	72090	phv00072090.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	H062	DO YOU NOW SMOKE CIGARETTES (AS OF 1 MONTH AGO)?
69	Cigarette smoking	72091	phv00072091.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	H063	HOW MANY CIGARETTES DO YOU SMOKE PER DAY NOW?
69	Cigarette smoking	72092	phv00072092.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	H064	ON AVERAGE, SINCE YOUR LAST EXAM, HOW MANY CIGARETTES DID YOU SMOKE PER DAY?
69	Cigarette smoking	72093	phv00072093.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	H065	HOW OLD WERE YOU WHEN YOU FIRST STARTED REGULAR CIGARETTE SMOKING?
69	Cigarette smoking	72094	phv00072094.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	H066	IF YOU HAVE STOPPED SMOKING CIGARETTES COMPLETELY, HOW OLD WERE YOU WHEN YOU STOPPED?
69	Cigarette smoking	251241	phv00251241.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	g676	Respiratory Questionnaire - Smoking: How many years have you smoked/did you smoke? Collection Interval: Exam 2
69	Cigarette smoking	251242	phv00251242.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	g677	Respiratory Questionnaire - Smoking: How many cigarette do/did you smoke a day? Collection Interval: Exam 2
69	Cigarette smoking	251243	phv00251243.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	g678	Respiratory Questionnaire - Smoking: If you no longer smoke, when did you quit? Collection Interval: Exam 2
69	Cigarette smoking	251295	phv00251295.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	h060	Medical History - Smoking - Cigarettes: Since your last exam have you smoked cigarettes regularly? Collection Interval: Exam 3
69	Cigarette smoking	251296	phv00251296.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	h061	Medical History - Smoking - Cigarettes: Have you smoked cigarettes regularly in the last year? Collection Interval: Exam 3
69	Cigarette smoking	251297	phv00251297.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	h062	Medical History - Smoking - Cigarettes: Do you now smoke cigarettes (as of 1 month ago)? Collection Interval: Exam 3
69	Cigarette smoking	251298	phv00251298.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	h063	Medical History - Smoking - Cigarettes: How many cigarettes do you smoke per day now? Collection Interval: Exam 3
69	Cigarette smoking	251299	phv00251299.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	h064	Medical History - Smoking - Cigarettes: On average, since your last exam, how many cigarettes did you smoke per day? Collection Interval: Exam 3
69	Cigarette smoking	251300	phv00251300.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	h065	Medical History - Smoking - Cigarettes: How old were you when you first started regular cigarette smoking? Collection Interval: Exam 3
69	Cigarette smoking	251301	phv00251301.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:46:35+00:00	2018-10-03 14:46:35+00:00 	h066	Medical History - Smoking - Cigarettes: If you have stopped smoking cigarettes completely, how old were you when you stopped? Collection Interval: Exam 3
69	Cigarette smoking	781	phv00000781.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	MF331	HISTORY OF SMOKING: NUMBER OF CIGARETTES/DAY SMOKED NOW, EXAM 5
69	Cigarette smoking	977	phv00000977.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	MF537	PRESENT HISTORY OF SMOKING: NUMBER OF CIGARETTES/DAY, EXAM 7
69	Cigarette smoking	72095	phv00072095.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	H067	DURING THE TIME YOU WERE SMOKING SINCE YOUR LAST EXAM, DID YOU EVER STOP SMOKING FOR > 6 MONTHS?
69	Cigarette smoking	72096	phv00072096.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	H068	DURING THE TIME SINCE YOUR LAST EXAM, FOR HOW MANY YEARS IN TOTAL DID YOU STOP SMOKING CIGARETTES?
69	Cigarette smoking	251302	phv00251302.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	h067	Medical History - Smoking - Cigarettes: During the time you were smoking since your last exam, did you ever stop smoking for > 6 months? Collection Interval: Exam 3
69	Cigarette smoking	251303	phv00251303.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	h068	Medical History - Smoking - Cigarettes: During the time since your last exam, for how many years in total did you stop smoking cigarettes? Collection Interval: Exam 3
69	Cigarette smoking	254041	phv00254041.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	j062	Medical History - Smoking-Cigarettes: Since your last exam have you smoked cigarettes regularly?
69	Cigarette smoking	254042	phv00254042.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	j063	Medical History - Smoking-Cigarettes: Have you smoked cigarettes regularly in the last year?
69	Cigarette smoking	254043	phv00254043.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	j064	Medical History - Smoking-Cigarettes: Do you now smoke cigarettes (as of 1 month ago)?
69	Cigarette smoking	254044	phv00254044.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	j065	Medical History - Smoking-Cigarettes: How many cigarettes do you smoke per day now?
69	Cigarette smoking	254045	phv00254045.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	j066	"Medical History - Smoking-Cigarettes: Question refers to ""since your last exam"": During the time you were smoking, on average how many cigarettes per day did you smoke?"
69	Cigarette smoking	254046	phv00254046.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	j067	"Medical History - Smoking-Cigarettes: Question refers to ""since your last exam"": If you have stopped smoking cigarettes completely, how old were you when you stopped?"
69	Cigarette smoking	254047	phv00254047.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	j068	"Medical History - Smoking-Cigarettes: Question refers to ""since your last exam"": When you were smoking, did you ever stop smoking for >6 months?"
69	Cigarette smoking	254048	phv00254048.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:49:36+00:00	2018-10-03 14:49:36+00:00 	j069	"Medical History - Smoking-Cigarettes: Question refers to ""since your last exam"": For how many years in total did you stop smoking cigarettes?"
69	Cigarette smoking	546	phv00000546.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	MF74	CIGARETTES SMOKED PER DAY
69	Cigarette smoking	980	phv00000980.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	MF540	PRESENT HISTORY OF SMOKING: USES CIGARETTE WITH FILTER, EXAM 7
69	Cigarette smoking	981	phv00000981.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	MF541	PRESENT HISTORY OF SMOKING: INHALES CIGARETTES, EXAM 7
69	Cigarette smoking	982	phv00000982.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	MF542	PRESENT HISTORY OF SMOKING: PORTION OF CIGARETTE SMOKED, EXAM 7
69	Cigarette smoking	22719	phv00022719.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	RQ018	NOW SMOKE CIGARETTES (WITHIN THE LAST WEEK)
69	Cigarette smoking	22720	phv00022720.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	RQ019	EVER SMOKED CIGARETTES FOR AS LONG AS A YEAR (IF YES, ANSWER RQ020-RQ022)
69	Cigarette smoking	22722	phv00022722.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	RQ021	NUMBER OF CIGARETTES SMOKE(D) A DAY
69	Cigarette smoking	55317	phv00055317.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	MOSTOP15	If no to [SMKNOW15]: month stopped smoking?
69	Cigarette smoking	56741	phv00056741.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	sh320	Have you smoked as many as 20 packs of cigarettes in your whole lifetime?
69	Cigarette smoking	56742	phv00056742.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	sh321	If sh320=1, how many years ago did you START smoking?
69	Cigarette smoking	56828	phv00056828.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	ms211a	How much did you smoke during the 4 hours before you went to sleep last night? Number of cigarettes
69	Cigarette smoking	72628	phv00072628.v4.p10	pht000748.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	PCIG6HR	Have you smoked cigarettes in the last 6 hours?
69	Cigarette smoking	72629	phv00072629.v4.p10	pht000748.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	PCIGHR	"If ""yes"" to PICG6HR: How many hours and minutes since your last cigarette?"
69	Cigarette smoking	72630	phv00072630.v4.p10	pht000748.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 14:56:00+00:00	2018-10-03 14:56:00+00:00 	PCIGMIN	"If ""yes"" to PICG6HR: How many hours and minutes since your last cigarette?"
69	Cigarette smoking	24445	phv00024445.v5.p10	pht000195.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:00:07+00:00	2018-10-03 15:00:07+00:00 	smoke6hr	HAVE YOU SMOKED CIGARETTES IN THE LAST 6 HOURS? (RENAMED FROM EF08)
69	Cigarette smoking	24886	phv00024886.v1.p10	pht000211.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:00:07+00:00	2018-10-03 15:00:07+00:00 	SMOKE6HR	HAVE YOU SMOKED CIGARETTES IN THE LAST 6 HOURS? (RENAMED FROM TM05)
69	Cigarette smoking	24887	phv00024887.v1.p10	pht000211.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:00:07+00:00	2018-10-03 15:00:07+00:00 	TM06	IF YES (TO TM05), HOW MANY HOURS SINCE YOUR LAST CIGARETTE?
69	Cigarette smoking	24888	phv00024888.v1.p10	pht000211.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:00:07+00:00	2018-10-03 15:00:07+00:00 	TM07	IF YES (TO TM05), HOW MANY MINUTES SINCE YOUR LAST CIGARETTE?
69	Cigarette smoking	55316	phv00055316.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:00:07+00:00	2018-10-03 15:00:07+00:00 	SMKNOW15	Do you now smoke cigarettes?
69	Cigarette smoking	56589	phv00056589.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:00:07+00:00	2018-10-03 15:00:07+00:00 	smokstat_s1	Smoking Status
69	Cigarette smoking	55318	phv00055318.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:00:07+00:00	2018-10-03 15:00:07+00:00 	yrstop15	If no to [SMKNOW15]: year stopped smoking?
69	Cigarette smoking	56725	phv00056725.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:00:07+00:00	2018-10-03 15:00:07+00:00 	smokstat_s2	Smoking status (never=0, current=1, former=2)
69	Cigarette smoking	56743	phv00056743.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:00:07+00:00	2018-10-03 15:00:07+00:00 	sh322	Since you began smoking, was there ever a period of one year or more that you did NOT smoke?
69	Cigarette smoking	56744	phv00056744.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:00:07+00:00	2018-10-03 15:00:07+00:00 	sh323	Are you currently still smoking?
69	Cigarette smoking	56745	phv00056745.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:00:07+00:00	2018-10-03 15:00:07+00:00 	sh324	On average, during the entire time you smoked, how many cigarettes did you usually smoke per day?
69	Cigarette smoking	56780	phv00056780.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:00:07+00:00	2018-10-03 15:00:07+00:00 	sh323a	If sh323=0, how many years ago did you STOP smoking?
69	Cigarette smoking	7998	phv00007998.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:37:57+00:00	2018-10-03 15:37:57+00:00 	B381	CURRENT SMOKING-REG LAST 2 YRS
69	Cigarette smoking	7745	phv00007745.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 15:42:15+00:00	2018-10-03 15:42:15+00:00 	B95	NO. OF CIGARETTES SMOKED THIS MORNING
69	Cigarette smoking	1836	phv00001836.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	FE106	INTERIM HISTORY OF SMOKING: EVER SMOKED
69	Cigarette smoking	1837	phv00001837.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	FE107	INTERIM HISTORY OF SMOKING: SMOKED AT LEAST ONE YR. IN LAST TWO YRS.
69	Cigarette smoking	3832	phv00003832.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	FL188	DOES PATIENT INHALE
69	Cigarette smoking	4275	phv00004275.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	FM234	DOES PATIENT INHALE
69	Cigarette smoking	7617	phv00007617.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	A104	INHALES
69	Cigarette smoking	7735	phv00007735.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	B85	EVER SMOKED
69	Cigarette smoking	8864	phv00008864.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	D095	DOES PATIENT INHALE
69	Cigarette smoking	9780	phv00009780.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	F290	DO YOU INHALE
69	Cigarette smoking	21636	phv00021636.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	BW35	LIVE-BIRTH PREGNANCY #1: IF YES TO BW34, WRITE IN NUMBER  SMOKED PER DAY
69	Cigarette smoking	21648	phv00021648.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	BW48	LIVE-BIRTH PREGNANCY #2: IF YES TO BW47, WRITE IN NUMBER  SMOKED PER DAY
69	Cigarette smoking	21660	phv00021660.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	BW61	LIVE-BIRTH PREGNANCY #3: IF YES TO BW60, WRITE IN  NUMBER SMOKED PER DAY
69	Cigarette smoking	21672	phv00021672.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	BW74	LIVE-BIRTH PREGNANCY #4: IF YES TO BW73, WRITE IN  NUMBER SMOKED PER DAY
69	Cigarette smoking	21684	phv00021684.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:10:49+00:00	2018-10-05 15:10:49+00:00 	BW87	LIVE-BIRTH PREGNANCY #5: IF YES TO BW86, WRITE IN  NUMBER SMOKED PER DAY
69	Cigarette smoking	10261	phv00010261.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:13:35+00:00	2018-10-05 15:13:35+00:00 	G118	DO YOU INHALE?
69	Cigarette smoking	10667	phv00010667.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:13:35+00:00	2018-10-05 15:13:35+00:00 	G676	RESPIRATORY: HOW MANY YEARS HAVE YOU SMOKED/DID YOU SMOKE?
69	Cigarette smoking	10669	phv00010669.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:13:35+00:00	2018-10-05 15:13:35+00:00 	G678	RESPIRATORY: IF YOU NO LONGER SMOKE, WHEN DID YOU QUIT?
69	Cigarette smoking	22721	phv00022721.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:13:35+00:00	2018-10-05 15:13:35+00:00 	RQ020	HOW MANY YEARS HAVE YOU SMOKED / DID YOU SMOKE
69	Cigarette smoking	22723	phv00022723.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:13:35+00:00	2018-10-05 15:13:35+00:00 	RQ022	IF NO LONGER SMOKE, WHEN QUIT
69	Cigarette smoking	56779	phv00056779.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-05 15:13:35+00:00	2018-10-05 15:13:35+00:00 	sh322a	"If sh322=1, If 'Yes"" (there was a period of one year or more that you did not smoke,) how many years did you NOT smoke?"
69	Cigarette smoking	707	phv00000707.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-09 17:12:57+00:00	2018-10-09 17:12:57+00:00 	MF252	INTERIM HISTORY OF TOBACCO USAGE, EXAM 4
69	Cigarette smoking	7616	phv00007616.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-09 17:13:52+00:00	2018-10-09 17:13:52+00:00 	A103	USES FILTER
69	Cigarette smoking	7751	phv00007751.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-09 17:14:40+00:00	2018-10-09 17:14:40+00:00 	B101	REASON FOR STOPPING
69	Cigarette smoking	7609	phv00007609.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:26:12+00:00	2018-10-17 17:26:12+00:00 	A96	SMOKED AT LEAST 1 YEAR
69	Cigarette smoking	7753	phv00007753.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:26:40+00:00	2018-10-17 17:26:40+00:00 	B103	CARD CODE
69	Cigarette smoking	1255	phv00001255.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:28:39+00:00	2018-10-17 17:28:39+00:00 	FB83	INTERIM HISTORY OF SMOKING:  SMOKED AT LEAST ONE YEAR IN LAST TWO YEARS
69	Cigarette smoking	1449	phv00001449.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:29:08+00:00	2018-10-17 17:29:08+00:00 	FC99	INTERIM HISTORY OF SMOKING: SMOKED AT LEAST ONE YEAR IN LAST TWO YEARS
69	Cigarette smoking	1633	phv00001633.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:29:33+00:00	2018-10-17 17:29:33+00:00 	FD92	INTERIM HISTORY OF SMOKING:  SMOKED AT LEAST ONE YEAR IN LAST TWO YEARS
69	Cigarette smoking	1842	phv00001842.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:30:37+00:00	2018-10-17 17:30:37+00:00 	FE112	INTERIM HISTORY OF SMOKING: TIME PATTERN:
69	Cigarette smoking	2237	phv00002237.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:31:54+00:00	2018-10-17 17:31:54+00:00 	FG103	INTERIM HISTORY OF SMOKING: SMOKED AT LEAST ONE YR. IN LAST TWO YRS.
69	Cigarette smoking	2458	phv00002458.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:32:46+00:00	2018-10-17 17:32:46+00:00 	FH101	INTERIM HISTORY OF SMOKING: SMOKED AT LEAST ONE YR. IN LAST TWO YRS.
69	Cigarette smoking	780	phv00000780.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:33:54+00:00	2018-10-17 17:33:54+00:00 	MF330	HISTORY OF SMOKING: PRESENT HABIT, EXAM 5
69	Cigarette smoking	784	phv00000784.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:34:26+00:00	2018-10-17 17:34:26+00:00 	MF334	HISTORY OF SMOKING: CHANGE IN HABIT IN PAST TWO YEARS, EXAM 5
69	Cigarette smoking	543	phv00000543.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:34:49+00:00	2018-10-17 17:34:49+00:00 	MF71	"TOBACCO USED ""NOW"" OR ""EVER"""
69	Cigarette smoking	544	phv00000544.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:35:12+00:00	2018-10-17 17:35:12+00:00 	MF72	"DURATION OF TOBACCO USE (WHEN SMOKING ""NOW"")"
69	Cigarette smoking	545	phv00000545.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-17 17:35:28+00:00	2018-10-17 17:35:28+00:00 	MF73	"PERIOD OF LAPSE IN TOBACCO USE (WHEN NOT SMOKING ""NOW"")"
70	Subcohort	176003	phv00176003.v1.p3	pht003090.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:55:38+00:00	2018-04-29 00:55:38+00:00 	group3	GROUP 3 COHORT INDICATOR
70	Subcohort	176005	phv00176005.v1.p3	pht003090.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:55:48+00:00	2018-04-29 00:55:48+00:00 	casecohdes	CASE-COHORT DESIGNATION
70	Subcohort	165066	phv00165066.v1.p3	pht002515.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 00:55:54+00:00	2018-04-29 00:55:54+00:00 	cachrt1a	RANDOM COHORT AND CASES NOT IN COHORT
70	Subcohort	1035	phv00001035.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:04:37+00:00	2018-05-15 17:04:37+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	1186	phv00001186.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:05:08+00:00	2018-05-15 17:05:08+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	1362	phv00001362.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:05:23+00:00	2018-05-15 17:05:23+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	1558	phv00001558.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:05:44+00:00	2018-05-15 17:05:44+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	1802	phv00001802.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:06:06+00:00	2018-05-15 17:06:06+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	2019	phv00002019.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:06:28+00:00	2018-05-15 17:06:28+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	2203	phv00002203.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:06:46+00:00	2018-05-15 17:06:46+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	2424	phv00002424.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:07:07+00:00	2018-05-15 17:07:07+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	2667	phv00002667.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:07:25+00:00	2018-05-15 17:07:25+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	2945	phv00002945.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:07:42+00:00	2018-05-15 17:07:42+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	3260	phv00003260.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:08:36+00:00	2018-05-15 17:08:36+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	3666	phv00003666.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:08:51+00:00	2018-05-15 17:08:51+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	4082	phv00004082.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:09:06+00:00	2018-05-15 17:09:06+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	4524	phv00004524.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:09:22+00:00	2018-05-15 17:09:22+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	4938	phv00004938.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:09:40+00:00	2018-05-15 17:09:40+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	4940	phv00004940.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:09:55+00:00	2018-05-15 17:09:55+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	5558	phv00005558.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:10:15+00:00	2018-05-15 17:10:15+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	6031	phv00006031.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:10:35+00:00	2018-05-15 17:10:35+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	6326	phv00006326.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:10:55+00:00	2018-05-15 17:10:55+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	6664	phv00006664.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:11:15+00:00	2018-05-15 17:11:15+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	7096	phv00007096.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:11:39+00:00	2018-05-15 17:11:39+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	7674	phv00007674.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:12:20+00:00	2018-05-15 17:12:20+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	8378	phv00008378.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:12:36+00:00	2018-05-15 17:12:36+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	8742	phv00008742.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:13:34+00:00	2018-05-15 17:13:34+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	9126	phv00009126.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:14:16+00:00	2018-05-15 17:14:16+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	9129	phv00009129.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:15:17+00:00	2018-05-15 17:15:17+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	9580	phv00009580.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:15:36+00:00	2018-05-15 17:15:36+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	10139	phv00010139.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:15:53+00:00	2018-05-15 17:15:53+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	10767	phv00010767.v10.p10	pht000039.v11.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:16:38+00:00	2018-05-15 17:16:38+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	10782	phv00010782.v2.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:17:02+00:00	2018-05-15 17:17:02+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Exam 1 - Exam 28
70	Subcohort	10803	phv00010803.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:17:43+00:00	2018-05-15 17:17:43+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	11014	phv00011014.v1.p10	pht000042.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:17:58+00:00	2018-05-15 17:17:58+00:00 	IDTYPE	Framingham cohort identifier
70	Subcohort	11073	phv00011073.v6.p10	pht000043.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:18:14+00:00	2018-05-15 17:18:14+00:00 	IDTYPE	Framingham cohort identifier
70	Subcohort	11079	phv00011079.v1.p10	pht000044.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:18:36+00:00	2018-05-15 17:18:36+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21398	phv00021398.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:19:02+00:00	2018-05-15 17:19:02+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21569	phv00021569.v5.p10	pht000076.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:19:14+00:00	2018-05-15 17:19:14+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21588	phv00021588.v5.p10	pht000077.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:19:24+00:00	2018-05-15 17:19:24+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21607	phv00021607.v5.p10	pht000078.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:19:34+00:00	2018-05-15 17:19:34+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21686	phv00021686.v5.p10	pht000079.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:20:16+00:00	2018-05-15 17:20:16+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21689	phv00021689.v5.p10	pht000080.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:20:28+00:00	2018-05-15 17:20:28+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21694	phv00021694.v5.p10	pht000081.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:20:39+00:00	2018-05-15 17:20:39+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21696	phv00021696.v5.p10	pht000082.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:20:50+00:00	2018-05-15 17:20:50+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21699	phv00021699.v5.p10	pht000083.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:21:02+00:00	2018-05-15 17:21:02+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21739	phv00021739.v5.p10	pht000084.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:21:17+00:00	2018-05-15 17:21:17+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21742	phv00021742.v5.p10	pht000085.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:21:32+00:00	2018-05-15 17:21:32+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21749	phv00021749.v1.p10	pht000086.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:21:48+00:00	2018-05-15 17:21:48+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	21753	phv00021753.v5.p10	pht000087.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:22:00+00:00	2018-05-15 17:22:00+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21756	phv00021756.v4.p10	pht000088.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:22:17+00:00	2018-05-15 17:22:17+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21822	phv00021822.v4.p10	pht000089.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:22:37+00:00	2018-05-15 17:22:37+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21874	phv00021874.v1.p10	pht000090.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:23:05+00:00	2018-05-15 17:23:05+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21930	phv00021930.v5.p10	pht000091.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:24:49+00:00	2018-05-15 17:24:49+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	21932	phv00021932.v5.p10	pht000092.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:25:05+00:00	2018-05-15 17:25:05+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21938	phv00021938.v5.p10	pht000093.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:25:15+00:00	2018-05-15 17:25:15+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21960	phv00021960.v1.p10	pht000094.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:25:28+00:00	2018-05-15 17:25:28+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	21962	phv00021962.v5.p10	pht000095.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:25:41+00:00	2018-05-15 17:25:41+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21965	phv00021965.v5.p10	pht000096.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:25:57+00:00	2018-05-15 17:25:57+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	21984	phv00021984.v1.p10	pht000097.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:26:12+00:00	2018-05-15 17:26:12+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	21986	phv00021986.v5.p10	pht000098.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:26:26+00:00	2018-05-15 17:26:26+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	22306	phv00022306.v5.p10	pht000099.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:26:48+00:00	2018-05-15 17:26:48+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	22552	phv00022552.v5.p10	pht000100.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:27:44+00:00	2018-05-15 17:27:44+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	22554	phv00022554.v5.p10	pht000101.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:27:54+00:00	2018-05-15 17:27:54+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	22567	phv00022567.v4.p10	pht000102.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:28:11+00:00	2018-05-15 17:28:11+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	22580	phv00022580.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:28:29+00:00	2018-05-15 17:28:29+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	22673	phv00022673.v5.p10	pht000104.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:28:44+00:00	2018-05-15 17:28:44+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	22676	phv00022676.v5.p10	pht000105.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:29:11+00:00	2018-05-15 17:29:11+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	22698	phv00022698.v5.p10	pht000106.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:29:23+00:00	2018-05-15 17:29:23+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	22701	phv00022701.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:29:46+00:00	2018-05-15 17:29:46+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	22728	phv00022728.v1.p10	pht000108.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:30:05+00:00	2018-05-15 17:30:05+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	22730	phv00022730.v5.p10	pht000109.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:30:19+00:00	2018-05-15 17:30:19+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	22768	phv00022768.v5.p10	pht000110.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:30:31+00:00	2018-05-15 17:30:31+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	22780	phv00022780.v4.p10	pht000111.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:30:48+00:00	2018-05-15 17:30:48+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	22787	phv00022787.v5.p10	pht000112.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:31:46+00:00	2018-05-15 17:31:46+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	22791	phv00022791.v5.p10	pht000113.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:32:05+00:00	2018-05-15 17:32:05+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	23128	phv00023128.v1.p10	pht000138.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:32:51+00:00	2018-05-15 17:32:51+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23149	phv00023149.v3.p10	pht000139.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:33:08+00:00	2018-05-15 17:33:08+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23158	phv00023158.v3.p10	pht000140.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:34:25+00:00	2018-05-15 17:34:25+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23169	phv00023169.v4.p10	pht000141.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:34:39+00:00	2018-05-15 17:34:39+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	23193	phv00023193.v3.p10	pht000144.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:35:13+00:00	2018-05-15 17:35:13+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23199	phv00023199.v3.p10	pht000145.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:35:37+00:00	2018-05-15 17:35:37+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23205	phv00023205.v5.p10	pht000146.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:36:02+00:00	2018-05-15 17:36:02+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23210	phv00023210.v3.p10	pht000147.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:36:17+00:00	2018-05-15 17:36:17+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23253	phv00023253.v5.p10	pht000149.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:37:24+00:00	2018-05-15 17:37:24+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	23495	phv00023495.v5.p10	pht000150.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:37:35+00:00	2018-05-15 17:37:35+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23556	phv00023556.v5.p10	pht000151.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:38:00+00:00	2018-05-15 17:38:00+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23560	phv00023560.v5.p10	pht000152.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:38:14+00:00	2018-05-15 17:38:14+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	23626	phv00023626.v1.p10	pht000155.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:38:41+00:00	2018-05-15 17:38:41+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	23631	phv00023631.v5.p10	pht000156.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:38:54+00:00	2018-05-15 17:38:54+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	23711	phv00023711.v1.p10	pht000158.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:39:16+00:00	2018-05-15 17:39:16+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23788	phv00023788.v1.p10	pht000160.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:39:31+00:00	2018-05-15 17:39:31+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23795	phv00023795.v5.p10	pht000161.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:39:45+00:00	2018-05-15 17:39:45+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23798	phv00023798.v5.p10	pht000162.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:40:29+00:00	2018-05-15 17:40:29+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23805	phv00023805.v5.p10	pht000163.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:40:38+00:00	2018-05-15 17:40:38+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	23807	phv00023807.v5.p10	pht000164.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:40:49+00:00	2018-05-15 17:40:49+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23810	phv00023810.v5.p10	pht000165.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:41:07+00:00	2018-05-15 17:41:07+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23852	phv00023852.v5.p10	pht000167.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:41:19+00:00	2018-05-15 17:41:19+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23873	phv00023873.v1.p10	pht000168.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:41:30+00:00	2018-05-15 17:41:30+00:00 	IDTYPE	Framingham Cohort Identifier Collection Interval: Exams 20, 22, 24
70	Subcohort	23884	phv00023884.v4.p10	pht000169.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:41:43+00:00	2018-05-15 17:41:43+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	23889	phv00023889.v3.p10	pht000170.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:41:59+00:00	2018-05-15 17:41:59+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23891	phv00023891.v5.p10	pht000171.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:42:12+00:00	2018-05-15 17:42:12+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	23912	phv00023912.v5.p10	pht000175.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:43:04+00:00	2018-05-15 17:43:04+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	24059	phv00024059.v5.p10	pht000182.v12.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:43:15+00:00	2018-05-15 17:43:15+00:00 	idtype	Refers to the Framingham cohort the sample comes from, useful to identify which files phenotypes will be found
70	Subcohort	24361	phv00024361.v4.p10	pht000191.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:43:29+00:00	2018-05-15 17:43:29+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	24366	phv00024366.v5.p10	pht000192.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:43:43+00:00	2018-05-15 17:43:43+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	24368	phv00024368.v5.p10	pht000193.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:44:04+00:00	2018-05-15 17:44:04+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	24372	phv00024372.v4.p10	pht000194.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:44:22+00:00	2018-05-15 17:44:22+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	24438	phv00024438.v5.p10	pht000195.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:44:37+00:00	2018-05-15 17:44:37+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	24511	phv00024511.v3.p10	pht000196.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:44:50+00:00	2018-05-15 17:44:50+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	24555	phv00024555.v5.p10	pht000197.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:45:02+00:00	2018-05-15 17:45:02+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	24559	phv00024559.v5.p10	pht000198.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:45:58+00:00	2018-05-15 17:45:58+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	24586	phv00024586.v2.p10	pht000200.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:46:08+00:00	2018-05-15 17:46:08+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	24646	phv00024646.v1.p10	pht000201.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:46:17+00:00	2018-05-15 17:46:17+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	24656	phv00024656.v5.p10	pht000202.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:46:28+00:00	2018-05-15 17:46:28+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	24669	phv00024669.v5.p10	pht000203.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:46:42+00:00	2018-05-15 17:46:42+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	24679	phv00024679.v5.p10	pht000204.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:46:56+00:00	2018-05-15 17:46:56+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	24681	phv00024681.v5.p10	pht000205.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:47:13+00:00	2018-05-15 17:47:13+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	24720	phv00024720.v1.p10	pht000206.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:47:29+00:00	2018-05-15 17:47:29+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	24722	phv00024722.v4.p10	pht000207.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:47:46+00:00	2018-05-15 17:47:46+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	24757	phv00024757.v3.p10	pht000208.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:47:58+00:00	2018-05-15 17:47:58+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	24759	phv00024759.v5.p10	pht000209.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:48:11+00:00	2018-05-15 17:48:11+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	24803	phv00024803.v4.p10	pht000210.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:48:33+00:00	2018-05-15 17:48:33+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	24847	phv00024847.v1.p10	pht000211.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:48:50+00:00	2018-05-15 17:48:50+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	36219	phv00036219.v5.p10	pht000293.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:49:11+00:00	2018-05-15 17:49:11+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	36250	phv00036250.v1.p10	pht000294.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:49:33+00:00	2018-05-15 17:49:33+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	36318	phv00036318.v3.p10	pht000295.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:49:55+00:00	2018-05-15 17:49:55+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	36345	phv00036345.v3.p10	pht000298.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:54:15+00:00	2018-05-15 17:54:15+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	36348	phv00036348.v8.p10	pht000299.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:54:25+00:00	2018-05-15 17:54:25+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	36380	phv00036380.v5.p10	pht000300.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:54:34+00:00	2018-05-15 17:54:34+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	36400	phv00036400.v5.p10	pht000301.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:54:42+00:00	2018-05-15 17:54:42+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	36403	phv00036403.v1.p10	pht000302.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:54:52+00:00	2018-05-15 17:54:52+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	36406	phv00036406.v3.p10	pht000303.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:55:03+00:00	2018-05-15 17:55:03+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	36409	phv00036409.v3.p10	pht000304.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:55:11+00:00	2018-05-15 17:55:11+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	36412	phv00036412.v3.p10	pht000305.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:55:20+00:00	2018-05-15 17:55:20+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	36416	phv00036416.v3.p10	pht000306.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:55:29+00:00	2018-05-15 17:55:29+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	36418	phv00036418.v5.p10	pht000307.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:55:38+00:00	2018-05-15 17:55:38+00:00 	IDTYPE	Framingham Cohort Identifier
70	Subcohort	36458	phv00036458.v5.p10	pht000308.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:55:47+00:00	2018-05-15 17:55:47+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	36470	phv00036470.v11.p10	pht000309.v12.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:55:56+00:00	2018-05-15 17:55:56+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Events reviewed through 12/2015
70	Subcohort	36492	phv00036492.v4.p10	pht000313.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:56:05+00:00	2018-05-15 17:56:05+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	51865	phv00051865.v4.p10	pht000366.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:56:22+00:00	2018-05-15 17:56:22+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	54650	phv00054650.v1.p10	pht000386.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:56:33+00:00	2018-05-15 17:56:33+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	54661	phv00054661.v2.p10	pht000387.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:56:42+00:00	2018-05-15 17:56:42+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	54676	phv00054676.v3.p10	pht000388.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:56:54+00:00	2018-05-15 17:56:54+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	54693	phv00054693.v7.p10	pht000389.v9.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:57:04+00:00	2018-05-15 17:57:04+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	55021	phv00055021.v1.p10	pht000390.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:57:14+00:00	2018-05-15 17:57:14+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	55087	phv00055087.v1.p10	pht000391.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:57:24+00:00	2018-05-15 17:57:24+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	55154	phv00055154.v4.p10	pht000392.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:57:35+00:00	2018-05-15 17:57:35+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	55162	phv00055162.v5.p10	pht000393.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:57:44+00:00	2018-05-15 17:57:44+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	55164	phv00055164.v4.p10	pht000394.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:57:56+00:00	2018-05-15 17:57:56+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	56607	phv00056607.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:58:08+00:00	2018-05-15 17:58:08+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	56716	phv00056716.v2.p10	pht000396.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:58:22+00:00	2018-05-15 17:58:22+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	57968	phv00057968.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:58:46+00:00	2018-05-15 17:58:46+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	64580	phv00064580.v1.p10	pht000602.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:58:56+00:00	2018-05-15 17:58:56+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	64595	phv00064595.v1.p10	pht000603.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:59:04+00:00	2018-05-15 17:59:04+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	64600	phv00064600.v2.p10	pht000604.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:59:12+00:00	2018-05-15 17:59:12+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	64602	phv00064602.v2.p10	pht000605.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:59:20+00:00	2018-05-15 17:59:20+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	64608	phv00064608.v2.p10	pht000606.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:59:28+00:00	2018-05-15 17:59:28+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	65174	phv00065174.v2.p10	pht000607.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:59:37+00:00	2018-05-15 17:59:37+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	65287	phv00065287.v1.p10	pht000608.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:59:46+00:00	2018-05-15 17:59:46+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	65291	phv00065291.v2.p10	pht000609.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 17:59:55+00:00	2018-05-15 17:59:55+00:00 	IDtype	COHORT IDENTIFIER
70	Subcohort	65396	phv00065396.v2.p10	pht000610.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:00:03+00:00	2018-05-15 18:00:03+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	65450	phv00065450.v4.p10	pht000611.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:00:13+00:00	2018-05-15 18:00:13+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	65453	phv00065453.v4.p10	pht000612.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:00:24+00:00	2018-05-15 18:00:24+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	66665	phv00066665.v4.p10	pht000670.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:00:33+00:00	2018-05-15 18:00:33+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Offspring Exam 8  and Omni 1 Exam 3
70	Subcohort	66687	phv00066687.v4.p10	pht000671.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:00:43+00:00	2018-05-15 18:00:43+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	66692	phv00066692.v4.p10	pht000672.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:00:54+00:00	2018-05-15 18:00:54+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	66749	phv00066749.v4.p10	pht000673.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:01:07+00:00	2018-05-15 18:01:07+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	66766	phv00066766.v4.p10	pht000674.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:01:19+00:00	2018-05-15 18:01:19+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	66817	phv00066817.v2.p10	pht000675.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:01:28+00:00	2018-05-15 18:01:28+00:00 	IDTYPE	FRAMINGHAM COHORT IDENTIFIER
70	Subcohort	66832	phv00066832.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:01:37+00:00	2018-05-15 18:01:37+00:00 	IDTYPE	Framingham Cohort Identifier
70	Subcohort	68240	phv00068240.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:01:50+00:00	2018-05-15 18:01:50+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	68707	phv00068707.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:02:00+00:00	2018-05-15 18:02:00+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	69161	phv00069161.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:02:09+00:00	2018-05-15 18:02:09+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	70890	phv00070890.v4.p10	pht000683.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:02:18+00:00	2018-05-15 18:02:18+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	69659	phv00069659.v4.p10	pht000684.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:02:28+00:00	2018-05-15 18:02:28+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	69667	phv00069667.v1.p10	pht000685.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:02:40+00:00	2018-05-15 18:02:40+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	69669	phv00069669.v4.p10	pht000686.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:03:07+00:00	2018-05-15 18:03:07+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	69677	phv00069677.v4.p10	pht000687.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:03:15+00:00	2018-05-15 18:03:15+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	69682	phv00069682.v3.p10	pht000688.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:03:23+00:00	2018-05-15 18:03:23+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	70889	phv00070889.v4.p10	pht000689.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:03:30+00:00	2018-05-15 18:03:30+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	69841	phv00069841.v10.p10	pht000690.v11.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:03:38+00:00	2018-05-15 18:03:38+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	69847	phv00069847.v10.p10	pht000691.v11.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:03:46+00:00	2018-05-15 18:03:46+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	70364	phv00070364.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:03:56+00:00	2018-05-15 18:03:56+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	70742	phv00070742.v2.p10	pht000693.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:04:04+00:00	2018-05-15 18:04:04+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	70904	phv00070904.v3.p10	pht000694.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:04:15+00:00	2018-05-15 18:04:15+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	71880	phv00071880.v6.p10	pht000740.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:04:27+00:00	2018-05-15 18:04:27+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	71883	phv00071883.v3.p10	pht000741.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:04:37+00:00	2018-05-15 18:04:37+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Cases reviewed through Feb 2011
70	Subcohort	71888	phv00071888.v4.p10	pht000742.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:04:50+00:00	2018-05-15 18:04:50+00:00 	IDTYPE	Framingham cohort identifier
70	Subcohort	71900	phv00071900.v3.p10	pht000743.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:04:59+00:00	2018-05-15 18:04:59+00:00 	idtype	Framingham cohort identifier Collection Interval: Through 2005
70	Subcohort	71908	phv00071908.v2.p10	pht000744.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:05:08+00:00	2018-05-15 18:05:08+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994)
70	Subcohort	72013	phv00072013.v2.p10	pht000745.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:05:17+00:00	2018-05-15 18:05:17+00:00 	idtype	Framingham cohort identifier Collection Interval: 1998-2003
70	Subcohort	72019	phv00072019.v4.p10	pht000746.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:05:29+00:00	2018-05-15 18:05:29+00:00 	IDTYPE	Framingham Cohort Identifier
70	Subcohort	72044	phv00072044.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:05:41+00:00	2018-05-15 18:05:41+00:00 	IDTYPE	FRAMINGHAM COHORT IDENTIFIER
70	Subcohort	72619	phv00072619.v4.p10	pht000748.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:05:49+00:00	2018-05-15 18:05:49+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	73718	phv00073718.v4.p10	pht000820.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:06:02+00:00	2018-05-15 18:06:02+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	73721	phv00073721.v2.p10	pht000821.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:06:13+00:00	2018-05-15 18:06:13+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	73725	phv00073725.v2.p10	pht000822.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:06:24+00:00	2018-05-15 18:06:24+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	73728	phv00073728.v2.p10	pht000823.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:07:11+00:00	2018-05-15 18:07:11+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	73734	phv00073734.v4.p10	pht000824.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:07:23+00:00	2018-05-15 18:07:23+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	73737	phv00073737.v2.p10	pht000825.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:07:33+00:00	2018-05-15 18:07:33+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	73740	phv00073740.v2.p10	pht000826.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:07:57+00:00	2018-05-15 18:07:57+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	73754	phv00073754.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:09:35+00:00	2018-05-15 18:09:35+00:00 	IDTYPE	Framingham Cohort Identifier Collection Interval: Exam 28
70	Subcohort	73785	phv00073785.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:09:43+00:00	2018-05-15 18:09:43+00:00 	IDTYPE	Framingham Cohort Identifier
70	Subcohort	73817	phv00073817.v1.p10	pht000830.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:09:50+00:00	2018-05-15 18:09:50+00:00 	idtype	Framingham Cohort Identifier Collection Interval: Exam 20
70	Subcohort	73827	phv00073827.v4.p10	pht000832.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:10:29+00:00	2018-05-15 18:10:29+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	76324	phv00076324.v2.p10	pht000903.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:10:37+00:00	2018-05-15 18:10:37+00:00 	idtype	Framingham Cohort Identifier Collection Interval: 2002-2005
70	Subcohort	76336	phv00076336.v3.p10	pht000904.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:10:46+00:00	2018-05-15 18:10:46+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	76348	phv00076348.v2.p10	pht000905.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:10:55+00:00	2018-05-15 18:10:55+00:00 	IDTYPE	Framingham Cohort Identifier Collection Interval: 2002-2005
70	Subcohort	76359	phv00076359.v3.p10	pht000906.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:11:11+00:00	2018-05-15 18:11:11+00:00 	IDTYPE	Framingham Cohort Identifier
70	Subcohort	76365	phv00076365.v4.p10	pht000907.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:12:02+00:00	2018-05-15 18:12:02+00:00 	IDTYPE	Framingham cohort identifier
70	Subcohort	76381	phv00076381.v6.p10	pht000908.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:12:14+00:00	2018-05-15 18:12:14+00:00 	IDTYPE	Framingham Heart Study Cohort Identifier
70	Subcohort	76395	phv00076395.v3.p10	pht000909.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:12:26+00:00	2018-05-15 18:12:26+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	76398	phv00076398.v4.p10	pht000910.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:12:34+00:00	2018-05-15 18:12:34+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	80750	phv00080750.v2.p10	pht001039.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:12:45+00:00	2018-05-15 18:12:45+00:00 	IDTYPE	Framingham Cohort Identifier
70	Subcohort	80762	phv00080762.v2.p10	pht001040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:12:56+00:00	2018-05-15 18:12:56+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	80764	phv00080764.v4.p10	pht001041.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:13:06+00:00	2018-05-15 18:13:06+00:00 	IDTYPE	Framingham Cohort Identifier
70	Subcohort	80769	phv00080769.v2.p10	pht001042.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:13:17+00:00	2018-05-15 18:13:17+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	80998	phv00080998.v2.p10	pht001043.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:13:26+00:00	2018-05-15 18:13:26+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	81009	phv00081009.v5.p10	pht001044.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:13:35+00:00	2018-05-15 18:13:35+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	81012	phv00081012.v1.p10	pht001045.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:13:43+00:00	2018-05-15 18:13:43+00:00 	IDTYPE	Framingham Cohort Identifier Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38)
70	Subcohort	89301	phv00089301.v6.p10	pht001177.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:13:52+00:00	2018-05-15 18:13:52+00:00 	IDTYPE	Framingham Cohort Identifier
70	Subcohort	89306	phv00089306.v6.p10	pht001178.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:14:03+00:00	2018-05-15 18:14:03+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	89333	phv00089333.v1.p10	pht001179.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:14:13+00:00	2018-05-15 18:14:13+00:00 	IDTYPE	Framingham Cohort Identifier Collection Interval: Exams 17 - 21
70	Subcohort	89412	phv00089412.v2.p10	pht001182.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:14:23+00:00	2018-05-15 18:14:23+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	89417	phv00089417.v2.p10	pht001183.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:14:36+00:00	2018-05-15 18:14:36+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Cases reviewed through July 2012
70	Subcohort	90344	phv00090344.v2.p10	pht001224.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:14:47+00:00	2018-05-15 18:14:47+00:00 	idtype	Framingham Cohort Identifier Collection Interval: 2002-2005
70	Subcohort	90347	phv00090347.v2.p10	pht001225.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:15:15+00:00	2018-05-15 18:15:15+00:00 	IDTYPE	Framingham Cohort Identifier
70	Subcohort	90353	phv00090353.v2.p10	pht001226.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:15:23+00:00	2018-05-15 18:15:23+00:00 	IDTYPE	Framingham Cohort Identifier Collection Interval: 2002-2005
70	Subcohort	90357	phv00090357.v2.p10	pht001227.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:15:30+00:00	2018-05-15 18:15:30+00:00 	IDTYPE	Framingham Cohort Identifier
70	Subcohort	90363	phv00090363.v2.p10	pht001228.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:15:38+00:00	2018-05-15 18:15:38+00:00 	idtype	Framingham Cohort Identifier Collection Interval: Exam 7
70	Subcohort	121941	phv00121941.v2.p10	pht001892.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:15:50+00:00	2018-05-15 18:15:50+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	121954	phv00121954.v3.p10	pht001893.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:15:59+00:00	2018-05-15 18:15:59+00:00 	IDtype	Framingham Cohort Identifier
70	Subcohort	121970	phv00121970.v2.p10	pht001894.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:16:07+00:00	2018-05-15 18:16:07+00:00 	IDtype	Framingham Cohort Identifier
70	Subcohort	141867	phv00141867.v4.p10	pht002072.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:16:15+00:00	2018-05-15 18:16:15+00:00 	IDTYPE	Framingham Heart Study cohort group
70	Subcohort	141874	phv00141874.v3.p10	pht002073.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:16:25+00:00	2018-05-15 18:16:25+00:00 	idtype	Framingham Cohort Identifier Collection Interval: Test performed 1995-1998
70	Subcohort	141914	phv00141914.v2.p10	pht002074.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:16:34+00:00	2018-05-15 18:16:34+00:00 	idtype	FHS Cohort Identifier
70	Subcohort	142045	phv00142045.v2.p10	pht002075.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:16:47+00:00	2018-05-15 18:16:47+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Cases reviewed through 4/2012
70	Subcohort	142053	phv00142053.v4.p10	pht002076.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:26:42+00:00	2018-05-15 18:26:42+00:00 	idtype	Framingham Heart Study cohort group
70	Subcohort	142393	phv00142393.v4.p10	pht002077.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:26:51+00:00	2018-05-15 18:26:51+00:00 	idtype	FHS Cohort Identifier
70	Subcohort	142423	phv00142423.v4.p10	pht002078.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:27:00+00:00	2018-05-15 18:27:00+00:00 	idtype	Framingham Heart Study cohort group
70	Subcohort	142461	phv00142461.v1.p10	pht002080.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:27:08+00:00	2018-05-15 18:27:08+00:00 	idtype	FHS Cohort Identifier Collection Interval: Exams 10, 14, and 22
70	Subcohort	156629	phv00156629.v4.p10	pht002141.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:27:16+00:00	2018-05-15 18:27:16+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	156638	phv00156638.v4.p10	pht002142.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:27:24+00:00	2018-05-15 18:27:24+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	156647	phv00156647.v4.p10	pht002143.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:27:33+00:00	2018-05-15 18:27:33+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	156664	phv00156664.v3.p10	pht002144.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:27:41+00:00	2018-05-15 18:27:41+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	156676	phv00156676.v3.p10	pht002145.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:27:50+00:00	2018-05-15 18:27:50+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	156684	phv00156684.v4.p10	pht002146.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:27:58+00:00	2018-05-15 18:27:58+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	156709	phv00156709.v1.p10	pht002147.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:28:06+00:00	2018-05-15 18:28:06+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Scan done 2002 - 2005
70	Subcohort	156741	phv00156741.v2.p10	pht002148.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:28:15+00:00	2018-05-15 18:28:15+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	156750	phv00156750.v2.p10	pht002149.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:28:23+00:00	2018-05-15 18:28:23+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	157295	phv00157295.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:28:30+00:00	2018-05-15 18:28:30+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	157770	phv00157770.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:28:43+00:00	2018-05-15 18:28:43+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	158090	phv00158090.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:28:50+00:00	2018-05-15 18:28:50+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	158539	phv00158539.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:28:58+00:00	2018-05-15 18:28:58+00:00 	idtype	COHORT IDENTIFIER
70	Subcohort	158542	phv00158542.v3.p10	pht002154.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:29:05+00:00	2018-05-15 18:29:05+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	158551	phv00158551.v3.p10	pht002155.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:29:13+00:00	2018-05-15 18:29:13+00:00 	idtype	Framingham Cohort Identifier
70	Subcohort	159486	phv00159486.v4.p10	pht002232.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:29:21+00:00	2018-05-15 18:29:21+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	159493	phv00159493.v4.p10	pht002233.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:29:30+00:00	2018-05-15 18:29:30+00:00 	IDTYPE	Framingham Heart Study cohort group
70	Subcohort	159549	phv00159549.v4.p10	pht002234.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:29:38+00:00	2018-05-15 18:29:38+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	159552	phv00159552.v4.p10	pht002235.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:29:47+00:00	2018-05-15 18:29:47+00:00 	IDTYPE	Framingham Heart Study cohort group
70	Subcohort	159554	phv00159554.v3.p10	pht002236.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:29:58+00:00	2018-05-15 18:29:58+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Exam dates from 12/2000 to 6/2008
70	Subcohort	161912	phv00161912.v3.p10	pht002343.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:30:07+00:00	2018-05-15 18:30:07+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	161914	phv00161914.v4.p10	pht002344.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:30:15+00:00	2018-05-15 18:30:15+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	162080	phv00162080.v1.p10	pht002346.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:30:23+00:00	2018-05-15 18:30:23+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Test done at Generation 3 Exam 2 between April 2010 and March 2011
70	Subcohort	162092	phv00162092.v1.p10	pht002347.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:30:31+00:00	2018-05-15 18:30:31+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: CT scans done between 2002-2005
70	Subcohort	162100	phv00162100.v2.p10	pht002348.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:30:39+00:00	2018-05-15 18:30:39+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Test done 1995 - 1998
70	Subcohort	162110	phv00162110.v1.p10	pht002349.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:30:47+00:00	2018-05-15 18:30:47+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Test done at Generation 3 Exam 2 between September 2010 to March 2011
70	Subcohort	162673	phv00162673.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:30:56+00:00	2018-05-15 18:30:56+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	163417	phv00163417.v4.p10	pht002424.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:31:05+00:00	2018-05-15 18:31:05+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	163438	phv00163438.v2.p10	pht002425.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:31:13+00:00	2018-05-15 18:31:13+00:00 	IDTYPE	Framingham Heart Study cohort group Collection Interval: Exam 8
70	Subcohort	163440	phv00163440.v2.p10	pht002426.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:31:21+00:00	2018-05-15 18:31:21+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	163449	phv00163449.v3.p10	pht002427.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:31:29+00:00	2018-05-15 18:31:29+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	163453	phv00163453.v1.p10	pht002428.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:31:45+00:00	2018-05-15 18:31:45+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Exams 8, 9, 10
70	Subcohort	163455	phv00163455.v1.p10	pht002429.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:31:53+00:00	2018-05-15 18:31:53+00:00 	idtype	Participant Cohort Group Collection Interval: Original Cohort Exam 11 and Offspring Exam 1
70	Subcohort	163498	phv00163498.v1.p10	pht002430.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:32:01+00:00	2018-05-15 18:32:01+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	163501	phv00163501.v3.p10	pht002431.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:32:10+00:00	2018-05-15 18:32:10+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Original Cohort Exams 27 and 28, Offspring Exam 8
70	Subcohort	163511	phv00163511.v1.p10	pht002432.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:32:26+00:00	2018-05-15 18:32:26+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	166709	phv00166709.v4.p10	pht002564.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:32:34+00:00	2018-05-15 18:32:34+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	166776	phv00166776.v4.p10	pht002565.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:32:42+00:00	2018-05-15 18:32:42+00:00 	idtype	Framingham cohort identifier
70	Subcohort	166831	phv00166831.v3.p10	pht002566.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:32:49+00:00	2018-05-15 18:32:49+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	166938	phv00166938.v3.p10	pht002567.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:32:57+00:00	2018-05-15 18:32:57+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	166940	phv00166940.v5.p10	pht002568.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:33:04+00:00	2018-05-15 18:33:04+00:00 	IDTYPE	Framingham cohort identifier
70	Subcohort	166964	phv00166964.v4.p10	pht002569.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:33:12+00:00	2018-05-15 18:33:12+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	166970	phv00166970.v1.p10	pht002570.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:33:24+00:00	2018-05-15 18:33:24+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	166997	phv00166997.v1.p10	pht002571.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:33:35+00:00	2018-05-15 18:33:35+00:00 	idtype	Framingham cohort identifier Collection Interval: Scans done between 2002-2005
70	Subcohort	167000	phv00167000.v5.p10	pht002572.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:33:44+00:00	2018-05-15 18:33:44+00:00 	IDTYPE	FRAMINGHAM HEART STUDY COHORT IDENTIFIER
70	Subcohort	167132	phv00167132.v1.p10	pht002573.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:33:51+00:00	2018-05-15 18:33:51+00:00 	IDTYPE	FRAMINGHAM HEART STUDY COHORT IDENTIFIER
70	Subcohort	171859	phv00171859.v5.p10	pht002851.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:33:59+00:00	2018-05-15 18:33:59+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	171862	phv00171862.v2.p10	pht002852.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:34:07+00:00	2018-05-15 18:34:07+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	171872	phv00171872.v4.p10	pht002853.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:34:16+00:00	2018-05-15 18:34:16+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	171878	phv00171878.v1.p10	pht002854.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:34:25+00:00	2018-05-15 18:34:25+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	172157	phv00172157.v4.p10	pht002888.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:34:32+00:00	2018-05-15 18:34:32+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	172160	phv00172160.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:34:41+00:00	2018-05-15 18:34:41+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	172211	phv00172211.v4.p10	pht002890.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:34:49+00:00	2018-05-15 18:34:49+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	172219	phv00172219.v4.p10	pht002891.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:35:01+00:00	2018-05-15 18:35:01+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	172231	phv00172231.v4.p10	pht002892.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:35:10+00:00	2018-05-15 18:35:10+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	172241	phv00172241.v4.p10	pht002893.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:35:20+00:00	2018-05-15 18:35:20+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	172303	phv00172303.v1.p10	pht002894.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:35:28+00:00	2018-05-15 18:35:28+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Exam 5
70	Subcohort	172357	phv00172357.v1.p10	pht002895.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:35:36+00:00	2018-05-15 18:35:36+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	172360	phv00172360.v4.p10	pht002896.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:35:45+00:00	2018-05-15 18:35:45+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	172368	phv00172368.v4.p10	pht002897.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:35:56+00:00	2018-05-15 18:35:56+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	172382	phv00172382.v2.p10	pht002898.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:36:11+00:00	2018-05-15 18:36:11+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	172387	phv00172387.v4.p10	pht002899.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:36:18+00:00	2018-05-15 18:36:18+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	173095	phv00173095.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:36:25+00:00	2018-05-15 18:36:25+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	177238	phv00177238.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:36:33+00:00	2018-05-15 18:36:33+00:00 	idtype	Framingham Heart Study participant cohort identifier
70	Subcohort	177785	phv00177785.v1.p10	pht003095.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:36:41+00:00	2018-05-15 18:36:41+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	177804	phv00177804.v2.p10	pht003096.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:36:50+00:00	2018-05-15 18:36:50+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Scans done from January 2002 through July 2008
70	Subcohort	177810	phv00177810.v3.p10	pht003097.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:36:58+00:00	2018-05-15 18:36:58+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	177893	phv00177893.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:37:07+00:00	2018-05-15 18:37:07+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	177928	phv00177928.v4.p10	pht003099.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:37:16+00:00	2018-05-15 18:37:16+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	190689	phv00190689.v3.p10	pht003309.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:37:24+00:00	2018-05-15 18:37:24+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	190761	phv00190761.v2.p10	pht003310.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:37:34+00:00	2018-05-15 18:37:34+00:00 	idtype	Framingham participant IDTYPE
70	Subcohort	190764	phv00190764.v2.p10	pht003311.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:37:42+00:00	2018-05-15 18:37:42+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Tests performed between 1995 and 1998
70	Subcohort	190767	phv00190767.v1.p10	pht003312.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:37:50+00:00	2018-05-15 18:37:50+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Exam 5
70	Subcohort	190791	phv00190791.v2.p10	pht003313.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:37:59+00:00	2018-05-15 18:37:59+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: 12/2000 - 6/2009
70	Subcohort	190811	phv00190811.v3.p10	pht003315.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:38:09+00:00	2018-05-15 18:38:09+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	190815	phv00190815.v4.p10	pht003316.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:38:19+00:00	2018-05-15 18:38:19+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	190828	phv00190828.v3.p10	pht003317.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:38:29+00:00	2018-05-15 18:38:29+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	190975	phv00190975.v3.p10	pht003334.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:38:39+00:00	2018-05-15 18:38:39+00:00 	IDTYPE	Framingham Heart Study Cohort Identifier Collection Interval: Cases reviewed  1/1949 - 12/2012
70	Subcohort	190980	phv00190980.v5.p10	pht003335.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:39:29+00:00	2018-05-15 18:39:29+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	195382	phv00195382.v1.p10	pht003459.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:39:37+00:00	2018-05-15 18:39:37+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	195489	phv00195489.v1.p10	pht003462.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:39:47+00:00	2018-05-15 18:39:47+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	195497	phv00195497.v1.p10	pht003463.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:39:57+00:00	2018-05-15 18:39:57+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	196511	phv00196511.v2.p10	pht003628.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:40:06+00:00	2018-05-15 18:40:06+00:00 	IDTYPE	FHS cohort identifier
70	Subcohort	196515	phv00196515.v1.p10	pht003629.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:40:19+00:00	2018-05-15 18:40:19+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	196519	phv00196519.v3.p10	pht003630.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:40:33+00:00	2018-05-15 18:40:33+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	196531	phv00196531.v2.p10	pht003631.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:40:55+00:00	2018-05-15 18:40:55+00:00 	idtype	Idtype
70	Subcohort	196547	phv00196547.v2.p10	pht003632.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:41:05+00:00	2018-05-15 18:41:05+00:00 	idtype	Study Group Identifier
70	Subcohort	196564	phv00196564.v2.p10	pht003633.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:41:14+00:00	2018-05-15 18:41:14+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	196581	phv00196581.v2.p10	pht003634.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:41:21+00:00	2018-05-15 18:41:21+00:00 	idtype	Framingham Heart Study cohort identifier, Albuterol Collection Interval: Offspring Exam 8, Omni 1 Exam 3
70	Subcohort	201100	phv00201100.v1.p10	pht003782.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:41:29+00:00	2018-05-15 18:41:29+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Cases Reviewed Through 2013
70	Subcohort	201990	phv00201990.v2.p10	pht003901.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:41:38+00:00	2018-05-15 18:41:38+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	201994	phv00201994.v2.p10	pht003902.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:41:46+00:00	2018-05-15 18:41:46+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	201998	phv00201998.v2.p10	pht003903.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:41:55+00:00	2018-05-15 18:41:55+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	202013	phv00202013.v2.p10	pht003904.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:42:02+00:00	2018-05-15 18:42:02+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	202019	phv00202019.v3.p10	pht003905.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:42:11+00:00	2018-05-15 18:42:11+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	202022	phv00202022.v4.p10	pht003906.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:42:19+00:00	2018-05-15 18:42:19+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	202066	phv00202066.v3.p10	pht003910.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:42:29+00:00	2018-05-15 18:42:29+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	219225	phv00219225.v2.p10	pht004361.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:42:39+00:00	2018-05-15 18:42:39+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	219233	phv00219233.v1.p10	pht004362.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:42:50+00:00	2018-05-15 18:42:50+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Offspring Exam 6
70	Subcohort	219545	phv00219545.v2.p10	pht004363.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:43:08+00:00	2018-05-15 18:43:08+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	219551	phv00219551.v1.p10	pht004364.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:43:17+00:00	2018-05-15 18:43:17+00:00 	idtype	Framingham Heart Study participant cohort identifier Collection Interval: 2005-2010
70	Subcohort	220689	phv00220689.v3.p10	pht004365.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:43:32+00:00	2018-05-15 18:43:32+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Brain MRI Scans Dates 3/1999 to 8/2011
70	Subcohort	220703	phv00220703.v3.p10	pht004366.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:43:40+00:00	2018-05-15 18:43:40+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	220740	phv00220740.v1.p10	pht004367.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:43:47+00:00	2018-05-15 18:43:47+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: 1999-2005
70	Subcohort	220744	phv00220744.v2.p10	pht004368.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:43:55+00:00	2018-05-15 18:43:55+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	220750	phv00220750.v1.p10	pht004369.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:44:05+00:00	2018-05-15 18:44:05+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	220756	phv00220756.v1.p10	pht004370.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:44:14+00:00	2018-05-15 18:44:14+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	220822	phv00220822.v3.p10	pht004374.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:44:26+00:00	2018-05-15 18:44:26+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	220864	phv00220864.v2.p10	pht004375.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:44:35+00:00	2018-05-15 18:44:35+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Questionnaire administered at Original cohort Exams 14 and 15
70	Subcohort	227010	phv00227010.v1.p10	pht004800.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:44:58+00:00	2018-05-15 18:44:58+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	227013	phv00227013.v1.p10	pht004801.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:45:15+00:00	2018-05-15 18:45:15+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Exam 1
70	Subcohort	227024	phv00227024.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:45:22+00:00	2018-05-15 18:45:22+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	227074	phv00227074.v1.p10	pht004803.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:45:30+00:00	2018-05-15 18:45:30+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	227081	phv00227081.v1.p10	pht004804.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:45:37+00:00	2018-05-15 18:45:37+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	227083	phv00227083.v1.p10	pht004805.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:45:45+00:00	2018-05-15 18:45:45+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	227088	phv00227088.v1.p10	pht004806.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:45:57+00:00	2018-05-15 18:45:57+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Exam 1
70	Subcohort	227158	phv00227158.v1.p10	pht004807.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:46:09+00:00	2018-05-15 18:46:09+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	227163	phv00227163.v1.p10	pht004808.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:46:18+00:00	2018-05-15 18:46:18+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	227262	phv00227262.v1.p10	pht004809.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:46:29+00:00	2018-05-15 18:46:29+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Test performed at Offspring Exam9 and Omni 1 Exam 4
70	Subcohort	227293	phv00227293.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:46:39+00:00	2018-05-15 18:46:39+00:00 	idtype	Framingham Heart Study participant identifier within cohort (counts are observations, not participants)
70	Subcohort	227329	phv00227329.v1.p10	pht004811.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:46:47+00:00	2018-05-15 18:46:47+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	238808	phv00238808.v1.p10	pht004812.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:46:55+00:00	2018-05-15 18:46:55+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	250283	phv00250283.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:47:03+00:00	2018-05-15 18:47:03+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Exam 1
70	Subcohort	250719	phv00250719.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:47:10+00:00	2018-05-15 18:47:10+00:00 	idtype	Framingham Heart Study participant cohort identifier Collection Interval: Exam 2
70	Subcohort	251263	phv00251263.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:47:19+00:00	2018-05-15 18:47:19+00:00 	idtype	Framingham Heart Study participant cohort identifier Collection Interval: Exam 3
70	Subcohort	254011	phv00254011.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:47:29+00:00	2018-05-15 18:47:29+00:00 	idtype	Framingham Heart Study participant cohort identifier
70	Subcohort	254597	phv00254597.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:47:37+00:00	2018-05-15 18:47:37+00:00 	idtype	Framingham Heart Study participant cohort identifier Collection Interval: Exam 29
70	Subcohort	254990	phv00254990.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:47:46+00:00	2018-05-15 18:47:46+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Original Cohort Exam 30
70	Subcohort	255340	phv00255340.v1.p10	pht005143.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:47:55+00:00	2018-05-15 18:47:55+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	255417	phv00255417.v1.p10	pht005144.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:48:03+00:00	2018-05-15 18:48:03+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	255435	phv00255435.v1.p10	pht005145.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:48:11+00:00	2018-05-15 18:48:11+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	255462	phv00255462.v1.p10	pht005146.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:48:18+00:00	2018-05-15 18:48:18+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	256865	phv00256865.v1.p10	pht005147.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:48:26+00:00	2018-05-15 18:48:26+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Exam 8
70	Subcohort	256868	phv00256868.v1.p10	pht005148.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:48:34+00:00	2018-05-15 18:48:34+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	257537	phv00257537.v1.p10	pht005149.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:48:42+00:00	2018-05-15 18:48:42+00:00 	IDTYPE	Framingham Heart Study participant cohort identifier
70	Subcohort	257556	phv00257556.v1.p10	pht005150.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:48:56+00:00	2018-05-15 18:48:56+00:00 	idtype	Framingham Heart Study participant cohort identifier
70	Subcohort	257577	phv00257577.v1.p10	pht005151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:49:03+00:00	2018-05-15 18:49:03+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Test performed at Exam 2
70	Subcohort	257589	phv00257589.v1.p10	pht005152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:49:17+00:00	2018-05-15 18:49:17+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	257593	phv00257593.v1.p10	pht005153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:49:25+00:00	2018-05-15 18:49:25+00:00 	IDTYPE	FRAMINGHAM HEART STUDY COHORT IDENTIFIER
70	Subcohort	257600	phv00257600.v1.p10	pht005154.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:49:33+00:00	2018-05-15 18:49:33+00:00 	IDTYPE	FRAMINGHAM HEART STUDY COHORT IDENTIFIER
70	Subcohort	257606	phv00257606.v1.p10	pht005155.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:49:41+00:00	2018-05-15 18:49:41+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	257612	phv00257612.v1.p10	pht005156.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:49:49+00:00	2018-05-15 18:49:49+00:00 	IDTYPE	Framingham Heart Study cohort group Collection Interval: 2002 - 2005
70	Subcohort	257628	phv00257628.v1.p10	pht005157.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:49:57+00:00	2018-05-15 18:49:57+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	257641	phv00257641.v1.p10	pht005158.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:50:06+00:00	2018-05-15 18:50:06+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	257660	phv00257660.v1.p10	pht005159.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:50:13+00:00	2018-05-15 18:50:13+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	257665	phv00257665.v1.p10	pht005160.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:50:22+00:00	2018-05-15 18:50:22+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	257669	phv00257669.v1.p10	pht005161.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:50:30+00:00	2018-05-15 18:50:30+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	257674	phv00257674.v1.p10	pht005162.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:50:40+00:00	2018-05-15 18:50:40+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	257678	phv00257678.v1.p10	pht005163.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:50:47+00:00	2018-05-15 18:50:47+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	257684	phv00257684.v1.p10	pht005164.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:50:55+00:00	2018-05-15 18:50:55+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	257716	phv00257716.v1.p10	pht005165.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:51:06+00:00	2018-05-15 18:51:06+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	257783	phv00257783.v1.p10	pht005166.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:51:16+00:00	2018-05-15 18:51:16+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	257798	phv00257798.v1.p10	pht005167.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:51:28+00:00	2018-05-15 18:51:28+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Omni 1 Exam 3
70	Subcohort	257814	phv00257814.v1.p10	pht005168.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:51:37+00:00	2018-05-15 18:51:37+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4
70	Subcohort	257830	phv00257830.v1.p10	pht005169.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:51:45+00:00	2018-05-15 18:51:45+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4
70	Subcohort	257848	phv00257848.v1.p10	pht005170.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:51:55+00:00	2018-05-15 18:51:55+00:00 	idtype	Study Group Identifier
70	Subcohort	257864	phv00257864.v1.p10	pht005171.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:52:03+00:00	2018-05-15 18:52:03+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4
70	Subcohort	257881	phv00257881.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:52:12+00:00	2018-05-15 18:52:12+00:00 	idtype	Framingham Heart Study cohort identifier (counts are observations, not participants)
70	Subcohort	257913	phv00257913.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:52:20+00:00	2018-05-15 18:52:20+00:00 	idtype	Framingham Heart Study cohort identifier (counts are observations, not participants) Collection Interval: Original Cohort Exams 29, 30 and 31
70	Subcohort	257947	phv00257947.v1.p10	pht005174.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:52:37+00:00	2018-05-15 18:52:37+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	257969	phv00257969.v1.p10	pht005175.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:52:53+00:00	2018-05-15 18:52:53+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Exam performed at Exam 17 through Exam 32
70	Subcohort	261077	phv00261077.v1.p10	pht005389.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:53:01+00:00	2018-05-15 18:53:01+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	273701	phv00273701.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:53:09+00:00	2018-05-15 18:53:09+00:00 	idtype	Framingham Heart Study cohort identifier within a cohort Collection Interval: Exam 1
70	Subcohort	274194	phv00274194.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:53:16+00:00	2018-05-15 18:53:16+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	274709	phv00274709.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:53:24+00:00	2018-05-15 18:53:24+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Original Cohort Exam 31
70	Subcohort	275064	phv00275064.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:53:32+00:00	2018-05-15 18:53:32+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Original Cohort Exam 32
70	Subcohort	275398	phv00275398.v1.p10	pht006009.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:53:40+00:00	2018-05-15 18:53:40+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	275401	phv00275401.v1.p10	pht006010.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:53:48+00:00	2018-05-15 18:53:48+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Exam 2
70	Subcohort	275411	phv00275411.v1.p10	pht006011.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:53:58+00:00	2018-05-15 18:53:58+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Omni 1 Exam 3
70	Subcohort	275423	phv00275423.v1.p10	pht006012.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:54:07+00:00	2018-05-15 18:54:07+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	275428	phv00275428.v1.p10	pht006013.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:54:14+00:00	2018-05-15 18:54:14+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	276559	phv00276559.v1.p10	pht006014.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:54:22+00:00	2018-05-15 18:54:22+00:00 	idtype	Framingham Heart Study cohort identifier Collection Interval: Test Performed after Offspring Exam 9
70	Subcohort	276584	phv00276584.v1.p10	pht006015.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:54:31+00:00	2018-05-15 18:54:31+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	276642	phv00276642.v1.p10	pht006016.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:54:40+00:00	2018-05-15 18:54:40+00:00 	idtype	Framingham Heart Study cohort identifier
70	Subcohort	276649	phv00276649.v1.p10	pht006017.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:54:49+00:00	2018-05-15 18:54:49+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Original cohort: Baseline 1967-1969 Original cohort: Follow-up 1992 - 1993 Offsp
70	Subcohort	276845	phv00276845.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:54:57+00:00	2018-05-15 18:54:57+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	276909	phv00276909.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:55:08+00:00	2018-05-15 18:55:08+00:00 	IDTYPE	Framingham Heart Study participant identifier within cohort (counts are observations, not participants) Collection Interval: Exam 3
70	Subcohort	276928	phv00276928.v1.p10	pht006020.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:55:17+00:00	2018-05-15 18:55:17+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Cumulative through Exam 2
70	Subcohort	276939	phv00276939.v1.p10	pht006021.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:55:26+00:00	2018-05-15 18:55:26+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Cumulative through Exam 2
70	Subcohort	276950	phv00276950.v1.p10	pht006022.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:55:34+00:00	2018-05-15 18:55:34+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: Cases reviewed through Exam 3
70	Subcohort	276964	phv00276964.v1.p10	pht006023.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:55:44+00:00	2018-05-15 18:55:44+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	276970	phv00276970.v1.p10	pht006024.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:55:52+00:00	2018-05-15 18:55:52+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	276976	phv00276976.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:56:00+00:00	2018-05-15 18:56:00+00:00 	IDTYPE	Framingham Heart Study cohort identifier Collection Interval: 1975 through 2014
70	Subcohort	277016	phv00277016.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:56:22+00:00	2018-05-15 18:56:22+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	277066	phv00277066.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-15 18:56:40+00:00	2018-05-15 18:56:40+00:00 	IDTYPE	Framingham Heart Study cohort identifier
70	Subcohort	23894	phv00023894.v1.p10	pht000172.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-05-16 12:33:08+00:00	2018-05-16 12:33:08+00:00 	IDTYPE	COHORT IDENTIFIER
70	Subcohort	126148	phv00126148.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:31:36+00:00	2018-06-12 01:31:36+00:00 	PLKA1	Participant type
70	Subcohort	100290	phv00100290.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 21:57:09+00:00	2018-06-27 21:57:09+00:00 	PERSTAT	COHORT
70	Subcohort	100682	phv00100682.v1.p1	pht001456.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 21:57:47+00:00	2018-06-27 21:57:47+00:00 	PERSTAT	Cohort
70	Subcohort	100809	phv00100809.v1.p1	pht001466.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 21:58:23+00:00	2018-06-27 21:58:23+00:00 	PERSTAT	COHORT
70	Subcohort	100867	phv00100867.v1.p1	pht001469.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 21:58:43+00:00	2018-06-27 21:58:43+00:00 	PERSTAT	Cohort
70	Subcohort	101122	phv00101122.v1.p1	pht001470.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 21:59:02+00:00	2018-06-27 21:59:02+00:00 	PERSTAT	COHORT
70	Subcohort	101232	phv00101232.v1.p1	pht001472.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 21:59:18+00:00	2018-06-27 21:59:18+00:00 	PERSTAT	COHORT
70	Subcohort	101234	phv00101234.v1.p1	pht001473.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 21:59:32+00:00	2018-06-27 21:59:32+00:00 	PERSTAT	COHORT
70	Subcohort	101949	phv00101949.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 21:59:46+00:00	2018-06-27 21:59:46+00:00 	PERSTAT	COHORT
70	Subcohort	102584	phv00102584.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:01:05+00:00	2018-06-27 22:01:05+00:00 	PERSTAT	COHORT
70	Subcohort	106430	phv00106430.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:01:20+00:00	2018-06-27 22:01:20+00:00 	PERSTAT	COHORT
70	Subcohort	107355	phv00107355.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:01:35+00:00	2018-06-27 22:01:35+00:00 	PERSTAT	COHORT
70	Subcohort	107781	phv00107781.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:01:50+00:00	2018-06-27 22:01:50+00:00 	PERSTAT	COHORT
70	Subcohort	108392	phv00108392.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:02:06+00:00	2018-06-27 22:02:06+00:00 	PERSTAT	COHORT
70	Subcohort	109143	phv00109143.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:02:19+00:00	2018-06-27 22:02:19+00:00 	PERSTAT	COHORT
70	Subcohort	109856	phv00109856.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:02:31+00:00	2018-06-27 22:02:31+00:00 	PERSTAT	COHORT
70	Subcohort	80424	phv00080424.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:07:26+00:00	2018-06-28 22:07:26+00:00 	CTFLAG	CT Participant
70	Subcohort	80425	phv00080425.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:07:59+00:00	2018-06-28 22:07:59+00:00 	OSFLAG	OS Participant
70	Subcohort	80426	phv00080426.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:08:12+00:00	2018-06-28 22:08:12+00:00 	HRTFLAG	HRT Participant
70	Subcohort	80427	phv00080427.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:08:25+00:00	2018-06-28 22:08:25+00:00 	DMFLAG	DM Participant
70	Subcohort	80428	phv00080428.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:08:45+00:00	2018-06-28 22:08:45+00:00 	CADFLAG	CAD Participant
70	Subcohort	80429	phv00080429.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:08:57+00:00	2018-06-28 22:08:57+00:00 	HRTARM	HRT Arm
70	Subcohort	80430	phv00080430.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:09:18+00:00	2018-06-28 22:09:18+00:00 	DMARM	DM Arm
70	Subcohort	80431	phv00080431.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:09:31+00:00	2018-06-28 22:09:31+00:00 	CADARM	CaD Arm
70	Subcohort	80433	phv00080433.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:09:43+00:00	2018-06-28 22:09:43+00:00 	BMDFLAG	Rand to BMD
70	Subcohort	192297	phv00192297.v3.p3	pht003395.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:11:41+00:00	2018-06-28 22:11:41+00:00 	EXTFLAG	Enrolled in WHI Extension 1
70	Subcohort	192300	phv00192300.v3.p3	pht003395.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:12:00+00:00	2018-06-28 22:12:00+00:00 	EXT2FLAG	Enrolled in WHI Extension 2
70	Subcohort	192302	phv00192302.v3.p3	pht003395.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:12:15+00:00	2018-06-28 22:12:15+00:00 	EXT2MRC	Extension 2 MRC Participant
70	Subcohort	192303	phv00192303.v3.p3	pht003395.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-28 22:12:26+00:00	2018-06-28 22:12:26+00:00 	EXT2SRC	Extension 2 SRC Participant
71	Clinic visit	127610	phv00127610.v1.p1	pht001959.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:43:40+00:00	2018-03-16 01:43:40+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	125926	phv00125926.v1.p1	pht001945.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-16 01:53:16+00:00	2018-03-16 01:53:16+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	124550	phv00124550.v1.p1	pht001921.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-20 09:49:43+00:00	2018-03-20 09:49:43+00:00 	VISIT	CONTACT OCCASION [visit 1]
71	Clinic visit	124605	phv00124605.v1.p1	pht001922.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-20 09:49:43+00:00	2018-03-20 09:49:43+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	124615	phv00124615.v1.p1	pht001923.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-20 09:49:43+00:00	2018-03-20 09:49:43+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	124637	phv00124637.v1.p1	pht001924.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-20 09:49:43+00:00	2018-03-20 09:49:43+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	124668	phv00124668.v1.p1	pht001926.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-20 09:49:43+00:00	2018-03-20 09:49:43+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	124676	phv00124676.v1.p1	pht001927.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-20 09:49:43+00:00	2018-03-20 09:49:43+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	124710	phv00124710.v1.p1	pht001928.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-20 09:49:43+00:00	2018-03-20 09:49:43+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	127523	phv00127523.v1.p1	pht001956.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-22 21:33:29+00:00	2018-03-22 21:33:29+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	127578	phv00127578.v1.p1	pht001957.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-22 21:33:29+00:00	2018-03-22 21:33:29+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	127592	phv00127592.v1.p1	pht001958.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-22 21:33:29+00:00	2018-03-22 21:33:29+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	127669	phv00127669.v1.p1	pht001962.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-22 21:33:29+00:00	2018-03-22 21:33:29+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	127671	phv00127671.v1.p1	pht001963.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-22 21:33:29+00:00	2018-03-22 21:33:29+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	127754	phv00127754.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-22 21:33:29+00:00	2018-03-22 21:33:29+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	127985	phv00127985.v1.p1	pht001965.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-22 21:33:29+00:00	2018-03-22 21:33:29+00:00 	VISIT	CONTACT OCCASION [visit 1]
71	Clinic visit	128027	phv00128027.v1.p1	pht001966.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-22 21:33:29+00:00	2018-03-22 21:33:29+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	128604	phv00128604.v1.p1	pht001982.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-03-22 21:33:29+00:00	2018-03-22 21:33:29+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	21570	phv00021570.v5.p10	pht000076.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 16:58:30+00:00	2018-06-04 16:58:30+00:00 	EXAM	EXAM CYCLE 7  (N=3257)
71	Clinic visit	21589	phv00021589.v5.p10	pht000077.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 16:59:24+00:00	2018-06-04 16:59:24+00:00 	EXAM	EXAM CYCLE 6
71	Clinic visit	21987	phv00021987.v5.p10	pht000098.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:00:02+00:00	2018-06-04 17:00:02+00:00 	EXAM	EXAM CYCLE NUMBER
71	Clinic visit	23129	phv00023129.v1.p10	pht000138.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:00:27+00:00	2018-06-04 17:00:27+00:00 	EXAM	EXAM CYCLE 23
71	Clinic visit	24716	phv00024716.v1.p10	pht000206.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:00:46+00:00	2018-06-04 17:00:46+00:00 	EXAM	EXAM MEASURED (9-11, 21-23)
71	Clinic visit	80751	phv00080751.v2.p10	pht001039.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:01:21+00:00	2018-06-04 17:01:21+00:00 	EXAM	FHS Exam number corresponding to the sample
71	Clinic visit	23206	phv00023206.v5.p10	pht000146.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:01:40+00:00	2018-06-04 17:01:40+00:00 	EXAM	EXAM CYCLE 7
71	Clinic visit	36344	phv00036344.v3.p10	pht000298.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:01:57+00:00	2018-06-04 17:01:57+00:00 	exam	EXAM CYCLE: 1
71	Clinic visit	23554	phv00023554.v5.p10	pht000151.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:02:19+00:00	2018-06-04 17:02:19+00:00 	EXAM	EXAM 3-4 (PREDOMINANTLY EXAM 3, N=10 FOR EXAM 4)
71	Clinic visit	73733	phv00073733.v4.p10	pht000824.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:02:41+00:00	2018-06-04 17:02:41+00:00 	exam	Exam cycle of pain questionnaire
71	Clinic visit	24556	phv00024556.v5.p10	pht000197.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:04:00+00:00	2018-06-04 17:04:00+00:00 	hrv_exam	FHS EXAM NUMBER
71	Clinic visit	36251	phv00036251.v1.p10	pht000294.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:04:41+00:00	2018-06-04 17:04:41+00:00 	Exam	EXAM NUMBER
71	Clinic visit	36220	phv00036220.v5.p10	pht000293.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:05:02+00:00	2018-06-04 17:05:02+00:00 	Exam	EXAM NUMBER 6 - 7
71	Clinic visit	227020	phv00227020.v1.p10	pht004801.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:05:32+00:00	2018-06-04 17:05:32+00:00 	EXAM	Exam number Collection Interval: Exam 1
71	Clinic visit	275406	phv00275406.v1.p10	pht006010.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:05:50+00:00	2018-06-04 17:05:50+00:00 	EXAM	Exam number Collection Interval: Exam 2
71	Clinic visit	275424	phv00275424.v1.p10	pht006012.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:06:09+00:00	2018-06-04 17:06:09+00:00 	EXAM	Exam number
71	Clinic visit	227084	phv00227084.v1.p10	pht004805.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:06:28+00:00	2018-06-04 17:06:28+00:00 	EXAM	Framingham Heart Study cohort exam number
71	Clinic visit	172230	phv00172230.v4.p10	pht002892.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:20:51+00:00	2018-06-04 17:20:51+00:00 	exam	Exam Number
71	Clinic visit	227161	phv00227161.v1.p10	pht004807.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:21:16+00:00	2018-06-04 17:21:16+00:00 	EXAM	Framingham Heart Study cohort exam number
71	Clinic visit	219546	phv00219546.v2.p10	pht004363.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:22:04+00:00	2018-06-04 17:22:04+00:00 	EXAM	Framingham Heart Study exam number
71	Clinic visit	81047	phv00081047.v1.p10	pht001045.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:22:39+00:00	2018-06-04 17:22:39+00:00 	exam	Cohort exam corresponding to sample Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38)
71	Clinic visit	36317	phv00036317.v3.p10	pht000295.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:23:13+00:00	2018-06-04 17:23:13+00:00 	exam	EXAM INDICATOR WHEN XRAY WAS OBTAINED
71	Clinic visit	70899	phv00070899.v1.p10	pht000685.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:23:33+00:00	2018-06-04 17:23:33+00:00 	exam	EXAM CYCLE: 7
71	Clinic visit	22649	phv00022649.v1.p10	pht000103.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:23:59+00:00	2018-06-04 17:23:59+00:00 	EXAM	EXAM CYCLE OF TEST
71	Clinic visit	22702	phv00022702.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:24:17+00:00	2018-06-04 17:24:17+00:00 	EXAM	FRAMINGHAM EXAM CYCLE 5-6
71	Clinic visit	22727	phv00022727.v1.p10	pht000108.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:24:55+00:00	2018-06-04 17:24:55+00:00 	RHDEXAM	EXAM OF FIRST RHEUMATIC HEART DISEASE
71	Clinic visit	167002	phv00167002.v5.p10	pht002572.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:25:37+00:00	2018-06-04 17:25:37+00:00 	EXAM	EXAM NUMBER
71	Clinic visit	167134	phv00167134.v1.p10	pht002573.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:25:56+00:00	2018-06-04 17:25:56+00:00 	EXAM	EXAM NUMBER
71	Clinic visit	156740	phv00156740.v2.p10	pht002148.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:26:13+00:00	2018-06-04 17:26:13+00:00 	EXAM	Exam number
71	Clinic visit	163456	phv00163456.v1.p10	pht002429.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:26:45+00:00	2018-06-04 17:26:45+00:00 	exam_number	Number of Exam Collection Interval: Original Cohort Exam 11 and Offspring Exam 1
71	Clinic visit	159556	phv00159556.v3.p10	pht002236.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:50:32+00:00	2018-06-04 17:50:32+00:00 	exam	Closest Framingham exam cycle Collection Interval: Exam dates from 12/2000 to 6/2008
71	Clinic visit	163502	phv00163502.v3.p10	pht002431.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:50:56+00:00	2018-06-04 17:50:56+00:00 	exam	Exam number Collection Interval: Original Cohort Exams 27 and 28, Offspring Exam 8
71	Clinic visit	227327	phv00227327.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:51:29+00:00	2018-06-04 17:51:29+00:00 	exam	Exam number (counts are observations, not participants)
71	Clinic visit	257914	phv00257914.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:52:38+00:00	2018-06-04 17:52:38+00:00 	exam	Exam number (counts are observations, not participants) Collection Interval: Original Cohort Exams 29, 30 and 31
71	Clinic visit	257948	phv00257948.v1.p10	pht005174.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:54:58+00:00	2018-06-04 17:54:58+00:00 	exam	EXAM NUMBER
71	Clinic visit	257970	phv00257970.v1.p10	pht005175.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 17:55:24+00:00	2018-06-04 17:55:24+00:00 	exam	EXAM NUMBER Collection Interval: Exam performed at Exam 17 through Exam 32
71	Clinic visit	55165	phv00055165.v4.p10	pht000394.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-04 18:10:45+00:00	2018-06-04 18:10:45+00:00 	EXAM	EXAM CYCLE 7
71	Clinic visit	124739	phv00124739.v1.p1	pht001929.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 14:56:56+00:00	2018-06-08 14:56:56+00:00 	VISIT	CONTACT OCCASION [visit 1]
71	Clinic visit	124863	phv00124863.v1.p1	pht001930.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 15:02:45+00:00	2018-06-08 15:02:45+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	124987	phv00124987.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 15:11:40+00:00	2018-06-08 15:11:40+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	125072	phv00125072.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:28:42+00:00	2018-06-08 16:28:42+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	125157	phv00125157.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:44:42+00:00	2018-06-08 16:44:42+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	125243	phv00125243.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 16:58:26+00:00	2018-06-08 16:58:26+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	125329	phv00125329.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-08 17:05:06+00:00	2018-06-08 17:05:06+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	128495	phv00128495.v1.p1	pht001977.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-17 18:29:41+00:00	2018-06-17 18:29:41+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	127121	phv00127121.v1.p1	pht001954.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 01:40:40+00:00	2018-06-20 01:40:40+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	128172	phv00128172.v1.p1	pht001968.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:38:54+00:00	2018-06-20 16:38:54+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	128245	phv00128245.v1.p1	pht001970.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:40:10+00:00	2018-06-20 16:40:10+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	128382	phv00128382.v1.p1	pht001975.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:45:34+00:00	2018-06-20 16:45:34+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	128578	phv00128578.v1.p1	pht001979.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:55:38+00:00	2018-06-20 16:55:38+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	128587	phv00128587.v1.p1	pht001980.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:55:55+00:00	2018-06-20 16:55:55+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	128331	phv00128331.v1.p1	pht001973.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:56:44+00:00	2018-06-20 16:56:44+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	128085	phv00128085.v1.p1	pht001967.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:16:32+00:00	2018-06-20 18:16:32+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	100772	phv00100772.v1.p1	pht001463.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 23:54:19+00:00	2018-06-27 23:54:19+00:00 	SampleYear	Year sample taken
71	Clinic visit	99570	phv00099570.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:28:35+00:00	2018-06-29 16:28:35+00:00 	YEAR	Number of YEARS SINCE BASELINE
71	Clinic visit	100283	phv00100283.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:28:47+00:00	2018-06-29 16:28:47+00:00 	YEAR	Number of YEARS SINCE BASELINE
71	Clinic visit	100692	phv00100692.v1.p1	pht001459.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:29:21+00:00	2018-06-29 16:29:21+00:00 	YEAR	Year CAC was measured
71	Clinic visit	101404	phv00101404.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:29:43+00:00	2018-06-29 16:29:43+00:00 	YEAR	Number of YEARS SINCE BASELINE
71	Clinic visit	102282	phv00102282.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:29:58+00:00	2018-06-29 16:29:58+00:00 	YEAR	NUMBER OF YEARS SINCE BASELINE
71	Clinic visit	103855	phv00103855.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:30:12+00:00	2018-06-29 16:30:12+00:00 	YEAR	Number of  YEARS SINCE BASELINE
71	Clinic visit	104543	phv00104543.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:30:24+00:00	2018-06-29 16:30:24+00:00 	YEAR	Number of YEARS SINCE BASELINE
71	Clinic visit	105620	phv00105620.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:30:34+00:00	2018-06-29 16:30:34+00:00 	YEAR	Number of YEARS SINCE BASELINE
71	Clinic visit	107591	phv00107591.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:30:47+00:00	2018-06-29 16:30:47+00:00 	YEAR	Number of YEARS SINCE BASELINE
71	Clinic visit	108391	phv00108391.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:30:57+00:00	2018-06-29 16:30:57+00:00 	YEAR	Number of YEARS SINCE BASELINE
71	Clinic visit	109142	phv00109142.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:31:08+00:00	2018-06-29 16:31:08+00:00 	YEAR	Number of YEARS SINCE BASELINE
71	Clinic visit	110524	phv00110524.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-29 16:31:27+00:00	2018-06-29 16:31:27+00:00 	YEAR	Number of YEARS SINCE BASELINE
71	Clinic visit	77317	phv00077317.v6.p3	pht000983.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:24:20+00:00	2018-06-29 22:24:20+00:00 	HIPVTYP	Hip scan visit type
71	Clinic visit	77318	phv00077318.v6.p3	pht000983.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:24:20+00:00	2018-06-29 22:24:20+00:00 	HIPVY	Hip scan visit year
71	Clinic visit	77330	phv00077330.v6.p3	pht000984.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:25:21+00:00	2018-06-29 22:25:21+00:00 	SPNVTYP	Spine scan visit type
71	Clinic visit	77331	phv00077331.v6.p3	pht000984.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:25:21+00:00	2018-06-29 22:25:21+00:00 	SPNVY	Spine scan visit year
71	Clinic visit	283349	phv00283349.v1.p3	pht006218.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:25:21+00:00	2018-06-29 22:25:21+00:00 	VTYP	Visit Type
71	Clinic visit	283350	phv00283350.v1.p3	pht006218.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:26:00+00:00	2018-06-29 22:26:00+00:00 	VISITYR	Visit Year
71	Clinic visit	77339	phv00077339.v6.p3	pht000985.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:26:48+00:00	2018-06-29 22:26:48+00:00 	WBVTYP	Whole body scan visit type
71	Clinic visit	77340	phv00077340.v6.p3	pht000985.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:26:48+00:00	2018-06-29 22:26:48+00:00 	WBVY	Whole body visit year
71	Clinic visit	77361	phv00077361.v6.p3	pht000986.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:27:19+00:00	2018-06-29 22:27:19+00:00 	CBCVTYP	CBC Visit type
71	Clinic visit	77362	phv00077362.v6.p3	pht000986.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:27:19+00:00	2018-06-29 22:27:19+00:00 	CBCVY	CBC Visit year
71	Clinic visit	77370	phv00077370.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:28:16+00:00	2018-06-29 22:28:16+00:00 	COREVTYP	Visit Type
71	Clinic visit	77371	phv00077371.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:28:16+00:00	2018-06-29 22:28:16+00:00 	COREVY	Visit year
71	Clinic visit	77442	phv00077442.v6.p3	pht000989.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:29:18+00:00	2018-06-29 22:29:18+00:00 	ECGFUVTYP	Follow-up ECG visit type
71	Clinic visit	77443	phv00077443.v6.p3	pht000989.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:29:18+00:00	2018-06-29 22:29:18+00:00 	ECGFUVY	Follow-up ECG visit year
71	Clinic visit	78829	phv00078829.v6.p3	pht001004.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:49:34+00:00	2018-06-29 22:49:34+00:00 	F35VTYP	Visit Type
71	Clinic visit	78830	phv00078830.v6.p3	pht001004.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:49:34+00:00	2018-06-29 22:49:34+00:00 	F35VY	Visit year
71	Clinic visit	79313	phv00079313.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:49:34+00:00	2018-06-29 22:49:34+00:00 	F41VTYP	Visit Type
71	Clinic visit	79314	phv00079314.v6.p3	pht001009.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:49:34+00:00	2018-06-29 22:49:34+00:00 	F41VY	Visit year
71	Clinic visit	79850	phv00079850.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:49:34+00:00	2018-06-29 22:49:34+00:00 	F80VTYP	Visit Type
71	Clinic visit	79851	phv00079851.v6.p3	pht001019.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:49:34+00:00	2018-06-29 22:49:34+00:00 	F80VY	Visit year
71	Clinic visit	111655	phv00111655.v6.p3	pht001517.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:49:34+00:00	2018-06-29 22:49:34+00:00 	F60VTYP	F60 Visit type
71	Clinic visit	111656	phv00111656.v6.p3	pht001517.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:49:34+00:00	2018-06-29 22:49:34+00:00 	F60VY	F60 Visit year
71	Clinic visit	156380	phv00156380.v5.p3	pht002125.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:49:35+00:00	2018-06-29 22:49:35+00:00 	F60VTYP	Visit Type
71	Clinic visit	156381	phv00156381.v5.p3	pht002125.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:49:35+00:00	2018-06-29 22:49:35+00:00 	F60VY	Visit year
71	Clinic visit	78868	phv00078868.v6.p3	pht001005.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F37VTYP	Visit Type
71	Clinic visit	78869	phv00078869.v6.p3	pht001005.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F37VY	Visit year
71	Clinic visit	79086	phv00079086.v6.p3	pht001006.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F38VTYP	Visit Type
71	Clinic visit	79087	phv00079087.v6.p3	pht001006.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F38VY	Visit year
71	Clinic visit	79229	phv00079229.v6.p3	pht001007.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F39VTYP	Visit Type
71	Clinic visit	79230	phv00079230.v6.p3	pht001007.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F39VY	Visit year
71	Clinic visit	79305	phv00079305.v6.p3	pht001008.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F40VTYP	F40 Visit type
71	Clinic visit	79306	phv00079306.v6.p3	pht001008.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F40VY	F40 Visit year
71	Clinic visit	79871	phv00079871.v6.p3	pht001020.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F81VTYP	Visit Type
71	Clinic visit	79872	phv00079872.v6.p3	pht001020.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F81VY	Visit year
71	Clinic visit	79908	phv00079908.v6.p3	pht001021.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F82VTYP	Visit Type
71	Clinic visit	79909	phv00079909.v6.p3	pht001021.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F82VY	Visit year
71	Clinic visit	79923	phv00079923.v6.p3	pht001022.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F83VTYP	Visit Type
71	Clinic visit	79924	phv00079924.v6.p3	pht001022.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F83VY	Visit year
71	Clinic visit	79943	phv00079943.v6.p3	pht001023.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F84VTYP	Visit Type
71	Clinic visit	79944	phv00079944.v6.p3	pht001023.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:53:35+00:00	2018-06-29 22:53:35+00:00 	F84VY	Visit year
71	Clinic visit	79982	phv00079982.v6.p3	pht001025.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	F90VTYP	Visit Type
71	Clinic visit	79983	phv00079983.v6.p3	pht001025.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	F90VY	Visit year
71	Clinic visit	79997	phv00079997.v6.p3	pht001026.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	F92VTYP	Visit Type
71	Clinic visit	79998	phv00079998.v6.p3	pht001026.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	F92VY	Visit year
71	Clinic visit	154926	phv00154926.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	ECGVTYP	ECG visit type
71	Clinic visit	154927	phv00154927.v5.p3	pht002118.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	ECGVY	ECG visit year
71	Clinic visit	155605	phv00155605.v5.p3	pht002120.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	F85VTYP	Visit Type
71	Clinic visit	155606	phv00155606.v5.p3	pht002120.v5.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	F85VY	Visit year
71	Clinic visit	169399	phv00169399.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	F150VTYP	Visit Type
71	Clinic visit	169400	phv00169400.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	F150VY	Visit Year
71	Clinic visit	169507	phv00169507.v4.p3	pht002750.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	F153VTYP	F153 Visit type
71	Clinic visit	169508	phv00169508.v4.p3	pht002750.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	F153VY	F153 Visit year
71	Clinic visit	169545	phv00169545.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	F154VTYP	Visit Type
71	Clinic visit	169546	phv00169546.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:55:12+00:00	2018-06-29 22:55:12+00:00 	F154VY	Visit Year
71	Clinic visit	169603	phv00169603.v4.p3	pht002754.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:36+00:00	2018-06-29 22:56:36+00:00 	F44VTYP	Visit Type
71	Clinic visit	169604	phv00169604.v4.p3	pht002754.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:36+00:00	2018-06-29 22:56:36+00:00 	F44VY	F44 Visit year or number
71	Clinic visit	192305	phv00192305.v3.p3	pht003396.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:36+00:00	2018-06-29 22:56:36+00:00 	F151VTYP	Visit Type
71	Clinic visit	192306	phv00192306.v3.p3	pht003396.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:36+00:00	2018-06-29 22:56:36+00:00 	F151VY	Visit Year
71	Clinic visit	192334	phv00192334.v3.p3	pht003397.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:36+00:00	2018-06-29 22:56:36+00:00 	F33VTYP	Visit Type
71	Clinic visit	192335	phv00192335.v3.p3	pht003397.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:36+00:00	2018-06-29 22:56:36+00:00 	F33VY	Visit year
71	Clinic visit	192360	phv00192360.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:36+00:00	2018-06-29 22:56:36+00:00 	F45VTYP	Visit Type
71	Clinic visit	192361	phv00192361.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:36+00:00	2018-06-29 22:56:36+00:00 	F45VY	Visit year
71	Clinic visit	193847	phv00193847.v3.p3	pht003418.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:36+00:00	2018-06-29 22:56:36+00:00 	DRAWVTYP	Visit Type
71	Clinic visit	193848	phv00193848.v3.p3	pht003418.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:36+00:00	2018-06-29 22:56:36+00:00 	DRAWVY	Specimen Draw Visit Year
71	Clinic visit	282952	phv00282952.v1.p3	pht006212.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:55+00:00	2018-06-29 22:56:55+00:00 	ADHVTYP	Visit type for CaD adherence period
71	Clinic visit	282953	phv00282953.v1.p3	pht006212.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:55+00:00	2018-06-29 22:56:55+00:00 	ADHVY	Visit year for CaD adherence period
71	Clinic visit	282965	phv00282965.v1.p3	pht006213.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:55+00:00	2018-06-29 22:56:55+00:00 	ADHVTYP	Visit type for HRT adherence period
71	Clinic visit	282966	phv00282966.v1.p3	pht006213.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:56:56+00:00	2018-06-29 22:56:56+00:00 	ADHVY	Visit year for HRT adherence period
71	Clinic visit	282979	phv00282979.v1.p3	pht006214.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:58:16+00:00	2018-06-29 22:58:16+00:00 	F155VTYP	Visit type
71	Clinic visit	282980	phv00282980.v1.p3	pht006214.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:58:16+00:00	2018-06-29 22:58:16+00:00 	F155VY	Visit year
71	Clinic visit	283184	phv00283184.v1.p3	pht006215.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:58:16+00:00	2018-06-29 22:58:16+00:00 	F156VTYP	Visit Type
71	Clinic visit	283185	phv00283185.v1.p3	pht006215.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:58:16+00:00	2018-06-29 22:58:16+00:00 	F156VY	Visit Year
71	Clinic visit	283186	phv00283186.v1.p3	pht006215.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:58:16+00:00	2018-06-29 22:58:16+00:00 	F156X2VY	Extension 2 visit year
71	Clinic visit	283252	phv00283252.v1.p3	pht006216.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:58:16+00:00	2018-06-29 22:58:16+00:00 	F157VTYP	Visit Type
71	Clinic visit	283253	phv00283253.v1.p3	pht006216.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:58:16+00:00	2018-06-29 22:58:16+00:00 	F157VY	Visit Year
71	Clinic visit	283254	phv00283254.v1.p3	pht006216.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:58:16+00:00	2018-06-29 22:58:16+00:00 	F157X2VY	Extension 2 visit year
71	Clinic visit	283287	phv00283287.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:58:16+00:00	2018-06-29 22:58:16+00:00 	F301VTYP	Visit Type
71	Clinic visit	283288	phv00283288.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-06-29 22:58:16+00:00	2018-06-29 22:58:16+00:00 	F301VY	Visit Year
71	Clinic visit	125664	phv00125664.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:06:14+00:00	2018-07-09 20:06:14+00:00 	visit	CONTACT YEAR
71	Clinic visit	125575	phv00125575.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:08:28+00:00	2018-07-09 20:08:28+00:00 	visit	CONTACT YEAR
71	Clinic visit	125753	phv00125753.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:17:37+00:00	2018-07-09 20:17:37+00:00 	VISIT	CONTACT YEAR
71	Clinic visit	125840	phv00125840.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 20:32:08+00:00	2018-07-09 20:32:08+00:00 	VISIT	CONTACT YEAR
71	Clinic visit	127458	phv00127458.v1.p1	pht001955.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-10 16:45:09+00:00	2018-07-10 16:45:09+00:00 	VISIT	CONTACT OCCASION
71	Clinic visit	278175	phv00278175.v1.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:12:52+00:00	2018-08-10 21:12:52+00:00 	Visit_Year	Year of visit, to use for longitudinal analysis Collection Interval: Collected in Exam 1
71	Clinic visit	278174	phv00278174.v1.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 21:14:31+00:00	2018-08-10 21:14:31+00:00 	Study_Phase	Phase of COPDGene study: baseline, phase 2 Collection Interval: Collected in Exam 1
71	Clinic visit	210894	phv00210894.v1.p1	pht004204.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-13 19:07:18+00:00	2018-08-13 19:07:18+00:00 	TIAECY	Contact year [10] [TIA/Stroke Form, Cohort Visit 4]
71	Clinic visit	210963	phv00210963.v1.p1	pht004205.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-13 19:07:27+00:00	2018-08-13 19:07:27+00:00 	TIBECY	Administrative information. Contact Year [10]. [TIA/Stroke Form, Cohort Visit 4]
71	Clinic visit	210596	phv00210596.v1.p1	pht004202.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-13 19:07:35+00:00	2018-08-13 19:07:35+00:00 	TIACCY	Contact year [4] [TIA/Stroke, exam 2]
71	Clinic visit	210470	phv00210470.v1.p1	pht004201.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-13 19:07:43+00:00	2018-08-13 19:07:43+00:00 	TIABCY	Contact year [1] [TIA/Stroke, exam 1]
71	Clinic visit	210785	phv00210785.v1.p1	pht004203.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-13 19:07:50+00:00	2018-08-13 19:07:50+00:00 	TIADCY	Contact year [7] [TIA/Stroke, exam 3]
71	Clinic visit	277281	phv00277281.v1.p1	pht006030.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:06:28+00:00	2018-08-14 22:06:28+00:00 	EXAMYEAR	Year of examination Collection Interval: 2007-2009
71	Clinic visit	277328	phv00277328.v1.p1	pht006034.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:11:56+00:00	2018-08-14 22:11:56+00:00 	EXAMYEAR	Year of examination Collection Interval: 2009-2011
71	Clinic visit	277508	phv00277508.v1.p1	pht006039.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:40:36+00:00	2018-08-14 22:40:36+00:00 	EXAMYEAR	Year of examination Collection Interval: 1996-2000
71	Clinic visit	277655	phv00277655.v1.p1	pht006044.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:57:13+00:00	2018-08-14 22:57:13+00:00 	EXAMYEAR_MR	Year of MR scan Collection Interval: 2002-2006
71	Clinic visit	277759	phv00277759.v1.p1	pht006046.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:07:23+00:00	2018-08-14 23:07:23+00:00 	EXAMYEAR	Year of examination Collection Interval: 2000-2004
71	Clinic visit	307741	phv00307741.v1.p1	pht006649.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:51:23+00:00	2018-08-15 23:51:23+00:00 	EXAMYEAR	Year of examination Collection Interval: 2006-2011
71	Clinic visit	307789	phv00307789.v1.p1	pht006653.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:54:48+00:00	2018-08-15 23:54:48+00:00 	EXAMYEAR	Year of examination Collection Interval: 1996-2000
71	Clinic visit	307936	phv00307936.v1.p1	pht006658.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:06:51+00:00	2018-08-16 00:06:51+00:00 	EXAMYEAR_MR	Year of MR scan Collection Interval: 2002-2006
71	Clinic visit	307950	phv00307950.v1.p1	pht006659.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:08:51+00:00	2018-08-16 00:08:51+00:00 	EXAMYEAR	Year of examination Collection Interval: 2000-2004
71	Clinic visit	124330	phv00124330.v1.p1	pht001903.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:01:28+00:00	2018-08-16 23:01:28+00:00 	rectype	Visit
71	Clinic visit	122012	phv00122012.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:01:53+00:00	2018-08-16 23:01:53+00:00 	visit	Visit Number
71	Clinic visit	253221	phv00253221.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:32:37+00:00	2018-08-24 16:32:37+00:00 	CLINDATE_YR	Year of baseline clinic visit
71	Clinic visit	258036	phv00258036.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:54:48+00:00	2018-08-24 16:54:48+00:00 	CLINDATE	Date of clinic visit
71	Clinic visit	121453	phv00121453.v2.p2	pht001869.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-18 19:29:07+00:00	2018-12-18 19:29:07+00:00 	YTCNT	CONTACT PERIOD
71	Clinic visit	121677	phv00121677.v2.p2	pht001871.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-18 19:29:46+00:00	2018-12-18 19:29:46+00:00 	YTCNT	CONTACT PERIOD
71	Clinic visit	121472	phv00121472.v2.p2	pht001870.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-18 19:30:04+00:00	2018-12-18 19:30:04+00:00 	YTCNT	CONTACT PERIOD
71	Clinic visit	121181	phv00121181.v2.p2	pht001867.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-12-18 19:33:08+00:00	2018-12-18 19:33:08+00:00 	YTCNT	CONTACT CODE
71	Clinic visit	259377	phv00259377.v1.p2	pht005311.v1.p2	phs001013.v2.p2	Heart and Vascular Health Study (HVH)	1013	2	2018-12-20 19:41:47+00:00	2018-12-20 19:41:47+00:00 	indexy	Index Year
72	Fasting	253225	phv00253225.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 21:59:57+00:00	2018-03-14 21:59:57+00:00 	FASTTIME	Time fasting prior to blood draw
72	Fasting	204681	phv00204681.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 15:59:50+00:00	2018-03-19 15:59:50+00:00 	FAST0823	Visit 2, fast 8 hrs. or more, definition 2 [Cohort, Exam 2]
72	Fasting	204682	phv00204682.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:00:14+00:00	2018-03-19 16:00:14+00:00 	FAST1223	Visit 2, fast 12 hrs. or more, definition 2 [Cohort, Exam 2]
72	Fasting	204732	phv00204732.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:00:38+00:00	2018-03-19 16:00:38+00:00 	FAST0802	Fasting time of 8 hours or more [Cohort, Exam 1]
72	Fasting	204733	phv00204733.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:01:04+00:00	2018-03-19 16:01:04+00:00 	FAST1202	Fasting time of 12 hours or more [Cohort, Exam 1]
72	Fasting	204902	phv00204902.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:01:21+00:00	2018-03-19 16:01:21+00:00 	FAST0834	Fasting time of 8 hours or more [Cohort, Exam 3]
72	Fasting	204903	phv00204903.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:02:07+00:00	2018-03-19 16:02:07+00:00 	FAST1234	Fasting time of 12 hours or more [Cohort, Exam 3]
72	Fasting	204956	phv00204956.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:02:42+00:00	2018-03-19 16:02:42+00:00 	FAST0841	Fasting time of 8 hours or more [Cohort, Exam 4]
72	Fasting	204957	phv00204957.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:03:10+00:00	2018-03-19 16:03:10+00:00 	FAST1241	Fasting time of 12 hours or more [Cohort, Exam 4]
72	Fasting	206629	phv00206629.v1.p1	pht004096.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:12:58+00:00	2018-03-19 16:12:58+00:00 	GTSA3	Has participant fasted at least 12 hours? Q3 [Oral Glucose Tolerance Screening Form, exam 4]
72	Fasting	206637	phv00206637.v1.p1	pht004097.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-19 16:13:53+00:00	2018-03-19 16:13:53+00:00 	GTSB3	Has participant fasted at least 10 hours? Q3 [Oral Glucose Tolerance Screening Version B, exam 4]
72	Fasting	112660	phv00112660.v2.p2	pht001563.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:12:40+00:00	2018-04-17 20:12:40+00:00 	A05FSTMN	NUMBER OF MINUTES FASTING
72	Fasting	112661	phv00112661.v2.p2	pht001563.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:12:40+00:00	2018-04-17 20:12:40+00:00 	A05FAST	12 HR FAST BEFORE BLOOD DRAWN
72	Fasting	114299	phv00114299.v2.p2	pht001599.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:12:40+00:00	2018-04-17 20:12:40+00:00 	B05FSTMN	NUMBER OF MINUTES FASTING
72	Fasting	114300	phv00114300.v2.p2	pht001599.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:12:40+00:00	2018-04-17 20:12:40+00:00 	B05FAST	12 HR FAST BEFORE BLOOD DRAWN
72	Fasting	115407	phv00115407.v2.p2	pht001654.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:12:40+00:00	2018-04-17 20:12:40+00:00 	C05FSTMN	NUMBER OF MINUTES FASTING
72	Fasting	115408	phv00115408.v2.p2	pht001654.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:12:40+00:00	2018-04-17 20:12:40+00:00 	C05FAST	12 HR FAST BEFORE BLOOD DRAWN
72	Fasting	116645	phv00116645.v2.p2	pht001709.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:12:40+00:00	2018-04-17 20:12:40+00:00 	D05FSTMN	NUMBER OF MINUTES FASTING
72	Fasting	116646	phv00116646.v2.p2	pht001709.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:12:40+00:00	2018-04-17 20:12:40+00:00 	D05FAST	12 HR FAST BEFORE BLOOD DRAWN
72	Fasting	118414	phv00118414.v2.p2	pht001759.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:12:40+00:00	2018-04-17 20:12:40+00:00 	E05FSTMN	NUMBER OF MINUTES FASTING
72	Fasting	118415	phv00118415.v2.p2	pht001759.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:12:40+00:00	2018-04-17 20:12:40+00:00 	E05FAST	12 HR FAST BEFORE BLOOD DRAW?
72	Fasting	119786	phv00119786.v2.p2	pht001809.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:12:40+00:00	2018-04-17 20:12:40+00:00 	F05FSTMN	NUMBER OF MINUTES FASTING
72	Fasting	119787	phv00119787.v2.p2	pht001809.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-04-17 20:12:40+00:00	2018-04-17 20:12:40+00:00 	F05FAST	12 HR FAST BEFORE BLOOD DRAW?
72	Fasting	83303	phv00083303.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:02:58+00:00	2018-04-29 01:02:58+00:00 	lastdrk1	HOW LONG AGO LAST DRINK OR EAT? (HRS)
72	Fasting	84980	phv00084980.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:03:07+00:00	2018-04-29 01:03:07+00:00 	lastdrk1	HOW LONG AGO LAST DRINK OR EAT? (HRS)
72	Fasting	86410	phv00086410.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:03:14+00:00	2018-04-29 01:03:14+00:00 	lastdrk3	HOW LONG AGO LAST EAT OR DRINK? (hrs)
72	Fasting	85927	phv00085927.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:03:22+00:00	2018-04-29 01:03:22+00:00 	lastdrk2	HOW LONG AGO LAST EAT OR DRINK? (HRS)
72	Fasting	86842	phv00086842.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:03:29+00:00	2018-04-29 01:03:29+00:00 	lastdrk4	HOW LONG AGO LAST EAT OR DRINK? (Hrs)
72	Fasting	87524	phv00087524.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:03:35+00:00	2018-04-29 01:03:35+00:00 	lastdrkf	HOW LONG AGO LAST DRINK OR EAT? (hrs)
72	Fasting	82696	phv00082696.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:03:42+00:00	2018-04-29 01:03:42+00:00 	ecgfst1	PARTICIPANT FASTING?
72	Fasting	82697	phv00082697.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:03:54+00:00	2018-04-29 01:03:54+00:00 	eceattm1	TIME LAST ATE OR DRANK
72	Fasting	227071	phv00227071.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:11:34+00:00	2018-06-05 15:11:34+00:00 	FAST_H	Number of hours fasting
72	Fasting	71889	phv00071889.v4.p10	pht000742.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:13:17+00:00	2018-06-05 15:13:17+00:00 	FASTING	Fasting 8 hours
72	Fasting	172200	phv00172200.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:13:45+00:00	2018-06-05 15:13:45+00:00 	fasting	Fasting at least 10 hours
72	Fasting	227021	phv00227021.v1.p10	pht004801.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:14:08+00:00	2018-06-05 15:14:08+00:00 	FASTING	Number of hours fasting Collection Interval: Exam 1
72	Fasting	227070	phv00227070.v1.p10	pht004802.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:14:33+00:00	2018-06-05 15:14:33+00:00 	FASTING	Fasting status
72	Fasting	255347	phv00255347.v1.p10	pht005143.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:14:58+00:00	2018-06-05 15:14:58+00:00 	FASTING	Fasting at least 8 hours
72	Fasting	275407	phv00275407.v1.p10	pht006010.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:15:22+00:00	2018-06-05 15:15:22+00:00 	FASTING	Fasting status Collection Interval: Exam 2
72	Fasting	275412	phv00275412.v1.p10	pht006011.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:15:49+00:00	2018-06-05 15:15:49+00:00 	FASTING	Fasting 8 hours Collection Interval: Omni 1 Exam 3
72	Fasting	172199	phv00172199.v2.p10	pht002889.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-05 15:42:43+00:00	2018-06-05 15:42:43+00:00 	hrs_fasting	Number of hours fasting
72	Fasting	126016	phv00126016.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:06:41+00:00	2018-06-12 01:06:41+00:00 	GLF01ST	Glucose fasting status
72	Fasting	126044	phv00126044.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:20:45+00:00	2018-06-12 01:20:45+00:00 	LPF01	Fasting and non-fasting status for lipid profile
72	Fasting	126129	phv00126129.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:42:14+00:00	2018-06-20 17:42:14+00:00 	FST01TM	FST01TM
72	Fasting	126130	phv00126130.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:42:14+00:00	2018-06-20 17:42:14+00:00 	FST01HR	FST01HR
72	Fasting	277396	phv00277396.v1.p1	pht006036.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:41:36+00:00	2018-08-02 18:41:36+00:00 	FAST10HR	Is the participant fasting at least 10 hours? Collection Interval: 2009-2011
72	Fasting	277572	phv00277572.v1.p1	pht006041.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:41:46+00:00	2018-08-02 18:41:46+00:00 	FAST10HR	Compute length of time fasting: Is the participant fasting at least 10 hours? Collection Interval: 1996-2000
72	Fasting	277840	phv00277840.v1.p1	pht006048.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:41:53+00:00	2018-08-02 18:41:53+00:00 	FAST10HR	Compute length of time fasting: Is the participant fasting at least 10 hours? Collection Interval: 2000-2004
72	Fasting	307853	phv00307853.v1.p1	pht006655.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:42:01+00:00	2018-08-02 18:42:01+00:00 	FAST10HR	Compute length of time fasting: Is the participant fasting at least 10 hours? Collection Interval: 1996-2000
72	Fasting	308033	phv00308033.v1.p1	pht006661.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-02 18:42:10+00:00	2018-08-02 18:42:10+00:00 	FAST10HR	Compute length of time fasting: Is the participant fasting at least 10 hours? Collection Interval: 2000-2004
72	Fasting	118384	phv00118384.v2.p2	pht001759.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 22:42:31+00:00	2018-08-28 22:42:31+00:00 	E05FST8H	PARTICIPANT FAST FOR AT LEAST 8 HOURS? Q 13
72	Fasting	258726	phv00258726.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 12:48:53+00:00	2018-09-06 12:48:53+00:00 	Fasting	Fasting Status
72	Fasting	77373	phv00077373.v6.p3	pht000987.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-20 22:12:41+00:00	2018-09-20 22:12:41+00:00 	FASTHRS	Fasting hours
72	Fasting	193854	phv00193854.v3.p3	pht003418.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-20 22:13:05+00:00	2018-09-20 22:13:05+00:00 	FASTHRS	Fasting hours
72	Fasting	283302	phv00283302.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-20 22:13:34+00:00	2018-09-20 22:13:34+00:00 	FASTHRS	Fasting hours
72	Fasting	99347	phv00099347.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:52:27+00:00	2018-09-27 17:52:27+00:00 	FAST12	FASTING
72	Fasting	99923	phv00099923.v1.p1	pht001451.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:52:39+00:00	2018-09-27 17:52:39+00:00 	FAST30	HOURS SINCE LAST ATE OR DRANK
72	Fasting	101781	phv00101781.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:53:35+00:00	2018-09-27 17:53:35+00:00 	TIMEAT14	HOURS SINCE LAST EATEN
72	Fasting	102469	phv00102469.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:53:45+00:00	2018-09-27 17:53:45+00:00 	TIMEAT14	HOURS SINCE LAST EATEN
72	Fasting	104027	phv00104027.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:53:54+00:00	2018-09-27 17:53:54+00:00 	TIMEAT14	HOURS SINCE LAST EATEN
72	Fasting	104693	phv00104693.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:54:04+00:00	2018-09-27 17:54:04+00:00 	TIMEAT14	HOURS SINCE LAST EATEN
72	Fasting	105431	phv00105431.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:54:12+00:00	2018-09-27 17:54:12+00:00 	TIMEAT14	HOURS SINCE LAST EATEN
72	Fasting	106793	phv00106793.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:54:21+00:00	2018-09-27 17:54:21+00:00 	TIMEAT14	HOURS SINCE LAST EATEN
72	Fasting	107761	phv00107761.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:54:31+00:00	2018-09-27 17:54:31+00:00 	TIMEAT14	HOURS SINCE LAST EATEN
72	Fasting	108492	phv00108492.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:54:39+00:00	2018-09-27 17:54:39+00:00 	TIMEAT14	HOURS SINCE LAST EATEN
72	Fasting	110276	phv00110276.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:54:47+00:00	2018-09-27 17:54:47+00:00 	TIMEAT14	HOURS SINCE LAST EATEN
72	Fasting	102449	phv00102449.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:55:09+00:00	2018-09-27 17:55:09+00:00 	TIMATE12	HOURS SINCE EATEN
72	Fasting	105411	phv00105411.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:55:17+00:00	2018-09-27 17:55:17+00:00 	TIMATE12	HOURS SINCE EATEN
72	Fasting	106774	phv00106774.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:55:26+00:00	2018-09-27 17:55:26+00:00 	TIMATE12	HOURS SINCE EATEN
72	Fasting	107745	phv00107745.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:55:35+00:00	2018-09-27 17:55:35+00:00 	TIMATE12	HOURS SINCE EATEN
72	Fasting	108479	phv00108479.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:55:48+00:00	2018-09-27 17:55:48+00:00 	TIMATE12	HOURS SINCE EATEN
72	Fasting	109241	phv00109241.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:56:01+00:00	2018-09-27 17:56:01+00:00 	TIMATE12	HOURS SINCE EATEN
72	Fasting	110349	phv00110349.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 17:56:09+00:00	2018-09-27 17:56:09+00:00 	TIMATE12	HOURS SINCE EATEN
72	Fasting	1049	phv00001049.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:13+00:00	2018-10-03 17:37:13+00:00 	FA15	BLOOD ANALYSIS:  FASTING
72	Fasting	1201	phv00001201.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:13+00:00	2018-10-03 17:37:13+00:00 	FB24	BLOOD ANALYSIS:  FASTING
72	Fasting	1378	phv00001378.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:13+00:00	2018-10-03 17:37:13+00:00 	FC20	BLOOD ANALYSIS: FASTING
72	Fasting	1391	phv00001391.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:13+00:00	2018-10-03 17:37:13+00:00 	FC35	GLUCOSE CHALLENGE: TIME OF LAST EATING, AM OR PM
72	Fasting	1392	phv00001392.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:13+00:00	2018-10-03 17:37:13+00:00 	FC36	GLUCOSE CHALLENGE: TIME OF LAST EATING. HOUR
72	Fasting	1393	phv00001393.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:13+00:00	2018-10-03 17:37:13+00:00 	FC37	GLUCOSE CHALLENGE: TIME OF LAST EATING, MINUTE
72	Fasting	1573	phv00001573.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:13+00:00	2018-10-03 17:37:13+00:00 	FD28	GLUCOSE CHALLENGE: TIME OF LAST EATING, AM OR PM
72	Fasting	1574	phv00001574.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:13+00:00	2018-10-03 17:37:13+00:00 	FD29	GLUCOSE CHALLENGE: TIME OF LAST EATING, HOUR
72	Fasting	1575	phv00001575.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:13+00:00	2018-10-03 17:37:13+00:00 	FD30	GLUCOSE CHALLENGE: TIME OF LAST EATING, MINUTE
72	Fasting	1797	phv00001797.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:14+00:00	2018-10-03 17:37:14+00:00 	FD301	BLOOD ANALYSIS - FASTING 12 HOURS OR MORE
72	Fasting	7550	phv00007550.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:14+00:00	2018-10-03 17:37:14+00:00 	A23	FASTING 12 HRS. OR MORE
72	Fasting	7986	phv00007986.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:14+00:00	2018-10-03 17:37:14+00:00 	B368	BLOOD ANALYSIS-FASTING LIPIDS: FASTING 12 HRS. OR MORE
72	Fasting	8773	phv00008773.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:14+00:00	2018-10-03 17:37:14+00:00 	D418	NUMBER OF HOURS FASTING
72	Fasting	9562	phv00009562.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:14+00:00	2018-10-03 17:37:14+00:00 	E040	NUMBER OF HOURS FASTING
72	Fasting	10117	phv00010117.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:14+00:00	2018-10-03 17:37:14+00:00 	F021	NUMBER OF HOURS FASTING
72	Fasting	10137	phv00010137.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:14+00:00	2018-10-03 17:37:14+00:00 	F728	BLOOD ANALYSIS - FASTING
72	Fasting	250297	phv00250297.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:37:14+00:00	2018-10-03 17:37:14+00:00 	e040	Numerical Data - Part I: Number of hours fasting Collection Interval: Exam 1
72	Fasting	932	phv00000932.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:38:20+00:00	2018-10-03 17:38:20+00:00 	MF490	BLOOD ANALYSIS: FASTING BLOOD, EXAM 7
72	Fasting	10145	phv00010145.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:38:20+00:00	2018-10-03 17:38:20+00:00 	G707	FASTING STATUS
72	Fasting	10504	phv00010504.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:38:20+00:00	2018-10-03 17:38:20+00:00 	G447	REGIONAL ANTHROPOMETRY - NUMBER OF HOURS FASTING
72	Fasting	21237	phv00021237.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:38:20+00:00	2018-10-03 17:38:20+00:00 	G3A453	NUMBER OF HOURS FASTING
72	Fasting	251067	phv00251067.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:38:20+00:00	2018-10-03 17:38:20+00:00 	g447	Numerical Data - Part I - Regional Anthropometry: Number of hours fasting Collection Interval: Exam 2
72	Fasting	251544	phv00251544.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:38:20+00:00	2018-10-03 17:38:20+00:00 	h409	Numerical Data - Part I: Regional Anthropometry: Are you fasting >= than 8 hours? Collection Interval: Exam 3
72	Fasting	274059	phv00274059.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:38:20+00:00	2018-10-03 17:38:20+00:00 	g3a453	Number of hours fasting Collection Interval: Exam 1
72	Fasting	274550	phv00274550.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-10-03 17:38:20+00:00	2018-10-03 17:38:20+00:00 	g3a453	Number of hours fasting
73	Geographic site	226256	phv00226256.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-03-14 21:55:48+00:00	2018-03-14 21:55:48+00:00 	CENTER	Center
73	Geographic site	204692	phv00204692.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 15:01:55+00:00	2018-03-15 15:01:55+00:00 	CENTERID	Recoded Center ID [Cohort, Exam 2]
73	Geographic site	204813	phv00204813.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 15:02:21+00:00	2018-03-15 15:02:21+00:00 	CENTERID	Recoded Center ID [Cohort, Exam 1]
73	Geographic site	204920	phv00204920.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 15:02:48+00:00	2018-03-15 15:02:48+00:00 	CENTERID	Recoded center ID [Cohort, Exam 3]
73	Geographic site	205016	phv00205016.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-03-15 15:03:19+00:00	2018-03-15 15:03:19+00:00 	CENTERID	Recoded Center ID [Cohort, Exam 4]
73	Geographic site	82644	phv00082644.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:11:50+00:00	2018-04-29 01:11:50+00:00 	site1c	SITE
73	Geographic site	84447	phv00084447.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:11:56+00:00	2018-04-29 01:11:56+00:00 	site1c	SITE
73	Geographic site	85783	phv00085783.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:12:02+00:00	2018-04-29 01:12:02+00:00 	site2c	SITE AT EXAM 2
73	Geographic site	86269	phv00086269.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:12:08+00:00	2018-04-29 01:12:08+00:00 	site3c	SITE AT EXAM3
73	Geographic site	86737	phv00086737.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:12:14+00:00	2018-04-29 01:12:14+00:00 	site4c	SITE AT EXAM 4
73	Geographic site	87075	phv00087075.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:12:21+00:00	2018-04-29 01:12:21+00:00 	sitefc	FIELD CENTER WHERE EXAMINED
73	Geographic site	142679	phv00142679.v4.p3	pht002100.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:12:27+00:00	2018-04-29 01:12:27+00:00 	site	SITE
73	Geographic site	150533	phv00150533.v1.p3	pht002108.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:12:33+00:00	2018-04-29 01:12:33+00:00 	site	SITE
73	Geographic site	152531	phv00152531.v2.p3	pht002109.v2.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:12:38+00:00	2018-04-29 01:12:38+00:00 	site	SITE
73	Geographic site	174587	phv00174587.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:12:44+00:00	2018-04-29 01:12:44+00:00 	site5c	SITE AT EXAM 5
73	Geographic site	175857	phv00175857.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:13:22+00:00	2018-04-29 01:13:22+00:00 	site1c	SITE
73	Geographic site	175880	phv00175880.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:13:27+00:00	2018-04-29 01:13:27+00:00 	site	SITE
73	Geographic site	175942	phv00175942.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:13:33+00:00	2018-04-29 01:13:33+00:00 	sitefc	FAMILY COHORT: FIELD CENTER WHERE EXAMINED
73	Geographic site	176010	phv00176010.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:13:39+00:00	2018-04-29 01:13:39+00:00 	site5c	SITE AT EXAM 5
73	Geographic site	219023	phv00219023.v1.p3	pht004326.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-04-29 01:13:45+00:00	2018-04-29 01:13:45+00:00 	sitesc	SITE AT STRESS EXAM
73	Geographic site	250284	phv00250284.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:42:51+00:00	2018-06-14 18:42:51+00:00 	e020	Numerical Data - Part I: Site of exam Collection Interval: Exam 1
73	Geographic site	251057	phv00251057.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:43:12+00:00	2018-06-14 18:43:12+00:00 	g436	Numerical Data - Part I - Basic Information: Site of exam Collection Interval: Exam 2
73	Geographic site	251531	phv00251531.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:43:34+00:00	2018-06-14 18:43:34+00:00 	h392	Numerical Data - Part I: Basic Information: Site of Exam Collection Interval: Exam 3
73	Geographic site	254283	phv00254283.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:44:15+00:00	2018-06-14 18:44:15+00:00 	j469	Numerical Data/Anthropometry: Basic Information - Site of Exam
73	Geographic site	254761	phv00254761.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:44:49+00:00	2018-06-14 18:44:49+00:00 	fv251	Numerical Data (Anthropometry) - Basic Information: Site of Exam Collection Interval: Exam 29
73	Geographic site	255154	phv00255154.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:45:34+00:00	2018-06-14 18:45:34+00:00 	fw297	Numerical Data: Basic Information - Site of Exam Collection Interval: Original Cohort Exam 30
73	Geographic site	274879	phv00274879.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:45:55+00:00	2018-06-14 18:45:55+00:00 	FX297	Numerical Data: Basic Information - Site of Exam Collection Interval: Original Cohort Exam 31
73	Geographic site	275237	phv00275237.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-06-14 18:46:13+00:00	2018-06-14 18:46:13+00:00 	fy297	Numerical Data: Basic Information - Site of Exam Collection Interval: Original Cohort Exam 32
73	Geographic site	99453	phv00099453.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:16:01+00:00	2018-06-27 22:16:01+00:00 	CLINIC	CHS SITE
73	Geographic site	100291	phv00100291.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:16:39+00:00	2018-06-27 22:16:39+00:00 	CLINIC	CHS CLINIC
73	Geographic site	100696	phv00100696.v1.p1	pht001460.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:16:55+00:00	2018-06-27 22:16:55+00:00 	CLINIC	No description provided
73	Geographic site	102623	phv00102623.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:17:08+00:00	2018-06-27 22:17:08+00:00 	CLINIC	CHS SITE
73	Geographic site	105114	phv00105114.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:17:22+00:00	2018-06-27 22:17:22+00:00 	CLINIC	CLINIC
73	Geographic site	108814	phv00108814.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:17:45+00:00	2018-06-27 22:17:45+00:00 	CLINIC	CHS SITE
73	Geographic site	106546	phv00106546.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:18:04+00:00	2018-06-27 22:18:04+00:00 	CLINIC	CLINIC
73	Geographic site	109510	phv00109510.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:18:20+00:00	2018-06-27 22:18:20+00:00 	CLINIC	CHS SITE
73	Geographic site	198806	phv00198806.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-06-27 22:18:32+00:00	2018-06-27 22:18:32+00:00 	clinic	Clinic identification number
73	Geographic site	80435	phv00080435.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-07-02 20:56:59+00:00	2018-07-02 20:56:59+00:00 	REGION	U. S. Region
73	Geographic site	126005	phv00126005.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-02 21:54:32+00:00	2018-08-02 21:54:32+00:00 	COUNTY	COUNTY
73	Geographic site	202105	phv00202105.v2.p1	pht003918.v2.p1	phs000741.v2.p1	GOLDN	741	2	2018-08-02 21:56:00+00:00	2018-08-02 21:56:00+00:00 	center	Recruitment center
73	Geographic site	159569	phv00159569.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-02 21:56:10+00:00	2018-08-02 21:56:10+00:00 	deid_center	De-identified site code Collection Interval: Collected in Exam 1
73	Geographic site	258677	phv00258677.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-08-02 21:56:41+00:00	2018-08-02 21:56:41+00:00 	Census_Region	Census Region of Samoa
73	Geographic site	121847	phv00121847.v1.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-08-02 21:57:00+00:00	2018-08-02 21:57:00+00:00 	state_enroll	State of residence at current appt date
73	Geographic site	112418	phv00112418.v2.p2	pht001559.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-16 22:33:03+00:00	2018-08-16 22:33:03+00:00 	A01LCEN	A01LCEN
73	Geographic site	116398	phv00116398.v2.p2	pht001700.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 19:12:28+00:00	2018-08-23 19:12:28+00:00 	CENTER_CARE	CENTER FOR CARE PROJECT
74	Medication/supplement use	126136	phv00126136.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:32:31+00:00	2018-06-12 01:32:31+00:00 	HRM01	Current female hormone use
74	Medication/supplement use	126055	phv00126055.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:37:59+00:00	2018-06-12 01:37:59+00:00 	CLM01	Anti-hypercholesterolemic medication status
74	Medication/supplement use	126023	phv00126023.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:39:44+00:00	2018-06-12 01:39:44+00:00 	DMM01T	Antidiabetic medication type
74	Medication/supplement use	126024	phv00126024.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:39:59+00:00	2018-06-12 01:39:59+00:00 	DMM01	Antidiabetic medication status
74	Medication/supplement use	126026	phv00126026.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:40:16+00:00	2018-06-12 01:40:16+00:00 	SRMED	Self-reported anti-diabetic medication
74	Medication/supplement use	126053	phv00126053.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:41:00+00:00	2018-06-12 01:41:00+00:00 	LPM01	Anti-hyperlipidemic medication status
74	Medication/supplement use	126054	phv00126054.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-12 01:41:15+00:00	2018-06-12 01:41:15+00:00 	TRM01	Anti-hypertriglyceridemic medication status
74	Medication/supplement use	123029	phv00123029.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-06-18 19:17:08+00:00	2018-06-18 19:17:08+00:00 	xbpmeds	Meds: On specified BP medication
74	Medication/supplement use	126299	phv00126299.v1.p1	pht001951.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 01:33:51+00:00	2018-06-20 01:33:51+00:00 	DITA138	Use supplements (y/n)
74	Medication/supplement use	126304	phv00126304.v1.p1	pht001952.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 01:34:21+00:00	2018-06-20 01:34:21+00:00 	lffq_supp_use	LFFQ: use of supplements indicated
74	Medication/supplement use	126444	phv00126444.v1.p1	pht001952.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 01:35:04+00:00	2018-06-20 01:35:04+00:00 	ravg_supp_use	0/1 supplement user
74	Medication/supplement use	126574	phv00126574.v1.p1	pht001952.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 01:36:06+00:00	2018-06-20 01:36:06+00:00 	sffq_supp_use	SFFQ: use of supplements indicated
74	Medication/supplement use	126712	phv00126712.v1.p1	pht001953.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 01:37:24+00:00	2018-06-20 01:37:24+00:00 	lffq_supp_use	LFFQ: use of supplements indicated
74	Medication/supplement use	126853	phv00126853.v1.p1	pht001953.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 01:38:07+00:00	2018-06-20 01:38:07+00:00 	ravg_supp_use	0/1 supplement user
74	Medication/supplement use	126983	phv00126983.v1.p1	pht001953.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 01:38:50+00:00	2018-06-20 01:38:50+00:00 	sffq_supp_use	SFFQ: use of supplements indicated
74	Medication/supplement use	127668	phv00127668.v1.p1	pht001962.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 14:08:12+00:00	2018-06-20 14:08:12+00:00 	ahfscode	Msrahfscode
74	Medication/supplement use	127664	phv00127664.v2.p1	pht001962.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 14:08:25+00:00	2018-06-20 14:08:25+00:00 	medconc	Medconc
74	Medication/supplement use	127665	phv00127665.v2.p1	pht001962.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 14:08:37+00:00	2018-06-20 14:08:37+00:00 	gpicode	Msragpicode
74	Medication/supplement use	127666	phv00127666.v2.p1	pht001962.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 14:08:50+00:00	2018-06-20 14:08:50+00:00 	tccode	Msratccode
74	Medication/supplement use	127667	phv00127667.v1.p1	pht001962.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 14:09:09+00:00	2018-06-20 14:09:09+00:00 	tcname	Msratcname
74	Medication/supplement use	125033	phv00125033.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:57:41+00:00	2018-06-20 15:57:41+00:00 	AFUA17	17. Are you now taking aspirin or a medicine containing aspirin on a regular basis?
74	Medication/supplement use	125118	phv00125118.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:57:55+00:00	2018-06-20 15:57:55+00:00 	AFUA17	17. Are you now taking aspirin or a medicine containing aspirin on a regular basis?
74	Medication/supplement use	125204	phv00125204.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:58:07+00:00	2018-06-20 15:58:07+00:00 	AFUB17	17. Are you now taking aspirin or a medicine containing aspirin on a regular basis?
74	Medication/supplement use	125290	phv00125290.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:58:17+00:00	2018-06-20 15:58:17+00:00 	AFUB17	17. Are you now taking aspirin or a medicine containing aspirin on a regular basis?
74	Medication/supplement use	125491	phv00125491.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:58:28+00:00	2018-06-20 15:58:28+00:00 	AFUC49	49. Are you now taking aspirin, or a medicine containing aspirin on a regular basis?
74	Medication/supplement use	125545	phv00125545.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 15:58:45+00:00	2018-06-20 15:58:45+00:00 	AFUI17	TAKING ASPRIN REGULARLY           Q17
74	Medication/supplement use	125634	phv00125634.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:02:02+00:00	2018-06-20 16:02:02+00:00 	AFUI17	TAKING ASPRIN REGULARLY           Q17
74	Medication/supplement use	125723	phv00125723.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:02:19+00:00	2018-06-20 16:02:19+00:00 	AFUJ17	TAKING ASPRIN REGULARLY           Q17
74	Medication/supplement use	125810	phv00125810.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:02:34+00:00	2018-06-20 16:02:34+00:00 	AFUK17	TAKING ASPRIN REGULARLY             Q17
74	Medication/supplement use	128271	phv00128271.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:32:03+00:00	2018-06-20 16:32:03+00:00 	RHXA13	13:Age start taking birth control pills?
74	Medication/supplement use	128272	phv00128272.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:32:21+00:00	2018-06-20 16:32:21+00:00 	RHXA14	14:Currently taking birth control pills?
74	Medication/supplement use	128273	phv00128273.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:32:45+00:00	2018-06-20 16:32:45+00:00 	RHXA15	15:Age stop taking birth control pills?
74	Medication/supplement use	128329	phv00128329.v1.p1	pht001972.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:41:45+00:00	2018-06-20 16:41:45+00:00 	ahfscode	Ahfscode
74	Medication/supplement use	128325	phv00128325.v1.p1	pht001972.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:43:10+00:00	2018-06-20 16:43:10+00:00 	medconc	Medconc
74	Medication/supplement use	128326	phv00128326.v1.p1	pht001972.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:43:10+00:00	2018-06-20 16:43:10+00:00 	gpicode	Gpicode
74	Medication/supplement use	128327	phv00128327.v1.p1	pht001972.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:43:10+00:00	2018-06-20 16:43:10+00:00 	tcname	Tcname
74	Medication/supplement use	128328	phv00128328.v1.p1	pht001972.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 16:43:10+00:00	2018-06-20 16:43:10+00:00 	tccode	Tccode
74	Medication/supplement use	126038	phv00126038.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:45:20+00:00	2018-06-20 17:45:20+00:00 	BPM01	Antihypertensive medication
74	Medication/supplement use	126058	phv00126058.v1.p1	pht001949.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 17:48:32+00:00	2018-06-20 17:48:32+00:00 	MED01CT	Medication accountability
74	Medication/supplement use	124762	phv00124762.v1.p1	pht001929.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:26:23+00:00	2018-06-20 18:26:23+00:00 	AFOV1C	1c. What medication did you take for your heart condition?
74	Medication/supplement use	124743	phv00124743.v1.p1	pht001929.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:28:16+00:00	2018-06-20 18:28:16+00:00 	AFOV1B	1b. Other heart condition, such as congestive heart failure
74	Medication/supplement use	124742	phv00124742.v1.p1	pht001929.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:28:31+00:00	2018-06-20 18:28:31+00:00 	AFOV1A	1a. Chest pain or angina
74	Medication/supplement use	124866	phv00124866.v1.p1	pht001930.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:29:32+00:00	2018-06-20 18:29:32+00:00 	AFOV1A	1a. Chest pain or angina
74	Medication/supplement use	124867	phv00124867.v1.p1	pht001930.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:29:45+00:00	2018-06-20 18:29:45+00:00 	AFOV1B	1b. Other heart condition, such as congestive heart failure
74	Medication/supplement use	124886	phv00124886.v1.p1	pht001930.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-06-20 18:30:07+00:00	2018-06-20 18:30:07+00:00 	AFOV1C	1c. What medication did you take for your heart condition?
74	Medication/supplement use	125122	phv00125122.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:30:13+00:00	2018-07-09 19:30:13+00:00 	AFUA19B	19b. Since your JHS visit, have you taken or used any female hormone pills, skin patches, shots or implants?
74	Medication/supplement use	125123	phv00125123.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:31:00+00:00	2018-07-09 19:31:00+00:00 	AFUA19C	19c. Name 1
74	Medication/supplement use	125124	phv00125124.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:31:16+00:00	2018-07-09 19:31:16+00:00 	AFUA20	20. Code 1
74	Medication/supplement use	125121	phv00125121.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-09 19:37:23+00:00	2018-07-09 19:37:23+00:00 	AFUA19A	19a. Since we last contacted you, have you taken or used any female hormone pills, skin patches, shots or implants?
74	Medication/supplement use	125040	phv00125040.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:08:17+00:00	2018-07-12 18:08:17+00:00 	AFUA21	21. Have you also used a second female hormone since we last contacted you?
74	Medication/supplement use	125041	phv00125041.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:08:17+00:00	2018-07-12 18:08:17+00:00 	AFUA21A	21a. Name 2
74	Medication/supplement use	125042	phv00125042.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:08:17+00:00	2018-07-12 18:08:17+00:00 	AFUA22	22. Code 2
74	Medication/supplement use	125125	phv00125125.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:08:17+00:00	2018-07-12 18:08:17+00:00 	AFUA21	21. Have you also used a second female hormone since we last contacted you?
74	Medication/supplement use	125126	phv00125126.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:08:17+00:00	2018-07-12 18:08:17+00:00 	AFUA21A	21a. Name 2
74	Medication/supplement use	125127	phv00125127.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:08:17+00:00	2018-07-12 18:08:17+00:00 	AFUA22	22. Code 2
74	Medication/supplement use	125201	phv00125201.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:10:34+00:00	2018-07-12 18:10:34+00:00 	AFUB16A	16a. High blood pressure
74	Medication/supplement use	125202	phv00125202.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:10:34+00:00	2018-07-12 18:10:34+00:00 	AFUB16B	16b. High blood cholesterol
74	Medication/supplement use	125203	phv00125203.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:10:34+00:00	2018-07-12 18:10:34+00:00 	AFUB16C	16c. Diabetes or high blood sugar
74	Medication/supplement use	125207	phv00125207.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:10:34+00:00	2018-07-12 18:10:34+00:00 	AFUB19A	19a. Since we last contacted you, have you taken or used any female hormone pills, skin patches, shots or implants?
74	Medication/supplement use	125208	phv00125208.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:10:34+00:00	2018-07-12 18:10:34+00:00 	AFUB19B	19b. Since your JHS visit, have you taken or used any female hormone pills, skin patches, shots or implants?
74	Medication/supplement use	125209	phv00125209.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:10:34+00:00	2018-07-12 18:10:34+00:00 	AFUB19C	19c. Name 1
74	Medication/supplement use	125287	phv00125287.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:10:34+00:00	2018-07-12 18:10:34+00:00 	AFUB16A	16a. High blood pressure
74	Medication/supplement use	125288	phv00125288.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:10:34+00:00	2018-07-12 18:10:34+00:00 	AFUB16B	16b. High blood cholesterol
74	Medication/supplement use	125289	phv00125289.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:10:34+00:00	2018-07-12 18:10:34+00:00 	AFUB16C	16c. Diabetes or high blood sugar
74	Medication/supplement use	125293	phv00125293.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:10:34+00:00	2018-07-12 18:10:34+00:00 	AFUB19A	19a. Since we last contacted you, have you taken or used any female hormone pills, skin patches, shots or implants?
74	Medication/supplement use	125294	phv00125294.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:10:34+00:00	2018-07-12 18:10:34+00:00 	AFUB19B	19b. Since your JHS visit, have you taken or used any female hormone pills, skin patches, shots or implants?
74	Medication/supplement use	125295	phv00125295.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:10:34+00:00	2018-07-12 18:10:34+00:00 	AFUB19C	19c. Name 1
74	Medication/supplement use	125210	phv00125210.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:12:45+00:00	2018-07-12 18:12:45+00:00 	AFUB20	20. Code 1
74	Medication/supplement use	125211	phv00125211.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:12:45+00:00	2018-07-12 18:12:45+00:00 	AFUB21	21. Have you also used a second female hormone since we last contacted you?
74	Medication/supplement use	125212	phv00125212.v1.p1	pht001933.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:12:45+00:00	2018-07-12 18:12:45+00:00 	AFUB21A	21a. Name 2
74	Medication/supplement use	125296	phv00125296.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:12:45+00:00	2018-07-12 18:12:45+00:00 	AFUB20	20. Code 1
74	Medication/supplement use	125297	phv00125297.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:12:45+00:00	2018-07-12 18:12:45+00:00 	AFUB21	21. Have you also used a second female hormone since we last contacted you?
74	Medication/supplement use	125298	phv00125298.v1.p1	pht001934.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:12:45+00:00	2018-07-12 18:12:45+00:00 	AFUB21A	21a. Name 2
74	Medication/supplement use	125030	phv00125030.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:15:16+00:00	2018-07-12 18:15:16+00:00 	AFUA16A	16a. High blood pressure
74	Medication/supplement use	125031	phv00125031.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:15:16+00:00	2018-07-12 18:15:16+00:00 	AFUA16B	16b. High blood cholesterol
74	Medication/supplement use	125032	phv00125032.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:15:16+00:00	2018-07-12 18:15:16+00:00 	AFUA16C	16c. Diabetes or high blood sugar
74	Medication/supplement use	125115	phv00125115.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:15:16+00:00	2018-07-12 18:15:16+00:00 	AFUA16A	16a. High blood pressure
74	Medication/supplement use	125116	phv00125116.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:15:16+00:00	2018-07-12 18:15:16+00:00 	AFUA16B	16b. High blood cholesterol
74	Medication/supplement use	125117	phv00125117.v1.p1	pht001932.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:15:16+00:00	2018-07-12 18:15:16+00:00 	AFUA16C	16c. Diabetes or high blood sugar
74	Medication/supplement use	125036	phv00125036.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:17:00+00:00	2018-07-12 18:17:00+00:00 	AFUA19A	19a. Since we last contacted you, have you taken or used any female hormone pills, skin patches, shots or implants?
74	Medication/supplement use	125037	phv00125037.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:18:28+00:00	2018-07-12 18:18:28+00:00 	AFUA19B	19b. Since your JHS visit, have you taken or used any female hormone pills, skin patches, shots or implants?
74	Medication/supplement use	125038	phv00125038.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:18:28+00:00	2018-07-12 18:18:28+00:00 	AFUA19C	19c. Name 1
74	Medication/supplement use	125039	phv00125039.v1.p1	pht001931.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-12 18:19:04+00:00	2018-07-12 18:19:04+00:00 	AFUA20	20. Code 1
74	Medication/supplement use	204685	phv00204685.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:06:19+00:00	2018-07-19 15:06:19+00:00 	HYPTMDCODE21	Hypertension lowering medication within past 2 weeks (visit 2) [Cohort, Exam 2]
74	Medication/supplement use	204689	phv00204689.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:06:47+00:00	2018-07-19 15:06:47+00:00 	CHOLMDCODE21	Cholesterol lowering medication W/in 2 wks.: using 2004 Med. code, visit 2 [Cohort, Exam 2]
74	Medication/supplement use	204690	phv00204690.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:09:14+00:00	2018-07-19 15:09:14+00:00 	CHOLMDCODE22	Medications which secondarily affect cholesterol: using 2004 Med. Code, visit 2 [Cohort, Exam 2]
74	Medication/supplement use	204607	phv00204607.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:21:23+00:00	2018-07-19 15:21:23+00:00 	ASPIRINCODE21	Used aspirin-containing analgesics (at visit 2) in last 2 weeks (0=no, 1=yes), based on 2004 Med. code [Cohort, Exam 2]
74	Medication/supplement use	204694	phv00204694.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:21:42+00:00	2018-07-19 15:21:42+00:00 	ASPIRINCODE01	Used aspirin-containing analgesics (at visit 1) in last 2 weeks (0=no, 1=yes), based on 2004 Med code [Cohort, Exam 1]
74	Medication/supplement use	204825	phv00204825.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:22:04+00:00	2018-07-19 15:22:04+00:00 	ASPIRINCODE31	Used aspirin-containing analgesics (at visit 3) in last 2 weeks (0=no, 1=yes), based on 2004 Med. code [Cohort, Exam 3]
74	Medication/supplement use	204929	phv00204929.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:22:22+00:00	2018-07-19 15:22:22+00:00 	ASPIRINCODE41	Used aspirin-containing analgesics (at visit 4) in last 2 weeks (0=no, 1=yes), based on 2004 med code [Cohort, Exam 4]
74	Medication/supplement use	204608	phv00204608.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:22:56+00:00	2018-07-19 15:22:56+00:00 	STATINCODE21	Used statin (at visit 2) last 2weeks (0=no, 1=yes) based on 2004 Med. code [Cohort, Exam 2]
74	Medication/supplement use	204695	phv00204695.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:23:15+00:00	2018-07-19 15:23:15+00:00 	STATINCODE01	Statin use in the past 2 weeks based on 2004 medication codes [Cohort, Exam 1]
74	Medication/supplement use	204826	phv00204826.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:23:35+00:00	2018-07-19 15:23:35+00:00 	STATINCODE31	Used statin (at visit 3) last 2 weeks (0=no, 1=yes) based on 2004 Med. code [Cohort, Exam 3]
74	Medication/supplement use	204930	phv00204930.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:23:52+00:00	2018-07-19 15:23:52+00:00 	STATINCODE41	Used statin (at visit 4) last 2 weeks (0=no, 1=yes) based on 2004 med code [Cohort, Exam 4]
74	Medication/supplement use	204658	phv00204658.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:55:41+00:00	2018-07-19 15:55:41+00:00 	HYPTMD21	Hypertension Meds (self reported) [Cohort, Exam 2]
74	Medication/supplement use	204754	phv00204754.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:56:16+00:00	2018-07-19 15:56:16+00:00 	HYPTMD01	Blood pressure lowering medications in the past 2 weeks [Cohort, Exam 1]
74	Medication/supplement use	204798	phv00204798.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:56:35+00:00	2018-07-19 15:56:35+00:00 	HYPTMDCODE01	Hypertension lowering medication within past 2 weeks [Cohort, Exam 1]
74	Medication/supplement use	204858	phv00204858.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:56:58+00:00	2018-07-19 15:56:58+00:00 	HYPTMD31	Visit 3, hypertension medications, definition 1 [Cohort, Exam 3]
74	Medication/supplement use	204913	phv00204913.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:57:33+00:00	2018-07-19 15:57:33+00:00 	HYPTMDCODE31	Hypertension lowering medication within past 2 weeks (visit 3) [Cohort, Exam 3]
74	Medication/supplement use	204961	phv00204961.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:57:53+00:00	2018-07-19 15:57:53+00:00 	HYPTMD41	Visit 3, hypertension medications, definition 1 [Cohort, Exam 4]
74	Medication/supplement use	205008	phv00205008.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 15:58:23+00:00	2018-07-19 15:58:23+00:00 	HYPTMDCODE41	Hypertension lowering medication within past 2 weeks (visit 4) [Cohort, Exam 4]
74	Medication/supplement use	204802	phv00204802.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:01:56+00:00	2018-07-19 16:01:56+00:00 	CHOLMDCODE01	Cholesterol lowering medication in past 2 weeks: using 2004 Med. code, visit 1 [Cohort, Exam 1]
74	Medication/supplement use	204803	phv00204803.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:02:14+00:00	2018-07-19 16:02:14+00:00 	CHOLMDCODE02	Medications which secondarily affect cholesterol: using 2004 Med. Code, visit 1 [Cohort, Exam 1]
74	Medication/supplement use	204917	phv00204917.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:02:30+00:00	2018-07-19 16:02:30+00:00 	CHOLMDCODE31	Cholesterol lowering medication within 2 wks.: using 2004 Med. Code, visit 3 [Cohort, Exam 3]
74	Medication/supplement use	204918	phv00204918.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:02:51+00:00	2018-07-19 16:02:51+00:00 	CHOLMDCODE32	Medications which secondarily affect cholesterol: using 2004 Med. code, visit 3 [Cohort, Exam 3]
74	Medication/supplement use	205012	phv00205012.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:03:19+00:00	2018-07-19 16:03:19+00:00 	CHOLMDCODE41	Cholesterol lowering medication within 2wks: using 2004 med code -visit 3 [Cohort, Exam 4]
74	Medication/supplement use	205013	phv00205013.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:03:58+00:00	2018-07-19 16:03:58+00:00 	CHOLMDCODE42	Medications which secondarily affect cholesterol: using 2004 med code -visit 4 [Cohort, Exam 4]
74	Medication/supplement use	204609	phv00204609.v1.p1	pht004062.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:07:36+00:00	2018-07-19 16:07:36+00:00 	ANTICOAGCODE21	Used anticoagulants (at visit 2) last 2 weeks (0=no, 1=yes) based on 2004 Med. code [Cohort, Exam 2]
74	Medication/supplement use	204696	phv00204696.v1.p1	pht004063.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:08:05+00:00	2018-07-19 16:08:05+00:00 	ANTICOAGCODE01	Used anticoagulants (at visit 1) last 2 weeks (0=no, 1=yes) based on 2004 Med. code [Cohort, Exam 1]
74	Medication/supplement use	204827	phv00204827.v1.p1	pht004064.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:08:24+00:00	2018-07-19 16:08:24+00:00 	ANTICOAGCODE31	Used anticoagulants (at visit 3) last 2 weeks (0=no, 1=yes) based on 2004 Med. code [Cohort, Exam 3]
74	Medication/supplement use	204931	phv00204931.v1.p1	pht004065.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:09:04+00:00	2018-07-19 16:09:04+00:00 	ANTICOAGCODE41	Used anticoagulants (at visit 4) last 2 weeks (0=no, 1=yes) based on 2004 med code [Cohort, Exam 4]
74	Medication/supplement use	202953	phv00202953.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:24:28+00:00	2018-07-19 16:24:28+00:00 	AFUcomp16a_G	[Interview]. Did you take any medications during the past two weeks for high blood pressure [Annual Follow-up Questionnaire Form, AFUG]
74	Medication/supplement use	202954	phv00202954.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:24:45+00:00	2018-07-19 16:24:45+00:00 	AFUcomp16b_G	[Interview]. Did you take any medications during the past two weeks for high blood cholesterol [Annual Follow-up Questionnaire Form, AFUG]
74	Medication/supplement use	202955	phv00202955.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:25:12+00:00	2018-07-19 16:25:12+00:00 	AFUcomp16c_G	[Interview]. Did you take any medications during the past two weeks for high blood sugar [Annual Follow-up Questionnaire Form, AFUG]
74	Medication/supplement use	203007	phv00203007.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:25:30+00:00	2018-07-19 16:25:30+00:00 	AFUcomp46d_L	[Interview]. Did you take any medications during the past two weeks for heart failure? [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203008	phv00203008.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:26:15+00:00	2018-07-19 16:26:15+00:00 	AFUcomp47_L	[Interview]. Does the participant have medications to report? [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203009	phv00203009.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:26:41+00:00	2018-07-19 16:26:41+00:00 	AFUcomp48a_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203010	phv00203010.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:27:01+00:00	2018-07-19 16:27:01+00:00 	AFUcomp48b_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203011	phv00203011.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:27:18+00:00	2018-07-19 16:27:18+00:00 	AFUcomp48c_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203012	phv00203012.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:27:34+00:00	2018-07-19 16:27:34+00:00 	AFUcomp48d_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203013	phv00203013.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:27:51+00:00	2018-07-19 16:27:51+00:00 	AFUcomp48e_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203014	phv00203014.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:28:09+00:00	2018-07-19 16:28:09+00:00 	AFUcomp48f_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203015	phv00203015.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:28:26+00:00	2018-07-19 16:28:26+00:00 	AFUcomp48g_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203016	phv00203016.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:28:47+00:00	2018-07-19 16:28:47+00:00 	AFUcomp48h_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203017	phv00203017.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:29:06+00:00	2018-07-19 16:29:06+00:00 	AFUcomp48i_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203018	phv00203018.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:29:25+00:00	2018-07-19 16:29:25+00:00 	AFUcomp48j_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203019	phv00203019.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:29:45+00:00	2018-07-19 16:29:45+00:00 	AFUcomp48k_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203020	phv00203020.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:30:03+00:00	2018-07-19 16:30:03+00:00 	AFUcomp48l_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203021	phv00203021.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:30:20+00:00	2018-07-19 16:30:20+00:00 	AFUcomp48m_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203022	phv00203022.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:30:38+00:00	2018-07-19 16:30:38+00:00 	AFUcomp48n_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203023	phv00203023.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:30:55+00:00	2018-07-19 16:30:55+00:00 	AFUcomp48o_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203024	phv00203024.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:31:22+00:00	2018-07-19 16:31:22+00:00 	AFUcomp48p_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203025	phv00203025.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:31:38+00:00	2018-07-19 16:31:38+00:00 	AFUcomp48q_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203026	phv00203026.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:31:53+00:00	2018-07-19 16:31:53+00:00 	AFUcomp48r_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203027	phv00203027.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:32:10+00:00	2018-07-19 16:32:10+00:00 	AFUcomp48s_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUL]
74	Medication/supplement use	203028	phv00203028.v1.p1	pht004030.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:32:28+00:00	2018-07-19 16:32:28+00:00 	AFUcomp48t_L	[Interview]. Does the participant have medications to report?  Medication name [Annual Follow-up Questionnaire Form, AFUM]
74	Medication/supplement use	214282	phv00214282.v1.p1	pht004228.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:46:40+00:00	2018-07-19 16:46:40+00:00 	TKPILL02	How often do you take sleeping pills or other medication to help you sleep?
74	Medication/supplement use	209382	phv00209382.v1.p1	pht004156.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:47:18+00:00	2018-07-19 16:47:18+00:00 	RHXC23A	Medication name. Q23a [Hormone Names and Codes, exam 4]
74	Medication/supplement use	209381	phv00209381.v1.p1	pht004156.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:47:38+00:00	2018-07-19 16:47:38+00:00 	RHXC11A	Medication name. Q11a [Hormone Names and Codes, exam 4]
74	Medication/supplement use	209380	phv00209380.v1.p1	pht004156.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:48:04+00:00	2018-07-19 16:48:04+00:00 	AHF24	Medication code (AHF code). Q24 [Hormone Names and Codes, exam 4]
74	Medication/supplement use	209379	phv00209379.v1.p1	pht004156.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:48:26+00:00	2018-07-19 16:48:26+00:00 	AHF12	Medication code (AHF code). Q12 [Hormone Names and Codes, exam 4]
74	Medication/supplement use	209369	phv00209369.v1.p1	pht004154.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:48:44+00:00	2018-07-19 16:48:44+00:00 	AHF38	6 Digit medication (AHF code). Q-38 [Hormone Names and Codes, exam 1]
74	Medication/supplement use	209368	phv00209368.v1.p1	pht004154.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:49:01+00:00	2018-07-19 16:49:01+00:00 	AHF31	6 Digit medication code (AHF code). Q-31 [Hormone Names and Codes, exam 1]
74	Medication/supplement use	209367	phv00209367.v1.p1	pht004154.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:49:17+00:00	2018-07-19 16:49:17+00:00 	AHF24	6 Digit medication code (AHF code). Q-24 [Hormone Names and Codes, exam 1]
74	Medication/supplement use	209366	phv00209366.v1.p1	pht004154.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:49:35+00:00	2018-07-19 16:49:35+00:00 	AHF17	6 Digit medication code (AHF code). Q-17 [Hormone Names and Codes, exam 1]
74	Medication/supplement use	208324	phv00208324.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:50:02+00:00	2018-07-19 16:50:02+00:00 	MSRD30DMONTHS	Months of started taking nasaid since exam 1 [Medication Survey Form, exam 4]
74	Medication/supplement use	208323	phv00208323.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:50:20+00:00	2018-07-19 16:50:20+00:00 	MSRD29EMONTHS	Months of started taking aspirin since exam 1 [Medication Survey Form, exam 4]
74	Medication/supplement use	203058	phv00203058.v1.p1	pht004031.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:51:37+00:00	2018-07-19 16:51:37+00:00 	AMHA11	Please think back about the time when you FIRST came to the ARIC clinic on [date]. At that time, were you taking a nonsteroidal anti-inflammatory or arthritis medication on a regular basis? Q11 [AFU Medical History Form, AMH]
74	Medication/supplement use	203062	phv00203062.v1.p1	pht004031.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:52:13+00:00	2018-07-19 16:52:13+00:00 	AMHA12	Are you now taking a nonsteroidal anti-inflammatory or arthritis medication on a regular basis? Q12 [AFU Medical History Form, AMH]
74	Medication/supplement use	203185	phv00203185.v1.p1	pht004035.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:53:09+00:00	2018-07-19 16:53:09+00:00 	ANTD7	[History of hair loss]. Have you ever received or used any treatment for baldness, such as hair implantation or a medication prescribed by a doctor? Q7 [Anthropometry Form, ANTD, exam 4]
74	Medication/supplement use	203799	phv00203799.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:54:01+00:00	2018-07-19 16:54:01+00:00 	CORA23A	Was the decedent taking any of the following medications as an outpatient within the four weeks prior to death? Nitrates? Q23a [Coroner / Medical Examiner Form]
74	Medication/supplement use	203800	phv00203800.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:54:17+00:00	2018-07-19 16:54:17+00:00 	CORA23B	Was the decedent taking any of the following medications as an outpatient within the four weeks prior to death? Calcium channel blockers. 23b [Coroner / Medical Examiner Form]
74	Medication/supplement use	203801	phv00203801.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:54:34+00:00	2018-07-19 16:54:34+00:00 	CORA23C	Was the decedent taking any of the following medications as an outpatient within the four weeks prior to death? Beta-blockers. Q23c [Coroner / Medical Examiner Form]
74	Medication/supplement use	203802	phv00203802.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:54:51+00:00	2018-07-19 16:54:51+00:00 	CORA23D	Was the decedent taking any of the following medications as an outpatient within the four weeks prior to death? Digitalis. Q23d [Coroner / Medical Examiner Form]
74	Medication/supplement use	203803	phv00203803.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:55:10+00:00	2018-07-19 16:55:10+00:00 	CORA23E	Was the decedent taking any of the following medications as an outpatient within the four weeks prior to death? ACE or angiotensin II inhibitors. Q23e [Coroner / Medical Examiner Form]
74	Medication/supplement use	203804	phv00203804.v1.p1	pht004047.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:55:26+00:00	2018-07-19 16:55:26+00:00 	CORA23F	Was the decedent taking any of the following medications as an outpatient within the four weeks prior to death? Aspirin. Q23f [Coroner / Medical Examiner Form]
74	Medication/supplement use	204156	phv00204156.v1.p1	pht004053.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:55:56+00:00	2018-07-19 16:55:56+00:00 	HRAA31L	[Second transfer]. Were any of the following drugs given during this hospitalization or at discharge? Lipid lowering medications (Statins, Niacin, Other). Q31l [Hospital Abstraction Form]
74	Medication/supplement use	204414	phv00204414.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:56:22+00:00	2018-07-19 16:56:22+00:00 	PHQA04A	[Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? Nitrates. Q4a [Physician Questionnaire Form, exam 1]
74	Medication/supplement use	204415	phv00204415.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:56:37+00:00	2018-07-19 16:56:37+00:00 	PHQA04B	[Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? Calcium channel blockers. Q4b [Physician Questionnaire Form, exam 1]
74	Medication/supplement use	204416	phv00204416.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:56:51+00:00	2018-07-19 16:56:51+00:00 	PHQA04C	[Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? Digitalis. Q4c [Physician Questionnaire Form, exam 1]
74	Medication/supplement use	204417	phv00204417.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:57:16+00:00	2018-07-19 16:57:16+00:00 	PHQA04D	[Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? Beta-blockers. Q4d [Physician Questionnaire Form, exam 1]
74	Medication/supplement use	204418	phv00204418.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:57:36+00:00	2018-07-19 16:57:36+00:00 	PHQA04D1	[Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? Aspirin. Q4d1 [Physician Questionnaire Form, exam 1]
74	Medication/supplement use	204419	phv00204419.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:57:58+00:00	2018-07-19 16:57:58+00:00 	PHQA04D2	[Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? ACE or angiotensin II inhibitors. Q4d2 [Physician Questionnaire Form, exam 1]
74	Medication/supplement use	204420	phv00204420.v1.p1	pht004059.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:58:17+00:00	2018-07-19 16:58:17+00:00 	PHQA04E	[Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? Other cardiovascular drugs. Q4e [Physician Questionnaire Form, exam 1]
74	Medication/supplement use	205052	phv00205052.v1.p1	pht004067.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:58:49+00:00	2018-07-19 16:58:49+00:00 	DSRA14	Are you taking prednisone or an immunosuppressive medication? Q14 [Dental Screening Form, exam 4]
74	Medication/supplement use	206628	phv00206628.v1.p1	pht004096.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:59:07+00:00	2018-07-19 16:59:07+00:00 	GTSA2	Do you regularly take medication to control diabetes? Q2 [Oral Glucose Tolerance Screening Form, exam 4]
74	Medication/supplement use	206636	phv00206636.v1.p1	pht004097.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 16:59:22+00:00	2018-07-19 16:59:22+00:00 	GTSB2	Do you regularly take medication to control diabetes (high blood sugar)? Q2 [Oral Glucose Tolerance Screening Version B, exam 4]
74	Medication/supplement use	206919	phv00206919.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:00:06+00:00	2018-07-19 17:00:06+00:00 	HFAA59	[Medication]. Q59 - Ace inhibitors prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206920	phv00206920.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:00:35+00:00	2018-07-19 17:00:35+00:00 	HFAA59A	[Medication]. Q59a - Ace inhibitors at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206921	phv00206921.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:00:58+00:00	2018-07-19 17:00:58+00:00 	HFAA60	[Medication]. Q60 - Angiotensin II receptor blockers prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206964	phv00206964.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:01:14+00:00	2018-07-19 17:01:14+00:00 	HFAA60A	[Medication]. Q60a - Angiotensin II reception blockers at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206965	phv00206965.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:01:30+00:00	2018-07-19 17:01:30+00:00 	HFAA61A	[Medication]. Q61a - Antiarrhythmic: amiodarone prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206966	phv00206966.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:01:50+00:00	2018-07-19 17:01:50+00:00 	HFAA61A1	[Medication]. Q61a1- Antiarrhythmic: amiodarone at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206967	phv00206967.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:02:08+00:00	2018-07-19 17:02:08+00:00 	HFAA61B	[Medication]. Q61b - Antiarrhythmic: other prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206968	phv00206968.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:02:23+00:00	2018-07-19 17:02:23+00:00 	HFAA61B1	[Medication]. Q61b1- Antiarrhythmic: other at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206969	phv00206969.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:02:38+00:00	2018-07-19 17:02:38+00:00 	HFAA62	[Medication]. Q62 - Anticoagulants prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206970	phv00206970.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:02:54+00:00	2018-07-19 17:02:54+00:00 	HFAA62A	[Medication]. Q62a - Anticoagulants at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206971	phv00206971.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:03:10+00:00	2018-07-19 17:03:10+00:00 	HFAA63	[Medication]. Q63 - Anti-inflammatory prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206972	phv00206972.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:03:26+00:00	2018-07-19 17:03:26+00:00 	HFAA63A	[Medication]. Q63a - Anti-inflammatory at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206973	phv00206973.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:03:48+00:00	2018-07-19 17:03:48+00:00 	HFAA64A	[Medication]. Q64a - Antiplatelets: aspirin prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206974	phv00206974.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:04:04+00:00	2018-07-19 17:04:04+00:00 	HFAA64A1	[Medication]. Q64a1- Antiplatelets: aspirin at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206975	phv00206975.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:04:40+00:00	2018-07-19 17:04:40+00:00 	HFAA64B	[Medication]. Q64b - Antiplatelets: other prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206976	phv00206976.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:05:28+00:00	2018-07-19 17:05:28+00:00 	HFAA64B1	[Medication]. Q64b1- Antiplatelets: other at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206977	phv00206977.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:06:12+00:00	2018-07-19 17:06:12+00:00 	HFAA65	[Medication]. Q65 - Beta blockers prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206978	phv00206978.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:06:50+00:00	2018-07-19 17:06:50+00:00 	HFAA65A	[Medication]. Q65a - Beta blockers at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206979	phv00206979.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:07:06+00:00	2018-07-19 17:07:06+00:00 	HFAA66	[Medication]. Q66 - Calcium channel blockers prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206980	phv00206980.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:07:36+00:00	2018-07-19 17:07:36+00:00 	HFAA66A	[Medication]. Q66a - Calcium channel blockers at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206981	phv00206981.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:07:54+00:00	2018-07-19 17:07:54+00:00 	HFAA67	[Medication]. Q67 - Digitalis prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206982	phv00206982.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:08:14+00:00	2018-07-19 17:08:14+00:00 	HFAA67A	[Medication]. Q67a - Digitalis at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206983	phv00206983.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:08:30+00:00	2018-07-19 17:08:30+00:00 	HFAA68	[Medication]. Q68 - Diuretics prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206984	phv00206984.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:08:51+00:00	2018-07-19 17:08:51+00:00 	HFAA68A	[Medication]. Q68a - Diuretics at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206985	phv00206985.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:09:08+00:00	2018-07-19 17:09:08+00:00 	HFAA69	[Medication]. Q69 - Aldosterone blocker prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206986	phv00206986.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:09:24+00:00	2018-07-19 17:09:24+00:00 	HFAA69A	[Medication]. Q69a - Aldosterone blocker at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206987	phv00206987.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:09:47+00:00	2018-07-19 17:09:47+00:00 	HFAA70A	[Medication]. Q70a - Lipid lowering statins prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206988	phv00206988.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:10:04+00:00	2018-07-19 17:10:04+00:00 	HFAA70A1	[Medication]. Q70a1- Lipid lowering statins at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206989	phv00206989.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:10:21+00:00	2018-07-19 17:10:21+00:00 	HFAA70B	[Medication]. Q70b - Lipid lowering other prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206990	phv00206990.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:10:39+00:00	2018-07-19 17:10:39+00:00 	HFAA70B1	[Medication]. Q70b1- Lipid lowering other at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206991	phv00206991.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:11:00+00:00	2018-07-19 17:11:00+00:00 	HFAA71	[Medication]. Q71 - Nitrates prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206992	phv00206992.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:11:21+00:00	2018-07-19 17:11:21+00:00 	HFAA71A	[Medication]. Q71a - Nitrates at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206993	phv00206993.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:11:54+00:00	2018-07-19 17:11:54+00:00 	HFAA72	[Medication]. Q72 - Hydralazine prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206994	phv00206994.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:12:16+00:00	2018-07-19 17:12:16+00:00 	HFAA72A	[Medication]. Q72a - Hydralazine [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206995	phv00206995.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:12:38+00:00	2018-07-19 17:12:38+00:00 	HFAA73A	[Medication]. Q73a - IV inotropes [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	206996	phv00206996.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:13:27+00:00	2018-07-19 17:13:27+00:00 	HFAA73B	[Medication]. Q73b - IV diuretics [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	207048	phv00207048.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:13:57+00:00	2018-07-19 17:13:57+00:00 	HFAA73C	[Medication]. Q73c - IV vasodilators (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	207049	phv00207049.v1.p1	pht004102.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:14:17+00:00	2018-07-19 17:14:17+00:00 	HFAA73D	[Medication]. Q73d - IV antiarrythmics (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA]
74	Medication/supplement use	207842	phv00207842.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:29:52+00:00	2018-07-19 17:29:52+00:00 	MSRA04AA	[Medication records]. Medication name & concentration. Q4aa [Medication Survey Form, exam 1]
74	Medication/supplement use	207843	phv00207843.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 17:30:27+00:00	2018-07-19 17:30:27+00:00 	MSRA04AB	[Medication records]. Medication code No. Q4ab [Medication Survey Form, exam 1]
74	Medication/supplement use	207846	phv00207846.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 19:59:09+00:00	2018-07-19 19:59:09+00:00 	MSRA04BA	[Medication records]. Medication name & concentration.Q4ba [Medication Survey Form, exam 1]
74	Medication/supplement use	207847	phv00207847.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 19:59:31+00:00	2018-07-19 19:59:31+00:00 	MSRA04BB	[Medication records]. Medication Code No. Q4bb [Medication Survey Form, exam 1]
74	Medication/supplement use	207850	phv00207850.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:00:31+00:00	2018-07-19 20:00:31+00:00 	MSRA04CA	[Medication records]. Medication name & concentration. Q4ca [Medication Survey Form, exam 1]
74	Medication/supplement use	207851	phv00207851.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:00:53+00:00	2018-07-19 20:00:53+00:00 	MSRA04CB	[Medication records]. Medication code No. Q4cb [Medication Survey Form, exam 1]
74	Medication/supplement use	207854	phv00207854.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:01:39+00:00	2018-07-19 20:01:39+00:00 	MSRA04DA	[Medication records]. Medication name & concentration. Q4da [Medication Survey Form, exam 1]
74	Medication/supplement use	207855	phv00207855.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:01:59+00:00	2018-07-19 20:01:59+00:00 	MSRA04DB	[Medication records]. Medication code No. Q4db [Medication Survey Form, exam 1]
74	Medication/supplement use	207858	phv00207858.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:02:24+00:00	2018-07-19 20:02:24+00:00 	MSRA04EA	[Medication records]. Medication name & concentration. Q4ea [Medication Survey Form, exam 1]
74	Medication/supplement use	207859	phv00207859.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:02:46+00:00	2018-07-19 20:02:46+00:00 	MSRA04EB	[Medication records]. Medication code No. Q4eb [Medication Survey Form, exam 1]
74	Medication/supplement use	207862	phv00207862.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:05:51+00:00	2018-07-19 20:05:51+00:00 	MSRA04FA	[Medication records]. Medication name & concentration. Q4fa [Medication Survey Form, exam 1]
74	Medication/supplement use	207863	phv00207863.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:07:37+00:00	2018-07-19 20:07:37+00:00 	MSRA04FB	[Medication records]. Medication code No. Q4fb [Medication Survey Form, exam 1]
74	Medication/supplement use	207866	phv00207866.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:17:44+00:00	2018-07-19 20:17:44+00:00 	MSRA04GA	[Medication records]. Medication name & concentration. Q4ga [Medication Survey Form, exam 1]
74	Medication/supplement use	207867	phv00207867.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:18:02+00:00	2018-07-19 20:18:02+00:00 	MSRA04GB	[Medication records]. Medication code No. Q4gb [Medication Survey Form, exam 1]
74	Medication/supplement use	207870	phv00207870.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:18:20+00:00	2018-07-19 20:18:20+00:00 	MSRA04HA	[Medication records]. Medication name & concentration. Q4ha [Medication Survey Form, exam 1]
74	Medication/supplement use	207871	phv00207871.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:18:42+00:00	2018-07-19 20:18:42+00:00 	MSRA04HB	[Medication records]. Medication code No. Q4hb [Medication Survey Form, exam 1]
74	Medication/supplement use	207874	phv00207874.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:19:22+00:00	2018-07-19 20:19:22+00:00 	MSRA04IA	[Medication records]. Medication name & concentration. Q4ia [Medication Survey Form, exam 1]
74	Medication/supplement use	207875	phv00207875.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:19:42+00:00	2018-07-19 20:19:42+00:00 	MSRA04IB	[Medication records]. Medication code No. Q4ib [Medication Survey Form, exam 1]
74	Medication/supplement use	207878	phv00207878.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:20:02+00:00	2018-07-19 20:20:02+00:00 	MSRA04JA	[Medication records]. Medication name & concentration. Q4ja [Medication Survey Form, exam 1]
74	Medication/supplement use	207879	phv00207879.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:20:20+00:00	2018-07-19 20:20:20+00:00 	MSRA04JB	Medication code No. Q4jb [Medication Survey Form, exam 1]
74	Medication/supplement use	207882	phv00207882.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:20:39+00:00	2018-07-19 20:20:39+00:00 	MSRA04KA	[Medication records]. Medication name & concentration. Q4ka [Medication Survey Form, exam 1]
74	Medication/supplement use	207883	phv00207883.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:21:00+00:00	2018-07-19 20:21:00+00:00 	MSRA04KB	[Medication records]. Medication code No. Q4kb [Medication Survey Form, exam 1]
74	Medication/supplement use	207886	phv00207886.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:21:19+00:00	2018-07-19 20:21:19+00:00 	MSRA04LA	[Medication records]. Medication name & concentration. Q4la [Medication Survey Form, exam 1]
74	Medication/supplement use	207887	phv00207887.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:21:43+00:00	2018-07-19 20:21:43+00:00 	MSRA04LB	[Medication records]. Medication code No. Q4lb [Medication Survey Form, exam 1]
74	Medication/supplement use	207890	phv00207890.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:22:04+00:00	2018-07-19 20:22:04+00:00 	MSRA04MA	[Medication records]. Medication name & concentration. Q4ma [Medication Survey Form, exam 1]
74	Medication/supplement use	207891	phv00207891.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:22:25+00:00	2018-07-19 20:22:25+00:00 	MSRA04MB	[Medication records]. Medication code No. Q4mb [Medication Survey Form, exam 1]
74	Medication/supplement use	207894	phv00207894.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:22:43+00:00	2018-07-19 20:22:43+00:00 	MSRA04NA	[Medication records]. Medication name & concentration. Q4na [Medication Survey Form, exam 1]
74	Medication/supplement use	207895	phv00207895.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:23:02+00:00	2018-07-19 20:23:02+00:00 	MSRA04NB	[Medication records]. Medication code No. Q4nb [Medication Survey Form, exam 1]
74	Medication/supplement use	207898	phv00207898.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:23:20+00:00	2018-07-19 20:23:20+00:00 	MSRA04OA	[Medication records]. Medication name & concentration. Q4oa [Medication Survey Form, exam 1]
74	Medication/supplement use	207899	phv00207899.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:23:41+00:00	2018-07-19 20:23:41+00:00 	MSRA04OB	[Medication records]. Medication code No. Q4ob [Medication Survey Form, exam 1]
74	Medication/supplement use	207902	phv00207902.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:24:02+00:00	2018-07-19 20:24:02+00:00 	MSRA04PA	[Medication records]. Medication name & concentration. Q4pa [Medication Survey Form, exam 1]
74	Medication/supplement use	207903	phv00207903.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:24:19+00:00	2018-07-19 20:24:19+00:00 	MSRA04PB	[Medication records]. Medication code No. Q4pb [Medication Survey Form, exam 1]
74	Medication/supplement use	207906	phv00207906.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:24:41+00:00	2018-07-19 20:24:41+00:00 	MSRA04QA	[Medication records]. Medication name & concentration. Q4qa [Medication Survey Form, exam 1]
74	Medication/supplement use	207907	phv00207907.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:25:07+00:00	2018-07-19 20:25:07+00:00 	MSRA04QB	[Medication records]. Medication code No. Q4qb [Medication Survey Form, exam 1]
74	Medication/supplement use	207913	phv00207913.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:26:40+00:00	2018-07-19 20:26:40+00:00 	MSRA08A	[Interview]. Were any of the medications you took during the past two weeks for: High blood pressure? Q8a [Medication Survey Form, exam 1]
74	Medication/supplement use	207914	phv00207914.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:27:16+00:00	2018-07-19 20:27:16+00:00 	MSRA08B	[Interview]. Were any of the medications you took during the past two weeks for: angina or chest pain? Q8b [Medication Survey Form, exam 1]
74	Medication/supplement use	207915	phv00207915.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:27:36+00:00	2018-07-19 20:27:36+00:00 	MSRA08C	[Interview]. Were any of the medications you took during the past two weeks for: control of heart rhythm? Q8c [Medication Survey Form, exam 1]
74	Medication/supplement use	207916	phv00207916.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:27:56+00:00	2018-07-19 20:27:56+00:00 	MSRA08D	[Interview]. Were any of the medications you took during the past two weeks for: heart failure? Q8d [Medication Survey Form, exam 1]
74	Medication/supplement use	207917	phv00207917.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:28:16+00:00	2018-07-19 20:28:16+00:00 	MSRA08E	[Interview]. Were any of the medications you took during the past two weeks for: blood thinning? Q8e [Medication Survey Form, exam 1]
74	Medication/supplement use	207918	phv00207918.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:28:40+00:00	2018-07-19 20:28:40+00:00 	MSRA08F	[Interview]. Were any of the medications you took during the past two weeks for: diabetes or high blood sugar? Q8f [Medication Survey Form, exam 1]
74	Medication/supplement use	207919	phv00207919.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:28:58+00:00	2018-07-19 20:28:58+00:00 	MSRA08G	[Interview]. Were any of the medications you took during the past two weeks for: stroke? Q8g [Medication Survey Form, exam 1]
74	Medication/supplement use	207920	phv00207920.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:29:26+00:00	2018-07-19 20:29:26+00:00 	MSRA08H	[Interview]. Were any of the medications you took during the past two weeks for: leg pain when walking? Q8h [Medication Survey Form, exam 1]
74	Medication/supplement use	207921	phv00207921.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:29:48+00:00	2018-07-19 20:29:48+00:00 	MSRA09	[Interview]. During the past two weeks, did you take any Aspirin, Alka-Seltzer, a cold medicine, or a headache powder? Q9 [Medication Survey Form, exam 1]
74	Medication/supplement use	207922	phv00207922.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 20:30:11+00:00	2018-07-19 20:30:11+00:00 	MSRA10	[Interview]. During the past two weeks, did you take any (other) medication for arthritis, fever, or muscle aches and pains, (or menstrual cramps)? Q10 [Medication Survey Form, exam 1]
74	Medication/supplement use	207929	phv00207929.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:31:09+00:00	2018-07-19 21:31:09+00:00 	MSRB04A	[Medication records]. Medication name and concentration. Q4A [Medication Survey Form, exam 2]
74	Medication/supplement use	207930	phv00207930.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:31:27+00:00	2018-07-19 21:31:27+00:00 	MSRB04B	[Medication records]. Medication code number. Q4B [Medication Survey Form, exam 2]
74	Medication/supplement use	207933	phv00207933.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:31:52+00:00	2018-07-19 21:31:52+00:00 	MSRB05A	[Medication records]. Medication name and concentration Q5A [Medication Survey Form, exam 2]
74	Medication/supplement use	207934	phv00207934.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:32:17+00:00	2018-07-19 21:32:17+00:00 	MSRB05B	[Medication records]. Medication code number. Q5B [Medication Survey Form, exam 2]
74	Medication/supplement use	207937	phv00207937.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:32:56+00:00	2018-07-19 21:32:56+00:00 	MSRB06A	[Medication records]. Medication name and concentration. Q6A [Medication Survey Form, exam 2]
74	Medication/supplement use	207938	phv00207938.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:33:29+00:00	2018-07-19 21:33:29+00:00 	MSRB06B	[Medication records]. Medication code number. Q6B [Medication Survey Form, exam 2]
74	Medication/supplement use	207941	phv00207941.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:33:56+00:00	2018-07-19 21:33:56+00:00 	MSRB07A	[Medication records]. Medication name and concentration. Q7A [Medication Survey Form, exam 2]
74	Medication/supplement use	207942	phv00207942.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:34:28+00:00	2018-07-19 21:34:28+00:00 	MSRB07B	[Medication records]. Medication code number. Q7B [Medication Survey Form, exam 2]
74	Medication/supplement use	207945	phv00207945.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:34:53+00:00	2018-07-19 21:34:53+00:00 	MSRB08A	[Medication records]. Medication name and concentration. Q8A [Medication Survey Form, exam 2]
74	Medication/supplement use	207946	phv00207946.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:35:17+00:00	2018-07-19 21:35:17+00:00 	MSRB08B	[Medication records]. Medication code number. Q8B [Medication Survey Form, exam 2]
74	Medication/supplement use	207949	phv00207949.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:35:56+00:00	2018-07-19 21:35:56+00:00 	MSRB09A	[Medication records]. Medication name and concentration. Q9A [Medication Survey Form, exam 2]
74	Medication/supplement use	207950	phv00207950.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:36:13+00:00	2018-07-19 21:36:13+00:00 	MSRB09B	[Medication records]. Medication code number. Q9B [Medication Survey Form, exam 2]
74	Medication/supplement use	207953	phv00207953.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:36:33+00:00	2018-07-19 21:36:33+00:00 	MSRB10A	[Medication records]. Medication name and concentration. Q10A [Medication Survey Form, exam 2]
74	Medication/supplement use	207954	phv00207954.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:36:50+00:00	2018-07-19 21:36:50+00:00 	MSRB10B	[Medication records]. Medication code number. Q10B [Medication Survey Form, exam 2]
74	Medication/supplement use	207957	phv00207957.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:37:10+00:00	2018-07-19 21:37:10+00:00 	MSRB11A	[Medication records]. Medication name and concentration. Q11A [Medication Survey Form, exam 2]
74	Medication/supplement use	207958	phv00207958.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:37:29+00:00	2018-07-19 21:37:29+00:00 	MSRB11B	[Medication records]. Medication code number. Q11B [Medication Survey Form, exam 2]
74	Medication/supplement use	207961	phv00207961.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:37:49+00:00	2018-07-19 21:37:49+00:00 	MSRB12A	[Medication records]. Medication name and concentration. Q12A [Medication Survey Form, exam 2]
74	Medication/supplement use	207962	phv00207962.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:38:06+00:00	2018-07-19 21:38:06+00:00 	MSRB12B	[Medication records]. Medication code number. Q12B [Medication Survey Form, exam 2]
74	Medication/supplement use	207965	phv00207965.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:40:31+00:00	2018-07-19 21:40:31+00:00 	MSRB13A	[Medication records]. Medication name and concentration. Q13A [Medication Survey Form, exam 2]
74	Medication/supplement use	207966	phv00207966.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:40:49+00:00	2018-07-19 21:40:49+00:00 	MSRB13B	[Medication records]. Medication code number. Q13B [Medication Survey Form, exam 2]
74	Medication/supplement use	207969	phv00207969.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:41:17+00:00	2018-07-19 21:41:17+00:00 	MSRB14A	[Medication records]. Medication name and concentration. Q14A [Medication Survey Form, exam 2]
74	Medication/supplement use	207970	phv00207970.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:41:35+00:00	2018-07-19 21:41:35+00:00 	MSRB14B	[Medication records]. Medication code number. Q14B [Medication Survey Form, exam 2]
74	Medication/supplement use	207973	phv00207973.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:42:01+00:00	2018-07-19 21:42:01+00:00 	MSRB15A	[Medication records]. Medication name and concentration. Q15A [Medication Survey Form, exam 2]
74	Medication/supplement use	207974	phv00207974.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:42:25+00:00	2018-07-19 21:42:25+00:00 	MSRB15B	[Medication records]. Medication code number. Q15B [Medication Survey Form, exam 2]
74	Medication/supplement use	207978	phv00207978.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:43:18+00:00	2018-07-19 21:43:18+00:00 	MSRB16B	[Medication records]. Medication code number. Q16B [Medication Survey Form, exam 2]
74	Medication/supplement use	207977	phv00207977.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:43:38+00:00	2018-07-19 21:43:38+00:00 	MSRB16A	[Medication records]. Medication name and concentration. Q16A [Medication Survey Form, exam 2]
74	Medication/supplement use	207981	phv00207981.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:44:12+00:00	2018-07-19 21:44:12+00:00 	MSRB17A	[Medication records]. Medication name and concentration. Q17A [Medication Survey Form, exam 2]
74	Medication/supplement use	207982	phv00207982.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:44:33+00:00	2018-07-19 21:44:33+00:00 	MSRB17B	[Medication records]. Medication code number. Q17B [Medication Survey Form, exam 2]
74	Medication/supplement use	207985	phv00207985.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:44:56+00:00	2018-07-19 21:44:56+00:00 	MSRB18A	[Medication records]. Medication name and concentration. Q18A [Medication Survey Form, exam 2]
74	Medication/supplement use	207986	phv00207986.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:45:14+00:00	2018-07-19 21:45:14+00:00 	MSRB18B	[Medication records]. Medication code number. Q18B [Medication Survey Form, exam 2]
74	Medication/supplement use	207989	phv00207989.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:45:51+00:00	2018-07-19 21:45:51+00:00 	MSRB19A	[Medication records]. Medication name and concentration. Q19A [Medication Survey Form, exam 2]
74	Medication/supplement use	207990	phv00207990.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:46:08+00:00	2018-07-19 21:46:08+00:00 	MSRB19B	[Medication records]. Medication code number. Q19B [Medication Survey Form, exam 2]
74	Medication/supplement use	207993	phv00207993.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:46:25+00:00	2018-07-19 21:46:25+00:00 	MSRB20A	[Medication records]. Medication name and concentration. Q20A [Medication Survey Form, exam 2]
74	Medication/supplement use	207994	phv00207994.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:46:44+00:00	2018-07-19 21:46:44+00:00 	MSRB20B	[Medication records]. Medication code number. Q20B [Medication Survey Form, exam 2]
74	Medication/supplement use	208001	phv00208001.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:48:44+00:00	2018-07-19 21:48:44+00:00 	MSRB24A	[Interview].  Were any of the medications you took during the past two weeks for: high blood pressure. Q24A [Medication Survey Form, exam 2]
74	Medication/supplement use	208002	phv00208002.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:49:06+00:00	2018-07-19 21:49:06+00:00 	MSRB24B	[Interview].  Were any of the medications you took during the past two weeks for: angina or chest pain. Q24B [Medication Survey Form, exam 2]
74	Medication/supplement use	208003	phv00208003.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:49:25+00:00	2018-07-19 21:49:25+00:00 	MSRB24C	[Interview].  Were any of the medications you took during the past two weeks for: control of heart rhythm. Q24C [Medication Survey Form, exam 2]
74	Medication/supplement use	208004	phv00208004.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:49:45+00:00	2018-07-19 21:49:45+00:00 	MSRB24D	[Interview].  Were any of the medications you took during the past two weeks for: heart failure. Q24D [Medication Survey Form, exam 2]
74	Medication/supplement use	208005	phv00208005.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:50:07+00:00	2018-07-19 21:50:07+00:00 	MSRB24E	[Interview].  Were any of the medications you took during the past two weeks for: blood thinning. Q24E [Medication Survey Form, exam 2]
74	Medication/supplement use	208006	phv00208006.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:50:26+00:00	2018-07-19 21:50:26+00:00 	MSRB24F	[Interview].  Were any of the medications you took during the past two weeks for: diabetes or high blood sugar. Q24F [Medication Survey Form, exam 2]
74	Medication/supplement use	208007	phv00208007.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:50:47+00:00	2018-07-19 21:50:47+00:00 	MSRB24G	[Interview].  Were any of the medications you took during the past two weeks for: stroke. Q24G [Medication Survey Form, exam 2]
74	Medication/supplement use	208008	phv00208008.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:51:15+00:00	2018-07-19 21:51:15+00:00 	MSRB24H	[Interview].  Were any of the medications you took during the past two weeks for: leg pain when walking. Q24H [Medication Survey Form, exam 2]
74	Medication/supplement use	208009	phv00208009.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:51:37+00:00	2018-07-19 21:51:37+00:00 	MSRB25	[Interview].  During the past two weeks, did you take any aspirin, Alka-Seltzer, cold medicine, or headache powder? Q25 [Medication Survey Form, exam 2]
74	Medication/supplement use	208010	phv00208010.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-07-19 21:51:56+00:00	2018-07-19 21:51:56+00:00 	MSRB26	[Interview].  During the Past two weeks, did you take any [other] medication for arthritis, fever, or muscle aches and pains, (or menstrual cramps)? Q26 [Medication Survey Form, exam 2]
74	Medication/supplement use	125479	phv00125479.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:17:46+00:00	2018-07-30 14:17:46+00:00 	AFUC48I	48i. Medication name
74	Medication/supplement use	125480	phv00125480.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:17:46+00:00	2018-07-30 14:17:46+00:00 	AFUC48J	48j. Medication name
74	Medication/supplement use	125481	phv00125481.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:17:46+00:00	2018-07-30 14:17:46+00:00 	AFUC48K	48k. Medication name
74	Medication/supplement use	125482	phv00125482.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:17:46+00:00	2018-07-30 14:17:46+00:00 	AFUC48L	48l. Medication name
74	Medication/supplement use	125483	phv00125483.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:17:46+00:00	2018-07-30 14:17:46+00:00 	AFUC48M	48m. Medication name
74	Medication/supplement use	125484	phv00125484.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:17:46+00:00	2018-07-30 14:17:46+00:00 	AFUC48N	48n. Medication name
74	Medication/supplement use	125485	phv00125485.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:17:46+00:00	2018-07-30 14:17:46+00:00 	AFUC48O	48o. Medication name
74	Medication/supplement use	125486	phv00125486.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:20:15+00:00	2018-07-30 14:20:15+00:00 	AFUC48P	48p. Medication name
74	Medication/supplement use	125487	phv00125487.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:20:15+00:00	2018-07-30 14:20:15+00:00 	AFUC48Q	48q. Medication name
74	Medication/supplement use	125488	phv00125488.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:20:15+00:00	2018-07-30 14:20:15+00:00 	AFUC48R	48r. Medication name
74	Medication/supplement use	125489	phv00125489.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:20:15+00:00	2018-07-30 14:20:15+00:00 	AFUC48S	48s. Medication name
74	Medication/supplement use	125490	phv00125490.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:20:15+00:00	2018-07-30 14:20:15+00:00 	AFUC48T	48t. Medication name
74	Medication/supplement use	125470	phv00125470.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:26:50+00:00	2018-07-30 14:26:50+00:00 	AFUC47	47. Does the participant have medications to report
74	Medication/supplement use	125471	phv00125471.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:26:50+00:00	2018-07-30 14:26:50+00:00 	AFUC48A	48a. Medication name
74	Medication/supplement use	125472	phv00125472.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:26:50+00:00	2018-07-30 14:26:50+00:00 	AFUC48B	48b. Medication name
74	Medication/supplement use	125473	phv00125473.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:26:50+00:00	2018-07-30 14:26:50+00:00 	AFUC48C	48c. Medication name
74	Medication/supplement use	125474	phv00125474.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:26:50+00:00	2018-07-30 14:26:50+00:00 	AFUC48D	48d. Medication name
74	Medication/supplement use	125475	phv00125475.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:26:50+00:00	2018-07-30 14:26:50+00:00 	AFUC48E	48e. Medication name
74	Medication/supplement use	125476	phv00125476.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:26:50+00:00	2018-07-30 14:26:50+00:00 	AFUC48F	48f. Medication name
74	Medication/supplement use	125477	phv00125477.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:26:50+00:00	2018-07-30 14:26:50+00:00 	AFUC48G	48g. Medication name
74	Medication/supplement use	125466	phv00125466.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:35:25+00:00	2018-07-30 14:35:25+00:00 	AFUC46A	46a. High blood pressure
74	Medication/supplement use	125467	phv00125467.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:35:25+00:00	2018-07-30 14:35:25+00:00 	AFUC46B	46b. High blood cholesterol
74	Medication/supplement use	125468	phv00125468.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:35:25+00:00	2018-07-30 14:35:25+00:00 	AFUC46C	46c. Diabetes or high blood sugar
74	Medication/supplement use	125469	phv00125469.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:35:25+00:00	2018-07-30 14:35:25+00:00 	AFUC46D	46d. Heart failure
74	Medication/supplement use	125478	phv00125478.v1.p1	pht001935.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:35:25+00:00	2018-07-30 14:35:25+00:00 	AFUC48H	48h. Medication name
74	Medication/supplement use	125547	phv00125547.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:36:16+00:00	2018-07-30 14:36:16+00:00 	AFUI19A	FEMALE HORMONE SINCE LAST CONTACT Q19A
74	Medication/supplement use	125548	phv00125548.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:36:16+00:00	2018-07-30 14:36:16+00:00 	AFUI19B	FEMALE HORMONE SINCE LAST VISIT   Q19B
74	Medication/supplement use	125549	phv00125549.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:36:16+00:00	2018-07-30 14:36:16+00:00 	AFUI19C	NAME OF FEMALE HORMONES           Q19C
74	Medication/supplement use	125636	phv00125636.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:36:16+00:00	2018-07-30 14:36:16+00:00 	AFUI19A	FEMALE HORMONE SINCE LAST CONTACT Q19A
74	Medication/supplement use	125637	phv00125637.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:36:16+00:00	2018-07-30 14:36:16+00:00 	AFUI19B	FEMALE HORMONE SINCE LAST VISIT   Q19B
74	Medication/supplement use	125638	phv00125638.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:36:16+00:00	2018-07-30 14:36:16+00:00 	AFUI19C	NAME OF FEMALE HORMONES           Q19C
74	Medication/supplement use	125550	phv00125550.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:56:06+00:00	2018-07-30 14:56:06+00:00 	AFUI19D	NAME OF FEMALE HORMONES           Q19D
74	Medication/supplement use	125551	phv00125551.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:56:06+00:00	2018-07-30 14:56:06+00:00 	AFUI20	FEMALE HORMONE CODE 1             Q20
74	Medication/supplement use	125552	phv00125552.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:56:06+00:00	2018-07-30 14:56:06+00:00 	AFUI21	USE OF SECOND FEMALE HORMONE      Q21
74	Medication/supplement use	125553	phv00125553.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:56:06+00:00	2018-07-30 14:56:06+00:00 	AFUI21A	NAME 2 OF FEMALE HORMONE          Q21A
74	Medication/supplement use	125639	phv00125639.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:56:06+00:00	2018-07-30 14:56:06+00:00 	AFUI19D	NAME OF FEMALE HORMONES           Q19D
74	Medication/supplement use	125640	phv00125640.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:56:06+00:00	2018-07-30 14:56:06+00:00 	AFUI20	FEMALE HORMONE CODE 1             Q20
74	Medication/supplement use	125641	phv00125641.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:56:06+00:00	2018-07-30 14:56:06+00:00 	AFUI21	USE OF SECOND FEMALE HORMONE      Q21
74	Medication/supplement use	125642	phv00125642.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:56:06+00:00	2018-07-30 14:56:06+00:00 	AFUI21A	NAME 2 OF FEMALE HORMONE          Q21A
74	Medication/supplement use	125542	phv00125542.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:59:26+00:00	2018-07-30 14:59:26+00:00 	AFUI16A	MEDS FOR HIGH BP IN LAST 2 WKS    Q16A
74	Medication/supplement use	125543	phv00125543.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:59:26+00:00	2018-07-30 14:59:26+00:00 	AFUI16B	MEDS FOR HIGH CHOL IN LAST 2 WKS  Q16B
74	Medication/supplement use	125544	phv00125544.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:59:26+00:00	2018-07-30 14:59:26+00:00 	AFUI16C	MEDS FOR DIAB, BLOOD SUGAR IN 2WK Q16C
74	Medication/supplement use	125554	phv00125554.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:59:26+00:00	2018-07-30 14:59:26+00:00 	AFUI21B	NAME 2 OF FEMALE HORMONE          Q21B
74	Medication/supplement use	125555	phv00125555.v1.p1	pht001936.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:59:26+00:00	2018-07-30 14:59:26+00:00 	AFUI22	FEMALE HORMONE CODE 2             Q22
74	Medication/supplement use	125631	phv00125631.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:59:26+00:00	2018-07-30 14:59:26+00:00 	AFUI16A	MEDS FOR HIGH BP IN LAST 2 WKS    Q16A
74	Medication/supplement use	125632	phv00125632.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:59:26+00:00	2018-07-30 14:59:26+00:00 	AFUI16B	MEDS FOR HIGH CHOL IN LAST 2 WKS  Q16B
74	Medication/supplement use	125633	phv00125633.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:59:26+00:00	2018-07-30 14:59:26+00:00 	AFUI16C	MEDS FOR DIAB, BLOOD SUGAR IN 2WK Q16C
74	Medication/supplement use	125643	phv00125643.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:59:26+00:00	2018-07-30 14:59:26+00:00 	AFUI21B	NAME 2 OF FEMALE HORMONE          Q21B
74	Medication/supplement use	125644	phv00125644.v1.p1	pht001937.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 14:59:26+00:00	2018-07-30 14:59:26+00:00 	AFUI22	FEMALE HORMONE CODE 2             Q22
74	Medication/supplement use	125720	phv00125720.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:02:55+00:00	2018-07-30 15:02:55+00:00 	AFUJ16A	MEDS FOR HIGH BP IN LAST 2 WKS    Q16A
74	Medication/supplement use	125721	phv00125721.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:02:55+00:00	2018-07-30 15:02:55+00:00 	AFUJ16B	MEDS FOR HIGH CHOL IN LAST 2 WKS  Q16B
74	Medication/supplement use	125722	phv00125722.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:02:55+00:00	2018-07-30 15:02:55+00:00 	AFUJ16C	MEDS FOR DIAB, BLOOD SUGAR IN 2WK Q16C
74	Medication/supplement use	125725	phv00125725.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:02:55+00:00	2018-07-30 15:02:55+00:00 	AFUJ19A	FEMALE HORMONE SINCE LAST CONTACT Q19A
74	Medication/supplement use	125726	phv00125726.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:02:55+00:00	2018-07-30 15:02:55+00:00 	AFUJ19B	FEMALE HORMONE SINCE LAST VISIT   Q19B
74	Medication/supplement use	125727	phv00125727.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:02:55+00:00	2018-07-30 15:02:55+00:00 	AFUJ19C	NAME OF FEMALE HORMONES           Q19C
74	Medication/supplement use	125728	phv00125728.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:02:55+00:00	2018-07-30 15:02:55+00:00 	AFUJ19D	NAME OF FEMALE HORMONES           Q19D
74	Medication/supplement use	125729	phv00125729.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:07:02+00:00	2018-07-30 15:07:02+00:00 	AFUJ20	FEMALE HORMONE CODE 1             Q20
74	Medication/supplement use	125730	phv00125730.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:07:02+00:00	2018-07-30 15:07:02+00:00 	AFUJ21	USE OF SECOND FEMALE HORMONE      Q21
74	Medication/supplement use	125731	phv00125731.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:07:02+00:00	2018-07-30 15:07:02+00:00 	AFUJ21A	NAME 2 OF FEMALE HORMONE          Q21A
74	Medication/supplement use	125732	phv00125732.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:07:02+00:00	2018-07-30 15:07:02+00:00 	AFUJ21B	NAME 2 OF FEMALE HORMONE          Q21B
74	Medication/supplement use	125733	phv00125733.v1.p1	pht001938.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:07:02+00:00	2018-07-30 15:07:02+00:00 	AFUJ22	FEMALE HORMONE CODE 2             Q22
74	Medication/supplement use	125812	phv00125812.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:07:02+00:00	2018-07-30 15:07:02+00:00 	AFUK19A	FEMALE HORMONE SINCE LAST CONTACT   Q19A
74	Medication/supplement use	125813	phv00125813.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:07:02+00:00	2018-07-30 15:07:02+00:00 	AFUK19B	FEMALE HORMONE SINCE LAST VISIT     Q19B
74	Medication/supplement use	125814	phv00125814.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:07:02+00:00	2018-07-30 15:07:02+00:00 	AFUK19C	NAME OF FEMALE HORMONES             Q19C
74	Medication/supplement use	125815	phv00125815.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:07:02+00:00	2018-07-30 15:07:02+00:00 	AFUK19D	NAME OF FEMALE HORMONES             Q19D
74	Medication/supplement use	125816	phv00125816.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:07:02+00:00	2018-07-30 15:07:02+00:00 	AFUK20	FEMALE HORMONE CODE 1               Q20
74	Medication/supplement use	125807	phv00125807.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:10:07+00:00	2018-07-30 15:10:07+00:00 	AFUK16A	MEDS FOR HIGH BP IN LAST 2 WKS      Q16A
74	Medication/supplement use	125808	phv00125808.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:10:07+00:00	2018-07-30 15:10:07+00:00 	AFUK16B	MEDS FOR HIGH CHOL IN LAST 2 WKS    Q16B
74	Medication/supplement use	125809	phv00125809.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:10:07+00:00	2018-07-30 15:10:07+00:00 	AFUK16C	MEDS FOR DIAB, BLOOD SUGAR IN 2WK   Q16C
74	Medication/supplement use	125817	phv00125817.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:10:07+00:00	2018-07-30 15:10:07+00:00 	AFUK21	USE OF SECOND FEMALE HORMONE        Q21
74	Medication/supplement use	125818	phv00125818.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:10:07+00:00	2018-07-30 15:10:07+00:00 	AFUK21A	NAME 2 OF FEMALE HORMONE            Q21A
74	Medication/supplement use	125819	phv00125819.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:10:07+00:00	2018-07-30 15:10:07+00:00 	AFUK21B	NAME 2 OF FEMALE HORMONE            Q21B
74	Medication/supplement use	125820	phv00125820.v1.p1	pht001939.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:10:07+00:00	2018-07-30 15:10:07+00:00 	AFUK22	FEMALE HORMONE CODE 2               Q22
74	Medication/supplement use	128270	phv00128270.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:16:10+00:00	2018-07-30 15:16:10+00:00 	RHXA12	12: Ever taken birth control pills?
74	Medication/supplement use	128274	phv00128274.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:16:10+00:00	2018-07-30 15:16:10+00:00 	RHXA16	16: Years you have used birth control?
74	Medication/supplement use	128275	phv00128275.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:16:10+00:00	2018-07-30 15:16:10+00:00 	RHXA17	17: Taken female hormone pills, etc.?
74	Medication/supplement use	128276	phv00128276.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:16:10+00:00	2018-07-30 15:16:10+00:00 	RHXA18A	18a: Name 1
74	Medication/supplement use	128277	phv00128277.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:16:10+00:00	2018-07-30 15:16:10+00:00 	RHXA18B	18b: Concentration 1 (mg or mcg)
74	Medication/supplement use	128278	phv00128278.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:16:10+00:00	2018-07-30 15:16:10+00:00 	RHXA18C	18c: Second hormone (mg or mcg)
74	Medication/supplement use	128279	phv00128279.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:16:10+00:00	2018-07-30 15:16:10+00:00 	RHXA18D	18d: Code1
74	Medication/supplement use	128280	phv00128280.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:16:10+00:00	2018-07-30 15:16:10+00:00 	RHXA19	19: Age start taking this hormone?
74	Medication/supplement use	128281	phv00128281.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:16:10+00:00	2018-07-30 15:16:10+00:00 	RHXA20	20: Currently taking this hormone?
74	Medication/supplement use	128282	phv00128282.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:17:53+00:00	2018-07-30 15:17:53+00:00 	RHXA21	21: Age stop taking this hormone?
74	Medication/supplement use	128283	phv00128283.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:17:53+00:00	2018-07-30 15:17:53+00:00 	RHXA22A	22a: How long used this hormone (years)
74	Medication/supplement use	128284	phv00128284.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:17:53+00:00	2018-07-30 15:17:53+00:00 	RHXA22B	22b: How long used this hormone (months)
74	Medication/supplement use	128285	phv00128285.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:17:53+00:00	2018-07-30 15:17:53+00:00 	RHXA23	23:Days took this hormone in 4 wk period
74	Medication/supplement use	128286	phv00128286.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:17:53+00:00	2018-07-30 15:17:53+00:00 	RHXA24A	24a: Used a second female hormone?
74	Medication/supplement use	128287	phv00128287.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:17:53+00:00	2018-07-30 15:17:53+00:00 	RHXA24B	24b: Name 2
74	Medication/supplement use	128288	phv00128288.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:17:53+00:00	2018-07-30 15:17:53+00:00 	RHXA24C	24c: Concentration 2 (mg or mcg)
74	Medication/supplement use	128289	phv00128289.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:17:53+00:00	2018-07-30 15:17:53+00:00 	RHXA24D	24d: Second hormone (mg or mcg)
74	Medication/supplement use	128290	phv00128290.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA25	25: Age start taking this hormone?
74	Medication/supplement use	128291	phv00128291.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA26	26: Currenlty taking this hormone?
74	Medication/supplement use	128292	phv00128292.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA27	27: Age stop taking this hormone
74	Medication/supplement use	128293	phv00128293.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA28A	28a: How long used this hormone (years)
74	Medication/supplement use	128294	phv00128294.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA28B	28b: How long used this hormone (months)
74	Medication/supplement use	128295	phv00128295.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA29	29:Days took this hormone in 4 wk period
74	Medication/supplement use	128296	phv00128296.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA24E	24e: Code 2
74	Medication/supplement use	128297	phv00128297.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA30A	30a: Used a third female hormone?
74	Medication/supplement use	128298	phv00128298.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA30B	30b: Name 3
74	Medication/supplement use	128299	phv00128299.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA30C	30c: Concentration 3 (mg or mcg units)
74	Medication/supplement use	128300	phv00128300.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA30D	30d: Second hormone (mg or mcg)
74	Medication/supplement use	128301	phv00128301.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA30E	30e: Code 3
74	Medication/supplement use	128302	phv00128302.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA31	31: Age first start taking hormone
74	Medication/supplement use	128303	phv00128303.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA32	32: Currently taking this hormone
74	Medication/supplement use	128304	phv00128304.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA33	33: Age stop taking this hormone
74	Medication/supplement use	128305	phv00128305.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA34A	34a: How long used this hormone (years)
74	Medication/supplement use	128306	phv00128306.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA34B	34b: How long used this hormone (months)
74	Medication/supplement use	128307	phv00128307.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA35	35:Days took this hormone in 4 wk period
74	Medication/supplement use	128308	phv00128308.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:25:06+00:00	2018-07-30 15:25:06+00:00 	RHXA36A	36a: How you used a fourth hormone?
74	Medication/supplement use	128309	phv00128309.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:28:00+00:00	2018-07-30 15:28:00+00:00 	RHXA36B	36b: Name 4:
74	Medication/supplement use	128310	phv00128310.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:28:00+00:00	2018-07-30 15:28:00+00:00 	RHXA36C	36c: Concentration 4 (mg or mcg)
74	Medication/supplement use	128311	phv00128311.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:28:00+00:00	2018-07-30 15:28:00+00:00 	RHXA36D	36d: Second hormone (mg or mcg)
74	Medication/supplement use	128312	phv00128312.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:28:00+00:00	2018-07-30 15:28:00+00:00 	RHXA36E	36e: Code 4
74	Medication/supplement use	128313	phv00128313.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:28:00+00:00	2018-07-30 15:28:00+00:00 	RHXA37	37: Age start taking this hormone
74	Medication/supplement use	128314	phv00128314.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:28:00+00:00	2018-07-30 15:28:00+00:00 	RHXA38	38: Currently taking this hormone?
74	Medication/supplement use	128315	phv00128315.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:28:00+00:00	2018-07-30 15:28:00+00:00 	RHXA39	39: Age stop taking this hormone
74	Medication/supplement use	128316	phv00128316.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:28:00+00:00	2018-07-30 15:28:00+00:00 	RHXA40A	40a: How long used this hormone (years)
74	Medication/supplement use	128317	phv00128317.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:28:00+00:00	2018-07-30 15:28:00+00:00 	RHXA40B	40b: How long used this hormone (months)
74	Medication/supplement use	127755	phv00127755.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:31:40+00:00	2018-07-30 15:31:40+00:00 	MSRA1	1: Bring in all medications used?
74	Medication/supplement use	127756	phv00127756.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:31:40+00:00	2018-07-30 15:31:40+00:00 	MSRA2	2: Because you forgot medications?
74	Medication/supplement use	127762	phv00127762.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:31:40+00:00	2018-07-30 15:31:40+00:00 	MSRA4D	MSRA4D
74	Medication/supplement use	127759	phv00127759.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:31:40+00:00	2018-07-30 15:31:40+00:00 	MSRA4A	MSRA4A
74	Medication/supplement use	127760	phv00127760.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:31:40+00:00	2018-07-30 15:31:40+00:00 	MSRA4B	MSRA4B
74	Medication/supplement use	127761	phv00127761.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:31:40+00:00	2018-07-30 15:31:40+00:00 	MSRA4C	MSRA4C
74	Medication/supplement use	127764	phv00127764.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:31:40+00:00	2018-07-30 15:31:40+00:00 	MSRA5A	MSRA5A
74	Medication/supplement use	127765	phv00127765.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:31:40+00:00	2018-07-30 15:31:40+00:00 	MSRA5B	MSRA5B
74	Medication/supplement use	127766	phv00127766.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:31:40+00:00	2018-07-30 15:31:40+00:00 	MSRA5C	MSRA5C
74	Medication/supplement use	128318	phv00128318.v1.p1	pht001971.v1.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-07-30 15:31:40+00:00	2018-07-30 15:31:40+00:00 	RHXA41	41:Days took this hormone in 4 wk period
74	Medication/supplement use	208016	phv00208016.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:25:46+00:00	2018-08-02 12:25:46+00:00 	MSRC4A	[Medication records]. Medication name and concentration. Q4a [Medication Survey Form, exam 3]
74	Medication/supplement use	208017	phv00208017.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:26:11+00:00	2018-08-02 12:26:11+00:00 	MSRC4B	[Medication records]. Medication code number. Q4b [Medication Survey Form, exam 3]
74	Medication/supplement use	208019	phv00208019.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:27:04+00:00	2018-08-02 12:27:04+00:00 	MSRC5A	[Medication records]. Medication name and concentration. Q5a [Medication Survey Form, exam 3]
74	Medication/supplement use	208020	phv00208020.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:27:32+00:00	2018-08-02 12:27:32+00:00 	MSRC5B	[Medication records]. Medication code number. Q5b [Medication Survey Form, exam 3]
74	Medication/supplement use	208022	phv00208022.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:28:04+00:00	2018-08-02 12:28:04+00:00 	MSRC6A	[Medication records]. Medication name and concentration. Q6a [Medication Survey Form, exam 3]
74	Medication/supplement use	208023	phv00208023.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:31:34+00:00	2018-08-02 12:31:34+00:00 	MSRC6B	[Medication records]. Medication code number. Q6b [Medication Survey Form, exam 3]
74	Medication/supplement use	208025	phv00208025.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:33:17+00:00	2018-08-02 12:33:17+00:00 	MSRC7A	[Medication records]. Medication name and concentration. Q7a [Medication Survey Form, exam 3]
74	Medication/supplement use	208026	phv00208026.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:33:42+00:00	2018-08-02 12:33:42+00:00 	MSRC7B	[Medication records]. Medication code number. Q7b [Medication Survey Form, exam 3]
74	Medication/supplement use	208028	phv00208028.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC8A	[Medication records]. Medication name and concentration. Q8a [Medication Survey Form, exam 3]
74	Medication/supplement use	208029	phv00208029.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC8B	[Medication records]. Medication code number. Q8b [Medication Survey Form, exam 3]
74	Medication/supplement use	208031	phv00208031.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC9A	[Medication records]. Medication name and concentration. Q9a [Medication Survey Form, exam 3]
74	Medication/supplement use	208032	phv00208032.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC9B	[Medication records]. Medication code number. Q9b [Medication Survey Form, exam 3]
74	Medication/supplement use	208034	phv00208034.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC10A	[Medication records]. Medication name and concentration. Q10a [Medication Survey Form, exam 3]
74	Medication/supplement use	208035	phv00208035.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC10B	[Medication records]. Medication code number. Q10b [Medication Survey Form, exam 3]
74	Medication/supplement use	208037	phv00208037.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC11A	[Medication records]. Medication name and concentration. Q11a [Medication Survey Form, exam 3]
74	Medication/supplement use	208038	phv00208038.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC11B	[Medication records]. Medication code number. Q11b [Medication Survey Form, exam 3]
74	Medication/supplement use	208040	phv00208040.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC12A	[Medication records]. Medication name and concentration. Q12a [Medication Survey Form, exam 3]
74	Medication/supplement use	208041	phv00208041.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC12B	[Medication records]. Medication code number. Q12b [Medication Survey Form, exam 3]
74	Medication/supplement use	208043	phv00208043.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC13A	[Medication records]. Medication name and concentration. Q13a [Medication Survey Form, exam 3]
74	Medication/supplement use	208044	phv00208044.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC13B	[Medication records]. Medication code number. Q13b [Medication Survey Form, exam 3]
74	Medication/supplement use	208046	phv00208046.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC14A	[Medication records]. Medication name and concentration. Q14a [Medication Survey Form, exam 3]
74	Medication/supplement use	208047	phv00208047.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC14B	[Medication records]. Medication code number. Q14b [Medication Survey Form, exam 3]
74	Medication/supplement use	208049	phv00208049.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC15A	[Medication records]. Medication name and concentration. Q15a [Medication Survey Form, exam 3]
74	Medication/supplement use	208050	phv00208050.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC15B	[Medication records]. Medication code number. Q15b [Medication Survey Form, exam 3]
74	Medication/supplement use	208052	phv00208052.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC16A	[Medication records]. Medication name and concentration. Q16a [Medication Survey Form, exam 3]
74	Medication/supplement use	208053	phv00208053.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC16B	[Medication records]. Medication code number. Q16b [Medication Survey Form, exam 3]
74	Medication/supplement use	208055	phv00208055.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC17A	[Medication records]. Medication name and concentration. Q17a [Medication Survey Form, exam 3]
74	Medication/supplement use	208056	phv00208056.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC17B	[Medication records]. Medication code number. Q17b [Medication Survey Form, exam 3]
74	Medication/supplement use	208058	phv00208058.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC18A	[Medication records]. Medication name and concentration. Q18a [Medication Survey Form, exam 3]
74	Medication/supplement use	208059	phv00208059.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC18B	[Medication records]. Medication code number. Q18b [Medication Survey Form, exam 3]
74	Medication/supplement use	208061	phv00208061.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC19A	[Medication records]. Medication name and concentration. Q19a [Medication Survey Form, exam 3]
74	Medication/supplement use	208062	phv00208062.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC19B	[Medication records]. Medication code number. Q19b [Medication Survey Form, exam 3]
74	Medication/supplement use	208064	phv00208064.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC20A	[Medication records]. Medication name and concentration. Q20a [Medication Survey Form, exam 3]
74	Medication/supplement use	208065	phv00208065.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:41:22+00:00	2018-08-02 12:41:22+00:00 	MSRC20B	[Medication records]. Medication code number. Q20b [Medication Survey Form, exam 3]
74	Medication/supplement use	208067	phv00208067.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:42:35+00:00	2018-08-02 12:42:35+00:00 	MSRC24A	[Interview]. Were any of the medications you took during the past two weeks for: high blood pressure. Q24a [Medication Survey Form, exam 3]
74	Medication/supplement use	208068	phv00208068.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:43:11+00:00	2018-08-02 12:43:11+00:00 	MSRC24F	[Interview]. Were any of the medications you took during the past two weeks for: blood thinning. Q24f [Medication Survey Form, exam 3]
74	Medication/supplement use	208069	phv00208069.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:44:12+00:00	2018-08-02 12:44:12+00:00 	MSRC24B	[Interview]. Were any of the medications you took during the past two weeks for: high blood cholesterol. Q24b [Medication Survey Form, exam 3]
74	Medication/supplement use	208070	phv00208070.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:44:34+00:00	2018-08-02 12:44:34+00:00 	MSRC24G	[Interview]. Were any of the medications you took during the past two weeks for: diabetes or high blood sugar. Q24g [Medication Survey Form, exam 3]
74	Medication/supplement use	208071	phv00208071.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:45:01+00:00	2018-08-02 12:45:01+00:00 	MSRC24C	[Interview]. Were any of the medications you took during the past two weeks for: angina or chest pain. Q24c [Medication Survey Form, exam 3]
74	Medication/supplement use	208072	phv00208072.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:45:25+00:00	2018-08-02 12:45:25+00:00 	MSRC24H	[Interview]. Were any of the medications you took during the past two weeks for: stroke Q24h [Medication Survey Form, exam 3]
74	Medication/supplement use	208073	phv00208073.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:45:50+00:00	2018-08-02 12:45:50+00:00 	MSRC24D	[Interview]. Were any of the medications you took during the past two weeks for: control of heart rhythm. Q24d [Medication Survey Form, exam 3]
74	Medication/supplement use	208074	phv00208074.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:46:13+00:00	2018-08-02 12:46:13+00:00 	MSRC24I	[Interview]. Were any of the medications you took during the past two weeks for: leg pain when walking. Q24i [Medication Survey Form, exam 3]
74	Medication/supplement use	208075	phv00208075.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:46:36+00:00	2018-08-02 12:46:36+00:00 	MSRC24E	[Interview]. Were any of the medications you took during the past two weeks for: heart failure. Q24e [Medication Survey Form, exam 3]
74	Medication/supplement use	208076	phv00208076.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:47:53+00:00	2018-08-02 12:47:53+00:00 	MSRC25	[Interview]. During the past two weeks, did you take any aspirin, Alka-Seltzer, cold medicine or headache powder? Q25 [Medication Survey Form, exam 3]
74	Medication/supplement use	208078	phv00208078.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:48:26+00:00	2018-08-02 12:48:26+00:00 	MSRC28	[Interview]. During the past two weeks, did you take any [other] medication for arthritis, fever, or muscle aches and pains, (or menstrual cramps)? Q28 [Medication Survey Form, exam 3]
74	Medication/supplement use	208081	phv00208081.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:49:13+00:00	2018-08-02 12:49:13+00:00 	MSRC26	[Interview]. How many days during the last two weeks did you take aspirin, or a medication that contains aspirin? Q26 [Medication Survey Form, exam 3]
74	Medication/supplement use	208085	phv00208085.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 12:57:11+00:00	2018-08-02 12:57:11+00:00 	MSRA04AA	Medication and concentration. Q4m01a [Medication Codes, exam 1]
74	Medication/supplement use	208086	phv00208086.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:05:00+00:00	2018-08-02 19:05:00+00:00 	MSRA04BA	Medication and concentration. Q4m02a [Medication Codes, exam 1]
74	Medication/supplement use	208087	phv00208087.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:05:27+00:00	2018-08-02 19:05:27+00:00 	MSRA04CA	Medication and concentration. Q4m03a [Medication Codes, exam 1]
74	Medication/supplement use	208088	phv00208088.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:05:45+00:00	2018-08-02 19:05:45+00:00 	MSRA04DA	Medication and concentration. Q4m04a [Medication Codes, exam 1]
74	Medication/supplement use	208089	phv00208089.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:06:10+00:00	2018-08-02 19:06:10+00:00 	MSRA04EA	Medication and concentration. Q4m05a [Medication Codes, exam 1]
74	Medication/supplement use	208090	phv00208090.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:06:30+00:00	2018-08-02 19:06:30+00:00 	MSRA04FA	Medication and concentration. Q4m06a [Medication Codes, exam 1]
74	Medication/supplement use	208091	phv00208091.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:11:04+00:00	2018-08-02 19:11:04+00:00 	MSRA04GA	Medication and concentration. Q4m07a [Medication Codes, exam 1]
74	Medication/supplement use	208092	phv00208092.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:11:04+00:00	2018-08-02 19:11:04+00:00 	MSRA04HA	Medication and concentration. Q4m08a [Medication Codes, exam 1]
74	Medication/supplement use	208093	phv00208093.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:11:04+00:00	2018-08-02 19:11:04+00:00 	MSRA04IA	Medication and concentration. Q4m09a [Medication Codes, exam 1]
74	Medication/supplement use	208094	phv00208094.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:11:04+00:00	2018-08-02 19:11:04+00:00 	MSRA04JA	Medication and concentration. Q4m10a [Medication Codes, exam 1]
74	Medication/supplement use	208095	phv00208095.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:11:04+00:00	2018-08-02 19:11:04+00:00 	MSRA04KA	Medication and concentration. Q4m11a [Medication Codes, exam 1]
74	Medication/supplement use	208096	phv00208096.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:11:04+00:00	2018-08-02 19:11:04+00:00 	MSRA04LA	Medication and concentration. Q4m12a [Medication Codes, exam 1]
74	Medication/supplement use	208097	phv00208097.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:11:04+00:00	2018-08-02 19:11:04+00:00 	MSRA04MA	Medication and concentration. Q4m13a [Medication Codes, exam 1]
74	Medication/supplement use	208098	phv00208098.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:11:04+00:00	2018-08-02 19:11:04+00:00 	MSRA04NA	Medication and concentration. Q4m14a [Medication Codes, exam 1]
74	Medication/supplement use	208099	phv00208099.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:11:04+00:00	2018-08-02 19:11:04+00:00 	MSRA04OA	Medication and concentration. Q4m15a [Medication Codes, exam 1]
74	Medication/supplement use	208100	phv00208100.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:11:04+00:00	2018-08-02 19:11:04+00:00 	MSRA04PA	Medication and concentration. Q4m16a [Medication Codes, exam 1]
74	Medication/supplement use	208101	phv00208101.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:11:04+00:00	2018-08-02 19:11:04+00:00 	MSRA04QA	Medication and concentration. Q4m17a [Medication Codes, exam 1]
74	Medication/supplement use	208102	phv00208102.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE1	2004 drug code. Q4m01b [Medication Codes, exam 1]
74	Medication/supplement use	208103	phv00208103.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE2	2004 drug code. Q4m02b [Medication Codes, exam 1]
74	Medication/supplement use	208104	phv00208104.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE3	2004 drug code. Q4m03b [Medication Codes, exam 1]
74	Medication/supplement use	208105	phv00208105.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE4	2004 drug code. Q4m04b [Medication Codes, exam 1]
74	Medication/supplement use	208106	phv00208106.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE5	2004 drug code. Q4m05b [Medication Codes, exam 1]
74	Medication/supplement use	208107	phv00208107.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE6	2004 drug code. Q4m06b [Medication Codes, exam 1]
74	Medication/supplement use	208110	phv00208110.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE9	2004 drug code. Q4m09b [Medication Codes, exam 1]
74	Medication/supplement use	208111	phv00208111.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE10	2004 drug code. Q4m10b [Medication Codes, exam 1]
74	Medication/supplement use	208112	phv00208112.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE11	2004 drug code. Q4m11b [Medication Codes, exam 1]
74	Medication/supplement use	208113	phv00208113.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE12	2004 drug code. Q4m12b [Medication Codes, exam 1]
74	Medication/supplement use	208114	phv00208114.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE13	2004 drug code. Q4m13b [Medication Codes, exam 1]
74	Medication/supplement use	208115	phv00208115.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE14	2004 drug code. Q4m14b [Medication Codes, exam 1]
74	Medication/supplement use	208116	phv00208116.v1.p1	pht004132.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE15	2004 drug code. Q4m15b [Medication Codes, exam 1]
74	Medication/supplement use	208222	phv00208222.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE16	2004 drug code. Q19b [Medication Codes, exam 4]
74	Medication/supplement use	208223	phv00208223.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:15:03+00:00	2018-08-02 19:15:03+00:00 	CODE17	2004 drug code. Q20b [Medication Codes, exam 4]
74	Medication/supplement use	208120	phv00208120.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB04A	Medication name and concentration. Q4a [Medication Codes, exam 2]
74	Medication/supplement use	208121	phv00208121.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB05A	Medication name and concentration. Q5a [Medication Codes, exam 2]
74	Medication/supplement use	208122	phv00208122.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB06A	Medication name and concentration. Q6a [Medication Codes, exam 2]
74	Medication/supplement use	208123	phv00208123.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB07A	Medication name and concentration. Q7a [Medication Codes, exam 2]
74	Medication/supplement use	208124	phv00208124.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB08A	Medication name and concentration. Q8a [Medication Codes, exam 2]
74	Medication/supplement use	208125	phv00208125.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB09A	Medication name and concentration. Q9a [Medication Codes, exam 2]
74	Medication/supplement use	208126	phv00208126.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB10A	Medication name and concentration. Q10a [Medication Codes, exam 2]
74	Medication/supplement use	208127	phv00208127.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB11A	Medication name and concentration. Q11a [Medication Codes, exam 2]
74	Medication/supplement use	208128	phv00208128.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB12A	Medication name and concentration. Q12a [Medication Codes, exam 2]
74	Medication/supplement use	208129	phv00208129.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB13A	Medication name and concentration. Q13a [Medication Codes, exam 2]
74	Medication/supplement use	208130	phv00208130.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB14A	Medication name and concentration. Q14a [Medication Codes, exam 2]
74	Medication/supplement use	208131	phv00208131.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB15A	Medication name and concentration. Q15a [Medication Codes, exam 2]
74	Medication/supplement use	208132	phv00208132.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB16A	Medication name and concentration. Q16a [Medication Codes, exam 2]
74	Medication/supplement use	208133	phv00208133.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB17A	Medication name and concentration. Q17a [Medication Codes, exam 2]
74	Medication/supplement use	208134	phv00208134.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB18A	Medication name and concentration. Q18a [Medication Codes, exam 2]
74	Medication/supplement use	208135	phv00208135.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB19A	Medication name and concentration. Q19a [Medication Codes, exam 2]
74	Medication/supplement use	208136	phv00208136.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:21:59+00:00	2018-08-02 19:21:59+00:00 	MSRB20A	Medication name and concentration. Q20a [Medication Codes, exam 2]
74	Medication/supplement use	208137	phv00208137.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE1	2004 drug code. Q04b [Medication Codes, exam 2]
74	Medication/supplement use	208138	phv00208138.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE2	2004 drug code. Q05b [Medication Codes, exam 2]
74	Medication/supplement use	208139	phv00208139.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE3	2004 drug code. Q06b [Medication Codes, exam 2]
74	Medication/supplement use	208140	phv00208140.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE4	2004 drug code. Q07b [Medication Codes, exam 2]
74	Medication/supplement use	208141	phv00208141.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE5	2004 drug code. Q08b [Medication Codes, exam 2]
74	Medication/supplement use	208142	phv00208142.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE6	2004 drug code. Q09b [Medication Codes, exam 2]
74	Medication/supplement use	208143	phv00208143.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE7	2004 drug code. Q10b [Medication Codes, exam 2]
74	Medication/supplement use	208144	phv00208144.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE8	2004 drug code. Q11b [Medication Codes, exam 2]
74	Medication/supplement use	208145	phv00208145.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE9	2004 drug code. Q12b [Medication Codes, exam 2]
74	Medication/supplement use	208146	phv00208146.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE10	2004 drug code. Q13b [Medication Codes, exam 2]
74	Medication/supplement use	208147	phv00208147.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE11	2004 drug code. Q14b [Medication Codes, exam 2]
74	Medication/supplement use	208148	phv00208148.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE12	2004 drug code. Q15b [Medication Codes, exam 2]
74	Medication/supplement use	208149	phv00208149.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE13	2004 drug code. Q16b [Medication Codes, exam 2]
74	Medication/supplement use	208150	phv00208150.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE14	2004 drug code. Q17b [Medication Codes, exam 2]
74	Medication/supplement use	208151	phv00208151.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE15	2004 drug code. Q18b [Medication Codes, exam 2]
74	Medication/supplement use	208152	phv00208152.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE16	2004 drug code. Q19b [Medication Codes, exam 2]
74	Medication/supplement use	208153	phv00208153.v1.p1	pht004133.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:45:28+00:00	2018-08-02 19:45:28+00:00 	CODE17	2004 drug code. Q20b [Medication Codes, exam 2]
74	Medication/supplement use	208155	phv00208155.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC4A	Medication name and concentration. Q4 A [Medication Codes, exam 3]
74	Medication/supplement use	208156	phv00208156.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC5A	Medication name and concentration. Q5 A [Medication Codes, exam 3]
74	Medication/supplement use	208157	phv00208157.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC6A	Medication name and concentration. Q6 A [Medication Codes, exam 3]
74	Medication/supplement use	208158	phv00208158.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC7A	Medication name and concentration. Q7 A [Medication Codes, exam 3]
74	Medication/supplement use	208159	phv00208159.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC8A	Medication name and concentration. Q8 A [Medication Codes, exam 3]
74	Medication/supplement use	208160	phv00208160.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC9A	Medication name and concentration. Q9 A [Medication Codes, exam 3]
74	Medication/supplement use	208161	phv00208161.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC10A	Medication name and concentration Q10 A [Medication Codes, exam 3]
74	Medication/supplement use	208162	phv00208162.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC11A	Medication name and concentration. Q11 A [Medication Codes, exam 3]
74	Medication/supplement use	208163	phv00208163.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC12A	Medication name and concentration. Q12 A [Medication Codes, exam 3]
74	Medication/supplement use	208164	phv00208164.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC13A	Medication name and concentration. Q13 A [Medication Codes, exam 3]
74	Medication/supplement use	208165	phv00208165.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC14A	Medication name and concentration. Q14 A [Medication Codes, exam 3]
74	Medication/supplement use	208166	phv00208166.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC15A	Medication name and concentration. Q15 A [Medication Codes, exam 3]
74	Medication/supplement use	208167	phv00208167.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC16A	Medication name and concentration. Q16 A [Medication Codes, exam 3]
74	Medication/supplement use	208168	phv00208168.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC17A	Medication name and concentration. Q17 A [Medication Codes, exam 3]
74	Medication/supplement use	208169	phv00208169.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC18A	Medication name and concentration. Q18 A [Medication Codes, exam 3]
74	Medication/supplement use	208170	phv00208170.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC19A	Medication name and concentration. Q19 A [Medication Codes, exam 3]
74	Medication/supplement use	208171	phv00208171.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	MSRC20A	Medication name and concentration. Q20 A [Medication Codes, exam 3]
74	Medication/supplement use	208172	phv00208172.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE1	2004 drug code. Q04b [Medication Codes, exam 3]
74	Medication/supplement use	208173	phv00208173.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE2	2004 drug code. Q05b [Medication Codes, exam 3]
74	Medication/supplement use	208174	phv00208174.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE3	2004 drug code. Q06b [Medication Codes, exam 3]
74	Medication/supplement use	208175	phv00208175.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE4	2004 drug code. Q07b [Medication Codes, exam 3]
74	Medication/supplement use	208176	phv00208176.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE5	2004 drug code. Q08b [Medication Codes, exam 3]
74	Medication/supplement use	208177	phv00208177.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE6	2004 drug code. Q09b [Medication Codes, exam 3]
74	Medication/supplement use	208178	phv00208178.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE7	2004 drug code. Q10b [Medication Codes, exam 3]
74	Medication/supplement use	208179	phv00208179.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE8	2004 drug code. Q11b [Medication Codes, exam 3]
74	Medication/supplement use	208180	phv00208180.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE9	2004 drug code. Q12b [Medication Codes, exam 3]
74	Medication/supplement use	208181	phv00208181.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE10	2004 drug code. Q13b [Medication Codes, exam 3]
74	Medication/supplement use	208182	phv00208182.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE11	2004 drug code. Q14b [Medication Codes, exam 3]
74	Medication/supplement use	208183	phv00208183.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE12	2004 drug code. Q15b [Medication Codes, exam 3]
74	Medication/supplement use	208184	phv00208184.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE13	2004 drug code. Q16b [Medication Codes, exam 3]
74	Medication/supplement use	208185	phv00208185.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE14	2004 drug code. Q17b [Medication Codes, exam 3]
74	Medication/supplement use	208186	phv00208186.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE15	2004 drug code. Q18b [Medication Codes, exam 3]
74	Medication/supplement use	208187	phv00208187.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE16	2004 drug code. Q19b [Medication Codes, exam 3]
74	Medication/supplement use	208188	phv00208188.v1.p1	pht004134.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:51:20+00:00	2018-08-02 19:51:20+00:00 	CODE17	2004 drug code. Q20b [Medication Codes, exam 3]
74	Medication/supplement use	208190	phv00208190.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD4A	Medication name. Q4a [Medication Codes, exam 4]
74	Medication/supplement use	208191	phv00208191.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD5A	Medication name. Q5a [Medication Codes, exam 4]
74	Medication/supplement use	208192	phv00208192.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD6A	Medication name. Q6a [Medication Codes, exam 4]
74	Medication/supplement use	208193	phv00208193.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD7A	Medication name. Q7a [Medication Codes, exam 4]
74	Medication/supplement use	208194	phv00208194.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD8A	Medication name. Q8a [Medication Codes, exam 4]
74	Medication/supplement use	208195	phv00208195.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD9A	Medication name. Q9a [Medication Codes, exam 4]
74	Medication/supplement use	208196	phv00208196.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD10A	Medication name. Q10a [Medication Codes, exam 4]
74	Medication/supplement use	208197	phv00208197.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD11A	Medication name. Q11a [Medication Codes, exam 4]
74	Medication/supplement use	208198	phv00208198.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD12A	Medication name. Q12a [Medication Codes, exam 4]
74	Medication/supplement use	208199	phv00208199.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD13A	Medication name. Q13a [Medication Codes, exam 4]
74	Medication/supplement use	208200	phv00208200.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD14A	Medication name. Q14a [Medication Codes, exam 4]
74	Medication/supplement use	208201	phv00208201.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD15A	Medication name. Q15a [Medication Codes, exam 4]
74	Medication/supplement use	208202	phv00208202.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD16A	Medication name. Q16a [Medication Codes, exam 4]
74	Medication/supplement use	208203	phv00208203.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD17A	Medication name. Q17a [Medication Codes, exam 4]
74	Medication/supplement use	208204	phv00208204.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD18A	Medication name. Q18a [Medication Codes, exam 4]
74	Medication/supplement use	208205	phv00208205.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD19A	Medication name. Q19a [Medication Codes, exam 4]
74	Medication/supplement use	208206	phv00208206.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:55:51+00:00	2018-08-02 19:55:51+00:00 	MSRD20A	Medication name. Q20a [Medication Codes, exam 4]
74	Medication/supplement use	208207	phv00208207.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE1	2004 drug code. Q04b [Medication Codes, exam 4]
74	Medication/supplement use	208208	phv00208208.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE2	2004 drug code. Q05b [Medication Codes, exam 4]
74	Medication/supplement use	208209	phv00208209.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE3	2004 drug code. Q06b [Medication Codes, exam 4]
74	Medication/supplement use	208210	phv00208210.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE4	2004 drug code. Q07b [Medication Codes, exam 4]
74	Medication/supplement use	208211	phv00208211.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE5	2004 drug code. Q08b [Medication Codes, exam 4]
74	Medication/supplement use	208212	phv00208212.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE6	2004 drug code. Q09b [Medication Codes, exam 4]
74	Medication/supplement use	208213	phv00208213.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE7	2004 drug code. Q10b [Medication Codes, exam 4]
74	Medication/supplement use	208214	phv00208214.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE8	2004 drug code. Q11b [Medication Codes, exam 4]
74	Medication/supplement use	208215	phv00208215.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE9	2004 drug code. Q12b [Medication Codes, exam 4]
74	Medication/supplement use	208216	phv00208216.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE10	2004 drug code. Q13b [Medication Codes, exam 4]
74	Medication/supplement use	208217	phv00208217.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE11	2004 drug code. Q14b [Medication Codes, exam 4]
74	Medication/supplement use	208218	phv00208218.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE12	2004 drug code. Q15b [Medication Codes, exam 4]
74	Medication/supplement use	208219	phv00208219.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE13	2004 drug code. Q16b [Medication Codes, exam 4]
74	Medication/supplement use	208220	phv00208220.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE14	2004 drug code. Q17b [Medication Codes, exam 4]
74	Medication/supplement use	208221	phv00208221.v1.p1	pht004135.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 19:59:38+00:00	2018-08-02 19:59:38+00:00 	CODE15	2004 drug code. Q18b [Medication Codes, exam 4]
74	Medication/supplement use	208228	phv00208228.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD4A	[Medication records]. Medication A name. Q4a [Medication Survey Form, exam 4]
74	Medication/supplement use	208232	phv00208232.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD5A	[Medication records]. Medication B name. Q5a [Medication Survey Form, exam 4]
74	Medication/supplement use	208236	phv00208236.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD6A	[Medication records]. Medication C name. Q6a [Medication Survey Form, exam 4]
74	Medication/supplement use	208240	phv00208240.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD7A	[Medication records]. Medication D name. Q7a [Medication Survey Form, exam 4]
74	Medication/supplement use	208244	phv00208244.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD8A	[Medication records]. Medication E name. Q8a [Medication Survey Form, exam 4]
74	Medication/supplement use	208248	phv00208248.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD9A	[Medication records]. Medication F name. Q9a [Medication Survey Form, exam 4]
74	Medication/supplement use	208252	phv00208252.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD10A	[Medication records]. Medication G name. Q10a [Medication Survey Form, exam 4]
74	Medication/supplement use	208256	phv00208256.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD11A	[Medication records]. Medication H name. Q11a [Medication Survey Form, exam 4]
74	Medication/supplement use	208260	phv00208260.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD12A	[Medication records]. Medication I name. Q12a [Medication Survey Form, exam 4]
74	Medication/supplement use	208264	phv00208264.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD13A	[Medication records]. Medication J name. Q13a [Medication Survey Form, exam 4]
74	Medication/supplement use	208268	phv00208268.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD14A	[Medication records]. Medication K name. Q14a [Medication Survey Form, exam 4]
74	Medication/supplement use	208272	phv00208272.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD15A	[Medication records]. Medication L name. Q15a [Medication Survey Form, exam 4]
74	Medication/supplement use	208276	phv00208276.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD16A	[Medication records]. Medication M name. Q16a [Medication Survey Form, exam 4]
74	Medication/supplement use	208280	phv00208280.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD17A	[Medication records]. Medication N name. Q17a [Medication Survey Form, exam 4]
74	Medication/supplement use	208284	phv00208284.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD18A	[Medication records]. Medication O name. Q18a [Medication Survey Form, exam 4]
74	Medication/supplement use	208288	phv00208288.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD19A	[Medication records]. Medication P name. Q19a [Medication Survey Form, exam 4]
74	Medication/supplement use	208292	phv00208292.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:10:56+00:00	2018-08-02 20:10:56+00:00 	MSRD20A	[Medication records]. Medication Q name Q20a [Medication Survey Form, exam 4]
74	Medication/supplement use	208229	phv00208229.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD4B	[Medication records]. Medication A concentration. Q4b [Medication Survey Form, exam 4]
74	Medication/supplement use	208233	phv00208233.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD5B	[Medication records]. Medication B concentration. Q5b [Medication Survey Form, exam 4]
74	Medication/supplement use	208237	phv00208237.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD6B	[Medication records]. Medication C concentration. Q6b [Medication Survey Form, exam 4]
74	Medication/supplement use	208241	phv00208241.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD7B	[Medication records]. Medication D concentration. Q7b [Medication Survey Form, exam 4]
74	Medication/supplement use	208245	phv00208245.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD8B	[Medication records]. Medication E concentration. Q8b [Medication Survey Form, exam 4]
74	Medication/supplement use	208249	phv00208249.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD9B	[Medication records]. Medication F concentration. Q9b [Medication Survey Form, exam 4]
74	Medication/supplement use	208253	phv00208253.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD10B	[Medication records]. Medication G concentration. Q10b [Medication Survey Form, exam 4]
74	Medication/supplement use	208257	phv00208257.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD11B	[Medication records]. Medication H concentration. Q11b [Medication Survey Form, exam 4]
74	Medication/supplement use	208261	phv00208261.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD12B	[Medication records]. Medication I concentration. Q12b [Medication Survey Form, exam 4]
74	Medication/supplement use	208265	phv00208265.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD13B	[Medication records]. Medication J concentration. Q13b [Medication Survey Form, exam 4]
74	Medication/supplement use	208269	phv00208269.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD14B	[Medication records]. Medication K concentration. Q14b [Medication Survey Form, exam 4]
74	Medication/supplement use	208273	phv00208273.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD15B	[Medication records]. Medication L concentration. Q15b [Medication Survey Form, exam 4]
74	Medication/supplement use	208277	phv00208277.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD16B	[Medication records]. Medication M concentration. Q16b [Medication Survey Form, exam 4]
74	Medication/supplement use	208281	phv00208281.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD17B	[Medication records]. Medication N concentration. Q17b [Medication Survey Form, exam 4]
74	Medication/supplement use	208285	phv00208285.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD18B	[Medication records]. Medication O concentration. Q18b [Medication Survey Form, exam 4]
74	Medication/supplement use	208289	phv00208289.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD19B	[Medication records]. Medication P concentration. Q19b [Medication Survey Form, exam 4]
74	Medication/supplement use	208293	phv00208293.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:14:39+00:00	2018-08-02 20:14:39+00:00 	MSRD20B	[Medication records]. Medication Q concentration. Q20b [Medication Survey Form, exam 4]
74	Medication/supplement use	208230	phv00208230.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD4C	[Medication records]. Medication A code number. Q4c [Medication Survey Form, exam 4]
74	Medication/supplement use	208234	phv00208234.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD5C	[Medication records]. Medication B code number. Q5c [Medication Survey Form, exam 4]
74	Medication/supplement use	208238	phv00208238.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD6C	[Medication records]. Medication C code number. Q6c [Medication Survey Form, exam 4]
74	Medication/supplement use	208242	phv00208242.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD7C	[Medication records]. Medication D code number. Q7c [Medication Survey Form, exam 4]
74	Medication/supplement use	208246	phv00208246.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD8C	[Medication records]. Medication E code number. Q8c [Medication Survey Form, exam 4]
74	Medication/supplement use	208250	phv00208250.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD9C	[Medication records]. Medication F code number. Q9c [Medication Survey Form, exam 4]
74	Medication/supplement use	208254	phv00208254.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD10C	[Medication records]. Medication G code number. Q10c [Medication Survey Form, exam 4]
74	Medication/supplement use	208258	phv00208258.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD11C	[Medication records]. Medication H code number. Q11c [Medication Survey Form, exam 4]
74	Medication/supplement use	208262	phv00208262.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD12C	[Medication records]. Medication I code number. Q12c [Medication Survey Form, exam 4]
74	Medication/supplement use	208266	phv00208266.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD13C	[Medication records]. Medication J code number. Q13c [Medication Survey Form, exam 4]
74	Medication/supplement use	208270	phv00208270.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD14C	[Medication records]. Medication K code number. Q14c [Medication Survey Form, exam 4]
74	Medication/supplement use	208274	phv00208274.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD15C	[Medication records]. Medication L code number. Q15c [Medication Survey Form, exam 4]
74	Medication/supplement use	208278	phv00208278.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD16C	[Medication records]. Medication M code number. Q16c [Medication Survey Form, exam 4]
74	Medication/supplement use	208282	phv00208282.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD17C	[Medication records]. Medication N code number. Q17c [Medication Survey Form, exam 4]
74	Medication/supplement use	208286	phv00208286.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD18C	[Medication records]. Medication O code number. Q18c [Medication Survey Form, exam 4]
74	Medication/supplement use	208290	phv00208290.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD19C	[Medication records]. Medication P code number. Q19c [Medication Survey Form, exam 4]
74	Medication/supplement use	208294	phv00208294.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:04+00:00	2018-08-02 20:18:04+00:00 	MSRD20C	[Medication records]. Medication Q code number. Q20c [Medication Survey Form, exam 4]
74	Medication/supplement use	208296	phv00208296.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:18:34+00:00	2018-08-02 20:18:34+00:00 	MSRD24A	[Interview]. Were any of the medications you took during the past two weeks for: high blood pressure. Q24a [Medication Survey Form, exam 4]
74	Medication/supplement use	208297	phv00208297.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:19:02+00:00	2018-08-02 20:19:02+00:00 	MSRD24B	[Interview]. Were any of the medications you took during the past two weeks for: high blood cholesterol. Q24b [Medication Survey Form, exam 4]
74	Medication/supplement use	208298	phv00208298.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:19:26+00:00	2018-08-02 20:19:26+00:00 	MSRD24C	[Interview]. Were any of the medications you took during the past two weeks for: angina or chest pain. Q24c [Medication Survey Form, exam 4]
74	Medication/supplement use	208299	phv00208299.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:19:49+00:00	2018-08-02 20:19:49+00:00 	MSRD24D	[Interview]. Were any of the medications you took during the past two weeks for: control of heart rhythm. Q24d [Medication Survey Form, exam 4]
74	Medication/supplement use	208300	phv00208300.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:20:35+00:00	2018-08-02 20:20:35+00:00 	MSRD24E	[Interview]. Were any of the medications you took during the past two weeks for: heart failure. Q24e [Medication Survey Form, exam 4]
74	Medication/supplement use	208316	phv00208316.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:22:00+00:00	2018-08-02 20:22:00+00:00 	MSRD26	[Interview]. How many days during the last two weeks did you take aspirin, or a medication that contains aspirin? Q26 [Medication Survey Form, exam 4]
74	Medication/supplement use	208313	phv00208313.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:22:30+00:00	2018-08-02 20:22:30+00:00 	MSRD30B	[Interview]. Except for aspirin or Tylenol, are you NOW taking other non-steroidal anti-inflammatory drugs or arthritis medicines on a regular basis? Examples include Ibuprofen, Advil, Nuprin, Motrin, Naprosyn, Feldene and Clinoril. What is the brand name of the medicine?  If Other, specify? Q30b [Medication Survey Form, exam 4]
74	Medication/supplement use	208312	phv00208312.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:23:15+00:00	2018-08-02 20:23:15+00:00 	MSRD30A	[Interview]. Except for aspirin or Tylenol, are you NOW taking other non-steroidal anti-inflammatory drugs or arthritis medicines on a regular basis? Examples include Ibuprofen, Advil, Nuprin, Motrin, Naprosyn, Feldene and Clinoril. What is the brand name of the medicine?  [Medication Survey Form, exam 4]
74	Medication/supplement use	208311	phv00208311.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:23:50+00:00	2018-08-02 20:23:50+00:00 	MSRD30	[Interview]. Except for aspirin or Tylenol, are you NOW taking other non-steroidal anti-inflammatory drugs or arthritis medicines on a regular basis? Examples include Ibuprofen, Advil, Nuprin, Motrin, Naprosyn, Feldene and Clinoril. Q30 [Medication Survey Form, exam 4]
74	Medication/supplement use	208309	phv00208309.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:24:20+00:00	2018-08-02 20:24:20+00:00 	MSRD29A	[Interview]. What is the strength of aspirin in the pill? Q29a [Medication Survey Form, exam 4]
74	Medication/supplement use	208308	phv00208308.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:24:44+00:00	2018-08-02 20:24:44+00:00 	MSRD29	[Interview]. Are you NOW taking aspirin, or a medicine containing aspirin, on a regular basis? This does not include Tylenol nor Advil. Q29 [Medication Survey Form, exam 4]
74	Medication/supplement use	208307	phv00208307.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:25:26+00:00	2018-08-02 20:25:26+00:00 	MSRD28	[Interview]. During the past two weeks, did you take any [other] medication for arthritis, fever, or muscle aches and pains, (or menstrual cramps)? Q28 [Medication Survey Form, exam 4]
74	Medication/supplement use	208305	phv00208305.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:25:48+00:00	2018-08-02 20:25:48+00:00 	MSRD25	[Interview]. During the past two weeks, did you take any aspirin, Alka-Seltzer, cold medicine or headache powder? Q25 [Medication Survey Form, exam 4]
74	Medication/supplement use	208304	phv00208304.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:26:11+00:00	2018-08-02 20:26:11+00:00 	MSRD24I	[Interview]. Were any of the medications you took during the past two weeks for: leg pain when walking. Q24i [Medication Survey Form, exam 4]
74	Medication/supplement use	208303	phv00208303.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:26:33+00:00	2018-08-02 20:26:33+00:00 	MSRD24H	[Interview]. Were any of the medications you took during the past two weeks for: stroke. Q24h [Medication Survey Form, exam 4]
74	Medication/supplement use	208302	phv00208302.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:26:57+00:00	2018-08-02 20:26:57+00:00 	MSRD24G	[Interview]. Were any of the medications you took during the past two weeks for: diabetes or high blood sugar. Q24g [Medication Survey Form, exam 4]
74	Medication/supplement use	208301	phv00208301.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-02 20:27:18+00:00	2018-08-02 20:27:18+00:00 	MSRD24F	[Interview]. Were any of the medications you took during the past two weeks for: blood thinning. Q24f [Medication Survey Form, exam 4]
74	Medication/supplement use	127767	phv00127767.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 14:36:28+00:00	2018-08-06 14:36:28+00:00 	MSRA5D	MSRA5D
74	Medication/supplement use	127772	phv00127772.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 14:36:28+00:00	2018-08-06 14:36:28+00:00 	MSRA6D	MSRA6D
74	Medication/supplement use	127769	phv00127769.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 14:36:28+00:00	2018-08-06 14:36:28+00:00 	MSRA6A	MSRA6A
74	Medication/supplement use	127770	phv00127770.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 14:36:28+00:00	2018-08-06 14:36:28+00:00 	MSRA6B	MSRA6B
74	Medication/supplement use	127771	phv00127771.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 14:36:28+00:00	2018-08-06 14:36:28+00:00 	MSRA6C	MSRA6C
74	Medication/supplement use	127776	phv00127776.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA7C	MSRA7C
74	Medication/supplement use	127777	phv00127777.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA7D	MSRA7D
74	Medication/supplement use	127781	phv00127781.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA8C	MSRA8C
74	Medication/supplement use	127782	phv00127782.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA8D	MSRA8D
74	Medication/supplement use	127797	phv00127797.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA9D	MSRA9D
74	Medication/supplement use	127799	phv00127799.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA10A	MSRA10A
74	Medication/supplement use	127801	phv00127801.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA10C	MSRA10C
74	Medication/supplement use	127802	phv00127802.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA10D	MSRA10D
74	Medication/supplement use	127806	phv00127806.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA11C	MSRA11C
74	Medication/supplement use	127807	phv00127807.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA11D	MSRA11D
74	Medication/supplement use	127809	phv00127809.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA12A	MSRA12A
74	Medication/supplement use	127811	phv00127811.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA12C	MSRA12C
74	Medication/supplement use	127812	phv00127812.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA12D	MSRA12D
74	Medication/supplement use	127814	phv00127814.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA13A	MSRA13A
74	Medication/supplement use	127816	phv00127816.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA13C	MSRA13C
74	Medication/supplement use	127817	phv00127817.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA13D	MSRA13D
74	Medication/supplement use	127774	phv00127774.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA7A	MSRA7A
74	Medication/supplement use	127775	phv00127775.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA7B	MSRA7B
74	Medication/supplement use	127779	phv00127779.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:08+00:00	2018-08-06 15:18:08+00:00 	MSRA8A	MSRA8A
74	Medication/supplement use	127780	phv00127780.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:09+00:00	2018-08-06 15:18:09+00:00 	MSRA8B	MSRA8B
74	Medication/supplement use	127794	phv00127794.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:09+00:00	2018-08-06 15:18:09+00:00 	MSRA9A	MSRA9A
74	Medication/supplement use	127795	phv00127795.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:09+00:00	2018-08-06 15:18:09+00:00 	MSRA9B	MSRA9B
74	Medication/supplement use	127796	phv00127796.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:09+00:00	2018-08-06 15:18:09+00:00 	MSRA9C	MSRA9C
74	Medication/supplement use	127800	phv00127800.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:09+00:00	2018-08-06 15:18:09+00:00 	MSRA10B	MSRA10B
74	Medication/supplement use	127804	phv00127804.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:09+00:00	2018-08-06 15:18:09+00:00 	MSRA11A	MSRA11A
74	Medication/supplement use	127805	phv00127805.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:09+00:00	2018-08-06 15:18:09+00:00 	MSRA11B	MSRA11B
74	Medication/supplement use	127810	phv00127810.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:09+00:00	2018-08-06 15:18:09+00:00 	MSRA12B	MSRA12B
74	Medication/supplement use	127815	phv00127815.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:18:09+00:00	2018-08-06 15:18:09+00:00 	MSRA13B	MSRA13B
74	Medication/supplement use	127829	phv00127829.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA14A	MSRA14A
74	Medication/supplement use	127831	phv00127831.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA14C	MSRA14C
74	Medication/supplement use	127832	phv00127832.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA14D	MSRA14D
74	Medication/supplement use	127834	phv00127834.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA15A	MSRA15A
74	Medication/supplement use	127836	phv00127836.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA15C	MSRA15C
74	Medication/supplement use	127837	phv00127837.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA15D	MSRA15D
74	Medication/supplement use	127839	phv00127839.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA16A	MSRA16A
74	Medication/supplement use	127841	phv00127841.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA16C	MSRA16C
74	Medication/supplement use	127842	phv00127842.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA16D	MSRA16D
74	Medication/supplement use	127844	phv00127844.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA17A	MSRA17A
74	Medication/supplement use	127846	phv00127846.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA17C	MSRA17C
74	Medication/supplement use	127847	phv00127847.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA17D	MSRA17D
74	Medication/supplement use	127849	phv00127849.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA18A	MSRA18A
74	Medication/supplement use	127850	phv00127850.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA18B	MSRA18B
74	Medication/supplement use	127851	phv00127851.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA18C	MSRA18C
74	Medication/supplement use	127852	phv00127852.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA18D	MSRA18D
74	Medication/supplement use	127864	phv00127864.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA19A	MSRA19A
74	Medication/supplement use	127865	phv00127865.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA19B	MSRA19B
74	Medication/supplement use	127866	phv00127866.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA19C	MSRA19C
74	Medication/supplement use	127867	phv00127867.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA19D	MSRA19D
74	Medication/supplement use	127830	phv00127830.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA14B	MSRA14B
74	Medication/supplement use	127835	phv00127835.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA15B	MSRA15B
74	Medication/supplement use	127840	phv00127840.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA16B	MSRA16B
74	Medication/supplement use	127845	phv00127845.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:20:53+00:00	2018-08-06 15:20:53+00:00 	MSRA17B	MSRA17B
74	Medication/supplement use	127869	phv00127869.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA20A	MSRA20A
74	Medication/supplement use	127870	phv00127870.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA20B	MSRA20B
74	Medication/supplement use	127871	phv00127871.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA20C	MSRA20C
74	Medication/supplement use	127872	phv00127872.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA20D	MSRA20D
74	Medication/supplement use	127874	phv00127874.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA21A	MSRA21A
74	Medication/supplement use	127875	phv00127875.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA21B	MSRA21B
74	Medication/supplement use	127876	phv00127876.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA21C	MSRA21C
74	Medication/supplement use	127877	phv00127877.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA21D	MSRA21D
74	Medication/supplement use	127879	phv00127879.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA22A	MSRA22A
74	Medication/supplement use	127880	phv00127880.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA22B	MSRA22B
74	Medication/supplement use	127881	phv00127881.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA22C	MSRA22C
74	Medication/supplement use	127882	phv00127882.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA22D	MSRA22D
74	Medication/supplement use	127884	phv00127884.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA23A	MSRA23A
74	Medication/supplement use	127886	phv00127886.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA23C	MSRA23C
74	Medication/supplement use	127887	phv00127887.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA23D	MSRA23D
74	Medication/supplement use	127885	phv00127885.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:22:31+00:00	2018-08-06 15:22:31+00:00 	MSRA23B	MSRA23B
74	Medication/supplement use	127899	phv00127899.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:23:38+00:00	2018-08-06 15:23:38+00:00 	MSRA24A	MSRA24A
74	Medication/supplement use	127900	phv00127900.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:23:38+00:00	2018-08-06 15:23:38+00:00 	MSRA24B	MSRA24B
74	Medication/supplement use	127901	phv00127901.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:23:38+00:00	2018-08-06 15:23:38+00:00 	MSRA24C	MSRA24C
74	Medication/supplement use	127902	phv00127902.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:23:38+00:00	2018-08-06 15:23:38+00:00 	MSRA24D	MSRA24D
74	Medication/supplement use	127904	phv00127904.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:23:38+00:00	2018-08-06 15:23:38+00:00 	MSRA25A	MSRA25A
74	Medication/supplement use	127905	phv00127905.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:23:38+00:00	2018-08-06 15:23:38+00:00 	MSRA25B	MSRA25B
74	Medication/supplement use	127906	phv00127906.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:23:38+00:00	2018-08-06 15:23:38+00:00 	MSRA25C	MSRA25C
74	Medication/supplement use	127907	phv00127907.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:23:38+00:00	2018-08-06 15:23:38+00:00 	MSRA25D	MSRA25D
74	Medication/supplement use	127909	phv00127909.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:23:38+00:00	2018-08-06 15:23:38+00:00 	MSRA26A	MSRA26A
74	Medication/supplement use	127910	phv00127910.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:23:38+00:00	2018-08-06 15:23:38+00:00 	MSRA26B	MSRA26B
74	Medication/supplement use	127911	phv00127911.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:23:38+00:00	2018-08-06 15:23:38+00:00 	MSRA26C	MSRA26C
74	Medication/supplement use	127912	phv00127912.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:23:38+00:00	2018-08-06 15:23:38+00:00 	MSRA26D	MSRA26D
74	Medication/supplement use	127914	phv00127914.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA27	27: Total number of medicatons in bag.
74	Medication/supplement use	127915	phv00127915.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA28	28: Medications unable to transcribe.
74	Medication/supplement use	127922	phv00127922.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA30A	30a: Past 2 wks took high blood pressure medications?
74	Medication/supplement use	127923	phv00127923.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA30B	30b: Past 2 wks took high blood cholesterol?
74	Medication/supplement use	127924	phv00127924.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA30C	30c: Past 2 wks took angina/chest pain medications?
74	Medication/supplement use	127925	phv00127925.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA30D	30d: Past 2 wks took control of heart rhythm medications?
74	Medication/supplement use	127926	phv00127926.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA30E	30e: Took medications for heart failure?
74	Medication/supplement use	127927	phv00127927.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA30F	30f: Took medications for blood thinning?
74	Medication/supplement use	127928	phv00127928.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA30G	30g: Took medications for diabetes/high blood sugar?
74	Medication/supplement use	127929	phv00127929.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA30H	30h: Took medications for stroke
74	Medication/supplement use	127930	phv00127930.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA30I	30i: Took medications for leg pain when walking?
74	Medication/supplement use	127931	phv00127931.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA31A	30a: In a hurry, too busy, forgot to take medications
74	Medication/supplement use	127932	phv00127932.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA31B	31b: Medication was inconvenient to take
74	Medication/supplement use	127933	phv00127933.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA31C	31c: Medication wouldn't do any good-did not take
74	Medication/supplement use	127934	phv00127934.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA31D	31d: Medication made you feel bad-did not take
74	Medication/supplement use	127935	phv00127935.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA31E	31e: Can't carry out normal activities-did not take medications
74	Medication/supplement use	127936	phv00127936.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA31F	31f: Thought you might become addicted-did not take medications
74	Medication/supplement use	127937	phv00127937.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA31G	31g: Don't like to take medicine
74	Medication/supplement use	127938	phv00127938.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA31H	31h: Trying to do without taking medications
74	Medication/supplement use	127939	phv00127939.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA31I	31i: No money to purchase medication
74	Medication/supplement use	127940	phv00127940.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA31J	31j: Did not have medication available
74	Medication/supplement use	127941	phv00127941.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA31K	31k: Other reasons for not taking a medication
74	Medication/supplement use	127942	phv00127942.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:29:47+00:00	2018-08-06 15:29:47+00:00 	MSRA31L	31l: Specify why not taking medication
74	Medication/supplement use	127943	phv00127943.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA32	32: Past 2 weeks, take any aspirin?
74	Medication/supplement use	127944	phv00127944.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA33	33: Now taking aspirin?
74	Medication/supplement use	127945	phv00127945.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA34A	34a: Strength of aspirin in the pill
74	Medication/supplement use	127946	phv00127946.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA34B	34b: How may days a week, taking medication?
74	Medication/supplement use	127947	phv00127947.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA34C	34c: Pills taking per week, on average?
74	Medication/supplement use	127948	phv00127948.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA34D	34d: Purpose for taking this medication?
74	Medication/supplement use	127950	phv00127950.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA35A	35a: Now taking other non-steroidal drugs?
74	Medication/supplement use	127951	phv00127951.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA35B	35b: Brand name of medication?
74	Medication/supplement use	127952	phv00127952.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA35C	35c: If 'Other', specify
74	Medication/supplement use	127953	phv00127953.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA35D	35d: Average pills per week you are taking?
74	Medication/supplement use	127955	phv00127955.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA36A	36a: Have you used vinegar?
74	Medication/supplement use	127956	phv00127956.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA36B	36b: How many days during past 2 weeks did you used vinegar?
74	Medication/supplement use	127957	phv00127957.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA36C	36c: For what purpose did you used vinegar?
74	Medication/supplement use	127958	phv00127958.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA37A	37a: Past 2 weeks have you used epsom salts?
74	Medication/supplement use	127959	phv00127959.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA37B	37b: How many days during past 2 weeks did you use epsom salts?
74	Medication/supplement use	127960	phv00127960.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA37C	37c: For what purpose did you use epsom salts?
74	Medication/supplement use	127962	phv00127962.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA38B	38b: How many days during the past 2 weeks did you use lemon/juice?
74	Medication/supplement use	127963	phv00127963.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA38C	38c: For what purpose did you used lemon/lemon juice?
74	Medication/supplement use	127964	phv00127964.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA39A	39a: Past 2 weeks have you used garlic?
74	Medication/supplement use	127965	phv00127965.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA39B	39b: How many days during the past 2 weeks did you use garlic?
74	Medication/supplement use	127966	phv00127966.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA39C	39c: For what purpose did you used garlic?
74	Medication/supplement use	127967	phv00127967.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA40A	40a: Past 2 weeks did you use Teas?
74	Medication/supplement use	127968	phv00127968.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA40B	40b: How many days past 2 weeks used teas?
74	Medication/supplement use	127969	phv00127969.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA40C	40c: For what purpose did you used teas?
74	Medication/supplement use	127970	phv00127970.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA40D	40d: Specify type of teas
74	Medication/supplement use	127949	phv00127949.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA34E	34e: When did you start taking aspirin (mm/yyyy)?
74	Medication/supplement use	127954	phv00127954.v2.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:37:53+00:00	2018-08-06 15:37:53+00:00 	MSRA35E	35e: When did you start taking (mm/yy)?
74	Medication/supplement use	127961	phv00127961.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:38:11+00:00	2018-08-06 15:38:11+00:00 	MSRA38A	38a: Lemon juice or lemon?
74	Medication/supplement use	127971	phv00127971.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRA41A	41a: Past 2 weeks did you use roots?
74	Medication/supplement use	127972	phv00127972.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRA41B	41b: How many days the past 2 wks did you use roots?
74	Medication/supplement use	127973	phv00127973.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRA41C	41c: Purpose you use roots?
74	Medication/supplement use	127974	phv00127974.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRA41D	41d: Specify type of roots used
74	Medication/supplement use	127975	phv00127975.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRA42A	42a: Any other home remedies used (2 weeks)?
74	Medication/supplement use	127976	phv00127976.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRA42B	42b: How many days for past 2 wks took remedies?
74	Medication/supplement use	127977	phv00127977.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRA42C	42c: What purpose took home remedies?
74	Medication/supplement use	127978	phv00127978.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRA42D	42d: Specify type of home remedie
74	Medication/supplement use	127979	phv00127979.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRA43A	43a: Any other home remedies?
74	Medication/supplement use	127980	phv00127980.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRA43B	43b: Home remedies for your heart or other symptoms?
74	Medication/supplement use	127981	phv00127981.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRA43C	43c: What other symptoms?
74	Medication/supplement use	127982	phv00127982.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRA43D	43d: How often have you used home remedies?
74	Medication/supplement use	127983	phv00127983.v1.p1	pht001964.v2.p1	phs000286.v5.p1	Jackson Heart Study	286	5	2018-08-06 15:41:15+00:00	2018-08-06 15:41:15+00:00 	MSRAflag	Data record present: Yes/No
74	Medication/supplement use	159648	phv00159648.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:14:21+00:00	2018-08-10 22:14:21+00:00 	CurrentMedUse	Currently do you use medications to treat breathing problem Collection Interval: Collected in Exam 1
74	Medication/supplement use	159647	phv00159647.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:14:30+00:00	2018-08-10 22:14:30+00:00 	CortsterOral	Oral corticosteroids Collection Interval: Collected in Exam 1
74	Medication/supplement use	159646	phv00159646.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:14:38+00:00	2018-08-10 22:14:38+00:00 	Cortsterinhal	Inhaled corticosteroids Collection Interval: Collected in Exam 1
74	Medication/supplement use	159645	phv00159645.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:14:47+00:00	2018-08-10 22:14:47+00:00 	combivent	Combination short-acting medication Collection Interval: Collected in Exam 1
74	Medication/supplement use	159644	phv00159644.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:14:55+00:00	2018-08-10 22:14:55+00:00 	CombcCSBagon	Combination inhaled corticosteroid and beta-agonist Collection Interval: Collected in Exam 1
74	Medication/supplement use	159643	phv00159643.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:15:04+00:00	2018-08-10 22:15:04+00:00 	bagonistlongact	Long-acting beta-agonist Collection Interval: Collected in Exam 1
74	Medication/supplement use	159642	phv00159642.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:15:12+00:00	2018-08-10 22:15:12+00:00 	bagonist	Inhaled short-acting beta-agonist Collection Interval: Collected in Exam 1
74	Medication/supplement use	159653	phv00159653.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:16:14+00:00	2018-08-10 22:16:14+00:00 	tiotrop	Tiotroprium bromide Collection Interval: Collected in Exam 1
74	Medication/supplement use	159652	phv00159652.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:16:20+00:00	2018-08-10 22:16:20+00:00 	theoph	Theophylline Collection Interval: Collected in Exam 1
74	Medication/supplement use	159651	phv00159651.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:16:28+00:00	2018-08-10 22:16:28+00:00 	nebulizer	Nebulizer for an inhaled medication Collection Interval: Collected in Exam 1
74	Medication/supplement use	159649	phv00159649.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:16:36+00:00	2018-08-10 22:16:36+00:00 	ipratrop	Ipratropium bromide Collection Interval: Collected in Exam 1
74	Medication/supplement use	169343	phv00169343.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:18:50+00:00	2018-08-10 22:18:50+00:00 	TreatSteroiTimes	If yes how many times Collection Interval: Collected in Exam 1
74	Medication/supplement use	169342	phv00169342.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:18:56+00:00	2018-08-10 22:18:56+00:00 	TreatSteroids	Been treated with steroid pills or injections Collection Interval: Collected in Exam 1
74	Medication/supplement use	169341	phv00169341.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:19:04+00:00	2018-08-10 22:19:04+00:00 	TreatChestTimes	How many times treated with antibiotics for chest illness Collection Interval: Collected in Exam 1
74	Medication/supplement use	169340	phv00169340.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:19:11+00:00	2018-08-10 22:19:11+00:00 	TreatChestIll	Have you been to treated with antibiotics for chest illness Collection Interval: Collected in Exam 1
74	Medication/supplement use	159676	phv00159676.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:20:52+00:00	2018-08-10 22:20:52+00:00 	MedorTreatAttack	Have you ever required medicine/treatment for attacks Collection Interval: Collected in Exam 1
74	Medication/supplement use	169351	phv00169351.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:20:59+00:00	2018-08-10 22:20:59+00:00 	COPDExac_NewRx_Antib_Ster	Episodes past year: number of times doctor new prescription [antibiotics or steroids] Collection Interval: Collected in Exam 1
74	Medication/supplement use	169350	phv00169350.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:21:05+00:00	2018-08-10 22:21:05+00:00 	COPDExac_Antib_Ster_Home	Episodes past year: number of times antibiotics or steroids at home Collection Interval: Collected in Exam 1
74	Medication/supplement use	159799	phv00159799.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:21:13+00:00	2018-08-10 22:21:13+00:00 	COPDExac_UsualMed	"Episodes past year: number of times ""Increased usual medication"" Collection Interval: Collected in Exam 1"
74	Medication/supplement use	159740	phv00159740.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:22:48+00:00	2018-08-10 22:22:48+00:00 	SleepApTreat	Sleep apnea: in past 12 months have you received any treatment for sleep apnea Collection Interval: Collected in Exam 1
74	Medication/supplement use	159735	phv00159735.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:22:55+00:00	2018-08-10 22:22:55+00:00 	CopdTreat	COPD: received medical treatment or used medications/inhaler Collection Interval: Collected in Exam 1
74	Medication/supplement use	169349	phv00169349.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:23:03+00:00	2018-08-10 22:23:03+00:00 	EmphTreat	Emphysema: received medical treatment or used medications/inhaler Collection Interval: Collected in Exam 1
74	Medication/supplement use	169346	phv00169346.v3.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:23:11+00:00	2018-08-10 22:23:11+00:00 	ChronBroncTreat	Chronic bronchitis: received medical treatment or used medications/inhaler Collection Interval: Collected in Exam 1
74	Medication/supplement use	159716	phv00159716.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:23:20+00:00	2018-08-10 22:23:20+00:00 	HayFevTreat	Hayfever: received medical treatment or used medications/nasal spray Collection Interval: Collected in Exam 1
74	Medication/supplement use	159708	phv00159708.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-10 22:23:29+00:00	2018-08-10 22:23:29+00:00 	AsthmaTreat	Asthma: received medical treatment or used medications/inhaler Collection Interval: Collected in Exam 1
74	Medication/supplement use	123024	phv00123024.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-14 20:58:39+00:00	2018-08-14 20:58:39+00:00 	activeasthma	Asthma: MD dx of Asthma and on Asthma meds in past 3 days
74	Medication/supplement use	277317	phv00277317.v1.p1	pht006032.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:10:55+00:00	2018-08-14 22:10:55+00:00 	MEDS_URICACID	Taking Medication That Affect Uric Acid? Collection Interval: 2007-2009
74	Medication/supplement use	277316	phv00277316.v1.p1	pht006032.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:11:03+00:00	2018-08-14 22:11:03+00:00 	MEDS_LIPIDS	Taking any Lipid Lowering Medication? Collection Interval: 2007-2009
74	Medication/supplement use	277315	phv00277315.v1.p1	pht006032.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:11:10+00:00	2018-08-14 22:11:10+00:00 	MEDS_HYT	Taking any Anti-Hypertension Medication? Collection Interval: 2007-2009
74	Medication/supplement use	277314	phv00277314.v1.p1	pht006032.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:11:19+00:00	2018-08-14 22:11:19+00:00 	MEDS_DIABETES	Taking any Anti-Diabetic Medication? Collection Interval: 2007-2009
74	Medication/supplement use	277409	phv00277409.v1.p1	pht006037.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:24:22+00:00	2018-08-14 22:24:22+00:00 	ASPIRIN1	In the last month, have you been regularly taking aspirin -- I mean daily or every other day? Collection Interval: 2009-2011
74	Medication/supplement use	277410	phv00277410.v1.p1	pht006037.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:24:47+00:00	2018-08-14 22:24:47+00:00 	ASPIRIN2	Do you take aspirin because your physician recommended it, or on your own? Collection Interval: 2009-2011
74	Medication/supplement use	277416	phv00277416.v1.p1	pht006037.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:25:16+00:00	2018-08-14 22:25:16+00:00 	meds_NUTRIENTS	Taking any Nutritional Supplement? Collection Interval: 2009-2011
74	Medication/supplement use	277415	phv00277415.v1.p1	pht006037.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:25:24+00:00	2018-08-14 22:25:24+00:00 	meds_UricAcid	Taking Medication That Affect Uric Acid? Collection Interval: 2009-2011
74	Medication/supplement use	277414	phv00277414.v1.p1	pht006037.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:25:32+00:00	2018-08-14 22:25:32+00:00 	meds_BRAIN	Taking Medication that Affects the Brain? Collection Interval: 2009-2011
74	Medication/supplement use	277413	phv00277413.v1.p1	pht006037.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:25:40+00:00	2018-08-14 22:25:40+00:00 	meds_DIABETES	Taking any Anti-Diabetic Medication? Collection Interval: 2009-2011
74	Medication/supplement use	277412	phv00277412.v1.p1	pht006037.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:25:47+00:00	2018-08-14 22:25:47+00:00 	meds_LIPIDS	Taking any Lipid Lowering Medication? Collection Interval: 2009-2011
74	Medication/supplement use	277411	phv00277411.v1.p1	pht006037.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:25:54+00:00	2018-08-14 22:25:54+00:00 	meds_HYT	Taking any Anti-Hypertension Medication? Collection Interval: 2009-2011
74	Medication/supplement use	277426	phv00277426.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:27:45+00:00	2018-08-14 22:27:45+00:00 	HYT_RXAGE	In what year or how old were you when you last took prescription medication to lower your bp? -age Collection Interval: 2009-2011
74	Medication/supplement use	277425	phv00277425.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:27:52+00:00	2018-08-14 22:27:52+00:00 	HYT_RXYR	In what year or how old were you when you last took prescription medication to lower your bp? -year Collection Interval: 2009-2011
74	Medication/supplement use	277424	phv00277424.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:27:59+00:00	2018-08-14 22:27:59+00:00 	HYT_RX	Are you currently taking prescription medication to lower your blood pressure? Collection Interval: 2009-2011
74	Medication/supplement use	277423	phv00277423.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:28:06+00:00	2018-08-14 22:28:06+00:00 	HMED_AGE	In what year or how old were you when medication was first prescribed? - age Collection Interval: 2009-2011
74	Medication/supplement use	277422	phv00277422.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:28:13+00:00	2018-08-14 22:28:13+00:00 	HMED_YR	In what year or how old were you when medication was first prescribed? - year Collection Interval: 2009-2011
74	Medication/supplement use	277421	phv00277421.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:28:20+00:00	2018-08-14 22:28:20+00:00 	HYT_MED	Has medication ever been prescribed by a physician to lower your blood pressure? Collection Interval: 2009-2011
74	Medication/supplement use	277451	phv00277451.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:32:58+00:00	2018-08-14 22:32:58+00:00 	HBS_INS	Has insulin ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 2009-2011
74	Medication/supplement use	277450	phv00277450.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:33:05+00:00	2018-08-14 22:33:05+00:00 	HBS_MED	Has oral medication ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 2009-2011
74	Medication/supplement use	277495	phv00277495.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:37:14+00:00	2018-08-14 22:37:14+00:00 	BIRTHC	In the last month have you taken or used any oral contraceptives/shots/or implants for birth control? Collection Interval: 2009-2011
74	Medication/supplement use	277492	phv00277492.v1.p1	pht006038.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:37:21+00:00	2018-08-14 22:37:21+00:00 	HOR_EST	In the last month have you taken or used any pills/skin patches/or shots for hormone or estrogen therapy? Collection Interval: 2009-2011
74	Medication/supplement use	277590	phv00277590.v1.p1	pht006042.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:45:44+00:00	2018-08-14 22:45:44+00:00 	meds_NUTRIENTS	Taking any Nutritional Supplement? Collection Interval: 1996-2000
74	Medication/supplement use	277589	phv00277589.v1.p1	pht006042.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:45:51+00:00	2018-08-14 22:45:51+00:00 	meds_UricAcid	Taking Medication That Affect Uric Acid? Collection Interval: 1996-2000
74	Medication/supplement use	277588	phv00277588.v1.p1	pht006042.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:45:58+00:00	2018-08-14 22:45:58+00:00 	meds_BRAIN	Taking Medication that Affects the Brain? Collection Interval: 1996-2000
74	Medication/supplement use	277587	phv00277587.v1.p1	pht006042.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:46:05+00:00	2018-08-14 22:46:05+00:00 	meds_DIABETES	Taking any Anti-Diabetic Medication? Collection Interval: 1996-2000
74	Medication/supplement use	277586	phv00277586.v1.p1	pht006042.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:46:13+00:00	2018-08-14 22:46:13+00:00 	meds_LIPIDS	Taking any Lipid Lowering Medication? Collection Interval: 1996-2000
74	Medication/supplement use	277585	phv00277585.v1.p1	pht006042.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:46:20+00:00	2018-08-14 22:46:20+00:00 	meds_HYT	Taking any Anti-Hypertension Medication? Collection Interval: 1996-2000
74	Medication/supplement use	277584	phv00277584.v1.p1	pht006042.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:46:28+00:00	2018-08-14 22:46:28+00:00 	ASPIRIN	In the last month, have you taken aspirin on a daily basis? Collection Interval: 1996-2000
74	Medication/supplement use	277597	phv00277597.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:46:49+00:00	2018-08-14 22:46:49+00:00 	HMED_AGE	In what year or how old were you when medication was first prescribed? - age Collection Interval: 1996-2000
74	Medication/supplement use	277596	phv00277596.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:46:56+00:00	2018-08-14 22:46:56+00:00 	HMED_YR	In what year or how old were you when medication was first prescribed? - year Collection Interval: 1996-2000
74	Medication/supplement use	277595	phv00277595.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:47:03+00:00	2018-08-14 22:47:03+00:00 	HYT_MED	Has medication ever been prescribed by a physician to lower your blood pressure? Collection Interval: 1996-2000
74	Medication/supplement use	277617	phv00277617.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:53:29+00:00	2018-08-14 22:53:29+00:00 	IN_AGE	In what year or how old were you when insulin was first prescribed? - age Collection Interval: 1996-2000
74	Medication/supplement use	277616	phv00277616.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:53:37+00:00	2018-08-14 22:53:37+00:00 	IN_YR	In what year or how old were you when insulin was first prescribed? - year Collection Interval: 1996-2000
74	Medication/supplement use	277615	phv00277615.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:53:44+00:00	2018-08-14 22:53:44+00:00 	hbs_ins	Has insulin ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 1996-2000
74	Medication/supplement use	277614	phv00277614.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:53:52+00:00	2018-08-14 22:53:52+00:00 	HBSMED_A	In what year or how old were you when it was first prescribed? - age Collection Interval: 1996-2000
74	Medication/supplement use	277613	phv00277613.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:53:59+00:00	2018-08-14 22:53:59+00:00 	HBSMED_Y	In what year or how old were you when it was first prescribed? - year Collection Interval: 1996-2000
74	Medication/supplement use	277612	phv00277612.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:54:08+00:00	2018-08-14 22:54:08+00:00 	HBS_MED	Has an oral medication ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 1996-2000
74	Medication/supplement use	277652	phv00277652.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:56:48+00:00	2018-08-14 22:56:48+00:00 	BIRTHC	In the last month; have you taken or used any oral contraceptives; shots; or implants for birth control? Collection Interval: 1996-2000
74	Medication/supplement use	277649	phv00277649.v1.p1	pht006043.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 22:56:55+00:00	2018-08-14 22:56:55+00:00 	HOR_EST	In the last month have you taken or used any pills/skin patches/shots for hormone/estrogen replacement therapy? Collection Interval: 1996-2000
74	Medication/supplement use	277865	phv00277865.v1.p1	pht006049.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:12:14+00:00	2018-08-14 23:12:14+00:00 	meds_NUTRIENTS	Taking any Nutritional Supplement? Collection Interval: 2000-2004
74	Medication/supplement use	277864	phv00277864.v1.p1	pht006049.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:12:21+00:00	2018-08-14 23:12:21+00:00 	meds_UricAcid	Taking Medication That Affect Uric Acid? Collection Interval: 2000-2004
74	Medication/supplement use	277863	phv00277863.v1.p1	pht006049.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:12:28+00:00	2018-08-14 23:12:28+00:00 	meds_BRAIN	Taking Medication that Affects the Brain? Collection Interval: 2000-2004
74	Medication/supplement use	277862	phv00277862.v1.p1	pht006049.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:12:35+00:00	2018-08-14 23:12:35+00:00 	meds_DIABETES	Taking any Anti-Diabetic Medication? Collection Interval: 2000-2004
74	Medication/supplement use	277861	phv00277861.v1.p1	pht006049.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:12:43+00:00	2018-08-14 23:12:43+00:00 	meds_LIPIDS	Taking any Lipid Lowering Medication? Collection Interval: 2000-2004
74	Medication/supplement use	277860	phv00277860.v1.p1	pht006049.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:12:51+00:00	2018-08-14 23:12:51+00:00 	meds_HYT	Taking any Anti-Hypertension Medication? Collection Interval: 2000-2004
74	Medication/supplement use	277859	phv00277859.v1.p1	pht006049.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:12:59+00:00	2018-08-14 23:12:59+00:00 	ASPIRIN2	Do you take aspirin because your physician recommended it, or on your own? Collection Interval: 2000-2004
74	Medication/supplement use	277858	phv00277858.v1.p1	pht006049.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:13:06+00:00	2018-08-14 23:13:06+00:00 	ASPIRIN1	In the last month, have you been regularly taking aspirin -- I mean daily or every other day? Collection Interval: 2000-2004
74	Medication/supplement use	277875	phv00277875.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:13:43+00:00	2018-08-14 23:13:43+00:00 	HYT_RXAGE	In what year or how old were you when you last took prescription medication to lower your bp? -age Collection Interval: 2000-2004
74	Medication/supplement use	277874	phv00277874.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:13:50+00:00	2018-08-14 23:13:50+00:00 	HYT_RXYR	In what year or how old were you when you last took prescription medication to lower your bp? -year Collection Interval: 2000-2004
74	Medication/supplement use	277873	phv00277873.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:13:56+00:00	2018-08-14 23:13:56+00:00 	HYT_RX	Are you currently taking prescription medication to lower your blood pressure? Collection Interval: 2000-2004
74	Medication/supplement use	277872	phv00277872.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:14:02+00:00	2018-08-14 23:14:02+00:00 	HMED_AGE	In what year or how old were you when medication was first prescribed? - age Collection Interval: 2000-2004
74	Medication/supplement use	277871	phv00277871.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:14:09+00:00	2018-08-14 23:14:09+00:00 	HMED_YR	In what year or how old were you when medication was first prescribed? - year Collection Interval: 2000-2004
74	Medication/supplement use	277870	phv00277870.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:14:16+00:00	2018-08-14 23:14:16+00:00 	HYT_MED	Has medication ever been prescribed by a physician to lower your blood pressure? Collection Interval: 2000-2004
74	Medication/supplement use	277904	phv00277904.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:17:45+00:00	2018-08-14 23:17:45+00:00 	IN_AGE	In what year or how old were you when insulin was first prescribed? - age Collection Interval: 2000-2004
74	Medication/supplement use	277903	phv00277903.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:17:52+00:00	2018-08-14 23:17:52+00:00 	IN_YR	In what year or how old were you when insulin was first prescribed? - year Collection Interval: 2000-2004
74	Medication/supplement use	277902	phv00277902.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:17:59+00:00	2018-08-14 23:17:59+00:00 	hbs_ins	Has insulin ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 2000-2004
74	Medication/supplement use	277901	phv00277901.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:18:05+00:00	2018-08-14 23:18:05+00:00 	HBSMED_A	In what year or how old were you when it was first prescribed? - age Collection Interval: 2000-2004
74	Medication/supplement use	277900	phv00277900.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:18:12+00:00	2018-08-14 23:18:12+00:00 	HBSMED_Y	In what year or how old were you when it was first prescribed? - year Collection Interval: 2000-2004
74	Medication/supplement use	277899	phv00277899.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-14 23:18:18+00:00	2018-08-14 23:18:18+00:00 	HBS_MED	Has oral medication ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 2000-2004
74	Medication/supplement use	277956	phv00277956.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:50:25+00:00	2018-08-15 23:50:25+00:00 	BIRTHC	In the last month have you taken or used any oral contraceptives/shots/or implants for birth control? Collection Interval: 2000-2004
74	Medication/supplement use	277953	phv00277953.v1.p1	pht006050.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:50:32+00:00	2018-08-15 23:50:32+00:00 	HOR_EST	In the last month have you taken or used any pills/skin patches/or shots for hormone or estrogen therapy? Collection Interval: 2000-2004
74	Medication/supplement use	307777	phv00307777.v1.p1	pht006651.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:53:57+00:00	2018-08-15 23:53:57+00:00 	MEDS_URICACID	Taking Medication That Affect Uric Acid? Collection Interval: 2006-2011
74	Medication/supplement use	307776	phv00307776.v1.p1	pht006651.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:54:05+00:00	2018-08-15 23:54:05+00:00 	MEDS_LIPIDS	Taking any Lipid Lowering Medication? Collection Interval: 2006-2011
74	Medication/supplement use	307775	phv00307775.v1.p1	pht006651.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:54:12+00:00	2018-08-15 23:54:12+00:00 	MEDS_HYT	Taking any Anti-Hypertension Medication? Collection Interval: 2006-2011
74	Medication/supplement use	307774	phv00307774.v1.p1	pht006651.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:54:19+00:00	2018-08-15 23:54:19+00:00 	MEDS_DIABETES	Taking any Anti-Diabetic Medication? Collection Interval: 2006-2011
74	Medication/supplement use	307871	phv00307871.v1.p1	pht006656.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:58:24+00:00	2018-08-15 23:58:24+00:00 	meds_NUTRIENTS	Taking any Nutritional Supplement? Collection Interval: 1996-2000
74	Medication/supplement use	307870	phv00307870.v1.p1	pht006656.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:58:32+00:00	2018-08-15 23:58:32+00:00 	meds_UricAcid	Taking Medication That Affect Uric Acid? Collection Interval: 1996-2000
74	Medication/supplement use	307869	phv00307869.v1.p1	pht006656.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:58:39+00:00	2018-08-15 23:58:39+00:00 	meds_BRAIN	Taking Medication that Affects the Brain? Collection Interval: 1996-2000
74	Medication/supplement use	307868	phv00307868.v1.p1	pht006656.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:58:48+00:00	2018-08-15 23:58:48+00:00 	meds_DIABETES	Taking any Anti-Diabetic Medication? Collection Interval: 1996-2000
74	Medication/supplement use	307867	phv00307867.v1.p1	pht006656.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:58:55+00:00	2018-08-15 23:58:55+00:00 	meds_LIPIDS	Taking any Lipid Lowering Medication? Collection Interval: 1996-2000
74	Medication/supplement use	307866	phv00307866.v1.p1	pht006656.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:59:03+00:00	2018-08-15 23:59:03+00:00 	meds_HYT	Taking any Anti-Hypertension Medication? Collection Interval: 1996-2000
74	Medication/supplement use	307865	phv00307865.v1.p1	pht006656.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:59:11+00:00	2018-08-15 23:59:11+00:00 	ASPIRIN	In the last month, have you taken aspirin on a daily basis? Collection Interval: 1996-2000
74	Medication/supplement use	307878	phv00307878.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:59:37+00:00	2018-08-15 23:59:37+00:00 	HMED_AGE	In what year or how old were you when medication was first prescribed? - age Collection Interval: 1996-2000
74	Medication/supplement use	307877	phv00307877.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:59:43+00:00	2018-08-15 23:59:43+00:00 	HMED_YR	In what year or how old were you when medication was first prescribed? - year Collection Interval: 1996-2000
74	Medication/supplement use	307876	phv00307876.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-15 23:59:51+00:00	2018-08-15 23:59:51+00:00 	HYT_MED	Has medication ever been prescribed by a physician to lower your blood pressure? Collection Interval: 1996-2000
74	Medication/supplement use	307898	phv00307898.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:02:54+00:00	2018-08-16 00:02:54+00:00 	IN_AGE	In what year or how old were you when insulin was first prescribed? - age Collection Interval: 1996-2000
74	Medication/supplement use	307897	phv00307897.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:03:02+00:00	2018-08-16 00:03:02+00:00 	IN_YR	In what year or how old were you when insulin was first prescribed? - year Collection Interval: 1996-2000
74	Medication/supplement use	307896	phv00307896.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:03:12+00:00	2018-08-16 00:03:12+00:00 	hbs_ins	Has insulin ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 1996-2000
74	Medication/supplement use	307895	phv00307895.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:03:26+00:00	2018-08-16 00:03:26+00:00 	HBSMED_A	In what year or how old were you when it was first prescribed? - age Collection Interval: 1996-2000
74	Medication/supplement use	307894	phv00307894.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:03:34+00:00	2018-08-16 00:03:34+00:00 	HBSMED_Y	In what year or how old were you when it was first prescribed? - year Collection Interval: 1996-2000
74	Medication/supplement use	307893	phv00307893.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:03:42+00:00	2018-08-16 00:03:42+00:00 	HBS_MED	Has an oral medication ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 1996-2000
74	Medication/supplement use	307933	phv00307933.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:06:19+00:00	2018-08-16 00:06:19+00:00 	BIRTHC	In the last month; have you taken or used any oral contraceptives; shots; or implants for birth control? Collection Interval: 1996-2000
74	Medication/supplement use	307930	phv00307930.v1.p1	pht006657.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:06:26+00:00	2018-08-16 00:06:26+00:00 	HOR_EST	In the last month have you taken or used any pills/skin patches/shots for hormone/estrogen replacement therapy? Collection Interval: 1996-2000
74	Medication/supplement use	308058	phv00308058.v1.p1	pht006662.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:13:15+00:00	2018-08-16 00:13:15+00:00 	meds_NUTRIENTS	Taking any Nutritional Supplement? Collection Interval: 2000-2004
74	Medication/supplement use	308057	phv00308057.v1.p1	pht006662.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:13:22+00:00	2018-08-16 00:13:22+00:00 	meds_UricAcid	Taking Medication That Affect Uric Acid? Collection Interval: 2000-2004
74	Medication/supplement use	308056	phv00308056.v1.p1	pht006662.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:13:29+00:00	2018-08-16 00:13:29+00:00 	meds_BRAIN	Taking Medication that Affects the Brain? Collection Interval: 2000-2004
74	Medication/supplement use	308055	phv00308055.v1.p1	pht006662.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:13:36+00:00	2018-08-16 00:13:36+00:00 	meds_DIABETES	Taking any Anti-Diabetic Medication? Collection Interval: 2000-2004
74	Medication/supplement use	308054	phv00308054.v1.p1	pht006662.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:13:44+00:00	2018-08-16 00:13:44+00:00 	meds_LIPIDS	Taking any Lipid Lowering Medication? Collection Interval: 2000-2004
74	Medication/supplement use	308053	phv00308053.v1.p1	pht006662.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:13:51+00:00	2018-08-16 00:13:51+00:00 	meds_HYT	Taking any Anti-Hypertension Medication? Collection Interval: 2000-2004
74	Medication/supplement use	308052	phv00308052.v1.p1	pht006662.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:14:00+00:00	2018-08-16 00:14:00+00:00 	ASPIRIN2	Do you take aspirin because your physician recommended it, or on your own? Collection Interval: 2000-2004
74	Medication/supplement use	308051	phv00308051.v1.p1	pht006662.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:14:08+00:00	2018-08-16 00:14:08+00:00 	ASPIRIN1	In the last month, have you been regularly taking aspirin -- I mean daily or every other day? Collection Interval: 2000-2004
74	Medication/supplement use	308068	phv00308068.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:14:38+00:00	2018-08-16 00:14:38+00:00 	HYT_RXAGE	In what year or how old were you when you last took prescription medication to lower your bp? -age Collection Interval: 2000-2004
74	Medication/supplement use	308067	phv00308067.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:14:45+00:00	2018-08-16 00:14:45+00:00 	HYT_RXYR	In what year or how old were you when you last took prescription medication to lower your bp? -year Collection Interval: 2000-2004
74	Medication/supplement use	308066	phv00308066.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:14:51+00:00	2018-08-16 00:14:51+00:00 	HYT_RX	Are you currently taking prescription medication to lower your blood pressure? Collection Interval: 2000-2004
74	Medication/supplement use	308065	phv00308065.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:15:00+00:00	2018-08-16 00:15:00+00:00 	HMED_AGE	In what year or how old were you when medication was first prescribed? - age Collection Interval: 2000-2004
74	Medication/supplement use	308064	phv00308064.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:15:07+00:00	2018-08-16 00:15:07+00:00 	HMED_YR	In what year or how old were you when medication was first prescribed? - year Collection Interval: 2000-2004
74	Medication/supplement use	308063	phv00308063.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:15:15+00:00	2018-08-16 00:15:15+00:00 	HYT_MED	Has medication ever been prescribed by a physician to lower your blood pressure? Collection Interval: 2000-2004
74	Medication/supplement use	308097	phv00308097.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:20:29+00:00	2018-08-16 00:20:29+00:00 	IN_AGE	In what year or how old were you when insulin was first prescribed? - age Collection Interval: 2000-2004
74	Medication/supplement use	308096	phv00308096.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:20:37+00:00	2018-08-16 00:20:37+00:00 	IN_YR	In what year or how old were you when insulin was first prescribed? - year Collection Interval: 2000-2004
74	Medication/supplement use	308095	phv00308095.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:20:44+00:00	2018-08-16 00:20:44+00:00 	hbs_ins	Has insulin ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 2000-2004
74	Medication/supplement use	308094	phv00308094.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:20:51+00:00	2018-08-16 00:20:51+00:00 	HBSMED_A	In what year or how old were you when it was first prescribed? - age Collection Interval: 2000-2004
74	Medication/supplement use	308093	phv00308093.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:20:58+00:00	2018-08-16 00:20:58+00:00 	HBSMED_Y	In what year or how old were you when it was first prescribed? - year Collection Interval: 2000-2004
74	Medication/supplement use	308092	phv00308092.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:21:07+00:00	2018-08-16 00:21:07+00:00 	HBS_MED	Has oral medication ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 2000-2004
74	Medication/supplement use	308149	phv00308149.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:24:47+00:00	2018-08-16 00:24:47+00:00 	BIRTHC	In the last month have you taken or used any oral contraceptives/shots/or implants for birth control? Collection Interval: 2000-2004
74	Medication/supplement use	308146	phv00308146.v1.p1	pht006663.v1.p1	phs001238.v1.p1	Genetic Epidemiology Network of Arteriopathy (GENOA)	1238	1	2018-08-16 00:24:55+00:00	2018-08-16 00:24:55+00:00 	HOR_EST	In the last month have you taken or used any pills/skin patches/or shots for hormone or estrogen therapy? Collection Interval: 2000-2004
74	Medication/supplement use	159576	phv00159576.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-16 17:01:29+00:00	2018-08-16 17:01:29+00:00 	O2_suppl_6MW	Supplemental O2 used during 6-min walk L/min Collection Interval: Collected in Exam 1
74	Medication/supplement use	160267	phv00160267.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-16 17:01:35+00:00	2018-08-16 17:01:35+00:00 	O2use_sleep	Oxygen use: sleep Collection Interval: Collected in Exam 1
74	Medication/supplement use	160266	phv00160266.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-16 17:01:45+00:00	2018-08-16 17:01:45+00:00 	O2use_exercise	Oxygen use: exercise Collection Interval: Collected in Exam 1
74	Medication/supplement use	160265	phv00160265.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-16 17:01:52+00:00	2018-08-16 17:01:52+00:00 	O2use_rest	Oxygen use: at rest Collection Interval: Collected in Exam 1
74	Medication/supplement use	159588	phv00159588.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-16 17:01:59+00:00	2018-08-16 17:01:59+00:00 	O2_Years	How long have they used supplemental 02 [years] Collection Interval: Collected in Exam 1
74	Medication/supplement use	159586	phv00159586.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-16 17:02:07+00:00	2018-08-16 17:02:07+00:00 	O2_Therapy	Does subject use supplemental 02 therapy Collection Interval: Collected in Exam 1
74	Medication/supplement use	159585	phv00159585.v4.p2	pht002239.v4.p2	phs000179.v5.p2	COPDGene	179	5	2018-08-16 17:02:15+00:00	2018-08-16 17:02:15+00:00 	O2_Hours_Day	On typical 24-hour day how many hours supplemental 02 used [hours] Collection Interval: Collected in Exam 1
74	Medication/supplement use	122120	phv00122120.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:06:36+00:00	2018-08-16 23:06:36+00:00 	BPMED	Ever take blood pressure medicine (A)
74	Medication/supplement use	122121	phv00122121.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:06:48+00:00	2018-08-16 23:06:48+00:00 	BPMEDNOW	Still take blood pressure medicine (A)
74	Medication/supplement use	122122	phv00122122.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:07:00+00:00	2018-08-16 23:07:00+00:00 	ASTHPIL	Ever take breathing medicine (AC)
74	Medication/supplement use	122123	phv00122123.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:07:17+00:00	2018-08-16 23:07:17+00:00 	ASTPLNOW	Still take asthma spray
74	Medication/supplement use	122124	phv00122124.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:07:27+00:00	2018-08-16 23:07:27+00:00 	ASTHSPY	Ever take asthma spray (AC)
74	Medication/supplement use	122126	phv00122126.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:07:37+00:00	2018-08-16 23:07:37+00:00 	HRTPIL	Ever take heart pills (A)
74	Medication/supplement use	122127	phv00122127.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:07:46+00:00	2018-08-16 23:07:46+00:00 	HRTPLNOW	Still take heart pill (A)
74	Medication/supplement use	122128	phv00122128.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:07:57+00:00	2018-08-16 23:07:57+00:00 	H2OPIL	Ever take water pills (A)
74	Medication/supplement use	122129	phv00122129.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:08:09+00:00	2018-08-16 23:08:09+00:00 	H2OPLNOW	Still take water pill (A)
74	Medication/supplement use	122130	phv00122130.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:08:41+00:00	2018-08-16 23:08:41+00:00 	SLPPIL	Ever take sleeping pills (A)
74	Medication/supplement use	122131	phv00122131.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:08:47+00:00	2018-08-16 23:08:47+00:00 	SLPPLNOW	Still take sleeping pills (A)
74	Medication/supplement use	122132	phv00122132.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:08:54+00:00	2018-08-16 23:08:54+00:00 	NASDEC	Ever take antihistamine (AC)
74	Medication/supplement use	122133	phv00122133.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:09:00+00:00	2018-08-16 23:09:00+00:00 	NASDCNOW	Still take antihistamines (A)
74	Medication/supplement use	122134	phv00122134.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:09:07+00:00	2018-08-16 23:09:07+00:00 	THYRMED	Ever take thyroid medicine (AC)
74	Medication/supplement use	122135	phv00122135.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:09:14+00:00	2018-08-16 23:09:14+00:00 	THYRMNOW	Still take thyroid medicine (A)
74	Medication/supplement use	122136	phv00122136.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:09:20+00:00	2018-08-16 23:09:20+00:00 	TRANQUIL	Ever take tranquilizers (AC)
74	Medication/supplement use	122137	phv00122137.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:09:26+00:00	2018-08-16 23:09:26+00:00 	TRANQNOW	Still take tranquilizers (A)
74	Medication/supplement use	122138	phv00122138.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:09:33+00:00	2018-08-16 23:09:33+00:00 	PROG	Ever take progesterone/hormones etc (A)
74	Medication/supplement use	122139	phv00122139.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:09:39+00:00	2018-08-16 23:09:39+00:00 	PROGNOW	Still take progesterone/hormones etc (A)
74	Medication/supplement use	122394	phv00122394.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:42:56+00:00	2018-08-16 23:42:56+00:00 	CPAP	Recommended or prescribed CPAP (Continuous Positive Airway Pressure)
74	Medication/supplement use	122558	phv00122558.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:47:58+00:00	2018-08-16 23:47:58+00:00 	TYPETX	Type of sleep apnea treatment
74	Medication/supplement use	122559	phv00122559.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:48:28+00:00	2018-08-16 23:48:28+00:00 	TXOTHER	Other type of treatment for sleep apnea
74	Medication/supplement use	122626	phv00122626.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:52:34+00:00	2018-08-16 23:52:34+00:00 	MEDICN	Took medications on day of study (AC)
74	Medication/supplement use	122627	phv00122627.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:52:57+00:00	2018-08-16 23:52:57+00:00 	SEDATIVE	Took sedatives on day of study (AC)
74	Medication/supplement use	122628	phv00122628.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:53:05+00:00	2018-08-16 23:53:05+00:00 	STIMULAN	Took stimulants on day of study (AC)
74	Medication/supplement use	122629	phv00122629.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:53:11+00:00	2018-08-16 23:53:11+00:00 	ANTIHIST	Took antihistamines on day of study (AC)
74	Medication/supplement use	122630	phv00122630.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:53:18+00:00	2018-08-16 23:53:18+00:00 	BRONCHIO	Took bronchodilators on day of study (AC)
74	Medication/supplement use	122631	phv00122631.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:53:24+00:00	2018-08-16 23:53:24+00:00 	DIURETIC	Took diuretics on day of study (AC)
74	Medication/supplement use	122633	phv00122633.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:53:32+00:00	2018-08-16 23:53:32+00:00 	OTHER	List of other medications taken day of study
74	Medication/supplement use	122906	phv00122906.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:55:52+00:00	2018-08-16 23:55:52+00:00 	OTHER1	Meds: list of other medications taken day of study
74	Medication/supplement use	122907	phv00122907.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:55:58+00:00	2018-08-16 23:55:58+00:00 	OTHER2	Meds: list of other medications taken day of study
74	Medication/supplement use	122908	phv00122908.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:56:03+00:00	2018-08-16 23:56:03+00:00 	ACETAMIN	Meds: Acetaminophen
74	Medication/supplement use	122909	phv00122909.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:56:09+00:00	2018-08-16 23:56:09+00:00 	BABYASPR	Meds: Baby aspirin
74	Medication/supplement use	122910	phv00122910.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:56:15+00:00	2018-08-16 23:56:15+00:00 	IBUPROFE	Meds: Ibuprofen
74	Medication/supplement use	122911	phv00122911.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:56:21+00:00	2018-08-16 23:56:21+00:00 	ANTIINFL	Meds: Other anti-inflammatory analgesics, 2+ times/week
74	Medication/supplement use	122912	phv00122912.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:56:27+00:00	2018-08-16 23:56:27+00:00 	CELEVIOX	Meds: Celebrex or Vioxx
74	Medication/supplement use	122913	phv00122913.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:56:33+00:00	2018-08-16 23:56:33+00:00 	THIAZIDE	Meds: Thiazide diuretic
74	Medication/supplement use	122914	phv00122914.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:56:39+00:00	2018-08-16 23:56:39+00:00 	LASIX	Meds: Lasix
74	Medication/supplement use	122915	phv00122915.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:56:47+00:00	2018-08-16 23:56:47+00:00 	CALCBLOC	Meds: Calcium blocker
74	Medication/supplement use	122916	phv00122916.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:57:33+00:00	2018-08-16 23:57:33+00:00 	BETBLOC	Meds: Beta-blocker
74	Medication/supplement use	122917	phv00122917.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:57:41+00:00	2018-08-16 23:57:41+00:00 	ACEINHIB	Meds: ACE Inhibitors
74	Medication/supplement use	122918	phv00122918.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:57:46+00:00	2018-08-16 23:57:46+00:00 	ANTIHYPE	Meds: Other antihypertensive
74	Medication/supplement use	122919	phv00122919.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:57:52+00:00	2018-08-16 23:57:52+00:00 	ORALSTER	Meds: Steroids taken orally
74	Medication/supplement use	122920	phv00122920.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:57:58+00:00	2018-08-16 23:57:58+00:00 	INSTEROI	Meds: Inhaled steroids
74	Medication/supplement use	122921	phv00122921.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:58:05+00:00	2018-08-16 23:58:05+00:00 	INBRONCH	Meds: Inhaled bronchodilator
74	Medication/supplement use	122922	phv00122922.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:58:12+00:00	2018-08-16 23:58:12+00:00 	DIGOXIN	Meds: Digoxin
74	Medication/supplement use	122923	phv00122923.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:58:55+00:00	2018-08-16 23:58:55+00:00 	ANTIARRH	Meds: Antiarrhythmic
74	Medication/supplement use	122924	phv00122924.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:59:00+00:00	2018-08-16 23:59:00+00:00 	BLODTHIN	Meds: Coumadin (blood thinner)
74	Medication/supplement use	122925	phv00122925.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:59:07+00:00	2018-08-16 23:59:07+00:00 	CHOLLOWD	Meds: Cholesterol lowering drugs
74	Medication/supplement use	122926	phv00122926.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:59:13+00:00	2018-08-16 23:59:13+00:00 	CHOLYRS	Meds: If yes, Number of years used
74	Medication/supplement use	122927	phv00122927.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:59:19+00:00	2018-08-16 23:59:19+00:00 	OTHCHLDR	Meds: Other cholesterol lowering drug
74	Medication/supplement use	122928	phv00122928.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:59:26+00:00	2018-08-16 23:59:26+00:00 	CIMETIDI	Meds: Cimetidine
74	Medication/supplement use	122929	phv00122929.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:59:32+00:00	2018-08-16 23:59:32+00:00 	H2BLOC	Meds: Other H2 Blocker
74	Medication/supplement use	122930	phv00122930.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:59:42+00:00	2018-08-16 23:59:42+00:00 	PRILPREV	Meds: Prilosec or Prevacid
74	Medication/supplement use	122931	phv00122931.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-16 23:59:49+00:00	2018-08-16 23:59:49+00:00 	INSULIN	Meds: Insulin
74	Medication/supplement use	122932	phv00122932.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:01:10+00:00	2018-08-17 00:01:10+00:00 	ORALGLUC	Meds: Oral Hypoglycemic
74	Medication/supplement use	122933	phv00122933.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:01:18+00:00	2018-08-17 00:01:18+00:00 	ANTIDEPR	Meds: Anti depressant
74	Medication/supplement use	122934	phv00122934.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:01:25+00:00	2018-08-17 00:01:25+00:00 	PROZAC	Meds: Prozac
74	Medication/supplement use	122935	phv00122935.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:01:33+00:00	2018-08-17 00:01:33+00:00 	ZOLOFT	Meds: Zoloft
74	Medication/supplement use	122936	phv00122936.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:01:40+00:00	2018-08-17 00:01:40+00:00 	PAXIL	Meds: Paxil
74	Medication/supplement use	122937	phv00122937.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:01:48+00:00	2018-08-17 00:01:48+00:00 	CELEXA	Meds: Celexa
74	Medication/supplement use	122938	phv00122938.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:01:56+00:00	2018-08-17 00:01:56+00:00 	OTHANTID	Meds:  Other antidepressants
74	Medication/supplement use	122939	phv00122939.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:02:03+00:00	2018-08-17 00:02:03+00:00 	TQUILIZE	Meds: Tranquilizers
74	Medication/supplement use	122940	phv00122940.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:02:11+00:00	2018-08-17 00:02:11+00:00 	MERIDIA	Meds: Meridia
74	Medication/supplement use	122941	phv00122941.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:02:18+00:00	2018-08-17 00:02:18+00:00 	PHENTERM	Meds: Phentermine
74	Medication/supplement use	122942	phv00122942.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:02:56+00:00	2018-08-17 00:02:56+00:00 	XENICAL	Meds: Xenical
74	Medication/supplement use	122943	phv00122943.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:03:03+00:00	2018-08-17 00:03:03+00:00 	THRYD	Meds: Thyroid
74	Medication/supplement use	122944	phv00122944.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:03:10+00:00	2018-08-17 00:03:10+00:00 	DEMENTIA	Meds: Dementia
74	Medication/supplement use	122945	phv00122945.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:03:17+00:00	2018-08-17 00:03:17+00:00 	SLEEPMED	Meds: Sleeping medicine
74	Medication/supplement use	122946	phv00122946.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:03:24+00:00	2018-08-17 00:03:24+00:00 	ANTIHIS	Meds: Antihistamine
74	Medication/supplement use	122947	phv00122947.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:03:31+00:00	2018-08-17 00:03:31+00:00 	NITRATES	Meds: Nitrates
74	Medication/supplement use	122948	phv00122948.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:03:38+00:00	2018-08-17 00:03:38+00:00 	NITROGLY	Meds: Nitroglycerin
74	Medication/supplement use	122949	phv00122949.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:03:46+00:00	2018-08-17 00:03:46+00:00 	THEOPHYL	Meds: Theophylline
74	Medication/supplement use	122950	phv00122950.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:03:53+00:00	2018-08-17 00:03:53+00:00 	ADHDMED	Meds: ADHD (Adderall, Ritalin, Stratera)
74	Medication/supplement use	122951	phv00122951.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:04:01+00:00	2018-08-17 00:04:01+00:00 	REGMEDOT	Meds: Other regular medicine
74	Medication/supplement use	122952	phv00122952.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:04:38+00:00	2018-08-17 00:04:38+00:00 	OTHREG1	Meds: specify other medication (1)
74	Medication/supplement use	122953	phv00122953.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:04:48+00:00	2018-08-17 00:04:48+00:00 	OTHREG2	Meds: specify other medication (2)
74	Medication/supplement use	122954	phv00122954.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:04:56+00:00	2018-08-17 00:04:56+00:00 	OTHREG3	Meds: specify other medication (3)
74	Medication/supplement use	122955	phv00122955.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:05:02+00:00	2018-08-17 00:05:02+00:00 	OTHREG4	Meds: specify other medication (4)
74	Medication/supplement use	122956	phv00122956.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:05:08+00:00	2018-08-17 00:05:08+00:00 	MULTIVIT	Meds: Do you currently take a multi-vitamin?
74	Medication/supplement use	122957	phv00122957.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:05:15+00:00	2018-08-17 00:05:15+00:00 	PSYCHO	Meds: Anti-psychotic medicines (Serex, Lithium, Sericol)
74	Medication/supplement use	122958	phv00122958.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:05:22+00:00	2018-08-17 00:05:22+00:00 	ALLOPURI	Meds: Allopurinol (Zyloprin)
74	Medication/supplement use	122959	phv00122959.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:05:29+00:00	2018-08-17 00:05:29+00:00 	BCONTROL	Meds: Birth Control
74	Medication/supplement use	122960	phv00122960.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:05:36+00:00	2018-08-17 00:05:36+00:00 	PREMARIN	Meds: Premarin
74	Medication/supplement use	122961	phv00122961.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:05:42+00:00	2018-08-17 00:05:42+00:00 	PREMPRO	Meds: Prempro
74	Medication/supplement use	122962	phv00122962.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:06:00+00:00	2018-08-17 00:06:00+00:00 	ESTRACE	Meds: Estrace
74	Medication/supplement use	122963	phv00122963.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:06:06+00:00	2018-08-17 00:06:06+00:00 	ESTRATE	Meds: Estratest
74	Medication/supplement use	122964	phv00122964.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:06:12+00:00	2018-08-17 00:06:12+00:00 	OTHHPILL	Meds: Other hormones or birth control pills?
74	Medication/supplement use	122965	phv00122965.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 00:06:19+00:00	2018-08-17 00:06:19+00:00 	OTHPILSP	Meds: specify other hormones or birth control pills
74	Medication/supplement use	113017	phv00113017.v2.p2	pht001569.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:15:05+00:00	2018-08-17 18:15:05+00:00 	A08OTMED	TAKING ANY OTHER PRESCRIPTION DRUGS
74	Medication/supplement use	113016	phv00113016.v2.p2	pht001569.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:15:13+00:00	2018-08-17 18:15:13+00:00 	A08ASMA	TAKE MEDICINE FOR ASTHMA
74	Medication/supplement use	113015	phv00113015.v2.p2	pht001569.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:15:20+00:00	2018-08-17 18:15:20+00:00 	A08HORMN	EVER TAKEN HORMONES, EXCLUDING BC
74	Medication/supplement use	113014	phv00113014.v2.p2	pht001569.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:15:29+00:00	2018-08-17 18:15:29+00:00 	A08BRTHC	EVER TAKEN BIRTH CONTROL PILLS
74	Medication/supplement use	113013	phv00113013.v2.p2	pht001569.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:15:36+00:00	2018-08-17 18:15:36+00:00 	A08HRMED	EVER TAKEN MEDS FOR A HEART CONDITION
74	Medication/supplement use	113012	phv00113012.v2.p2	pht001569.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:15:43+00:00	2018-08-17 18:15:43+00:00 	A08BPMED	EVER TAKEN MEDS FOR HIGH BLOOD PRESSURE
74	Medication/supplement use	113154	phv00113154.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:24:07+00:00	2018-08-17 18:24:07+00:00 	A09MDTYP	MEDIC'N FOLL'UP PAGE NAME (MED TYPE)
74	Medication/supplement use	113155	phv00113155.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:25:39+00:00	2018-08-17 18:25:39+00:00 	A09MDNOW	TAKING MED NOW?
74	Medication/supplement use	113157	phv00113157.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:25:51+00:00	2018-08-17 18:25:51+00:00 	A09MDNM	NAME OF MEDICATION
74	Medication/supplement use	113161	phv00113161.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:34:25+00:00	2018-08-17 18:34:25+00:00 	A09MDCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	113160	phv00113160.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:34:31+00:00	2018-08-17 18:34:31+00:00 	A09MDCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	113159	phv00113159.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:34:38+00:00	2018-08-17 18:34:38+00:00 	A09MDCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	113158	phv00113158.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:34:46+00:00	2018-08-17 18:34:46+00:00 	A09MDCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	113166	phv00113166.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:35:15+00:00	2018-08-17 18:35:15+00:00 	A09MDTUS	TOTAL TIME USED MEDICATION, MONTHS
74	Medication/supplement use	113165	phv00113165.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:35:22+00:00	2018-08-17 18:35:22+00:00 	A09MDRSN	REASON FOR USE (ASTH & OTHER MEDS ONLY)
74	Medication/supplement use	113164	phv00113164.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:35:28+00:00	2018-08-17 18:35:28+00:00 	A09MDTMO	MONTHS USED MEDICATION
74	Medication/supplement use	113163	phv00113163.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:35:36+00:00	2018-08-17 18:35:36+00:00 	A09MDTYR	YEARS USED MEDICATION
74	Medication/supplement use	113162	phv00113162.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 18:35:43+00:00	2018-08-17 18:35:43+00:00 	A09MDLUS	TIME SINCE LAST USED MEDICATION
74	Medication/supplement use	123028	phv00123028.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:56:35+00:00	2018-08-17 19:56:35+00:00 	bpmedx	Meds: Self-report of BP medication use or on specified BP medication
74	Medication/supplement use	123030	phv00123030.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:56:44+00:00	2018-08-17 19:56:44+00:00 	statins	Meds: Use of cholesterol lowering drugs (chollowd, othchldr)
74	Medication/supplement use	123031	phv00123031.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:56:51+00:00	2018-08-17 19:56:51+00:00 	aspirintherapy	Meds: aspirin 4-7 days/wk
74	Medication/supplement use	123032	phv00123032.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:56:58+00:00	2018-08-17 19:56:58+00:00 	inflmed	Meds: anti-inflammatory meds (ibubrofen, celebrex, oral steroids)
74	Medication/supplement use	123033	phv00123033.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:57:06+00:00	2018-08-17 19:57:06+00:00 	othregmd	Specify other regular medicine
74	Medication/supplement use	123034	phv00123034.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:57:13+00:00	2018-08-17 19:57:13+00:00 	psychmeds	Meds: Anit-depressant or anti-anxiety medications
74	Medication/supplement use	123035	phv00123035.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:57:20+00:00	2018-08-17 19:57:20+00:00 	hrtx	Meds: Hormone Replacement Therapy
74	Medication/supplement use	123036	phv00123036.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:57:51+00:00	2018-08-17 19:57:51+00:00 	prescpap	Ever prescribed CPAP
74	Medication/supplement use	123037	phv00123037.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 19:57:58+00:00	2018-08-17 19:57:58+00:00 	regcpap	Current regular use of CPAP (at least 50% of time)
74	Medication/supplement use	123157	phv00123157.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:05:25+00:00	2018-08-17 20:05:25+00:00 	BPMEDYR	73 Blood pressure medicine in last year (L)
74	Medication/supplement use	123158	phv00123158.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:05:31+00:00	2018-08-17 20:05:31+00:00 	BPMED3DY	73 Blood pressure meds in last 3 days (L)
74	Medication/supplement use	123159	phv00123159.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:05:37+00:00	2018-08-17 20:05:37+00:00 	ASTHPLYR	73 Breathing pills in last yr (L)
74	Medication/supplement use	123160	phv00123160.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:05:44+00:00	2018-08-17 20:05:44+00:00 	ASTPL3DY	73 Breathing pills in last 3 days (L)
74	Medication/supplement use	123161	phv00123161.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:05:50+00:00	2018-08-17 20:05:50+00:00 	ASTHSPYR	73 Breathing sprays in last yr (L)
74	Medication/supplement use	123162	phv00123162.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:06:29+00:00	2018-08-17 20:06:29+00:00 	ASTSP3DY	73 Breathing spray in last 3 days (L)
74	Medication/supplement use	123163	phv00123163.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:06:36+00:00	2018-08-17 20:06:36+00:00 	HRTPLYR	73 Heart pills in last yr (L)
74	Medication/supplement use	123164	phv00123164.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:06:42+00:00	2018-08-17 20:06:42+00:00 	HRTPL3DY	73 Heart pills in last 3 days (L)
74	Medication/supplement use	123165	phv00123165.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:13:33+00:00	2018-08-17 20:13:33+00:00 	H2OPILYR	73 Water pills in last yr (L)
74	Medication/supplement use	123166	phv00123166.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:13:38+00:00	2018-08-17 20:13:38+00:00 	H2OPL3DY	73 Water pills in last 3 days (L)
74	Medication/supplement use	123167	phv00123167.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:13:44+00:00	2018-08-17 20:13:44+00:00 	SLPPILYR	73 Sleeping pills in last yr (L)
74	Medication/supplement use	123168	phv00123168.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:13:51+00:00	2018-08-17 20:13:51+00:00 	SLPPL3DY	73 Sleep pills in last 3 days (L)
74	Medication/supplement use	123169	phv00123169.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:14:01+00:00	2018-08-17 20:14:01+00:00 	NASDECYR	73 Antihistamines in last yr (L)
74	Medication/supplement use	123170	phv00123170.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:14:08+00:00	2018-08-17 20:14:08+00:00 	NASDC3DY	73 Antihistamines in last 3 days (L)
74	Medication/supplement use	123171	phv00123171.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 20:14:15+00:00	2018-08-17 20:14:15+00:00 	THYRMDYR	73 Thyroid medicines in last yr (L)
74	Medication/supplement use	113670	phv00113670.v2.p2	pht001584.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:05:35+00:00	2018-08-17 21:05:35+00:00 	A21MED	PT USES CARDIOVASCULAR MEDICATIONS. Q 6
74	Medication/supplement use	123172	phv00123172.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:42:43+00:00	2018-08-17 21:42:43+00:00 	THYRM3DY	73 Thyroid meds in last 3 days (L)
74	Medication/supplement use	123173	phv00123173.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:42:49+00:00	2018-08-17 21:42:49+00:00 	TRANQUYR	73 Tranquilizers  in last yr (L)
74	Medication/supplement use	123174	phv00123174.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:42:56+00:00	2018-08-17 21:42:56+00:00 	TRANQ3DY	73 Tranquilizers in last 3 days (L)
74	Medication/supplement use	123175	phv00123175.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:44:46+00:00	2018-08-17 21:44:46+00:00 	PROGYR	73 Progesterone  in last yr (L)
74	Medication/supplement use	123176	phv00123176.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:44:51+00:00	2018-08-17 21:44:51+00:00 	PROG3DY	73 Progesterone in last 3 days (L)
74	Medication/supplement use	123177	phv00123177.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:44:57+00:00	2018-08-17 21:44:57+00:00 	STIMYR	73 Stimulants  in last yr (L)
74	Medication/supplement use	123178	phv00123178.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:45:03+00:00	2018-08-17 21:45:03+00:00 	STIM3DY	73 Stimulants in last 3 days (L)
74	Medication/supplement use	123179	phv00123179.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:45:08+00:00	2018-08-17 21:45:08+00:00 	ACETAMON	74 Last month have you used acetaminophen
74	Medication/supplement use	123180	phv00123180.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:45:14+00:00	2018-08-17 21:45:14+00:00 	ACETADAY	74 How many days per week do you take acetaminophen
74	Medication/supplement use	123181	phv00123181.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:45:20+00:00	2018-08-17 21:45:20+00:00 	ACETAMNO	74 On average, how many tablets acetaminophen taken
74	Medication/supplement use	123182	phv00123182.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:45:52+00:00	2018-08-17 21:45:52+00:00 	BABYAMON	74 Last month have you taken baby aspirin
74	Medication/supplement use	123183	phv00123183.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:45:59+00:00	2018-08-17 21:45:59+00:00 	BABYADAY	74 How many days per week taken baby aspirin
74	Medication/supplement use	123184	phv00123184.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:46:05+00:00	2018-08-17 21:46:05+00:00 	BABYASNO	74 On average how many baby aspirin taken
74	Medication/supplement use	123185	phv00123185.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:46:12+00:00	2018-08-17 21:46:12+00:00 	ASPIRMON	74 Last month have you used aspirin
74	Medication/supplement use	123186	phv00123186.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:46:18+00:00	2018-08-17 21:46:18+00:00 	ASPIRDAY	74 How many days per week do you take aspirin
74	Medication/supplement use	123187	phv00123187.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:46:23+00:00	2018-08-17 21:46:23+00:00 	ASPRINNO	74 On average how many aspirin taken
74	Medication/supplement use	123188	phv00123188.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:46:29+00:00	2018-08-17 21:46:29+00:00 	IBUPRMON	74 Last month have you used ibuprofen
74	Medication/supplement use	123189	phv00123189.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:46:35+00:00	2018-08-17 21:46:35+00:00 	IBUPRDAY	74 Days per week ibuprofen taken
74	Medication/supplement use	123190	phv00123190.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:46:41+00:00	2018-08-17 21:46:41+00:00 	IBUPRONO	74 On average how many ibuprofen taken
74	Medication/supplement use	123191	phv00123191.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:46:46+00:00	2018-08-17 21:46:46+00:00 	NOMULVIT	74 How many multi-vitamins do you take per week?
74	Medication/supplement use	123192	phv00123192.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:47:07+00:00	2018-08-17 21:47:07+00:00 	ALLBEEC	74 Mult Vit: Allbee + C
74	Medication/supplement use	123193	phv00123193.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:47:13+00:00	2018-08-17 21:47:13+00:00 	CENTSENT	74 Mult Vit: Centrum, Century, Sentury
74	Medication/supplement use	123194	phv00123194.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:47:19+00:00	2018-08-17 21:47:19+00:00 	ONEADAYE	74 Mult Vit: One A Day Essential
74	Medication/supplement use	123195	phv00123195.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:47:24+00:00	2018-08-17 21:47:24+00:00 	THERAGRM	74 Mult Vit: Theragran
74	Medication/supplement use	123196	phv00123196.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:47:33+00:00	2018-08-17 21:47:33+00:00 	CALIT600	74 Mult Vit: Calitrate 600
74	Medication/supplement use	123197	phv00123197.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:47:38+00:00	2018-08-17 21:47:38+00:00 	CENTSILV	74 Mult Vit: Centrum Silver
74	Medication/supplement use	123198	phv00123198.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:47:44+00:00	2018-08-17 21:47:44+00:00 	ONEADAYM	74 Mult Vit: One A Day Maximum
74	Medication/supplement use	123199	phv00123199.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:47:49+00:00	2018-08-17 21:47:49+00:00 	THERAGMM	74 Mult Vit: Theragram M
74	Medication/supplement use	123200	phv00123200.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:47:55+00:00	2018-08-17 21:47:55+00:00 	CVSDAILY	74 Mult Vit: VS Daily
74	Medication/supplement use	123201	phv00123201.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:48:01+00:00	2018-08-17 21:48:01+00:00 	FORNU100	74 Mult Vit: Formula 100, Nutri-100
74	Medication/supplement use	123202	phv00123202.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:48:42+00:00	2018-08-17 21:48:42+00:00 	ONEADAYW	74 Mult Vit: One A Day Womens
74	Medication/supplement use	123203	phv00123203.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:48:47+00:00	2018-08-17 21:48:47+00:00 	UNICAP	74 Mult Vit: Unicap
74	Medication/supplement use	123204	phv00123204.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:48:54+00:00	2018-08-17 21:48:54+00:00 	CVSMINER	74 Mult Vit: CVS Daily w Minerals
74	Medication/supplement use	123205	phv00123205.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:48:59+00:00	2018-08-17 21:48:59+00:00 	HEALTPAC	74 Mult Vit: Health Balance Daily Pack
74	Medication/supplement use	123206	phv00123206.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:49:04+00:00	2018-08-17 21:49:04+00:00 	PROTEGRA	74 Mult Vit: Protegra
74	Medication/supplement use	123207	phv00123207.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:49:09+00:00	2018-08-17 21:49:09+00:00 	UNICAPM	74 Mult Vit: Unicap-M
74	Medication/supplement use	123208	phv00123208.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:49:14+00:00	2018-08-17 21:49:14+00:00 	CVSPROVI	74 Mult Vit: CVS Pro-Vite
74	Medication/supplement use	123209	phv00123209.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:49:19+00:00	2018-08-17 21:49:19+00:00 	HDFORWPL	74 Mult Vit: Healthy Direction Forward Plus
74	Medication/supplement use	123210	phv00123210.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:49:25+00:00	2018-08-17 21:49:25+00:00 	SHAKLEE	74 Mult Vit: Shaklee Vita-Lea
74	Medication/supplement use	123211	phv00123211.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:49:31+00:00	2018-08-17 21:49:31+00:00 	UNICAPSR	74 Mult Vit: Unicap Senior
74	Medication/supplement use	123229	phv00123229.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:50:05+00:00	2018-08-17 21:50:05+00:00 	FOLDOSDY	74 Folic acid dose per day
74	Medication/supplement use	123228	phv00123228.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:50:11+00:00	2018-08-17 21:50:11+00:00 	FOLICACD	74 Do you take Folic Acid?
74	Medication/supplement use	123227	phv00123227.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:50:17+00:00	2018-08-17 21:50:17+00:00 	YOUVITIR	74 Does your multivitamin include iron?
74	Medication/supplement use	123226	phv00123226.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:50:23+00:00	2018-08-17 21:50:23+00:00 	YOURVITA	74 Mult Vit: specify
74	Medication/supplement use	123225	phv00123225.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:50:28+00:00	2018-08-17 21:50:28+00:00 	ONEDAYAP	74 Mult Vit: One A Day Antioxidant Plus
74	Medication/supplement use	123224	phv00123224.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:50:34+00:00	2018-08-17 21:50:34+00:00 	CENTVITS	74 Mult Vit: Central Vite Select
74	Medication/supplement use	123223	phv00123223.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:50:41+00:00	2018-08-17 21:50:41+00:00 	OCUVITPL	74 Mult Vit: Ocuvite Plus
74	Medication/supplement use	123222	phv00123222.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:50:46+00:00	2018-08-17 21:50:46+00:00 	ZBEC	74 Mult Vit: Z-Bec
74	Medication/supplement use	123221	phv00123221.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:50:51+00:00	2018-08-17 21:50:51+00:00 	SURBEXT	74 Mult Vit: Surbex T
74	Medication/supplement use	123220	phv00123220.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:50:56+00:00	2018-08-17 21:50:56+00:00 	CENVITPL	74 Mult Vit: Central Vite Plus
74	Medication/supplement use	123219	phv00123219.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:51:01+00:00	2018-08-17 21:51:01+00:00 	OCUVITE	74 Mult Vit: Ocuvite
74	Medication/supplement use	123218	phv00123218.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:51:06+00:00	2018-08-17 21:51:06+00:00 	STRESSTB	74 Mult Vit: Stresstabs
74	Medication/supplement use	123217	phv00123217.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:51:11+00:00	2018-08-17 21:51:11+00:00 	WOMPOWPK	74 Mult Vit: Women Power Pack
74	Medication/supplement use	123216	phv00123216.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:51:17+00:00	2018-08-17 21:51:17+00:00 	CENTRALV	74 Mult Vit: Central Vite
74	Medication/supplement use	123215	phv00123215.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:51:29+00:00	2018-08-17 21:51:29+00:00 	VIMIN75	74 Mult Vit: VI-MIN 75
74	Medication/supplement use	123214	phv00123214.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:51:34+00:00	2018-08-17 21:51:34+00:00 	SOLOTRON	74 Mult Vit: Solotron for Women
74	Medication/supplement use	123213	phv00123213.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:51:39+00:00	2018-08-17 21:51:39+00:00 	NUSKINPK	74 Mult Vit: Nuskin Life Pack
74	Medication/supplement use	123212	phv00123212.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:51:45+00:00	2018-08-17 21:51:45+00:00 	CVSMEGML	74 Mult Vit: CVS Mega Multi
74	Medication/supplement use	114365	phv00114365.v2.p2	pht001601.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:52:19+00:00	2018-08-17 21:52:19+00:00 	B08OTMED	TAKING OTHER PRESCRIPTION DRUGS. Q 6
74	Medication/supplement use	114364	phv00114364.v2.p2	pht001601.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:52:25+00:00	2018-08-17 21:52:25+00:00 	B08ASMA	TAKE MEDICINE FOR ASTHMA. Q 6
74	Medication/supplement use	114363	phv00114363.v2.p2	pht001601.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:52:33+00:00	2018-08-17 21:52:33+00:00 	B08HORMN	EVER TAKEN HORMONES EXCLUDING BCP? Q 6
74	Medication/supplement use	114362	phv00114362.v2.p2	pht001601.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:52:40+00:00	2018-08-17 21:52:40+00:00 	B08BRTHC	EVER TAKEN BC PILLS?
74	Medication/supplement use	114361	phv00114361.v2.p2	pht001601.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:52:47+00:00	2018-08-17 21:52:47+00:00 	B08HRMED	EVER TAKEN MEDS FOR HEART. Q 6
74	Medication/supplement use	114360	phv00114360.v2.p2	pht001601.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-17 21:52:55+00:00	2018-08-17 21:52:55+00:00 	B08BPMED	EVER TAKEN MEDS FOR HBP. Q 6
74	Medication/supplement use	123241	phv00123241.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:58:18+00:00	2018-08-17 21:58:18+00:00 	HORMONES	76 Ever use prescription female hormones?
74	Medication/supplement use	123243	phv00123243.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:58:23+00:00	2018-08-17 21:58:23+00:00 	PATCHEST	76 Ever use -  patch estrogen
74	Medication/supplement use	123244	phv00123244.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:58:28+00:00	2018-08-17 21:58:28+00:00 	VAGESTRO	76 Ever use -  vaginal estrogen
74	Medication/supplement use	123245	phv00123245.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:58:34+00:00	2018-08-17 21:58:34+00:00 	OGEN	76 Ever use -  Ogen
74	Medication/supplement use	123246	phv00123246.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:58:40+00:00	2018-08-17 21:58:40+00:00 	OTHESTRO	76 Ever use -  Other Estrogen
74	Medication/supplement use	123247	phv00123247.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:58:46+00:00	2018-08-17 21:58:46+00:00 	SPECEST	76 Ever use -  Specify hormone
74	Medication/supplement use	123248	phv00123248.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:58:51+00:00	2018-08-17 21:58:51+00:00 	PROCYCMP	76 Ever use -  Provera/Cycrin/MPA
74	Medication/supplement use	123249	phv00123249.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:58:57+00:00	2018-08-17 21:58:57+00:00 	VAGINAL	76 Ever use -  Vaginal
74	Medication/supplement use	123250	phv00123250.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:59:10+00:00	2018-08-17 21:59:10+00:00 	MICRONIZ	76 Ever use -  Micronized (e.g. Prometrium)
74	Medication/supplement use	123251	phv00123251.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:59:15+00:00	2018-08-17 21:59:15+00:00 	OTHPROG	76 Ever use -  Other Progesterone
74	Medication/supplement use	123252	phv00123252.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:59:20+00:00	2018-08-17 21:59:20+00:00 	SPECPROG	76 Ever use -  specify progesterone
74	Medication/supplement use	123253	phv00123253.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:59:26+00:00	2018-08-17 21:59:26+00:00 	PREMPROP	76 Ever use -  Prempro (pink)
74	Medication/supplement use	123254	phv00123254.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:59:30+00:00	2018-08-17 21:59:30+00:00 	PREMPROB	76 Ever use -  Prempro (blue)
74	Medication/supplement use	123255	phv00123255.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:59:35+00:00	2018-08-17 21:59:35+00:00 	PREMPHAS	76 Ever use -  Premphase
74	Medication/supplement use	123256	phv00123256.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:59:41+00:00	2018-08-17 21:59:41+00:00 	COMBIPAT	76 Ever use -  Combipatch
74	Medication/supplement use	123257	phv00123257.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-17 21:59:46+00:00	2018-08-17 21:59:46+00:00 	FEMHRT	76 Ever use -  FemHRT
74	Medication/supplement use	123811	phv00123811.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:56:08+00:00	2018-08-21 17:56:08+00:00 	LANYMED	PreSleep: Have you taken any medication today?
74	Medication/supplement use	123812	phv00123812.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:56:12+00:00	2018-08-21 17:56:12+00:00 	LSEDS	PreSleep: Sedatives today?
74	Medication/supplement use	123813	phv00123813.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:56:17+00:00	2018-08-21 17:56:17+00:00 	LSTIM	PreSleep: Stimulants today?
74	Medication/supplement use	123814	phv00123814.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:56:21+00:00	2018-08-21 17:56:21+00:00 	LANTI	PreSleep: Antihistamines today?
74	Medication/supplement use	123815	phv00123815.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:56:26+00:00	2018-08-21 17:56:26+00:00 	LBRON	PreSleep: Bronchodilators today?
74	Medication/supplement use	123816	phv00123816.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:56:30+00:00	2018-08-21 17:56:30+00:00 	LSPLPIL	PreSleep: Sleeping Pill today?
74	Medication/supplement use	123817	phv00123817.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:56:35+00:00	2018-08-21 17:56:35+00:00 	LDECON	PreSleep: Decongestant today?
74	Medication/supplement use	123818	phv00123818.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:56:39+00:00	2018-08-21 17:56:39+00:00 	LABOTHMD	PreSleep: Other medication(s) today?
74	Medication/supplement use	123819	phv00123819.v1.p1	pht001902.v1.p1	phs000284.v1.p1	Cleveland Family Study	284	1	2018-08-21 17:56:45+00:00	2018-08-21 17:56:45+00:00 	LOMED	PreSleep: Specify other medication(s) today
74	Medication/supplement use	226253	phv00226253.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:09:18+00:00	2018-08-22 21:09:18+00:00 	ASTHMA_MEDS	Asthma Med Use - self/scanned (current asthma by MD diagnosis)
74	Medication/supplement use	226260	phv00226260.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:20:57+00:00	2018-08-22 21:20:57+00:00 	COPD_MEDS	COPD Med Use - self/scanned (ever COPD by MD diagnosis)
74	Medication/supplement use	114452	phv00114452.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:28:48+00:00	2018-08-22 21:28:48+00:00 	B09BCCD3	MED CLASSIFICATION CODE 3 OF 3
74	Medication/supplement use	114451	phv00114451.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:29:05+00:00	2018-08-22 21:29:05+00:00 	B09BCCD2	MED CLASSIFICATION CODE 2 OF 3
74	Medication/supplement use	114450	phv00114450.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:29:20+00:00	2018-08-22 21:29:20+00:00 	B09BCCD1	MED CLASSIFICATION CODE 1 OF 3
74	Medication/supplement use	114449	phv00114449.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:29:40+00:00	2018-08-22 21:29:40+00:00 	B09BCN	BRAND OF BIRTH CONTROL PILL
74	Medication/supplement use	114448	phv00114448.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:29:56+00:00	2018-08-22 21:29:56+00:00 	B09ST_DT	DATE LAST STOPPED BCP'S
74	Medication/supplement use	114458	phv00114458.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:32:17+00:00	2018-08-22 21:32:17+00:00 	B09BCTMO	DURATION OF BCP USE, MONTHS
74	Medication/supplement use	114457	phv00114457.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:32:42+00:00	2018-08-22 21:32:42+00:00 	B09BCTYR	DURATION OF BCP USE, YEARS
74	Medication/supplement use	114456	phv00114456.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:33:01+00:00	2018-08-22 21:33:01+00:00 	B09BCTM1	DURATION OF BCP USE: EX-USERS, MONTHS
74	Medication/supplement use	114455	phv00114455.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:33:16+00:00	2018-08-22 21:33:16+00:00 	B09BCTY1	DURATION OF BCP USE: EX-USERS, YEARS
74	Medication/supplement use	114454	phv00114454.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:33:52+00:00	2018-08-22 21:33:52+00:00 	B09BCXD	DATE LAST STOPPED BCP'S EXACT/APPX?
74	Medication/supplement use	114453	phv00114453.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:34:20+00:00	2018-08-22 21:34:20+00:00 	B09BCNOW	TAKING BCP MED NOW?
74	Medication/supplement use	114460	phv00114460.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:34:46+00:00	2018-08-22 21:34:46+00:00 	B09BCCUS	DURATION OF BCP USE, SINCE LAST STARTED
74	Medication/supplement use	114459	phv00114459.v2.p2	pht001611.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:36:57+00:00	2018-08-22 21:36:57+00:00 	B09BCTUS	B09BCTUS
74	Medication/supplement use	114464	phv00114464.v2.p2	pht001612.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:39:40+00:00	2018-08-22 21:39:40+00:00 	B09HBNM	NAME OF HBP MED
74	Medication/supplement use	114462	phv00114462.v2.p2	pht001612.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:40:46+00:00	2018-08-22 21:40:46+00:00 	B09HBTUS	TOTAL DURATION, HBP MED USE, MONTHS
74	Medication/supplement use	114468	phv00114468.v2.p2	pht001612.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:40:59+00:00	2018-08-22 21:40:59+00:00 	B09HBCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	114467	phv00114467.v2.p2	pht001612.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:41:10+00:00	2018-08-22 21:41:10+00:00 	B09HBCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	114466	phv00114466.v2.p2	pht001612.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:41:28+00:00	2018-08-22 21:41:28+00:00 	B09HBCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	114465	phv00114465.v2.p2	pht001612.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:41:44+00:00	2018-08-22 21:41:44+00:00 	B09HBCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	114463	phv00114463.v2.p2	pht001612.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:42:15+00:00	2018-08-22 21:42:15+00:00 	B09HBNUM	MEDICATION NUMBER: HBP MED
74	Medication/supplement use	114472	phv00114472.v2.p2	pht001612.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:43:25+00:00	2018-08-22 21:43:25+00:00 	B09HBTMO	DURATION OF HBP MED USE: MONTHS
74	Medication/supplement use	114471	phv00114471.v2.p2	pht001612.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:44:00+00:00	2018-08-22 21:44:00+00:00 	B09HBTYR	DURATION OF HBP MED USE: YEARS
74	Medication/supplement use	114470	phv00114470.v2.p2	pht001612.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:44:15+00:00	2018-08-22 21:44:15+00:00 	B09HBLUS	TIME SINCE LAST USED HBP MED
74	Medication/supplement use	114469	phv00114469.v2.p2	pht001612.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:44:27+00:00	2018-08-22 21:44:27+00:00 	B09HBNOW	TAKING HBP MED NOW?
74	Medication/supplement use	113156	phv00113156.v2.p2	pht001571.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:50:54+00:00	2018-08-22 21:50:54+00:00 	A09MDNBR	SEQUENCE NR FOR THIS MED TYPE
74	Medication/supplement use	226313	phv00226313.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:53:01+00:00	2018-08-22 21:53:01+00:00 	MED_ANTIANGINAL	Antianginals
74	Medication/supplement use	226314	phv00226314.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:53:18+00:00	2018-08-22 21:53:18+00:00 	MED_ANTIANXI	Antianxiety agents
74	Medication/supplement use	226315	phv00226315.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:53:26+00:00	2018-08-22 21:53:26+00:00 	MED_ANTIARRHYTHMICS	Antiarrhythmics
74	Medication/supplement use	226316	phv00226316.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:53:33+00:00	2018-08-22 21:53:33+00:00 	MED_ANTIASTHMATICS	Antiasthmatic or bronchodilator agents
74	Medication/supplement use	114480	phv00114480.v2.p2	pht001613.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:53:35+00:00	2018-08-22 21:53:35+00:00 	B09HMCD4	MED CLASSIFICATION CODE 4 OF 4. Q 4.03A
74	Medication/supplement use	226317	phv00226317.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:53:41+00:00	2018-08-22 21:53:41+00:00 	MED_ANTICOAG	Anticoagulants
74	Medication/supplement use	114479	phv00114479.v2.p2	pht001613.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:53:47+00:00	2018-08-22 21:53:47+00:00 	B09HMCD3	MED CLASSIFICATION CODE 3 OF 4. Q 4.03A
74	Medication/supplement use	226318	phv00226318.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:53:49+00:00	2018-08-22 21:53:49+00:00 	MED_ANTICOAG_COUMARIN	Coumarin anticoagulants
74	Medication/supplement use	114478	phv00114478.v2.p2	pht001613.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:53:58+00:00	2018-08-22 21:53:58+00:00 	B09HMCD2	MED CLASSIFICATION CODE 2 OF 4. Q 4.03A
74	Medication/supplement use	226319	phv00226319.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:53:58+00:00	2018-08-22 21:53:58+00:00 	MED_ANTICOAG_HEPARIN	Heparin anticoagulants
74	Medication/supplement use	226320	phv00226320.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:54:08+00:00	2018-08-22 21:54:08+00:00 	MED_ANTIDEPRESS	Antidepressants
74	Medication/supplement use	114477	phv00114477.v2.p2	pht001613.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:54:10+00:00	2018-08-22 21:54:10+00:00 	B09HMCD1	MED CLASSIFICATION CODE 1 OF 4. Q 4.03A
74	Medication/supplement use	114476	phv00114476.v2.p2	pht001613.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:54:22+00:00	2018-08-22 21:54:22+00:00 	B09HMNM	NAME OF MED. Q 4.03A
74	Medication/supplement use	226321	phv00226321.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:54:22+00:00	2018-08-22 21:54:22+00:00 	MED_ANTIDEPRE_SSRI	Antidepressants - selective serotonin re-uptake inhibitors
74	Medication/supplement use	226322	phv00226322.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:54:30+00:00	2018-08-22 21:54:30+00:00 	MED_ANTIDEPRE_TRICYC	Antidepressants tricyclic antidepressants
74	Medication/supplement use	114475	phv00114475.v2.p2	pht001613.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:54:35+00:00	2018-08-22 21:54:35+00:00 	B09HMNUM	MEDICATION NUMBER. Q 4.03A
74	Medication/supplement use	114474	phv00114474.v2.p2	pht001613.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:54:49+00:00	2018-08-22 21:54:49+00:00 	B09HMTUS	TOTAL DURATION OF HORMONE USE, MONTHS
74	Medication/supplement use	226323	phv00226323.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:55:04+00:00	2018-08-22 21:55:04+00:00 	MED_ANTIDIAB	Antidiabetics
74	Medication/supplement use	226324	phv00226324.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:55:11+00:00	2018-08-22 21:55:11+00:00 	MED_ANTIHYPERT	Antihypertensives
74	Medication/supplement use	114485	phv00114485.v2.p2	pht001613.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:55:16+00:00	2018-08-22 21:55:16+00:00 	B09RESO	REASON MEDICATION TAKEN
74	Medication/supplement use	226325	phv00226325.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:55:18+00:00	2018-08-22 21:55:18+00:00 	MED_ANTIHYPERT_ACEI	ACE inhibitors
74	Medication/supplement use	226326	phv00226326.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:55:25+00:00	2018-08-22 21:55:25+00:00 	MED_ANTIHYPERT_AT2RAS	Angiotensin II receptor antagonists
74	Medication/supplement use	114484	phv00114484.v2.p2	pht001613.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:55:29+00:00	2018-08-22 21:55:29+00:00 	B09HMTMO	MOS USED MED. Q 4.03C
74	Medication/supplement use	226327	phv00226327.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:55:32+00:00	2018-08-22 21:55:32+00:00 	MED_ANTIPLATELET	Antiplatelets
74	Medication/supplement use	226328	phv00226328.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:55:39+00:00	2018-08-22 21:55:39+00:00 	MED_ANTIPSYCHO	Antipsychotics
74	Medication/supplement use	114483	phv00114483.v2.p2	pht001613.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:55:43+00:00	2018-08-22 21:55:43+00:00 	B09HMTYR	YRS USED MED. Q 4.03C
74	Medication/supplement use	226329	phv00226329.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:55:46+00:00	2018-08-22 21:55:46+00:00 	MED_ASPIRIN	Aspirin-containing analgesics
74	Medication/supplement use	226330	phv00226330.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:55:52+00:00	2018-08-22 21:55:52+00:00 	MED_BB	Beta blockers
74	Medication/supplement use	114482	phv00114482.v2.p2	pht001613.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:55:59+00:00	2018-08-22 21:55:59+00:00 	B09HMLUS	TIME SINCE LAST USED MED. Q 4.03B
74	Medication/supplement use	226331	phv00226331.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-22 21:55:59+00:00	2018-08-22 21:55:59+00:00 	MED_BB_OPHTHALMIC	Ophthalmic beta blockers
74	Medication/supplement use	114481	phv00114481.v2.p2	pht001613.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 21:56:10+00:00	2018-08-22 21:56:10+00:00 	B09HMNOW	TAKING MED NOW? Q 4.03A
74	Medication/supplement use	114497	phv00114497.v2.p2	pht001614.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:23:31+00:00	2018-08-22 22:23:31+00:00 	B09HTTMO	DURATION OF HEART MED USE: MONTHS. Q 4.01C
74	Medication/supplement use	114496	phv00114496.v2.p2	pht001614.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:23:39+00:00	2018-08-22 22:23:39+00:00 	B09HTTYR	DURATION OF HEART MED USE: YEARS. Q 4.01C
74	Medication/supplement use	114495	phv00114495.v2.p2	pht001614.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:23:47+00:00	2018-08-22 22:23:47+00:00 	B09HTLUS	TIME SINCE LAST USED HEART MED. Q 4.01B
74	Medication/supplement use	114494	phv00114494.v2.p2	pht001614.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:23:54+00:00	2018-08-22 22:23:54+00:00 	B09HTNOW	TAKING HEART MED NOW? Q 4.01A
74	Medication/supplement use	114493	phv00114493.v2.p2	pht001614.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:24:02+00:00	2018-08-22 22:24:02+00:00 	B09HTCD4	MED CLASSIFICATION CODE 4 OF 4. Q 4.01A
74	Medication/supplement use	114492	phv00114492.v2.p2	pht001614.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:24:09+00:00	2018-08-22 22:24:09+00:00 	B09HTCD3	MED CLASSIFICATION CODE 3 OF 4. Q 4.01A
74	Medication/supplement use	114491	phv00114491.v2.p2	pht001614.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:24:15+00:00	2018-08-22 22:24:15+00:00 	B09HTCD2	MED CLASSIFICATION CODE 2 OF 4. Q 4.01A
74	Medication/supplement use	114490	phv00114490.v2.p2	pht001614.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:24:23+00:00	2018-08-22 22:24:23+00:00 	B09HTCD1	MED CLASSIFICATION CODE 1 OF 4. Q 4.01A
74	Medication/supplement use	114489	phv00114489.v2.p2	pht001614.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:24:30+00:00	2018-08-22 22:24:30+00:00 	B09HTNM	NAME OF HEART MED
74	Medication/supplement use	114488	phv00114488.v2.p2	pht001614.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:24:37+00:00	2018-08-22 22:24:37+00:00 	B09HTNUM	MEDICATION NUMBER: HEART MED
74	Medication/supplement use	114487	phv00114487.v2.p2	pht001614.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:24:44+00:00	2018-08-22 22:24:44+00:00 	B09HTTUS	TOTAL DURATION, HEART MED USE, MONTHS
74	Medication/supplement use	114509	phv00114509.v2.p2	pht001615.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:32:45+00:00	2018-08-22 22:32:45+00:00 	B09OTTMO	DURATION OF OTHER MED USE: MONTHS
74	Medication/supplement use	114508	phv00114508.v2.p2	pht001615.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:32:54+00:00	2018-08-22 22:32:54+00:00 	B09OTTYR	DURATION OF OTHER MED USE: YEARS
74	Medication/supplement use	114507	phv00114507.v2.p2	pht001615.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:33:01+00:00	2018-08-22 22:33:01+00:00 	B09OTLUS	TIME SINCE LAST USED THIS MED
74	Medication/supplement use	114506	phv00114506.v2.p2	pht001615.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:33:10+00:00	2018-08-22 22:33:10+00:00 	B09OTNOW	TAKING OTHER MED NOW?
74	Medication/supplement use	114505	phv00114505.v2.p2	pht001615.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:33:17+00:00	2018-08-22 22:33:17+00:00 	B09OTCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	114504	phv00114504.v2.p2	pht001615.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:33:24+00:00	2018-08-22 22:33:24+00:00 	B09OTCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	114503	phv00114503.v2.p2	pht001615.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:33:32+00:00	2018-08-22 22:33:32+00:00 	B09OTCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	114502	phv00114502.v2.p2	pht001615.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:33:40+00:00	2018-08-22 22:33:40+00:00 	B09OTCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	114501	phv00114501.v2.p2	pht001615.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:33:47+00:00	2018-08-22 22:33:47+00:00 	B09OTNM	NAME OF MED
74	Medication/supplement use	114500	phv00114500.v2.p2	pht001615.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:33:55+00:00	2018-08-22 22:33:55+00:00 	B09OTNUM	MEDICATION NUMBER - PRESCRIPTION
74	Medication/supplement use	114499	phv00114499.v2.p2	pht001615.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:34:02+00:00	2018-08-22 22:34:02+00:00 	B09OTTUS	TOTAL DURATION, OTHER MED USE, MONTHS
74	Medication/supplement use	114510	phv00114510.v2.p2	pht001615.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 22:36:11+00:00	2018-08-22 22:36:11+00:00 	B09RESO	B09RESO
74	Medication/supplement use	114997	phv00114997.v2.p2	pht001635.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:44:50+00:00	2018-08-22 23:44:50+00:00 	B30LENGB	LENGTH OF USE, IN DAYS, MED#2. Q 4
74	Medication/supplement use	114996	phv00114996.v2.p2	pht001635.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:44:56+00:00	2018-08-22 23:44:56+00:00 	B30NAMEB	NAME OF MEDICATION #2. Q 4
74	Medication/supplement use	114995	phv00114995.v2.p2	pht001635.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:45:05+00:00	2018-08-22 23:45:05+00:00 	B30LENGA	LENGTH OF USE, IN DAYS, MED #1. Q 4
74	Medication/supplement use	114994	phv00114994.v2.p2	pht001635.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:45:12+00:00	2018-08-22 23:45:12+00:00 	B30NAMEA	NAME OF MED #1. Q 4
74	Medication/supplement use	114993	phv00114993.v2.p2	pht001635.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-22 23:45:18+00:00	2018-08-22 23:45:18+00:00 	B30APLMD	APPLIED MED? Q 4
74	Medication/supplement use	207844	phv00207844.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 14:52:39+00:00	2018-08-23 14:52:39+00:00 	MSRA04AC	[Medication records]. Medication A prescription type. Q4ac [Medication Survey Form, exam 1]
74	Medication/supplement use	207845	phv00207845.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 14:53:09+00:00	2018-08-23 14:53:09+00:00 	MSRA04AD	[Medication records]. Take medication A in past 24 hrs? Q4ad [Medication Survey Form, exam 1]
74	Medication/supplement use	207908	phv00207908.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 14:54:05+00:00	2018-08-23 14:54:05+00:00 	MSRA04QC	[Medication records]. Medication Q prescription type. Q4qc [Medication Survey Form, exam 1]
74	Medication/supplement use	207848	phv00207848.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 14:54:59+00:00	2018-08-23 14:54:59+00:00 	MSRA04BC	[Medication records]. Medication B prescription type. Q4bc [Medication Survey Form, exam 1]
74	Medication/supplement use	207849	phv00207849.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 14:55:19+00:00	2018-08-23 14:55:19+00:00 	MSRA04BD	[Medication records]. Take medication B in past 24 hrs? Q4bd [Medication Survey Form, exam 1]
74	Medication/supplement use	207852	phv00207852.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 14:55:42+00:00	2018-08-23 14:55:42+00:00 	MSRA04CC	[Medication records]. Medication C prescription type. Q4cc [Medication Survey Form, exam 1]
74	Medication/supplement use	207853	phv00207853.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 14:56:01+00:00	2018-08-23 14:56:01+00:00 	MSRA04CD	[Medication records]. Take medication C in past 24 hrs? Q4cd [Medication Survey Form, exam 1]
74	Medication/supplement use	207856	phv00207856.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 14:56:33+00:00	2018-08-23 14:56:33+00:00 	MSRA04DC	[Medication records]. Medication D prescription type. Q4dc [Medication Survey Form, exam 1]
74	Medication/supplement use	207857	phv00207857.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 14:56:57+00:00	2018-08-23 14:56:57+00:00 	MSRA04DD	[Medication records]. Take medication D in past 24 hrs? Q4dd [Medication Survey Form, exam 1]
74	Medication/supplement use	207860	phv00207860.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 14:57:23+00:00	2018-08-23 14:57:23+00:00 	MSRA04EC	[Medication records]. Medication E prescription type. Q4ec [Medication Survey Form, exam 1]
74	Medication/supplement use	207861	phv00207861.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 14:57:53+00:00	2018-08-23 14:57:53+00:00 	MSRA04ED	[Medication records]. Take medication E in past 24 hrs? Q4ed [Medication Survey Form, exam 1]
74	Medication/supplement use	207864	phv00207864.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:19:21+00:00	2018-08-23 15:19:21+00:00 	MSRA04FC	[Medication records]. Medication F prescription type. Q4fc [Medication Survey Form, exam 1]
74	Medication/supplement use	207865	phv00207865.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:19:37+00:00	2018-08-23 15:19:37+00:00 	MSRA04FD	[Medication records]. Take medication F in past 24 hrs? Q4fd [Medication Survey Form, exam 1]
74	Medication/supplement use	207868	phv00207868.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:21:18+00:00	2018-08-23 15:21:18+00:00 	MSRA04GC	[Medication records]. Medication G prescription type. Q4gc [Medication Survey Form, exam 1]
74	Medication/supplement use	207869	phv00207869.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:21:36+00:00	2018-08-23 15:21:36+00:00 	MSRA04GD	[Medication records]. Take medication G in past 24 hrs? Q4gd [Medication Survey Form, exam 1]
74	Medication/supplement use	207872	phv00207872.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:22:00+00:00	2018-08-23 15:22:00+00:00 	MSRA04HC	[Medication records]. Medication H prescription type. Q4hc [Medication Survey Form, exam 1]
74	Medication/supplement use	207873	phv00207873.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:22:15+00:00	2018-08-23 15:22:15+00:00 	MSRA04HD	[Medication records]. Take medication H in past 24 hrs? Q4hd [Medication Survey Form, exam 1]
74	Medication/supplement use	207876	phv00207876.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:22:31+00:00	2018-08-23 15:22:31+00:00 	MSRA04IC	[Medication records]. Medication I prescription type. Q4ic [Medication Survey Form, exam 1]
74	Medication/supplement use	207877	phv00207877.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:22:48+00:00	2018-08-23 15:22:48+00:00 	MSRA04ID	[Medication records]. Take medication I in past 24 hrs? Q4id [Medication Survey Form, exam 1]
74	Medication/supplement use	207880	phv00207880.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:23:07+00:00	2018-08-23 15:23:07+00:00 	MSRA04JC	[Medication records]. Medication J prescription type. Q4jc [Medication Survey Form, exam 1]
74	Medication/supplement use	207881	phv00207881.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:23:23+00:00	2018-08-23 15:23:23+00:00 	MSRA04JD	[Medication records]. Take medication J in past 24 hrs? Q4jd [Medication Survey Form, exam 1]
74	Medication/supplement use	207884	phv00207884.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:23:42+00:00	2018-08-23 15:23:42+00:00 	MSRA04KC	[Medication records]. Medication K prescription type. Q4kc [Medication Survey Form, exam 1]
74	Medication/supplement use	207885	phv00207885.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:24:00+00:00	2018-08-23 15:24:00+00:00 	MSRA04KD	[Medication records]. Take medication K in past 24 hrs? Q4kd [Medication Survey Form, exam 1]
74	Medication/supplement use	207888	phv00207888.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:24:33+00:00	2018-08-23 15:24:33+00:00 	MSRA04LC	[Medication records]. Medication L prescription type. Q4lc [Medication Survey Form, exam 1]
74	Medication/supplement use	207889	phv00207889.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:27:57+00:00	2018-08-23 15:27:57+00:00 	MSRA04LD	[Medication records]. Take medication L in past 24 hrs? Q4ld [Medication Survey Form, exam 1]
74	Medication/supplement use	207892	phv00207892.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:28:17+00:00	2018-08-23 15:28:17+00:00 	MSRA04MC	[Medication records]. Medication M prescription type. Q4mc [Medication Survey Form, exam 1]
74	Medication/supplement use	207893	phv00207893.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:28:41+00:00	2018-08-23 15:28:41+00:00 	MSRA04MD	[Medication records]. Take medication M in past 24 hrs? Q4md [Medication Survey Form, exam 1]
74	Medication/supplement use	207896	phv00207896.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:28:58+00:00	2018-08-23 15:28:58+00:00 	MSRA04NC	[Medication records]. Medication N prescription type. Q4nc [Medication Survey Form, exam 1]
74	Medication/supplement use	207897	phv00207897.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:29:16+00:00	2018-08-23 15:29:16+00:00 	MSRA04ND	[Medication records]. Take medication N in past 24 hrs? Q4nd [Medication Survey Form, exam 1]
74	Medication/supplement use	207900	phv00207900.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:29:35+00:00	2018-08-23 15:29:35+00:00 	MSRA04OC	[Medication records]. Medication O prescription type. Q4oc [Medication Survey Form, exam 1]
74	Medication/supplement use	207901	phv00207901.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:29:54+00:00	2018-08-23 15:29:54+00:00 	MSRA04OD	[Medication records]. Take medication O in past 24 hrs? Q4od [Medication Survey Form, exam 1]
74	Medication/supplement use	207904	phv00207904.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:30:13+00:00	2018-08-23 15:30:13+00:00 	MSRA04PC	[Medication records]. Medication P prescription type. Q4pc [Medication Survey Form, exam 1]
74	Medication/supplement use	207905	phv00207905.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:30:30+00:00	2018-08-23 15:30:30+00:00 	MSRA04PD	[Medication records]. Take medication P in past 24 hrs? Q4pd [Medication Survey Form, exam 1]
74	Medication/supplement use	207909	phv00207909.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:31:01+00:00	2018-08-23 15:31:01+00:00 	MSRA04QD	[Medication records]. Take medication Q in past 24 hrs? Q4qd [Medication Survey Form, exam 1]
74	Medication/supplement use	207931	phv00207931.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:34:59+00:00	2018-08-23 15:34:59+00:00 	MSRB04C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q4C [Medication Survey Form, exam 2]
74	Medication/supplement use	207932	phv00207932.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:35:15+00:00	2018-08-23 15:35:15+00:00 	MSRB04D	[Medication records]. Did you take this medication in the past 24 hours? Q4D [Medication Survey Form, exam 2]
74	Medication/supplement use	207935	phv00207935.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:35:38+00:00	2018-08-23 15:35:38+00:00 	MSRB05C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q5C [Medication Survey Form, exam 2]
74	Medication/supplement use	207936	phv00207936.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:36:01+00:00	2018-08-23 15:36:01+00:00 	MSRB05D	[Medication records]. Did you take this medication in the past 24 hours? Q5D [Medication Survey Form, exam 2]
74	Medication/supplement use	207939	phv00207939.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:36:43+00:00	2018-08-23 15:36:43+00:00 	MSRB06C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q6C [Medication Survey Form, exam 2]
74	Medication/supplement use	207940	phv00207940.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:37:00+00:00	2018-08-23 15:37:00+00:00 	MSRB06D	[Medication records]. Did you take this medication in the past 24 hours? Q6D [Medication Survey Form, exam 2]
74	Medication/supplement use	207943	phv00207943.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:37:17+00:00	2018-08-23 15:37:17+00:00 	MSRB07C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q7C [Medication Survey Form, exam 2]
74	Medication/supplement use	207944	phv00207944.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:37:34+00:00	2018-08-23 15:37:34+00:00 	MSRB07D	[Medication records]. Did you take this medication in the past 24 hours? Q7D [Medication Survey Form, exam 2]
74	Medication/supplement use	207947	phv00207947.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:37:51+00:00	2018-08-23 15:37:51+00:00 	MSRB08C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q8C [Medication Survey Form, exam 2]
74	Medication/supplement use	207948	phv00207948.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:38:09+00:00	2018-08-23 15:38:09+00:00 	MSRB08D	[Medication records]. Did you take this medication in the past 24 hours? Q8D [Medication Survey Form, exam 2]
74	Medication/supplement use	207951	phv00207951.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:38:42+00:00	2018-08-23 15:38:42+00:00 	MSRB09C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q9C [Medication Survey Form, exam 2]
74	Medication/supplement use	207952	phv00207952.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:39:00+00:00	2018-08-23 15:39:00+00:00 	MSRB09D	[Medication records]. Did you take this medication in the past 24 hours? Q9D [Medication Survey Form, exam 2]
74	Medication/supplement use	207955	phv00207955.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:39:19+00:00	2018-08-23 15:39:19+00:00 	MSRB10C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q10C [Medication Survey Form, exam 2]
74	Medication/supplement use	207956	phv00207956.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:39:38+00:00	2018-08-23 15:39:38+00:00 	MSRB10D	[Medication records]. Did you take this medication in the past 24 hours? Q10D [Medication Survey Form, exam 2]
74	Medication/supplement use	207959	phv00207959.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:39:55+00:00	2018-08-23 15:39:55+00:00 	MSRB11C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q11C [Medication Survey Form, exam 2]
74	Medication/supplement use	207960	phv00207960.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:40:11+00:00	2018-08-23 15:40:11+00:00 	MSRB11D	[Medication records]. Did you take this medication in the past 24 hours? Q11D [Medication Survey Form, exam 2]
74	Medication/supplement use	207963	phv00207963.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:40:28+00:00	2018-08-23 15:40:28+00:00 	MSRB12C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q12C [Medication Survey Form, exam 2]
74	Medication/supplement use	207964	phv00207964.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:40:49+00:00	2018-08-23 15:40:49+00:00 	MSRB12D	[Medication records]. Did you take this medication in the past 24 hours? Q12D [Medication Survey Form, exam 2]
74	Medication/supplement use	207967	phv00207967.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:41:16+00:00	2018-08-23 15:41:16+00:00 	MSRB13C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q13C [Medication Survey Form, exam 2]
74	Medication/supplement use	207968	phv00207968.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:41:31+00:00	2018-08-23 15:41:31+00:00 	MSRB13D	[Medication records]. Did you take this medication in the past 24 hours? Q13D [Medication Survey Form, exam 2]
74	Medication/supplement use	207971	phv00207971.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:41:50+00:00	2018-08-23 15:41:50+00:00 	MSRB14C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q14C [Medication Survey Form, exam 2]
74	Medication/supplement use	207972	phv00207972.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:42:12+00:00	2018-08-23 15:42:12+00:00 	MSRB14D	[Medication records]. Did you take this medication in the past 24 hours? Q14D [Medication Survey Form, exam 2]
74	Medication/supplement use	207975	phv00207975.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:42:43+00:00	2018-08-23 15:42:43+00:00 	MSRB15C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q15C [Medication Survey Form, exam 2]
74	Medication/supplement use	207976	phv00207976.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:42:58+00:00	2018-08-23 15:42:58+00:00 	MSRB15D	[Medication records]. Did you take this medication in the past 24 hours? Q15D [Medication Survey Form, exam 2]
74	Medication/supplement use	207979	phv00207979.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:43:15+00:00	2018-08-23 15:43:15+00:00 	MSRB16C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q16C [Medication Survey Form, exam 2]
74	Medication/supplement use	207980	phv00207980.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:43:33+00:00	2018-08-23 15:43:33+00:00 	MSRB16D	[Medication records]. Did you take this medication in the past 24 hours? Q16D [Medication Survey Form, exam 2]
74	Medication/supplement use	207983	phv00207983.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:44:00+00:00	2018-08-23 15:44:00+00:00 	MSRB17C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q17C [Medication Survey Form, exam 2]
74	Medication/supplement use	207984	phv00207984.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:44:16+00:00	2018-08-23 15:44:16+00:00 	MSRB17D	[Medication records]. Did you take this medication in the past 24 hours? Q17D [Medication Survey Form, exam 2]
74	Medication/supplement use	207987	phv00207987.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:44:33+00:00	2018-08-23 15:44:33+00:00 	MSRB18C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q18C [Medication Survey Form, exam 2]
74	Medication/supplement use	207988	phv00207988.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:44:48+00:00	2018-08-23 15:44:48+00:00 	MSRB18D	[Medication records]. Did you take this medication in the past 24 hours? Q18D [Medication Survey Form, exam 2]
74	Medication/supplement use	207991	phv00207991.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:45:03+00:00	2018-08-23 15:45:03+00:00 	MSRB19C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q19C [Medication Survey Form, exam 2]
74	Medication/supplement use	207992	phv00207992.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:45:17+00:00	2018-08-23 15:45:17+00:00 	MSRB19D	[Medication records]. Did you take this medication in the past 24 hours? Q19D [Medication Survey Form, exam 2]
74	Medication/supplement use	207995	phv00207995.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:45:35+00:00	2018-08-23 15:45:35+00:00 	MSRB20C	[Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q20C [Medication Survey Form, exam 2]
74	Medication/supplement use	207996	phv00207996.v1.p1	pht004130.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:45:52+00:00	2018-08-23 15:45:52+00:00 	MSRB20D	[Medication records]. Did you take this medication in the past 24 hours? Q20D [Medication Survey Form, exam 2]
74	Medication/supplement use	208018	phv00208018.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:47:03+00:00	2018-08-23 15:47:03+00:00 	MSRC4D	[Medication records]. Did you take this medication in the past 24 hours? Q4d [Medication Survey Form, exam 3]
74	Medication/supplement use	208021	phv00208021.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:48:15+00:00	2018-08-23 15:48:15+00:00 	MSRC5D	[Medication records]. Did you take this medication in the past 24 hours? Q5d [Medication Survey Form, exam 3]
74	Medication/supplement use	208024	phv00208024.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:48:28+00:00	2018-08-23 15:48:28+00:00 	MSRC6D	[Medication records]. Did you take this medication in the past 24 hours? Q6d [Medication Survey Form, exam 3]
74	Medication/supplement use	208027	phv00208027.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:49:12+00:00	2018-08-23 15:49:12+00:00 	MSRC7D	[Medication records]. Did you take this medication in the past 24 hours? Q7d [Medication Survey Form, exam 3]
74	Medication/supplement use	208030	phv00208030.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:49:32+00:00	2018-08-23 15:49:32+00:00 	MSRC8D	[Medication records]. Did you take this medication in the past 24 hours? Q8d [Medication Survey Form, exam 3]
74	Medication/supplement use	208033	phv00208033.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:49:47+00:00	2018-08-23 15:49:47+00:00 	MSRC9D	[Medication records]. Did you take this medication in the past 24 hours? Q9d [Medication Survey Form, exam 3]
74	Medication/supplement use	208036	phv00208036.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:50:01+00:00	2018-08-23 15:50:01+00:00 	MSRC10D	[Medication records]. Did you take this medication in the past 24 hours? Q10d [Medication Survey Form, exam 3]
74	Medication/supplement use	208039	phv00208039.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:55:04+00:00	2018-08-23 15:55:04+00:00 	MSRC11D	[Medication records]. Did you take this medication in the past 24 hours? Q11d [Medication Survey Form, exam 3]
74	Medication/supplement use	208042	phv00208042.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:55:23+00:00	2018-08-23 15:55:23+00:00 	MSRC12D	[Medication records]. Did you take this medication in the past 24 hours? Q12d [Medication Survey Form, exam 3]
74	Medication/supplement use	208045	phv00208045.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:55:41+00:00	2018-08-23 15:55:41+00:00 	MSRC13D	[Medication records]. Did you take this medication in the past 24 hours? Q13d [Medication Survey Form, exam 3]
74	Medication/supplement use	208048	phv00208048.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 15:56:07+00:00	2018-08-23 15:56:07+00:00 	MSRC14D	[Medication records]. Did you take this medication in the past 24 hours? Q14d [Medication Survey Form, exam 3]
74	Medication/supplement use	208051	phv00208051.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:29:11+00:00	2018-08-23 16:29:11+00:00 	MSRC15D	[Medication records]. Did you take this medication in the past 24 hours? Q15d [Medication Survey Form, exam 3]
74	Medication/supplement use	208054	phv00208054.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:29:28+00:00	2018-08-23 16:29:28+00:00 	MSRC16D	[Medication records]. Did you take this medication in the past 24 hours? Q16d [Medication Survey Form, exam 3]
74	Medication/supplement use	208057	phv00208057.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:29:47+00:00	2018-08-23 16:29:47+00:00 	MSRC17D	[Medication records]. Did you take this medication in the past 24 hours? Q17d [Medication Survey Form, exam 3]
74	Medication/supplement use	208060	phv00208060.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:30:10+00:00	2018-08-23 16:30:10+00:00 	MSRC18D	[Medication records]. Did you take this medication in the past 24 hours? Q18d [Medication Survey Form, exam 3]
74	Medication/supplement use	208063	phv00208063.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:30:32+00:00	2018-08-23 16:30:32+00:00 	MSRC19D	[Medication records]. Did you take this medication in the past 24 hours? Q19d [Medication Survey Form, exam 3]
74	Medication/supplement use	208066	phv00208066.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:30:54+00:00	2018-08-23 16:30:54+00:00 	MSRC20D	[Medication records]. Did you take this medication in the past 24 hours? Q20d [Medication Survey Form, exam 3]
74	Medication/supplement use	208077	phv00208077.v1.p1	pht004131.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:32:04+00:00	2018-08-23 16:32:04+00:00 	MSRC27	[Interview]. For what purpose are you taking aspirin? Q27 [Medication Survey Form, exam 3]
74	Medication/supplement use	208231	phv00208231.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:33:42+00:00	2018-08-23 16:33:42+00:00 	MSRD4D	[Medication records]. Did you take this medication in the past 24 hours? Q4d [Medication Survey Form, exam 4]
74	Medication/supplement use	208235	phv00208235.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:34:05+00:00	2018-08-23 16:34:05+00:00 	MSRD5D	[Medication records]. Did you take this medication in the past 24 hours? Q5d [Medication Survey Form, exam 4]
74	Medication/supplement use	208239	phv00208239.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:34:22+00:00	2018-08-23 16:34:22+00:00 	MSRD6D	[Medication records]. Did you take this medication in the past 24 hours? Q6d [Medication Survey Form, exam 4]
74	Medication/supplement use	208243	phv00208243.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:36:58+00:00	2018-08-23 16:36:58+00:00 	MSRD7D	[Medication records]. Did you take this medication in the past 24 hours? Q7d [Medication Survey Form, exam 4]
74	Medication/supplement use	208247	phv00208247.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:37:16+00:00	2018-08-23 16:37:16+00:00 	MSRD8D	[Medication records]. Did you take this medication in the past 24 hours? Q8d [Medication Survey Form, exam 4]
74	Medication/supplement use	208251	phv00208251.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:37:43+00:00	2018-08-23 16:37:43+00:00 	MSRD9D	[Medication records]. Did you take this medication in the past 24 hours? Q9d [Medication Survey Form, exam 4]
74	Medication/supplement use	208255	phv00208255.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:38:08+00:00	2018-08-23 16:38:08+00:00 	MSRD10D	[Medication records]. Did you take this medication in the past 24 hours? Q10d [Medication Survey Form, exam 4]
74	Medication/supplement use	208259	phv00208259.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:38:28+00:00	2018-08-23 16:38:28+00:00 	MSRD11D	[Medication records]. Did you take this medication in the past 24 hours? Q11d [Medication Survey Form, exam 4]
74	Medication/supplement use	208263	phv00208263.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:38:46+00:00	2018-08-23 16:38:46+00:00 	MSRD12D	[Medication records]. Did you take this medication in the past 24 hours? Q12d [Medication Survey Form, exam 4]
74	Medication/supplement use	208267	phv00208267.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:39:10+00:00	2018-08-23 16:39:10+00:00 	MSRD13D	[Medication records]. Did you take this medication in the past 24 hours? Q13d [Medication Survey Form, exam 4]
74	Medication/supplement use	208271	phv00208271.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:39:25+00:00	2018-08-23 16:39:25+00:00 	MSRD14D	[Medication records]. Did you take this medication in the past 24 hours? Q14d [Medication Survey Form, exam 4]
74	Medication/supplement use	208275	phv00208275.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:39:41+00:00	2018-08-23 16:39:41+00:00 	MSRD15D	[Medication records]. Did you take this medication in the past 24 hours? Q15d [Medication Survey Form, exam 4]
74	Medication/supplement use	208279	phv00208279.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:39:57+00:00	2018-08-23 16:39:57+00:00 	MSRD16D	[Medication records]. Did you take this medication in the past 24 hours? Q16d [Medication Survey Form, exam 4]
74	Medication/supplement use	208283	phv00208283.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:40:12+00:00	2018-08-23 16:40:12+00:00 	MSRD17D	[Medication records]. Did you take this medication in the past 24 hours? Q17d [Medication Survey Form, exam 4]
74	Medication/supplement use	208287	phv00208287.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:40:28+00:00	2018-08-23 16:40:28+00:00 	MSRD18D	[Medication records]. Did you take this medication in the past 24 hours? Q18d [Medication Survey Form, exam 4]
74	Medication/supplement use	208291	phv00208291.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:40:45+00:00	2018-08-23 16:40:45+00:00 	MSRD19D	[Medication records]. Did you take this medication in the past 24 hours? Q19d [Medication Survey Form, exam 4]
74	Medication/supplement use	208295	phv00208295.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:41:16+00:00	2018-08-23 16:41:16+00:00 	MSRD20D	[Medication records]. Did you take this medication in the past 24 hours? Q20d [Medication Survey Form, exam 4]
74	Medication/supplement use	208306	phv00208306.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:41:54+00:00	2018-08-23 16:41:54+00:00 	MSRD27	[Interview]. For what purpose are you taking aspirin? Q27 [Medication Survey Form, exam 4]
74	Medication/supplement use	208310	phv00208310.v1.p1	pht004136.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-08-23 16:42:26+00:00	2018-08-23 16:42:26+00:00 	MSRD29D	[Interview]. For what purpose are you taking this medication? Q29d [Medication Survey Form, exam 4]
74	Medication/supplement use	115487	phv00115487.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 16:59:45+00:00	2018-08-23 16:59:45+00:00 	C08HMNOW	TAKING HORMONES OTHER THAN BCP. Q 17
74	Medication/supplement use	115486	phv00115486.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 16:59:52+00:00	2018-08-23 16:59:52+00:00 	C08BCNOW	CURRENTLY USING BCP. Q 16
74	Medication/supplement use	115479	phv00115479.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:00:00+00:00	2018-08-23 17:00:00+00:00 	C08OTMED	CURRENTLY TAKING OTHER PRSCR MEDICATION. Q 13
74	Medication/supplement use	115478	phv00115478.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:00:07+00:00	2018-08-23 17:00:07+00:00 	C08ASMA	CURRENTLY TAKING ASTHMA MEDICATION. Q 12
74	Medication/supplement use	115477	phv00115477.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:00:13+00:00	2018-08-23 17:00:13+00:00 	C08CHNOW	CURRENTLY TAKING CHOLESTEROL MEDICATION. Q 11
74	Medication/supplement use	115476	phv00115476.v2.p2	pht001656.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:00:21+00:00	2018-08-23 17:00:21+00:00 	C08HBNOW	CURRENTLY TAKING HBP MEDICATION. Q 10
74	Medication/supplement use	115495	phv00115495.v2.p2	pht001657.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:10:06+00:00	2018-08-23 17:10:06+00:00 	C09ASCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	115494	phv00115494.v2.p2	pht001657.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:10:12+00:00	2018-08-23 17:10:12+00:00 	C09ASCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	115493	phv00115493.v2.p2	pht001657.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:10:19+00:00	2018-08-23 17:10:19+00:00 	C09ASCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	115492	phv00115492.v2.p2	pht001657.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:10:26+00:00	2018-08-23 17:10:26+00:00 	C09ASCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	115491	phv00115491.v2.p2	pht001657.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:10:33+00:00	2018-08-23 17:10:33+00:00 	C09ASNM	NAME OF ASTHMA MEDICATION
74	Medication/supplement use	115490	phv00115490.v2.p2	pht001657.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:10:40+00:00	2018-08-23 17:10:40+00:00 	C09ASNUM	MEDICATION NUMBER :ASTHMA
74	Medication/supplement use	115506	phv00115506.v2.p2	pht001658.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:11:20+00:00	2018-08-23 17:11:20+00:00 	C09BCCUS	DURATION OF BCP USE, SINCE LAST STARTED
74	Medication/supplement use	115505	phv00115505.v2.p2	pht001658.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:11:27+00:00	2018-08-23 17:11:27+00:00 	C09BCTUS	DURATION OF BCP USE, SINCE FIRST STARTED
74	Medication/supplement use	115504	phv00115504.v2.p2	pht001658.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:11:34+00:00	2018-08-23 17:11:34+00:00 	C09BCTMO	DURATION OF BCP USE, MONTHS
74	Medication/supplement use	115503	phv00115503.v2.p2	pht001658.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:11:42+00:00	2018-08-23 17:11:42+00:00 	C09BCTYR	DURATION OF BCP USE, YEARS
74	Medication/supplement use	115502	phv00115502.v2.p2	pht001658.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:11:50+00:00	2018-08-23 17:11:50+00:00 	C09BCTM1	DURATION OF BCP USE: EX-USERS, MONTHS
74	Medication/supplement use	115501	phv00115501.v2.p2	pht001658.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:11:57+00:00	2018-08-23 17:11:57+00:00 	C09BCTY1	DURATION OF BCP USE: EX-USERS, YEARS
74	Medication/supplement use	115500	phv00115500.v2.p2	pht001658.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:12:05+00:00	2018-08-23 17:12:05+00:00 	C09BCCD3	MED CLASSIFICATION CODE 3 OF 3
74	Medication/supplement use	115499	phv00115499.v2.p2	pht001658.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:12:13+00:00	2018-08-23 17:12:13+00:00 	C09BCCD2	MED CLASSIFICATION CODE 2 OF 3
74	Medication/supplement use	115498	phv00115498.v2.p2	pht001658.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:12:20+00:00	2018-08-23 17:12:20+00:00 	C09BCCD1	MED CLASSIFICATION CODE 1 OF 3
74	Medication/supplement use	115497	phv00115497.v2.p2	pht001658.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:12:27+00:00	2018-08-23 17:12:27+00:00 	C09BCNAM	BRAND OF BIRTH CONTROL PILL
74	Medication/supplement use	115514	phv00115514.v1.p2	pht001659.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:12:57+00:00	2018-08-23 17:12:57+00:00 	C09CHCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	115513	phv00115513.v1.p2	pht001659.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:13:04+00:00	2018-08-23 17:13:04+00:00 	C09CHCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	115512	phv00115512.v1.p2	pht001659.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:13:13+00:00	2018-08-23 17:13:13+00:00 	C09CHCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	115511	phv00115511.v1.p2	pht001659.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:13:20+00:00	2018-08-23 17:13:20+00:00 	C09CHCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	115510	phv00115510.v1.p2	pht001659.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:13:27+00:00	2018-08-23 17:13:27+00:00 	C09CHNM	NAME OF CHOL LOWERING MEDICATION. Q 11a
74	Medication/supplement use	115509	phv00115509.v1.p2	pht001659.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:13:34+00:00	2018-08-23 17:13:34+00:00 	C09CHNUM	MEDICATION NUMBER: CHOL LOWERING MED
74	Medication/supplement use	115522	phv00115522.v2.p2	pht001660.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:13:59+00:00	2018-08-23 17:13:59+00:00 	C09HBCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	115521	phv00115521.v2.p2	pht001660.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:14:06+00:00	2018-08-23 17:14:06+00:00 	C09HBCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	115520	phv00115520.v2.p2	pht001660.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:14:13+00:00	2018-08-23 17:14:13+00:00 	C09HBCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	115519	phv00115519.v2.p2	pht001660.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:14:21+00:00	2018-08-23 17:14:21+00:00 	C09HBCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	115518	phv00115518.v2.p2	pht001660.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:14:28+00:00	2018-08-23 17:14:28+00:00 	C09HBNM	NAME OF HBP MEDICATION. Q 10a
74	Medication/supplement use	115517	phv00115517.v2.p2	pht001660.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:14:36+00:00	2018-08-23 17:14:36+00:00 	C09HBNUM	MEDICATION NUMBER: HBP MED
74	Medication/supplement use	115530	phv00115530.v1.p2	pht001661.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:15:00+00:00	2018-08-23 17:15:00+00:00 	C09HMCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	115529	phv00115529.v1.p2	pht001661.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:15:08+00:00	2018-08-23 17:15:08+00:00 	C09HMCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	115528	phv00115528.v1.p2	pht001661.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:15:16+00:00	2018-08-23 17:15:16+00:00 	C09HMCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	115527	phv00115527.v1.p2	pht001661.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:15:23+00:00	2018-08-23 17:15:23+00:00 	C09HMCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	115526	phv00115526.v1.p2	pht001661.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:15:30+00:00	2018-08-23 17:15:30+00:00 	C09HMNM	NAME OF HORMONE MEDICATION. Q 17a
74	Medication/supplement use	115525	phv00115525.v1.p2	pht001661.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:15:38+00:00	2018-08-23 17:15:38+00:00 	C09HMNUM	MEDICATION NUMBER: HORMONES
74	Medication/supplement use	115538	phv00115538.v2.p2	pht001662.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:16:10+00:00	2018-08-23 17:16:10+00:00 	C09OTCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	115537	phv00115537.v2.p2	pht001662.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:16:18+00:00	2018-08-23 17:16:18+00:00 	C09OTCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	115536	phv00115536.v2.p2	pht001662.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:16:25+00:00	2018-08-23 17:16:25+00:00 	C09OTCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	115535	phv00115535.v2.p2	pht001662.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:16:33+00:00	2018-08-23 17:16:33+00:00 	C09OTCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	115534	phv00115534.v2.p2	pht001662.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:16:41+00:00	2018-08-23 17:16:41+00:00 	C09OTNM	NAME OF 'OTHER'MEDICATION. Q 13a
74	Medication/supplement use	115533	phv00115533.v2.p2	pht001662.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 17:16:52+00:00	2018-08-23 17:16:52+00:00 	C09OTNUM	MEDICATION NUMBER - PRESCRIPTION
74	Medication/supplement use	116463	phv00116463.v2.p2	pht001704.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 19:23:55+00:00	2018-08-23 19:23:55+00:00 	D47Q10A	Q10A: MEDICATION 1
74	Medication/supplement use	116448	phv00116448.v2.p2	pht001704.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 19:24:01+00:00	2018-08-23 19:24:01+00:00 	D47Q10	Q10: TAKE MEDICATION DURING COLLECTION?
74	Medication/supplement use	116468	phv00116468.v2.p2	pht001704.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 19:24:17+00:00	2018-08-23 19:24:17+00:00 	D47Q10F	Q10F: MEDICATION 6
74	Medication/supplement use	116467	phv00116467.v2.p2	pht001704.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 19:24:24+00:00	2018-08-23 19:24:24+00:00 	D47Q10E	Q10E: MEDICATION 5
74	Medication/supplement use	116466	phv00116466.v2.p2	pht001704.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 19:24:31+00:00	2018-08-23 19:24:31+00:00 	D47Q10D	Q10D: MEDICATION 4
74	Medication/supplement use	116465	phv00116465.v2.p2	pht001704.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 19:24:38+00:00	2018-08-23 19:24:38+00:00 	D47Q10C	Q10C: MEDICATION 3
74	Medication/supplement use	116464	phv00116464.v2.p2	pht001704.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-23 19:24:44+00:00	2018-08-23 19:24:44+00:00 	D47Q10B	Q10B: MEDICATION 2
74	Medication/supplement use	117068	phv00117068.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:22:05+00:00	2018-08-24 00:22:05+00:00 	D08ASP	TAKE ASPIRIN 3 TIMES/WK? Q 26
74	Medication/supplement use	117067	phv00117067.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:22:12+00:00	2018-08-24 00:22:12+00:00 	D08OTMED	CURRENTLY TAKING ANY OTHER MEDS. Q 25
74	Medication/supplement use	117066	phv00117066.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:22:19+00:00	2018-08-24 00:22:19+00:00 	D08ASMA	CURRENTLY TAKING MEDS FOR ASTHMA. Q 24
74	Medication/supplement use	117065	phv00117065.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:22:26+00:00	2018-08-24 00:22:26+00:00 	D08CHNOW	CURRENTLY TAKING MEDS TO LOWER CHOLEST. Q 23
74	Medication/supplement use	117064	phv00117064.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:22:33+00:00	2018-08-24 00:22:33+00:00 	D08HBNOW	CURRENTLY TAKING MEDS FOR HBP. Q 22
74	Medication/supplement use	117106	phv00117106.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:23:48+00:00	2018-08-24 00:23:48+00:00 	D08HMNOW	CURRENTLY TAKING HORMONES EXCLUDING BCP? Q 43
74	Medication/supplement use	117105	phv00117105.v2.p2	pht001715.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:23:55+00:00	2018-08-24 00:23:55+00:00 	D08BCNOW	CURRENTLY TAKING BC PILLS? Q 42
74	Medication/supplement use	117141	phv00117141.v2.p2	pht001717.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:40:55+00:00	2018-08-24 00:40:55+00:00 	D10PATCH	NOW USING A NICOTINE PATCH? Q 7
74	Medication/supplement use	120070	phv00120070.v2.p2	pht001818.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:41:02+00:00	2018-08-24 00:41:02+00:00 	F10GUMWK	USED NICOTINE GUM IN PAST WEEK. Q 6
74	Medication/supplement use	120069	phv00120069.v2.p2	pht001818.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:41:09+00:00	2018-08-24 00:41:09+00:00 	F10GUMEV	EVER USED NICOTINE GUM? Q 6
74	Medication/supplement use	118770	phv00118770.v2.p2	pht001778.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:41:16+00:00	2018-08-24 00:41:16+00:00 	E10GUMWK	USED NICOTINE GUM IN PAST WEEK. Q 6
74	Medication/supplement use	118769	phv00118769.v2.p2	pht001778.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:41:23+00:00	2018-08-24 00:41:23+00:00 	E10GUMEV	EVER USED NICOTINE GUM? Q 6
74	Medication/supplement use	117140	phv00117140.v2.p2	pht001717.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:41:30+00:00	2018-08-24 00:41:30+00:00 	D10GUM	CURRENTLY USES NICOTINE GUM. Q 6
74	Medication/supplement use	115586	phv00115586.v2.p2	pht001665.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:41:38+00:00	2018-08-24 00:41:38+00:00 	C10GUM	CURRENTLY USES NICOTINE GUM. Q 6
74	Medication/supplement use	114576	phv00114576.v2.p2	pht001625.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:41:44+00:00	2018-08-24 00:41:44+00:00 	B10GUM	HAS USED NICOTINE GUM. Q 6
74	Medication/supplement use	113217	phv00113217.v2.p2	pht001573.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:41:53+00:00	2018-08-24 00:41:53+00:00 	A10GUM	SUBJECT HAS USED NICOTINE GUM. Q 6
74	Medication/supplement use	120078	phv00120078.v2.p2	pht001818.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:42:40+00:00	2018-08-24 00:42:40+00:00 	F10PATWK	USED NICOTINE PATCH IN PAST WEEK
74	Medication/supplement use	120071	phv00120071.v2.p2	pht001818.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:42:47+00:00	2018-08-24 00:42:47+00:00 	F10PATEV	EVER USED NICOTINE PATCH? Q 7
74	Medication/supplement use	118772	phv00118772.v2.p2	pht001778.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:42:54+00:00	2018-08-24 00:42:54+00:00 	E10PATWK	USED NICOTINE PATCH IN PAST WEEK. Q 7
74	Medication/supplement use	118771	phv00118771.v2.p2	pht001778.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 00:43:00+00:00	2018-08-24 00:43:00+00:00 	E10PATEV	EVER USED NICOTINE PATCH? Q 7
74	Medication/supplement use	226332	phv00226332.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:21:51+00:00	2018-08-24 16:21:51+00:00 	MED_CACB	Calcium channel blockers
74	Medication/supplement use	226333	phv00226333.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:21:59+00:00	2018-08-24 16:21:59+00:00 	MED_CARDIACGLYCOSIDES	Cardiac glycosides
74	Medication/supplement use	226334	phv00226334.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:22:06+00:00	2018-08-24 16:22:06+00:00 	MED_CHEMO	Chemotherapy
74	Medication/supplement use	226335	phv00226335.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:22:12+00:00	2018-08-24 16:22:12+00:00 	MED_CLOPID	Clopidogrel (Plavix)
74	Medication/supplement use	226336	phv00226336.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:22:19+00:00	2018-08-24 16:22:19+00:00 	MED_CONTRACEPTIVES	Contraceptives
74	Medication/supplement use	226337	phv00226337.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:22:25+00:00	2018-08-24 16:22:25+00:00 	MED_COX2	COX-2 inhibitors
74	Medication/supplement use	226338	phv00226338.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:22:31+00:00	2018-08-24 16:22:31+00:00 	MED_CURRENT_HRT	Any hormone repl. therapy
74	Medication/supplement use	226339	phv00226339.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:22:37+00:00	2018-08-24 16:22:37+00:00 	MED_DIURETIC	Diuretics
74	Medication/supplement use	226340	phv00226340.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:22:44+00:00	2018-08-24 16:22:44+00:00 	MED_DIURETIC_THIAZIDE	Thiazide diuretics
74	Medication/supplement use	226341	phv00226341.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:22:50+00:00	2018-08-24 16:22:50+00:00 	MED_ESTROGENS	Estrogens
74	Medication/supplement use	226342	phv00226342.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:23:08+00:00	2018-08-24 16:23:08+00:00 	MED_ESTROGEN_COMBO	Estrogens - combinations only
74	Medication/supplement use	226343	phv00226343.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:23:14+00:00	2018-08-24 16:23:14+00:00 	MED_FERTILITY_REG	Fertility regulators
74	Medication/supplement use	226344	phv00226344.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:23:22+00:00	2018-08-24 16:23:22+00:00 	MED_FIBARES_NICOACID	Fibric/nicotinic acids (trt of TG and HDL)
74	Medication/supplement use	226345	phv00226345.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:23:28+00:00	2018-08-24 16:23:28+00:00 	MED_INSULIN	Insulins
74	Medication/supplement use	226346	phv00226346.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:23:34+00:00	2018-08-24 16:23:34+00:00 	MED_LHRH	LHRH/GnRH only
74	Medication/supplement use	226347	phv00226347.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:23:40+00:00	2018-08-24 16:23:40+00:00 	MED_LHRH_AG	LHRH/GnRH agonist analog
74	Medication/supplement use	226348	phv00226348.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:23:46+00:00	2018-08-24 16:23:46+00:00 	MED_LHRH_ANT	LHRH/GnRH antagonists
74	Medication/supplement use	226349	phv00226349.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:23:52+00:00	2018-08-24 16:23:52+00:00 	MED_LLD	Lipid lowering drugs/antihyperlipidemics (LLD)
74	Medication/supplement use	226350	phv00226350.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:23:57+00:00	2018-08-24 16:23:57+00:00 	MED_METFORMIN	Metformins
74	Medication/supplement use	226351	phv00226351.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:24:17+00:00	2018-08-24 16:24:17+00:00 	MED_NSAID	NSAIDs
74	Medication/supplement use	226352	phv00226352.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:24:22+00:00	2018-08-24 16:24:22+00:00 	MED_OI_STEROID	Oral/inhalantable glucocorticorsteroids
74	Medication/supplement use	226353	phv00226353.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:24:28+00:00	2018-08-24 16:24:28+00:00 	MED_PROGESTINS	Progestins
74	Medication/supplement use	226354	phv00226354.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:24:34+00:00	2018-08-24 16:24:34+00:00 	MED_PULMONARY	Pulmonary medication
74	Medication/supplement use	226355	phv00226355.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:24:40+00:00	2018-08-24 16:24:40+00:00 	MED_SERM	Selective estrogen receptor modulators
74	Medication/supplement use	226356	phv00226356.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:24:48+00:00	2018-08-24 16:24:48+00:00 	MED_STATIN	Statins
74	Medication/supplement use	226361	phv00226361.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:25:59+00:00	2018-08-24 16:25:59+00:00 	MHEA16D	Diabetes - insulin Trt for diabetes self (MHEA16D)
74	Medication/supplement use	226360	phv00226360.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:26:30+00:00	2018-08-24 16:26:30+00:00 	MHEA16C	Diabetes - insulin TrtSelf (MHEA16C)
74	Medication/supplement use	258039	phv00258039.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:55:04+00:00	2018-08-24 16:55:04+00:00 	HYPERT_TREATMENT	Treatment of hypertension - NHANES
74	Medication/supplement use	258052	phv00258052.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:56:55+00:00	2018-08-24 16:56:55+00:00 	ELEVATED_BP_PLUSMEDS	Elevated blood pressure or antihypert med use
74	Medication/supplement use	258053	phv00258053.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:57:17+00:00	2018-08-24 16:57:17+00:00 	HIGH_TRIG_PLUSMEDS	High triglycerides or fibares nicoacid med use
74	Medication/supplement use	258054	phv00258054.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:57:23+00:00	2018-08-24 16:57:23+00:00 	LOW_HDL_PLUSMEDS	Low HDL or fibares nicoacid med use
74	Medication/supplement use	258055	phv00258055.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 16:57:29+00:00	2018-08-24 16:57:29+00:00 	ELEVATED_BP_SELFMEDS	Elevated blood pressure or self-reported antihypert med use
74	Medication/supplement use	258083	phv00258083.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:03:57+00:00	2018-08-24 17:03:57+00:00 	RSEA37	Medical treatment: asthma in 12 months (RSEA37)
74	Medication/supplement use	258104	phv00258104.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:05:24+00:00	2018-08-24 17:05:24+00:00 	SLEA8	Take sleeping pills (SLEA8)
74	Medication/supplement use	258117	phv00258117.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:08:18+00:00	2018-08-24 17:08:18+00:00 	THIAZIDE	Thiazide diuretic: 1=Reported taking thiazide diuretic, 0=Not exposed
74	Medication/supplement use	258118	phv00258118.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:08:23+00:00	2018-08-24 17:08:23+00:00 	TCA	Tri & tetracyclic antidepressant: 1=Reported taking tri & tetracyclic antidepressant, 0=Not exposed
74	Medication/supplement use	258119	phv00258119.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:08:33+00:00	2018-08-24 17:08:33+00:00 	SULFON	Sulfonylurea: 1=Reported taking sulfonylurea, 0=Not exposed
74	Medication/supplement use	258120	phv00258120.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:08:40+00:00	2018-08-24 17:08:40+00:00 	ORAL_BB	Oral/parental beta blockers: 1=Reported taking oral/parental beta blockers, 0=Not exposed
74	Medication/supplement use	258121	phv00258121.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:08:47+00:00	2018-08-24 17:08:47+00:00 	DILTIAZEM	Diltiazem: 1=Reported taking diltiazem, 0=Not Exposed
74	Medication/supplement use	258122	phv00258122.v1.p1	pht004715.v1.p1	phs000810.v1.p1	Hispanic Community Health Study /Study of Latinos (HCHS/SOL)	810	1	2018-08-24 17:08:52+00:00	2018-08-24 17:08:52+00:00 	VERAPAMIL	Verapamil: 1=Reported taking verapamil, 0=Not exposed
74	Medication/supplement use	252997	phv00252997.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:15:17+00:00	2018-08-24 17:15:17+00:00 	htn_med_baseline	Taking medication for hypertension at baseline visit
74	Medication/supplement use	252999	phv00252999.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:15:38+00:00	2018-08-24 17:15:38+00:00 	t2d_med_baseline	Taking medication for type 2 diabetes at baseline visit
74	Medication/supplement use	253021	phv00253021.v1.p1	pht005002.v1.p1	phs000956.v2.p1	Genetics of Cardiometabolic Health in the Amish	956	2	2018-08-24 17:22:34+00:00	2018-08-24 17:22:34+00:00 	lipid_med_baseline	Taking medication for hypercholesterolemia at baseline visit
74	Medication/supplement use	117455	phv00117455.v2.p2	pht001726.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:35:15+00:00	2018-08-24 22:35:15+00:00 	D09ASSOR	SOURCE OF ASTHMA MEDICATION. Q 24b
74	Medication/supplement use	117454	phv00117454.v2.p2	pht001726.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:35:24+00:00	2018-08-24 22:35:24+00:00 	D09ASCD4	MED CLASSIFICATION CODE 4 OF 4. Q 24a
74	Medication/supplement use	117453	phv00117453.v2.p2	pht001726.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:35:31+00:00	2018-08-24 22:35:31+00:00 	D09ASCD3	MED CLASSIFICATION CODE 3 OF 4. Q 24a
74	Medication/supplement use	117452	phv00117452.v2.p2	pht001726.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:35:38+00:00	2018-08-24 22:35:38+00:00 	D09ASCD2	MED CLASSIFICATION CODE 2 OF 4. Q 24a
74	Medication/supplement use	117451	phv00117451.v2.p2	pht001726.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:35:46+00:00	2018-08-24 22:35:46+00:00 	D09ASCD1	MED CLASSIFICATION CODE 1 OF 4. Q 24a
74	Medication/supplement use	117450	phv00117450.v2.p2	pht001726.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:35:54+00:00	2018-08-24 22:35:54+00:00 	D09ASNM	NAME OF ASTHMA MEDICATION. Q 24a
74	Medication/supplement use	117449	phv00117449.v2.p2	pht001726.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:36:01+00:00	2018-08-24 22:36:01+00:00 	D09ASNUM	MEDICATION NUMBER: ASTHMA MED
74	Medication/supplement use	117467	phv00117467.v2.p2	pht001727.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:36:35+00:00	2018-08-24 22:36:35+00:00 	D09BCCUS	DURATION OF BCP USE, SINCE LAST STARTED
74	Medication/supplement use	117466	phv00117466.v2.p2	pht001727.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:36:42+00:00	2018-08-24 22:36:42+00:00 	D09BCTUS	DURATION OF BCP USE, SINCE FIRST STARTED
74	Medication/supplement use	117465	phv00117465.v2.p2	pht001727.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:36:49+00:00	2018-08-24 22:36:49+00:00 	D09BCSOR	SOURCE OF MEDICATION NAME
74	Medication/supplement use	117464	phv00117464.v2.p2	pht001727.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:36:56+00:00	2018-08-24 22:36:56+00:00 	D09BCTMO	DURATION OF BCP USE: CURRENT, MONTHS
74	Medication/supplement use	117463	phv00117463.v2.p2	pht001727.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:37:03+00:00	2018-08-24 22:37:03+00:00 	D09BCTYR	DURATION OF BCP USE: CURRENT, YEARS
74	Medication/supplement use	117462	phv00117462.v2.p2	pht001727.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:37:13+00:00	2018-08-24 22:37:13+00:00 	D09BCTM1	DURATION OF BCP USE: TOTAL, MONTHS
74	Medication/supplement use	117461	phv00117461.v2.p2	pht001727.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:37:20+00:00	2018-08-24 22:37:20+00:00 	D09BCTY1	DURATION OF BCP USE: TOTAL, YEARS
74	Medication/supplement use	117460	phv00117460.v2.p2	pht001727.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:37:27+00:00	2018-08-24 22:37:27+00:00 	D09BCCD3	MED CLASSIFICATION CODE 3 OF 3
74	Medication/supplement use	117459	phv00117459.v2.p2	pht001727.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:37:34+00:00	2018-08-24 22:37:34+00:00 	D09BCCD2	MED CLASSIFICATION CODE 2 OF 3
74	Medication/supplement use	117458	phv00117458.v2.p2	pht001727.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:37:40+00:00	2018-08-24 22:37:40+00:00 	D09BCCD1	MED CLASSIFICATION CODE 1 OF 3
74	Medication/supplement use	117457	phv00117457.v2.p2	pht001727.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:37:47+00:00	2018-08-24 22:37:47+00:00 	D09BCNAM	BRAND OF BIRTH CONTROL PILL
74	Medication/supplement use	117476	phv00117476.v1.p2	pht001728.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:38:11+00:00	2018-08-24 22:38:11+00:00 	D09CHSOR	SOURCE OF CHOLESTEROL MEDICATION. Q 23b
74	Medication/supplement use	117475	phv00117475.v1.p2	pht001728.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:38:17+00:00	2018-08-24 22:38:17+00:00 	D09CHCD4	MED CLASSIFICATION CODE 4 OF 4. Q 23a
74	Medication/supplement use	117474	phv00117474.v1.p2	pht001728.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:38:25+00:00	2018-08-24 22:38:25+00:00 	D09CHCD3	MED CLASSIFICATION CODE 3 OF 4. Q 23a
74	Medication/supplement use	117473	phv00117473.v1.p2	pht001728.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:38:32+00:00	2018-08-24 22:38:32+00:00 	D09CHCD2	MED CLASSIFICATION CODE 2 OF 4. Q 23a
74	Medication/supplement use	117472	phv00117472.v1.p2	pht001728.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:38:40+00:00	2018-08-24 22:38:40+00:00 	D09CHCD1	MED CLASSIFICATION CODE 1 OF 4. Q 23a
74	Medication/supplement use	117471	phv00117471.v1.p2	pht001728.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:38:47+00:00	2018-08-24 22:38:47+00:00 	D09CHNM	NAME OF CHOL LOWERING MEDICATION. Q 23a
74	Medication/supplement use	117470	phv00117470.v1.p2	pht001728.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:38:54+00:00	2018-08-24 22:38:54+00:00 	D09CHNUM	MEDICATION NUMBER: CHOL LOWERING MED
74	Medication/supplement use	117485	phv00117485.v2.p2	pht001729.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:39:17+00:00	2018-08-24 22:39:17+00:00 	D09HBSOR	SOURCE OF HBP MEDICATION. Q 22b
74	Medication/supplement use	117484	phv00117484.v2.p2	pht001729.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:39:24+00:00	2018-08-24 22:39:24+00:00 	D09HBCD4	MED CLASSIFICATION CODE 4 OF 4. Q 22a
74	Medication/supplement use	117483	phv00117483.v2.p2	pht001729.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:39:32+00:00	2018-08-24 22:39:32+00:00 	D09HBCD3	MED CLASSIFICATION CODE 3 OF 4. Q 22a
74	Medication/supplement use	117482	phv00117482.v2.p2	pht001729.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:39:39+00:00	2018-08-24 22:39:39+00:00 	D09HBCD2	MED CLASSIFICATION CODE 2 OF 4. Q 22a
74	Medication/supplement use	117481	phv00117481.v2.p2	pht001729.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:42:32+00:00	2018-08-24 22:42:32+00:00 	D09HBCD1	MED CLASSIFICATION CODE 1 OF 4. Q 22a
74	Medication/supplement use	117480	phv00117480.v2.p2	pht001729.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:42:39+00:00	2018-08-24 22:42:39+00:00 	D09HBNM	NAME OF HBP MEDICATION. Q 22a
74	Medication/supplement use	117479	phv00117479.v2.p2	pht001729.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:42:45+00:00	2018-08-24 22:42:45+00:00 	D09HBNUM	MEDICATION NUMBER: HBP MED
74	Medication/supplement use	117494	phv00117494.v2.p2	pht001730.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:43:09+00:00	2018-08-24 22:43:09+00:00 	D09HMSOR	SOURCE OF HORMONE MEDICATION. Q 43b
74	Medication/supplement use	117493	phv00117493.v2.p2	pht001730.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:43:15+00:00	2018-08-24 22:43:15+00:00 	D09HMCD4	MED CLASSIFICATION CODE 4 OF 4. Q 43a
74	Medication/supplement use	117492	phv00117492.v2.p2	pht001730.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:43:21+00:00	2018-08-24 22:43:21+00:00 	D09HMCD3	MED CLASSIFICATION CODE 3 OF 4. Q 43a
74	Medication/supplement use	117491	phv00117491.v2.p2	pht001730.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:43:28+00:00	2018-08-24 22:43:28+00:00 	D09HMCD2	MED CLASSIFICATION CODE 2 OF 4. Q 43a
74	Medication/supplement use	117490	phv00117490.v2.p2	pht001730.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:43:34+00:00	2018-08-24 22:43:34+00:00 	D09HMCD1	MED CLASSIFICATION CODE 1 OF 4. Q 43a
74	Medication/supplement use	117489	phv00117489.v2.p2	pht001730.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:43:41+00:00	2018-08-24 22:43:41+00:00 	D09HMNM	NAME OF HORMONE MEDICATION. Q 43a
74	Medication/supplement use	117488	phv00117488.v2.p2	pht001730.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:43:47+00:00	2018-08-24 22:43:47+00:00 	D09HMNUM	MEDICATION NUMBER: HORMONES
74	Medication/supplement use	117504	phv00117504.v2.p2	pht001731.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:44:14+00:00	2018-08-24 22:44:14+00:00 	D09RESO	REASON FOR TAKING MEDICATION
74	Medication/supplement use	117503	phv00117503.v2.p2	pht001731.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:44:20+00:00	2018-08-24 22:44:20+00:00 	D09OTNUM	MEDICATION NUMBER: 'OTHER' MED
74	Medication/supplement use	117502	phv00117502.v2.p2	pht001731.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:44:27+00:00	2018-08-24 22:44:27+00:00 	D09OTSOR	SOURCE OF 'OTHER' MEDICATION. Q 25c
74	Medication/supplement use	117501	phv00117501.v2.p2	pht001731.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:44:34+00:00	2018-08-24 22:44:34+00:00 	D09OTCD4	MED CLASSIFICATION CODE 4 OF 4. Q 25
74	Medication/supplement use	117500	phv00117500.v2.p2	pht001731.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:44:40+00:00	2018-08-24 22:44:40+00:00 	D09OTCD3	MED CLASSIFICATION CODE 3 OF 4. Q 25
74	Medication/supplement use	117499	phv00117499.v2.p2	pht001731.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:44:48+00:00	2018-08-24 22:44:48+00:00 	D09OTCD2	MED CLASSIFICATION CODE 2 OF 4. Q 25
74	Medication/supplement use	117498	phv00117498.v2.p2	pht001731.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:44:55+00:00	2018-08-24 22:44:55+00:00 	D09OTCD1	MED CLASSIFICATION CODE 1 OF 4. Q 25
74	Medication/supplement use	117497	phv00117497.v2.p2	pht001731.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-24 22:45:02+00:00	2018-08-24 22:45:02+00:00 	D09OTNM	NAME OF 'OTHER' MEDICATION. Q 25a
74	Medication/supplement use	118387	phv00118387.v2.p2	pht001759.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 22:42:04+00:00	2018-08-28 22:42:04+00:00 	E05STERD	USING STEROIDS? Q 15
74	Medication/supplement use	118386	phv00118386.v2.p2	pht001759.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 22:42:11+00:00	2018-08-28 22:42:11+00:00 	E05INSUL	CURRENTLY TAKING INSULIN OR ORAL DRUGS? Q 14
74	Medication/supplement use	118579	phv00118579.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:00:31+00:00	2018-08-28 23:00:31+00:00 	E08BRTHC	EVER TAKEN BIRTH CONTROL PILLS? Q 42
74	Medication/supplement use	118548	phv00118548.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:00:38+00:00	2018-08-28 23:00:38+00:00 	E08ASP	TAKE ASPIRIN 3 TIMES/WK? Q 28
74	Medication/supplement use	118547	phv00118547.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:00:46+00:00	2018-08-28 23:00:46+00:00 	E08OTMED	CURRENTLY TAKING ANY OTHER MEDS. Q 27
74	Medication/supplement use	118546	phv00118546.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:00:53+00:00	2018-08-28 23:00:53+00:00 	E08ASMA	CURRENTLY TAKING MEDS FOR ASTHMA. Q 26
74	Medication/supplement use	118545	phv00118545.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:01:02+00:00	2018-08-28 23:01:02+00:00 	E08CHNOW	CURRENTLY TAKING MEDS TO LOWER CHOLEST. Q 25
74	Medication/supplement use	118544	phv00118544.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:01:12+00:00	2018-08-28 23:01:12+00:00 	E08HBNOW	CURRENTLY TAKING MEDS FOR HBP. Q 24
74	Medication/supplement use	118581	phv00118581.v2.p2	pht001761.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:01:42+00:00	2018-08-28 23:01:42+00:00 	E08HMNOW	CURRENTLY TAKING HORMONES EXCLUDING BCP? Q 44
74	Medication/supplement use	118633	phv00118633.v2.p2	pht001762.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:02:33+00:00	2018-08-28 23:02:33+00:00 	E08CPMED	CHEST PAIN/PRESSURE, ANGINA MEDICATIONS. Q 14
74	Medication/supplement use	118649	phv00118649.v2.p2	pht001765.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:03:55+00:00	2018-08-28 23:03:55+00:00 	E09MDOTH	MISS TAKING PILLS FOR ANY REASON?
74	Medication/supplement use	118648	phv00118648.v2.p2	pht001765.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:04:02+00:00	2018-08-28 23:04:02+00:00 	E09MDSCK	MISS TAKING PILLS WHEN FEELING SICK?
74	Medication/supplement use	118647	phv00118647.v2.p2	pht001765.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:04:09+00:00	2018-08-28 23:04:09+00:00 	E09MDBTR	MISS TAKING PILLS WHEN FEELING BETTER?
74	Medication/supplement use	118646	phv00118646.v2.p2	pht001765.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:04:15+00:00	2018-08-28 23:04:15+00:00 	E09MDCLS	EVER CARELESS IN TAKING PILLS?
74	Medication/supplement use	118645	phv00118645.v2.p2	pht001765.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:04:22+00:00	2018-08-28 23:04:22+00:00 	E09MDFGT	EVER FORGET TO TAKE PILLS?
74	Medication/supplement use	118653	phv00118653.v2.p2	pht001766.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:05:42+00:00	2018-08-28 23:05:42+00:00 	E09ASPRS	PURPOSE FOR TAKING ASPIRIN. Q 28b
74	Medication/supplement use	118652	phv00118652.v2.p2	pht001766.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:05:49+00:00	2018-08-28 23:05:49+00:00 	E09ASPNO	NUMBER OF ASPIRIN TAKEN PER WEEK. Q 28a
74	Medication/supplement use	118663	phv00118663.v2.p2	pht001767.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:06:22+00:00	2018-08-28 23:06:22+00:00 	E09ASNM	NAME OF ASTHMA MEDICATION. Q 26a
74	Medication/supplement use	118662	phv00118662.v2.p2	pht001767.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:06:28+00:00	2018-08-28 23:06:28+00:00 	E09ASSOR	SOURCE OF ASTHMA MEDICATION NAME. Q 26b
74	Medication/supplement use	118661	phv00118661.v2.p2	pht001767.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:06:34+00:00	2018-08-28 23:06:34+00:00 	E09ASCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	118660	phv00118660.v2.p2	pht001767.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:06:41+00:00	2018-08-28 23:06:41+00:00 	E09ASCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	118659	phv00118659.v2.p2	pht001767.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:06:49+00:00	2018-08-28 23:06:49+00:00 	E09ASCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	118658	phv00118658.v2.p2	pht001767.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:06:56+00:00	2018-08-28 23:06:56+00:00 	E09ASCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	118657	phv00118657.v2.p2	pht001767.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:07:02+00:00	2018-08-28 23:07:02+00:00 	E09ASNUM	MEDICATION NUMBER: ASTHMA MED
74	Medication/supplement use	118672	phv00118672.v1.p2	pht001768.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:07:28+00:00	2018-08-28 23:07:28+00:00 	E09CHNM	NAME OF CHOL LOWERING MED. Q 25a
74	Medication/supplement use	118671	phv00118671.v1.p2	pht001768.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:07:35+00:00	2018-08-28 23:07:35+00:00 	E09CHSOR	SOURCE OF CHOLESTEROL MED NAME. Q 25b
74	Medication/supplement use	118670	phv00118670.v1.p2	pht001768.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:07:42+00:00	2018-08-28 23:07:42+00:00 	E09CHCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	118669	phv00118669.v1.p2	pht001768.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:07:49+00:00	2018-08-28 23:07:49+00:00 	E09CHCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	118668	phv00118668.v1.p2	pht001768.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:07:56+00:00	2018-08-28 23:07:56+00:00 	E09CHCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	118667	phv00118667.v1.p2	pht001768.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:08:03+00:00	2018-08-28 23:08:03+00:00 	E09CHCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	118666	phv00118666.v1.p2	pht001768.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:08:09+00:00	2018-08-28 23:08:09+00:00 	E09CHNUM	MEDICATION NUMBER: CHOL LOWERING MED
74	Medication/supplement use	118681	phv00118681.v1.p2	pht001769.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:08:33+00:00	2018-08-28 23:08:33+00:00 	E09CPNM	NAME OF ANTI-ANGINAL MED
74	Medication/supplement use	118680	phv00118680.v1.p2	pht001769.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:08:40+00:00	2018-08-28 23:08:40+00:00 	E09CPSOR	SOURCE OF ANTI-ANGINAL MED NAME
74	Medication/supplement use	118679	phv00118679.v1.p2	pht001769.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:08:46+00:00	2018-08-28 23:08:46+00:00 	E09CPCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	118678	phv00118678.v1.p2	pht001769.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:08:52+00:00	2018-08-28 23:08:52+00:00 	E09CPCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	118677	phv00118677.v1.p2	pht001769.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:08:59+00:00	2018-08-28 23:08:59+00:00 	E09CPCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	118676	phv00118676.v1.p2	pht001769.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:09:05+00:00	2018-08-28 23:09:05+00:00 	E09CPCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	118675	phv00118675.v1.p2	pht001769.v1.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:09:13+00:00	2018-08-28 23:09:13+00:00 	E09CPNUM	MEDICATION NUMBER: ANTI-ANGINAL MED
74	Medication/supplement use	118690	phv00118690.v2.p2	pht001770.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:09:35+00:00	2018-08-28 23:09:35+00:00 	E09HBNM	NAME OF HBP MEDICATION
74	Medication/supplement use	118689	phv00118689.v2.p2	pht001770.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:09:42+00:00	2018-08-28 23:09:42+00:00 	E09HBSOR	SOURCE OF HBP MED NAME. Q 24b
74	Medication/supplement use	118688	phv00118688.v2.p2	pht001770.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:09:50+00:00	2018-08-28 23:09:50+00:00 	E09HBCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	118687	phv00118687.v2.p2	pht001770.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:09:57+00:00	2018-08-28 23:09:57+00:00 	E09HBCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	118686	phv00118686.v2.p2	pht001770.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:10:05+00:00	2018-08-28 23:10:05+00:00 	E09HBCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	118685	phv00118685.v2.p2	pht001770.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:10:13+00:00	2018-08-28 23:10:13+00:00 	E09HBCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	118684	phv00118684.v2.p2	pht001770.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:10:25+00:00	2018-08-28 23:10:25+00:00 	E09HBNUM	MEDICATION NUMBER: HBP MED. Q 24a
74	Medication/supplement use	118699	phv00118699.v2.p2	pht001771.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:10:51+00:00	2018-08-28 23:10:51+00:00 	E09HMNM	NAME OF HORMONE MEDICATION. Q 44a
74	Medication/supplement use	118698	phv00118698.v2.p2	pht001771.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:10:58+00:00	2018-08-28 23:10:58+00:00 	E09HMSOR	SOURCE OF HORMONE MED NAME. Q 44b
74	Medication/supplement use	118697	phv00118697.v2.p2	pht001771.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:11:05+00:00	2018-08-28 23:11:05+00:00 	E09HMCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	118696	phv00118696.v2.p2	pht001771.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:11:13+00:00	2018-08-28 23:11:13+00:00 	E09HMCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	118695	phv00118695.v2.p2	pht001771.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:11:20+00:00	2018-08-28 23:11:20+00:00 	E09HMCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	118694	phv00118694.v2.p2	pht001771.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:11:26+00:00	2018-08-28 23:11:26+00:00 	E09HMCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	118693	phv00118693.v2.p2	pht001771.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:11:33+00:00	2018-08-28 23:11:33+00:00 	E09HMNUM	MEDICATION NUMBER: HORMONE MED
74	Medication/supplement use	118709	phv00118709.v2.p2	pht001772.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:21:56+00:00	2018-08-28 23:21:56+00:00 	E09OCCD	PAST/CURRENT: CODE OF MOST RECENT OC USED
74	Medication/supplement use	118708	phv00118708.v2.p2	pht001772.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:22:02+00:00	2018-08-28 23:22:02+00:00 	E09OCCUR	CURRENT USER: MOS OF MOST RECENT USE
74	Medication/supplement use	118707	phv00118707.v2.p2	pht001772.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:22:09+00:00	2018-08-28 23:22:09+00:00 	E09OCLST	PAST USER: MOS SINCE LAST EPISODE OF USE
74	Medication/supplement use	118706	phv00118706.v2.p2	pht001772.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:22:15+00:00	2018-08-28 23:22:15+00:00 	E09OC3MO	USED OC IN 3 MOS BEFORE EXAM DATE
74	Medication/supplement use	118705	phv00118705.v2.p2	pht001772.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:22:22+00:00	2018-08-28 23:22:22+00:00 	E09OCLNG	LONGEST CONT INTERVAL OF OC USE (MONTHS)
74	Medication/supplement use	118704	phv00118704.v2.p2	pht001772.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:22:29+00:00	2018-08-28 23:22:29+00:00 	E09OCYR	YEAR BEGAN TO USE OC
74	Medication/supplement use	118703	phv00118703.v2.p2	pht001772.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:22:36+00:00	2018-08-28 23:22:36+00:00 	E09OCTOT	TOTAL # OF MONTHS OF OC USE
74	Medication/supplement use	118702	phv00118702.v2.p2	pht001772.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:22:42+00:00	2018-08-28 23:22:42+00:00 	E09OCNOW	OC STATUS AS OF EXAM DATE
74	Medication/supplement use	118714	phv00118714.v2.p2	pht001773.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:23:45+00:00	2018-08-28 23:23:45+00:00 	E09OTNUM	MEDICATION NUMBER: OTHER PRESCRIP MED
74	Medication/supplement use	118721	phv00118721.v2.p2	pht001773.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:23:51+00:00	2018-08-28 23:23:51+00:00 	E09RESO	REASON FOR TAKING OTHER PRESCRIPTION MED. Q 27b
74	Medication/supplement use	118720	phv00118720.v2.p2	pht001773.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:23:58+00:00	2018-08-28 23:23:58+00:00 	E09OTNM	NAME OF OTHER PRESCRIPTION MED. Q 27a
74	Medication/supplement use	118719	phv00118719.v2.p2	pht001773.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:24:04+00:00	2018-08-28 23:24:04+00:00 	E09OTSOR	SOURCE OF OTHER PRESCRIPTION MED NAME. Q 27c
74	Medication/supplement use	118718	phv00118718.v2.p2	pht001773.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:24:10+00:00	2018-08-28 23:24:10+00:00 	E09OTCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	118717	phv00118717.v2.p2	pht001773.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:24:16+00:00	2018-08-28 23:24:16+00:00 	E09OTCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	118716	phv00118716.v2.p2	pht001773.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:24:23+00:00	2018-08-28 23:24:23+00:00 	E09OTCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	118715	phv00118715.v2.p2	pht001773.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-28 23:24:29+00:00	2018-08-28 23:24:29+00:00 	E09OTCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	119289	phv00119289.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:38:43+00:00	2018-08-29 20:38:43+00:00 	E48STABF	FREQ (DAY/WEEK/MONTH) TAKEN (STRESS-TAB). Q 4
74	Medication/supplement use	119288	phv00119288.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:38:50+00:00	2018-08-29 20:38:50+00:00 	E48STABN	NUMBER TAKEN (STRESS-TAB). Q 4
74	Medication/supplement use	119287	phv00119287.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:38:57+00:00	2018-08-29 20:38:57+00:00 	E48STAB	TAKEN STRESS-TAB MULTIPLE VITAMIN? Q 4
74	Medication/supplement use	119286	phv00119286.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:39:04+00:00	2018-08-29 20:39:04+00:00 	E481DAYF	FREQ (DAY/WEEK/MONTH) TAKEN (ONE-A-DAY). Q 4
74	Medication/supplement use	119285	phv00119285.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:39:11+00:00	2018-08-29 20:39:11+00:00 	E481DAYN	NUMBER TAKEN (ONE-A-DAY). Q 4
74	Medication/supplement use	119284	phv00119284.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:39:18+00:00	2018-08-29 20:39:18+00:00 	E481DAY	TAKEN ONE-A-DAY MULTIPLE VITAMINS? Q 4
74	Medication/supplement use	119283	phv00119283.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:39:25+00:00	2018-08-29 20:39:25+00:00 	E48VIT	TAKEN VITAMINS OR MINERALS IN PAST YEAR? Q 4
74	Medication/supplement use	119298	phv00119298.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:39:48+00:00	2018-08-29 20:39:48+00:00 	E48VITBF	FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN B). Q4
74	Medication/supplement use	119297	phv00119297.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:39:55+00:00	2018-08-29 20:39:55+00:00 	E48VITBN	NUMBER TAKEN (VITAMIN B). Q 4
74	Medication/supplement use	119296	phv00119296.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:40:02+00:00	2018-08-29 20:40:02+00:00 	E48VITB	TAKEN VITAMIN B? Q 4
74	Medication/supplement use	119295	phv00119295.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:40:09+00:00	2018-08-29 20:40:09+00:00 	E48VITAF	FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN A). Q 4
74	Medication/supplement use	119294	phv00119294.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:40:15+00:00	2018-08-29 20:40:15+00:00 	E48VITAN	NUMBER TAKEN (VITAMIN A). Q 4
74	Medication/supplement use	119293	phv00119293.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:40:22+00:00	2018-08-29 20:40:22+00:00 	E48VITA	TAKEN VITAMIN A? Q 4
74	Medication/supplement use	119292	phv00119292.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:40:30+00:00	2018-08-29 20:40:30+00:00 	E48THERF	FREQ (DAY/WEEK/MONTH) TAKEN (THERAP). Q4
74	Medication/supplement use	119291	phv00119291.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:40:37+00:00	2018-08-29 20:40:37+00:00 	E48THERN	NUMBER TAKEN (THERAP/THERAGRAN TYPE). Q 4
74	Medication/supplement use	119290	phv00119290.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:40:43+00:00	2018-08-29 20:40:43+00:00 	E48THER	TAKEN THERAPEUTIC/THERAGRAN TYPE VITS? Q 4
74	Medication/supplement use	119307	phv00119307.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:41:13+00:00	2018-08-29 20:41:13+00:00 	E48BCARF	FREQ (DAY/WEEK/MONTH) TAKEN (BETA-CAROT). Q 4
74	Medication/supplement use	119306	phv00119306.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:41:19+00:00	2018-08-29 20:41:19+00:00 	E48BCARN	NUMBER TAKEN (BETA-CAROTENE). Q 4
74	Medication/supplement use	119305	phv00119305.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:41:26+00:00	2018-08-29 20:41:26+00:00 	E48BCAR	TAKEN BETA-CAROTENE? Q 4
74	Medication/supplement use	119304	phv00119304.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:41:32+00:00	2018-08-29 20:41:32+00:00 	E48VITEF	FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN E). Q4
74	Medication/supplement use	119303	phv00119303.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:41:38+00:00	2018-08-29 20:41:38+00:00 	E48VITEN	NUMBER TAKEN (VITAMIN E). Q 4
74	Medication/supplement use	119302	phv00119302.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:41:44+00:00	2018-08-29 20:41:44+00:00 	E48VITE	TAKEN VITAMIN E? Q 4
74	Medication/supplement use	119301	phv00119301.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:41:51+00:00	2018-08-29 20:41:51+00:00 	E48VITCF	FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN C). Q4
74	Medication/supplement use	119300	phv00119300.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:41:57+00:00	2018-08-29 20:41:57+00:00 	E48VITCN	NUMBER TAKEN (VITAMIN C). Q4
74	Medication/supplement use	119299	phv00119299.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:42:03+00:00	2018-08-29 20:42:03+00:00 	E48VITC	TAKEN VITAMIN C? Q 4
74	Medication/supplement use	119316	phv00119316.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:42:32+00:00	2018-08-29 20:42:32+00:00 	E48NIACF	FREQ (DAY/WEEK/MONTH) TAKEN (NIACIN). Q 4
74	Medication/supplement use	119315	phv00119315.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:42:38+00:00	2018-08-29 20:42:38+00:00 	E48NIACN	NUMBER TAKEN (NIACIN). Q 4
74	Medication/supplement use	119314	phv00119314.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:42:45+00:00	2018-08-29 20:42:45+00:00 	E48NIAC	TAKEN NIACIN? Q 4
74	Medication/supplement use	119313	phv00119313.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:42:51+00:00	2018-08-29 20:42:51+00:00 	E48FISHF	FREQ (DAY/WEEK/MONTH) TAKEN (FISH OIL). Q 4
74	Medication/supplement use	119312	phv00119312.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:42:58+00:00	2018-08-29 20:42:58+00:00 	E48FISHN	NUMBER TAKEN (FISH OIL). Q 4
74	Medication/supplement use	119311	phv00119311.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:43:05+00:00	2018-08-29 20:43:05+00:00 	E48FISH	TAKEN FISH OIL? Q 4
74	Medication/supplement use	119310	phv00119310.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:43:12+00:00	2018-08-29 20:43:12+00:00 	E48ANTIF	FREQ (DAY/WEEK/MONTH) TAKEN (ANTIOX). Q 4
74	Medication/supplement use	119309	phv00119309.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:43:18+00:00	2018-08-29 20:43:18+00:00 	E48ANTIN	NUMBER TAKEN (ANTIOXIDANT). Q 4
74	Medication/supplement use	119308	phv00119308.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:43:25+00:00	2018-08-29 20:43:25+00:00 	E48ANTI	TAKEN ANTIOXIDANT COMBINATION? Q 4
74	Medication/supplement use	119325	phv00119325.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:44:06+00:00	2018-08-29 20:44:06+00:00 	E48IRONF	FREQ (DAY/WEEK/MONTH) TAKEN (IRON). Q 4
74	Medication/supplement use	119324	phv00119324.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:44:12+00:00	2018-08-29 20:44:12+00:00 	E48IRONN	NUMBER TAKEN (IRON). Q 4
74	Medication/supplement use	119323	phv00119323.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:44:19+00:00	2018-08-29 20:44:19+00:00 	E48IRON	TAKEN IRON? Q 4
74	Medication/supplement use	119322	phv00119322.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:44:26+00:00	2018-08-29 20:44:26+00:00 	E48CALCF	FREQ (DAY/WEEK/MONTH) TAKEN (CALCIUM). Q 4
74	Medication/supplement use	119321	phv00119321.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:44:32+00:00	2018-08-29 20:44:32+00:00 	E48CALCN	NUMBER TAKEN (CALCIUM). Q 4
74	Medication/supplement use	119320	phv00119320.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:44:39+00:00	2018-08-29 20:44:39+00:00 	E48CALC	TAKEN CALCIUM? Q 4
74	Medication/supplement use	119319	phv00119319.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:44:45+00:00	2018-08-29 20:44:45+00:00 	E48SELEF	FREQ (DAY/WEEK/MONTH) TAKEN (SELENIUM). Q 4
74	Medication/supplement use	119318	phv00119318.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:44:54+00:00	2018-08-29 20:44:54+00:00 	E48SELEN	NUMBER TAKEN (SELENIUM). Q 4
74	Medication/supplement use	119317	phv00119317.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:45:00+00:00	2018-08-29 20:45:00+00:00 	E48SELE	TAKEN SELENIUM? Q 4
74	Medication/supplement use	119334	phv00119334.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:45:33+00:00	2018-08-29 20:45:33+00:00 	E48CODF	FREQ (DAY/WEEK/MONTH) TAKEN (COD LV OIL). Q 4
74	Medication/supplement use	119333	phv00119333.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:45:42+00:00	2018-08-29 20:45:42+00:00 	E48CODN	NUMBER TAKEN (COD LIVER OIL). Q4
74	Medication/supplement use	119332	phv00119332.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:45:49+00:00	2018-08-29 20:45:49+00:00 	E48COD	TAKEN COD LIVER OIL? Q 4
74	Medication/supplement use	119331	phv00119331.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:45:57+00:00	2018-08-29 20:45:57+00:00 	E48BREWF	"FREQ (DAY/WK/MO) TAKEN (BREWER""S YEAST). Q 4"
74	Medication/supplement use	119330	phv00119330.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:46:04+00:00	2018-08-29 20:46:04+00:00 	E48BREWN	"NUMBER TAKEN (BREWER""S YEAST). Q 4"
74	Medication/supplement use	119329	phv00119329.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:46:13+00:00	2018-08-29 20:46:13+00:00 	E48BREW	"TAKEN BREWER""S YEAST? Q 4"
74	Medication/supplement use	119328	phv00119328.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:46:20+00:00	2018-08-29 20:46:20+00:00 	E48ZINCF	FREQ (DAY/WEEK/MONTH) TAKEN (ZINC). Q 4
74	Medication/supplement use	119327	phv00119327.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:46:28+00:00	2018-08-29 20:46:28+00:00 	E48ZINCN	NUMBER TAKEN (ZINC). Q 4
74	Medication/supplement use	119326	phv00119326.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:46:34+00:00	2018-08-29 20:46:34+00:00 	E48ZINC	TAKEN ZINC? Q 4
74	Medication/supplement use	119340	phv00119340.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:48:16+00:00	2018-08-29 20:48:16+00:00 	E48OTHVF	FREQ (DAY/WEEK/MONTH) TAKEN (OTHER VIT). Q 4
74	Medication/supplement use	119339	phv00119339.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:48:23+00:00	2018-08-29 20:48:23+00:00 	E48OTHVN	NUMBER TAKEN (OTHER VITAMINS). Q 4
74	Medication/supplement use	119338	phv00119338.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:48:30+00:00	2018-08-29 20:48:30+00:00 	E48OTHV	TAKEN OTHER VITAMINS? Q 4
74	Medication/supplement use	119337	phv00119337.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:48:37+00:00	2018-08-29 20:48:37+00:00 	E48GARLF	FREQ (DAY/WEEK/MONTH) TAKEN (GARLIC). Q 4
74	Medication/supplement use	119336	phv00119336.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:48:43+00:00	2018-08-29 20:48:43+00:00 	E48GARLN	NUMBER TAKEN (GARLIC). Q 4
74	Medication/supplement use	119335	phv00119335.v2.p2	pht001791.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:48:50+00:00	2018-08-29 20:48:50+00:00 	E48GARL	TAKEN GARLIC? Q 4
74	Medication/supplement use	119431	phv00119431.v2.p2	pht001793.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:51:14+00:00	2018-08-29 20:51:14+00:00 	E50TWDFR	HOW OFTEN DOUBLE DIET PILLS. Q 16
74	Medication/supplement use	119430	phv00119430.v2.p2	pht001793.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:51:21+00:00	2018-08-29 20:51:21+00:00 	E50TWDP	DOUBLE DIET PILLS TO LOSE WEIGHT. Q 16
74	Medication/supplement use	119429	phv00119429.v2.p2	pht001793.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:51:28+00:00	2018-08-29 20:51:28+00:00 	E50DPFR	HOW OFTEN DIET PILLS. Q 15
74	Medication/supplement use	119428	phv00119428.v2.p2	pht001793.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:51:35+00:00	2018-08-29 20:51:35+00:00 	E50USEDP	DIET PILLS TO LOSE WEIGHT. Q 15
74	Medication/supplement use	119423	phv00119423.v2.p2	pht001793.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:51:41+00:00	2018-08-29 20:51:41+00:00 	E50DIUFR	HOW OFTEN DOUBLE DIURETICS. Q 12
74	Medication/supplement use	119422	phv00119422.v2.p2	pht001793.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:51:49+00:00	2018-08-29 20:51:49+00:00 	E50DIUR	DOUBLE DIURETICS TO LOSE WEIGHT. Q 12
74	Medication/supplement use	119421	phv00119421.v2.p2	pht001793.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:51:55+00:00	2018-08-29 20:51:55+00:00 	E50LAXFR	HOW OFTEN DOUBLE LAXATIVES. Q 11
74	Medication/supplement use	119420	phv00119420.v2.p2	pht001793.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:52:02+00:00	2018-08-29 20:52:02+00:00 	E50LAX	DOUBLE LAXATIVES TO LOSE WEIGHT. Q 11
74	Medication/supplement use	119433	phv00119433.v2.p2	pht001793.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:53:49+00:00	2018-08-29 20:53:49+00:00 	E50MLRFR	HOW OFTEN DIETARY PRODUCTS. Q 17
74	Medication/supplement use	119432	phv00119432.v2.p2	pht001793.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:53:55+00:00	2018-08-29 20:53:55+00:00 	E50MEALR	DIETARY PRODUCTS TO LOSE WEIGHT. Q 17
74	Medication/supplement use	119508	phv00119508.v2.p2	pht001795.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:58:54+00:00	2018-08-29 20:58:54+00:00 	E53MEDS	TAKE MEDS?
74	Medication/supplement use	119474	phv00119474.v2.p2	pht001795.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 20:59:40+00:00	2018-08-29 20:59:40+00:00 	E53MEDSX	TAKE MEDS-COMMENT
74	Medication/supplement use	119943	phv00119943.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:13:26+00:00	2018-08-29 21:13:26+00:00 	F08ASP	TAKE ASPIRIN 3 TIMES/WK? Q 32
74	Medication/supplement use	119942	phv00119942.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:13:33+00:00	2018-08-29 21:13:33+00:00 	F08OTMED	CURRENTLY TAKING ANY OTHER MEDS. Q 31
74	Medication/supplement use	119936	phv00119936.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:13:40+00:00	2018-08-29 21:13:40+00:00 	F08DEPMD	CURRENTLY TAKING MEDS FOR DEPRESSION. Q 30
74	Medication/supplement use	119935	phv00119935.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:13:46+00:00	2018-08-29 21:13:46+00:00 	F08ASMA	CURRENTLY TAKING MEDS FOR ASTHMA. Q 29
74	Medication/supplement use	119934	phv00119934.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:13:53+00:00	2018-08-29 21:13:53+00:00 	F08CHNOW	CURRENTLY TAKING MEDS TO LOWER CHOLEST. Q 28
74	Medication/supplement use	119933	phv00119933.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:14:00+00:00	2018-08-29 21:14:00+00:00 	F08HBNOW	CURRENTLY TAKING MEDS FOR HBP. Q 27
74	Medication/supplement use	119972	phv00119972.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:15:16+00:00	2018-08-29 21:15:16+00:00 	F08MEDS3	MED FOR INFERTILITY,POLYCYSTIC OVARIAN. Q 39b
74	Medication/supplement use	119971	phv00119971.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:15:22+00:00	2018-08-29 21:15:22+00:00 	F08MEDS2	MED FOR IRREGUL PERIODS,POLYCYSTIC OVAR. Q 39b
74	Medication/supplement use	119970	phv00119970.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:15:29+00:00	2018-08-29 21:15:29+00:00 	F08MEDS1	MED FOR HAIR GROWTH/ACNE,POLYCYSTIC OV. Q 39b
74	Medication/supplement use	119966	phv00119966.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:15:35+00:00	2018-08-29 21:15:35+00:00 	F08HMNOW	CURRENTLY TAKING HORMONES EXCLUDING BCP? Q 42
74	Medication/supplement use	119965	phv00119965.v2.p2	pht001811.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:15:41+00:00	2018-08-29 21:15:41+00:00 	F08BRTHC	EVER TAKEN BIRTH CONTROL PILLS? Q 41
74	Medication/supplement use	119992	phv00119992.v2.p2	pht001812.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:16:17+00:00	2018-08-29 21:16:17+00:00 	F09ASPRS	PURPOSE FOR TAKING ASPIRIN. Q 32b
74	Medication/supplement use	119991	phv00119991.v2.p2	pht001812.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:16:23+00:00	2018-08-29 21:16:23+00:00 	F09ASPNO	NUMBER OF ASPIRINS TAKEN PER WEEK. Q 32a
74	Medication/supplement use	120006	phv00120006.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:17:13+00:00	2018-08-29 21:17:13+00:00 	F09BCNUM	MEDICATION NUMBER. Q 41a
74	Medication/supplement use	120005	phv00120005.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:18:54+00:00	2018-08-29 21:18:54+00:00 	F09BCXD	STOP DATE: EXACT/APPROXIMATE. Q 41b.2
74	Medication/supplement use	120004	phv00120004.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:19:01+00:00	2018-08-29 21:19:01+00:00 	F09BCTM1	MONTHS SINCE LAST STARTED BCP. Q 41b.1
74	Medication/supplement use	120003	phv00120003.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:19:17+00:00	2018-08-29 21:19:17+00:00 	F09BCTY1	YEARS SINCE LAST STARTED BCP. Q 41b.1
74	Medication/supplement use	120002	phv00120002.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:19:24+00:00	2018-08-29 21:19:24+00:00 	F09BCTMO	MONTHS OF BCP ALTOGETHER. Q 41c
74	Medication/supplement use	120001	phv00120001.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:19:30+00:00	2018-08-29 21:19:30+00:00 	F09BCTYR	YEARS OF BCP ALTOGETHER. Q 41c
74	Medication/supplement use	120000	phv00120000.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:19:36+00:00	2018-08-29 21:19:36+00:00 	F09BCNOW	CURRENTLY TAKING BIRTH CONTROL PILLS? Q 41b
74	Medication/supplement use	119999	phv00119999.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:19:43+00:00	2018-08-29 21:19:43+00:00 	F09BCCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	119998	phv00119998.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:19:50+00:00	2018-08-29 21:19:50+00:00 	F09BCCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	119997	phv00119997.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:19:57+00:00	2018-08-29 21:19:57+00:00 	F09BCCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	119996	phv00119996.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:20:03+00:00	2018-08-29 21:20:03+00:00 	F09BCCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	120012	phv00120012.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:20:32+00:00	2018-08-29 21:20:32+00:00 	F09ST_DT	DATE STOPPED TAKING BCP. Q 41b.2
74	Medication/supplement use	120010	phv00120010.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:20:37+00:00	2018-08-29 21:20:37+00:00 	F09BCNAM	MEDICATION NAME
74	Medication/supplement use	120009	phv00120009.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:20:53+00:00	2018-08-29 21:20:53+00:00 	F09STPDT	DATE STOPPED TAKING BCP
74	Medication/supplement use	120008	phv00120008.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:20:59+00:00	2018-08-29 21:20:59+00:00 	F09STPMO	MONTH STOPPED TAKING BCP
74	Medication/supplement use	120007	phv00120007.v2.p2	pht001813.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:21:05+00:00	2018-08-29 21:21:05+00:00 	F09STPYR	YEAR STOPPED TAKING BCP
74	Medication/supplement use	120014	phv00120014.v2.p2	pht001814.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:23:16+00:00	2018-08-29 21:23:16+00:00 	F09MFUIT	FOLLOW-UP FOR WHICH ITEM ON FORM 8. Q 1
74	Medication/supplement use	120022	phv00120022.v2.p2	pht001814.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:23:36+00:00	2018-08-29 21:23:36+00:00 	F09RESO	REASON FOR THIS MEDICATION. Q 3
74	Medication/supplement use	120021	phv00120021.v2.p2	pht001814.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:23:42+00:00	2018-08-29 21:23:42+00:00 	F09MDSOR	SOURCE OF MEDICATION NAME. Q 4
74	Medication/supplement use	120020	phv00120020.v2.p2	pht001814.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:23:48+00:00	2018-08-29 21:23:48+00:00 	F09MDCD4	MED CLASSIFICATION CODE 4 OF 4
74	Medication/supplement use	120019	phv00120019.v2.p2	pht001814.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:23:54+00:00	2018-08-29 21:23:54+00:00 	F09MDCD3	MED CLASSIFICATION CODE 3 OF 4
74	Medication/supplement use	120018	phv00120018.v2.p2	pht001814.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:24:02+00:00	2018-08-29 21:24:02+00:00 	F09MDCD2	MED CLASSIFICATION CODE 2 OF 4
74	Medication/supplement use	120017	phv00120017.v2.p2	pht001814.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:24:09+00:00	2018-08-29 21:24:09+00:00 	F09MDCD1	MED CLASSIFICATION CODE 1 OF 4
74	Medication/supplement use	120016	phv00120016.v2.p2	pht001814.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:24:17+00:00	2018-08-29 21:24:17+00:00 	F09MDNM	MEDICATION NAME. Q 2
74	Medication/supplement use	120015	phv00120015.v2.p2	pht001814.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 21:24:23+00:00	2018-08-29 21:24:23+00:00 	F09MDNUM	MEDICATION NUMBER. Q 1
74	Medication/supplement use	120334	phv00120334.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:37:50+00:00	2018-08-29 22:37:50+00:00 	F48VITE	TAKEN VITAMIN E? Q 2
74	Medication/supplement use	120333	phv00120333.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:37:57+00:00	2018-08-29 22:37:57+00:00 	F48VITC	TAKEN VITAMIN C? Q 2
74	Medication/supplement use	120332	phv00120332.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:38:05+00:00	2018-08-29 22:38:05+00:00 	F48VITB	TAKEN VITAMIN B? Q 2
74	Medication/supplement use	120331	phv00120331.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:38:12+00:00	2018-08-29 22:38:12+00:00 	F48VITA	TAKEN VITAMIN A? Q 2
74	Medication/supplement use	120330	phv00120330.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:38:19+00:00	2018-08-29 22:38:19+00:00 	F48THER	TAKEN THERAPEUTIC/THERAGRAN TYPE VITS? Q 2
74	Medication/supplement use	120329	phv00120329.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:38:27+00:00	2018-08-29 22:38:27+00:00 	F48STAB	TAKEN STRESS-TAB MULTIPLE VITAMIN? Q 2
74	Medication/supplement use	120328	phv00120328.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:38:34+00:00	2018-08-29 22:38:34+00:00 	F481DAY	TAKEN ONE-A-DAY MULTIPLE VITAMINS? Q 2
74	Medication/supplement use	120327	phv00120327.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:38:41+00:00	2018-08-29 22:38:41+00:00 	F48VIT	TAKEN VITAMINS OR MINERALS IN PAST YEAR? Q 2
74	Medication/supplement use	120342	phv00120342.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:39:07+00:00	2018-08-29 22:39:07+00:00 	F48ZINC	TAKEN ZINC? Q 2
74	Medication/supplement use	120341	phv00120341.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:39:13+00:00	2018-08-29 22:39:13+00:00 	F48IRON	TAKEN IRON? Q 2
74	Medication/supplement use	120340	phv00120340.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:39:21+00:00	2018-08-29 22:39:21+00:00 	F48CALC	TAKEN CALCIUM? Q 2
74	Medication/supplement use	120339	phv00120339.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:39:28+00:00	2018-08-29 22:39:28+00:00 	F48SELE	TAKEN SELENIUM? Q 2
74	Medication/supplement use	120338	phv00120338.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:39:35+00:00	2018-08-29 22:39:35+00:00 	F48NIAC	TAKEN NIACIN? Q 2
74	Medication/supplement use	120337	phv00120337.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:39:41+00:00	2018-08-29 22:39:41+00:00 	F48FISH	TAKEN FISH OIL? Q 2
74	Medication/supplement use	120336	phv00120336.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:39:48+00:00	2018-08-29 22:39:48+00:00 	F48ANTI	TAKEN ANTIOXIDANT COMBINATION? Q 2
74	Medication/supplement use	120335	phv00120335.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:39:54+00:00	2018-08-29 22:39:54+00:00 	F48BCAR	TAKEN BETA-CAROTENE? Q 2
74	Medication/supplement use	120352	phv00120352.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:40:23+00:00	2018-08-29 22:40:23+00:00 	F48THERF	FREQ (DAY/WEEK/MONTH) TAKEN (THERAP). Q 2
74	Medication/supplement use	120351	phv00120351.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:40:30+00:00	2018-08-29 22:40:30+00:00 	F48THERN	NUMBER TAKEN (THERAP/THERAGRAN TYPE). Q 2
74	Medication/supplement use	120350	phv00120350.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:40:37+00:00	2018-08-29 22:40:37+00:00 	F48STABF	FREQ (DAY/WEEK/MONTH) TAKEN (STRESS-TAB). Q 2
74	Medication/supplement use	120349	phv00120349.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:40:44+00:00	2018-08-29 22:40:44+00:00 	F48STABN	NUMBER TAKEN (STRESS-TAB). Q 2
74	Medication/supplement use	120348	phv00120348.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:40:53+00:00	2018-08-29 22:40:53+00:00 	F481DAYF	FREQ (DAY/WEEK/MONTH) TAKEN (ONE-A-DAY). Q 2
74	Medication/supplement use	120347	phv00120347.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:41:00+00:00	2018-08-29 22:41:00+00:00 	F481DAYN	NUMBER TAKEN (ONE-A-DAY). Q 2
74	Medication/supplement use	120346	phv00120346.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:41:07+00:00	2018-08-29 22:41:07+00:00 	F48OTHV	TAKEN OTHER VITAMINS? Q 2
74	Medication/supplement use	120345	phv00120345.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:41:15+00:00	2018-08-29 22:41:15+00:00 	F48GARL	TAKEN GARLIC? Q 2
74	Medication/supplement use	120344	phv00120344.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:41:23+00:00	2018-08-29 22:41:23+00:00 	F48COD	TAKEN COD LIVER OIL? Q 2
74	Medication/supplement use	120343	phv00120343.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:41:29+00:00	2018-08-29 22:41:29+00:00 	F48BREW	"TAKEN BREWER""S YEAST? Q 2"
74	Medication/supplement use	120362	phv00120362.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:41:56+00:00	2018-08-29 22:41:56+00:00 	F48BCARF	FREQ (DAY/WEEK/MONTH) TAKEN (BETA-CAROT). Q 2
74	Medication/supplement use	120361	phv00120361.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:42:02+00:00	2018-08-29 22:42:02+00:00 	F48BCARN	NUMBER TAKEN (BETA-CAROTENE). Q 2
74	Medication/supplement use	120360	phv00120360.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:42:08+00:00	2018-08-29 22:42:08+00:00 	F48VITEF	FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN E). Q 2
74	Medication/supplement use	120359	phv00120359.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:42:15+00:00	2018-08-29 22:42:15+00:00 	F48VITEN	NUMBER TAKEN (VITAMIN E). Q 2
74	Medication/supplement use	120358	phv00120358.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:42:23+00:00	2018-08-29 22:42:23+00:00 	F48VITCF	FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN C). Q 2
74	Medication/supplement use	120357	phv00120357.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:42:30+00:00	2018-08-29 22:42:30+00:00 	F48VITCN	NUMBER TAKEN (VITAMIN C). Q 2
74	Medication/supplement use	120356	phv00120356.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:42:39+00:00	2018-08-29 22:42:39+00:00 	F48VITBF	FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN B). Q 2
74	Medication/supplement use	120355	phv00120355.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:42:45+00:00	2018-08-29 22:42:45+00:00 	F48VITBN	NUMBER TAKEN (VITAMIN B). Q 2
74	Medication/supplement use	120354	phv00120354.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:42:53+00:00	2018-08-29 22:42:53+00:00 	F48VITAF	FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN A). Q 2
74	Medication/supplement use	120353	phv00120353.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:43:02+00:00	2018-08-29 22:43:02+00:00 	F48VITAN	NUMBER TAKEN (VITAMIN A). Q 2
74	Medication/supplement use	120376	phv00120376.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:43:34+00:00	2018-08-29 22:43:34+00:00 	F48ZINCF	FREQ (DAY/WEEK/MONTH) TAKEN (ZINC). Q 2
74	Medication/supplement use	120375	phv00120375.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:43:40+00:00	2018-08-29 22:43:40+00:00 	F48ZINCN	NUMBER TAKEN (ZINC). Q 2
74	Medication/supplement use	120374	phv00120374.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:43:47+00:00	2018-08-29 22:43:47+00:00 	F48IRONF	FREQ (DAY/WEEK/MONTH) TAKEN (IRON). Q 2
74	Medication/supplement use	120373	phv00120373.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:43:54+00:00	2018-08-29 22:43:54+00:00 	F48IRONN	NUMBER TAKEN (IRON). Q 2
74	Medication/supplement use	120372	phv00120372.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:44:01+00:00	2018-08-29 22:44:01+00:00 	F48CALCF	FREQ (DAY/WEEK/MONTH) TAKEN (CALCIUM). Q 2
74	Medication/supplement use	120371	phv00120371.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:44:08+00:00	2018-08-29 22:44:08+00:00 	F48CALCN	NUMBER TAKEN (CALCIUM). Q 2
74	Medication/supplement use	120370	phv00120370.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:44:15+00:00	2018-08-29 22:44:15+00:00 	F48SELEF	FREQ (DAY/WEEK/MONTH) TAKEN (SELENIUM). Q 2
74	Medication/supplement use	120369	phv00120369.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:44:22+00:00	2018-08-29 22:44:22+00:00 	F48SELEN	NUMBER TAKEN (SELENIUM). Q 2
74	Medication/supplement use	120368	phv00120368.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:44:29+00:00	2018-08-29 22:44:29+00:00 	F48NIACF	FREQ (DAY/WEEK/MONTH) TAKEN (NIACIN). Q 2
74	Medication/supplement use	120367	phv00120367.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:44:36+00:00	2018-08-29 22:44:36+00:00 	F48NIACN	NUMBER TAKEN (NIACIN). Q 2
74	Medication/supplement use	120366	phv00120366.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:44:42+00:00	2018-08-29 22:44:42+00:00 	F48FISHF	FREQ (DAY/WEEK/MONTH) TAKEN (FISH OIL). Q 2
74	Medication/supplement use	120365	phv00120365.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:44:49+00:00	2018-08-29 22:44:49+00:00 	F48FISHN	NUMBER TAKEN (FISH OIL). Q 2
74	Medication/supplement use	120364	phv00120364.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:44:56+00:00	2018-08-29 22:44:56+00:00 	F48ANTIF	FREQ (DAY/WEEK/MONTH) TAKEN (ANTIOX). Q 2
74	Medication/supplement use	120363	phv00120363.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:45:02+00:00	2018-08-29 22:45:02+00:00 	F48ANTIN	NUMBER TAKEN (ANTIOXIDANT). Q 2
74	Medication/supplement use	120398	phv00120398.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:46:09+00:00	2018-08-29 22:46:09+00:00 	F48OTVTX	TEXT RESPONSE - OTHER VITAMINS TAKEN. Q 2
74	Medication/supplement use	120384	phv00120384.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:46:16+00:00	2018-08-29 22:46:16+00:00 	F48OTHVF	FREQ (DAY/WEEK/MONTH) TAKEN (OTHER VIT). Q 2
74	Medication/supplement use	120383	phv00120383.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:46:24+00:00	2018-08-29 22:46:24+00:00 	F48OTHVN	NUMBER TAKEN (OTHER VITAMINS). Q 2
74	Medication/supplement use	120382	phv00120382.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:46:31+00:00	2018-08-29 22:46:31+00:00 	F48GARLF	FREQ (DAY/WEEK/MONTH) TAKEN (GARLIC). Q 2
74	Medication/supplement use	120381	phv00120381.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:46:39+00:00	2018-08-29 22:46:39+00:00 	F48GARLN	NUMBER TAKEN (GARLIC). Q 2
74	Medication/supplement use	120380	phv00120380.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:46:46+00:00	2018-08-29 22:46:46+00:00 	F48CODF	FREQ (DAY/WEEK/MONTH) TAKEN (COD LV OIL). Q 2
74	Medication/supplement use	120379	phv00120379.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:46:53+00:00	2018-08-29 22:46:53+00:00 	F48CODN	NUMBER TAKEN (COD LIVER OIL). Q 2
74	Medication/supplement use	120378	phv00120378.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:47:02+00:00	2018-08-29 22:47:02+00:00 	F48BREWF	"FREQ (DAY/WK/MO) TAKEN (BREWER""S YEAST). Q 2"
74	Medication/supplement use	120377	phv00120377.v2.p2	pht001825.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:47:09+00:00	2018-08-29 22:47:09+00:00 	F48BREWN	"NUMBER TAKEN (BREWER""S YEAST). Q 2"
74	Medication/supplement use	120550	phv00120550.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:58:59+00:00	2018-08-29 22:58:59+00:00 	F68OTHR	USED BC FOR OTH REASON, AGE 20-30. Q 5
74	Medication/supplement use	120549	phv00120549.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:59:06+00:00	2018-08-29 22:59:06+00:00 	F68VAGBL	USED BC FOR VAGINAL BLEED, AGE 20-30. Q 5
74	Medication/supplement use	120548	phv00120548.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:59:12+00:00	2018-08-29 22:59:12+00:00 	F68PAIN	USED BC FOR PAINFUL OVUL, AGE 20-30. Q 5
74	Medication/supplement use	120547	phv00120547.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:59:18+00:00	2018-08-29 22:59:18+00:00 	F68REGPD	USED BC TO REGULATE PERIOD, AGE 20-30. Q 5
74	Medication/supplement use	120546	phv00120546.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:59:25+00:00	2018-08-29 22:59:25+00:00 	F68CRMPS	USED BC TO CONTROL CRAMPS, AGE 20-30. Q 5
74	Medication/supplement use	120545	phv00120545.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:59:32+00:00	2018-08-29 22:59:32+00:00 	F68ACNE	USED BC TO CONTROL ACNE, AGE 20-30. Q 5
74	Medication/supplement use	120544	phv00120544.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 22:59:39+00:00	2018-08-29 22:59:39+00:00 	F68BC	USED BC FOR BIRTH CONTROL, AGE 20-30. Q 5
74	Medication/supplement use	120575	phv00120575.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:01:26+00:00	2018-08-29 23:01:26+00:00 	F68YOTHR	USED BC FOR OTHER REASON, PAST 12 MOS. Q16
74	Medication/supplement use	120574	phv00120574.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:01:33+00:00	2018-08-29 23:01:33+00:00 	F68YVAGB	USED BC FOR VAGINAL BLEED, PAST 12 MOS. Q 16
74	Medication/supplement use	120573	phv00120573.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:01:39+00:00	2018-08-29 23:01:39+00:00 	F68YPAIN	USED BC FOR PAINFUL OVUL, PAST 12 MOS. Q16
74	Medication/supplement use	120572	phv00120572.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:01:46+00:00	2018-08-29 23:01:46+00:00 	F68YRGPD	USED BC TO REGULATE PERIOD, PAST 12 MOS. Q 16
74	Medication/supplement use	120571	phv00120571.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:01:53+00:00	2018-08-29 23:01:53+00:00 	F68YCRMP	USED BC TO CONTROL CRAMPS, PAST 12 MOS. Q 16
74	Medication/supplement use	120570	phv00120570.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:02:00+00:00	2018-08-29 23:02:00+00:00 	F68YACNE	USED BC TO CONTROL ACNE, PAST 12 MOS. Q 16
74	Medication/supplement use	120569	phv00120569.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:02:06+00:00	2018-08-29 23:02:06+00:00 	F68YBC	USED BC FOR BIRTH CONTROL, PAST 12 MOS. Q 16
74	Medication/supplement use	120613	phv00120613.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:03:48+00:00	2018-08-29 23:03:48+00:00 	F68OTMED	TEXT-OTH NON-PRESCRIP Rx, LAST 12 MOS. Q 25
74	Medication/supplement use	120612	phv00120612.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:03:56+00:00	2018-08-29 23:03:56+00:00 	F68YOTHT	TEXT-OTH REAS FOR BC, PAST 12 MOS. Q 16
74	Medication/supplement use	120611	phv00120611.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:04:02+00:00	2018-08-29 23:04:02+00:00 	F68OTHTC	TEXT - OTH REASON FOR BC, AGE 20-30. Q 5
74	Medication/supplement use	120589	phv00120589.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:04:08+00:00	2018-08-29 23:04:08+00:00 	F68HORMN	PRESCRIBED HORMONES FOR HOT FLASHES? Q 23a
74	Medication/supplement use	120609	phv00120609.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:06:07+00:00	2018-08-29 23:06:07+00:00 	F68NONE	TOOK NO NONPRESCRIP Rx, LAST 12 MOS. Q 25
74	Medication/supplement use	120608	phv00120608.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:06:13+00:00	2018-08-29 23:06:13+00:00 	F68OTHER	MEDICINALLY TOOK OTH TREAT, LST 12 MOS. Q 25
74	Medication/supplement use	120607	phv00120607.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:06:19+00:00	2018-08-29 23:06:19+00:00 	F68BVIT	MEDICINALLY TOOK VIT B, LAST 12 MOS. Q 25
74	Medication/supplement use	120606	phv00120606.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:06:25+00:00	2018-08-29 23:06:25+00:00 	F68GNSNG	MEDICINALLY TOOK GINS, LAST 12 MOS. Q 25
74	Medication/supplement use	120605	phv00120605.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:06:31+00:00	2018-08-29 23:06:31+00:00 	F68SJWRT	MEDICINALLY TOOK STJOHNS WRT, LST 12MOS. Q 25
74	Medication/supplement use	120604	phv00120604.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:06:38+00:00	2018-08-29 23:06:38+00:00 	F68COHOS	MEDICINALLY TOOK BLK COHSH, LAST 12 MOS. Q 25
74	Medication/supplement use	120603	phv00120603.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:06:44+00:00	2018-08-29 23:06:44+00:00 	F68PHYTE	MEDICINALLY TOOK PHYTOEST, LAST 12 MOS. Q 25
74	Medication/supplement use	120602	phv00120602.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:06:50+00:00	2018-08-29 23:06:50+00:00 	F68DHEA	MEDICINALLY TOOK DHEA , LAST 12 MOS. Q 25
74	Medication/supplement use	120601	phv00120601.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:06:57+00:00	2018-08-29 23:06:57+00:00 	F68PROGS	MEDICINALLY TOOK PROGESTER, LAST 12 MOS. Q 25
74	Medication/supplement use	120600	phv00120600.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:07:06+00:00	2018-08-29 23:07:06+00:00 	F68WDYAM	MEDICINALLY TOOK WILD YAMS, LAST 12 MOS. Q 25
74	Medication/supplement use	120576	phv00120576.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:07:44+00:00	2018-08-29 23:07:44+00:00 	F68YNOBC	DID NOT USE BC, PAST 12 MONTHS. Q16
74	Medication/supplement use	120551	phv00120551.v2.p2	pht001840.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:07:51+00:00	2018-08-29 23:07:51+00:00 	F68NOBCP	DID NOT USE BIRTH CONTROL, AGE 20-30. Q 5
74	Medication/supplement use	120716	phv00120716.v2.p2	pht001850.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:13:13+00:00	2018-08-29 23:13:13+00:00 	FHL196	6) ANY MEDS OVER COUNTER
74	Medication/supplement use	120715	phv00120715.v2.p2	pht001850.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:13:19+00:00	2018-08-29 23:13:19+00:00 	FHL195	5) ANY MEDS OVER COUNTER
74	Medication/supplement use	120714	phv00120714.v2.p2	pht001850.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:13:25+00:00	2018-08-29 23:13:25+00:00 	FHL194	4) ANY MEDS OVER COUNTER
74	Medication/supplement use	120713	phv00120713.v2.p2	pht001850.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:13:32+00:00	2018-08-29 23:13:32+00:00 	FHL193	3) ANY MEDS OVER COUNTER
74	Medication/supplement use	120712	phv00120712.v2.p2	pht001850.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:13:38+00:00	2018-08-29 23:13:38+00:00 	FHL192	2) ANY MEDS OVER COUNTER
74	Medication/supplement use	120711	phv00120711.v2.p2	pht001850.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:13:44+00:00	2018-08-29 23:13:44+00:00 	FHL191	1) ANY MEDS OVER COUNTER
74	Medication/supplement use	120747	phv00120747.v2.p2	pht001851.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-29 23:15:59+00:00	2018-08-29 23:15:59+00:00 	FDIABMED	TAKING DIABETES MEDS (1=NO,2=YES)
74	Medication/supplement use	120990	phv00120990.v2.p2	pht001856.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:03:31+00:00	2018-08-30 00:03:31+00:00 	F09MDSCK	MISS TAKING PILLS WHEN FEELING SICK?
74	Medication/supplement use	120989	phv00120989.v2.p2	pht001856.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:03:39+00:00	2018-08-30 00:03:39+00:00 	F09MDBTR	MISS TAKING PILLS WHEN FEELING BETTER?
74	Medication/supplement use	120988	phv00120988.v2.p2	pht001856.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:03:45+00:00	2018-08-30 00:03:45+00:00 	F09MDCLS	EVER CARELESS IN TAKING PILLS?
74	Medication/supplement use	120987	phv00120987.v2.p2	pht001856.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:03:54+00:00	2018-08-30 00:03:54+00:00 	F09MDFGT	EVER FORGET TO TAKE PILLS?
74	Medication/supplement use	120991	phv00120991.v2.p2	pht001856.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 00:04:03+00:00	2018-08-30 00:04:03+00:00 	F09MDOTH	MISS TAKING PILLS FOR ANY REASON?
74	Medication/supplement use	121750	phv00121750.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:15:16+00:00	2018-08-30 20:15:16+00:00 	B09ASTMO	DURATION OF ASTHMA MED USE: MONTHS. Q 4.04C
74	Medication/supplement use	121749	phv00121749.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:15:23+00:00	2018-08-30 20:15:23+00:00 	B09ASTYR	DURATION OF ASTHMA MED USE: YEARS. Q 4.04C
74	Medication/supplement use	121748	phv00121748.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:15:30+00:00	2018-08-30 20:15:30+00:00 	B09ASLUS	TIME SINCE LAST USED ASTHMA MED. Q 4.04B
74	Medication/supplement use	121747	phv00121747.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:15:36+00:00	2018-08-30 20:15:36+00:00 	B09ASNOW	TAKING MED NOW? Q 4.04A
74	Medication/supplement use	121746	phv00121746.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:15:43+00:00	2018-08-30 20:15:43+00:00 	B09ASCD4	MED CLASSIFICATION CODE 4 OF 4. Q 4.04A
74	Medication/supplement use	121745	phv00121745.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:15:49+00:00	2018-08-30 20:15:49+00:00 	B09ASCD3	MED CLASSIFICATION CODE 3 OF 4. Q 4.04A
74	Medication/supplement use	121744	phv00121744.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:15:56+00:00	2018-08-30 20:15:56+00:00 	B09ASCD2	MED CLASSIFICATION CODE 2 OF 4. Q 4.04A
74	Medication/supplement use	121743	phv00121743.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:16:03+00:00	2018-08-30 20:16:03+00:00 	B09ASCD1	MED CLASSIFICATION CODE 1 OF 4. Q 4.04A
74	Medication/supplement use	121742	phv00121742.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:16:10+00:00	2018-08-30 20:16:10+00:00 	B09ASNM	NAME OF MED. Q 4.04A
74	Medication/supplement use	121741	phv00121741.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:16:16+00:00	2018-08-30 20:16:16+00:00 	B09ASNUM	MEDICATION NUMBER :ASTHMA
74	Medication/supplement use	121740	phv00121740.v2.p2	pht001875.v2.p2	phs000285.v3.p2	Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort	285	3	2018-08-30 20:16:22+00:00	2018-08-30 20:16:22+00:00 	B09ASTUS	TOTAL DURATION OF ASTHMA MED USE: MONTHS
74	Medication/supplement use	258772	phv00258772.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 13:05:59+00:00	2018-09-06 13:05:59+00:00 	Hd_meds_name	Name of heart disease meds
74	Medication/supplement use	258774	phv00258774.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 13:06:36+00:00	2018-09-06 13:06:36+00:00 	Past_hd_meds	Have you taken heart diseasemeds in the past?
74	Medication/supplement use	258777	phv00258777.v1.p1	pht005253.v1.p1	phs000914.v1.p1	GWAS of Adiposity in Samoans	914	1	2018-09-06 13:08:04+00:00	2018-09-06 13:08:04+00:00 	Hd_traditional_meds	Are you taking traditional remedies for heart disease?
74	Medication/supplement use	121863	phv00121863.v2.p1	pht001886.v2.p1	phs000289.v2.p1	GENEVA GWAS of VTE	289	2	2018-09-07 15:51:52+00:00	2018-09-07 15:51:52+00:00 	OC_clot	Taking oral contraceptives in the three months prior to first clot
74	Medication/supplement use	169606	phv00169606.v4.p3	pht002754.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:46:06+00:00	2018-09-21 18:46:06+00:00 	MEDSEQ	F44 Medication sequence id within visit
74	Medication/supplement use	169607	phv00169607.v4.p3	pht002754.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:46:23+00:00	2018-09-21 18:46:23+00:00 	MEDNDC	F44 Medication National Drug Code (NDC)
74	Medication/supplement use	169608	phv00169608.v4.p3	pht002754.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:46:34+00:00	2018-09-21 18:46:34+00:00 	ADULTDY	F44 Adult duration of medication use (days)
74	Medication/supplement use	169609	phv00169609.v4.p3	pht002754.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:46:48+00:00	2018-09-21 18:46:48+00:00 	ADULTY	F44 Adult duration of medication use (years)
74	Medication/supplement use	169610	phv00169610.v4.p3	pht002754.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:49:41+00:00	2018-09-21 18:49:41+00:00 	CORT	F44 Oral daily use of a glucocorticosteroid
74	Medication/supplement use	169611	phv00169611.v4.p3	pht002754.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:49:51+00:00	2018-09-21 18:49:51+00:00 	TCCODE	F44 Medication Therapeutic Class Code
74	Medication/supplement use	169535	phv00169535.v4.p3	pht002751.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:51:49+00:00	2018-09-21 18:51:49+00:00 	F153SEQ	F153 Medication sequence id within form
74	Medication/supplement use	169536	phv00169536.v4.p3	pht002751.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:52:21+00:00	2018-09-21 18:52:21+00:00 	F153MEDTYPE	F153 Form section - medication type
74	Medication/supplement use	169537	phv00169537.v4.p3	pht002751.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:52:29+00:00	2018-09-21 18:52:29+00:00 	F153TAKEMED	F153 Taking this medication
74	Medication/supplement use	169538	phv00169538.v4.p3	pht002751.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:52:38+00:00	2018-09-21 18:52:38+00:00 	F153MEDNDC	F153 Medication National Drug Code (NDC)
74	Medication/supplement use	169539	phv00169539.v4.p3	pht002751.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:52:45+00:00	2018-09-21 18:52:45+00:00 	F153MEDNDCVER	F153 Medication National Drug Code (NDC) Version
74	Medication/supplement use	169540	phv00169540.v4.p3	pht002751.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:52:54+00:00	2018-09-21 18:52:54+00:00 	F153FREQ	F153 How often taking this medication
74	Medication/supplement use	169541	phv00169541.v4.p3	pht002751.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:53:03+00:00	2018-09-21 18:53:03+00:00 	F153DUR	F153 How long taking this medication
74	Medication/supplement use	169542	phv00169542.v4.p3	pht002751.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:53:16+00:00	2018-09-21 18:53:16+00:00 	F153ADULTY	F153 Adult years taking this medication
74	Medication/supplement use	169543	phv00169543.v4.p3	pht002751.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 18:53:29+00:00	2018-09-21 18:53:29+00:00 	F153TCCODE	F153 Medication Therapeutic Class Code
74	Medication/supplement use	192363	phv00192363.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45VITA	Supplemental Vitamin A, mcg RE
74	Medication/supplement use	192364	phv00192364.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45VITE	Supplemental Alpha-tocopherol, IU
74	Medication/supplement use	192365	phv00192365.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45VITB1	Supplemental Vitamin B1 (Thiamine), mg
74	Medication/supplement use	192366	phv00192366.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45VTB12	Supplemental Vitamin B12, mcg
74	Medication/supplement use	192367	phv00192367.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45VITB2	Supplemental Vitamin B2 (Riboflavin), mg
74	Medication/supplement use	192368	phv00192368.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45VITB6	Supplemental Vitamin B6, mg
74	Medication/supplement use	192369	phv00192369.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45BETA	Supplemental Beta-carotene, mcg
74	Medication/supplement use	192370	phv00192370.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45BIOT	Supplemental Biotin, mcg
74	Medication/supplement use	192371	phv00192371.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45VITC	Supplemental Vitamin C, mg
74	Medication/supplement use	192372	phv00192372.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45CALC	Supplemental Calcium, mg
74	Medication/supplement use	192373	phv00192373.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45CHROM	Supplemental Chromium, mcg
74	Medication/supplement use	192374	phv00192374.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45COPP	Supplemental Copper, mg
74	Medication/supplement use	192375	phv00192375.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45VITD	Supplemental Vitamin D, mcg
74	Medication/supplement use	192376	phv00192376.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45FOLIC	Supplemental Folic Acid, mcg
74	Medication/supplement use	192377	phv00192377.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45IRON	Supplemental Iron, mg
74	Medication/supplement use	192378	phv00192378.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45MAGN	Supplemental Magnesium, mg
74	Medication/supplement use	192379	phv00192379.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45MANG	Supplemental Manganese, mg
74	Medication/supplement use	192380	phv00192380.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45MOLYB	Supplemental Molybdenum, mcg
74	Medication/supplement use	192381	phv00192381.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45NIAC	Supplemental Niacin, mg
74	Medication/supplement use	192382	phv00192382.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45PANTO	Supplemental Pantothenic Acid, mg
74	Medication/supplement use	192383	phv00192383.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45RETIN	Supplemental Retinol, mcg
74	Medication/supplement use	192384	phv00192384.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45SELEN	Supplemental Selenium, mcg
74	Medication/supplement use	192385	phv00192385.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45ZINC	Supplemental Zinc, mg
74	Medication/supplement use	192386	phv00192386.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45MULTI	Multivitamin without Minerals
74	Medication/supplement use	192387	phv00192387.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45MVMIN	Multivitamin with Minerals
74	Medication/supplement use	192388	phv00192388.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45STRES	Stress Formula Pills
74	Medication/supplement use	192389	phv00192389.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45OTHCM	Other Comb Pill (not multivit/stress)
74	Medication/supplement use	192390	phv00192390.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:00:42+00:00	2018-09-21 19:00:42+00:00 	F45COMBP	Any Combination Pill
74	Medication/supplement use	192391	phv00192391.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKVITA	F45 Taking vitamin A from single sup
74	Medication/supplement use	192392	phv00192392.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKVITE	F45 Taking alpha-toco from single sup
74	Medication/supplement use	192393	phv00192393.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKVITB1	F45 Taking vitamin B1 from single sup
74	Medication/supplement use	192394	phv00192394.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKVITB12	F45 Taking vitamin B12 from single sup
74	Medication/supplement use	192395	phv00192395.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKVITB2	F45 Taking vitamin B2 from single sup
74	Medication/supplement use	192396	phv00192396.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKVITB6	F45 Taking vitamin B6 from single sup
74	Medication/supplement use	192397	phv00192397.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKBETA	F45 Taking beta-carotene from single sup
74	Medication/supplement use	192398	phv00192398.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKBIOT	F45 Taking biotin from single sup
74	Medication/supplement use	192399	phv00192399.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKVITC	F45 Taking vitamin C from single sup
74	Medication/supplement use	192400	phv00192400.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKCALC	F45 Taking calcium from single sup
74	Medication/supplement use	192401	phv00192401.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKCHROM	F45 Taking chromium from single sup
74	Medication/supplement use	192402	phv00192402.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKCOPP	F45 Taking copper from single sup
74	Medication/supplement use	192403	phv00192403.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKVITD	F45 Taking vitamin D from single sup
74	Medication/supplement use	192404	phv00192404.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKFOLIC	F45 Taking folic acid from single sup
74	Medication/supplement use	192405	phv00192405.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKIRON	F45 Taking iron from single sup
74	Medication/supplement use	192406	phv00192406.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKMAGN	F45 Taking magnesium from single sup
74	Medication/supplement use	192407	phv00192407.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKMANG	F45 Taking manganese from single sup
74	Medication/supplement use	192408	phv00192408.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKMOLYB	F45 Taking molybdenum from single sup
74	Medication/supplement use	192409	phv00192409.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 19:04:51+00:00	2018-09-21 19:04:51+00:00 	TKNIAC	F45 Taking niacin from single sup
74	Medication/supplement use	192410	phv00192410.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:12:53+00:00	2018-09-21 20:12:53+00:00 	TKPANTO	F45 Taking pantothenic acid from single sup
74	Medication/supplement use	192411	phv00192411.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:12:53+00:00	2018-09-21 20:12:53+00:00 	TKRETIN	F45 Taking retinol from single sup
74	Medication/supplement use	192412	phv00192412.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:12:53+00:00	2018-09-21 20:12:53+00:00 	TKSELEN	F45 Taking selenium from single sup
74	Medication/supplement use	192413	phv00192413.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:12:53+00:00	2018-09-21 20:12:53+00:00 	TKZINC	F45 Taking zinc from single sup
74	Medication/supplement use	192414	phv00192414.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:12:53+00:00	2018-09-21 20:12:53+00:00 	F45MVYR	Multivitamin without Minerals adult years taken
74	Medication/supplement use	192415	phv00192415.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:12:53+00:00	2018-09-21 20:12:53+00:00 	F45MVMYR	Multivitamin with Minerals adult years taken
74	Medication/supplement use	192416	phv00192416.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:12:53+00:00	2018-09-21 20:12:53+00:00 	F45STRYR	Stress Formula Pills adult years taken
74	Medication/supplement use	192417	phv00192417.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:12:53+00:00	2018-09-21 20:12:53+00:00 	F45OTHYR	Other Comb Pill (not multivit/stress) adult years taken
74	Medication/supplement use	192418	phv00192418.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:12:53+00:00	2018-09-21 20:12:53+00:00 	F45CALCY	Calcium adult years taken
74	Medication/supplement use	192419	phv00192419.v3.p3	pht003398.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:12:53+00:00	2018-09-21 20:12:53+00:00 	F45VITDY	Vitamin D adult years taken
74	Medication/supplement use	78511	phv00078511.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:19:00+00:00	2018-09-21 20:19:00+00:00 	HICHOLRP	High cholesterol requiring pills ever
74	Medication/supplement use	78558	phv00078558.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:21:15+00:00	2018-09-21 20:21:15+00:00 	HYPTPILL	Pills for hypertension ever
74	Medication/supplement use	78559	phv00078559.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:21:23+00:00	2018-09-21 20:21:23+00:00 	HYPTPILN	Pills for hypertension now
74	Medication/supplement use	78561	phv00078561.v6.p3	pht000999.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:21:34+00:00	2018-09-21 20:21:34+00:00 	ANGNPILN	Pills for angina now
74	Medication/supplement use	78470	phv00078470.v6.p3	pht000998.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:36:40+00:00	2018-09-21 20:36:40+00:00 	DIABPILL	Pills for diabetes ever
74	Medication/supplement use	78469	phv00078469.v6.p3	pht000998.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:36:54+00:00	2018-09-21 20:36:54+00:00 	INSULINW	Insulin shots now
74	Medication/supplement use	78468	phv00078468.v6.p3	pht000998.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:37:15+00:00	2018-09-21 20:37:15+00:00 	INSULIN	Insulin shots ever
74	Medication/supplement use	78505	phv00078505.v6.p3	pht000998.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:38:00+00:00	2018-09-21 20:38:00+00:00 	DIABTRT	Diabetes treated (pills or shots)
74	Medication/supplement use	77996	phv00077996.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:39:47+00:00	2018-09-21 20:39:47+00:00 	OSTPL_6	Used prescription osteoporosis medication
74	Medication/supplement use	78272	phv00078272.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:39:55+00:00	2018-09-21 20:39:55+00:00 	OSTPL_8	Used prescription osteoporosis medication
74	Medication/supplement use	169402	phv00169402.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:40:02+00:00	2018-09-21 20:40:02+00:00 	OSTPL_X	Used prescription osteoporosis meds
74	Medication/supplement use	77999	phv00077999.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:40:40+00:00	2018-09-21 20:40:40+00:00 	OSTUNTK_6	Don't know what kind of osteoporosis medication
74	Medication/supplement use	78280	phv00078280.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:40:48+00:00	2018-09-21 20:40:48+00:00 	OSTUNTK_8	Don't know what kind of osteoporosis medication
74	Medication/supplement use	78128	phv00078128.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:41:24+00:00	2018-09-21 20:41:24+00:00 	WTLOTHER_7	Other prescription weight loss meds
74	Medication/supplement use	78252	phv00078252.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:41:36+00:00	2018-09-21 20:41:36+00:00 	WTLOTHER_8	Other prescription weight loss meds
74	Medication/supplement use	78376	phv00078376.v6.p3	pht000996.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:41:46+00:00	2018-09-21 20:41:46+00:00 	WTLOTHER_9	Other weight loss rx meds
74	Medication/supplement use	79641	phv00079641.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:42:45+00:00	2018-09-21 20:42:45+00:00 	ESTROGEN	Estrogen past year
74	Medication/supplement use	170619	phv00170619.v4.p3	pht002769.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:42:54+00:00	2018-09-21 20:42:54+00:00 	F33ESTROGEN	F33 Estrogen or Estrogen Combination Pills
74	Medication/supplement use	170701	phv00170701.v4.p3	pht002770.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:43:02+00:00	2018-09-21 20:43:02+00:00 	F33ESTROGEN	F33 Estrogen or Estrogen Combination Pills
74	Medication/supplement use	79651	phv00079651.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:43:40+00:00	2018-09-21 20:43:40+00:00 	PROGEST	Progesterone past year
74	Medication/supplement use	193130	phv00193130.v3.p3	pht003406.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:44:16+00:00	2018-09-21 20:44:16+00:00 	AFMEDRATE	Rate control with meds
74	Medication/supplement use	193131	phv00193131.v3.p3	pht003406.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:44:23+00:00	2018-09-21 20:44:23+00:00 	AFMEDRYTHM	Rhythm control with meds
74	Medication/supplement use	193132	phv00193132.v3.p3	pht003406.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:44:48+00:00	2018-09-21 20:44:48+00:00 	AFANTICOAG	Anticoagulation meds
74	Medication/supplement use	79032	phv00079032.v6.p3	pht001005.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:45:19+00:00	2018-09-21 20:45:19+00:00 	MEDSLEEP	Take medication for sleep
74	Medication/supplement use	79184	phv00079184.v6.p3	pht001006.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:45:26+00:00	2018-09-21 20:45:26+00:00 	MEDSLEEP	Did you take medication for sleep
74	Medication/supplement use	283085	phv00283085.v1.p3	pht006214.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:45:34+00:00	2018-09-21 20:45:34+00:00 	MEDSLEEP	Did you take medication or alcohol to sleep
74	Medication/supplement use	283303	phv00283303.v1.p3	pht006217.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:45:52+00:00	2018-09-21 20:45:52+00:00 	DIABMEDS	Diabetes meds taken
74	Medication/supplement use	77712	phv00077712.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:47:55+00:00	2018-09-21 20:47:55+00:00 	OESTRANW_4	Olestra/past year
74	Medication/supplement use	79482	phv00079482.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:48:42+00:00	2018-09-21 20:48:42+00:00 	ESTR	Estratest use
74	Medication/supplement use	79483	phv00079483.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:48:51+00:00	2018-09-21 20:48:51+00:00 	ESTRMIN	Age first used estratest
74	Medication/supplement use	79484	phv00079484.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:49:05+00:00	2018-09-21 20:49:05+00:00 	ESTRMAX	Age last used estratest
74	Medication/supplement use	79485	phv00079485.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:49:16+00:00	2018-09-21 20:49:16+00:00 	ESTRSTAT	Estratest usage status
74	Medication/supplement use	79486	phv00079486.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:49:26+00:00	2018-09-21 20:49:26+00:00 	ESTRTIME	Estratest duration (years)
74	Medication/supplement use	79642	phv00079642.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:49:39+00:00	2018-09-21 20:49:39+00:00 	ESTR_M	Months used estrogen past year
74	Medication/supplement use	79643	phv00079643.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:49:48+00:00	2018-09-21 20:49:48+00:00 	ESTR_T	Type of estrogen used the longest
74	Medication/supplement use	79644	phv00079644.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:49:57+00:00	2018-09-21 20:49:57+00:00 	ESTR_P	Estrogen pill past year
74	Medication/supplement use	79645	phv00079645.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:50:06+00:00	2018-09-21 20:50:06+00:00 	ESTR_PD	Estrogen pills used, days/month
74	Medication/supplement use	79646	phv00079646.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:50:15+00:00	2018-09-21 20:50:15+00:00 	ESTR_PL	Type estrogen pill used longest
74	Medication/supplement use	79647	phv00079647.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:50:25+00:00	2018-09-21 20:50:25+00:00 	ESTR_DD	Dose of estrogen pill taken each day
74	Medication/supplement use	79648	phv00079648.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:50:35+00:00	2018-09-21 20:50:35+00:00 	ESTR_SP	Estrogen skin patch past year
74	Medication/supplement use	79649	phv00079649.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:50:43+00:00	2018-09-21 20:50:43+00:00 	ESTR_SPD	Dose of estrogen skin patch
74	Medication/supplement use	79650	phv00079650.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:50:52+00:00	2018-09-21 20:50:52+00:00 	ESTR_SPN	Times/week changed estrogen skin patch
74	Medication/supplement use	79468	phv00079468.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TOTPSTAT	Estrogen + progesterone usage status
74	Medication/supplement use	79469	phv00079469.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TOTPTIME	Lifetime estrogen + progest duration
74	Medication/supplement use	79470	phv00079470.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TOTH	HRT use ever
74	Medication/supplement use	79471	phv00079471.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TOTHCAT	HRT duration by category
74	Medication/supplement use	79472	phv00079472.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TOTHMIN	Age first used HRT
74	Medication/supplement use	79473	phv00079473.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TOTHMAX	Age last used HRT
74	Medication/supplement use	79474	phv00079474.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TOTHSTAT	HRT usage status
74	Medication/supplement use	79475	phv00079475.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TOTHTIME	Lifetime HRT duration
74	Medication/supplement use	79477	phv00079477.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TEST	Testosterone or other male hormone use
74	Medication/supplement use	79478	phv00079478.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TESTMIN	Age first used testosterone
74	Medication/supplement use	79479	phv00079479.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TESTMAX	Age last used testosterone
74	Medication/supplement use	79480	phv00079480.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TESTSTAT	Testosterone or other male hormone status
74	Medication/supplement use	79481	phv00079481.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:58:04+00:00	2018-09-21 20:58:04+00:00 	TESTTIME	Testosterone or other male hormone duration (years)
74	Medication/supplement use	79458	phv00079458.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:59:24+00:00	2018-09-21 20:59:24+00:00 	TOTE	Unopposed estrogen use ever
74	Medication/supplement use	79459	phv00079459.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:59:24+00:00	2018-09-21 20:59:24+00:00 	TOTECAT	Unopposed estrogen duration by category
74	Medication/supplement use	79460	phv00079460.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:59:24+00:00	2018-09-21 20:59:24+00:00 	TOTEMIN	Age first used unopposed estrogen
74	Medication/supplement use	79461	phv00079461.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:59:24+00:00	2018-09-21 20:59:24+00:00 	TOTEMAX	Age last used unopposed estrogen
74	Medication/supplement use	79462	phv00079462.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:59:24+00:00	2018-09-21 20:59:24+00:00 	TOTESTAT	Unopposed estrogen usage status
74	Medication/supplement use	79463	phv00079463.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:59:24+00:00	2018-09-21 20:59:24+00:00 	TOTETIME	Lifetime unopposed estrogen duration
74	Medication/supplement use	79464	phv00079464.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:59:24+00:00	2018-09-21 20:59:24+00:00 	TOTP	Estrogen + progesterone use ever
74	Medication/supplement use	79465	phv00079465.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:59:24+00:00	2018-09-21 20:59:24+00:00 	TOTPCAT	Estrogen + progesterone duration by category
74	Medication/supplement use	79466	phv00079466.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:59:24+00:00	2018-09-21 20:59:24+00:00 	TOTPMIN	Age first used estrogen + progesterone
74	Medication/supplement use	79467	phv00079467.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 20:59:24+00:00	2018-09-21 20:59:24+00:00 	TOTPMAX	Age last used estrogen + progesterone
74	Medication/supplement use	79442	phv00079442.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	OC	Oral contraceptive use ever
74	Medication/supplement use	79443	phv00079443.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	OCAGEMIN	Age first used OC
74	Medication/supplement use	79444	phv00079444.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	OCAGEMAX	Age last used OC
74	Medication/supplement use	79445	phv00079445.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	OCTIME	OC duration (years)
74	Medication/supplement use	79446	phv00079446.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	OCBPREG	OC use before first term pregnancy
74	Medication/supplement use	79447	phv00079447.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	OCBPTIME	OC use before first term preg duration (years)
74	Medication/supplement use	79448	phv00079448.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	DES	DES (diethylstilbestrol) use ever
74	Medication/supplement use	79449	phv00079449.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	DESAGEMIN	Age started DES
74	Medication/supplement use	79450	phv00079450.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	DESAGEMAX	Age stopped DES
74	Medication/supplement use	79451	phv00079451.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	DESTIME	DES Duration (years)
74	Medication/supplement use	79452	phv00079452.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	DMPA	DMPA (depo-provera) use ever
74	Medication/supplement use	79453	phv00079453.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	DMPAGEMIN	Age first used DMPA
74	Medication/supplement use	79454	phv00079454.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	DMPAGEMAX	Age last used DMPA
74	Medication/supplement use	79455	phv00079455.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	DMPATIME	DMPA duration (years)
74	Medication/supplement use	79456	phv00079456.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	DMPAFREQ	DMPA frequency of use
74	Medication/supplement use	79457	phv00079457.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:01:58+00:00	2018-09-21 21:01:58+00:00 	DMPAUOM	DMPA frequency UOM
74	Medication/supplement use	169555	phv00169555.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:03:49+00:00	2018-09-21 21:03:49+00:00 	BCANASTDUR	How long taken anastrozole
74	Medication/supplement use	169556	phv00169556.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:03:49+00:00	2018-09-21 21:03:49+00:00 	BCEXEME	Ever taken exemestane
74	Medication/supplement use	169557	phv00169557.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:03:49+00:00	2018-09-21 21:03:49+00:00 	BCEXEMEDUR	How long taken exemestane
74	Medication/supplement use	169558	phv00169558.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:03:49+00:00	2018-09-21 21:03:49+00:00 	BCLETRO	Ever taken letrozole
74	Medication/supplement use	169559	phv00169559.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:03:49+00:00	2018-09-21 21:03:49+00:00 	BCLETRODUR	How long taken letrozole
74	Medication/supplement use	169560	phv00169560.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:03:49+00:00	2018-09-21 21:03:49+00:00 	BCSERM	Ever taken other SERM or aromatase inhibitor
74	Medication/supplement use	169561	phv00169561.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:03:49+00:00	2018-09-21 21:03:49+00:00 	BCSERMDUR	How long taken this other SERM or aromatase inhibitor
74	Medication/supplement use	169548	phv00169548.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:05:28+00:00	2018-09-21 21:05:28+00:00 	BCTAMOX	Ever taken tamoxifen
74	Medication/supplement use	169549	phv00169549.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:05:28+00:00	2018-09-21 21:05:28+00:00 	BCTAMOXDUR	How long taken tamoxifen
74	Medication/supplement use	169550	phv00169550.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:05:28+00:00	2018-09-21 21:05:28+00:00 	BCRALOX	Ever taken raloxifene
74	Medication/supplement use	169551	phv00169551.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:05:28+00:00	2018-09-21 21:05:28+00:00 	BCRALOXDUR	How long taken raloxifene
74	Medication/supplement use	169552	phv00169552.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:05:28+00:00	2018-09-21 21:05:28+00:00 	BCTOREM	Ever taken toremifene
74	Medication/supplement use	169553	phv00169553.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:05:28+00:00	2018-09-21 21:05:28+00:00 	BCTOREMDUR	How long taken toremifene
74	Medication/supplement use	169554	phv00169554.v4.p3	pht002752.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:05:28+00:00	2018-09-21 21:05:28+00:00 	BCANAST	Ever taken anastrozole
74	Medication/supplement use	169466	phv00169466.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:14:33+00:00	2018-09-21 21:14:33+00:00 	PCRM_X	Used Progesterone skin cream
74	Medication/supplement use	169467	phv00169467.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:14:33+00:00	2018-09-21 21:14:33+00:00 	PCRMDUR_X	Months used Progesterone skin cream
74	Medication/supplement use	169468	phv00169468.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:14:33+00:00	2018-09-21 21:14:33+00:00 	PSHT_X	Had Progesterone shots
74	Medication/supplement use	169469	phv00169469.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:14:33+00:00	2018-09-21 21:14:33+00:00 	PSHTDUR_X	Months had Progesterone shots
74	Medication/supplement use	169470	phv00169470.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:14:33+00:00	2018-09-21 21:14:33+00:00 	PVAG_X	Used Progesterone vaginal cream
74	Medication/supplement use	169471	phv00169471.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:14:33+00:00	2018-09-21 21:14:33+00:00 	PVAGDUR_X	Months used Progesterone vaginal cream
74	Medication/supplement use	169472	phv00169472.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:14:33+00:00	2018-09-21 21:14:33+00:00 	PIUD_X	Used intrauterine Progestin device (IUD)
74	Medication/supplement use	169473	phv00169473.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:14:33+00:00	2018-09-21 21:14:33+00:00 	PIUDDUR_X	Months used Progestin IUD
74	Medication/supplement use	169474	phv00169474.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:14:33+00:00	2018-09-21 21:14:33+00:00 	EST_X	Estrogen use last year
74	Medication/supplement use	169475	phv00169475.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:14:33+00:00	2018-09-21 21:14:33+00:00 	PRG_X	Progesterone use last year
74	Medication/supplement use	169476	phv00169476.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:14:33+00:00	2018-09-21 21:14:33+00:00 	HRT_X	Hormone use last year (estrogen or progesterone)
74	Medication/supplement use	169456	phv00169456.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:15:52+00:00	2018-09-21 21:15:52+00:00 	ECRMDUR_X	Months used Estrogen skin cream
74	Medication/supplement use	169457	phv00169457.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:15:52+00:00	2018-09-21 21:15:52+00:00 	ESHT_X	Had Estrogen shots
74	Medication/supplement use	169458	phv00169458.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:15:52+00:00	2018-09-21 21:15:52+00:00 	ESHTDUR_X	Months had Estrogen shots
74	Medication/supplement use	169459	phv00169459.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:15:52+00:00	2018-09-21 21:15:52+00:00 	EVAG_X	Used Estrogen vaginal cream, ring, capsule
74	Medication/supplement use	169460	phv00169460.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:15:52+00:00	2018-09-21 21:15:52+00:00 	EVAGDUR_X	Months used vaginal forms of Estrogen
74	Medication/supplement use	169461	phv00169461.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:15:52+00:00	2018-09-21 21:15:52+00:00 	P_X	Used prescription Progesterone
74	Medication/supplement use	169462	phv00169462.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:15:52+00:00	2018-09-21 21:15:52+00:00 	PPL_X	Used Progesterone pill
74	Medication/supplement use	169463	phv00169463.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:15:52+00:00	2018-09-21 21:15:52+00:00 	PPLDUR_X	Months used Progesterone pill
74	Medication/supplement use	169465	phv00169465.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:15:52+00:00	2018-09-21 21:15:52+00:00 	PPLDAY_X	Days per month used Progesterone pill
74	Medication/supplement use	169446	phv00169446.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:18:22+00:00	2018-09-21 21:18:22+00:00 	ETPL_X	Used prescription Estrogen+Testosterone pills
74	Medication/supplement use	169447	phv00169447.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:18:22+00:00	2018-09-21 21:18:22+00:00 	ETDUR_X	Months used Estrogen+Testosterone pills
74	Medication/supplement use	169448	phv00169448.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:18:22+00:00	2018-09-21 21:18:22+00:00 	ETTYPE_X	Type of Estrogen+Testosterone pills used longest
74	Medication/supplement use	169449	phv00169449.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:18:22+00:00	2018-09-21 21:18:22+00:00 	E_X	Used prescription Estrogen
74	Medication/supplement use	169450	phv00169450.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:18:22+00:00	2018-09-21 21:18:22+00:00 	EPL_X	Used oral Estrogen pill
74	Medication/supplement use	169451	phv00169451.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:18:22+00:00	2018-09-21 21:18:22+00:00 	EPLDUR_X	Months used oral Estrogen pills
74	Medication/supplement use	169452	phv00169452.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:18:22+00:00	2018-09-21 21:18:22+00:00 	EPLTYPE_X	Kind of Oral Estrogen pills taken
74	Medication/supplement use	169453	phv00169453.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:18:22+00:00	2018-09-21 21:18:22+00:00 	EPCH_X	Used Estrogen skin patch
74	Medication/supplement use	169454	phv00169454.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:18:22+00:00	2018-09-21 21:18:22+00:00 	EPCHDUR_X	Months used Estrogen skin patch
74	Medication/supplement use	169455	phv00169455.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:18:22+00:00	2018-09-21 21:18:22+00:00 	ECRM_X	Used Estrogen skin cream
74	Medication/supplement use	169436	phv00169436.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:51:47+00:00	2018-09-21 21:51:47+00:00 	HRTEST_X	Estrogen or Progesterone - Results from test
74	Medication/supplement use	169437	phv00169437.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:51:47+00:00	2018-09-21 21:51:47+00:00 	HRMEDIA_X	Estrogen or Progesterone - Info in media
74	Medication/supplement use	169438	phv00169438.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:51:47+00:00	2018-09-21 21:51:47+00:00 	HROTH_X	Estrogen or Progesterone - Other reason
74	Medication/supplement use	169439	phv00169439.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:51:47+00:00	2018-09-21 21:51:47+00:00 	EPPLPA_X	Used prescription Estrogen+Progesterone
74	Medication/supplement use	169440	phv00169440.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:51:47+00:00	2018-09-21 21:51:47+00:00 	EPPL_X	Used Estrogen+Progesterone pill combination
74	Medication/supplement use	169441	phv00169441.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:51:47+00:00	2018-09-21 21:51:47+00:00 	EPPLDUR_X	Months used Estrogen+Progesterone pill combo
74	Medication/supplement use	169442	phv00169442.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:51:47+00:00	2018-09-21 21:51:47+00:00 	EPPA_X	Used Estrogen+Progesterone patch combination
74	Medication/supplement use	169443	phv00169443.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:51:47+00:00	2018-09-21 21:51:47+00:00 	EPPADUR_X	Months used Estrogen+Progesterone patch combo
74	Medication/supplement use	169444	phv00169444.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:51:47+00:00	2018-09-21 21:51:47+00:00 	EPOTH_X	Used Estrogen+Progesterone other combination
74	Medication/supplement use	169445	phv00169445.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:51:47+00:00	2018-09-21 21:51:47+00:00 	EPOTHDUR_X	Months used Estrogen+Progesterone other combo
74	Medication/supplement use	169416	phv00169416.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:57:01+00:00	2018-09-21 21:57:01+00:00 	NATHOR_X	Used non-prescription natural hormones
74	Medication/supplement use	169417	phv00169417.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:57:01+00:00	2018-09-21 21:57:01+00:00 	YAMCRM_X	Natural - Wild yam cream
74	Medication/supplement use	169418	phv00169418.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:57:01+00:00	2018-09-21 21:57:01+00:00 	YAMPLS_X	Natural - Wild yam pills
74	Medication/supplement use	169419	phv00169419.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:57:01+00:00	2018-09-21 21:57:01+00:00 	PRGCRM_X	Natural - Progesterone cream
74	Medication/supplement use	169420	phv00169420.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:57:01+00:00	2018-09-21 21:57:01+00:00 	PRGSUP_X	Natural - Progesterone suppositories
74	Medication/supplement use	169421	phv00169421.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:57:01+00:00	2018-09-21 21:57:01+00:00 	DHEAPL_X	Natural - DHEA pills
74	Medication/supplement use	169422	phv00169422.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:57:01+00:00	2018-09-21 21:57:01+00:00 	PHYPLS_X	Natural - Phytoestrogen pills or powder
74	Medication/supplement use	169423	phv00169423.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:57:01+00:00	2018-09-21 21:57:01+00:00 	PHYCRM_X	Natural - Phytoestrogen creams
74	Medication/supplement use	169424	phv00169424.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:57:01+00:00	2018-09-21 21:57:01+00:00 	PHYFDS_X	Natural - Phytoestrogen-enriched foods
74	Medication/supplement use	169425	phv00169425.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:57:01+00:00	2018-09-21 21:57:01+00:00 	NTOTHR_X	Natural - Other
74	Medication/supplement use	169426	phv00169426.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:57:01+00:00	2018-09-21 21:57:01+00:00 	NTDNTK_X	Natural - Don't know
74	Medication/supplement use	169427	phv00169427.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:57:01+00:00	2018-09-21 21:57:01+00:00 	HRPST1YR_X	Used prescription Estrogen or Progesterone
74	Medication/supplement use	169406	phv00169406.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:59:09+00:00	2018-09-21 21:59:09+00:00 	OSTPAMID_X	Osteoporosis - Pamidronate (Aredia)
74	Medication/supplement use	169407	phv00169407.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:59:09+00:00	2018-09-21 21:59:09+00:00 	OSTZOLEN_X	Osteoporosis - Zolendronate (Zometa)
74	Medication/supplement use	169408	phv00169408.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:59:09+00:00	2018-09-21 21:59:09+00:00 	OSTPTH_X	Osteoporosis - Parathyroid hormone (PTH,Forteo)
74	Medication/supplement use	169409	phv00169409.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:59:09+00:00	2018-09-21 21:59:09+00:00 	OSTOTHER_X	Osteoporosis - Other medication
74	Medication/supplement use	169410	phv00169410.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:59:09+00:00	2018-09-21 21:59:09+00:00 	OSTDNTK_X	Osteoporosis - Don't know medication
74	Medication/supplement use	169411	phv00169411.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:59:09+00:00	2018-09-21 21:59:09+00:00 	SRM_X	Used SERMs
74	Medication/supplement use	169412	phv00169412.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:59:09+00:00	2018-09-21 21:59:09+00:00 	SRMEVST_X	SERMs - Raloxifene (Evista)
74	Medication/supplement use	169413	phv00169413.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:59:09+00:00	2018-09-21 21:59:09+00:00 	SRMNOLV_X	SERMs - Tamoxifen (Nolvadex )
74	Medication/supplement use	169414	phv00169414.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:59:09+00:00	2018-09-21 21:59:09+00:00 	SRMOTHR_X	SERMS - Other
74	Medication/supplement use	169415	phv00169415.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 21:59:09+00:00	2018-09-21 21:59:09+00:00 	SRMDNTK_X	SERMs - Don't know
74	Medication/supplement use	77997	phv00077997.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:01:11+00:00	2018-09-21 22:01:11+00:00 	OSTALND_6	Alendronate (Fosamax)
74	Medication/supplement use	77998	phv00077998.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:01:11+00:00	2018-09-21 22:01:11+00:00 	OSTCALC_6	Calcitonin (Miacalcin)
74	Medication/supplement use	78273	phv00078273.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:01:11+00:00	2018-09-21 22:01:11+00:00 	OSTALND_8	Alendronate (Fosamax)
74	Medication/supplement use	78274	phv00078274.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:01:11+00:00	2018-09-21 22:01:11+00:00 	OSTCALC_8	Calcitonin (Miacalcin)
74	Medication/supplement use	169403	phv00169403.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:01:11+00:00	2018-09-21 22:01:11+00:00 	OSTALND_X	Osteoporosis - Alendronate (Fosamax)
74	Medication/supplement use	169404	phv00169404.v3.p3	pht002748.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:01:11+00:00	2018-09-21 22:01:11+00:00 	OSTCALC_X	Osteoporosis - Calcitonin (Miacalcin)
74	Medication/supplement use	77722	phv00077722.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:04:47+00:00	2018-09-21 22:04:47+00:00 	NATHOR_4	Natural hormones in past year
74	Medication/supplement use	77723	phv00077723.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:04:54+00:00	2018-09-21 22:04:54+00:00 	YAMCRM_4	Natural/wild yam or prog cream
74	Medication/supplement use	77724	phv00077724.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:05:02+00:00	2018-09-21 22:05:02+00:00 	YAMPLS_4	Natural/wild yam pills
74	Medication/supplement use	77725	phv00077725.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:05:09+00:00	2018-09-21 22:05:09+00:00 	PRGSUP_4	Natural/Progest suppositories
74	Medication/supplement use	77726	phv00077726.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:05:25+00:00	2018-09-21 22:05:25+00:00 	DHEAPL_4	Natural/DHEA pills
74	Medication/supplement use	77727	phv00077727.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:05:33+00:00	2018-09-21 22:05:33+00:00 	PHYPLS_4	Natural/Phytoestrogen pills
74	Medication/supplement use	77728	phv00077728.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:05:40+00:00	2018-09-21 22:05:40+00:00 	PHYCRM_4	Natural/Phytoestrogen creams
74	Medication/supplement use	77729	phv00077729.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:05:48+00:00	2018-09-21 22:05:48+00:00 	PHYFDS_4	Natural/Phytoestrogen foods
74	Medication/supplement use	77730	phv00077730.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:05:56+00:00	2018-09-21 22:05:56+00:00 	NTOTHR_4	Natural/Other
74	Medication/supplement use	77731	phv00077731.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:06:03+00:00	2018-09-21 22:06:03+00:00 	NTDNTK_4	Natural/Don't know
74	Medication/supplement use	77732	phv00077732.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:06:12+00:00	2018-09-21 22:06:12+00:00 	HRPST1YR_4	Used female hormones in past year
74	Medication/supplement use	77733	phv00077733.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:06:56+00:00	2018-09-21 22:06:56+00:00 	EPPL_4	Combined estr/progest pills
74	Medication/supplement use	77734	phv00077734.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:07:03+00:00	2018-09-21 22:07:03+00:00 	EPDUR_4	Months used estr/progest pills
74	Medication/supplement use	77735	phv00077735.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:07:10+00:00	2018-09-21 22:07:10+00:00 	ETPL_4	Combined estr/testost pills
74	Medication/supplement use	77736	phv00077736.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:07:18+00:00	2018-09-21 22:07:18+00:00 	ETDUR_4	Months used estr/testost pills
74	Medication/supplement use	77737	phv00077737.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:07:26+00:00	2018-09-21 22:07:26+00:00 	ETTYPE_4	Estr/testost pill used longest
74	Medication/supplement use	77738	phv00077738.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:07:35+00:00	2018-09-21 22:07:35+00:00 	EPL_4	Used estrogen pills
74	Medication/supplement use	77739	phv00077739.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:07:42+00:00	2018-09-21 22:07:42+00:00 	EPLDUR_4	Months used estrogen pills
74	Medication/supplement use	77741	phv00077741.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:07:49+00:00	2018-09-21 22:07:49+00:00 	EPLTYPE_4	Estrogen pills used longest
74	Medication/supplement use	77742	phv00077742.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:07:56+00:00	2018-09-21 22:07:56+00:00 	EPLDOSE_4	Estrogen pill dose per day
74	Medication/supplement use	77743	phv00077743.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:08:54+00:00	2018-09-21 22:08:54+00:00 	ESHT_4	Took estrogen shots
74	Medication/supplement use	77744	phv00077744.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:09:01+00:00	2018-09-21 22:09:01+00:00 	ESHTDUR_4	Months took estrogen shots
74	Medication/supplement use	77745	phv00077745.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:09:08+00:00	2018-09-21 22:09:08+00:00 	ECRM_4	Used estrogen vaginally
74	Medication/supplement use	77746	phv00077746.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:09:15+00:00	2018-09-21 22:09:15+00:00 	ECRMDUR_4	Months used vaginal estrogen
74	Medication/supplement use	77747	phv00077747.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:09:22+00:00	2018-09-21 22:09:22+00:00 	EPCH_4	Used estrogen skin patch
74	Medication/supplement use	77748	phv00077748.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:09:29+00:00	2018-09-21 22:09:29+00:00 	EPCHDUR_4	Months used skin patch
74	Medication/supplement use	77749	phv00077749.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:09:37+00:00	2018-09-21 22:09:37+00:00 	EPCHTYPE_4	Skin patch used longest
74	Medication/supplement use	77750	phv00077750.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:09:45+00:00	2018-09-21 22:09:45+00:00 	EPCHDOSE_4	Skin patch dose
74	Medication/supplement use	77751	phv00077751.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:09:52+00:00	2018-09-21 22:09:52+00:00 	EPCHCHNG_4	Skin patch changed per week
74	Medication/supplement use	77752	phv00077752.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:10:00+00:00	2018-09-21 22:10:00+00:00 	PPL_4	Used progesterone pills
74	Medication/supplement use	77753	phv00077753.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:10:08+00:00	2018-09-21 22:10:08+00:00 	PPLDUR_4	Months used progest pills
74	Medication/supplement use	77754	phv00077754.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:10:16+00:00	2018-09-21 22:10:16+00:00 	PPLDAY_4	Progest pills days per month
74	Medication/supplement use	77755	phv00077755.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:10:23+00:00	2018-09-21 22:10:23+00:00 	PPLTYPE_4	Progest pills used longest
74	Medication/supplement use	77756	phv00077756.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:10:31+00:00	2018-09-21 22:10:31+00:00 	PPLDOSE_4	Progest pill dose per day
74	Medication/supplement use	77794	phv00077794.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:11:15+00:00	2018-09-21 22:11:15+00:00 	EST_4	Estrogen use last year
74	Medication/supplement use	77795	phv00077795.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:11:22+00:00	2018-09-21 22:11:22+00:00 	PRG_4	Progesterone use last year
74	Medication/supplement use	77796	phv00077796.v6.p3	pht000991.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:11:28+00:00	2018-09-21 22:11:28+00:00 	HRT_4	Hormone use last year (estrogen or progesterone)
74	Medication/supplement use	77597	phv00077597.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:13:30+00:00	2018-09-21 22:13:30+00:00 	NATHOR2_3	Past 2 years used 'Natural' hormones
74	Medication/supplement use	77598	phv00077598.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:13:37+00:00	2018-09-21 22:13:37+00:00 	YAMCRM2_3	Used wild yam or progesterone creams
74	Medication/supplement use	77599	phv00077599.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:13:44+00:00	2018-09-21 22:13:44+00:00 	YAMPLS2_3	Used wild yam pills
74	Medication/supplement use	77600	phv00077600.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:13:51+00:00	2018-09-21 22:13:51+00:00 	PRGSUP2_3	Used progsterone suppositories
74	Medication/supplement use	77601	phv00077601.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:14:29+00:00	2018-09-21 22:14:29+00:00 	DHEAPL2_3	Used DHEA (dehydroepiandosterone) pills
74	Medication/supplement use	77602	phv00077602.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:14:36+00:00	2018-09-21 22:14:36+00:00 	PHYPLS2_3	Used Phytoestrogen pills (soy or flax)
74	Medication/supplement use	77603	phv00077603.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:14:45+00:00	2018-09-21 22:14:45+00:00 	PHYCRM2_3	Used Phystoestrogen creams (soy or flax)
74	Medication/supplement use	77604	phv00077604.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:14:53+00:00	2018-09-21 22:14:53+00:00 	PHYFDS2_3	Used Phytoestrogen containing foods (tofu, soybeans)
74	Medication/supplement use	77605	phv00077605.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:15:02+00:00	2018-09-21 22:15:02+00:00 	NTOTHR2_3	Used other natural hormones
74	Medication/supplement use	77606	phv00077606.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:15:12+00:00	2018-09-21 22:15:12+00:00 	NTDNTK2_3	Used unknown natural hormone
74	Medication/supplement use	77607	phv00077607.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:15:22+00:00	2018-09-21 22:15:22+00:00 	HRPST2YR_3	Past 2 years used prescribed female hormones
74	Medication/supplement use	77608	phv00077608.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:16:22+00:00	2018-09-21 22:16:22+00:00 	EPPL_3	Used Estrogen and Progestin pills
74	Medication/supplement use	77609	phv00077609.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:16:31+00:00	2018-09-21 22:16:31+00:00 	EPDUR_3	Used Estrogen and Progestin - how many months
74	Medication/supplement use	77610	phv00077610.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:16:38+00:00	2018-09-21 22:16:38+00:00 	ETPL_3	Used Estrogen and Testosterone pills
74	Medication/supplement use	77611	phv00077611.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:16:45+00:00	2018-09-21 22:16:45+00:00 	ETDUR_3	Used Estrogen and Testosterone pills - how many months
74	Medication/supplement use	77612	phv00077612.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:16:54+00:00	2018-09-21 22:16:54+00:00 	ETTYPE_3	Used Estrogen and Testosterone - what type
74	Medication/supplement use	77613	phv00077613.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:17:01+00:00	2018-09-21 22:17:01+00:00 	EPL_3	Used Estrogen pills
74	Medication/supplement use	77614	phv00077614.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:17:09+00:00	2018-09-21 22:17:09+00:00 	EPLDUR_3	Used Estrogen pills - how many months
74	Medication/supplement use	77615	phv00077615.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:17:17+00:00	2018-09-21 22:17:17+00:00 	EPLDAYS_3	Used Estrogen pills - average number of days
74	Medication/supplement use	77616	phv00077616.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:17:24+00:00	2018-09-21 22:17:24+00:00 	EPLTYPE_3	Estrogen pills used longest
74	Medication/supplement use	77617	phv00077617.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:17:33+00:00	2018-09-21 22:17:33+00:00 	EPLDOSE_3	Estrogen pills - dosage
74	Medication/supplement use	77618	phv00077618.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:17:40+00:00	2018-09-21 22:17:40+00:00 	ESHT_3	Used Estrogen shots
74	Medication/supplement use	77619	phv00077619.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:17:48+00:00	2018-09-21 22:17:48+00:00 	ESHTDUR_3	Used Estrogen shots - how many months
74	Medication/supplement use	77620	phv00077620.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:17:55+00:00	2018-09-21 22:17:55+00:00 	ECRM_3	Used Estrogen vaginal cream or suppository
74	Medication/supplement use	77621	phv00077621.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:18:03+00:00	2018-09-21 22:18:03+00:00 	ECRMDUR_3	Estrogen vaginal cream or suppository - how many months
74	Medication/supplement use	77622	phv00077622.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:18:12+00:00	2018-09-21 22:18:12+00:00 	EPCH_3	Used Estrogen skin patch containing
74	Medication/supplement use	77623	phv00077623.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:18:19+00:00	2018-09-21 22:18:19+00:00 	EPCHDUR_3	Used Estrogen skin patch - how many months
74	Medication/supplement use	77624	phv00077624.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:18:27+00:00	2018-09-21 22:18:27+00:00 	EPCHTYPE_3	Used Estrogen Skin patch - what type
74	Medication/supplement use	77625	phv00077625.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:18:35+00:00	2018-09-21 22:18:35+00:00 	EPCHDOSE_3	Estrogen skin patch - dosage
74	Medication/supplement use	77626	phv00077626.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:18:42+00:00	2018-09-21 22:18:42+00:00 	EPCHCHNG_3	Estrogen skin patch - times changed per week
74	Medication/supplement use	77627	phv00077627.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:19:07+00:00	2018-09-21 22:19:07+00:00 	PPL_3	Used Progesterone
74	Medication/supplement use	77628	phv00077628.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:19:16+00:00	2018-09-21 22:19:16+00:00 	PPLDUR_3	Used Progesterone - how many months
74	Medication/supplement use	77629	phv00077629.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:19:23+00:00	2018-09-21 22:19:23+00:00 	PPLDAY_3	Used Progesterone - average number days per month
74	Medication/supplement use	77630	phv00077630.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:19:32+00:00	2018-09-21 22:19:32+00:00 	PPLTYPE_3	Used Progesterone - what type
74	Medication/supplement use	77631	phv00077631.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:19:40+00:00	2018-09-21 22:19:40+00:00 	PPLDOSE_3	Progesterone - dosage
74	Medication/supplement use	77668	phv00077668.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:20:05+00:00	2018-09-21 22:20:05+00:00 	ELST2YR_3	Estrogen use last 2 years
74	Medication/supplement use	77669	phv00077669.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:20:12+00:00	2018-09-21 22:20:12+00:00 	PLST2YR_3	Progesterone use last 2 years
74	Medication/supplement use	77670	phv00077670.v6.p3	pht000990.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:20:19+00:00	2018-09-21 22:20:19+00:00 	HLST2YR_3	Hormone use last 2 years (estrogen or progesterone)
74	Medication/supplement use	77832	phv00077832.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:21:59+00:00	2018-09-21 22:21:59+00:00 	NATHOR_5	Natural hormones in past year
74	Medication/supplement use	77833	phv00077833.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:24:42+00:00	2018-09-21 22:24:42+00:00 	YAMCRM_5	Natural/wild yam or prog cream
74	Medication/supplement use	77834	phv00077834.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:24:49+00:00	2018-09-21 22:24:49+00:00 	YAMPLS_5	Natural/wild yam pills
74	Medication/supplement use	77835	phv00077835.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:24:56+00:00	2018-09-21 22:24:56+00:00 	PRGSUP_5	Natural/Progest suppositories
74	Medication/supplement use	77836	phv00077836.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:25:02+00:00	2018-09-21 22:25:02+00:00 	DHEAPL_5	Natural/DHEA pills
74	Medication/supplement use	77837	phv00077837.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:25:10+00:00	2018-09-21 22:25:10+00:00 	PHYPLS_5	Natural/Phytoestrogen pills
74	Medication/supplement use	77838	phv00077838.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:25:18+00:00	2018-09-21 22:25:18+00:00 	PHYCRM_5	Natural/Phytoestrogen creams
74	Medication/supplement use	77839	phv00077839.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:26:00+00:00	2018-09-21 22:26:00+00:00 	PHYFDS_5	Natural/Phytoestrogen foods
74	Medication/supplement use	77840	phv00077840.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:26:08+00:00	2018-09-21 22:26:08+00:00 	NTOTHR_5	Natural/Other
74	Medication/supplement use	77841	phv00077841.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:26:14+00:00	2018-09-21 22:26:14+00:00 	NTDNTK_5	Natural/Don't know
74	Medication/supplement use	77842	phv00077842.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:26:22+00:00	2018-09-21 22:26:22+00:00 	HRPST1YR_5	Used female hormones/past year
74	Medication/supplement use	77843	phv00077843.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:26:28+00:00	2018-09-21 22:26:28+00:00 	EPPL_5	Combined estr/progest pills
74	Medication/supplement use	77844	phv00077844.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:26:37+00:00	2018-09-21 22:26:37+00:00 	EPDUR_5	Months used estr/progest pills
74	Medication/supplement use	77845	phv00077845.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:26:44+00:00	2018-09-21 22:26:44+00:00 	ETPL_5	Combined estr/testost pills
74	Medication/supplement use	77846	phv00077846.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:26:51+00:00	2018-09-21 22:26:51+00:00 	ETDUR_5	Months used estr/testost pills
74	Medication/supplement use	77847	phv00077847.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:26:59+00:00	2018-09-21 22:26:59+00:00 	ETTYPE_5	Estr/testost pill used longest
74	Medication/supplement use	77848	phv00077848.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:27:42+00:00	2018-09-21 22:27:42+00:00 	EPL_5	Used estrogen pills
74	Medication/supplement use	77849	phv00077849.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:27:49+00:00	2018-09-21 22:27:49+00:00 	EPLDUR_5	Months used estrogen pills
74	Medication/supplement use	77850	phv00077850.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:27:56+00:00	2018-09-21 22:27:56+00:00 	EPLDAYS_5	Estrogen pills days per month
74	Medication/supplement use	77851	phv00077851.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:28:03+00:00	2018-09-21 22:28:03+00:00 	EPLTYPE_5	Estrogen pills used longest
74	Medication/supplement use	77852	phv00077852.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:28:10+00:00	2018-09-21 22:28:10+00:00 	EPLDOSE_5	Estrogen pill dose per day
74	Medication/supplement use	77853	phv00077853.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:28:16+00:00	2018-09-21 22:28:16+00:00 	ESHT_5	Took estrogen shots
74	Medication/supplement use	77854	phv00077854.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:28:24+00:00	2018-09-21 22:28:24+00:00 	ESHTDUR_5	Months took estrogen shots
74	Medication/supplement use	77855	phv00077855.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:28:31+00:00	2018-09-21 22:28:31+00:00 	ECRM_5	Used estrogen vaginally
74	Medication/supplement use	77856	phv00077856.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:28:38+00:00	2018-09-21 22:28:38+00:00 	ECRMDUR_5	Months used vaginal estrogen
74	Medication/supplement use	77857	phv00077857.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:28:44+00:00	2018-09-21 22:28:44+00:00 	EPCH_5	Used estrogen skin patch
74	Medication/supplement use	77858	phv00077858.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:28:50+00:00	2018-09-21 22:28:50+00:00 	EPCHDUR_5	Months used skin patch
74	Medication/supplement use	77859	phv00077859.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:28:57+00:00	2018-09-21 22:28:57+00:00 	EPCHTYPE_5	Skin patch used longest
74	Medication/supplement use	77860	phv00077860.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:29:04+00:00	2018-09-21 22:29:04+00:00 	EPCHDOSE_5	Skin patch dose
74	Medication/supplement use	77861	phv00077861.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:29:10+00:00	2018-09-21 22:29:10+00:00 	EPCHCHNG_5	Skin patch changed per week
74	Medication/supplement use	77866	phv00077866.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:29:44+00:00	2018-09-21 22:29:44+00:00 	PPLDOSE_5	Progest pill dose per day
74	Medication/supplement use	77865	phv00077865.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:29:51+00:00	2018-09-21 22:29:51+00:00 	PPLTYPE_5	Progest pills used longest
74	Medication/supplement use	77864	phv00077864.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:30:02+00:00	2018-09-21 22:30:02+00:00 	PPLDAY_5	Progest pills days per month
74	Medication/supplement use	77863	phv00077863.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:30:11+00:00	2018-09-21 22:30:11+00:00 	PPLDUR_5	Months used progest pills
74	Medication/supplement use	77862	phv00077862.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:30:21+00:00	2018-09-21 22:30:21+00:00 	PPL_5	Used progesterone pills
74	Medication/supplement use	77904	phv00077904.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:30:42+00:00	2018-09-21 22:30:42+00:00 	EST_5	Estrogen use last year
74	Medication/supplement use	77905	phv00077905.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:30:48+00:00	2018-09-21 22:30:48+00:00 	PRG_5	Progesterone use last year
74	Medication/supplement use	77906	phv00077906.v6.p3	pht000992.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:30:54+00:00	2018-09-21 22:30:54+00:00 	HRT_5	Hormone use last year (estrogen or progesterone)
74	Medication/supplement use	77985	phv00077985.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:32:15+00:00	2018-09-21 22:32:15+00:00 	NATHOR_6	Natural hormones in past year
74	Medication/supplement use	77986	phv00077986.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:32:23+00:00	2018-09-21 22:32:23+00:00 	YAMCRM_6	Natural/wild yam cream
74	Medication/supplement use	77987	phv00077987.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:32:29+00:00	2018-09-21 22:32:29+00:00 	YAMPLS_6	Natural/Wild yam pills
74	Medication/supplement use	77988	phv00077988.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:32:38+00:00	2018-09-21 22:32:38+00:00 	PRGCRM_6	Natural/Progesterone cream
74	Medication/supplement use	77989	phv00077989.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:32:45+00:00	2018-09-21 22:32:45+00:00 	PRGSUP_6	Natural/Progest suppositories
74	Medication/supplement use	77990	phv00077990.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:32:53+00:00	2018-09-21 22:32:53+00:00 	DHEAPL_6	Natural/DHEA pills
74	Medication/supplement use	77991	phv00077991.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:33:00+00:00	2018-09-21 22:33:00+00:00 	PHYPLS_6	Natural/Phytoest pills/powder
74	Medication/supplement use	77992	phv00077992.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:33:06+00:00	2018-09-21 22:33:06+00:00 	PHYCRM_6	Natural/Phytoestrogen creams
74	Medication/supplement use	77993	phv00077993.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:33:13+00:00	2018-09-21 22:33:13+00:00 	PHYFDS_6	Natural/Phytoestrogen foods
74	Medication/supplement use	77994	phv00077994.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:33:20+00:00	2018-09-21 22:33:20+00:00 	NTOTHR_6	Natural/Other
74	Medication/supplement use	77995	phv00077995.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:33:27+00:00	2018-09-21 22:33:27+00:00 	NTDNTK_6	Natural/Don't know
74	Medication/supplement use	78000	phv00078000.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:34:06+00:00	2018-09-21 22:34:06+00:00 	SRM_6	Use non-estrogen prescription
74	Medication/supplement use	78001	phv00078001.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:34:14+00:00	2018-09-21 22:34:14+00:00 	SRMEVST_6	Non-estrogen rx/Evista (Raloxifene)
74	Medication/supplement use	78002	phv00078002.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:34:22+00:00	2018-09-21 22:34:22+00:00 	SRMNOLU_6	Non-estrogen rx/Nolvadex (Tamoxifen)
74	Medication/supplement use	78003	phv00078003.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:34:29+00:00	2018-09-21 22:34:29+00:00 	SRMOTHR_6	Non-estrogen rx/Other
74	Medication/supplement use	78004	phv00078004.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:34:35+00:00	2018-09-21 22:34:35+00:00 	SRMDNTK_6	Non-estrogen rx/Don't know
74	Medication/supplement use	78005	phv00078005.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:34:43+00:00	2018-09-21 22:34:43+00:00 	HRPST1YR_6	Used female hormones/past year
74	Medication/supplement use	78006	phv00078006.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:34:50+00:00	2018-09-21 22:34:50+00:00 	EPPLPA_6	Comb estr/progest pills/patch
74	Medication/supplement use	78007	phv00078007.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:34:57+00:00	2018-09-21 22:34:57+00:00 	EPDUR_6	Months comb estr/progesterone
74	Medication/supplement use	78008	phv00078008.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:35:46+00:00	2018-09-21 22:35:46+00:00 	EPTYPE_6	Which estr/progest combination
74	Medication/supplement use	78009	phv00078009.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:35:53+00:00	2018-09-21 22:35:53+00:00 	ETPL_6	Combined estr/testost pills
74	Medication/supplement use	78010	phv00078010.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:35:59+00:00	2018-09-21 22:35:59+00:00 	ETDUR_6	Months used estr/testost pills
74	Medication/supplement use	78011	phv00078011.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:36:06+00:00	2018-09-21 22:36:06+00:00 	ETTYPE_6	Estr/testost pill used longest
74	Medication/supplement use	78012	phv00078012.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:36:14+00:00	2018-09-21 22:36:14+00:00 	E_6	Estrogen pill,patch,cream,shot
74	Medication/supplement use	78013	phv00078013.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:36:20+00:00	2018-09-21 22:36:20+00:00 	EPL_6	Did you use any Estrogen pill
74	Medication/supplement use	78014	phv00078014.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:36:27+00:00	2018-09-21 22:36:27+00:00 	EPLDUR_6	Months used estrogen pills
74	Medication/supplement use	78015	phv00078015.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:36:33+00:00	2018-09-21 22:36:33+00:00 	EPLTYPE_6	Kind of estrogen pills
74	Medication/supplement use	78016	phv00078016.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:36:40+00:00	2018-09-21 22:36:40+00:00 	EPCH_6	Did you use an estrogen patch?
74	Medication/supplement use	78017	phv00078017.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:36:47+00:00	2018-09-21 22:36:47+00:00 	EPCHDUR_6	How many months used patch?
74	Medication/supplement use	78018	phv00078018.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:36:55+00:00	2018-09-21 22:36:55+00:00 	ECRM_6	Did you use an estrogen cream?
74	Medication/supplement use	78019	phv00078019.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:37:01+00:00	2018-09-21 22:37:01+00:00 	ECRMDUR_6	How many months used cream?
74	Medication/supplement use	78020	phv00078020.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:37:08+00:00	2018-09-21 22:37:08+00:00 	ESHT_6	Estrogen shots
74	Medication/supplement use	78021	phv00078021.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:37:15+00:00	2018-09-21 22:37:15+00:00 	ESHTDUR_6	Months took estrogen shots
74	Medication/supplement use	78022	phv00078022.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:37:45+00:00	2018-09-21 22:37:45+00:00 	P_6	Progesterone pill, cream shot
74	Medication/supplement use	78023	phv00078023.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:37:51+00:00	2018-09-21 22:37:51+00:00 	PPL_6	Progesterone pill or capsule
74	Medication/supplement use	78024	phv00078024.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:37:58+00:00	2018-09-21 22:37:58+00:00 	PPLDUR_6	Months progesterone pill/ caps
74	Medication/supplement use	78025	phv00078025.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:38:07+00:00	2018-09-21 22:38:07+00:00 	PPLTYPE_6	Kind of progesterone
74	Medication/supplement use	78026	phv00078026.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:38:14+00:00	2018-09-21 22:38:14+00:00 	PPLDAY_6	Progest pills days per month
74	Medication/supplement use	78027	phv00078027.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:38:20+00:00	2018-09-21 22:38:20+00:00 	PCRM_6	Progesterone/Progestin cream
74	Medication/supplement use	78028	phv00078028.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:38:27+00:00	2018-09-21 22:38:27+00:00 	PCRMDUR_6	Months used progesterone cream
74	Medication/supplement use	78029	phv00078029.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:38:33+00:00	2018-09-21 22:38:33+00:00 	PSHT_6	Have progesterone shots
74	Medication/supplement use	78030	phv00078030.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:38:40+00:00	2018-09-21 22:38:40+00:00 	PSHTDUR_6	Months used progesterone shots
74	Medication/supplement use	78108	phv00078108.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:39:14+00:00	2018-09-21 22:39:14+00:00 	HRT_6	Hormone use last year (estrogen or progesterone)
74	Medication/supplement use	78106	phv00078106.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:39:20+00:00	2018-09-21 22:39:20+00:00 	EST_6	Estrogen use last year
74	Medication/supplement use	78107	phv00078107.v6.p3	pht000993.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:39:28+00:00	2018-09-21 22:39:28+00:00 	PRG_6	Progesterone use last year
74	Medication/supplement use	78129	phv00078129.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:40:13+00:00	2018-09-21 22:40:13+00:00 	NATHOR_7	Natural hormones in past year
74	Medication/supplement use	78130	phv00078130.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:40:20+00:00	2018-09-21 22:40:20+00:00 	YAMCRM_7	Natural/wild yam cream
74	Medication/supplement use	78131	phv00078131.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:40:26+00:00	2018-09-21 22:40:26+00:00 	YAMPLS_7	Natural/Wild yam pills
74	Medication/supplement use	78132	phv00078132.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:40:37+00:00	2018-09-21 22:40:37+00:00 	PRGCRM_7	Natural/Progesterone cream
74	Medication/supplement use	78133	phv00078133.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:40:44+00:00	2018-09-21 22:40:44+00:00 	PRGSUP_7	Natural/Progest suppositories
74	Medication/supplement use	78134	phv00078134.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:40:51+00:00	2018-09-21 22:40:51+00:00 	DHEAPL_7	Natural/DHEA pills
74	Medication/supplement use	78135	phv00078135.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:40:59+00:00	2018-09-21 22:40:59+00:00 	PHYPLS_7	Natural/Phytoest pills/powder
74	Medication/supplement use	78136	phv00078136.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:41:06+00:00	2018-09-21 22:41:06+00:00 	PHYCRM_7	Natural/Phytoestrogen creams
74	Medication/supplement use	78137	phv00078137.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:41:14+00:00	2018-09-21 22:41:14+00:00 	PHYFDS_7	Natural/Phytoestrogen foods
74	Medication/supplement use	78138	phv00078138.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:41:24+00:00	2018-09-21 22:41:24+00:00 	NTOTHR_7	Natural/Other
74	Medication/supplement use	78139	phv00078139.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:41:31+00:00	2018-09-21 22:41:31+00:00 	NTDNTK_7	Natural/Don't know
74	Medication/supplement use	78140	phv00078140.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:42:08+00:00	2018-09-21 22:42:08+00:00 	SRM_7	Use non-estrogen prescription?
74	Medication/supplement use	78141	phv00078141.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:42:15+00:00	2018-09-21 22:42:15+00:00 	SRMEVST_7	Evista (Raloxifene)
74	Medication/supplement use	78142	phv00078142.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:42:21+00:00	2018-09-21 22:42:21+00:00 	SRMNOLU_7	Nolvadex (Tamoxifen)
74	Medication/supplement use	78143	phv00078143.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:42:27+00:00	2018-09-21 22:42:27+00:00 	SRMOTHR_7	Other/ non-estrogen
74	Medication/supplement use	78144	phv00078144.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:42:34+00:00	2018-09-21 22:42:34+00:00 	SRMDNTK_7	Don't know/non-estrogen
74	Medication/supplement use	78145	phv00078145.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:42:40+00:00	2018-09-21 22:42:40+00:00 	HRPST1YR_7	Used female hormones/past year
74	Medication/supplement use	78146	phv00078146.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:42:47+00:00	2018-09-21 22:42:47+00:00 	EPPLPA_7	Comb estr/progest pills/patch
74	Medication/supplement use	78147	phv00078147.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:42:54+00:00	2018-09-21 22:42:54+00:00 	EPDUR_7	Months comb estr/progesterone
74	Medication/supplement use	78148	phv00078148.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:43:00+00:00	2018-09-21 22:43:00+00:00 	EPTYPE_7	Which estr/progest combination
74	Medication/supplement use	78149	phv00078149.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:43:07+00:00	2018-09-21 22:43:07+00:00 	ETPL_7	Combined estr/testost pills
74	Medication/supplement use	78150	phv00078150.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:43:14+00:00	2018-09-21 22:43:14+00:00 	ETDUR_7	Months used estr/testost pills
74	Medication/supplement use	78151	phv00078151.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:43:21+00:00	2018-09-21 22:43:21+00:00 	ETTYPE_7	Estr/testost pill used longest
74	Medication/supplement use	78152	phv00078152.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:43:29+00:00	2018-09-21 22:43:29+00:00 	E_7	Estrogen pill,patch,cream,shot
74	Medication/supplement use	78153	phv00078153.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:43:36+00:00	2018-09-21 22:43:36+00:00 	EPL_7	Did you use any Estrogen pill
74	Medication/supplement use	78154	phv00078154.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:43:58+00:00	2018-09-21 22:43:58+00:00 	EPLDUR_7	Months used estrogen pills
74	Medication/supplement use	78155	phv00078155.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:44:05+00:00	2018-09-21 22:44:05+00:00 	EPLTYPE_7	Kind of estrogen pills
74	Medication/supplement use	78156	phv00078156.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:44:11+00:00	2018-09-21 22:44:11+00:00 	EPCH_7	Did you use an estrogen patch?
74	Medication/supplement use	78157	phv00078157.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:44:17+00:00	2018-09-21 22:44:17+00:00 	EPCHDUR_7	How many months used patch?
74	Medication/supplement use	78158	phv00078158.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:44:24+00:00	2018-09-21 22:44:24+00:00 	ECRM_7	Did you use an estrogen cream?
74	Medication/supplement use	78159	phv00078159.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:44:30+00:00	2018-09-21 22:44:30+00:00 	ECRMDUR_7	How many months used cream?
74	Medication/supplement use	78160	phv00078160.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:45:02+00:00	2018-09-21 22:45:02+00:00 	ESHT_7	Estrogen shots
74	Medication/supplement use	78161	phv00078161.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:45:08+00:00	2018-09-21 22:45:08+00:00 	ESHTDUR_7	Months took estrogen shots
74	Medication/supplement use	78162	phv00078162.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:45:14+00:00	2018-09-21 22:45:14+00:00 	P_7	Progesterone pill, cream shot
74	Medication/supplement use	78163	phv00078163.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:45:23+00:00	2018-09-21 22:45:23+00:00 	PPL_7	Progesterone pill or capsule
74	Medication/supplement use	78164	phv00078164.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:45:29+00:00	2018-09-21 22:45:29+00:00 	PPLDUR_7	Months progesterone pill/ caps
74	Medication/supplement use	78165	phv00078165.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:45:35+00:00	2018-09-21 22:45:35+00:00 	PPLTYPE_7	Kind of progesterone
74	Medication/supplement use	78166	phv00078166.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:45:42+00:00	2018-09-21 22:45:42+00:00 	PPLDAY_7	Progest pills days per month
74	Medication/supplement use	78167	phv00078167.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:45:49+00:00	2018-09-21 22:45:49+00:00 	PCRM_7	Progesterone/Progestin cream
74	Medication/supplement use	78168	phv00078168.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:45:57+00:00	2018-09-21 22:45:57+00:00 	PCRMDUR_7	Months used progesterone cream
74	Medication/supplement use	78169	phv00078169.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:46:05+00:00	2018-09-21 22:46:05+00:00 	PSHT_7	Have progesterone shots
74	Medication/supplement use	78170	phv00078170.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:46:13+00:00	2018-09-21 22:46:13+00:00 	PSHTDUR_7	Months used progesterone shots
74	Medication/supplement use	78230	phv00078230.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:46:46+00:00	2018-09-21 22:46:46+00:00 	EST_7	Estrogen use last year
74	Medication/supplement use	78231	phv00078231.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:46:53+00:00	2018-09-21 22:46:53+00:00 	PRG_7	Progesterone use last year
74	Medication/supplement use	78232	phv00078232.v6.p3	pht000994.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:47:01+00:00	2018-09-21 22:47:01+00:00 	HRT_7	Hormone use last year (estrogen or progesterone)
74	Medication/supplement use	78261	phv00078261.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	NATHOR_8	Natural hormones in past year
74	Medication/supplement use	78262	phv00078262.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	YAMCRM_8	Natural/wild yam cream
74	Medication/supplement use	78263	phv00078263.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	YAMPLS_8	Natural/wild yam pills
74	Medication/supplement use	78264	phv00078264.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	PRGCRM_8	Natural/Progesterone cream
74	Medication/supplement use	78265	phv00078265.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	PRGSUP_8	Natural/Progest suppositories
74	Medication/supplement use	78266	phv00078266.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	DHEAPL_8	Natural/DHEA pills
74	Medication/supplement use	78267	phv00078267.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	PHYPLS_8	Natural/Phytoest pills/powder
74	Medication/supplement use	78270	phv00078270.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	NTOTHR_8	Natural/Other
74	Medication/supplement use	78271	phv00078271.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	NTDNTK_8	Natural/Don't know
74	Medication/supplement use	78275	phv00078275.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	OSTRISED_8	Risedronate (Actonel)
74	Medication/supplement use	78276	phv00078276.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	OSTPAMID_8	Pamidronate (Aredia)
74	Medication/supplement use	78278	phv00078278.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	OSTPTH_8	Parathyroid hormone (PTH) (Forteo)
74	Medication/supplement use	78279	phv00078279.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	OSTOTHER_8	Other specified prescription osteoporosis medication
74	Medication/supplement use	78281	phv00078281.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	SRM_8	Use non-estrogen prescription
74	Medication/supplement use	78282	phv00078282.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	SRMEVST_8	Non-estrogen rx/Evista (Raloxifene)
74	Medication/supplement use	78283	phv00078283.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:53:15+00:00	2018-09-21 22:53:15+00:00 	SRMNOLU_8	Non-estrogen rx/Nolvadex (Tamoxifen)
74	Medication/supplement use	78284	phv00078284.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	SRMOTHR_8	Non-estrogen rx/Other
74	Medication/supplement use	78285	phv00078285.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	SRMDNTK_8	Non-estrogen rx/Don't know
74	Medication/supplement use	78286	phv00078286.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	HRPST1YR_8	Used female hormones/past year
74	Medication/supplement use	78287	phv00078287.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	EPPLPA_8	Comb estr/progest pills/patch
74	Medication/supplement use	78288	phv00078288.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	EPDUR_8	Months comb estr/progesterone
74	Medication/supplement use	78289	phv00078289.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	EPTYPE_8	Which estr/progest combination
74	Medication/supplement use	78290	phv00078290.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	ETPL_8	Combined estr/testost pills
74	Medication/supplement use	78291	phv00078291.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	ETDUR_8	Months used estr/testost pills
74	Medication/supplement use	78292	phv00078292.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	ETTYPE_8	Estr/testost pill used longest
74	Medication/supplement use	78293	phv00078293.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	E_8	Estrogen pill,patch,cream,shot
74	Medication/supplement use	78294	phv00078294.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	EPL_8	Did you use any Estrogen pill
74	Medication/supplement use	78295	phv00078295.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	EPLDUR_8	Months used estrogen pills
74	Medication/supplement use	78296	phv00078296.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	EPLTYPE_8	Kind of estrogen pills
74	Medication/supplement use	78297	phv00078297.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	EPCH_8	Did you use an estrogen patch?
74	Medication/supplement use	78298	phv00078298.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	EPCHDUR_8	How many months used patch?
74	Medication/supplement use	78301	phv00078301.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	ESHT_8	Estrogen shots
74	Medication/supplement use	78302	phv00078302.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	ESHTDUR_8	Months took estrogen shots
74	Medication/supplement use	78303	phv00078303.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	P_8	Progesterone pill, cream shot
74	Medication/supplement use	78304	phv00078304.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	PPL_8	Progesterone pill or capsule
74	Medication/supplement use	78305	phv00078305.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	PPLDUR_8	Months progesterone pill/ caps
74	Medication/supplement use	78306	phv00078306.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	PPLTYPE_8	Kind of progesterone
74	Medication/supplement use	78307	phv00078307.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 22:56:31+00:00	2018-09-21 22:56:31+00:00 	PPLDAY_8	Progest pills days per month
74	Medication/supplement use	78308	phv00078308.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:01:07+00:00	2018-09-21 23:01:07+00:00 	PCRM_8	Progesterone/Progestin cream
74	Medication/supplement use	78309	phv00078309.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:01:13+00:00	2018-09-21 23:01:13+00:00 	PCRMDUR_8	Months used progesterone cream
74	Medication/supplement use	78310	phv00078310.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:01:20+00:00	2018-09-21 23:01:20+00:00 	PSHT_8	Have progesterone shots
74	Medication/supplement use	78311	phv00078311.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:01:25+00:00	2018-09-21 23:01:25+00:00 	PSHTDUR_8	Months used progesterone shots
74	Medication/supplement use	78354	phv00078354.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:01:32+00:00	2018-09-21 23:01:32+00:00 	EST_8	Estrogen use last year
74	Medication/supplement use	78355	phv00078355.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:01:39+00:00	2018-09-21 23:01:39+00:00 	PRG_8	Progesterone use last year
74	Medication/supplement use	78356	phv00078356.v6.p3	pht000995.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:01:46+00:00	2018-09-21 23:01:46+00:00 	HRT_8	Hormone use last year (estrogen or progesterone)
74	Medication/supplement use	78503	phv00078503.v6.p3	pht000998.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:03:59+00:00	2018-09-21 23:03:59+00:00 	HORMSTAT	HRT use ever
74	Medication/supplement use	79639	phv00079639.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:07:45+00:00	2018-09-21 23:07:45+00:00 	HRTCMBP	Combined HRT same pill past year
74	Medication/supplement use	79640	phv00079640.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:07:51+00:00	2018-09-21 23:07:51+00:00 	HRTCMBPM	Combined HRT same pill months/past year
74	Medication/supplement use	79652	phv00079652.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:08:54+00:00	2018-09-21 23:08:54+00:00 	PROG_M	Months used progesterone past year
74	Medication/supplement use	79653	phv00079653.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:09:01+00:00	2018-09-21 23:09:01+00:00 	PROG_T	Type of progesterone past year
74	Medication/supplement use	79654	phv00079654.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:09:13+00:00	2018-09-21 23:09:13+00:00 	PROG_P	Progesterone pill past year
74	Medication/supplement use	79655	phv00079655.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:09:20+00:00	2018-09-21 23:09:20+00:00 	PROG_PD	Progesterone pills used, days/month
74	Medication/supplement use	79656	phv00079656.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:09:43+00:00	2018-09-21 23:09:43+00:00 	PROVERA	Provera/Cycrin/Amen past year
74	Medication/supplement use	79657	phv00079657.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:10:27+00:00	2018-09-21 23:10:27+00:00 	PROVERAD	Provera/Cycrin/Amen dose past year
74	Medication/supplement use	79658	phv00079658.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:10:33+00:00	2018-09-21 23:10:33+00:00 	MICRPROG	Micronized progesterone past year
74	Medication/supplement use	79683	phv00079683.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:10:58+00:00	2018-09-21 23:10:58+00:00 	ELSTYR	Estrogen use in last year
74	Medication/supplement use	79684	phv00079684.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:11:04+00:00	2018-09-21 23:11:04+00:00 	PLSTYR	Progesterone use in last year
74	Medication/supplement use	79685	phv00079685.v6.p3	pht001014.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:11:10+00:00	2018-09-21 23:11:10+00:00 	HLSTYR	Hormone use in last year (estr or prog)
74	Medication/supplement use	79476	phv00079476.v6.p3	pht001011.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:12:31+00:00	2018-09-21 23:12:31+00:00 	PCYCLE	Progesterone cycle during last PERT use
74	Medication/supplement use	80429	phv00080429.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:13:12+00:00	2018-09-21 23:13:12+00:00 	HRTARM	HRT Arm
74	Medication/supplement use	80430	phv00080430.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:13:18+00:00	2018-09-21 23:13:18+00:00 	DMARM	DM Arm
74	Medication/supplement use	80431	phv00080431.v6.p3	pht001031.v6.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:13:24+00:00	2018-09-21 23:13:24+00:00 	CADARM	CaD Arm
74	Medication/supplement use	193669	phv00193669.v3.p3	pht003413.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:14:49+00:00	2018-09-21 23:14:49+00:00 	F33DIABTX	F33 Diabetes Treated
74	Medication/supplement use	193781	phv00193781.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:14:55+00:00	2018-09-21 23:14:55+00:00 	F33DIABTX	F33 Diabetes Treated
74	Medication/supplement use	170685	phv00170685.v4.p3	pht002770.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:15:01+00:00	2018-09-21 23:15:01+00:00 	F33DIABTX	F33 Diabetes Treated
74	Medication/supplement use	170603	phv00170603.v4.p3	pht002769.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:15:08+00:00	2018-09-21 23:15:08+00:00 	F33DIABTX	F33 Diabetes Treated
74	Medication/supplement use	282990	phv00282990.v1.p3	pht006214.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:16:21+00:00	2018-09-21 23:16:21+00:00 	HRPST1YR	Used female hormones in past year
74	Medication/supplement use	283206	phv00283206.v1.p3	pht006215.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:16:45+00:00	2018-09-21 23:16:45+00:00 	PNEUMONIASHOT	Ever had a pneumonia shot
74	Medication/supplement use	283205	phv00283205.v1.p3	pht006215.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:17:03+00:00	2018-09-21 23:17:03+00:00 	FLUSHOT	Flu shot in the past 12 months
74	Medication/supplement use	170599	phv00170599.v4.p3	pht002769.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:23:27+00:00	2018-09-21 23:23:27+00:00 	F33DIABPILLS	F33 Diabetes Pills
74	Medication/supplement use	170681	phv00170681.v4.p3	pht002770.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:23:37+00:00	2018-09-21 23:23:37+00:00 	F33DIABPILLS	F33 Diabetes Pills
74	Medication/supplement use	193673	phv00193673.v3.p3	pht003413.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:23:44+00:00	2018-09-21 23:23:44+00:00 	F33DIABPILLS	F33 Diabetes Pills
74	Medication/supplement use	193785	phv00193785.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:23:51+00:00	2018-09-21 23:23:51+00:00 	F33DIABPILLS	F33 Diabetes Pills
74	Medication/supplement use	170607	phv00170607.v4.p3	pht002769.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:27:37+00:00	2018-09-21 23:27:37+00:00 	F33PILLSHYP	F33 Pills For Hypertension
74	Medication/supplement use	170689	phv00170689.v4.p3	pht002770.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:27:43+00:00	2018-09-21 23:27:43+00:00 	F33PILLSHYP	F33 Pills For Hypertension
74	Medication/supplement use	193667	phv00193667.v3.p3	pht003413.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:27:49+00:00	2018-09-21 23:27:49+00:00 	F33PILLSHYP	F33 Pills for Hypertension
74	Medication/supplement use	193779	phv00193779.v3.p3	pht003414.v3.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:27:57+00:00	2018-09-21 23:27:57+00:00 	F33PILLSHYP	F33 Pills For Hypertension
74	Medication/supplement use	170613	phv00170613.v4.p3	pht002769.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:29:00+00:00	2018-09-21 23:29:00+00:00 	F33OSTEOPILLS	F33 Osteoporosis Pills
74	Medication/supplement use	170695	phv00170695.v4.p3	pht002770.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:29:06+00:00	2018-09-21 23:29:06+00:00 	F33OSTEOPILLS	F33 Osteoporosis Pills
74	Medication/supplement use	170617	phv00170617.v4.p3	pht002769.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:29:31+00:00	2018-09-21 23:29:31+00:00 	F33CHOLESPILLS	F33 Cholesterol Pills
74	Medication/supplement use	170699	phv00170699.v4.p3	pht002770.v4.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:29:37+00:00	2018-09-21 23:29:37+00:00 	F33CHOLESPILLS	F33 Cholesterol Pills
74	Medication/supplement use	283685	phv00283685.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:31:48+00:00	2018-09-21 23:31:48+00:00 	STATINPRIOR	F136 Statins prior
74	Medication/supplement use	283686	phv00283686.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:31:54+00:00	2018-09-21 23:31:54+00:00 	STATINDSCH	F136 Statins discharge
74	Medication/supplement use	283687	phv00283687.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:32:48+00:00	2018-09-21 23:32:48+00:00 	LIPIDOTHPRIOR	F136 Other lipid lowering agents prior
74	Medication/supplement use	283688	phv00283688.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:32:54+00:00	2018-09-21 23:32:54+00:00 	LIPIDOTHDSCH	F136 Other lipid lowering agents discharge
74	Medication/supplement use	283681	phv00283681.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:34:13+00:00	2018-09-21 23:34:13+00:00 	DIURETICPRIOR	F136 Diuretics prior
74	Medication/supplement use	283682	phv00283682.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:34:19+00:00	2018-09-21 23:34:19+00:00 	DIURETICDSCH	F136 Diuretics discharge
74	Medication/supplement use	283683	phv00283683.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:34:27+00:00	2018-09-21 23:34:27+00:00 	ALDOSTPRIOR	F136 Aldosterone blocker prior
74	Medication/supplement use	283684	phv00283684.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:34:33+00:00	2018-09-21 23:34:33+00:00 	ALDOSTDSCH	F136 Aldosterone blocker discharge
74	Medication/supplement use	283689	phv00283689.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:34:40+00:00	2018-09-21 23:34:40+00:00 	NITRATESPRIOR	F136 Nitrates prior
74	Medication/supplement use	283690	phv00283690.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:34:46+00:00	2018-09-21 23:34:46+00:00 	NITRATESDSCH	F136 Nitrates discharge
74	Medication/supplement use	283691	phv00283691.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:34:52+00:00	2018-09-21 23:34:52+00:00 	HYDRALAZINEPRIOR	F136 Hydralazine prior
74	Medication/supplement use	283692	phv00283692.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:34:59+00:00	2018-09-21 23:34:59+00:00 	HYDRALAZINEDSCH	F136 Hydralazine discharge
74	Medication/supplement use	283693	phv00283693.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:35:06+00:00	2018-09-21 23:35:06+00:00 	IVINOTROP	F136 IV Inotropes
74	Medication/supplement use	283694	phv00283694.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:35:12+00:00	2018-09-21 23:35:12+00:00 	IVDIURETICS	F136 IV Diuretics
74	Medication/supplement use	283678	phv00283678.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:36:46+00:00	2018-09-21 23:36:46+00:00 	BETABDSCH	F136 Beta blockers discharge
74	Medication/supplement use	283677	phv00283677.v1.p3	pht006223.v1.p3	phs000200.v11.p3	Women's Health Initiative (WHI)	200	11	2018-09-21 23:36:52+00:00	2018-09-21 23:36:52+00:00 	BETABPRIOR	F136 Beta blockers prior
74	Medication/supplement use	80818	phv00080818.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:20:46+00:00	2018-09-24 11:20:46+00:00 	RX1	CURRENT TREATMENT FOR DIABETES EXAM 1
74	Medication/supplement use	80827	phv00080827.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:21:02+00:00	2018-09-24 11:21:02+00:00 	RX10	CURRENT TREATMENT FOR DIABETES EXAM 10
74	Medication/supplement use	80828	phv00080828.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:21:13+00:00	2018-09-24 11:21:13+00:00 	RX11	CURRENT TREATMENT FOR DIABETES EXAM 11
74	Medication/supplement use	80802	phv00080802.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:21:22+00:00	2018-09-24 11:21:22+00:00 	RX12	CURRENT TREATMENT FOR DIABETES EXAM 12
74	Medication/supplement use	80803	phv00080803.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:21:40+00:00	2018-09-24 11:21:40+00:00 	RX13	CURRENT TREATMENT FOR DIABETES EXAM 13
74	Medication/supplement use	80804	phv00080804.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:21:52+00:00	2018-09-24 11:21:52+00:00 	RX14	CURRENT TREATMENT FOR DIABETES EXAM 14
74	Medication/supplement use	80805	phv00080805.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:22:02+00:00	2018-09-24 11:22:02+00:00 	RX15	CURRENT TREATMENT FOR DIABETES EXAM 15
74	Medication/supplement use	80806	phv00080806.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:22:12+00:00	2018-09-24 11:22:12+00:00 	RX16	CURRENT TREATMENT FOR DIABETES EXAM 16
74	Medication/supplement use	80807	phv00080807.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:22:23+00:00	2018-09-24 11:22:23+00:00 	RX17	CURRENT TREATMENT FOR DIABETES EXAM 17
74	Medication/supplement use	80808	phv00080808.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:22:33+00:00	2018-09-24 11:22:33+00:00 	RX18	CURRENT TREATMENT FOR DIABETES EXAM 18
74	Medication/supplement use	80809	phv00080809.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:22:43+00:00	2018-09-24 11:22:43+00:00 	RX19	CURRENT TREATMENT FOR DIABETES EXAM 19
74	Medication/supplement use	80819	phv00080819.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:22:54+00:00	2018-09-24 11:22:54+00:00 	RX2	CURRENT TREATMENT FOR DIABETES EXAM 2
74	Medication/supplement use	80810	phv00080810.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:23:04+00:00	2018-09-24 11:23:04+00:00 	RX20	CURRENT TREATMENT FOR DIABETES EXAM 20
74	Medication/supplement use	80811	phv00080811.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:23:15+00:00	2018-09-24 11:23:15+00:00 	RX21	CURRENT TREATMENT FOR DIABETES EXAM 21
74	Medication/supplement use	80812	phv00080812.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:23:24+00:00	2018-09-24 11:23:24+00:00 	RX22	CURRENT TREATMENT FOR DIABETES EXAM 22
74	Medication/supplement use	80813	phv00080813.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:23:34+00:00	2018-09-24 11:23:34+00:00 	RX23	CURRENT TREATMENT FOR DIABETES EXAM 23
74	Medication/supplement use	80814	phv00080814.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:23:48+00:00	2018-09-24 11:23:48+00:00 	RX24	CURRENT TREATMENT FOR DIABETES EXAM 24
74	Medication/supplement use	80815	phv00080815.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:23:57+00:00	2018-09-24 11:23:57+00:00 	RX25	CURRENT TREATMENT FOR DIABETES EXAM 25
74	Medication/supplement use	80816	phv00080816.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:24:08+00:00	2018-09-24 11:24:08+00:00 	RX26	CURRENT TREATMENT FOR DIABETES EXAM 26
74	Medication/supplement use	80817	phv00080817.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:24:18+00:00	2018-09-24 11:24:18+00:00 	RX27	CURRENT TREATMENT FOR DIABETES EXAM 27
74	Medication/supplement use	80820	phv00080820.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:24:28+00:00	2018-09-24 11:24:28+00:00 	RX3	CURRENT TREATMENT FOR DIABETES EXAM 3
74	Medication/supplement use	80821	phv00080821.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:24:38+00:00	2018-09-24 11:24:38+00:00 	RX4	CURRENT TREATMENT FOR DIABETES EXAM 4
74	Medication/supplement use	80822	phv00080822.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:24:47+00:00	2018-09-24 11:24:47+00:00 	RX5	CURRENT TREATMENT FOR DIABETES EXAM 5
74	Medication/supplement use	80823	phv00080823.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:24:57+00:00	2018-09-24 11:24:57+00:00 	RX6	CURRENT TREATMENT FOR DIABETES EXAM 6
74	Medication/supplement use	80824	phv00080824.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:25:07+00:00	2018-09-24 11:25:07+00:00 	RX7	CURRENT TREATMENT FOR DIABETES EXAM 7
74	Medication/supplement use	80825	phv00080825.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:25:28+00:00	2018-09-24 11:25:28+00:00 	RX8	CURRENT TREATMENT FOR DIABETES EXAM 8
74	Medication/supplement use	80826	phv00080826.v1.p10	pht000040.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:25:38+00:00	2018-09-24 11:25:38+00:00 	RX9	CURRENT TREATMENT FOR DIABETES EXAM 9
74	Medication/supplement use	10784	phv00010784.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:28:06+00:00	2018-09-24 11:28:06+00:00 	DMRX1	UNDER TREATMENT FOR DIABETES EXAM 1 (SOURCE: A84 (EXAM 1 - CALCULATED))
74	Medication/supplement use	10785	phv00010785.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:28:16+00:00	2018-09-24 11:28:16+00:00 	DMRX2	UNDER TREATMENT FOR DIABETES EXAM 2 (SOURCE: B65/B68 (EXAM 2 - CALCULATED))
74	Medication/supplement use	10786	phv00010786.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:28:25+00:00	2018-09-24 11:28:25+00:00 	DMRX3	UNDER TREATMENT FOR DIABETES EXAM 3 (SOURCE: C29/C30 (EXAM 3 - CALCULATED))
74	Medication/supplement use	10787	phv00010787.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:28:33+00:00	2018-09-24 11:28:33+00:00 	DMRX4	UNDER TREATMENT FOR DIABETES EXAM 4 (SOURCE: D035/D037 (EXAM 4 - CALCULATED))
74	Medication/supplement use	10788	phv00010788.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:28:41+00:00	2018-09-24 11:28:41+00:00 	DMRX5	UNDER TREATMENT FOR DIABETES EXAM 5 (SOURCE: E254/E256 (EXAM 5 - CALCUALTED))
74	Medication/supplement use	10789	phv00010789.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:28:50+00:00	2018-09-24 11:28:50+00:00 	DMRX6	UNDER TREATMENT FOR DIABETES EXAM 6 (SOURCE: F218/F220 (EXAM 6 - CALCULATED))
74	Medication/supplement use	10790	phv00010790.v5.p10	pht000041.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:28:58+00:00	2018-09-24 11:28:58+00:00 	DMRX7	UNDER TREATMENT FOR DIABETES EXAM 7 (SOURCE: G050 G052-059 (EXAM 7 - CALCULATED))
74	Medication/supplement use	177245	phv00177245.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:31:01+00:00	2018-09-24 11:31:01+00:00 	g3b0009	Medical History - Medications: Do you take aspirin regularly?
74	Medication/supplement use	177246	phv00177246.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:31:13+00:00	2018-09-24 11:31:13+00:00 	g3b0010	Medical History - Medications: Number of aspirins taken regularly
74	Medication/supplement use	177247	phv00177247.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:31:26+00:00	2018-09-24 11:31:26+00:00 	g3b0011	Medical History - Medications: Aspirin frequency per
74	Medication/supplement use	177248	phv00177248.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:31:39+00:00	2018-09-24 11:31:39+00:00 	g3b0012	Medical History - Medications: Usual dose of aspirin
74	Medication/supplement use	177250	phv00177250.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:31:53+00:00	2018-09-24 11:31:53+00:00 	g3b0014	Medical History - Medications: Since your last exam have you taken medication for high blood pressure of hypertension?
74	Medication/supplement use	177252	phv00177252.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:32:05+00:00	2018-09-24 11:32:05+00:00 	g3b0016	Medical History - Medications: Since your last exam have you taken medication for high blood cholesterol or high triglycerides?
74	Medication/supplement use	177254	phv00177254.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:32:24+00:00	2018-09-24 11:32:24+00:00 	g3b0018	Medical History - Medications: Since your last exam have you taken medication for high blood sugar or diabetes?
74	Medication/supplement use	177255	phv00177255.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:32:35+00:00	2018-09-24 11:32:35+00:00 	g3b0019	Medical History - Medications: Since your last exam have you taken medication for cardiovascular disease? (example: angina/chest pain, heart failure, atrial fibrillation/heart rhythm abnormality, stroke, leg pain when walking, peripheral artery disease)
74	Medication/supplement use	177258	phv00177258.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:32:49+00:00	2018-09-24 11:32:49+00:00 	g3b0029	Medical History-Female Reproductive History: Since your last exam have you taken or used birth control pills, shots, or hormone implants for birth control or medical indications (not post menopausal hormone replacement)?
74	Medication/supplement use	177577	phv00177577.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:35:18+00:00	2018-09-24 11:35:18+00:00 	g3b0603	Respiratory Disease Questionnaire-Technician administered: Do you take inhalers or bronchodilators?
74	Medication/supplement use	177578	phv00177578.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:35:33+00:00	2018-09-24 11:35:33+00:00 	g3b0604	Respiratory Disease Questionnaire-Technician administered: Do you use any of these medications - albuterol, atrovent, proventin, combivent, maxair, volmax, xopenex, bronkometer, preo-air, pirbuterol, levalbuterol, metaproterenol, or ipratropium
74	Medication/supplement use	177579	phv00177579.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:35:45+00:00	2018-09-24 11:35:45+00:00 	g3b0605	Respiratory Disease Questionnaire-Technician administered: How many hours ago did you last use the medication, either by inhaler or nebulizer?
74	Medication/supplement use	177580	phv00177580.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:36:19+00:00	2018-09-24 11:36:19+00:00 	g3b0606	Respiratory Disease Questionnaire-Technician administered: Do you take any of the following inhalers - serevent, advair, foradil, salmeterol, formoterol, spiriva, symbicort, brovana, arformoterol, or tiotropium
74	Medication/supplement use	177581	phv00177581.v2.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:36:45+00:00	2018-09-24 11:36:45+00:00 	g3b0607	Respiratory Disease Questionnaire-Technician administered: How many hours ago did you last use the medication?
74	Medication/supplement use	253878	phv00253878.v1.p10	pht003094.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:39:39+00:00	2018-09-24 11:39:39+00:00 	g3b0083	Medical History - Female Reproductive History: Have you since your last exam taken hormone replacement therapy (estrogen/progesterone) or a selective estrogen receptor modulator (such as evista or raloxifene)?
74	Medication/supplement use	273707	phv00273707.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:41:16+00:00	2018-09-24 11:41:16+00:00 	g3a008	Take aspirin regularly? Collection Interval: Exam 1
74	Medication/supplement use	273708	phv00273708.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:41:34+00:00	2018-09-24 11:41:34+00:00 	g3a009	If take aspirin regularly: Number aspirins taken Collection Interval: Exam 1
74	Medication/supplement use	273709	phv00273709.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:41:43+00:00	2018-09-24 11:41:43+00:00 	g3a010	If take aspirin regularly: Frequency per Collection Interval: Exam 1
74	Medication/supplement use	273710	phv00273710.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:41:54+00:00	2018-09-24 11:41:54+00:00 	g3a011	If take aspirin regularly: Usual dose Collection Interval: Exam 1
74	Medication/supplement use	273711	phv00273711.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:42:05+00:00	2018-09-24 11:42:05+00:00 	g3a012	Have you ever taken medication for hypertension/high blood pressure? Collection Interval: Exam 1
74	Medication/supplement use	273712	phv00273712.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:42:38+00:00	2018-09-24 11:42:38+00:00 	g3a013	If yes to G3A012, at what age did you begin Collection Interval: Exam 1
74	Medication/supplement use	273713	phv00273713.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:42:51+00:00	2018-09-24 11:42:51+00:00 	g3a014	Have you ever taken medication for high blood cholesterol? Collection Interval: Exam 1
74	Medication/supplement use	273714	phv00273714.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:43:07+00:00	2018-09-24 11:43:07+00:00 	g3a015	If yes to G3A014, at what age did you begin taking medication for high blood cholesterol? Collection Interval: Exam 1
74	Medication/supplement use	273715	phv00273715.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:43:26+00:00	2018-09-24 11:43:26+00:00 	g3a016	Have you ever taken medication for high blood sugar or diabetes? Collection Interval: Exam 1
74	Medication/supplement use	273716	phv00273716.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:43:41+00:00	2018-09-24 11:43:41+00:00 	g3a017	If yes to G3A016, at what age did you begin Collection Interval: Exam 1
74	Medication/supplement use	273717	phv00273717.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:43:55+00:00	2018-09-24 11:43:55+00:00 	g3a018	If yes to G3A016, was insulin your first diabetes medication? Collection Interval: Exam 1
74	Medication/supplement use	273719	phv00273719.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:44:21+00:00	2018-09-24 11:44:21+00:00 	g3a020	Have you ever taken medication for cardiovascular disease (for example angina/chest pain, heart failure, atrial fibrillation/heart rhythm abnormality, stroke, leg pain when walking?) Collection Interval: Exam 1
74	Medication/supplement use	273720	phv00273720.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:44:34+00:00	2018-09-24 11:44:34+00:00 	g3a021	If yes to G3A020, at what age did you begin Collection Interval: Exam 1
74	Medication/supplement use	273722	phv00273722.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:46:36+00:00	2018-09-24 11:46:36+00:00 	g3a024	Have you ever taken or used oral contraceptive pills, shots, or hormone implants for birth control or medical indications (not post menopausal hormone replacement)? Collection Interval: Exam 1
74	Medication/supplement use	273723	phv00273723.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:46:50+00:00	2018-09-24 11:46:50+00:00 	g3a025	If OCP use, what is the name of the current or most recent oral contraceptive, shot or implant used? Collection Interval: Exam 1
74	Medication/supplement use	273724	phv00273724.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:47:00+00:00	2018-09-24 11:47:00+00:00 	g3a026	If OCP use, strength Collection Interval: Exam 1
74	Medication/supplement use	273725	phv00273725.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:47:10+00:00	2018-09-24 11:47:10+00:00 	g3a027	If OCP use, form Collection Interval: Exam 1
74	Medication/supplement use	273726	phv00273726.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:47:30+00:00	2018-09-24 11:47:30+00:00 	g3a032	If OCP use, what is the total number of years over your lifetime that you used oral contraceptives pills, shots, or hormone implants? Collection Interval: Exam 1
74	Medication/supplement use	273742	phv00273742.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:47:50+00:00	2018-09-24 11:47:50+00:00 	g3a053	If periods stopped: Have you ever taken hormone replacement therapy (estrogen/progesterone)? Collection Interval: Exam 1
74	Medication/supplement use	273743	phv00273743.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:48:11+00:00	2018-09-24 11:48:11+00:00 	g3a054	If taken HRT: What age did you begin hormone replacement therapy? Collection Interval: Exam 1
74	Medication/supplement use	273744	phv00273744.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:48:20+00:00	2018-09-24 11:48:20+00:00 	g3a055	If taken HRT: For how long did you take hormones (years)? Collection Interval: Exam 1
74	Medication/supplement use	273745	phv00273745.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:48:29+00:00	2018-09-24 11:48:29+00:00 	g3a056	If taken HRT: For how long did you take hormones (months)? Collection Interval: Exam 1
74	Medication/supplement use	273746	phv00273746.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:48:40+00:00	2018-09-24 11:48:40+00:00 	g3a057	If taken HRT: Estrogen use ever? Collection Interval: Exam 1
74	Medication/supplement use	273747	phv00273747.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:48:51+00:00	2018-09-24 11:48:51+00:00 	g3a058	If estrogen use ever: Name of most recent estrogen preparation Collection Interval: Exam 1
74	Medication/supplement use	273748	phv00273748.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:49:01+00:00	2018-09-24 11:49:01+00:00 	g3a059	If estrogen use ever: The strength of estrogen Collection Interval: Exam 1
74	Medication/supplement use	273749	phv00273749.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:49:11+00:00	2018-09-24 11:49:11+00:00 	g3a060	If estrogen use ever: Number of days per month taken Collection Interval: Exam 1
74	Medication/supplement use	273750	phv00273750.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:49:26+00:00	2018-09-24 11:49:26+00:00 	g3a061	If taken HRT: Progesterone use ever? Collection Interval: Exam 1
74	Medication/supplement use	273751	phv00273751.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:49:34+00:00	2018-09-24 11:49:34+00:00 	g3a062	If progesterone use ever: Name of most recent progesterone preparation Collection Interval: Exam 1
74	Medication/supplement use	273752	phv00273752.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:49:47+00:00	2018-09-24 11:49:47+00:00 	g3a063	If progesterone use ever: The strength of progesterone Collection Interval: Exam 1
74	Medication/supplement use	273753	phv00273753.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:49:56+00:00	2018-09-24 11:49:56+00:00 	g3a064	If progesterone use ever: Number of days per month taken Collection Interval: Exam 1
74	Medication/supplement use	273754	phv00273754.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:50:06+00:00	2018-09-24 11:50:06+00:00 	g3a065	If periods stopped: Have you used Evista (raloxifene) or Nolvadex (tamoxifen) or other selective estrogen receptor modulator (SERM)? Collection Interval: Exam 1
74	Medication/supplement use	273755	phv00273755.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:50:14+00:00	2018-09-24 11:50:14+00:00 	g3a066	If used SERMs: Number of months used? Collection Interval: Exam 1
74	Medication/supplement use	273756	phv00273756.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:50:27+00:00	2018-09-24 11:50:27+00:00 	g3a067	If use SERMs: Current use? Collection Interval: Exam 1
74	Medication/supplement use	273757	phv00273757.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:51:03+00:00	2018-09-24 11:51:03+00:00 	g3a068	If periods stopped: Do you take over-the-counter alternative, herbal, or natural soy-based preparations to treat menopausal symptoms? Collection Interval: Exam 1
74	Medication/supplement use	273758	phv00273758.v1.p10	pht006005.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 11:51:16+00:00	2018-09-24 11:51:16+00:00 	g3a069	If yes to G3A068: Specify preparation Collection Interval: Exam 1
74	Medication/supplement use	250298	phv00250298.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:23:04+00:00	2018-09-24 12:23:04+00:00 	e041	Numerical Data - Part I: Number of days since last dose of aspirin Collection Interval: Exam 1
74	Medication/supplement use	250355	phv00250355.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:23:29+00:00	2018-09-24 12:23:29+00:00 	e218	Medical History - Cardiovascular Medications: Number of aspirins Collection Interval: Exam 1
74	Medication/supplement use	250356	phv00250356.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:23:40+00:00	2018-09-24 12:23:40+00:00 	e219	Medical History - Cardiovascular Medications: Time interval for aspirin taken Collection Interval: Exam 1
74	Medication/supplement use	250357	phv00250357.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:26:48+00:00	2018-09-24 12:26:48+00:00 	e220	Medical History - Cardiovascular Medications: Any of the cardiovascular medications below Collection Interval: Exam 1
74	Medication/supplement use	250358	phv00250358.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:26:58+00:00	2018-09-24 12:26:58+00:00 	e221	Medical History - Cardiovascular Medications: Currently receiving medication for the treatment of hypertension? Collection Interval: Exam 1
74	Medication/supplement use	250359	phv00250359.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:27:06+00:00	2018-09-24 12:27:06+00:00 	e222	Medical History - Cardiovascular Medications: Cardiac Glycosides Collection Interval: Exam 1
74	Medication/supplement use	250360	phv00250360.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:27:15+00:00	2018-09-24 12:27:15+00:00 	e223	Medical History - Cardiovascular Medications: Nitroglycerine Collection Interval: Exam 1
74	Medication/supplement use	250361	phv00250361.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:27:23+00:00	2018-09-24 12:27:23+00:00 	e224	Medical History - Cardiovascular Medications: Longer acting nitrates (Isordil, Cardilate, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250362	phv00250362.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:27:32+00:00	2018-09-24 12:27:32+00:00 	e225	Medical History - Cardiovascular Medications: Calcium Channel Blockers (Nifedipine, Verapamil, Diltiazem) Collection Interval: Exam 1
74	Medication/supplement use	250363	phv00250363.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:27:40+00:00	2018-09-24 12:27:40+00:00 	e226	Medical History - Cardiovascular Medications: Beta Blockers Collection Interval: Exam 1
74	Medication/supplement use	250364	phv00250364.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:27:48+00:00	2018-09-24 12:27:48+00:00 	e227	Medical History - Cardiovascular Medications: Beta Blockers Group Collection Interval: Exam 1
74	Medication/supplement use	250365	phv00250365.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:27:55+00:00	2018-09-24 12:27:55+00:00 	e228	Medical History - Cardiovascular Medications: Beta Blockers dose Collection Interval: Exam 1
74	Medication/supplement use	250366	phv00250366.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:28:02+00:00	2018-09-24 12:28:02+00:00 	e229	Medical History - Cardiovascular Medications: Loop diuretics (Lasix, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250367	phv00250367.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:28:21+00:00	2018-09-24 12:28:21+00:00 	e230	Medical History - Cardiovascular Medications: Thiazide/K-sparing diuretics (Dyazide, Maxide, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250368	phv00250368.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:28:33+00:00	2018-09-24 12:28:33+00:00 	e231	Medical History - Cardiovascular Medications: Thiazide diuretics Collection Interval: Exam 1
74	Medication/supplement use	250369	phv00250369.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:28:42+00:00	2018-09-24 12:28:42+00:00 	e232	Medical History - Cardiovascular Medications: K-sparing diuretics (Aldactone, Triamterene) Collection Interval: Exam 1
74	Medication/supplement use	250370	phv00250370.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:28:50+00:00	2018-09-24 12:28:50+00:00 	e233	Medical History - Cardiovascular Medications: Potassium supplements Collection Interval: Exam 1
74	Medication/supplement use	250371	phv00250371.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:28:59+00:00	2018-09-24 12:28:59+00:00 	e234	Medical History - Cardiovascular Medications: Reserpine derivatives Collection Interval: Exam 1
74	Medication/supplement use	250372	phv00250372.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:29:07+00:00	2018-09-24 12:29:07+00:00 	e235	Medical History - Cardiovascular Medications: Methyldopa (Aldomet) Collection Interval: Exam 1
74	Medication/supplement use	250373	phv00250373.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:29:22+00:00	2018-09-24 12:29:22+00:00 	e236	Medical History - Cardiovascular Medications: Alpha-1 agonist (Clonidine, Wytensin, Guanabenz) Collection Interval: Exam 1
74	Medication/supplement use	250374	phv00250374.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:29:29+00:00	2018-09-24 12:29:29+00:00 	e237	Medical History - Cardiovascular Medications: Alpha-2 blockers (Prazosin, Terazosin, Doxazosin) Collection Interval: Exam 1
74	Medication/supplement use	250375	phv00250375.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:29:39+00:00	2018-09-24 12:29:39+00:00 	e238	Medical History - Cardiovascular Medications: Renin-angiotensin blocking drugs (Captopril, Enalapril, Lisinopril) Collection Interval: Exam 1
74	Medication/supplement use	250376	phv00250376.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:29:47+00:00	2018-09-24 12:29:47+00:00 	e239	Medical History - Cardiovascular Medications: Peripheral vasodilators (Hydralazine, Minoxidil, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250377	phv00250377.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:29:57+00:00	2018-09-24 12:29:57+00:00 	e240	Medical History - Cardiovascular Medications: Other anti-hypertensives Collection Interval: Exam 1
74	Medication/supplement use	250378	phv00250378.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:30:06+00:00	2018-09-24 12:30:06+00:00 	e241	Medical History - Cardiovascular Medications: Antiarrhythmics (Quinidine, Procainamide, Norpace, Disopyramide, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250379	phv00250379.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:30:15+00:00	2018-09-24 12:30:15+00:00 	e242	Medical History - Cardiovascular Medications: Antiplatelet (Anturane, Persantine, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250380	phv00250380.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:30:25+00:00	2018-09-24 12:30:25+00:00 	e243	Medical History - Cardiovascular Medications: Anticoagulants (Coudmadin, Warfarin, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250381	phv00250381.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:30:34+00:00	2018-09-24 12:30:34+00:00 	e244	Medical History - Cardiovascular Medications: Other cardiac medication Collection Interval: Exam 1
74	Medication/supplement use	250382	phv00250382.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:30:44+00:00	2018-09-24 12:30:44+00:00 	e245	Medical History - Other Medications: Anti cholesterol drugs (Resins, e.g. Questran, Colestid) Collection Interval: Exam 1
74	Medication/supplement use	250383	phv00250383.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:30:52+00:00	2018-09-24 12:30:52+00:00 	e246	Medical History - Other Medications: Anti cholesterol drugs (Niacin or Nicotinic Acid) Collection Interval: Exam 1
74	Medication/supplement use	250384	phv00250384.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:31:31+00:00	2018-09-24 12:31:31+00:00 	e247	Medical History - Other Medications: Anti cholesterol drugs (Fibrates, e.g. Gemfibrozil) Collection Interval: Exam 1
74	Medication/supplement use	250385	phv00250385.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:31:40+00:00	2018-09-24 12:31:40+00:00 	e248	Medical History - Other Medications: Anti cholesterol drugs (Statins, e.g. Lovastatin, Pravastatin) Collection Interval: Exam 1
74	Medication/supplement use	250386	phv00250386.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:31:50+00:00	2018-09-24 12:31:50+00:00 	e249	Medical History - Other Medications: Anti cholesterol drugs (Other) Collection Interval: Exam 1
74	Medication/supplement use	250387	phv00250387.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:32:00+00:00	2018-09-24 12:32:00+00:00 	e250	Medical History - Other Medications: Antigout--uric acid lowering (Allopurinol, Probenecid etc.) Collection Interval: Exam 1
74	Medication/supplement use	250388	phv00250388.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:32:09+00:00	2018-09-24 12:32:09+00:00 	e251	Medical History - Other Medications: Antigout (Colchicine) Collection Interval: Exam 1
74	Medication/supplement use	250389	phv00250389.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:32:20+00:00	2018-09-24 12:32:20+00:00 	e252	Medical History - Other Medications: Thyroid extract (Dessicated thyroid) Collection Interval: Exam 1
74	Medication/supplement use	250390	phv00250390.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:32:29+00:00	2018-09-24 12:32:29+00:00 	e253	Medical History - Other Medications: Thyroxine (Synthroid etc.) Collection Interval: Exam 1
74	Medication/supplement use	250391	phv00250391.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:32:38+00:00	2018-09-24 12:32:38+00:00 	e254	Medical History - Other Medications: Insulin Collection Interval: Exam 1
74	Medication/supplement use	250392	phv00250392.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:32:46+00:00	2018-09-24 12:32:46+00:00 	e255	Medical History - Other Medications: Total units of insulin per day Collection Interval: Exam 1
74	Medication/supplement use	250393	phv00250393.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:32:54+00:00	2018-09-24 12:32:54+00:00 	e256	Medical History - Other Medications: Oral hypoglycemics Collection Interval: Exam 1
74	Medication/supplement use	250394	phv00250394.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:33:03+00:00	2018-09-24 12:33:03+00:00 	e257	Medical History - Other Medications: Oral/patch estrogen Collection Interval: Exam 1
74	Medication/supplement use	250395	phv00250395.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:33:14+00:00	2018-09-24 12:33:14+00:00 	e258	Medical History - Other Medications: Oral glucocorticoids (Prednisone, Cortisone, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250396	phv00250396.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:33:23+00:00	2018-09-24 12:33:23+00:00 	e259	Medical History - Other Medications: Non-steroidal anti-inflammatory agents (Motrin, Ibuprofen, Naprosyn, Indocin, Clinoril) Collection Interval: Exam 1
74	Medication/supplement use	250397	phv00250397.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:33:32+00:00	2018-09-24 12:33:32+00:00 	e260	Medical History - Other Medications: Analgesic-narcotics (Demerol, Codeine, Dilaudid, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250398	phv00250398.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:33:41+00:00	2018-09-24 12:33:41+00:00 	e261	Medical History - Other Medications: Analgesic-non-narcotics (Acetaminophen, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250399	phv00250399.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:33:50+00:00	2018-09-24 12:33:50+00:00 	e262	Medical History - Other Medications: Bronchodilators, Aerosols, etc. Collection Interval: Exam 1
74	Medication/supplement use	250400	phv00250400.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:33:59+00:00	2018-09-24 12:33:59+00:00 	e263	Medical History - Other Medications: Antihistamines Collection Interval: Exam 1
74	Medication/supplement use	250401	phv00250401.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:34:09+00:00	2018-09-24 12:34:09+00:00 	e264	Medical History - Other Medications: Antiulcer (Tagamet, Ranitidine, Probanthine, H ion inhibitors) Collection Interval: Exam 1
74	Medication/supplement use	250402	phv00250402.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:34:17+00:00	2018-09-24 12:34:17+00:00 	e265	Medical History - Other Medications: Anti-anxiety, Sedative/Hypnotics etc. (Librium, Valium, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250403	phv00250403.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:34:26+00:00	2018-09-24 12:34:26+00:00 	e266	Medical History - Other Medications: Sleeping pills Collection Interval: Exam 1
74	Medication/supplement use	250404	phv00250404.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:34:36+00:00	2018-09-24 12:34:36+00:00 	e267	Medical History - Other Medications: Anti-depressants Collection Interval: Exam 1
74	Medication/supplement use	250405	phv00250405.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:34:44+00:00	2018-09-24 12:34:44+00:00 	e268	Medical History - Other Medications: Eye drops Collection Interval: Exam 1
74	Medication/supplement use	250406	phv00250406.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:34:54+00:00	2018-09-24 12:34:54+00:00 	e269	Medical History - Other Medications: Antibiotics Collection Interval: Exam 1
74	Medication/supplement use	250407	phv00250407.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:35:02+00:00	2018-09-24 12:35:02+00:00 	e270	Medical History - Other Medications: Anti-parkinson drugs (Sinemet, L-Dopa, Symmetrel, Cogentin, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250408	phv00250408.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:35:11+00:00	2018-09-24 12:35:11+00:00 	e271	Medical History - Other Medications: Anticonvulsants (Dilantin, Phenobarb, Tegretol, Mysoline, etc.) Collection Interval: Exam 1
74	Medication/supplement use	250409	phv00250409.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:35:20+00:00	2018-09-24 12:35:20+00:00 	e272	Medical History - Other Medications: Others Collection Interval: Exam 1
74	Medication/supplement use	250413	phv00250413.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:35:51+00:00	2018-09-24 12:35:51+00:00 	e280	Medical History - Female Genitourinary Disease: Oral contraceptives in interim Collection Interval: Exam 1
74	Medication/supplement use	250414	phv00250414.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:35:59+00:00	2018-09-24 12:35:59+00:00 	e281	Medical History - Female Genitourinary Disease: Conjugated estrogen use in interim (e.g. Premarin) Collection Interval: Exam 1
74	Medication/supplement use	250415	phv00250415.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:36:09+00:00	2018-09-24 12:36:09+00:00 	e282	Medical History - Female Genitourinary Disease: Oral dose per day of premarin or conjugated Estrogens Collection Interval: Exam 1
74	Medication/supplement use	250416	phv00250416.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:36:18+00:00	2018-09-24 12:36:18+00:00 	e283	Medical History - Female Genitourinary Disease: Patch dose per day of estrogen Collection Interval: Exam 1
74	Medication/supplement use	250417	phv00250417.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:36:29+00:00	2018-09-24 12:36:29+00:00 	e284	Medical History - Female Genitourinary Disease: Number of days per month taking estrogens Collection Interval: Exam 1
74	Medication/supplement use	250418	phv00250418.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:36:39+00:00	2018-09-24 12:36:39+00:00 	e285	Medical History - Female Genitourinary Disease: Estrogen cream use in interim Collection Interval: Exam 1
74	Medication/supplement use	250419	phv00250419.v1.p10	pht004813.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:37:06+00:00	2018-09-24 12:37:06+00:00 	e286	Medical History - Female Genitourinary Disease: Progesterone use in interim Collection Interval: Exam 1
74	Medication/supplement use	274200	phv00274200.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:46:46+00:00	2018-09-24 12:46:46+00:00 	g3a008	Take aspirin regularly?
74	Medication/supplement use	274201	phv00274201.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:46:57+00:00	2018-09-24 12:46:57+00:00 	g3a009	If take aspirin regularly: Number aspirins taken
74	Medication/supplement use	274202	phv00274202.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:47:08+00:00	2018-09-24 12:47:08+00:00 	g3a010	If take aspirin regularly: Frequency per
74	Medication/supplement use	274203	phv00274203.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:47:18+00:00	2018-09-24 12:47:18+00:00 	g3a011	If take aspirin regularly: Usual dose
74	Medication/supplement use	274204	phv00274204.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:47:30+00:00	2018-09-24 12:47:30+00:00 	g3a012	Have you ever taken medication for hypertension/high blood pressure?
74	Medication/supplement use	274205	phv00274205.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:47:40+00:00	2018-09-24 12:47:40+00:00 	g3a013	If yes to G3A012, at what age did you begin
74	Medication/supplement use	274206	phv00274206.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:47:48+00:00	2018-09-24 12:47:48+00:00 	g3a014	Have you ever taken medication for high blood cholesterol?
74	Medication/supplement use	274207	phv00274207.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:47:59+00:00	2018-09-24 12:47:59+00:00 	g3a015	If yes to G3A014, at what age did you begin taking medication for this?
74	Medication/supplement use	274208	phv00274208.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:48:08+00:00	2018-09-24 12:48:08+00:00 	g3a016	Have you ever taken medication for high blood sugar or diabetes?
74	Medication/supplement use	274209	phv00274209.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:48:18+00:00	2018-09-24 12:48:18+00:00 	g3a017	If yes to G3A016, at what age did you begin
74	Medication/supplement use	274210	phv00274210.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:48:27+00:00	2018-09-24 12:48:27+00:00 	g3a018	If yes to G3A016, was insulin your first diabetes medication?
74	Medication/supplement use	274212	phv00274212.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:48:52+00:00	2018-09-24 12:48:52+00:00 	g3a020	Have you ever taken medication for cardiovascular disease (for example angina/chest pain, heart failure, atrial fibrillation/heart rhythm abnormality, stroke, leg pain when walking?)
74	Medication/supplement use	274213	phv00274213.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:49:03+00:00	2018-09-24 12:49:03+00:00 	g3a021	If yes to G3A020, at what age did you begin
74	Medication/supplement use	274215	phv00274215.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:49:13+00:00	2018-09-24 12:49:13+00:00 	g3a024	Have you ever taken or used oral contraceptive pills, shots, or hormone implants for birth control or medical indications (not post menopausal hormone replacement)?
74	Medication/supplement use	274216	phv00274216.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:49:23+00:00	2018-09-24 12:49:23+00:00 	g3a025	If OCP use, what is the name of the current or most recent oral contraceptive, shot or implant used?
74	Medication/supplement use	274217	phv00274217.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:49:32+00:00	2018-09-24 12:49:32+00:00 	g3a026	If OCP use, strength
74	Medication/supplement use	274218	phv00274218.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:49:41+00:00	2018-09-24 12:49:41+00:00 	g3a027	If OCP use, form
74	Medication/supplement use	274219	phv00274219.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:49:57+00:00	2018-09-24 12:49:57+00:00 	g3a032	If OCP use, what is the total number of years over your lifetime that you used oral contraceptives pills, shots, or hormone implants?
74	Medication/supplement use	274235	phv00274235.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:50:12+00:00	2018-09-24 12:50:12+00:00 	g3a053	If periods stopped: Have you ever taken hormone replacement therapy (estrogen/progesterone)?
74	Medication/supplement use	274236	phv00274236.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:50:23+00:00	2018-09-24 12:50:23+00:00 	g3a054	If taken HRT: What age did you begin hormone replacement therapy?
74	Medication/supplement use	274237	phv00274237.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:50:33+00:00	2018-09-24 12:50:33+00:00 	g3a055	If taken HRT: For how long did you take hormones (years)?
74	Medication/supplement use	274238	phv00274238.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:50:44+00:00	2018-09-24 12:50:44+00:00 	g3a056	If taken HRT: For how long did you take hormones (months)?
74	Medication/supplement use	274239	phv00274239.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:50:55+00:00	2018-09-24 12:50:55+00:00 	g3a057	If taken HRT: Estrogen use ever?
74	Medication/supplement use	274240	phv00274240.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:51:08+00:00	2018-09-24 12:51:08+00:00 	g3a058	If estrogen use ever: Name of most recent estrogen preparation
74	Medication/supplement use	274241	phv00274241.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:51:16+00:00	2018-09-24 12:51:16+00:00 	g3a059	If estrogen use ever: The strength of estrogen
74	Medication/supplement use	274242	phv00274242.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:51:24+00:00	2018-09-24 12:51:24+00:00 	g3a060	If estrogen use ever: Number of days per month taken
74	Medication/supplement use	274243	phv00274243.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:51:34+00:00	2018-09-24 12:51:34+00:00 	g3a061	If taken HRT: Progesterone use ever?
74	Medication/supplement use	274244	phv00274244.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:51:42+00:00	2018-09-24 12:51:42+00:00 	g3a062	If progesterone use ever: Name of most recent progesterone preparation
74	Medication/supplement use	274245	phv00274245.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:51:57+00:00	2018-09-24 12:51:57+00:00 	g3a063	If progesterone use ever: The strength of progesterone
74	Medication/supplement use	274246	phv00274246.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:52:06+00:00	2018-09-24 12:52:06+00:00 	g3a064	If progesterone use ever: Number of days per month taken
74	Medication/supplement use	274247	phv00274247.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:52:15+00:00	2018-09-24 12:52:15+00:00 	g3a065	If periods stopped: Have you used Evista (raloxifene) or Nolvadex (tamoxifen) or other selective estrogen receptor modulator (SERM)?
74	Medication/supplement use	274248	phv00274248.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:52:24+00:00	2018-09-24 12:52:24+00:00 	g3a066	If used SERMs: Number of months used?
74	Medication/supplement use	274249	phv00274249.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:52:52+00:00	2018-09-24 12:52:52+00:00 	g3a067	If use SERMs: Current use?
74	Medication/supplement use	274250	phv00274250.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:53:07+00:00	2018-09-24 12:53:07+00:00 	g3a068	If periods stopped: Do you take over-the-counter alternative, herbal, or natural soy-based preparations to treat menopausal symptoms?
74	Medication/supplement use	274251	phv00274251.v1.p10	pht006006.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 12:53:19+00:00	2018-09-24 12:53:19+00:00 	g3a069	If yes to G3A068: Specify OTC menopausal symptom preparation
74	Medication/supplement use	250725	phv00250725.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:08:54+00:00	2018-09-24 13:08:54+00:00 	g008	Medical History - Cardiovascular Medications: In the interim have you taken medication for the treatment of hypertension? Collection Interval: Exam 2
74	Medication/supplement use	250726	phv00250726.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:09:04+00:00	2018-09-24 13:09:04+00:00 	g009	Medical History - Cardiovascular Medications: Any of the cardiovascular medications in the following section, if yes, continue Collection Interval: Exam 2
74	Medication/supplement use	250727	phv00250727.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:09:14+00:00	2018-09-24 13:09:14+00:00 	g010	Medical History - Cardiovascular Medications: Cardiac glycosides Collection Interval: Exam 2
74	Medication/supplement use	250728	phv00250728.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:09:24+00:00	2018-09-24 13:09:24+00:00 	g011	Medical History - Cardiovascular Medications: Nitroglycerine Collection Interval: Exam 2
74	Medication/supplement use	250729	phv00250729.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:09:34+00:00	2018-09-24 13:09:34+00:00 	g012	Medical History - Cardiovascular Medications: Longer acting nitrates Collection Interval: Exam 2
74	Medication/supplement use	250730	phv00250730.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:09:45+00:00	2018-09-24 13:09:45+00:00 	g013	Medical History - Cardiovascular Medications: Calcium channel blockers (specify) Collection Interval: Exam 2
74	Medication/supplement use	250731	phv00250731.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:09:55+00:00	2018-09-24 13:09:55+00:00 	g014	Medical History - Cardiovascular Medications: Calcium channel blocker group Collection Interval: Exam 2
74	Medication/supplement use	250732	phv00250732.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:10:14+00:00	2018-09-24 13:10:14+00:00 	g015	Medical History - Cardiovascular Medications: Tablet size of calcium channel broker Collection Interval: Exam 2
74	Medication/supplement use	250733	phv00250733.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:10:23+00:00	2018-09-24 13:10:23+00:00 	g016	Medical History - Cardiovascular Medications: Number of times calcium channel blocker taken per day Collection Interval: Exam 2
74	Medication/supplement use	250734	phv00250734.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:10:34+00:00	2018-09-24 13:10:34+00:00 	g017	Medical History - Cardiovascular Medications: Beta blockers (specify) Collection Interval: Exam 2
74	Medication/supplement use	250735	phv00250735.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:10:43+00:00	2018-09-24 13:10:43+00:00 	g018	Medical History - Cardiovascular Medications: Beta blocker group Collection Interval: Exam 2
74	Medication/supplement use	250736	phv00250736.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:10:52+00:00	2018-09-24 13:10:52+00:00 	g019	Medical History - Cardiovascular Medications: Dose of beta blocker Collection Interval: Exam 2
74	Medication/supplement use	250737	phv00250737.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:11:01+00:00	2018-09-24 13:11:01+00:00 	g020	Medical History - Cardiovascular Medications: Loop diuretics (Lasix, etc.) Collection Interval: Exam 2
74	Medication/supplement use	250738	phv00250738.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:11:10+00:00	2018-09-24 13:11:10+00:00 	g021	Medical History - Cardiovascular Medications: Thiazide/K-sparing diuretics (Dyazide, Maxide, etc.) Collection Interval: Exam 2
74	Medication/supplement use	250739	phv00250739.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:11:20+00:00	2018-09-24 13:11:20+00:00 	g022	Medical History - Cardiovascular Medications: Thiazide diuretics Collection Interval: Exam 2
74	Medication/supplement use	250740	phv00250740.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:11:28+00:00	2018-09-24 13:11:28+00:00 	g023	Medical History - Cardiovascular Medications: K-sparing diuretics (Aldactone, Triamterene) Collection Interval: Exam 2
74	Medication/supplement use	250741	phv00250741.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:11:41+00:00	2018-09-24 13:11:41+00:00 	g024	Medical History - Cardiovascular Medications: Potassium supplements Collection Interval: Exam 2
74	Medication/supplement use	250742	phv00250742.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:11:52+00:00	2018-09-24 13:11:52+00:00 	g025	Medical History - Cardiovascular Medications: Reserpine derivatives Collection Interval: Exam 2
74	Medication/supplement use	250743	phv00250743.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:12:04+00:00	2018-09-24 13:12:04+00:00 	g026	Medical History - Cardiovascular Medications: Methyldopa (Aldomet) Collection Interval: Exam 2
74	Medication/supplement use	250744	phv00250744.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:12:13+00:00	2018-09-24 13:12:13+00:00 	g027	Medical History - Cardiovascular Medications: Alpha-1 agonist (Clonidine, Wytensin, Guanabenz) Collection Interval: Exam 2
74	Medication/supplement use	250745	phv00250745.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:12:23+00:00	2018-09-24 13:12:23+00:00 	g028	Medical History - Cardiovascular Medications: Alpha-2 blockers (Prazosin, Terazosin, Doxazosin) Collection Interval: Exam 2
74	Medication/supplement use	250746	phv00250746.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:12:33+00:00	2018-09-24 13:12:33+00:00 	g029	Medical History - Cardiovascular Medications: Renin-angiotensin blocking drugs (ACE) (Captopril, Enalapril, Lisinopril) Collection Interval: Exam 2
74	Medication/supplement use	250747	phv00250747.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:12:43+00:00	2018-09-24 13:12:43+00:00 	g030	Medical History - Cardiovascular Medications: Peripheral vasodilators (Hydralazine, Minoxidil, etc.) Collection Interval: Exam 2
74	Medication/supplement use	250748	phv00250748.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:12:54+00:00	2018-09-24 13:12:54+00:00 	g031	Medical History - Cardiovascular Medications: Angiotensin II antagonists (Losartan etc.) Collection Interval: Exam 2
74	Medication/supplement use	250749	phv00250749.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:13:05+00:00	2018-09-24 13:13:05+00:00 	g032	Medical History - Cardiovascular Medications: Other anti-hypertensives (Losartan etc.) Collection Interval: Exam 2
74	Medication/supplement use	250750	phv00250750.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:13:13+00:00	2018-09-24 13:13:13+00:00 	g033	Medical History - Cardiovascular Medications: Antiarrhythmics (Quinidine, Procainamide, Amiodarone, Sotalol, Disopyramide, etc.) Collection Interval: Exam 2
74	Medication/supplement use	250751	phv00250751.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:13:24+00:00	2018-09-24 13:13:24+00:00 	g034	Medical History - Cardiovascular Medications: Antiplatelet (Anturane, Persantine, Ticlopidine), specify Collection Interval: Exam 2
74	Medication/supplement use	250752	phv00250752.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:13:33+00:00	2018-09-24 13:13:33+00:00 	g035	Medical History - Cardiovascular Medications: Anticoagulants (Coumadin, Warfarin, etc.) Collection Interval: Exam 2
74	Medication/supplement use	250753	phv00250753.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:13:41+00:00	2018-09-24 13:13:41+00:00 	g036	Medical History - Cardiovascular Medications: Other cardiac medication (specify) Collection Interval: Exam 2
74	Medication/supplement use	250754	phv00250754.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:13:49+00:00	2018-09-24 13:13:49+00:00 	g037	Medical History - Aspirin: Take aspirin regularly? Collection Interval: Exam 2
74	Medication/supplement use	250755	phv00250755.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:13:58+00:00	2018-09-24 13:13:58+00:00 	g038	Medical History - Aspirin: Number aspirin taken regularly Collection Interval: Exam 2
74	Medication/supplement use	250756	phv00250756.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:14:20+00:00	2018-09-24 13:14:20+00:00 	g039	Medical History - Aspirin: Aspirin frequency - number taken regularly Collection Interval: Exam 2
74	Medication/supplement use	250757	phv00250757.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:15:32+00:00	2018-09-24 13:15:32+00:00 	g040	Medical History - Aspirin: Usual aspirin dose for above Collection Interval: Exam 2
74	Medication/supplement use	250758	phv00250758.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:15:40+00:00	2018-09-24 13:15:40+00:00 	g041	Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Resins-e.g. Questran, Colestid) Collection Interval: Exam 2
74	Medication/supplement use	250759	phv00250759.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:15:48+00:00	2018-09-24 13:15:48+00:00 	g042	Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Niacin or Nicotinic acid) Collection Interval: Exam 2
74	Medication/supplement use	250760	phv00250760.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:15:56+00:00	2018-09-24 13:15:56+00:00 	g043	Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Fibrates-e.g. Gemfibrozil) Collection Interval: Exam 2
74	Medication/supplement use	250761	phv00250761.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:16:05+00:00	2018-09-24 13:16:05+00:00 	g044	Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Statins-e.g. Lovastatin, Pravastatin) Collection Interval: Exam 2
74	Medication/supplement use	250762	phv00250762.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:16:13+00:00	2018-09-24 13:16:13+00:00 	g045	Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (other-specify) Collection Interval: Exam 2
74	Medication/supplement use	250763	phv00250763.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:16:29+00:00	2018-09-24 13:16:29+00:00 	g046	Medical History - Interim Non-cardiovascular Medications I: Antigout-uric acid lowering (Allopurinol, Probenecid ect) Collection Interval: Exam 2
74	Medication/supplement use	250764	phv00250764.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:16:38+00:00	2018-09-24 13:16:38+00:00 	g047	Medical History - Interim Non-cardiovascular Medications I: Antigout - (Colchicine) Collection Interval: Exam 2
74	Medication/supplement use	250765	phv00250765.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:16:50+00:00	2018-09-24 13:16:50+00:00 	g048	Medical History - Interim Non-cardiovascular Medications I: Thyroid extract (Dessicated Thyroid) Collection Interval: Exam 2
74	Medication/supplement use	250766	phv00250766.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:16:58+00:00	2018-09-24 13:16:58+00:00 	g049	Medical History - Interim Non-cardiovascular Medications I: Thyroixine (Synthroid etc.) Collection Interval: Exam 2
74	Medication/supplement use	250767	phv00250767.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:17:07+00:00	2018-09-24 13:17:07+00:00 	g050	Medical History - Interim Non-cardiovascular Medications I: Insulin Collection Interval: Exam 2
74	Medication/supplement use	250768	phv00250768.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:17:19+00:00	2018-09-24 13:17:19+00:00 	g051	Medical History - Interim Non-cardiovascular Medications I: Total units of insulin a day Collection Interval: Exam 2
74	Medication/supplement use	250769	phv00250769.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:17:28+00:00	2018-09-24 13:17:28+00:00 	g052	Medical History - Interim Non-cardiovascular Medications I: Oral hypoglycemics Collection Interval: Exam 2
74	Medication/supplement use	250770	phv00250770.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:17:50+00:00	2018-09-24 13:17:50+00:00 	g053	Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Metformin Collection Interval: Exam 2
74	Medication/supplement use	250771	phv00250771.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:18:06+00:00	2018-09-24 13:18:06+00:00 	g054	Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Triglitazone Collection Interval: Exam 2
74	Medication/supplement use	250772	phv00250772.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:18:16+00:00	2018-09-24 13:18:16+00:00 	g055	Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Glipizide Collection Interval: Exam 2
74	Medication/supplement use	250773	phv00250773.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:18:26+00:00	2018-09-24 13:18:26+00:00 	g056	Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Glyburide Collection Interval: Exam 2
74	Medication/supplement use	250774	phv00250774.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:18:35+00:00	2018-09-24 13:18:35+00:00 	g057	Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Chlorpropamide Collection Interval: Exam 2
74	Medication/supplement use	250775	phv00250775.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:18:44+00:00	2018-09-24 13:18:44+00:00 	g058	Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Other (specify) Collection Interval: Exam 2
74	Medication/supplement use	250776	phv00250776.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:18:52+00:00	2018-09-24 13:18:52+00:00 	g059	Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Unknown Collection Interval: Exam 2
74	Medication/supplement use	250777	phv00250777.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:19:02+00:00	2018-09-24 13:19:02+00:00 	g060	Medical History - Interim Non-cardiovascular Medications I: Oral/patch estrogen (for women users also see estrogen section G088-G096) Collection Interval: Exam 2
74	Medication/supplement use	250778	phv00250778.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:19:11+00:00	2018-09-24 13:19:11+00:00 	g061	Medical History - Interim Non-cardiovascular Medications I: Oral glucocorticoids (Prednisone, Cortisone, etc.) Collection Interval: Exam 2
74	Medication/supplement use	250779	phv00250779.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:19:19+00:00	2018-09-24 13:19:19+00:00 	g062	Medical History - Non-cardiovascular Medications II - Interim Medications: Non-steroidal anti-inflammatory agents (NSAIDS) (Motrin, Ibuprofen, Naprosyn, Indocin, Cliinoril) Collection Interval: Exam 2
74	Medication/supplement use	250780	phv00250780.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:19:28+00:00	2018-09-24 13:19:28+00:00 	g063	Medical History - Non-cardiovascular Medications II - Interim Medications: Analgesic-narcotics (Demerol, Codeline, Dilaudid, etc.) Collection Interval: Exam 2
74	Medication/supplement use	250781	phv00250781.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:19:36+00:00	2018-09-24 13:19:36+00:00 	g064	Medical History - Non-cardiovascular Medications II - Interim Medications: Analgesic-non-narcotics (Acetaminophen etc.) Collection Interval: Exam 2
74	Medication/supplement use	250782	phv00250782.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:19:46+00:00	2018-09-24 13:19:46+00:00 	g065	Medical History - Non-cardiovascular Medications II - Interim Medications: Antihistamines Collection Interval: Exam 2
74	Medication/supplement use	250783	phv00250783.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:19:54+00:00	2018-09-24 13:19:54+00:00 	g066	Medical History - Non-cardiovascular Medications II - Interim Medications: Antiulcer (Tagamet, Ranitidine, Probanthine, H ion inhibitors) Collection Interval: Exam 2
74	Medication/supplement use	250784	phv00250784.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:20:01+00:00	2018-09-24 13:20:01+00:00 	g067	Medical History - Non-cardiovascular Medications II - Interim Medications: Anti-anxiety, Sedative/Hypnotics etc. (Librium, Valium, etc.) Collection Interval: Exam 2
74	Medication/supplement use	250785	phv00250785.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:20:09+00:00	2018-09-24 13:20:09+00:00 	g068	Medical History - Non-cardiovascular Medications II - Interim Medications: Sleeping pills Collection Interval: Exam 2
74	Medication/supplement use	250786	phv00250786.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:20:17+00:00	2018-09-24 13:20:17+00:00 	g069	Medical History - Non-cardiovascular Medications II - Interim Medications: Anti-depressants Collection Interval: Exam 2
74	Medication/supplement use	250787	phv00250787.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:20:26+00:00	2018-09-24 13:20:26+00:00 	g070	Medical History - Non-cardiovascular Medications II - Interim Medications: Eyedrops Collection Interval: Exam 2
74	Medication/supplement use	250788	phv00250788.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:20:36+00:00	2018-09-24 13:20:36+00:00 	g071	Medical History - Non-cardiovascular Medications II - Interim Medications: Antibiotics Collection Interval: Exam 2
74	Medication/supplement use	250789	phv00250789.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:21:08+00:00	2018-09-24 13:21:08+00:00 	g072	Medical History - Non-cardiovascular Medications II - Interim Medications: Anti-parkinson drugs (Sinemet, L-dopa, Symmetrel, Cogentin, etc.) Collection Interval: Exam 2
74	Medication/supplement use	250790	phv00250790.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:21:20+00:00	2018-09-24 13:21:20+00:00 	g073	Medical History - Non-cardiovascular Medications II - Interim Medications: Anticonvulsants (Dilantin, Phenobarbital, Tegretol, Mysoline etc.) Collection Interval: Exam 2
74	Medication/supplement use	250791	phv00250791.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:21:29+00:00	2018-09-24 13:21:29+00:00 	g074	Medical History - Non-cardiovascular Medications II - Interim Medications: Bronchodilators and aerosols Collection Interval: Exam 2
74	Medication/supplement use	250792	phv00250792.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:21:42+00:00	2018-09-24 13:21:42+00:00 	g075	Medical History - Non-cardiovascular Medications II - Interim Medications: Osteroporosis medications Collection Interval: Exam 2
74	Medication/supplement use	250793	phv00250793.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:21:54+00:00	2018-09-24 13:21:54+00:00 	g076	Medical History - Non-cardiovascular Medications II - Interim Medications: Others specify Collection Interval: Exam 2
74	Medication/supplement use	250798	phv00250798.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:22:20+00:00	2018-09-24 13:22:20+00:00 	g087	Medical History - Female Genitourinary Disease 1: Oral contraceptives in interim Collection Interval: Exam 2
74	Medication/supplement use	250799	phv00250799.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:22:29+00:00	2018-09-24 13:22:29+00:00 	g088	Medical History - Female Genitourinary Disease 2: Estrogen replacement in interim Collection Interval: Exam 2
74	Medication/supplement use	250800	phv00250800.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:22:37+00:00	2018-09-24 13:22:37+00:00 	g089	Medical History - Female Genitourinary Disease 2: Dose/day of premarin conjugated estrogens, or other oral estrogen Collection Interval: Exam 2
74	Medication/supplement use	250801	phv00250801.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:22:46+00:00	2018-09-24 13:22:46+00:00 	g090	Medical History - Female Genitourinary Disease 2: Patch dose of estrogen Collection Interval: Exam 2
74	Medication/supplement use	250802	phv00250802.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:22:56+00:00	2018-09-24 13:22:56+00:00 	g091	Medical History - Female Genitourinary Disease 2: Number of days a month taking estrogens Collection Interval: Exam 2
74	Medication/supplement use	250803	phv00250803.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:23:07+00:00	2018-09-24 13:23:07+00:00 	g092	Medical History - Female Genitourinary Disease 2: Number of years on estrogen Collection Interval: Exam 2
74	Medication/supplement use	250804	phv00250804.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:23:17+00:00	2018-09-24 13:23:17+00:00 	g093	Medical History - Female Genitourinary Disease 2: Estrogen cream use in interim Collection Interval: Exam 2
74	Medication/supplement use	250805	phv00250805.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:23:25+00:00	2018-09-24 13:23:25+00:00 	g094	Medical History - Female Genitourinary Disease 2: Progestin replacement in interim Collection Interval: Exam 2
74	Medication/supplement use	250806	phv00250806.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:23:35+00:00	2018-09-24 13:23:35+00:00 	g095	Medical History - Female Genitourinary Disease 2: Dose/day of progestin Collection Interval: Exam 2
74	Medication/supplement use	250807	phv00250807.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:23:43+00:00	2018-09-24 13:23:43+00:00 	g096	Medical History - Female Genitourinary Disease 2: Number of days a month taking progestins Collection Interval: Exam 2
74	Medication/supplement use	251237	phv00251237.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:25:37+00:00	2018-09-24 13:25:37+00:00 	g672	Respiratory Questionnaire - Asthma: Are you currently taking any medicines (including inhalers, aerosols, or tablets) for asthma? Collection Interval: Exam 2
74	Medication/supplement use	251244	phv00251244.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:25:55+00:00	2018-09-24 13:25:55+00:00 	g679	Respiratory Questionnaire - Steroid Medications: Are you currently taking any steroid medications? Collection Interval: Exam 2
74	Medication/supplement use	251245	phv00251245.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:26:07+00:00	2018-09-24 13:26:07+00:00 	g680	Respiratory Questionnaire - Smoking: If yes, by what route - Oral Collection Interval: Exam 2
74	Medication/supplement use	251248	phv00251248.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:27:23+00:00	2018-09-24 13:27:23+00:00 	g683	Respiratory Questionnaire: If yes, by what route - Nasal Collection Interval: Exam 2
74	Medication/supplement use	251271	phv00251271.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:29:40+00:00	2018-09-24 13:29:40+00:00 	h010	Medical History - Medications: Do you take aspirin regularly? Collection Interval: Exam 3
74	Medication/supplement use	251272	phv00251272.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:29:53+00:00	2018-09-24 13:29:53+00:00 	h011	Medical History - Medications: Number of aspirins taken regularly Collection Interval: Exam 3
74	Medication/supplement use	251273	phv00251273.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:30:00+00:00	2018-09-24 13:30:00+00:00 	h012	Medical History - Medications: Aspirin frequency per Collection Interval: Exam 3
74	Medication/supplement use	251274	phv00251274.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:30:08+00:00	2018-09-24 13:30:08+00:00 	h013	Medical History - Medications: Usual dose of aspirin Collection Interval: Exam 3
74	Medication/supplement use	251275	phv00251275.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:30:16+00:00	2018-09-24 13:30:16+00:00 	h014	Medical History - Medications: Since your last exam have you taken medication for high blood pressure or hypertension? Collection Interval: Exam 3
74	Medication/supplement use	251276	phv00251276.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:30:23+00:00	2018-09-24 13:30:23+00:00 	h015	Medical History - Medications: Since your last exam have you taken medication for high blood cholesterol or high triglycerides? Collection Interval: Exam 3
74	Medication/supplement use	251277	phv00251277.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:30:30+00:00	2018-09-24 13:30:30+00:00 	h016	Medical History - Medications: Since your last exam have you been told by a doctor you have high blood sugar or diabetes? Collection Interval: Exam 3
74	Medication/supplement use	251278	phv00251278.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:30:49+00:00	2018-09-24 13:30:49+00:00 	h017	Medical History - Medications: Since your last exam have you taken medication for cardiovascular disease? Collection Interval: Exam 3
74	Medication/supplement use	251279	phv00251279.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:31:03+00:00	2018-09-24 13:31:03+00:00 	h024	Medical History - Female Reproductive History - Part 1: Since your last exam have you taken or used oral contraceptive pills, shots, or hormone implants for birth control or medical indications (not post menopausal hormone replacement)? Collection Interval: Exam 3
74	Medication/supplement use	251280	phv00251280.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:31:18+00:00	2018-09-24 13:31:18+00:00 	h027	Medical History - Female Reproductive History - Part 1: What is the form of the current or most recent oral contraceptive, shot or implant used? Collection Interval: Exam 3
74	Medication/supplement use	251284	phv00251284.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:31:31+00:00	2018-09-24 13:31:31+00:00 	h045	Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Since your last exam have you taken hormone replacement therapy? (estrogen/progesterone) Collection Interval: Exam 3
74	Medication/supplement use	251285	phv00251285.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:31:42+00:00	2018-09-24 13:31:42+00:00 	h046	Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - At what age did you begin hormone replacement therapy? Collection Interval: Exam 3
74	Medication/supplement use	251286	phv00251286.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:31:53+00:00	2018-09-24 13:31:53+00:00 	h047	Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - For how long did you take hormones? - years Collection Interval: Exam 3
74	Medication/supplement use	251287	phv00251287.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:32:02+00:00	2018-09-24 13:32:02+00:00 	h048	Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - For how long did you take hormones? - months Collection Interval: Exam 3
74	Medication/supplement use	251288	phv00251288.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:32:13+00:00	2018-09-24 13:32:13+00:00 	h049	Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Estrogen use? Collection Interval: Exam 3
74	Medication/supplement use	251289	phv00251289.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:32:23+00:00	2018-09-24 13:32:23+00:00 	h052	Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Number of days per month estrogen was taken Collection Interval: Exam 3
74	Medication/supplement use	251290	phv00251290.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:32:34+00:00	2018-09-24 13:32:34+00:00 	h053	Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Progesterone use? Collection Interval: Exam 3
74	Medication/supplement use	251291	phv00251291.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:32:46+00:00	2018-09-24 13:32:46+00:00 	h056	Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Number of days per month progesterone was taken Collection Interval: Exam 3
74	Medication/supplement use	251292	phv00251292.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:32:57+00:00	2018-09-24 13:32:57+00:00 	h057	Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Have you used Evista (raloxifene) or Nolvadex (tamoxifen) or other selective estrogen receptor modulator (SERM)? Collection Interval: Exam 3
74	Medication/supplement use	251293	phv00251293.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:33:35+00:00	2018-09-24 13:33:35+00:00 	h058	Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Have you used Evista (raloxifene) or Nolvadex (tamoxifen) or other selective estrogen receptor modulator (SERM)? - Number of months used Collection Interval: Exam 3
74	Medication/supplement use	251294	phv00251294.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:34:19+00:00	2018-09-24 13:34:19+00:00 	h059	Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Have you used Evista (raloxifene) or Nolvadex (tamoxifen) or other selective estrogen receptor modulator (SERM)? - Current use Collection Interval: Exam 3
74	Medication/supplement use	251726	phv00251726.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:35:37+00:00	2018-09-24 13:35:37+00:00 	h670	Respiratory Disease Questionnaire - Technician Administered: Inhaler Use: Do you take inhalers or bronchodilators? Collection Interval: Exam 3
74	Medication/supplement use	251727	phv00251727.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:35:48+00:00	2018-09-24 13:35:48+00:00 	h671	Respiratory Disease Questionnaire - Technician Administered: Inhaler Use: Do you use any of these medications - Albuterol, Proventil, Ventolin, Combivent, Maxari, Volmax, Xopenex, Bronkoometer, pirubuterol, levalbuterol, or metaproterenol? Collection Interval: Exam 3
74	Medication/supplement use	251729	phv00251729.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 13:36:13+00:00	2018-09-24 13:36:13+00:00 	h673	Respiratory Disease Questionnaire - Technician Administered: Inhaler Use: Do you take any of the following inhalers - Serevent, Advair, Foradil, salmeterol, or formoterol? Collection Interval: Exam 3
74	Medication/supplement use	254019	phv00254019.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:17:20+00:00	2018-09-24 14:17:20+00:00 	j010	Medical History - Medications: Do you take aspirin regularly?
74	Medication/supplement use	254020	phv00254020.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:17:35+00:00	2018-09-24 14:17:35+00:00 	j011	Medical History - Medications: Number of aspirins taken regularly
74	Medication/supplement use	254021	phv00254021.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:17:47+00:00	2018-09-24 14:17:47+00:00 	j012	Medical History - Medications: Aspirin frequency per (day, week, month, year)
74	Medication/supplement use	254022	phv00254022.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:17:58+00:00	2018-09-24 14:17:58+00:00 	j013	Medical History - Medications: Usual dose of aspirin
74	Medication/supplement use	254024	phv00254024.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:18:15+00:00	2018-09-24 14:18:15+00:00 	j015	Medical History - Medications: Since your last exam have you taken medication for high blood pressure of hypertension?
74	Medication/supplement use	254026	phv00254026.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:18:28+00:00	2018-09-24 14:18:28+00:00 	j017	Medical History - Medications: Since your last exam have you taken medication for high blood cholesterol or high triglycerides?
74	Medication/supplement use	254028	phv00254028.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:18:39+00:00	2018-09-24 14:18:39+00:00 	j019	Medical History - Medications: Since your last exam have you taken medication for high blood sugar or diabetes?
74	Medication/supplement use	254029	phv00254029.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:18:51+00:00	2018-09-24 14:18:51+00:00 	j020	Medical History - Medications: Since your last exam have you taken medication for cardiovascular disease? (example: angina/chest pain, heart failure, atrial fibrillation/heart rhythm abnormality, stroke, leg pain when walking, peripheral artery disease)
74	Medication/supplement use	254032	phv00254032.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:19:08+00:00	2018-09-24 14:19:08+00:00 	j032	Medical History - Female Reproductive History, Part 1: Since your last exam have you taken or used birth control pills, shots, or hormone implants for birth control or medical indications (not post menopausal hormone replacement)?
74	Medication/supplement use	254502	phv00254502.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:20:19+00:00	2018-09-24 14:20:19+00:00 	j845	Respiratory Disease Questionnaire Part 1-Tech administered: Inhaler use: Do you take inhalers or bronchodilators?
74	Medication/supplement use	254503	phv00254503.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:20:30+00:00	2018-09-24 14:20:30+00:00 	j846	Respiratory Disease Questionnaire Part 1-Tech administered: Inhaler use: Do you take any of the inhaled medications?
74	Medication/supplement use	254504	phv00254504.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:20:38+00:00	2018-09-24 14:20:38+00:00 	j847	Respiratory Disease Questionnaire Part 1-Tech administered: Inhaler use: How many hours ago did you last use the medication, either by inhaler or nebulizer?
74	Medication/supplement use	254505	phv00254505.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:20:47+00:00	2018-09-24 14:20:47+00:00 	j848	Respiratory Disease Questionnaire Part 1-Tech administered: Inhaler use: Do you take any of the following inhaled medications?
74	Medication/supplement use	254506	phv00254506.v1.p10	pht005140.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:20:56+00:00	2018-09-24 14:20:56+00:00 	j849	Respiratory Disease Questionnaire Part 1-Tech administered: Inhaler use: How many hours ago did you last use the medication, either by inhaler or nebulizer?
74	Medication/supplement use	254605	phv00254605.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:43:15+00:00	2018-09-24 14:43:15+00:00 	fv010	Medical History - Medications: Since your last exam have you taken medication for the treatment of hypertension? (high blood pressure) Collection Interval: Exam 29
74	Medication/supplement use	254606	phv00254606.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:43:28+00:00	2018-09-24 14:43:28+00:00 	fv011	Medical History - Medications: Take aspirin regularly? Collection Interval: Exam 29
74	Medication/supplement use	254607	phv00254607.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:43:43+00:00	2018-09-24 14:43:43+00:00 	fv012	Medical History - Medications: Number aspirins taken regularly Collection Interval: Exam 29
74	Medication/supplement use	254608	phv00254608.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:50:27+00:00	2018-09-24 14:50:27+00:00 	fv013	Medical History - Medications: Aspirin frequency, number taken regularly Collection Interval: Exam 29
74	Medication/supplement use	254609	phv00254609.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:50:39+00:00	2018-09-24 14:50:39+00:00 	fv014	Medical History - Medications: Usual aspirin dose Collection Interval: Exam 29
74	Medication/supplement use	254827	phv00254827.v1.p10	pht005141.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:51:41+00:00	2018-09-24 14:51:41+00:00 	fv371	Instrumental Activities of Daily Living (Lawton IADL): Do you take medicines or use any medications? Collection Interval: Exam 29
74	Medication/supplement use	254996	phv00254996.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:56:37+00:00	2018-09-24 14:56:37+00:00 	fw008	Medical History - Medications - Hypertension: Have you taken medication for the treatment of hypertension since last exam? Collection Interval: Original Cohort Exam 30
74	Medication/supplement use	254997	phv00254997.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:56:46+00:00	2018-09-24 14:56:46+00:00 	fw009	Medical History - Medications : Do you take aspirin regularly? Collection Interval: Original Cohort Exam 30
74	Medication/supplement use	254998	phv00254998.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:56:54+00:00	2018-09-24 14:56:54+00:00 	fw010	Medical History - Medications : Number of aspirin taken regularly Collection Interval: Original Cohort Exam 30
74	Medication/supplement use	254999	phv00254999.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:57:03+00:00	2018-09-24 14:57:03+00:00 	fw011	Medical History - Medications: Aspirin frequency per Collection Interval: Original Cohort Exam 30
74	Medication/supplement use	255000	phv00255000.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:57:12+00:00	2018-09-24 14:57:12+00:00 	fw012	Medical History - Medications: Usual dose of aspirin Collection Interval: Original Cohort Exam 30
74	Medication/supplement use	255214	phv00255214.v1.p10	pht005142.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 14:58:12+00:00	2018-09-24 14:58:12+00:00 	fw429	LAWTON - Do you take medicines or use any medications? Collection Interval: Original Cohort Exam 30
74	Medication/supplement use	274716	phv00274716.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:00:09+00:00	2018-09-24 15:00:09+00:00 	FX008	Medical History - Medications - Hypertension: Have you taken medication for the treatment of hypertension since last exam? Collection Interval: Original Cohort Exam 31
74	Medication/supplement use	274717	phv00274717.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:00:17+00:00	2018-09-24 15:00:17+00:00 	FX009	Medical History - Medications : Do you take aspirin regularly? Collection Interval: Original Cohort Exam 31
74	Medication/supplement use	274718	phv00274718.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:00:26+00:00	2018-09-24 15:00:26+00:00 	FX010	Medical History - Medications : Number of aspirin taken regularly Collection Interval: Original Cohort Exam 31
74	Medication/supplement use	274719	phv00274719.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:00:35+00:00	2018-09-24 15:00:35+00:00 	FX011	Medical History - Medications: Aspirin frequency per Collection Interval: Original Cohort Exam 31
74	Medication/supplement use	274720	phv00274720.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:00:44+00:00	2018-09-24 15:00:44+00:00 	FX012	Medical History - Medications: Usual dose of aspirin Collection Interval: Original Cohort Exam 31
74	Medication/supplement use	274939	phv00274939.v1.p10	pht006007.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:01:29+00:00	2018-09-24 15:01:29+00:00 	FX429	LAWTON - Do you take medicines or use any medications? Collection Interval: Original Cohort Exam 31
74	Medication/supplement use	275071	phv00275071.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:07:48+00:00	2018-09-24 15:07:48+00:00 	fy008	Medical History - Medications : Have you taken medication for the treatment of hypertension since last exam? Collection Interval: Original Cohort Exam 32
74	Medication/supplement use	275074	phv00275074.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:08:02+00:00	2018-09-24 15:08:02+00:00 	fy009	Medical History - Medications : Do you take aspirin regularly? Collection Interval: Original Cohort Exam 32
74	Medication/supplement use	275075	phv00275075.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:08:12+00:00	2018-09-24 15:08:12+00:00 	fy010	Medical History - Medications : Number of aspirin taken regularly Collection Interval: Original Cohort Exam 32
74	Medication/supplement use	275076	phv00275076.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:08:28+00:00	2018-09-24 15:08:28+00:00 	fy011	Medical History - Medications: Aspirin frequency per Collection Interval: Original Cohort Exam 32
74	Medication/supplement use	275077	phv00275077.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:08:37+00:00	2018-09-24 15:08:37+00:00 	fy012	Medical History - Medications: Usual dose of aspirin Collection Interval: Original Cohort Exam 32
74	Medication/supplement use	275297	phv00275297.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:09:45+00:00	2018-09-24 15:09:45+00:00 	fy429	LAWTON - Do you take medicines or use any medications? Collection Interval: Original Cohort Exam 32
74	Medication/supplement use	275072	phv00275072.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:10:15+00:00	2018-09-24 15:10:15+00:00 	fy620	Medical History - Medications : Have you taken medication for the treatment of high blood cholesterol or high triglycerides? Collection Interval: Original Cohort Exam 32
74	Medication/supplement use	275073	phv00275073.v1.p10	pht006008.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:10:24+00:00	2018-09-24 15:10:24+00:00 	fy621	Medical History - Medications : Have you taken medication for the treatment of high blood sugar or diabetes? Collection Interval: Original Cohort Exam 32
74	Medication/supplement use	1539	phv00001539.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:15:50+00:00	2018-09-24 15:15:50+00:00 	FC205	ECG: TAKING DIGITALIS OR QUINIDINE
74	Medication/supplement use	1541	phv00001541.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:16:04+00:00	2018-09-24 15:16:04+00:00 	FC209	CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION
74	Medication/supplement use	1436	phv00001436.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:16:26+00:00	2018-09-24 15:16:26+00:00 	FC82	INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES
74	Medication/supplement use	1437	phv00001437.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:16:44+00:00	2018-09-24 15:16:44+00:00 	FC83	INTERIM HISTORY OF MEDICINE USED: NITRITES
74	Medication/supplement use	1438	phv00001438.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:16:53+00:00	2018-09-24 15:16:53+00:00 	FC84	INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE)
74	Medication/supplement use	1439	phv00001439.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:17:20+00:00	2018-09-24 15:17:20+00:00 	FC85	INTERIM HISTORY OF MEDICINE USED: DIURETICS
74	Medication/supplement use	1440	phv00001440.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:17:29+00:00	2018-09-24 15:17:29+00:00 	FC86	INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES
74	Medication/supplement use	1441	phv00001441.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:17:37+00:00	2018-09-24 15:17:37+00:00 	FC87	INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS
74	Medication/supplement use	1442	phv00001442.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:17:46+00:00	2018-09-24 15:17:46+00:00 	FC88	INTERIM HISTORY OF MEDICINE USED: THYROID
74	Medication/supplement use	1443	phv00001443.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:18:29+00:00	2018-09-24 15:18:29+00:00 	FC89	INTERIM HISTORY OF MEDICINE USED: ANTITHYROID
74	Medication/supplement use	1444	phv00001444.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:18:40+00:00	2018-09-24 15:18:40+00:00 	FC90	INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS
74	Medication/supplement use	1445	phv00001445.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:19:23+00:00	2018-09-24 15:19:23+00:00 	FC91	INTERIM HISTORY OF MEDICINE USED: HYPOGLYCEMIC AGENTS
74	Medication/supplement use	1446	phv00001446.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:19:35+00:00	2018-09-24 15:19:35+00:00 	FC92	INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS
74	Medication/supplement use	1447	phv00001447.v1.p10	pht000012.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:19:45+00:00	2018-09-24 15:19:45+00:00 	FC96	MENOPAUSE: HORMONE THERAPY
74	Medication/supplement use	1730	phv00001730.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:21:13+00:00	2018-09-24 15:21:13+00:00 	FD201	ECG: TAKING DIGITALIS OR QUINIDINE
74	Medication/supplement use	1768	phv00001768.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:21:33+00:00	2018-09-24 15:21:33+00:00 	FD259	CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION
74	Medication/supplement use	1619	phv00001619.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:21:57+00:00	2018-09-24 15:21:57+00:00 	FD74	INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES
74	Medication/supplement use	1620	phv00001620.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:22:16+00:00	2018-09-24 15:22:16+00:00 	FD75	INTERIM HISTORY OF MEDICINE USED: NITRITES
74	Medication/supplement use	1621	phv00001621.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:22:27+00:00	2018-09-24 15:22:27+00:00 	FD76	INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE)
74	Medication/supplement use	1622	phv00001622.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:26:15+00:00	2018-09-24 15:26:15+00:00 	FD77	INTERIM HISTORY OF MEDICINE USED: DIURETICS
74	Medication/supplement use	1623	phv00001623.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:26:25+00:00	2018-09-24 15:26:25+00:00 	FD78	INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES (EXCLUDE DIURETICS)
74	Medication/supplement use	1624	phv00001624.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:26:36+00:00	2018-09-24 15:26:36+00:00 	FD79	INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS
74	Medication/supplement use	1625	phv00001625.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:26:43+00:00	2018-09-24 15:26:43+00:00 	FD80	INTERIM HISTORY OF MEDICINE USED: THYROID
74	Medication/supplement use	1626	phv00001626.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:26:51+00:00	2018-09-24 15:26:51+00:00 	FD81	INTERIM HISTORY OF MEDICINE USED: ANTITHYROID
74	Medication/supplement use	1627	phv00001627.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:26:58+00:00	2018-09-24 15:26:58+00:00 	FD82	INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS
74	Medication/supplement use	1628	phv00001628.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:27:05+00:00	2018-09-24 15:27:05+00:00 	FD83	INTERIM HISTORY OF MEDICINE USED: HYPOGLYCEMIC AGENTS
74	Medication/supplement use	1629	phv00001629.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:27:13+00:00	2018-09-24 15:27:13+00:00 	FD84	INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS
74	Medication/supplement use	1630	phv00001630.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:27:20+00:00	2018-09-24 15:27:20+00:00 	FD85	INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR OR AEROSOL
74	Medication/supplement use	1631	phv00001631.v1.p10	pht000013.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:27:31+00:00	2018-09-24 15:27:31+00:00 	FD86	INTERIM HISTORY OF MEDICINE USED: HORMONE THERAPY
74	Medication/supplement use	1834	phv00001834.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:29:00+00:00	2018-09-24 15:29:00+00:00 	FE100	INTERIM HISTORY OF MEDICINE USED: ASPIRIN - TABS/DAY
74	Medication/supplement use	1994	phv00001994.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:29:31+00:00	2018-09-24 15:29:31+00:00 	FE281	ECG: TAKING DIGITALIS OR QUINIDINE
74	Medication/supplement use	2000	phv00002000.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:29:42+00:00	2018-09-24 15:29:42+00:00 	FE318	CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION
74	Medication/supplement use	1819	phv00001819.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:30:11+00:00	2018-09-24 15:30:11+00:00 	FE85	INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES
74	Medication/supplement use	1820	phv00001820.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:30:20+00:00	2018-09-24 15:30:20+00:00 	FE86	INTERIM HISTORY OF MEDICINE USED: NITRITES
74	Medication/supplement use	1821	phv00001821.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:30:27+00:00	2018-09-24 15:30:27+00:00 	FE87	INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE)
74	Medication/supplement use	1822	phv00001822.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:30:36+00:00	2018-09-24 15:30:36+00:00 	FE88	INTERIM HISTORY OF MEDICINE USED: DIURETICS
74	Medication/supplement use	1823	phv00001823.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:30:49+00:00	2018-09-24 15:30:49+00:00 	FE89	INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES (EXCLUDE DIURETICS)
74	Medication/supplement use	1824	phv00001824.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:30:56+00:00	2018-09-24 15:30:56+00:00 	FE90	INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS
74	Medication/supplement use	1825	phv00001825.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:31:08+00:00	2018-09-24 15:31:08+00:00 	FE91	INTERIM HISTORY OF MEDICINE USED: THYROID
74	Medication/supplement use	1826	phv00001826.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:31:15+00:00	2018-09-24 15:31:15+00:00 	FE92	INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS
74	Medication/supplement use	1827	phv00001827.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:31:24+00:00	2018-09-24 15:31:24+00:00 	FE93	INTERIM HISTORY OF MEDICINE USED: INSULIN
74	Medication/supplement use	1828	phv00001828.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:31:32+00:00	2018-09-24 15:31:32+00:00 	FE94	INTERIM HISTORY OF MEDICINE USED: ORINASE
74	Medication/supplement use	1829	phv00001829.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:31:40+00:00	2018-09-24 15:31:40+00:00 	FE95	INTERIM HISTORY OF MEDICINE USED: OTHER HYPOGLYCEMIC AGENTS
74	Medication/supplement use	1830	phv00001830.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:31:48+00:00	2018-09-24 15:31:48+00:00 	FE96	INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS
74	Medication/supplement use	1831	phv00001831.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:31:57+00:00	2018-09-24 15:31:57+00:00 	FE97	INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR OR AEROSOL
74	Medication/supplement use	1832	phv00001832.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:32:05+00:00	2018-09-24 15:32:05+00:00 	FE98	INTERIM HISTORY OF MEDICINE USED: OTHER MEDICINES
74	Medication/supplement use	1833	phv00001833.v1.p10	pht000014.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:32:13+00:00	2018-09-24 15:32:13+00:00 	FE99	INTERIM HISTORY OF MEDICINE USED: HORMONE TREATMENT
74	Medication/supplement use	2051	phv00002051.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:34:42+00:00	2018-09-24 15:34:42+00:00 	FF100	INTERIM HISTORY OF MEDICINE USED: OTHER MEDICINES
74	Medication/supplement use	2052	phv00002052.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:34:51+00:00	2018-09-24 15:34:51+00:00 	FF101	INTERIM HISTORY OF MEDICINE USED: HORMONE TREATMENT
74	Medication/supplement use	2053	phv00002053.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:35:00+00:00	2018-09-24 15:35:00+00:00 	FF102	INTERIM HISTORY OF MEDICINE USED: ASPIRIN - TABS/WEEK
74	Medication/supplement use	2174	phv00002174.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:35:22+00:00	2018-09-24 15:35:22+00:00 	FF244	ECG: TAKING DIGITALIS OR QUINIDINE
74	Medication/supplement use	2181	phv00002181.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:35:37+00:00	2018-09-24 15:35:37+00:00 	FF251	CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION
74	Medication/supplement use	2038	phv00002038.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:36:03+00:00	2018-09-24 15:36:03+00:00 	FF87	INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES
74	Medication/supplement use	2039	phv00002039.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:36:10+00:00	2018-09-24 15:36:10+00:00 	FF88	INTERIM HISTORY OF MEDICINE USED: NITRITES
74	Medication/supplement use	2040	phv00002040.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:36:18+00:00	2018-09-24 15:36:18+00:00 	FF89	INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE)
74	Medication/supplement use	2041	phv00002041.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:36:26+00:00	2018-09-24 15:36:26+00:00 	FF90	INTERIM HISTORY OF MEDICINE USED: DIURETICS
74	Medication/supplement use	2042	phv00002042.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:36:33+00:00	2018-09-24 15:36:33+00:00 	FF91	INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES (EXCLUDE DIURETICS)
74	Medication/supplement use	2043	phv00002043.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:36:41+00:00	2018-09-24 15:36:41+00:00 	FF92	INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS
74	Medication/supplement use	2044	phv00002044.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:36:49+00:00	2018-09-24 15:36:49+00:00 	FF93	INTERIM HISTORY OF MEDICINE USED: THYROID
74	Medication/supplement use	2045	phv00002045.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:36:57+00:00	2018-09-24 15:36:57+00:00 	FF94	INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS
74	Medication/supplement use	2046	phv00002046.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:37:04+00:00	2018-09-24 15:37:04+00:00 	FF95	INTERIM HISTORY OF MEDICINE USED: INSULIN
74	Medication/supplement use	2047	phv00002047.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:37:12+00:00	2018-09-24 15:37:12+00:00 	FF96	INTERIM HISTORY OF MEDICINE USED: ORINASE
74	Medication/supplement use	2048	phv00002048.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:37:26+00:00	2018-09-24 15:37:26+00:00 	FF97	INTERIM HISTORY OF MEDICINE USED: OTHER HYPOGLYCEMIC AGENTS
74	Medication/supplement use	2049	phv00002049.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:37:34+00:00	2018-09-24 15:37:34+00:00 	FF98	INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS
74	Medication/supplement use	2050	phv00002050.v1.p10	pht000015.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:37:42+00:00	2018-09-24 15:37:42+00:00 	FF99	INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR OR AEROSOL
74	Medication/supplement use	2235	phv00002235.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:39:16+00:00	2018-09-24 15:39:16+00:00 	FG100	INTERIM HISTORY OF MEDICINE USED: HORMONE TREATMENT
74	Medication/supplement use	2369	phv00002369.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:39:45+00:00	2018-09-24 15:39:45+00:00 	FG252	ECG: TAKING DIGITALIS OR QUINIDINE
74	Medication/supplement use	2376	phv00002376.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:39:58+00:00	2018-09-24 15:39:58+00:00 	FG259	CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION
74	Medication/supplement use	2219	phv00002219.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:40:25+00:00	2018-09-24 15:40:25+00:00 	FG84	INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES
74	Medication/supplement use	2220	phv00002220.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:40:34+00:00	2018-09-24 15:40:34+00:00 	FG85	INTERIM HISTORY OF MEDICINE USED: NITRITES
74	Medication/supplement use	2221	phv00002221.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:40:41+00:00	2018-09-24 15:40:41+00:00 	FG86	INTERIM HISTORY OF MEDICINE USE: PROPRANOLOL
74	Medication/supplement use	2222	phv00002222.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:40:49+00:00	2018-09-24 15:40:49+00:00 	FG87	INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE)
74	Medication/supplement use	2223	phv00002223.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:40:56+00:00	2018-09-24 15:40:56+00:00 	FG88	INTERIM HISTORY OF MEDICINE USED: DIURETICS-HYPERTENSION
74	Medication/supplement use	2224	phv00002224.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:41:04+00:00	2018-09-24 15:41:04+00:00 	FG89	INTERIM HISTORY OF MEDICINE USED: DIURETICS-OTHER
74	Medication/supplement use	2225	phv00002225.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:41:12+00:00	2018-09-24 15:41:12+00:00 	FG90	INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES (EXCLUDE DIURETICS)
74	Medication/supplement use	2226	phv00002226.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:41:19+00:00	2018-09-24 15:41:19+00:00 	FG91	INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS
74	Medication/supplement use	2227	phv00002227.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:41:27+00:00	2018-09-24 15:41:27+00:00 	FG92	INTERIM HISTORY OF MEDICINE USED: THYROID
74	Medication/supplement use	2228	phv00002228.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:41:34+00:00	2018-09-24 15:41:34+00:00 	FG93	INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS
74	Medication/supplement use	2229	phv00002229.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:41:42+00:00	2018-09-24 15:41:42+00:00 	FG94	INTERIM HISTORY OF MEDICINE USED: INSULIN
74	Medication/supplement use	2230	phv00002230.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:41:51+00:00	2018-09-24 15:41:51+00:00 	FG95	INTERIM HISTORY OF MEDICINE USED: ORAL HYPOGLYCEMIC AGENTS
74	Medication/supplement use	2231	phv00002231.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:41:59+00:00	2018-09-24 15:41:59+00:00 	FG96	INTERIM HISTORY OF MEDICINE USED: SLEEPING PILLS
74	Medication/supplement use	2232	phv00002232.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:42:07+00:00	2018-09-24 15:42:07+00:00 	FG97	INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS
74	Medication/supplement use	2233	phv00002233.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:42:16+00:00	2018-09-24 15:42:16+00:00 	FG98	INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR OR AEROSOL
74	Medication/supplement use	2234	phv00002234.v1.p10	pht000016.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:42:25+00:00	2018-09-24 15:42:25+00:00 	FG99	INTERIM HISTORY OF MEDICINE USED: OTHER MEDICINES
74	Medication/supplement use	2457	phv00002457.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:43:34+00:00	2018-09-24 15:43:34+00:00 	FH100	INTERIM HISTORY OF MEDICINE USED: OTHER MEDICINES
74	Medication/supplement use	2609	phv00002609.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:44:04+00:00	2018-09-24 15:44:04+00:00 	FH269	ECG: TAKING DIGITALIS OR QUINIDINE
74	Medication/supplement use	2615	phv00002615.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:44:18+00:00	2018-09-24 15:44:18+00:00 	FH276	CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION
74	Medication/supplement use	2439	phv00002439.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:44:45+00:00	2018-09-24 15:44:45+00:00 	FH82	INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES
74	Medication/supplement use	2440	phv00002440.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:44:53+00:00	2018-09-24 15:44:53+00:00 	FH83	INTERIM HISTORY OF MEDICINE USED: NITRITES
74	Medication/supplement use	2441	phv00002441.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:45:02+00:00	2018-09-24 15:45:02+00:00 	FH84	INTERIM HISTORY OF MEDICINE USE: PROPRANOLOL
74	Medication/supplement use	2442	phv00002442.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:45:11+00:00	2018-09-24 15:45:11+00:00 	FH85	INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE)
74	Medication/supplement use	2443	phv00002443.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:45:20+00:00	2018-09-24 15:45:20+00:00 	FH86	INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES (EXCLUDE DIURETICS)
74	Medication/supplement use	2444	phv00002444.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:45:29+00:00	2018-09-24 15:45:29+00:00 	FH87	INTERIM HISTORY OF MEDICINE USED: ALDOMET
74	Medication/supplement use	2445	phv00002445.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:45:36+00:00	2018-09-24 15:45:36+00:00 	FH88	INTERIM HISTORY OF MEDICINE USED: SPIRONOLACTONE
74	Medication/supplement use	2446	phv00002446.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:45:45+00:00	2018-09-24 15:45:45+00:00 	FH89	INTERIM HISTORY OF MEDICINE USED: DIURETICS-HYPERTENSION
74	Medication/supplement use	2447	phv00002447.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:45:54+00:00	2018-09-24 15:45:54+00:00 	FH90	INTERIM HISTORY OF MEDICINE USED: DIURETICS-OTHER
74	Medication/supplement use	2448	phv00002448.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:46:03+00:00	2018-09-24 15:46:03+00:00 	FH91	INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS
74	Medication/supplement use	2449	phv00002449.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:46:10+00:00	2018-09-24 15:46:10+00:00 	FH92	INTERIM HISTORY OF MEDICINE USED: THYROID
74	Medication/supplement use	2450	phv00002450.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:46:20+00:00	2018-09-24 15:46:20+00:00 	FH93	INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS
74	Medication/supplement use	2451	phv00002451.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:46:28+00:00	2018-09-24 15:46:28+00:00 	FH94	INTERIM HISTORY OF MEDICINE USED: INSULIN
74	Medication/supplement use	2452	phv00002452.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:46:35+00:00	2018-09-24 15:46:35+00:00 	FH95	INTERIM HISTORY OF MEDICINE USED: ORAL HYPOGLYCEMIC AGENTS
74	Medication/supplement use	2453	phv00002453.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:46:44+00:00	2018-09-24 15:46:44+00:00 	FH96	INTERIM HISTORY OF MEDICINE USED: SLEEPING PILLS
74	Medication/supplement use	2454	phv00002454.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:46:52+00:00	2018-09-24 15:46:52+00:00 	FH97	INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS
74	Medication/supplement use	2455	phv00002455.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:47:03+00:00	2018-09-24 15:47:03+00:00 	FH98	INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR OR AEROSOL
74	Medication/supplement use	2456	phv00002456.v1.p10	pht000017.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:47:14+00:00	2018-09-24 15:47:14+00:00 	FH99	INTERIM HISTORY OF MEDICINE USED: HORMONE TREATMENT
74	Medication/supplement use	2821	phv00002821.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:48:49+00:00	2018-09-24 15:48:49+00:00 	FI187	CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION
74	Medication/supplement use	2693	phv00002693.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:49:28+00:00	2018-09-24 15:49:28+00:00 	FI41	INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES
74	Medication/supplement use	2694	phv00002694.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:49:35+00:00	2018-09-24 15:49:35+00:00 	FI42	INTERIM HISTORY OF MEDICINE USED: NITRITES
74	Medication/supplement use	2695	phv00002695.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:49:43+00:00	2018-09-24 15:49:43+00:00 	FI43	INTERIM HISTORY OF MEDICINE USE: PROPRANOLOL
74	Medication/supplement use	2696	phv00002696.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:49:50+00:00	2018-09-24 15:49:50+00:00 	FI44	INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE)
74	Medication/supplement use	2697	phv00002697.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:49:58+00:00	2018-09-24 15:49:58+00:00 	FI45	INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES (EXCLUDE DIURETICS)
74	Medication/supplement use	2698	phv00002698.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:50:06+00:00	2018-09-24 15:50:06+00:00 	FI46	INTERIM HISTORY OF MEDICINE USED: ALDOMET
74	Medication/supplement use	2699	phv00002699.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:50:14+00:00	2018-09-24 15:50:14+00:00 	FI47	INTERIM HISTORY OF MEDICINE USED: SPIRONOLACTONE
74	Medication/supplement use	2700	phv00002700.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:50:22+00:00	2018-09-24 15:50:22+00:00 	FI48	INTERIM HISTORY OF MEDICINE USED: DIURETICS-HYPERTENSION
74	Medication/supplement use	2701	phv00002701.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:50:30+00:00	2018-09-24 15:50:30+00:00 	FI49	INTERIM HISTORY OF MEDICINE USED: DIURETICS-OTHER
74	Medication/supplement use	2702	phv00002702.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:50:39+00:00	2018-09-24 15:50:39+00:00 	FI50	INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS
74	Medication/supplement use	2703	phv00002703.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:50:50+00:00	2018-09-24 15:50:50+00:00 	FI51	INTERIM HISTORY OF MEDICINE USED: THYROID
74	Medication/supplement use	2704	phv00002704.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:51:04+00:00	2018-09-24 15:51:04+00:00 	FI52	INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS
74	Medication/supplement use	2705	phv00002705.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:51:12+00:00	2018-09-24 15:51:12+00:00 	FI53	INTERIM HISTORY OF MEDICINE USED: INSULIN
74	Medication/supplement use	2706	phv00002706.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:51:19+00:00	2018-09-24 15:51:19+00:00 	FI54	INTERIM HISTORY OF MEDICINE USED: ORAL HYPOGLYCEMIC AGENTS
74	Medication/supplement use	2707	phv00002707.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:51:31+00:00	2018-09-24 15:51:31+00:00 	FI55	INTERIM HISTORY OF MEDICINE USED: SLEEPING PILLS
74	Medication/supplement use	2708	phv00002708.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:51:39+00:00	2018-09-24 15:51:39+00:00 	FI56	INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS
74	Medication/supplement use	2709	phv00002709.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:51:48+00:00	2018-09-24 15:51:48+00:00 	FI57	INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR OR AEROSOL
74	Medication/supplement use	2710	phv00002710.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:51:56+00:00	2018-09-24 15:51:56+00:00 	FI58	INTERIM HISTORY OF MEDICINE USED: HORMONE TREATMENT
74	Medication/supplement use	2711	phv00002711.v1.p10	pht000018.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:52:07+00:00	2018-09-24 15:52:07+00:00 	FI59	INTERIM HISTORY OF MEDICINE USED: OTHER MEDICINES
74	Medication/supplement use	2953	phv00002953.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:53:43+00:00	2018-09-24 15:53:43+00:00 	FJ10	INTERIM HISTORY OF MEDICINE USE: LONGER ACTING NITRATES
74	Medication/supplement use	2954	phv00002954.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:54:02+00:00	2018-09-24 15:54:02+00:00 	FJ11	INTERIM HISTORY OF MEDICINE USED: CALCIUM CHANNEL BLOCKERS
74	Medication/supplement use	2955	phv00002955.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:54:14+00:00	2018-09-24 15:54:14+00:00 	FJ12	INTERIM HISTORY OF MEDICINE USED: BETA BLOCKER
74	Medication/supplement use	2956	phv00002956.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:54:26+00:00	2018-09-24 15:54:26+00:00 	FJ13	INTERIM HISTORY OF MEDICINE USED: ANTIARRHYTHMICS
74	Medication/supplement use	3062	phv00003062.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:54:38+00:00	2018-09-24 15:54:38+00:00 	FJ134	THYROID DISEASE: EVER TAKEN THYROID MEDICATION
74	Medication/supplement use	2957	phv00002957.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:54:49+00:00	2018-09-24 15:54:49+00:00 	FJ14	INTERIM HISTORY OF MEDICINE USED: ANTIPLATELET
74	Medication/supplement use	2958	phv00002958.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:55:01+00:00	2018-09-24 15:55:01+00:00 	FJ15	INTERIM HISTORY OF MEDICINE USED: DIURETICS
74	Medication/supplement use	2959	phv00002959.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:55:11+00:00	2018-09-24 15:55:11+00:00 	FJ16	INTERIM HISTORY OF MEDICINE USED: K-SPARING DIURETICS
74	Medication/supplement use	2960	phv00002960.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:55:22+00:00	2018-09-24 15:55:22+00:00 	FJ17	INTERIM HISTORY OF MEDICINE USED: RESERPINE DERIVATIVES
74	Medication/supplement use	2961	phv00002961.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:55:37+00:00	2018-09-24 15:55:37+00:00 	FJ18	INTERIM HISTORY OF MEDICINE USED: METHYLDOPA
74	Medication/supplement use	2962	phv00002962.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:55:47+00:00	2018-09-24 15:55:47+00:00 	FJ19	INTERIM HISTORY OF MEDICINE USED: CLONIDINE
74	Medication/supplement use	2963	phv00002963.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:55:59+00:00	2018-09-24 15:55:59+00:00 	FJ20	INTERIM HISTORY OF MEDICINE USED: GANGLIONIC BLOCKERS
74	Medication/supplement use	2964	phv00002964.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:56:12+00:00	2018-09-24 15:56:12+00:00 	FJ21	INTERIM HISTORY OF MEDICINE USED: PERIPHERAL VASODILATORS
74	Medication/supplement use	2965	phv00002965.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:56:25+00:00	2018-09-24 15:56:25+00:00 	FJ22	INTERIM HISTORY OF MEDICINE USED: UNKNOWN HYPERTENSIVE MEDICATIONS
74	Medication/supplement use	2966	phv00002966.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:56:39+00:00	2018-09-24 15:56:39+00:00 	FJ23	INTERIM HISTORY OF MEDICINE USED: ANTICHOLESTEROL DRUGS
74	Medication/supplement use	2967	phv00002967.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:56:51+00:00	2018-09-24 15:56:51+00:00 	FJ24	INTERIM HISTORY OF MEDICINE USED: ANTIGOUT
74	Medication/supplement use	2968	phv00002968.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:57:06+00:00	2018-09-24 15:57:06+00:00 	FJ25	INTERIM HISTORY OF MEDICINE USED: THYROID
74	Medication/supplement use	2969	phv00002969.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:57:23+00:00	2018-09-24 15:57:23+00:00 	FJ26	INTERIM HISTORY OF MEDICINE USED: ORAL HYPOGLYCEMICS
74	Medication/supplement use	2970	phv00002970.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:57:42+00:00	2018-09-24 15:57:42+00:00 	FJ27	INTERIM HISTORY OF MEDICINE USED: INSULIN
74	Medication/supplement use	2971	phv00002971.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:57:53+00:00	2018-09-24 15:57:53+00:00 	FJ28	INTERIM HISTORY OF MEDICINE USED: ESTROGEN
74	Medication/supplement use	2972	phv00002972.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:58:09+00:00	2018-09-24 15:58:09+00:00 	FJ29	INTERIM HISTORY OF MEDICINE USED: STEROIDS
74	Medication/supplement use	3198	phv00003198.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:58:23+00:00	2018-09-24 15:58:23+00:00 	FJ296	ECG: TAKING DIGITALIS
74	Medication/supplement use	2973	phv00002973.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:58:34+00:00	2018-09-24 15:58:34+00:00 	FJ30	INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR, AEROSOLS, ETC.
74	Medication/supplement use	2974	phv00002974.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:58:47+00:00	2018-09-24 15:58:47+00:00 	FJ31	INTERIM HISTORY OF MEDICINE USED: ANTIHISTAMINES
74	Medication/supplement use	3219	phv00003219.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:59:13+00:00	2018-09-24 15:59:13+00:00 	FJ318	HEART: UNDER TREATMENT FOR HYPERTENSION
74	Medication/supplement use	2975	phv00002975.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:59:29+00:00	2018-09-24 15:59:29+00:00 	FJ32	INTERIM HISTORY OF MEDICINE USED: SLEEPING PILLS
74	Medication/supplement use	2976	phv00002976.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:59:39+00:00	2018-09-24 15:59:39+00:00 	FJ33	INTERIM HISTORY OF MEDICINE USED: SEDATIVE/HYPNOTIC
74	Medication/supplement use	2977	phv00002977.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 15:59:51+00:00	2018-09-24 15:59:51+00:00 	FJ34	INTERIM HISTORY OF MEDICINE USED: ANTIDEPRESSANTS
74	Medication/supplement use	2978	phv00002978.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:00:19+00:00	2018-09-24 16:00:19+00:00 	FJ35	INTERIM HISTORY OF MEDICINE USED: POTASSIUM SUPPLEMENT
74	Medication/supplement use	2979	phv00002979.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:00:27+00:00	2018-09-24 16:00:27+00:00 	FJ36	INTERIM HISTORY OF MEDICINE USED: OTHER
74	Medication/supplement use	2980	phv00002980.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:00:37+00:00	2018-09-24 16:00:37+00:00 	FJ37	INTERIM HISTORY OF MEDICINE USED: NO OF TABS, ASPIRIN/WEEK
74	Medication/supplement use	2951	phv00002951.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:01:09+00:00	2018-09-24 16:01:09+00:00 	FJ8	INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES
74	Medication/supplement use	2952	phv00002952.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:01:27+00:00	2018-09-24 16:01:27+00:00 	FJ9	INTERIM HISTORY OF MEDICINE USED: NITROGLYCERINE
74	Medication/supplement use	3035	phv00003035.v1.p10	pht000019.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:01:41+00:00	2018-09-24 16:01:41+00:00 	FJ95	CHEST DISCOMFORT: RELIEVED BY NITROGLYCERINE
74	Medication/supplement use	3348	phv00003348.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:40:23+00:00	2018-09-24 16:40:23+00:00 	FK100	MEDICINE USE: HYPERTENSIVE MEDICATIONS
74	Medication/supplement use	3349	phv00003349.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:40:59+00:00	2018-09-24 16:40:59+00:00 	FK101	TYPE OF HYPERTENSIVE MEDICATIONS
74	Medication/supplement use	3350	phv00003350.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:41:08+00:00	2018-09-24 16:41:08+00:00 	FK102	MEDICINE USE: ANTICHOLESTEROL DRUG
74	Medication/supplement use	3351	phv00003351.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:41:15+00:00	2018-09-24 16:41:15+00:00 	FK103	TYPE OF ANTICHOLESTEROL DRUG
74	Medication/supplement use	3352	phv00003352.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:41:23+00:00	2018-09-24 16:41:23+00:00 	FK104	MEDICINE USE: ANTIGOUT
74	Medication/supplement use	3353	phv00003353.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:41:35+00:00	2018-09-24 16:41:35+00:00 	FK105	TYPE OF ANTIGOUT MEDICINE
74	Medication/supplement use	3354	phv00003354.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:43:08+00:00	2018-09-24 16:43:08+00:00 	FK106	MEDICINE USE: THYROID
74	Medication/supplement use	3355	phv00003355.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:43:15+00:00	2018-09-24 16:43:15+00:00 	FK107	TYPE OF THYROID
74	Medication/supplement use	3356	phv00003356.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:43:35+00:00	2018-09-24 16:43:35+00:00 	FK108	MEDICINE USE: ORAL HYPOGLYCEMICS
74	Medication/supplement use	3357	phv00003357.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:43:43+00:00	2018-09-24 16:43:43+00:00 	FK109	TYPE OF ORAL HYPOGLYCEMICS
74	Medication/supplement use	3358	phv00003358.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:43:51+00:00	2018-09-24 16:43:51+00:00 	FK110	MEDICINE USE: INSULIN
74	Medication/supplement use	3359	phv00003359.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:43:58+00:00	2018-09-24 16:43:58+00:00 	FK111	TYPE OF INSULIN
74	Medication/supplement use	3360	phv00003360.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:44:05+00:00	2018-09-24 16:44:05+00:00 	FK112	MEDICINE USE: ESTROGEN
74	Medication/supplement use	3361	phv00003361.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:44:12+00:00	2018-09-24 16:44:12+00:00 	FK113	TYPE OF ESTROGEN
74	Medication/supplement use	3362	phv00003362.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:44:19+00:00	2018-09-24 16:44:19+00:00 	FK114	MEDICINE USE: STEROIDS
74	Medication/supplement use	3363	phv00003363.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:44:27+00:00	2018-09-24 16:44:27+00:00 	FK115	TYPE OF STEROIDS
74	Medication/supplement use	3364	phv00003364.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:44:36+00:00	2018-09-24 16:44:36+00:00 	FK116	MEDICINE USE: BRONCHODILATOR, AEROSOLS
74	Medication/supplement use	3365	phv00003365.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:44:43+00:00	2018-09-24 16:44:43+00:00 	FK117	TYPE OF BRONCHODILATOR, AEROSOLS
74	Medication/supplement use	3366	phv00003366.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:44:55+00:00	2018-09-24 16:44:55+00:00 	FK118	MEDICINE USE: ANTIHISTAMINES
74	Medication/supplement use	3367	phv00003367.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:45:11+00:00	2018-09-24 16:45:11+00:00 	FK119	TYPE OF ANTIHISTAMINES
74	Medication/supplement use	3368	phv00003368.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:45:19+00:00	2018-09-24 16:45:19+00:00 	FK120	MEDICINE USE: SLEEPING PILLS
74	Medication/supplement use	3369	phv00003369.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:45:26+00:00	2018-09-24 16:45:26+00:00 	FK121	TYPE OF SLEEPING PILLS
74	Medication/supplement use	3370	phv00003370.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:45:33+00:00	2018-09-24 16:45:33+00:00 	FK122	MEDICINE USE: SEDATIVE/HYPNOTIC
74	Medication/supplement use	3371	phv00003371.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:45:42+00:00	2018-09-24 16:45:42+00:00 	FK123	TYPE OF SEDATIVE/HYPNOTIC
74	Medication/supplement use	3372	phv00003372.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:45:50+00:00	2018-09-24 16:45:50+00:00 	FK124	MEDICINE USE: ANTIDEPRESSANTS
74	Medication/supplement use	3373	phv00003373.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:45:57+00:00	2018-09-24 16:45:57+00:00 	FK125	TYPE OF ANTIDEPRESSANTS
74	Medication/supplement use	3374	phv00003374.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:46:05+00:00	2018-09-24 16:46:05+00:00 	FK126	MEDICINE USE: POTASSIUM SUPPLEMENT
74	Medication/supplement use	3376	phv00003376.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:46:37+00:00	2018-09-24 16:46:37+00:00 	FK128	MEDICINE USE: OTHER DRUG
74	Medication/supplement use	3377	phv00003377.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:46:48+00:00	2018-09-24 16:46:48+00:00 	FK129	TYPE OF OTHER DRUG
74	Medication/supplement use	3378	phv00003378.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:46:56+00:00	2018-09-24 16:46:56+00:00 	FK130	MEDICINE USE: # OF ASPIRIN TABLETS PER WEEK
74	Medication/supplement use	3421	phv00003421.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:47:15+00:00	2018-09-24 16:47:15+00:00 	FK176	PAIN RELIEVED BY NITROGLYCERINE
74	Medication/supplement use	3448	phv00003448.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:47:52+00:00	2018-09-24 16:47:52+00:00 	FK215	THYROID DISEASE: THYROID MEDICATION IN INTERIM
74	Medication/supplement use	3613	phv00003613.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:48:33+00:00	2018-09-24 16:48:33+00:00 	FK391	ECG: TAKING DIGITALIS
74	Medication/supplement use	3635	phv00003635.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:48:52+00:00	2018-09-24 16:48:52+00:00 	FK413	HEART: UNDER TREATMENT FOR HYPERTENSION
74	Medication/supplement use	3320	phv00003320.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:49:15+00:00	2018-09-24 16:49:15+00:00 	FK72	MEDICINE USE: CARDIAC GLYCOSIDES
74	Medication/supplement use	3321	phv00003321.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:49:22+00:00	2018-09-24 16:49:22+00:00 	FK73	TYPE OF CARDIAC GLYCOSIDES
74	Medication/supplement use	3322	phv00003322.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:50:25+00:00	2018-09-24 16:50:25+00:00 	FK74	MEDICINE USE: NITROGLYCERINE
74	Medication/supplement use	3323	phv00003323.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:50:33+00:00	2018-09-24 16:50:33+00:00 	FK75	TYPE OF NITROGLYCERINE
74	Medication/supplement use	3324	phv00003324.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:50:40+00:00	2018-09-24 16:50:40+00:00 	FK76	MEDICINE USE: LONGER ACTING NITRATES
74	Medication/supplement use	3325	phv00003325.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:50:47+00:00	2018-09-24 16:50:47+00:00 	FK77	TYPE OF LONGER ACTING NITRATES
74	Medication/supplement use	3326	phv00003326.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:50:54+00:00	2018-09-24 16:50:54+00:00 	FK78	MEDICINE USE: CALCIUM CHANNEL BLOCKERS
74	Medication/supplement use	3327	phv00003327.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:51:02+00:00	2018-09-24 16:51:02+00:00 	FK79	TYPE OF CALCIUM CHANNEL BLOCKERS
74	Medication/supplement use	3328	phv00003328.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:51:09+00:00	2018-09-24 16:51:09+00:00 	FK80	MEDICINE USE: BETA BLOCKERS
74	Medication/supplement use	3329	phv00003329.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:51:18+00:00	2018-09-24 16:51:18+00:00 	FK81	TYPE OF BETA BLOCKERS
74	Medication/supplement use	3330	phv00003330.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:51:26+00:00	2018-09-24 16:51:26+00:00 	FK82	MEDICINE USE: ANTIARRHYTHMICS
74	Medication/supplement use	3331	phv00003331.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:51:33+00:00	2018-09-24 16:51:33+00:00 	FK83	TYPE OF ANTIARRHYTHMICS
74	Medication/supplement use	3332	phv00003332.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:51:41+00:00	2018-09-24 16:51:41+00:00 	FK84	MEDICINE USE: ANTIPLATELET
74	Medication/supplement use	3333	phv00003333.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:51:54+00:00	2018-09-24 16:51:54+00:00 	FK85	TYPE OF ANTIPLATELET
74	Medication/supplement use	3334	phv00003334.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:52:01+00:00	2018-09-24 16:52:01+00:00 	FK86	MEDICINE USE: DIURETICS
74	Medication/supplement use	3335	phv00003335.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:52:09+00:00	2018-09-24 16:52:09+00:00 	FK87	TYPE OF DIURETICS
74	Medication/supplement use	3336	phv00003336.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:52:19+00:00	2018-09-24 16:52:19+00:00 	FK88	MEDICINE USE: K-SPARING DIURETICS
74	Medication/supplement use	3337	phv00003337.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:52:28+00:00	2018-09-24 16:52:28+00:00 	FK89	TYPE OF K-SPARING DIURETICS
74	Medication/supplement use	3338	phv00003338.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:52:37+00:00	2018-09-24 16:52:37+00:00 	FK90	MEDICINE USE: RESERPINE DERIVATIVES
74	Medication/supplement use	3339	phv00003339.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:52:49+00:00	2018-09-24 16:52:49+00:00 	FK91	TYPE OF RESERPINE DERIVATIVES
74	Medication/supplement use	3340	phv00003340.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:52:58+00:00	2018-09-24 16:52:58+00:00 	FK92	MEDICINE USE: METHYLDOPA
74	Medication/supplement use	3341	phv00003341.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:53:07+00:00	2018-09-24 16:53:07+00:00 	FK93	TYPE OF METHYLDOPA
74	Medication/supplement use	3342	phv00003342.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:53:15+00:00	2018-09-24 16:53:15+00:00 	FK94	MEDICINE USE: CLONIDINE
74	Medication/supplement use	3343	phv00003343.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:53:24+00:00	2018-09-24 16:53:24+00:00 	FK95	TYPE OF CLONIDINE
74	Medication/supplement use	3344	phv00003344.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:53:33+00:00	2018-09-24 16:53:33+00:00 	FK96	MEDICINE USE: GANGLIONIC BLOCKERS
74	Medication/supplement use	3345	phv00003345.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:53:42+00:00	2018-09-24 16:53:42+00:00 	FK97	TYPE OF GANGLIONIC BLOCKERS
74	Medication/supplement use	3346	phv00003346.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:53:51+00:00	2018-09-24 16:53:51+00:00 	FK98	MEDICINE USE: PERIPHERAL VASODILATORS
74	Medication/supplement use	3347	phv00003347.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:54:00+00:00	2018-09-24 16:54:00+00:00 	FK99	TYPE OF PERIPHERAL VASODILATORS
74	Medication/supplement use	3764	phv00003764.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:58:22+00:00	2018-09-24 16:58:22+00:00 	FL119	CARDIAC GLYCOSIDES
74	Medication/supplement use	3765	phv00003765.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:59:26+00:00	2018-09-24 16:59:26+00:00 	FL120	NITROGLYCERINE
74	Medication/supplement use	3766	phv00003766.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:59:33+00:00	2018-09-24 16:59:33+00:00 	FL121	LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.)
74	Medication/supplement use	3767	phv00003767.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:59:41+00:00	2018-09-24 16:59:41+00:00 	FL122	CALCIUM CHANNEL BLOCKERS
74	Medication/supplement use	3768	phv00003768.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:59:49+00:00	2018-09-24 16:59:49+00:00 	FL123	BETA BLOCKERS
74	Medication/supplement use	3769	phv00003769.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 16:59:56+00:00	2018-09-24 16:59:56+00:00 	FL124	ANTIARRHYTHMICS (QUINIDINE, PROCAINE, NORPACE, ETC.)
74	Medication/supplement use	3770	phv00003770.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:00:04+00:00	2018-09-24 17:00:04+00:00 	FL125	ANTIPLATELET (ANTURANE, PERSANTINE, ETC.)
74	Medication/supplement use	3771	phv00003771.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:00:14+00:00	2018-09-24 17:00:14+00:00 	FL126	ANTICOAGULANTS (COUMADIN, ETC.)
74	Medication/supplement use	3772	phv00003772.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:02:17+00:00	2018-09-24 17:02:17+00:00 	FL127	THIAZIDE DIURETICS
74	Medication/supplement use	3773	phv00003773.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:02:25+00:00	2018-09-24 17:02:25+00:00 	FL128	LOOP DIURETICS (LASIX, ETC.)
74	Medication/supplement use	3774	phv00003774.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:02:32+00:00	2018-09-24 17:02:32+00:00 	FL129	K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE)
74	Medication/supplement use	3775	phv00003775.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:02:40+00:00	2018-09-24 17:02:40+00:00 	FL130	RESERPINE DERIVATIVES
74	Medication/supplement use	3776	phv00003776.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:02:47+00:00	2018-09-24 17:02:47+00:00 	FL131	METHYLDOPA (ALDOMET)
74	Medication/supplement use	3777	phv00003777.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:02:55+00:00	2018-09-24 17:02:55+00:00 	FL132	CLONIDINE (CATAPRES)
74	Medication/supplement use	3778	phv00003778.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:03:01+00:00	2018-09-24 17:03:01+00:00 	FL133	WYTENSIN
74	Medication/supplement use	3779	phv00003779.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:03:08+00:00	2018-09-24 17:03:08+00:00 	FL134	GANGLIONIC BLOCKERS
74	Medication/supplement use	3780	phv00003780.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:03:15+00:00	2018-09-24 17:03:15+00:00 	FL135	RENIN-AGIOTENSIN BLOCKING DRUGS (CAPTOPRIL)
74	Medication/supplement use	3782	phv00003782.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:03:39+00:00	2018-09-24 17:03:39+00:00 	FL137	OTHER ANTI-HYPERTENSIVES
74	Medication/supplement use	3783	phv00003783.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:03:45+00:00	2018-09-24 17:03:45+00:00 	FL138	OTHER CARDIAC MEDICATION
74	Medication/supplement use	3784	phv00003784.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:03:56+00:00	2018-09-24 17:03:56+00:00 	FL139	ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.)
74	Medication/supplement use	3785	phv00003785.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:04:03+00:00	2018-09-24 17:04:03+00:00 	FL140	ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.)
74	Medication/supplement use	3786	phv00003786.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:04:12+00:00	2018-09-24 17:04:12+00:00 	FL141	ANTIGOUT - COLCHICINE
74	Medication/supplement use	3787	phv00003787.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:04:20+00:00	2018-09-24 17:04:20+00:00 	FL142	THYROID EXTRACT (DESSICATED THYROID)
74	Medication/supplement use	3788	phv00003788.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:04:27+00:00	2018-09-24 17:04:27+00:00 	FL143	THYROXINE (SYNTHROID ETC.)
74	Medication/supplement use	3789	phv00003789.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:04:37+00:00	2018-09-24 17:04:37+00:00 	FL144	INSULIN
74	Medication/supplement use	3680	phv00003680.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:04:44+00:00	2018-09-24 17:04:44+00:00 	FL145	TOTAL UNITS OF INSULIN PER DAY
74	Medication/supplement use	3790	phv00003790.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:04:52+00:00	2018-09-24 17:04:52+00:00 	FL146	ORAL HYPOGLYCEMICS
74	Medication/supplement use	3791	phv00003791.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:05:00+00:00	2018-09-24 17:05:00+00:00 	FL147	ORAL ESTROGEN
74	Medication/supplement use	3792	phv00003792.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:05:08+00:00	2018-09-24 17:05:08+00:00 	FL148	ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.)
74	Medication/supplement use	3793	phv00003793.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:05:17+00:00	2018-09-24 17:05:17+00:00 	FL149	NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL)
74	Medication/supplement use	3794	phv00003794.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:05:26+00:00	2018-09-24 17:05:26+00:00 	FL150	ANALGESIC - NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.)
74	Medication/supplement use	3795	phv00003795.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:06:08+00:00	2018-09-24 17:06:08+00:00 	FL151	ANALGESIC - NON-NARCOTICS (ACETAMINOPHEN, ETC.)
74	Medication/supplement use	3796	phv00003796.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:06:19+00:00	2018-09-24 17:06:19+00:00 	FL152	BRONCHODILATOR, AEROSOLS
74	Medication/supplement use	3797	phv00003797.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:06:27+00:00	2018-09-24 17:06:27+00:00 	FL153	ANTIHISTAMINES
74	Medication/supplement use	3798	phv00003798.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:06:34+00:00	2018-09-24 17:06:34+00:00 	FL154	ANTIULCER (TAGMET, PROBANTHINE, H-ION INHIBITORS)
74	Medication/supplement use	3799	phv00003799.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:06:43+00:00	2018-09-24 17:06:43+00:00 	FL155	ANTI-ANXIETY, SEDATIVE/HYPNOTICS, ETC. (LIBRIUM, VALIUM, ETC.)
74	Medication/supplement use	3800	phv00003800.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:06:51+00:00	2018-09-24 17:06:51+00:00 	FL156	SLEEPING PILLS
74	Medication/supplement use	3801	phv00003801.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:06:58+00:00	2018-09-24 17:06:58+00:00 	FL157	ANTI-DEPRESSANTS
74	Medication/supplement use	3802	phv00003802.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:07:08+00:00	2018-09-24 17:07:08+00:00 	FL158	EYE DROPS
74	Medication/supplement use	3803	phv00003803.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:07:16+00:00	2018-09-24 17:07:16+00:00 	FL159	POTASSIUM SUPPLEMENT
74	Medication/supplement use	3804	phv00003804.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:07:23+00:00	2018-09-24 17:07:23+00:00 	FL160	ANTIBIOTICS
74	Medication/supplement use	3805	phv00003805.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:07:32+00:00	2018-09-24 17:07:32+00:00 	FL161	OTHER DRUG
74	Medication/supplement use	3806	phv00003806.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:07:48+00:00	2018-09-24 17:07:48+00:00 	FL162	# OF ASPIRIN PER WEEK
74	Medication/supplement use	3807	phv00003807.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:07:55+00:00	2018-09-24 17:07:55+00:00 	FL163	# OF MULTIVITAMINS PER WEEK
74	Medication/supplement use	3808	phv00003808.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:08:03+00:00	2018-09-24 17:08:03+00:00 	FL164	# OF VITAMIN C TABS PER WEEK
74	Medication/supplement use	3809	phv00003809.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:08:11+00:00	2018-09-24 17:08:11+00:00 	FL165	# OF VITAMIN D TABS PER WEEK
74	Medication/supplement use	3810	phv00003810.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:08:19+00:00	2018-09-24 17:08:19+00:00 	FL166	# OF CALCIUM SUPPLEMENT TABS PER WEEK
74	Medication/supplement use	3811	phv00003811.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:08:28+00:00	2018-09-24 17:08:28+00:00 	FL167	# OF ANTACID TABS PER WEEK
74	Medication/supplement use	3812	phv00003812.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:08:36+00:00	2018-09-24 17:08:36+00:00 	FL168	# OF ANTACID TABLESPOONS PER WEEK
74	Medication/supplement use	3818	phv00003818.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:08:54+00:00	2018-09-24 17:08:54+00:00 	FL174	CONJUGATED ESTROGEN USE IN INTERIM (E.G. PREMARIN)
74	Medication/supplement use	3819	phv00003819.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:09:04+00:00	2018-09-24 17:09:04+00:00 	FL175	DOSE/DAY PREMARIN OR CONJ ESTROGEN
74	Medication/supplement use	3820	phv00003820.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:09:11+00:00	2018-09-24 17:09:11+00:00 	FL176	DAYS/MONTH TAKING PREMARIN
74	Medication/supplement use	3821	phv00003821.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:09:18+00:00	2018-09-24 17:09:18+00:00 	FL177	PROGESTERONE USE DURING INTERIM
74	Medication/supplement use	4078	phv00004078.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:10:30+00:00	2018-09-24 17:10:30+00:00 	FL519	TREATMENT FOR BLOOD PRESSURE, EXAM19
74	Medication/supplement use	4186	phv00004186.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:12:57+00:00	2018-09-24 17:12:57+00:00 	FM135	ARE YOU PRESENTLY UNDER TREATMENT FOR RHEUMATOID ARTHRITIS?
74	Medication/supplement use	4197	phv00004197.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:13:10+00:00	2018-09-24 17:13:10+00:00 	FM155	# OF ASPIRIN PER WEEK
74	Medication/supplement use	4198	phv00004198.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:13:21+00:00	2018-09-24 17:13:21+00:00 	FM156	ANY CARDIOVASCULAR MEDICATIONS?
74	Medication/supplement use	4199	phv00004199.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:13:31+00:00	2018-09-24 17:13:31+00:00 	FM157	MEDICINE USE: CARDIAC GLYCOSIDES
74	Medication/supplement use	4200	phv00004200.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:14:17+00:00	2018-09-24 17:14:17+00:00 	FM158	MEDICINE USE: NITROGLYCERINE
74	Medication/supplement use	4201	phv00004201.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:14:26+00:00	2018-09-24 17:14:26+00:00 	FM159	MEDICINE USE: LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.)
74	Medication/supplement use	4202	phv00004202.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:14:34+00:00	2018-09-24 17:14:34+00:00 	FM160	MEDICINE USE: CALCIUM CHANNEL BLOCKERS
74	Medication/supplement use	4203	phv00004203.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:14:41+00:00	2018-09-24 17:14:41+00:00 	FM161	MEDICINE USE: BETA BLOCKERS
74	Medication/supplement use	4204	phv00004204.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:14:49+00:00	2018-09-24 17:14:49+00:00 	FM162	MEDICINE USE: ANTIARRHYTHMICS (QUINIDINE, PROCAINE, NORPACE, ETC.)
74	Medication/supplement use	4205	phv00004205.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:14:57+00:00	2018-09-24 17:14:57+00:00 	FM163	MEDICINE USE: ANTIPLATELET (ANTURANE, PERSANTINE, ETC.)
74	Medication/supplement use	4206	phv00004206.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:15:05+00:00	2018-09-24 17:15:05+00:00 	FM164	MEDICINE USE: ANTICOAGULANTS (COUMADIN, ETC.)
74	Medication/supplement use	4207	phv00004207.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:15:12+00:00	2018-09-24 17:15:12+00:00 	FM165	MEDICINE USE: THIAZIDE DIURETICS
74	Medication/supplement use	4208	phv00004208.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:15:21+00:00	2018-09-24 17:15:21+00:00 	FM166	MEDICINE USE: LOOP DIURETICS (LASIX, ETC.)
74	Medication/supplement use	4209	phv00004209.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:15:28+00:00	2018-09-24 17:15:28+00:00 	FM167	MEDICINE USE: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE)
74	Medication/supplement use	4210	phv00004210.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:15:40+00:00	2018-09-24 17:15:40+00:00 	FM168	MEDICINE USE: RESERPINE DERIVATIVES
74	Medication/supplement use	4211	phv00004211.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:15:52+00:00	2018-09-24 17:15:52+00:00 	FM169	MEDICINE USE: METHYLDOPA (ALDOMET)
74	Medication/supplement use	4212	phv00004212.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:16:00+00:00	2018-09-24 17:16:00+00:00 	FM170	MEDICINE USE: CLONIDINE (CATAPRES)
74	Medication/supplement use	4213	phv00004213.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:16:27+00:00	2018-09-24 17:16:27+00:00 	FM171	MEDICINE USE: WYTENSIN
74	Medication/supplement use	4214	phv00004214.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:16:34+00:00	2018-09-24 17:16:34+00:00 	FM172	MEDICINE USE: GANGLIONIC BLOCKERS
74	Medication/supplement use	4215	phv00004215.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:16:42+00:00	2018-09-24 17:16:42+00:00 	FM173	MEDICINE USE: RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL)
74	Medication/supplement use	4216	phv00004216.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:16:50+00:00	2018-09-24 17:16:50+00:00 	FM174	MEDICINE USE: PERIPHERAL VASODILATORS (HYDRALAZINE, MINIPRES, MINOXIDIL, ETC.)
74	Medication/supplement use	4217	phv00004217.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:17:00+00:00	2018-09-24 17:17:00+00:00 	FM175	MEDICINE USE: OTHER ANTI-HYPERTENSIVES
74	Medication/supplement use	4218	phv00004218.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:17:07+00:00	2018-09-24 17:17:07+00:00 	FM176	MEDICINE USE: OTHER CARDIAC MEDICATION
74	Medication/supplement use	4219	phv00004219.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:17:15+00:00	2018-09-24 17:17:15+00:00 	FM177	MEDICINE USE: ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.)
74	Medication/supplement use	4220	phv00004220.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:17:23+00:00	2018-09-24 17:17:23+00:00 	FM178	MEDICINE USE: ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.)
74	Medication/supplement use	4221	phv00004221.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:17:33+00:00	2018-09-24 17:17:33+00:00 	FM179	MEDICINE USE: ANTIGOUT - (COLCHICINE)
74	Medication/supplement use	4222	phv00004222.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:17:42+00:00	2018-09-24 17:17:42+00:00 	FM180	MEDICINE USE: THYROID EXTRACT (DESSICATED THYROID)
74	Medication/supplement use	4223	phv00004223.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:17:55+00:00	2018-09-24 17:17:55+00:00 	FM181	MEDICINE USE: THYROXINE (SYNTHROID ETC.)
74	Medication/supplement use	4224	phv00004224.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:18:03+00:00	2018-09-24 17:18:03+00:00 	FM182	MEDICINE USE: INSULIN
74	Medication/supplement use	4094	phv00004094.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:18:44+00:00	2018-09-24 17:18:44+00:00 	FM183	MEDICINE USE: TOTAL UNITS OF INSULIN PER DAY
74	Medication/supplement use	4225	phv00004225.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:18:51+00:00	2018-09-24 17:18:51+00:00 	FM184	MEDICINE USE: ORAL HYPOGLYCEMICS
74	Medication/supplement use	4226	phv00004226.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:18:59+00:00	2018-09-24 17:18:59+00:00 	FM185	MEDICINE USE: ORAL ESTROGEN
74	Medication/supplement use	4227	phv00004227.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:19:08+00:00	2018-09-24 17:19:08+00:00 	FM186	MEDICINE USE: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.)
74	Medication/supplement use	4228	phv00004228.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:19:16+00:00	2018-09-24 17:19:16+00:00 	FM187	MEDICINE USE: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL)
74	Medication/supplement use	4229	phv00004229.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:19:25+00:00	2018-09-24 17:19:25+00:00 	FM188	MEDICINE USE: ANALGESIC - NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.)
74	Medication/supplement use	4230	phv00004230.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:19:33+00:00	2018-09-24 17:19:33+00:00 	FM189	MEDICINE USE: ANALGESIC - NON-NARCOTICS (ACETAMINOPHEN, ETC.)
74	Medication/supplement use	4231	phv00004231.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:19:41+00:00	2018-09-24 17:19:41+00:00 	FM190	MEDICINE USE: BRONCHODILATOR, AEROSOLS
74	Medication/supplement use	4232	phv00004232.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:19:54+00:00	2018-09-24 17:19:54+00:00 	FM191	MEDICINE USE: ANTIHISTAMINES
74	Medication/supplement use	4233	phv00004233.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:20:02+00:00	2018-09-24 17:20:02+00:00 	FM192	MEDICINE USE: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS)
74	Medication/supplement use	4234	phv00004234.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:20:13+00:00	2018-09-24 17:20:13+00:00 	FM193	MEDICINE USE: ANTI-ANXIETY, SEDATIVE/HYPNOTICS, ETC. (LIBRIUM, VALIUM, ETC.)
74	Medication/supplement use	4235	phv00004235.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:20:22+00:00	2018-09-24 17:20:22+00:00 	FM194	MEDICINE USE: SLEEPING PILLS
74	Medication/supplement use	4236	phv00004236.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:20:31+00:00	2018-09-24 17:20:31+00:00 	FM195	MEDICINE USE: ANTI-DEPRESSANTS
74	Medication/supplement use	4237	phv00004237.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:20:39+00:00	2018-09-24 17:20:39+00:00 	FM196	MEDICINE USE: EYEDROPS
74	Medication/supplement use	4238	phv00004238.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:20:49+00:00	2018-09-24 17:20:49+00:00 	FM197	MEDICINE USE: POTASSIUM SUPPLEMENTS
74	Medication/supplement use	4239	phv00004239.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:20:57+00:00	2018-09-24 17:20:57+00:00 	FM198	MEDICINE USE: ANTIBIOTICS
74	Medication/supplement use	4240	phv00004240.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:22:49+00:00	2018-09-24 17:22:49+00:00 	FM199	MEDICINE USE: OTHER DRUG
74	Medication/supplement use	4243	phv00004243.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:23:10+00:00	2018-09-24 17:23:10+00:00 	FM202	CONJUGATED ESTROGEN USE IN INTERIM (E.G. PREMARIN)
74	Medication/supplement use	4244	phv00004244.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:23:18+00:00	2018-09-24 17:23:18+00:00 	FM203	DOSE/DAY PREMARIN OR CONJ. ESTROGENS
74	Medication/supplement use	4245	phv00004245.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:23:24+00:00	2018-09-24 17:23:24+00:00 	FM204	DAYS PER MONTH TAKING PREMARIN
74	Medication/supplement use	4246	phv00004246.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:23:32+00:00	2018-09-24 17:23:32+00:00 	FM205	ESTROGEN CREAM USE DURING INTERIM
74	Medication/supplement use	4247	phv00004247.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:23:42+00:00	2018-09-24 17:23:42+00:00 	FM206	PROGESTERONE USE DURING INTERIM
74	Medication/supplement use	4520	phv00004520.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:24:51+00:00	2018-09-24 17:24:51+00:00 	FM474A	CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION
74	Medication/supplement use	4522	phv00004522.v1.p10	pht000022.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:25:10+00:00	2018-09-24 17:25:10+00:00 	FM539	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	4599	phv00004599.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:27:42+00:00	2018-09-24 17:27:42+00:00 	FN100	LOOP DIURETICS (LASIX, ETC.)
74	Medication/supplement use	4600	phv00004600.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:27:49+00:00	2018-09-24 17:27:49+00:00 	FN101	THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC.)
74	Medication/supplement use	4601	phv00004601.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:27:56+00:00	2018-09-24 17:27:56+00:00 	FN102	THIAZIDE DIURETICS
74	Medication/supplement use	4602	phv00004602.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:28:03+00:00	2018-09-24 17:28:03+00:00 	FN103	K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE, AMILORIDE)
74	Medication/supplement use	4603	phv00004603.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:28:11+00:00	2018-09-24 17:28:11+00:00 	FN104	POTASSIUM SUPPLEMENTS
74	Medication/supplement use	4604	phv00004604.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:28:20+00:00	2018-09-24 17:28:20+00:00 	FN105	RESERPINE DERIVATIVES
74	Medication/supplement use	4605	phv00004605.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:28:31+00:00	2018-09-24 17:28:31+00:00 	FN106	METHYLDOPA (ALDOMET)
74	Medication/supplement use	4606	phv00004606.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:28:40+00:00	2018-09-24 17:28:40+00:00 	FN107	ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ)
74	Medication/supplement use	4607	phv00004607.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:28:47+00:00	2018-09-24 17:28:47+00:00 	FN108	ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN)
74	Medication/supplement use	4608	phv00004608.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:28:55+00:00	2018-09-24 17:28:55+00:00 	FN109	RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL, ENALAPRIL, LISINOPRIL)
74	Medication/supplement use	4609	phv00004609.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:29:03+00:00	2018-09-24 17:29:03+00:00 	FN110	PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC.)
74	Medication/supplement use	4610	phv00004610.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:29:10+00:00	2018-09-24 17:29:10+00:00 	FN111	OTHER ANTI-HYPERTENSIVES
74	Medication/supplement use	4611	phv00004611.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:29:18+00:00	2018-09-24 17:29:18+00:00 	FN112	ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE, ETC.)
74	Medication/supplement use	4612	phv00004612.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:29:26+00:00	2018-09-24 17:29:26+00:00 	FN113	ANTIPLATELET (ANTURANE, PERSANTINE, ETC.)
74	Medication/supplement use	4613	phv00004613.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:29:37+00:00	2018-09-24 17:29:37+00:00 	FN114	ANITCOAGULANTS (COUMADIN, WARFARIN, ETC.)
74	Medication/supplement use	4614	phv00004614.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:29:45+00:00	2018-09-24 17:29:45+00:00 	FN115	OTHER CARDIAC MEDICATION
74	Medication/supplement use	4615	phv00004615.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:29:52+00:00	2018-09-24 17:29:52+00:00 	FN116	ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, LOVASTATIN, ETC.)
74	Medication/supplement use	4616	phv00004616.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:30:01+00:00	2018-09-24 17:30:01+00:00 	FN117	ANTIGOUT--URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.)
74	Medication/supplement use	4617	phv00004617.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:30:08+00:00	2018-09-24 17:30:08+00:00 	FN118	ANTIGOUT (COLCHICINE)
74	Medication/supplement use	4618	phv00004618.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:30:15+00:00	2018-09-24 17:30:15+00:00 	FN119	THYROID EXTRACT (DESSICATED THYROID)
74	Medication/supplement use	4619	phv00004619.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:30:23+00:00	2018-09-24 17:30:23+00:00 	FN120	THYROXINE (SYNTHROID, ETC.)
74	Medication/supplement use	4620	phv00004620.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:30:49+00:00	2018-09-24 17:30:49+00:00 	FN121	INSULIN
74	Medication/supplement use	4536	phv00004536.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:30:57+00:00	2018-09-24 17:30:57+00:00 	FN122	INSULIN/TOTAL UNITS PER DAY
74	Medication/supplement use	4621	phv00004621.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:31:05+00:00	2018-09-24 17:31:05+00:00 	FN123	ORAL HYPOGLYCEMICS
74	Medication/supplement use	4622	phv00004622.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:31:12+00:00	2018-09-24 17:31:12+00:00 	FN124	ORAL ESTROGEN
74	Medication/supplement use	4623	phv00004623.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:31:21+00:00	2018-09-24 17:31:21+00:00 	FN125	ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.)
74	Medication/supplement use	4624	phv00004624.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:31:28+00:00	2018-09-24 17:31:28+00:00 	FN126	NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL)
74	Medication/supplement use	4625	phv00004625.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:31:37+00:00	2018-09-24 17:31:37+00:00 	FN127	ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.)
74	Medication/supplement use	4626	phv00004626.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:31:45+00:00	2018-09-24 17:31:45+00:00 	FN128	ANALGESIC-NON-NARCOTICS (ACETAMINOPHEN, ETC.)
74	Medication/supplement use	4627	phv00004627.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:31:55+00:00	2018-09-24 17:31:55+00:00 	FN129	BRONCHODILATORS, AEROSOLS, ETC.
74	Medication/supplement use	4628	phv00004628.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:32:02+00:00	2018-09-24 17:32:02+00:00 	FN130	ANTIHISTAMINES
74	Medication/supplement use	4629	phv00004629.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:32:11+00:00	2018-09-24 17:32:11+00:00 	FN131	ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H-ION INHIBITORS)
74	Medication/supplement use	4630	phv00004630.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:32:19+00:00	2018-09-24 17:32:19+00:00 	FN132	ANTI-ANXIETY, SEDATIVE/HYPNOTICS ETC. (LIBRIUM, VALIUM, ETC.)
74	Medication/supplement use	4631	phv00004631.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:32:28+00:00	2018-09-24 17:32:28+00:00 	FN133	SLEEPING PILLS
74	Medication/supplement use	4632	phv00004632.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:32:35+00:00	2018-09-24 17:32:35+00:00 	FN134	ANTI-DEPRESSANTS
74	Medication/supplement use	4633	phv00004633.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:32:42+00:00	2018-09-24 17:32:42+00:00 	FN135	EYEDROPS
74	Medication/supplement use	4634	phv00004634.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:32:50+00:00	2018-09-24 17:32:50+00:00 	FN136	ANTIBIOTICS
74	Medication/supplement use	4635	phv00004635.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:32:59+00:00	2018-09-24 17:32:59+00:00 	FN137	ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.)
74	Medication/supplement use	4636	phv00004636.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:33:06+00:00	2018-09-24 17:33:06+00:00 	FN138	ANTICONVULSANTS (DILANTIN, PHENOBARB, TEGRETOL, MYSOLINE, ETC.)
74	Medication/supplement use	4637	phv00004637.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:33:15+00:00	2018-09-24 17:33:15+00:00 	FN139	MEDICATIONS - OTHERS
74	Medication/supplement use	4650	phv00004650.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:33:38+00:00	2018-09-24 17:33:38+00:00 	FN152	CONJUGATED ESTROGEN USE IN INTERIM (E.G. PREMARIN)
74	Medication/supplement use	4651	phv00004651.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:33:50+00:00	2018-09-24 17:33:50+00:00 	FN153	ORAL DOSE/DAY OF PREMARIN OR CONJ. ESTROGEN
74	Medication/supplement use	4652	phv00004652.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:33:57+00:00	2018-09-24 17:33:57+00:00 	FN154	NUMBER OF DAYS/MONTH TAKING PREMARIN - FEMALE
74	Medication/supplement use	4653	phv00004653.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:34:05+00:00	2018-09-24 17:34:05+00:00 	FN155	ESTROGEN CREAM USE IN INTERIM
74	Medication/supplement use	4654	phv00004654.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:34:13+00:00	2018-09-24 17:34:13+00:00 	FN156	PROGESTERONE USE IN INTERIM
74	Medication/supplement use	4934	phv00004934.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:36:10+00:00	2018-09-24 17:36:10+00:00 	FN507	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	4592	phv00004592.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:36:46+00:00	2018-09-24 17:36:46+00:00 	FN93	NUMBER OF ASPIRINS PER WEEK
74	Medication/supplement use	4593	phv00004593.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:36:54+00:00	2018-09-24 17:36:54+00:00 	FN94	TAKING ANY CARDIOVASCULAR MEDS BELOW?
74	Medication/supplement use	4594	phv00004594.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:37:02+00:00	2018-09-24 17:37:02+00:00 	FN95	CARDIAC GLYCOSIDES
74	Medication/supplement use	4595	phv00004595.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:37:10+00:00	2018-09-24 17:37:10+00:00 	FN96	NITROGLYCERINE
74	Medication/supplement use	4596	phv00004596.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:37:18+00:00	2018-09-24 17:37:18+00:00 	FN97	LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.)
74	Medication/supplement use	4597	phv00004597.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:37:26+00:00	2018-09-24 17:37:26+00:00 	FN98	CALCIUM CHANNEL BLOCKERS (NIFEDIPINE, VERAPAMIL, DILTIAZEM)
74	Medication/supplement use	4598	phv00004598.v1.p10	pht000023.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 17:37:35+00:00	2018-09-24 17:37:35+00:00 	FN99	BETA BLOCKERS
74	Medication/supplement use	4944	phv00004944.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:24:19+00:00	2018-09-24 18:24:19+00:00 	FO091	NUMBER OF ASPIRINS PER TIME INTERVAL
74	Medication/supplement use	4945	phv00004945.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:24:26+00:00	2018-09-24 18:24:26+00:00 	FO092	TIME INTERVAL FOR ASPIRIN TAKEN
74	Medication/supplement use	4946	phv00004946.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:24:33+00:00	2018-09-24 18:24:33+00:00 	FO093	CURRENTLY RECEIVING MEDICATION FOR THE TREATMENT OF HYPERTENSION?
74	Medication/supplement use	4947	phv00004947.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:24:40+00:00	2018-09-24 18:24:40+00:00 	FO094	(TAKING) ANY CARDIOVASCULAR MEDICATIONS BELOW?
74	Medication/supplement use	4948	phv00004948.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:24:47+00:00	2018-09-24 18:24:47+00:00 	FO095	MEDICATION USE: CARDIAC GLYCOSIDES
74	Medication/supplement use	4949	phv00004949.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:24:54+00:00	2018-09-24 18:24:54+00:00 	FO096	MEDICATION USE: NITROGLYCERINE
74	Medication/supplement use	4950	phv00004950.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:25:01+00:00	2018-09-24 18:25:01+00:00 	FO097	MEDICATION USE: LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.)
74	Medication/supplement use	4951	phv00004951.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:25:07+00:00	2018-09-24 18:25:07+00:00 	FO098	MEDICATION USE: CALCIUM CHANNEL BLOCKERS (NIFIDIPINE, VERAPAMIL, DILTIAZEM)
74	Medication/supplement use	4952	phv00004952.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:25:14+00:00	2018-09-24 18:25:14+00:00 	FO099	MEDICATION USE: BETA BLOCKERS
74	Medication/supplement use	4953	phv00004953.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:25:26+00:00	2018-09-24 18:25:26+00:00 	FO100	MEDICATION USE: BETA BLOCKERS GROUP
74	Medication/supplement use	4954	phv00004954.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:25:32+00:00	2018-09-24 18:25:32+00:00 	FO101	MEDICATION USE: BETA BLOCKERS DOSE (MG/DAY)
74	Medication/supplement use	4955	phv00004955.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:25:40+00:00	2018-09-24 18:25:40+00:00 	FO102	MEDICATION USE: LOOP DIURETICS (LASIX, ETC.)
74	Medication/supplement use	4956	phv00004956.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:25:46+00:00	2018-09-24 18:25:46+00:00 	FO103	MEDICATION USE: THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC.)
74	Medication/supplement use	4957	phv00004957.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:25:54+00:00	2018-09-24 18:25:54+00:00 	FO104	MEDICATION USE: THIAZIDE DIURETICS
74	Medication/supplement use	4958	phv00004958.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:26:01+00:00	2018-09-24 18:26:01+00:00 	FO105	MEDICATION USE: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE, AMILORIDE)
74	Medication/supplement use	4959	phv00004959.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:26:09+00:00	2018-09-24 18:26:09+00:00 	FO106	MEDICATION USE: POTASSIUM SUPPLEMENTS
74	Medication/supplement use	4960	phv00004960.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:26:18+00:00	2018-09-24 18:26:18+00:00 	FO107	MEDICATION USE: RESERPINE DERIVATIVES
74	Medication/supplement use	4961	phv00004961.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:26:25+00:00	2018-09-24 18:26:25+00:00 	FO108	MEDICATION USE: METHYLDOPA (ALDOMET)
74	Medication/supplement use	4962	phv00004962.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:26:35+00:00	2018-09-24 18:26:35+00:00 	FO109	MEDICATION USE: ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ)
74	Medication/supplement use	4963	phv00004963.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:27:23+00:00	2018-09-24 18:27:23+00:00 	FO110	MEDICATION USE: ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN)
74	Medication/supplement use	4964	phv00004964.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:27:31+00:00	2018-09-24 18:27:31+00:00 	FO111	MEDICATION USE: RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL, ENALAPRIL, LISINOPRIL)
74	Medication/supplement use	4965	phv00004965.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:27:39+00:00	2018-09-24 18:27:39+00:00 	FO112	MEDICATION USE: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC.)
74	Medication/supplement use	4966	phv00004966.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:27:47+00:00	2018-09-24 18:27:47+00:00 	FO113	MEDICATION USE: OTHER ANTI-HYPERTENSIVES
74	Medication/supplement use	4967	phv00004967.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:27:56+00:00	2018-09-24 18:27:56+00:00 	FO114	MEDICATION USE: ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE, ETC.)
74	Medication/supplement use	4968	phv00004968.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:28:04+00:00	2018-09-24 18:28:04+00:00 	FO115	MEDICATION USE: ANTIPLATELET (ANTURANE, PERSANTINE, ETC.)
74	Medication/supplement use	4969	phv00004969.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:28:11+00:00	2018-09-24 18:28:11+00:00 	FO116	MEDICATION USE: ANTICOAGULANTS (COUMADIN, WARFARIN, ETC.)
74	Medication/supplement use	4970	phv00004970.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:28:19+00:00	2018-09-24 18:28:19+00:00 	FO117	MEDICATION USE: OTHER CARDIAC MEDICATION
74	Medication/supplement use	4971	phv00004971.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:28:27+00:00	2018-09-24 18:28:27+00:00 	FO118	"(TAKING) ANY OF THE ""NON-CARDIOVASCULAR MEDICATIONS"" BELOW?"
74	Medication/supplement use	4972	phv00004972.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:28:35+00:00	2018-09-24 18:28:35+00:00 	FO119	MEDICATION USE: ANTI CHOLESTEROL DRUGS (RESINS -- E.G. QUESTRAN, COLESTID)
74	Medication/supplement use	4973	phv00004973.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:28:43+00:00	2018-09-24 18:28:43+00:00 	FO120	MEDICATION USE: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID)
74	Medication/supplement use	4974	phv00004974.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:29:09+00:00	2018-09-24 18:29:09+00:00 	FO121	MEDICATION USE: ANTI CHOLESTEROL DRUGS (FIBRATES -- E.G. GEMFIBROZIL)
74	Medication/supplement use	4975	phv00004975.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:29:20+00:00	2018-09-24 18:29:20+00:00 	FO122	MEDICATION USE: ANTI CHOLESTEROL DRUGS (STATINS -- E.G. LOVASTATIN, PRAVASTATIN)
74	Medication/supplement use	4976	phv00004976.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:29:27+00:00	2018-09-24 18:29:27+00:00 	FO123	MEDICATION USE: ANTI CHOLESTEROL DRUGS (OTHER)
74	Medication/supplement use	4977	phv00004977.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:29:34+00:00	2018-09-24 18:29:34+00:00 	FO124	MEDICATION USE: ANTIGOUT--URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.)
74	Medication/supplement use	4978	phv00004978.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:29:41+00:00	2018-09-24 18:29:41+00:00 	FO125	MEDICATION USE: ANTIGOUT (COLCHICINE)
74	Medication/supplement use	4979	phv00004979.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:29:49+00:00	2018-09-24 18:29:49+00:00 	FO126	MEDICATION USE: THYROID EXTRACT (DESSICATED THYROID)
74	Medication/supplement use	4980	phv00004980.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:29:56+00:00	2018-09-24 18:29:56+00:00 	FO127	MEDICATION USE: THYROXINE (SYNTHROID, ETC.)
74	Medication/supplement use	4981	phv00004981.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:30:12+00:00	2018-09-24 18:30:12+00:00 	FO128	MEDICATION USE: INSULIN
74	Medication/supplement use	4982	phv00004982.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:30:19+00:00	2018-09-24 18:30:19+00:00 	FO129	MEDICATION USE: TOTAL UNITS OF INSULIN PER DAY
74	Medication/supplement use	4983	phv00004983.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:30:29+00:00	2018-09-24 18:30:29+00:00 	FO130	MEDICATION USE: ORAL HYPOGLYCEMICS
74	Medication/supplement use	4984	phv00004984.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:30:36+00:00	2018-09-24 18:30:36+00:00 	FO131	MEDICATION USE: ORAL/PATCH ESTROGEN (FOR WOMEN USERS ALSO SEE ESTROGEN SECTION)
74	Medication/supplement use	4985	phv00004985.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:30:45+00:00	2018-09-24 18:30:45+00:00 	FO132	MEDICATION USE: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.)
74	Medication/supplement use	4986	phv00004986.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:30:55+00:00	2018-09-24 18:30:55+00:00 	FO133	MEDICATION USE: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL)
74	Medication/supplement use	4987	phv00004987.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:31:02+00:00	2018-09-24 18:31:02+00:00 	FO134	MEDICATION USE: IF TAKING NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, DO YOU TAKE THEM EVERY DAY?
74	Medication/supplement use	4988	phv00004988.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:31:09+00:00	2018-09-24 18:31:09+00:00 	FO135	MEDICATION USE: ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.)
74	Medication/supplement use	4989	phv00004989.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:31:17+00:00	2018-09-24 18:31:17+00:00 	FO136	MEDICATION USE: ANALGESIC-NON-NARCOTICS (ACETAMINOPHEN, ETC.)
74	Medication/supplement use	4990	phv00004990.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:31:25+00:00	2018-09-24 18:31:25+00:00 	FO137	MEDICATION USE: BRONCHODILATORS, AEROSOLS, ETC
74	Medication/supplement use	4991	phv00004991.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:31:34+00:00	2018-09-24 18:31:34+00:00 	FO138	MEDICATION USE: ANTIHISTAMINES
74	Medication/supplement use	4992	phv00004992.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:31:42+00:00	2018-09-24 18:31:42+00:00 	FO139	MEDICATION USE: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H-ION INHIBITORS)
74	Medication/supplement use	4993	phv00004993.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:31:56+00:00	2018-09-24 18:31:56+00:00 	FO140	MEDICATION USE: ANTI-ANXIETY,SEDATIVE/HYPNOTICS ETC. (LIBRIUM, VALIUM, ETC.)
74	Medication/supplement use	4994	phv00004994.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:32:08+00:00	2018-09-24 18:32:08+00:00 	FO141	MEDICATION USE: SLEEPING PILLS
74	Medication/supplement use	4995	phv00004995.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:32:18+00:00	2018-09-24 18:32:18+00:00 	FO142	MEDICATION USE: ANTI-DEPRESSANTS
74	Medication/supplement use	4996	phv00004996.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:32:26+00:00	2018-09-24 18:32:26+00:00 	FO143	MEDICATION USE: EYEDROPS
74	Medication/supplement use	4997	phv00004997.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:32:34+00:00	2018-09-24 18:32:34+00:00 	FO144	MEDICATION USE: ANTIBIOTICS
74	Medication/supplement use	4998	phv00004998.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:32:42+00:00	2018-09-24 18:32:42+00:00 	FO145	MEDICATION USE: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.)
74	Medication/supplement use	4999	phv00004999.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:32:58+00:00	2018-09-24 18:32:58+00:00 	FO146	MEDICATION USE: ANTICONVULSANTS (DILANTIN, PHENOBARB, TEGRETOL, MYSOLINE, ETC.)
74	Medication/supplement use	5000	phv00005000.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:33:07+00:00	2018-09-24 18:33:07+00:00 	FO147	MEDICATION USE: NON-CARDIOVASCULAR MEDICATION - OTHER
74	Medication/supplement use	5004	phv00005004.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:33:35+00:00	2018-09-24 18:33:35+00:00 	FO151	CONJUGATED ESTROGEN USE IN INTERIM (E.G. PREMARIN)
74	Medication/supplement use	5005	phv00005005.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:33:43+00:00	2018-09-24 18:33:43+00:00 	FO152	ORAL DOSE/DAY OF PREMARIN OR CONJ. ESTROGEN - FEMALE
74	Medication/supplement use	5006	phv00005006.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:33:51+00:00	2018-09-24 18:33:51+00:00 	FO153	PATCH DOSE/DAY OF ESTROGEN - FEMALE
74	Medication/supplement use	5007	phv00005007.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:34:00+00:00	2018-09-24 18:34:00+00:00 	FO154	NUMBER OF DAYS/MONTH TAKING ESTROGENS - FEMALE
74	Medication/supplement use	5008	phv00005008.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:34:08+00:00	2018-09-24 18:34:08+00:00 	FO155	ESTROGEN CREAM USE IN INTERIM - FEMALE
74	Medication/supplement use	5009	phv00005009.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:34:16+00:00	2018-09-24 18:34:16+00:00 	FO156	PROGESTERONE USE IN INTERIM - FEMALE
74	Medication/supplement use	5456	phv00005456.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:35:20+00:00	2018-09-24 18:35:20+00:00 	FO643	ARTHRITIS B - DO YOU TAKE MEDICATION DAILY FOR YOUR JOINT PAIN, ACHING OR STIFFNESS?
74	Medication/supplement use	5457	phv00005457.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:35:32+00:00	2018-09-24 18:35:32+00:00 	FO644	ARTHRITIS B - IF YES (TO FO643), WHAT IS THE NAME OF THE MEDICATION?
74	Medication/supplement use	5555	phv00005555.v1.p10	pht000024.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:35:58+00:00	2018-09-24 18:35:58+00:00 	FO728	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	5563	phv00005563.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:40:49+00:00	2018-09-24 18:40:49+00:00 	FP044	NUMBER OF ASPIRINS PER TIME INTERVAL
74	Medication/supplement use	5564	phv00005564.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:41:01+00:00	2018-09-24 18:41:01+00:00 	FP045	TIME INTERVAL FOR ASPIRIN TAKEN
74	Medication/supplement use	5565	phv00005565.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:41:09+00:00	2018-09-24 18:41:09+00:00 	FP046	USUAL ASPIRIN DOSE FOR ABOVE (FP045)
74	Medication/supplement use	5566	phv00005566.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:41:16+00:00	2018-09-24 18:41:16+00:00 	FP047	CURRENTLY RECEIVING MEDICATION FOR THE TREATMENT OF HYPERTENSION?
74	Medication/supplement use	5567	phv00005567.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:41:24+00:00	2018-09-24 18:41:24+00:00 	FP048	ANY CARDIOVASCULAR MEDICATIONS BELOW TAKEN IN INTERIM?
74	Medication/supplement use	5568	phv00005568.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:41:32+00:00	2018-09-24 18:41:32+00:00 	FP049	MEDICATION USE: CARDIAC GLYCOSIDES
74	Medication/supplement use	5569	phv00005569.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:41:39+00:00	2018-09-24 18:41:39+00:00 	FP050	MEDICATION USE: NITROGLYCERINE
74	Medication/supplement use	5570	phv00005570.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:41:47+00:00	2018-09-24 18:41:47+00:00 	FP051	MEDICATION USE: LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.)
74	Medication/supplement use	5571	phv00005571.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:41:55+00:00	2018-09-24 18:41:55+00:00 	FP052	MEDICATION USE: CALCIUM CHANNEL BLOCKERS (NIFIDIPINE, VERAPAMIL, DILTIAZEM)
74	Medication/supplement use	5572	phv00005572.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:42:03+00:00	2018-09-24 18:42:03+00:00 	FP053	MEDICATION USE: BETA BLOCKERS
74	Medication/supplement use	5573	phv00005573.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:42:10+00:00	2018-09-24 18:42:10+00:00 	FP054	MEDICATION USE: BETA BLOCKERS GROUP
74	Medication/supplement use	5574	phv00005574.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:42:19+00:00	2018-09-24 18:42:19+00:00 	FP055	MEDICATION USE: BETA BLOCKERS DOSE (MG/DAY)
74	Medication/supplement use	5575	phv00005575.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:42:27+00:00	2018-09-24 18:42:27+00:00 	FP056	MEDICATION USE: LOOP DIURETICS (LASIX, ETC.)
74	Medication/supplement use	5576	phv00005576.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:42:34+00:00	2018-09-24 18:42:34+00:00 	FP057	MEDICATION USE: THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC.)
74	Medication/supplement use	5577	phv00005577.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:42:42+00:00	2018-09-24 18:42:42+00:00 	FP058	MEDICATION USE: THIAZIDE DIURETICS
74	Medication/supplement use	5578	phv00005578.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:42:49+00:00	2018-09-24 18:42:49+00:00 	FP059	MEDICATION USE: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE, AMILORIDE)
74	Medication/supplement use	5579	phv00005579.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:42:56+00:00	2018-09-24 18:42:56+00:00 	FP060	MEDICATION USE: POTASSIUM SUPPLEMENTS
74	Medication/supplement use	5580	phv00005580.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:43:13+00:00	2018-09-24 18:43:13+00:00 	FP061	MEDICATION USE: RESERPINE DERIVATIVES
74	Medication/supplement use	5581	phv00005581.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:43:20+00:00	2018-09-24 18:43:20+00:00 	FP062	MEDICATION USE: METHYLDOPA (ALDOMET)
74	Medication/supplement use	5582	phv00005582.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:43:28+00:00	2018-09-24 18:43:28+00:00 	FP063	MEDICATION USE: ALPHA AGONIST (CLONIDINE, WYTENSIN, GUANABENZ)
74	Medication/supplement use	5583	phv00005583.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:43:35+00:00	2018-09-24 18:43:35+00:00 	FP064	MEDICATION USE: ALPHA BLOCKERS (PRAZOSIN, TERAZOSIN)
74	Medication/supplement use	5584	phv00005584.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:43:43+00:00	2018-09-24 18:43:43+00:00 	FP065	MEDICATION USE: RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL, ENALAPRIL, LISINOPRIL)
74	Medication/supplement use	5585	phv00005585.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:43:54+00:00	2018-09-24 18:43:54+00:00 	FP066	MEDICATION USE: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC.)
74	Medication/supplement use	5586	phv00005586.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:44:01+00:00	2018-09-24 18:44:01+00:00 	FP067	MEDICATION USE: OTHER ANTI-HYPERTENSIVES
74	Medication/supplement use	5587	phv00005587.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:44:08+00:00	2018-09-24 18:44:08+00:00 	FP068	MEDICATION USE: ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE, ETC.)
74	Medication/supplement use	5588	phv00005588.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:44:17+00:00	2018-09-24 18:44:17+00:00 	FP069	MEDICATION USE: ANTIPLATELET (ANTURANE, PERSANTINE, ETC.)
74	Medication/supplement use	5589	phv00005589.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:44:24+00:00	2018-09-24 18:44:24+00:00 	FP070	MEDICATION USE: ANITCOAGULANTS (COUMADIN, WARFARIN, ETC.)
74	Medication/supplement use	5590	phv00005590.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:44:34+00:00	2018-09-24 18:44:34+00:00 	FP071	MEDICATION USE: OTHER CARDIAC MEDICATION
74	Medication/supplement use	5591	phv00005591.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:44:42+00:00	2018-09-24 18:44:42+00:00 	FP072	ANY OF THE NON-CARDIOVASCULAR MEDICATIONS BELOW TAKEN IN INTERIM?
74	Medication/supplement use	5592	phv00005592.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:44:50+00:00	2018-09-24 18:44:50+00:00 	FP073	MEDICATION USE: ANTI CHOLESTEROL DRUGS (RESINS--E.G. QUESTRAN, COLESTID)
74	Medication/supplement use	5593	phv00005593.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:45:03+00:00	2018-09-24 18:45:03+00:00 	FP074	MEDICATION USE: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID)
74	Medication/supplement use	5594	phv00005594.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:45:12+00:00	2018-09-24 18:45:12+00:00 	FP075	MEDICATION USE: ANTI CHOLESTEROL DRUGS (FIBRATES--E.G. GEMFIBROZIL)
74	Medication/supplement use	5595	phv00005595.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:45:19+00:00	2018-09-24 18:45:19+00:00 	FP076	MEDICATION USE: ANTI CHOLESTEROL DRUGS (STATINS--E.G. LOVASTATIN, PRAVASTATIN)
74	Medication/supplement use	5596	phv00005596.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:45:27+00:00	2018-09-24 18:45:27+00:00 	FP077	MEDICATION USE: ANTI CHOLESTEROL DRUGS--OTHER
74	Medication/supplement use	5597	phv00005597.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:45:34+00:00	2018-09-24 18:45:34+00:00 	FP078	MEDICATION USE: ANTIGOUT--URIC ACID LOWERING (ALLOPURINOL, PROBENECID ETC.)
74	Medication/supplement use	5598	phv00005598.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:45:42+00:00	2018-09-24 18:45:42+00:00 	FP079	MEDICATION USE: ANTIGOUT--(COLCHICINE)
74	Medication/supplement use	5599	phv00005599.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:45:50+00:00	2018-09-24 18:45:50+00:00 	FP080	MEDICATION USE: THYROID EXTRACT (DESSICATED THYROID)
74	Medication/supplement use	5600	phv00005600.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:46:24+00:00	2018-09-24 18:46:24+00:00 	FP081	MEDICATION USE: THYROXINE (SYNTHROID ETC.)
74	Medication/supplement use	5601	phv00005601.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:46:32+00:00	2018-09-24 18:46:32+00:00 	FP082	MEDICATION USE: INSULIN
74	Medication/supplement use	5602	phv00005602.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:46:40+00:00	2018-09-24 18:46:40+00:00 	FP083	MEDICATION USE: INSULIN/TOTAL UNITS PER DAY
74	Medication/supplement use	5603	phv00005603.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:46:47+00:00	2018-09-24 18:46:47+00:00 	FP084	MEDICATION USE: ORAL HYPOGLYCEMICS
74	Medication/supplement use	5604	phv00005604.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:46:54+00:00	2018-09-24 18:46:54+00:00 	FP085	MEDICATION USE: ORAL/PATCH ESTROGEN
74	Medication/supplement use	5605	phv00005605.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:47:02+00:00	2018-09-24 18:47:02+00:00 	FP086	MEDICATION USE: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.)
74	Medication/supplement use	5606	phv00005606.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:47:10+00:00	2018-09-24 18:47:10+00:00 	FP087	MEDICATION USE: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL)
74	Medication/supplement use	5607	phv00005607.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:47:17+00:00	2018-09-24 18:47:17+00:00 	FP088	MEDICATION USE: IF TAKING NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, DO YOU TAKE THEM EVERY DAY?
74	Medication/supplement use	5608	phv00005608.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:47:24+00:00	2018-09-24 18:47:24+00:00 	FP089	MEDICATION USE: ANALGESIC--NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.)
74	Medication/supplement use	5609	phv00005609.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:47:32+00:00	2018-09-24 18:47:32+00:00 	FP090	MEDICATION USE: ANALGESIC--NON-NARCOTICS (ACETAMINOPHEN ETC.)
74	Medication/supplement use	5610	phv00005610.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:47:39+00:00	2018-09-24 18:47:39+00:00 	FP091	MEDICATION USE: BRONCHODILATORS, AEROSOLS, ETC
74	Medication/supplement use	5611	phv00005611.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:47:47+00:00	2018-09-24 18:47:47+00:00 	FP092	MEDICATION USE: ANTIHISTAMINES
74	Medication/supplement use	5612	phv00005612.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:48:26+00:00	2018-09-24 18:48:26+00:00 	FP093	MEDICATION USE: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS)
74	Medication/supplement use	5613	phv00005613.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:48:34+00:00	2018-09-24 18:48:34+00:00 	FP094	MEDICATION USE: ANTI-ANXIETY,SEDATIVE/HYPNOTICS ETC. (LIBRIUM, VALIUM ETC.)
74	Medication/supplement use	5614	phv00005614.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:48:42+00:00	2018-09-24 18:48:42+00:00 	FP095	MEDICATION USE: SLEEPING PILLS
74	Medication/supplement use	5615	phv00005615.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:48:50+00:00	2018-09-24 18:48:50+00:00 	FP096	MEDICATION USE: ANTI-DEPRESSANTS
74	Medication/supplement use	5616	phv00005616.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:48:57+00:00	2018-09-24 18:48:57+00:00 	FP097	MEDICATION USE: EYEDROPS
74	Medication/supplement use	5617	phv00005617.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:49:05+00:00	2018-09-24 18:49:05+00:00 	FP098	MEDICATION USE: ANTIBIOTICS
74	Medication/supplement use	5618	phv00005618.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:49:14+00:00	2018-09-24 18:49:14+00:00 	FP099	MEDICATION USE: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.)
74	Medication/supplement use	5619	phv00005619.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:49:22+00:00	2018-09-24 18:49:22+00:00 	FP100	MEDICATION USE: ANTICONVULSANTS (DILANTIN, PHENOBARB, TEGRETOL, MYSOLINE ETC.)
74	Medication/supplement use	5620	phv00005620.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:49:30+00:00	2018-09-24 18:49:30+00:00 	FP101	MEDICATION USE: MEDICATIONS - OTHERS (INCLUDING VITAMINS)
74	Medication/supplement use	5640	phv00005640.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:57:23+00:00	2018-09-24 18:57:23+00:00 	FP121	USING FEMALE HORMONES IN INTERIM
74	Medication/supplement use	5641	phv00005641.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:57:40+00:00	2018-09-24 18:57:40+00:00 	FP122	SYSTEMIC ESTROGEN IN INTERIM
74	Medication/supplement use	5642	phv00005642.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:57:49+00:00	2018-09-24 18:57:49+00:00 	FP123	ORAL DOSE/DAY OF PREMARIN OR CONJ. ESTROGEN - FEMALE
74	Medication/supplement use	5643	phv00005643.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:58:00+00:00	2018-09-24 18:58:00+00:00 	FP124	PATCH DOSE/DAY OF ESTROGEN - FEMALE
74	Medication/supplement use	5644	phv00005644.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:58:08+00:00	2018-09-24 18:58:08+00:00 	FP125	NUMBER OF DAYS/MONTH TAKING ESTROGEN - FEMALE
74	Medication/supplement use	5645	phv00005645.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:58:18+00:00	2018-09-24 18:58:18+00:00 	FP126	ESTROGEN CREAM USE IN INTERIM - FEMALE
74	Medication/supplement use	5646	phv00005646.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:58:28+00:00	2018-09-24 18:58:28+00:00 	FP127	PROGESTERONE USE IN INTERIM - FEMALE
74	Medication/supplement use	5683	phv00005683.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:58:46+00:00	2018-09-24 18:58:46+00:00 	FP167	CHEST DISCOMFORT -- NITROGLYCERINE TRIED FOR RELIEF
74	Medication/supplement use	6020	phv00006020.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:59:44+00:00	2018-09-24 18:59:44+00:00 	FP587	ARTHRITIS - DO YOU TAKE MEDICATION FOR YOUR JOINT PAIN, ACHING OR STIFNESS?
74	Medication/supplement use	6021	phv00006021.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 18:59:56+00:00	2018-09-24 18:59:56+00:00 	FP588	ARTHRITIS - IF YES (TO FP587), WHAT IS THE NAME OF THE MEDICATION?
74	Medication/supplement use	6024	phv00006024.v1.p10	pht000025.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-24 19:00:09+00:00	2018-09-24 19:00:09+00:00 	FP592	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	6113	phv00006113.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:24:51+00:00	2018-09-25 11:24:51+00:00 	FQ128	TAKE ASPIRIN REGULARLY
74	Medication/supplement use	6114	phv00006114.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:25:03+00:00	2018-09-25 11:25:03+00:00 	FQ129	NUMBER OF ASPIRINS TAKEN REGULARLY
74	Medication/supplement use	6115	phv00006115.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:25:10+00:00	2018-09-25 11:25:10+00:00 	FQ130	ASPIRIN FREQUENCY - NUMBER TAKEN REGULARLY
74	Medication/supplement use	6116	phv00006116.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:25:17+00:00	2018-09-25 11:25:17+00:00 	FQ131	USUAL ASPIRIN DOSE FOR ABOVE
74	Medication/supplement use	6117	phv00006117.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:25:25+00:00	2018-09-25 11:25:25+00:00 	FQ132	CURRENTLY RECEIVING MEDICATION FOR HYPERTENSION?
74	Medication/supplement use	6118	phv00006118.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:25:33+00:00	2018-09-25 11:25:33+00:00 	FQ133	TAKING ANY OF THE CARDIOVASCULAR MEDICATION ON THIS PAGE? (PAGE INCLUDES FQ134 - FQ157)
74	Medication/supplement use	6119	phv00006119.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:25:40+00:00	2018-09-25 11:25:40+00:00 	FQ134	MEDICATION USE - CARDIAC GLYCOSIDES
74	Medication/supplement use	6120	phv00006120.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:25:47+00:00	2018-09-25 11:25:47+00:00 	FQ135	MEDICATION USE - NITROGLYCERINE
74	Medication/supplement use	6121	phv00006121.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:25:55+00:00	2018-09-25 11:25:55+00:00 	FQ136	MEDICATION USE - LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC)
74	Medication/supplement use	6122	phv00006122.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:26:03+00:00	2018-09-25 11:26:03+00:00 	FQ137	MEDICATION USE - CALCIUM CHANNEL BLOCKERS (NIFEDIPINE, VERAPAMIL, DILTIAZEM)
74	Medication/supplement use	6123	phv00006123.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:26:12+00:00	2018-09-25 11:26:12+00:00 	FQ138	MEDICATION USE - SHORT OR LONG ACTING CALCIUM CHANNEL BLOCKERS
74	Medication/supplement use	6124	phv00006124.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:26:21+00:00	2018-09-25 11:26:21+00:00 	FQ139	MEDICATION USE - BETA BLOCKERS
74	Medication/supplement use	6125	phv00006125.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:26:28+00:00	2018-09-25 11:26:28+00:00 	FQ140	MEDICATION USE - BETA BLOCKER GROUP
74	Medication/supplement use	6126	phv00006126.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:26:36+00:00	2018-09-25 11:26:36+00:00 	FQ141	MEDICATION USE - DOSE OF BETA BLOCKER
74	Medication/supplement use	6127	phv00006127.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:26:44+00:00	2018-09-25 11:26:44+00:00 	FQ142	MEDICATION USE - LOOP DIURECTICS (LASIX)
74	Medication/supplement use	6128	phv00006128.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:26:51+00:00	2018-09-25 11:26:51+00:00 	FQ143	MEDICATION USE - THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE)
74	Medication/supplement use	6129	phv00006129.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:26:59+00:00	2018-09-25 11:26:59+00:00 	FQ144	MEDICATION USE - THIAZIDE DIURETICS
74	Medication/supplement use	6130	phv00006130.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:27:06+00:00	2018-09-25 11:27:06+00:00 	FQ145	MEDICATION USE - K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE)
74	Medication/supplement use	6131	phv00006131.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:27:16+00:00	2018-09-25 11:27:16+00:00 	FQ146	MEDICATION USE - POTASSIUM SUPPLEMENTS
74	Medication/supplement use	6132	phv00006132.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:27:28+00:00	2018-09-25 11:27:28+00:00 	FQ147	MEDICATION USE - RESERPINE DERIVATIVES
74	Medication/supplement use	6133	phv00006133.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:27:40+00:00	2018-09-25 11:27:40+00:00 	FQ148	MEDICATION USE - METHYLDOPA (ALDOMET)
74	Medication/supplement use	6134	phv00006134.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:27:48+00:00	2018-09-25 11:27:48+00:00 	FQ149	MEDICATION USE - ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ)
74	Medication/supplement use	6135	phv00006135.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:27:55+00:00	2018-09-25 11:27:55+00:00 	FQ150	MEDICATION USE - ALPHA-2 AGONIST (PRAZOSIN, TERAZOSIN, DOXAZOSIN)
74	Medication/supplement use	6136	phv00006136.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:28:09+00:00	2018-09-25 11:28:09+00:00 	FQ151	MEDICATION USE - RENIN-ANGIOTENSIN BLOCKING DRUGS (ACE) (CAPTOPRIL, ENALAPRIL, LISINOPRIL)
74	Medication/supplement use	6137	phv00006137.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:28:17+00:00	2018-09-25 11:28:17+00:00 	FQ152	MEDICATION USE - PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC)
74	Medication/supplement use	6138	phv00006138.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:28:24+00:00	2018-09-25 11:28:24+00:00 	FQ153	MEDICATION USE - OTHER ANTI-HYPERTENSIVES
74	Medication/supplement use	6139	phv00006139.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:28:34+00:00	2018-09-25 11:28:34+00:00 	FQ154	MEDICATION USE - ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE)
74	Medication/supplement use	6140	phv00006140.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:28:43+00:00	2018-09-25 11:28:43+00:00 	FQ155	MEDICATION USE - ANTIPLATELET (ANTURANE, PERSANTINE)
74	Medication/supplement use	6141	phv00006141.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:28:51+00:00	2018-09-25 11:28:51+00:00 	FQ156	MEDICATION USE - ANTICOAGUALANTS (COUMADIN, WARFARIN)
74	Medication/supplement use	6142	phv00006142.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:28:59+00:00	2018-09-25 11:28:59+00:00 	FQ157	MEDICATION USE - OTHER CARDIAC MEDICATION
74	Medication/supplement use	6143	phv00006143.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:29:07+00:00	2018-09-25 11:29:07+00:00 	FQ158	MEDICATION USE - ANTI CHOLESTEROL DRUGS, (RESINS - E.G. QUESTRAN, COLESTID)
74	Medication/supplement use	6144	phv00006144.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:29:17+00:00	2018-09-25 11:29:17+00:00 	FQ159	MEDICATION USE - ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID)
74	Medication/supplement use	6145	phv00006145.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:29:26+00:00	2018-09-25 11:29:26+00:00 	FQ160	MEDICATION USE - ANTI CHOLESTEROL DRUGS, (FILBRATES- E.G. GEMFIBROZIL)
74	Medication/supplement use	6146	phv00006146.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:29:52+00:00	2018-09-25 11:29:52+00:00 	FQ161	MEDICATION USE - ANTI CHOLESTEROL DRUGS, (STATINS - E.G. LOVASTATIN, PRAVASTATIN)
74	Medication/supplement use	6147	phv00006147.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:29:59+00:00	2018-09-25 11:29:59+00:00 	FQ162	MEDICATION USE - ANTI CHOLESTEROL DRUGS (OTHER)
74	Medication/supplement use	6148	phv00006148.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:30:07+00:00	2018-09-25 11:30:07+00:00 	FQ163	MEDICATION USE - ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC)
74	Medication/supplement use	6149	phv00006149.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:30:14+00:00	2018-09-25 11:30:14+00:00 	FQ164	MEDICATION USE - ANTIGOUT (COLCHICINE)
74	Medication/supplement use	6150	phv00006150.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:30:22+00:00	2018-09-25 11:30:22+00:00 	FQ165	MEDICATION USE - THYROID EXTRACT (DESSICATED THYROID)
74	Medication/supplement use	6151	phv00006151.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:30:30+00:00	2018-09-25 11:30:30+00:00 	FQ166	MEDICATION USE - THYROXINE (SYNTHROID, ETC)
74	Medication/supplement use	6152	phv00006152.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:30:38+00:00	2018-09-25 11:30:38+00:00 	FQ167	MEDICATION USE - INSULIN
74	Medication/supplement use	6153	phv00006153.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:30:45+00:00	2018-09-25 11:30:45+00:00 	FQ168	MEDICATION USE - IF YES (TO FQ167), HOW MANY UNITS OF INSULIN / DAY
74	Medication/supplement use	6154	phv00006154.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:30:52+00:00	2018-09-25 11:30:52+00:00 	FQ169	MEDICATION USE - ORAL HYPOGLYCEMICS
74	Medication/supplement use	6155	phv00006155.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:30:59+00:00	2018-09-25 11:30:59+00:00 	FQ170	MEDICATION USE - ORAL/PATCH ESTROGEN (FOR WOMEN USERS ALSO SEE ESTROGEN SECTION)
74	Medication/supplement use	6156	phv00006156.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:31:07+00:00	2018-09-25 11:31:07+00:00 	FQ171	MEDICATION USE - ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC)
74	Medication/supplement use	6157	phv00006157.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:31:15+00:00	2018-09-25 11:31:15+00:00 	FQ172	MEDICATION USE - NON-STERIODAL ANTI-INFLAMMATORY AGENTS (NSAIDS) (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL)
74	Medication/supplement use	6158	phv00006158.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:31:24+00:00	2018-09-25 11:31:24+00:00 	FQ173	MEDICATION USE - ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC)
74	Medication/supplement use	6159	phv00006159.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:31:34+00:00	2018-09-25 11:31:34+00:00 	FQ174	MEDICATION USE - ANALGESTIC-NON-NARCOTICS (ACETAMINOPHEN, ETC)
74	Medication/supplement use	6160	phv00006160.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:31:42+00:00	2018-09-25 11:31:42+00:00 	FQ175	MEDICATION USE - ANTIHISTAMINES
74	Medication/supplement use	6161	phv00006161.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:31:49+00:00	2018-09-25 11:31:49+00:00 	FQ176	MEDICATION USE - ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS)
74	Medication/supplement use	6162	phv00006162.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:31:56+00:00	2018-09-25 11:31:56+00:00 	FQ177	MEDICATION USE - ANTI-ANXIETY, SEDATIVE/HYPNOTICS (LIBRIUM, VALIUM, ETC)
74	Medication/supplement use	6163	phv00006163.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:32:04+00:00	2018-09-25 11:32:04+00:00 	FQ178	MEDICATION USE - SLEEPING PILLS
74	Medication/supplement use	6164	phv00006164.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:32:12+00:00	2018-09-25 11:32:12+00:00 	FQ179	MEDICATION USE - ANTI-DEPRESSANTS
74	Medication/supplement use	6165	phv00006165.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:32:19+00:00	2018-09-25 11:32:19+00:00 	FQ180	MEDICATION USE - EYEDROPS
74	Medication/supplement use	6166	phv00006166.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:32:26+00:00	2018-09-25 11:32:26+00:00 	FQ181	MEDICATION USE - ANTIBIOTICS
74	Medication/supplement use	6167	phv00006167.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:32:35+00:00	2018-09-25 11:32:35+00:00 	FQ182	MEDICATION USE - ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMETREL, COGENTIN, ETC)
74	Medication/supplement use	6168	phv00006168.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:32:42+00:00	2018-09-25 11:32:42+00:00 	FQ183	MEDICATION USE - ANTICONVULSANTS (DILANTIN, PHENOBARBITAL, TEGRETOL, MYSOLINE, ETC)
74	Medication/supplement use	6169	phv00006169.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:32:50+00:00	2018-09-25 11:32:50+00:00 	FQ184	MEDICATION USE - BRONCHODILATORS & AEROSOLS
74	Medication/supplement use	6170	phv00006170.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:32:58+00:00	2018-09-25 11:32:58+00:00 	FQ185	MEDICATIONS USE - OTHER
74	Medication/supplement use	6171	phv00006171.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:33:08+00:00	2018-09-25 11:33:08+00:00 	FQ186	ESTROGEN REPLACEMENT IN INTERIM (E.G. PREMARIN)
74	Medication/supplement use	6172	phv00006172.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:33:16+00:00	2018-09-25 11:33:16+00:00 	FQ187	DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS OR OTHER ORAL ESTROGENS
74	Medication/supplement use	6173	phv00006173.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:33:25+00:00	2018-09-25 11:33:25+00:00 	FQ188	PATCH DOSE OF ESTROGEN
74	Medication/supplement use	6174	phv00006174.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:33:34+00:00	2018-09-25 11:33:34+00:00 	FQ189	NUMBER OF DAYS A MONTH TAKING ESTROGENS
74	Medication/supplement use	6175	phv00006175.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:33:41+00:00	2018-09-25 11:33:41+00:00 	FQ190	PROGESTERONE USE INTERIM
74	Medication/supplement use	6324	phv00006324.v1.p10	pht000026.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 11:34:43+00:00	2018-09-25 11:34:43+00:00 	FQ394	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	6453	phv00006453.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:21:52+00:00	2018-09-25 13:21:52+00:00 	FR180	TAKE ASPIRIN REGULARLY
74	Medication/supplement use	6454	phv00006454.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:22:06+00:00	2018-09-25 13:22:06+00:00 	FR181	IF YES TO FR180, NUMBER OF ASPIRIN TAKEN REGULARLY
74	Medication/supplement use	6455	phv00006455.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:22:13+00:00	2018-09-25 13:22:13+00:00 	FR182	IF YES TO FR180, ASPIRIN FREQUENCY
74	Medication/supplement use	6456	phv00006456.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:22:20+00:00	2018-09-25 13:22:20+00:00 	FR183	IF YES TO FR180, USUAL ASPIRIN DOSE
74	Medication/supplement use	6457	phv00006457.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:22:28+00:00	2018-09-25 13:22:28+00:00 	FR184	CURRENTLY RECEIVING MEDICATION FOR THE TREATMENT OF HYPERTENSION?
74	Medication/supplement use	6458	phv00006458.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:22:37+00:00	2018-09-25 13:22:37+00:00 	FR185	ANY OF THE CARDIOVASCULAR MEDICATIONS BELOW ON THIS PAGE?
74	Medication/supplement use	6459	phv00006459.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:22:45+00:00	2018-09-25 13:22:45+00:00 	FR186	CARDIOVASCULAR MEDICATIONS - CARDIAC GLYCOSIDES
74	Medication/supplement use	6460	phv00006460.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:23:03+00:00	2018-09-25 13:23:03+00:00 	FR187	CARDIOVASCULAR MEDICATIONS - NITROGLYCERINE
74	Medication/supplement use	6461	phv00006461.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:23:10+00:00	2018-09-25 13:23:10+00:00 	FR188	CARDIOVASCULAR MEDICATIONS - LONGER ACTING NITRATES (ISORDIL, CARDILATE)
74	Medication/supplement use	6462	phv00006462.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:23:17+00:00	2018-09-25 13:23:17+00:00 	FR189	CARDIOVASCULAR MEDICATIONS - CALCIUM CHANNEL BLOCKERS (SPECIFY)
74	Medication/supplement use	6463	phv00006463.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:23:25+00:00	2018-09-25 13:23:25+00:00 	FR190	CARDIOVASCULAR MEDICATIONS - CALCIUM CHANNEL BLOCKER GROUP
74	Medication/supplement use	6464	phv00006464.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:23:33+00:00	2018-09-25 13:23:33+00:00 	FR191	CARDIOVASCULAR MEDICATIONS - TABLET SIZE OF CALCIUM CHANNEL BLOCKER (MG)
74	Medication/supplement use	6465	phv00006465.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:23:41+00:00	2018-09-25 13:23:41+00:00 	FR192	CARDIOVASCULAR MEDICATIONS - NUMBER OF TIMES CALCIUM CHANNEL BLOCKER TAKEN PER DAY
74	Medication/supplement use	6466	phv00006466.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:23:50+00:00	2018-09-25 13:23:50+00:00 	FR193	CARDIOVASCULAR MEDICATIONS - BETA BLOCKERS (SPECIFY)
74	Medication/supplement use	6467	phv00006467.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:24:01+00:00	2018-09-25 13:24:01+00:00 	FR194	CARDIOVASCULAR MEDICATIONS - BETA BLOCKER GROUP
74	Medication/supplement use	6468	phv00006468.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:24:09+00:00	2018-09-25 13:24:09+00:00 	FR195	CARDIOVASCULAR MEDICATIONS - DOSE OF BETA BLOCKER
74	Medication/supplement use	6469	phv00006469.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:24:17+00:00	2018-09-25 13:24:17+00:00 	FR196	CARDIOVASCULAR MEDICATIONS - LOOP DIURETICS (LASIX, ETC)
74	Medication/supplement use	6470	phv00006470.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:24:24+00:00	2018-09-25 13:24:24+00:00 	FR197	CARDIOVASCULAR MEDICATIONS - THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC.)
74	Medication/supplement use	6471	phv00006471.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:24:33+00:00	2018-09-25 13:24:33+00:00 	FR198	CARDIOVASCULAR MEDICATIONS - THIAZIDE DIURETICS
74	Medication/supplement use	6472	phv00006472.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:24:41+00:00	2018-09-25 13:24:41+00:00 	FR199	CARDIOVASCULAR MEDICATIONS - K-SPARING DIURECTICS (ALDACTONE, TRIAMTERENE)
74	Medication/supplement use	6473	phv00006473.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:24:50+00:00	2018-09-25 13:24:50+00:00 	FR200	CARDIOVASCULAR MEDICATIONS - POTASSIUM SUPPLEMENTS
74	Medication/supplement use	6474	phv00006474.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:25:13+00:00	2018-09-25 13:25:13+00:00 	FR201	CARDIOVASCULAR MEDICATIONS - ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ)
74	Medication/supplement use	6475	phv00006475.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:25:22+00:00	2018-09-25 13:25:22+00:00 	FR202	CARDIOVASCULAR MEDICATIONS - ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN, DOXAZOSIN)
74	Medication/supplement use	6476	phv00006476.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:25:29+00:00	2018-09-25 13:25:29+00:00 	FR203	CARDIOVASCULAR MEDICATIONS - RENIN-ANGIOTENSIN BLOCKING DRUGS (ACE) (CAPTOPRIL, ENALAPRIL, LISINOPRIL)
74	Medication/supplement use	6477	phv00006477.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:25:36+00:00	2018-09-25 13:25:36+00:00 	FR204	CARDIOVASCULAR MEDICATIONS - PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL,ETC)
74	Medication/supplement use	6478	phv00006478.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:25:50+00:00	2018-09-25 13:25:50+00:00 	FR205	CARDIOVASCULAR MEDICATIONS - OTHER ANTI-HYPERTENSIVES (SPECIFY)
74	Medication/supplement use	6479	phv00006479.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:25:58+00:00	2018-09-25 13:25:58+00:00 	FR206	CARDIOVASCULAR MEDICATIONS - ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE NORPACE, DISOPYRAMIDE, ETC.)
74	Medication/supplement use	6480	phv00006480.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:26:05+00:00	2018-09-25 13:26:05+00:00 	FR207	CARDIOVASCULAR MEDICATIONS - ANTIPLATELET (ANTURANE, PERSANTINE, ETC.)
74	Medication/supplement use	6481	phv00006481.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:26:15+00:00	2018-09-25 13:26:15+00:00 	FR208	CARDIOVASCULAR MEDICATIONS - ANTICOAGULANTS (COUMADIN, WARFARIN, ETC.)
74	Medication/supplement use	6482	phv00006482.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:26:23+00:00	2018-09-25 13:26:23+00:00 	FR209	CARDIOVASCULAR MEDICATIONS - OTHER CARDIAC MEDICATIONS (SPECIFY)
74	Medication/supplement use	6483	phv00006483.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:26:30+00:00	2018-09-25 13:26:30+00:00 	FR210	OTHER MEDICATIONS - ANTI CHOLESTEROL DRUGS (RESINS -- E.G. QUESTRAN, COLESTID)
74	Medication/supplement use	6484	phv00006484.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:26:38+00:00	2018-09-25 13:26:38+00:00 	FR211	OTHER MEDICATIONS - ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIS ACID)
74	Medication/supplement use	6485	phv00006485.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:26:46+00:00	2018-09-25 13:26:46+00:00 	FR212	OTHER MEDICATIONS - ANTI CHOLESTEROL DRUGS (FIBRATES -- E.G. GEMFIBROZIL)
74	Medication/supplement use	6486	phv00006486.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:26:55+00:00	2018-09-25 13:26:55+00:00 	FR213	OTHER MEDICATIONS - ANTI CHOLESTEROL DRUGS (STATINS -- E.G. LOVASTATIN, PRAVASTATIN)
74	Medication/supplement use	6487	phv00006487.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:27:03+00:00	2018-09-25 13:27:03+00:00 	FR214	OTHER MEDICATIONS - ANTI CHOLESTEROL DRUGS (OTHER-SPECIFY)
74	Medication/supplement use	6488	phv00006488.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:27:11+00:00	2018-09-25 13:27:11+00:00 	FR215	OTHER MEDICATIONS - ANTIGOUT -- URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.)
74	Medication/supplement use	6489	phv00006489.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:27:19+00:00	2018-09-25 13:27:19+00:00 	FR216	OTHER MEDICATIONS - ANTIGOUT - (COLCHICINE)
74	Medication/supplement use	6490	phv00006490.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:27:29+00:00	2018-09-25 13:27:29+00:00 	FR217	OTHER MEDICATIONS - THYROID EXTRACT (DESSICATED THYROID)
74	Medication/supplement use	6491	phv00006491.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:27:41+00:00	2018-09-25 13:27:41+00:00 	FR218	OTHER MEDICATIONS - THYROXINE (SYNTHROID, ETC)
74	Medication/supplement use	6492	phv00006492.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:27:50+00:00	2018-09-25 13:27:50+00:00 	FR219	OTHER MEDICATIONS - INSULIN
74	Medication/supplement use	6493	phv00006493.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:27:58+00:00	2018-09-25 13:27:58+00:00 	FR220	OTHER MEDICATIONS - TOTAL UNITS OF INSULIN A DAY
74	Medication/supplement use	6494	phv00006494.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:28:11+00:00	2018-09-25 13:28:11+00:00 	FR221	OTHER MEDICATIONS - ORAL HYPOGLYCEMICS (SPECIFY BRAND)
74	Medication/supplement use	6495	phv00006495.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:28:20+00:00	2018-09-25 13:28:20+00:00 	FR222	OTHER MEDICATIONS - ORAL/PATCH ESTROGEN (FOR WOMEN USERS ALSO SEE ESTROGEN SECTION)
74	Medication/supplement use	6496	phv00006496.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:28:28+00:00	2018-09-25 13:28:28+00:00 	FR223	OTHER MEDICATIONS - ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.)
74	Medication/supplement use	6497	phv00006497.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:28:35+00:00	2018-09-25 13:28:35+00:00 	FR224	OTHER MEDICATIONS - NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL)
74	Medication/supplement use	6498	phv00006498.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:28:43+00:00	2018-09-25 13:28:43+00:00 	FR225	OTHER MEDICATIONS - ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.)
74	Medication/supplement use	6499	phv00006499.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:28:51+00:00	2018-09-25 13:28:51+00:00 	FR226	OTHER MEDICATIONS - ANALGESIC-NON NARCOTICS (ACETAMINOPHEN, ETC.)
74	Medication/supplement use	6500	phv00006500.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:29:00+00:00	2018-09-25 13:29:00+00:00 	FR227	OTHER MEDICATIONS - ANTIHISTAMINES
74	Medication/supplement use	6501	phv00006501.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:29:09+00:00	2018-09-25 13:29:09+00:00 	FR228	OTHER MEDICATIONS - ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE H-ION INHIBITORS)
74	Medication/supplement use	6502	phv00006502.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:29:17+00:00	2018-09-25 13:29:17+00:00 	FR229	OTHER MEDICATIONS - ANTI-ANXIETY, SEDATIVE/HYPNOTICS ETC. (LIBRIUM, VALIUM ETC)
74	Medication/supplement use	6503	phv00006503.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:29:25+00:00	2018-09-25 13:29:25+00:00 	FR230	OTHER MEDICATIONS - SLEEPING PILLS
74	Medication/supplement use	6504	phv00006504.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:29:45+00:00	2018-09-25 13:29:45+00:00 	FR231	OTHER MEDICATIONS - ANTI-DEPRESSANTS
74	Medication/supplement use	6505	phv00006505.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:29:52+00:00	2018-09-25 13:29:52+00:00 	FR232	OTHER MEDICATIONS - EYE DROPS
74	Medication/supplement use	6506	phv00006506.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:35:11+00:00	2018-09-25 13:35:11+00:00 	FR233	OTHER MEDICATIONS - ANTIBIOTICS
74	Medication/supplement use	6507	phv00006507.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:35:22+00:00	2018-09-25 13:35:22+00:00 	FR234	OTHER MEDICATIONS - ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.)
74	Medication/supplement use	6508	phv00006508.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:35:39+00:00	2018-09-25 13:35:39+00:00 	FR235	OTHER MEDICATIONS - ANTICONVULSANTS (DILANTIN, PHENOBARBITAL, TEGRETOL, MYSOLINE, ETC.)
74	Medication/supplement use	6509	phv00006509.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:35:46+00:00	2018-09-25 13:35:46+00:00 	FR236	OTHER MEDICATIONS - BRONCHODILATORS AND AEROSOLS
74	Medication/supplement use	6510	phv00006510.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:35:53+00:00	2018-09-25 13:35:53+00:00 	FR237	OTHER MEDICATIONS - OSTEOPOROSIS MEDICATIONS (ALENDRONATE (FOSAMAX), CALCITONIN, ETIDRONATE, EVISTA (RALOXIFERE))
74	Medication/supplement use	6511	phv00006511.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:36:02+00:00	2018-09-25 13:36:02+00:00 	FR238	OTHER MEDICATIONS - OTHERS SPECIFY (INCLUDE VITAMINS)
74	Medication/supplement use	6514	phv00006514.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:36:27+00:00	2018-09-25 13:36:27+00:00 	FR241	FEMALE GENITOURINARY ESTROGEN REPLACEMENT IN INTERIM (E.G. PREMARIN)
74	Medication/supplement use	6515	phv00006515.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:36:40+00:00	2018-09-25 13:36:40+00:00 	FR242	FEMALE GENITOURINARY DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS, OR OTHER ORAL ESTROGEN
74	Medication/supplement use	6516	phv00006516.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:36:48+00:00	2018-09-25 13:36:48+00:00 	FR243	FEMALE GENITOURINARY PATCH DOSE OF ESTROGEN
74	Medication/supplement use	6517	phv00006517.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:36:56+00:00	2018-09-25 13:36:56+00:00 	FR244	FEMALE GENITOURINARY NUMBER OF DAYS A MONTH TAKING ESTROGEN
74	Medication/supplement use	6518	phv00006518.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:37:04+00:00	2018-09-25 13:37:04+00:00 	FR245	FEMALE GENITOURINARY ESTROGEN CREAM USE IN INTERIM
74	Medication/supplement use	6519	phv00006519.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:37:14+00:00	2018-09-25 13:37:14+00:00 	FR246	FEMALE GENITOURINARY PROGESTIN REPLACEMENT IN INTERIM (E.G. PROVERA)
74	Medication/supplement use	6520	phv00006520.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:37:21+00:00	2018-09-25 13:37:21+00:00 	FR247	FEMALE GENITOURINARY DOSE/DAY OF PROGESTIN
74	Medication/supplement use	6521	phv00006521.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:37:29+00:00	2018-09-25 13:37:29+00:00 	FR248	FEMALE GENITOURINARY NUMBER OF DAYS PER MONTH TAKING PROGESTINS
74	Medication/supplement use	6658	phv00006658.v1.p10	pht000027.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:38:18+00:00	2018-09-25 13:38:18+00:00 	FR434	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	6845	phv00006845.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:59:25+00:00	2018-09-25 13:59:25+00:00 	FS236	CURRENTLY RECEIVING MEDICATION FOR THE TREATMENT OF HYPERTENSION?
74	Medication/supplement use	6846	phv00006846.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 13:59:56+00:00	2018-09-25 13:59:56+00:00 	FS237	ANY OF THE CARDIOVASCULAR MEDICATIONS BELOW ON THIS PAGE?
74	Medication/supplement use	6847	phv00006847.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:00:08+00:00	2018-09-25 14:00:08+00:00 	FS238	CARDIOVASCULAR MEDICATIONS: CARDIAC GLYCOSIDES
74	Medication/supplement use	6848	phv00006848.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:00:16+00:00	2018-09-25 14:00:16+00:00 	FS239	CARDIOVASCULAR MEDICATIONS: NITROGLYCERINE
74	Medication/supplement use	6849	phv00006849.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:00:24+00:00	2018-09-25 14:00:24+00:00 	FS240	CARDIOVASCULAR MEDICATIONS: LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC)
74	Medication/supplement use	6850	phv00006850.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:00:32+00:00	2018-09-25 14:00:32+00:00 	FS241	CARDIOVASCULAR MEDICATIONS: CALCIUM CHANNEL BLOCKERS
74	Medication/supplement use	6851	phv00006851.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:00:40+00:00	2018-09-25 14:00:40+00:00 	FS242	CALCIUM CHANNEL BLOCKER GROUP
74	Medication/supplement use	6852	phv00006852.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:00:47+00:00	2018-09-25 14:00:47+00:00 	FS243	CALCIUM CHANNEL BLOCKER: TABLET SIZE OF CALCIUM CHANNEL BLOCKER (MG)
74	Medication/supplement use	6853	phv00006853.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:00:55+00:00	2018-09-25 14:00:55+00:00 	FS244	CALCIUM CHANNEL BLOCKER: NUMBER OF TIMES CALCIUM CHANNEL BLOCKER TAKEN PER DAY
74	Medication/supplement use	6854	phv00006854.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:01:03+00:00	2018-09-25 14:01:03+00:00 	FS245	CARDIOVASCULAR MEDICATIONS: BETA BLOCKERS
74	Medication/supplement use	6855	phv00006855.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:01:16+00:00	2018-09-25 14:01:16+00:00 	FS246	BETA BLOCKER GROUP
74	Medication/supplement use	6856	phv00006856.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:01:27+00:00	2018-09-25 14:01:27+00:00 	FS247	BETA BLOCKER: DOSE (MG/DAY) OF BETA BLOCKERS
74	Medication/supplement use	6857	phv00006857.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:01:37+00:00	2018-09-25 14:01:37+00:00 	FS248	CARDIOVASCULAR MEDICATIONS: LOOP DIURETICS (LASIX, ETC)
74	Medication/supplement use	6858	phv00006858.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:01:49+00:00	2018-09-25 14:01:49+00:00 	FS249	CARDIOVASCULAR MEDICATIONS: THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC)
74	Medication/supplement use	6859	phv00006859.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:01:58+00:00	2018-09-25 14:01:58+00:00 	FS250	CARDIOVASCULAR MEDICATIONS: THIAZIDE DIURETICS
74	Medication/supplement use	6860	phv00006860.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:02:10+00:00	2018-09-25 14:02:10+00:00 	FS251	CARDIOVASCULAR MEDICATIONS: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE)
74	Medication/supplement use	6861	phv00006861.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:02:19+00:00	2018-09-25 14:02:19+00:00 	FS252	CARDIOVASCULAR MEDICATIONS: POTASSIUM SUPPLEMENTS
74	Medication/supplement use	6862	phv00006862.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:02:27+00:00	2018-09-25 14:02:27+00:00 	FS253	CARDIOVASCULAR MEDICATIONS: RESERPINE DERIVATIVES
74	Medication/supplement use	6863	phv00006863.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:02:38+00:00	2018-09-25 14:02:38+00:00 	FS254	CARDIOVASCULAR MEDICATIONS: METHYLDOPA (ALDOMET)
74	Medication/supplement use	6864	phv00006864.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:02:58+00:00	2018-09-25 14:02:58+00:00 	FS255	CARDIOVASCULAR MEDICATIONS: ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ)
74	Medication/supplement use	6865	phv00006865.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:03:45+00:00	2018-09-25 14:03:45+00:00 	FS256	CARDIOVASCULAR MEDICATIONS: ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN, DOXAZOSIN)
74	Medication/supplement use	6866	phv00006866.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:03:53+00:00	2018-09-25 14:03:53+00:00 	FS257	CARDIOVASCULAR MEDICATIONS: RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL, ENALAPRIL, LISINOPRIL)
74	Medication/supplement use	6867	phv00006867.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:04:02+00:00	2018-09-25 14:04:02+00:00 	FS258	CARDIOVASCULAR MEDICATIONS: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC)
74	Medication/supplement use	6868	phv00006868.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:04:10+00:00	2018-09-25 14:04:10+00:00 	FS259	CARDIOVASCULAR MEDICATIONS: ANGIOTENSIN II ANTAGONISTS (LOSARTAN, ETC)
74	Medication/supplement use	6869	phv00006869.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:04:18+00:00	2018-09-25 14:04:18+00:00 	FS260	CARDIOVASCULAR MEDICATIONS: OTHER ANTI-HYPERTENSIVES
74	Medication/supplement use	6870	phv00006870.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:04:54+00:00	2018-09-25 14:04:54+00:00 	FS261	CARDIOVASCULAR MEDICATIONS: ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE, ETC.)
74	Medication/supplement use	6871	phv00006871.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:05:05+00:00	2018-09-25 14:05:05+00:00 	FS262	CARDIOVASCULAR MEDICATIONS: ANTIPLATELET (ANTURANE, PERSANTINE, ETC.)
74	Medication/supplement use	6872	phv00006872.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:05:13+00:00	2018-09-25 14:05:13+00:00 	FS263	CARDIOVASCULAR MEDICATIONS: ANTICOAGULANTS (COUMADIN, WARFARIN, ETC.)
74	Medication/supplement use	6873	phv00006873.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:05:20+00:00	2018-09-25 14:05:20+00:00 	FS264	CARDIOVASCULAR MEDICATIONS: OTHER CARDIAC MEDICATION
74	Medication/supplement use	6874	phv00006874.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:05:28+00:00	2018-09-25 14:05:28+00:00 	FS265	TAKE ASPIRIN REGULARLY?
74	Medication/supplement use	6875	phv00006875.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:05:36+00:00	2018-09-25 14:05:36+00:00 	FS266	ASPIRIN: NUMBER ASPIRINS TAKEN REGULARLY
74	Medication/supplement use	6876	phv00006876.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:05:45+00:00	2018-09-25 14:05:45+00:00 	FS267	ASPIRIN: ASPIRIN FREQUENCY
74	Medication/supplement use	6877	phv00006877.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:05:55+00:00	2018-09-25 14:05:55+00:00 	FS268	ASPIRIN: USUAL ASPIRIN DOSE
74	Medication/supplement use	6878	phv00006878.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:06:03+00:00	2018-09-25 14:06:03+00:00 	FS269	NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)
74	Medication/supplement use	6879	phv00006879.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:06:10+00:00	2018-09-25 14:06:10+00:00 	FS270	NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID)
74	Medication/supplement use	6880	phv00006880.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:06:19+00:00	2018-09-25 14:06:19+00:00 	FS271	NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL)
74	Medication/supplement use	6881	phv00006881.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:06:27+00:00	2018-09-25 14:06:27+00:00 	FS272	NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (STATINS - E.G. LOVASTATIN, PRAVASTATIN)
74	Medication/supplement use	6882	phv00006882.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:06:34+00:00	2018-09-25 14:06:34+00:00 	FS273	NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (OTHER)
74	Medication/supplement use	6883	phv00006883.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:06:44+00:00	2018-09-25 14:06:44+00:00 	FS274	NONCARDIOVASCULAR MEDICATIONS: ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.)
74	Medication/supplement use	6884	phv00006884.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:06:52+00:00	2018-09-25 14:06:52+00:00 	FS275	NONCARDIOVASCULAR MEDICATIONS: ANTIGOUT (COLCHICINE)
74	Medication/supplement use	6885	phv00006885.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:07:01+00:00	2018-09-25 14:07:01+00:00 	FS276	NONCARDIOVASCULAR MEDICATIONS: THYROID EXTRACT (DESICCATED THYROID)
74	Medication/supplement use	6886	phv00006886.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:07:11+00:00	2018-09-25 14:07:11+00:00 	FS277	NONCARDIOVASCULAR MEDICATIONS: THYROXINE (SYNTHROID, ETC.)
74	Medication/supplement use	6887	phv00006887.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:07:20+00:00	2018-09-25 14:07:20+00:00 	FS278	NONCARDIOVASCULAR MEDICATIONS: INSULIN
74	Medication/supplement use	6888	phv00006888.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:07:29+00:00	2018-09-25 14:07:29+00:00 	FS279	INSULIN: TOTAL UNITS A DAY
74	Medication/supplement use	6889	phv00006889.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:07:40+00:00	2018-09-25 14:07:40+00:00 	FS280	NONCARDIOVASCULAR MEDICATIONS: ORAL HYPOGLYCEMICS
74	Medication/supplement use	6890	phv00006890.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:08:04+00:00	2018-09-25 14:08:04+00:00 	FS281	ORAL HYPOGLYCEMICS: METFORMIN
74	Medication/supplement use	6891	phv00006891.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:08:11+00:00	2018-09-25 14:08:11+00:00 	FS282	ORAL HYPOGLYCEMICS: ROSIGLITAZONE
74	Medication/supplement use	6892	phv00006892.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:08:19+00:00	2018-09-25 14:08:19+00:00 	FS283	ORAL HYPOGLYCEMICS: GLIPIZIDE
74	Medication/supplement use	6893	phv00006893.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:08:28+00:00	2018-09-25 14:08:28+00:00 	FS284	ORAL HYPOGLYCEMICS: GLYBURIDE
74	Medication/supplement use	6894	phv00006894.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:08:36+00:00	2018-09-25 14:08:36+00:00 	FS285	ORAL HYPOGLYCEMICS: CHLORPROPAMIDE
74	Medication/supplement use	6895	phv00006895.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:08:47+00:00	2018-09-25 14:08:47+00:00 	FS286	ORAL HYPOGLYCEMICS: REPAGLINIDE
74	Medication/supplement use	6896	phv00006896.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:08:56+00:00	2018-09-25 14:08:56+00:00 	FS287	ORAL HYPOGLYCEMICS: GLIMEPRIRIDE
74	Medication/supplement use	6897	phv00006897.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:09:04+00:00	2018-09-25 14:09:04+00:00 	FS288	ORAL HYPOGLYCEMICS: OTHER
74	Medication/supplement use	6898	phv00006898.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:09:12+00:00	2018-09-25 14:09:12+00:00 	FS289	ORAL HYPOGLYCEMICS: UNKNOWN
74	Medication/supplement use	6899	phv00006899.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:09:20+00:00	2018-09-25 14:09:20+00:00 	FS290	NONCARDIOVASCULAR MEDICATIONS: ORAL/PATCH ESTROGEN (FOR WOMEN USERS ALSO SEE ESTROGEN SECTION)
74	Medication/supplement use	6900	phv00006900.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:09:29+00:00	2018-09-25 14:09:29+00:00 	FS291	NONCARDIOVASCULAR MEDICATIONS: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.)
74	Medication/supplement use	6901	phv00006901.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:09:37+00:00	2018-09-25 14:09:37+00:00 	FS292	NONCARDIOVASCULAR MEDICATIONS: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL)
74	Medication/supplement use	6902	phv00006902.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:09:46+00:00	2018-09-25 14:09:46+00:00 	FS293	NONCARDIOVASCULAR MEDICATIONS: ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.)
74	Medication/supplement use	6903	phv00006903.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:09:55+00:00	2018-09-25 14:09:55+00:00 	FS294	NONCARDIOVASCULAR MEDICATIONS: ANALGESIC NON-NARCOTICS (ACETAMINOPHEN, ETC.)
74	Medication/supplement use	6904	phv00006904.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:10:02+00:00	2018-09-25 14:10:02+00:00 	FS295	NONCARDIOVASCULAR MEDICATIONS: ANTIHISTAMINES
74	Medication/supplement use	6905	phv00006905.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:10:10+00:00	2018-09-25 14:10:10+00:00 	FS296	NONCARDIOVASCULAR MEDICATIONS: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS)
74	Medication/supplement use	6906	phv00006906.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:10:17+00:00	2018-09-25 14:10:17+00:00 	FS297	NONCARDIOVASCULAR MEDICATIONS: ANTI-ANXIETY, SEDATIVE/HYPNOTICS (LIBRIUM, VALIUM, ETC.)
74	Medication/supplement use	6907	phv00006907.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:10:26+00:00	2018-09-25 14:10:26+00:00 	FS298	NONCARDIOVASCULAR MEDICATIONS: SLEEPING PILLS
74	Medication/supplement use	6908	phv00006908.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:10:35+00:00	2018-09-25 14:10:35+00:00 	FS299	NONCARDIOVASCULAR MEDICATIONS: ANTI-DEPRESSANTS
74	Medication/supplement use	6909	phv00006909.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:10:43+00:00	2018-09-25 14:10:43+00:00 	FS300	NONCARDIOVASCULAR MEDICATIONS: EYE DROPS
74	Medication/supplement use	6910	phv00006910.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:11:04+00:00	2018-09-25 14:11:04+00:00 	FS301	NONCARDIOVASCULAR MEDICATIONS: ANTIBIOTICS
74	Medication/supplement use	6911	phv00006911.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:11:11+00:00	2018-09-25 14:11:11+00:00 	FS302	NONCARDIOVASCULAR MEDICATIONS: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.)
74	Medication/supplement use	6912	phv00006912.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:11:19+00:00	2018-09-25 14:11:19+00:00 	FS303	NONCARDIOVASCULAR MEDICATIONS: ANTICONVULSANTS (DILANTIN, PHENOBARBITAL, TEGRETOL, MYSOLINE, ETC.)
74	Medication/supplement use	6913	phv00006913.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:11:29+00:00	2018-09-25 14:11:29+00:00 	FS304	NONCARDIOVASCULAR MEDICATIONS: MEDICATIONS FOR MEMORY LOSS OR DEMENTIA (TACRINE, DONEPAZIL)
74	Medication/supplement use	6914	phv00006914.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:11:37+00:00	2018-09-25 14:11:37+00:00 	FS305	NONCARDIOVASCULAR MEDICATIONS: BRONCHODILATORS AND AEROSOLS
74	Medication/supplement use	6915	phv00006915.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:11:46+00:00	2018-09-25 14:11:46+00:00 	FS306	NONCARDIOVASCULAR MEDICATIONS: OSTEOPOROSIS MEDICATIONS
74	Medication/supplement use	6916	phv00006916.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:11:54+00:00	2018-09-25 14:11:54+00:00 	FS307	OSTEOPOROSIS MEDICATIONS: BISPHOSPHORATES (ALENDRONATE, (FOSAMAX), ETIDRONATE)
74	Medication/supplement use	6917	phv00006917.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:12:04+00:00	2018-09-25 14:12:04+00:00 	FS308	OSTEOPOROSIS MEDICATIONS: CALCITONIN
74	Medication/supplement use	6918	phv00006918.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:12:12+00:00	2018-09-25 14:12:12+00:00 	FS309	OSTEOPOROSIS MEDICATIONS: SERMS, EVISTA (RALOXIFENE)
74	Medication/supplement use	6919	phv00006919.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:12:21+00:00	2018-09-25 14:12:21+00:00 	FS310	OSTEOPOROSIS MEDICATIONS: OTHER
74	Medication/supplement use	6920	phv00006920.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:12:32+00:00	2018-09-25 14:12:32+00:00 	FS311	NONCARDIOVASCULAR MEDICATIONS: OTHERS (INCLUDING VITAMINS)
74	Medication/supplement use	6923	phv00006923.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:18:13+00:00	2018-09-25 14:18:13+00:00 	FS314	FEMALE HORMONE REPLACEMENT: ESTROGEN REPLACEMENT IN INTERIM (E.G. PREMARIN)
74	Medication/supplement use	6924	phv00006924.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:18:27+00:00	2018-09-25 14:18:27+00:00 	FS315	FEMALE HORMONE REPLACEMENT: DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS, OR OTHER ORAL ESTROGEN
74	Medication/supplement use	6926	phv00006926.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:18:48+00:00	2018-09-25 14:18:48+00:00 	FS317	FEMALE HORMONE REPLACEMENT: NUMBER OF DAYS A MONTH TAKING ESTROGENS
74	Medication/supplement use	6927	phv00006927.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:18:58+00:00	2018-09-25 14:18:58+00:00 	FS318	FEMALE HORMONE REPLACEMENT: ESTROGEN CREAM USE IN INTERIM
74	Medication/supplement use	6928	phv00006928.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:19:21+00:00	2018-09-25 14:19:21+00:00 	FS319	FEMALE HORMONE REPLACEMENT: PROGESTIN REPLACEMENT IN INTERIM (E.G. PROVERA)
74	Medication/supplement use	6929	phv00006929.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:19:33+00:00	2018-09-25 14:19:33+00:00 	FS320	FEMALE HORMONE REPLACEMENT: DOSE/DAY OF PROGESTIN
74	Medication/supplement use	6930	phv00006930.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:19:41+00:00	2018-09-25 14:19:41+00:00 	FS321	FEMALE HORMONE REPLACEMENT: NUMBER OF DAYS A MONTH TAKING PROGESTINS
74	Medication/supplement use	7093	phv00007093.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:20:26+00:00	2018-09-25 14:20:26+00:00 	FS539	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	7282	phv00007282.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:43:11+00:00	2018-09-25 14:43:11+00:00 	FT243	IN THE INTERIM HAVE YOU TAKEN MEDICATION FOR THE TREATMENT OF HYPERTENSION?
74	Medication/supplement use	7283	phv00007283.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:43:34+00:00	2018-09-25 14:43:34+00:00 	FT244	ANY OF THE CARDIOVASCULAR MEDICATIONS IN THE FOLLOWING SECTION?
74	Medication/supplement use	7284	phv00007284.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:43:41+00:00	2018-09-25 14:43:41+00:00 	FT245	CARDIOVASCULAR MEDICATIONS: CARDIAC GLYCOSIDES
74	Medication/supplement use	7285	phv00007285.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:43:47+00:00	2018-09-25 14:43:47+00:00 	FT246	CARDIOVASCULAR MEDICATIONS: NITROGLYCERINE
74	Medication/supplement use	7286	phv00007286.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:43:54+00:00	2018-09-25 14:43:54+00:00 	FT247	CARDIOVASCULAR MEDICATIONS: LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC)
74	Medication/supplement use	7287	phv00007287.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:44:01+00:00	2018-09-25 14:44:01+00:00 	FT248	CARDIOVASCULAR MEDICATIONS: CALCIUM CHANNEL BLOCKERS
74	Medication/supplement use	7288	phv00007288.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:44:08+00:00	2018-09-25 14:44:08+00:00 	FT249	CALCIUM CHANNEL BLOCKER GROUP
74	Medication/supplement use	7289	phv00007289.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:44:15+00:00	2018-09-25 14:44:15+00:00 	FT250	CALCIUM CHANNEL BLOCKER: TABLET SIZE OF CALCIUM CHANNEL BLOCKER (MG)
74	Medication/supplement use	7290	phv00007290.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:44:22+00:00	2018-09-25 14:44:22+00:00 	FT251	CALCIUM CHANNEL BLOCKER: NUMBER OF TIMES CALCIUM CHANNEL BLOCKER TAKEN PER DAY
74	Medication/supplement use	7291	phv00007291.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:44:29+00:00	2018-09-25 14:44:29+00:00 	FT252	CARDIOVASCULAR MEDICATIONS: BETA BLOCKERS
74	Medication/supplement use	7292	phv00007292.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:44:38+00:00	2018-09-25 14:44:38+00:00 	FT253	BETA BLOCKER GROUP
74	Medication/supplement use	7293	phv00007293.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:44:45+00:00	2018-09-25 14:44:45+00:00 	FT254	BETA BLOCKER: DOSE (MG/DAY) OF BETA BLOCKERS
74	Medication/supplement use	7294	phv00007294.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:44:52+00:00	2018-09-25 14:44:52+00:00 	FT255	CARDIOVASCULAR MEDICATIONS: LOOP DIURETICS (LASIX, ETC)
74	Medication/supplement use	7295	phv00007295.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:44:59+00:00	2018-09-25 14:44:59+00:00 	FT256	CARDIOVASCULAR MEDICATIONS: THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC)
74	Medication/supplement use	7296	phv00007296.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:45:07+00:00	2018-09-25 14:45:07+00:00 	FT257	CARDIOVASCULAR MEDICATIONS: THIAZIDE DIURETICS
74	Medication/supplement use	7297	phv00007297.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:45:15+00:00	2018-09-25 14:45:15+00:00 	FT258	CARDIOVASCULAR MEDICATIONS: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE)
74	Medication/supplement use	7298	phv00007298.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:45:26+00:00	2018-09-25 14:45:26+00:00 	FT259	CARDIOVASCULAR MEDICATIONS: POTASSIUM SUPPLEMENTS
74	Medication/supplement use	7299	phv00007299.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:45:33+00:00	2018-09-25 14:45:33+00:00 	FT260	CARDIOVASCULAR MEDICATIONS: RESERPINE DERIVATIVES
74	Medication/supplement use	7300	phv00007300.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:45:40+00:00	2018-09-25 14:45:40+00:00 	FT261	CARDIOVASCULAR MEDICATIONS: METHYLDOPA (ALDOMET)
74	Medication/supplement use	7301	phv00007301.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:45:47+00:00	2018-09-25 14:45:47+00:00 	FT262	CARDIOVASCULAR MEDICATIONS: ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ)
74	Medication/supplement use	7302	phv00007302.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:45:54+00:00	2018-09-25 14:45:54+00:00 	FT263	CARDIOVASCULAR MEDICATIONS: ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN, DOXAZOSIN)
74	Medication/supplement use	7303	phv00007303.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:46:01+00:00	2018-09-25 14:46:01+00:00 	FT264	CARDIOVASCULAR MEDICATIONS: RENIN-ANGIOTENSIN BLOCKING DRUGS (ACE) (CAPTOPRIL, ENALAPRIL, LISINOPRIL)
74	Medication/supplement use	7304	phv00007304.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:46:09+00:00	2018-09-25 14:46:09+00:00 	FT265	CARDIOVASCULAR MEDICATIONS: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC)
74	Medication/supplement use	7305	phv00007305.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:46:16+00:00	2018-09-25 14:46:16+00:00 	FT266	CARDIOVASCULAR MEDICATIONS: ANGIOTENSIN II ANTAGONISTS (LOSARTAN, ETC)
74	Medication/supplement use	7306	phv00007306.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:46:23+00:00	2018-09-25 14:46:23+00:00 	FT267	CARDIOVASCULAR MEDICATIONS: OTHER ANTI-HYPERTENSIVES
74	Medication/supplement use	7307	phv00007307.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:46:34+00:00	2018-09-25 14:46:34+00:00 	FT268	CARDIOVASCULAR MEDICATIONS: ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE, ETC.)
74	Medication/supplement use	7308	phv00007308.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:46:41+00:00	2018-09-25 14:46:41+00:00 	FT269	CARDIOVASCULAR MEDICATIONS: ANTIPLATELET (ANTURANE, PERSANTINE, ETC.)
74	Medication/supplement use	7309	phv00007309.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:46:47+00:00	2018-09-25 14:46:47+00:00 	FT270	CARDIOVASCULAR MEDICATIONS: ANTICOAGULANTS (COUMADIN, WARFARIN, ETC.)
74	Medication/supplement use	7310	phv00007310.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:47:17+00:00	2018-09-25 14:47:17+00:00 	FT271	CARDIOVASCULAR MEDICATIONS: OTHER CARDIAC MEDICATION
74	Medication/supplement use	7311	phv00007311.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:47:25+00:00	2018-09-25 14:47:25+00:00 	FT272	TAKE ASPIRIN REGULARLY?
74	Medication/supplement use	7312	phv00007312.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:47:32+00:00	2018-09-25 14:47:32+00:00 	FT273	ASPIRIN: NUMBER ASPIRINS TAKEN REGULARLY
74	Medication/supplement use	7313	phv00007313.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:47:39+00:00	2018-09-25 14:47:39+00:00 	FT274	ASPIRIN: ASPIRIN FREQUENCY
74	Medication/supplement use	7314	phv00007314.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:47:47+00:00	2018-09-25 14:47:47+00:00 	FT275	ASPIRIN: USUAL ASPIRIN DOSE
74	Medication/supplement use	7315	phv00007315.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:47:56+00:00	2018-09-25 14:47:56+00:00 	FT276	NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)
74	Medication/supplement use	7316	phv00007316.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:48:04+00:00	2018-09-25 14:48:04+00:00 	FT277	NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID)
74	Medication/supplement use	7317	phv00007317.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:48:12+00:00	2018-09-25 14:48:12+00:00 	FT278	NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL)
74	Medication/supplement use	7318	phv00007318.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:48:19+00:00	2018-09-25 14:48:19+00:00 	FT279	NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (STATINS - E.G. LOVASTATIN, PRAVASTATIN)
74	Medication/supplement use	7319	phv00007319.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:48:28+00:00	2018-09-25 14:48:28+00:00 	FT280	NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (OTHER)
74	Medication/supplement use	7320	phv00007320.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:48:36+00:00	2018-09-25 14:48:36+00:00 	FT281	NONCARDIOVASCULAR MEDICATIONS: ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.)
74	Medication/supplement use	7321	phv00007321.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:48:43+00:00	2018-09-25 14:48:43+00:00 	FT282	NONCARDIOVASCULAR MEDICATIONS: ANTIGOUT (COLCHICINE)
74	Medication/supplement use	7322	phv00007322.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:48:50+00:00	2018-09-25 14:48:50+00:00 	FT283	NONCARDIOVASCULAR MEDICATIONS: THYROID EXTRACT (DESICCATED THYROID)
74	Medication/supplement use	7323	phv00007323.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:48:58+00:00	2018-09-25 14:48:58+00:00 	FT284	NONCARDIOVASCULAR MEDICATIONS: THYROXINE (SYNTHROID, ETC.)
74	Medication/supplement use	7324	phv00007324.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:49:06+00:00	2018-09-25 14:49:06+00:00 	FT285	NONCARDIOVASCULAR MEDICATIONS: INSULIN
74	Medication/supplement use	7325	phv00007325.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:49:14+00:00	2018-09-25 14:49:14+00:00 	FT286	INSULIN: TOTAL UNITS A DAY
74	Medication/supplement use	7326	phv00007326.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:49:21+00:00	2018-09-25 14:49:21+00:00 	FT287	NONCARDIOVASCULAR MEDICATIONS: ORAL HYPOGLYCEMICS
74	Medication/supplement use	7327	phv00007327.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:49:29+00:00	2018-09-25 14:49:29+00:00 	FT288	ORAL HYPOGLYCEMICS: METFORMIN
74	Medication/supplement use	7328	phv00007328.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:49:37+00:00	2018-09-25 14:49:37+00:00 	FT289	ORAL HYPOGLYCEMICS: ROSIGLITAZONE
74	Medication/supplement use	7329	phv00007329.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:49:45+00:00	2018-09-25 14:49:45+00:00 	FT290	ORAL HYPOGLYCEMICS: GLIPIZIDE
74	Medication/supplement use	7330	phv00007330.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:49:55+00:00	2018-09-25 14:49:55+00:00 	FT291	ORAL HYPOGLYCEMICS: GLYBURIDE
74	Medication/supplement use	7331	phv00007331.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:50:04+00:00	2018-09-25 14:50:04+00:00 	FT292	ORAL HYPOGLYCEMICS: REPAGLINIDE
74	Medication/supplement use	7332	phv00007332.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:50:11+00:00	2018-09-25 14:50:11+00:00 	FT293	ORAL HYPOGLYCEMICS: GLIMEPRIRIDE
74	Medication/supplement use	7333	phv00007333.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:50:20+00:00	2018-09-25 14:50:20+00:00 	FT294	HYPOGLYCEMICS: CHLORPROPAMIDE
74	Medication/supplement use	7334	phv00007334.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:50:33+00:00	2018-09-25 14:50:33+00:00 	FT295	ORAL HYPOGLYCEMICS: OTHER
74	Medication/supplement use	7335	phv00007335.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:50:40+00:00	2018-09-25 14:50:40+00:00 	FT296	ORAL HYPOGLYCEMICS: UNKNOWN
74	Medication/supplement use	7336	phv00007336.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:50:48+00:00	2018-09-25 14:50:48+00:00 	FT297	NONCARDIOVASCULAR MEDICATIONS: ORAL/PATCH ESTROGEN (FOR WOMEN USERS ALSO SEE ESTROGEN SECTION)
74	Medication/supplement use	7337	phv00007337.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:50:56+00:00	2018-09-25 14:50:56+00:00 	FT298	NONCARDIOVASCULAR MEDICATIONS: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.)
74	Medication/supplement use	7338	phv00007338.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:51:04+00:00	2018-09-25 14:51:04+00:00 	FT299	NONCARDIOVASCULAR MEDICATIONS: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL)
74	Medication/supplement use	7339	phv00007339.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:51:13+00:00	2018-09-25 14:51:13+00:00 	FT300	NONCARDIOVASCULAR MEDICATIONS: ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.)
74	Medication/supplement use	7340	phv00007340.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:51:37+00:00	2018-09-25 14:51:37+00:00 	FT301	NONCARDIOVASCULAR MEDICATIONS: ANALGESIC NON-NARCOTICS (ACETAMINOPHEN, ETC.)
74	Medication/supplement use	7341	phv00007341.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:51:44+00:00	2018-09-25 14:51:44+00:00 	FT302	NONCARDIOVASCULAR MEDICATIONS: ANTIHISTAMINES
74	Medication/supplement use	7342	phv00007342.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:51:52+00:00	2018-09-25 14:51:52+00:00 	FT303	NONCARDIOVASCULAR MEDICATIONS: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS)
74	Medication/supplement use	7343	phv00007343.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:52:01+00:00	2018-09-25 14:52:01+00:00 	FT304	NONCARDIOVASCULAR MEDICATIONS: ANTI-ANXIETY, SEDATIVE/HYPNOTICS (LIBRIUM, VALIUM, ETC.)
74	Medication/supplement use	7344	phv00007344.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:52:08+00:00	2018-09-25 14:52:08+00:00 	FT305	NONCARDIOVASCULAR MEDICATIONS: SLEEPING PILLS
74	Medication/supplement use	7345	phv00007345.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:52:16+00:00	2018-09-25 14:52:16+00:00 	FT306	NONCARDIOVASCULAR MEDICATIONS: ANTI-DEPRESSANTS
74	Medication/supplement use	7346	phv00007346.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:52:27+00:00	2018-09-25 14:52:27+00:00 	FT307	NONCARDIOVASCULAR MEDICATIONS: EYE DROPS
74	Medication/supplement use	7347	phv00007347.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:52:35+00:00	2018-09-25 14:52:35+00:00 	FT308	NONCARDIOVASCULAR MEDICATIONS: ANTIBIOTICS
74	Medication/supplement use	7348	phv00007348.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:52:47+00:00	2018-09-25 14:52:47+00:00 	FT309	NONCARDIOVASCULAR MEDICATIONS: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.)
74	Medication/supplement use	7349	phv00007349.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:53:00+00:00	2018-09-25 14:53:00+00:00 	FT310	NONCARDIOVASCULAR MEDICATIONS: MEDICATIONS FOR MEMORY LOSS OR DEMENTIA (TACRINE, DONEPAZIL)
74	Medication/supplement use	7350	phv00007350.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:53:09+00:00	2018-09-25 14:53:09+00:00 	FT311	NONCARDIOVASCULAR MEDICATIONS: ANTICONVULSANTS (DILANTIN, PHENOBARBITAL, TEGRETOL, MYSOLINE, ETC.)
74	Medication/supplement use	7351	phv00007351.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:53:16+00:00	2018-09-25 14:53:16+00:00 	FT312	NONCARDIOVASCULAR MEDICATIONS: BRONCHODILATORS AND AEROSOLS
74	Medication/supplement use	7352	phv00007352.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:53:24+00:00	2018-09-25 14:53:24+00:00 	FT313	NONCARDIOVASCULAR MEDICATIONS: OSTEOPOROSIS MEDICATIONS
74	Medication/supplement use	7353	phv00007353.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:53:31+00:00	2018-09-25 14:53:31+00:00 	FT314	OSTEOPOROSIS MEDICATIONS: BISPHOSPHORATES (ALENDRONATE, (FOSAMAX), ETIDRONATE)
74	Medication/supplement use	7354	phv00007354.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:53:39+00:00	2018-09-25 14:53:39+00:00 	FT315	OSTEOPOROSIS MEDICATIONS: CALCITONIN
74	Medication/supplement use	7355	phv00007355.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:53:47+00:00	2018-09-25 14:53:47+00:00 	FT316	OSTEOPOROSIS MEDICATIONS: SERMS, EVISTA (RALOXIFENE)
74	Medication/supplement use	7356	phv00007356.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:53:55+00:00	2018-09-25 14:53:55+00:00 	FT317	OSTEOPOROSIS MEDICATIONS: OTHER
74	Medication/supplement use	7357	phv00007357.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:54:04+00:00	2018-09-25 14:54:04+00:00 	FT318	NONCARDIOVASCULAR MEDICATIONS: OTHERS (INCLUDING VITAMINS)
74	Medication/supplement use	7362	phv00007362.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:54:28+00:00	2018-09-25 14:54:28+00:00 	FT323	FEMALE HORMONE REPLACEMENT: ESTROGEN REPLACEMENT IN INTERIM (E.G. PREMARIN)
74	Medication/supplement use	7363	phv00007363.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:54:42+00:00	2018-09-25 14:54:42+00:00 	FT324	FEMALE HORMONE REPLACEMENT: DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS, OR OTHER ORAL ESTROGEN
74	Medication/supplement use	7364	phv00007364.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:54:55+00:00	2018-09-25 14:54:55+00:00 	FT325	FEMALE HORMONE REPLACEMENT: PATCH DOSE OF ESTROGEN
74	Medication/supplement use	7365	phv00007365.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:55:04+00:00	2018-09-25 14:55:04+00:00 	FT326	FEMALE HORMONE REPLACEMENT: NUMBER OF DAYS A MONTH TAKING ESTROGENS
74	Medication/supplement use	7366	phv00007366.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:56:34+00:00	2018-09-25 14:56:34+00:00 	FT327	FEMALE HORMONE REPLACEMENT: ESTROGEN CREAM USE IN INTERIM
74	Medication/supplement use	7367	phv00007367.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:56:44+00:00	2018-09-25 14:56:44+00:00 	FT328	FEMALE HORMONE REPLACEMENT: PROGESTIN REPLACEMENT IN INTERIM (E.G. PROVERA)
74	Medication/supplement use	7368	phv00007368.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:56:52+00:00	2018-09-25 14:56:52+00:00 	FT329	FEMALE HORMONE REPLACEMENT: DOSE/DAY OF PROGESTIN
74	Medication/supplement use	7369	phv00007369.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:57:00+00:00	2018-09-25 14:57:00+00:00 	FT330	FEMALE HORMONE REPLACEMENT: NUMBER OF DAYS A MONTH TAKING PROGESTINS
74	Medication/supplement use	7532	phv00007532.v1.p10	pht000029.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 14:57:52+00:00	2018-09-25 14:57:52+00:00 	FT539	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	70370	phv00070370.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:08:05+00:00	2018-09-25 15:08:05+00:00 	FU009	HYPERTENSION: SINCE YOUR LAST EXAM HAVE YOU TAKEN MEDICATION FOR THE TREATMENT OF HYPERTENSION? (HIGH BLOOD PRESSURE)
74	Medication/supplement use	70371	phv00070371.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:08:16+00:00	2018-09-25 15:08:16+00:00 	FU010	ASPIRIN: TAKE ASPIRIN REGULARLY?
74	Medication/supplement use	70372	phv00070372.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:08:24+00:00	2018-09-25 15:08:24+00:00 	FU011	ASPIRIN: NUMBER ASPIRINS TAKEN REGULARLY
74	Medication/supplement use	70373	phv00070373.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:08:32+00:00	2018-09-25 15:08:32+00:00 	FU012	ASPIRIN: ASPIRIN FREQUENCY - NUMBER TAKEN REGULARLY
74	Medication/supplement use	70374	phv00070374.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:08:42+00:00	2018-09-25 15:08:42+00:00 	FU013	ASPIRIN: USUAL ASPIRIN DOSE FOR ABOVE
74	Medication/supplement use	70379	phv00070379.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:09:01+00:00	2018-09-25 15:09:01+00:00 	FU023	FEMALE HORMONE REPLACEMENT: ESTROGEN USE SINCE YOUR LAST EXAM?
74	Medication/supplement use	70380	phv00070380.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:09:12+00:00	2018-09-25 15:09:12+00:00 	FU024	FEMALE HORMONE REPLACEMENT: NAME OF MOST RECENT ESTROGEN PREPARATION - CHARACTER VARIABLE; (BLANK) = UNKNOWN, OR NO ESTROGEN PREPARATION USE (197)
74	Medication/supplement use	70381	phv00070381.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:09:19+00:00	2018-09-25 15:09:19+00:00 	FU025	FEMALE HORMONE REPLACEMENT: ESTROGEN PREPARATION: STRENGTH CHARACTER VARIABLE; (BLANK) = UNKNOWN, OR NO ESTROGEN PREPARATION USE (199)
74	Medication/supplement use	70382	phv00070382.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:09:26+00:00	2018-09-25 15:09:26+00:00 	FU026	FEMALE HORMONE REPLACEMENT: ESTROGEN PREPARATION: NUMBER OF DAYS PER MONTH TAKEN
74	Medication/supplement use	70383	phv00070383.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:09:33+00:00	2018-09-25 15:09:33+00:00 	FU027	FEMALE HORMONE REPLACEMENT: ESTROGEN CREAM USE SINCE LAST EXAM
74	Medication/supplement use	70384	phv00070384.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:09:40+00:00	2018-09-25 15:09:40+00:00 	FU028	FEMALE HORMONE REPLACEMENT: PROGESTERONE USE SINCE YOUR LAST EXAM?
74	Medication/supplement use	70385	phv00070385.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:09:47+00:00	2018-09-25 15:09:47+00:00 	FU029	FEMALE HORMONE REPLACEMENT: NAME OF MOST RECENT PROGESTERONE PREPARATION - CHARACTER VARIABLE; (BLANK) = UNKNOWN, OR NO PROGESTERONE PREPARATION USE (207)
74	Medication/supplement use	70386	phv00070386.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:09:54+00:00	2018-09-25 15:09:54+00:00 	FU030	FEMALE HORMONE REPLACEMENT: PROGESERONE PREPARATION: STRENGTH CHARACTER VARIABLE; (BLANK) = UNKNOWN, OR NO PROGESTERONE PREPARATION USE (207)
74	Medication/supplement use	70387	phv00070387.v1.p10	pht000692.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:10:02+00:00	2018-09-25 15:10:02+00:00 	FU031	FEMALE HORMONE REPLACEMENT: PROGESTERONE PREPARATION: NUMBER OF DAYS PER MONTH TAKEN
74	Medication/supplement use	597	phv00000597.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 15:34:30+00:00	2018-09-25 15:34:30+00:00 	MF129	INTERIM HISTORY OF DRUGS TAKEN: DIGITALIS, EXAM 2
74	Medication/supplement use	598	phv00000598.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:49:04+00:00	2018-09-25 17:49:04+00:00 	MF130	INTERIM HISTORY OF DRUGS TAKEN: HORMONES, EXAM 2
74	Medication/supplement use	496	phv00000496.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:49:30+00:00	2018-09-25 17:49:30+00:00 	MF22	HISTORY OF DRUGS TAKEN: DIGITALIS OR NITRITES, EXAM 1
74	Medication/supplement use	704	phv00000704.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:49:49+00:00	2018-09-25 17:49:49+00:00 	MF249	INTERIM HISTORY OF DRUGS TAKEN: DIGITALIS, EXAM 4
74	Medication/supplement use	705	phv00000705.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:50:00+00:00	2018-09-25 17:50:00+00:00 	MF250	INTERIM HISTORY OF DRUGS TAKEN: HYPOTENSIVES, EXAM 4
74	Medication/supplement use	778	phv00000778.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:50:19+00:00	2018-09-25 17:50:19+00:00 	MF328	LIFETIME HISTORY OF HORMONE THERAPY, EXAM 5
74	Medication/supplement use	866	phv00000866.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:50:40+00:00	2018-09-25 17:50:40+00:00 	MF417	INTERIM HISTORY OF DRUGS TAKEN: HYPOTENSIVE, EXAM 6
74	Medication/supplement use	951	phv00000951.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:51:00+00:00	2018-09-25 17:51:00+00:00 	MF509	INTERIM HISTORY OF DRUGS TAKEN: DIGITALIS, EXAM 7
74	Medication/supplement use	953	phv00000953.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:51:11+00:00	2018-09-25 17:51:11+00:00 	MF511	INTERIM HISTORY OF DRUGS TAKEN: HYPOTENSIVE, EXAM 7
74	Medication/supplement use	954	phv00000954.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:51:37+00:00	2018-09-25 17:51:37+00:00 	MF512	INTERIM HISTORY OF DRUGS TAKEN: HYPOCHOLESTEROL, EXAM 7
74	Medication/supplement use	958	phv00000958.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:51:57+00:00	2018-09-25 17:51:57+00:00 	MF516	INTERIM HISTORY OF DIET FOLLOWED: HYPOCHOLESTEROL, EXAM 7
74	Medication/supplement use	965	phv00000965.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:52:11+00:00	2018-09-25 17:52:11+00:00 	MF523	LIFETIME HISTORY OF DIABETES: TREATMENT OF DIABETES, EXAM 7
74	Medication/supplement use	975	phv00000975.v1.p10	pht000009.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:52:28+00:00	2018-09-25 17:52:28+00:00 	MF535	LIFETIME HISTORY OF MENOPAUSE: HORMONE THERAPY, EXAM 7
74	Medication/supplement use	1127	phv00001127.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:55:59+00:00	2018-09-25 17:55:59+00:00 	FA116	MEDICINE TAKEN DURING INTERIM:  DIGITALIS
74	Medication/supplement use	1128	phv00001128.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:56:12+00:00	2018-09-25 17:56:12+00:00 	FA117	MEDICINE TAKEN DURING INTERIM:  NITRITES
74	Medication/supplement use	1129	phv00001129.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:56:19+00:00	2018-09-25 17:56:19+00:00 	FA118	MEDICINE TAKEN DURING INTERIM:  QUINIDINE
74	Medication/supplement use	1130	phv00001130.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:56:26+00:00	2018-09-25 17:56:26+00:00 	FA119	MEDICINE TAKEN DURING INTERIM:  DIURETIC
74	Medication/supplement use	1131	phv00001131.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:56:38+00:00	2018-09-25 17:56:38+00:00 	FA120	MEDICINE TAKEN DURING INTERIM:  HYPOTENSIVE
74	Medication/supplement use	1132	phv00001132.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:56:45+00:00	2018-09-25 17:56:45+00:00 	FA121	MEDICINE TAKEN DURING INTERIM:  HYPOCHOLESTEROL
74	Medication/supplement use	1133	phv00001133.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:56:52+00:00	2018-09-25 17:56:52+00:00 	FA122	MEDICINE TAKEN DURING INTERIM:  ANTICOAGULANT
74	Medication/supplement use	1134	phv00001134.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:56:59+00:00	2018-09-25 17:56:59+00:00 	FA123	MEDICINE TAKEN DURING INTERIM:  THYROID
74	Medication/supplement use	1135	phv00001135.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:57:07+00:00	2018-09-25 17:57:07+00:00 	FA124	MEDICINE TAKEN DURING INTERIM:  ANTIBACTERIAL
74	Medication/supplement use	1141	phv00001141.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:57:26+00:00	2018-09-25 17:57:26+00:00 	FA135	MENOPAUSE:  HORMONE THERAPY, PRESENT USE
74	Medication/supplement use	1142	phv00001142.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:57:34+00:00	2018-09-25 17:57:34+00:00 	FA136	MENOPAUSE:  HORMONE THERAPY, PAST USE
74	Medication/supplement use	1183	phv00001183.v1.p10	pht000010.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:57:57+00:00	2018-09-25 17:57:57+00:00 	FA188	FDI:  STATUS & TREATMENT OF BLOOD PRESSURE DURING INTERIM BEFORE EXAM 8
74	Medication/supplement use	1344	phv00001344.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:59:06+00:00	2018-09-25 17:59:06+00:00 	FB196	ECG:  TAKING DIGITALIS OR QUINIDINE
74	Medication/supplement use	1346	phv00001346.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:59:20+00:00	2018-09-25 17:59:20+00:00 	FB221	CLINICAL DIAGNOSTIC IMPRESSION:  UNDER TREATMENT FOR HYPERTENSION
74	Medication/supplement use	1242	phv00001242.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:59:40+00:00	2018-09-25 17:59:40+00:00 	FB65	INTERIM HISTORY OF MEDICINE:  DIGITALIS
74	Medication/supplement use	1243	phv00001243.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:59:48+00:00	2018-09-25 17:59:48+00:00 	FB66	INTERIM HISTORY OF MEDICINE:  NITRITES
74	Medication/supplement use	1244	phv00001244.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 17:59:55+00:00	2018-09-25 17:59:55+00:00 	FB67	INTERIM HISTORY OF MEDICINE:  QUINIDINE (OR PROCAINAMIDE)
74	Medication/supplement use	1245	phv00001245.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:00:03+00:00	2018-09-25 18:00:03+00:00 	FB68	INTERIM HISTORY OF MEDICINE:  DIURETICS
74	Medication/supplement use	1246	phv00001246.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:00:12+00:00	2018-09-25 18:00:12+00:00 	FB69	INTERIM HISTORY OF MEDICINE:  HYPOTENSIVES
74	Medication/supplement use	1247	phv00001247.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:00:20+00:00	2018-09-25 18:00:20+00:00 	FB70	INTERIM HISTORY OF MEDICINE:  HYPOCHOLESTEROL
74	Medication/supplement use	1248	phv00001248.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:00:30+00:00	2018-09-25 18:00:30+00:00 	FB71	INTERIM HISTORY OF MEDICINE:  THYROID
74	Medication/supplement use	1249	phv00001249.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:00:38+00:00	2018-09-25 18:00:38+00:00 	FB72	INTERIM HISTORY OF MEDICINE:  ANTITHYROID
74	Medication/supplement use	1250	phv00001250.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:00:49+00:00	2018-09-25 18:00:49+00:00 	FB73	INTERIM HISTORY OF MEDICINE:  ANTICOAGULANTS
74	Medication/supplement use	1251	phv00001251.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:00:57+00:00	2018-09-25 18:00:57+00:00 	FB74	INTERIM HISTORY OF MEDICINE:  ANTIBACTERIAL
74	Medication/supplement use	1252	phv00001252.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:01:05+00:00	2018-09-25 18:01:05+00:00 	FB75	INTERIM HISTORY OF MEDICINE:  TRANQUILIZERS
74	Medication/supplement use	1253	phv00001253.v1.p10	pht000011.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:01:20+00:00	2018-09-25 18:01:20+00:00 	FB80	INTERIM HISTORY OF MENOPAUSE:  HORMONE THERAPY
74	Medication/supplement use	7664	phv00007664.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:02:53+00:00	2018-09-25 18:02:53+00:00 	A162	TAKING DIGITALIS OR QUINIDINE
74	Medication/supplement use	7587	phv00007587.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:03:16+00:00	2018-09-25 18:03:16+00:00 	A74	CARDIAC GLYCOSIDES
74	Medication/supplement use	7588	phv00007588.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:03:24+00:00	2018-09-25 18:03:24+00:00 	A75	NITRITES
74	Medication/supplement use	7589	phv00007589.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:03:31+00:00	2018-09-25 18:03:31+00:00 	A76	QUINIDINE
74	Medication/supplement use	7590	phv00007590.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:03:39+00:00	2018-09-25 18:03:39+00:00 	A77	DIURETICS  FOR FLUID RETENTION
74	Medication/supplement use	7591	phv00007591.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:03:46+00:00	2018-09-25 18:03:46+00:00 	A78	DIURETICS FOR BLOOD PRESSURE
74	Medication/supplement use	7592	phv00007592.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:03:53+00:00	2018-09-25 18:03:53+00:00 	A79	HYPOTENSIVES (EXCLUDING DIURETICS)
74	Medication/supplement use	7593	phv00007593.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:04:07+00:00	2018-09-25 18:04:07+00:00 	A80	ANTI-CHOLESTEROL AGENTS
74	Medication/supplement use	7594	phv00007594.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:04:14+00:00	2018-09-25 18:04:14+00:00 	A81	THYROID
74	Medication/supplement use	7595	phv00007595.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:04:21+00:00	2018-09-25 18:04:21+00:00 	A82	ANTI-THYROID
74	Medication/supplement use	7596	phv00007596.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:04:29+00:00	2018-09-25 18:04:29+00:00 	A83	ANTI-COAGULANTS
74	Medication/supplement use	7597	phv00007597.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:04:37+00:00	2018-09-25 18:04:37+00:00 	A84	HYPOGLYCEMIC AGENTS (SPECIFY)
74	Medication/supplement use	7598	phv00007598.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:04:46+00:00	2018-09-25 18:04:46+00:00 	A85	TRANQUILIZERS
74	Medication/supplement use	7599	phv00007599.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:04:57+00:00	2018-09-25 18:04:57+00:00 	A86	BRONCHODILATOR OR AEROSOL
74	Medication/supplement use	7600	phv00007600.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:05:05+00:00	2018-09-25 18:05:05+00:00 	A87	OTHER (C-V DRUGS)
74	Medication/supplement use	7606	phv00007606.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:05:21+00:00	2018-09-25 18:05:21+00:00 	A93	ORAL CONTRACEPTIVE
74	Medication/supplement use	7607	phv00007607.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:05:30+00:00	2018-09-25 18:05:30+00:00 	A94	PREMARIN
74	Medication/supplement use	7608	phv00007608.v5.p10	pht000030.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:05:42+00:00	2018-09-25 18:05:42+00:00 	A95	OTHER (SPECIFY)
74	Medication/supplement use	7927	phv00007927.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:07:56+00:00	2018-09-25 18:07:56+00:00 	B295	TREATMENT FOR HYPERTENSION
74	Medication/supplement use	7985	phv00007985.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:08:29+00:00	2018-09-25 18:08:29+00:00 	B367	BLOOD ANALYSIS-FASTING LIPIDS: CREAM AFTER 12 HRS. OR MORE
74	Medication/supplement use	7992	phv00007992.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:08:45+00:00	2018-09-25 18:08:45+00:00 	B374	CURRENTLY TAKING MEDICATION FOR HYPERTENSION
74	Medication/supplement use	7702	phv00007702.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:09:13+00:00	2018-09-25 18:09:13+00:00 	B52	CARDIAC GLYCOSIDES
74	Medication/supplement use	7703	phv00007703.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:09:26+00:00	2018-09-25 18:09:26+00:00 	B53	NITRITES
74	Medication/supplement use	7704	phv00007704.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:09:52+00:00	2018-09-25 18:09:52+00:00 	B54	PROPRANOLOL
74	Medication/supplement use	7705	phv00007705.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:10:05+00:00	2018-09-25 18:10:05+00:00 	B55	QUINIDINE
74	Medication/supplement use	7706	phv00007706.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:10:19+00:00	2018-09-25 18:10:19+00:00 	B56	HYPOTENSIVE (EXCLUDING DIURETICS)
74	Medication/supplement use	7707	phv00007707.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:10:40+00:00	2018-09-25 18:10:40+00:00 	B57	ALDOMET
74	Medication/supplement use	7708	phv00007708.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:10:51+00:00	2018-09-25 18:10:51+00:00 	B58	SPIRONOLACTONE
74	Medication/supplement use	7709	phv00007709.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:11:03+00:00	2018-09-25 18:11:03+00:00 	B59	DIURETICS-HYPERTENSION
74	Medication/supplement use	7710	phv00007710.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:11:16+00:00	2018-09-25 18:11:16+00:00 	B60	DIURETICS-OTHER
74	Medication/supplement use	7711	phv00007711.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:11:29+00:00	2018-09-25 18:11:29+00:00 	B61	ANTI-CHOLESTEROL AGENT
74	Medication/supplement use	7712	phv00007712.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:11:50+00:00	2018-09-25 18:11:50+00:00 	B62	THYROID
74	Medication/supplement use	7713	phv00007713.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:11:58+00:00	2018-09-25 18:11:58+00:00 	B63	ANTI-COAGULANTS
74	Medication/supplement use	7714	phv00007714.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:12:08+00:00	2018-09-25 18:12:08+00:00 	B64	BRONCHODILATOR OR AEROSOL
74	Medication/supplement use	7715	phv00007715.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:12:18+00:00	2018-09-25 18:12:18+00:00 	B65	ORAL HYPOGLYCEMIC AGENTS
74	Medication/supplement use	7716	phv00007716.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:13:20+00:00	2018-09-25 18:13:20+00:00 	B66	SLEEPING PILLS
74	Medication/supplement use	7717	phv00007717.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:13:31+00:00	2018-09-25 18:13:31+00:00 	B67	TRANQUILIZERS
74	Medication/supplement use	7718	phv00007718.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:13:43+00:00	2018-09-25 18:13:43+00:00 	B68	INSULIN
74	Medication/supplement use	7719	phv00007719.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:13:57+00:00	2018-09-25 18:13:57+00:00 	B69	ASPIRIN TABS/DAY
74	Medication/supplement use	7728	phv00007728.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:14:31+00:00	2018-09-25 18:14:31+00:00 	B78	MENOPAUSE: ORAL CONTRACEPTIVE
74	Medication/supplement use	7729	phv00007729.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:14:39+00:00	2018-09-25 18:14:39+00:00 	B79	MENOPAUSE: CODE # OF BRAND & DOSAGE
74	Medication/supplement use	7730	phv00007730.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:14:52+00:00	2018-09-25 18:14:52+00:00 	B80	MENOPAUSE: TOTAL # OF YEARS OC MEDICATION TAKEN
74	Medication/supplement use	7731	phv00007731.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:15:00+00:00	2018-09-25 18:15:00+00:00 	B81	MENOPAUSE: EVER TAKEN PREMARIN
74	Medication/supplement use	7732	phv00007732.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:15:10+00:00	2018-09-25 18:15:10+00:00 	B82	MENOPAUSE: TOTAL # OF YEARS PREMARIN TAKEN
74	Medication/supplement use	7733	phv00007733.v5.p10	pht000031.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:15:23+00:00	2018-09-25 18:15:23+00:00 	B83	NO. OF PILLS TAKEN PER MONTH
74	Medication/supplement use	8385	phv00008385.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:17:35+00:00	2018-09-25 18:17:35+00:00 	C10	LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.)
74	Medication/supplement use	8386	phv00008386.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:17:43+00:00	2018-09-25 18:17:43+00:00 	C11	CALCIUM CHANNEL BLOCKERS
74	Medication/supplement use	8387	phv00008387.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:18:09+00:00	2018-09-25 18:18:09+00:00 	C12	BETA BLOCKERS
74	Medication/supplement use	8388	phv00008388.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:18:21+00:00	2018-09-25 18:18:21+00:00 	C13	ANTI-ARRHYTHMICS (QUINIDINE, PROCAINE, NORPACE, ETC.)
74	Medication/supplement use	8389	phv00008389.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:18:30+00:00	2018-09-25 18:18:30+00:00 	C14	PERIPHERAL VASODILATORS (HYDRALZINE, MINIPRES, MONOXIDIL, ETC.)
74	Medication/supplement use	8390	phv00008390.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:18:44+00:00	2018-09-25 18:18:44+00:00 	C15	ANTI-PLATELET DRUGS (ANTURANE, PERSANTINE, ETC.)
74	Medication/supplement use	8391	phv00008391.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:18:57+00:00	2018-09-25 18:18:57+00:00 	C16	OTHER ANTI-HYPERTENSIVE DRUGS
74	Medication/supplement use	8392	phv00008392.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:19:18+00:00	2018-09-25 18:19:18+00:00 	C17	DIURETICS (THIAZIDES, LASIX, ETC.)
74	Medication/supplement use	8393	phv00008393.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:19:31+00:00	2018-09-25 18:19:31+00:00 	C18	OTHER CARDIAC MEDICATION
74	Medication/supplement use	8394	phv00008394.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:19:42+00:00	2018-09-25 18:19:42+00:00 	C19	POTASSIUM SPARING DIURETICS (ALDACTONE, TRIAMTERENE)
74	Medication/supplement use	8395	phv00008395.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:19:52+00:00	2018-09-25 18:19:52+00:00 	C20	RESERPINE DERIVATIVES
74	Medication/supplement use	8396	phv00008396.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:20:09+00:00	2018-09-25 18:20:09+00:00 	C21	METHYLDOPA (ALDOMET)
74	Medication/supplement use	8397	phv00008397.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:20:26+00:00	2018-09-25 18:20:26+00:00 	C22	CLONIDINE (CATAPRES)
74	Medication/supplement use	8398	phv00008398.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:20:33+00:00	2018-09-25 18:20:33+00:00 	C23	WYTENSIN
74	Medication/supplement use	8399	phv00008399.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:20:45+00:00	2018-09-25 18:20:45+00:00 	C24	GANGLIONIC BLOCKERS
74	Medication/supplement use	8400	phv00008400.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:21:03+00:00	2018-09-25 18:21:03+00:00 	C25	RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL)
74	Medication/supplement use	8401	phv00008401.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:21:17+00:00	2018-09-25 18:21:17+00:00 	C26	ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.)
74	Medication/supplement use	8402	phv00008402.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:21:39+00:00	2018-09-25 18:21:39+00:00 	C27	ANTIGOUT
74	Medication/supplement use	8403	phv00008403.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:21:52+00:00	2018-09-25 18:21:52+00:00 	C28	THYROID
74	Medication/supplement use	8404	phv00008404.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:22:02+00:00	2018-09-25 18:22:02+00:00 	C29	INSULIN
74	Medication/supplement use	8405	phv00008405.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:22:25+00:00	2018-09-25 18:22:25+00:00 	C30	ORAL HYPOGLYCEMICS
74	Medication/supplement use	8406	phv00008406.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:22:48+00:00	2018-09-25 18:22:48+00:00 	C31	ESTROGEN
74	Medication/supplement use	8407	phv00008407.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:22:56+00:00	2018-09-25 18:22:56+00:00 	C32	STEROIDS
74	Medication/supplement use	8408	phv00008408.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:23:06+00:00	2018-09-25 18:23:06+00:00 	C33	NON-STEROIDAL ANTI-INFLAMMATORY (MOTRIN, IBUPROFEN ETC.)
74	Medication/supplement use	8409	phv00008409.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:23:28+00:00	2018-09-25 18:23:28+00:00 	C34	ANALGESIC-NARCOTIC (DEMEROL, CODEINE, DILAUDID ETC.)
74	Medication/supplement use	8410	phv00008410.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:23:37+00:00	2018-09-25 18:23:37+00:00 	C35	ANALGESIC-NON-NARCOTIC (ACETAMINOPHEN ETC.)
74	Medication/supplement use	8411	phv00008411.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:23:49+00:00	2018-09-25 18:23:49+00:00 	C36	BRONCHODILATORS, AEROSOLS,ETC
74	Medication/supplement use	8412	phv00008412.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:24:04+00:00	2018-09-25 18:24:04+00:00 	C37	ANTIHISTAMINES
74	Medication/supplement use	8413	phv00008413.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:24:38+00:00	2018-09-25 18:24:38+00:00 	C38	ANTI-ACID MEDICATIONS
74	Medication/supplement use	8414	phv00008414.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:24:51+00:00	2018-09-25 18:24:51+00:00 	C39	ANTIULCER (TAGAMET, PROBANTHINE, H-ION INHIBITORS)
74	Medication/supplement use	8415	phv00008415.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:25:19+00:00	2018-09-25 18:25:19+00:00 	C40	ANTI-ANXIETY, SEDATIVE/HYPNOTICS ETC. (LIBRIUM, VALIUM ETC.)
74	Medication/supplement use	8416	phv00008416.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:25:37+00:00	2018-09-25 18:25:37+00:00 	C41	SLEEPING PILLS
74	Medication/supplement use	8417	phv00008417.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:25:54+00:00	2018-09-25 18:25:54+00:00 	C42	ANTI-DEPRESSANTS
74	Medication/supplement use	8418	phv00008418.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:26:13+00:00	2018-09-25 18:26:13+00:00 	C43	EYEDROPS
74	Medication/supplement use	8419	phv00008419.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:26:26+00:00	2018-09-25 18:26:26+00:00 	C44	POTASSIUM SUPPLEMENT
74	Medication/supplement use	8420	phv00008420.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:26:49+00:00	2018-09-25 18:26:49+00:00 	C45	ANTIBIOTICS
74	Medication/supplement use	8734	phv00008734.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:27:26+00:00	2018-09-25 18:27:26+00:00 	C450	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	8421	phv00008421.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:27:40+00:00	2018-09-25 18:27:40+00:00 	C46	OTHERS (SPECIFY BELOW)
74	Medication/supplement use	8429	phv00008429.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:27:53+00:00	2018-09-25 18:27:53+00:00 	C54	MENOPAUSE: ORAL CONTRACEPTIVES IN INTERIM
74	Medication/supplement use	8430	phv00008430.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:28:15+00:00	2018-09-25 18:28:15+00:00 	C55	MENOPAUSE: PREMARIN USE IN INTERIM
74	Medication/supplement use	8431	phv00008431.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:28:30+00:00	2018-09-25 18:28:30+00:00 	C56	MENOPAUSE: NUMBER OF PREMARIN PILLS (0.625 MG) TAKEN PER MONTH
74	Medication/supplement use	8382	phv00008382.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:28:47+00:00	2018-09-25 18:28:47+00:00 	C7	# OF ASPIRINS PER WEEK
74	Medication/supplement use	8383	phv00008383.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:29:00+00:00	2018-09-25 18:29:00+00:00 	C8	CARDIAC GLYCOSIDES
74	Medication/supplement use	8384	phv00008384.v5.p10	pht000032.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:29:22+00:00	2018-09-25 18:29:22+00:00 	C9	NITROGLYCERIN
74	Medication/supplement use	8778	phv00008778.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:34:50+00:00	2018-09-25 18:34:50+00:00 	D008	NUMBER OF ASPIRIN PER WEEK
74	Medication/supplement use	8779	phv00008779.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:35:11+00:00	2018-09-25 18:35:11+00:00 	D009	ANY CARDIOVASCULAR MEDICATIONS?
74	Medication/supplement use	8780	phv00008780.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:35:19+00:00	2018-09-25 18:35:19+00:00 	D010	CARDIAC GLYCOSIDES
74	Medication/supplement use	8781	phv00008781.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:35:26+00:00	2018-09-25 18:35:26+00:00 	D011	NITROGLYCERINE
74	Medication/supplement use	8782	phv00008782.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:35:33+00:00	2018-09-25 18:35:33+00:00 	D012	LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.)
74	Medication/supplement use	8783	phv00008783.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:35:40+00:00	2018-09-25 18:35:40+00:00 	D013	CALCIUM CHANNEL BLOCKERS
74	Medication/supplement use	8784	phv00008784.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:35:47+00:00	2018-09-25 18:35:47+00:00 	D014	BETA BLOCKERS
74	Medication/supplement use	8785	phv00008785.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:35:55+00:00	2018-09-25 18:35:55+00:00 	D015	ANTIARRHYTHMICS (QUINIDINE, PROCAINE, NORPACE, ETC.)
74	Medication/supplement use	8786	phv00008786.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:36:05+00:00	2018-09-25 18:36:05+00:00 	D016	ANTIPLATELET (ANTURANE, PERSANTINE, ETC.)
74	Medication/supplement use	8787	phv00008787.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:36:12+00:00	2018-09-25 18:36:12+00:00 	D017	ANTICOAGULANTS (COUMADIN, ETC.)
74	Medication/supplement use	8788	phv00008788.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:36:19+00:00	2018-09-25 18:36:19+00:00 	D018	THIAZIDE DIURETICS
74	Medication/supplement use	8789	phv00008789.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:36:26+00:00	2018-09-25 18:36:26+00:00 	D019	LOOP DIURETICS (LASIX, ETC.)
74	Medication/supplement use	8790	phv00008790.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:36:33+00:00	2018-09-25 18:36:33+00:00 	D020	K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE)
74	Medication/supplement use	8791	phv00008791.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:36:42+00:00	2018-09-25 18:36:42+00:00 	D021	RESERPINE DERIVATIVES
74	Medication/supplement use	8792	phv00008792.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:36:49+00:00	2018-09-25 18:36:49+00:00 	D022	METHYLDOPA (ALDOMET)
74	Medication/supplement use	8793	phv00008793.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:36:56+00:00	2018-09-25 18:36:56+00:00 	D023	CLONIDINE (CATAPRES)
74	Medication/supplement use	8794	phv00008794.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:37:05+00:00	2018-09-25 18:37:05+00:00 	D024	WYTENSIN
74	Medication/supplement use	8795	phv00008795.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:37:13+00:00	2018-09-25 18:37:13+00:00 	D025	GANGLIONIC BLOCKERS
74	Medication/supplement use	8796	phv00008796.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:37:21+00:00	2018-09-25 18:37:21+00:00 	D026	RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL)
74	Medication/supplement use	8797	phv00008797.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:37:30+00:00	2018-09-25 18:37:30+00:00 	D027	PERIPHERAL VASODILATORS (HYDRALAZINE, MINIPRES, MINOXIDIL, ETC.)
74	Medication/supplement use	8798	phv00008798.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:37:37+00:00	2018-09-25 18:37:37+00:00 	D028	OTHER ANTI-HYPERTENSIVES
74	Medication/supplement use	8799	phv00008799.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:37:44+00:00	2018-09-25 18:37:44+00:00 	D029	OTHER CARDIAC MEDICATION
74	Medication/supplement use	8800	phv00008800.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:37:52+00:00	2018-09-25 18:37:52+00:00 	D030	ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.)
74	Medication/supplement use	8801	phv00008801.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:38:02+00:00	2018-09-25 18:38:02+00:00 	D031	ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.)
74	Medication/supplement use	8802	phv00008802.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:38:09+00:00	2018-09-25 18:38:09+00:00 	D032	ANTIGOUT (COLCHICINE)
74	Medication/supplement use	8803	phv00008803.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:38:16+00:00	2018-09-25 18:38:16+00:00 	D033	THYROID EXTRACT (DESSICATED THYROID)
74	Medication/supplement use	8804	phv00008804.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:38:25+00:00	2018-09-25 18:38:25+00:00 	D034	THYROXINE (SYNTHROID ETC.)
74	Medication/supplement use	8805	phv00008805.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:38:31+00:00	2018-09-25 18:38:31+00:00 	D035	INSULIN
74	Medication/supplement use	8744	phv00008744.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:38:42+00:00	2018-09-25 18:38:42+00:00 	D036	TOTAL UNITS OF INSULIN PER DAY
74	Medication/supplement use	8806	phv00008806.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:38:50+00:00	2018-09-25 18:38:50+00:00 	D037	ORAL HYPOGLYCEMICS
74	Medication/supplement use	8807	phv00008807.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:38:57+00:00	2018-09-25 18:38:57+00:00 	D038	ORAL ESTROGEN
74	Medication/supplement use	8808	phv00008808.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:39:06+00:00	2018-09-25 18:39:06+00:00 	D039	ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.)
74	Medication/supplement use	8809	phv00008809.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:39:13+00:00	2018-09-25 18:39:13+00:00 	D040	NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL)
74	Medication/supplement use	8810	phv00008810.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:39:35+00:00	2018-09-25 18:39:35+00:00 	D041	ANALGESIC - NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.)
74	Medication/supplement use	8811	phv00008811.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:39:44+00:00	2018-09-25 18:39:44+00:00 	D042	ANALGESIC - NON-NARCOTICS (ACETAMINOPHEN, ETC.)
74	Medication/supplement use	8812	phv00008812.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:39:51+00:00	2018-09-25 18:39:51+00:00 	D043	BRONCHODILATORS, AEROSOLS, ETC.
74	Medication/supplement use	8813	phv00008813.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:40:00+00:00	2018-09-25 18:40:00+00:00 	D044	ANTIHISTAMINES
74	Medication/supplement use	8814	phv00008814.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:40:07+00:00	2018-09-25 18:40:07+00:00 	D045	ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H-ION INHIBITORS)
74	Medication/supplement use	8815	phv00008815.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:40:15+00:00	2018-09-25 18:40:15+00:00 	D046	ANTI-ANXIETY, SEDATIVE/HYPNOTICS, ETC (LIBRIUM, VALIUM, ETC.)
74	Medication/supplement use	8816	phv00008816.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:40:22+00:00	2018-09-25 18:40:22+00:00 	D047	SLEEPING PILLS
74	Medication/supplement use	8817	phv00008817.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:40:31+00:00	2018-09-25 18:40:31+00:00 	D048	ANTI-DEPRESSANTS
74	Medication/supplement use	8818	phv00008818.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:40:38+00:00	2018-09-25 18:40:38+00:00 	D049	EYE DROPS
74	Medication/supplement use	8819	phv00008819.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:40:46+00:00	2018-09-25 18:40:46+00:00 	D050	POTASSIUM SUPPLEMENTS
74	Medication/supplement use	8820	phv00008820.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:40:55+00:00	2018-09-25 18:40:55+00:00 	D051	ANTIBIOTICS
74	Medication/supplement use	8821	phv00008821.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:41:05+00:00	2018-09-25 18:41:05+00:00 	D052	OTHER DRUG
74	Medication/supplement use	8829	phv00008829.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:41:21+00:00	2018-09-25 18:41:21+00:00 	D060	ORAL CONTRACEPTIVES IN INTERIM
74	Medication/supplement use	8830	phv00008830.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:41:30+00:00	2018-09-25 18:41:30+00:00 	D061	CONJUGATED ESTROGEN USED IN INTERIM (E.G. PREMARIN)
74	Medication/supplement use	8831	phv00008831.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:41:38+00:00	2018-09-25 18:41:38+00:00 	D062	DOSE/DAY PREMARIN OR CONJUGATED ESTROGEN
74	Medication/supplement use	8832	phv00008832.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:41:46+00:00	2018-09-25 18:41:46+00:00 	D063	DAYS PER MONTH TAKING PREMARIN
74	Medication/supplement use	8833	phv00008833.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:41:53+00:00	2018-09-25 18:41:53+00:00 	D064	ESTROGEN CREAM USE DURING INTERIM
74	Medication/supplement use	8834	phv00008834.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:42:01+00:00	2018-09-25 18:42:01+00:00 	D065	PROGESTERONE USE DURING INTERIM
74	Medication/supplement use	9119	phv00009119.v5.p10	pht000033.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:42:53+00:00	2018-09-25 18:42:53+00:00 	D445	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	9563	phv00009563.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:45:32+00:00	2018-09-25 18:45:32+00:00 	E041	# OF DAYS SINCE LAST DOSE OF ASPIRIN
74	Medication/supplement use	9171	phv00009171.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:45:51+00:00	2018-09-25 18:45:51+00:00 	E218	NUMBER OF ASPIRINS PER TIME INTERVAL
74	Medication/supplement use	9172	phv00009172.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:46:20+00:00	2018-09-25 18:46:20+00:00 	E219	TIME INTERVAL FOR ASPIRIN TAKEN
74	Medication/supplement use	9173	phv00009173.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:46:26+00:00	2018-09-25 18:46:26+00:00 	E220	TAKING ANY CARDIOVASCULAR MEDS BELOW?
74	Medication/supplement use	9174	phv00009174.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:46:35+00:00	2018-09-25 18:46:35+00:00 	E221	CURRENTLY RECEIVING MEDICATION FOR THE TREATMENT OF HYPERTENSION
74	Medication/supplement use	9175	phv00009175.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:46:44+00:00	2018-09-25 18:46:44+00:00 	E222	CARDIAC GLYCOSIDES
74	Medication/supplement use	9176	phv00009176.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:46:51+00:00	2018-09-25 18:46:51+00:00 	E223	NITROGLYCERINE
74	Medication/supplement use	9177	phv00009177.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:46:58+00:00	2018-09-25 18:46:58+00:00 	E224	LONGER ACTING NITRATES
74	Medication/supplement use	9178	phv00009178.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:47:04+00:00	2018-09-25 18:47:04+00:00 	E225	CALCIUM CHANNEL BLOCKERS
74	Medication/supplement use	9179	phv00009179.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:47:12+00:00	2018-09-25 18:47:12+00:00 	E226	BETA BLOCKERS
74	Medication/supplement use	9180	phv00009180.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:47:18+00:00	2018-09-25 18:47:18+00:00 	E227	BETA BLOCKERS GROUP
74	Medication/supplement use	9181	phv00009181.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:47:26+00:00	2018-09-25 18:47:26+00:00 	E228	BETA BLOCKERS DOSE (MG/DAY)
74	Medication/supplement use	9182	phv00009182.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:47:34+00:00	2018-09-25 18:47:34+00:00 	E229	LOOP DIURETICS
74	Medication/supplement use	9183	phv00009183.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:47:45+00:00	2018-09-25 18:47:45+00:00 	E230	THIAZIDE/K-SPARING DIURETICS
74	Medication/supplement use	9184	phv00009184.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:47:52+00:00	2018-09-25 18:47:52+00:00 	E231	THIAZIDE DIURETICS
74	Medication/supplement use	9185	phv00009185.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:48:02+00:00	2018-09-25 18:48:02+00:00 	E232	K-SPARING DIURETICS
74	Medication/supplement use	9186	phv00009186.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:48:10+00:00	2018-09-25 18:48:10+00:00 	E233	POTASSIUM SUPPLEMENTS
74	Medication/supplement use	9187	phv00009187.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:48:20+00:00	2018-09-25 18:48:20+00:00 	E234	RESERPINE DERIVATIVES
74	Medication/supplement use	9188	phv00009188.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:48:27+00:00	2018-09-25 18:48:27+00:00 	E235	METHYLDOPA
74	Medication/supplement use	9189	phv00009189.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:48:39+00:00	2018-09-25 18:48:39+00:00 	E236	ALPHA-1 AGONIST
74	Medication/supplement use	9190	phv00009190.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:48:48+00:00	2018-09-25 18:48:48+00:00 	E237	ALPHA-2 BLOCKERS
74	Medication/supplement use	9191	phv00009191.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:48:59+00:00	2018-09-25 18:48:59+00:00 	E238	RENIN-ANGIOTENSIN BLOCKING DRUGS
74	Medication/supplement use	9192	phv00009192.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:49:07+00:00	2018-09-25 18:49:07+00:00 	E239	PERIPHERAL VASODILATORS
74	Medication/supplement use	9193	phv00009193.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:49:20+00:00	2018-09-25 18:49:20+00:00 	E240	OTHER ANTI-HYPERTENSIVES
74	Medication/supplement use	9194	phv00009194.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:49:28+00:00	2018-09-25 18:49:28+00:00 	E241	ANTIARRHYTHMICS
74	Medication/supplement use	9195	phv00009195.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:49:34+00:00	2018-09-25 18:49:34+00:00 	E242	ANTIPLATELET
74	Medication/supplement use	9196	phv00009196.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:49:41+00:00	2018-09-25 18:49:41+00:00 	E243	ANITCOAGULANTS
74	Medication/supplement use	9197	phv00009197.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:49:49+00:00	2018-09-25 18:49:49+00:00 	E244	OTHER CARDIAC MEDICATION
74	Medication/supplement use	9198	phv00009198.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:49:57+00:00	2018-09-25 18:49:57+00:00 	E245	ANTI CHOLESTEROL DRUGS-RESINS
74	Medication/supplement use	9199	phv00009199.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:50:06+00:00	2018-09-25 18:50:06+00:00 	E246	ANTI CHOLESTEROL DRUGS-NIACIN
74	Medication/supplement use	9200	phv00009200.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:50:20+00:00	2018-09-25 18:50:20+00:00 	E247	ANTI CHOLESTEROL DRUGS-FIBRATES
74	Medication/supplement use	9201	phv00009201.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:50:31+00:00	2018-09-25 18:50:31+00:00 	E248	ANTI CHOLESTEROL DRUGS-STATINS
74	Medication/supplement use	9202	phv00009202.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:50:39+00:00	2018-09-25 18:50:39+00:00 	E249	ANTI CHOLESTEROL DRUGS-OTHER
74	Medication/supplement use	9203	phv00009203.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:52:27+00:00	2018-09-25 18:52:27+00:00 	E250	ANTIGOUT--URIC ACID LOWERING
74	Medication/supplement use	9204	phv00009204.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:52:34+00:00	2018-09-25 18:52:34+00:00 	E251	ANTIGOUT (COLCHICINE)
74	Medication/supplement use	9205	phv00009205.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:52:41+00:00	2018-09-25 18:52:41+00:00 	E252	THYROID EXTRACT
74	Medication/supplement use	9206	phv00009206.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:52:48+00:00	2018-09-25 18:52:48+00:00 	E253	THYROXINE
74	Medication/supplement use	9207	phv00009207.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:52:58+00:00	2018-09-25 18:52:58+00:00 	E254	INSULIN
74	Medication/supplement use	9208	phv00009208.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:53:05+00:00	2018-09-25 18:53:05+00:00 	E255	INSULIN/TOTAL UNITS PER DAY
74	Medication/supplement use	9209	phv00009209.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:53:12+00:00	2018-09-25 18:53:12+00:00 	E256	ORAL HYPOGLYCEMICS
74	Medication/supplement use	9210	phv00009210.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:53:20+00:00	2018-09-25 18:53:20+00:00 	E257	ORAL/PATCH ESTROGEN
74	Medication/supplement use	9211	phv00009211.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:53:36+00:00	2018-09-25 18:53:36+00:00 	E258	ORAL GLUCOCORTICOIDS
74	Medication/supplement use	9212	phv00009212.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:53:44+00:00	2018-09-25 18:53:44+00:00 	E259	NON-STEROIDAL ANTI-INFLAMMATORY AGENTS
74	Medication/supplement use	9213	phv00009213.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:53:51+00:00	2018-09-25 18:53:51+00:00 	E260	ANALGESIC-NARCOTICS
74	Medication/supplement use	9214	phv00009214.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:53:58+00:00	2018-09-25 18:53:58+00:00 	E261	ANALGESIC-NON-NARCOTICS
74	Medication/supplement use	9215	phv00009215.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:54:29+00:00	2018-09-25 18:54:29+00:00 	E262	BRONCHODILATORS, AEROSOLS, ETC
74	Medication/supplement use	9216	phv00009216.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:54:36+00:00	2018-09-25 18:54:36+00:00 	E263	ANTIHISTAMINES
74	Medication/supplement use	9217	phv00009217.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:54:44+00:00	2018-09-25 18:54:44+00:00 	E264	ANTIULCER
74	Medication/supplement use	9218	phv00009218.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:54:51+00:00	2018-09-25 18:54:51+00:00 	E265	ANTI-ANXIETY, SEDATIVE/HYPNOTICS, ETC
74	Medication/supplement use	9219	phv00009219.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:54:58+00:00	2018-09-25 18:54:58+00:00 	E266	SLEEPING PILLS
74	Medication/supplement use	9220	phv00009220.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:55:05+00:00	2018-09-25 18:55:05+00:00 	E267	ANTI-DEPRESSANTS
74	Medication/supplement use	9221	phv00009221.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:55:12+00:00	2018-09-25 18:55:12+00:00 	E268	EYEDROPS
74	Medication/supplement use	9222	phv00009222.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:55:20+00:00	2018-09-25 18:55:20+00:00 	E269	ANTIBIOTICS
74	Medication/supplement use	9223	phv00009223.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:55:28+00:00	2018-09-25 18:55:28+00:00 	E270	ANTI-PARKINSON DRUGS
74	Medication/supplement use	9224	phv00009224.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:55:39+00:00	2018-09-25 18:55:39+00:00 	E271	ANTICONVULSANTS
74	Medication/supplement use	9225	phv00009225.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:55:48+00:00	2018-09-25 18:55:48+00:00 	E272	MEDICATIONS - OTHERS
74	Medication/supplement use	9233	phv00009233.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:56:08+00:00	2018-09-25 18:56:08+00:00 	E280	ORAL CONTRACEPTIVES IN INTERIM - FEMALE
74	Medication/supplement use	9128	phv00009128.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:56:18+00:00	2018-09-25 18:56:18+00:00 	E280A	NAME OF ORAL CONTRCPTVE LAST USED - FEMALE XXXXXXXXXXXXXXXX -
74	Medication/supplement use	9234	phv00009234.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:56:31+00:00	2018-09-25 18:56:31+00:00 	E281	CONJUGATED ESTROGEN USE IN INTERIM -FEMALE
74	Medication/supplement use	9235	phv00009235.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:56:40+00:00	2018-09-25 18:56:40+00:00 	E282	ORAL DOSE/DAY OF PREMARIN OR CONJ. ESTROGEN - FEMALE
74	Medication/supplement use	9236	phv00009236.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:56:48+00:00	2018-09-25 18:56:48+00:00 	E283	PATCH DOSE/DAY OF ESTROGEN - FEMALE
74	Medication/supplement use	9237	phv00009237.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:56:56+00:00	2018-09-25 18:56:56+00:00 	E284	NUMBER OF DAYS/MONTH TAKING PREMARIN - FEMALE
74	Medication/supplement use	9238	phv00009238.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:57:04+00:00	2018-09-25 18:57:04+00:00 	E285	ESTROGEN CREAM USE IN INTERIM - FEMALE
74	Medication/supplement use	9239	phv00009239.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:57:11+00:00	2018-09-25 18:57:11+00:00 	E286	PROGESTERONE USE IN INTERIM - FEMALE
74	Medication/supplement use	9571	phv00009571.v5.p10	pht000034.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-25 18:59:10+00:00	2018-09-25 18:59:10+00:00 	E664	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	10118	phv00010118.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:21:12+00:00	2018-09-26 11:21:12+00:00 	F022	NUMBER OF DAYS SINCE LAST DOSE OF ASPIRIN (TYPICAL VALUE 1 TO 7 FOR USE IN PAST WEEK)
74	Medication/supplement use	9670	phv00009670.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:22:31+00:00	2018-09-26 11:22:31+00:00 	F180	TAKE ASPIRIN REGULARLY
74	Medication/supplement use	9671	phv00009671.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:22:39+00:00	2018-09-26 11:22:39+00:00 	F181	NUMBER OF ASPIRIN TAKEN REGULARLY
74	Medication/supplement use	9672	phv00009672.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:22:46+00:00	2018-09-26 11:22:46+00:00 	F182	ASPIRIN FREQUENCY
74	Medication/supplement use	9673	phv00009673.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:22:53+00:00	2018-09-26 11:22:53+00:00 	F183	USUAL ASPIRIN DOSE FOR ABOVE
74	Medication/supplement use	9674	phv00009674.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:23:01+00:00	2018-09-26 11:23:01+00:00 	F184	CURRENTLY RECEIVING MEDICATION FOR THE TREATMENT OF HYPERTENSION
74	Medication/supplement use	9675	phv00009675.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:23:08+00:00	2018-09-26 11:23:08+00:00 	F185	ANY OF THE CARDIOVASCULAR MEDICATIONS BELOW ON THIS PAGE
74	Medication/supplement use	9676	phv00009676.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:23:24+00:00	2018-09-26 11:23:24+00:00 	F186	CARDIOVASCULAR MEDICATIONS : CARDIAC GLYCOSIDES
74	Medication/supplement use	9677	phv00009677.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:23:31+00:00	2018-09-26 11:23:31+00:00 	F187	CARDIOVASCULAR MEDICATIONS : NITROGLYCERINE
74	Medication/supplement use	9678	phv00009678.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:23:39+00:00	2018-09-26 11:23:39+00:00 	F188	CARDIOVASCULAR MEDICATIONS : LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC)
74	Medication/supplement use	9679	phv00009679.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:23:46+00:00	2018-09-26 11:23:46+00:00 	F189	CARDIOVASCULAR MEDICATIONS : CALCIUM CHANNEL BLOCKERS (NIFEDIPINE, VERAPAMIL, DILTIAZEM)
74	Medication/supplement use	9680	phv00009680.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:23:53+00:00	2018-09-26 11:23:53+00:00 	F190	CARDIOVASCULAR MEDICATIONS : BETA BLOCKERS
74	Medication/supplement use	9681	phv00009681.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:24:00+00:00	2018-09-26 11:24:00+00:00 	F191	BETA BLOCKER GROUP
74	Medication/supplement use	9682	phv00009682.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:24:08+00:00	2018-09-26 11:24:08+00:00 	F192	DOSE (MG/DAY) OF BETA BLOCKER
74	Medication/supplement use	9683	phv00009683.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:24:15+00:00	2018-09-26 11:24:15+00:00 	F193	CARDIOVASCULAR MEDICATIONS: LOOP DIURECTICS (LASIX, ETC)
74	Medication/supplement use	9684	phv00009684.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:24:22+00:00	2018-09-26 11:24:22+00:00 	F194	CARDIOVASCULAR MEDICATIONS: THIAZIDE/K-SPARING DIURECTICS (DYAZIDE, MAXIDE, ETC)
74	Medication/supplement use	9685	phv00009685.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:24:30+00:00	2018-09-26 11:24:30+00:00 	F195	CARDIOVASCULAR MEDICATIONS: THIAZIDE DIURETICS
74	Medication/supplement use	9686	phv00009686.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:24:37+00:00	2018-09-26 11:24:37+00:00 	F196	CARDIOVASCULAR MEDICATIONS: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE)
74	Medication/supplement use	9687	phv00009687.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:24:46+00:00	2018-09-26 11:24:46+00:00 	F197	CARDIOVASCULAR MEDICATIONS: POTASSIUM SUPPLEMENTS
74	Medication/supplement use	9688	phv00009688.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:24:54+00:00	2018-09-26 11:24:54+00:00 	F198	CARDIOVASCULAR MEDICATIONS: RESERPINE DERIVATIVES
74	Medication/supplement use	9689	phv00009689.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:25:02+00:00	2018-09-26 11:25:02+00:00 	F199	CARDIOVASCULAR MEDICATIONS: METHYLDOPA (ALDOMET)
74	Medication/supplement use	9690	phv00009690.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:25:09+00:00	2018-09-26 11:25:09+00:00 	F200	CARDIOVASCULAR MEDICATIONS: ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ)
74	Medication/supplement use	9691	phv00009691.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:25:16+00:00	2018-09-26 11:25:16+00:00 	F201	CARDIOVASCULAR MEDICATIONS: ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN, DOXAZOSIN)
74	Medication/supplement use	9692	phv00009692.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:25:24+00:00	2018-09-26 11:25:24+00:00 	F202	CARDIOVASCULAR MEDICATIONS: RENIN-ANGIOTENSIN BLOCKING DRUGS (ACE) (CAPTOPRIL, ENALAPRIL, LISINOPRIL)
74	Medication/supplement use	9693	phv00009693.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:25:33+00:00	2018-09-26 11:25:33+00:00 	F203	CARDIOVASCULAR MEDICATIONS: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC)
74	Medication/supplement use	9694	phv00009694.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:25:42+00:00	2018-09-26 11:25:42+00:00 	F204	CARDIOVASCULAR MEDICATIONS: OTHER ANTI-HYPERTENSIVES
74	Medication/supplement use	9695	phv00009695.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:25:50+00:00	2018-09-26 11:25:50+00:00 	F205	CARDIOVASCULAR MEDICATIONS: ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE, ETC)
74	Medication/supplement use	9696	phv00009696.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:25:57+00:00	2018-09-26 11:25:57+00:00 	F206	CARDIOVASCULAR MEDICATIONS: ANTIPLATELET (ANTURANE, PERSANTINE, ETC)
74	Medication/supplement use	9697	phv00009697.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:26:05+00:00	2018-09-26 11:26:05+00:00 	F207	CARDIOVASCULAR MEDICATIONS: ANTICOAGULANTS (COUMADIN, WARFARIN, ETC)
74	Medication/supplement use	9698	phv00009698.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:26:13+00:00	2018-09-26 11:26:13+00:00 	F208	CARDIOVASCULAR MEDICATIONS: OTHER CARDIAC MEDICATION
74	Medication/supplement use	9699	phv00009699.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:26:22+00:00	2018-09-26 11:26:22+00:00 	F209	MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)
74	Medication/supplement use	9700	phv00009700.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:26:30+00:00	2018-09-26 11:26:30+00:00 	F210	MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID)
74	Medication/supplement use	9701	phv00009701.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:26:56+00:00	2018-09-26 11:26:56+00:00 	F211	MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL)
74	Medication/supplement use	9702	phv00009702.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:27:04+00:00	2018-09-26 11:27:04+00:00 	F212	MEDICATIONS: ANTI CHOLESTEROL DRUGS (STATINS - E.G. LOVASTATIN, PRAVASTATIN)
74	Medication/supplement use	9703	phv00009703.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:27:12+00:00	2018-09-26 11:27:12+00:00 	F213	MEDICATIONS: ANTI CHOLESTEROL DRUGS - OTHER
74	Medication/supplement use	9704	phv00009704.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:27:20+00:00	2018-09-26 11:27:20+00:00 	F214	MEDICATIONS: ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC)
74	Medication/supplement use	9705	phv00009705.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:27:28+00:00	2018-09-26 11:27:28+00:00 	F215	MEDICATIONS: ANTIGOUT (COLCHICINE)
74	Medication/supplement use	9706	phv00009706.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:27:36+00:00	2018-09-26 11:27:36+00:00 	F216	MEDICATIONS: THYROID EXTRACT (DESSICATED THYROID)
74	Medication/supplement use	9707	phv00009707.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:27:44+00:00	2018-09-26 11:27:44+00:00 	F217	MEDICATIONS: THYROXINE (SYNTHROID, ETC)
74	Medication/supplement use	9708	phv00009708.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:27:55+00:00	2018-09-26 11:27:55+00:00 	F218	MEDICATIONS: INSULIN
74	Medication/supplement use	9709	phv00009709.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:28:02+00:00	2018-09-26 11:28:02+00:00 	F219	HOW MANY UNITS OF INSULIN/DAY
74	Medication/supplement use	9710	phv00009710.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:28:10+00:00	2018-09-26 11:28:10+00:00 	F220	MEDICATIONS: ORAL HYPOGLYCEMICS
74	Medication/supplement use	9711	phv00009711.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:28:18+00:00	2018-09-26 11:28:18+00:00 	F221	MEDICATIONS: ORAL/PATCH ESTROGEN (FOR WOMEN USERS ALSO SEE ESTROGEN SECTION)
74	Medication/supplement use	9712	phv00009712.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:28:26+00:00	2018-09-26 11:28:26+00:00 	F222	MEDICATIONS: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE)
74	Medication/supplement use	9713	phv00009713.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:28:33+00:00	2018-09-26 11:28:33+00:00 	F223	MEDICATIONS: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL)
74	Medication/supplement use	9714	phv00009714.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:28:41+00:00	2018-09-26 11:28:41+00:00 	F224	MEDICATIONS: ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC)
74	Medication/supplement use	9715	phv00009715.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:28:51+00:00	2018-09-26 11:28:51+00:00 	F225	MEDICATIONS: ANALGESIC-NON-NARCOTICS (ACETAMINOPHEN, ETC)
74	Medication/supplement use	9716	phv00009716.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:29:00+00:00	2018-09-26 11:29:00+00:00 	F226	MEDICATIONS: ANTIHISTAMINES
74	Medication/supplement use	9717	phv00009717.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:29:08+00:00	2018-09-26 11:29:08+00:00 	F227	MEDICATIONS: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS)
74	Medication/supplement use	9718	phv00009718.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:29:15+00:00	2018-09-26 11:29:15+00:00 	F228	MEDICATIONS: ANTI-ANXIETY, SEDATIVE/HYPNOTICS (LIBRIUM, VALIUM)
74	Medication/supplement use	9719	phv00009719.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:29:22+00:00	2018-09-26 11:29:22+00:00 	F229	MEDICATIONS: SLEEPING PILLS
74	Medication/supplement use	9720	phv00009720.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:29:29+00:00	2018-09-26 11:29:29+00:00 	F230	MEDICATIONS: ANTI-DEPRESSANTS
74	Medication/supplement use	9721	phv00009721.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:29:36+00:00	2018-09-26 11:29:36+00:00 	F231	MEDICATIONS: EYEDROPS
74	Medication/supplement use	9722	phv00009722.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:29:44+00:00	2018-09-26 11:29:44+00:00 	F232	MEDICATIONS: ANTIBIOTICS
74	Medication/supplement use	9723	phv00009723.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:29:52+00:00	2018-09-26 11:29:52+00:00 	F233	MEDICATIONS: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC)
74	Medication/supplement use	9724	phv00009724.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:30:00+00:00	2018-09-26 11:30:00+00:00 	F234	MEDICATIONS: ANTICONVULSANTS (DILANTIN, PHENOBARBITAL, TEGRETOL, MYSOLINE, ETC)
74	Medication/supplement use	9725	phv00009725.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:30:09+00:00	2018-09-26 11:30:09+00:00 	F235	MEDICATIONS: BRONCHODILATORS AND AEROSOLS
74	Medication/supplement use	9726	phv00009726.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:30:17+00:00	2018-09-26 11:30:17+00:00 	F236	MEDICATIONS: OTHER
74	Medication/supplement use	9736	phv00009736.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:30:34+00:00	2018-09-26 11:30:34+00:00 	F246	ORAL CONTRACEPTIVES IN INTERIM
74	Medication/supplement use	9737	phv00009737.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:30:49+00:00	2018-09-26 11:30:49+00:00 	F247	ESTROGEN REPLACEMENT IN INTERIM (E.G.PREMARIN)
74	Medication/supplement use	9738	phv00009738.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:30:56+00:00	2018-09-26 11:30:56+00:00 	F248	DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS, OR OTHER ORAL ESTROGEN (PICK NEAREST DOSE)
74	Medication/supplement use	9739	phv00009739.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:31:06+00:00	2018-09-26 11:31:06+00:00 	F249	PATCH DOSE OF ESTROGEN
74	Medication/supplement use	9740	phv00009740.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:31:13+00:00	2018-09-26 11:31:13+00:00 	F250	NUMBER OF DAYS A MONTH TAKING ESTROGENS
74	Medication/supplement use	9741	phv00009741.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:31:21+00:00	2018-09-26 11:31:21+00:00 	F251	ESTROGEN CREAM USE INTERIM
74	Medication/supplement use	9742	phv00009742.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:31:29+00:00	2018-09-26 11:31:29+00:00 	F252	PROGESTERONE USE INTERIM
74	Medication/supplement use	9816	phv00009816.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:31:57+00:00	2018-09-26 11:31:57+00:00 	F329	RELIEF BY NITROGLYCERINE IN LESS THAN 15 MIN
74	Medication/supplement use	10131	phv00010131.v5.p10	pht000035.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:32:33+00:00	2018-09-26 11:32:33+00:00 	F721	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	10151	phv00010151.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:34:07+00:00	2018-09-26 11:34:07+00:00 	G008	IN THE INTERIM HAVE YOU TAKEN MEDICATION FOR THE TREATMENT OF HYPERTENSION?
74	Medication/supplement use	10152	phv00010152.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:34:31+00:00	2018-09-26 11:34:31+00:00 	G009	ANY OF THE CARDIOVASCULAR MEDICATIONS IN THE FOLLOWING SECTION?
74	Medication/supplement use	10153	phv00010153.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:34:40+00:00	2018-09-26 11:34:40+00:00 	G010	CARDIOVASCULAR MEDICATIONS: CARDIAC GLYCOSIDES
74	Medication/supplement use	10154	phv00010154.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:34:48+00:00	2018-09-26 11:34:48+00:00 	G011	CARDIOVASCULAR MEDICATIONS: NITROGLYCERINE
74	Medication/supplement use	10155	phv00010155.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:34:55+00:00	2018-09-26 11:34:55+00:00 	G012	CARDIOVASCULAR MEDICATIONS: LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.)
74	Medication/supplement use	10156	phv00010156.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:35:02+00:00	2018-09-26 11:35:02+00:00 	G013	CARDIOVASCULAR MEDICATIONS: CALCIUM CHANNEL BLOCKERS (NIFEDIPINE, VERAPAMIL, DILTIAZEM)
74	Medication/supplement use	10157	phv00010157.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:35:09+00:00	2018-09-26 11:35:09+00:00 	G014	CALCIUM CHANNEL BLOCKER GROUP
74	Medication/supplement use	10158	phv00010158.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:35:16+00:00	2018-09-26 11:35:16+00:00 	G015	CALCIUM CHANNEL BLOCKER: TABLET SIZE OF CALCIUM CHANNEL BLOCKER (NUMBER OF MG)
74	Medication/supplement use	10159	phv00010159.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:35:23+00:00	2018-09-26 11:35:23+00:00 	G016	CALCIUM CHANNEL BLOCKER: NUMBER OF TIMES CALCIUM CHANNEL BLOCKER TAKEN PER DAY
74	Medication/supplement use	10160	phv00010160.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:39:12+00:00	2018-09-26 11:39:12+00:00 	G017	CARDIOVASCULAR MEDICATIONS: BETA BLOCKERS
74	Medication/supplement use	10161	phv00010161.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:39:20+00:00	2018-09-26 11:39:20+00:00 	G018	BETA BLOCKER GROUP
74	Medication/supplement use	10162	phv00010162.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:39:27+00:00	2018-09-26 11:39:27+00:00 	G019	BETA BLOCKER GROUP: DOSE (MG/DAY) OF BETA BLOCKER
74	Medication/supplement use	10163	phv00010163.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:39:34+00:00	2018-09-26 11:39:34+00:00 	G020	CARDIOVASCULAR MEDICATIONS: LOOP DIURETICS (LASIX, ETC.)
74	Medication/supplement use	10164	phv00010164.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:39:41+00:00	2018-09-26 11:39:41+00:00 	G021	CARDIOVASCULAR MEDICATIONS: THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC.)
74	Medication/supplement use	10165	phv00010165.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:39:50+00:00	2018-09-26 11:39:50+00:00 	G022	CARDIOVASCULAR MEDICATIONS: THIAZIDE DIURETICS
74	Medication/supplement use	10166	phv00010166.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:39:58+00:00	2018-09-26 11:39:58+00:00 	G023	CARDIOVASCULAR MEDICATIONS: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE)
74	Medication/supplement use	10167	phv00010167.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:40:05+00:00	2018-09-26 11:40:05+00:00 	G024	CARDIOVASCULAR MEDICATIONS: POTASSIUM SUPPLEMENTS
74	Medication/supplement use	10168	phv00010168.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:40:12+00:00	2018-09-26 11:40:12+00:00 	G025	CARDIOVASCULAR MEDICATIONS: RESERPINE DERIVATIVES
74	Medication/supplement use	10169	phv00010169.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:40:18+00:00	2018-09-26 11:40:18+00:00 	G026	CARDIOVASCULAR MEDICATIONS: METHYLDOPA (ALDOMET)
74	Medication/supplement use	10170	phv00010170.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:40:25+00:00	2018-09-26 11:40:25+00:00 	G027	CARDIOVASCULAR MEDICATIONS: ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ)
74	Medication/supplement use	10171	phv00010171.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:40:33+00:00	2018-09-26 11:40:33+00:00 	G028	CARDIOVASCULAR MEDICATIONS: ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN, DOXAZOSIN)
74	Medication/supplement use	10172	phv00010172.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:40:40+00:00	2018-09-26 11:40:40+00:00 	G029	CARDIOVASCULAR MEDICATIONS: RENIN-ANGIOTENSIN BLOCKING DRUGS (ACE) (CAPTOPRIL, ENALAPRIL, LISINOPRIL)
74	Medication/supplement use	10173	phv00010173.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:40:48+00:00	2018-09-26 11:40:48+00:00 	G030	CARDIOVASCULAR MEDICATIONS: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC.)
74	Medication/supplement use	10174	phv00010174.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:40:55+00:00	2018-09-26 11:40:55+00:00 	G031	CARDIOVASCULAR MEDICATIONS: ANGIOTENSIN II ANTAGONISTS (LOSARTAN, ETC.)
74	Medication/supplement use	10175	phv00010175.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:41:08+00:00	2018-09-26 11:41:08+00:00 	G032	CARDIOVASCULAR MEDICATIONS: OTHER ANTI-HYPERTENSIVES
74	Medication/supplement use	10176	phv00010176.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:41:17+00:00	2018-09-26 11:41:17+00:00 	G033	CARDIOVASCULAR MEDICATIONS: ANTI-ARRHYTHMICS (QUINIDINE, PROCAINAMIDE, AMIODARONE, SOTALOL DISOPYRAMIDE, ETC.)
74	Medication/supplement use	10177	phv00010177.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:41:23+00:00	2018-09-26 11:41:23+00:00 	G034	CARDIOVASCULAR MEDICATIONS: ANTIPLATELET (ANTURANE, PERSANTINE, TICLOPIDINE)
74	Medication/supplement use	10178	phv00010178.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:41:31+00:00	2018-09-26 11:41:31+00:00 	G035	CARDIOVASCULAR MEDICATIONS: ANTICOAGULANTS (COUMADIN, WARFARIN, ETC.)
74	Medication/supplement use	10179	phv00010179.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:41:38+00:00	2018-09-26 11:41:38+00:00 	G036	CARDIOVASCULAR MEDICATIONS: OTHER CARDIAC MEDICATION
74	Medication/supplement use	10180	phv00010180.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:41:46+00:00	2018-09-26 11:41:46+00:00 	G037	TAKE ASPIRIN REGULARLY?
74	Medication/supplement use	10181	phv00010181.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:41:53+00:00	2018-09-26 11:41:53+00:00 	G038	ASPIRIN: NUMBER TAKEN REGULARLY
74	Medication/supplement use	10182	phv00010182.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:42:00+00:00	2018-09-26 11:42:00+00:00 	G039	ASPIRIN: ASPIRIN FREQUENCY - NUMBER TAKEN REGULARLY
74	Medication/supplement use	10183	phv00010183.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:42:08+00:00	2018-09-26 11:42:08+00:00 	G040	ASPIRIN: USUAL ASPIRIN DOSE FOR ABOVE
74	Medication/supplement use	10184	phv00010184.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:42:37+00:00	2018-09-26 11:42:37+00:00 	G041	NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)
74	Medication/supplement use	10185	phv00010185.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:42:44+00:00	2018-09-26 11:42:44+00:00 	G042	NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID)
74	Medication/supplement use	10186	phv00010186.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:42:51+00:00	2018-09-26 11:42:51+00:00 	G043	NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL)
74	Medication/supplement use	10187	phv00010187.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:42:58+00:00	2018-09-26 11:42:58+00:00 	G044	NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (STATINS - E.G. LOVASTATIN, PRAVASTATIN)
74	Medication/supplement use	10188	phv00010188.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:43:05+00:00	2018-09-26 11:43:05+00:00 	G045	NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (OTHER - SPECIFY)
74	Medication/supplement use	10189	phv00010189.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:43:12+00:00	2018-09-26 11:43:12+00:00 	G046	NON-CARDIOVASCULAR MEDICATIONS: ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.)
74	Medication/supplement use	10190	phv00010190.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:43:20+00:00	2018-09-26 11:43:20+00:00 	G047	NON-CARDIOVASCULAR MEDICATIONS: ANTIGOUT (COLCHICINE)
74	Medication/supplement use	10191	phv00010191.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:43:27+00:00	2018-09-26 11:43:27+00:00 	G048	NON-CARDIOVASCULAR MEDICATIONS: THYROID EXTRACT (DESICCATED THYROID)
74	Medication/supplement use	10192	phv00010192.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:43:34+00:00	2018-09-26 11:43:34+00:00 	G049	NON-CARDIOVASCULAR MEDICATIONS: THYROXINE (SYNTHROID, ETC.)
74	Medication/supplement use	10193	phv00010193.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:43:42+00:00	2018-09-26 11:43:42+00:00 	G050	NON-CARDIOVASCULAR MEDICATIONS: INSULIN
74	Medication/supplement use	10194	phv00010194.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:43:51+00:00	2018-09-26 11:43:51+00:00 	G051	INSULIN: TOTAL UNITS A DAY
74	Medication/supplement use	10195	phv00010195.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:43:58+00:00	2018-09-26 11:43:58+00:00 	G052	NON-CARDIOVASCULAR MEDICATIONS: ORAL HYPOGLYCEMICS
74	Medication/supplement use	10196	phv00010196.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:44:08+00:00	2018-09-26 11:44:08+00:00 	G053	ORAL HYPOGLYCEMICS: METFORMIN
74	Medication/supplement use	10197	phv00010197.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:44:15+00:00	2018-09-26 11:44:15+00:00 	G054	ORAL HYPOGLYCEMICS: TRIGLITAZONE
74	Medication/supplement use	10198	phv00010198.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:44:22+00:00	2018-09-26 11:44:22+00:00 	G055	ORAL HYPOGLYCEMICS: GLIPIZIDE
74	Medication/supplement use	10199	phv00010199.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:44:29+00:00	2018-09-26 11:44:29+00:00 	G056	ORAL HYPOGLYCEMICS: GLYBURIDE
74	Medication/supplement use	10200	phv00010200.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:44:37+00:00	2018-09-26 11:44:37+00:00 	G057	ORAL HYPOGLYCEMICS: CHLORPROPAMIDE
74	Medication/supplement use	10201	phv00010201.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:44:44+00:00	2018-09-26 11:44:44+00:00 	G058	ORAL HYPOGLYCEMICS: OTHER (SPECIFY)
74	Medication/supplement use	10202	phv00010202.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:44:51+00:00	2018-09-26 11:44:51+00:00 	G059	ORAL HYPOGLYCEMICS: UNKNOWN
74	Medication/supplement use	10203	phv00010203.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:45:02+00:00	2018-09-26 11:45:02+00:00 	G060	NON-CARDIOVASCULAR MEDICATIONS: ORAL/PATCH ESTROGEN
74	Medication/supplement use	10204	phv00010204.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:45:09+00:00	2018-09-26 11:45:09+00:00 	G061	NON-CARDIOVASCULAR MEDICATIONS: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.)
74	Medication/supplement use	10205	phv00010205.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:45:17+00:00	2018-09-26 11:45:17+00:00 	G062	NON-CARDIOVASCULAR MEDICATIONS: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL)
74	Medication/supplement use	10206	phv00010206.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:45:23+00:00	2018-09-26 11:45:23+00:00 	G063	NON-CARDIOVASCULAR MEDICATIONS: ANALGESIC NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.)
74	Medication/supplement use	10207	phv00010207.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:45:32+00:00	2018-09-26 11:45:32+00:00 	G064	NON-CARDIOVASCULAR MEDICATIONS: ANALGESIC NON-NARCOTICS (ACETAMINOPHEN, ETC.)
74	Medication/supplement use	10208	phv00010208.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:45:40+00:00	2018-09-26 11:45:40+00:00 	G065	NON-CARDIOVASCULAR MEDICATIONS: ANTIHISTAMINES
74	Medication/supplement use	10209	phv00010209.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:45:47+00:00	2018-09-26 11:45:47+00:00 	G066	NON-CARDIOVASCULAR MEDICATIONS: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS)
74	Medication/supplement use	10210	phv00010210.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:45:55+00:00	2018-09-26 11:45:55+00:00 	G067	NON-CARDIOVASCULAR MEDICATIONS: ANTI-ANXIETY, SEDATIVE/ HYPNOTICS (LIBRIUM, VALIUM, ETC.)
74	Medication/supplement use	10211	phv00010211.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:46:03+00:00	2018-09-26 11:46:03+00:00 	G068	NON-CARDIOVASCULAR MEDICATIONS: SLEEPING PILLS
74	Medication/supplement use	10212	phv00010212.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:46:10+00:00	2018-09-26 11:46:10+00:00 	G069	NON-CARDIOVASCULAR MEDICATIONS: ANTI-DEPRESSANTS
74	Medication/supplement use	10213	phv00010213.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:46:18+00:00	2018-09-26 11:46:18+00:00 	G070	NON-CARDIOVASCULAR MEDICATIONS: EYEDROPS
74	Medication/supplement use	10214	phv00010214.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:46:36+00:00	2018-09-26 11:46:36+00:00 	G071	NON-CARDIOVASCULAR MEDICATIONS: ANTIBIOTICS
74	Medication/supplement use	10215	phv00010215.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:46:44+00:00	2018-09-26 11:46:44+00:00 	G072	NON-CARDIOVASCULAR MEDICATIONS: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.)
74	Medication/supplement use	10216	phv00010216.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:46:51+00:00	2018-09-26 11:46:51+00:00 	G073	NON-CARDIOVASCULAR MEDICATIONS: ANTICONVULSANTS (DILANTIN, PHENOBARBITAL, TEGRETOL, MYSOLINE, ETC.)
74	Medication/supplement use	10217	phv00010217.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:46:59+00:00	2018-09-26 11:46:59+00:00 	G074	NON-CARDIOVASCULAR MEDICATIONS: BRONCHODILATORS AND AEROSOLS
74	Medication/supplement use	10218	phv00010218.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:47:06+00:00	2018-09-26 11:47:06+00:00 	G075	NON-CARDIOVASCULAR MEDICATIONS: OSTEOPOROSIS MEDICATIONS
74	Medication/supplement use	10219	phv00010219.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:47:14+00:00	2018-09-26 11:47:14+00:00 	G076	NON-CARDIOVASCULAR MEDICATIONS: OTHERS
74	Medication/supplement use	10230	phv00010230.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:47:28+00:00	2018-09-26 11:47:28+00:00 	G087	ORAL CONTRACEPTIVES IN INTERIM
74	Medication/supplement use	10231	phv00010231.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:47:44+00:00	2018-09-26 11:47:44+00:00 	G088	ESTROGEN REPLACEMENT IN INTERIM (E.G. PREMARIN)
74	Medication/supplement use	10232	phv00010232.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:47:51+00:00	2018-09-26 11:47:51+00:00 	G089	DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS, OR OTHER ORAL ESTROGEN
74	Medication/supplement use	10233	phv00010233.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:47:58+00:00	2018-09-26 11:47:58+00:00 	G090	PATCH DOSE OF ESTROGEN
74	Medication/supplement use	10234	phv00010234.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:48:07+00:00	2018-09-26 11:48:07+00:00 	G091	NUMBER OF DAYS A MONTH TAKING ESTROGENS
74	Medication/supplement use	10235	phv00010235.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:48:15+00:00	2018-09-26 11:48:15+00:00 	G092	NUMBER OF YEARS ON ESTROGEN
74	Medication/supplement use	10236	phv00010236.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:48:24+00:00	2018-09-26 11:48:24+00:00 	G093	ESTROGEN CREAM USE IN INTERIM
74	Medication/supplement use	10237	phv00010237.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:48:32+00:00	2018-09-26 11:48:32+00:00 	G094	PROGESTIN REPLACEMENT IN INTERIM
74	Medication/supplement use	10238	phv00010238.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:48:39+00:00	2018-09-26 11:48:39+00:00 	G095	DOSE/DAY OF PROGESTIN
74	Medication/supplement use	10239	phv00010239.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:48:47+00:00	2018-09-26 11:48:47+00:00 	G096	NUMBER OF DAYS A MONTH TAKING PROGESTINS
74	Medication/supplement use	10663	phv00010663.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:49:59+00:00	2018-09-26 11:49:59+00:00 	G672	RESPIRATORY: ARE YOU CURRENTLY TAKING ANY MEDICATIONS (INCLUDING INHALERS, AEROSOLS, OR TABLETS) FOR ASTHMA?
74	Medication/supplement use	10670	phv00010670.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:50:11+00:00	2018-09-26 11:50:11+00:00 	G679	RESPIRATORY: ARE YOU CURRENTLY TAKING ANY STEROID MEDICATIONS?
74	Medication/supplement use	10671	phv00010671.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:50:27+00:00	2018-09-26 11:50:27+00:00 	G680	RESPIRATORY: IF YES TO G679, BY WHAT ROUTE - ORAL (CHECK ALL THAT APPLY)
74	Medication/supplement use	10674	phv00010674.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:50:40+00:00	2018-09-26 11:50:40+00:00 	G683	RESPIRATORY: IF YES TO G679, BY WHAT ROUTE - NASAL (CHECK ALL THAT APPLY)
74	Medication/supplement use	10692	phv00010692.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 11:51:04+00:00	2018-09-26 11:51:04+00:00 	G708	TREATMENT FOR BLOOD PRESSURE
74	Medication/supplement use	72053	phv00072053.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:04:39+00:00	2018-09-26 12:04:39+00:00 	H010	TAKE ASPIRIN REGULARLY?
74	Medication/supplement use	72054	phv00072054.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:04:51+00:00	2018-09-26 12:04:51+00:00 	H011	IF TAKING ASPIRIN, NUMBER OF ASPIRINS TAKEN REGULARLY
74	Medication/supplement use	72055	phv00072055.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:04:59+00:00	2018-09-26 12:04:59+00:00 	H012	IF TAKING ASPIRIN, FREQUENCY PER
74	Medication/supplement use	72056	phv00072056.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:05:05+00:00	2018-09-26 12:05:05+00:00 	H013	IF TAKING ASPIRIN, USUAL DOSE
74	Medication/supplement use	72052	phv00072052.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:05:14+00:00	2018-09-26 12:05:14+00:00 	H014	SINCE YOUR LAST EXAM HAVE YOU TAKEN MEDICATION FOR HYPERTENSION/HIGH BLOOD PRESSURE?
74	Medication/supplement use	72057	phv00072057.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:05:31+00:00	2018-09-26 12:05:31+00:00 	H015	SINCE YOUR LAST EXAM HAVE YOU TAKEN MEDICATION FOR HIGH BLOOD CHOLESTEROL OR HIGH TRIGLYCERIDES?
74	Medication/supplement use	72058	phv00072058.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:05:48+00:00	2018-09-26 12:05:48+00:00 	H017	SINCE YOUR LAST EXAM HAVE YOU TAKEN MEDICATION FOR CARDIOVASCULAR DISEASE (FOR EXAMPLE ANGINA/CHEST PAIN, HEART FAILURE, ATRIAL FIBRILLATION/HEART RHYTHM ABNORMALITY, STROKE, LEG PAIN WHEN WALKING?)
74	Medication/supplement use	72061	phv00072061.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:05:59+00:00	2018-09-26 12:05:59+00:00 	H024	SINCE YOUR LAST EXAM HAVE YOU TAKEN OR USED ORAL CONTRACEPTIVE PILLS, SHOTS, OR HORMONE IMPLANTS FOR BIRTH CONTROL OR MEDICAL INDICATIONS (NOT POST MENOPAUSAL HORMONE REPLACEMENT)?
74	Medication/supplement use	72062	phv00072062.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:06:13+00:00	2018-09-26 12:06:13+00:00 	H025	WHAT IS THE NAME OF THE CURRENT OR MOST RECENT ORAL CONTRACEPTIVE, SHOT OR IMPLANT USED? - NAME
74	Medication/supplement use	72068	phv00072068.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:06:20+00:00	2018-09-26 12:06:20+00:00 	H026	WHAT IS THE NAME OF THE CURRENT OR MOST RECENT ORAL CONTRACEPTIVE, SHOT OR IMPLANT USED? - STRENGTH
74	Medication/supplement use	72063	phv00072063.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:06:28+00:00	2018-09-26 12:06:28+00:00 	H027	WHAT IS THE NAME OF THE CURRENT OR MOST RECENT ORAL CONTRACEPTIVE, SHOT OR IMPLANT USED? - FORM
74	Medication/supplement use	72074	phv00072074.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:07:10+00:00	2018-09-26 12:07:10+00:00 	H046	WHAT AGE DID YOU BEGIN HORMONE REPLACEMENT THERAPY?
74	Medication/supplement use	72075	phv00072075.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:07:20+00:00	2018-09-26 12:07:20+00:00 	H047	"FOR HOW LONG DID YOU TAKE HORMONES? - ""YEAR"" PART OF DURATION"
74	Medication/supplement use	72076	phv00072076.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:07:27+00:00	2018-09-26 12:07:27+00:00 	H048	"FOR HOW LONG DID YOU TAKE HORMONES? - ""MONTH"" PART OF DURATION"
74	Medication/supplement use	72077	phv00072077.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:07:34+00:00	2018-09-26 12:07:34+00:00 	H049	ESTROGEN USE?
74	Medication/supplement use	72078	phv00072078.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:07:41+00:00	2018-09-26 12:07:41+00:00 	H050	NAME OF MOST RECENT ESTROGEN PREPARATION
74	Medication/supplement use	72079	phv00072079.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:07:49+00:00	2018-09-26 12:07:49+00:00 	H051	STRENGTH OF MOST RECENT ESTROGEN PREPARATION
74	Medication/supplement use	72087	phv00072087.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:08:01+00:00	2018-09-26 12:08:01+00:00 	H052	NUMBER OF DAYS PER MONTH ESTROGEN TAKEN
74	Medication/supplement use	72080	phv00072080.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:08:09+00:00	2018-09-26 12:08:09+00:00 	H053	PROGESTERONE USE?
74	Medication/supplement use	72081	phv00072081.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:08:17+00:00	2018-09-26 12:08:17+00:00 	H054	NAME OF MOST RECENT PROGESTERONE PREPARATION
74	Medication/supplement use	72082	phv00072082.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:08:24+00:00	2018-09-26 12:08:24+00:00 	H055	STRENGTH OF MOST RECENT PROGESTERONE PREPARATION
74	Medication/supplement use	72083	phv00072083.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:08:31+00:00	2018-09-26 12:08:31+00:00 	H056	NUMBER OF DAYS PER MONTH PREGESTERONE TAKEN
74	Medication/supplement use	72084	phv00072084.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:08:44+00:00	2018-09-26 12:08:44+00:00 	H057	IF PERIODS HAVE STOPPED, HAVE YOU USED EVISTA (RALOXIFENE) OR NOLVADEX (TAMOXIFEN) OR OTHER SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)?
74	Medication/supplement use	72085	phv00072085.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:08:57+00:00	2018-09-26 12:08:57+00:00 	H058	NUMBER OF MONTHS SERMS USED
74	Medication/supplement use	72086	phv00072086.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:09:06+00:00	2018-09-26 12:09:06+00:00 	H059	CURRENT SERMS USE?
74	Medication/supplement use	72511	phv00072511.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:10:31+00:00	2018-09-26 12:10:31+00:00 	H670	DO YOU TAKE INHALERS OR BRONCHODILATORS?
74	Medication/supplement use	72512	phv00072512.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:10:42+00:00	2018-09-26 12:10:42+00:00 	H671	DO YOU USE ANY OF THESE MEDICATIONS - ALBUTEROL, PROVENTIL, VENTOLIN, COMBIVENT, MAXAIR, VOLMAX, XOPENEX, BRONKOOMETER, PIRBUTEROL, LEVALBUTEROL, OR METAPROTERENOL?
74	Medication/supplement use	72513	phv00072513.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:10:50+00:00	2018-09-26 12:10:50+00:00 	H672	HOW MANY HOURS AGO DID YOU LAST USE THE MEDICATION, EITHER BY INHALER OR NEBULIZER?
74	Medication/supplement use	72514	phv00072514.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:10:58+00:00	2018-09-26 12:10:58+00:00 	H673	DO YOU TAKE ANY OF THE FOLLOWING INHALERS? SEREVENT, ADVAIR, FORADIL, SALMETEROL, OR FORMOTEROL
74	Medication/supplement use	72515	phv00072515.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:11:08+00:00	2018-09-26 12:11:08+00:00 	H674	HOW MANY HOURS AGO DID YOU LAST USE THE MEDICATION?
74	Medication/supplement use	20873	phv00020873.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:13:29+00:00	2018-09-26 12:13:29+00:00 	G3A008	TAKE ASPIRIN REGULARLY?
74	Medication/supplement use	20874	phv00020874.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:13:44+00:00	2018-09-26 12:13:44+00:00 	G3A009	IF TAKE ASPIRIN REGULARLY: NUMBER ASPIRINS TAKEN
74	Medication/supplement use	20875	phv00020875.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:13:51+00:00	2018-09-26 12:13:51+00:00 	G3A010	IF TAKE ASPIRIN REGULARLY: FREQUENCY PER
74	Medication/supplement use	20876	phv00020876.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:13:59+00:00	2018-09-26 12:13:59+00:00 	G3A011	IF TAKE ASPIRIN REGULARLY: USUAL DOSE
74	Medication/supplement use	20877	phv00020877.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:14:06+00:00	2018-09-26 12:14:06+00:00 	G3A012	HAVE YOU EVER TAKEN MEDICATION FOR HYPERTENSION/HIGH BLOOD PRESSURE?
74	Medication/supplement use	20878	phv00020878.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:14:13+00:00	2018-09-26 12:14:13+00:00 	G3A013	IF YES TO G3A012, AT WHAT AGE DID YOU BEGIN
74	Medication/supplement use	20879	phv00020879.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:14:20+00:00	2018-09-26 12:14:20+00:00 	G3A014	HAVE YOU EVER TAKEN MEDICATION FOR HIGH BLOOD CHOLESTEROL?
74	Medication/supplement use	20880	phv00020880.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:14:28+00:00	2018-09-26 12:14:28+00:00 	G3A015	IF YES TO G3A014, AT WHAT AGE DID YOU BEGIN
74	Medication/supplement use	20881	phv00020881.v5.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:14:36+00:00	2018-09-26 12:14:36+00:00 	G3A016	HAVE YOU EVER TAKEN MEDICATION FOR HIGH BLOOD SUGAR OR DIABETES?
74	Medication/supplement use	20882	phv00020882.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:14:44+00:00	2018-09-26 12:14:44+00:00 	G3A017	IF YES TO G3A016, AT WHAT AGE DID YOU BEGIN
74	Medication/supplement use	20883	phv00020883.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:14:51+00:00	2018-09-26 12:14:51+00:00 	G3A018	IF YES TO G3A016, WAS INSULIN YOUR FIRST DIABETES MEDICATION?
74	Medication/supplement use	20885	phv00020885.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:16:06+00:00	2018-09-26 12:16:06+00:00 	G3A020	HAVE YOU EVER TAKEN MEDICATION FOR CARDIOVASCULAR DISEASE (FOR EXAMPLE ANGINA/CHEST PAIN, HEART FAILURE, ARTIAL FIBRILLATION/ HEART RHYTHM ABNORMALITY, STROKE, LEG PAIN WHEN WALKING?)
74	Medication/supplement use	20886	phv00020886.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:16:17+00:00	2018-09-26 12:16:17+00:00 	G3A021	IF YES TO G3A020, AT WHAT AGE DID YOU BEGIN
74	Medication/supplement use	20888	phv00020888.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:16:30+00:00	2018-09-26 12:16:30+00:00 	G3A024	HAVE YOU EVER TAKEN OR USED ORAL CONTRACEPTIVE PILLS, SHOTS, OR HORMONE IMPLANTS FOR BIRTH CONTROL OR MEDICAL INDICATIONS (NOT POST MENOPAUSAL HORMONE REPLACEMENT)?
74	Medication/supplement use	20889	phv00020889.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:16:41+00:00	2018-09-26 12:16:41+00:00 	G3A025	IF OCP USE, WHAT IS THE NAME OF THE CURRENT OR MOST RECENT ORAL CONTRACEPTIVE, SHOT OR IMPLANT USED?
74	Medication/supplement use	20890	phv00020890.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:16:48+00:00	2018-09-26 12:16:48+00:00 	G3A026	IF OCP USE, STRENGTH
74	Medication/supplement use	20891	phv00020891.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:16:55+00:00	2018-09-26 12:16:55+00:00 	G3A027	IF OCP USE, FORM
74	Medication/supplement use	20892	phv00020892.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:17:14+00:00	2018-09-26 12:17:14+00:00 	G3A032	IF OCP USE, WHAT IS THE TOTAL NUMBER OF YEARS OVER YOUR LIFETIME THAT YOU USED ORAL CONTRACEPTIVES PILLS, SHOTS, OR HORMONE IMPLANTS?
74	Medication/supplement use	20908	phv00020908.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:17:32+00:00	2018-09-26 12:17:32+00:00 	G3A053	IF PERIODS STOPPED: HAVE YOU EVER TAKEN HORMONE REPLACEMENT THERAPY (ESTROGEN/PROGESTERONE)?
74	Medication/supplement use	20909	phv00020909.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:17:47+00:00	2018-09-26 12:17:47+00:00 	G3A054	IF TAKEN HRT: WHAT AGE DID YOU BEGIN HORMONE REPLACEMENT THERAPY?
74	Medication/supplement use	20910	phv00020910.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:17:55+00:00	2018-09-26 12:17:55+00:00 	G3A055	IF TAKEN HRT: FOR HOW LONG DID YOU TAKE HORMONES (YEARS)?
74	Medication/supplement use	20911	phv00020911.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:18:03+00:00	2018-09-26 12:18:03+00:00 	G3A056	IF TAKEN HRT: FOR HOW LONG DID YOU TAKE HORMONES (MONTHS)?
74	Medication/supplement use	20912	phv00020912.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:18:12+00:00	2018-09-26 12:18:12+00:00 	G3A057	IF TAKEN HRT: ESTROGEN USE EVER?
74	Medication/supplement use	20913	phv00020913.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:18:21+00:00	2018-09-26 12:18:21+00:00 	G3A058	IF ESTROGEN USE EVER: NAME OF MOST RECENT ESTROGEN PREPARATION
74	Medication/supplement use	20914	phv00020914.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:18:30+00:00	2018-09-26 12:18:30+00:00 	G3A059	IF ESTROGEN USE EVER: THE STRENGTH OF ESTROGEN
74	Medication/supplement use	20915	phv00020915.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:18:42+00:00	2018-09-26 12:18:42+00:00 	G3A060	IF ESTROGEN USE EVER: NUMBER OF DAYS PER MONTH TAKEN
74	Medication/supplement use	20916	phv00020916.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:19:03+00:00	2018-09-26 12:19:03+00:00 	G3A061	IF TAKEN HRT: PROGESTERONE USE EVER?
74	Medication/supplement use	20917	phv00020917.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:19:15+00:00	2018-09-26 12:19:15+00:00 	G3A062	IF PROGESTERONE USE EVER: NAME OF MOST RECENT PROGESTERONE PREPARATION
74	Medication/supplement use	20918	phv00020918.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:19:23+00:00	2018-09-26 12:19:23+00:00 	G3A063	IF PROGESTERONE USE EVER: THE STRENGTH OF PROGESTERONE
74	Medication/supplement use	20919	phv00020919.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:19:30+00:00	2018-09-26 12:19:30+00:00 	G3A064	IF PROGESTERONE USE EVER: NUMBER OF DAYS PER MONTH TAKEN
74	Medication/supplement use	20920	phv00020920.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:19:38+00:00	2018-09-26 12:19:38+00:00 	G3A065	IF PERIODS STOPPED: HAVE YOU USED EVISTA (RALOXIFENE) OR NOLVADEX (TAMOXIFEN) OR OTHER SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)?
74	Medication/supplement use	20921	phv00020921.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:19:50+00:00	2018-09-26 12:19:50+00:00 	G3A066	IF USED SERMS: NUMBER OF MONTHS USED?
74	Medication/supplement use	20922	phv00020922.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:19:57+00:00	2018-09-26 12:19:57+00:00 	G3A067	IF USE SERMS: CURRENT USE?
74	Medication/supplement use	20923	phv00020923.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:20:11+00:00	2018-09-26 12:20:11+00:00 	G3A068	IF PERIODS STOPPED: DO YOU TAKE OVER-THE-COUNTER ALTERNATIVE, HERBAL, OR NATURAL SOY-BASED PREPARATIONS TO TREAT MENOPAUSAL SYMPTOMS?
74	Medication/supplement use	20924	phv00020924.v4.p10	pht000074.v10.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:20:22+00:00	2018-09-26 12:20:22+00:00 	G3A069	IF YES TO G3A068: SPECIFY PREPARATION
74	Medication/supplement use	69859	phv00069859.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:36:30+00:00	2018-09-26 12:36:30+00:00 	ADUR	FFQ: VITAMIN A SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68247	phv00068247.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:36:30+00:00	2018-09-26 12:36:30+00:00 	ADUR	FFQ: VITAMIN A SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68815	phv00068815.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:36:30+00:00	2018-09-26 12:36:30+00:00 	ADUR	FFQ: VITAMIN A SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	156758	phv00156758.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:36:30+00:00	2018-09-26 12:36:30+00:00 	ADUR	FFQ: VIT A SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157392	phv00157392.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:36:30+00:00	2018-09-26 12:36:30+00:00 	ADUR	FFQ: VITAMIN A SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157868	phv00157868.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:36:30+00:00	2018-09-26 12:36:30+00:00 	ADUR	FFQ: VITAMIN A SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	158185	phv00158185.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:36:30+00:00	2018-09-26 12:36:30+00:00 	ADUR	FFQ: VITAMIN A SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	162118	phv00162118.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:36:30+00:00	2018-09-26 12:36:30+00:00 	ADUR	FFQ: VIT A SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	69889	phv00069889.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:39:14+00:00	2018-09-26 12:39:14+00:00 	B_Y	FFQ: TAKE BREWER'S YEAST SUPPLEMENT
74	Medication/supplement use	68277	phv00068277.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:39:14+00:00	2018-09-26 12:39:14+00:00 	B_Y	FFQ: TAKE BREWER'S YEAST SUPPLEMENT
74	Medication/supplement use	68845	phv00068845.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:39:14+00:00	2018-09-26 12:39:14+00:00 	B_Y	FFQ: TAKE BREWER'S YEAST SUPPLEMENT
74	Medication/supplement use	156788	phv00156788.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:39:14+00:00	2018-09-26 12:39:14+00:00 	B_Y	FFQ: TAKE BREWER'S YEAST SUPPLEMENT
74	Medication/supplement use	157421	phv00157421.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:39:14+00:00	2018-09-26 12:39:14+00:00 	B_Y	FFQ: TAKE BREWER'S YEAST SUPPLEMENT
74	Medication/supplement use	157898	phv00157898.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:39:14+00:00	2018-09-26 12:39:14+00:00 	B_Y	FFQ: TAKE BREWER'S YEAST SUPPLEMENT
74	Medication/supplement use	158215	phv00158215.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:39:14+00:00	2018-09-26 12:39:14+00:00 	B_Y	FFQ: TAKE BREWER'S YEAST SUPPLEMENT
74	Medication/supplement use	162148	phv00162148.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:39:14+00:00	2018-09-26 12:39:14+00:00 	B_Y	FFQ: TAKE BREWER'S YEAST SUPPLEMENT
74	Medication/supplement use	69865	phv00069865.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6DUR	FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	69866	phv00069866.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6D	FFQ: VITAMIN B6 SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68253	phv00068253.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6DUR	FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68254	phv00068254.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6D	FFQ: VITAMIN B6 SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68821	phv00068821.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6DUR	FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68822	phv00068822.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6D	FFQ: VITAMIN B6 SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	156764	phv00156764.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6DUR	FFQ: VIT B6 SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	156765	phv00156765.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6D	FFQ: VIT B6 SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157398	phv00157398.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6DUR	FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157399	phv00157399.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6D	FFQ: VITAMIN B6 SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157874	phv00157874.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6DUR	FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157875	phv00157875.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6D	FFQ: VITAMIN B6 SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	158191	phv00158191.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6DUR	FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	158192	phv00158192.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6D	FFQ: VITAMIN B6 SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	162124	phv00162124.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6DUR	FFQ: VIT B6 SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	162125	phv00162125.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:43:46+00:00	2018-09-26 12:43:46+00:00 	B6D	FFQ: VIT B6 SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	69890	phv00069890.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:45:23+00:00	2018-09-26 12:45:23+00:00 	BCAROT	FFQ: TAKE BETA-CAROTENE SUPPLEMENT
74	Medication/supplement use	68278	phv00068278.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:45:23+00:00	2018-09-26 12:45:23+00:00 	BCAROT	FFQ: TAKE BETA-CAROTENE SUPPLEMENT
74	Medication/supplement use	68846	phv00068846.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:45:23+00:00	2018-09-26 12:45:23+00:00 	BCAROT	FFQ: TAKE BETA-CAROTENE SUPPLEMENT
74	Medication/supplement use	156789	phv00156789.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:45:23+00:00	2018-09-26 12:45:23+00:00 	BCAROT	FFQ: TAKE BETA-CAROTENE SUPPLEMENT
74	Medication/supplement use	157422	phv00157422.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:45:23+00:00	2018-09-26 12:45:23+00:00 	BCAROT	FFQ: TAKE BETA-CAROTENE SUPPLEMENT
74	Medication/supplement use	157899	phv00157899.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:45:23+00:00	2018-09-26 12:45:23+00:00 	BCAROT	FFQ: TAKE BETA-CAROTENE SUPPLEMENT
74	Medication/supplement use	158216	phv00158216.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:45:23+00:00	2018-09-26 12:45:23+00:00 	BCAROT	FFQ: TAKE BETA-CAROTENE SUPPLEMENT
74	Medication/supplement use	162149	phv00162149.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:45:23+00:00	2018-09-26 12:45:23+00:00 	BCAROT	FFQ: TAKE BETA-CAROTENE SUPPLEMENT
74	Medication/supplement use	69880	phv00069880.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CADUR	FFQ: CALCIUM SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	69881	phv00069881.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CAD	FFQ: CALCIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68268	phv00068268.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CADUR	FFQ: CALCIUM SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68269	phv00068269.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CAD	FFQ: CALCIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68836	phv00068836.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CADUR	FFQ: CALCIUM SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68837	phv00068837.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CAD	FFQ: CALCIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	156779	phv00156779.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CADUR	FFQ: CALCIUM SUPPLEMENT YEARS OF DUR
74	Medication/supplement use	156780	phv00156780.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CAD	FFQ: CALCIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157412	phv00157412.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CADUR	FFQ: CALCIUM SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157413	phv00157413.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CAD	FFQ: CALCIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157889	phv00157889.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CADUR	FFQ: CALCIUM SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157890	phv00157890.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CAD	FFQ: CALCIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	158206	phv00158206.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CADUR	FFQ: CALCIUM SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	158207	phv00158207.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CAD	FFQ: CALCIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	162139	phv00162139.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CADUR	FFQ: CALCIUM SUPPLEMENT YEARS OF DUR
74	Medication/supplement use	162140	phv00162140.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:47:40+00:00	2018-09-26 12:47:40+00:00 	CAD	FFQ: CALCIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	69862	phv00069862.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:49:22+00:00	2018-09-26 12:49:22+00:00 	CDUR	FFQ: VITAMIN C SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68250	phv00068250.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:49:22+00:00	2018-09-26 12:49:22+00:00 	CDUR	FFQ: VITAMIN C SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68818	phv00068818.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:49:22+00:00	2018-09-26 12:49:22+00:00 	CDUR	FFQ: VITAMIN C SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	156761	phv00156761.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:49:22+00:00	2018-09-26 12:49:22+00:00 	CDUR	FFQ: VIT C SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157395	phv00157395.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:49:22+00:00	2018-09-26 12:49:22+00:00 	CDUR	FFQ: VITAMIN C SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157871	phv00157871.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:49:22+00:00	2018-09-26 12:49:22+00:00 	CDUR	FFQ: VITAMIN C SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	158188	phv00158188.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:49:22+00:00	2018-09-26 12:49:22+00:00 	CDUR	FFQ: VITAMIN C SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	162121	phv00162121.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:49:22+00:00	2018-09-26 12:49:22+00:00 	CDUR	FFQ: VIT C SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	69885	phv00069885.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:50:38+00:00	2018-09-26 12:50:38+00:00 	CODLIV	FFQ: TAKE COD LIVER OIL SUPPLEMENT
74	Medication/supplement use	68273	phv00068273.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:50:38+00:00	2018-09-26 12:50:38+00:00 	CODLIV	FFQ: TAKE COD LIVER OIL SUPPLEMENT
74	Medication/supplement use	68841	phv00068841.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:50:38+00:00	2018-09-26 12:50:38+00:00 	CODLIV	FFQ: TAKE COD LIVER OIL SUPPLEMENT
74	Medication/supplement use	156784	phv00156784.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:50:38+00:00	2018-09-26 12:50:38+00:00 	CODLIV	FFQ: TAKE COD LIVER OIL SUPPLEMENT
74	Medication/supplement use	157417	phv00157417.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:50:38+00:00	2018-09-26 12:50:38+00:00 	CODLIV	FFQ: TAKE COD LIVER OIL SUPPLEMENT
74	Medication/supplement use	157894	phv00157894.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:50:38+00:00	2018-09-26 12:50:38+00:00 	CODLIV	FFQ: TAKE COD LIVER OIL SUPPLEMENT
74	Medication/supplement use	158211	phv00158211.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:50:38+00:00	2018-09-26 12:50:38+00:00 	CODLIV	FFQ: TAKE COD LIVER OIL SUPPLEMENT
74	Medication/supplement use	162144	phv00162144.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:50:38+00:00	2018-09-26 12:50:38+00:00 	CODLIV	FFQ: TAKE COD LIVER OIL SUPPLEMENT
74	Medication/supplement use	69868	phv00069868.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:52:07+00:00	2018-09-26 12:52:07+00:00 	EDUR	FFQ: VITAMIN E SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68256	phv00068256.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:52:07+00:00	2018-09-26 12:52:07+00:00 	EDUR	FFQ: VITAMIN E SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68824	phv00068824.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:52:07+00:00	2018-09-26 12:52:07+00:00 	EDUR	FFQ: VITAMIN E SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	156767	phv00156767.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:52:07+00:00	2018-09-26 12:52:07+00:00 	EDUR	FFQ: VIT E SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157401	phv00157401.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:52:07+00:00	2018-09-26 12:52:07+00:00 	EDUR	FFQ: VITAMIN E SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157877	phv00157877.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:52:07+00:00	2018-09-26 12:52:07+00:00 	EDUR	FFQ: VITAMIN E SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	158194	phv00158194.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:52:07+00:00	2018-09-26 12:52:07+00:00 	EDUR	FFQ: VITAMIN E SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	162127	phv00162127.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 12:52:07+00:00	2018-09-26 12:52:07+00:00 	EDUR	FFQ: VIT E SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	69874	phv00069874.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FEDUR	FFQ: IRON SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	69875	phv00069875.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FED	FFQ: IRON SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68262	phv00068262.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FEDUR	FFQ: IRON SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68263	phv00068263.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FED	FFQ: IRON SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68830	phv00068830.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FEDUR	FFQ: IRON SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68831	phv00068831.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FED	FFQ: IRON SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	156773	phv00156773.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FEDUR	FFQ: IRON SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	156774	phv00156774.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FED	FFQ: IRON SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157407	phv00157407.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FEDUR	FFQ: IRON SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157408	phv00157408.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FED	FFQ: IRON SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157883	phv00157883.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FEDUR	FFQ: IRON SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157884	phv00157884.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FED	FFQ: IRON SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	158200	phv00158200.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FEDUR	FFQ: IRON SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	158201	phv00158201.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FED	FFQ: IRON SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	162133	phv00162133.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FEDUR	FFQ: IRON SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	162134	phv00162134.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:18:18+00:00	2018-09-26 14:18:18+00:00 	FED	FFQ: IRON SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	69887	phv00069887.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:20:08+00:00	2018-09-26 14:20:08+00:00 	IODINE	FFQ: TAKE IODINE SUPPLEMENT
74	Medication/supplement use	68275	phv00068275.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:20:08+00:00	2018-09-26 14:20:08+00:00 	IODINE	FFQ: TAKE IODINE SUPPLEMENT
74	Medication/supplement use	68843	phv00068843.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:20:08+00:00	2018-09-26 14:20:08+00:00 	IODINE	FFQ: TAKE IODINE SUPPLEMENT
74	Medication/supplement use	156786	phv00156786.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:20:08+00:00	2018-09-26 14:20:08+00:00 	IODINE	FFQ: TAKE IODINE SUPPLEMENT
74	Medication/supplement use	157419	phv00157419.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:20:08+00:00	2018-09-26 14:20:08+00:00 	IODINE	FFQ: TAKE IODINE SUPPLEMENT
74	Medication/supplement use	157896	phv00157896.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:20:08+00:00	2018-09-26 14:20:08+00:00 	IODINE	FFQ: TAKE IODINE SUPPLEMENT
74	Medication/supplement use	158213	phv00158213.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:20:08+00:00	2018-09-26 14:20:08+00:00 	IODINE	FFQ: TAKE IODINE SUPPLEMENT
74	Medication/supplement use	162146	phv00162146.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:20:08+00:00	2018-09-26 14:20:08+00:00 	IODINE	FFQ: TAKE IODINE SUPPLEMENT
74	Medication/supplement use	69891	phv00069891.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:21:24+00:00	2018-09-26 14:21:24+00:00 	MG	FFQ: TAKE MAGNESIUM SUPPLEMENT
74	Medication/supplement use	68279	phv00068279.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:21:24+00:00	2018-09-26 14:21:24+00:00 	MG	FFQ: TAKE MAGNESIUM SUPPLEMENT
74	Medication/supplement use	68847	phv00068847.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:21:24+00:00	2018-09-26 14:21:24+00:00 	MG	FFQ: TAKE MAGNESIUM SUPPLEMENT
74	Medication/supplement use	156790	phv00156790.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:21:24+00:00	2018-09-26 14:21:24+00:00 	MG	FFQ: TAKE MAGNESIUM SUPPLEMENT
74	Medication/supplement use	157423	phv00157423.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:21:24+00:00	2018-09-26 14:21:24+00:00 	MG	FFQ: TAKE MAGNESIUM SUPPLEMENT
74	Medication/supplement use	157900	phv00157900.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:21:24+00:00	2018-09-26 14:21:24+00:00 	MG	FFQ: TAKE MAGNESIUM SUPPLEMENT
74	Medication/supplement use	158217	phv00158217.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:21:24+00:00	2018-09-26 14:21:24+00:00 	MG	FFQ: TAKE MAGNESIUM SUPPLEMENT
74	Medication/supplement use	162150	phv00162150.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:21:24+00:00	2018-09-26 14:21:24+00:00 	MG	FFQ: TAKE MAGNESIUM SUPPLEMENT
74	Medication/supplement use	69886	phv00069886.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:27:20+00:00	2018-09-26 14:27:20+00:00 	OMEGA3	FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT
74	Medication/supplement use	68274	phv00068274.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:27:20+00:00	2018-09-26 14:27:20+00:00 	OMEGA3	FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT
74	Medication/supplement use	68842	phv00068842.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:27:20+00:00	2018-09-26 14:27:20+00:00 	OMEGA3	FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT
74	Medication/supplement use	156785	phv00156785.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:27:20+00:00	2018-09-26 14:27:20+00:00 	OMEGA3	FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT
74	Medication/supplement use	157418	phv00157418.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:27:20+00:00	2018-09-26 14:27:20+00:00 	OMEGA3	FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT
74	Medication/supplement use	157895	phv00157895.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:27:20+00:00	2018-09-26 14:27:20+00:00 	OMEGA3	FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT
74	Medication/supplement use	158212	phv00158212.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:27:20+00:00	2018-09-26 14:27:20+00:00 	OMEGA3	FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT
74	Medication/supplement use	162145	phv00162145.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:27:20+00:00	2018-09-26 14:27:20+00:00 	OMEGA3	FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT
74	Medication/supplement use	69892	phv00069892.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:30:55+00:00	2018-09-26 14:30:55+00:00 	OTHERS	FFQ: TAKE OTHER SUPPLEMENT
74	Medication/supplement use	68280	phv00068280.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:30:55+00:00	2018-09-26 14:30:55+00:00 	OTHERS	FFQ: TAKE OTHER SUPPLEMENT
74	Medication/supplement use	68848	phv00068848.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:30:55+00:00	2018-09-26 14:30:55+00:00 	OTHERS	FFQ: TAKE OTHER SUPPLEMENT
74	Medication/supplement use	156791	phv00156791.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:30:55+00:00	2018-09-26 14:30:55+00:00 	OTHERS	FFQ: TAKE OTHER SUPPLEMENT
74	Medication/supplement use	157424	phv00157424.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:30:55+00:00	2018-09-26 14:30:55+00:00 	OTHERS	FFQ: TAKE OTHER SUPPLEMENT
74	Medication/supplement use	157901	phv00157901.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:30:55+00:00	2018-09-26 14:30:55+00:00 	OTHERS	FFQ: TAKE OTHER SUPPLEMENT
74	Medication/supplement use	158218	phv00158218.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:30:55+00:00	2018-09-26 14:30:55+00:00 	OTHERS	FFQ: TAKE OTHER SUPPLEMENT
74	Medication/supplement use	162151	phv00162151.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:30:55+00:00	2018-09-26 14:30:55+00:00 	OTHERS	FFQ: TAKE OTHER SUPPLEMENT
74	Medication/supplement use	69870	phv00069870.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SEL	FFQ: TAKE SELENIUM SUPPLEMENT
74	Medication/supplement use	69871	phv00069871.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELDUR	FFQ: SELENIUM SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	69872	phv00069872.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELD	FFQ: SELENIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68258	phv00068258.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SEL	FFQ: TAKE SELENIUM SUPPLEMENT
74	Medication/supplement use	68259	phv00068259.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELDUR	FFQ: SELENIUM SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68260	phv00068260.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELD	FFQ: SELENIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68826	phv00068826.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SEL	FFQ: TAKE SELENIUM SUPPLEMENT
74	Medication/supplement use	68827	phv00068827.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELDUR	FFQ: SELENIUM SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68828	phv00068828.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELD	FFQ: SELENIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	156769	phv00156769.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SEL	FFQ: TAKE SELENIUM SUPPLEMENT
74	Medication/supplement use	156770	phv00156770.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELDUR	FFQ: SELENIUM SUPPLEMENT YEARS OF DUR
74	Medication/supplement use	156771	phv00156771.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELD	FFQ: SELENIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157403	phv00157403.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SEL	FFQ: TAKE SELENIUM SUPPLEMENT
74	Medication/supplement use	157404	phv00157404.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELDUR	FFQ: SELENIUM SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157405	phv00157405.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELD	FFQ: SELENIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157879	phv00157879.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SEL	FFQ: TAKE SELENIUM SUPPLEMENT
74	Medication/supplement use	157880	phv00157880.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELDUR	FFQ: SELENIUM SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157881	phv00157881.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELD	FFQ: SELENIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	158196	phv00158196.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SEL	FFQ: TAKE SELENIUM SUPPLEMENT
74	Medication/supplement use	158197	phv00158197.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELDUR	FFQ: SELENIUM SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	158198	phv00158198.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELD	FFQ: SELENIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	162129	phv00162129.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SEL	FFQ: TAKE SELENIUM SUPPLEMENT
74	Medication/supplement use	162130	phv00162130.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELDUR	FFQ: SELENIUM SUPPLEMENT YEARS OF DUR
74	Medication/supplement use	162131	phv00162131.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:34:31+00:00	2018-09-26 14:34:31+00:00 	SELD	FFQ: SELENIUM SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	69884	phv00069884.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:35:44+00:00	2018-09-26 14:35:44+00:00 	VB	FFQ: TAKE VITAMIN B-COMPLEX SUPPLEMENT
74	Medication/supplement use	68272	phv00068272.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:35:44+00:00	2018-09-26 14:35:44+00:00 	VB	FFQ: TAKE VITAMIN B-COMPLEX SUPPLEMENT
74	Medication/supplement use	68840	phv00068840.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:35:44+00:00	2018-09-26 14:35:44+00:00 	VB	FFQ: TAKE VITAMIN B-COMPLEX SUPPLEMENT
74	Medication/supplement use	156783	phv00156783.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:35:44+00:00	2018-09-26 14:35:44+00:00 	VB	FFQ: TAKE VIT B-COMPLEX SUPPLEMENT
74	Medication/supplement use	157416	phv00157416.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:35:44+00:00	2018-09-26 14:35:44+00:00 	VB	FFQ: TAKE VITAMIN B-COMPLEX SUPPLEMENT
74	Medication/supplement use	157893	phv00157893.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:35:44+00:00	2018-09-26 14:35:44+00:00 	VB	FFQ: TAKE VITAMIN B-COMPLEX SUPPLEMENT
74	Medication/supplement use	158210	phv00158210.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:35:44+00:00	2018-09-26 14:35:44+00:00 	VB	FFQ: TAKE VITAMIN B-COMPLEX SUPPLEMENT
74	Medication/supplement use	162143	phv00162143.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:35:44+00:00	2018-09-26 14:35:44+00:00 	VB	FFQ: TAKE VIT B-COMPLEX SUPPLEMENT
74	Medication/supplement use	69876	phv00069876.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZN	FFQ: TAKE ZINC SUPPLEMENT
74	Medication/supplement use	69877	phv00069877.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZNDUR	FFQ: ZINC SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	69878	phv00069878.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZND	FFQ: ZINC SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68264	phv00068264.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZN	FFQ: TAKE ZINC SUPPLEMENT
74	Medication/supplement use	68265	phv00068265.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZNDUR	FFQ: ZINC SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68266	phv00068266.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZND	FFQ: ZINC SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68832	phv00068832.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZN	FFQ: TAKE ZINC SUPPLEMENT
74	Medication/supplement use	68833	phv00068833.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZNDUR	FFQ: ZINC SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	68834	phv00068834.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZND	FFQ: ZINC SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	156775	phv00156775.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZN	FFQ: TAKE ZINC SUPPLEMENT
74	Medication/supplement use	156776	phv00156776.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZNDUR	FFQ: ZINC SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	156777	phv00156777.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZND	FFQ: ZINC SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157409	phv00157409.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZN	FFQ: TAKE ZINC SUPPLEMENT
74	Medication/supplement use	157410	phv00157410.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZNDUR	FFQ: ZINC SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157411	phv00157411.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZND	FFQ: ZINC SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157885	phv00157885.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZN	FFQ: TAKE ZINC SUPPLEMENT
74	Medication/supplement use	157886	phv00157886.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZNDUR	FFQ: ZINC SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	157887	phv00157887.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZND	FFQ: ZINC SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	158202	phv00158202.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZN	FFQ: TAKE ZINC SUPPLEMENT
74	Medication/supplement use	158203	phv00158203.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZNDUR	FFQ: ZINC SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	158204	phv00158204.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZND	FFQ: ZINC SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	162135	phv00162135.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZN	FFQ: TAKE ZINC SUPPLEMENT
74	Medication/supplement use	162136	phv00162136.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	zndur	FFQ: ZINC SUPPLEMENT YEARS OF DURATION
74	Medication/supplement use	162137	phv00162137.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:39:48+00:00	2018-09-26 14:39:48+00:00 	ZND	FFQ: ZINC SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	69860	phv00069860.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:44:28+00:00	2018-09-26 14:44:28+00:00 	AD	FFQ: VITAMIN A SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68248	phv00068248.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:44:28+00:00	2018-09-26 14:44:28+00:00 	AD	FFQ: VITAMIN A SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68816	phv00068816.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:44:28+00:00	2018-09-26 14:44:28+00:00 	AD	FFQ: VITAMIN A SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	156759	phv00156759.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:44:28+00:00	2018-09-26 14:44:28+00:00 	AD	FFQ: VIT A SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157393	phv00157393.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:44:28+00:00	2018-09-26 14:44:28+00:00 	AD	FFQ: VITAMIN A SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157869	phv00157869.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:44:28+00:00	2018-09-26 14:44:28+00:00 	AD	FFQ: VITAMIN A SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	158186	phv00158186.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:44:28+00:00	2018-09-26 14:44:28+00:00 	AD	FFQ: VITAMIN A SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	162119	phv00162119.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:44:28+00:00	2018-09-26 14:44:28+00:00 	AD	FFQ: VIT A SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	69864	phv00069864.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:49:53+00:00	2018-09-26 14:49:53+00:00 	B6	FFQ: TAKE VITAMIN B6 SUPPLEMENT
74	Medication/supplement use	68252	phv00068252.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:49:53+00:00	2018-09-26 14:49:53+00:00 	B6	FFQ: TAKE VITAMIN B6 SUPPLEMENT
74	Medication/supplement use	68820	phv00068820.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:49:53+00:00	2018-09-26 14:49:53+00:00 	B6	FFQ: TAKE VITAMIN B6 SUPPLEMENT
74	Medication/supplement use	156763	phv00156763.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:49:53+00:00	2018-09-26 14:49:53+00:00 	B6	FFQ: TAKE VIT B6 SUPPLEMENT
74	Medication/supplement use	157397	phv00157397.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:49:53+00:00	2018-09-26 14:49:53+00:00 	B6	FFQ: TAKE VITAMIN B6 SUPPLEMENT
74	Medication/supplement use	157873	phv00157873.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:49:53+00:00	2018-09-26 14:49:53+00:00 	B6	FFQ: TAKE VITAMIN B6 SUPPLEMENT
74	Medication/supplement use	158190	phv00158190.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:49:53+00:00	2018-09-26 14:49:53+00:00 	B6	FFQ: TAKE VITAMIN B6 SUPPLEMENT
74	Medication/supplement use	162123	phv00162123.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:49:53+00:00	2018-09-26 14:49:53+00:00 	B6	FFQ: TAKE VIT B6 SUPPLEMENT
74	Medication/supplement use	69863	phv00069863.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:53:13+00:00	2018-09-26 14:53:13+00:00 	CD	FFQ: VITAMIN C SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68251	phv00068251.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:53:13+00:00	2018-09-26 14:53:13+00:00 	CD	FFQ: VITAMIN C SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68819	phv00068819.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:53:13+00:00	2018-09-26 14:53:13+00:00 	CD	FFQ: VITAMIN C SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	156762	phv00156762.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:53:13+00:00	2018-09-26 14:53:13+00:00 	CD	FFQ: VIT C SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157396	phv00157396.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:53:13+00:00	2018-09-26 14:53:13+00:00 	CD	FFQ: VITAMIN C SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157872	phv00157872.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:53:13+00:00	2018-09-26 14:53:13+00:00 	CD	FFQ: VITAMIN C SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	158189	phv00158189.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:53:13+00:00	2018-09-26 14:53:13+00:00 	CD	FFQ: VITAMIN C SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	162122	phv00162122.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:53:13+00:00	2018-09-26 14:53:13+00:00 	CD	FFQ: VIT C SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	69888	phv00069888.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:54:20+00:00	2018-09-26 14:54:20+00:00 	CU	FFQ: TAKE COPPER SUPPLEMENT
74	Medication/supplement use	68276	phv00068276.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:54:20+00:00	2018-09-26 14:54:20+00:00 	CU	FFQ: TAKE COPPER SUPPLEMENT
74	Medication/supplement use	68844	phv00068844.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:54:20+00:00	2018-09-26 14:54:20+00:00 	CU	FFQ: TAKE COPPER SUPPLEMENT
74	Medication/supplement use	156787	phv00156787.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:54:20+00:00	2018-09-26 14:54:20+00:00 	CU	FFQ: TAKE COPPER SUPPLEMENT
74	Medication/supplement use	157420	phv00157420.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:54:20+00:00	2018-09-26 14:54:20+00:00 	CU	FFQ: TAKE COPPER SUPPLEMENT
74	Medication/supplement use	157897	phv00157897.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:54:20+00:00	2018-09-26 14:54:20+00:00 	CU	FFQ: TAKE COPPER SUPPLEMENT
74	Medication/supplement use	158214	phv00158214.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:54:20+00:00	2018-09-26 14:54:20+00:00 	CU	FFQ: TAKE COPPER SUPPLEMENT
74	Medication/supplement use	162147	phv00162147.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:54:20+00:00	2018-09-26 14:54:20+00:00 	CU	FFQ: TAKE COPPER SUPPLEMENT
74	Medication/supplement use	69869	phv00069869.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:55:45+00:00	2018-09-26 14:55:45+00:00 	ED	FFQ: VITAMIN E SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68257	phv00068257.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:55:45+00:00	2018-09-26 14:55:45+00:00 	ED	FFQ: VITAMIN E SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	68825	phv00068825.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:55:45+00:00	2018-09-26 14:55:45+00:00 	ED	FFQ: VITAMIN E SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	156768	phv00156768.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:55:46+00:00	2018-09-26 14:55:46+00:00 	ED	FFQ: VIT E SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157402	phv00157402.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:55:46+00:00	2018-09-26 14:55:46+00:00 	ED	FFQ: VITAMIN E SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	157878	phv00157878.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:55:46+00:00	2018-09-26 14:55:46+00:00 	ED	FFQ: VITAMIN E SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	158195	phv00158195.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:55:46+00:00	2018-09-26 14:55:46+00:00 	ED	FFQ: VITAMIN E SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	162128	phv00162128.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:55:46+00:00	2018-09-26 14:55:46+00:00 	ED	FFQ: VIT E SUPPLEMENT DOSE PER DAY
74	Medication/supplement use	69858	phv00069858.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:57:13+00:00	2018-09-26 14:57:13+00:00 	A	FFQ: TAKE VITAMIN A SUPPLEMENT
74	Medication/supplement use	69861	phv00069861.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:59:31+00:00	2018-09-26 14:59:31+00:00 	C	FFQ: TAKE VITAMIN C SUPPLEMENT
74	Medication/supplement use	69879	phv00069879.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 14:59:51+00:00	2018-09-26 14:59:51+00:00 	CA	FFQ: TAKE CALCIUM SUPPLEMENT
74	Medication/supplement use	69883	phv00069883.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:00:48+00:00	2018-09-26 15:00:48+00:00 	D	FFQ: TAKE VITAMIN D SUPPLEMENT
74	Medication/supplement use	69867	phv00069867.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:01:02+00:00	2018-09-26 15:01:02+00:00 	E	FFQ: TAKE VITAMIN E SUPPLEMENT
74	Medication/supplement use	69882	phv00069882.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:01:20+00:00	2018-09-26 15:01:20+00:00 	FA	FFQ: TAKE FOLIC ACID SUPPLEMENT
74	Medication/supplement use	69873	phv00069873.v4.p10	pht000680.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:01:33+00:00	2018-09-26 15:01:33+00:00 	FE	FFQ: TAKE IRON SUPPLEMENT
74	Medication/supplement use	157391	phv00157391.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:03:42+00:00	2018-09-26 15:03:42+00:00 	A	FFQ: TAKE VITAMIN A SUPPLEMENT
74	Medication/supplement use	157394	phv00157394.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:03:56+00:00	2018-09-26 15:03:56+00:00 	C	FFQ: TAKE VITAMIN C SUPPLEMENT
74	Medication/supplement use	157736	phv00157736.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:04:06+00:00	2018-09-26 15:04:06+00:00 	CA	FFQ: TAKE CALCIUM SUPPLEMENT
74	Medication/supplement use	157415	phv00157415.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:04:24+00:00	2018-09-26 15:04:24+00:00 	D	FFQ: TAKE VITAMIN D SUPPLEMENT
74	Medication/supplement use	157400	phv00157400.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:04:34+00:00	2018-09-26 15:04:34+00:00 	E	FFQ: TAKE VITAMIN E SUPPLEMENT
74	Medication/supplement use	157414	phv00157414.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:04:46+00:00	2018-09-26 15:04:46+00:00 	FA	FFQ: TAKE FOLIC ACID SUPPLEMENT
74	Medication/supplement use	157406	phv00157406.v1.p10	pht002151.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:04:58+00:00	2018-09-26 15:04:58+00:00 	FE	FFQ: TAKE IRON SUPPLEMENT
74	Medication/supplement use	157867	phv00157867.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:06:44+00:00	2018-09-26 15:06:44+00:00 	A	FFQ: TAKE VITAMIN A SUPPLEMENT
74	Medication/supplement use	157870	phv00157870.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:07:02+00:00	2018-09-26 15:07:02+00:00 	C	FFQ: TAKE VITAMIN C SUPPLEMENT
74	Medication/supplement use	157888	phv00157888.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:07:13+00:00	2018-09-26 15:07:13+00:00 	CA	FFQ: TAKE CALCIUM SUPPLEMENT
74	Medication/supplement use	157892	phv00157892.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:07:31+00:00	2018-09-26 15:07:31+00:00 	D	FFQ: TAKE VITAMIN D SUPPLEMENT
74	Medication/supplement use	157876	phv00157876.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:07:43+00:00	2018-09-26 15:07:43+00:00 	E	FFQ: TAKE VITAMIN E SUPPLEMENT
74	Medication/supplement use	157891	phv00157891.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:07:57+00:00	2018-09-26 15:07:57+00:00 	FA	FFQ: TAKE FOLIC ACID SUPPLEMENT
74	Medication/supplement use	157882	phv00157882.v1.p10	pht002152.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:08:09+00:00	2018-09-26 15:08:09+00:00 	FE	FFQ: TAKE IRON SUPPLEMENT
74	Medication/supplement use	158184	phv00158184.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:09:54+00:00	2018-09-26 15:09:54+00:00 	A	FFQ: TAKE VITAMIN A SUPPLEMENT
74	Medication/supplement use	158187	phv00158187.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:10:10+00:00	2018-09-26 15:10:10+00:00 	C	FFQ: TAKE VITAMIN C SUPPLEMENT
74	Medication/supplement use	158205	phv00158205.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:10:26+00:00	2018-09-26 15:10:26+00:00 	CA	FFQ: TAKE CALCIUM SUPPLEMENT
74	Medication/supplement use	158209	phv00158209.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:10:51+00:00	2018-09-26 15:10:51+00:00 	D	FFQ: TAKE VITAMIN D SUPPLEMENT
74	Medication/supplement use	158193	phv00158193.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:11:04+00:00	2018-09-26 15:11:04+00:00 	E	FFQ: TAKE VITAMIN E SUPPLEMENT
74	Medication/supplement use	158208	phv00158208.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:11:19+00:00	2018-09-26 15:11:19+00:00 	FA	FFQ: TAKE FOLIC ACID SUPPLEMENT
74	Medication/supplement use	158199	phv00158199.v1.p10	pht002153.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:11:31+00:00	2018-09-26 15:11:31+00:00 	FE	FFQ: TAKE IRON SUPPLEMENT
74	Medication/supplement use	68246	phv00068246.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:15:39+00:00	2018-09-26 15:15:39+00:00 	A	FFQ: TAKE VITAMIN A SUPPLEMENT
74	Medication/supplement use	68249	phv00068249.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:15:53+00:00	2018-09-26 15:15:53+00:00 	C	FFQ: TAKE VITAMIN C SUPPLEMENT
74	Medication/supplement use	68267	phv00068267.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:16:04+00:00	2018-09-26 15:16:04+00:00 	CA	FFQ: TAKE CALCIUM SUPPLEMENT
74	Medication/supplement use	68271	phv00068271.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:16:24+00:00	2018-09-26 15:16:24+00:00 	D	FFQ: TAKE VITAMIN D SUPPLEMENT
74	Medication/supplement use	68255	phv00068255.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:17:04+00:00	2018-09-26 15:17:04+00:00 	E	FFQ: TAKE VITAMIN E SUPPLEMENT
74	Medication/supplement use	68270	phv00068270.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:17:16+00:00	2018-09-26 15:17:16+00:00 	FA	FFQ: TAKE FOLIC ACID SUPPLEMENT
74	Medication/supplement use	68261	phv00068261.v4.p10	pht000681.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:17:28+00:00	2018-09-26 15:17:28+00:00 	FE	FFQ: TAKE IRON SUPPLEMENT
74	Medication/supplement use	68814	phv00068814.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:19:20+00:00	2018-09-26 15:19:20+00:00 	A	FFQ: TAKE VITAMIN A SUPPLEMENT
74	Medication/supplement use	68817	phv00068817.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:19:43+00:00	2018-09-26 15:19:43+00:00 	C	FFQ: TAKE VITAMIN C SUPPLEMENT
74	Medication/supplement use	68835	phv00068835.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:19:56+00:00	2018-09-26 15:19:56+00:00 	CA	FFQ: TAKE CALCIUM SUPPLEMENT
74	Medication/supplement use	68839	phv00068839.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:20:11+00:00	2018-09-26 15:20:11+00:00 	D	FFQ: TAKE VITAMIN D SUPPLEMENT
74	Medication/supplement use	68823	phv00068823.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:20:22+00:00	2018-09-26 15:20:22+00:00 	E	FFQ: TAKE VITAMIN E SUPPLEMENT
74	Medication/supplement use	68838	phv00068838.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:20:36+00:00	2018-09-26 15:20:36+00:00 	FA	FFQ: TAKE FOLIC ACID SUPPLEMENT
74	Medication/supplement use	68829	phv00068829.v4.p10	pht000682.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:20:46+00:00	2018-09-26 15:20:46+00:00 	FE	FFQ: TAKE IRON SUPPLEMENT
74	Medication/supplement use	156757	phv00156757.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:22:46+00:00	2018-09-26 15:22:46+00:00 	A	FFQ: TAKE VIT A SUPPLEMENT
74	Medication/supplement use	156760	phv00156760.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:23:06+00:00	2018-09-26 15:23:06+00:00 	C	FFQ: TAKE VIT C SUPPLEMENT
74	Medication/supplement use	156778	phv00156778.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:23:18+00:00	2018-09-26 15:23:18+00:00 	CA	FFQ: TAKE CALCIUM SUPPLEMENT
74	Medication/supplement use	156782	phv00156782.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:23:37+00:00	2018-09-26 15:23:37+00:00 	D	FFQ: TAKE VIT D SUPPLEMENT
74	Medication/supplement use	156766	phv00156766.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:23:48+00:00	2018-09-26 15:23:48+00:00 	E	FFQ: TAKE VIT E SUPPLEMENT
74	Medication/supplement use	156781	phv00156781.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:24:00+00:00	2018-09-26 15:24:00+00:00 	FA	FFQ: TAKE FOLIC ACID SUPPLEMENT
74	Medication/supplement use	156772	phv00156772.v2.p10	pht002150.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:24:11+00:00	2018-09-26 15:24:11+00:00 	FE	FFQ: TAKE IRON SUPPLEMENT
74	Medication/supplement use	162117	phv00162117.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:26:40+00:00	2018-09-26 15:26:40+00:00 	A	FFQ: TAKE VIT A SUPPLEMENT
74	Medication/supplement use	162120	phv00162120.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:26:56+00:00	2018-09-26 15:26:56+00:00 	C	FFQ: TAKE VIT C SUPPLEMENT
74	Medication/supplement use	162138	phv00162138.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:27:09+00:00	2018-09-26 15:27:09+00:00 	CA	FFQ: TAKE CALCIUM SUPPLEMENT
74	Medication/supplement use	162142	phv00162142.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:27:26+00:00	2018-09-26 15:27:26+00:00 	D	FFQ: TAKE VIT D SUPPLEMENT
74	Medication/supplement use	162126	phv00162126.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:27:40+00:00	2018-09-26 15:27:40+00:00 	E	FFQ: TAKE VIT E SUPPLEMENT
74	Medication/supplement use	162141	phv00162141.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:27:53+00:00	2018-09-26 15:27:53+00:00 	FA	FFQ: TAKE FOLIC ACID SUPPLEMENT
74	Medication/supplement use	162132	phv00162132.v4.p10	pht002350.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:28:04+00:00	2018-09-26 15:28:04+00:00 	FE	FFQ: TAKE IRON SUPPLEMENT
74	Medication/supplement use	172407	phv00172407.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:32:45+00:00	2018-09-26 15:32:45+00:00 	Q_AD	FFQ: Vitamin A supplement dose per day
74	Medication/supplement use	172428	phv00172428.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:33:31+00:00	2018-09-26 15:33:31+00:00 	Q_B12	FFQ: Take vitamin B12 supplement
74	Medication/supplement use	172412	phv00172412.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:33:55+00:00	2018-09-26 15:33:55+00:00 	Q_B6	FFQ: Take vitamin B6 supplement
74	Medication/supplement use	172413	phv00172413.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:34:13+00:00	2018-09-26 15:34:13+00:00 	Q_B6D	FFQ: Vitamin B6 supplement dose per day
74	Medication/supplement use	172431	phv00172431.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:34:57+00:00	2018-09-26 15:34:57+00:00 	Q_BCAR	FFQ: Take beta-carotene supplement
74	Medication/supplement use	172440	phv00172440.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:35:11+00:00	2018-09-26 15:35:11+00:00 	Q_BCOMPL	FFQ: Take B-complex supplement
74	Medication/supplement use	172418	phv00172418.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:35:54+00:00	2018-09-26 15:35:54+00:00 	Q_CAD	FFQ: Calcium supplement dose per day
74	Medication/supplement use	172417	phv00172417.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:36:06+00:00	2018-09-26 15:36:06+00:00 	Q_CALCIUM	FFQ: Take calcium supplement
74	Medication/supplement use	172411	phv00172411.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:36:18+00:00	2018-09-26 15:36:18+00:00 	Q_CD	FFQ: Vitamin C supplement dose per day
74	Medication/supplement use	172438	phv00172438.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:36:33+00:00	2018-09-26 15:36:33+00:00 	Q_CHOL	FFQ: Take choline supplement
74	Medication/supplement use	172427	phv00172427.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:36:52+00:00	2018-09-26 15:36:52+00:00 	Q_COD_LIV_OIL	FFQ: Take cod liver oil supplement
74	Medication/supplement use	172437	phv00172437.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:37:07+00:00	2018-09-26 15:37:07+00:00 	Q_COQ10	FFQ: Take coenzyme Q10 supplement
74	Medication/supplement use	172435	phv00172435.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:37:24+00:00	2018-09-26 15:37:24+00:00 	Q_CR	FFQ: Take chromium supplement
74	Medication/supplement use	172442	phv00172442.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:38:02+00:00	2018-09-26 15:38:02+00:00 	Q_DHEA	FFQ: Take DHEA supplement
74	Medication/supplement use	172415	phv00172415.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:38:34+00:00	2018-09-26 15:38:34+00:00 	Q_ED	FFQ: Vitamin E supplement dose per day
74	Medication/supplement use	172416	phv00172416.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:38:43+00:00	2018-09-26 15:38:43+00:00 	Q_ETYPE	FFQ: Type of vitamin E supplement
74	Medication/supplement use	172430	phv00172430.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:39:17+00:00	2018-09-26 15:39:17+00:00 	Q_FLAX	FFQ: Take flax seed supplement
74	Medication/supplement use	172439	phv00172439.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:39:27+00:00	2018-09-26 15:39:27+00:00 	Q_FOLIC_ACID	FFQ: Take folic acid supplement
74	Medication/supplement use	172443	phv00172443.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:39:57+00:00	2018-09-26 15:39:57+00:00 	Q_IRON	FFQ: Take iron supplement
74	Medication/supplement use	172429	phv00172429.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:40:19+00:00	2018-09-26 15:40:19+00:00 	Q_LINSEED	FFQ: Take flax seed oil supplement
74	Medication/supplement use	172436	phv00172436.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:40:35+00:00	2018-09-26 15:40:35+00:00 	Q_LECITHIN	FFQ: Take lecithin supplement
74	Medication/supplement use	172441	phv00172441.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:40:47+00:00	2018-09-26 15:40:47+00:00 	Q_LYCO	FFQ: Take lycopene supplement
74	Medication/supplement use	172432	phv00172432.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:41:29+00:00	2018-09-26 15:41:29+00:00 	Q_MAGNESIUM	FFQ: Take magnesium supplement
74	Medication/supplement use	172426	phv00172426.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:41:40+00:00	2018-09-26 15:41:40+00:00 	Q_METAMUCIL	FFQ: Take Metamucil/Citrucel supplement
74	Medication/supplement use	172434	phv00172434.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:42:09+00:00	2018-09-26 15:42:09+00:00 	Q_NIACIN2	FFQ: Take niacin supplement
74	Medication/supplement use	172433	phv00172433.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:42:42+00:00	2018-09-26 15:42:42+00:00 	Q_OMEGA_3_EPA	FFQ: Take fish oil supplement
74	Medication/supplement use	172444	phv00172444.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:43:04+00:00	2018-09-26 15:43:04+00:00 	Q_OTHERS	FFQ: Take other supplement
74	Medication/supplement use	172419	phv00172419.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:43:32+00:00	2018-09-26 15:43:32+00:00 	Q_SEL	FFQ: Take selenium supplement
74	Medication/supplement use	172420	phv00172420.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:43:40+00:00	2018-09-26 15:43:40+00:00 	Q_SELD	FFQ: Selenium supplement dose per day
74	Medication/supplement use	172406	phv00172406.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:44:28+00:00	2018-09-26 15:44:28+00:00 	Q_VITAMIN_A	FFQ: Take vitamin A supplement
74	Medication/supplement use	172408	phv00172408.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:44:36+00:00	2018-09-26 15:44:36+00:00 	Q_VITAMIN_K	FFQ: Take potassium supplement
74	Medication/supplement use	172410	phv00172410.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:44:43+00:00	2018-09-26 15:44:43+00:00 	Q_VITAMIN_C	FFQ: Take vitamin C supplement
74	Medication/supplement use	172414	phv00172414.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:44:51+00:00	2018-09-26 15:44:51+00:00 	Q_VITAMIN_E	FFQ: Take vitamin E supplement
74	Medication/supplement use	172421	phv00172421.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:45:00+00:00	2018-09-26 15:45:00+00:00 	Q_VITAMIN_D	FFQ: Take vitamin D supplement
74	Medication/supplement use	172422	phv00172422.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:45:09+00:00	2018-09-26 15:45:09+00:00 	Q_VITDD	FFQ: Vitamin D supplement dose per day
74	Medication/supplement use	172423	phv00172423.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:45:42+00:00	2018-09-26 15:45:42+00:00 	Q_ZINC	FFQ: Take zinc supplement
74	Medication/supplement use	172424	phv00172424.v1.p10	pht002900.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:45:51+00:00	2018-09-26 15:45:51+00:00 	Q_ZND	FFQ: Zinc supplement dose per day
74	Medication/supplement use	36444	phv00036444.v5.p10	pht000307.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:54:40+00:00	2018-09-26 15:54:40+00:00 	EST1	Current estrogen user at exam 1
74	Medication/supplement use	70740	phv00070740.v3.p10	pht000693.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:54:50+00:00	2018-09-26 15:54:50+00:00 	EST1	Estrogen Use At Exam 1
74	Medication/supplement use	276932	phv00276932.v1.p10	pht006020.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:54:57+00:00	2018-09-26 15:54:57+00:00 	EST1	Estrogen use at Exam 1 Collection Interval: Cumulative through Exam 2
74	Medication/supplement use	276943	phv00276943.v1.p10	pht006021.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:55:06+00:00	2018-09-26 15:55:06+00:00 	EST1	Estrogen use at Exam 1 Collection Interval: Cumulative through Exam 2
74	Medication/supplement use	276954	phv00276954.v1.p10	pht006022.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:55:15+00:00	2018-09-26 15:55:15+00:00 	EST1	Estrogen use at Exam 1 Collection Interval: Cases reviewed through Exam 3
74	Medication/supplement use	36445	phv00036445.v5.p10	pht000307.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:57:11+00:00	2018-09-26 15:57:11+00:00 	EST2	Current estrogen user at exam 2
74	Medication/supplement use	172149	phv00172149.v1.p10	pht000693.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:57:11+00:00	2018-09-26 15:57:11+00:00 	EST2	Estrogen Use At Exam 2
74	Medication/supplement use	276933	phv00276933.v1.p10	pht006020.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:57:11+00:00	2018-09-26 15:57:11+00:00 	EST2	Estrogen use at Exam 2 Collection Interval: Cumulative through Exam 2
74	Medication/supplement use	276944	phv00276944.v1.p10	pht006021.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:57:11+00:00	2018-09-26 15:57:11+00:00 	EST2	Estrogen use at Exam 2 Collection Interval: Cumulative through Exam 2
74	Medication/supplement use	276955	phv00276955.v1.p10	pht006022.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:57:11+00:00	2018-09-26 15:57:11+00:00 	EST2	Estrogen use at Exam 2 Collection Interval: Cases reviewed through Exam 3
74	Medication/supplement use	36446	phv00036446.v6.p10	pht000307.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:57:58+00:00	2018-09-26 15:57:58+00:00 	EST3	Current estrogen user at exam 3
74	Medication/supplement use	276956	phv00276956.v1.p10	pht006022.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:57:58+00:00	2018-09-26 15:57:58+00:00 	EST3	Estrogen use at Exam 3 Collection Interval: Cases reviewed through Exam 3
74	Medication/supplement use	36443	phv00036443.v6.p10	pht000307.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:59:29+00:00	2018-09-26 15:59:29+00:00 	EST7	Current estrogen user at exam 7
74	Medication/supplement use	36447	phv00036447.v6.p10	pht000307.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:59:29+00:00	2018-09-26 15:59:29+00:00 	EST4	Current estrogen user at exam 4
74	Medication/supplement use	36448	phv00036448.v6.p10	pht000307.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:59:29+00:00	2018-09-26 15:59:29+00:00 	EST5	Current estrogen user at exam 5
74	Medication/supplement use	36449	phv00036449.v6.p10	pht000307.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:59:29+00:00	2018-09-26 15:59:29+00:00 	EST6	Current estrogen user at exam 6
74	Medication/supplement use	76390	phv00076390.v4.p10	pht000307.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 15:59:29+00:00	2018-09-26 15:59:29+00:00 	EST8	Current estrogen user at exam 8
74	Medication/supplement use	172150	phv00172150.v1.p10	pht000693.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:00:57+00:00	2018-09-26 17:00:57+00:00 	SERM1	Selective Estrogen Receptor Modulator Use At Exam 1
74	Medication/supplement use	172151	phv00172151.v1.p10	pht000693.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:00:57+00:00	2018-09-26 17:00:57+00:00 	SERM2	Selective Estrogen Receptor Modulator Use At Exam 2
74	Medication/supplement use	276934	phv00276934.v1.p10	pht006020.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:00:57+00:00	2018-09-26 17:00:57+00:00 	SERM1	Selective Estrogen Receptor Modulators (SERMS) use at Exam 1 Collection Interval: Cumulative through Exam 2
74	Medication/supplement use	276935	phv00276935.v1.p10	pht006020.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:00:57+00:00	2018-09-26 17:00:57+00:00 	SERM2	Selective Estrogen Receptor Modulators (SERMs) use at Exam 2 Collection Interval: Cumulative through Exam 2
74	Medication/supplement use	276945	phv00276945.v1.p10	pht006021.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:00:57+00:00	2018-09-26 17:00:57+00:00 	SERM1	Selective Estrogen Receptor Modulators (SERMs) use at Exam 1 Collection Interval: Cumulative through Exam 2
74	Medication/supplement use	276946	phv00276946.v1.p10	pht006021.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:00:57+00:00	2018-09-26 17:00:57+00:00 	SERM2	Selective Estrogen Receptor Modulators (SERMs) use at Exam 2 Collection Interval: Cumulative through Exam 2
74	Medication/supplement use	276957	phv00276957.v1.p10	pht006022.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:00:57+00:00	2018-09-26 17:00:57+00:00 	SERM1	Selective Estrogen Receptor Modulators (SERMs) use at Exam 1 Collection Interval: Cases reviewed through Exam 3
74	Medication/supplement use	276958	phv00276958.v1.p10	pht006022.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:00:57+00:00	2018-09-26 17:00:57+00:00 	SERM2	Selective Estrogen Receptor Modulators (SERMs) use at Exam 2 Collection Interval: Cases reviewed through Exam 3
74	Medication/supplement use	276959	phv00276959.v1.p10	pht006022.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:00:57+00:00	2018-09-26 17:00:57+00:00 	SERM3	Selective Estrogen Receptor Modulators (SERMs) use at Exam 3 Collection Interval: Cases reviewed through Exam 3
74	Medication/supplement use	22717	phv00022717.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:02:11+00:00	2018-09-26 17:02:11+00:00 	RQ016	CURRENTLY TAKING ANY MEDICINES (INC. INHALERS, AEROSOLS, OR TABLETS) FOR ASTHMA
74	Medication/supplement use	22724	phv00022724.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:02:11+00:00	2018-09-26 17:02:11+00:00 	RQ023	CURRENTLY TAKING ANY STEROID MEDICATIONS
74	Medication/supplement use	22725	phv00022725.v5.p10	pht000107.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:02:11+00:00	2018-09-26 17:02:11+00:00 	RQ024	IF TAKING ANY STEROID MEDICATIONS, BY WHAT ROUTE (IF TAKEN BY MORE THAN ONE ROUTE, HIERARCHY OF ROUTES IS INJECTED, ORAL, INHALED, NASAL, SKIN...)
74	Medication/supplement use	55377	phv00055377.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:04:31+00:00	2018-09-26 17:04:31+00:00 	ACE1	Ace inhibitors
74	Medication/supplement use	22770	phv00022770.v5.p10	pht000110.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:05:21+00:00	2018-09-26 17:05:21+00:00 	E2	ESTROGEN (PG/ML)
74	Medication/supplement use	56924	phv00056924.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:07:45+00:00	2018-09-26 17:07:45+00:00 	A2A2	Angiotensin type 2 antagonists
74	Medication/supplement use	55378	phv00055378.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:08:32+00:00	2018-09-26 17:08:32+00:00 	ACED1	Ace inhibitors and diuretics
74	Medication/supplement use	56926	phv00056926.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:08:32+00:00	2018-09-26 17:08:32+00:00 	ACE2	ACE inhibitors without diuretics
74	Medication/supplement use	56927	phv00056927.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:08:32+00:00	2018-09-26 17:08:32+00:00 	ACED2	ACE inhibitors with diuretics
74	Medication/supplement use	56928	phv00056928.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:09:06+00:00	2018-09-26 17:09:06+00:00 	ADPI2	Inhibitors of ADP-induced platelet aggregation
74	Medication/supplement use	55342	phv00055342.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ANAR1A1	Anti-arrhythmics, class 1A
74	Medication/supplement use	55363	phv00055363.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ALPHA1	Alpha-blockers w/o diuretics
74	Medication/supplement use	55364	phv00055364.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ALPHAD1	Alpha-blockers with diuretics
74	Medication/supplement use	55365	phv00055365.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ANAR1B1	Anti-arrhythmics, class 1b
74	Medication/supplement use	55366	phv00055366.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ANAR1C1	Anti-arrhythmics, class 1c
74	Medication/supplement use	55367	phv00055367.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ANAR31	Anti-arrhythmics, class 3
74	Medication/supplement use	56929	phv00056929.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	AGDI2	Alpha-glucosidase inhibitors
74	Medication/supplement use	56930	phv00056930.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ALPHA2	Alpha-blockers without diuretics
74	Medication/supplement use	56931	phv00056931.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ALPHAD2	Alpha-blockers with diuretics
74	Medication/supplement use	56932	phv00056932.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ALZH2	Acetylcholine esterase inhibitors for alzh's
74	Medication/supplement use	56933	phv00056933.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	AMLOD2	Amlodipine
74	Medication/supplement use	56934	phv00056934.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ANAR1A2	Anti-arrhythmics, class 1A
74	Medication/supplement use	56935	phv00056935.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ANAR1B2	Anti-arrhythmics, class 1B
74	Medication/supplement use	56936	phv00056936.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ANAR1C2	Anti-arrhythmics, class 1C
74	Medication/supplement use	56937	phv00056937.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:11:46+00:00	2018-09-26 17:11:46+00:00 	ANAR32	Anti-arrhythmics, class 3
74	Medication/supplement use	55321	phv00055321.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	ASA15	In last two weeks, did you take any aspirin or aspirin containing meds?
74	Medication/supplement use	55322	phv00055322.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	ASALW15	How many days did you take aspirin or aspirin containing meds in last week?
74	Medication/supplement use	55350	phv00055350.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	ANTPSY1	Anti-psychotic
74	Medication/supplement use	55351	phv00055351.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	ASA1	Aspirin (anti-inflam agents)
74	Medication/supplement use	55353	phv00055353.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	BENZOD1	Benzodiazepines
74	Medication/supplement use	55369	phv00055369.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	BASQ1	Bile-acid sequestrants
74	Medication/supplement use	55374	phv00055374.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	BETA1	Beta blockers
74	Medication/supplement use	55375	phv00055375.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	BETAD1	Beta blockers and diuretics
74	Medication/supplement use	56702	phv00056702.v2.p10	pht000396.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	aspirin	How often aspirin or aspirin-containing meds is taken
74	Medication/supplement use	56938	phv00056938.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	APSY2	Anti-psychotic medications
74	Medication/supplement use	56939	phv00056939.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	ASA2	Aspirin from 280804 (anti-inflam agents)
74	Medication/supplement use	56940	phv00056940.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	BASQ2	Bile-acid sequestrants
74	Medication/supplement use	56941	phv00056941.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	BENZOD2	Benzodiazepines
74	Medication/supplement use	56942	phv00056942.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	BETA2	Beta-blockers without diuretics
74	Medication/supplement use	56943	phv00056943.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:14:57+00:00	2018-09-26 17:14:57+00:00 	BETAD2	Beta-blockers with diuretics
74	Medication/supplement use	55361	phv00055361.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	CCBIR1	All immediate-release CCB
74	Medication/supplement use	55362	phv00055362.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	CCBSR1	All slow-release CCB
74	Medication/supplement use	55376	phv00055376.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	CCB1	Any calcium channel blocker
74	Medication/supplement use	55382	phv00055382.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	DIG1	Digitalis
74	Medication/supplement use	56701	phv00056701.v2.p10	pht000396.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	bpmeds	Treated for high blood pressure with meds since sleep study
74	Medication/supplement use	56944	phv00056944.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	BGND2	Biguanides
74	Medication/supplement use	56945	phv00056945.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	CCB2	Any calcium-channel blocker = CCIR or CCBSR or CCBT
74	Medication/supplement use	56946	phv00056946.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	CCBIR2	Immediate-release CCBS = NFIR or DIHIR or VERIR or DLTIR
74	Medication/supplement use	56947	phv00056947.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	CCBSR2	Slow-release CCBS = NIFSR or DIHSR or VERSR or DLTSR or AMLOD
74	Medication/supplement use	56948	phv00056948.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	CCBT2	T-type calcium-channel blocker
74	Medication/supplement use	56949	phv00056949.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	COX22	Cox-2 inhibitors (NSAID agents); separate from NSAID variable
74	Medication/supplement use	56950	phv00056950.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	DIG2	Digitalis preparations
74	Medication/supplement use	56951	phv00056951.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	DIHIR2	Immediate-release dihyroprydines other than nifedipine
74	Medication/supplement use	56952	phv00056952.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	DIHSR2	Slow-release dihydropyridines other than nifedipine or amlodipine
74	Medication/supplement use	56953	phv00056953.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	DLTIR2	Immediate-release diltiazem
74	Medication/supplement use	56954	phv00056954.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:18:17+00:00	2018-09-26 17:18:17+00:00 	DLTSR2	Slow-release diltiazem
74	Medication/supplement use	55339	phv00055339.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	ESTRGN1	Estrogens
74	Medication/supplement use	55341	phv00055341.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	HTNMED1	Any hypertension meds
74	Medication/supplement use	55345	phv00055345.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	INSULN1	Insulin
74	Medication/supplement use	55359	phv00055359.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	HCTZ1	Thiazide diuretics w/o k-sparing
74	Medication/supplement use	55360	phv00055360.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	HCTZK1	Thiazide diuretics with k-sparing
74	Medication/supplement use	55372	phv00055372.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	ISTRD1	Inhaled steroids for asthma
74	Medication/supplement use	56788	phv00056788.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	hi202	Aspirin:  the last two weeks, did you take any aspirin or aspirin-containing medicines such as Bufferin, Anacin, or Ascriptin
74	Medication/supplement use	56955	phv00056955.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	EDD2	Erectile dysfunction drugs
74	Medication/supplement use	56956	phv00056956.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	ESTRGN2	Estrogens, excluding vaginal creams
74	Medication/supplement use	56957	phv00056957.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	FIBR2	Fibrates
74	Medication/supplement use	56958	phv00056958.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	H2B2	H2 blockers
74	Medication/supplement use	56959	phv00056959.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	HCTZ2	Thiazide diuretics without k-sparing agents
74	Medication/supplement use	56960	phv00056960.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	HCTZK2	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	56961	phv00056961.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	HPRNS2	Heparins
74	Medication/supplement use	56962	phv00056962.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	INSLN2	Insulins
74	Medication/supplement use	56963	phv00056963.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	IPRTR2	Anticholinergics and combination with beta2-agonist
74	Medication/supplement use	56964	phv00056964.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	ISTRD2	Inhaled steroids for asthma
74	Medication/supplement use	57006	phv00057006.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:21:50+00:00	2018-09-26 17:21:50+00:00 	HTNMED2	Any antihypertensive medication
74	Medication/supplement use	55343	phv00055343.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:23:37+00:00	2018-09-26 17:23:37+00:00 	LIPID1	Any lipid lowering med
74	Medication/supplement use	55348	phv00055348.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:23:37+00:00	2018-09-26 17:23:37+00:00 	MAOI1	Monoamine oxidase inhibitors
74	Medication/supplement use	55358	phv00055358.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:23:37+00:00	2018-09-26 17:23:37+00:00 	LOOP1	Loop diuretics
74	Medication/supplement use	56965	phv00056965.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:23:37+00:00	2018-09-26 17:23:37+00:00 	KBLKR2	K-channel blockers to enhance insulin secretion for diabetics
74	Medication/supplement use	56966	phv00056966.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:23:37+00:00	2018-09-26 17:23:37+00:00 	KCL2	Potassium supplements
74	Medication/supplement use	56967	phv00056967.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:23:37+00:00	2018-09-26 17:23:37+00:00 	KSPR2	Potassium-sparing agents alone
74	Medication/supplement use	56968	phv00056968.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:23:37+00:00	2018-09-26 17:23:37+00:00 	LOOP2	Loop diuretics
74	Medication/supplement use	56969	phv00056969.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:23:37+00:00	2018-09-26 17:23:37+00:00 	MAOI2	MAO inhibitors
74	Medication/supplement use	56970	phv00056970.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:23:37+00:00	2018-09-26 17:23:37+00:00 	MLPD2	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	57005	phv00057005.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:23:37+00:00	2018-09-26 17:23:37+00:00 	LIPID2	Any lipid-lowering medication
74	Medication/supplement use	55324	phv00055324.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:25:36+00:00	2018-09-26 17:25:36+00:00 	NITRO15	MD prescribed nitro in last year?
74	Medication/supplement use	55352	phv00055352.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:25:36+00:00	2018-09-26 17:25:36+00:00 	NSAID1	Non-steroidal anti-inflam (no aspirin)
74	Medication/supplement use	55356	phv00055356.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:25:36+00:00	2018-09-26 17:25:36+00:00 	NTCA1	Non-tricyclic antidepressants
74	Medication/supplement use	55370	phv00055370.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:25:36+00:00	2018-09-26 17:25:36+00:00 	NIAC1	Niacin and nicotinic acid
74	Medication/supplement use	55383	phv00055383.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:25:36+00:00	2018-09-26 17:25:36+00:00 	NTG1	Nitrates
74	Medication/supplement use	56971	phv00056971.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:25:36+00:00	2018-09-26 17:25:36+00:00 	NIAC2	Niacin and nicotinic acid
74	Medication/supplement use	56972	phv00056972.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:25:36+00:00	2018-09-26 17:25:36+00:00 	NIFIR2	Immediate-release nifedipine
74	Medication/supplement use	56973	phv00056973.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:25:36+00:00	2018-09-26 17:25:36+00:00 	NIFSR2	Slow-release nifedipine
74	Medication/supplement use	56974	phv00056974.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:25:36+00:00	2018-09-26 17:25:36+00:00 	NSAID2	Non-steroidal anti-inflammatory agents, excluding aspirin
74	Medication/supplement use	56975	phv00056975.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:25:36+00:00	2018-09-26 17:25:36+00:00 	NTCA2	Non-tricyclic antidepressants other than MAOI
74	Medication/supplement use	56976	phv00056976.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:25:36+00:00	2018-09-26 17:25:36+00:00 	NTG2	Nitrates
74	Medication/supplement use	56977	phv00056977.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:25:36+00:00	2018-09-26 17:25:36+00:00 	OAIA2	Oral anti-inflammatory asthma drugs (leukotriene receptor antagonists and inhibitors of lipo-oxygenase)
74	Medication/supplement use	55340	phv00055340.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	PROGST1	Progestins
74	Medication/supplement use	55344	phv00055344.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	OHGA1	Oral hypogycemics
74	Medication/supplement use	55354	phv00055354.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	PREMAR1	Premarin
74	Medication/supplement use	55355	phv00055355.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	PDEI1	Phosphodiesterase inhibitors
74	Medication/supplement use	55368	phv00055368.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	PVDL1	Peripheral vasodilators
74	Medication/supplement use	55373	phv00055373.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	OSTRD1	Oral steroids
74	Medication/supplement use	56978	phv00056978.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	OHGA2	Oral hypoglycemic agents
74	Medication/supplement use	56979	phv00056979.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	OSTRD2	Oral steroids
74	Medication/supplement use	56980	phv00056980.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	OTCH2B2	Over-the-counter h2-blockers
74	Medication/supplement use	56981	phv00056981.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	PDEI2	Phosphodiesterase inhibitors
74	Medication/supplement use	56982	phv00056982.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	PPI2	Proton pump inhibitors
74	Medication/supplement use	56983	phv00056983.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	PRGSTN2	Progestins
74	Medication/supplement use	56984	phv00056984.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	PRKNSN2	Drugs to treat parkinson's
74	Medication/supplement use	56985	phv00056985.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	PRMRN2	Premarin (conjugated estrogens)
74	Medication/supplement use	56986	phv00056986.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	PROB2	Probucol
74	Medication/supplement use	56987	phv00056987.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:28:38+00:00	2018-09-26 17:28:38+00:00 	PVDL2	Peripheral vasodilators, exclude dipyridamole
74	Medication/supplement use	55323	phv00055323.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	SLPILL15	Do you take sleeping pills at least 1 day per week?
74	Medication/supplement use	55346	phv00055346.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	SYMPTH1	Sympathomimetic (adrenergic) agents
74	Medication/supplement use	55347	phv00055347.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	TCA1	Tri- and tetra- cyclic anti-depressants
74	Medication/supplement use	55349	phv00055349.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	TCAP1	Drug combination -- tricyclics and anti-psychotic
74	Medication/supplement use	55371	phv00055371.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	THRY1	Thyroid agents
74	Medication/supplement use	55380	phv00055380.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	VASOD1	Vasodilators and diuretics (including alphad)
74	Medication/supplement use	55479	phv00055479.v5.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	TkPill02	How often do you take sleeping pills or other medication to help you sleep?
74	Medication/supplement use	56660	phv00056660.v2.p10	pht000396.v4.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	sleepPills	Take sleeping pills or other medication to aid in sleeping
74	Medication/supplement use	56762	phv00056762.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	sh308g	Take sleeping pills or other medication to help you sleep (please indicate how often you experience this)
74	Medication/supplement use	56988	phv00056988.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	SLF12	First generation sulfonylureas
74	Medication/supplement use	56989	phv00056989.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	SLF22	Second generation sulfonylureas
74	Medication/supplement use	56990	phv00056990.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	STTN2	HMG COA reducatace inhibitors (statins)
74	Medication/supplement use	56991	phv00056991.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	SYMPTH2	Sympathomimetics, oral and inhaled
74	Medication/supplement use	56992	phv00056992.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	TCA2	Tri-cyclic antidepressants
74	Medication/supplement use	56993	phv00056993.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	TCAP2	Tri-cyclic antidepressants plus anti-psychotics combinations
74	Medication/supplement use	56994	phv00056994.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	THRY2	Thyroid agents
74	Medication/supplement use	56995	phv00056995.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	THZD2	Thiazolidinediones
74	Medication/supplement use	56996	phv00056996.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	URCOS2	Uricosurics
74	Medication/supplement use	56997	phv00056997.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	VASO2	Vasodilators, a mixed group
74	Medication/supplement use	56998	phv00056998.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:33:26+00:00	2018-09-26 17:33:26+00:00 	VASOD2	Vasodilators with diuretics, a mixed group
74	Medication/supplement use	55357	phv00055357.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:34:35+00:00	2018-09-26 17:34:35+00:00 	WARF1	Oral anticoagulants
74	Medication/supplement use	56999	phv00056999.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:34:35+00:00	2018-09-26 17:34:35+00:00 	VERIR2	Immediate-release verapamil
74	Medication/supplement use	57000	phv00057000.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:34:35+00:00	2018-09-26 17:34:35+00:00 	VERSR2	Slow-release verapamil
74	Medication/supplement use	57001	phv00057001.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:34:35+00:00	2018-09-26 17:34:35+00:00 	WARF2	Oral anticoagulants including warfarin, coumadin, and anisindione
74	Medication/supplement use	57003	phv00057003.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:34:35+00:00	2018-09-26 17:34:35+00:00 	XOI2	Xanthine oxidase inhibitors
74	Medication/supplement use	76376	phv00076376.v6.p10	pht000908.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:40:56+00:00	2018-09-26 17:40:56+00:00 	ATHROMRX	Discharge antithrombotics
74	Medication/supplement use	253890	phv00253890.v1.p10	pht003334.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:41:07+00:00	2018-09-26 17:41:07+00:00 	ATHROMRX	Discharge antithrombotics Collection Interval: Cases reviewed  1/1949 - 12/2012
74	Medication/supplement use	76373	phv00076373.v6.p10	pht000908.v7.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:43:06+00:00	2018-09-26 17:43:06+00:00 	CARVERRX	Cardioversion medications,  if CARVER=2 or 4
74	Medication/supplement use	253896	phv00253896.v1.p10	pht003334.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:43:17+00:00	2018-09-26 17:43:17+00:00 	CARVERRX	Cardioversion medications,  if CARVER=2 or 4 Collection Interval: Cases reviewed  1/1949 - 12/2012
74	Medication/supplement use	276805	phv00276805.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF076	Discharge medication - ACEI
74	Medication/supplement use	276806	phv00276806.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF077	Discharge medication - Beta Blocker
74	Medication/supplement use	276807	phv00276807.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF078	Discharge medication - Furosemide
74	Medication/supplement use	276808	phv00276808.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF079	Discharge medication - Spironolactone
74	Medication/supplement use	276809	phv00276809.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF080	Discharge medication - Angiotensin Receptor Blocker
74	Medication/supplement use	276810	phv00276810.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF081	Discharge medication - Coumadin
74	Medication/supplement use	276811	phv00276811.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF082	Discharge medication - Hydralazine
74	Medication/supplement use	276812	phv00276812.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF083	Discharge medication - Statin
74	Medication/supplement use	276813	phv00276813.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF084	Discharge medication - Aspirin
74	Medication/supplement use	276814	phv00276814.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF085	Discharge medication - Digitalis
74	Medication/supplement use	276815	phv00276815.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF086	Discharge medication - NSAIDs
74	Medication/supplement use	276871	phv00276871.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF072	COPD, regular bronchodilator or steroid user - not PRN
74	Medication/supplement use	276872	phv00276872.v1.p10	pht006018.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:45:50+00:00	2018-09-26 17:45:50+00:00 	CHF073	COPD, PRN user of bronchodilator or steroids
74	Medication/supplement use	66820	phv00066820.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod2	ATC code for second drug in compound
74	Medication/supplement use	66826	phv00066826.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod1	ATC code for medication or first drug in compound
74	Medication/supplement use	66838	phv00066838.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod3	ATC code for third drug in compound
74	Medication/supplement use	73742	phv00073742.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod2	ATC code for second drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73748	phv00073748.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod1	ATC code for medication or first drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73760	phv00073760.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod3	ATC code for third drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73773	phv00073773.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod2	ATC code for second drug in compound
74	Medication/supplement use	73779	phv00073779.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod1	ATC code for medication or first drug in compound
74	Medication/supplement use	73791	phv00073791.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod3	ATC code for third drug in compound
74	Medication/supplement use	177902	phv00177902.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod1	ATC code for medication or first drug in compound (character variable)
74	Medication/supplement use	177903	phv00177903.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod2	ATC code for second drug in compound (character variable)
74	Medication/supplement use	177904	phv00177904.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod3	ATC code for third drug in compound (character variable)
74	Medication/supplement use	227300	phv00227300.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod1	ATC code for medication or first drug in compound (character variable)
74	Medication/supplement use	227301	phv00227301.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod2	ATC code for second drug in compound (character variable)
74	Medication/supplement use	227302	phv00227302.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod3	ATC code for third drug in compound (character variable)
74	Medication/supplement use	257888	phv00257888.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod1	ATC code for medication or first drug in compound (character variable)
74	Medication/supplement use	257889	phv00257889.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod2	ATC code for second drug in compound (character variable)
74	Medication/supplement use	257890	phv00257890.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod3	ATC code for third drug in compound (character variable)
74	Medication/supplement use	257922	phv00257922.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod1	ATC code for medication or first drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257923	phv00257923.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod2	ATC code for second drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257924	phv00257924.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod3	ATC code for third drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	276897	phv00276897.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod2	ATC code for second drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276903	phv00276903.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod1	ATC code for medication or first drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276915	phv00276915.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:50:19+00:00	2018-09-26 17:50:19+00:00 	atc_cod3	ATC code for third drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	66830	phv00066830.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	chem_gp1	Description/Label for chemical subgroup - medication or first drug in compound
74	Medication/supplement use	66839	phv00066839.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	atc_cod4	ATC code for fourth drug in compound
74	Medication/supplement use	73752	phv00073752.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	chem_gp1	Description/Label for chemical subgroup - medication or first drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73761	phv00073761.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	atc_cod4	ATC code for fourth drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73783	phv00073783.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	chem_gp1	Description/Label for chemical subgroup - medication or first drug in compound
74	Medication/supplement use	73792	phv00073792.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	atc_cod4	ATC code for fourth drug in compound
74	Medication/supplement use	177905	phv00177905.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	atc_cod4	ATC code for fourth drug in compound (character variable)
74	Medication/supplement use	177918	phv00177918.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	chem_gp1	Description/label for chemical subgroup - medication or first drug in compound (character variable)
74	Medication/supplement use	227303	phv00227303.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	atc_cod4	ATC code for fourth drug in compound (character variable)
74	Medication/supplement use	227316	phv00227316.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	chem_gp1	Description/label for chemical subgroup - medication or first drug in compound (character variable)
74	Medication/supplement use	257891	phv00257891.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	atc_cod4	ATC code for fourth drug in compound (character variable)
74	Medication/supplement use	257904	phv00257904.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	chem_gp1	Description/label for chemical subgroup - medication or first drug in compound (character variable)
74	Medication/supplement use	257925	phv00257925.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	atc_cod4	ATC code for fourth drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257938	phv00257938.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	chem_gp1	Description/label for chemical subgroup - medication or first drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	276907	phv00276907.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	chem_gp1	Description/label for chemical subgroup - medication or first drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276916	phv00276916.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:51:38+00:00	2018-09-26 17:51:38+00:00 	atc_cod4	ATC code for fourth drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	66824	phv00066824.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp2	Description/Label for chemical subgroup - second drug in compound
74	Medication/supplement use	66843	phv00066843.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp3	Description/Label for chemical subgroup - third drug in compound
74	Medication/supplement use	66848	phv00066848.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp4	Description/Label for chemical subgroup - fourth drug in compound
74	Medication/supplement use	73746	phv00073746.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp2	Description/Label for chemical subgroup - second drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73765	phv00073765.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp3	Description/Label for chemical subgroup - third drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73770	phv00073770.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp4	Description/Label for chemical subgroup - fourth drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73777	phv00073777.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp2	Description/Label for chemical subgroup - second drug in compound
74	Medication/supplement use	73796	phv00073796.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp3	Description/Label for chemical subgroup - third drug in compound
74	Medication/supplement use	73801	phv00073801.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp4	Description/Label for chemical subgroup - fourth drug in compound
74	Medication/supplement use	177919	phv00177919.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp2	Description/label for chemical subgroup - second drug in compound (character variable)
74	Medication/supplement use	177920	phv00177920.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp3	Description/label for chemical subgroup - third drug in compound (character variable)
74	Medication/supplement use	177921	phv00177921.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp4	Description/label for chemical subgroup - forth drug in compound (character variable)
74	Medication/supplement use	227317	phv00227317.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp2	Description/label for chemical subgroup - second drug in compound (character variable)
74	Medication/supplement use	227318	phv00227318.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp3	Description/label for chemical subgroup - third drug in compound (character variable)
74	Medication/supplement use	227319	phv00227319.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp4	Description/label for chemical subgroup - forth drug in compound (character variable)
74	Medication/supplement use	257905	phv00257905.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp2	Description/label for chemical subgroup - second drug in compound (character variable)
74	Medication/supplement use	257906	phv00257906.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp3	Description/label for chemical subgroup - third drug in compound (character variable)
74	Medication/supplement use	257907	phv00257907.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp4	Description/label for chemical subgroup - forth drug in compound (character variable)
74	Medication/supplement use	257939	phv00257939.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp2	Description/label for chemical subgroup - second drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257940	phv00257940.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp3	Description/label for chemical subgroup - third drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257941	phv00257941.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp4	Description/label for chemical subgroup - forth drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	276901	phv00276901.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp2	Description/label for chemical subgroup - second drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276920	phv00276920.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp3	Description/label for chemical subgroup - third drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276925	phv00276925.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:53:28+00:00	2018-09-26 17:53:28+00:00 	chem_gp4	Description/label for chemical subgroup - forth drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	66825	phv00066825.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm2	Description/Label for chemical substance - second drug in compound
74	Medication/supplement use	66831	phv00066831.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm1	Description/Label for chemical substance - medication or first drug in compound
74	Medication/supplement use	66844	phv00066844.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm3	Description/Label for chemical substance - third drug in compound
74	Medication/supplement use	73747	phv00073747.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm2	Description/Label for chemical substance - second drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73753	phv00073753.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm1	Description/Label for chemical substance - medication or first drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73766	phv00073766.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm3	Description/Label for chemical substance - third drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73778	phv00073778.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm2	Description/Label for chemical substance - second drug in compound
74	Medication/supplement use	73784	phv00073784.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm1	Description/Label for chemical substance - medication or first drug in compound
74	Medication/supplement use	73797	phv00073797.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm3	Description/Label for chemical substance - third drug in compound
74	Medication/supplement use	177922	phv00177922.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm1	Description/label for chemical substance - medication or first drug in compound (character variable)
74	Medication/supplement use	177923	phv00177923.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm2	Description/label for chemical substance - second drug in compound (character variable)
74	Medication/supplement use	177924	phv00177924.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm3	Description/label for chemical substance - third drug in compound (character variable)
74	Medication/supplement use	227320	phv00227320.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm1	Description/label for chemical substance - medication or first drug in compound (character variable)
74	Medication/supplement use	227321	phv00227321.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm2	Description/label for chemical substance - second drug in compound (character variable)
74	Medication/supplement use	227322	phv00227322.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:17+00:00	2018-09-26 17:55:17+00:00 	chem_nm3	Description/label for chemical substance - third drug in compound (character variable)
74	Medication/supplement use	257908	phv00257908.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:18+00:00	2018-09-26 17:55:18+00:00 	chem_nm1	Description/label for chemical substance - medication or first drug in compound (character variable)
74	Medication/supplement use	257909	phv00257909.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:18+00:00	2018-09-26 17:55:18+00:00 	chem_nm2	Description/label for chemical substance - second drug in compound (character variable)
74	Medication/supplement use	257942	phv00257942.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:18+00:00	2018-09-26 17:55:18+00:00 	chem_nm1	Description/label for chemical substance - medication or first drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257943	phv00257943.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:18+00:00	2018-09-26 17:55:18+00:00 	chem_nm2	Description/label for chemical substance - second drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257944	phv00257944.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:18+00:00	2018-09-26 17:55:18+00:00 	chem_nm3	Description/label for chemical substance - third drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	276902	phv00276902.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:18+00:00	2018-09-26 17:55:18+00:00 	chem_nm2	Description/label for chemical substance - second drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276908	phv00276908.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:55:18+00:00	2018-09-26 17:55:18+00:00 	chem_nm1	Description/label for chemical substance - medication or first drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	66833	phv00066833.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	MEDNAME	Medication name
74	Medication/supplement use	66835	phv00066835.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	MEDNUM	Number taken for a given period (medper)
74	Medication/supplement use	66849	phv00066849.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	chem_nm4	Description/Label for chemical substance - fourth drug in compound
74	Medication/supplement use	73755	phv00073755.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	MEDNAME	Medication name Collection Interval: Exam 28
74	Medication/supplement use	73757	phv00073757.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	MEDNUM	Number taken for a given period (medper) Collection Interval: Exam 28
74	Medication/supplement use	73771	phv00073771.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	chem_nm4	Description/Label for chemical substance - fourth drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73786	phv00073786.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	MEDNAME	Medication name
74	Medication/supplement use	73788	phv00073788.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	MEDNUM	Number taken for a given period (medper)
74	Medication/supplement use	73802	phv00073802.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	chem_nm4	Description/Label for chemical substance - fourth drug in compound
74	Medication/supplement use	177894	phv00177894.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	medname	Medication name (character variable)
74	Medication/supplement use	177897	phv00177897.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	mednum	Number taken for given period (MEDPER)
74	Medication/supplement use	177925	phv00177925.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	chem_nm4	Description/label for chemical substance - forth drug in compound (character variable)
74	Medication/supplement use	227294	phv00227294.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	medname	Medication name (character variable)
74	Medication/supplement use	227296	phv00227296.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	mednum	Number taken for given period (MEDPER)
74	Medication/supplement use	227323	phv00227323.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	chem_nm4	Description/label for chemical substance - forth drug in compound (character variable)
74	Medication/supplement use	257882	phv00257882.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	medname	Medication name (character variable)
74	Medication/supplement use	257884	phv00257884.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	mednum	Number taken for given period (MEDPER)
74	Medication/supplement use	257911	phv00257911.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	chem_nm4	Description/label for chemical substance - forth drug in compound (character variable)
74	Medication/supplement use	257915	phv00257915.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	medname	Medication name (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257918	phv00257918.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	mednum	Number taken for given period (MEDPER) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257945	phv00257945.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	chem_nm4	Description/label for chemical substance - forth drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	276910	phv00276910.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	MEDNAME	Medication name (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276912	phv00276912.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	MEDNUM	Number taken for given period Collection Interval: Exam 3
74	Medication/supplement use	276926	phv00276926.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 17:58:46+00:00	2018-09-26 17:58:46+00:00 	chem_nm4	Description/label for chemical substance - forth drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	66834	phv00066834.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	MEDSTREN	Medication strength
74	Medication/supplement use	66836	phv00066836.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	MEDPER	Period range
74	Medication/supplement use	66837	phv00066837.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	MEDPRN	Medication taken as needed
74	Medication/supplement use	73756	phv00073756.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	MEDSTREN	Medication strength Collection Interval: Exam 28
74	Medication/supplement use	73758	phv00073758.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	MEDPER	Period range Collection Interval: Exam 28
74	Medication/supplement use	73759	phv00073759.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	MEDPRN	Medication taken as needed Collection Interval: Exam 28
74	Medication/supplement use	73787	phv00073787.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	MEDSTREN	Medication strength
74	Medication/supplement use	73789	phv00073789.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	MEDPER	Period range
74	Medication/supplement use	73790	phv00073790.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	MEDPRN	Medication taken as needed
74	Medication/supplement use	177895	phv00177895.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medstren	Medication strength (character variable)
74	Medication/supplement use	177898	phv00177898.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medper	Period range
74	Medication/supplement use	177899	phv00177899.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medprn	Medication taken as needed
74	Medication/supplement use	177900	phv00177900.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medotc	CHECK if over the counter medication
74	Medication/supplement use	227295	phv00227295.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medstren	Medication strength (character variable)
74	Medication/supplement use	227297	phv00227297.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medper	Period range
74	Medication/supplement use	227298	phv00227298.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medprn	Medication taken as needed
74	Medication/supplement use	227326	phv00227326.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medotc	Medication over the counter
74	Medication/supplement use	257883	phv00257883.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medstren	Medication strength (character variable)
74	Medication/supplement use	257885	phv00257885.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medper	Period range medication taken
74	Medication/supplement use	257886	phv00257886.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medprn	Medication taken as needed?
74	Medication/supplement use	257916	phv00257916.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medstren	Medication strength (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257919	phv00257919.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medper	Period range Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257920	phv00257920.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	medprn	Medication taken as needed Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	276911	phv00276911.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	MEDSTREN	Medication strength (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276913	phv00276913.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	MEDPER	Period range Collection Interval: Exam 3
74	Medication/supplement use	276914	phv00276914.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:01:24+00:00	2018-09-26 18:01:24+00:00 	MEDPRN	Medication taken as needed Collection Interval: Exam 3
74	Medication/supplement use	66823	phv00066823.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:46+00:00	2018-09-26 18:04:46+00:00 	phrm_gp2	Description/Label for pharmacological subgroup - second drug in compound
74	Medication/supplement use	66829	phv00066829.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:46+00:00	2018-09-26 18:04:46+00:00 	phrm_gp1	Description/Label for pharmacological subgroup - medication or first drug in compound
74	Medication/supplement use	66842	phv00066842.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:46+00:00	2018-09-26 18:04:46+00:00 	phrm_gp3	Description/Label for pharmacological subgroup - third drug in compound
74	Medication/supplement use	66847	phv00066847.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:46+00:00	2018-09-26 18:04:46+00:00 	phrm_gp4	Description/Label for pharmacological subgroup - fourth drug in compound
74	Medication/supplement use	73745	phv00073745.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:46+00:00	2018-09-26 18:04:46+00:00 	phrm_gp2	Description/Label for pharmacological subgroup - second drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73751	phv00073751.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:46+00:00	2018-09-26 18:04:46+00:00 	phrm_gp1	Description/Label for pharmacological subgroup - medication or first drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73764	phv00073764.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp3	Description/Label for pharmacological subgroup - third drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73769	phv00073769.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp4	Description/Label for pharmacological subgroup - fourth drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73776	phv00073776.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp2	Description/Label for pharmacological subgroup - second drug in compound
74	Medication/supplement use	73782	phv00073782.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp1	Description/Label for pharmacological subgroup - medication or first drug in compound
74	Medication/supplement use	73795	phv00073795.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp3	Description/Label for pharmacological subgroup - third drug in compound
74	Medication/supplement use	73800	phv00073800.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp4	Description/Label for pharmacological subgroup - fourth drug in compound
74	Medication/supplement use	177914	phv00177914.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp1	Description/label for pharmacological subgroup - medication or first drug in compound (character variable)
74	Medication/supplement use	177915	phv00177915.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp2	Description/label for pharmacological subgroup - second drug in compound (character variable)
74	Medication/supplement use	177916	phv00177916.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp3	Description/label for pharmacological subgroup - third drug in compound (character variable)
74	Medication/supplement use	177917	phv00177917.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp4	Description/label for pharmacological subgroup - forth drug in compound (character variable)
74	Medication/supplement use	227312	phv00227312.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp1	Description/label for pharmacological subgroup - medication or first drug in compound (character variable)
74	Medication/supplement use	227313	phv00227313.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp2	Description/label for pharmacological subgroup - second drug in compound (character variable)
74	Medication/supplement use	227314	phv00227314.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp3	Description/label for pharmacological subgroup - third drug in compound (character variable)
74	Medication/supplement use	227315	phv00227315.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp4	Description/label for pharmacological subgroup - forth drug in compound (character variable)
74	Medication/supplement use	257900	phv00257900.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp1	Description/label for pharmacological subgroup - medication or first drug in compound (character variable)
74	Medication/supplement use	257901	phv00257901.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp2	Description/label for pharmacological subgroup - second drug in compound (character variable)
74	Medication/supplement use	257902	phv00257902.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp3	Description/label for pharmacological subgroup - third drug in compound (character variable)
74	Medication/supplement use	257903	phv00257903.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp4	Description/label for pharmacological subgroup - forth drug in compound (character variable)
74	Medication/supplement use	257934	phv00257934.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp1	Description/label for pharmacological subgroup - medication or first drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257935	phv00257935.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp2	Description/label for pharmacological subgroup - second drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257936	phv00257936.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp3	Description/label for pharmacological subgroup - third drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257937	phv00257937.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp4	Description/label for pharmacological subgroup - forth drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	276900	phv00276900.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp2	Description/label for pharmacological subgroup - second drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276906	phv00276906.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp1	Description/label for pharmacological subgroup - medication or first drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276919	phv00276919.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp3	Description/label for pharmacological subgroup - third drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276924	phv00276924.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:04:47+00:00	2018-09-26 18:04:47+00:00 	phrm_gp4	Description/label for pharmacological subgroup - forth drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	66821	phv00066821.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:23+00:00	2018-09-26 18:06:23+00:00 	system2	Description/Label for anatomical main group - second drug in compound
74	Medication/supplement use	66827	phv00066827.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:23+00:00	2018-09-26 18:06:23+00:00 	system1	Description/Label for anatomical main group - medication or first drug in compound
74	Medication/supplement use	73743	phv00073743.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system2	Description/Label for anatomical main group - second drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73749	phv00073749.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system1	Description/Label for anatomical main group - medication or first drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73774	phv00073774.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system2	Description/Label for anatomical main group - second drug in compound
74	Medication/supplement use	73780	phv00073780.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system1	Description/Label for anatomical main group - medication or first drug in compound
74	Medication/supplement use	177896	phv00177896.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	route	Medication route
74	Medication/supplement use	177906	phv00177906.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system1	Description/label for anatomical main group - medication or first drug in compound (character variable)
74	Medication/supplement use	177907	phv00177907.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system2	Description/label for anatomical main group - second drug in compound (character variable)
74	Medication/supplement use	227304	phv00227304.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system1	Description/label for anatomical main group - medication or first drug in compound (character variable)
74	Medication/supplement use	227305	phv00227305.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system2	Description/label for anatomical main group - second drug in compound (character variable)
74	Medication/supplement use	227325	phv00227325.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	route	Medication route
74	Medication/supplement use	257892	phv00257892.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system1	Description/label for anatomical main group - medication or first drug in compound (character variable)
74	Medication/supplement use	257893	phv00257893.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system2	Description/label for anatomical main group - second drug in compound (character variable)
74	Medication/supplement use	257917	phv00257917.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	route	Medication route Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257926	phv00257926.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system1	Description/label for anatomical main group - medication or first drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257927	phv00257927.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system2	Description/label for anatomical main group - second drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	276898	phv00276898.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system2	Description/label for anatomical main group - second drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276904	phv00276904.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:06:24+00:00	2018-09-26 18:06:24+00:00 	system1	Description/label for anatomical main group - medication or first drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	66840	phv00066840.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system3	Description/Label for anatomical main group - third drug in compound
74	Medication/supplement use	66845	phv00066845.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system4	Description/Label for anatomical main group - fourth drug in compound
74	Medication/supplement use	73762	phv00073762.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system3	Description/Label for anatomical main group - third drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73767	phv00073767.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system4	Description/Label for anatomical main group - fourth drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73793	phv00073793.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system3	Description/Label for anatomical main group - third drug in compound
74	Medication/supplement use	73798	phv00073798.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system4	Description/Label for anatomical main group - fourth drug in compound
74	Medication/supplement use	177908	phv00177908.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system3	Description/label for anatomical main group - third drug in compound (character variable)
74	Medication/supplement use	177909	phv00177909.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system4	Description/label for anatomical main group - forth drug in compound (character variable)
74	Medication/supplement use	227306	phv00227306.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system3	Description/label for anatomical main group - third drug in compound (character variable)
74	Medication/supplement use	227307	phv00227307.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system4	Description/label for anatomical main group - forth drug in compound (character variable)
74	Medication/supplement use	257894	phv00257894.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system3	Description/label for anatomical main group - third drug in compound (character variable)
74	Medication/supplement use	257895	phv00257895.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system4	Description/label for anatomical main group - forth drug in compound (character variable)
74	Medication/supplement use	257928	phv00257928.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system3	Description/label for anatomical main group - third drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257929	phv00257929.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system4	Description/label for anatomical main group - forth drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	276917	phv00276917.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system3	Description/label for anatomical main group - third drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276922	phv00276922.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:07:31+00:00	2018-09-26 18:07:31+00:00 	system4	Description/label for anatomical main group - forth drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	66822	phv00066822.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp2	Description/Label for therapeutic subgroup - second drug in compound
74	Medication/supplement use	66828	phv00066828.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp1	Description/Label for therapeutic subgroup - medication or first drug in compound
74	Medication/supplement use	66841	phv00066841.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp3	Description/Label for therapeutic subgroup - third drug in compound
74	Medication/supplement use	73744	phv00073744.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp2	Description/Label for therapeutic subgroup - second drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73750	phv00073750.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp1	Description/Label for therapeutic subgroup - medication or first drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73763	phv00073763.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp3	Description/Label for therapeutic subgroup - third drug in compound Collection Interval: Exam 28
74	Medication/supplement use	73775	phv00073775.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp2	Description/Label for therapeutic subgroup - second drug in compound
74	Medication/supplement use	73781	phv00073781.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp1	Description/Label for therapeutic subgroup - medication or first drug in compound
74	Medication/supplement use	73794	phv00073794.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp3	Description/Label for therapeutic subgroup - third drug in compound
74	Medication/supplement use	177910	phv00177910.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp1	Description/label for therapeutic subgroup - medication or first drug in compound (character variable)
74	Medication/supplement use	177911	phv00177911.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp2	Description/label for therapeutic subgroup - second drug in compound (character variable)
74	Medication/supplement use	177912	phv00177912.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp3	Description/label for therapeutic subgroup - third drug in compound (character variable)
74	Medication/supplement use	227308	phv00227308.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp1	Description/label for therapeutic subgroup - medication or first drug in compound (character variable)
74	Medication/supplement use	227309	phv00227309.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp2	Description/label for therapeutic subgroup - second drug in compound (character variable)
74	Medication/supplement use	227310	phv00227310.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp3	Description/label for therapeutic subgroup - third drug in compound (character variable)
74	Medication/supplement use	257896	phv00257896.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp1	Description/label for therapeutic subgroup - medication or first drug in compound (character variable)
74	Medication/supplement use	257897	phv00257897.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp2	Description/label for therapeutic subgroup - second drug in compound (character variable)
74	Medication/supplement use	257898	phv00257898.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp3	Description/label for therapeutic subgroup - third drug in compound (character variable)
74	Medication/supplement use	257930	phv00257930.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp1	Description/label for therapeutic subgroup - medication or first drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257931	phv00257931.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp2	Description/label for therapeutic subgroup - second drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	257932	phv00257932.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp3	Description/label for therapeutic subgroup - third drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	276899	phv00276899.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp2	Description/label for therapeutic subgroup - second drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276905	phv00276905.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp1	Description/label for therapeutic subgroup - medication or first drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	276918	phv00276918.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:09:13+00:00	2018-09-26 18:09:13+00:00 	ther_gp3	Description/label for therapeutic subgroup - third drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	66846	phv00066846.v5.p10	pht000676.v6.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:11:04+00:00	2018-09-26 18:11:04+00:00 	ther_gp4	Description/Label for therapeutic subgroup - fourth drug in compoud
74	Medication/supplement use	73768	phv00073768.v1.p10	pht000827.v2.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:11:04+00:00	2018-09-26 18:11:04+00:00 	ther_gp4	Description/Label for therapeutic subgroup - fourth drug in compoud Collection Interval: Exam 28
74	Medication/supplement use	73799	phv00073799.v4.p10	pht000828.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:11:04+00:00	2018-09-26 18:11:04+00:00 	ther_gp4	Description/Label for therapeutic subgroup - fourth drug in compoud
74	Medication/supplement use	177913	phv00177913.v3.p10	pht003098.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:11:04+00:00	2018-09-26 18:11:04+00:00 	ther_gp4	Description/label for therapeutic subgroup - forth drug in compound (character variable)
74	Medication/supplement use	227311	phv00227311.v1.p10	pht004810.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:11:04+00:00	2018-09-26 18:11:04+00:00 	ther_gp4	Description/label for therapeutic subgroup - forth drug in compound (character variable)
74	Medication/supplement use	257899	phv00257899.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:11:04+00:00	2018-09-26 18:11:04+00:00 	ther_gp4	Description/label for therapeutic subgroup - forth drug in compound (character variable)
74	Medication/supplement use	257933	phv00257933.v1.p10	pht005173.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:11:04+00:00	2018-09-26 18:11:04+00:00 	ther_gp4	Description/label for therapeutic subgroup - forth drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31
74	Medication/supplement use	276923	phv00276923.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:11:04+00:00	2018-09-26 18:11:04+00:00 	ther_gp4	Description/label for therapeutic subgroup - forth drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	277000	phv00277000.v1.p10	pht006025.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:11:04+00:00	2018-09-26 18:11:04+00:00 	ORAL	Oral contraceptive or hormone replacement Collection Interval: 1975 through 2014
74	Medication/supplement use	277057	phv00277057.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	DMRX1	Treated for diabetes, Exam 1
74	Medication/supplement use	277058	phv00277058.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	DMRX2	Treated for diabetes, Exam 2
74	Medication/supplement use	277059	phv00277059.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	HRX1	Treated for hypertension, Exam 1
74	Medication/supplement use	277060	phv00277060.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	HRX2	Treated for hypertension, Exam 2
74	Medication/supplement use	277236	phv00277236.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	DMRX1	Treated for diabetes, Exam 1
74	Medication/supplement use	277237	phv00277237.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	DMRX2	Treated for diabetes, Exam 2
74	Medication/supplement use	277238	phv00277238.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	DMRX3	Treated for diabetes, Exam 3
74	Medication/supplement use	277239	phv00277239.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	DMRX4	Treated for diabetes, Exam 4
74	Medication/supplement use	277240	phv00277240.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	DMRX5	Treated for diabetes, Exam 5
74	Medication/supplement use	277241	phv00277241.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	DMRX6	Treated for diabetes, Exam 6
74	Medication/supplement use	277242	phv00277242.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	DMRX7	Treated for diabetes, Exam 7
74	Medication/supplement use	277243	phv00277243.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	DMRX8	Treated for diabetes, Exam 8
74	Medication/supplement use	277244	phv00277244.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	DMRX9	Treated for diabetes, Exam 9
74	Medication/supplement use	277245	phv00277245.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	HRX1	Treated for hypertension, Exam 1
74	Medication/supplement use	277246	phv00277246.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	HRX2	Treated for hypertension, Exam 2
74	Medication/supplement use	277247	phv00277247.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	HRX3	Treated for hypertension, Exam 3
74	Medication/supplement use	277248	phv00277248.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	HRX4	Treated for hypertension, Exam 4
74	Medication/supplement use	277249	phv00277249.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	HRX5	Treated for hypertension, Exam 5
74	Medication/supplement use	277250	phv00277250.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	HRX6	Treated for hypertension, Exam 6
74	Medication/supplement use	277251	phv00277251.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	HRX7	Treated for hypertension, Exam 7
74	Medication/supplement use	277252	phv00277252.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	HRX8	Treated for hypertension, Exam 8
74	Medication/supplement use	277253	phv00277253.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:33:42+00:00	2018-09-26 18:33:42+00:00 	HRX9	Treated for hypertension, Exam 9
74	Medication/supplement use	277061	phv00277061.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:34:48+00:00	2018-09-26 18:34:48+00:00 	LIPRX1	Treated for lipids, Exam 1
74	Medication/supplement use	277062	phv00277062.v1.p10	pht006026.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:34:48+00:00	2018-09-26 18:34:48+00:00 	LIPRX2	Treated for lipids, Exam 2
74	Medication/supplement use	277254	phv00277254.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:34:48+00:00	2018-09-26 18:34:48+00:00 	LIPRX1	Treated for lipids, Exam 1
74	Medication/supplement use	277255	phv00277255.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:34:48+00:00	2018-09-26 18:34:48+00:00 	LIPRX2	Treated for lipids, Exam 2
74	Medication/supplement use	277256	phv00277256.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:34:48+00:00	2018-09-26 18:34:48+00:00 	LIPRX3	Treated for lipids, Exam 3
74	Medication/supplement use	277257	phv00277257.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:34:48+00:00	2018-09-26 18:34:48+00:00 	LIPRX4	Treated for lipids, Exam 4
74	Medication/supplement use	277258	phv00277258.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:34:48+00:00	2018-09-26 18:34:48+00:00 	LIPRX5	Treated for lipids, Exam 5
74	Medication/supplement use	277259	phv00277259.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:34:48+00:00	2018-09-26 18:34:48+00:00 	LIPRX6	Treated for lipids, Exam 6
74	Medication/supplement use	277260	phv00277260.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:34:48+00:00	2018-09-26 18:34:48+00:00 	LIPRX7	Treated for lipids, Exam 7
74	Medication/supplement use	277261	phv00277261.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:34:48+00:00	2018-09-26 18:34:48+00:00 	LIPRX8	Treated for lipids, Exam 8
74	Medication/supplement use	277262	phv00277262.v1.p10	pht006027.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-26 18:34:48+00:00	2018-09-26 18:34:48+00:00 	LIPRX9	Treated for lipids, Exam 9
74	Medication/supplement use	99346	phv00099346.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:25:02+00:00	2018-09-27 18:25:02+00:00 	INSUL12	TAKE INSULIN
74	Medication/supplement use	99454	phv00099454.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:25:37+00:00	2018-09-27 18:25:37+00:00 	ASPIRIN	ASPIRIN USE > 2 DAYS IN 2 WKS
74	Medication/supplement use	99455	phv00099455.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:25:50+00:00	2018-09-27 18:25:50+00:00 	ANYBETA	ANY BETA BLOCKER
74	Medication/supplement use	99456	phv00099456.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:26:00+00:00	2018-09-27 18:26:00+00:00 	ANYVASO	ANY VASO DILATOR
74	Medication/supplement use	99457	phv00099457.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:26:10+00:00	2018-09-27 18:26:10+00:00 	ANYACE	ANY ACE INHIBITOR
74	Medication/supplement use	99554	phv00099554.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:26:47+00:00	2018-09-27 18:26:47+00:00 	TAKMED06	TAKE ANY MEDICATIONS
74	Medication/supplement use	99556	phv00099556.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:27:02+00:00	2018-09-27 18:27:02+00:00 	ASPR06	ASPIRIN/ASPIRIN-CONTAINING MEDICINES
74	Medication/supplement use	99557	phv00099557.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:27:14+00:00	2018-09-27 18:27:14+00:00 	DAYASP06	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	99558	phv00099558.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:27:27+00:00	2018-09-27 18:27:27+00:00 	FSHOIL06	CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS
74	Medication/supplement use	99559	phv00099559.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:27:39+00:00	2018-09-27 18:27:39+00:00 	DAYFSH06	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	99560	phv00099560.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:27:51+00:00	2018-09-27 18:27:51+00:00 	ANTHST06	ANTIHISTAMINES (COLD PILLS, ALLERGY PILLS)
74	Medication/supplement use	99561	phv00099561.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:28:02+00:00	2018-09-27 18:28:02+00:00 	SLPILL06	SLEEPING PILLS
74	Medication/supplement use	99563	phv00099563.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:28:13+00:00	2018-09-27 18:28:13+00:00 	CALC06	CALCIUM SUPPLEMENTS
74	Medication/supplement use	99573	phv00099573.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:28:33+00:00	2018-09-27 18:28:33+00:00 	NOMEDS06	Total Medications
74	Medication/supplement use	99574	phv00099574.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:28:43+00:00	2018-09-27 18:28:43+00:00 	A2A06	Angiotensin type 2 antagonists
74	Medication/supplement use	99575	phv00099575.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:29:05+00:00	2018-09-27 18:29:05+00:00 	A2AD06	Combinations of angiotensin II antagonists
74	Medication/supplement use	99576	phv00099576.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:29:14+00:00	2018-09-27 18:29:14+00:00 	ACE06	ACE Inhibitors without diuretics
74	Medication/supplement use	99577	phv00099577.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:29:22+00:00	2018-09-27 18:29:22+00:00 	ACED06	ACE Inhibitors with diuretics
74	Medication/supplement use	99578	phv00099578.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:29:38+00:00	2018-09-27 18:29:38+00:00 	ADPI06	Inhibitors of ADP-induced platelet aggregation
74	Medication/supplement use	99579	phv00099579.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:29:50+00:00	2018-09-27 18:29:50+00:00 	AGDI06	Alpha-Glucosidase Inhibitors
74	Medication/supplement use	99580	phv00099580.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:30:03+00:00	2018-09-27 18:30:03+00:00 	ALPHA06	Alpha-blockers without diuretics
74	Medication/supplement use	99581	phv00099581.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:30:13+00:00	2018-09-27 18:30:13+00:00 	ALPHAD06	Alpha-blockers with diuretics
74	Medication/supplement use	99582	phv00099582.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:30:26+00:00	2018-09-27 18:30:26+00:00 	ALZH06	Acetylcholine esterase inhibitors for Al
74	Medication/supplement use	99583	phv00099583.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:30:39+00:00	2018-09-27 18:30:39+00:00 	AMLOD06	Amlodipine
74	Medication/supplement use	99584	phv00099584.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:30:56+00:00	2018-09-27 18:30:56+00:00 	ANAR1A06	Anti-arrhythmics,  class 1A
74	Medication/supplement use	99585	phv00099585.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:31:04+00:00	2018-09-27 18:31:04+00:00 	ANAR1B06	Anti-arrhythmics,  class 1B
74	Medication/supplement use	99586	phv00099586.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:31:14+00:00	2018-09-27 18:31:14+00:00 	ANAR1C06	Anti-arrhythmics,  class 1C
74	Medication/supplement use	99587	phv00099587.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:31:25+00:00	2018-09-27 18:31:25+00:00 	ANAR306	Anti-arrhythmics,  class 3
74	Medication/supplement use	56925	phv00056925.v2.p10	pht000397.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 18:45:10+00:00	2018-09-27 18:45:10+00:00 	A2AD2	Combinations of angiotensin II antagonists plus diuretics
74	Medication/supplement use	251728	phv00251728.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 18:47:28+00:00	2018-09-27 18:47:28+00:00 	h672	Respiratory Disease Questionnaire - Technician Administered: Inhaler Use: How many hours ago did you last use the medication, either by inhaler or nebulizer? Collection Interval: Exam 3
74	Medication/supplement use	251730	phv00251730.v1.p10	pht004815.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 18:47:46+00:00	2018-09-27 18:47:46+00:00 	h674	Respiratory Disease Questionnaire - Technician Administered: Inhaler Use: How many hours ago did you last use the medication? Collection Interval: Exam 3
74	Medication/supplement use	55379	phv00055379.v4.p10	pht000395.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-27 18:48:31+00:00	2018-09-27 18:48:31+00:00 	VASO1	Vasodilators (including alpha)
74	Medication/supplement use	99588	phv00099588.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:49:34+00:00	2018-09-27 18:49:34+00:00 	ANTPSY06	Anti-psychotic medications
74	Medication/supplement use	99589	phv00099589.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:49:46+00:00	2018-09-27 18:49:46+00:00 	ASA06	Aspirin from 280804  (anti-inflam agents)
74	Medication/supplement use	99590	phv00099590.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:49:58+00:00	2018-09-27 18:49:58+00:00 	BASQ06	Bile-acid sequestrants
74	Medication/supplement use	99591	phv00099591.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:50:10+00:00	2018-09-27 18:50:10+00:00 	BENZOD06	Benzodiazepines
74	Medication/supplement use	99592	phv00099592.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:50:40+00:00	2018-09-27 18:50:40+00:00 	BETA06	Beta-blockers without diuretics
74	Medication/supplement use	99593	phv00099593.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:50:50+00:00	2018-09-27 18:50:50+00:00 	BETAD06	Beta-blockers with diuretics
74	Medication/supplement use	99594	phv00099594.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:51:21+00:00	2018-09-27 18:51:21+00:00 	BGND06	Biguanides
74	Medication/supplement use	99595	phv00099595.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:51:33+00:00	2018-09-27 18:51:33+00:00 	CCB06	Any calcium-channel blocker = CCIR or CC
74	Medication/supplement use	99596	phv00099596.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:51:47+00:00	2018-09-27 18:51:47+00:00 	CCBIR06	Immediate-release CCBs = NIFIR or DIHIR
74	Medication/supplement use	99597	phv00099597.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:51:58+00:00	2018-09-27 18:51:58+00:00 	CCBSR06	Slow-release CCBs = NIFSR or DIHSR or VE
74	Medication/supplement use	99598	phv00099598.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:52:08+00:00	2018-09-27 18:52:08+00:00 	CCBT06	T-type calcium-channel blocker
74	Medication/supplement use	99599	phv00099599.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:52:23+00:00	2018-09-27 18:52:23+00:00 	COX206	Cox-2 inhibitors  (NSAID agents); seperat
74	Medication/supplement use	99600	phv00099600.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:52:38+00:00	2018-09-27 18:52:38+00:00 	DIG06	Digitalis preparations
74	Medication/supplement use	99601	phv00099601.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:52:50+00:00	2018-09-27 18:52:50+00:00 	DIHIR06	Immediate-release dihydropyridines other
74	Medication/supplement use	99602	phv00099602.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:52:59+00:00	2018-09-27 18:52:59+00:00 	DIHSR06	Slow-release dihydropyridines other than
74	Medication/supplement use	99603	phv00099603.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:53:09+00:00	2018-09-27 18:53:09+00:00 	DLTIR06	Immediate-release diltiazem
74	Medication/supplement use	99604	phv00099604.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:53:21+00:00	2018-09-27 18:53:21+00:00 	DLTSR06	Slow-release diltiazem
74	Medication/supplement use	99605	phv00099605.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:53:31+00:00	2018-09-27 18:53:31+00:00 	EDD06	Erectile dysfunction drugs
74	Medication/supplement use	99606	phv00099606.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:53:38+00:00	2018-09-27 18:53:38+00:00 	ESTRGN06	Estrogens,  excluding vaginal creams
74	Medication/supplement use	99607	phv00099607.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:53:47+00:00	2018-09-27 18:53:47+00:00 	FIBR06	Fibrates
74	Medication/supplement use	99608	phv00099608.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:54:23+00:00	2018-09-27 18:54:23+00:00 	H2B06	H-2 Blockers
74	Medication/supplement use	99609	phv00099609.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:54:40+00:00	2018-09-27 18:54:40+00:00 	HCTZ06	Thiazide diuretics without k-sparing age
74	Medication/supplement use	99610	phv00099610.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:55:21+00:00	2018-09-27 18:55:21+00:00 	HCTZK06	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	99611	phv00099611.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:56:08+00:00	2018-09-27 18:56:08+00:00 	HPRNS06	Heparins
74	Medication/supplement use	99621	phv00099621.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:56:23+00:00	2018-09-27 18:56:23+00:00 	NIAC06	Niacin and nicotinic acid
74	Medication/supplement use	99620	phv00099620.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:56:33+00:00	2018-09-27 18:56:33+00:00 	MLPD06	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	99619	phv00099619.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:56:41+00:00	2018-09-27 18:56:41+00:00 	MAOI06	MAO Inhibitors
74	Medication/supplement use	99618	phv00099618.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:56:51+00:00	2018-09-27 18:56:51+00:00 	LOOP06	Loop diuretics
74	Medication/supplement use	99617	phv00099617.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:57:00+00:00	2018-09-27 18:57:00+00:00 	KSPR06	Potassium-sparing agents alone
74	Medication/supplement use	99616	phv00099616.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:57:09+00:00	2018-09-27 18:57:09+00:00 	KCL06	Potassium supplements
74	Medication/supplement use	99615	phv00099615.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:57:19+00:00	2018-09-27 18:57:19+00:00 	KBLKR06	K-channel blockers to enhance insulin se
74	Medication/supplement use	99614	phv00099614.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:57:30+00:00	2018-09-27 18:57:30+00:00 	ISTRD06	Inhaled steroids for asthma
74	Medication/supplement use	99613	phv00099613.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:57:40+00:00	2018-09-27 18:57:40+00:00 	IPRTR06	Anticholinergics + combination with beta
74	Medication/supplement use	99612	phv00099612.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:57:53+00:00	2018-09-27 18:57:53+00:00 	INSULN06	Insulins
74	Medication/supplement use	99622	phv00099622.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:58:14+00:00	2018-09-27 18:58:14+00:00 	NIFIR06	Immediate-release nifedipine
74	Medication/supplement use	99623	phv00099623.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:58:25+00:00	2018-09-27 18:58:25+00:00 	NIFSR06	Slow-release nifedipine
74	Medication/supplement use	99624	phv00099624.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:58:33+00:00	2018-09-27 18:58:33+00:00 	NSAID06	Non-steroidal anti-inflammatory agents,
74	Medication/supplement use	99625	phv00099625.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:58:42+00:00	2018-09-27 18:58:42+00:00 	NTCA06	Non-tricyclic antidepressants other than
74	Medication/supplement use	99626	phv00099626.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:58:53+00:00	2018-09-27 18:58:53+00:00 	NTG06	Nitrates
74	Medication/supplement use	99627	phv00099627.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:59:02+00:00	2018-09-27 18:59:02+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
74	Medication/supplement use	99628	phv00099628.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:59:10+00:00	2018-09-27 18:59:10+00:00 	OHGA06	Oral hypoglycemic agents
74	Medication/supplement use	99629	phv00099629.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:59:19+00:00	2018-09-27 18:59:19+00:00 	OSTRD06	Oral steroids
74	Medication/supplement use	99630	phv00099630.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:59:29+00:00	2018-09-27 18:59:29+00:00 	OTCH2B06	('60) Over-the-counter H-2 blockers'
74	Medication/supplement use	99631	phv00099631.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 18:59:52+00:00	2018-09-27 18:59:52+00:00 	PDEI06	Phosphodiesterase inhibitors
74	Medication/supplement use	99632	phv00099632.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:00:01+00:00	2018-09-27 19:00:01+00:00 	PPI06	Proton pump inhibitors
74	Medication/supplement use	99633	phv00099633.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:00:12+00:00	2018-09-27 19:00:12+00:00 	PROGST06	Progestins
74	Medication/supplement use	99635	phv00099635.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:00:24+00:00	2018-09-27 19:00:24+00:00 	PREMAR06	Premarin  (conjugated estrogens)
74	Medication/supplement use	99634	phv00099634.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:00:35+00:00	2018-09-27 19:00:35+00:00 	PRKNSN06	Drugs used to treat Parkinson s
74	Medication/supplement use	99637	phv00099637.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:00:54+00:00	2018-09-27 19:00:54+00:00 	PVDL06	Peripheral vasodilators,  exclude dipyrid
74	Medication/supplement use	99636	phv00099636.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:01:03+00:00	2018-09-27 19:01:03+00:00 	PROB06	Probucol
74	Medication/supplement use	99638	phv00099638.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:01:17+00:00	2018-09-27 19:01:17+00:00 	SLF106	First generation sulfonylureas
74	Medication/supplement use	99639	phv00099639.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:01:26+00:00	2018-09-27 19:01:26+00:00 	SLF206	Second generation sulfonylureas
74	Medication/supplement use	99640	phv00099640.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:01:35+00:00	2018-09-27 19:01:35+00:00 	STTN06	HMG-CoA reductase inhibitors
74	Medication/supplement use	99641	phv00099641.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:01:46+00:00	2018-09-27 19:01:46+00:00 	SYMPTH06	Sympathomimetics,  oral and inhaled
74	Medication/supplement use	99642	phv00099642.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:01:55+00:00	2018-09-27 19:01:55+00:00 	TCA06	Tricyclic anti-depressants
74	Medication/supplement use	99643	phv00099643.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:02:05+00:00	2018-09-27 19:02:05+00:00 	TCAP06	Tri-cyclic anti-depressants plus anti-ps
74	Medication/supplement use	99644	phv00099644.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:02:13+00:00	2018-09-27 19:02:13+00:00 	THRY06	Thyroid agents
74	Medication/supplement use	99645	phv00099645.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:02:23+00:00	2018-09-27 19:02:23+00:00 	THZD06	Thiazolidinediones
74	Medication/supplement use	99646	phv00099646.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:02:41+00:00	2018-09-27 19:02:41+00:00 	URCOS06	Uricosurics
74	Medication/supplement use	99647	phv00099647.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:02:57+00:00	2018-09-27 19:02:57+00:00 	VASO06	Vasodilators,  a mixed group
74	Medication/supplement use	99649	phv00099649.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:03:07+00:00	2018-09-27 19:03:07+00:00 	VERIR06	Immediate-release verapamil
74	Medication/supplement use	99648	phv00099648.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:03:18+00:00	2018-09-27 19:03:18+00:00 	VASOD06	Vasodilators with diuretics,  a mixed group
74	Medication/supplement use	99650	phv00099650.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:03:29+00:00	2018-09-27 19:03:29+00:00 	VERSR06	Slow-release verapamil
74	Medication/supplement use	99651	phv00099651.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:03:41+00:00	2018-09-27 19:03:41+00:00 	WARF06	Oral anticoagulants
74	Medication/supplement use	99652	phv00099652.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:03:57+00:00	2018-09-27 19:03:57+00:00 	WTLS06	Weight loss drugs
74	Medication/supplement use	99654	phv00099654.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:04:08+00:00	2018-09-27 19:04:08+00:00 	DIURET06	Any diuretic
74	Medication/supplement use	99655	phv00099655.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:04:18+00:00	2018-09-27 19:04:18+00:00 	LIPID06	Any lipid-lowering medication
74	Medication/supplement use	99656	phv00099656.v1.p1	pht001450.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 19:04:30+00:00	2018-09-27 19:04:30+00:00 	HTNMED06	Any hypertension medication
74	Medication/supplement use	100437	phv00100437.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:52:00+00:00	2018-09-27 20:52:00+00:00 	ASPIRIN	ASPIRIN USE > 2 DAYS IN 2 WKS
74	Medication/supplement use	100438	phv00100438.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:52:11+00:00	2018-09-27 20:52:11+00:00 	ANYDIUR	ANY DIURETIC
74	Medication/supplement use	100439	phv00100439.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:52:20+00:00	2018-09-27 20:52:20+00:00 	ANYBETA	ANY BETA BLOCKER
74	Medication/supplement use	100440	phv00100440.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:52:31+00:00	2018-09-27 20:52:31+00:00 	ANYVASO	ANY VASO DILATOR
74	Medication/supplement use	100441	phv00100441.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:52:43+00:00	2018-09-27 20:52:43+00:00 	ANYACE	ANY ACE INHIBITOR
74	Medication/supplement use	100468	phv00100468.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:53:10+00:00	2018-09-27 20:53:10+00:00 	ESTBLNC	Estrogen at baseline,  no creams
74	Medication/supplement use	100472	phv00100472.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:53:38+00:00	2018-09-27 20:53:38+00:00 	ASPR06	ASPIRIN/ASPIRIN-CONTAINING MEDICINES
74	Medication/supplement use	100473	phv00100473.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:53:49+00:00	2018-09-27 20:53:49+00:00 	DAYASP06	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	100474	phv00100474.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:54:00+00:00	2018-09-27 20:54:00+00:00 	FSHOIL06	CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS
74	Medication/supplement use	100475	phv00100475.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:54:12+00:00	2018-09-27 20:54:12+00:00 	DAYFSH06	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	100476	phv00100476.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:54:26+00:00	2018-09-27 20:54:26+00:00 	ANTHST06	ANTIHISTAMINES(COLD PILLS, ALLERGY PILLS)
74	Medication/supplement use	100477	phv00100477.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:54:38+00:00	2018-09-27 20:54:38+00:00 	SLPILL06	SLEEPING PILLS
74	Medication/supplement use	100478	phv00100478.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:54:45+00:00	2018-09-27 20:54:45+00:00 	LAXATV06	LAXATIVES
74	Medication/supplement use	100479	phv00100479.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:54:54+00:00	2018-09-27 20:54:54+00:00 	CALC06	CALCIUM SUPPLEMENTS
74	Medication/supplement use	100482	phv00100482.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:55:16+00:00	2018-09-27 20:55:16+00:00 	NITRO06	PRESCRIBE NITROGLYCERIN IN THE LAST YEAR
74	Medication/supplement use	100511	phv00100511.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:55:41+00:00	2018-09-27 20:55:41+00:00 	NOMEDS06	Number of medications
74	Medication/supplement use	100512	phv00100512.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:55:50+00:00	2018-09-27 20:55:50+00:00 	TAKMED06	TAKE ANY MEDICATIONS
74	Medication/supplement use	100513	phv00100513.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:56:00+00:00	2018-09-27 20:56:00+00:00 	A2A06	Angiotensin type 2 antagonists
74	Medication/supplement use	100514	phv00100514.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:56:08+00:00	2018-09-27 20:56:08+00:00 	A2AD06	Combinations of angiotensin II antagonis
74	Medication/supplement use	100515	phv00100515.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:56:20+00:00	2018-09-27 20:56:20+00:00 	ACE06	ACE Inhibitors without diuretics
74	Medication/supplement use	100516	phv00100516.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:56:36+00:00	2018-09-27 20:56:36+00:00 	ACED06	ACE Inhibitors with diuretics
74	Medication/supplement use	100517	phv00100517.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:56:49+00:00	2018-09-27 20:56:49+00:00 	ADPI06	Inhibitors of ADP-induced platelet aggre
74	Medication/supplement use	100518	phv00100518.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:57:08+00:00	2018-09-27 20:57:08+00:00 	AGDI06	Alpha-Glucosidase Inhibitors
74	Medication/supplement use	100519	phv00100519.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:57:19+00:00	2018-09-27 20:57:19+00:00 	ALPHA06	Alpha-blockers without diuretics
74	Medication/supplement use	100522	phv00100522.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:57:33+00:00	2018-09-27 20:57:33+00:00 	AMLOD06	Amlodipine
74	Medication/supplement use	100521	phv00100521.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:57:41+00:00	2018-09-27 20:57:41+00:00 	ALZH06	Acetylcholine esterase inhibitors for Al
74	Medication/supplement use	100520	phv00100520.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:57:50+00:00	2018-09-27 20:57:50+00:00 	ALPHAD06	Alpha-blockers with diuretics
74	Medication/supplement use	100523	phv00100523.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:58:08+00:00	2018-09-27 20:58:08+00:00 	ANAR1A06	Anti-arrhythmics,  class 1A
74	Medication/supplement use	100524	phv00100524.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:58:18+00:00	2018-09-27 20:58:18+00:00 	ANAR1B06	Anti-arrhythmics,  class 1B
74	Medication/supplement use	100525	phv00100525.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:58:26+00:00	2018-09-27 20:58:26+00:00 	ANAR1C06	Anti-arrhythmics,  class 1C
74	Medication/supplement use	100526	phv00100526.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:58:34+00:00	2018-09-27 20:58:34+00:00 	ANAR306	Anti-arrhythmics,  class 3
74	Medication/supplement use	100527	phv00100527.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:58:51+00:00	2018-09-27 20:58:51+00:00 	ANTPSY06	Anti-psychotic medications
74	Medication/supplement use	100528	phv00100528.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:58:59+00:00	2018-09-27 20:58:59+00:00 	ASA06	Aspirin from 280804 (anti-inflammatory agents)
74	Medication/supplement use	100529	phv00100529.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:59:10+00:00	2018-09-27 20:59:10+00:00 	BASQ06	Bile-acid sequestrants
74	Medication/supplement use	100530	phv00100530.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:59:19+00:00	2018-09-27 20:59:19+00:00 	BENZOD06	Benzodiazepines
74	Medication/supplement use	100531	phv00100531.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:59:29+00:00	2018-09-27 20:59:29+00:00 	BETA06	Beta-blockers without diuretics
74	Medication/supplement use	100532	phv00100532.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:59:37+00:00	2018-09-27 20:59:37+00:00 	BETAD06	Beta-blockers with diuretics
74	Medication/supplement use	100533	phv00100533.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:59:46+00:00	2018-09-27 20:59:46+00:00 	BGND06	Biguanides
74	Medication/supplement use	100534	phv00100534.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 20:59:53+00:00	2018-09-27 20:59:53+00:00 	CCB06	Any calcium-channel blocker = CCIR or CC
74	Medication/supplement use	100535	phv00100535.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:00:07+00:00	2018-09-27 21:00:07+00:00 	CCBIR06	Immediate-release CCBs = NIFIR or DIHIR
74	Medication/supplement use	100536	phv00100536.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:09:09+00:00	2018-09-27 21:09:09+00:00 	CCBSR06	Slow-release CCBs = NIFSR or DIHSR or VE
74	Medication/supplement use	100537	phv00100537.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:09:23+00:00	2018-09-27 21:09:23+00:00 	CCBT06	T-type calcium-channel blocker
74	Medication/supplement use	100538	phv00100538.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:09:32+00:00	2018-09-27 21:09:32+00:00 	COX206	Cox-2 inhibitors (NSAID agents); seperat
74	Medication/supplement use	100539	phv00100539.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:09:44+00:00	2018-09-27 21:09:44+00:00 	DIG06	Digitalis preparations
74	Medication/supplement use	100540	phv00100540.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:10:18+00:00	2018-09-27 21:10:18+00:00 	DIHIR06	Immediate-release dihyropyridines other
74	Medication/supplement use	100541	phv00100541.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:12:18+00:00	2018-09-27 21:12:18+00:00 	DIHSR06	Slow-release dihydropyridines other than
74	Medication/supplement use	100542	phv00100542.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:12:28+00:00	2018-09-27 21:12:28+00:00 	DLTIR06	Immediate-release diltiazem
74	Medication/supplement use	100543	phv00100543.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:12:52+00:00	2018-09-27 21:12:52+00:00 	DLTSR06	Slow-release diltiazem
74	Medication/supplement use	100544	phv00100544.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:13:20+00:00	2018-09-27 21:13:20+00:00 	EDD06	Erectile dysfunction drugs
74	Medication/supplement use	100545	phv00100545.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:13:31+00:00	2018-09-27 21:13:31+00:00 	ESTRGN06	Estrogens,  excluding vaginal creams
74	Medication/supplement use	100546	phv00100546.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:13:43+00:00	2018-09-27 21:13:43+00:00 	FIBR06	Fibrates
74	Medication/supplement use	100547	phv00100547.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:13:53+00:00	2018-09-27 21:13:53+00:00 	H2B06	H-2 Blockers
74	Medication/supplement use	100548	phv00100548.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:14:09+00:00	2018-09-27 21:14:09+00:00 	HCTZ06	Thiazide diuretics without k-sparing age
74	Medication/supplement use	100549	phv00100549.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:14:21+00:00	2018-09-27 21:14:21+00:00 	HCTZK06	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	100550	phv00100550.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:14:32+00:00	2018-09-27 21:14:32+00:00 	HPRNS06	Heparins
74	Medication/supplement use	100551	phv00100551.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:14:42+00:00	2018-09-27 21:14:42+00:00 	INSULN06	Insulins
74	Medication/supplement use	100552	phv00100552.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:14:52+00:00	2018-09-27 21:14:52+00:00 	IPRTR06	Anticholinergics + combination with beta
74	Medication/supplement use	100553	phv00100553.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:15:01+00:00	2018-09-27 21:15:01+00:00 	ISTRD06	Inhaled steroids for asthma
74	Medication/supplement use	100554	phv00100554.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:15:11+00:00	2018-09-27 21:15:11+00:00 	KBLKR06	K-channel blockers to enhance insulin se
74	Medication/supplement use	100555	phv00100555.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:15:19+00:00	2018-09-27 21:15:19+00:00 	KCL06	Potassium supplements
74	Medication/supplement use	100556	phv00100556.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:15:28+00:00	2018-09-27 21:15:28+00:00 	KSPR06	Potassium-sparing agents alone
74	Medication/supplement use	100557	phv00100557.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:15:49+00:00	2018-09-27 21:15:49+00:00 	LOOP06	Loop diuretics
74	Medication/supplement use	100558	phv00100558.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:16:19+00:00	2018-09-27 21:16:19+00:00 	MAOI06	MAO Inhibitors
74	Medication/supplement use	100559	phv00100559.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:16:26+00:00	2018-09-27 21:16:26+00:00 	MLPD06	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	100560	phv00100560.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:16:40+00:00	2018-09-27 21:16:40+00:00 	NIAC06	Niacin and nicotinic acid
74	Medication/supplement use	100561	phv00100561.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:17:04+00:00	2018-09-27 21:17:04+00:00 	NIFIR06	Immediate-release nifedipine
74	Medication/supplement use	100562	phv00100562.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:17:17+00:00	2018-09-27 21:17:17+00:00 	NIFSR06	Slow-release nifedipine
74	Medication/supplement use	100563	phv00100563.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:17:26+00:00	2018-09-27 21:17:26+00:00 	NSAID06	Non-steroidal anti-inflammatory agents,
74	Medication/supplement use	100565	phv00100565.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:17:36+00:00	2018-09-27 21:17:36+00:00 	NTG06	Nitrates
74	Medication/supplement use	100564	phv00100564.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:17:47+00:00	2018-09-27 21:17:47+00:00 	NTCA06	Non-tricyclic antidepressants other than
74	Medication/supplement use	100566	phv00100566.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:18:02+00:00	2018-09-27 21:18:02+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
74	Medication/supplement use	100567	phv00100567.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:18:16+00:00	2018-09-27 21:18:16+00:00 	OHGA06	Oral hypoglycemic agents
74	Medication/supplement use	100568	phv00100568.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:18:26+00:00	2018-09-27 21:18:26+00:00 	OSTRD06	Oral steroids
74	Medication/supplement use	100569	phv00100569.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:18:36+00:00	2018-09-27 21:18:36+00:00 	OTCH2B06	('60) Over-the-counter H-2 blockers
74	Medication/supplement use	100570	phv00100570.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:18:56+00:00	2018-09-27 21:18:56+00:00 	PDEI06	Phosphodiesterase inhibitors
74	Medication/supplement use	100571	phv00100571.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:19:05+00:00	2018-09-27 21:19:05+00:00 	PPI06	Proton pump inhibitors
74	Medication/supplement use	100572	phv00100572.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:19:17+00:00	2018-09-27 21:19:17+00:00 	PROGST06	Progestins
74	Medication/supplement use	100573	phv00100573.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:19:26+00:00	2018-09-27 21:19:26+00:00 	PRKNSN06	Drugs used to treat Parkinson`s
74	Medication/supplement use	100574	phv00100574.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:19:36+00:00	2018-09-27 21:19:36+00:00 	PREMAR06	Premarin (conjugated estrogens)
74	Medication/supplement use	100575	phv00100575.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:19:44+00:00	2018-09-27 21:19:44+00:00 	PROB06	Probucol
74	Medication/supplement use	100576	phv00100576.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:19:55+00:00	2018-09-27 21:19:55+00:00 	PVDL06	Peripheral vasodilators,  exclude dipyrid
74	Medication/supplement use	100577	phv00100577.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:20:07+00:00	2018-09-27 21:20:07+00:00 	SLF106	First generation sulfonylureas
74	Medication/supplement use	100578	phv00100578.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:20:16+00:00	2018-09-27 21:20:16+00:00 	SLF206	Second generation sulfonylureas
74	Medication/supplement use	100579	phv00100579.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:20:26+00:00	2018-09-27 21:20:26+00:00 	STTN06	HMG-CoA reductase inhibitors
74	Medication/supplement use	100580	phv00100580.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:20:43+00:00	2018-09-27 21:20:43+00:00 	SYMPTH06	Sympathomimetics,  oral and inhaled
74	Medication/supplement use	100581	phv00100581.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:20:53+00:00	2018-09-27 21:20:53+00:00 	TCA06	Tricyclic anti-depressants
74	Medication/supplement use	100582	phv00100582.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:21:02+00:00	2018-09-27 21:21:02+00:00 	TCAP06	Tri-cyclic anti-depressants plus anti-ps
74	Medication/supplement use	100583	phv00100583.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:21:12+00:00	2018-09-27 21:21:12+00:00 	THRY06	Thyroid agents
74	Medication/supplement use	100584	phv00100584.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:21:20+00:00	2018-09-27 21:21:20+00:00 	THZD06	Thiazolidinediones
74	Medication/supplement use	100585	phv00100585.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:21:30+00:00	2018-09-27 21:21:30+00:00 	URCOS06	Uricosurics
74	Medication/supplement use	100586	phv00100586.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:22:05+00:00	2018-09-27 21:22:05+00:00 	VASO06	Vasodilators,  a mixed group
74	Medication/supplement use	100587	phv00100587.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:22:19+00:00	2018-09-27 21:22:19+00:00 	VASOD06	Vasodilators with diuretics,  a mixed gro
74	Medication/supplement use	100588	phv00100588.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:22:30+00:00	2018-09-27 21:22:30+00:00 	VERIR06	Immediate-release verapamil
74	Medication/supplement use	100589	phv00100589.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:22:41+00:00	2018-09-27 21:22:41+00:00 	VERSR06	Slow-release verapamil
74	Medication/supplement use	100590	phv00100590.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:23:00+00:00	2018-09-27 21:23:00+00:00 	WARF06	Oral anticoagulants
74	Medication/supplement use	100591	phv00100591.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:23:08+00:00	2018-09-27 21:23:08+00:00 	WTLS06	Weight loss drugs
74	Medication/supplement use	100592	phv00100592.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:23:23+00:00	2018-09-27 21:23:23+00:00 	XOI06	Xanthine oxidase inhibitors
74	Medication/supplement use	100593	phv00100593.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:23:30+00:00	2018-09-27 21:23:30+00:00 	DIURET06	Any diuretic
74	Medication/supplement use	100594	phv00100594.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:23:38+00:00	2018-09-27 21:23:38+00:00 	LIPID06	Any lipid-lowering medication
74	Medication/supplement use	100595	phv00100595.v1.p1	pht001452.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:23:50+00:00	2018-09-27 21:23:50+00:00 	HTNMED06	Any hypertension medication
74	Medication/supplement use	104304	phv00104304.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:28:14+00:00	2018-09-27 21:28:14+00:00 	PREMAR38	TAKE PREMARIN FOR HOT FLASHES
74	Medication/supplement use	104305	phv00104305.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:28:27+00:00	2018-09-27 21:28:27+00:00 	ESTROG38	TAKE ESTROGENS OR OTHER FEMALE HORMONES
74	Medication/supplement use	104306	phv00104306.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:28:37+00:00	2018-09-27 21:28:37+00:00 	MED138	SPECIFY MEDICATION 1
74	Medication/supplement use	104307	phv00104307.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:28:46+00:00	2018-09-27 21:28:46+00:00 	MED238	SPECIFY MEDICATION 2
74	Medication/supplement use	104308	phv00104308.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:28:54+00:00	2018-09-27 21:28:54+00:00 	MED338	SPECIFY MEDICATION 3
74	Medication/supplement use	104357	phv00104357.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:29:21+00:00	2018-09-27 21:29:21+00:00 	ASPIRIN	ASPIRIN USE > 2 DAYS IN 2 WKS
74	Medication/supplement use	104358	phv00104358.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:29:29+00:00	2018-09-27 21:29:29+00:00 	ANYDIUR	ANY DIURETIC
74	Medication/supplement use	104359	phv00104359.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:29:38+00:00	2018-09-27 21:29:38+00:00 	ANYBETA	ANY BETA BLOCKER
74	Medication/supplement use	104360	phv00104360.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:29:46+00:00	2018-09-27 21:29:46+00:00 	ANYVASO	ANY VASO DILATOR
74	Medication/supplement use	104361	phv00104361.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:29:58+00:00	2018-09-27 21:29:58+00:00 	ANYACE	ANY ACE INHIBITOR
74	Medication/supplement use	104362	phv00104362.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:30:19+00:00	2018-09-27 21:30:19+00:00 	TAKMED06	TAKE ANY MEDICATIONS
74	Medication/supplement use	104364	phv00104364.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:30:33+00:00	2018-09-27 21:30:33+00:00 	ASPR06	ASPIRIN/ASPIRIN-CONTAINING MEDICINES
74	Medication/supplement use	104365	phv00104365.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:30:51+00:00	2018-09-27 21:30:51+00:00 	DAYASP06	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	104366	phv00104366.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:31:08+00:00	2018-09-27 21:31:08+00:00 	FSHOIL06	CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS
74	Medication/supplement use	104367	phv00104367.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:31:17+00:00	2018-09-27 21:31:17+00:00 	DAYFSH06	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	104368	phv00104368.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:31:29+00:00	2018-09-27 21:31:29+00:00 	ANTHST06	ANTIHISTAMINES(COLD PILLS, ALLERGY PILLS)
74	Medication/supplement use	104369	phv00104369.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:31:41+00:00	2018-09-27 21:31:41+00:00 	SLPILL06	SLEEPING PILLS
74	Medication/supplement use	104370	phv00104370.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:31:48+00:00	2018-09-27 21:31:48+00:00 	LAXATV06	LAXATIVES
74	Medication/supplement use	104371	phv00104371.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:31:57+00:00	2018-09-27 21:31:57+00:00 	CALC06	CALCIUM SUPPLEMENTS
74	Medication/supplement use	104374	phv00104374.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:32:11+00:00	2018-09-27 21:32:11+00:00 	NITRO06	PRESCRIBE NITROGLYCERIN IN THE LAST YEAR
74	Medication/supplement use	104381	phv00104381.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:32:46+00:00	2018-09-27 21:32:46+00:00 	NOMEDS06	Total Medications
74	Medication/supplement use	104382	phv00104382.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:32:59+00:00	2018-09-27 21:32:59+00:00 	A2A06	Angiotensin type 2 antagonists
74	Medication/supplement use	104383	phv00104383.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:33:07+00:00	2018-09-27 21:33:07+00:00 	A2AD06	Combinations of angiotensin II antagonist
74	Medication/supplement use	104384	phv00104384.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:33:16+00:00	2018-09-27 21:33:16+00:00 	ACE06	ACE Inhibitors without diuretics
74	Medication/supplement use	104385	phv00104385.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:33:24+00:00	2018-09-27 21:33:24+00:00 	ACED06	ACE Inhibitors with diuretics
74	Medication/supplement use	104386	phv00104386.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:33:33+00:00	2018-09-27 21:33:33+00:00 	ADPI06	Inhibitors of ADP-induced platelet aggregation
74	Medication/supplement use	104387	phv00104387.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:33:42+00:00	2018-09-27 21:33:42+00:00 	AGDI06	Alpha-Glucosidase Inhibitors
74	Medication/supplement use	104388	phv00104388.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:33:52+00:00	2018-09-27 21:33:52+00:00 	ALPHA06	Alpha-blockers without diuretics
74	Medication/supplement use	104389	phv00104389.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:33:59+00:00	2018-09-27 21:33:59+00:00 	ALPHAD06	Alpha-blockers with diuretics
74	Medication/supplement use	104390	phv00104390.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:34:10+00:00	2018-09-27 21:34:10+00:00 	ALZH06	Acetylcholine esterase inhibitors for Al
74	Medication/supplement use	104391	phv00104391.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:34:42+00:00	2018-09-27 21:34:42+00:00 	AMLOD06	Amlodipine
74	Medication/supplement use	104392	phv00104392.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:34:52+00:00	2018-09-27 21:34:52+00:00 	ANAR1A06	Anti-arrhythmics, class 1A
74	Medication/supplement use	104393	phv00104393.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:35:01+00:00	2018-09-27 21:35:01+00:00 	ANAR1B06	Anti-arrhythmics, class 1B
74	Medication/supplement use	104394	phv00104394.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:35:11+00:00	2018-09-27 21:35:11+00:00 	ANAR1C06	Anti-arrhythmics, class 1C
74	Medication/supplement use	104395	phv00104395.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:35:20+00:00	2018-09-27 21:35:20+00:00 	ANAR306	Anti-arrhythmics, class 3
74	Medication/supplement use	104396	phv00104396.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:35:34+00:00	2018-09-27 21:35:34+00:00 	ANTPSY06	Anti-psychotic medications
74	Medication/supplement use	104397	phv00104397.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:35:43+00:00	2018-09-27 21:35:43+00:00 	ASA06	Aspirin from 280804 (anti-inflammatory agents)
74	Medication/supplement use	104398	phv00104398.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:41:57+00:00	2018-09-27 21:41:57+00:00 	BASQ06	Bile-acid sequestrants
74	Medication/supplement use	104399	phv00104399.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:42:07+00:00	2018-09-27 21:42:07+00:00 	BENZOD06	Benzodiazepines
74	Medication/supplement use	104400	phv00104400.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:42:19+00:00	2018-09-27 21:42:19+00:00 	BETA06	Beta-blockers without diuretics
74	Medication/supplement use	104402	phv00104402.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:42:27+00:00	2018-09-27 21:42:27+00:00 	BGND06	Biguanides
74	Medication/supplement use	104401	phv00104401.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:42:38+00:00	2018-09-27 21:42:38+00:00 	BETAD06	Beta-blockers with diuretics
74	Medication/supplement use	104403	phv00104403.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:42:53+00:00	2018-09-27 21:42:53+00:00 	CCB06	Any calcium-channel blocker = CCIR or CC
74	Medication/supplement use	104404	phv00104404.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:43:02+00:00	2018-09-27 21:43:02+00:00 	CCBIR06	Immediate-release CCBs = NIFIR or DIHIR
74	Medication/supplement use	104405	phv00104405.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:43:15+00:00	2018-09-27 21:43:15+00:00 	CCBSR06	Slow-release CCBs = NIFSR or DIHSR or VE
74	Medication/supplement use	104406	phv00104406.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:43:24+00:00	2018-09-27 21:43:24+00:00 	CCBT06	T-type calcium-channel blocker
74	Medication/supplement use	104407	phv00104407.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:43:32+00:00	2018-09-27 21:43:32+00:00 	COX206	Cox-2 inhibitors (NSAID agents); seperat
74	Medication/supplement use	104408	phv00104408.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:43:47+00:00	2018-09-27 21:43:47+00:00 	DIG06	Digitalis preparations
74	Medication/supplement use	104412	phv00104412.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:44:00+00:00	2018-09-27 21:44:00+00:00 	DLTSR06	Slow-release diltiazem
74	Medication/supplement use	104411	phv00104411.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:44:16+00:00	2018-09-27 21:44:16+00:00 	DLTIR06	Immediate-release diltiazem
74	Medication/supplement use	104410	phv00104410.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:44:29+00:00	2018-09-27 21:44:29+00:00 	DIHSR06	Slow-release dihydropyridines other than
74	Medication/supplement use	104409	phv00104409.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:44:39+00:00	2018-09-27 21:44:39+00:00 	DIHIR06	Immediate-release dihyropyridines other
74	Medication/supplement use	104413	phv00104413.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:44:55+00:00	2018-09-27 21:44:55+00:00 	EDD06	Erectile dysfunction drugs
74	Medication/supplement use	104414	phv00104414.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:45:02+00:00	2018-09-27 21:45:02+00:00 	ESTRGN06	Estrogens, excluding vaginal creams
74	Medication/supplement use	104415	phv00104415.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:45:10+00:00	2018-09-27 21:45:10+00:00 	FIBR06	Fibrates
74	Medication/supplement use	104416	phv00104416.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:45:24+00:00	2018-09-27 21:45:24+00:00 	H2B06	H-2 Blockers
74	Medication/supplement use	104418	phv00104418.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:45:35+00:00	2018-09-27 21:45:35+00:00 	HCTZK06	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	104417	phv00104417.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:45:44+00:00	2018-09-27 21:45:44+00:00 	HCTZ06	Thiazide diuretics without k-sparing age
74	Medication/supplement use	104419	phv00104419.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:45:52+00:00	2018-09-27 21:45:52+00:00 	HPRNS06	Heparins
74	Medication/supplement use	104420	phv00104420.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:46:05+00:00	2018-09-27 21:46:05+00:00 	INSULN06	Insulins
74	Medication/supplement use	104421	phv00104421.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:46:15+00:00	2018-09-27 21:46:15+00:00 	IPRTR06	Anticholinergics + combination with beta
74	Medication/supplement use	104422	phv00104422.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:46:24+00:00	2018-09-27 21:46:24+00:00 	ISTRD06	Inhaled steroids for asthma
74	Medication/supplement use	104423	phv00104423.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:46:49+00:00	2018-09-27 21:46:49+00:00 	KBLKR06	K-channel blockers to enhance insulin se
74	Medication/supplement use	104424	phv00104424.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:46:58+00:00	2018-09-27 21:46:58+00:00 	KCL06	Potassium supplements
74	Medication/supplement use	104425	phv00104425.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:47:06+00:00	2018-09-27 21:47:06+00:00 	KSPR06	Potassium-sparing agents alone
74	Medication/supplement use	104426	phv00104426.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:47:16+00:00	2018-09-27 21:47:16+00:00 	LOOP06	Loop diuretics
74	Medication/supplement use	104427	phv00104427.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:47:26+00:00	2018-09-27 21:47:26+00:00 	MAOI06	MAO Inhibitors
74	Medication/supplement use	104428	phv00104428.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:47:41+00:00	2018-09-27 21:47:41+00:00 	MLPD06	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	104429	phv00104429.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:47:49+00:00	2018-09-27 21:47:49+00:00 	NIAC06	Niacin and nicotinic acid
74	Medication/supplement use	104430	phv00104430.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:48:01+00:00	2018-09-27 21:48:01+00:00 	NIFIR06	Immediate-release nifedipine
74	Medication/supplement use	104431	phv00104431.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:48:09+00:00	2018-09-27 21:48:09+00:00 	NIFSR06	Slow-release nifedipine
74	Medication/supplement use	104432	phv00104432.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:48:20+00:00	2018-09-27 21:48:20+00:00 	NSAID06	Non-steroidal anti-inflammatory agents,
74	Medication/supplement use	104433	phv00104433.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:48:29+00:00	2018-09-27 21:48:29+00:00 	NTCA06	Non-tricyclic antidepressants other than
74	Medication/supplement use	104434	phv00104434.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:48:36+00:00	2018-09-27 21:48:36+00:00 	NTG06	Nitrates
74	Medication/supplement use	104435	phv00104435.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:48:47+00:00	2018-09-27 21:48:47+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
74	Medication/supplement use	104436	phv00104436.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:49:12+00:00	2018-09-27 21:49:12+00:00 	OHGA06	Oral hypoglycemic agents
74	Medication/supplement use	104437	phv00104437.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:49:24+00:00	2018-09-27 21:49:24+00:00 	OSTRD06	Oral steroids
74	Medication/supplement use	104438	phv00104438.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:49:32+00:00	2018-09-27 21:49:32+00:00 	OTCH2B06	('60) Over-the-counter H-2 blockers'
74	Medication/supplement use	104439	phv00104439.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:49:40+00:00	2018-09-27 21:49:40+00:00 	PDEI06	Phosphodiesterase inhibitors
74	Medication/supplement use	104440	phv00104440.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:49:49+00:00	2018-09-27 21:49:49+00:00 	PPI06	Proton pump inhibitors
74	Medication/supplement use	104441	phv00104441.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:49:56+00:00	2018-09-27 21:49:56+00:00 	PROGST06	Progestins
74	Medication/supplement use	104445	phv00104445.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:50:07+00:00	2018-09-27 21:50:07+00:00 	PVDL06	Peripheral vasodilators, exclude dipyrid
74	Medication/supplement use	104444	phv00104444.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:50:20+00:00	2018-09-27 21:50:20+00:00 	PROB06	Probucol
74	Medication/supplement use	104443	phv00104443.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:50:31+00:00	2018-09-27 21:50:31+00:00 	PREMAR06	Premarin (conjugated estrogens)
74	Medication/supplement use	104442	phv00104442.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:50:39+00:00	2018-09-27 21:50:39+00:00 	PRKNSN06	Drugs used to treat Parkinson s
74	Medication/supplement use	104446	phv00104446.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:54:37+00:00	2018-09-27 21:54:37+00:00 	SLF106	First generation sulfonylureas
74	Medication/supplement use	104447	phv00104447.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:54:49+00:00	2018-09-27 21:54:49+00:00 	SLF206	Second generation sulfonylureas
74	Medication/supplement use	104448	phv00104448.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:54:59+00:00	2018-09-27 21:54:59+00:00 	STTN06	HMG-CoA reductase inhibitors
74	Medication/supplement use	104449	phv00104449.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:55:06+00:00	2018-09-27 21:55:06+00:00 	SYMPTH06	Sympathomimetics, oral and inhaled
74	Medication/supplement use	104450	phv00104450.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:55:19+00:00	2018-09-27 21:55:19+00:00 	TCA06	Tricyclic anti-depressants
74	Medication/supplement use	104451	phv00104451.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:55:27+00:00	2018-09-27 21:55:27+00:00 	TCAP06	Tricyclic anti-depressants plus anti-ps
74	Medication/supplement use	104452	phv00104452.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:55:37+00:00	2018-09-27 21:55:37+00:00 	THRY06	Thyroid agents
74	Medication/supplement use	104453	phv00104453.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:55:45+00:00	2018-09-27 21:55:45+00:00 	THZD06	Thiazolidinediones
74	Medication/supplement use	104454	phv00104454.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:55:54+00:00	2018-09-27 21:55:54+00:00 	URCOS06	Uricosurics
74	Medication/supplement use	104455	phv00104455.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:56:14+00:00	2018-09-27 21:56:14+00:00 	VASO06	Vasodilators, a mixed group
74	Medication/supplement use	104456	phv00104456.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:56:24+00:00	2018-09-27 21:56:24+00:00 	VASOD06	Vasodilators with diuretics, a mixed gro
74	Medication/supplement use	104457	phv00104457.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:56:32+00:00	2018-09-27 21:56:32+00:00 	VERIR06	Immediate-release verapamil
74	Medication/supplement use	104458	phv00104458.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:56:48+00:00	2018-09-27 21:56:48+00:00 	VERSR06	Slow-release verapamil
74	Medication/supplement use	104459	phv00104459.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:56:57+00:00	2018-09-27 21:56:57+00:00 	WARF06	Oral anticoagulants
74	Medication/supplement use	104460	phv00104460.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:57:07+00:00	2018-09-27 21:57:07+00:00 	WTLS06	Weight loss drugs
74	Medication/supplement use	104461	phv00104461.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:57:19+00:00	2018-09-27 21:57:19+00:00 	XOI06	Xanthine oxidase inhibitors
74	Medication/supplement use	104462	phv00104462.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:57:27+00:00	2018-09-27 21:57:27+00:00 	DIURET06	Any diuretic
74	Medication/supplement use	104463	phv00104463.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:57:35+00:00	2018-09-27 21:57:35+00:00 	LIPID06	Any lipid-lowering medication
74	Medication/supplement use	104464	phv00104464.v1.p1	pht001488.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:57:43+00:00	2018-09-27 21:57:43+00:00 	HTNMED06	Any hypertension medication
74	Medication/supplement use	104770	phv00104770.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:59:18+00:00	2018-09-27 21:59:18+00:00 	ASPR06	ASPIRIN/ASPIRIN-CONTAINING MEDICINES
74	Medication/supplement use	104771	phv00104771.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:59:26+00:00	2018-09-27 21:59:26+00:00 	DAYASP06	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	104772	phv00104772.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:59:35+00:00	2018-09-27 21:59:35+00:00 	FSHOIL06	CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS
74	Medication/supplement use	104773	phv00104773.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:59:45+00:00	2018-09-27 21:59:45+00:00 	DAYFSH06	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	104774	phv00104774.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 21:59:59+00:00	2018-09-27 21:59:59+00:00 	ANTHST06	ANTIHISTAMINES(COLD PILLS, ALLERGY PILLS)
74	Medication/supplement use	104775	phv00104775.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:00:08+00:00	2018-09-27 22:00:08+00:00 	SLPILL06	SLEEPING PILLS
74	Medication/supplement use	104776	phv00104776.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:00:17+00:00	2018-09-27 22:00:17+00:00 	LAXATV06	LAXATIVES
74	Medication/supplement use	104777	phv00104777.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:00:26+00:00	2018-09-27 22:00:26+00:00 	CALC06	CALCIUM SUPPLEMENTS
74	Medication/supplement use	104780	phv00104780.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:00:36+00:00	2018-09-27 22:00:36+00:00 	NITRO06	PRESCRIBE NITROGLYCERIN IN THE LAST YEAR
74	Medication/supplement use	104923	phv00104923.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:01:16+00:00	2018-09-27 22:01:16+00:00 	ESTROC39	CURRENTLY TAKING ESTROGEN
74	Medication/supplement use	104924	phv00104924.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:01:25+00:00	2018-09-27 22:01:25+00:00 	ECDAY39	CURRENT ESTROGEN DAYS/MONTH
74	Medication/supplement use	104925	phv00104925.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:01:39+00:00	2018-09-27 22:01:39+00:00 	ECMO39	MONTHS CURRENTLY TAKING ESTROGEN
74	Medication/supplement use	104932	phv00104932.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:02:08+00:00	2018-09-27 22:02:08+00:00 	ESTROP39	TOOK ESTROGEN IN THE PAST
74	Medication/supplement use	104933	phv00104933.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:02:20+00:00	2018-09-27 22:02:20+00:00 	EPDAY39	PAST USE OF ESTROGEN DAYS/MONTH
74	Medication/supplement use	104934	phv00104934.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:02:38+00:00	2018-09-27 22:02:38+00:00 	EYR39	YEAR STOPPED TAKING ESTROGEN
74	Medication/supplement use	104943	phv00104943.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:02:57+00:00	2018-09-27 22:02:57+00:00 	PROGC39	CURRENTLY TAKING PROGESTIN
74	Medication/supplement use	104944	phv00104944.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:03:08+00:00	2018-09-27 22:03:08+00:00 	PCDAY39	CURRENT PROGESTIN DAYS/MONTH
74	Medication/supplement use	105011	phv00105011.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:04:13+00:00	2018-09-27 22:04:13+00:00 	NOMEDS06	Total Medications
74	Medication/supplement use	105012	phv00105012.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:04:25+00:00	2018-09-27 22:04:25+00:00 	A2A06	Angiotensin type 2 antagonists
74	Medication/supplement use	105013	phv00105013.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:04:36+00:00	2018-09-27 22:04:36+00:00 	A2AD06	Combinations of angiotensin II antagonist
74	Medication/supplement use	105015	phv00105015.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:21:19+00:00	2018-09-27 22:21:19+00:00 	ACED06	ACE Inhibitors with diuretics
74	Medication/supplement use	105014	phv00105014.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:21:32+00:00	2018-09-27 22:21:32+00:00 	ACE06	ACE Inhibitors without diuretics
74	Medication/supplement use	105016	phv00105016.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:22:01+00:00	2018-09-27 22:22:01+00:00 	ADPI06	Inhibitors of ADP-induced platelet aggregation
74	Medication/supplement use	105017	phv00105017.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:22:13+00:00	2018-09-27 22:22:13+00:00 	AGDI06	Alpha-Glucosidase Inhibitors
74	Medication/supplement use	105018	phv00105018.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:22:23+00:00	2018-09-27 22:22:23+00:00 	ALPHA06	Alpha-blockers without diuretics
74	Medication/supplement use	105019	phv00105019.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:22:55+00:00	2018-09-27 22:22:55+00:00 	ALPHAD06	Alpha-blockers with diuretics
74	Medication/supplement use	105020	phv00105020.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:23:06+00:00	2018-09-27 22:23:06+00:00 	ALZH06	Acetylcholine esterase inhibitors for Al
74	Medication/supplement use	105021	phv00105021.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:23:17+00:00	2018-09-27 22:23:17+00:00 	AMLOD06	Amlodipine
74	Medication/supplement use	105022	phv00105022.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:23:27+00:00	2018-09-27 22:23:27+00:00 	ANAR1A06	Anti-arrhythmics, class 1A
74	Medication/supplement use	105023	phv00105023.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:23:37+00:00	2018-09-27 22:23:37+00:00 	ANAR1B06	Anti-arrhythmics, class 1B
74	Medication/supplement use	105024	phv00105024.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:23:47+00:00	2018-09-27 22:23:47+00:00 	ANAR1C06	Anti-arrhythmics, class 1C
74	Medication/supplement use	105025	phv00105025.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:24:00+00:00	2018-09-27 22:24:00+00:00 	ANAR306	Anti-arrhythmics, class 3
74	Medication/supplement use	105026	phv00105026.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:24:11+00:00	2018-09-27 22:24:11+00:00 	ANTPSY06	Anti-psychotic medications
74	Medication/supplement use	105027	phv00105027.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:24:22+00:00	2018-09-27 22:24:22+00:00 	ASA06	Aspirin from 280804 (anti-inflam agents)
74	Medication/supplement use	105028	phv00105028.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:24:38+00:00	2018-09-27 22:24:38+00:00 	BASQ06	Bile-acid sequestrants
74	Medication/supplement use	105029	phv00105029.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:24:52+00:00	2018-09-27 22:24:52+00:00 	BENZOD06	Benzodiazepines
74	Medication/supplement use	105030	phv00105030.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:25:09+00:00	2018-09-27 22:25:09+00:00 	BETA06	Beta-blockers without diuretics
74	Medication/supplement use	105031	phv00105031.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:25:25+00:00	2018-09-27 22:25:25+00:00 	BETAD06	Beta-blockers with diuretics
74	Medication/supplement use	105032	phv00105032.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:25:35+00:00	2018-09-27 22:25:35+00:00 	BGND06	Biguanides
74	Medication/supplement use	105033	phv00105033.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:25:44+00:00	2018-09-27 22:25:44+00:00 	CCB06	Any calcium-channel blocker = CCIR or CC
74	Medication/supplement use	105034	phv00105034.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:25:54+00:00	2018-09-27 22:25:54+00:00 	CCBIR06	Immediate-release CCBs = NIFIR or DIHIR
74	Medication/supplement use	105035	phv00105035.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:26:05+00:00	2018-09-27 22:26:05+00:00 	CCBSR06	Slow-release CCBs = NIFSR or DIHSR or VE
74	Medication/supplement use	105036	phv00105036.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:26:25+00:00	2018-09-27 22:26:25+00:00 	CCBT06	T-type calcium-channel blocker
74	Medication/supplement use	105037	phv00105037.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:26:34+00:00	2018-09-27 22:26:34+00:00 	COX206	Cox-2 inhibitors (NSAID agents); seperat
74	Medication/supplement use	105038	phv00105038.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:26:47+00:00	2018-09-27 22:26:47+00:00 	DIG06	Digitalis preparations
74	Medication/supplement use	105039	phv00105039.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:26:59+00:00	2018-09-27 22:26:59+00:00 	DIHIR06	Immediate-release dihyropyridines other
74	Medication/supplement use	105040	phv00105040.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:27:16+00:00	2018-09-27 22:27:16+00:00 	DIHSR06	Slow-release dihydropyridines other than
74	Medication/supplement use	105041	phv00105041.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:27:29+00:00	2018-09-27 22:27:29+00:00 	DLTIR06	Immediate-release diltiazem
74	Medication/supplement use	105042	phv00105042.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:27:45+00:00	2018-09-27 22:27:45+00:00 	DLTSR06	Slow-release diltiazem
74	Medication/supplement use	105043	phv00105043.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:27:55+00:00	2018-09-27 22:27:55+00:00 	EDD06	Erectile dysfunction drugs
74	Medication/supplement use	105046	phv00105046.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:28:07+00:00	2018-09-27 22:28:07+00:00 	H2B06	H-2 Blockers
74	Medication/supplement use	105047	phv00105047.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:28:17+00:00	2018-09-27 22:28:17+00:00 	HCTZ06	Thiazide diuretics without k-sparing age
74	Medication/supplement use	105048	phv00105048.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:28:29+00:00	2018-09-27 22:28:29+00:00 	HCTZK06	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	105049	phv00105049.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:28:47+00:00	2018-09-27 22:28:47+00:00 	HPRNS06	Heparins
74	Medication/supplement use	105050	phv00105050.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:29:07+00:00	2018-09-27 22:29:07+00:00 	INSULN06	Insulins
74	Medication/supplement use	105051	phv00105051.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:29:45+00:00	2018-09-27 22:29:45+00:00 	IPRTR06	Anticholinergics + combination with beta
74	Medication/supplement use	105053	phv00105053.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:30:09+00:00	2018-09-27 22:30:09+00:00 	KBLKR06	K-channel blockers to enhance insulin se
74	Medication/supplement use	105052	phv00105052.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:30:20+00:00	2018-09-27 22:30:20+00:00 	ISTRD06	Inhaled steroids for asthma
74	Medication/supplement use	105054	phv00105054.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:30:40+00:00	2018-09-27 22:30:40+00:00 	KCL06	Potassium supplements
74	Medication/supplement use	105056	phv00105056.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:30:49+00:00	2018-09-27 22:30:49+00:00 	LOOP06	Loop diuretics
74	Medication/supplement use	105055	phv00105055.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:31:00+00:00	2018-09-27 22:31:00+00:00 	KSPR06	Potassium-sparing agents alone
74	Medication/supplement use	105057	phv00105057.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:31:27+00:00	2018-09-27 22:31:27+00:00 	MAOI06	MAO Inhibitors
74	Medication/supplement use	105058	phv00105058.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:31:38+00:00	2018-09-27 22:31:38+00:00 	MLPD06	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	105059	phv00105059.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:31:49+00:00	2018-09-27 22:31:49+00:00 	NIAC06	Niacin and nicotinic acid
74	Medication/supplement use	105060	phv00105060.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:32:12+00:00	2018-09-27 22:32:12+00:00 	NIFIR06	Immediate-release nifedipine
74	Medication/supplement use	105062	phv00105062.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:32:21+00:00	2018-09-27 22:32:21+00:00 	NSAID06	Non-steroidal anti-inflammatory agents,
74	Medication/supplement use	105063	phv00105063.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:32:33+00:00	2018-09-27 22:32:33+00:00 	NTCA06	Non-tricyclic antidepressants other than
74	Medication/supplement use	105064	phv00105064.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:32:44+00:00	2018-09-27 22:32:44+00:00 	NTG06	Nitrates
74	Medication/supplement use	105065	phv00105065.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:33:01+00:00	2018-09-27 22:33:01+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
74	Medication/supplement use	105066	phv00105066.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:33:13+00:00	2018-09-27 22:33:13+00:00 	OHGA06	Oral hypoglycemic agents
74	Medication/supplement use	105067	phv00105067.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:33:23+00:00	2018-09-27 22:33:23+00:00 	OSTRD06	Oral steroids
74	Medication/supplement use	105068	phv00105068.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:33:36+00:00	2018-09-27 22:33:36+00:00 	OTCH2B06	('60) Over-the-counter H-2 blockers'
74	Medication/supplement use	105069	phv00105069.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:34:09+00:00	2018-09-27 22:34:09+00:00 	PDEI06	Phosphodiesterase inhibitors
74	Medication/supplement use	105070	phv00105070.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:34:18+00:00	2018-09-27 22:34:18+00:00 	PPI06	Proton pump inhibitors
74	Medication/supplement use	105071	phv00105071.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:34:29+00:00	2018-09-27 22:34:29+00:00 	PROGST06	Progestins
74	Medication/supplement use	105072	phv00105072.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:34:38+00:00	2018-09-27 22:34:38+00:00 	PRKNSN06	Drugs used to treat Parkinson s
74	Medication/supplement use	105073	phv00105073.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:34:53+00:00	2018-09-27 22:34:53+00:00 	PREMAR06	Premarin (conjugated estrogens)
74	Medication/supplement use	105074	phv00105074.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:35:06+00:00	2018-09-27 22:35:06+00:00 	PROB06	Probucol
74	Medication/supplement use	105075	phv00105075.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:35:16+00:00	2018-09-27 22:35:16+00:00 	PVDL06	Peripheral vasodilators, exclude dipyrid
74	Medication/supplement use	105076	phv00105076.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:35:42+00:00	2018-09-27 22:35:42+00:00 	SLF106	First generation sulfonylureas
74	Medication/supplement use	105077	phv00105077.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:35:50+00:00	2018-09-27 22:35:50+00:00 	SLF206	Second generation sulfonylureas
74	Medication/supplement use	105078	phv00105078.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:35:58+00:00	2018-09-27 22:35:58+00:00 	STTN06	HMG-CoA reductase inhibitors
74	Medication/supplement use	105079	phv00105079.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:36:08+00:00	2018-09-27 22:36:08+00:00 	SYMPTH06	Sympathomimetics, oral and inhaled
74	Medication/supplement use	105080	phv00105080.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:36:22+00:00	2018-09-27 22:36:22+00:00 	TCA06	Tricyclic anti-depressants
74	Medication/supplement use	105081	phv00105081.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:36:31+00:00	2018-09-27 22:36:31+00:00 	TCAP06	Tri-cyclic anti-depressants plus anti-ps
74	Medication/supplement use	105082	phv00105082.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:36:39+00:00	2018-09-27 22:36:39+00:00 	THRY06	Thyroid agents
74	Medication/supplement use	105083	phv00105083.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:40:31+00:00	2018-09-27 22:40:31+00:00 	THZD06	Thiazolidinediones
74	Medication/supplement use	105084	phv00105084.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:40:55+00:00	2018-09-27 22:40:55+00:00 	URCOS06	Uricosurics
74	Medication/supplement use	105085	phv00105085.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:41:11+00:00	2018-09-27 22:41:11+00:00 	VASO06	Vasodilators, a mixed group
74	Medication/supplement use	105086	phv00105086.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:41:22+00:00	2018-09-27 22:41:22+00:00 	VASOD06	Vasodilators with diuretics, a mixed gro
74	Medication/supplement use	105087	phv00105087.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:41:33+00:00	2018-09-27 22:41:33+00:00 	VERIR06	Immediate-release verapamil
74	Medication/supplement use	105089	phv00105089.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:41:45+00:00	2018-09-27 22:41:45+00:00 	WARF06	Oral anticoagulants
74	Medication/supplement use	105090	phv00105090.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:41:58+00:00	2018-09-27 22:41:58+00:00 	WTLS06	Weight loss drugs
74	Medication/supplement use	105091	phv00105091.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:42:08+00:00	2018-09-27 22:42:08+00:00 	XOI06	Xanthine oxidase inhibitors
74	Medication/supplement use	105092	phv00105092.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:42:24+00:00	2018-09-27 22:42:24+00:00 	DIURET06	Any diuretic
74	Medication/supplement use	105093	phv00105093.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:42:35+00:00	2018-09-27 22:42:35+00:00 	LIPID06	Any lipid-lowering medication
74	Medication/supplement use	105094	phv00105094.v1.p1	pht001489.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-27 22:42:49+00:00	2018-09-27 22:42:49+00:00 	HTNMED06	Any hypertension medication
74	Medication/supplement use	10672	phv00010672.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 12:39:01+00:00	2018-09-28 12:39:01+00:00 	G681	RESPIRATORY: IF YES TO G679, BY WHAT ROUTE - INJECTED (CHECK ALL THAT APPLY)
74	Medication/supplement use	251246	phv00251246.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 12:39:10+00:00	2018-09-28 12:39:10+00:00 	g681	Respiratory Questionnaire: If yes, by what route - Injected Collection Interval: Exam 2
74	Medication/supplement use	10673	phv00010673.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 12:39:30+00:00	2018-09-28 12:39:30+00:00 	G682	RESPIRATORY: IF YES TO G679, BY WHAT ROUTE - INHALED (CHECK ALL THAT APPLY)
74	Medication/supplement use	251247	phv00251247.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 12:39:39+00:00	2018-09-28 12:39:39+00:00 	g682	Respiratory Questionnaire: If yes, by what route - Inhaled Collection Interval: Exam 2
74	Medication/supplement use	10675	phv00010675.v5.p10	pht000036.v8.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 12:39:59+00:00	2018-09-28 12:39:59+00:00 	G684	RESPIRATORY: IF YES TO G679, BY WHAT ROUTE - SKIN (CHECK ALL THAT APPLY)
74	Medication/supplement use	251249	phv00251249.v1.p10	pht004814.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 12:40:07+00:00	2018-09-28 12:40:07+00:00 	g684	Respiratory Questionnaire: If yes, by what route - Skin Collection Interval: Exam 2
74	Medication/supplement use	257910	phv00257910.v1.p10	pht005172.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:13:57+00:00	2018-09-28 13:13:57+00:00 	chem_nm3	Description/label for chemical substance - third drug in compound (character variable)
74	Medication/supplement use	276921	phv00276921.v1.p10	pht006019.v1.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:14:10+00:00	2018-09-28 13:14:10+00:00 	chem_nm3	Description/label for chemical substance - third drug in compound (character variable) Collection Interval: Exam 3
74	Medication/supplement use	3375	phv00003375.v1.p10	pht000020.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:17:27+00:00	2018-09-28 13:17:27+00:00 	FK127	TYPE OF POTASSIUM SUPPLEMENT
74	Medication/supplement use	3781	phv00003781.v1.p10	pht000021.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:19:23+00:00	2018-09-28 13:19:23+00:00 	FL136	PERIPHERAL VASODILATORS (HYDRALZINE, MINIPRES, MINOXIDIL, ETC.)
74	Medication/supplement use	6925	phv00006925.v1.p10	pht000028.v3.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:21:43+00:00	2018-09-28 13:21:43+00:00 	FS316	FEMALE HORMONE REPLACEMENT: PATCH DOSE OF ESTROGEN
74	Medication/supplement use	72073	phv00072073.v4.p10	pht000747.v5.p10	phs000007.v29.p10	Framingham Heart Study	7	29	2018-09-28 13:23:23+00:00	2018-09-28 13:23:23+00:00 	H045	IF PERIODS HAVE STOPPED, SINCE YOUR LAST EXAM HAVE YOU TAKEN HORMONE REPLACEMENT THERAPY? (ESTROGEN/PROGESTERONE)
74	Medication/supplement use	105623	phv00105623.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:36:47+00:00	2018-09-28 15:36:47+00:00 	ASPIRIN	ASPIRIN USE > 2 DAYS IN 2 WKS
74	Medication/supplement use	105624	phv00105624.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:36:58+00:00	2018-09-28 15:36:58+00:00 	ANYDIUR	ANY DIURETIC
74	Medication/supplement use	105625	phv00105625.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:37:12+00:00	2018-09-28 15:37:12+00:00 	ANYBETA	ANY BETA BLOCKER
74	Medication/supplement use	105626	phv00105626.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:37:24+00:00	2018-09-28 15:37:24+00:00 	ANYVASO	ANY VASO DILATOR
74	Medication/supplement use	105627	phv00105627.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:37:35+00:00	2018-09-28 15:37:35+00:00 	ANYACE	ANY ACE INHIBITOR
74	Medication/supplement use	105632	phv00105632.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:37:52+00:00	2018-09-28 15:37:52+00:00 	ASPR06	ASPIRIN/ASPIRIN-CONTAINING MEDICINES
74	Medication/supplement use	105633	phv00105633.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:38:01+00:00	2018-09-28 15:38:01+00:00 	DAYASP06	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	105634	phv00105634.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:38:11+00:00	2018-09-28 15:38:11+00:00 	FSHOIL06	CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS
74	Medication/supplement use	105635	phv00105635.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:38:21+00:00	2018-09-28 15:38:21+00:00 	DAYFSH06	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	105636	phv00105636.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:38:34+00:00	2018-09-28 15:38:34+00:00 	ANTHST06	ANTIHISTAMINES(COLD PILLS, ALLERGY PILLS)
74	Medication/supplement use	105637	phv00105637.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:38:46+00:00	2018-09-28 15:38:46+00:00 	SLPILL06	SLEEPING PILLS
74	Medication/supplement use	105638	phv00105638.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:38:56+00:00	2018-09-28 15:38:56+00:00 	LAXATV06	LAXATIVES
74	Medication/supplement use	105639	phv00105639.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:39:11+00:00	2018-09-28 15:39:11+00:00 	CALC06	CALCIUM SUPPLEMENTS
74	Medication/supplement use	105642	phv00105642.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:39:40+00:00	2018-09-28 15:39:40+00:00 	NITRO06	PRESCRIBE NITROGLYCERIN IN THE LAST YEAR
74	Medication/supplement use	106173	phv00106173.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:42:51+00:00	2018-09-28 15:42:51+00:00 	VITAM58	DID YOU TAKE A VITAMIN SUPPLEMENT
74	Medication/supplement use	106175	phv00106175.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:44:39+00:00	2018-09-28 15:44:39+00:00 	MDAYS58	DAYS TOOK A MULTIVITAMIN
74	Medication/supplement use	106176	phv00106176.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:44:48+00:00	2018-09-28 15:44:48+00:00 	VITA58	DID YOU TAKE VITAMIN A
74	Medication/supplement use	106177	phv00106177.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:45:02+00:00	2018-09-28 15:45:02+00:00 	ADAYS58	DAYS TOOK VITAMIN A
74	Medication/supplement use	106178	phv00106178.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:45:13+00:00	2018-09-28 15:45:13+00:00 	VITC58	DID YOU TAKE VITAMIN C
74	Medication/supplement use	106179	phv00106179.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:45:22+00:00	2018-09-28 15:45:22+00:00 	CDAYS58	DAYS TOOK VITAMIN C
74	Medication/supplement use	106180	phv00106180.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:45:33+00:00	2018-09-28 15:45:33+00:00 	VITE58	DID YOU TAKE VITAMIN E
74	Medication/supplement use	106181	phv00106181.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:45:46+00:00	2018-09-28 15:45:46+00:00 	EDAYS58	DAYS TOOK VITAMIN E
74	Medication/supplement use	106305	phv00106305.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:46:27+00:00	2018-09-28 15:46:27+00:00 	ESTROC58	CURRENTLY TAKING ESTROGEN
74	Medication/supplement use	106306	phv00106306.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:46:39+00:00	2018-09-28 15:46:39+00:00 	ECDAY58	CURRENT ESTROGEN DAYS/MONTH
74	Medication/supplement use	106307	phv00106307.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:46:55+00:00	2018-09-28 15:46:55+00:00 	ECYR58	YEARS CURRENTLY TAKING ESTROGEN
74	Medication/supplement use	106316	phv00106316.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:47:10+00:00	2018-09-28 15:47:10+00:00 	EPDAY58	PAST USE OF ESTROGEN DAYS/MONTH
74	Medication/supplement use	106327	phv00106327.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:47:26+00:00	2018-09-28 15:47:26+00:00 	PROGC58	CURRENTLY TAKING PROGESTIN
74	Medication/supplement use	106330	phv00106330.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:47:38+00:00	2018-09-28 15:47:38+00:00 	PROGP58	TOOK PROGESTIN IN THE PAST
74	Medication/supplement use	106431	phv00106431.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:48:19+00:00	2018-09-28 15:48:19+00:00 	NOMEDS06	Number of medications
74	Medication/supplement use	106433	phv00106433.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:48:29+00:00	2018-09-28 15:48:29+00:00 	A2A06	Angiotensin type 2 antagonists
74	Medication/supplement use	106434	phv00106434.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:48:38+00:00	2018-09-28 15:48:38+00:00 	A2AD06	Combinations of angiotensin II antagonist
74	Medication/supplement use	106435	phv00106435.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:48:46+00:00	2018-09-28 15:48:46+00:00 	ACE06	ACE Inhibitors without diuretics
74	Medication/supplement use	106436	phv00106436.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:48:54+00:00	2018-09-28 15:48:54+00:00 	ACED06	ACE Inhibitors with diuretics
74	Medication/supplement use	106437	phv00106437.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:49:11+00:00	2018-09-28 15:49:11+00:00 	ADPI06	Inhibitors of ADP-induced platelet aggregation
74	Medication/supplement use	106438	phv00106438.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:49:23+00:00	2018-09-28 15:49:23+00:00 	AGDI06	Alpha-Glucosidase Inhibitors
74	Medication/supplement use	106439	phv00106439.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:49:35+00:00	2018-09-28 15:49:35+00:00 	ALPHA06	Alpha-blockers without diuretics
74	Medication/supplement use	106440	phv00106440.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:49:46+00:00	2018-09-28 15:49:46+00:00 	ALPHAD06	Alpha-blockers with diuretics
74	Medication/supplement use	106441	phv00106441.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:49:56+00:00	2018-09-28 15:49:56+00:00 	ALZH06	Acetylcholine esterase inhibitors for Al
74	Medication/supplement use	106442	phv00106442.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:50:05+00:00	2018-09-28 15:50:05+00:00 	AMLOD06	Amlodipine
74	Medication/supplement use	106443	phv00106443.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:50:26+00:00	2018-09-28 15:50:26+00:00 	ANAR1A06	Anti-arrhythmics, class 1A
74	Medication/supplement use	106444	phv00106444.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:50:34+00:00	2018-09-28 15:50:34+00:00 	ANAR1B06	Anti-arrhythmics, class 1B
74	Medication/supplement use	106445	phv00106445.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:50:43+00:00	2018-09-28 15:50:43+00:00 	ANAR1C06	Anti-arrhythmics, class 1C
74	Medication/supplement use	106446	phv00106446.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:50:52+00:00	2018-09-28 15:50:52+00:00 	ANAR306	Anti-arrhythmics, class 3
74	Medication/supplement use	106447	phv00106447.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:51:00+00:00	2018-09-28 15:51:00+00:00 	ANTPSY06	Anti-psychotic medications
74	Medication/supplement use	106448	phv00106448.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:51:09+00:00	2018-09-28 15:51:09+00:00 	ASA06	Aspirin from 280804 (anti-inflammatory agents)
74	Medication/supplement use	106449	phv00106449.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:51:17+00:00	2018-09-28 15:51:17+00:00 	BASQ06	Bile-acid sequestrants
74	Medication/supplement use	106450	phv00106450.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:51:29+00:00	2018-09-28 15:51:29+00:00 	BENZOD06	Benzodiazepines
74	Medication/supplement use	106451	phv00106451.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:51:38+00:00	2018-09-28 15:51:38+00:00 	BETA06	Beta-blockers without diuretics
74	Medication/supplement use	106452	phv00106452.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:51:46+00:00	2018-09-28 15:51:46+00:00 	BETAD06	Beta-blockers with diuretics
74	Medication/supplement use	106453	phv00106453.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:51:56+00:00	2018-09-28 15:51:56+00:00 	BGND06	Biguanides
74	Medication/supplement use	106454	phv00106454.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:52:07+00:00	2018-09-28 15:52:07+00:00 	CCB06	Any calcium-channel blocker = CCIR or CC
74	Medication/supplement use	106455	phv00106455.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:52:15+00:00	2018-09-28 15:52:15+00:00 	CCBIR06	Immediate-release CCBs = NIFIR or DIHIR
74	Medication/supplement use	106456	phv00106456.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:52:28+00:00	2018-09-28 15:52:28+00:00 	CCBSR06	Slow-release CCBs = NIFSR or DIHSR or VE
74	Medication/supplement use	106457	phv00106457.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:52:37+00:00	2018-09-28 15:52:37+00:00 	CCBT06	T-type calcium-channel blocker
74	Medication/supplement use	106458	phv00106458.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:52:46+00:00	2018-09-28 15:52:46+00:00 	COX206	Cox-2 inhibitors (NSAID agents); seperat
74	Medication/supplement use	106459	phv00106459.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:52:57+00:00	2018-09-28 15:52:57+00:00 	DIG06	Digitalis preparations
74	Medication/supplement use	106460	phv00106460.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:53:05+00:00	2018-09-28 15:53:05+00:00 	DIHIR06	Immediate-release dihyropyridines other
74	Medication/supplement use	106461	phv00106461.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:53:13+00:00	2018-09-28 15:53:13+00:00 	DIHSR06	Slow-release dihydropyridines other than
74	Medication/supplement use	106462	phv00106462.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:53:23+00:00	2018-09-28 15:53:23+00:00 	DLTIR06	Immediate-release diltiazem
74	Medication/supplement use	106463	phv00106463.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:53:37+00:00	2018-09-28 15:53:37+00:00 	DLTSR06	Slow-release diltiazem
74	Medication/supplement use	106464	phv00106464.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:53:47+00:00	2018-09-28 15:53:47+00:00 	EDD06	Erectile dysfunction drugs
74	Medication/supplement use	106465	phv00106465.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:53:55+00:00	2018-09-28 15:53:55+00:00 	ESTRGN06	Estrogens, excluding vaginal creams
74	Medication/supplement use	106466	phv00106466.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:54:01+00:00	2018-09-28 15:54:01+00:00 	FIBR06	Fibrates
74	Medication/supplement use	106467	phv00106467.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:54:10+00:00	2018-09-28 15:54:10+00:00 	H2B06	H-2 Blockers
74	Medication/supplement use	106468	phv00106468.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:54:18+00:00	2018-09-28 15:54:18+00:00 	HCTZ06	Thiazide diuretics without k-sparing age
74	Medication/supplement use	106469	phv00106469.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:54:28+00:00	2018-09-28 15:54:28+00:00 	HCTZK06	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	106470	phv00106470.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:54:36+00:00	2018-09-28 15:54:36+00:00 	HPRNS06	Heparins
74	Medication/supplement use	106471	phv00106471.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:54:51+00:00	2018-09-28 15:54:51+00:00 	INSULN06	Insulins
74	Medication/supplement use	106472	phv00106472.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:55:03+00:00	2018-09-28 15:55:03+00:00 	IPRTR06	Anticholinergics + combination with beta
74	Medication/supplement use	106473	phv00106473.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:55:11+00:00	2018-09-28 15:55:11+00:00 	ISTRD06	Inhaled steroids for asthma
74	Medication/supplement use	106474	phv00106474.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:55:19+00:00	2018-09-28 15:55:19+00:00 	KBLKR06	K-channel blockers to enhance insulin se
74	Medication/supplement use	106475	phv00106475.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:55:28+00:00	2018-09-28 15:55:28+00:00 	KCL06	Potassium supplements
74	Medication/supplement use	106476	phv00106476.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:55:40+00:00	2018-09-28 15:55:40+00:00 	KSPR06	Potassium-sparing agents alone
74	Medication/supplement use	106477	phv00106477.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:55:48+00:00	2018-09-28 15:55:48+00:00 	LOOP06	Loop diuretics
74	Medication/supplement use	106478	phv00106478.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:56:01+00:00	2018-09-28 15:56:01+00:00 	MAOI06	MAO Inhibitors
74	Medication/supplement use	106479	phv00106479.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:56:10+00:00	2018-09-28 15:56:10+00:00 	MLPD06	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	106480	phv00106480.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:56:27+00:00	2018-09-28 15:56:27+00:00 	NIAC06	Niacin and nicotinic acid
74	Medication/supplement use	106481	phv00106481.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:56:35+00:00	2018-09-28 15:56:35+00:00 	NIFIR06	Immediate-release nifedipine
74	Medication/supplement use	106482	phv00106482.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:56:49+00:00	2018-09-28 15:56:49+00:00 	NIFSR06	Slow-release nifedipine
74	Medication/supplement use	106483	phv00106483.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:57:01+00:00	2018-09-28 15:57:01+00:00 	NSAID06	Non-steroidal anti-inflammatory agents,
74	Medication/supplement use	106484	phv00106484.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:57:15+00:00	2018-09-28 15:57:15+00:00 	NTCA06	Non-tricyclic antidepressants other than
74	Medication/supplement use	106485	phv00106485.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:57:26+00:00	2018-09-28 15:57:26+00:00 	NTG06	Nitrates
74	Medication/supplement use	106486	phv00106486.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:57:35+00:00	2018-09-28 15:57:35+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
74	Medication/supplement use	106487	phv00106487.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:57:43+00:00	2018-09-28 15:57:43+00:00 	OHGA06	Oral hypoglycemic agents
74	Medication/supplement use	106488	phv00106488.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:57:52+00:00	2018-09-28 15:57:52+00:00 	OSTRD06	Oral steroids
74	Medication/supplement use	106489	phv00106489.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:58:04+00:00	2018-09-28 15:58:04+00:00 	OTCH2B06	('60) Over-the-counter H-2 blockers
74	Medication/supplement use	106490	phv00106490.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:58:15+00:00	2018-09-28 15:58:15+00:00 	PDEI06	Phosphodiesterase inhibitors
74	Medication/supplement use	106491	phv00106491.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:58:24+00:00	2018-09-28 15:58:24+00:00 	PPI06	Proton pump inhibitors
74	Medication/supplement use	106492	phv00106492.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:58:34+00:00	2018-09-28 15:58:34+00:00 	PROGST06	Progestins
74	Medication/supplement use	106493	phv00106493.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:58:44+00:00	2018-09-28 15:58:44+00:00 	PRKNSN06	Drugs used to treat Parkinson s
74	Medication/supplement use	106494	phv00106494.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:58:51+00:00	2018-09-28 15:58:51+00:00 	PREMAR06	Premarin (conjugated estrogens)
74	Medication/supplement use	106495	phv00106495.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:59:00+00:00	2018-09-28 15:59:00+00:00 	PROB06	Probucol
74	Medication/supplement use	106496	phv00106496.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:59:08+00:00	2018-09-28 15:59:08+00:00 	PVDL06	Peripheral vasodilators, exclude dipyrid
74	Medication/supplement use	106497	phv00106497.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:59:17+00:00	2018-09-28 15:59:17+00:00 	SLF106	First generation sulfonylureas
74	Medication/supplement use	106498	phv00106498.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:59:26+00:00	2018-09-28 15:59:26+00:00 	SLF206	Second generation sulfonylureas
74	Medication/supplement use	106499	phv00106499.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:59:35+00:00	2018-09-28 15:59:35+00:00 	STTN06	HMG-CoA reductase inhibitors
74	Medication/supplement use	106500	phv00106500.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:59:47+00:00	2018-09-28 15:59:47+00:00 	SYMPTH06	Sympathomimetics, oral and inhaled
74	Medication/supplement use	106501	phv00106501.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 15:59:55+00:00	2018-09-28 15:59:55+00:00 	TCA06	Tricyclic anti-depressants
74	Medication/supplement use	106502	phv00106502.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:00:05+00:00	2018-09-28 16:00:05+00:00 	TCAP06	Tri-cyclic anti-depressants plus anti-ps
74	Medication/supplement use	106503	phv00106503.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:00:15+00:00	2018-09-28 16:00:15+00:00 	THRY06	Thyroid agents
74	Medication/supplement use	106504	phv00106504.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:00:24+00:00	2018-09-28 16:00:24+00:00 	THZD06	Thiazolidinediones
74	Medication/supplement use	106505	phv00106505.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:00:32+00:00	2018-09-28 16:00:32+00:00 	URCOS06	Uricosurics
74	Medication/supplement use	106506	phv00106506.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:00:41+00:00	2018-09-28 16:00:41+00:00 	VASO06	Vasodilators, a mixed group
74	Medication/supplement use	106507	phv00106507.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:00:48+00:00	2018-09-28 16:00:48+00:00 	VASOD06	Vasodilators with diuretics, a mixed gro
74	Medication/supplement use	106508	phv00106508.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:00:56+00:00	2018-09-28 16:00:56+00:00 	VERIR06	Immediate-release verapamil
74	Medication/supplement use	106509	phv00106509.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:01:04+00:00	2018-09-28 16:01:04+00:00 	VERSR06	Slow-release verapamil
74	Medication/supplement use	106510	phv00106510.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:01:19+00:00	2018-09-28 16:01:19+00:00 	WARF06	Oral anticoagulants
74	Medication/supplement use	106511	phv00106511.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:01:31+00:00	2018-09-28 16:01:31+00:00 	WTLS06	Weight loss drugs
74	Medication/supplement use	106512	phv00106512.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:01:39+00:00	2018-09-28 16:01:39+00:00 	XOI06	Xanthine oxidase inhibitors
74	Medication/supplement use	106513	phv00106513.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:01:48+00:00	2018-09-28 16:01:48+00:00 	DIURET06	Any diuretic
74	Medication/supplement use	106514	phv00106514.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:01:57+00:00	2018-09-28 16:01:57+00:00 	LIPID06	Any lipid-lowering medication
74	Medication/supplement use	106515	phv00106515.v1.p1	pht001490.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:02:05+00:00	2018-09-28 16:02:05+00:00 	HTNMED06	Any hypertension medication
74	Medication/supplement use	107204	phv00107204.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:29:51+00:00	2018-09-28 16:29:51+00:00 	MLTVIT29	TAKEN MULTIPLE OR OTHER VITAMIN
74	Medication/supplement use	107205	phv00107205.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:30:03+00:00	2018-09-28 16:30:03+00:00 	MULTI29	TOOK MULTIPLE VITAMIN
74	Medication/supplement use	107206	phv00107206.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:30:16+00:00	2018-09-28 16:30:16+00:00 	MDAYS29	DAYS TOOK MULTIPLE VITAMIN
74	Medication/supplement use	107207	phv00107207.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:30:27+00:00	2018-09-28 16:30:27+00:00 	VITA29	TOOK VITAMIN A
74	Medication/supplement use	107208	phv00107208.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:30:39+00:00	2018-09-28 16:30:39+00:00 	ADAYS29	DAYS TOOK VITAMIN A
74	Medication/supplement use	107209	phv00107209.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:30:49+00:00	2018-09-28 16:30:49+00:00 	VITC29	TOOK VITAMIN C
74	Medication/supplement use	107211	phv00107211.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:31:06+00:00	2018-09-28 16:31:06+00:00 	VITE29	TOOK VITAMIN E
74	Medication/supplement use	107210	phv00107210.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:31:29+00:00	2018-09-28 16:31:29+00:00 	CDAYS29	DAYS TOOK VITAMIN C
74	Medication/supplement use	107212	phv00107212.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:31:52+00:00	2018-09-28 16:31:52+00:00 	EDAYS29	DAYS TOOK VITAMIN E
74	Medication/supplement use	107243	phv00107243.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:32:14+00:00	2018-09-28 16:32:14+00:00 	ESTROC29	CURRENTLY TAKING ESTROGEN
74	Medication/supplement use	107244	phv00107244.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:32:25+00:00	2018-09-28 16:32:25+00:00 	ECDAY29	DAYS PER MONTH TAKE ESTROGEN
74	Medication/supplement use	107265	phv00107265.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:32:43+00:00	2018-09-28 16:32:43+00:00 	PROGC29	CURRENTLY TAKING PROGESTIN
74	Medication/supplement use	107266	phv00107266.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:32:54+00:00	2018-09-28 16:32:54+00:00 	PCDAY29	DAYS PER MONTH TAKING PROGESTIN
74	Medication/supplement use	107348	phv00107348.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:34:07+00:00	2018-09-28 16:34:07+00:00 	ASPIRIN	ASPIRIN USE > 2 DAYS IN 2 WKS
74	Medication/supplement use	107356	phv00107356.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:34:17+00:00	2018-09-28 16:34:17+00:00 	NOMEDS06	Number of medications
74	Medication/supplement use	107357	phv00107357.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:34:28+00:00	2018-09-28 16:34:28+00:00 	TAKMED06	TAKE ANY MEDICATIONS
74	Medication/supplement use	107358	phv00107358.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:34:37+00:00	2018-09-28 16:34:37+00:00 	A2A06	Angiotensin type 2 antagonists
74	Medication/supplement use	107349	phv00107349.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:34:49+00:00	2018-09-28 16:34:49+00:00 	ANYDIUR	ANY DIURETIC
74	Medication/supplement use	107350	phv00107350.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:34:57+00:00	2018-09-28 16:34:57+00:00 	ANYBETA	ANY BETA BLOCKER
74	Medication/supplement use	107351	phv00107351.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:35:08+00:00	2018-09-28 16:35:08+00:00 	ANYVASO	ANY VASO DILATOR
74	Medication/supplement use	107352	phv00107352.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:35:16+00:00	2018-09-28 16:35:16+00:00 	ANYACE	ANY ACE INHIBITOR
74	Medication/supplement use	107359	phv00107359.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:35:30+00:00	2018-09-28 16:35:30+00:00 	A2AD06	Combinations of angiotensin II antagonist
74	Medication/supplement use	107360	phv00107360.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:35:38+00:00	2018-09-28 16:35:38+00:00 	ACE06	ACE Inhibitors without diuretics
74	Medication/supplement use	107361	phv00107361.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:35:46+00:00	2018-09-28 16:35:46+00:00 	ACED06	ACE Inhibitors with diuretics
74	Medication/supplement use	107362	phv00107362.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:35:55+00:00	2018-09-28 16:35:55+00:00 	ADPI06	Inhibitors of ADP-induced platelet aggregation
74	Medication/supplement use	107363	phv00107363.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:36:04+00:00	2018-09-28 16:36:04+00:00 	AGDI06	Alpha-Glucosidase Inhibitors
74	Medication/supplement use	107364	phv00107364.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:36:12+00:00	2018-09-28 16:36:12+00:00 	ALPHA06	Alpha-blockers without diuretics
74	Medication/supplement use	107365	phv00107365.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:36:22+00:00	2018-09-28 16:36:22+00:00 	ALPHAD06	Alpha-blockers with diuretics
74	Medication/supplement use	107366	phv00107366.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:36:31+00:00	2018-09-28 16:36:31+00:00 	ALZH06	Acetylcholine esterase inhibitors for Al
74	Medication/supplement use	107367	phv00107367.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:36:41+00:00	2018-09-28 16:36:41+00:00 	AMLOD06	Amlodipine
74	Medication/supplement use	107368	phv00107368.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:36:49+00:00	2018-09-28 16:36:49+00:00 	ANAR1A06	Anti-arrhythmics,  class 1A
74	Medication/supplement use	107369	phv00107369.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:36:57+00:00	2018-09-28 16:36:57+00:00 	ANAR1B06	Anti-arrhythmics,  class 1B
74	Medication/supplement use	107370	phv00107370.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:37:04+00:00	2018-09-28 16:37:04+00:00 	ANAR1C06	Anti-arrhythmics,  class 1C
74	Medication/supplement use	107371	phv00107371.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:37:15+00:00	2018-09-28 16:37:15+00:00 	ANAR306	Anti-arrhythmics,  class 3
74	Medication/supplement use	107372	phv00107372.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:37:27+00:00	2018-09-28 16:37:27+00:00 	ANTPSY06	Anti-psychotic medications
74	Medication/supplement use	107373	phv00107373.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:37:35+00:00	2018-09-28 16:37:35+00:00 	ASA06	Aspirin from 280804 (anti-inflammatory agents)
74	Medication/supplement use	107374	phv00107374.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:37:48+00:00	2018-09-28 16:37:48+00:00 	BASQ06	Bile-acid sequestrants
74	Medication/supplement use	107375	phv00107375.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:37:55+00:00	2018-09-28 16:37:55+00:00 	BENZOD06	Benzodiazepines
74	Medication/supplement use	107376	phv00107376.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:38:04+00:00	2018-09-28 16:38:04+00:00 	BETA06	Beta-blockers without diuretics
74	Medication/supplement use	107377	phv00107377.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:38:13+00:00	2018-09-28 16:38:13+00:00 	BETAD06	Beta-blockers with diuretics
74	Medication/supplement use	107378	phv00107378.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:38:21+00:00	2018-09-28 16:38:21+00:00 	BGND06	Biguanides
74	Medication/supplement use	107379	phv00107379.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:38:29+00:00	2018-09-28 16:38:29+00:00 	CCB06	Any calcium-channel blocker = CCIR or CC
74	Medication/supplement use	107380	phv00107380.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:38:36+00:00	2018-09-28 16:38:36+00:00 	CCBIR06	Immediate-release CCBs = NIFIR or DIHIR
74	Medication/supplement use	107381	phv00107381.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:38:45+00:00	2018-09-28 16:38:45+00:00 	CCBSR06	Slow-release CCBs = NIFSR or DIHSR or VE
74	Medication/supplement use	107382	phv00107382.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:38:54+00:00	2018-09-28 16:38:54+00:00 	CCBT06	T-type calcium-channel blocker
74	Medication/supplement use	107383	phv00107383.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:39:02+00:00	2018-09-28 16:39:02+00:00 	COX206	Cox-2 inhibitors (NSAID agents) ; seperat
74	Medication/supplement use	107384	phv00107384.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:39:11+00:00	2018-09-28 16:39:11+00:00 	DIG06	Digitalis preparations
74	Medication/supplement use	107385	phv00107385.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:39:20+00:00	2018-09-28 16:39:20+00:00 	DIHIR06	Immediate-release dihyropyridines other
74	Medication/supplement use	107386	phv00107386.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:39:27+00:00	2018-09-28 16:39:27+00:00 	DIHSR06	Slow-release dihydropyridines other than
74	Medication/supplement use	107387	phv00107387.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:39:35+00:00	2018-09-28 16:39:35+00:00 	DLTIR06	Immediate-release diltiazem
74	Medication/supplement use	107389	phv00107389.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:39:46+00:00	2018-09-28 16:39:46+00:00 	EDD06	Erectile dysfunction drugs
74	Medication/supplement use	107390	phv00107390.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:39:56+00:00	2018-09-28 16:39:56+00:00 	ESTRGN06	Estrogens,  excluding vaginal creams
74	Medication/supplement use	107391	phv00107391.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:40:04+00:00	2018-09-28 16:40:04+00:00 	FIBR06	Fibrates
74	Medication/supplement use	107392	phv00107392.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:40:12+00:00	2018-09-28 16:40:12+00:00 	H2B06	H-2 Blockers
74	Medication/supplement use	107393	phv00107393.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:40:20+00:00	2018-09-28 16:40:20+00:00 	HCTZ06	Thiazide diuretics without k-sparing age
74	Medication/supplement use	107394	phv00107394.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:40:29+00:00	2018-09-28 16:40:29+00:00 	HCTZK06	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	107395	phv00107395.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:40:38+00:00	2018-09-28 16:40:38+00:00 	HPRNS06	Heparins
74	Medication/supplement use	107396	phv00107396.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:40:47+00:00	2018-09-28 16:40:47+00:00 	INSULN06	Insulins
74	Medication/supplement use	107397	phv00107397.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:40:55+00:00	2018-09-28 16:40:55+00:00 	IPRTR06	Anticholinergics + combination with beta
74	Medication/supplement use	107398	phv00107398.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:41:04+00:00	2018-09-28 16:41:04+00:00 	ISTRD06	Inhaled steroids for asthma
74	Medication/supplement use	107399	phv00107399.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:41:13+00:00	2018-09-28 16:41:13+00:00 	KBLKR06	K-channel blockers to enhance insulin se
74	Medication/supplement use	107400	phv00107400.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:41:22+00:00	2018-09-28 16:41:22+00:00 	KCL06	Potassium supplements
74	Medication/supplement use	107401	phv00107401.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:41:31+00:00	2018-09-28 16:41:31+00:00 	KSPR06	Potassium-sparing agents alone
74	Medication/supplement use	107402	phv00107402.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:41:41+00:00	2018-09-28 16:41:41+00:00 	LOOP06	Loop diuretics
74	Medication/supplement use	107403	phv00107403.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:41:50+00:00	2018-09-28 16:41:50+00:00 	MAOI06	MAO Inhibitors
74	Medication/supplement use	107404	phv00107404.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:41:58+00:00	2018-09-28 16:41:58+00:00 	MLPD06	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	107405	phv00107405.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:42:08+00:00	2018-09-28 16:42:08+00:00 	NIAC06	Niacin and nicotinic acid
74	Medication/supplement use	107406	phv00107406.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:42:20+00:00	2018-09-28 16:42:20+00:00 	NIFIR06	Immediate-release nifedipine
74	Medication/supplement use	107407	phv00107407.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:42:28+00:00	2018-09-28 16:42:28+00:00 	NIFSR06	Slow-release nifedipine
74	Medication/supplement use	107408	phv00107408.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:42:39+00:00	2018-09-28 16:42:39+00:00 	NSAID06	Non-steroidal anti-inflammatory agents,
74	Medication/supplement use	107409	phv00107409.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:42:47+00:00	2018-09-28 16:42:47+00:00 	NTCA06	Non-tricyclic antidepressants other than
74	Medication/supplement use	107410	phv00107410.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:42:57+00:00	2018-09-28 16:42:57+00:00 	NTG06	Nitrates
74	Medication/supplement use	107411	phv00107411.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:43:06+00:00	2018-09-28 16:43:06+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
74	Medication/supplement use	107412	phv00107412.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:43:15+00:00	2018-09-28 16:43:15+00:00 	OHGA06	Oral hypoglycemic agents
74	Medication/supplement use	107413	phv00107413.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:43:23+00:00	2018-09-28 16:43:23+00:00 	OSTRD06	Oral steroids
74	Medication/supplement use	107414	phv00107414.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:43:32+00:00	2018-09-28 16:43:32+00:00 	OTCH2B06	('60)  Over-the-counter H-2 blockers
74	Medication/supplement use	107415	phv00107415.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:43:40+00:00	2018-09-28 16:43:40+00:00 	PDEI06	Phosphodiesterase inhibitors
74	Medication/supplement use	107416	phv00107416.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:43:48+00:00	2018-09-28 16:43:48+00:00 	PPI06	Proton pump inhibitors
74	Medication/supplement use	107417	phv00107417.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:43:57+00:00	2018-09-28 16:43:57+00:00 	PROGST06	Progestins
74	Medication/supplement use	107418	phv00107418.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:44:05+00:00	2018-09-28 16:44:05+00:00 	PRKNSN06	Drugs used to treat Parkinson s
74	Medication/supplement use	107419	phv00107419.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:44:12+00:00	2018-09-28 16:44:12+00:00 	PREMAR06	Premarin (conjugated estrogens)
74	Medication/supplement use	107420	phv00107420.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:44:20+00:00	2018-09-28 16:44:20+00:00 	PROB06	Probucol
74	Medication/supplement use	107421	phv00107421.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:44:33+00:00	2018-09-28 16:44:33+00:00 	PVDL06	Peripheral vasodilators,  exclude dipyrid
74	Medication/supplement use	107422	phv00107422.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:44:41+00:00	2018-09-28 16:44:41+00:00 	SLF106	First generation sulfonylureas
74	Medication/supplement use	107423	phv00107423.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:44:48+00:00	2018-09-28 16:44:48+00:00 	SLF206	Second generation sulfonylureas
74	Medication/supplement use	107424	phv00107424.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:44:57+00:00	2018-09-28 16:44:57+00:00 	STTN06	HMG-CoA reductase inhibitors
74	Medication/supplement use	107425	phv00107425.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:45:05+00:00	2018-09-28 16:45:05+00:00 	SYMPTH06	Sympathomimetics,  oral and inhaled
74	Medication/supplement use	107426	phv00107426.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:45:12+00:00	2018-09-28 16:45:12+00:00 	TCA06	Tricyclic anti-depressants
74	Medication/supplement use	107427	phv00107427.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:45:20+00:00	2018-09-28 16:45:20+00:00 	TCAP06	Tri-cyclic anti-depressants plus anti-ps
74	Medication/supplement use	107428	phv00107428.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:45:27+00:00	2018-09-28 16:45:27+00:00 	THRY06	Thyroid agents
74	Medication/supplement use	107429	phv00107429.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:45:37+00:00	2018-09-28 16:45:37+00:00 	THZD06	Thiazolidinediones
74	Medication/supplement use	107430	phv00107430.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:45:52+00:00	2018-09-28 16:45:52+00:00 	URCOS06	Uricosurics
74	Medication/supplement use	107431	phv00107431.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:46:03+00:00	2018-09-28 16:46:03+00:00 	VASO06	Vasodilators,  a mixed group
74	Medication/supplement use	107432	phv00107432.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:46:12+00:00	2018-09-28 16:46:12+00:00 	VASOD06	Vasodilators with diuretics,  a mixed gro
74	Medication/supplement use	107433	phv00107433.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:46:20+00:00	2018-09-28 16:46:20+00:00 	VERIR06	Immediate-release verapamil
74	Medication/supplement use	107434	phv00107434.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:46:27+00:00	2018-09-28 16:46:27+00:00 	VERSR06	Slow-release verapamil
74	Medication/supplement use	107435	phv00107435.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:46:36+00:00	2018-09-28 16:46:36+00:00 	WARF06	Oral anticoagulants
74	Medication/supplement use	107436	phv00107436.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:46:46+00:00	2018-09-28 16:46:46+00:00 	WTLS06	Weight loss drugs
74	Medication/supplement use	107437	phv00107437.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:46:56+00:00	2018-09-28 16:46:56+00:00 	XOI06	Xanthine oxidase inhibitors
74	Medication/supplement use	107438	phv00107438.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:47:06+00:00	2018-09-28 16:47:06+00:00 	DIURET06	Any diuretic
74	Medication/supplement use	107439	phv00107439.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:47:14+00:00	2018-09-28 16:47:14+00:00 	LIPID06	Any lipid-lowering medication
74	Medication/supplement use	107440	phv00107440.v1.p1	pht001491.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 16:47:24+00:00	2018-09-28 16:47:24+00:00 	HTNMED06	Any hypertension medication
74	Medication/supplement use	107782	phv00107782.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:27:31+00:00	2018-09-28 17:27:31+00:00 	ANYACE	ANY ACE INHIBITOR
74	Medication/supplement use	107783	phv00107783.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:27:40+00:00	2018-09-28 17:27:40+00:00 	ANYBETA	ANY BETA BLOCKER
74	Medication/supplement use	107784	phv00107784.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:27:50+00:00	2018-09-28 17:27:50+00:00 	ANYVASO	ANY VASO DILATOR
74	Medication/supplement use	107785	phv00107785.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:27:58+00:00	2018-09-28 17:27:58+00:00 	ANYDIUR	ANY DIURETIC
74	Medication/supplement use	108064	phv00108064.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:29:08+00:00	2018-09-28 17:29:08+00:00 	MLTVIT59	TAKEN MULTIPLE OR OTHER VITAMIN
74	Medication/supplement use	108066	phv00108066.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:29:18+00:00	2018-09-28 17:29:18+00:00 	MDAYS59	DAYS TOOK MULTIPLE VITAMIN
74	Medication/supplement use	108065	phv00108065.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:29:27+00:00	2018-09-28 17:29:27+00:00 	MULTI59	TOOK MULTIPLE VITAMIN
74	Medication/supplement use	108067	phv00108067.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:29:35+00:00	2018-09-28 17:29:35+00:00 	VITA59	TOOK VITAMIN A
74	Medication/supplement use	108068	phv00108068.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:29:44+00:00	2018-09-28 17:29:44+00:00 	ADAYS59	DAYS TOOK VITAMIN A
74	Medication/supplement use	108069	phv00108069.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:29:53+00:00	2018-09-28 17:29:53+00:00 	VITC59	TOOK VITAMIN C
74	Medication/supplement use	108070	phv00108070.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:30:10+00:00	2018-09-28 17:30:10+00:00 	CDAYS59	DAYS TOOK VITAMIN C
74	Medication/supplement use	108071	phv00108071.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:30:19+00:00	2018-09-28 17:30:19+00:00 	VITE59	TOOK VITAMIN E
74	Medication/supplement use	108072	phv00108072.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:30:29+00:00	2018-09-28 17:30:29+00:00 	EDAYS59	DAYS TOOK VITAMIN E
74	Medication/supplement use	108073	phv00108073.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:30:38+00:00	2018-09-28 17:30:38+00:00 	ASPR59	ASPIRIN/ASPIRIN-CONTAINING MEDICINES
74	Medication/supplement use	108074	phv00108074.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:30:53+00:00	2018-09-28 17:30:53+00:00 	DAYASP59	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	108075	phv00108075.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:31:03+00:00	2018-09-28 17:31:03+00:00 	FSHOIL59	CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS
74	Medication/supplement use	108077	phv00108077.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:31:18+00:00	2018-09-28 17:31:18+00:00 	ANTHST59	ANTIHISTAMINES(COLD PILLS, ALLERGY PILLS)
74	Medication/supplement use	108078	phv00108078.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:31:35+00:00	2018-09-28 17:31:35+00:00 	SLPILL59	SLEEPING PILLS
74	Medication/supplement use	108079	phv00108079.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:31:45+00:00	2018-09-28 17:31:45+00:00 	LAXATV59	LAXATIVES
74	Medication/supplement use	108080	phv00108080.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:31:55+00:00	2018-09-28 17:31:55+00:00 	CALC59	CALCIUM SUPPLEMENTS
74	Medication/supplement use	108113	phv00108113.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:32:21+00:00	2018-09-28 17:32:21+00:00 	ESTROC59	CURRENTLY TAKING ESTROGEN
74	Medication/supplement use	108114	phv00108114.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:32:31+00:00	2018-09-28 17:32:31+00:00 	ECDAY59	DAYS PER MONTH TAKE ESTROGEN
74	Medication/supplement use	108135	phv00108135.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:32:42+00:00	2018-09-28 17:32:42+00:00 	PROGC59	CURRENTLY TAKING PROGESTIN
74	Medication/supplement use	108136	phv00108136.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:32:54+00:00	2018-09-28 17:32:54+00:00 	PCDAY59	DAYS PER MONTH TAKING PROGESTIN
74	Medication/supplement use	108213	phv00108213.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:33:18+00:00	2018-09-28 17:33:18+00:00 	ASPIRIN	ASPIRIN USE > 2 DAYS IN 2 WKS
74	Medication/supplement use	108218	phv00108218.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:33:31+00:00	2018-09-28 17:33:31+00:00 	NOMEDS06	Total Medications
74	Medication/supplement use	108219	phv00108219.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:33:41+00:00	2018-09-28 17:33:41+00:00 	A2A06	Angiotensin type 2 antagonists
74	Medication/supplement use	108220	phv00108220.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:33:49+00:00	2018-09-28 17:33:49+00:00 	A2AD06	Combinations of angiotensin II antagonists
74	Medication/supplement use	108221	phv00108221.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:34:00+00:00	2018-09-28 17:34:00+00:00 	ACE06	ACE Inhibitors without diuretics
74	Medication/supplement use	108222	phv00108222.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:34:09+00:00	2018-09-28 17:34:09+00:00 	ACED06	ACE Inhibitors with diuretics
74	Medication/supplement use	108223	phv00108223.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:34:18+00:00	2018-09-28 17:34:18+00:00 	ADPI06	Inhibitors of ADP-induced platelet aggregation
74	Medication/supplement use	108224	phv00108224.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:34:26+00:00	2018-09-28 17:34:26+00:00 	AGDI06	Alpha-Glucosidase Inhibitors
74	Medication/supplement use	108225	phv00108225.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:34:33+00:00	2018-09-28 17:34:33+00:00 	ALPHA06	Alpha-blockers without diuretics
74	Medication/supplement use	108226	phv00108226.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:34:46+00:00	2018-09-28 17:34:46+00:00 	ALPHAD06	Alpha-blockers with diuretics
74	Medication/supplement use	108227	phv00108227.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:34:57+00:00	2018-09-28 17:34:57+00:00 	ALZH06	Acetylcholine esterase inhibitors for Al
74	Medication/supplement use	108228	phv00108228.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:35:10+00:00	2018-09-28 17:35:10+00:00 	AMLOD06	Amlodipine
74	Medication/supplement use	108229	phv00108229.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:35:19+00:00	2018-09-28 17:35:19+00:00 	ANAR1A06	Anti-arrhythmics, class 1A
74	Medication/supplement use	108230	phv00108230.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:35:32+00:00	2018-09-28 17:35:32+00:00 	ANAR1B06	Anti-arrhythmics, class 1B
74	Medication/supplement use	108231	phv00108231.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:35:48+00:00	2018-09-28 17:35:48+00:00 	ANAR1C06	Anti-arrhythmics, class 1C
74	Medication/supplement use	108232	phv00108232.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:35:57+00:00	2018-09-28 17:35:57+00:00 	ANAR306	Anti-arrhythmics, class 3
74	Medication/supplement use	108233	phv00108233.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:36:11+00:00	2018-09-28 17:36:11+00:00 	ANTPSY06	Anti-psychotic medications
74	Medication/supplement use	108234	phv00108234.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:36:20+00:00	2018-09-28 17:36:20+00:00 	ASA06	Aspirin from 280804 (anti-inflammatory agents)
74	Medication/supplement use	108235	phv00108235.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:36:29+00:00	2018-09-28 17:36:29+00:00 	BASQ06	Bile-acid sequestrants
74	Medication/supplement use	108236	phv00108236.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:36:43+00:00	2018-09-28 17:36:43+00:00 	BENZOD06	Benzodiazepines
74	Medication/supplement use	108237	phv00108237.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:36:53+00:00	2018-09-28 17:36:53+00:00 	BETA06	Beta-blockers without diuretics
74	Medication/supplement use	108238	phv00108238.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:37:01+00:00	2018-09-28 17:37:01+00:00 	BETAD06	Beta-blockers with diuretics
74	Medication/supplement use	108239	phv00108239.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:37:09+00:00	2018-09-28 17:37:09+00:00 	BGND06	Biguanides
74	Medication/supplement use	108240	phv00108240.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:37:25+00:00	2018-09-28 17:37:25+00:00 	CCB06	Any calcium-channel blocker = CCIR or CC
74	Medication/supplement use	108241	phv00108241.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:37:40+00:00	2018-09-28 17:37:40+00:00 	CCBIR06	Immediate-release CCBs = NIFIR or DIHIR
74	Medication/supplement use	108242	phv00108242.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:37:48+00:00	2018-09-28 17:37:48+00:00 	CCBSR06	Slow-release CCBs = NIFSR or DIHSR or VE
74	Medication/supplement use	108243	phv00108243.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:37:58+00:00	2018-09-28 17:37:58+00:00 	CCBT06	T-type calcium-channel blocker
74	Medication/supplement use	108244	phv00108244.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:48:11+00:00	2018-09-28 17:48:11+00:00 	COX206	Cox-2 inhibitors (NSAID agents); seperat
74	Medication/supplement use	108245	phv00108245.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:48:20+00:00	2018-09-28 17:48:20+00:00 	DIG06	Digitalis preparations
74	Medication/supplement use	108246	phv00108246.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:48:31+00:00	2018-09-28 17:48:31+00:00 	DIHIR06	Immediate-release dihyropyridines other
74	Medication/supplement use	108247	phv00108247.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:48:41+00:00	2018-09-28 17:48:41+00:00 	DIHSR06	Slow-release dihydropyridines other than
74	Medication/supplement use	108248	phv00108248.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:48:51+00:00	2018-09-28 17:48:51+00:00 	DLTIR06	Immediate-release diltiazem
74	Medication/supplement use	108249	phv00108249.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:49:00+00:00	2018-09-28 17:49:00+00:00 	DLTSR06	Slow-release diltiazem
74	Medication/supplement use	108250	phv00108250.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:53:13+00:00	2018-09-28 17:53:13+00:00 	EDD06	Erectile dysfunction drugs
74	Medication/supplement use	108251	phv00108251.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:53:24+00:00	2018-09-28 17:53:24+00:00 	ESTRGN06	Estrogens, excluding vaginal creams
74	Medication/supplement use	108252	phv00108252.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:53:37+00:00	2018-09-28 17:53:37+00:00 	FIBR06	Fibrates
74	Medication/supplement use	108253	phv00108253.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:53:51+00:00	2018-09-28 17:53:51+00:00 	H2B06	H-2 Blockers
74	Medication/supplement use	108254	phv00108254.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:54:00+00:00	2018-09-28 17:54:00+00:00 	HCTZ06	Thiazide diuretics without k-sparing age
74	Medication/supplement use	108255	phv00108255.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:54:08+00:00	2018-09-28 17:54:08+00:00 	HCTZK06	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	108256	phv00108256.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:54:16+00:00	2018-09-28 17:54:16+00:00 	HPRNS06	Heparins
74	Medication/supplement use	108257	phv00108257.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:54:24+00:00	2018-09-28 17:54:24+00:00 	INSULN06	Insulins
74	Medication/supplement use	108258	phv00108258.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:54:33+00:00	2018-09-28 17:54:33+00:00 	IPRTR06	Anticholinergics + combination with beta
74	Medication/supplement use	108259	phv00108259.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:54:43+00:00	2018-09-28 17:54:43+00:00 	ISTRD06	Inhaled steroids for asthma
74	Medication/supplement use	108260	phv00108260.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:54:54+00:00	2018-09-28 17:54:54+00:00 	KBLKR06	K-channel blockers to enhance insulin se
74	Medication/supplement use	108261	phv00108261.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:55:06+00:00	2018-09-28 17:55:06+00:00 	KCL06	Potassium supplements
74	Medication/supplement use	108262	phv00108262.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:55:16+00:00	2018-09-28 17:55:16+00:00 	KSPR06	Potassium-sparing agents alone
74	Medication/supplement use	108263	phv00108263.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:55:57+00:00	2018-09-28 17:55:57+00:00 	LOOP06	Loop diuretics
74	Medication/supplement use	108264	phv00108264.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:56:06+00:00	2018-09-28 17:56:06+00:00 	MAOI06	MAO Inhibitors
74	Medication/supplement use	108265	phv00108265.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:56:15+00:00	2018-09-28 17:56:15+00:00 	MLPD06	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	108266	phv00108266.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:56:26+00:00	2018-09-28 17:56:26+00:00 	NIAC06	Niacin and nicotinic acid
74	Medication/supplement use	108267	phv00108267.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:56:34+00:00	2018-09-28 17:56:34+00:00 	NIFIR06	Immediate-release nifedipine
74	Medication/supplement use	108268	phv00108268.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:56:42+00:00	2018-09-28 17:56:42+00:00 	NIFSR06	Slow-release nifedipine
74	Medication/supplement use	108269	phv00108269.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:56:50+00:00	2018-09-28 17:56:50+00:00 	NSAID06	Non-steroidal anti-inflammatory agents,
74	Medication/supplement use	108270	phv00108270.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:56:58+00:00	2018-09-28 17:56:58+00:00 	NTCA06	Non-tricyclic antidepressants other than
74	Medication/supplement use	108271	phv00108271.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:57:08+00:00	2018-09-28 17:57:08+00:00 	NTG06	Nitrates
74	Medication/supplement use	108272	phv00108272.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:57:19+00:00	2018-09-28 17:57:19+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
74	Medication/supplement use	108273	phv00108273.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:57:28+00:00	2018-09-28 17:57:28+00:00 	OHGA06	Oral hypoglycemic agents
74	Medication/supplement use	108274	phv00108274.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:57:35+00:00	2018-09-28 17:57:35+00:00 	OSTRD06	Oral steroids
74	Medication/supplement use	108275	phv00108275.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:57:49+00:00	2018-09-28 17:57:49+00:00 	OTCH2B06	('60) Over-the-counter H-2 blockers'
74	Medication/supplement use	108276	phv00108276.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:57:58+00:00	2018-09-28 17:57:58+00:00 	PDEI06	Phosphodiesterase inhibitors
74	Medication/supplement use	108277	phv00108277.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:58:06+00:00	2018-09-28 17:58:06+00:00 	PPI06	Proton pump inhibitors
74	Medication/supplement use	108278	phv00108278.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:58:15+00:00	2018-09-28 17:58:15+00:00 	PROGST06	Progestins
74	Medication/supplement use	108279	phv00108279.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:58:23+00:00	2018-09-28 17:58:23+00:00 	PRKNSN06	Drugs used to treat Parkinson s
74	Medication/supplement use	108280	phv00108280.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:58:37+00:00	2018-09-28 17:58:37+00:00 	PREMAR06	Premarin (conjugated estrogens)
74	Medication/supplement use	108281	phv00108281.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:58:45+00:00	2018-09-28 17:58:45+00:00 	PROB06	Probucol
74	Medication/supplement use	108282	phv00108282.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:58:53+00:00	2018-09-28 17:58:53+00:00 	PVDL06	Peripheral vasodilators, exclude dipyrid
74	Medication/supplement use	108283	phv00108283.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:59:01+00:00	2018-09-28 17:59:01+00:00 	SLF106	First generation sulfonylureas
74	Medication/supplement use	108284	phv00108284.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:59:26+00:00	2018-09-28 17:59:26+00:00 	SLF206	Second generation sulfonylureas
74	Medication/supplement use	108285	phv00108285.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:59:35+00:00	2018-09-28 17:59:35+00:00 	STTN06	HMG-CoA reductase inhibitors
74	Medication/supplement use	108286	phv00108286.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:59:44+00:00	2018-09-28 17:59:44+00:00 	SYMPTH06	Sympathomimetics, oral and inhaled
74	Medication/supplement use	108287	phv00108287.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 17:59:53+00:00	2018-09-28 17:59:53+00:00 	TCA06	Tricyclic anti-depressants
74	Medication/supplement use	108288	phv00108288.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:00:01+00:00	2018-09-28 18:00:01+00:00 	TCAP06	Tri-cyclic anti-depressants plus anti-ps
74	Medication/supplement use	108289	phv00108289.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:00:11+00:00	2018-09-28 18:00:11+00:00 	THRY06	Thyroid agents
74	Medication/supplement use	108290	phv00108290.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:00:23+00:00	2018-09-28 18:00:23+00:00 	THZD06	Thiazolidinediones
74	Medication/supplement use	108291	phv00108291.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:00:30+00:00	2018-09-28 18:00:30+00:00 	URCOS06	Uricosurics
74	Medication/supplement use	108292	phv00108292.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:00:37+00:00	2018-09-28 18:00:37+00:00 	VASO06	Vasodilators, a mixed group
74	Medication/supplement use	108293	phv00108293.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:00:44+00:00	2018-09-28 18:00:44+00:00 	VASOD06	Vasodilators with diuretics, a mixed gro
74	Medication/supplement use	108294	phv00108294.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:00:56+00:00	2018-09-28 18:00:56+00:00 	VERIR06	Immediate-release verapamil
74	Medication/supplement use	108295	phv00108295.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:01:05+00:00	2018-09-28 18:01:05+00:00 	VERSR06	Slow-release verapamil
74	Medication/supplement use	108296	phv00108296.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:01:13+00:00	2018-09-28 18:01:13+00:00 	WARF06	Oral anticoagulants
74	Medication/supplement use	108297	phv00108297.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:01:21+00:00	2018-09-28 18:01:21+00:00 	WTLS06	Weight loss drugs
74	Medication/supplement use	108298	phv00108298.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:01:29+00:00	2018-09-28 18:01:29+00:00 	XOI06	Xanthine oxidase inhibitors
74	Medication/supplement use	108299	phv00108299.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:01:39+00:00	2018-09-28 18:01:39+00:00 	DIURET06	Any diuretic
74	Medication/supplement use	108300	phv00108300.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:01:47+00:00	2018-09-28 18:01:47+00:00 	LIPID06	Any lipid-lowering medication
74	Medication/supplement use	108301	phv00108301.v1.p1	pht001492.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 18:01:58+00:00	2018-09-28 18:01:58+00:00 	HTNMED06	Any hypertension medication
74	Medication/supplement use	108747	phv00108747.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:00:49+00:00	2018-09-28 20:00:49+00:00 	ESTROC59	CURRENTLY TAKING ESTROGEN
74	Medication/supplement use	108748	phv00108748.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:00:59+00:00	2018-09-28 20:00:59+00:00 	ECDAY59	DAYS PER MONTH TAKE ESTROGEN
74	Medication/supplement use	108755	phv00108755.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:01:12+00:00	2018-09-28 20:01:12+00:00 	PROGC59	CURRENTLY TAKING PROGESTIN
74	Medication/supplement use	108756	phv00108756.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:01:21+00:00	2018-09-28 20:01:21+00:00 	PCDAY59	DAYS PER MONTH TAKING PROGESTIN
74	Medication/supplement use	108841	phv00108841.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:01:48+00:00	2018-09-28 20:01:48+00:00 	ANYACE	ANY ACE INHIBITOR
74	Medication/supplement use	108842	phv00108842.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:01:55+00:00	2018-09-28 20:01:55+00:00 	ANYBETA	ANY BETA BLOCKER
74	Medication/supplement use	108843	phv00108843.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:02:05+00:00	2018-09-28 20:02:05+00:00 	ANYVASO	ANY VASO DILATOR
74	Medication/supplement use	108844	phv00108844.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:02:15+00:00	2018-09-28 20:02:15+00:00 	ANYDIUR	ANY DIURETIC
74	Medication/supplement use	108845	phv00108845.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:02:24+00:00	2018-09-28 20:02:24+00:00 	ASPIRIN	ASPIRIN USE > 2 DAYS IN 2 WEEKS
74	Medication/supplement use	108972	phv00108972.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:03:08+00:00	2018-09-28 20:03:08+00:00 	NOMEDS06	Total Medications
74	Medication/supplement use	108973	phv00108973.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:03:17+00:00	2018-09-28 20:03:17+00:00 	A2A06	Angiotensin type 2 antagonists
74	Medication/supplement use	108974	phv00108974.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:03:25+00:00	2018-09-28 20:03:25+00:00 	A2AD06	Combinations of angiotensin II antagonists
74	Medication/supplement use	108975	phv00108975.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:03:33+00:00	2018-09-28 20:03:33+00:00 	ACE06	ACE Inhibitors without diuretics
74	Medication/supplement use	108976	phv00108976.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:03:41+00:00	2018-09-28 20:03:41+00:00 	ACED06	ACE Inhibitors with diuretics
74	Medication/supplement use	108977	phv00108977.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:03:56+00:00	2018-09-28 20:03:56+00:00 	ADPI06	Inhibitors of ADP-induced platelet aggregation
74	Medication/supplement use	108978	phv00108978.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:04:08+00:00	2018-09-28 20:04:08+00:00 	AGDI06	Alpha-Glucosidase Inhibitors
74	Medication/supplement use	108979	phv00108979.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:04:17+00:00	2018-09-28 20:04:17+00:00 	ALPHA06	Alpha-blockers without diuretics
74	Medication/supplement use	108980	phv00108980.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:04:30+00:00	2018-09-28 20:04:30+00:00 	ALPHAD06	Alpha-blockers with diuretics
74	Medication/supplement use	108981	phv00108981.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:04:38+00:00	2018-09-28 20:04:38+00:00 	ALZH06	Acetylcholine esterase inhibitors for Al
74	Medication/supplement use	108982	phv00108982.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:04:52+00:00	2018-09-28 20:04:52+00:00 	AMLOD06	Amlodipine
74	Medication/supplement use	108983	phv00108983.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:05:02+00:00	2018-09-28 20:05:02+00:00 	ANAR1A06	Anti-arrhythmics,  class 1A
74	Medication/supplement use	108984	phv00108984.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:05:10+00:00	2018-09-28 20:05:10+00:00 	ANAR1B06	Anti-arrhythmics,  class 1B
74	Medication/supplement use	108985	phv00108985.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:05:17+00:00	2018-09-28 20:05:17+00:00 	ANAR1C06	Anti-arrhythmics,  class 1C
74	Medication/supplement use	108986	phv00108986.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:05:25+00:00	2018-09-28 20:05:25+00:00 	ANAR306	Anti-arrhythmics,  class 3
74	Medication/supplement use	108987	phv00108987.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:05:38+00:00	2018-09-28 20:05:38+00:00 	ANTPSY06	Anti-psychotic medications
74	Medication/supplement use	108988	phv00108988.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:05:47+00:00	2018-09-28 20:05:47+00:00 	ASA06	Aspirin from 280804 (anti-inflammatory agents)
74	Medication/supplement use	108989	phv00108989.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:05:55+00:00	2018-09-28 20:05:55+00:00 	BASQ06	Bile-acid sequestrants
74	Medication/supplement use	108990	phv00108990.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:06:04+00:00	2018-09-28 20:06:04+00:00 	BENZOD06	Benzodiazepines
74	Medication/supplement use	108991	phv00108991.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:06:13+00:00	2018-09-28 20:06:13+00:00 	BETA06	Beta-blockers without diuretics
74	Medication/supplement use	108992	phv00108992.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:06:25+00:00	2018-09-28 20:06:25+00:00 	BETAD06	Beta-blockers with diuretics
74	Medication/supplement use	108993	phv00108993.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:06:32+00:00	2018-09-28 20:06:32+00:00 	BGND06	Biguanides
74	Medication/supplement use	108994	phv00108994.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:06:41+00:00	2018-09-28 20:06:41+00:00 	CCB06	Any calcium-channel blocker = CCIR or CC
74	Medication/supplement use	108998	phv00108998.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:06:49+00:00	2018-09-28 20:06:49+00:00 	COX206	Cox-2 inhibitors (NSAID agents); seperat
74	Medication/supplement use	108999	phv00108999.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:06:57+00:00	2018-09-28 20:06:57+00:00 	DIG06	Digitalis preparations
74	Medication/supplement use	109000	phv00109000.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:07:08+00:00	2018-09-28 20:07:08+00:00 	DIHIR06	Immediate-release dihyropyridines other
74	Medication/supplement use	109001	phv00109001.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:07:16+00:00	2018-09-28 20:07:16+00:00 	DIHSR06	Slow-release dihydropyridines other than
74	Medication/supplement use	109002	phv00109002.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:07:24+00:00	2018-09-28 20:07:24+00:00 	DLTIR06	Immediate-release diltiazem
74	Medication/supplement use	109003	phv00109003.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:07:32+00:00	2018-09-28 20:07:32+00:00 	DLTSR06	Slow-release diltiazem
74	Medication/supplement use	109004	phv00109004.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:07:43+00:00	2018-09-28 20:07:43+00:00 	EDD06	Erectile dysfunction drugs
74	Medication/supplement use	109005	phv00109005.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:07:53+00:00	2018-09-28 20:07:53+00:00 	ESTRGN06	Estrogens,  excluding vaginal creams
74	Medication/supplement use	109006	phv00109006.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:08:00+00:00	2018-09-28 20:08:00+00:00 	FIBR06	Fibrates
74	Medication/supplement use	109007	phv00109007.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:08:08+00:00	2018-09-28 20:08:08+00:00 	H2B06	H-2 Blockers
74	Medication/supplement use	109008	phv00109008.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:08:16+00:00	2018-09-28 20:08:16+00:00 	HCTZ06	Thiazide diuretics without k-sparing age
74	Medication/supplement use	109009	phv00109009.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:08:26+00:00	2018-09-28 20:08:26+00:00 	HCTZK06	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	109010	phv00109010.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:08:52+00:00	2018-09-28 20:08:52+00:00 	HPRNS06	Heparins
74	Medication/supplement use	109011	phv00109011.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:08:59+00:00	2018-09-28 20:08:59+00:00 	INSULN06	Insulins
74	Medication/supplement use	109012	phv00109012.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:09:07+00:00	2018-09-28 20:09:07+00:00 	IPRTR06	Anticholinergics + combination with beta
74	Medication/supplement use	109013	phv00109013.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:09:15+00:00	2018-09-28 20:09:15+00:00 	ISTRD06	Inhaled steroids for asthma
74	Medication/supplement use	109014	phv00109014.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:09:23+00:00	2018-09-28 20:09:23+00:00 	KBLKR06	K-channel blockers to enhance insulin se
74	Medication/supplement use	109015	phv00109015.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:09:32+00:00	2018-09-28 20:09:32+00:00 	KCL06	Potassium supplements
74	Medication/supplement use	109016	phv00109016.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:09:46+00:00	2018-09-28 20:09:46+00:00 	KSPR06	Potassium-sparing agents alone
74	Medication/supplement use	109017	phv00109017.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:10:00+00:00	2018-09-28 20:10:00+00:00 	LOOP06	Loop diuretics
74	Medication/supplement use	109018	phv00109018.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:10:09+00:00	2018-09-28 20:10:09+00:00 	MAOI06	MAO Inhibitors
74	Medication/supplement use	109019	phv00109019.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:10:34+00:00	2018-09-28 20:10:34+00:00 	MLPD06	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	109020	phv00109020.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:10:46+00:00	2018-09-28 20:10:46+00:00 	NIAC06	Niacin and nicotinic acid
74	Medication/supplement use	109021	phv00109021.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:11:03+00:00	2018-09-28 20:11:03+00:00 	NIFIR06	Immediate-release nifedipine
74	Medication/supplement use	109022	phv00109022.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:11:12+00:00	2018-09-28 20:11:12+00:00 	NIFSR06	Slow-release nifedipine
74	Medication/supplement use	109023	phv00109023.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:11:21+00:00	2018-09-28 20:11:21+00:00 	NSAID06	Non-steroidal anti-inflammatory agents,
74	Medication/supplement use	109024	phv00109024.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:11:31+00:00	2018-09-28 20:11:31+00:00 	NTCA06	Non-tricyclic antidepressants other than
74	Medication/supplement use	109025	phv00109025.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:11:38+00:00	2018-09-28 20:11:38+00:00 	NTG06	Nitrates
74	Medication/supplement use	109026	phv00109026.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:11:46+00:00	2018-09-28 20:11:46+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
74	Medication/supplement use	109027	phv00109027.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:11:53+00:00	2018-09-28 20:11:53+00:00 	OHGA06	Oral hypoglycemic agents
74	Medication/supplement use	109028	phv00109028.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:12:01+00:00	2018-09-28 20:12:01+00:00 	OSTRD06	Oral steroids
74	Medication/supplement use	109029	phv00109029.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:12:09+00:00	2018-09-28 20:12:09+00:00 	OTCH2B06	('60) Over-the-counter H-2 blockers'
74	Medication/supplement use	109030	phv00109030.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:12:17+00:00	2018-09-28 20:12:17+00:00 	PDEI06	Phosphodiesterase inhibitors
74	Medication/supplement use	109031	phv00109031.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:12:25+00:00	2018-09-28 20:12:25+00:00 	PPI06	Proton pump inhibitors
74	Medication/supplement use	109032	phv00109032.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:12:34+00:00	2018-09-28 20:12:34+00:00 	PROGST06	Progestins
74	Medication/supplement use	109033	phv00109033.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:12:44+00:00	2018-09-28 20:12:44+00:00 	PRKNSN06	Drugs used to treat Parkinson s
74	Medication/supplement use	109034	phv00109034.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:12:52+00:00	2018-09-28 20:12:52+00:00 	PREMAR06	Premarin (conjugated estrogens)
74	Medication/supplement use	109035	phv00109035.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:12:59+00:00	2018-09-28 20:12:59+00:00 	PROB06	Probucol
74	Medication/supplement use	109036	phv00109036.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:13:06+00:00	2018-09-28 20:13:06+00:00 	PVDL06	Peripheral vasodilators,  exclude dipyrid
74	Medication/supplement use	109037	phv00109037.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:13:15+00:00	2018-09-28 20:13:15+00:00 	SLF106	First generation sulfonylureas
74	Medication/supplement use	109038	phv00109038.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:13:25+00:00	2018-09-28 20:13:25+00:00 	SLF206	Second generation sulfonylureas
74	Medication/supplement use	109039	phv00109039.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:13:34+00:00	2018-09-28 20:13:34+00:00 	STTN06	HMG-CoA reductase inhibitors
74	Medication/supplement use	109040	phv00109040.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:13:41+00:00	2018-09-28 20:13:41+00:00 	SYMPTH06	Sympathomimetics,  oral and inhaled
74	Medication/supplement use	109041	phv00109041.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:13:51+00:00	2018-09-28 20:13:51+00:00 	TCA06	Tricyclic anti-depressants
74	Medication/supplement use	109042	phv00109042.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:13:58+00:00	2018-09-28 20:13:58+00:00 	TCAP06	Tri-cyclic anti-depressants plus anti-ps
74	Medication/supplement use	109043	phv00109043.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:14:06+00:00	2018-09-28 20:14:06+00:00 	THRY06	Thyroid agents
74	Medication/supplement use	109044	phv00109044.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:14:19+00:00	2018-09-28 20:14:19+00:00 	THZD06	Thiazolidinediones
74	Medication/supplement use	109045	phv00109045.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:14:29+00:00	2018-09-28 20:14:29+00:00 	URCOS06	Uricosurics
74	Medication/supplement use	109046	phv00109046.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:14:37+00:00	2018-09-28 20:14:37+00:00 	VASO06	Vasodilators,  a mixed group
74	Medication/supplement use	109047	phv00109047.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:14:46+00:00	2018-09-28 20:14:46+00:00 	VASOD06	Vasodilators with diuretics,  a mixed gro
74	Medication/supplement use	109048	phv00109048.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:14:53+00:00	2018-09-28 20:14:53+00:00 	VERIR06	Immediate-release verapamil
74	Medication/supplement use	109049	phv00109049.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:15:01+00:00	2018-09-28 20:15:01+00:00 	VERSR06	Slow-release verapamil
74	Medication/supplement use	109050	phv00109050.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:15:10+00:00	2018-09-28 20:15:10+00:00 	WARF06	Oral anticoagulants
74	Medication/supplement use	109051	phv00109051.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:15:17+00:00	2018-09-28 20:15:17+00:00 	WTLS06	Weight loss drugs
74	Medication/supplement use	109052	phv00109052.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:15:25+00:00	2018-09-28 20:15:25+00:00 	XOI06	Xanthine oxidase inhibitors
74	Medication/supplement use	109053	phv00109053.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:15:34+00:00	2018-09-28 20:15:34+00:00 	DIURET06	Any diuretic
74	Medication/supplement use	109054	phv00109054.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:15:45+00:00	2018-09-28 20:15:45+00:00 	LIPID06	Any lipid-lowering medication
74	Medication/supplement use	109055	phv00109055.v1.p1	pht001493.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:15:54+00:00	2018-09-28 20:15:54+00:00 	HTNMED06	Any hypertension medication
74	Medication/supplement use	109457	phv00109457.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:53:48+00:00	2018-09-28 20:53:48+00:00 	ASPR59	ASPIRIN/ASPIRIN-CONTAINING MEDICINES
74	Medication/supplement use	109458	phv00109458.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:53:58+00:00	2018-09-28 20:53:58+00:00 	DAYASP59	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	109461	phv00109461.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:54:16+00:00	2018-09-28 20:54:16+00:00 	NITRO59	PRESCRIBE NITROGLYCERIN IN THE LAST YEAR
74	Medication/supplement use	109504	phv00109504.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:54:46+00:00	2018-09-28 20:54:46+00:00 	ASPIRIN	ASPIRIN USE > 2 DAYS IN 2 WKS
74	Medication/supplement use	109505	phv00109505.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:54:55+00:00	2018-09-28 20:54:55+00:00 	ANYDIUR	ANY DIURETIC
74	Medication/supplement use	109506	phv00109506.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:55:03+00:00	2018-09-28 20:55:03+00:00 	ANYBETA	ANY BETA BLOCKER
74	Medication/supplement use	109507	phv00109507.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:55:14+00:00	2018-09-28 20:55:14+00:00 	ANYVASO	ANY VASO DILATOR
74	Medication/supplement use	109508	phv00109508.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:55:22+00:00	2018-09-28 20:55:22+00:00 	ANYACE	ANY ACE INHIBITOR
74	Medication/supplement use	109683	phv00109683.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:58:31+00:00	2018-09-28 20:58:31+00:00 	NOMEDS06	Total Medications
74	Medication/supplement use	109684	phv00109684.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:58:42+00:00	2018-09-28 20:58:42+00:00 	A2A06	Angiotensin type 2 antagonists
74	Medication/supplement use	109685	phv00109685.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:58:49+00:00	2018-09-28 20:58:49+00:00 	A2AD06	Combinations of angiotensin II antagonists
74	Medication/supplement use	109686	phv00109686.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:58:58+00:00	2018-09-28 20:58:58+00:00 	ACE06	ACE Inhibitors without diuretics
74	Medication/supplement use	109687	phv00109687.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:59:06+00:00	2018-09-28 20:59:06+00:00 	ACED06	ACE Inhibitors with diuretics
74	Medication/supplement use	109688	phv00109688.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:59:16+00:00	2018-09-28 20:59:16+00:00 	ADPI06	Inhibitors of ADP-induced platelet aggregation
74	Medication/supplement use	109689	phv00109689.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:59:27+00:00	2018-09-28 20:59:27+00:00 	AGDI06	Alpha-Glucosidase Inhibitors
74	Medication/supplement use	109690	phv00109690.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:59:34+00:00	2018-09-28 20:59:34+00:00 	ALPHA06	Alpha-blockers without diuretics
74	Medication/supplement use	109691	phv00109691.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:59:43+00:00	2018-09-28 20:59:43+00:00 	ALPHAD06	Alpha-blockers with diuretics
74	Medication/supplement use	109692	phv00109692.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 20:59:50+00:00	2018-09-28 20:59:50+00:00 	ALZH06	Acetylcholine esterase inhibitors for Al
74	Medication/supplement use	109693	phv00109693.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:00:00+00:00	2018-09-28 21:00:00+00:00 	AMLOD06	Amlodipine
74	Medication/supplement use	109694	phv00109694.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:00:10+00:00	2018-09-28 21:00:10+00:00 	ANAR1A06	Anti-arrhythmics,  class 1A
74	Medication/supplement use	109695	phv00109695.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:00:17+00:00	2018-09-28 21:00:17+00:00 	ANAR1B06	Anti-arrhythmics,  class 1B
74	Medication/supplement use	109696	phv00109696.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:00:26+00:00	2018-09-28 21:00:26+00:00 	ANAR1C06	Anti-arrhythmics,  class 1C
74	Medication/supplement use	109697	phv00109697.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:00:33+00:00	2018-09-28 21:00:33+00:00 	ANAR306	Anti-arrhythmics,  class 3
74	Medication/supplement use	109698	phv00109698.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:00:41+00:00	2018-09-28 21:00:41+00:00 	ANTPSY06	Anti-psychotic medications
74	Medication/supplement use	109699	phv00109699.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:00:49+00:00	2018-09-28 21:00:49+00:00 	ASA06	Aspirin from 280804 (anti-inflammatory agents)
74	Medication/supplement use	109700	phv00109700.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:00:58+00:00	2018-09-28 21:00:58+00:00 	BASQ06	Bile-acid sequestrants
74	Medication/supplement use	109701	phv00109701.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:01:06+00:00	2018-09-28 21:01:06+00:00 	BENZOD06	Benzodiazepines
74	Medication/supplement use	109702	phv00109702.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:01:16+00:00	2018-09-28 21:01:16+00:00 	BETA06	Beta-blockers without diuretics
74	Medication/supplement use	109703	phv00109703.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:01:25+00:00	2018-09-28 21:01:25+00:00 	BETAD06	Beta-blockers with diuretics
74	Medication/supplement use	109704	phv00109704.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:01:33+00:00	2018-09-28 21:01:33+00:00 	BGND06	Biguanides
74	Medication/supplement use	109705	phv00109705.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:01:42+00:00	2018-09-28 21:01:42+00:00 	CCB06	Any calcium-channel blocker = CCIR or CC
74	Medication/supplement use	109706	phv00109706.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:01:56+00:00	2018-09-28 21:01:56+00:00 	CCBIR06	Immediate-release CCBs = NIFIR or DIHIR
74	Medication/supplement use	109707	phv00109707.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:02:18+00:00	2018-09-28 21:02:18+00:00 	CCBSR06	Slow-release CCBs = NIFSR or DIHSR or VE
74	Medication/supplement use	109708	phv00109708.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:02:25+00:00	2018-09-28 21:02:25+00:00 	CCBT06	T-type calcium-channel blocker
74	Medication/supplement use	109709	phv00109709.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:02:33+00:00	2018-09-28 21:02:33+00:00 	COX206	Cox-2 inhibitors (NSAID agents); seperat
74	Medication/supplement use	109710	phv00109710.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:02:41+00:00	2018-09-28 21:02:41+00:00 	DIG06	Digitalis preparations
74	Medication/supplement use	109711	phv00109711.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:02:49+00:00	2018-09-28 21:02:49+00:00 	DIHIR06	Immediate-release dihyropyridines other
74	Medication/supplement use	109712	phv00109712.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:02:57+00:00	2018-09-28 21:02:57+00:00 	DIHSR06	Slow-release dihydropyridines other than
74	Medication/supplement use	109713	phv00109713.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:03:05+00:00	2018-09-28 21:03:05+00:00 	DLTIR06	Immediate-release diltiazem
74	Medication/supplement use	109714	phv00109714.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:03:14+00:00	2018-09-28 21:03:14+00:00 	DLTSR06	Slow-release diltiazem
74	Medication/supplement use	109715	phv00109715.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:03:22+00:00	2018-09-28 21:03:22+00:00 	EDD06	Erectile dysfunction drugs
74	Medication/supplement use	109716	phv00109716.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:03:30+00:00	2018-09-28 21:03:30+00:00 	ESTRGN06	Estrogens,  excluding vaginal creams
74	Medication/supplement use	109717	phv00109717.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:03:38+00:00	2018-09-28 21:03:38+00:00 	FIBR06	Fibrates
74	Medication/supplement use	109718	phv00109718.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:03:46+00:00	2018-09-28 21:03:46+00:00 	H2B06	H-2 Blockers
74	Medication/supplement use	109719	phv00109719.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:03:55+00:00	2018-09-28 21:03:55+00:00 	HCTZ06	Thiazide diuretics without k-sparing age
74	Medication/supplement use	109720	phv00109720.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:04:06+00:00	2018-09-28 21:04:06+00:00 	HCTZK06	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	109721	phv00109721.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:04:16+00:00	2018-09-28 21:04:16+00:00 	HPRNS06	Heparins
74	Medication/supplement use	109722	phv00109722.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:04:23+00:00	2018-09-28 21:04:23+00:00 	INSULN06	Insulins
74	Medication/supplement use	109723	phv00109723.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:04:33+00:00	2018-09-28 21:04:33+00:00 	IPRTR06	Anticholinergics + combination with beta
74	Medication/supplement use	109724	phv00109724.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:04:43+00:00	2018-09-28 21:04:43+00:00 	ISTRD06	Inhaled steroids for asthma
74	Medication/supplement use	109725	phv00109725.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:04:53+00:00	2018-09-28 21:04:53+00:00 	KBLKR06	K-channel blockers to enhance insulin se
74	Medication/supplement use	109726	phv00109726.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:05:02+00:00	2018-09-28 21:05:02+00:00 	KCL06	Potassium supplements
74	Medication/supplement use	109727	phv00109727.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:05:11+00:00	2018-09-28 21:05:11+00:00 	KSPR06	Potassium-sparing agents alone
74	Medication/supplement use	109728	phv00109728.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:05:21+00:00	2018-09-28 21:05:21+00:00 	LOOP06	Loop diuretics
74	Medication/supplement use	109729	phv00109729.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:05:32+00:00	2018-09-28 21:05:32+00:00 	MAOI06	MAO Inhibitors
74	Medication/supplement use	109730	phv00109730.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:05:42+00:00	2018-09-28 21:05:42+00:00 	MLPD06	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	109731	phv00109731.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:05:50+00:00	2018-09-28 21:05:50+00:00 	NIAC06	Niacin and nicotinic acid
74	Medication/supplement use	109732	phv00109732.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:06:01+00:00	2018-09-28 21:06:01+00:00 	NIFIR06	Immediate-release nifedipine
74	Medication/supplement use	109733	phv00109733.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:06:12+00:00	2018-09-28 21:06:12+00:00 	NIFSR06	Slow-release nifedipine
74	Medication/supplement use	109734	phv00109734.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:06:19+00:00	2018-09-28 21:06:19+00:00 	NSAID06	Non-steroidal anti-inflammatory agents,
74	Medication/supplement use	109735	phv00109735.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:06:26+00:00	2018-09-28 21:06:26+00:00 	NTCA06	Non-tricyclic antidepressants other than
74	Medication/supplement use	109736	phv00109736.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:06:36+00:00	2018-09-28 21:06:36+00:00 	NTG06	Nitrates
74	Medication/supplement use	109737	phv00109737.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:06:44+00:00	2018-09-28 21:06:44+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
74	Medication/supplement use	109738	phv00109738.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:06:51+00:00	2018-09-28 21:06:51+00:00 	OHGA06	Oral hypoglycemic agents
74	Medication/supplement use	109739	phv00109739.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:06:59+00:00	2018-09-28 21:06:59+00:00 	OSTRD06	Oral steroids
74	Medication/supplement use	109740	phv00109740.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:07:08+00:00	2018-09-28 21:07:08+00:00 	OTCH2B06	('60) Over-the-counter H-2 blockers'
74	Medication/supplement use	109741	phv00109741.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:07:17+00:00	2018-09-28 21:07:17+00:00 	PDEI06	Phosphodiesterase inhibitors
74	Medication/supplement use	109742	phv00109742.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:07:25+00:00	2018-09-28 21:07:25+00:00 	PPI06	Proton pump inhibitors
74	Medication/supplement use	109743	phv00109743.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:07:32+00:00	2018-09-28 21:07:32+00:00 	PROGST06	Progestins
74	Medication/supplement use	109744	phv00109744.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:07:41+00:00	2018-09-28 21:07:41+00:00 	PRKNSN06	Drugs used to treat Parkinson`s
74	Medication/supplement use	109745	phv00109745.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:07:52+00:00	2018-09-28 21:07:52+00:00 	PREMAR06	Premarin (conjugated estrogens)
74	Medication/supplement use	109746	phv00109746.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:08:03+00:00	2018-09-28 21:08:03+00:00 	PROB06	Probucol
74	Medication/supplement use	109747	phv00109747.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:08:11+00:00	2018-09-28 21:08:11+00:00 	PVDL06	Peripheral vasodilators,  exclude dipyrid
74	Medication/supplement use	109748	phv00109748.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:08:19+00:00	2018-09-28 21:08:19+00:00 	SLF106	First generation sulfonylureas
74	Medication/supplement use	109749	phv00109749.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:08:29+00:00	2018-09-28 21:08:29+00:00 	SLF206	Second generation sulfonylureas
74	Medication/supplement use	109750	phv00109750.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:08:38+00:00	2018-09-28 21:08:38+00:00 	STTN06	HMG-CoA reductase inhibitors
74	Medication/supplement use	109751	phv00109751.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:08:48+00:00	2018-09-28 21:08:48+00:00 	SYMPTH06	Sympathomimetics,  oral and inhaled
74	Medication/supplement use	109752	phv00109752.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:08:57+00:00	2018-09-28 21:08:57+00:00 	TCA06	Tricyclic anti-depressants
74	Medication/supplement use	109753	phv00109753.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:09:08+00:00	2018-09-28 21:09:08+00:00 	TCAP06	Tri-cyclic anti-depressants plus anti-ps
74	Medication/supplement use	109754	phv00109754.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:09:15+00:00	2018-09-28 21:09:15+00:00 	THRY06	Thyroid agents
74	Medication/supplement use	109755	phv00109755.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:09:24+00:00	2018-09-28 21:09:24+00:00 	THZD06	Thiazolidinediones
74	Medication/supplement use	109756	phv00109756.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:09:32+00:00	2018-09-28 21:09:32+00:00 	URCOS06	Uricosurics
74	Medication/supplement use	109757	phv00109757.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:09:49+00:00	2018-09-28 21:09:49+00:00 	VASO06	Vasodilators,  a mixed group
74	Medication/supplement use	109758	phv00109758.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:09:57+00:00	2018-09-28 21:09:57+00:00 	VASOD06	Vasodilators with diuretics,  a mixed gro
74	Medication/supplement use	109759	phv00109759.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:10:05+00:00	2018-09-28 21:10:05+00:00 	VERIR06	Immediate-release verapamil
74	Medication/supplement use	109760	phv00109760.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:10:13+00:00	2018-09-28 21:10:13+00:00 	VERSR06	Slow-release verapamil
74	Medication/supplement use	109761	phv00109761.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:10:22+00:00	2018-09-28 21:10:22+00:00 	WARF06	Oral anticoagulants
74	Medication/supplement use	109762	phv00109762.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:10:31+00:00	2018-09-28 21:10:31+00:00 	WTLS06	Weight loss drugs
74	Medication/supplement use	109763	phv00109763.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:10:40+00:00	2018-09-28 21:10:40+00:00 	XOI06	Xanthine oxidase inhibitors
74	Medication/supplement use	109764	phv00109764.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:10:48+00:00	2018-09-28 21:10:48+00:00 	DIURET06	Any diuretic
74	Medication/supplement use	109765	phv00109765.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:10:57+00:00	2018-09-28 21:10:57+00:00 	LIPID06	Any lipid-lowering medication
74	Medication/supplement use	109766	phv00109766.v1.p1	pht001494.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-09-28 21:11:04+00:00	2018-09-28 21:11:04+00:00 	HTNMED06	Any hypertension medication
74	Medication/supplement use	110185	phv00110185.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:39:16+00:00	2018-10-01 15:39:16+00:00 	ASPIRIN	ASPIRIN USE > 2 DAYS IN 2 WKS
74	Medication/supplement use	110186	phv00110186.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:39:29+00:00	2018-10-01 15:39:29+00:00 	ANYDIUR	ANY DIURETIC
74	Medication/supplement use	110187	phv00110187.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:39:40+00:00	2018-10-01 15:39:40+00:00 	ANYBETA	ANY BETA BLOCKER
74	Medication/supplement use	110188	phv00110188.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:39:48+00:00	2018-10-01 15:39:48+00:00 	ANYVASO	ANY VASO DILATOR
74	Medication/supplement use	110189	phv00110189.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:39:56+00:00	2018-10-01 15:39:56+00:00 	ANYACE	ANY ACE INHIBITOR
74	Medication/supplement use	110625	phv00110625.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:41:32+00:00	2018-10-01 15:41:32+00:00 	NOMEDS06	Total Medications
74	Medication/supplement use	110626	phv00110626.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:41:44+00:00	2018-10-01 15:41:44+00:00 	A2A06	Angiotensin type 2 antagonists
74	Medication/supplement use	110627	phv00110627.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:41:52+00:00	2018-10-01 15:41:52+00:00 	A2AD06	Combinations of angiotensin II antagonists
74	Medication/supplement use	110628	phv00110628.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:42:03+00:00	2018-10-01 15:42:03+00:00 	ACE06	ACE Inhibitors without diuretics
74	Medication/supplement use	110629	phv00110629.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:42:11+00:00	2018-10-01 15:42:11+00:00 	ACED06	ACE Inhibitors with diuretics
74	Medication/supplement use	110630	phv00110630.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:42:22+00:00	2018-10-01 15:42:22+00:00 	ADPI06	Inhibitors of ADP-induced platelet aggregation
74	Medication/supplement use	110631	phv00110631.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:42:31+00:00	2018-10-01 15:42:31+00:00 	AGDI06	Alpha-Glucosidase Inhibitors
74	Medication/supplement use	110632	phv00110632.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:42:39+00:00	2018-10-01 15:42:39+00:00 	ALPHA06	Alpha-blockers without diuretics
74	Medication/supplement use	110633	phv00110633.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:42:48+00:00	2018-10-01 15:42:48+00:00 	ALPHAD06	Alpha-blockers with diuretics
74	Medication/supplement use	110634	phv00110634.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:42:57+00:00	2018-10-01 15:42:57+00:00 	ALZH06	Acetylcholine esterase inhibitors for Al
74	Medication/supplement use	110635	phv00110635.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:43:04+00:00	2018-10-01 15:43:04+00:00 	AMLOD06	Amlodipine
74	Medication/supplement use	110636	phv00110636.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:43:13+00:00	2018-10-01 15:43:13+00:00 	ANAR1A06	Anti-arrhythmics,  class 1A
74	Medication/supplement use	110637	phv00110637.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:43:20+00:00	2018-10-01 15:43:20+00:00 	ANAR1B06	Anti-arrhythmics,  class 1B
74	Medication/supplement use	110638	phv00110638.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:43:29+00:00	2018-10-01 15:43:29+00:00 	ANAR1C06	Anti-arrhythmics,  class 1C
74	Medication/supplement use	110639	phv00110639.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:43:38+00:00	2018-10-01 15:43:38+00:00 	ANAR306	Anti-arrhythmics,  class 3
74	Medication/supplement use	110640	phv00110640.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:43:49+00:00	2018-10-01 15:43:49+00:00 	ANTPSY06	Anti-psychotic medications
74	Medication/supplement use	110641	phv00110641.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:43:57+00:00	2018-10-01 15:43:57+00:00 	ASA06	Aspirin from 280804 (anti-inflammatory agents)
74	Medication/supplement use	110642	phv00110642.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:44:06+00:00	2018-10-01 15:44:06+00:00 	BASQ06	Bile-acid sequestrants
74	Medication/supplement use	110643	phv00110643.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:44:15+00:00	2018-10-01 15:44:15+00:00 	BENZOD06	Benzodiazepines
74	Medication/supplement use	110644	phv00110644.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:44:24+00:00	2018-10-01 15:44:24+00:00 	BETA06	Beta-blockers without diuretics
74	Medication/supplement use	110645	phv00110645.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:44:35+00:00	2018-10-01 15:44:35+00:00 	BETAD06	Beta-blockers with diuretics
74	Medication/supplement use	110646	phv00110646.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:44:44+00:00	2018-10-01 15:44:44+00:00 	BGND06	Biguanides
74	Medication/supplement use	110647	phv00110647.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:44:53+00:00	2018-10-01 15:44:53+00:00 	CCB06	Any calcium-channel blocker = CCIR or CC
74	Medication/supplement use	110648	phv00110648.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:45:00+00:00	2018-10-01 15:45:00+00:00 	CCBIR06	Immediate-release CCBs = NIFIR or DIHIR
74	Medication/supplement use	110649	phv00110649.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:45:09+00:00	2018-10-01 15:45:09+00:00 	CCBSR06	Slow-release CCBs = NIFSR or DIHSR or VE
74	Medication/supplement use	110650	phv00110650.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:45:18+00:00	2018-10-01 15:45:18+00:00 	CCBT06	T-type calcium-channel blocker
74	Medication/supplement use	110651	phv00110651.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:45:27+00:00	2018-10-01 15:45:27+00:00 	COX206	Cox-2 inhibitors (NSAID agents); seperat
74	Medication/supplement use	110652	phv00110652.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:45:37+00:00	2018-10-01 15:45:37+00:00 	DIG06	Digitalis preparations
74	Medication/supplement use	110653	phv00110653.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:45:48+00:00	2018-10-01 15:45:48+00:00 	DIHIR06	Immediate-release dihyropyridines other
74	Medication/supplement use	110654	phv00110654.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:45:55+00:00	2018-10-01 15:45:55+00:00 	DIHSR06	Slow-release dihydropyridines other than
74	Medication/supplement use	110655	phv00110655.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:46:05+00:00	2018-10-01 15:46:05+00:00 	DLTIR06	Immediate-release diltiazem
74	Medication/supplement use	110656	phv00110656.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:46:18+00:00	2018-10-01 15:46:18+00:00 	DLTSR06	Slow-release diltiazem
74	Medication/supplement use	110657	phv00110657.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:46:27+00:00	2018-10-01 15:46:27+00:00 	EDD06	Erectile dysfunction drugs
74	Medication/supplement use	110658	phv00110658.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:46:35+00:00	2018-10-01 15:46:35+00:00 	ESTRGN06	Estrogens,  excluding vaginal creams
74	Medication/supplement use	110659	phv00110659.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:46:44+00:00	2018-10-01 15:46:44+00:00 	FIBR06	Fibrates
74	Medication/supplement use	110660	phv00110660.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:46:54+00:00	2018-10-01 15:46:54+00:00 	H2B06	H-2 Blockers
74	Medication/supplement use	110661	phv00110661.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:47:04+00:00	2018-10-01 15:47:04+00:00 	HCTZ06	Thiazide diuretics without k-sparing age
74	Medication/supplement use	110663	phv00110663.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:47:13+00:00	2018-10-01 15:47:13+00:00 	HPRNS06	Heparins
74	Medication/supplement use	110664	phv00110664.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:47:21+00:00	2018-10-01 15:47:21+00:00 	INSULN06	Insulins
74	Medication/supplement use	110665	phv00110665.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:47:34+00:00	2018-10-01 15:47:34+00:00 	IPRTR06	Anticholinergics + combination with beta
74	Medication/supplement use	110667	phv00110667.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:47:43+00:00	2018-10-01 15:47:43+00:00 	KBLKR06	K-channel blockers to enhance insulin se
74	Medication/supplement use	110668	phv00110668.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:47:52+00:00	2018-10-01 15:47:52+00:00 	KCL06	Potassium supplements
74	Medication/supplement use	110669	phv00110669.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:48:05+00:00	2018-10-01 15:48:05+00:00 	KSPR06	Potassium-sparing agents alone
74	Medication/supplement use	110670	phv00110670.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:48:13+00:00	2018-10-01 15:48:13+00:00 	LOOP06	Loop diuretics
74	Medication/supplement use	110671	phv00110671.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:48:21+00:00	2018-10-01 15:48:21+00:00 	MAOI06	MAO Inhibitors
74	Medication/supplement use	110672	phv00110672.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:48:30+00:00	2018-10-01 15:48:30+00:00 	MLPD06	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	110673	phv00110673.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:48:40+00:00	2018-10-01 15:48:40+00:00 	NIAC06	Niacin and nicotinic acid
74	Medication/supplement use	110674	phv00110674.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:48:49+00:00	2018-10-01 15:48:49+00:00 	NIFIR06	Immediate-release nifedipine
74	Medication/supplement use	110675	phv00110675.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:48:58+00:00	2018-10-01 15:48:58+00:00 	NIFSR06	Slow-release nifedipine
74	Medication/supplement use	110676	phv00110676.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:49:06+00:00	2018-10-01 15:49:06+00:00 	NSAID06	Non-steroidal anti-inflammatory agents,
74	Medication/supplement use	110677	phv00110677.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:49:17+00:00	2018-10-01 15:49:17+00:00 	NTCA06	Non-tricyclic antidepressants other than
74	Medication/supplement use	110678	phv00110678.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:49:48+00:00	2018-10-01 15:49:48+00:00 	NTG06	Nitrates
74	Medication/supplement use	110679	phv00110679.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:50:02+00:00	2018-10-01 15:50:02+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
74	Medication/supplement use	110680	phv00110680.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:50:13+00:00	2018-10-01 15:50:13+00:00 	OHGA06	Oral hypoglycemic agents
74	Medication/supplement use	110681	phv00110681.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:50:22+00:00	2018-10-01 15:50:22+00:00 	OSTRD06	Oral steroids
74	Medication/supplement use	110682	phv00110682.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:50:31+00:00	2018-10-01 15:50:31+00:00 	OTCH2B06	('60) Over-the-counter H-2 blockers'
74	Medication/supplement use	110683	phv00110683.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:50:39+00:00	2018-10-01 15:50:39+00:00 	PDEI06	Phosphodiesterase inhibitors
74	Medication/supplement use	110684	phv00110684.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:50:47+00:00	2018-10-01 15:50:47+00:00 	PPI06	Proton pump inhibitors
74	Medication/supplement use	110685	phv00110685.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:50:54+00:00	2018-10-01 15:50:54+00:00 	PROGST06	Progestins
74	Medication/supplement use	110686	phv00110686.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:51:03+00:00	2018-10-01 15:51:03+00:00 	PRKNSN06	Drugs used to treat Parkinson s
74	Medication/supplement use	110687	phv00110687.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:51:11+00:00	2018-10-01 15:51:11+00:00 	PREMAR06	Premarin (conjugated estrogens)
74	Medication/supplement use	110688	phv00110688.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:51:21+00:00	2018-10-01 15:51:21+00:00 	PROB06	Probucol
74	Medication/supplement use	110689	phv00110689.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:51:30+00:00	2018-10-01 15:51:30+00:00 	PVDL06	Peripheral vasodilators,  exclude dipyrid
74	Medication/supplement use	110690	phv00110690.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:51:38+00:00	2018-10-01 15:51:38+00:00 	SLF106	First generation sulfonylureas
74	Medication/supplement use	110691	phv00110691.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:51:46+00:00	2018-10-01 15:51:46+00:00 	SLF206	Second generation sulfonylureas
74	Medication/supplement use	110692	phv00110692.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:51:54+00:00	2018-10-01 15:51:54+00:00 	STTN06	HMG-CoA reductase inhibitors
74	Medication/supplement use	110693	phv00110693.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:52:01+00:00	2018-10-01 15:52:01+00:00 	SYMPTH06	Sympathomimetics,  oral and inhaled
74	Medication/supplement use	110694	phv00110694.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:52:08+00:00	2018-10-01 15:52:08+00:00 	TCA06	Tricyclic anti-depressants
74	Medication/supplement use	110695	phv00110695.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:52:17+00:00	2018-10-01 15:52:17+00:00 	TCAP06	Tri-cyclic anti-depressants plus anti-ps
74	Medication/supplement use	110696	phv00110696.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:52:25+00:00	2018-10-01 15:52:25+00:00 	THRY06	Thyroid agents
74	Medication/supplement use	110697	phv00110697.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:52:33+00:00	2018-10-01 15:52:33+00:00 	THZD06	Thiazolidinediones
74	Medication/supplement use	110698	phv00110698.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:52:46+00:00	2018-10-01 15:52:46+00:00 	URCOS06	Uricosurics
74	Medication/supplement use	110699	phv00110699.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:52:57+00:00	2018-10-01 15:52:57+00:00 	VASO06	Vasodilators,  a mixed group
74	Medication/supplement use	110700	phv00110700.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:53:11+00:00	2018-10-01 15:53:11+00:00 	VASOD06	Vasodilators with diuretics,  a mixed gro
74	Medication/supplement use	110701	phv00110701.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:53:20+00:00	2018-10-01 15:53:20+00:00 	VERIR06	Immediate-release verapamil
74	Medication/supplement use	110702	phv00110702.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:53:28+00:00	2018-10-01 15:53:28+00:00 	VERSR06	Slow-release verapamil
74	Medication/supplement use	110703	phv00110703.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:53:37+00:00	2018-10-01 15:53:37+00:00 	WARF06	Oral anticoagulants
74	Medication/supplement use	110704	phv00110704.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:53:44+00:00	2018-10-01 15:53:44+00:00 	WTLS06	Weight loss drugs
74	Medication/supplement use	110705	phv00110705.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:53:54+00:00	2018-10-01 15:53:54+00:00 	XOI06	Xanthine oxidase inhibitors
74	Medication/supplement use	110706	phv00110706.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:54:02+00:00	2018-10-01 15:54:02+00:00 	DIURET06	Any diuretic
74	Medication/supplement use	110707	phv00110707.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:54:11+00:00	2018-10-01 15:54:11+00:00 	LIPID06	Any lipid-lowering medication
74	Medication/supplement use	110708	phv00110708.v1.p1	pht001495.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:54:21+00:00	2018-10-01 15:54:21+00:00 	HTNMED06	Any hypertension medication
74	Medication/supplement use	101600	phv00101600.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:58:19+00:00	2018-10-01 15:58:19+00:00 	MLTVIT59	TAKEN MULTIPLE OR OTHER VITAMIN
74	Medication/supplement use	101601	phv00101601.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:58:29+00:00	2018-10-01 15:58:29+00:00 	MULTI59	TOOK MULTIPLE VITAMIN
74	Medication/supplement use	101602	phv00101602.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:58:37+00:00	2018-10-01 15:58:37+00:00 	MDAYS59	DAYS TOOK MULTIPLE VITAMIN
74	Medication/supplement use	101603	phv00101603.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:58:47+00:00	2018-10-01 15:58:47+00:00 	VITA59	TOOK VITAMIN A
74	Medication/supplement use	101604	phv00101604.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:58:54+00:00	2018-10-01 15:58:54+00:00 	ADAYS59	DAYS TOOK VITAMIN A
74	Medication/supplement use	101605	phv00101605.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:59:05+00:00	2018-10-01 15:59:05+00:00 	VITC59	TOOK VITAMIN C
74	Medication/supplement use	101607	phv00101607.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:59:16+00:00	2018-10-01 15:59:16+00:00 	VITE59	TOOK VITAMIN E
74	Medication/supplement use	101608	phv00101608.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:59:24+00:00	2018-10-01 15:59:24+00:00 	EDAYS59	DAYS TOOK VITAMIN E
74	Medication/supplement use	101609	phv00101609.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 15:59:33+00:00	2018-10-01 15:59:33+00:00 	ASPR59	ASPIRIN/ASPIRIN-CONTAINING MEDICINES
74	Medication/supplement use	101999	phv00101999.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:00:46+00:00	2018-10-01 16:00:46+00:00 	ANYDIUR	ANY DIURETIC
74	Medication/supplement use	102000	phv00102000.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:00:54+00:00	2018-10-01 16:00:54+00:00 	ANYBETA	ANY BETA BLOCKER
74	Medication/supplement use	102001	phv00102001.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:01:02+00:00	2018-10-01 16:01:02+00:00 	ANYVASO	ANY VASO DILATOR
74	Medication/supplement use	102002	phv00102002.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:01:10+00:00	2018-10-01 16:01:10+00:00 	ANYACE	ANY ACE INHIBITOR
74	Medication/supplement use	102005	phv00102005.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:01:22+00:00	2018-10-01 16:01:22+00:00 	ASPIRIN	Aspirin use > 2 days in last 2 weeks
74	Medication/supplement use	102004	phv00102004.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:01:39+00:00	2018-10-01 16:01:39+00:00 	DAYASP59	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	102089	phv00102089.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:02:04+00:00	2018-10-01 16:02:04+00:00 	NOMEDS06	Number of medications
74	Medication/supplement use	102090	phv00102090.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:02:13+00:00	2018-10-01 16:02:13+00:00 	TAKMED06	TAKE ANY MEDICATIONS
74	Medication/supplement use	102091	phv00102091.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:02:22+00:00	2018-10-01 16:02:22+00:00 	A2A06	Angiotensin type 2 antagonists
74	Medication/supplement use	102092	phv00102092.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:02:31+00:00	2018-10-01 16:02:31+00:00 	A2AD06	Combinations of angiotensin II antagonists
74	Medication/supplement use	102093	phv00102093.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:02:39+00:00	2018-10-01 16:02:39+00:00 	ACE06	ACE Inhibitors without diuretics
74	Medication/supplement use	102094	phv00102094.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:02:46+00:00	2018-10-01 16:02:46+00:00 	ACED06	ACE Inhibitors with diuretics
74	Medication/supplement use	102095	phv00102095.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:02:55+00:00	2018-10-01 16:02:55+00:00 	ADPI06	Inhibitors of ADP-induced platelet aggregation
74	Medication/supplement use	102096	phv00102096.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:03:05+00:00	2018-10-01 16:03:05+00:00 	AGDI06	Alpha-Glucosidase Inhibitors
74	Medication/supplement use	102097	phv00102097.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:03:18+00:00	2018-10-01 16:03:18+00:00 	ALPHA06	Alpha-blockers without diuretics
74	Medication/supplement use	102098	phv00102098.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:03:26+00:00	2018-10-01 16:03:26+00:00 	ALPHAD06	Alpha-blockers with diuretics
74	Medication/supplement use	102099	phv00102099.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:03:34+00:00	2018-10-01 16:03:34+00:00 	ALZH06	Acetylcholine esterase inhibitors for Al
74	Medication/supplement use	102100	phv00102100.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:03:41+00:00	2018-10-01 16:03:41+00:00 	AMLOD06	Amlodipine
74	Medication/supplement use	102101	phv00102101.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:03:49+00:00	2018-10-01 16:03:49+00:00 	ANAR1A06	Anti-arrhythmics,  class 1A
74	Medication/supplement use	102102	phv00102102.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:03:56+00:00	2018-10-01 16:03:56+00:00 	ANAR1B06	Anti-arrhythmics,  class 1B
74	Medication/supplement use	102103	phv00102103.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:04:04+00:00	2018-10-01 16:04:04+00:00 	ANAR1C06	Anti-arrhythmics,  class 1C
74	Medication/supplement use	102104	phv00102104.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:04:11+00:00	2018-10-01 16:04:11+00:00 	ANAR306	Anti-arrhythmics,  class 3
74	Medication/supplement use	102105	phv00102105.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:04:20+00:00	2018-10-01 16:04:20+00:00 	ANTPSY06	Anti-psychotic medications
74	Medication/supplement use	102107	phv00102107.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:05:09+00:00	2018-10-01 16:05:09+00:00 	BASQ06	Bile-acid sequestrants
74	Medication/supplement use	102106	phv00102106.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:05:18+00:00	2018-10-01 16:05:18+00:00 	ASA06	Aspirin from 280804 (anti-inflammatory agents)
74	Medication/supplement use	102108	phv00102108.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:05:33+00:00	2018-10-01 16:05:33+00:00 	BENZOD06	Benzodiazepines
74	Medication/supplement use	102109	phv00102109.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:05:49+00:00	2018-10-01 16:05:49+00:00 	BETA06	Beta-blockers without diuretics
74	Medication/supplement use	102110	phv00102110.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:06:02+00:00	2018-10-01 16:06:02+00:00 	BETAD06	Beta-blockers with diuretics
74	Medication/supplement use	102111	phv00102111.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:06:10+00:00	2018-10-01 16:06:10+00:00 	BGND06	Biguanides
74	Medication/supplement use	102112	phv00102112.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:06:20+00:00	2018-10-01 16:06:20+00:00 	CCB06	Any calcium-channel blocker = CCIR or CC
74	Medication/supplement use	102113	phv00102113.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:06:31+00:00	2018-10-01 16:06:31+00:00 	CCBIR06	Immediate-release CCBs = NIFIR or DIHIR
74	Medication/supplement use	102114	phv00102114.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:06:40+00:00	2018-10-01 16:06:40+00:00 	CCBSR06	Slow-release CCBs = NIFSR or DIHSR or VE
74	Medication/supplement use	102115	phv00102115.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:06:49+00:00	2018-10-01 16:06:49+00:00 	CCBT06	T-type calcium-channel blocker
74	Medication/supplement use	102116	phv00102116.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:06:57+00:00	2018-10-01 16:06:57+00:00 	COX206	Cox-2 inhibitors (NSAID agents); seperat
74	Medication/supplement use	102117	phv00102117.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:07:06+00:00	2018-10-01 16:07:06+00:00 	DIG06	Digitalis preparations
74	Medication/supplement use	102118	phv00102118.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:07:15+00:00	2018-10-01 16:07:15+00:00 	DIHIR06	Immediate-release dihyropyridines other
74	Medication/supplement use	102119	phv00102119.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:07:23+00:00	2018-10-01 16:07:23+00:00 	DIHSR06	Slow-release dihydropyridines other than
74	Medication/supplement use	102120	phv00102120.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:07:31+00:00	2018-10-01 16:07:31+00:00 	DLTIR06	Immediate-release diltiazem
74	Medication/supplement use	102121	phv00102121.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:08:00+00:00	2018-10-01 16:08:00+00:00 	DLTSR06	Slow-release diltiazem
74	Medication/supplement use	102122	phv00102122.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:08:16+00:00	2018-10-01 16:08:16+00:00 	EDD06	Erectile dysfunction drugs
74	Medication/supplement use	102123	phv00102123.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:08:25+00:00	2018-10-01 16:08:25+00:00 	ESTRGN06	Estrogens,  excluding vaginal creams
74	Medication/supplement use	102124	phv00102124.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:08:33+00:00	2018-10-01 16:08:33+00:00 	FIBR06	Fibrates
74	Medication/supplement use	102125	phv00102125.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:08:42+00:00	2018-10-01 16:08:42+00:00 	H2B06	H-2 Blockers
74	Medication/supplement use	102126	phv00102126.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:08:52+00:00	2018-10-01 16:08:52+00:00 	HCTZ06	Thiazide diuretics without k-sparing age
74	Medication/supplement use	102127	phv00102127.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:08:59+00:00	2018-10-01 16:08:59+00:00 	HCTZK06	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	102128	phv00102128.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:09:07+00:00	2018-10-01 16:09:07+00:00 	HPRNS06	Heparins
74	Medication/supplement use	102129	phv00102129.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:09:14+00:00	2018-10-01 16:09:14+00:00 	INSULN06	Insulins
74	Medication/supplement use	102130	phv00102130.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:09:22+00:00	2018-10-01 16:09:22+00:00 	IPRTR06	Anticholinergics + combination with beta
74	Medication/supplement use	102131	phv00102131.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:09:30+00:00	2018-10-01 16:09:30+00:00 	ISTRD06	Inhaled steroids for asthma
74	Medication/supplement use	102132	phv00102132.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:09:38+00:00	2018-10-01 16:09:38+00:00 	KBLKR06	K-channel blockers to enhance insulin se
74	Medication/supplement use	102133	phv00102133.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:09:47+00:00	2018-10-01 16:09:47+00:00 	KCL06	Potassium supplements
74	Medication/supplement use	102134	phv00102134.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:09:56+00:00	2018-10-01 16:09:56+00:00 	KSPR06	Potassium-sparing agents alone
74	Medication/supplement use	102135	phv00102135.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:10:05+00:00	2018-10-01 16:10:05+00:00 	LOOP06	Loop diuretics
74	Medication/supplement use	102136	phv00102136.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:10:14+00:00	2018-10-01 16:10:14+00:00 	MAOI06	MAO Inhibitors
74	Medication/supplement use	102137	phv00102137.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:10:21+00:00	2018-10-01 16:10:21+00:00 	MLPD06	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	102138	phv00102138.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:10:32+00:00	2018-10-01 16:10:32+00:00 	NIAC06	Niacin and nicotinic acid
74	Medication/supplement use	102139	phv00102139.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:10:41+00:00	2018-10-01 16:10:41+00:00 	NIFIR06	Immediate-release nifedipine
74	Medication/supplement use	102140	phv00102140.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:10:52+00:00	2018-10-01 16:10:52+00:00 	NIFSR06	Slow-release nifedipine
74	Medication/supplement use	102141	phv00102141.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:11:01+00:00	2018-10-01 16:11:01+00:00 	NSAID06	Non-steroidal anti-inflammatory agents,
74	Medication/supplement use	102142	phv00102142.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:11:13+00:00	2018-10-01 16:11:13+00:00 	NTCA06	Non-tricyclic antidepressants other than
74	Medication/supplement use	102143	phv00102143.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 16:11:23+00:00	2018-10-01 16:11:23+00:00 	NTG06	Nitrates
74	Medication/supplement use	102144	phv00102144.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:19:32+00:00	2018-10-01 18:19:32+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
74	Medication/supplement use	102145	phv00102145.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:19:40+00:00	2018-10-01 18:19:40+00:00 	OHGA06	Oral hypoglycemic agents
74	Medication/supplement use	102146	phv00102146.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:19:48+00:00	2018-10-01 18:19:48+00:00 	OSTRD06	Oral steroids
74	Medication/supplement use	102147	phv00102147.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:19:56+00:00	2018-10-01 18:19:56+00:00 	OTCH2B06	('60) Over-the-counter H-2 blockers
74	Medication/supplement use	102148	phv00102148.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:20:06+00:00	2018-10-01 18:20:06+00:00 	PDEI06	Phosphodiesterase inhibitors
74	Medication/supplement use	102149	phv00102149.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:20:15+00:00	2018-10-01 18:20:15+00:00 	PPI06	Proton pump inhibitors
74	Medication/supplement use	102150	phv00102150.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:20:25+00:00	2018-10-01 18:20:25+00:00 	PROGST06	Progestins
74	Medication/supplement use	102151	phv00102151.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:20:35+00:00	2018-10-01 18:20:35+00:00 	PRKNSN06	Drugs used to treat Parkinson s
74	Medication/supplement use	102152	phv00102152.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:20:44+00:00	2018-10-01 18:20:44+00:00 	PREMAR06	Premarin (conjugated estrogens)
74	Medication/supplement use	102153	phv00102153.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:20:53+00:00	2018-10-01 18:20:53+00:00 	PROB06	Probucol
74	Medication/supplement use	102154	phv00102154.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:21:02+00:00	2018-10-01 18:21:02+00:00 	PVDL06	Peripheral vasodilators,  exclude dipyrid
74	Medication/supplement use	102155	phv00102155.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:21:21+00:00	2018-10-01 18:21:21+00:00 	SLF106	First generation sulfonylureas
74	Medication/supplement use	102156	phv00102156.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:21:30+00:00	2018-10-01 18:21:30+00:00 	SLF206	Second generation sulfonylureas
74	Medication/supplement use	102157	phv00102157.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:21:39+00:00	2018-10-01 18:21:39+00:00 	STTN06	HMG-CoA reductase inhibitors
74	Medication/supplement use	102158	phv00102158.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:21:49+00:00	2018-10-01 18:21:49+00:00 	SYMPTH06	Sympathomimetics,  oral and inhaled
74	Medication/supplement use	102159	phv00102159.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:21:57+00:00	2018-10-01 18:21:57+00:00 	TCA06	Tricyclic anti-depressants
74	Medication/supplement use	102160	phv00102160.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:22:05+00:00	2018-10-01 18:22:05+00:00 	TCAP06	Tri-cyclic anti-depressants plus anti-ps
74	Medication/supplement use	102161	phv00102161.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:22:13+00:00	2018-10-01 18:22:13+00:00 	THRY06	Thyroid agents
74	Medication/supplement use	102162	phv00102162.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:22:22+00:00	2018-10-01 18:22:22+00:00 	THZD06	Thiazolidinediones
74	Medication/supplement use	102163	phv00102163.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:22:33+00:00	2018-10-01 18:22:33+00:00 	URCOS06	Uricosurics
74	Medication/supplement use	102164	phv00102164.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:22:41+00:00	2018-10-01 18:22:41+00:00 	VASO06	Vasodilators,  a mixed group
74	Medication/supplement use	102165	phv00102165.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:22:50+00:00	2018-10-01 18:22:50+00:00 	VASOD06	Vasodilators with diuretics,  a mixed group
74	Medication/supplement use	102166	phv00102166.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:23:00+00:00	2018-10-01 18:23:00+00:00 	VERIR06	Immediate-release verapamil
74	Medication/supplement use	102167	phv00102167.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:23:08+00:00	2018-10-01 18:23:08+00:00 	VERSR06	Slow-release verapamil
74	Medication/supplement use	102168	phv00102168.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:23:17+00:00	2018-10-01 18:23:17+00:00 	WARF06	Oral anticoagulants
74	Medication/supplement use	102169	phv00102169.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:23:27+00:00	2018-10-01 18:23:27+00:00 	WTLS06	Weight loss drugs
74	Medication/supplement use	102170	phv00102170.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:23:34+00:00	2018-10-01 18:23:34+00:00 	XOI06	Xanthine oxidase inhibitors
74	Medication/supplement use	102171	phv00102171.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:23:41+00:00	2018-10-01 18:23:41+00:00 	DIURET06	Any diuretic
74	Medication/supplement use	102172	phv00102172.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:23:48+00:00	2018-10-01 18:23:48+00:00 	LIPID06	Any lipid-lowering medication
74	Medication/supplement use	102173	phv00102173.v1.p1	pht001474.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:23:55+00:00	2018-10-01 18:23:55+00:00 	HTNMED06	Any hypertension medication
74	Medication/supplement use	102627	phv00102627.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:25:55+00:00	2018-10-01 18:25:55+00:00 	ANYACE	ANY ACE INHIBITOR
74	Medication/supplement use	102628	phv00102628.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:26:03+00:00	2018-10-01 18:26:03+00:00 	ANYBETA	ANY BETA BLOCKER
74	Medication/supplement use	102629	phv00102629.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:26:11+00:00	2018-10-01 18:26:11+00:00 	ANYVASO	ANY VASO DILATOR
74	Medication/supplement use	102630	phv00102630.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:26:20+00:00	2018-10-01 18:26:20+00:00 	ANYDIUR	ANY DIURETIC
74	Medication/supplement use	102779	phv00102779.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:26:55+00:00	2018-10-01 18:26:55+00:00 	MLTVIT59	TAKEN MULTIPLE OR OTHER VITAMIN
74	Medication/supplement use	102780	phv00102780.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:27:07+00:00	2018-10-01 18:27:07+00:00 	MULTI59	TOOK MULTIPLE VITAMIN
74	Medication/supplement use	102781	phv00102781.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:27:15+00:00	2018-10-01 18:27:15+00:00 	MDAYS59	DAYS TOOK MULTIPLE VITAMIN
74	Medication/supplement use	102782	phv00102782.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:27:27+00:00	2018-10-01 18:27:27+00:00 	VITA59	TOOK VITAMIN A
74	Medication/supplement use	102783	phv00102783.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:27:38+00:00	2018-10-01 18:27:38+00:00 	ADAYS59	DAYS TOOK VITAMIN A
74	Medication/supplement use	102784	phv00102784.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:27:47+00:00	2018-10-01 18:27:47+00:00 	VITC59	TOOK VITAMIN C
74	Medication/supplement use	102785	phv00102785.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:27:56+00:00	2018-10-01 18:27:56+00:00 	CDAYS59	DAYS TOOK VITAMIN C
74	Medication/supplement use	102786	phv00102786.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:28:09+00:00	2018-10-01 18:28:09+00:00 	VITE59	TOOK VITAMIN E
74	Medication/supplement use	102787	phv00102787.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:28:17+00:00	2018-10-01 18:28:17+00:00 	EDAYS59	DAYS TOOK VITAMIN E
74	Medication/supplement use	102788	phv00102788.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:28:28+00:00	2018-10-01 18:28:28+00:00 	ASPR59	ASPIRIN/ASPIRIN-CONTAINING MEDICINES
74	Medication/supplement use	102789	phv00102789.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:28:36+00:00	2018-10-01 18:28:36+00:00 	DAYASP59	DAYS TOOK THIS MEDICINE IN LAST TWO WEEK
74	Medication/supplement use	102817	phv00102817.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:28:54+00:00	2018-10-01 18:28:54+00:00 	ESTROC59	CURRENTLY TAKING ESTROGEN
74	Medication/supplement use	102818	phv00102818.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:29:04+00:00	2018-10-01 18:29:04+00:00 	ECDAY59	DAYS PER MONTH TAKE ESTROGEN
74	Medication/supplement use	102826	phv00102826.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:29:23+00:00	2018-10-01 18:29:23+00:00 	PROGC59	CURRENTLY TAKING PROGESTIN
74	Medication/supplement use	102827	phv00102827.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:29:34+00:00	2018-10-01 18:29:34+00:00 	PCDAY59	DAYS PER MONTH TAKING PROGESTIN
74	Medication/supplement use	102968	phv00102968.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:30:21+00:00	2018-10-01 18:30:21+00:00 	ASPIRIN	ASPIRIN USE >2 DAYS IN 2 WEEKS
74	Medication/supplement use	103062	phv00103062.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:30:46+00:00	2018-10-01 18:30:46+00:00 	NOMEDS06	Number of medications
74	Medication/supplement use	103063	phv00103063.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:30:54+00:00	2018-10-01 18:30:54+00:00 	TAKMED06	TAKE ANY MEDICATIONS
74	Medication/supplement use	103064	phv00103064.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:31:02+00:00	2018-10-01 18:31:02+00:00 	A2A06	Angiotensin type 2 antagonists
74	Medication/supplement use	103065	phv00103065.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:31:08+00:00	2018-10-01 18:31:08+00:00 	A2AD06	Combinations of angiotensin II antagonists
74	Medication/supplement use	103066	phv00103066.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:31:16+00:00	2018-10-01 18:31:16+00:00 	ACE06	ACE Inhibitors without diuretics
74	Medication/supplement use	103067	phv00103067.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:31:27+00:00	2018-10-01 18:31:27+00:00 	ACED06	ACE Inhibitors with diuretics
74	Medication/supplement use	103068	phv00103068.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:31:35+00:00	2018-10-01 18:31:35+00:00 	ADPI06	Inhibitors of ADP-induced platelet aggregation
74	Medication/supplement use	103069	phv00103069.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:31:43+00:00	2018-10-01 18:31:43+00:00 	AGDI06	Alpha-Glucosidase Inhibitors
74	Medication/supplement use	103070	phv00103070.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:31:51+00:00	2018-10-01 18:31:51+00:00 	ALPHA06	Alpha-blockers without diuretics
74	Medication/supplement use	103071	phv00103071.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:31:59+00:00	2018-10-01 18:31:59+00:00 	ALPHAD06	Alpha-blockers with diuretics
74	Medication/supplement use	103072	phv00103072.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:32:07+00:00	2018-10-01 18:32:07+00:00 	ALZH06	Acetylcholine esterase inhibitors for Al
74	Medication/supplement use	103073	phv00103073.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:32:14+00:00	2018-10-01 18:32:14+00:00 	AMLOD06	Amlodipine
74	Medication/supplement use	103074	phv00103074.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:32:21+00:00	2018-10-01 18:32:21+00:00 	ANAR1A06	Anti-arrhythmics, class 1A
74	Medication/supplement use	103075	phv00103075.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:36:54+00:00	2018-10-01 18:36:54+00:00 	ANAR1B06	Anti-arrhythmics, class 1B
74	Medication/supplement use	103076	phv00103076.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:37:04+00:00	2018-10-01 18:37:04+00:00 	ANAR1C06	Anti-arrhythmics, class 1C
74	Medication/supplement use	103077	phv00103077.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:37:11+00:00	2018-10-01 18:37:11+00:00 	ANAR306	Anti-arrhythmics, class 3
74	Medication/supplement use	103078	phv00103078.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:37:21+00:00	2018-10-01 18:37:21+00:00 	ANTPSY06	Anti-psychotic medications
74	Medication/supplement use	103079	phv00103079.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:37:29+00:00	2018-10-01 18:37:29+00:00 	ASA06	Aspirin from 280804 (anti-inflammatory agents)
74	Medication/supplement use	103080	phv00103080.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:37:37+00:00	2018-10-01 18:37:37+00:00 	BASQ06	Bile-acid sequestrants
74	Medication/supplement use	103081	phv00103081.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:37:44+00:00	2018-10-01 18:37:44+00:00 	BENZOD06	Benzodiazepines
74	Medication/supplement use	103082	phv00103082.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:37:51+00:00	2018-10-01 18:37:51+00:00 	BETA06	Beta-blockers without diuretics
74	Medication/supplement use	103083	phv00103083.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:38:01+00:00	2018-10-01 18:38:01+00:00 	BETAD06	Beta-blockers with diuretics
74	Medication/supplement use	103084	phv00103084.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:38:09+00:00	2018-10-01 18:38:09+00:00 	BGND06	Biguanides
74	Medication/supplement use	103085	phv00103085.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:38:17+00:00	2018-10-01 18:38:17+00:00 	CCB06	Any calcium-channel blocker = CCIR or CC
74	Medication/supplement use	103086	phv00103086.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:38:24+00:00	2018-10-01 18:38:24+00:00 	CCBIR06	Immediate-release CCBs = NIFIR or DIHIR
74	Medication/supplement use	103087	phv00103087.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:38:35+00:00	2018-10-01 18:38:35+00:00 	CCBSR06	Slow-release CCBs = NIFSR or DIHSR or VE
74	Medication/supplement use	103088	phv00103088.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:38:52+00:00	2018-10-01 18:38:52+00:00 	CCBT06	T-type calcium-channel blocker
74	Medication/supplement use	103089	phv00103089.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:39:04+00:00	2018-10-01 18:39:04+00:00 	COX206	Cox-2 inhibitors (NSAID agents); seperat
74	Medication/supplement use	103090	phv00103090.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:39:13+00:00	2018-10-01 18:39:13+00:00 	DIG06	Digitalis preparations
74	Medication/supplement use	103091	phv00103091.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:39:21+00:00	2018-10-01 18:39:21+00:00 	DIHIR06	Immediate-release dihyropyridines other
74	Medication/supplement use	103092	phv00103092.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:39:28+00:00	2018-10-01 18:39:28+00:00 	DIHSR06	Slow-release dihydropyridines other than
74	Medication/supplement use	103093	phv00103093.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:39:35+00:00	2018-10-01 18:39:35+00:00 	DLTIR06	Immediate-release diltiazem
74	Medication/supplement use	103094	phv00103094.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:39:48+00:00	2018-10-01 18:39:48+00:00 	DLTSR06	Slow-release diltiazem
74	Medication/supplement use	103095	phv00103095.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:40:00+00:00	2018-10-01 18:40:00+00:00 	EDD06	Erectile dysfunction drugs
74	Medication/supplement use	103096	phv00103096.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:40:09+00:00	2018-10-01 18:40:09+00:00 	ESTRGN06	Estrogens,  excluding vaginal creams
74	Medication/supplement use	103097	phv00103097.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:40:17+00:00	2018-10-01 18:40:17+00:00 	FIBR06	Fibrates
74	Medication/supplement use	103098	phv00103098.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:40:26+00:00	2018-10-01 18:40:26+00:00 	H2B06	H-2 Blockers
74	Medication/supplement use	103099	phv00103099.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:40:34+00:00	2018-10-01 18:40:34+00:00 	HCTZ06	Thiazide diuretics without k-sparing age
74	Medication/supplement use	103100	phv00103100.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:40:44+00:00	2018-10-01 18:40:44+00:00 	HCTZK06	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	103101	phv00103101.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:40:52+00:00	2018-10-01 18:40:52+00:00 	HPRNS06	Heparins
74	Medication/supplement use	103102	phv00103102.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:41:01+00:00	2018-10-01 18:41:01+00:00 	INSULN06	Insulins
74	Medication/supplement use	103105	phv00103105.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:41:12+00:00	2018-10-01 18:41:12+00:00 	KBLKR06	K-channel blockers to enhance insulin se
74	Medication/supplement use	103106	phv00103106.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:41:21+00:00	2018-10-01 18:41:21+00:00 	KCL06	Potassium supplements
74	Medication/supplement use	103107	phv00103107.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:41:29+00:00	2018-10-01 18:41:29+00:00 	KSPR06	Potassium-sparing agents alone
74	Medication/supplement use	103108	phv00103108.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:41:37+00:00	2018-10-01 18:41:37+00:00 	LOOP06	Loop diuretics
74	Medication/supplement use	103109	phv00103109.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:41:45+00:00	2018-10-01 18:41:45+00:00 	MAOI06	MAO Inhibitors
74	Medication/supplement use	103110	phv00103110.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:41:53+00:00	2018-10-01 18:41:53+00:00 	MLPD06	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	103111	phv00103111.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:42:02+00:00	2018-10-01 18:42:02+00:00 	NIAC06	Niacin and nicotinic acid
74	Medication/supplement use	103112	phv00103112.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:42:11+00:00	2018-10-01 18:42:11+00:00 	NIFIR06	Immediate-release nifedipine
74	Medication/supplement use	103113	phv00103113.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:42:20+00:00	2018-10-01 18:42:20+00:00 	NIFSR06	Slow-release nifedipine
74	Medication/supplement use	103114	phv00103114.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:42:27+00:00	2018-10-01 18:42:27+00:00 	NSAID06	Non-steroidal anti-inflammatory agents,
74	Medication/supplement use	103115	phv00103115.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:42:37+00:00	2018-10-01 18:42:37+00:00 	NTCA06	Non-tricyclic antidepressants other than
74	Medication/supplement use	103116	phv00103116.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:42:46+00:00	2018-10-01 18:42:46+00:00 	NTG06	Nitrates
74	Medication/supplement use	103117	phv00103117.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:42:55+00:00	2018-10-01 18:42:55+00:00 	OAIA06	Oral anti-inflammatory asthma drugs leuk
74	Medication/supplement use	103118	phv00103118.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:43:02+00:00	2018-10-01 18:43:02+00:00 	OHGA06	Oral hypoglycemic agents
74	Medication/supplement use	103119	phv00103119.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:43:10+00:00	2018-10-01 18:43:10+00:00 	OSTRD06	Oral steroids
74	Medication/supplement use	103120	phv00103120.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:43:18+00:00	2018-10-01 18:43:18+00:00 	OTCH2B06	('60) Over-the-counter H-2 blockers
74	Medication/supplement use	103121	phv00103121.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:43:27+00:00	2018-10-01 18:43:27+00:00 	PDEI06	Phosphodiesterase inhibitors
74	Medication/supplement use	103122	phv00103122.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:43:37+00:00	2018-10-01 18:43:37+00:00 	PPI06	Proton pump inhibitors
74	Medication/supplement use	103123	phv00103123.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:43:44+00:00	2018-10-01 18:43:44+00:00 	PROGST06	Progestins
74	Medication/supplement use	103124	phv00103124.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:43:51+00:00	2018-10-01 18:43:51+00:00 	PRKNSN06	Drugs used to treat Parkinson s
74	Medication/supplement use	103125	phv00103125.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:44:01+00:00	2018-10-01 18:44:01+00:00 	PREMAR06	Premarin (conjugated estrogens)
74	Medication/supplement use	103126	phv00103126.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:44:09+00:00	2018-10-01 18:44:09+00:00 	PROB06	Probucol
74	Medication/supplement use	103127	phv00103127.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:44:19+00:00	2018-10-01 18:44:19+00:00 	PVDL06	Peripheral vasodilators,  exclude dipyrid
74	Medication/supplement use	103128	phv00103128.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:44:27+00:00	2018-10-01 18:44:27+00:00 	SLF106	First generation sulfonylureas
74	Medication/supplement use	103129	phv00103129.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:44:35+00:00	2018-10-01 18:44:35+00:00 	SLF206	Second generation sulfonylureas
74	Medication/supplement use	103130	phv00103130.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:44:43+00:00	2018-10-01 18:44:43+00:00 	STTN06	HMG-CoA reductase inhibitors
74	Medication/supplement use	103131	phv00103131.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:44:51+00:00	2018-10-01 18:44:51+00:00 	SYMPTH06	Sympathomimetics,  oral and inhaled
74	Medication/supplement use	103132	phv00103132.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:45:00+00:00	2018-10-01 18:45:00+00:00 	TCA06	Tricyclic anti-depressants
74	Medication/supplement use	103133	phv00103133.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:45:10+00:00	2018-10-01 18:45:10+00:00 	TCAP06	Tri-cyclic anti-depressants plus anti-ps
74	Medication/supplement use	103134	phv00103134.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:45:17+00:00	2018-10-01 18:45:17+00:00 	THRY06	Thyroid agents
74	Medication/supplement use	103135	phv00103135.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:45:25+00:00	2018-10-01 18:45:25+00:00 	THZD06	Thiazolidinediones
74	Medication/supplement use	103136	phv00103136.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:45:33+00:00	2018-10-01 18:45:33+00:00 	URCOS06	Uricosurics
74	Medication/supplement use	103137	phv00103137.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:45:41+00:00	2018-10-01 18:45:41+00:00 	VASO06	Vasodilators,  a mixed group
74	Medication/supplement use	103138	phv00103138.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:45:49+00:00	2018-10-01 18:45:49+00:00 	VASOD06	Vasodilators with diuretics,  a mixed group
74	Medication/supplement use	103139	phv00103139.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:45:57+00:00	2018-10-01 18:45:57+00:00 	VERIR06	Immediate-release verapamil
74	Medication/supplement use	103140	phv00103140.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:46:05+00:00	2018-10-01 18:46:05+00:00 	VERSR06	Slow-release verapamil
74	Medication/supplement use	103141	phv00103141.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:46:13+00:00	2018-10-01 18:46:13+00:00 	WARF06	Oral anticoagulants
74	Medication/supplement use	103142	phv00103142.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:46:20+00:00	2018-10-01 18:46:20+00:00 	WTLS06	Weight loss drugs
74	Medication/supplement use	103143	phv00103143.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:46:28+00:00	2018-10-01 18:46:28+00:00 	XOI06	Xanthine oxidase inhibitors
74	Medication/supplement use	103144	phv00103144.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:46:36+00:00	2018-10-01 18:46:36+00:00 	DIURET06	Any diuretic
74	Medication/supplement use	103145	phv00103145.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:46:44+00:00	2018-10-01 18:46:44+00:00 	LIPID06	Any lipid-lowering medication
74	Medication/supplement use	103146	phv00103146.v1.p1	pht001475.v1.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 18:46:52+00:00	2018-10-01 18:46:52+00:00 	HTNMED06	Any hypertension medication
74	Medication/supplement use	197514	phv00197514.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:09:26+00:00	2018-10-01 20:09:26+00:00 	estrgn	Estrogens
74	Medication/supplement use	197515	phv00197515.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:09:39+00:00	2018-10-01 20:09:39+00:00 	progst	Progestins
74	Medication/supplement use	197516	phv00197516.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:09:47+00:00	2018-10-01 20:09:47+00:00 	htnmed	Any hypertension meds
74	Medication/supplement use	197517	phv00197517.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:10:00+00:00	2018-10-01 20:10:00+00:00 	anar1a	Class 1a anti-arrhythmics
74	Medication/supplement use	197518	phv00197518.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:10:08+00:00	2018-10-01 20:10:08+00:00 	lipid	Any lipid lowering med
74	Medication/supplement use	197519	phv00197519.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:10:25+00:00	2018-10-01 20:10:25+00:00 	ohga	Oral hypoglycemics
74	Medication/supplement use	197520	phv00197520.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:10:33+00:00	2018-10-01 20:10:33+00:00 	insuln	Insulin
74	Medication/supplement use	197521	phv00197521.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:10:42+00:00	2018-10-01 20:10:42+00:00 	sympth	Sympathomimetic (adrenergic) agents
74	Medication/supplement use	197522	phv00197522.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:10:50+00:00	2018-10-01 20:10:50+00:00 	tca	Tri- and tetra- cyclic anti-depressants
74	Medication/supplement use	197523	phv00197523.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:14:36+00:00	2018-10-01 20:14:36+00:00 	maoi	Monoamine oxidase inhibitors
74	Medication/supplement use	197524	phv00197524.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:14:58+00:00	2018-10-01 20:14:58+00:00 	tcap	Drug combination -- tricyclics and anti-psychotic
74	Medication/supplement use	197525	phv00197525.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:15:09+00:00	2018-10-01 20:15:09+00:00 	antpsy	Anti-psychotic
74	Medication/supplement use	197526	phv00197526.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:15:17+00:00	2018-10-01 20:15:17+00:00 	asa	Aspirin (anti-inflam agents)
74	Medication/supplement use	197527	phv00197527.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:15:28+00:00	2018-10-01 20:15:28+00:00 	nsaid	Non-steroidal anti-inflam (no aspirin)
74	Medication/supplement use	197528	phv00197528.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:15:43+00:00	2018-10-01 20:15:43+00:00 	benzod	Benzodiazepines
74	Medication/supplement use	197529	phv00197529.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:15:52+00:00	2018-10-01 20:15:52+00:00 	premar	Premarin
74	Medication/supplement use	197530	phv00197530.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:16:01+00:00	2018-10-01 20:16:01+00:00 	pdei	Phosphodiesterase inhibitors
74	Medication/supplement use	197531	phv00197531.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:16:11+00:00	2018-10-01 20:16:11+00:00 	ntca	Non-tricyclic antidepressants
74	Medication/supplement use	197532	phv00197532.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:16:20+00:00	2018-10-01 20:16:20+00:00 	warf	Oral anticoagulants
74	Medication/supplement use	197533	phv00197533.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:16:33+00:00	2018-10-01 20:16:33+00:00 	loop	Loop diuretics
74	Medication/supplement use	197534	phv00197534.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:16:43+00:00	2018-10-01 20:16:43+00:00 	hctz	Thiazide diuretics w-o K-sparing
74	Medication/supplement use	197535	phv00197535.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:16:52+00:00	2018-10-01 20:16:52+00:00 	hctzk	Thiazide diuretics with K-sparing
74	Medication/supplement use	197536	phv00197536.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:17:00+00:00	2018-10-01 20:17:00+00:00 	ccbir	All immediate-release CCB
74	Medication/supplement use	197537	phv00197537.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:17:08+00:00	2018-10-01 20:17:08+00:00 	ccbsr	All slow-release CCB
74	Medication/supplement use	197538	phv00197538.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:17:15+00:00	2018-10-01 20:17:15+00:00 	alpha	Alpha-blockers w-o diuretics
74	Medication/supplement use	197539	phv00197539.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:17:23+00:00	2018-10-01 20:17:23+00:00 	alphad	Alpha-blockers with diuretics
74	Medication/supplement use	197540	phv00197540.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:17:32+00:00	2018-10-01 20:17:32+00:00 	anar1b	Anti-arrhythmics, class 1b
74	Medication/supplement use	197541	phv00197541.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:17:39+00:00	2018-10-01 20:17:39+00:00 	anar1c	Anti-arrhythmics, class 1c
74	Medication/supplement use	197542	phv00197542.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:17:47+00:00	2018-10-01 20:17:47+00:00 	anar3	Anti-arrhythmics, class 3
74	Medication/supplement use	197543	phv00197543.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:17:55+00:00	2018-10-01 20:17:55+00:00 	pvdl	Peripheral vasodilators
74	Medication/supplement use	197544	phv00197544.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:18:02+00:00	2018-10-01 20:18:02+00:00 	basq	Bile-acid sequestrants
74	Medication/supplement use	197545	phv00197545.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:18:10+00:00	2018-10-01 20:18:10+00:00 	niac	Niacin and nicotinic acid
74	Medication/supplement use	197546	phv00197546.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:18:18+00:00	2018-10-01 20:18:18+00:00 	thry	Thyroid agents
74	Medication/supplement use	197547	phv00197547.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:18:33+00:00	2018-10-01 20:18:33+00:00 	istrd	Inhaled steroids for asthma
74	Medication/supplement use	197548	phv00197548.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:18:40+00:00	2018-10-01 20:18:40+00:00 	ostrd	Oral steroids
74	Medication/supplement use	197549	phv00197549.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:18:48+00:00	2018-10-01 20:18:48+00:00 	beta	Beta blockers
74	Medication/supplement use	197550	phv00197550.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:18:58+00:00	2018-10-01 20:18:58+00:00 	betad	Beta blockers and diuretics
74	Medication/supplement use	197551	phv00197551.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:19:05+00:00	2018-10-01 20:19:05+00:00 	ccb	Any calcium channel blocker
74	Medication/supplement use	197552	phv00197552.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:19:14+00:00	2018-10-01 20:19:14+00:00 	ace	Ace inhibitors
74	Medication/supplement use	197553	phv00197553.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:19:21+00:00	2018-10-01 20:19:21+00:00 	aced	Ace inhibitors and diuretics
74	Medication/supplement use	197554	phv00197554.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:19:28+00:00	2018-10-01 20:19:28+00:00 	vaso	Vasodilators (including alpha)
74	Medication/supplement use	197555	phv00197555.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:19:36+00:00	2018-10-01 20:19:36+00:00 	vasod	Vasodilators and diuretics (including alphad)
74	Medication/supplement use	197556	phv00197556.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:19:45+00:00	2018-10-01 20:19:45+00:00 	diuret	Any diuretic
74	Medication/supplement use	197557	phv00197557.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:19:56+00:00	2018-10-01 20:19:56+00:00 	dig	Digitalis
74	Medication/supplement use	197558	phv00197558.v1.p1	pht003699.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:20:06+00:00	2018-10-01 20:20:06+00:00 	ntg	Nitrates
74	Medication/supplement use	199029	phv00199029.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:21:18+00:00	2018-10-01 20:21:18+00:00 	a2a2	Angiotensin type 2 antagonists
74	Medication/supplement use	199030	phv00199030.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:21:28+00:00	2018-10-01 20:21:28+00:00 	a2ad2	Combinations of angiotensin ii antagonists plus diuretics
74	Medication/supplement use	199031	phv00199031.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:21:37+00:00	2018-10-01 20:21:37+00:00 	ace2	Ace inhibitors without diuretics
74	Medication/supplement use	199033	phv00199033.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:21:44+00:00	2018-10-01 20:21:44+00:00 	adpi2	Inhibitors of adp-induced platelet aggregation
74	Medication/supplement use	199034	phv00199034.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:21:54+00:00	2018-10-01 20:21:54+00:00 	agdi2	Alpha-glucosidase inhibitors
74	Medication/supplement use	199035	phv00199035.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:22:03+00:00	2018-10-01 20:22:03+00:00 	alpha2	Alpha-blockers without diuretics
74	Medication/supplement use	199036	phv00199036.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:22:11+00:00	2018-10-01 20:22:11+00:00 	alphad2	Alpha-blockers with diuretics
74	Medication/supplement use	199037	phv00199037.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:22:18+00:00	2018-10-01 20:22:18+00:00 	alzh2	Acetylcholine esterase inhibitors for alzh's
74	Medication/supplement use	199038	phv00199038.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:22:27+00:00	2018-10-01 20:22:27+00:00 	amlod2	Amlodipine
74	Medication/supplement use	199039	phv00199039.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:22:34+00:00	2018-10-01 20:22:34+00:00 	anar1a2	Anti-arrhythmics, class 1a
74	Medication/supplement use	199040	phv00199040.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:22:41+00:00	2018-10-01 20:22:41+00:00 	anar1b2	Anti-arrhythmics, class 1b
74	Medication/supplement use	199041	phv00199041.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:22:48+00:00	2018-10-01 20:22:48+00:00 	anar1c2	Anti-arrhythmics, class 1c
74	Medication/supplement use	199042	phv00199042.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:22:57+00:00	2018-10-01 20:22:57+00:00 	anar32	Anti-arrhythmics, class 3
74	Medication/supplement use	199043	phv00199043.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:23:05+00:00	2018-10-01 20:23:05+00:00 	apsy2	Anti-psychotic medications
74	Medication/supplement use	199044	phv00199044.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:23:15+00:00	2018-10-01 20:23:15+00:00 	asa2	Aspirin from 280804 (Anti-inflam agents)
74	Medication/supplement use	199045	phv00199045.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:23:23+00:00	2018-10-01 20:23:23+00:00 	basq2	Bile-acid sequestrants
74	Medication/supplement use	199046	phv00199046.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:23:30+00:00	2018-10-01 20:23:30+00:00 	benzod2	Benzodiazepines
74	Medication/supplement use	199047	phv00199047.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:23:38+00:00	2018-10-01 20:23:38+00:00 	beta2	Beta-blockers without diuretics
74	Medication/supplement use	199048	phv00199048.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:23:46+00:00	2018-10-01 20:23:46+00:00 	betad2	Beta-blockers with diuretics
74	Medication/supplement use	199049	phv00199049.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:23:56+00:00	2018-10-01 20:23:56+00:00 	bgnd2	Biguanides
74	Medication/supplement use	199050	phv00199050.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:24:07+00:00	2018-10-01 20:24:07+00:00 	ccb2	Any calcium-channel blocker = ccir or ccbsr or ccbt
74	Medication/supplement use	199051	phv00199051.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:24:17+00:00	2018-10-01 20:24:17+00:00 	ccbir2	Immediate-release ccbs = nifir or dihir or verir or dltir
74	Medication/supplement use	199052	phv00199052.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:24:26+00:00	2018-10-01 20:24:26+00:00 	ccbsr2	Slow-release ccbs = nifsr or dihsr or versr or dltsr or amlod
74	Medication/supplement use	199053	phv00199053.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:24:34+00:00	2018-10-01 20:24:34+00:00 	ccbt2	T-type calcium-channel blocker
74	Medication/supplement use	199054	phv00199054.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:24:42+00:00	2018-10-01 20:24:42+00:00 	cox22	Cox-2 inhibitors (nsaid agents); separate from nsaid variable
74	Medication/supplement use	199055	phv00199055.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:24:49+00:00	2018-10-01 20:24:49+00:00 	dig2	Digitalis preparations
74	Medication/supplement use	199056	phv00199056.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:25:01+00:00	2018-10-01 20:25:01+00:00 	dihir2	Immediate-release dihyropryidines other than nifedipine
74	Medication/supplement use	199057	phv00199057.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:25:09+00:00	2018-10-01 20:25:09+00:00 	dihsr2	Slow-release dihydropyridines other than nifedipine or amlopidine
74	Medication/supplement use	199058	phv00199058.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:25:18+00:00	2018-10-01 20:25:18+00:00 	dltir2	Immediate-release diltiazem
74	Medication/supplement use	199059	phv00199059.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:25:31+00:00	2018-10-01 20:25:31+00:00 	dltsr2	Slow-release diltiazem
74	Medication/supplement use	199060	phv00199060.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:25:41+00:00	2018-10-01 20:25:41+00:00 	edd2	Erectile dysfunction drugs
74	Medication/supplement use	199061	phv00199061.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:25:49+00:00	2018-10-01 20:25:49+00:00 	estrgn2	Estrogens, excluding vaginal creams
74	Medication/supplement use	199062	phv00199062.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:25:58+00:00	2018-10-01 20:25:58+00:00 	fibr2	Fibrates
74	Medication/supplement use	199063	phv00199063.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:26:05+00:00	2018-10-01 20:26:05+00:00 	h2b2	H-2 blockers
74	Medication/supplement use	199064	phv00199064.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:26:14+00:00	2018-10-01 20:26:14+00:00 	hctz2	Thiazide diuretics without k-sparing agents
74	Medication/supplement use	199065	phv00199065.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:26:22+00:00	2018-10-01 20:26:22+00:00 	hctzk2	Thiazide diuretics with k-sparing agents
74	Medication/supplement use	199066	phv00199066.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:26:35+00:00	2018-10-01 20:26:35+00:00 	hprns2	Heparins
74	Medication/supplement use	199067	phv00199067.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:26:46+00:00	2018-10-01 20:26:46+00:00 	insln2	Insulins
74	Medication/supplement use	199068	phv00199068.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:26:59+00:00	2018-10-01 20:26:59+00:00 	iprtr2	Anticholinergics + combination with beta2-agonist
74	Medication/supplement use	199069	phv00199069.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:27:08+00:00	2018-10-01 20:27:08+00:00 	istrd2	Inhaled steroids for asthma
74	Medication/supplement use	199070	phv00199070.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:27:17+00:00	2018-10-01 20:27:17+00:00 	kblkr2	K-channel blockers to enhance insulin secretion for diabetics
74	Medication/supplement use	199071	phv00199071.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:27:26+00:00	2018-10-01 20:27:26+00:00 	kcl2	Potassium supplements
74	Medication/supplement use	199072	phv00199072.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:27:33+00:00	2018-10-01 20:27:33+00:00 	kspr2	Potassium-sparing agents alone
74	Medication/supplement use	199073	phv00199073.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:29:45+00:00	2018-10-01 20:29:45+00:00 	loop2	Loop diuretics
74	Medication/supplement use	199074	phv00199074.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:29:56+00:00	2018-10-01 20:29:56+00:00 	maoi2	MAO inhibitors
74	Medication/supplement use	199075	phv00199075.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:30:04+00:00	2018-10-01 20:30:04+00:00 	mlpd2	Miscellaneous lipid-lowering drugs
74	Medication/supplement use	199076	phv00199076.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:30:12+00:00	2018-10-01 20:30:12+00:00 	niac2	Niacin and nicotinic acid
74	Medication/supplement use	199077	phv00199077.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:30:20+00:00	2018-10-01 20:30:20+00:00 	nifir2	Immediate-release nifedipine
74	Medication/supplement use	199078	phv00199078.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:30:29+00:00	2018-10-01 20:30:29+00:00 	nifsr2	Slow-release nifedipine
74	Medication/supplement use	199079	phv00199079.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:30:37+00:00	2018-10-01 20:30:37+00:00 	nsaid2	Non-steroidal Anti-inflammatory agents, excluding aspirin
74	Medication/supplement use	199080	phv00199080.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:30:48+00:00	2018-10-01 20:30:48+00:00 	ntca2	Non-tricyclic antidepressants other than MAO inhibitors
74	Medication/supplement use	199081	phv00199081.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:30:57+00:00	2018-10-01 20:30:57+00:00 	ntg2	Nitrates
74	Medication/supplement use	199082	phv00199082.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:31:05+00:00	2018-10-01 20:31:05+00:00 	oaia2	Oral Anti-inflammatory asthma drugs (leukotriene receptor antagonists and inhibitor)
74	Medication/supplement use	199083	phv00199083.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:31:13+00:00	2018-10-01 20:31:13+00:00 	ohga2	Oral hypoglycemic agents
74	Medication/supplement use	199084	phv00199084.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:31:21+00:00	2018-10-01 20:31:21+00:00 	ostrd2	Oral steroids
74	Medication/supplement use	199085	phv00199085.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:31:30+00:00	2018-10-01 20:31:30+00:00 	otch2b2	Over-the-counter H-2 blockers
74	Medication/supplement use	199086	phv00199086.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:31:39+00:00	2018-10-01 20:31:39+00:00 	pdei2	Phosphodiesterase inhibitors
74	Medication/supplement use	199087	phv00199087.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:31:47+00:00	2018-10-01 20:31:47+00:00 	ppi2	Proton pump inhibitors
74	Medication/supplement use	199088	phv00199088.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:31:55+00:00	2018-10-01 20:31:55+00:00 	prgstn2	Progestins
74	Medication/supplement use	199089	phv00199089.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:32:03+00:00	2018-10-01 20:32:03+00:00 	prknsn2	Drugs used to treat Parkinson's
74	Medication/supplement use	199090	phv00199090.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:32:12+00:00	2018-10-01 20:32:12+00:00 	prmrn2	Premarin (conjugated estrogens)
74	Medication/supplement use	199091	phv00199091.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:32:19+00:00	2018-10-01 20:32:19+00:00 	prob2	Probucol
74	Medication/supplement use	199092	phv00199092.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:32:27+00:00	2018-10-01 20:32:27+00:00 	pvdl2	Peripheral vasodilators, exclude dipyridamole
74	Medication/supplement use	199093	phv00199093.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:32:36+00:00	2018-10-01 20:32:36+00:00 	slf12	First generation sulfonylureas
74	Medication/supplement use	199094	phv00199094.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:32:44+00:00	2018-10-01 20:32:44+00:00 	slf22	Second generation sulfonylureas
74	Medication/supplement use	199095	phv00199095.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:32:53+00:00	2018-10-01 20:32:53+00:00 	sttn2	HMG CoA reductase inhibitors (statins)
74	Medication/supplement use	199096	phv00199096.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:33:00+00:00	2018-10-01 20:33:00+00:00 	sympth2	Sympathomimetics, oral and inhaled
74	Medication/supplement use	199097	phv00199097.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:33:12+00:00	2018-10-01 20:33:12+00:00 	tca2	Tricylic Anti-depressants
74	Medication/supplement use	199098	phv00199098.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:33:19+00:00	2018-10-01 20:33:19+00:00 	tcap2	Tri-cyclic Anti-depressants plus Anti-psychotics combinations
74	Medication/supplement use	199099	phv00199099.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:33:26+00:00	2018-10-01 20:33:26+00:00 	thry2	Thyroid agents
74	Medication/supplement use	199100	phv00199100.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:33:34+00:00	2018-10-01 20:33:34+00:00 	thzd2	Thiazolidinediones
74	Medication/supplement use	199101	phv00199101.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:33:42+00:00	2018-10-01 20:33:42+00:00 	urcos2	Uricosurics
74	Medication/supplement use	199102	phv00199102.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:33:49+00:00	2018-10-01 20:33:49+00:00 	vaso2	Vasodilators, a mixed group
74	Medication/supplement use	199103	phv00199103.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:33:57+00:00	2018-10-01 20:33:57+00:00 	vasod2	Vasodilators with diuretics, a mixed group
74	Medication/supplement use	199104	phv00199104.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:34:07+00:00	2018-10-01 20:34:07+00:00 	verir2	Immediate-release verapamil
74	Medication/supplement use	199105	phv00199105.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:34:15+00:00	2018-10-01 20:34:15+00:00 	versr2	Slow-release verapamil
74	Medication/supplement use	199106	phv00199106.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:34:27+00:00	2018-10-01 20:34:27+00:00 	warf2	Oral anticoagulants including warfarin, coumadin, and anisindione
74	Medication/supplement use	199107	phv00199107.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:34:35+00:00	2018-10-01 20:34:35+00:00 	wtls2	Weight loss drugs
74	Medication/supplement use	199108	phv00199108.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:34:42+00:00	2018-10-01 20:34:42+00:00 	xoi2	Xanthine oxidase inhibitors
74	Medication/supplement use	199109	phv00199109.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:34:50+00:00	2018-10-01 20:34:50+00:00 	diur2	Any diuretic
74	Medication/supplement use	199110	phv00199110.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:34:59+00:00	2018-10-01 20:34:59+00:00 	lipid2	Any lipid-lowering medication
74	Medication/supplement use	199111	phv00199111.v1.p1	pht003700.v2.p1	phs000287.v6.p1	Cardiovascular Health Study (CHS)	287	6	2018-10-01 20:35:08+00:00	2018-10-01 20:35:08+00:00 	htnmed2	Any Anti-hypertensive medication
74	Medication/supplement use	83081	phv00083081.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:02:14+00:00	2018-10-21 23:02:14+00:00 	a2a1c	ANGIOTENSIN TYPE 2 ANTAGONISTS
74	Medication/supplement use	83082	phv00083082.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:02:58+00:00	2018-10-21 23:02:58+00:00 	a2ad1c	COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS
74	Medication/supplement use	85326	phv00085326.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:03:05+00:00	2018-10-21 23:03:05+00:00 	a2a1c	ANGIOTENSIN TYPE 2 ANTAGONISTS
74	Medication/supplement use	85327	phv00085327.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:03:14+00:00	2018-10-21 23:03:14+00:00 	a2ad1c	COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS
74	Medication/supplement use	86015	phv00086015.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:03:21+00:00	2018-10-21 23:03:21+00:00 	a2a2c	ANGIOTENSIN TYPE 2 ANTAGONISTS
74	Medication/supplement use	86016	phv00086016.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:03:30+00:00	2018-10-21 23:03:30+00:00 	a2ad2c	COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS
74	Medication/supplement use	86497	phv00086497.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:03:38+00:00	2018-10-21 23:03:38+00:00 	a2a3c	ANGIOTENSIN TYPE 2 ANTAGONISTS
74	Medication/supplement use	86498	phv00086498.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:03:45+00:00	2018-10-21 23:03:45+00:00 	a2ad3c	COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS
74	Medication/supplement use	86934	phv00086934.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:03:51+00:00	2018-10-21 23:03:51+00:00 	a2a4c	ANGIOTENSIN TYPE 2 ANTAGONISTS
74	Medication/supplement use	86935	phv00086935.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:03:58+00:00	2018-10-21 23:03:58+00:00 	a2ad4c	COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS
74	Medication/supplement use	87302	phv00087302.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:04:05+00:00	2018-10-21 23:04:05+00:00 	a2afc	ANGIOTENSIN TYPE 2 ANTAGONISTS
74	Medication/supplement use	87303	phv00087303.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:04:15+00:00	2018-10-21 23:04:15+00:00 	a2adfc	COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS
74	Medication/supplement use	175327	phv00175327.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:04:21+00:00	2018-10-21 23:04:21+00:00 	a2a5c	ANGIOTENSIN TYPE 2 ANTAGONISTS
74	Medication/supplement use	175328	phv00175328.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:04:29+00:00	2018-10-21 23:04:29+00:00 	a2ad5c	COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS
74	Medication/supplement use	176750	phv00176750.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:04:36+00:00	2018-10-21 23:04:36+00:00 	a2a5c	ANGIOTENSIN TYPE 2 ANTAGONISTS
74	Medication/supplement use	176751	phv00176751.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:04:42+00:00	2018-10-21 23:04:42+00:00 	a2ad5c	COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS
74	Medication/supplement use	83083	phv00083083.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:06:10+00:00	2018-10-21 23:06:10+00:00 	ace1c	ACE INHIBITORS WITHOUT DIURETICS
74	Medication/supplement use	83084	phv00083084.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:06:18+00:00	2018-10-21 23:06:18+00:00 	aced1c	ACE INHIBITORS WITH DIURETICS
74	Medication/supplement use	85328	phv00085328.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:06:26+00:00	2018-10-21 23:06:26+00:00 	ace1c	ACE INHIBITORS WITHOUT DIURETICS
74	Medication/supplement use	85329	phv00085329.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:06:34+00:00	2018-10-21 23:06:34+00:00 	aced1c	ACE INHIBITORS WITH DIURETICS
74	Medication/supplement use	86001	phv00086001.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:06:42+00:00	2018-10-21 23:06:42+00:00 	ace2c	ACE INHIBITORS WITHOUT DIURETICS
74	Medication/supplement use	86002	phv00086002.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:06:53+00:00	2018-10-21 23:06:53+00:00 	aced2c	ACE INHIBITORS WITH DIURETICS
74	Medication/supplement use	86483	phv00086483.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:06:59+00:00	2018-10-21 23:06:59+00:00 	ace3c	ACE INHIBITORS WITHOUT DIURETICS
74	Medication/supplement use	86484	phv00086484.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:07:07+00:00	2018-10-21 23:07:07+00:00 	aced3c	ACE INHIBITORS WITH DIURETICS
74	Medication/supplement use	86920	phv00086920.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:07:14+00:00	2018-10-21 23:07:14+00:00 	ace4c	ACE INHIBITORS WITHOUT DIURETICS
74	Medication/supplement use	86921	phv00086921.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:07:20+00:00	2018-10-21 23:07:20+00:00 	aced4c	ACE INHIBITORS WITH DIURETICS
74	Medication/supplement use	87304	phv00087304.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:07:26+00:00	2018-10-21 23:07:26+00:00 	acefc	ACE INHIBITORS WITHOUT DIURETICS
74	Medication/supplement use	87305	phv00087305.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:07:34+00:00	2018-10-21 23:07:34+00:00 	acedfc	ACE INHIBITORS WITH DIURETICS
74	Medication/supplement use	175329	phv00175329.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:07:49+00:00	2018-10-21 23:07:49+00:00 	ace5c	ACE INHIBITORS WITHOUT DIURETICS
74	Medication/supplement use	175330	phv00175330.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:07:56+00:00	2018-10-21 23:07:56+00:00 	aced5c	ACE INHIBITORS WITH DIURETICS
74	Medication/supplement use	176752	phv00176752.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:08:04+00:00	2018-10-21 23:08:04+00:00 	ace5c	ACE INHIBITORS WITHOUT DIURETICS
74	Medication/supplement use	176753	phv00176753.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:08:12+00:00	2018-10-21 23:08:12+00:00 	aced5c	ACE INHIBITORS WITH DIURETICS
74	Medication/supplement use	83085	phv00083085.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:19:01+00:00	2018-10-21 23:19:01+00:00 	adpi1c	INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION
74	Medication/supplement use	85330	phv00085330.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:19:11+00:00	2018-10-21 23:19:11+00:00 	adpi1c	INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION
74	Medication/supplement use	86017	phv00086017.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:19:17+00:00	2018-10-21 23:19:17+00:00 	adpi2c	INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION
74	Medication/supplement use	86499	phv00086499.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:19:28+00:00	2018-10-21 23:19:28+00:00 	adpi3c	INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION
74	Medication/supplement use	86936	phv00086936.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:19:37+00:00	2018-10-21 23:19:37+00:00 	adpi4c	INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION
74	Medication/supplement use	87306	phv00087306.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:19:44+00:00	2018-10-21 23:19:44+00:00 	adpifc	INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION
74	Medication/supplement use	175331	phv00175331.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:19:51+00:00	2018-10-21 23:19:51+00:00 	adpi5c	INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION
74	Medication/supplement use	176754	phv00176754.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:20:13+00:00	2018-10-21 23:20:13+00:00 	adpi5c	INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION
74	Medication/supplement use	83086	phv00083086.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:21:38+00:00	2018-10-21 23:21:38+00:00 	agdi1c	ALPHA-GLUCOSIDASE INHIBITORS
74	Medication/supplement use	85331	phv00085331.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:21:44+00:00	2018-10-21 23:21:44+00:00 	agdi1c	ALPHA-GLUCOSIDASE INHIBITORS
74	Medication/supplement use	86018	phv00086018.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:21:52+00:00	2018-10-21 23:21:52+00:00 	agdi2c	ALPHA-GLUCOSIDASE INHIBITORS
74	Medication/supplement use	86500	phv00086500.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:21:58+00:00	2018-10-21 23:21:58+00:00 	agdi3c	ALPHA-GLUCOSIDASE INHIBITORS
74	Medication/supplement use	86937	phv00086937.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:22:04+00:00	2018-10-21 23:22:04+00:00 	agdi4c	ALPHA-GLUCOSIDASE INHIBITORS
74	Medication/supplement use	87307	phv00087307.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:22:23+00:00	2018-10-21 23:22:23+00:00 	agdifc	ALPHA-GLUCOSIDASE INHIBITORS
74	Medication/supplement use	175332	phv00175332.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:22:30+00:00	2018-10-21 23:22:30+00:00 	agdi5c	ALPHA-GLUCOSIDASE INHIBITORS
74	Medication/supplement use	176755	phv00176755.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:22:38+00:00	2018-10-21 23:22:38+00:00 	agdi5c	ALPHA-GLUCOSIDASE INHIBITORS
74	Medication/supplement use	175333	phv00175333.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:26:19+00:00	2018-10-21 23:26:19+00:00 	alpha5c	ALPHA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	175334	phv00175334.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:26:28+00:00	2018-10-21 23:26:28+00:00 	alphad5c	ALPHA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	176756	phv00176756.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:26:35+00:00	2018-10-21 23:26:35+00:00 	alpha5c	ALPHA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	176757	phv00176757.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:26:41+00:00	2018-10-21 23:26:41+00:00 	alphad5c	ALPHA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	83087	phv00083087.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:26:49+00:00	2018-10-21 23:26:49+00:00 	alpha1c	ALPHA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	83088	phv00083088.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:27:03+00:00	2018-10-21 23:27:03+00:00 	alphad1c	ALPHA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	85332	phv00085332.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:27:10+00:00	2018-10-21 23:27:10+00:00 	alpha1c	ALPHA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	85333	phv00085333.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:27:20+00:00	2018-10-21 23:27:20+00:00 	alphad1c	ALPHA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	86019	phv00086019.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:28:32+00:00	2018-10-21 23:28:32+00:00 	alpha2c	ALPHA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	86020	phv00086020.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:28:54+00:00	2018-10-21 23:28:54+00:00 	alphad2c	ALPHA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	86501	phv00086501.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:30:29+00:00	2018-10-21 23:30:29+00:00 	alpha3c	ALPHA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	86502	phv00086502.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:30:38+00:00	2018-10-21 23:30:38+00:00 	alphad3c	ALPHA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	86938	phv00086938.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:30:45+00:00	2018-10-21 23:30:45+00:00 	alpha4c	ALPHA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	86939	phv00086939.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:30:53+00:00	2018-10-21 23:30:53+00:00 	alphad4c	ALPHA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	87308	phv00087308.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:31:01+00:00	2018-10-21 23:31:01+00:00 	alphafc	ALPHA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	87309	phv00087309.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:31:11+00:00	2018-10-21 23:31:11+00:00 	alphadfc	ALPHA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	83089	phv00083089.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:32:28+00:00	2018-10-21 23:32:28+00:00 	alzh1c	ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZH'S
74	Medication/supplement use	85334	phv00085334.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:32:36+00:00	2018-10-21 23:32:36+00:00 	alzh1c	ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZH'
74	Medication/supplement use	86021	phv00086021.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:32:46+00:00	2018-10-21 23:32:46+00:00 	alzh2c	ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZH'S
74	Medication/supplement use	86503	phv00086503.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:32:56+00:00	2018-10-21 23:32:56+00:00 	alzh3c	ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZH'S
74	Medication/supplement use	86940	phv00086940.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:33:03+00:00	2018-10-21 23:33:03+00:00 	alzh4c	ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZH'S
74	Medication/supplement use	87310	phv00087310.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:33:11+00:00	2018-10-21 23:33:11+00:00 	alzhfc	ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZHEIMER'S
74	Medication/supplement use	175335	phv00175335.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:33:17+00:00	2018-10-21 23:33:17+00:00 	alzh5c	ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZHEIMERS
74	Medication/supplement use	176758	phv00176758.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:33:23+00:00	2018-10-21 23:33:23+00:00 	alzh5c	ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZHEIMERS
74	Medication/supplement use	83090	phv00083090.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:54:45+00:00	2018-10-21 23:54:45+00:00 	amlod1c	AMLODIPINE
74	Medication/supplement use	85335	phv00085335.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:54:52+00:00	2018-10-21 23:54:52+00:00 	amlod1c	AMLODIPINE
74	Medication/supplement use	86022	phv00086022.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:54:59+00:00	2018-10-21 23:54:59+00:00 	amlod2c	AMLODIPINE
74	Medication/supplement use	86504	phv00086504.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:55:06+00:00	2018-10-21 23:55:06+00:00 	amlod3c	AMLODIPINE
74	Medication/supplement use	86941	phv00086941.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:55:15+00:00	2018-10-21 23:55:15+00:00 	amlod4c	AMLODIPINE
74	Medication/supplement use	87311	phv00087311.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:55:22+00:00	2018-10-21 23:55:22+00:00 	amlodfc	AMLODIPINE
74	Medication/supplement use	175336	phv00175336.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:55:29+00:00	2018-10-21 23:55:29+00:00 	amlod5c	AMLODIPINE
74	Medication/supplement use	176759	phv00176759.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:55:36+00:00	2018-10-21 23:55:36+00:00 	amlod5c	AMLODIPINE
74	Medication/supplement use	83091	phv00083091.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:56:54+00:00	2018-10-21 23:56:54+00:00 	anar1a1c	ANTI-ARRHYTHMICS, CLASS 1A
74	Medication/supplement use	83092	phv00083092.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:57:01+00:00	2018-10-21 23:57:01+00:00 	anar1b1c	ANTI-ARRHYTHMICS, CLASS 1B
74	Medication/supplement use	83093	phv00083093.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:57:09+00:00	2018-10-21 23:57:09+00:00 	anar1c1c	ANTI-ARRHYTHMICS, CLASS 1C
74	Medication/supplement use	85336	phv00085336.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:57:16+00:00	2018-10-21 23:57:16+00:00 	anar1a1c	ANTI-ARRHYTHMICS, CLASS 1A
74	Medication/supplement use	85337	phv00085337.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:57:24+00:00	2018-10-21 23:57:24+00:00 	anar1b1c	ANTI-ARRHYTHMICS, CLASS 1B
74	Medication/supplement use	85338	phv00085338.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:57:38+00:00	2018-10-21 23:57:38+00:00 	anar1c1c	ANTI-ARRHYTHMICS, CLASS 1C
74	Medication/supplement use	86023	phv00086023.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:57:45+00:00	2018-10-21 23:57:45+00:00 	anar1a2c	ANTI-ARRHYTHMICS, CLASS 1A
74	Medication/supplement use	86024	phv00086024.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:57:52+00:00	2018-10-21 23:57:52+00:00 	anar1b2c	ANTI-ARRHYTHMICS, CLASS 1B
74	Medication/supplement use	86025	phv00086025.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:57:58+00:00	2018-10-21 23:57:58+00:00 	anar1c2c	ANTI-ARRHYTHMICS, CLASS 1C
74	Medication/supplement use	86505	phv00086505.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:58:04+00:00	2018-10-21 23:58:04+00:00 	anar1a3c	ANTI-ARRHYTHMICS, CLASS 1A
74	Medication/supplement use	86506	phv00086506.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:58:10+00:00	2018-10-21 23:58:10+00:00 	anar1b3c	ANTI-ARRHYTHMICS, CLASS 1B
74	Medication/supplement use	86507	phv00086507.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:58:17+00:00	2018-10-21 23:58:17+00:00 	anar1c3c	ANTI-ARRHYTHMICS, CLASS 1C
74	Medication/supplement use	86942	phv00086942.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:58:23+00:00	2018-10-21 23:58:23+00:00 	anar1a4c	ANTI-ARRHYTHMICS, CLASS 1A
74	Medication/supplement use	86943	phv00086943.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:58:29+00:00	2018-10-21 23:58:29+00:00 	anar1b4c	ANTI-ARRHYTHMICS, CLASS 1B
74	Medication/supplement use	86944	phv00086944.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:58:36+00:00	2018-10-21 23:58:36+00:00 	anar1c4c	ANTI-ARRHYTHMICS, CLASS 1C
74	Medication/supplement use	87312	phv00087312.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:58:43+00:00	2018-10-21 23:58:43+00:00 	anar1afc	ANTI-ARRHYTHMICS, CLASS 1A
74	Medication/supplement use	87313	phv00087313.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:58:51+00:00	2018-10-21 23:58:51+00:00 	anar1bfc	ANTI-ARRHYTHMICS, CLASS 1B
74	Medication/supplement use	87314	phv00087314.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:59:00+00:00	2018-10-21 23:59:00+00:00 	anar1cfc	ANTI-ARRHYTHMICS, CLASS 1C
74	Medication/supplement use	175337	phv00175337.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:59:06+00:00	2018-10-21 23:59:06+00:00 	anar1a5c	ANTI-ARRHYTHMICS, CLASS 1A
74	Medication/supplement use	175338	phv00175338.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:59:13+00:00	2018-10-21 23:59:13+00:00 	anar1b5c	ANTI-ARRHYTHMICS, CLASS 1B
74	Medication/supplement use	175339	phv00175339.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:59:20+00:00	2018-10-21 23:59:20+00:00 	anar1c5c	ANTI-ARRHYTHMICS, CLASS 1C
74	Medication/supplement use	176760	phv00176760.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:59:26+00:00	2018-10-21 23:59:26+00:00 	anar1a5c	ANTI-ARRHYTHMICS, CLASS 1A
74	Medication/supplement use	176761	phv00176761.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:59:32+00:00	2018-10-21 23:59:32+00:00 	anar1b5c	ANTI-ARRHYTHMICS, CLASS 1B
74	Medication/supplement use	176762	phv00176762.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-21 23:59:54+00:00	2018-10-21 23:59:54+00:00 	anar1c5c	ANTI-ARRHYTHMICS, CLASS 1C
74	Medication/supplement use	83094	phv00083094.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:00:51+00:00	2018-10-22 00:00:51+00:00 	anar31c	ANTI-ARRHYTHMICS, CLASS 3
74	Medication/supplement use	85339	phv00085339.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:00:57+00:00	2018-10-22 00:00:57+00:00 	anar31c	ANTI-ARRHYTHMICS, CLASS 3
74	Medication/supplement use	86026	phv00086026.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:01:06+00:00	2018-10-22 00:01:06+00:00 	anar32c	ANTI-ARRHYTHMICS, CLASS 3
74	Medication/supplement use	86508	phv00086508.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:01:17+00:00	2018-10-22 00:01:17+00:00 	anar33c	ANTI-ARRHYTHMICS, CLASS 3
74	Medication/supplement use	86945	phv00086945.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:01:24+00:00	2018-10-22 00:01:24+00:00 	anar34c	ANTI-ARRHYTHMICS, CLASS 3
74	Medication/supplement use	87315	phv00087315.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:01:31+00:00	2018-10-22 00:01:31+00:00 	anar3fc	ANTI-ARRHYTHMICS, CLASS 3
74	Medication/supplement use	175340	phv00175340.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:01:37+00:00	2018-10-22 00:01:37+00:00 	anar35c	ANTI-ARRHYTHMICS, CLASS 3
74	Medication/supplement use	176763	phv00176763.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:01:45+00:00	2018-10-22 00:01:45+00:00 	anar35c	ANTI-ARRHYTHMICS, CLASS 3
74	Medication/supplement use	83095	phv00083095.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:02:40+00:00	2018-10-22 00:02:40+00:00 	apsy1c	ANTI-PSYCHOTIC MEDICATIONS
74	Medication/supplement use	85340	phv00085340.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:02:47+00:00	2018-10-22 00:02:47+00:00 	apsy1c	ANTI-PSYCHOTIC MEDICATIONS
74	Medication/supplement use	86027	phv00086027.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:02:53+00:00	2018-10-22 00:02:53+00:00 	apsy2c	ANTI-PSYCHOTIC MEDICATIONS
74	Medication/supplement use	86509	phv00086509.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:02:59+00:00	2018-10-22 00:02:59+00:00 	apsy3c	ANTI-PSYCHOTIC MEDICATIONS
74	Medication/supplement use	86946	phv00086946.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:03:06+00:00	2018-10-22 00:03:06+00:00 	apsy4c	ANTI-PSYCHOTIC MEDICATIONS
74	Medication/supplement use	87316	phv00087316.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:03:12+00:00	2018-10-22 00:03:12+00:00 	apsyfc	ANTI-PSYCHOTIC MEDICATIONS
74	Medication/supplement use	175341	phv00175341.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:03:20+00:00	2018-10-22 00:03:20+00:00 	apsy5c	ANTI-PSYCHOTIC MEDICATIONS
74	Medication/supplement use	176764	phv00176764.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:03:28+00:00	2018-10-22 00:03:28+00:00 	apsy5c	ANTI-PSYCHOTIC MEDICATIONS
74	Medication/supplement use	83072	phv00083072.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:19:04+00:00	2018-10-22 00:19:04+00:00 	asacat1c	CURRENT ASPIRIN USE (TAKING ASPIRIN AT LEAST 3 DAYS PER WEEK AT BASELINE)
74	Medication/supplement use	83096	phv00083096.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:19:12+00:00	2018-10-22 00:19:12+00:00 	asa1c	ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS)
74	Medication/supplement use	85323	phv00085323.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:19:20+00:00	2018-10-22 00:19:20+00:00 	asacat1c	CURRENT ASPIRIN USE (TAKING ASPIRIN AT LEAST 3 DAYS PER WEEK AT BASELINE)
74	Medication/supplement use	85341	phv00085341.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:19:28+00:00	2018-10-22 00:19:28+00:00 	asa1c	ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS)
74	Medication/supplement use	85973	phv00085973.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:19:36+00:00	2018-10-22 00:19:36+00:00 	asacat2c	CURRENT ASPIRIN USE (TAKING ASPIRIN AT LEAST 3 DAYS PER WEEK AT EXAM 2)
74	Medication/supplement use	86003	phv00086003.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:19:44+00:00	2018-10-22 00:19:44+00:00 	asa2c	ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS)
74	Medication/supplement use	86455	phv00086455.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:19:53+00:00	2018-10-22 00:19:53+00:00 	asacat3C	CURRENT ASPIRIN USE (TAKING ASPIRIN AT LEAST 3 DAYS PER WEEK)
74	Medication/supplement use	86485	phv00086485.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:20:02+00:00	2018-10-22 00:20:02+00:00 	asa3c	ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS)
74	Medication/supplement use	86899	phv00086899.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:20:11+00:00	2018-10-22 00:20:11+00:00 	asacat4c	CURRENT ASPIRIN USE (TAKING ASPIRIN AT LEAST 3 DAYS PER WEEK)
74	Medication/supplement use	86922	phv00086922.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:20:20+00:00	2018-10-22 00:20:20+00:00 	asa4c	ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS)
74	Medication/supplement use	87317	phv00087317.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:20:28+00:00	2018-10-22 00:20:28+00:00 	asafc	ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS)
74	Medication/supplement use	175342	phv00175342.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:20:36+00:00	2018-10-22 00:20:36+00:00 	asa5c	ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS)
74	Medication/supplement use	176765	phv00176765.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:20:46+00:00	2018-10-22 00:20:46+00:00 	asa5c	ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS)
74	Medication/supplement use	83097	phv00083097.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:22:03+00:00	2018-10-22 00:22:03+00:00 	basq1c	BILE-ACID SEQUESTRANTS
74	Medication/supplement use	85342	phv00085342.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:22:19+00:00	2018-10-22 00:22:19+00:00 	basq1c	BILE-ACID SEQUESTRANTS
74	Medication/supplement use	86028	phv00086028.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:22:28+00:00	2018-10-22 00:22:28+00:00 	basq2c	BILE-ACID SEQUESTRANTS
74	Medication/supplement use	86510	phv00086510.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:22:37+00:00	2018-10-22 00:22:37+00:00 	basq3c	BILE-ACID SEQUESTRANTS
74	Medication/supplement use	86947	phv00086947.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:23:05+00:00	2018-10-22 00:23:05+00:00 	basq4c	BILE-ACID SEQUESTRANTS
74	Medication/supplement use	87318	phv00087318.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:23:16+00:00	2018-10-22 00:23:16+00:00 	basqfc	BILE-ACID SEQUESTRANTS
74	Medication/supplement use	175343	phv00175343.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:23:28+00:00	2018-10-22 00:23:28+00:00 	basq5c	BILE-ACID SEQUESTRANTS
74	Medication/supplement use	176766	phv00176766.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:23:44+00:00	2018-10-22 00:23:44+00:00 	basq5c	BILE-ACID SEQUESTRANTS
74	Medication/supplement use	83098	phv00083098.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:44:07+00:00	2018-10-22 00:44:07+00:00 	benzod1c	BENZODIAZEPINES
74	Medication/supplement use	85343	phv00085343.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:44:15+00:00	2018-10-22 00:44:15+00:00 	benzod1c	BENZODIAZEPINES
74	Medication/supplement use	86029	phv00086029.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:44:41+00:00	2018-10-22 00:44:41+00:00 	benzod2c	BENZODIAZEPINES
74	Medication/supplement use	86511	phv00086511.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:45:01+00:00	2018-10-22 00:45:01+00:00 	benzod3c	BENZODIAZEPINES
74	Medication/supplement use	86948	phv00086948.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:45:15+00:00	2018-10-22 00:45:15+00:00 	benzod4c	BENZODIAZEPINES
74	Medication/supplement use	87319	phv00087319.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:45:33+00:00	2018-10-22 00:45:33+00:00 	benzodfc	BENZODIAZEPINES
74	Medication/supplement use	175344	phv00175344.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:45:40+00:00	2018-10-22 00:45:40+00:00 	benzod5c	BENZODIAZEPINES
74	Medication/supplement use	176767	phv00176767.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:45:46+00:00	2018-10-22 00:45:46+00:00 	benzod5c	BENZODIAZEPINES
74	Medication/supplement use	83099	phv00083099.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:46:46+00:00	2018-10-22 00:46:46+00:00 	beta1c	BETA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	83100	phv00083100.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:46:54+00:00	2018-10-22 00:46:54+00:00 	betad1c	BETA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	85344	phv00085344.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:47:01+00:00	2018-10-22 00:47:01+00:00 	beta1c	BETA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	85345	phv00085345.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:47:07+00:00	2018-10-22 00:47:07+00:00 	betad1c	BETA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	86004	phv00086004.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:47:21+00:00	2018-10-22 00:47:21+00:00 	beta2c	BETA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	86005	phv00086005.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:47:27+00:00	2018-10-22 00:47:27+00:00 	betad2c	BETA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	86486	phv00086486.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:47:34+00:00	2018-10-22 00:47:34+00:00 	beta3c	BETA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	86487	phv00086487.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:47:41+00:00	2018-10-22 00:47:41+00:00 	betad3c	BETA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	86923	phv00086923.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:47:48+00:00	2018-10-22 00:47:48+00:00 	beta4c	BETA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	86924	phv00086924.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:47:54+00:00	2018-10-22 00:47:54+00:00 	betad4c	BETA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	87320	phv00087320.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:48:03+00:00	2018-10-22 00:48:03+00:00 	betafc	BETA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	87321	phv00087321.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:48:10+00:00	2018-10-22 00:48:10+00:00 	betadfc	BETA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	175345	phv00175345.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:48:18+00:00	2018-10-22 00:48:18+00:00 	beta5c	BETA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	175346	phv00175346.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:48:27+00:00	2018-10-22 00:48:27+00:00 	betad5c	BETA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	176768	phv00176768.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:48:39+00:00	2018-10-22 00:48:39+00:00 	beta5c	BETA-BLOCKERS WITHOUT DIURETICS
74	Medication/supplement use	176769	phv00176769.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:48:51+00:00	2018-10-22 00:48:51+00:00 	betad5c	BETA-BLOCKERS WITH DIURETICS
74	Medication/supplement use	83101	phv00083101.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:49:42+00:00	2018-10-22 00:49:42+00:00 	bgnd1c	BIGUANIDES
74	Medication/supplement use	85346	phv00085346.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:49:53+00:00	2018-10-22 00:49:53+00:00 	bgnd1c	BIGUANIDES
74	Medication/supplement use	86030	phv00086030.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:50:00+00:00	2018-10-22 00:50:00+00:00 	bgnd2c	BIGUANIDES
74	Medication/supplement use	86512	phv00086512.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:50:06+00:00	2018-10-22 00:50:06+00:00 	bgnd3c	BIGUANIDES
74	Medication/supplement use	86949	phv00086949.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:50:19+00:00	2018-10-22 00:50:19+00:00 	bgnd4c	BIGUANIDES
74	Medication/supplement use	87322	phv00087322.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:50:28+00:00	2018-10-22 00:50:28+00:00 	bgndfc	BIGUANIDES
74	Medication/supplement use	175347	phv00175347.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:50:36+00:00	2018-10-22 00:50:36+00:00 	bgnd5c	BIGUANIDES
74	Medication/supplement use	176770	phv00176770.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 00:50:44+00:00	2018-10-22 00:50:44+00:00 	bgnd5c	BIGUANIDES
74	Medication/supplement use	83102	phv00083102.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:08:51+00:00	2018-10-22 01:08:51+00:00 	ccb1c	ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT
74	Medication/supplement use	83103	phv00083103.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:08:59+00:00	2018-10-22 01:08:59+00:00 	ccbir1c	IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR
74	Medication/supplement use	83104	phv00083104.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:09:07+00:00	2018-10-22 01:09:07+00:00 	ccbsr1c	SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD
74	Medication/supplement use	83105	phv00083105.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:09:15+00:00	2018-10-22 01:09:15+00:00 	ccbt1c	T-TYPE CALCIUM-CHANNEL BLOCKER
74	Medication/supplement use	85347	phv00085347.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:09:35+00:00	2018-10-22 01:09:35+00:00 	ccb1c	ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT
74	Medication/supplement use	85348	phv00085348.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:09:42+00:00	2018-10-22 01:09:42+00:00 	ccbir1c	IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR
74	Medication/supplement use	85349	phv00085349.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:09:53+00:00	2018-10-22 01:09:53+00:00 	ccbsr1c	SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD
74	Medication/supplement use	85350	phv00085350.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:10:00+00:00	2018-10-22 01:10:00+00:00 	ccbt1c	T-TYPE CALCIUM-CHANNEL BLOCKER
74	Medication/supplement use	86006	phv00086006.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:10:13+00:00	2018-10-22 01:10:13+00:00 	ccb2c	ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT
74	Medication/supplement use	86031	phv00086031.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:10:19+00:00	2018-10-22 01:10:19+00:00 	ccbir2c	IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR
74	Medication/supplement use	86032	phv00086032.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:10:29+00:00	2018-10-22 01:10:29+00:00 	ccbsr2c	SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD
74	Medication/supplement use	86033	phv00086033.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:10:35+00:00	2018-10-22 01:10:35+00:00 	ccbt2c	T-TYPE CALCIUM-CHANNEL BLOCKER
74	Medication/supplement use	86488	phv00086488.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:10:43+00:00	2018-10-22 01:10:43+00:00 	ccb3c	ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT
74	Medication/supplement use	86513	phv00086513.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:10:51+00:00	2018-10-22 01:10:51+00:00 	ccbir3c	IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR
74	Medication/supplement use	86514	phv00086514.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:10:57+00:00	2018-10-22 01:10:57+00:00 	ccbsr3c	SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD
74	Medication/supplement use	86515	phv00086515.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:11:03+00:00	2018-10-22 01:11:03+00:00 	ccbt3c	T-TYPE CALCIUM-CHANNEL BLOCKER
74	Medication/supplement use	86925	phv00086925.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:11:09+00:00	2018-10-22 01:11:09+00:00 	ccb4c	ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT
74	Medication/supplement use	86950	phv00086950.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:11:15+00:00	2018-10-22 01:11:15+00:00 	ccbir4c	IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR
74	Medication/supplement use	86951	phv00086951.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:11:27+00:00	2018-10-22 01:11:27+00:00 	ccbsr4c	SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD
74	Medication/supplement use	86952	phv00086952.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:11:37+00:00	2018-10-22 01:11:37+00:00 	ccbt4c	T-TYPE CALCIUM-CHANNEL BLOCKER
74	Medication/supplement use	87323	phv00087323.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:11:45+00:00	2018-10-22 01:11:45+00:00 	ccbfc	ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT
74	Medication/supplement use	87324	phv00087324.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:11:52+00:00	2018-10-22 01:11:52+00:00 	ccbirfc	IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR
74	Medication/supplement use	87325	phv00087325.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:11:59+00:00	2018-10-22 01:11:59+00:00 	ccbsrfc	SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD
74	Medication/supplement use	87326	phv00087326.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:12:06+00:00	2018-10-22 01:12:06+00:00 	ccbtfc	T-TYPE CALCIUM-CHANNEL BLOCKER
74	Medication/supplement use	175348	phv00175348.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:12:13+00:00	2018-10-22 01:12:13+00:00 	ccb5c	ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT
74	Medication/supplement use	175349	phv00175349.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:12:20+00:00	2018-10-22 01:12:20+00:00 	ccbir5c	IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR
74	Medication/supplement use	175350	phv00175350.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:12:26+00:00	2018-10-22 01:12:26+00:00 	ccbsr5c	SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD
74	Medication/supplement use	175351	phv00175351.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:12:34+00:00	2018-10-22 01:12:34+00:00 	ccbt5c	T-TYPE CALCIUM-CHANNEL BLOCKER
74	Medication/supplement use	176771	phv00176771.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:12:41+00:00	2018-10-22 01:12:41+00:00 	ccb5c	ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT
74	Medication/supplement use	176772	phv00176772.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:12:48+00:00	2018-10-22 01:12:48+00:00 	ccbir5c	IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR
74	Medication/supplement use	176773	phv00176773.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:12:55+00:00	2018-10-22 01:12:55+00:00 	ccbsr5c	SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD
74	Medication/supplement use	176774	phv00176774.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:13:02+00:00	2018-10-22 01:13:02+00:00 	ccbt5c	T-TYPE CALCIUM-CHANNEL BLOCKER
74	Medication/supplement use	83106	phv00083106.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:13:57+00:00	2018-10-22 01:13:57+00:00 	cox21c	COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE
74	Medication/supplement use	85351	phv00085351.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:14:04+00:00	2018-10-22 01:14:04+00:00 	cox21c	COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE
74	Medication/supplement use	86007	phv00086007.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:14:10+00:00	2018-10-22 01:14:10+00:00 	cox22c	COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE
74	Medication/supplement use	86489	phv00086489.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:14:17+00:00	2018-10-22 01:14:17+00:00 	cox23c	COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE
74	Medication/supplement use	86926	phv00086926.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:14:24+00:00	2018-10-22 01:14:24+00:00 	cox24c	COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE
74	Medication/supplement use	87327	phv00087327.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:14:32+00:00	2018-10-22 01:14:32+00:00 	cox2fc	COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE
74	Medication/supplement use	175352	phv00175352.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:14:40+00:00	2018-10-22 01:14:40+00:00 	cox25c	COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE
74	Medication/supplement use	176775	phv00176775.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:14:46+00:00	2018-10-22 01:14:46+00:00 	cox25c	COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE
74	Medication/supplement use	83107	phv00083107.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:15:36+00:00	2018-10-22 01:15:36+00:00 	dig1c	DIGITALIS PREPARATIONS
74	Medication/supplement use	85352	phv00085352.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:15:43+00:00	2018-10-22 01:15:43+00:00 	dig1c	DIGITALIS PREPARATIONS
74	Medication/supplement use	86034	phv00086034.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:15:49+00:00	2018-10-22 01:15:49+00:00 	dig2c	DIGITALIS PREPARATIONS
74	Medication/supplement use	86516	phv00086516.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:15:56+00:00	2018-10-22 01:15:56+00:00 	dig3c	DIGITALIS PREPARATIONS
74	Medication/supplement use	86953	phv00086953.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:16:03+00:00	2018-10-22 01:16:03+00:00 	dig4c	DIGITALIS PREPARATIONS
74	Medication/supplement use	87328	phv00087328.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:16:10+00:00	2018-10-22 01:16:10+00:00 	digfc	DIGITALIS PREPARATIONS
74	Medication/supplement use	175353	phv00175353.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:16:16+00:00	2018-10-22 01:16:16+00:00 	dig5c	DIGITALIS PREPARATIONS
74	Medication/supplement use	176776	phv00176776.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:16:23+00:00	2018-10-22 01:16:23+00:00 	dig5c	DIGITALIS PREPARATIONS
74	Medication/supplement use	83108	phv00083108.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:17:35+00:00	2018-10-22 01:17:35+00:00 	dihir1c	IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE
74	Medication/supplement use	83109	phv00083109.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:17:55+00:00	2018-10-22 01:17:55+00:00 	dihsr1c	SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE
74	Medication/supplement use	85353	phv00085353.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:18:51+00:00	2018-10-22 01:18:51+00:00 	dihir1c	IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE
74	Medication/supplement use	85354	phv00085354.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:20:37+00:00	2018-10-22 01:20:37+00:00 	dihsr1c	SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE
74	Medication/supplement use	86035	phv00086035.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:21:27+00:00	2018-10-22 01:21:27+00:00 	dihir2c	IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE
74	Medication/supplement use	86036	phv00086036.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:21:34+00:00	2018-10-22 01:21:34+00:00 	dihsr2c	SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE
74	Medication/supplement use	86517	phv00086517.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:21:40+00:00	2018-10-22 01:21:40+00:00 	dihir3c	IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE
74	Medication/supplement use	86518	phv00086518.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:21:49+00:00	2018-10-22 01:21:49+00:00 	dihsr3c	SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE
74	Medication/supplement use	86954	phv00086954.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:21:55+00:00	2018-10-22 01:21:55+00:00 	dihir4c	IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE
74	Medication/supplement use	86955	phv00086955.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:22:02+00:00	2018-10-22 01:22:02+00:00 	dihsr4c	SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE
74	Medication/supplement use	87329	phv00087329.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:22:10+00:00	2018-10-22 01:22:10+00:00 	dihirfc	IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE
74	Medication/supplement use	87330	phv00087330.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:22:19+00:00	2018-10-22 01:22:19+00:00 	dihsrfc	SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE
74	Medication/supplement use	175354	phv00175354.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:22:45+00:00	2018-10-22 01:22:45+00:00 	dihir5c	IMMEDIATE-RELEASE DIHYROPYRIDINES OTHER THAN NIFEDIPINE
74	Medication/supplement use	175355	phv00175355.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:23:01+00:00	2018-10-22 01:23:01+00:00 	dihsr5c	SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE
74	Medication/supplement use	176777	phv00176777.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:23:15+00:00	2018-10-22 01:23:15+00:00 	dihir5c	IMMEDIATE-RELEASE DIHYROPYRIDINES OTHER THAN NIFEDIPINE
74	Medication/supplement use	176778	phv00176778.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:23:22+00:00	2018-10-22 01:23:22+00:00 	dihsr5c	SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE
74	Medication/supplement use	83110	phv00083110.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:24:53+00:00	2018-10-22 01:24:53+00:00 	dltir1c	IMMEDIATE-RELEASE DILTIAZEM
74	Medication/supplement use	83111	phv00083111.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:25:00+00:00	2018-10-22 01:25:00+00:00 	dltsr1c	SLOW-RELEASE DILTIAZEM
74	Medication/supplement use	85355	phv00085355.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:25:07+00:00	2018-10-22 01:25:07+00:00 	dltir1c	IMMEDIATE-RELEASE DILTIAZEM
74	Medication/supplement use	85356	phv00085356.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:25:14+00:00	2018-10-22 01:25:14+00:00 	dltsr1c	SLOW-RELEASE DILTIAZEM
74	Medication/supplement use	86037	phv00086037.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:25:24+00:00	2018-10-22 01:25:24+00:00 	dltir2c	IMMEDIATE-RELEASE DILTIAZEM
74	Medication/supplement use	86038	phv00086038.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:25:30+00:00	2018-10-22 01:25:30+00:00 	dltsr2c	SLOW-RELEASE DILTIAZEM
74	Medication/supplement use	86519	phv00086519.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:25:37+00:00	2018-10-22 01:25:37+00:00 	dltir3c	IMMEDIATE-RELEASE DILTIAZEM
74	Medication/supplement use	86520	phv00086520.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:25:43+00:00	2018-10-22 01:25:43+00:00 	dltsr3c	SLOW-RELEASE DILTIAZEM
74	Medication/supplement use	86956	phv00086956.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:25:50+00:00	2018-10-22 01:25:50+00:00 	dltir4c	IMMEDIATE-RELEASE DILTIAZEM
74	Medication/supplement use	86957	phv00086957.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:25:56+00:00	2018-10-22 01:25:56+00:00 	dltsr4c	SLOW-RELEASE DILTIAZEM
74	Medication/supplement use	87331	phv00087331.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:26:03+00:00	2018-10-22 01:26:03+00:00 	dltirfc	IMMEDIATE-RELEASE DILTIAZEM
74	Medication/supplement use	87332	phv00087332.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:26:10+00:00	2018-10-22 01:26:10+00:00 	dltsrfc	SLOW-RELEASE DILTIAZEM
74	Medication/supplement use	175356	phv00175356.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:26:19+00:00	2018-10-22 01:26:19+00:00 	dltir5c	IMMEDIATE-RELEASE DILTIAZEM
74	Medication/supplement use	175357	phv00175357.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:26:25+00:00	2018-10-22 01:26:25+00:00 	dltsr5c	SLOW-RELEASE DILTIAZEM
74	Medication/supplement use	176779	phv00176779.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:26:32+00:00	2018-10-22 01:26:32+00:00 	dltir5c	IMMEDIATE-RELEASE DILTIAZEM
74	Medication/supplement use	176780	phv00176780.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:26:39+00:00	2018-10-22 01:26:39+00:00 	dltsr5c	SLOW-RELEASE DILTIAZEM
74	Medication/supplement use	191178	phv00191178.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:27:27+00:00	2018-10-22 01:27:27+00:00 	dpp4i1c	DIPEPTIDYL PEPTIDASE-4 INHIBITOR
74	Medication/supplement use	195570	phv00195570.v1.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:27:34+00:00	2018-10-22 01:27:34+00:00 	dpp4i2c	DIPEPTIDYL PEPTIDASE-4 INHIBITOR
74	Medication/supplement use	191186	phv00191186.v1.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:27:48+00:00	2018-10-22 01:27:48+00:00 	dpp4i3c	DIPEPTIDYL PEPTIDASE-4 INHIBITOR
74	Medication/supplement use	191193	phv00191193.v1.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:28:00+00:00	2018-10-22 01:28:00+00:00 	dpp4i4c	DIPEPTIDYL PEPTIDASE-4 INHIBITOR
74	Medication/supplement use	191198	phv00191198.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:28:07+00:00	2018-10-22 01:28:07+00:00 	dpp4i5c	DIPEPTIDYL PEPTIDASE-4 INHIBITOR
74	Medication/supplement use	191696	phv00191696.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:28:14+00:00	2018-10-22 01:28:14+00:00 	dpp4i5c	DIPEPTIDYL PEPTIDASE-4 INHIBITOR
74	Medication/supplement use	83112	phv00083112.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:29:02+00:00	2018-10-22 01:29:02+00:00 	edd1c	ERECTILE DYSFUNCTION DRUGS
74	Medication/supplement use	85357	phv00085357.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:29:09+00:00	2018-10-22 01:29:09+00:00 	edd1c	ERECTILE DYSFUNCTION DRUGS
74	Medication/supplement use	86039	phv00086039.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:29:14+00:00	2018-10-22 01:29:14+00:00 	edd2c	ERECTILE DYSFUNCTION DRUGS
74	Medication/supplement use	86521	phv00086521.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:29:21+00:00	2018-10-22 01:29:21+00:00 	edd3c	ERECTILE DYSFUNCTION DRUGS
74	Medication/supplement use	86958	phv00086958.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:29:28+00:00	2018-10-22 01:29:28+00:00 	edd4c	ERECTILE DYSFUNCTION DRUGS
74	Medication/supplement use	87333	phv00087333.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:29:35+00:00	2018-10-22 01:29:35+00:00 	eddfc	ERECTILE DYSFUNCTION DRUGS
74	Medication/supplement use	175358	phv00175358.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:29:42+00:00	2018-10-22 01:29:42+00:00 	edd5c	ERECTILE DYSFUNCTION DRUGS
74	Medication/supplement use	176781	phv00176781.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:29:50+00:00	2018-10-22 01:29:50+00:00 	edd5c	ERECTILE DYSFUNCTION DRUGS
74	Medication/supplement use	83113	phv00083113.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:35:21+00:00	2018-10-22 01:35:21+00:00 	estrgn1c	ESTROGENS, EXCLUDING VAGINAL CREAMS
74	Medication/supplement use	85358	phv00085358.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:35:29+00:00	2018-10-22 01:35:29+00:00 	estrgn1c	ESTROGENS, EXCLUDING VAGINAL CREAMS
74	Medication/supplement use	86040	phv00086040.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:35:36+00:00	2018-10-22 01:35:36+00:00 	estrgn2c	ESTROGENS, EXCLUDING VAGINAL CREAMS
74	Medication/supplement use	86522	phv00086522.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:35:43+00:00	2018-10-22 01:35:43+00:00 	estrgn3c	ESTROGENS, EXCLUDING VAGINAL CREAMS
74	Medication/supplement use	86959	phv00086959.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:35:51+00:00	2018-10-22 01:35:51+00:00 	estrgn4c	ESTROGENS, EXCLUDING VAGINAL CREAMS
74	Medication/supplement use	87334	phv00087334.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:35:59+00:00	2018-10-22 01:35:59+00:00 	estrgnfc	ESTROGENS, EXCLUDING VAGINAL CREAMS
74	Medication/supplement use	175359	phv00175359.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:36:06+00:00	2018-10-22 01:36:06+00:00 	estrgn5c	ESTROGENS, EXCLUDING VAGINAL CREAMS
74	Medication/supplement use	176782	phv00176782.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:36:13+00:00	2018-10-22 01:36:13+00:00 	estrgn5c	ESTROGENS, EXCLUDING VAGINAL CREAMS
74	Medication/supplement use	83114	phv00083114.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:37:42+00:00	2018-10-22 01:37:42+00:00 	fibr1c	FIBRATES
74	Medication/supplement use	85359	phv00085359.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:37:48+00:00	2018-10-22 01:37:48+00:00 	fibr1c	FIBRATES
74	Medication/supplement use	86041	phv00086041.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:37:54+00:00	2018-10-22 01:37:54+00:00 	fibr2c	FIBRATES
74	Medication/supplement use	86523	phv00086523.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:38:03+00:00	2018-10-22 01:38:03+00:00 	fibr3c	FIBRATES
74	Medication/supplement use	86960	phv00086960.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:38:10+00:00	2018-10-22 01:38:10+00:00 	fibr4c	FIBRATES
74	Medication/supplement use	87335	phv00087335.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:38:18+00:00	2018-10-22 01:38:18+00:00 	fibrfc	FIBRATES
74	Medication/supplement use	175360	phv00175360.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:38:25+00:00	2018-10-22 01:38:25+00:00 	fibr5c	FIBRATES
74	Medication/supplement use	176783	phv00176783.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:38:31+00:00	2018-10-22 01:38:31+00:00 	fibr5c	FIBRATES
74	Medication/supplement use	175361	phv00175361.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:39:15+00:00	2018-10-22 01:39:15+00:00 	gout5c	ANY GOUT MEDICATIONS
74	Medication/supplement use	176784	phv00176784.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:39:21+00:00	2018-10-22 01:39:21+00:00 	gout5c	ANY GOUT MEDICATIONS
74	Medication/supplement use	83115	phv00083115.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:40:35+00:00	2018-10-22 01:40:35+00:00 	h2b1c	H-2 BLOCKERS
74	Medication/supplement use	83137	phv00083137.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:40:41+00:00	2018-10-22 01:40:41+00:00 	otch2b1c	OVER-THE-COUNTER H-2 BLOCKERS
74	Medication/supplement use	85360	phv00085360.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:40:49+00:00	2018-10-22 01:40:49+00:00 	h2b1c	H-2 BLOCKERS
74	Medication/supplement use	85382	phv00085382.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:40:56+00:00	2018-10-22 01:40:56+00:00 	otch2b1c	OVER-THE-COUNTER H-2 BLOCKERS
74	Medication/supplement use	86042	phv00086042.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:41:02+00:00	2018-10-22 01:41:02+00:00 	h2b2c	H-2 BLOCKERS
74	Medication/supplement use	86060	phv00086060.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:41:10+00:00	2018-10-22 01:41:10+00:00 	otch2b2c	OVER-THE-COUNTER H-2 BLOCKERS
74	Medication/supplement use	86524	phv00086524.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:41:17+00:00	2018-10-22 01:41:17+00:00 	h2b3c	H-2 BLOCKERS
74	Medication/supplement use	86542	phv00086542.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:41:23+00:00	2018-10-22 01:41:23+00:00 	otch2b3c	('60) OVER-THE-COUNTER H-2 BLOCKERS'
74	Medication/supplement use	86961	phv00086961.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:41:29+00:00	2018-10-22 01:41:29+00:00 	h2b4c	H-2 BLOCKERS
74	Medication/supplement use	86979	phv00086979.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:41:35+00:00	2018-10-22 01:41:35+00:00 	otch2b4c	('60) OVER-THE-COUNTER H-2 BLOCKERS'
74	Medication/supplement use	87336	phv00087336.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:41:43+00:00	2018-10-22 01:41:43+00:00 	h2bfc	H-2 BLOCKERS
74	Medication/supplement use	87357	phv00087357.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:41:53+00:00	2018-10-22 01:41:53+00:00 	otch2bfc	OVER-THE-COUNTER H-2 BLOCKERS
74	Medication/supplement use	175362	phv00175362.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:42:07+00:00	2018-10-22 01:42:07+00:00 	h2b5c	H-2 BLOCKERS
74	Medication/supplement use	175384	phv00175384.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:42:15+00:00	2018-10-22 01:42:15+00:00 	otch2b5c	OVER-THE-COUNTER H-2 BLOCKERS
74	Medication/supplement use	176785	phv00176785.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:42:22+00:00	2018-10-22 01:42:22+00:00 	h2b5c	H-2 BLOCKERS
74	Medication/supplement use	176807	phv00176807.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:42:29+00:00	2018-10-22 01:42:29+00:00 	otch2b5c	OVER-THE-COUNTER H-2 BLOCKERS
74	Medication/supplement use	83116	phv00083116.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:47:53+00:00	2018-10-22 01:47:53+00:00 	hctz1c	THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS
74	Medication/supplement use	83117	phv00083117.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:48:01+00:00	2018-10-22 01:48:01+00:00 	hctzk1c	THIAZIDE DIURETICS WITH K-SPARING AGENTS
74	Medication/supplement use	85361	phv00085361.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:48:08+00:00	2018-10-22 01:48:08+00:00 	hctz1c	THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS
74	Medication/supplement use	85362	phv00085362.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:48:15+00:00	2018-10-22 01:48:15+00:00 	hctzk1c	THIAZIDE DIURETICS WITH K-SPARING AGENTS
74	Medication/supplement use	86043	phv00086043.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:48:25+00:00	2018-10-22 01:48:25+00:00 	hctz2c	THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS
74	Medication/supplement use	86044	phv00086044.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:48:32+00:00	2018-10-22 01:48:32+00:00 	hctzk2c	THIAZIDE DIURETICS WITH K-SPARING AGENTS
74	Medication/supplement use	86525	phv00086525.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:48:39+00:00	2018-10-22 01:48:39+00:00 	hctz3c	THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS
74	Medication/supplement use	86526	phv00086526.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:48:50+00:00	2018-10-22 01:48:50+00:00 	hctzk3c	THIAZIDE DIURETICS WITH K-SPARING AGENTS
74	Medication/supplement use	86962	phv00086962.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:48:58+00:00	2018-10-22 01:48:58+00:00 	hctz4c	THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS
74	Medication/supplement use	86963	phv00086963.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:49:20+00:00	2018-10-22 01:49:20+00:00 	hctzk4c	THIAZIDE DIURETICS WITH K-SPARING AGENTS
74	Medication/supplement use	87337	phv00087337.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:49:28+00:00	2018-10-22 01:49:28+00:00 	hctzfc	THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS
74	Medication/supplement use	87338	phv00087338.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:49:41+00:00	2018-10-22 01:49:41+00:00 	hctzkfc	THIAZIDE DIURETICS WITH K-SPARING AGENTS
74	Medication/supplement use	175363	phv00175363.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:49:50+00:00	2018-10-22 01:49:50+00:00 	hctz5c	THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS
74	Medication/supplement use	175364	phv00175364.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:49:57+00:00	2018-10-22 01:49:57+00:00 	hctzk5c	THIAZIDE DIURETICS WITH K-SPARING AGENTS
74	Medication/supplement use	176786	phv00176786.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:50:04+00:00	2018-10-22 01:50:04+00:00 	hctz5c	THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS
74	Medication/supplement use	176787	phv00176787.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:50:10+00:00	2018-10-22 01:50:10+00:00 	hctzk5c	THIAZIDE DIURETICS WITH K-SPARING AGENTS
74	Medication/supplement use	83118	phv00083118.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:52:00+00:00	2018-10-22 01:52:00+00:00 	hprns1c	HEPARINS
74	Medication/supplement use	85363	phv00085363.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:52:06+00:00	2018-10-22 01:52:06+00:00 	hprns1c	HEPARINS
74	Medication/supplement use	86045	phv00086045.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:52:13+00:00	2018-10-22 01:52:13+00:00 	hprns2c	HEPARINS
74	Medication/supplement use	86527	phv00086527.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:52:19+00:00	2018-10-22 01:52:19+00:00 	hprns3c	HEPARINS
74	Medication/supplement use	86964	phv00086964.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:52:31+00:00	2018-10-22 01:52:31+00:00 	hprns4c	HEPARINS
74	Medication/supplement use	87339	phv00087339.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:52:37+00:00	2018-10-22 01:52:37+00:00 	hprnsfc	HEPARINS
74	Medication/supplement use	175365	phv00175365.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:52:43+00:00	2018-10-22 01:52:43+00:00 	hprns5c	HEPARINS
74	Medication/supplement use	176788	phv00176788.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:52:49+00:00	2018-10-22 01:52:49+00:00 	hprns5c	HEPARINS
74	Medication/supplement use	83119	phv00083119.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:53:42+00:00	2018-10-22 01:53:42+00:00 	insln1c	INSULINS
74	Medication/supplement use	85364	phv00085364.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:53:49+00:00	2018-10-22 01:53:49+00:00 	insln1c	INSULINS
74	Medication/supplement use	86008	phv00086008.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:53:56+00:00	2018-10-22 01:53:56+00:00 	insln2c	INSULINS
74	Medication/supplement use	86490	phv00086490.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:54:11+00:00	2018-10-22 01:54:11+00:00 	insln3c	INSULINS
74	Medication/supplement use	86927	phv00086927.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:54:18+00:00	2018-10-22 01:54:18+00:00 	insln4c	INSULINS
74	Medication/supplement use	87340	phv00087340.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:54:35+00:00	2018-10-22 01:54:35+00:00 	inslnfc	INSULINS
74	Medication/supplement use	175366	phv00175366.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:55:31+00:00	2018-10-22 01:55:31+00:00 	insln5c	INSULINS
74	Medication/supplement use	176789	phv00176789.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:55:39+00:00	2018-10-22 01:55:39+00:00 	insln5c	INSULINS
74	Medication/supplement use	83120	phv00083120.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:57:45+00:00	2018-10-22 01:57:45+00:00 	iprtr1c	ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200)
74	Medication/supplement use	85365	phv00085365.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:57:54+00:00	2018-10-22 01:57:54+00:00 	iprtr1c	ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200)
74	Medication/supplement use	86046	phv00086046.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:58:27+00:00	2018-10-22 01:58:27+00:00 	iprtr2c	ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200)
74	Medication/supplement use	86528	phv00086528.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:58:34+00:00	2018-10-22 01:58:34+00:00 	iprtr3c	ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200)
74	Medication/supplement use	86965	phv00086965.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 01:59:22+00:00	2018-10-22 01:59:22+00:00 	iprtr4c	ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200)
74	Medication/supplement use	87341	phv00087341.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:00:17+00:00	2018-10-22 02:00:17+00:00 	iprtrfc	ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200)
74	Medication/supplement use	175367	phv00175367.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:00:24+00:00	2018-10-22 02:00:24+00:00 	iprtr5c	ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200)
74	Medication/supplement use	176790	phv00176790.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:00:31+00:00	2018-10-22 02:00:31+00:00 	iprtr5c	ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200)
74	Medication/supplement use	83121	phv00083121.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:01:46+00:00	2018-10-22 02:01:46+00:00 	istrd1c	INHALED STEROIDS FOR ASTHMA
74	Medication/supplement use	85366	phv00085366.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:01:55+00:00	2018-10-22 02:01:55+00:00 	istrd1c	INHALED STEROIDS FOR ASTHMA
74	Medication/supplement use	86047	phv00086047.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:02:05+00:00	2018-10-22 02:02:05+00:00 	istrd2c	INHALED STEROIDS FOR ASTHMA
74	Medication/supplement use	86529	phv00086529.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:02:11+00:00	2018-10-22 02:02:11+00:00 	istrd3c	INHALED STEROIDS FOR ASTHMA
74	Medication/supplement use	86966	phv00086966.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:02:23+00:00	2018-10-22 02:02:23+00:00 	istrd4c	INHALED STEROIDS FOR ASTHMA
74	Medication/supplement use	87342	phv00087342.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:02:31+00:00	2018-10-22 02:02:31+00:00 	istrdfc	INHALED STEROIDS FOR ASTHMA
74	Medication/supplement use	175368	phv00175368.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:02:38+00:00	2018-10-22 02:02:38+00:00 	istrd5c	INHALED STEROIDS FOR ASTHMA
74	Medication/supplement use	175874	phv00175874.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:02:45+00:00	2018-10-22 02:02:45+00:00 	istrd1c	INHALED STEROIDS FOR ASTHMA
74	Medication/supplement use	175958	phv00175958.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:02:51+00:00	2018-10-22 02:02:51+00:00 	istrdfc	FAMILY COHORT: INHALED STEROIDS FOR ASTHMA
74	Medication/supplement use	176791	phv00176791.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:02:58+00:00	2018-10-22 02:02:58+00:00 	istrd5c	INHALED STEROIDS FOR ASTHMA
74	Medication/supplement use	83122	phv00083122.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:03:46+00:00	2018-10-22 02:03:46+00:00 	kblkr1c	K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS
74	Medication/supplement use	85367	phv00085367.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:04:19+00:00	2018-10-22 02:04:19+00:00 	kblkr1c	K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS
74	Medication/supplement use	86009	phv00086009.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:04:24+00:00	2018-10-22 02:04:24+00:00 	kblkr2c	K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS
74	Medication/supplement use	86491	phv00086491.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:04:31+00:00	2018-10-22 02:04:31+00:00 	kblkr3c	K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS
74	Medication/supplement use	86928	phv00086928.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:04:38+00:00	2018-10-22 02:04:38+00:00 	kblkr4c	K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS
74	Medication/supplement use	87343	phv00087343.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:04:44+00:00	2018-10-22 02:04:44+00:00 	kblkrfc	K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS
74	Medication/supplement use	175369	phv00175369.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:04:51+00:00	2018-10-22 02:04:51+00:00 	kblkr5c	K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS
74	Medication/supplement use	176792	phv00176792.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:04:57+00:00	2018-10-22 02:04:57+00:00 	kblkr5c	K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS
74	Medication/supplement use	83123	phv00083123.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:07:10+00:00	2018-10-22 02:07:10+00:00 	kcl1c	POTASSIUM SUPPLEMENTS
74	Medication/supplement use	85368	phv00085368.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:07:17+00:00	2018-10-22 02:07:17+00:00 	kcl1c	POTASSIUM SUPPLEMENTS
74	Medication/supplement use	86048	phv00086048.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:07:23+00:00	2018-10-22 02:07:23+00:00 	kcl2c	POTASSIUM SUPPLEMENTS
74	Medication/supplement use	86530	phv00086530.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:07:36+00:00	2018-10-22 02:07:36+00:00 	kcl3c	POTASSIUM SUPPLEMENTS
74	Medication/supplement use	86967	phv00086967.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:07:42+00:00	2018-10-22 02:07:42+00:00 	kcl4c	POTASSIUM SUPPLEMENTS
74	Medication/supplement use	87344	phv00087344.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:08:01+00:00	2018-10-22 02:08:01+00:00 	kclfc	POTASSIUM SUPPLEMENTS
74	Medication/supplement use	175370	phv00175370.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:08:11+00:00	2018-10-22 02:08:11+00:00 	kcl5c	POTASSIUM SUPPLEMENTS
74	Medication/supplement use	176793	phv00176793.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:08:39+00:00	2018-10-22 02:08:39+00:00 	kcl5c	POTASSIUM SUPPLEMENTS
74	Medication/supplement use	83124	phv00083124.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:09:52+00:00	2018-10-22 02:09:52+00:00 	kspr1c	POTASSIUM-SPARING AGENTS ALONE
74	Medication/supplement use	85369	phv00085369.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:10:01+00:00	2018-10-22 02:10:01+00:00 	kspr1c	POTASSIUM-SPARING AGENTS ALONE
74	Medication/supplement use	86049	phv00086049.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:10:14+00:00	2018-10-22 02:10:14+00:00 	kspr2c	POTASSIUM-SPARING AGENTS ALONE
74	Medication/supplement use	86531	phv00086531.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:10:21+00:00	2018-10-22 02:10:21+00:00 	kspr3c	POTASSIUM-SPARING AGENTS ALONE
74	Medication/supplement use	86968	phv00086968.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:10:29+00:00	2018-10-22 02:10:29+00:00 	kspr4c	POTASSIUM-SPARING AGENTS ALONE
74	Medication/supplement use	87345	phv00087345.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:10:56+00:00	2018-10-22 02:10:56+00:00 	ksprfc	POTASSIUM-SPARING AGENTS ALONE
74	Medication/supplement use	175371	phv00175371.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:11:05+00:00	2018-10-22 02:11:05+00:00 	kspr5c	POTASSIUM-SPARING AGENTS ALONE
74	Medication/supplement use	176794	phv00176794.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:11:14+00:00	2018-10-22 02:11:14+00:00 	kspr5c	POTASSIUM-SPARING AGENTS ALONE
74	Medication/supplement use	83125	phv00083125.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:12:17+00:00	2018-10-22 02:12:17+00:00 	loop1c	LOOP DIURETICS
74	Medication/supplement use	85370	phv00085370.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:12:25+00:00	2018-10-22 02:12:25+00:00 	loop1c	LOOP DIURETICS
74	Medication/supplement use	86050	phv00086050.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:12:31+00:00	2018-10-22 02:12:31+00:00 	loop2c	LOOP DIURETICS
74	Medication/supplement use	86532	phv00086532.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:12:40+00:00	2018-10-22 02:12:40+00:00 	loop3c	LOOP DIURETICS
74	Medication/supplement use	86969	phv00086969.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:12:49+00:00	2018-10-22 02:12:49+00:00 	loop4c	LOOP DIURETICS
74	Medication/supplement use	87346	phv00087346.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:12:55+00:00	2018-10-22 02:12:55+00:00 	loopfc	LOOP DIURETICS
74	Medication/supplement use	175372	phv00175372.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:13:03+00:00	2018-10-22 02:13:03+00:00 	loop5c	LOOP DIURETICS
74	Medication/supplement use	176795	phv00176795.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:13:10+00:00	2018-10-22 02:13:10+00:00 	loop5c	LOOP DIURETICS
74	Medication/supplement use	83126	phv00083126.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:29:43+00:00	2018-10-22 02:29:43+00:00 	maoi1c	MAO INHIBITORS
74	Medication/supplement use	85371	phv00085371.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:29:50+00:00	2018-10-22 02:29:50+00:00 	maoi1c	MAO INHIBITORS
74	Medication/supplement use	86051	phv00086051.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:29:56+00:00	2018-10-22 02:29:56+00:00 	maoi2c	MAO INHIBITORS
74	Medication/supplement use	86533	phv00086533.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:30:03+00:00	2018-10-22 02:30:03+00:00 	maoi3c	MAO INHIBITORS
74	Medication/supplement use	86970	phv00086970.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:30:10+00:00	2018-10-22 02:30:10+00:00 	maoi4c	MAO INHIBITORS
74	Medication/supplement use	87347	phv00087347.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:30:34+00:00	2018-10-22 02:30:34+00:00 	maoifc	MAO INHIBITORS
74	Medication/supplement use	175373	phv00175373.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:30:40+00:00	2018-10-22 02:30:40+00:00 	maoi5c	MAO INHIBITORS
74	Medication/supplement use	176796	phv00176796.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:30:46+00:00	2018-10-22 02:30:46+00:00 	maoi5c	MAO INHIBITORS
74	Medication/supplement use	83127	phv00083127.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:31:45+00:00	2018-10-22 02:31:45+00:00 	mlpd1c	MISCELLANEOUS LIPID-LOWERING DRUGS
74	Medication/supplement use	85372	phv00085372.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:31:52+00:00	2018-10-22 02:31:52+00:00 	mlpd1c	MISCELLANEOUS LIPID-LOWERING DRUGS
74	Medication/supplement use	86010	phv00086010.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:32:03+00:00	2018-10-22 02:32:03+00:00 	mlpd2c	MISCELLANEOUS LIPID-LOWERING DRUGS
74	Medication/supplement use	86492	phv00086492.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:32:09+00:00	2018-10-22 02:32:09+00:00 	mlpd3c	MISCELLANEOUS LIPID-LOWERING DRUGS
74	Medication/supplement use	86929	phv00086929.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:32:15+00:00	2018-10-22 02:32:15+00:00 	mlpd4c	MISCELLANEOUS LIPID-LOWERING DRUGS
74	Medication/supplement use	87348	phv00087348.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:32:24+00:00	2018-10-22 02:32:24+00:00 	mlpdfc	MISCELLANEOUS LIPID-LOWERING DRUGS
74	Medication/supplement use	175374	phv00175374.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:32:31+00:00	2018-10-22 02:32:31+00:00 	mlpd5c	MISCELLANEOUS LIPID-LOWERING DRUGS
74	Medication/supplement use	176797	phv00176797.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:32:40+00:00	2018-10-22 02:32:40+00:00 	mlpd5c	MISCELLANEOUS LIPID-LOWERING DRUGS
74	Medication/supplement use	191179	phv00191179.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:33:14+00:00	2018-10-22 02:33:14+00:00 	ndri1c	NOREPINEPHRINE-DOPAMINE REUPTAKE INHIBITOR
74	Medication/supplement use	195571	phv00195571.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:33:20+00:00	2018-10-22 02:33:20+00:00 	ndri2c	NOREPINEPHRINE-DOPAMINE REUPTAKE INHIBITOR
74	Medication/supplement use	191187	phv00191187.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:33:26+00:00	2018-10-22 02:33:26+00:00 	ndri3c	NOREPINEPHRINE-DOPAMINE REUPTAKE INHIBITOR
74	Medication/supplement use	191194	phv00191194.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:33:33+00:00	2018-10-22 02:33:33+00:00 	ndri4c	NOREPINEPHRINE-DOPAMINE REUPTAKE INHIBITOR
74	Medication/supplement use	191199	phv00191199.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:33:39+00:00	2018-10-22 02:33:39+00:00 	ndri5c	NOREPINEPHRINE-DOPAMINE REUPTAKE INHIBITOR
74	Medication/supplement use	191697	phv00191697.v2.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:33:51+00:00	2018-10-22 02:33:51+00:00 	ndri5c	NOREPINEPHRINE-DOPAMINE REUPTAKE INHIBITOR
74	Medication/supplement use	83128	phv00083128.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:34:36+00:00	2018-10-22 02:34:36+00:00 	niac1c	NIACIN AND NICOTINIC ACID
74	Medication/supplement use	85373	phv00085373.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:34:43+00:00	2018-10-22 02:34:43+00:00 	niac1c	NIACIN AND NICOTINIC ACID
74	Medication/supplement use	86052	phv00086052.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:34:49+00:00	2018-10-22 02:34:49+00:00 	niac2c	NIACIN AND NICOTINIC ACID
74	Medication/supplement use	86534	phv00086534.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:34:56+00:00	2018-10-22 02:34:56+00:00 	niac3c	NIACIN AND NICOTINIC ACID
74	Medication/supplement use	86971	phv00086971.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:35:02+00:00	2018-10-22 02:35:02+00:00 	niac4c	NIACIN AND NICOTINIC ACID
74	Medication/supplement use	87349	phv00087349.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:35:08+00:00	2018-10-22 02:35:08+00:00 	niacfc	NIACIN AND NICTOTINIC ACID
74	Medication/supplement use	175375	phv00175375.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:35:15+00:00	2018-10-22 02:35:15+00:00 	niac5c	NIACIN AND NICOTINIC ACID
74	Medication/supplement use	176798	phv00176798.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:35:22+00:00	2018-10-22 02:35:22+00:00 	niac5c	NIACIN AND NICOTINIC ACID
74	Medication/supplement use	83130	phv00083130.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:48:40+00:00	2018-10-22 02:48:40+00:00 	nifsr1c	SLOW-RELEASE NIFEDIPINE
74	Medication/supplement use	85374	phv00085374.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:48:46+00:00	2018-10-22 02:48:46+00:00 	nifir1c	IMMEDIATE-RELEASE NIFEDIPINE
74	Medication/supplement use	85375	phv00085375.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:49:01+00:00	2018-10-22 02:49:01+00:00 	nifsr1c	SLOW-RELEASE NIFEDIPINE
74	Medication/supplement use	86053	phv00086053.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:49:09+00:00	2018-10-22 02:49:09+00:00 	nifir2c	IMMEDIATE-RELEASE NIFEDIPINE
74	Medication/supplement use	86054	phv00086054.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:49:15+00:00	2018-10-22 02:49:15+00:00 	nifsr2c	SLOW-RELEASE NIFEDIPINE
74	Medication/supplement use	86535	phv00086535.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:49:23+00:00	2018-10-22 02:49:23+00:00 	nifir3c	IMMEDIATE-RELEASE NIFEDIPINE
74	Medication/supplement use	86536	phv00086536.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:49:30+00:00	2018-10-22 02:49:30+00:00 	nifsr3c	SLOW-RELEASE NIFEDIPINE
74	Medication/supplement use	86972	phv00086972.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:49:37+00:00	2018-10-22 02:49:37+00:00 	nifir4c	IMMEDIATE-RELEASE NIFEDIPINE
74	Medication/supplement use	86973	phv00086973.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:49:44+00:00	2018-10-22 02:49:44+00:00 	nifsr4c	SLOW-RELEASE NIFEDIPINE
74	Medication/supplement use	87350	phv00087350.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:49:51+00:00	2018-10-22 02:49:51+00:00 	nifirfc	IMMEDIATE-RELEASE NIFEDIPINE
74	Medication/supplement use	87351	phv00087351.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:49:58+00:00	2018-10-22 02:49:58+00:00 	nifsrfc	SLOW-RELEASE NIFEDIPINE
74	Medication/supplement use	175376	phv00175376.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:50:05+00:00	2018-10-22 02:50:05+00:00 	nifir5c	IMMEDIATE-RELEASE NIFEDIPINE
74	Medication/supplement use	175377	phv00175377.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:50:12+00:00	2018-10-22 02:50:12+00:00 	nifsr5c	SLOW-RELEASE NIFEDIPINE
74	Medication/supplement use	176799	phv00176799.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:50:18+00:00	2018-10-22 02:50:18+00:00 	nifir5c	IMMEDIATE-RELEASE NIFEDIPINE
74	Medication/supplement use	176800	phv00176800.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:50:25+00:00	2018-10-22 02:50:25+00:00 	nifsr5c	SLOW-RELEASE NIFEDIPINE
74	Medication/supplement use	83129	phv00083129.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 02:50:33+00:00	2018-10-22 02:50:33+00:00 	nifir1c	IMMEDIATE-RELEASE NIFEDIPINE
74	Medication/supplement use	83131	phv00083131.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:10:54+00:00	2018-10-22 03:10:54+00:00 	nsaid1c	NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN
74	Medication/supplement use	85376	phv00085376.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:11:01+00:00	2018-10-22 03:11:01+00:00 	nsaid1c	NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN
74	Medication/supplement use	86055	phv00086055.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:11:09+00:00	2018-10-22 03:11:09+00:00 	nsaid2c	NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN
74	Medication/supplement use	86537	phv00086537.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:11:15+00:00	2018-10-22 03:11:15+00:00 	nsaid3c	NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN
74	Medication/supplement use	86974	phv00086974.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:11:23+00:00	2018-10-22 03:11:23+00:00 	nsaid4c	NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN
74	Medication/supplement use	87352	phv00087352.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:11:31+00:00	2018-10-22 03:11:31+00:00 	nsaidfc	NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN
74	Medication/supplement use	175378	phv00175378.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:11:38+00:00	2018-10-22 03:11:38+00:00 	nsaid5c	NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN
74	Medication/supplement use	176801	phv00176801.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:11:44+00:00	2018-10-22 03:11:44+00:00 	nsaid5c	NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN
74	Medication/supplement use	83132	phv00083132.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:12:41+00:00	2018-10-22 03:12:41+00:00 	ntca1c	NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI
74	Medication/supplement use	85377	phv00085377.v3.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:12:47+00:00	2018-10-22 03:12:47+00:00 	ntca1c	NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI
74	Medication/supplement use	86056	phv00086056.v3.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:12:53+00:00	2018-10-22 03:12:53+00:00 	ntca2c	NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI
74	Medication/supplement use	86538	phv00086538.v3.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:13:00+00:00	2018-10-22 03:13:00+00:00 	ntca3c	NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI
74	Medication/supplement use	86975	phv00086975.v3.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:13:08+00:00	2018-10-22 03:13:08+00:00 	ntca4c	NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI
74	Medication/supplement use	87353	phv00087353.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:13:14+00:00	2018-10-22 03:13:14+00:00 	ntcafc	NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI
74	Medication/supplement use	175379	phv00175379.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:13:21+00:00	2018-10-22 03:13:21+00:00 	ntca5c	NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI
74	Medication/supplement use	176802	phv00176802.v2.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:13:29+00:00	2018-10-22 03:13:29+00:00 	ntca5c	NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI
74	Medication/supplement use	83133	phv00083133.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:14:19+00:00	2018-10-22 03:14:19+00:00 	ntg1c	NITRATES
74	Medication/supplement use	85378	phv00085378.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:14:25+00:00	2018-10-22 03:14:25+00:00 	ntg1c	NITRATES
74	Medication/supplement use	86057	phv00086057.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:14:32+00:00	2018-10-22 03:14:32+00:00 	ntg2c	NITRATES
74	Medication/supplement use	86539	phv00086539.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:14:38+00:00	2018-10-22 03:14:38+00:00 	ntg3c	NITRATES
74	Medication/supplement use	86976	phv00086976.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:14:44+00:00	2018-10-22 03:14:44+00:00 	ntg4c	NITRATES
74	Medication/supplement use	87354	phv00087354.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:14:51+00:00	2018-10-22 03:14:51+00:00 	ntgfc	NITRATES
74	Medication/supplement use	175380	phv00175380.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:14:56+00:00	2018-10-22 03:14:56+00:00 	ntg5c	NITRATES
74	Medication/supplement use	176803	phv00176803.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:15:03+00:00	2018-10-22 03:15:03+00:00 	ntg5c	NITRATES
74	Medication/supplement use	83134	phv00083134.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:15:47+00:00	2018-10-22 03:15:47+00:00 	oaia1c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
74	Medication/supplement use	85379	phv00085379.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:15:57+00:00	2018-10-22 03:15:57+00:00 	oaia1c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
74	Medication/supplement use	86058	phv00086058.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:16:03+00:00	2018-10-22 03:16:03+00:00 	oaia2c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
74	Medication/supplement use	86540	phv00086540.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:16:09+00:00	2018-10-22 03:16:09+00:00 	oaia3c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
74	Medication/supplement use	86977	phv00086977.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:16:17+00:00	2018-10-22 03:16:17+00:00 	oaia4c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
74	Medication/supplement use	87355	phv00087355.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:16:23+00:00	2018-10-22 03:16:23+00:00 	oaiafc	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
74	Medication/supplement use	175381	phv00175381.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:16:31+00:00	2018-10-22 03:16:31+00:00 	oaia5c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
74	Medication/supplement use	175959	phv00175959.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:16:38+00:00	2018-10-22 03:16:38+00:00 	oaiafc	FAMILY COHORT: ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
74	Medication/supplement use	176804	phv00176804.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:16:46+00:00	2018-10-22 03:16:46+00:00 	oaia5c	ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE
74	Medication/supplement use	83135	phv00083135.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:17:33+00:00	2018-10-22 03:17:33+00:00 	ohga1c	ORAL HYPOGLYCEMIC AGENTS-NOW CONTRUCTED FROM:
74	Medication/supplement use	85380	phv00085380.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:17:40+00:00	2018-10-22 03:17:40+00:00 	ohga1c	ORAL HYPOGLYCEMIC AGENTS-NOW CONSTRUCTED FROM:
74	Medication/supplement use	86011	phv00086011.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:17:49+00:00	2018-10-22 03:17:49+00:00 	ohga2c	ORAL HYPOGLYCEMIC AGENTS-NOW CONTRUCTED FROM:
74	Medication/supplement use	86493	phv00086493.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:17:56+00:00	2018-10-22 03:17:56+00:00 	ohga3c	ORAL HYPOGLYCEMIC AGENTS
74	Medication/supplement use	86930	phv00086930.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:18:04+00:00	2018-10-22 03:18:04+00:00 	ohga4c	ORAL HYPOGLYCEMIC AGENTS
74	Medication/supplement use	87103	phv00087103.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:18:10+00:00	2018-10-22 03:18:10+00:00 	ohgafc	ORAL HYPOGLYCEMIC AGENTS
74	Medication/supplement use	175382	phv00175382.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:18:16+00:00	2018-10-22 03:18:16+00:00 	ohga5c	ORAL HYPOGLYCEMIC AGENTS
74	Medication/supplement use	176805	phv00176805.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:18:23+00:00	2018-10-22 03:18:23+00:00 	ohga5c	ORAL HYPOGLYCEMIC AGENTS
74	Medication/supplement use	83136	phv00083136.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:19:06+00:00	2018-10-22 03:19:06+00:00 	ostrd1c	ORAL STEROIDS
74	Medication/supplement use	85381	phv00085381.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:19:13+00:00	2018-10-22 03:19:13+00:00 	ostrd1c	ORAL STEROIDS
74	Medication/supplement use	86059	phv00086059.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:19:20+00:00	2018-10-22 03:19:20+00:00 	ostrd2c	ORAL STEROIDS
74	Medication/supplement use	86541	phv00086541.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:19:26+00:00	2018-10-22 03:19:26+00:00 	ostrd3c	ORAL STEROIDS
74	Medication/supplement use	86978	phv00086978.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:19:32+00:00	2018-10-22 03:19:32+00:00 	ostrd4c	ORAL STEROIDS
74	Medication/supplement use	87356	phv00087356.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:19:38+00:00	2018-10-22 03:19:38+00:00 	ostrdfc	ORAL STEROIDS
74	Medication/supplement use	175383	phv00175383.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:19:45+00:00	2018-10-22 03:19:45+00:00 	ostrd5c	ORAL STEROIDS
74	Medication/supplement use	176806	phv00176806.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:19:52+00:00	2018-10-22 03:19:52+00:00 	ostrd5c	ORAL STEROIDS
74	Medication/supplement use	83138	phv00083138.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:20:51+00:00	2018-10-22 03:20:51+00:00 	pdei1c	PHOSPHODIESTERASE INHIBITORS
74	Medication/supplement use	85383	phv00085383.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:20:58+00:00	2018-10-22 03:20:58+00:00 	pdei1c	PHOSPHODIESTERASE INHIBITORS
74	Medication/supplement use	86061	phv00086061.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:21:05+00:00	2018-10-22 03:21:05+00:00 	pdei2c	PHOSPHODIESTERASE INHIBITORS
74	Medication/supplement use	86543	phv00086543.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:21:18+00:00	2018-10-22 03:21:18+00:00 	pdei3c	PHOSPHODIESTERASE INHIBITORS
74	Medication/supplement use	86980	phv00086980.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:21:25+00:00	2018-10-22 03:21:25+00:00 	pdei4c	PHOSPHODIESTERASE INHIBITORS
74	Medication/supplement use	87358	phv00087358.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:21:32+00:00	2018-10-22 03:21:32+00:00 	pdeifc	PHOSPHODIESTERASE INHIBITORS
74	Medication/supplement use	175385	phv00175385.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:21:38+00:00	2018-10-22 03:21:38+00:00 	pdei5c	PHOSPHODIESTERASE INHIBITORS
74	Medication/supplement use	176808	phv00176808.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:21:45+00:00	2018-10-22 03:21:45+00:00 	pdei5c	PHOSPHODIESTERASE INHIBITORS
74	Medication/supplement use	83139	phv00083139.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:22:32+00:00	2018-10-22 03:22:32+00:00 	ppi1c	PROTON PUMP INHIBITORS
74	Medication/supplement use	85384	phv00085384.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:22:39+00:00	2018-10-22 03:22:39+00:00 	ppi1c	PROTON PUMP INHIBITORS
74	Medication/supplement use	86062	phv00086062.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:22:47+00:00	2018-10-22 03:22:47+00:00 	ppi2c	PROTON PUMP INHIBITORS
74	Medication/supplement use	86544	phv00086544.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:22:54+00:00	2018-10-22 03:22:54+00:00 	ppi3c	PROTON PUMP INHIBITORS
74	Medication/supplement use	86981	phv00086981.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:23:01+00:00	2018-10-22 03:23:01+00:00 	ppi4c	PROTON PUMP INHIBITORS
74	Medication/supplement use	87359	phv00087359.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:23:08+00:00	2018-10-22 03:23:08+00:00 	ppifc	PROTON PUMP INHIBITORS
74	Medication/supplement use	175386	phv00175386.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:23:23+00:00	2018-10-22 03:23:23+00:00 	ppi5c	PROTON PUMP INHIBITORS
74	Medication/supplement use	176809	phv00176809.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:23:30+00:00	2018-10-22 03:23:30+00:00 	ppi5c	PROTON PUMP INHIBITORS
74	Medication/supplement use	83140	phv00083140.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:24:25+00:00	2018-10-22 03:24:25+00:00 	prgstn1c	PROGESTINS
74	Medication/supplement use	85385	phv00085385.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:24:34+00:00	2018-10-22 03:24:34+00:00 	prgstn1c	PROGESTINS
74	Medication/supplement use	86063	phv00086063.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:24:40+00:00	2018-10-22 03:24:40+00:00 	prgstn2c	PROGESTINS
74	Medication/supplement use	86545	phv00086545.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:24:47+00:00	2018-10-22 03:24:47+00:00 	prgstn3c	PROGESTINS
74	Medication/supplement use	86982	phv00086982.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:24:54+00:00	2018-10-22 03:24:54+00:00 	prgstn4c	PROGESTINS
74	Medication/supplement use	87360	phv00087360.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:25:00+00:00	2018-10-22 03:25:00+00:00 	prgstnfc	PROGESTINS
74	Medication/supplement use	175387	phv00175387.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:25:07+00:00	2018-10-22 03:25:07+00:00 	prgstn5c	PROGESTINS
74	Medication/supplement use	176810	phv00176810.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:25:14+00:00	2018-10-22 03:25:14+00:00 	prgstn5c	PROGESTINS
74	Medication/supplement use	83141	phv00083141.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:37:43+00:00	2018-10-22 03:37:43+00:00 	prknsn1c	DRUGS USED TO TREAT PARKINSON'S
74	Medication/supplement use	86064	phv00086064.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:38:12+00:00	2018-10-22 03:38:12+00:00 	prknsn2c	DRUGS USED TO TREAT PARKINSON'S
74	Medication/supplement use	86546	phv00086546.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:38:44+00:00	2018-10-22 03:38:44+00:00 	prknsn3c	DRUGS USED TO TREAT PARKINSON'S
74	Medication/supplement use	86983	phv00086983.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:39:19+00:00	2018-10-22 03:39:19+00:00 	prknsn4c	DRUGS USED TO TREAT PARKINSON'S
74	Medication/supplement use	85386	phv00085386.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:39:44+00:00	2018-10-22 03:39:44+00:00 	prknsn1c	DRUGS USED TO TREAT PARKINSON'S
74	Medication/supplement use	87361	phv00087361.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:40:01+00:00	2018-10-22 03:40:01+00:00 	prknsnfc	DRUGS USED TO TREAT PARKINSON'S
74	Medication/supplement use	175388	phv00175388.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:40:15+00:00	2018-10-22 03:40:15+00:00 	prknsn5c	DRUGS USED TO TREAT PARKINSON'S
74	Medication/supplement use	176811	phv00176811.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:40:27+00:00	2018-10-22 03:40:27+00:00 	prknsn5c	DRUGS USED TO TREAT PARKINSON'S
74	Medication/supplement use	83142	phv00083142.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:41:21+00:00	2018-10-22 03:41:21+00:00 	prmrn1c	PREMARIN (CONJUGATED ESTROGENS)
74	Medication/supplement use	85387	phv00085387.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:41:30+00:00	2018-10-22 03:41:30+00:00 	prmrn1c	PREMARIN (CONJUGATED ESTROGENS)
74	Medication/supplement use	86065	phv00086065.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:41:43+00:00	2018-10-22 03:41:43+00:00 	prmrn2c	PREMARIN (CONJUGATED ESTROGENS)
74	Medication/supplement use	86547	phv00086547.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:41:50+00:00	2018-10-22 03:41:50+00:00 	prmrn3c	PREMARIN (CONJUGATED ESTROGENS)
74	Medication/supplement use	86984	phv00086984.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:41:57+00:00	2018-10-22 03:41:57+00:00 	prmrn4c	PREMARIN (CONJUGATED ESTROGENS)
74	Medication/supplement use	87362	phv00087362.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:42:04+00:00	2018-10-22 03:42:04+00:00 	prmrnfc	PREMARIN (CONJUGATED ESTROGENS)
74	Medication/supplement use	175389	phv00175389.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:42:28+00:00	2018-10-22 03:42:28+00:00 	prmrn5c	PREMARIN (CONJUGATED ESTROGENS)
74	Medication/supplement use	176812	phv00176812.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:42:34+00:00	2018-10-22 03:42:34+00:00 	prmrn5c	PREMARIN (CONJUGATED ESTROGENS)
74	Medication/supplement use	83143	phv00083143.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:43:42+00:00	2018-10-22 03:43:42+00:00 	prob1c	PROBUCOL
74	Medication/supplement use	85388	phv00085388.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:43:53+00:00	2018-10-22 03:43:53+00:00 	prob1c	PROBUCOL
74	Medication/supplement use	86066	phv00086066.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:44:00+00:00	2018-10-22 03:44:00+00:00 	prob2c	PROBUCOL
74	Medication/supplement use	86548	phv00086548.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:44:17+00:00	2018-10-22 03:44:17+00:00 	prob3c	PROBUCOL
74	Medication/supplement use	86985	phv00086985.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:44:24+00:00	2018-10-22 03:44:24+00:00 	prob4c	PROBUCOL
74	Medication/supplement use	87363	phv00087363.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:44:31+00:00	2018-10-22 03:44:31+00:00 	probfc	PROBUCOL
74	Medication/supplement use	175390	phv00175390.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:44:38+00:00	2018-10-22 03:44:38+00:00 	prob5c	PROBUCOL
74	Medication/supplement use	176813	phv00176813.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:44:44+00:00	2018-10-22 03:44:44+00:00 	prob5c	PROBUCOL
74	Medication/supplement use	83144	phv00083144.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:49:57+00:00	2018-10-22 03:49:57+00:00 	pvdl1c	PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE
74	Medication/supplement use	85389	phv00085389.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:50:18+00:00	2018-10-22 03:50:18+00:00 	pvdl1c	PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE
74	Medication/supplement use	86067	phv00086067.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:50:25+00:00	2018-10-22 03:50:25+00:00 	pvdl2c	PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE
74	Medication/supplement use	86549	phv00086549.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:52:33+00:00	2018-10-22 03:52:33+00:00 	pvdl3c	PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE
74	Medication/supplement use	86986	phv00086986.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:52:44+00:00	2018-10-22 03:52:44+00:00 	pvdl4c	PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE
74	Medication/supplement use	87364	phv00087364.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:52:52+00:00	2018-10-22 03:52:52+00:00 	pvdlfc	PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE
74	Medication/supplement use	175391	phv00175391.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:52:58+00:00	2018-10-22 03:52:58+00:00 	pvdl5c	PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE
74	Medication/supplement use	176814	phv00176814.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:53:05+00:00	2018-10-22 03:53:05+00:00 	pvdl5c	PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE
74	Medication/supplement use	191180	phv00191180.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:53:36+00:00	2018-10-22 03:53:36+00:00 	sari1c	SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR
74	Medication/supplement use	195572	phv00195572.v1.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:53:45+00:00	2018-10-22 03:53:45+00:00 	sari2c	SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR
74	Medication/supplement use	191188	phv00191188.v1.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:53:51+00:00	2018-10-22 03:53:51+00:00 	sari3c	SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR
74	Medication/supplement use	191195	phv00191195.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:53:58+00:00	2018-10-22 03:53:58+00:00 	sari4c	SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR
74	Medication/supplement use	191200	phv00191200.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:54:05+00:00	2018-10-22 03:54:05+00:00 	sari5c	SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR
74	Medication/supplement use	191698	phv00191698.v2.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:54:11+00:00	2018-10-22 03:54:11+00:00 	sari5c	SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR
74	Medication/supplement use	83145	phv00083145.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:55:13+00:00	2018-10-22 03:55:13+00:00 	slf11c	FIRST GENERATION SULFONYLUREAS
74	Medication/supplement use	85390	phv00085390.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:55:19+00:00	2018-10-22 03:55:19+00:00 	slf11c	FIRST GENERATION SULFONYLUREAS
74	Medication/supplement use	86068	phv00086068.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:55:26+00:00	2018-10-22 03:55:26+00:00 	slf12c	FIRST GENERATION SULFONYLUREAS
74	Medication/supplement use	86550	phv00086550.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:55:32+00:00	2018-10-22 03:55:32+00:00 	slf13c	FIRST GENERATION SULFONYLUREAS
74	Medication/supplement use	86987	phv00086987.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:55:39+00:00	2018-10-22 03:55:39+00:00 	slf14c	FIRST GENERATION SULFONYLUREAS
74	Medication/supplement use	87365	phv00087365.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:55:45+00:00	2018-10-22 03:55:45+00:00 	slf1fc	FIRST GENERATION SULFONYLUREAS
74	Medication/supplement use	175392	phv00175392.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:55:53+00:00	2018-10-22 03:55:53+00:00 	slf15c	FIRST GENERATION SULFONYLUREAS
74	Medication/supplement use	176815	phv00176815.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:56:01+00:00	2018-10-22 03:56:01+00:00 	slf15c	FIRST GENERATION SULFONYLUREAS
74	Medication/supplement use	83146	phv00083146.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:56:43+00:00	2018-10-22 03:56:43+00:00 	slf21c	SECOND GENERATION SURLFONYLUREAS
74	Medication/supplement use	85391	phv00085391.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:56:49+00:00	2018-10-22 03:56:49+00:00 	slf21c	SECOND GENERATION SURLFONYLUREAS
74	Medication/supplement use	86069	phv00086069.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:57:01+00:00	2018-10-22 03:57:01+00:00 	slf22c	SECOND GENERATION SURLFONYLUREAS
74	Medication/supplement use	86551	phv00086551.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:57:08+00:00	2018-10-22 03:57:08+00:00 	slf23c	SECOND GENERATION SURLFONYLUREAS
74	Medication/supplement use	86988	phv00086988.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:57:15+00:00	2018-10-22 03:57:15+00:00 	slf24c	SECOND GENERATION SURLFONYLUREAS
74	Medication/supplement use	87366	phv00087366.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:57:23+00:00	2018-10-22 03:57:23+00:00 	slf2fc	SECOND GENERATION SURLFONYLUREAS
74	Medication/supplement use	175393	phv00175393.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:57:29+00:00	2018-10-22 03:57:29+00:00 	slf25c	SECOND GENERATION SURLFONYLUREAS
74	Medication/supplement use	176816	phv00176816.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:57:37+00:00	2018-10-22 03:57:37+00:00 	slf25c	SECOND GENERATION SURLFONYLUREAS
74	Medication/supplement use	191181	phv00191181.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:59:03+00:00	2018-10-22 03:59:03+00:00 	snri1c	SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS
74	Medication/supplement use	191182	phv00191182.v1.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:59:09+00:00	2018-10-22 03:59:09+00:00 	ssri1c	SELECTIVE SEROTONIN REUPTAKE INHIBITORS
74	Medication/supplement use	195573	phv00195573.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:59:16+00:00	2018-10-22 03:59:16+00:00 	snri2c	SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS
74	Medication/supplement use	195574	phv00195574.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:59:24+00:00	2018-10-22 03:59:24+00:00 	ssri2c	SELECTIVE SEROTONIN REUPTAKE INHIBITORS
74	Medication/supplement use	191189	phv00191189.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:59:31+00:00	2018-10-22 03:59:31+00:00 	snri3c	SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS
74	Medication/supplement use	191190	phv00191190.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:59:37+00:00	2018-10-22 03:59:37+00:00 	ssri3c	SELECTIVE SEROTONIN REUPTAKE INHIBITORS
74	Medication/supplement use	191196	phv00191196.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:59:44+00:00	2018-10-22 03:59:44+00:00 	snri4c	SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS
74	Medication/supplement use	191197	phv00191197.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:59:50+00:00	2018-10-22 03:59:50+00:00 	ssri4c	SELECTIVE SEROTONIN REUPTAKE INHIBITORS
74	Medication/supplement use	191201	phv00191201.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 03:59:56+00:00	2018-10-22 03:59:56+00:00 	snri5c	SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS
74	Medication/supplement use	191202	phv00191202.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:00:03+00:00	2018-10-22 04:00:03+00:00 	ssri5c	SELECTIVE SEROTONIN REUPTAKE INHIBITORS
74	Medication/supplement use	191699	phv00191699.v2.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:00:10+00:00	2018-10-22 04:00:10+00:00 	snri5c	SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS
74	Medication/supplement use	191700	phv00191700.v2.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:00:17+00:00	2018-10-22 04:00:17+00:00 	ssri5c	SELECTIVE SEROTONIN REUPTAKE INHIBITORS
74	Medication/supplement use	83147	phv00083147.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:01:12+00:00	2018-10-22 04:01:12+00:00 	sttn1c	HMG COA REDUCTASE INHIBITORS (STATINS)
74	Medication/supplement use	85392	phv00085392.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:01:18+00:00	2018-10-22 04:01:18+00:00 	sttn1c	HMG COA REDUCTASE INHIBITORS (STATINS)
74	Medication/supplement use	86070	phv00086070.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:01:25+00:00	2018-10-22 04:01:25+00:00 	sttn2c	HMG COA REDUCTASE INHIBITORS (STATINS)
74	Medication/supplement use	86552	phv00086552.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:01:31+00:00	2018-10-22 04:01:31+00:00 	sttn3c	HMG COA REDUCTASE INHIBITORS (STATINS)
74	Medication/supplement use	86989	phv00086989.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:01:38+00:00	2018-10-22 04:01:38+00:00 	sttn4c	HMG COA REDUCTASE INHIBITORS (STATINS)
74	Medication/supplement use	87367	phv00087367.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:01:44+00:00	2018-10-22 04:01:44+00:00 	sttnfc	HMG COA REDUCTASE INHIBITORS (STATINS)
74	Medication/supplement use	175394	phv00175394.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:01:50+00:00	2018-10-22 04:01:50+00:00 	sttn5c	HMG COA REDUCATACE INHIBITORS (STATINS)
74	Medication/supplement use	176817	phv00176817.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:01:56+00:00	2018-10-22 04:01:56+00:00 	sttn5c	HMG COA REDUCATACE INHIBITORS (STATINS)
74	Medication/supplement use	83148	phv00083148.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:02:38+00:00	2018-10-22 04:02:38+00:00 	sympth1c	SYMPATHOMIMETICS, ORAL AND INHALED
74	Medication/supplement use	85393	phv00085393.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:02:45+00:00	2018-10-22 04:02:45+00:00 	sympth1c	SYMPATHOMIMETICS, ORAL AND INHALED
74	Medication/supplement use	86071	phv00086071.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:02:51+00:00	2018-10-22 04:02:51+00:00 	sympth2c	SYMPATHOMIMETICS, ORAL AND INHALED
74	Medication/supplement use	86553	phv00086553.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:02:58+00:00	2018-10-22 04:02:58+00:00 	sympth3c	SYMPATHOMIMETICS, ORAL AND INHALED
74	Medication/supplement use	86990	phv00086990.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:03:04+00:00	2018-10-22 04:03:04+00:00 	sympth4c	SYMPATHOMIMETICS, ORAL AND INHALED
74	Medication/supplement use	87368	phv00087368.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:03:11+00:00	2018-10-22 04:03:11+00:00 	sympthfc	SYMPATHOMIMETICS, ORAL AND INHALED
74	Medication/supplement use	175395	phv00175395.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:03:17+00:00	2018-10-22 04:03:17+00:00 	sympth5c	SYMPATHOMIMETICS, ORAL AND INHALED
74	Medication/supplement use	176818	phv00176818.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:03:24+00:00	2018-10-22 04:03:24+00:00 	sympth5c	SYMPATHOMIMETICS, ORAL AND INHALED
74	Medication/supplement use	83149	phv00083149.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:04:40+00:00	2018-10-22 04:04:40+00:00 	tca1c	TRICYCLIC ANTI-DEPRESSANTS
74	Medication/supplement use	83150	phv00083150.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:04:46+00:00	2018-10-22 04:04:46+00:00 	tcap1c	TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS COMBINATIONS
74	Medication/supplement use	85394	phv00085394.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:04:52+00:00	2018-10-22 04:04:52+00:00 	tca1c	TRICYCLIC ANTI-DEPRESSANTS
74	Medication/supplement use	85395	phv00085395.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:05:00+00:00	2018-10-22 04:05:00+00:00 	tcap1c	TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS COMBINATIONS
74	Medication/supplement use	86072	phv00086072.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:05:06+00:00	2018-10-22 04:05:06+00:00 	tca2c	TRICYCLIC ANTI-DEPRESSANTS
74	Medication/supplement use	86073	phv00086073.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:05:12+00:00	2018-10-22 04:05:12+00:00 	tcap2c	TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS COMBINATIONS
74	Medication/supplement use	86554	phv00086554.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:05:19+00:00	2018-10-22 04:05:19+00:00 	tca3c	TRICYCLIC ANTI-DEPRESSANTS
74	Medication/supplement use	86555	phv00086555.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:05:25+00:00	2018-10-22 04:05:25+00:00 	tcap3c	TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS
74	Medication/supplement use	86991	phv00086991.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:05:32+00:00	2018-10-22 04:05:32+00:00 	tca4c	TRICYCLIC ANTI-DEPRESSANTS
74	Medication/supplement use	86992	phv00086992.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:05:38+00:00	2018-10-22 04:05:38+00:00 	tcap4c	TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS
74	Medication/supplement use	87369	phv00087369.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:05:45+00:00	2018-10-22 04:05:45+00:00 	tcafc	TRICYCLIC ANTI-DEPRESSANTS
74	Medication/supplement use	87370	phv00087370.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:05:52+00:00	2018-10-22 04:05:52+00:00 	tcapfc	TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS
74	Medication/supplement use	175396	phv00175396.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:05:59+00:00	2018-10-22 04:05:59+00:00 	tca5c	TRICYCLIC ANTI-DEPRESSANTS
74	Medication/supplement use	175397	phv00175397.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:06:06+00:00	2018-10-22 04:06:06+00:00 	tcap5c	TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS
74	Medication/supplement use	176819	phv00176819.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:06:13+00:00	2018-10-22 04:06:13+00:00 	tca5c	TRICYCLIC ANTI-DEPRESSANTS
74	Medication/supplement use	176820	phv00176820.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:06:20+00:00	2018-10-22 04:06:20+00:00 	tcap5c	TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS
74	Medication/supplement use	83151	phv00083151.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:09:21+00:00	2018-10-22 04:09:21+00:00 	thry1c	THYROID AGENTS
74	Medication/supplement use	85396	phv00085396.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:09:28+00:00	2018-10-22 04:09:28+00:00 	thry1c	THYROID AGENTS
74	Medication/supplement use	86074	phv00086074.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:09:35+00:00	2018-10-22 04:09:35+00:00 	thry2c	THYROID AGENTS
74	Medication/supplement use	86556	phv00086556.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:09:41+00:00	2018-10-22 04:09:41+00:00 	thry3c	THYROID AGENTS
74	Medication/supplement use	86993	phv00086993.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:09:48+00:00	2018-10-22 04:09:48+00:00 	thry4c	THYROID AGENTS
74	Medication/supplement use	87371	phv00087371.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:09:56+00:00	2018-10-22 04:09:56+00:00 	thryfc	THYROID AGENTS
74	Medication/supplement use	175398	phv00175398.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:10:03+00:00	2018-10-22 04:10:03+00:00 	thry5c	THYROID AGENTS
74	Medication/supplement use	176821	phv00176821.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:10:10+00:00	2018-10-22 04:10:10+00:00 	thry5c	THYROID AGENTS
74	Medication/supplement use	176822	phv00176822.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:10:57+00:00	2018-10-22 04:10:57+00:00 	thzd5c	THIAZOLIDINEDIONES
74	Medication/supplement use	175399	phv00175399.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:11:03+00:00	2018-10-22 04:11:03+00:00 	thzd5c	THIAZOLIDINEDIONES
74	Medication/supplement use	87372	phv00087372.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:11:10+00:00	2018-10-22 04:11:10+00:00 	thzdfc	THIAZOLIDINEDIONES
74	Medication/supplement use	86994	phv00086994.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:11:16+00:00	2018-10-22 04:11:16+00:00 	thzd4c	THIAZOLIDINEDIONES
74	Medication/supplement use	86557	phv00086557.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:11:22+00:00	2018-10-22 04:11:22+00:00 	thzd3c	THIAZOLIDINEDIONES
74	Medication/supplement use	86075	phv00086075.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:11:29+00:00	2018-10-22 04:11:29+00:00 	thzd2c	THIAZOLIDINEDIONES
74	Medication/supplement use	85397	phv00085397.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:11:35+00:00	2018-10-22 04:11:35+00:00 	thzd1c	THIAZOLIDINEDIONES
74	Medication/supplement use	83152	phv00083152.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:11:41+00:00	2018-10-22 04:11:41+00:00 	thzd1c	THIAZOLIDINEDIONES
74	Medication/supplement use	111944	phv00111944.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:12:45+00:00	2018-10-22 04:12:45+00:00 	uazqtd1c	UAZ DEFINITE ECG QT INTERVAL-ALTERING MEDICATION
74	Medication/supplement use	111945	phv00111945.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:12:53+00:00	2018-10-22 04:12:53+00:00 	uazqtp1c	UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION
74	Medication/supplement use	111946	phv00111946.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:13:00+00:00	2018-10-22 04:13:00+00:00 	uazqtd2c	UAZ DEFINITE ECG QT INTERVAL-ALTERING MEDICATION
74	Medication/supplement use	111947	phv00111947.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:13:07+00:00	2018-10-22 04:13:07+00:00 	uazqtp2c	UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION
74	Medication/supplement use	111949	phv00111949.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:13:14+00:00	2018-10-22 04:13:14+00:00 	uazqtd3c	UAZ DEFINITE ECG QT INTERVAL-ALTERING MEDICATION
74	Medication/supplement use	111950	phv00111950.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:13:20+00:00	2018-10-22 04:13:20+00:00 	uazqtp3c	UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION
74	Medication/supplement use	111953	phv00111953.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:13:26+00:00	2018-10-22 04:13:26+00:00 	uazqtd4c	UAZ DEFINITE ECG QT INTERVAL-ALTERING MEDICATION
74	Medication/supplement use	111954	phv00111954.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:13:32+00:00	2018-10-22 04:13:32+00:00 	uazqtp4c	UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION
74	Medication/supplement use	175411	phv00175411.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:13:38+00:00	2018-10-22 04:13:38+00:00 	uazqtd5c	UAZ DEFINITE ECG QT INTERVAL-ALTERING MEDICATION
74	Medication/supplement use	175412	phv00175412.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:13:45+00:00	2018-10-22 04:13:45+00:00 	uazqtp5c	UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION
74	Medication/supplement use	176834	phv00176834.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:13:51+00:00	2018-10-22 04:13:51+00:00 	uazqtd5c	UAZ DEFINITE ECG QT INTERVAL-ALTERING MEDICATION
74	Medication/supplement use	176835	phv00176835.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:13:57+00:00	2018-10-22 04:13:57+00:00 	uazqtp5c	UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION
74	Medication/supplement use	83153	phv00083153.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:14:43+00:00	2018-10-22 04:14:43+00:00 	urcos1c	URICOSURICS
74	Medication/supplement use	85398	phv00085398.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:14:49+00:00	2018-10-22 04:14:49+00:00 	urcos1c	URICOSURICS
74	Medication/supplement use	86076	phv00086076.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:14:55+00:00	2018-10-22 04:14:55+00:00 	urcos2c	URICOSURICS
74	Medication/supplement use	86558	phv00086558.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:15:02+00:00	2018-10-22 04:15:02+00:00 	urcos3c	URICOSURICS
74	Medication/supplement use	86995	phv00086995.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:15:09+00:00	2018-10-22 04:15:09+00:00 	urcos4c	URICOSURICS
74	Medication/supplement use	87373	phv00087373.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:15:15+00:00	2018-10-22 04:15:15+00:00 	urcosfc	URICOSURICS
74	Medication/supplement use	175400	phv00175400.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:15:21+00:00	2018-10-22 04:15:21+00:00 	urcos5c	URICOSURICS
74	Medication/supplement use	176823	phv00176823.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:15:27+00:00	2018-10-22 04:15:27+00:00 	urcos5c	URICOSURICS
74	Medication/supplement use	83154	phv00083154.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:18:06+00:00	2018-10-22 04:18:06+00:00 	vaso1c	VASODILATORS, A MIXED GROUP
74	Medication/supplement use	83155	phv00083155.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:18:12+00:00	2018-10-22 04:18:12+00:00 	vasod1c	VASODILATORS WITH DIURETICS, A MIXED GROUP
74	Medication/supplement use	85399	phv00085399.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:18:18+00:00	2018-10-22 04:18:18+00:00 	vaso1c	VASODILATORS, A MIXED GROUP
74	Medication/supplement use	85400	phv00085400.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:18:25+00:00	2018-10-22 04:18:25+00:00 	vasod1c	VASODILATORS WITH DIURETICS, A MIXED GROUP
74	Medication/supplement use	86077	phv00086077.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:18:32+00:00	2018-10-22 04:18:32+00:00 	vaso2c	VASODILATORS, A MIXED GROUP
74	Medication/supplement use	86078	phv00086078.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:18:41+00:00	2018-10-22 04:18:41+00:00 	vasod2c	VASODILATORS WITH DIURETICS, A MIXED GROUP
74	Medication/supplement use	86559	phv00086559.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:18:47+00:00	2018-10-22 04:18:47+00:00 	vaso3c	VASODILATORS, A MIXED GROUP
74	Medication/supplement use	86560	phv00086560.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:18:53+00:00	2018-10-22 04:18:53+00:00 	vasod3c	VASODILATORS WITH DIURETICS, A MIXED GROUP
74	Medication/supplement use	86996	phv00086996.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:18:59+00:00	2018-10-22 04:18:59+00:00 	vaso4c	VASODILATORS, A MIXED GROUP
74	Medication/supplement use	86997	phv00086997.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:19:05+00:00	2018-10-22 04:19:05+00:00 	vasod4c	VASODILATORS WITH DIURETICS, A MIXED GROUP
74	Medication/supplement use	87374	phv00087374.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:19:11+00:00	2018-10-22 04:19:11+00:00 	vasofc	VASODILATORS, A MIXED GROUP
74	Medication/supplement use	87375	phv00087375.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:19:18+00:00	2018-10-22 04:19:18+00:00 	vasodfc	VASODILATORS WITH DIURETICS, A MIXED GROUP
74	Medication/supplement use	175401	phv00175401.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:19:25+00:00	2018-10-22 04:19:25+00:00 	vaso5c	VASODILATORS, A MIXED GROUP
74	Medication/supplement use	175402	phv00175402.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:19:31+00:00	2018-10-22 04:19:31+00:00 	vasod5c	VASODILATORS WITH DIURETICS, A MIXED GROUP
74	Medication/supplement use	176824	phv00176824.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:19:37+00:00	2018-10-22 04:19:37+00:00 	vaso5c	VASODILATORS, A MIXED GROUP
74	Medication/supplement use	176825	phv00176825.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:19:44+00:00	2018-10-22 04:19:44+00:00 	vasod5c	VASODILATORS WITH DIURETICS, A MIXED GROUP
74	Medication/supplement use	83156	phv00083156.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:22:07+00:00	2018-10-22 04:22:07+00:00 	verir1c	IMMEDIATE-RELEASE VERAPAMIL
74	Medication/supplement use	83157	phv00083157.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:22:13+00:00	2018-10-22 04:22:13+00:00 	versr1c	SLOW-RELEASE VERAPAMIL
74	Medication/supplement use	85401	phv00085401.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:22:21+00:00	2018-10-22 04:22:21+00:00 	verir1c	IMMEDIATE-RELEASE VERAPAMIL
74	Medication/supplement use	85402	phv00085402.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:22:28+00:00	2018-10-22 04:22:28+00:00 	versr1c	SLOW-RELEASE VERAPAMIL
74	Medication/supplement use	86079	phv00086079.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:22:35+00:00	2018-10-22 04:22:35+00:00 	verir2c	IMMEDIATE-RELEASE VERAPAMIL
74	Medication/supplement use	86080	phv00086080.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:22:41+00:00	2018-10-22 04:22:41+00:00 	versr2c	SLOW-RELEASE VERAPAMIL
74	Medication/supplement use	86561	phv00086561.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:22:47+00:00	2018-10-22 04:22:47+00:00 	verir3c	IMMEDIATE-RELEASE VERAPAMIL
74	Medication/supplement use	86562	phv00086562.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:22:53+00:00	2018-10-22 04:22:53+00:00 	versr3c	SLOW-RELEASE VERAPAMIL
74	Medication/supplement use	86998	phv00086998.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:23:00+00:00	2018-10-22 04:23:00+00:00 	verir4c	IMMEDIATE-RELEASE VERAPAMIL
74	Medication/supplement use	86999	phv00086999.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:23:08+00:00	2018-10-22 04:23:08+00:00 	versr4c	SLOW-RELEASE VERAPAMIL
74	Medication/supplement use	87376	phv00087376.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:23:14+00:00	2018-10-22 04:23:14+00:00 	verirfc	IMMEDIATE-RELEASE VERAPAMIL
74	Medication/supplement use	87377	phv00087377.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:23:20+00:00	2018-10-22 04:23:20+00:00 	versrfc	SLOW-RELEASE VERAPAMIL
74	Medication/supplement use	175403	phv00175403.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:23:27+00:00	2018-10-22 04:23:27+00:00 	verir5c	IMMEDIATE-RELEASE VERAPAMIL
74	Medication/supplement use	175404	phv00175404.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:23:33+00:00	2018-10-22 04:23:33+00:00 	versr5c	SLOW-RELEASE VERAPAMIL
74	Medication/supplement use	176826	phv00176826.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:23:39+00:00	2018-10-22 04:23:39+00:00 	verir5c	IMMEDIATE-RELEASE VERAPAMIL
74	Medication/supplement use	176827	phv00176827.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:23:46+00:00	2018-10-22 04:23:46+00:00 	versr5c	SLOW-RELEASE VERAPAMIL
74	Medication/supplement use	83158	phv00083158.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:24:43+00:00	2018-10-22 04:24:43+00:00 	warf1c	ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE
74	Medication/supplement use	85403	phv00085403.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:24:49+00:00	2018-10-22 04:24:49+00:00 	warf1c	ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE
74	Medication/supplement use	86081	phv00086081.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:24:55+00:00	2018-10-22 04:24:55+00:00 	warf2c	ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE
74	Medication/supplement use	86563	phv00086563.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:25:03+00:00	2018-10-22 04:25:03+00:00 	warf3c	ORAL ANTICOAGULANTS
74	Medication/supplement use	87000	phv00087000.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:25:09+00:00	2018-10-22 04:25:09+00:00 	warf4c	ORAL ANTICOAGULANTS
74	Medication/supplement use	87378	phv00087378.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:25:16+00:00	2018-10-22 04:25:16+00:00 	warffc	ORAL ANTICOAGULANTS
74	Medication/supplement use	175405	phv00175405.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:25:22+00:00	2018-10-22 04:25:22+00:00 	warf5c	ORAL ANTICOAGULANTS
74	Medication/supplement use	176004	phv00176004.v1.p3	pht003090.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:25:29+00:00	2018-10-22 04:25:29+00:00 	warf1c	ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE
74	Medication/supplement use	176828	phv00176828.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:25:35+00:00	2018-10-22 04:25:35+00:00 	warf5c	ORAL ANTICOAGULANTS
74	Medication/supplement use	83159	phv00083159.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:26:17+00:00	2018-10-22 04:26:17+00:00 	wtls1c	WEIGHT LOSS DRUGS
74	Medication/supplement use	85404	phv00085404.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:26:24+00:00	2018-10-22 04:26:24+00:00 	wtls1c	WEIGHT LOSS DRUGS
74	Medication/supplement use	86082	phv00086082.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:26:35+00:00	2018-10-22 04:26:35+00:00 	wtls2c	WEIGHT LOSS DRUGS
74	Medication/supplement use	86564	phv00086564.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:26:42+00:00	2018-10-22 04:26:42+00:00 	wtls3c	WEIGHT LOSS DRUGS
74	Medication/supplement use	87001	phv00087001.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:26:50+00:00	2018-10-22 04:26:50+00:00 	wtls4c	WEIGHT LOSS DRUGS
74	Medication/supplement use	87379	phv00087379.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:26:59+00:00	2018-10-22 04:26:59+00:00 	wtlsfc	WEIGHT LOSS DRUGS
74	Medication/supplement use	175406	phv00175406.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:27:04+00:00	2018-10-22 04:27:04+00:00 	wtls5c	WEIGHT LOSS DRUGS
74	Medication/supplement use	176829	phv00176829.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:27:15+00:00	2018-10-22 04:27:15+00:00 	wtls5c	WEIGHT LOSS DRUGS
74	Medication/supplement use	83160	phv00083160.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:27:53+00:00	2018-10-22 04:27:53+00:00 	xoi1c	XANTHINE OXIDASE INHIBITORS
74	Medication/supplement use	85405	phv00085405.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:27:59+00:00	2018-10-22 04:27:59+00:00 	xoi1c	XANTHINE OXIDASE INHIBITORS
74	Medication/supplement use	86083	phv00086083.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:28:06+00:00	2018-10-22 04:28:06+00:00 	xoi2c	XANTHINE OXIDASE INHIBITORS
74	Medication/supplement use	86565	phv00086565.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:28:13+00:00	2018-10-22 04:28:13+00:00 	xoi3c	XANTHINE OXIDASE INHIBITORS
74	Medication/supplement use	87002	phv00087002.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:28:20+00:00	2018-10-22 04:28:20+00:00 	xoi4c	XANTHINE OXIDASE INHIBITORS
74	Medication/supplement use	87380	phv00087380.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:28:26+00:00	2018-10-22 04:28:26+00:00 	xoifc	XANTHINE OXIDASE INHIBITORS
74	Medication/supplement use	175407	phv00175407.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:28:33+00:00	2018-10-22 04:28:33+00:00 	xoi5c	XANTHINE OXIDASE INHIBITORS
74	Medication/supplement use	176830	phv00176830.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:28:39+00:00	2018-10-22 04:28:39+00:00 	xoi5c	XANTHINE OXIDASE INHIBITORS
74	Medication/supplement use	83161	phv00083161.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:29:17+00:00	2018-10-22 04:29:17+00:00 	diur1c	ANY DIURETIC
74	Medication/supplement use	85406	phv00085406.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:29:25+00:00	2018-10-22 04:29:25+00:00 	diur1c	ANY DIURETIC
74	Medication/supplement use	86012	phv00086012.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:29:32+00:00	2018-10-22 04:29:32+00:00 	diur2c	ANY DIURETIC
74	Medication/supplement use	86494	phv00086494.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:29:38+00:00	2018-10-22 04:29:38+00:00 	diur3c	ANY DIURETIC
74	Medication/supplement use	86931	phv00086931.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:29:46+00:00	2018-10-22 04:29:46+00:00 	diur4c	ANY DIURETIC
74	Medication/supplement use	87381	phv00087381.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:29:53+00:00	2018-10-22 04:29:53+00:00 	diurfc	ANY DIURETIC
74	Medication/supplement use	175408	phv00175408.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:30:01+00:00	2018-10-22 04:30:01+00:00 	diur5c	ANY DIURETIC
74	Medication/supplement use	176831	phv00176831.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:30:08+00:00	2018-10-22 04:30:08+00:00 	diur5c	ANY DIURETIC
74	Medication/supplement use	83162	phv00083162.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:31:31+00:00	2018-10-22 04:31:31+00:00 	lipid1c	ANY LIPID-LOWERING MEDICATION
74	Medication/supplement use	85407	phv00085407.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:31:38+00:00	2018-10-22 04:31:38+00:00 	lipid1c	ANY LIPID-LOWERING MEDICATION
74	Medication/supplement use	86013	phv00086013.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:31:45+00:00	2018-10-22 04:31:45+00:00 	lipid2c	ANY LIPID-LOWERING MEDICATION
74	Medication/supplement use	86495	phv00086495.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:31:52+00:00	2018-10-22 04:31:52+00:00 	lipid3c	ANY LIPID-LOWERING MEDICATION
74	Medication/supplement use	86932	phv00086932.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:31:59+00:00	2018-10-22 04:31:59+00:00 	lipid4c	ANY LIPID-LOWERING MEDICATION
74	Medication/supplement use	87104	phv00087104.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:32:06+00:00	2018-10-22 04:32:06+00:00 	lipidfc	ANY LIPID-LOWERING MEDICATION
74	Medication/supplement use	175409	phv00175409.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:32:15+00:00	2018-10-22 04:32:15+00:00 	lipid5c	ANY LIPID-LOWERING MEDICATION
74	Medication/supplement use	175868	phv00175868.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:32:22+00:00	2018-10-22 04:32:22+00:00 	lipid1c	ANY LIPID-LOWERING MEDICATION
74	Medication/supplement use	175952	phv00175952.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:32:28+00:00	2018-10-22 04:32:28+00:00 	lipidfc	FAMILY COHORT: ANY LIPID-LOWERING MEDICATION
74	Medication/supplement use	176832	phv00176832.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:32:38+00:00	2018-10-22 04:32:38+00:00 	lipid5c	ANY LIPID-LOWERING MEDICATION
74	Medication/supplement use	83163	phv00083163.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:33:25+00:00	2018-10-22 04:33:25+00:00 	htnmed1c	HYPERTENSION MEDICATION
74	Medication/supplement use	85324	phv00085324.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:33:46+00:00	2018-10-22 04:33:46+00:00 	htnmed1c	HYPERTENSION MEDICATION
74	Medication/supplement use	86014	phv00086014.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:33:52+00:00	2018-10-22 04:33:52+00:00 	htnmed2c	HYPERTENSION MEDICATION
74	Medication/supplement use	86496	phv00086496.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:33:58+00:00	2018-10-22 04:33:58+00:00 	htnmed3c	ANY HYPERTENSION MEDICATION
74	Medication/supplement use	86933	phv00086933.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:34:05+00:00	2018-10-22 04:34:05+00:00 	htnmed4c	ANY HYPERTENSION MEDICATION
74	Medication/supplement use	87093	phv00087093.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:34:12+00:00	2018-10-22 04:34:12+00:00 	htnmedfc	ANY HYPERTENSION MEDICATION
74	Medication/supplement use	175410	phv00175410.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:34:19+00:00	2018-10-22 04:34:19+00:00 	htnmed5c	ANY HYPERTENSION MEDICATION
74	Medication/supplement use	175864	phv00175864.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:34:25+00:00	2018-10-22 04:34:25+00:00 	htnmed1c	HYPERTENSION MEDICATION
74	Medication/supplement use	175949	phv00175949.v1.p3	pht003087.v1.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:34:31+00:00	2018-10-22 04:34:31+00:00 	htnmedfc	FAMILY COHORT: ANY HYPERTENSION MEDICATION
74	Medication/supplement use	176833	phv00176833.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:34:37+00:00	2018-10-22 04:34:37+00:00 	htnmed5c	ANY HYPERTENSION MEDICATION
74	Medication/supplement use	83302	phv00083302.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:39:28+00:00	2018-10-22 04:39:28+00:00 	diabins1	INSULIN OR ORAL HYPOGLYCEMICS FOR DIABETES?
74	Medication/supplement use	84979	phv00084979.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:39:37+00:00	2018-10-22 04:39:37+00:00 	diabins1	INSULIN OR ORAL HYPOGLYCEMICS FOR DIABETES?
74	Medication/supplement use	85926	phv00085926.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:39:45+00:00	2018-10-22 04:39:45+00:00 	diabins2	INSULIN OR ORAL HYPOGLYCEMICS FOR DIABETES?
74	Medication/supplement use	86409	phv00086409.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:39:51+00:00	2018-10-22 04:39:51+00:00 	diabins3	INSULIN OR ORAL HYPOGLYCEMICS FOR DIABETES?
74	Medication/supplement use	175455	phv00175455.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:39:59+00:00	2018-10-22 04:39:59+00:00 	diabins5	INSULIN OR HYPOGLYCEMICS FOR DIABETES
74	Medication/supplement use	176889	phv00176889.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:40:07+00:00	2018-10-22 04:40:07+00:00 	diabins5	INSULIN OR HYPOGLYCEMICS FOR DIABETES
74	Medication/supplement use	83067	phv00083067.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:47:11+00:00	2018-10-22 04:47:11+00:00 	aspirin1	ASPIRIN: EVER USED ON REGULAR BASIS
74	Medication/supplement use	83068	phv00083068.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:47:18+00:00	2018-10-22 04:47:18+00:00 	aspsage1	ASPIRIN: AGE STARTED REGULAR USE
74	Medication/supplement use	83069	phv00083069.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:47:28+00:00	2018-10-22 04:47:28+00:00 	aspnow1	ASPIRIN: CURRENTLY USING REGULARLY
74	Medication/supplement use	83070	phv00083070.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:47:36+00:00	2018-10-22 04:47:36+00:00 	aspdays1	ASPIRIN: DAYS PER WEEK
74	Medication/supplement use	83071	phv00083071.v1.p3	pht001111.v4.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:47:43+00:00	2018-10-22 04:47:43+00:00 	aspeage1	ASPIRIN: AGE STOPPED USING REGULARLY
74	Medication/supplement use	85304	phv00085304.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:48:29+00:00	2018-10-22 04:48:29+00:00 	aspirin1	ASPIRIN: EVER USED ON REGULAR BASIS
74	Medication/supplement use	85305	phv00085305.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:48:36+00:00	2018-10-22 04:48:36+00:00 	aspsage1	ASPIRIN: AGE STARTED REGULAR USE
74	Medication/supplement use	85306	phv00085306.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:48:42+00:00	2018-10-22 04:48:42+00:00 	aspnow1	ASPIRIN: CURRENTLY USING REGULARLY
74	Medication/supplement use	85307	phv00085307.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:48:50+00:00	2018-10-22 04:48:50+00:00 	aspdays1	ASPIRIN: DAYS PER WEEK
74	Medication/supplement use	85308	phv00085308.v2.p3	pht001116.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:48:56+00:00	2018-10-22 04:48:56+00:00 	aspeage1	ASPIRIN: AGE STOPPED USING REGULARLY
74	Medication/supplement use	85955	phv00085955.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:49:06+00:00	2018-10-22 04:49:06+00:00 	aspirin2	TAKING ASPIRIN ON REGULAR BASIS
74	Medication/supplement use	85956	phv00085956.v2.p3	pht001118.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:49:12+00:00	2018-10-22 04:49:12+00:00 	aspdays2	DAYS PER WEEK TAKING ASPIRIN
74	Medication/supplement use	86437	phv00086437.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:49:21+00:00	2018-10-22 04:49:21+00:00 	aspirin3	TAKING ASPIRIN ON REGULAR BASIS
74	Medication/supplement use	86438	phv00086438.v2.p3	pht001119.v8.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:49:29+00:00	2018-10-22 04:49:29+00:00 	aspdays3	DAYS PER WEEK TAKING ASPIRIN
74	Medication/supplement use	86881	phv00086881.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:49:38+00:00	2018-10-22 04:49:38+00:00 	aspirin4	TAKING ASPIRIN ON REGULAR BASIS
74	Medication/supplement use	86882	phv00086882.v2.p3	pht001120.v10.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:49:45+00:00	2018-10-22 04:49:45+00:00 	aspdays4	DAYS PER WEEK TAKING ASPIRIN
74	Medication/supplement use	87220	phv00087220.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:49:55+00:00	2018-10-22 04:49:55+00:00 	aspirinf	ASPIRIN USAGE ON REGULAR BASIS EVER
74	Medication/supplement use	87221	phv00087221.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:50:03+00:00	2018-10-22 04:50:03+00:00 	aspsagef	AGE STARTED REGULAR ASPIRIN USAGE
74	Medication/supplement use	87222	phv00087222.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:50:09+00:00	2018-10-22 04:50:09+00:00 	aspnowf	CURRENT REGULAR ASPIRIN USER
74	Medication/supplement use	87223	phv00087223.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:50:15+00:00	2018-10-22 04:50:15+00:00 	aspdaysf	CURRENT REGULAR ASPIRIN USER: NUMBER OF DAYS PER WEEK OF USAGE
74	Medication/supplement use	87224	phv00087224.v1.p3	pht001121.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:50:21+00:00	2018-10-22 04:50:21+00:00 	aspeagef	NO LONGER CURRENT REGULAR ASPIRIN USER: AGE STOPPED
74	Medication/supplement use	175271	phv00175271.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:50:28+00:00	2018-10-22 04:50:28+00:00 	aspirin5	TAKING ASPIRIN ON REGULAR BASIS
74	Medication/supplement use	175272	phv00175272.v1.p3	pht003086.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:50:35+00:00	2018-10-22 04:50:35+00:00 	aspdays5	DAYS PER WEEK TAKING ASPIRIN
74	Medication/supplement use	176694	phv00176694.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:50:42+00:00	2018-10-22 04:50:42+00:00 	aspirin5	TAKING ASPIRIN ON REGULAR BASIS
74	Medication/supplement use	176695	phv00176695.v1.p3	pht003091.v3.p3	phs000209.v13.p3	Multi-Ethnic Study of Atherosclerosis (MESA)	209	13	2018-10-22 04:50:49+00:00	2018-10-22 04:50:49+00:00 	aspdays5	DAYS PER WEEK TAKING ASPIRIN
74	Medication/supplement use	207837	phv00207837.v1.p1	pht004129.v1.p1	phs000280.v3.p1	Atherosclerosis Risk in Communities (ARIC)	280	3	2018-11-20 20:14:24+00:00	2018-11-20 20:14:24+00:00	MSRAFLAG	MSRAFLAG [Medication Survey Form, exam 1]